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and anxiety 
Molecular techniques 
and advances in brain imaging 
suggest new treatments 
for mental illness 
AYAM Outreach Program 
To better communicate with our alumni/ae, the AYAM is pleased to announce 
The Outreach Program, an effort to enhance and expand direct contact with our members. 
REUNION WEEKEND 
Save the date: June 6 and 7 for the 1997 
Alumni Reunion Weekend. Yale 
University President Richard C. Levin. Ph.D., 
will address alumni/ae at the Saturday annual 
meeting. Albert B. Deisseroth, M.D., Ph.D., chief 
of medical oncology, will make a presentation on 
new gene-therapy initiatives in cancer treatment. 
NEW DIRECTORY 
Soon, locating fellow alumni/ae will be easier 
with an updated Yale School of Medicine 
Alumni Directory, last published in 1992. 
Harris Publishing will be phoning to verify 
individual listings during eight weeks 
beginning December 9. 
REGIONAL EVENTS 
On the heels of alumni/ae receptions in New 
Haven, Boston, and San Francisco, the School 
of Medicine will be hosting events in San Diego 
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in early February, Washington, D.C., in March and 
Westchester, N.Y., in May. Details to follow in the mail. 
MINI REUNIONS 
Members of the Class of 1945 will convene for 
an informal reunion in April in Florida. If you and 
classmates are planning a similar event, please call 
the Office of Alumni Affairs at 203.785.4674. 
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2 Brain chemistry 
Remarkably close communi¬ 
cation at Yale between basic 
scientists and the psychia¬ 
trists who treat patients for 
mental illness has produced 
a better understanding of 
depression and provides the 
basis for a new generation of 
treatments. 
Cutting-edge imaging (p5) 
Depression and new mothers (p8) 
When fear is an illness 
“Extreme stress,” says a Yale 
researcher in psychiatry, "may be toxic 
to certain parts of the brain.” Studies 
here promise to unlock the secrets of 
anxiety and panic disorders, with the 
goal of one day providing treatments 
that distinguish between reasonable 
and unreasonable fear. 
Interview: 
Carolyn Slayman 
A distinguished 
researcher and leader in 
genetics, Carolyn W. 
Slayman. Ph.D.. is the 
school’s first deputy dean 
for academic and scien¬ 
tific affairs. On her mind: technology 
transfer, new structures for supporting 
faculty and research, and a streamlined 
process for recruiting and teaching 
graduate students. 
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18 Pure medicine 
Who are the physicians who care for 
the people in that netherworld between 
private health insurance and govern¬ 
ment-sponsored coverage for the poor? 
Meet Richard and Patricia Gibbs, two 
Yale medical alumni/ae who founded 
the San Francisco Free Clinic. 
On the cover: New imaging techniques are 
helping to explain the biochemical basis of 
depression, anxiety and other brain disorders. 
The SPECT brain images on the cover are 
from a new Yale study that indicates patients 
with panic disorder may have a significantly 
reduced number of benzodiazepine receptors. 
The bottom image highlights areas of the brain 
with abnormally low numbers of these Valium- 
binding receptors, averaged from a group of 15 
patients with panic disorder as compared 
to an equal number of healthy subjects. 
Cover Illustration by Peter Casolino/design by Jack* Design 
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PSYCHIATRY 
Crosstalk between clinicians and basic scientists 
at Yale is producing a new understanding of the 
brain and novel treatments 
—providing hope for the 30 percent of 
depressed patients unresponsive to existing 
medications. 
More than one trillion neurons make up 
the brain, its structures and pathways. 
Three decades of intensive, basic scien¬ 
tific research at Yale have produced 
evidence to decipher the mysteries of 
the brain, providing the basis for ratio¬ 
nal treatments for mental disorders, 
including anxiety and depression. 
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Braih 
chemistry 
By Marc Wortman 
Photographs by Frank Poole 
It was a year ago that Susan S., a patient at the Con¬ 
necticut Mental Health Center (CMHC) in New 
Haven, had fallen once again into a major depres¬ 
sion. She was tired and hopeless, exhausted by a 
long battle with depressive illness that had been 
severe enough to keep her from working during the 
past five years. 
Yale faculty on the staff of CMHC, the region’s 
principal public mental health facility, had used all 
the tools in their repertoire and were still unable to lift 
the leaden shroud blanketing the life of this 56-year- 
old woman. 
Her physician, Robert T. Malison, M.D. ’87, HS 
’87-91, worried about her prognosis. “When the aver¬ 
age person feels depressed, he can soon push through 
it,” says Dr. Malison, an assistant professor of psychia¬ 
try who heads the CMHC Depression Research Clinic. 
“But a person with a major depression can’t pull him- 
Marc Wortman is a free-lance writer in New Haven. 
self up by the bootstraps. It’s a much more severe, 
unrelenting syndrome.” 
As many as one quarter of all women and 12 per¬ 
cent of men will face at least one bout of major depres¬ 
sion in a lifetime. Of more than 15 million Americans 
affected by major depression each year, about two- 
thirds will respond to treatment with antidepressant 
medication. Those who do not may face a lifelong, dis¬ 
abling disease, and one out of 10 people suffering from 
long-term, major depression will commit suicide. In 
1990, the economic costs of depression were estimated 
to be $30 billion annually. 
For Susan S., being under the care of Yale psychia¬ 
trists meant that the most advanced neuroscience 
research in the world could be applied to her case. 
Yale’s psychiatry department is uniquely positioned to 
make new discoveries in the neurobiology of major 
psychiatric disorders, including depression. With a vari¬ 
ety of specialized clinical centers (at Yale Psychiatric 
Institute, the VA Connecticut Healthcare System cam¬ 
pus in West Haven, Yale-New Haven Hospital, and at 
CMHC, a 31-year collaboration by Yale and the State 
of Connecticut) Yale's world-renowned faculty treat 
thousands of patients with mental disorders. These 
clinicians often work literally across the hall from the 
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world’s leading basic neuroscience 
researchers. 
With new and sophisticated 
tools to help in the search for clues 
to brain abnormalities, the depart¬ 
ment’s scientists work in a wide 
range of disciplines encompassing 
brain imaging, pharmacology, 
genetics and molecular biology. 
This massive effort to understand 
the brain from multiple perspec¬ 
tives promises to uncover the 
secrets of when and why the brain 
malfunctions, causing mental ill¬ 
ness. In fact, the work has been so 
successful that the combined 
research program is ranked among 
the top three nationally in terms of 
research funding. 
A few steps from the clinical 
unit on the third floor of CMHC 
where Susan S. was being treated, 
a team of neuroscientists was 
busily exploring the nervous sys¬ 
tem, mostly by studying the brains 
of rats. That work is intended to 
provide keys to unlocking the 
secrets of the human brain, which 
in most basic structures is very 
similar to that of other animals. 
During the past three decades, 
researchers in those laboratories 
have pioneered many of the funda¬ 
mental advances in knowledge 
Recent findings about the influence 
of stress on one area of the brain, the 
hippocampus, suggest new ways of 
thinking about the cause of depression 
about depression and anxiety. Sci¬ 
entific data generated at Yale has 
been instrumental in improving 
treatment for the diseases, includ¬ 
ing groundbreaking work that 
enabled the development of such 
revolutionary antidepressants as 
fluoxetine, better known by its 
trade name of Prozac. “We’ve 
been building a body of basic 
knowledge for more than three 
decades that serves as the basis for 
many of today’s treatment 
advances,” says Dennis S. Char- 
ney, M.D., HS ’77-81, professor 
and deputy chair of psychiatry for 
research and education. 
The hippocampus, the curving 
dark ridge outlined in black in the 
brain images above, is the portion 
of the brain that controls emotions 
and memories. New studies show 
that stress can shrink the hip¬ 
pocampus and that this damage 
may contribute to the symptoms of 
depression. Laboratory research 
at Yale during the past three 
decades, says Eric J. Nestler, 
M.D., Ph.D., left, "provided some 
of the basic knowledge that drove 
the pharmaceutical companies to 
look for a Prozac. ” 
RETHINKING SEROTONIN 
Much remains unknown about 
depression and especially about 
cases such as Susan S., in which all 
known forms of treatment do not 
seem to help. Several members of 
the neuroscience faculty are strug¬ 
gling to understand why Susan S. 
and others like her might not 
respond to treatment. Using 
recently developed techniques for 
studying brain cells at the molecu¬ 
lar level, Ronald S. Duman, Ph.D., 
and colleagues George Heninger, 
M.D., and Eric J. Nestler, M.D. 
’83, HS '83-87, Ph.D. ’82, had 
been investigating the functions of 
different brain structures believed 
to be involved in depression. They 
observed in rats that stress could 
alter the function of certain brain 
regions affected by serotonin, and 
induce behaviors suggestive of 
human depression. 
Recent findings about the 
influence of stress on one area of 
the brain, the hippocampus, sug¬ 
gest new ways of thinking about 
the cause of depression. Studies in 
animals have shown that stress can 
cause the shrinking or even death 
of neurons in the hippocampus. 
Moreover, brain imaging studies 
have shown that the size of the hip¬ 
pocampus is reduced in patients 
with depression or post-traumatic 
stress disorder (PTSD). These find- 
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Opening a window on the brain 
As if a window had been cut 
into a brick wall, the revolu¬ 
tion in brain imaging technology 
has, for the first time, allowed 
researchers to peer into the actu¬ 
al functioning of the human brain. 
Yale is home to one of the world’s 
leading centers for the use of 
advanced brain imaging tech¬ 
nology for research into the neu¬ 
rochemical basis of mental disor¬ 
ders. “We can now get direct 
measurements of target sites in 
the brain,” says professor of psy¬ 
chiatry and pharmacology Robert 
B. Innis, M.D., Ph.D., HS '81-84, 
who directs the Neurochemical 
Brain Imaging Program. The pro¬ 
gram boasts an extensive com¬ 
plement of state-of-the-art equip¬ 
ment at the medical school and 
the West Haven campus of the VA 
Connecticut Healthcare System. 
“If we can understand what the 
chemical imbalance is that is 
causing an illness, that will help 
in diagnosis and enable us to 
design treatments for the specific 
imbalance.” 
The program forms “a nice 
bridge between basic science and 
clinical psychiatry,” says Ben¬ 
jamin S. Bunney, M.D., HS '68- 
71, the department chairman, 
who calls Dr. Innis the world 
leader in SPECT brain imaging. 
"What makes it special is that 
there's a foundation of basic sci¬ 
ence knowledge, derived from 
animals, that allows Bob to corre¬ 
late changes in the brain with 
the images. Because he’s first 
done the work in animals, imag¬ 
ing and then measuring brain 
function, he’s in a much better 
position to correctly interpret 
human images.” 
The potential payoff is enor¬ 
mous. For instance, Dr. Innis and 
colleagues at Yale have just 
developed a brain imaging tech¬ 
nique for diagnosing Parkinson's 
disease even before any physical 
symptoms develop. Early detec¬ 
tion would allow for more effec¬ 
tive treatment to restore the 
chemical imbalance in the 
dopamine system known to be 
responsible for the disease. A 
multi-center clinical trial is now 
under way to test this potentially 
revolutionary technique diagnos¬ 
ing Parkinson’s with SPECT imag¬ 
ing. (SPECT stands for single pho¬ 
ton emission computed tomogra¬ 
phy and is similar to, though sig¬ 
nificantly less expensive than, 
positron emission tomography or 
PET scanning.) 
Dr. Innis and his collabora¬ 
tors—Kenneth Marek, M.D., 
associate professor of neurology 
New SPECT brain imaging techniques devel¬ 
oped by Robert B. Innis, M.D., Ph.D . left and 
colleagues at Yale and the VA Connecticut 
Healthcare System have made possible the 
direct measurement of sites in the brain where 
antidepressant and anti-anxiety drugs work. 
Psychiatrists in the not-too-distantfuture may 
be able to send a patient for tests to diagnose 
or to monitor the treatment of patients with 
depression, obsessive-compulsive disorder 
and other neuropsychiatric illnesses. 
and director of the Yale Move¬ 
ment Disorders Clinic; and John 
P. Seibyl, M.D., associate profes¬ 
sor of diagnostic radiology and 
psychiatry, and director of the 
NeuroSPECT Center—developed 
extremely low-dose radioactive 
tracers to show the presence of 
the dopamine imbalance presag¬ 
ing Parkinson’s disease. 
While no clinical applications 
for brain imaging have been 
developed to date for depression 
and anxiety disorders, the new 
methods hold great promise. Psy¬ 
chiatrists in the not-too-distant 
future may be able to send a 
patient for tests to diagnose or 
confirm clinical depression, 
obsessive-compulsive disorder 
and other brain maladies. 
In association with Dr. Seibyl, 
Robert Malison, M.D., J. Douglas 
Bremner, M.D., and Dennis Char- 
ney, M.D., Dr. Innis has devel¬ 
oped brain imaging techniques to 
directly measure sites in the 
brain where antidepressant and 
anti-anxiety drugs work. In 
research that has yet to be pub¬ 
lished, the team produced brain 
images demonstrating a reduc¬ 
tion in the number of benzodi¬ 
azepine receptors in regions of 
the brain believed to be involved 
in panic attacks. Dr. Innis specu¬ 
lates that a chemical imbalance 
in these brain structures may trig¬ 
ger the onset of panic disorders. 
“Eventually,” says Dr. Innis, "we’ll 
be able to dissect types of mental 
disorders and optimize treat¬ 
ments or detect an unknown 
abnormality and develop a new 
treatment.” ■ 
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Much about the brain and its 
pathology still remains a vast, 
tantalizing mystery. Unraveling 
that complexity among the one 
trillion neurons in the human 
brain is overwhelmingly difficult. 
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Christopher J. McDougle, M.D., left, and Robert T. Malison, M.D., treat 
patients at the Connecticut Mental Health Center, literally across the hall 
from the world's leading basic neuroscience researchers. 
ings suggest that shrinking or dam¬ 
age to neurons in the hippocampus 
may contribute to the symptoms of 
depression. Interestingly. Dr. 
Duman and colleagues have found 
that antidepressant agents increase 
nerve growth factors that may block 
or reverse the damaging effects of 
stress in the hippocampus. 
The depressive effect of abnor¬ 
mally low serotonin levels, long 
thought to be at the root of depres¬ 
sion, “may in fact be far removed 
from its real cause,” says Dr. 
Duman, associate professor of psy¬ 
chiatry and pharmacology. This 
marks a major change in the under¬ 
standing of depression, potentially 
opening up a whole new and far 
more effective approach to treat¬ 
ment. Adds colleague Dennis Char- 
ney: “We’re moving beyond the 
hypothesis that suggests that a low 
serotonin level by itself is the cause 
of depression. There are 15 differ¬ 
ent serotonin receptors, all with dif¬ 
ferent functions. 
“We know so much more now, 
that it has become a question not 
only of serotonin levels but also 
where in the brain and which spe¬ 
cific part of the system,” says Dr. 
Charney. “Bit by bit, we're pinning 
down the biology of depression.” 
Currently available antidepres¬ 
sant medications are effective in 
most cases, but they work at an ago¬ 
nizingly slow speed, typically tak¬ 
ing two to four weeks before results 
appear. “If you're suicidal,” says 
Dr. Malison, “that delay can be 
fatal.” Hospital care, an option that 
is expensive and increasingly lim¬ 
ited by managed care contracts, 
may be necessary to monitor treat¬ 
ment during the time it takes for the 
drugs to work. (Psychiatric hospi¬ 
talization has been shortened so 
drastically under managed care— 
to an average of 9 days—that the 
patient often has been discharged 
before the medication has had an 
opportunity to work.) And sadly and 
often with tragic outcomes, a signif¬ 
icant number of all patients—as 
many as 30 percent—never respond 
at all to available medications. 
New theories on the treatment 
of depression—that slow process of 
rebuilding and reregulating the 
actual structure of the serotonin sys¬ 
tem and possibly other, yet uniden¬ 
tified, structures in the brain—may 
explain why the medications take so 
long to have an effect. And they 
hold a key to improved treatments. 
“What’s important,” says Dr. 
Heninger, professor of psychiatry, 
“is that we're making huge 
advances in the chemistry of ill¬ 
nesses that corrode souls. With the 
tools of science, we’re actually sav¬ 
ing souls.” 
A NEW APPROACH 
Dr. Duman, a basic scientist, 
hypothesized that supplementing 
antidepressant treatment with other 
medications targeting the specific 
rebuilding process might speed up 
patient recovery. In his search for a 
supplemental drug, he found 
papaverine, which formerly had 
been given to stroke patients to 
increase blood flow to certain 
regions of the brain that are now 
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Psychophamacology 
Tit Fcwtrth GrurraUo* at Pr'Ogress 
Psychiatry Chairman 
Benjamin S. Bitnney, 
M.D.: “Thefoundation 
of knowledge now exists 
to allow us to begin to 
develop treatments ratio¬ 
nally, rather than relying 
on serendipity’. ” 
known to be associated with 
depression. Papaverine had been 
superseded by newer stroke med¬ 
ications and was no longer in regu¬ 
lar use. “It was essentially just sit¬ 
ting on the shelf,” recalls Dr. Mali¬ 
son. Dr. Duman suggested to his 
clinical colleagues that they see 
whether it might not help treat a 
refractory case such as Susan S.'s, 
knowing that papaverine also 
increases the nerve growth factors 
that impact the hippocampus. 
Dr. Malison, a clinical psychi¬ 
atrist with a strong background in 
neurobiology, immediately saw Dr. 
Duman’s point. He treated Susan 
S. with a combination of standard 
antidepressant medications aug¬ 
mented with papaverine. Two 
weeks after the papaverine was 
first added to her medications, 
Susan S., who had not been able to 
get out of bed most days for 
months, bounded down the hall 
into Dr. Duman’s laboratory to 
shake his hand. “She was so 
happy,” he recalls. “It was the first 
time she’d felt better in years.” 
For Dr. Malison, it was a per¬ 
sonal triumph, as well as a poten¬ 
tial medical and research advance. 
“To this day,” he says, “seeing a 
depressed person get better is my 
most exciting experience. You 
watch a person like Susan go from 
bedridden—and unable to care for 
herself—to a rebirth.” 
That was in December 1995. 
In the months since then, Susan S. 
has remained free of major depres¬ 
sion and resumed many life activi¬ 
ties she had long abandoned. Drs. 
Duman and Malison have begun to 
explore whether, in fact, papaver¬ 
ine alone might not be an effective 
treatment for certain forms of 
depression. “That,” says Dr. Mali¬ 
son. “would be a major break¬ 
through.” 
SEEING THE LIVING BRAIN 
While the efficacy of treatment 
with papaverine will not be known 
until much more extensive trials 
are undertaken, such potentially 
promising advances are hallmarks 
of an ongoing revolution in neuro¬ 
science. In this Decade of the 
Brain, as the U.S. Congress desig¬ 
nated the century’s final years, our 
understanding of depression and 
other mental illnesses has 
exploded. Still, the need for 
improved treatments and preven¬ 
tion remains enormous. 
Until just a quarter century 
ago, the sort of investigations that 
led to providing hope for someone 
like Susan S. was not possible. 
According to Benjamin S. Bunney, 
M.D., HS '68-71, the Charles B.G. 
Murphy Professor and chairman of 
psychiatry and professor of phar¬ 
macology, discoveries about the 
brain and treatments for mental ill¬ 
ness were largely serendipitous. 
The brain's functions revealed 
themselves only when patients suf¬ 
fered accidents causing well- 
defined, traumatic brain lesions 
that changed or halted specific 
behaviors and thus demonstrated 
the operation of a region of the 
brain. Autopsies also showed struc¬ 
tural abnormalities, hinting at pos¬ 
sible regions to serve as targets for 
medications. Sometimes, as in the 
case of antidepressants, a medica¬ 
tion employed for one health rea¬ 
son—in that instance, treatment of 
tuberculosis with a monoamine 
oxidase inhibitor—had an unex¬ 
pected therapeutic side effect for 
another symptom. 
Much about the brain and its 
pathology still remains a vast, tan¬ 
talizing mystery. Unraveling that 
complexity among the one trillion 
neurons in the human brain is over¬ 
whelmingly difficult. Each neuron 
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potentially interconnects with 
untold numbers of other neurons, 
multiplying the effect of any chem¬ 
ical interaction. That creates a 
chain of possibilities in which the 
pathology may lie at almost any 
point in the linkage. 
If that complexity were not 
daunting enough, neuroscience 
researchers have their hands tied in 
a way that virtually no other med¬ 
ical field faces. “The problem,” 
says Dr. Bunney, “is that in living 
humans, you can’t go into the brain 
and mess about. Biopsy isn’t an 
option.” While autopsy does reveal 
abnormalities in brain anatomy 
after death, it comes too late to elu¬ 
cidate abnormal brain function. 
A revolution in imaging 
already has had a profound effect 
in removing some of those obsta¬ 
cles. “Psychiatrists were frus¬ 
trated,” says Dr. Malison, “because 
we couldn’t see directly into the 
living brain.” Now, magnetic reso- 
For most mothers, giving birth is 
one of the great moments of 
life. Nonetheless, nearly two- 
thirds of new mothers experience 
the blues, such as tearfulness, 
sadness and anxiety, for a period 
of a few days to two weeks after 
childbirth. 
For one in 10 new mothers, 
however, the baby blues becomes 
something more than just a pass¬ 
ing affliction. They develop a 
full-blown depression needing 
clinical treatment. In a few 
cases—two in 1,000—the disor¬ 
der cascades into manic or occa¬ 
sionally depressive psychosis, 
with some mothers committing 
infanticide or suicide. 
Although postpartum psychi¬ 
atric illness was first recognized 
The generation 
of scientific 
knowledge during the 
past two decades ... 
has been aided by 
the revolution in 
laboratory tech¬ 
niques, especially in 
molecular biology, 
imaging technology 
and genetics. 
and described in ancient Greece 
more than 2,000 years ago, it 
remains a poorly understood dis¬ 
order. It is not recognized by the 
American Psychiatric Associa¬ 
tion’s Diagnostic and Statistical 
Manual (DSM) as a disorder dis¬ 
tinct from depression occurring at 
other times. The Postpartum 
Mood Disorders Clinic on the Clin¬ 
ical Neuroscience Research Unit 
at CMHC is now undertaking the 
first controlled studies to further 
our understanding of the neurobi¬ 
ology of the disorder and develop 
the most effective treatments. 
Under the direction of C. Neill 
Epperson, M.D., a research fellow 
in psychiatry, the clinic is looking 
into the interplay between the nor¬ 
mal physiology of pregnancy and 
nance imaging (MRI) provides 
detailed views of the brain's struc¬ 
tures in thousands of cross-sec¬ 
tional views only millimeters thick. 
PET and SPECT imaging, super¬ 
imposed over MR scans, now 
record brain function. (See Open¬ 
ing a window on the brain) 
The path to this technical peak 
and its clearer view of the brain has 
been a long one. Early in the his¬ 
tory of brain research, scientists 
found they could alter behavior in 
laboratory animals by removing 
small sections of the brain associ¬ 
ated with those behaviors. The 
problem was that these lesions 
were non-specific. For example, 
the destruction of fibers running 
through one region of the brain 
would affect functions controlled 
by other regions. 
Research advanced with the 
discovery of neurotoxins that were 
selective in destroying certain 
types of neurons. And in 1963, a 
the neurobiology of the disorder. 
“Pregnancy,” says Dr. Epperson, 
“seems to be a trigger for a num¬ 
ber of psychiatric illnesses. It’s 
clearly a precipitant, but we’re not 
sure why.” The extraordinary 
changes the mother's body under¬ 
goes during pregnancy and deliv¬ 
ery may be a possible cause. The 
10- and 100-fold elevation of the 
sex hormones, estrogen and prog¬ 
esterone respectively, during 
pregnancy followed by their rapid 
decline after delivery is believed 
to have a major impact on the 
central nervous system. This may 
make postpartum depression bio¬ 
logically unlike other depressions. 
Establishing the nature of 
that link may help shed light on 
the baby blues and provide keys 
to treating postpartum and post¬ 
menopausal depression. ■ 
Shedding light on the baby blues 
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The running conversation between scientists 
who work in the laboratoiy and clinicians 
who see patients is the foundation of the Yale 
Way of psychiatric research. Left: Jingshan 
Chen, Ph.D, an associate research scientist, 
presents his findings on molecular mecha¬ 
nisms of addiction at the regular Friday 
morning molecular psychiatry conference 
attended by clinical and basic science faculty. 
It was at such a meeting that Ronald S. 
Duman, Ph.D., (below), suggested to col¬ 
league Robert T. Malison, M.D., that supple¬ 
mental doses of a hypertension drug called 
papaverine might help a patient who was not 
responding to antidepressant therapy. The 
treatment has worked in early studies. 
Swedish team was able to visual¬ 
ize for the first time, in animal 
brains, cells that contained neuro¬ 
transmitters, making it possible to 
study the functions of the sero¬ 
tonin, dopamine and norepineph¬ 
rine systems in animals. 
George K. Aghajanian, M.D. 
'58, who has pursued basic neuro¬ 
science research at Yale for nearly 
30 years, was the first American 
researcher to apply these tech¬ 
niques. His work exploring the 
serotonin system is only one of 
numerous areas for which he has 
laid the groundwork for many of 
the major advances in the field. For 
example, says colleague Eric 
Nestler, the Elizabeth Mears and 
House Jameson Professor of 
Psychiatry and Pharmacology, 
“work here provided some of the 
basic knowledge that drove the 
pharmaceutical companies to look 
for a Prozac.” 
The generation of scientific 
knowledge during the past two 
decades—with a dramatic increase 
in speed over the last five years— 
has been aided by the revolution in 
laboratory techniques, especially in 
molecular biology, imaging tech¬ 
nology and genetics. These 
advances have made it possible to 
map out some of those billions of 
neurochemical pathways. The new 
technologies permit neuroscientists 
to tap and then measure the electri- 
Above: Postdoctoral fellow 
William A.Carlezon, Ph.D., and 
graduate student Vidita Vaidya, 
discuss recent results that reveal 
changes in the hippocampus pos¬ 
sibly related to depression. 
cal firing of a single neuron, far too 
small for the naked eye to see, in 
the brains of animals. The func¬ 
tions and connections of the 
healthy neuron can then be traced, 
eventually pointing to possible 
means of repairing damaged or 
improperly functioning areas in 
humans. "The foundation of 
knowledge now exists,” says Dr. 
Bunney, “to allow us to begin to 
develop treatments rationally, 
rather than relying on serendipity.” 
FRUITS OF THE YALE WAY 
New antidepressents such as fluox¬ 
etine, sertraline and paroxetine— 
from a class known as selective 
serotonin reuptake inhibitors—are 
among the first generation of drugs 
derived via this new means of 
studying the brain. The develop¬ 
ment of many other highly tar¬ 
geted, so-called “designer" med¬ 
ications has followed. “They’re 
scalpels in their precision,” says 
Dr. Malison. (See Putting neuro¬ 
science research to work) Still bet¬ 
ter treatments for depressive disor¬ 
ders are on their way. "We’re 
bringing out amazing new knowl¬ 
edge about how the nervous sys¬ 
tem is formed, connected and 
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maintained,” says Dr. Aghajanian. 
“With that new knowledge," he 
explains, “we can then go back and 
re-examine the different clinical 
conditions. These advances have 
the promise of identifying where 
things are going wrong in the 
brain.” 
Not only do patients benefit 
the molecular malfunction at work 
in mental illness. “It clearly cuts 
both ways,” says Lawrence H. 
Price, M.D., HS ’78-82, former 
director of CMHC’s Clinical Neu¬ 
roscience Research Unit and a 
longtime Yale faculty member (he 
took up a new position at Brown 
University School of Medicine 
Training the next generation: George K. Aghajanian, M.D., front, whose 
basic work over the past 30 years has elucidated the function of neurotrans¬ 
mitters such as serotonin, was a mentor to psychiatry Chairman Benjamin 
S. Bunney, M.D., lower right. Both in turn helped train Eric J. Nestler, M.D., 
Ph.D., left, and Ronald S. Duman, Ph.D., standing next to him. Drs. Nestler 
and Duman have likewise shepherded the work of junior faculty David Self, 
Ph.D., rear center, and David Russell, M.D., Ph.D.. 
from the neuroscience synergy. 
Each new advance ih clinical 
research sends the basic scientists 
back to the bench with new insights 
into how a medication works. This 
gives them clues in their search for 
further advances in understanding 
in July). “The clinicians are always 
looking to the basic scientists 
for the definitive word on how it 
works, and they look to us in 
the clinic to see whether it really 
does work.” 
Dr. Chamey’s research team is 
credited with several seminal 
advances in the understanding and 
treatment of panic disorders and 
depression. Those achievements, 
he says, are a direct result of a 
working style shared by researchers 
that has come to be known as the 
Yale Way. He explains: “This close 
collaboration between the labora¬ 
tory and the clinic leads to funda¬ 
mental discoveries that have an 
impact on the field.” 
Most clinical researchers at 
Yale learn the vocabulary of the 
basic scientists, while the basic sci¬ 
entists familiarize themselves with 
the issues faced by clinicians. In 
many cases, individuals such as Dr. 
Bunney carry out both functions on 
an almost daily basis. Such close 
ties between clinical practice and 
basic research remain rare in most 
medical schools. “We’re close to 
unique in those interactions,” says 
Dr. Bunney. Few have so deliber¬ 
ately structured themselves to 
encourage cross-disciplinary inter¬ 
action. “Usually, these things take 
place in different buildings and 
even different departments. People 
from other universities are amazed 
to see in situ molecular hybridiza¬ 
tion being done across the hall from 
clinical assessment of patients.” 
A TRADITION OF CROSSTALK 
When George Aghajanian joined 
the psychiatry faculty in the early 
1960s, very few people believed 
that such interaction between basic 
science and clinical application was 
possible or even the appropriate 
focus of a psychiatry program. 
“Psychiatry used to be set off by 
itself from the rest of medicine,” 
says Dr. Aghajanian, professor of 
psychiatry and pharmacology. 
Most psychiatrists were devoted to 
highly intense interpersonal and 
behavioral modification therapies. 
Whatever the many benefits of 
those approaches may have been, 
treatment of many serious mental 
illnesses remained largely inade¬ 
quate. A visionary member of the 
department at the time, the late 
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Daniel Freedman, M.D., saw the 
fertile possibilities in bringing 
together the otherwise discon¬ 
nected talents of practicing clini¬ 
cians and laboratory-based investi¬ 
gators to study the brain and its ill¬ 
nesses. To open up doors to the 
future, he established one of the 
nation’s first medical training pro¬ 
grams in neuroscience research. 
“The building blocks for our 
present strength in biological psy¬ 
chiatry were established when Fritz 
Redlich recruited Daniel Freed¬ 
man,” says Dr. Bunney. Frederick 
C. Redlich, M.D., Yale’s chairman 
of psychiatry for 19 years until he 
became dean of the medical school 
in 1967, saw early on that biologi¬ 
cal approaches would complement 
the psychoanalytic work then in the 
mainstream and supported both 
models of inquiry. 
As results from the neuro¬ 
science research began to accumu¬ 
late, funding agencies came to rec¬ 
ognize the value of the pioneering 
approach to seeking out the causes 
of mental illnesses. In the Yale 
Department of Psychiatry, the 
training program has since been 
formalized via a longstanding, 
multi-million dollar National Insti¬ 
tute of Mental Health (NIMH) Pro¬ 
gram Grant as the Clinical and 
Basic Neuroscience Research 
Training Program in Psychiatry. In 
recent years other medical schools 
have followed suit, establishing 
their own versions of the Yale 
model. 
The program now covers a 
wide spectrum of clinically rele¬ 
vant neuroscience domains at Yale. 
Not only do clinicians and basic 
scientists work together on research 
projects, they also meet regularly 
for formal talks and seminars of 
mutual interest. Each week for the 
past 25 years, faculty and students 
alike have gathered for the “work- 
in-progress” presentations known 
as the Neuroscience Research Sem¬ 
inar in Psychiatry. Discussions 
begun there often lead to collabora¬ 
tive experiments. “That kind of 
crosstalk is a priority and not an 
accident here,” says Dr. Price. 
Dr. Price remembers well a 
dramatic moment when the benefits 
of the Yale Way became clear to 
him. He was chief resident on the 
adult psychiatric service at Yale- 
New Haven Hospital in 1982. A 
woman with a psychotic depression 
on the unit was in very poor condi¬ 
tion, but her health insurance cov¬ 
erage had been exhausted. As a last 
resort before her discharge. Dr. 
Price scheduled electroconvulsive 
therapy, a costly procedure which 
has many undesirable side effects 
such as short-term memory loss. 
During that week’s Neuro¬ 
science Research Seminar in Psy¬ 
chiatry, Dr. Aghajanian discussed a 
discovery from his laboratory 
based on the work of a former post¬ 
doctoral fellow, Claude deMon- 
tigny, M.D., (now at McGill Uni¬ 
versity). As part of a broader study 
of the neural actions of antidepres¬ 
sant medications. Dr. deMontigny 
had looked at whether lithium 
might also affect the serotonin sys¬ 
tem in the brain where antidepres¬ 
sants were known to bind. His sur¬ 
prising findings showed that 
lithium actually boosted the effect 
of the antidepressants in rats. He 
then carried out a preliminary study 
on human subjects at McGill, 
which was followed by a controlled 
study at Yale by Drs. Charney, 
Heninger and Aghajanian, confirm¬ 
ing its benefits. 
While those results were not 
yet known to the field. Dr. Agha¬ 
janian discussed them with Dr. 
Price, who thought that in the des¬ 
perate situation faced by his 
patient, lithium should be added to 
her medication. “The day after we 
gave her lithium,” Dr. Price recalls, 
“she was laughing for the first time 
in seven or eight months. That was 
the first change in her affect I’d 
seen in 30 days.” What is termed 
“lithium augmentation” became, 
within a few years, a standard part 
of treatment for major depression. 
Despite such breakthroughs, 
Dr. Aghajanian and colleagues con¬ 
tinue to struggle to understand the 
mechanisms of depression and 
develop a cure. “We still don’t 
know what causes depression,” 
says Dr. Bunney, “and we don't 
know how to prevent it.” One thing 
the basic scientists have learned is 
that talking therapy, while it does¬ 
n’t necessarily cure mental illness, 
can play a crucial role in the treat¬ 
ment of some patients. “In fact,” 
says Dr. Bunney, “it has been 
demonstrated that some forms of 
psychotherapy can alter brain 
chemistry.” 
The goal of prevention is 
far in the future and will 
certainly require the 
discovery of a genetic 
basis for the disease. That 
will be no simple matter 
The goal of prevention is far in 
the future and will certainly require 
the discovery of a genetic basis for 
the disease. That will be no simple 
matter: researchers now recognize 
that there are many different kinds 
of depression. Studies are under 
way to develop more targeted 
forms of treatment for specific 
types of depression. One day, there 
may be biological tests to diagnose 
different forms of depression. That 
will also indicate the most appro¬ 
priate treatments. 
In the nearer term, Yale investi¬ 
gators hope to reduce the delay in 
the effect of treatment to a matter 
of days instead of weeks. “The 
field needs a new fundamental 
advance to get beyond current 
treatments,” says Dr. Charney. 
“We’re focused like a laser beam 
on finding it.” YM 
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When 
fear 
is an illness 
Biological research sheds new light 
on PTSD, other anxiety disorders. 
By Marc Wortman 
Photographs by Frank Poole 
When American soldiers moved through the jun¬ 
gles of Vietnam, their survival depended on a 
constant state of anxiety. That anxiety kept 
their bodies alert for warning signs of danger. When 
threat proved real, fear prompted their bodies to sudden, 
life-saving actions. 
But after the war was over, some 15 percent of all 
returning soldiers could not turn off the anxiety and fear. 
While their lives were now at peace, their brains were 
still at war. For some, moving about in public areas 
became a terror-filled experience; for others, sudden 
noises could send them diving for cover. Many suffered 
nightmares, flashbacks and other involuntary memories 
of traumatic battlefield scenes. Many became depressed 
by the experience, while others turned to drugs and alco¬ 
hol to block their misery. With no visible war wound, 
tens of thousands still emerged disabled by their combat 
service, just as had the shell-shocked soldiers of World 
War I and every war since. 
War veterans are not alone in suffering anxiety and 
panic disorders. Approximately 15 percent of all people 
exposed to traumatic stress, such as child abuse, vio¬ 
lence, automobile accidents and natural cataclysms, will 
develop the illness. Others who suffer from recurrent, 
unprovoked and intense episodes of fear can point to no 
single precipitating factor, and likely have an environ¬ 
mental or genetic predisposition to the disorder. While 
some symptoms of anxiety disorders can be treated, no 
cure exists. Thanks to dramatic advances in neuroscience 
research, new hopes for treatment, cure and even preven¬ 
tion of anxiety disorders are emerging. Studies at Yale, 
especially those undertaken at the National Center for 
Post-Traumatic Stress Disorder (PTSD) at the VA Con- 
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Approximately 15 percent of all people 
exposed to traumatic stress will develop 
panic or anxiety disorder. Researchers now 
find that psychological trauma can change 
the chemistry and structure of the brain, 
says Dennis S. Charney, M.D., right, 
deputy chairman of psychiatry for research 
and education. “Whatyou want to do, ” 
says colleague and mentor George 
Heninger, M.D., left, “is develop a drug to 
treat generalized anxiety disorder, but not 
prevent the person from jumping out of the 
way of an oncoming car. ” 
necticut Healthcare System’s West Haven campus, 
have begun to open up an entirely new understanding 
about the nature of the disease, which afflicts between 
three and six million Americans. 
Dennis S. Charney, M.D., former psychiatry chief 
at the West Haven VA and now a deputy chair of the 
Department of Psychiatry, has led a team which has 
taken laboratory findings about fear and anxiety in ani¬ 
mals, along with new technologies for studying brain 
function, and applied them to the benefit of patients 
suffering from panic and anxiety disorders. 
Working from a theory of anxiety developed by 
psychiatry department colleague D. Eugene Redmond 
Jr., M.D., from his work with primates and patients 
with anxiety. Dr. Charney found that patients suffering 
from panic disorders are exquisitely sensitive to 
chemical stimulation of the brain’s neuroadrenergic 
system, which releases norepinephrine. The release 
of norepinephrine is a necessary and even healthy 
response to stress such as fear. It prepares the body 
at a very rapid speed to respond to danger by increasing 
blood pressure, raising the heart rate, elevating breath¬ 
ing and transferring energy to muscles. Once the 
danger is past, the fear response subsides rapidly in 
normal individuals. 
Dr. Chantey’s research group has shown that peo¬ 
ple who suffer panic attacks do not shut off their neu¬ 
roadrenergic, or adrenaline-release, function. “Most of 
us,” says Andrew Goddard. M.D., assistant professor of 
psychiatry and director of the Anxiety Disorders 
Research Clinic at the Connecticut Mental Health Cen¬ 
ter and a collaborator in the studies, “have a stress 
response which is time-limited, but those with an anxi¬ 
ety disorder have lost this capacity.” 
In 1995, Dr. Charney along with Steven South- 
wick, M.D., director of Yale’s PTSD program; J. Dou¬ 
glas Bremner, M.D., an assistant professor of psychia¬ 
try and a fellow in diagnostic radiology who works 
with brain imaging technologies; and Robert Innis, 
M.D., Ph.D., HS ’81-84, director of the department’s 
Neurochemical Brain Imaging Program, drew interna¬ 
tional attention with new studies of anxiety disorders 
combining brain imaging with behavioral investiga¬ 
tions. They showed that long-term high levels of anxi¬ 
ety lead to actual physical changes in the brain. “Psy¬ 
chological trauma,” says Dr. Charney, “can change the 
chemistry and structure of the brain. That was not 
thought to be possible.” 
Using magnetic resonance imaging (MRI) to com¬ 
pare anatomy while superimposing those images on 
positron emission tomography (PET) scans that show the 
brain's functioning as measured by metabolic changes, 
Dr. Bremner can actually view size and functional differ¬ 
ences in the brains of patients who suffer anxiety disor¬ 
ders such as PTSD. His findings demonstrate that Viet¬ 
nam veterans suffering from PTSD as well as child abuse 
victims with PTSD have a significantly shrunken hip¬ 
pocampus, an area of the brain that plays a crucial role in 
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memory. PTSD involves intrusive 
memories that lead to many symp¬ 
toms, including persistent panic 
attacks, depression and night¬ 
mares. Investigators speculate that 
traumatic stress sets off a process 
that eventually cascades into the 
chronic disorder. “Extreme stress,” 
says Dr. Bremner, “may be toxic to 
certain parts of the brain.” Dr. 
Charney compares it to an immune 
system disorder in which the 
brain’s own survival processes 
Some say love is an obses¬ 
sion. But is it a clinical 
disorder? 
According to research from 
Yale’s obsessive-compulsive dis¬ 
order (OCD) clinics at the Child 
Study Center and Connecticut 
Mental Health Center, early 
parental love and romantic infat¬ 
uation may share a common 
neurochemical thread with the 
obsessive fear of germs. 
Scientists have known for 
several decades that the hor¬ 
mone oxytocin plays a crucial 
role in the birth process and in 
nursing, and have have recently 
discovered that central oxytocin 
pathways are involved in pair¬ 
bonding and the initiation of 
maternal behavior in animals. 
Now, Yale researchers have 
found cerebrospinal fluid levels 
of oxytocin to be elevated in peo¬ 
ple with some forms of OCD, an 
anxiety disorder that affects 
nearly 2.5 million Americans. 
James F. Leckman, M.D., 
director of research at the Child 
Study Center, theorizes that 
changes in oxytocin levels may 
help explain why OCD patients 
suffer the obsessive-thought 
eventually damage its own cells. 
Those findings in patients are 
now being further refined using 
animal models. Psychiatry profes¬ 
sor Michael Davis, Ph.D. ’69, has 
recently shown in rats that two sep¬ 
arate systems in the brain with sim¬ 
ilar output connections may be 
responsible for fear on the one 
hand and anxiety on the other. That 
would help explain the differing 
time streams involved in the differ¬ 
ent behaviors. “You need a system 
preoccupations that also are 
often experienced by people in 
love and the parents of new¬ 
borns. Risk factors associated 
with the onset of OCD include 
the latter stages of pregnancy 
and early days following delivery, 
as well as major life changes 
such as the loss of a loved one, 
says Dr. Leckman, the Neison 
Harris Professor of Child Psychi¬ 
atry, Psychology and Pediatrics. 
Those findings are part of a 
large, ongoing research and clin¬ 
ical treatment program in the 
Child Study Center and the 
Department of Psychiatry, fund¬ 
ed by a program project grant 
from the National Institute of 
Mental Health designed to shed 
light on one of the most common 
anxiety disorders. People with 
OCD—about two to three per¬ 
cent of adults and about half 
that rate in children and adoles¬ 
cents—experience repeated, 
intrusive and unwanted thoughts 
and compulsive behavior. The 
bizarre ritualistic behaviors, 
intended to reduce the anxiety 
caused by the thoughts, include 
cleaning and hand-washing even 
to the point that skin bleeds, 
that can react very rapidly to the 
onset of danger,” explains Dr. 
Davis, “but maybe you need 
another system to respond in a sus¬ 
tained way.” 
For clinicians, the implications 
of Dr. Davis’s work are significant. 
Brain imaging now focuses on the 
separate systems, and pharmacolo¬ 
gists may be able to develop more 
effective anti-anxiety medications 
that bind to the anxiety center 
rather than the fear center. Current 
repeating phrases like a loved 
one’s name over and over, con¬ 
stant checking and rechecking of 
doors and switches, or driving 
back over the same road many 
times to make certain they had 
not caused an accident. 
“OCD is one of the most dif¬ 
ficult psychological conditions,” 
says David L. Pauls, Ph.D., asso¬ 
ciate professor in the Child 
Study Center, “because the per¬ 
son realizes the behavior is 
bizarre. They feel they are 
trapped and like there is no 
help." Eventually, people with 
severe OCD may find their 
uncontrollable rituals make it 
impossible for them to carry on 
normal life functioning. Not sur¬ 
prisingly, depression is often 
associated with OCD, which is 
classified as an anxiety disorder. 
Dr. Pauls is studying family 
patterns of OCD to begin to look 
for a genetic basis for the disor¬ 
der. His work is part of the 
broader investigations directed 
by Dr. Leckman to characterize 
the disorder and seek out its 
developmental antecedents. The 
research is also looking at the 
association between OCD and 
Tourette’s syndrome, a tic disor¬ 
der involving abrupt body move¬ 
ments, inappropriate touching of 
oneself and others, and the 
What's love got to do with it? 
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anti-anxiety drugs tend to cause 
sedation, which can be a danger in 
itself. As Dr. Davis says, quoting 
his colleague Dr. George Heninger, 
“What you want to do is develop a 
drug to treat generalized anxiety 
disorder, but not prevent the person 
from jumping out of the way of an 
oncoming car." 
The discovery of such a med¬ 
ication would be of tremendous 
benefit to Dr. Southwick’s patients 
at the National PTSD Center in 
need to shout out profanities. 
While many of us carry out 
personal rituals, such behavior 
only becomes a disorder when it 
interferes with normal function¬ 
ing. In fact, Yale researchers now 
believe that OCD may be a nor¬ 
mal developmental stage seen in 
young children, most often 
between ages 2 and 3 when ritu¬ 
alized behaviors, such as the 
need to hear stories over and 
over, repeat songs or eat specific 
foods, are common. 
Yale has been at the forefront 
of psychopharmacological 
research on OCD, conducting 
studies in the late 1980s that 
provided evidence of the benefits 
of fluvoxamine, one of the new 
generation of antidepressants 
known as selective serotonin 
reuptake inhibitors. 
Christopher J. McDougle, 
M.D., associate professor of psy¬ 
chiatry and in the Child Study 
Center, directs the adult OCD clin¬ 
ic. He says, “What we call OCD is 
not one disorder but a syn¬ 
drome.” The team of Drs. Leck- 
man, Pauls, McDougle and col¬ 
league C. Neill Epperson, M.D., 
have found that at least two dis¬ 
tinctive subtypes of OCD exist, 
the Tourette’s-related and non-tic- 
related. Onset of the tic-related 
form is more common in child¬ 
ln rats, two separate 
systems in the brain 
with similar output 
connections may be 
responsible for fear 
on the one hand and 
anxiety on the other 
hood and most often seen in 
boys. The non-tic-related form 
begins more often during and 
after puberty and afflicts women 
more frequently. The abnormal 
elevation of oxytocin is prevalent 
in the peri-pubertal form. 
Separating out the diagnoses 
has helped improve OCD treat¬ 
ment. Dr. McDougle and col¬ 
leagues developed a new and far 
more effective medication treat¬ 
ment for the tic-related form by 
combining a neuroleptic, or 
antipsychotic, medication with a 
serotonin reuptake inhibitor, such 
as fluvoxamine. Since the results 
of their study were published two 
years ago, the combination has 
become the standard treatment 
for the tic-related subtype of OCD. 
For their work, researchers 
draw on some of the nearly 60 
children and 150 adults seeking 
treatment for OCD each year at 
Yale clinics. Most people afflicted 
with OCD respond well to a com¬ 
bination of cognitive-behavioral 
therapies and pharmacological 
treatment with recently developed 
serotonin reuptake inhibitors. But 
just like those with a broken 
heart, for some who suffer from 
OCD, no cure has been found. ■ 
West Haven, one of four in the 
United States. Chronic PTSD is 
resistant to treatment, although 
antidepressant medications do 
reduce some symptoms. Drs. 
Southwick and Charney are also 
looking at drugs known as beta 
blockers that may reduce the sever¬ 
ity of traumatic memories. “Rat 
studies,” Dr. Southwick says, “sug¬ 
gest that interventions could be 
used around the time of the trauma 
itself before the memory becomes 
Changes in levels of the hor¬ 
mone oxytocin may help explain 
why OCD patients suffer the 
obsessive-thought preoccupa¬ 
tions that also are often experi¬ 
enced by people in love and the 
parents of newborns, says 
James F. Leckman, M.D., direc¬ 
tor of research at the Yale Child 
Study Center. 
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Michael Davis, Ph.D., is one of 
eight Yale faculty in psychiatry 
who ser\’e as scientific advisers 
to Neurogen Corp., a neuro¬ 
science drug development com¬ 
pany in Branford, Conn. “I’m 
more interested in the basic sci¬ 
ence, ” Dr. Davis says, “but I 
want somebody to apply it. ” 
Putting neuroscience 
research to work 
Most fundamental discoveries 
about the brain that have 
launched the neuroscience revo¬ 
lution have come in the highly 
specialized laboratories of acade¬ 
mic research centers like Yale. 
But taking those advances the 
next, time-consuming and enor¬ 
mously costly step to develop 
pharmaceutical compounds for 
commercial sale is generally 
beyond the scope and means of a 
medical school. That’s where pri¬ 
vate industry steps in. And some¬ 
times, academic investigators 
step out to help bring their knowl¬ 
edge to commercial application. 
“The kinds of things we do 
have applications for large num¬ 
bers of people with very debilitat¬ 
ing conditions,” says former psy¬ 
chiatry department professor 
John Tallman, Ph.D. A neuroscien¬ 
tist, he left the medical school in 
1989 to help found Neurogen 
Corp., a neuroscience drug devel¬ 
opment company in Branford, 
Conn. He is now the firm’s execu¬ 
tive vice president and scientific 
director. His departmental col¬ 
league Dorothy Gallager, Ph.D., 
soon followed him into the firm’s 
ranks. Eight of their former asso¬ 
ciates, all current faculty mem¬ 
bers, including Benjamin S. Bun- 
ney, M.D., Dennis Charney, M.D., 
D. Eugene Redmond, M.D., 
Michael Davis, Ph.D., George 
Heninger, M.D., Eric Nestler, 
M.D., Ph.D., Robert Roth, Ph.D., 
and George Aghajanian, M.D., 
serve as scientific advisers while 
continuing their primary research 
and educational roles at Yale. 
Although university regulations 
prohibit faculty from using acade¬ 
mic facilities for their own profit, 
faculty are permitted to serve as 
part-time consultants to firms. 
Neuroscience faculty are fre¬ 
quently called upon by pharma¬ 
ceutical firms to serve as scien¬ 
tific advisers. The Yale faculty 
thought their knowledge could be 
put to even more direct use. "We 
were tired of advising other com¬ 
panies who often did not follow 
through,” says Dr. Bunney. “We 
decided to put our expertise and 
ideas to a real test and created 
Neurogen.” 
With an infusion of support 
from several major pharmaceuti¬ 
cal firms, including Pfizer and 
Schering-Plough, Neurogen has 
grown into a publicly traded, high¬ 
ly respected pharmaceutical 
research firm employing more 
than 100 people. Pfizer Inc has 
licensed Neurogen to develop an 
anti-anxiety compound based on 
laboratory findings. “We think we 
can redefine therapies for anxiety 
in the same way Prozac did thera¬ 
pies for depression,” says Dr. 
Tallman. Neurogen has also 
expanded to develop its own com¬ 
pounds. It now has a number of 
other “designer” compounds cur¬ 
rently in development for the 
treatment of disorders ranging 
from schizophrenia to obesity. 
“It’s a good illustration of what 
can happen when you put basic 
research to work in the service of 
rational clinical drug develop¬ 
ment,” says Dr. Bunney. 
For someone like Dr. Davis, 
having Neurogen bring his work 
out of the laboratory and into the 
clinic makes his academic efforts 
all the more rewarding. “I’m more 
interested in the basic science,” 
he says, “but I want somebody to 
apply it. ” That’s the job for Dr. 
Tallman and company. “There’s 
an opportunity at Neurogen,” he 
says, “to contribute directly to 
the rapid development of 
improved treatments for the mil¬ 
lions of people suffering from 
severe, disabling neuropsychi¬ 
atric disorders.” ■ 
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Right: “ We 're bringing out 
amazing new knowledge about 
how the nervous system is 
formed, connected and main¬ 
tained, ” says George K. Agha- 
janian, M.D., professor ofpsy- 
chiatry and phannacology. 
Many of those advances have 
been made possible by the tools 
of molecular biology. 
Below: Postdoctoral fellow 
Maura Charlton, Ph.D., works 
in the laboratory’ with Ronald S. 
Duman, Ph.D. 
Not only adults 
suffer from PTSD. 
Children exposed 
to violence may 
develop the 
disorder as well. 
encoded and consolidated.” Future 
studies may determine if beta 
blockers, when given to emergency 
medical workers who are exposed 
to daily trauma, will attenuate trau¬ 
matic memories. “They have to be 
given right after the event,” Dr. 
Chamey says. "Timing is key. 
After the memory is encoded, the 
medication probably won't work.” 
Not only adults suffer from 
PTSD. Children exposed to vio¬ 
lence may develop the disorder as 
well. Dr. Southwick is collaborat¬ 
ing with Steven Marans, Ph.D., 
director of the Yale Child Study 
Center's Child Development-Com¬ 
munity Policing Program in New 
Haven, and center Director Donald 
J. Cohen. M.D. '66. on a wide 
range of PTSD studies building on 
the seminal work done with Viet¬ 
nam veterans. Plans include studies 
of the neurobiological mechanisms 
mediating symptoms in children 
following stress and of the efficacy 
of medication interventions for 
children with PTSD. Says Dr. 
Southwick, “We're trying to find 
strategies to help a person w ithin a 
short period after the trauma.” 
For Department of Psychiatry 
chair Dr. Bunney, the possibility 
that psychiatrists might one day be 
able to prevent children who have 
been exposed to severe trauma 
from developing lifelong disorders 
represents a triumph of neuro¬ 
science. “The excitement,” he says, 
“is that the potential is there. In a 
lot of illnesses, we already have 
pretty good treatments—compara¬ 
ble to what we have for physical 
diseases like hypertension and dia¬ 
betes—but they’re not cures and 
we can't prevent the disorders. 
"We're a long way off from 
that, but now we have the tools,” 
he says. “It’s a question of apply¬ 
ing them to develop better treat¬ 
ments and. ultimately, cures and 
prevention.” YM 
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Pure 
medicine 
By turning down reim¬ 
bursement, Richard and 
Patricia Gibbs of the 
San Francisco Free 
Clinic provide first- 
class care for uninsured 
patients and freedom 
for physicians to do 
what they do best. 
By David Davison 
Photographs by Matt Black 
What would a physician’s fantasy be 
if he or she won the lottery? “I 
would still practice medicine,” 
says Judith Mates, M.D., a San Francisco 
obstetrician, “but I sure would toss out all 
this paperwork.” 
Several times a month she does just 
that. Dr. Mates, who is president of the San 
Francisco Medical Society, is one of dozens 
of Bay Area physicians who volunteer their 
services to treat patients referred by the 
San Francisco Free Clinic. She is sharing 
a little bit of a fantasy made real by a hus- 
band-and-wife team of Yale-educated physi¬ 
cians who are practicing medicine without 
the paperwork. 
Richard Gibbs, M.D. '86, and Patricia 
Gibbs, M.D. ’87, founded the San Francisco 
Free Clinic in 1993 as an alternative, perhaps 
even an antidote, to their successful but 
unsatisfying conventional practice in family 
medicine. The mission of the clinic recalls 
an era when doctors provided treatment in 
the best interest of patients regardless of 
their ability to pay, and without a utilization 
review by a managed care provider. Patients 
who could afford to do so paid in cash, or 
perhaps with a couple of chickens from the 
farm. Third-party payers didn't exist. 
The clinic mission is simple, says Tricia 
Gibbs, its medical director: "We are devoted 
to taking care of patients without insurance.” 
At the San Francisco Free Clinic, the doctors 
have received expressions of appreciation 
from patients in the form of a piece of 
chocolate cake or a bit of carpentry work on 
a sticky clinic bathroom door. A brightly 
decorated metal box in the hallway receives 
about $3,000 per year from patients who 
have some change or a couple of dollars to 
donate. Patients at times cannot under¬ 
stand—or accept the fact—that insurance 
cards are useless and the services are free. 
On the way out, there is nothing for patients 
to sign, no forms to fill out. 
David Davison, a development officer for the 
School of Medicine, is a Yale Medicine colum¬ 
nist and contributor. 
Inset: Patricia Heilman Gibbs, M.D., and 
husband Richard D. Gibbs, M.D., work 
together while examining a patient at the 
San Francisco Free Clinic, which they 
founded in 1993. The Gibbses met as med¬ 
ical students at Yale in the mid-1980s. 
YALE MEDICINE 19 
A LIMITED AGENDA 
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Despite these seemingly quaint 
characteristics, one should not 
mistake the Free Clinic for a New 
Age alternative medicine lodge, or 
for a grassroots storefront dedi¬ 
cated to global health care reform. 
Orthodox primary care medicine 
is practiced here. At least half of 
the patients are employed; most 
are low-income families. Ninety- 
three percent have homes. 
"We aren't political,” says 
Tricia Gibbs, a Bay Area native 
who grew up in Brooklyn, 
N.Y. "We don’t want to save the 
world. We don’t organize letter¬ 
writing campaigns. We just want 
to keep going.” 
They keep going on a budget 
of $310,000 per year, raised mostly 
through an annual fund-raising 
event and occasional donations. 
The San Francisco Free Clinic 
works like a loosely organized 
health maintenance organization 
(HMO), with the focus on primary 
and preventive care. It is located in 
a converted, two-story, walk-up 
apartment building on Clement 
Patients at times cannot 
understand—or accept 
the fact—that insurance 
cards are useless and the 
services are free. On the 
way out, there is nothing 
for patients to sign, no 
forms to fill out. 
Street in the Richmond neighbor¬ 
hood, a working-class community. 
The facility consists of a waiting 
room, three exam rooms, a patient 
counseling room, an office and a 
cramped lab. 
“We do skin scrapings, skin 
biopsies, gram stains—it saves 
time and money to do these tests 
here, rather than send them out,” 
says Richard Gibbs. "As students, 
we were expected to know how to 
do these tests. Unfortunately, many 
physicians do not get the chance to 
use a lot of what they learned in 
medical school.” 
Since the clinic opened, word 
of mouth has been enough to 
attract patients. The word has got¬ 
ten around in the Bay Area philan¬ 
thropic community, too. Medica¬ 
tions, supplies and equipment are 
donated from a network of 30 
physicians and from a half dozen 
pharmaceutical companies. In 
almost all cases, patients are pro¬ 
vided with both short- and long¬ 
term medications without cost. 
Recently, an acquaintance of the 
Gibbses called to say he was 
insulted that he hadn’t been asked 
for a donation, then sent a check 
for $5,000. 
Richard Gibbs, the clinic’s 
president, estimates that for every 
dollar raised, three dollars worth of 
care is delivered. Money goes into 
services, not administration. From 
the outset, the idea was simple— 
just say no to all third-party pay¬ 
ments. The law says if you take 
fees from any payer, you must 
accept them from all payers, 
including the government. 
Private, non-profit health clin¬ 
ics number in the thousands across 
the country. But the vast majority 
are funded through government- 
backed third-party payments, pri¬ 
marily Medicaid. Since the mid- 
1960s, the U.S. Public Health Ser¬ 
vice has provided funding for com¬ 
munity health centers in rural and 
urban areas, designed to serve 
those living near or below the 
poverty line. These clinics now 
serve approximately 9 million peo¬ 
ple with primary care-oriented 
health services, but the system is 
far from comprehensive. Millions 
of Americans continue to fall 
through the cracks. 
San Francisco is also the home 
of a large and well-known commu¬ 
nity health program. The Haight- 
Ashbury Free Clinic—which 
started out in the 1960s as a store¬ 
front health clinic—now employs 
an army of administrators to keep 
up with the paperwork involved in 
managing government grants and 
in collecting Medi-Cal (state-run 
Medicaid) and Medicare payments. 
The politics of taking care of San 
Francisco’s indigent and welfare 
population is a big issue, and the 
Haight-Ashbury Free Clinic is 
often in the middle of it. The Gibb¬ 
ses acknowledge its important role 
and they refer patients there who 
are eligible for government med¬ 
ical insurance. 
But the San Francisco Free 
Clinic constituency is primarily the 
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Leaving behind the insurance and billing paperwork of private practice has given 
the Gibbses (and physicians they’ve recruited into their network of specialists) 
more time to focus on patients and the practice of medicine. Above, Richard Gibbs 
listens to patient Manuel Tolibas describe a shoulder injury before examining him 
and finding the muscles atrophied and weak. Dr. Gibbs teaches Mr. Tolibas 
stretching exercises to regain the normal range of motion in his shoulder, and pre¬ 
scribes an anti-infammatory medication. Before leaving, Mr. Tolibas shares a joke 
from his native Philippines. 
working poor—people and fami¬ 
lies caught between systems. 
Richard Gibbs points out that one 
out of four city residents has no 
insurance, including an estimated 
60,000 to 70,000 children. Nation¬ 
wide, the estimated number of peo¬ 
ple without insurance is 40 million. 
When welfare is simply not an 
option, and medical care is needed, 
a place like the Free Clinic fills a 
huge need. 
The San Francisco Free Clinic 
counted 3,024 patient visits in 
1995. Thirty percent of the visits 
were devoted to physical examina¬ 
tions, immunizations, pap smears, 
breast exams, TB screenings and 
smoking-cessation counseling. A 
few paid, part-time physicians pro¬ 
vide the basic services, assisted by 
volunteers. Typically, community- 
based health clinics ask doctors to 
volunteer their time on site, a 
model that has in some cases 
proven unworkable, as busy doc¬ 
tors can’t always follow through 
every week with their commitment 
to get to the clinic. That leaves 
patients frustrated and the clinic 
waiting room jammed. 
THE SAME KIND OF CARE 
The key to the San Francisco Free 
Clinic system is the network of 60 
volunteer physicians, specialists 
and sub-specialists around the city, 
who see patients right in their own 
offices after a referral by the clinic 
doctors. At the specialist’s office, a 
patient from the Free Clinic 
receives the same care as any other 
patient would. The only difference 
is that no fee is charged. Several 
radiology groups provide free 
imaging studies, including CT and 
MRI scans. X-rays and mammo¬ 
grams. A plastic surgeon donates a 
morning a month on site. 
One radiologist. Phillip Tir- 
man, M.D., who volunteers with 
obvious pleasure and pride, 
remembers his reaction to being 
asked to provide free services. “I 
started thinking back to the old 
medical school interview when I 
said one of the reasons I wanted to 
go into medicine was to help peo¬ 
ple,” he says. The Free Clinic pro¬ 
vides him with an opportunity to 
make good on those words 
expressed to interviewers in the 
early 1980s. (According to surveys 
by the Association of American 
Medical Colleges, today’s medical 
school applicants—faced with the 
prospect of a career under the con¬ 
trol of huge health systems and 
managed care—are more idealistic 
than ever about their motivation to 
enter medicine.) 
“In San Francisco, there is no 
shortage of specialists to take care 
of patients,” says Richard Gibbs. 
Filling a 
gap in 
care 
The San Francisco Free Clinic’s 
mission is to serve people who 
are not covered by private health 
insurance or eligible for care in gov¬ 
ernment-sponsored clinics. It 
accepts no reimbursement, unlike 
the approximately 2,600 federally 
qualified community health centers 
across the country. Most of those 
are private, not-for-profit organiza¬ 
tions that rely heavily on a base of 
federal funding to exist—typically 40 
percent of a center’s annual budget 
comes from grants from the Depart¬ 
ment of Health and Human Services. 
The balance comes from a mixture of 
private insurance and government 
reimbursement, including Medicaid 
and Medicare. These clinics, located 
in rural and urban areas, serve more 
than 9 million people nationwide. 
There are more than 33.4 million 
men, women and children who are 
Medicaid beneficiaries in the U.S. 
An estimated 43.2 million people 
are without access to a primary 
care provider. 
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Top: Anita Arora came to the San 
Francisco Free Clinic for relief from 
severe headaches. On a return visit, 
after her symptoms have diminshed 
with time and medication, she follows 
Patricia Gibbs' hand with her eyes in a 
test to rule out vision problems. 
Middle: Dr. Gibbs takes a close look 
at Ms. Arora's eyes for signs of 
intracranial pressure, which could 
indicate the presence of a tumor. The 
exam, and an MRI study provided by a 
local radiology practice, rule out both 
tumor and stroke as a cause for the 
headache pain. 
Bottom: After talking about the test 
results. Dr. Gibbs and Ms. Arora dis¬ 
cuss treatments that may help if her 
headaches return. 
Medications, supplies and 
equipment are donated from 
a network of 30 physicians 
and from a half-dozen 
pharmaceutical companies. 
Specialists donate an average of 
two patient visits per month. In a 
sense, the clinic is an HMO-style 
gatekeeper, but on its own terms. 
No insurance overseer or govern¬ 
ment bureaucrat superimposes 
rules and regulations. When 
patients need hospital services, 
four major San Francisco hospitals 
are available to provide charity 
care. One hospital has specifically 
allocated $40,000 of services for 
patients from the San Francisco 
Free Clinic. And that doesn’t count 
the donated time of hospital staff. 
Practicing medicine without 
middlemen “strips away every¬ 
thing that confuses doctors and 
patients,” says Tricia Gibbs, who 
had found, during her private prac¬ 
tice years, public trust in doctors to 
be low. “Patients have become sus¬ 
picious. At the Free Clinic, the 
patients know we’re here to help 
them. There’s a trust and a bond 
between the doctors and the 
patients.” Tricia Gibbs has noticed 
that her patients at the clinic are 
twice as likely to follow doctors 
orders than the patients she used to 
see. Strong patient compliance 
with smoking cessation and weight 
loss programs are typical of the 
clinic success story. 
In a feature segment on a local 
television newscast, a clinic patient 
gave her point of view. “We're 
treated with dignity and respect,” 
said the 61-year-old woman, who 
was being treated for pancreatitis. 
Before coming to the clinic, she 
held a job that carried no health 
insurance, and she was too young 
for Medicare. An acute attack 
landed her in the hospital for an 
operation and a nine-day stay. The 
routine care she now gets from Tri¬ 
cia Gibbs would have easily spot¬ 
ted her condition and prevented a 
painful, scary and expensive expe¬ 
rience. The question of paying off 
her $31,000 hospital bill is unre¬ 
solved, exemplifying the risks and 
the choices confronting many 
uninsured Americans. 
One-third of the patients at the 
San Francisco Free Clinic are from 
the city’s Asian community. An 
Asian American social worker on 
staff serves as both a language 
translator and a vital interpreter of 
cultural differences that can 
impede the efficacy of health care 
services for many people. Twenty 
percent of the clinic work is pedi¬ 
atrics. Extended families are a 
large part of the patient base. Word 
of mouth is more than enough to 
bring patients to the door. Media 
coverage, while it has generated a 
few donations, has also brought the 
problem of too many new patients 
seeking care. It is not a walk-in 
clinic; appointments are required 
and emergency care is still the 
purview of the local area hospitals. 
If a person has insurance, the clinic 
staff gives assistance finding 
another service provider. 
Last year when California vot¬ 
ers passed legislation excluding 
illegal immigrants from state ser¬ 
vices—including health care bene¬ 
fits—Richard and Tricia Gibbs 
convened a brief staff meeting. 
Everyone agreed that the clinic 
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in a challenging and complex clini¬ 
cal environment. They believe that 
what they learned at Yale was ideal 
preparation for their subsequent 
family medicine training, and for 
keeping up with advances in their 
profession today. 
“We let the literature guide 
our practice,” says Richard Gibbs. 
“Irrespective of primary-care train¬ 
ing or elaborate research, the 
teaching at Yale is what I remem¬ 
ber most. It was great.” 
“Yale provided me great role 
models,” says Tricia Gibbs, recall¬ 
ing surgery professor Barbara 
Kinder, M.D. ’71. and LeoM. 
Cooney, Jr.. M.D., the Humana 
Foundation Professor of Geriatric 
Medicine. “He was a great teacher.” 
remembers Tricia. Adds Richard: 
“We met in Dr. Cooney’s class.” 
The Gibbses have made the 
Free Clinic an active center for 
clinical training. It is a family prac¬ 
tice preceptor site for the Univer¬ 
sity of California, San Francisco, 
and for the Physician Assistant 
Program at Stanford University. 
Students and residents are there 
every day, providing invaluable 
patient care and learning medicine 
in the kind of ambulatory setting 
that is in demand by teaching pro¬ 
grams nationwide. A visit by Dean 
Gerard N. Burrow, M.D. '58, last 
Most specialty care for 
patients at the clinic is 
referred to physicians in 
the community, who see the 
Gibbses’ patients in their 
offices. An exception is the 
monthly appearance at the 
clinic by Lars M. Vistnes, 
M.D., chairman emeritus 
of plastic surgery at Stan¬ 
ford University School of 
Medicine. Left, Dr. Vistnes 
and Ann Gilmore, R.N., 
prepare for surgery to 
remove a growth from the 
mouth of a patient. 
would proceed as if the vote hadn’t 
happened, another luxury of being 
free of Medi-Cal rules and reim¬ 
bursements. “Who wants sick peo¬ 
ple in the community?” says 
Richard. The clinic takes care of 
anyone who is uninsured, period. 
As one would expect in a 
clinic focused on preventive care, 
child vaccinations, treatment for 
high blood pressure and routine 
exams are the norm. Volunteer 
nurses are an essential part of the 
medical team. According to both 
Tricia and Richard Gibbs, the most 
important and satisfying results 
from their work come from identi¬ 
fying a major ailment in time to 
effect preventive treatment. When 
a complicated case comes up that 
calls for expensive procedures or 
specialty care, the volunteer net¬ 
work is called upon. 
DRAWING ON THE YALE SYSTEM 
Both Richard and Patricia Gibbs 
attribute their self confidence and 
their skills as physicians to the Yale 
System of medical education. They 
draw on their training at Yale as 
they keep up with the rigors of 
practicing and teaching medicine 
year launched a plan to enable 
Yale medical students to train at 
the clinic. 
After meeting at Yale, Patricia 
and Richard were married in 1984. 
They both trained in family medi¬ 
cine at the University of Washing¬ 
ton. When they moved to the Bay 
One hospital has 
specifically allocated 
$40,000 of services for 
patients from the San 
Francisco Free Clinic. 
And that doesn Y count 
the donated time of 
hospital staff. 
Area in 1990, Richard (a former 
dancer) took a part-time job as 
the physician for the San Fran¬ 
cisco Ballet, where he still enjoys 
the orthopaedics dimension of 
the work. 
On a summer aftemon spent 
with a visitor to the clinic for this 
article. Richard and Tricia dart 
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The key to the San Francisco 
Free Clinic system is the network 
of 60 volunteer physicians, 
specialists and sub-specialists 
around the city. 
from room to room, taking care of 
patients, supervising students and 
fielding questions. Richard excuses 
himself from the discussion to look 
in on a patient exam being con¬ 
ducted by a student. Tricia takes a 
moment to phone the baby-sitter 
and make sure that their five chil¬ 
dren, who range in age from 4 to 
10, can do without her for a little 
longer that afternoon while she 
takes the time for a serious jog. 
A former member of the U.S. Ski 
Team, she is training to run in a 50- 
mile ultra-marathon. 
Richard and Tricia readily 
admit that their clinic model is not 
instantly replicable. They were 
able to throw off the collar of a 
conventional career, take a huge 
cut in income, and create the Free 
Clinic thanks to some important 
help. Tricia's father, a successful 
investment banker, and her mother, 
a well-connected philanthropist, 
pulled together the private dona¬ 
tions needed to get the clinic 
started. Her parents are key to 
putting on the annual fund-raising 
dinner that attracts a wide range of 
corporate and individual support¬ 
ers. When asked for the formula to 
succeed as a charity, Richard 
bluntly advises, “Load your board 
with heavy hitters.” When asked 
what they see ahead, their long¬ 
term expectations are neither 
grandiose nor unreasonable. 
“We could use a little more 
space,” says Tricia. 
“We need an endowment so 
we don’t have to fund-raise every 
year,” says Richard. 
“But we don't want to outgrow 
our resources, either,” Tricia adds. 
She also cites the ongoing need to 
fill gaps with more volunteer ser¬ 
vices from sub-specialists. 
Both Richard and Tricia qui¬ 
etly reiterate that they are not con¬ 
ducting a social experiment, nor do 
they hope to treat all of the people 
all of the time. “We’re not doing 
this just for the patients,” says Tri¬ 
cia Gibbs. "In the evening when 
we go home we usually feel good 
about the way we spent the day.” It 
seems like a simple wish. Ask the 
average doctor in private practice 
about his or her work and the dis¬ 
cussion usually revolves around 
the frustrations of dealing with 
insurance middlemen, the disap¬ 
pearance of the doctor’s autonomy 
and the gloomy prospects of 
shrinking incomes. 
The medical students, the resi¬ 
dents, the staff doctors and volun¬ 
teer specialists involved with the 
Free Clinic all show a different 
face. “It’s free for the physicians as 
well as for the patients,” is how 
one cardiologist put it to a televi¬ 
sion reporter. He wore a look of 
immense delight and satisfaction 
as he talked about the patients he 
treats as a volunteer. “If Dr. Gibbs 
wants me to do a test on a patient, I 
say, ‘Sure.’ I don’t have to get on 
the phone and call some bureau¬ 
crat. I don’t need an extra $100. 
What I need is an opportunity to 
fulfill my need to be a giver, and to 
be appreciated for it.” 
“We still have paperwork, but 
it’s not annoying paperwork,” says 
Tricia Gibbs. “We take notes and 
keep charts. But we don’t fill out 
forms.” The time they gain by not 
arguing with insurance companies 
or shuffling Medi-Cal forms saves 
about an hour a day, time that they 
invest in seeing more patients. 
What may seem like a fantasy to 
some physicians in private practice 
is the routine at the San Francisco 
Free Clinic. YM 
The success of the San Francisco Free Clinic is measured, in part, by the 
increasing number of medical students and residents who receive training 
there. Above, Richard Gibbs and Alexander Z. Rivkin, a Yale medical stu¬ 
dent now in his final year, talk during Mr. Rivkin’s primary care clerkship 
at the clinic in September. 
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INTERVIEW 
Carolyn W. Slayman, Ph.D 
“My job is to be the catalyst, ” 
says the school's first deputy dean 
for academic and scientific affairs. 
Photographs by Peter Casolino 
Carolyn W. Slayman had completed her Ph.D. 
training in biochemical genetics at the Rocke¬ 
feller University and taught in Western Reserve 
University’s biology department for three years 
when she started her career as an assistant profes¬ 
sor at the Yale University School of Medicine 
in 1967. 
Since then, her accomplishments have been 
characterized by firsts: the first woman to chair a 
medical school department at Yale and the first 
woman to become a deputy dean at the school. 
She was appointed chair of the Department of 
Human Genetics, later renamed the Department 
of Genetics, in 1984, and she was named deputy 
dean for academic and scientific affairs last fall 
when the school’s administration was restructured 
in response to the increasingly complex demands 
placed on academic medicine. In 1991, Yale Uni¬ 
versity recognized her academic excellence by 
naming her Sterling Professor of Genetics. 
Born in Portland, Maine, Dr. Slayman gradu¬ 
ated from Swarthmore College in 1958 with high¬ 
est honors in biology and chemistry. She received 
her Ph.D. degree in 1963 from Rockefeller Uni¬ 
versity, and spent the following year as a National 
Science Foundation postdoctoral fellow at Cam¬ 
bridge University. After serving on the Western 
Reserve University faculty in Cleveland, she 
came to Yale, where she has centered her research 
on the proteins that transport nutrients across cell 
membranes and the genes that code for those pro¬ 
teins. During this time, she has been a mentor and 
role model to many graduate students and post¬ 
doctoral felloes alike. 
She is active in professional organizations, 
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having recently completed a term 
on the National Advisory General 
Medical Sciences Council at the 
National Institutes of Health. She 
serves on the Scientific Review 
Board of the Howard Hughes Med¬ 
ical Institute and is a trustee of 
Bowdoin College in Brunswick. 
Maine. 
In this Yale Medicine inter¬ 
view, Dr. Slayman talks with 
Helaine Patterson, director of the 
School of Medicine’s Office of 
Public Information, about the 
direction of the school's academic 
and scientific affairs. 
YALE MEDICINE: LAST FALL, 
THE OFFICE OF THE DEAN WAS 
RESTRUCTURED AND THE POSI¬ 
TION AND OFFICE OF DEPUTY 
DEAN FOR ACADEMIC AND SCI¬ 
ENTIFIC AFFAIRS WAS ESTAB¬ 
LISHED. WHAT ARE THE 
OFFICE'S STRUCTURE AND 
MAJOR PROGRAMMATIC 
THRUSTS? 
Carolyn slayman: The office 
has a number of broad responsibili¬ 
ties for academic and scientific 
programs, and for the faculty of the 
medical school. Before describing 
them, though, let me begin by 
emphasizing my close working 
relationship with the other Deputy 
Deans: Joseph B. Warshaw, M.D., 
(clinical affairs) and Stephen M. 
Cohen (financial affairs and 
administration). As you can imag¬ 
ine, much of the planning and deci¬ 
sion-making that goes on at the 
medical school cuts across all three 
areas. When a senior faculty mem¬ 
ber is being recruited or a major 
new academic program is being 
launched, all three of the deputy 
deans work together. Likewise, all 
three of us are deeply involved in 
financial and space planning, and 
we meet regularly with the chairs 
and business managers of each of 
the medical school’s departments 
to make sure that thinking at the 
department level is woven into a 
broader picture for the school as a 
whole. In fact, it was exactly this 
kind of interweaving and sharing 
of responsibilities that Dean Bur¬ 
row had in mind when he reorga¬ 
nized the dean’s office last year. 
you mentioned that your 
OFFICE HAS A SPECIAL 
RESPONSIBILITY FOR THE 
FACULTY OF THE MEDICAL 
SCHOOL. COULD YOU 
DESCRIBE IT? 
As you know, the medical school 
has a large and extraordinarily tal¬ 
ented faculty who teach, do 
research and care for patients. In a 
very real sense, these people define 
the excellence of the place, and it’s 
critical to use the highest possible 
standards as we make decisions 
about appointments and promo¬ 
tions. It’s also critical to offer help 
and encouragement to the faculty 
as they cope with professional 
challenges and career decisions 
that can be quite stressful: how to 
find the next research grant, for 
example, or how to juggle respon¬ 
sibilities toward students, patients 
and co-workers. 
Last year, I learned a lot about 
the scope and structure of the med¬ 
ical school faculty by chairing both 
the Tenure Allotment Committee 
and the Senior Appointment and 
Promotions Committee. I also 
worked closely with Norman 
Siegel, M.D., [acting chairman 
of pediatrics] who headed a task 
force to examine our faculty ranks 
and tracks. The task force’s report 
will be ready soon, and it will 
recommend the creation of two 
new tracks—a clinician-educator 
track and an investigator track— 
to respond to the changing envi¬ 
ronment in health care and bio¬ 
medical research. 
WE UNDERSTAND THAT 
THERE HAVE ALSO BEEN 
CHANGES IN THE OFFICE OF 
FACULTY AFFAIRS. 
Yes, we’ve recruited a new associ- 
Carolyn W. Slayman, Ph.D., discusses opportunities for technology transfer 
with Jon Soderstrom, Ph.D., and Ben Muskin, new members of the expanded 
Office of Cooperative Research. The University opened a branch office at 
the medical school in July. The office guides faculty who have made discov¬ 
eries in their work to translate those discoveries into a form that can be 
patented and marketed. 
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“In a very real sense, the faculty 
define the excellence of the place, 
and it’s critical to use the highest 
possible standards as we make 
decisions about appointments 
and promotions.” 
ate dean for faculty affairs to head 
what Yale informally calls the 
faculty office: Morton G. Glick- 
man, M.D., a member of the 
Department of Diagnostic Radiol¬ 
ogy since 1973. 
The faculty office is where all 
of our appointments and promo¬ 
tions are handled and faculty 
records are kept. It does an enor¬ 
mous amount of advising of chairs 
and faculty members about matters 
of appointments, promotions and 
career development—questions 
that range from rather specific 
ones: “Am I eligible for sabbati¬ 
cal?” “What if I want to take a 
leave of absence?” to much more 
complicated ones, such as: “I am 
an assistant professor in a clinical 
department. I love research, but I 
also love working with patients. 
I’m not sure yet whether it makes 
sense for me to plan my career to 
advance through what Yale would 
call the academic track, where 
there’s a lot of emphasis on 
research, or along the clinical 
track, where there’s more emphasis 
on direct work with patients.” 
In addition, the school’s Office 
of Academic Development, headed 
by Associate Dean Merle Waxman, 
M.A., enhances academic growth 
and career development of faculty, 
fellows and students. Merle 
arranges educational programs 
and oversees mentoring opportuni¬ 
ties at the school, and works 
closely with other components of 
my office. 
Both Merle and Mort have 
wonderful opportunities to meet 
our faculty members at very early 
stages in their time at Yale and to 
help guide them in their careers. 
That’s also part of what comes 
under the heading of academic 
and scientific affairs. 
COULD YOU BRIEFLY DISCUSS 
SCIENTIFIC AFFAIRS, BOTH 
PROGRAMATICALLY AND 
ADMINISTRATIVELY? 
In scientific affairs, we are recon¬ 
figuring the school’s grants and 
contracts and technology-transfer 
activities to make resources avail¬ 
able to our faculty from the dean’s 
office as they seek external support 
for their work. The new director of 
our grants and contracts office is 
Jill Schneider, who holds an M.S. 
degree from Massachusetts Insti¬ 
tute of Technology’s Sloan School 
of Management. Jill has experience 
in the pharmaceutical industry and 
more recently as business manager 
of the Yale Department of Derma¬ 
tology, so she knows the Univer¬ 
sity very well. She works closely 
with the departments to streamline 
the process of submitting grants 
and to improve the way in which 
we disseminate information about 
grant possibilities. The faculty are 
very busy doing their own 
research, and yet they’re totally 
dependent on being able to gener¬ 
ate external support for it. We want 
to be sure that all faculty members 
are notified very quickly of new 
funding opportunities that may be 
relevant to their work. Jill will 
devise better systems, we hope 
Dr. Slay man talks with Ira Mellman, Ph.D., 
about the new Biological and Biomedical 
Sciences program, which has streamlined 
the application process for graduate stu¬ 
dents and broadened their opportunities 
within Yale. Dr. Mellman, professor of cell 
biology, is director of the new program. 
electronically, to get word out to 
our faculty when a new foundation 
is formed or the National Institutes 
of Health (NIH) announces a new 
program of research support on a 
particular disease or a particular 
problem in biomedical research. 
There’s a lot of re-engineering 
under way in the grants and con¬ 
tracts process. 
The second key person is Sara 
Rockwell, Ph.D., a radiation biolo¬ 
gist and faculty member since 
1974. Sara’s research has centered 
on the biology of cancer cells in 
solid tumors and on using that 
information to improve cancer 
therapy. She’s remaining active in 
the laboratory but will spend half 
of her time as director of our Office 
of Scientific Affairs. She’ll work 
very closely with Jill. Where the 
main emphasis of Jill’s work will 
be on administrative procedures, 
Sara will work more directly with 
the faculty. This spring, for exam¬ 
ple, Sara and others set up a series 
of well-attended workshops that 
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“The traditional 
department-based way of 
recruiting faculty has 
been a rigorous one, and 
it has allowed the 
medical school to build 
an enormously strong 
faculty of scientists and 
teachers, of whom we're 
very proud. ” 
focused on how to prepare an NIH 
grant application, how to describe 
a proposed scientific project, how 
to formulate the budget, and how 
to respond to criticisms that may 
come from the study section. She 
will continue these workshops and 
has others in mind—for example, 
to help postdoctoral fellows find 
ways to get fellowship support and 
apply for jobs. So, there’s an edu¬ 
cational function to the Office of 
Scientific Affairs. 
The other important compo¬ 
nent of Sara’s job is to serve as an 
active liaison between my part of 
the dean’s office and the medical 
school's various research support 
functions, including core research 
laboratories that offer our scientists 
access to modern technology such 
as confocal microscopy, DNA and 
protein sequencing, and the con¬ 
struction of transgenic mice. Sara 
will be a link from the dean’s 
office to help those core research 
laboratories improve their services. 
She also interacts in a very impor¬ 
tant way with the Yale Animal 
Resource Center. Because so much 
of our research involves laboratory 
animals, Sara works both with 
users of animals and with Robert 
Jacoby, D.M.V., Ph.D., professor 
and chairman of comparative med¬ 
icine and director of the Division 
of Animal Care, and his staff to be 
sure that we’re doing everything 
we can possibly do to keep our ani¬ 
mal facilities and practices up-to- 
date. And she is our link with the 
regulatory committees: the 
Human Investigation Committee, 
the Animal Care and Use Commit¬ 
tee, the Biosafety Committee, the 
Radiation Safety Committee—all 
of those committees which have 
critical functions in overseeing 
various aspects of medical research 
to make sure it’s done properly 
and safely. 
COOPERATIVE RESEARCH IS 
THE THIRD COMPONENT OF 
YOUR OFFICE. WHAT IS THE 
MEDICAL SCHOOL DOING TO 
FORM NEW PARTNERSHIPS 
WITH INDUSTRY? 
Quite a lot. On July 1, a branch of 
the University’s Office of Coopera¬ 
tive Research opened at the med¬ 
ical school. This office, set up in 
1982 through the efforts of the 
Provost, helps the faculty with 
matters of technology transfer. It 
guides people who have made dis¬ 
coveries in their work to translate 
those discoveries into a form that 
can be patented and marketed. As 
an example, one might cite Lyme 
Chair of the Department of Genet¬ 
ics before assuming her new role 
in the dean s office. Dr. Slayman 
remains active in research. “My 
laboratory is, fortunately, immedi¬ 
ately downstairs from my adminis¬ 
trative office, so a favorite thing to 
do when I get a break of even 15 or 
20 minutes is to pop downstairs 
and talk to a postdoctoral fellow 
about an experiment. It’s a nice 
way to punctuate the day. ” 
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Dr Slayman meets with Jill Schneider, right, director of the Office of Grants and 
Contracts. New systems are being devised to get word of finding opportunties to 
faculty quickly, says Dr Slayman: “There’s a lot of re-engineering under way in the 
grants and contracts process. ” 
disease, a very active area of 
study at Yale. Work on a Lyme 
disease vaccine has been helped 
by the efforts of the Office of 
Cooperative Research, putting 
Yale faculty members who work 
in this area in contact with a com¬ 
pany interested in testing and pro¬ 
ducing the vaccine. 
For more than 10 years, the 
cooperative research office has 
been based on the main campus, 
and we’ve all felt that it was a lit¬ 
tle too distant from the medical 
school. There’s a figure worth 
quoting here: more than 80 per¬ 
cent of Yale discoveries reported 
to the cooperative research office 
have come from the School of 
Medicine. All of this activity has 
prompted the need for a more 
prominent presence on Cedar 
Street. Yale is very fortunate this 
year to have recruited a new 
director for the Office of Cooper¬ 
ative Research, Gregory E. Gar¬ 
diner, Ph.D., who arrived in Febru¬ 
ary. Greg has set up a branch office 
in the medical school headed by E. 
Jonathan Soderstrom, Ph.D., who 
comes to us from Oak Ridge 
National Laboratory. Jon and his 
co-worker, R. Bennett Muskin, 
have begun to walk around the 
halls of the medical school, 
introducing themselves to our sci¬ 
entists and getting to know people 
who are doing work that is poten¬ 
tially transferable into the private 
sector. Their aim is to be as helpful 
as possible at an early stage in 
the research. 
Greg Gardiner, Jill Schneider 
and Sara Rockwell have been 
meeting together and meeting 
with me to think about ways in 
which their efforts can be inte¬ 
grated. Often people’s work is 
supported at the beginning by 
grants and later by contracts, so 
there should be a seamless flow 
in the availability of information 
and support to our faculty. As 
the three administrators work 
together to improve access to 
information and help, next year 
will be a key time when these 
efforts will begin to pay off in a 
way that’s visible to our faculty 
and research staff. 
ARE THERE OTHER AREAS IN 
WHICH YOUR OFFICE IS 
INVOLVED? 
Yes, I’ve also been working with a 
number of other key people in the 
medical school. I work directly 
with Nancy Roderer, M.L.S., who 
heads our medical library; with 
John Paton, Ph.D. who heads acad¬ 
emic computing; with James D. 
Jamieson, M.D., Ph.D., head of the 
M.D./Ph.D. program, and I’m 
looking forward to working with 
Ira S. Mellman, Ph.D., director of 
the combined graduate program in 
biological and biomedical sciences 
established this summer as a result 
of two years of very hard work 
throughout the University. We’re 
going to have a much better inte¬ 
grated Ph.D. program at Yale, and 
Ira will work closely with me, as 
well as with Graduate School Dean 
Thomas Appelquist, Ph.D. So, 
there’s an educational side of the 
office as well. 
DURING THE NEXT FOUR 
YEARS, WHICH WILL END THE 
20th CENTURY, ARE THERE 
ANY PROGRAMMATIC GOALS 
OR PARTICULAR AREAS OF 
RESEARCH OR SCIENTIFIC 
AFFAIRS THAT YOU THINK WILL 
BE EMPHASIZED? 
Absolutely. Let me talk about sev¬ 
eral things here. The first is the 
very important question of how the 
School of Medicine sets its scien¬ 
tific direction. This should not be 
the purview of any one person. It 
should be the result of collective, 
careful, wise thinking on the part 
of the academic leaders of our 
school. My job is to be a catalyst. I 
try to bring people together and 
foster active discussion that will 
guide us, as faculty positions 
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Dr. Slayman discusses an experi¬ 
ment with members of her labora¬ 
tory’ in Sterling Hall of Medicine. 
Her research has centered on the 
proteins that transport nutrients 
across cell membranes and the 
genes that code for those proteins. 
become available, to recruit new 
people in directions that are the 
most exciting ones we can possibly 
think of. 
The traditional, department- 
based way of recruiting faculty has 
been a rigorous one, and it has 
allowed the medical school to 
build an enormously strong faculty 
of scientists and teachers, of whom 
we're very proud. But as science 
becomes more interdisciplinary, 
it’s important for departments to 
work together in defining areas 
that the school wants to sustain and 
strengthen. An example would be 
cancer research. Many parts of the 
medical school have a current 
strength in cancer research, and an 
interest to make sure that we 
remain at the forefront of that field. 
Included would be the Cancer Cen¬ 
ter, which is an integrating struc¬ 
ture for the school; clinical depart¬ 
ments such as internal medicine 
and pediatrics, bridge departments 
such as pathology and genetics, 
and basic science departments like 
cell biology and pharmacology. 
Instead of having each department 
think separately about how it wants 
to sustain its strength and search 
for young faculty members when 
the opportunity arises, we want to 
encourage discussion across 
departments, to get people talking 
about the future of cancer research, 
the most promising directions, and 
where we should put our resources 
as we recruit new faculty members. 
To follow that particular example a 
step further, there’s a growing con¬ 
sensus that one of the most excit¬ 
ing areas in cancer research has to 
do with the regulation of the cell 
cycle. How are cells regulated as 
they go through cell division? We 
need to be stronger in this area. By 
coordinating recruitment of junior 
people over the next few years, the 
opportunity exists for us to build 
that kind of strength together more 
effectively than any one depart¬ 
ment would be able to do by itself. 
Along with the recruitment of 
faculty, we need to offer them an 
absolutely outstanding scientific 
environment. In particular, we 
must have first-rate laboratory 
space. It’s no secret that we are not 
happy with the current state of lab¬ 
oratory space at the medical 
school, although some is new and 
handsome, such as the Boyer Cen¬ 
ter, and some of the older areas 
have been nicely renovated over 
the past few years. There’s a lot of 
deferred maintenance, and we must 
embark on a program of renovation 
and modernization of our laborato¬ 
ries if our scientists are going to be 
able to do their best work. We’ll be 
modernizing existing laboratories, 
starting this year with the first floor 
of the B-Wing of Sterling Hall of 
Medicine. It is an old building but 
still has scientific life in it. The 
walls and basic structure are very 
sound, but the interior, particularly 
in the B-Wing and C-Wing labora¬ 
tories. has not been renovated for 
30 years and is really suffering. 
The air handling is inadequate, and 
other aspects of the infrastructure 
are limiting. The laboratories 
themselves, the benches and the 
sinks, even the layout, are a bit 
antiquated. The tendency now is 
for people to want to work in open 
laboratories in order to encourage 
cross fertilization between labora¬ 
tory groups. 
THE BOYER CENTER WOULD BE 
A GOOD EXAMPLE. 
Yes, the Boyer Center has doors 
that connect laboratories, so stu¬ 
dents and staff members from one 
group are always talking with peo¬ 
ple in the neighboring groups. In 
older space, this is simply not pos¬ 
sible. People didn’t recognize the 
value of that interconnectedness 
for a long time, and our older labo¬ 
ratories are laid out like separate 
little boxes, inhibiting discussion 
and the sharing of equipment and 
ideas. Not only do we want to 
upgrade the labs physically and 
make them function better, we also 
want to lay them out differently, 
more in tune with modern ways of 
doing research. 
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ANOTHER TOPIC. FOR MANY 
YEARS, PEER REVIEW HAS 
BEEN PART OF THE SCIENTIFIC 
TRADITION. ARE ANY MODIFI¬ 
CATIONS NEEDED? IF SO, 
WHAT NEEDS TO BE DONE FOR 
THE 21ST CENTURY? 
NIH, under the leadership of 
Harold Varmus, has been looking 
carefully at the peer review process 
recently, evaluating it and making 
changes. Yale medical school fac¬ 
ulty members have been very 
active in that evaluation. We have 
more than 50 scientists who sit on 
advisory councils of NIH institutes 
or serve on study sections. Our sci¬ 
entists are well-connected in Wash¬ 
ington and very much part of the 
self-examination that NIH has 
been going through. 
But I’ll focus my remarks on 
the medical school. We need not 
only to keep up-to-date with what’s 
going on in Washington, partici¬ 
pate in it and help it where we can, 
but we also need to think about our 
own local procedures. Discussions 
are under way about the possibility 
of a pre-review process that could 
help our scientists submit really 
strong, competitive applications 
for funding. Several other universi¬ 
ties and medical schools have a 
system in place where a faculty 
member who wants to submit a 
grant doesn’t send it directly 
through the grants and contracts 
office to Washington, but rather 
prepares it early enough so it can 
be read critically either by a col¬ 
league in the same department, by 
members of a large and diverse 
committee, operating out of the 
grants and contracts office. If one 
or two colleagues were to look at 
an early draft of a grant application 
and send it back with constructive 
criticism, this would be a kind of 
peer pre-review that would help 
the scientists realize: “Maybe that 
experiment has a flaw, and I’ll 
think about it again.” By having 
the benefit of constructive criti¬ 
cism, the application that goes 
down to NIH would be stronger 
and have a better chance of being 
funded. So, we'll be thinking very 
hard during the next year about 
whether we want to set up that kind 
of mechanism, at least on an exper¬ 
imental basis. We’ll be talking with 
our scientists to see whether 
they're interested in it. 
On the one hand, people are 
nervous about submitting grant 
applications these days. They 
know how competitive the situa¬ 
tion is at NIH, and they will want 
to do whatever they can to make 
their own applications as strong as 
possible. On the other hand, people 
are awfully busy. Anything that 
requires preparing an application, 
not just for the deadline but maybe 
a month ahead, and asks you to 
take a turn serving on one of these 
review committees and to give 
some of your time to help your col¬ 
leagues is a serious undertaking, 
and would have to be organized 
very carefully. 
FEDERAL SUPPORT FOR BIO¬ 
MEDICAL RESEARCH CONTIN¬ 
UES TO BE A MAJOR CONCERN 
IN WASHINGTON AND ON UNI¬ 
VERSITY CAMPUSES. HOW IS 
THE DEBATE IN WASHINGTON 
AFFECTING YALE? 
There’s an enormous amount of 
nervousness at Yale and in other 
research-intensive universities and 
medical schools, as you can imag¬ 
ine. We heaved a collective sigh of 
relief earlier this year when, some¬ 
what surprisingly, Congress was 
persuaded to give a healthy 
increase of 5.7 percent to the NIH 
budget for fiscal year 1996. That 
was terrific, and the funds are 
being very well used. But, as we all 
know, the political process in 
Washington works one year at a 
time, and it’s very hard to know 
what’s in store. 
The budget forecasts that 
we’ve seen for the future don't 
look good. Requests for funds for 
biomedical research are going to 
have to compete with other priori¬ 
ties, and it’ll be a very political 
process. Many of our scientists are 
active in professional societies, 
which are trying to educate the 
Congress. Many people in top 
administrative posts at Yale have 
themselves been quite active in 
making the case as strongly as 
they possibly can that this coun¬ 
try’s system of biomedical 
research, which has evolved over 
the past 50 years, shouldn't be 
allowed to go downhill because of 
lack of funding. 
AS A GENETICIST AND FORMER 
CHAIR OF GENETICS, ARE YOU 
STILL INVOLVED IN GENETIC 
RESEARCH? 
I’m determined to stay active as a 
faculty member in the Department 
of Genetics, and I have a research 
lab that is still going strong. We’ve 
done research for a number of 
years now on genes that code for 
transport proteins that move ions 
back and forth across the cell 
membrane. We’re making muta¬ 
tions and looking at the effect of 
mutations on ion transport. It’s 
very basic research. 
My laboratory is, fortunately, 
immediately downstairs from 
my administrative office, so a 
favorite thing to do when I get a 
break of even 15 or 20 minutes is 
to pop downstairs and talk to a 
postdoctoral fellow about an 
experiment. It’s a nice way to 
punctuate the day. YM 
“We need not only to keep 
up-to-date with what's 
going on in Washington, 
participate in it and help it 
where we can, but we also 
need to think about our own 
local procedures 
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GALLERY 
The haunted faces 
of mental illness 
Clements C. Fry Collection of Med¬ 
ical Prints and Drawings of the 
Historical Library of the Harvey 
Cushing/John Hay Whitney Med¬ 
ical Library. 
In part, they document a history 
of viewing mentally ill people as 
bizarre medical exhibits. They also 
show how the treatment and image 
of mental illness develop hand in 
glove. The medieval exorcism of 
devils (that failing, burning at the 
stake was common) gave way in the 
1600s to removal by “enlightened” 
physicians of “stones of folly” from 
the heads of the mentally ill. Pseu¬ 
doscience, quackery and cruelty 
were long part of treating the men¬ 
tally ill. During the late 1600s, con¬ 
finement and isolation of the men¬ 
tally ill began. The notoriety of 
Bedlam—popular name for Lon¬ 
don’s Hospital of St. Mary of Beth¬ 
lehem—soon came to express the 
horrors of life with mental illness. 
Beginning in the 19th century, 
the study of mental illness began to 
take on its modem, scientific cast. 
Lacking adequate tools for treat¬ 
ment, however, the diagnostic and 
artistic focus remained the experi- 
This engraving from Tony Robert-Fleury's 
1876 painting, Pinel Freeing the Insane, 
shows the release of patients at the 
Salpetriere asylum in Paris from their 
restraints by Philippe Pinel. The reform- 
minded Pinel was the first psychiatrist to 
attempt more humane treatment after more 
than two centuries of isolation cells and 
chains for the mentally ill. 
Madness as satanic possession 
marks the earliest images of mental 
illness from the Whitney/Cushing 
Medical Library’s exhaustive 
Clements C. Fry Collection of Med¬ 
ical Prints and Drawings. Exorcism 
was long believed a cure for mental 
illness. This 16th-century German 
woodcut, based on the story of a 
young, mentally ill woman believed 
possessed by the devil, shows the 
“therapy ” at work. Background 
image: An 1880 etching by Paul 
Richer portraying a demonic attack. 
The face of madness,” wrote 
the late French philosopher 
and historian Michel Fou¬ 
cault, “haunts the imagination of 
Western man.” Haunts is the correct 
metaphor. The words commonly 
used to describe mental illness con¬ 
vey this sense of invasion by pow¬ 
erful, malevolent forces: unhinged, 
plagued, possessed, weighted down, 
imbalanced and worse, often far 
worse. The artistic, religious and 
medical representations of mental 
illness turn these metaphors into 
terror-filled visual images. Devils 
and ghouls invade, stones grow 
from skulls, faces contort, objects 
crush, spikes pierce heads, brains 
spill forth. In image after image, the 
faces contort in the agony of being 
besieged by forces beyond control. 
Artists have long been drawn to 
the subject of mental illness. 
Images of fools, witches, madmen 
and demonic possession can be 
traced back to 14th-century illumi¬ 
nated manuscripts. Later artists, 
including Durer, Breughel, Hoga¬ 
rth, Goya and Van Gogh, found sub¬ 
ject matter there, too. This survey of 
historical images is culled from the 
Left: Quackery has long plagued treatment of 
the mentally ill. Note the assistant’s hand draw¬ 
ing out “stones of folly” from his pouch to be 
“extracted” by the surgeon from the patient’s 
head in Claes Janz Weydtmans early 17th-cen¬ 
tury Flemish engraving. 
Below: Spanish artist Daniel Urrabieto y Vierge 
worked in France in the late 19th century. Yard 
of an Asylum depicts the more humane condi¬ 
tions of the open, if walled, yard. 
ence of possession and the face of 
the possessed. Paul Richer, a 
superb draftsman as well as clini¬ 
cian working with Jean-Martin 
Charcot at the Salpetriere asylum 
in Paris, drew images of stages in 
mental illness, such as the 
“demonic attack” phase of hysteria 
reproduced here. Even the 20th- 
century American artist Boris 
Artzybasheff pictures the face of 
Anxiety as contorted and mon¬ 
strous as uncontrollable outside 
forces terrorize and overwhelm. 
Today’s representation of men¬ 
tal illness, the brain scan, goes 
beyond the face for the first time. 
Treatment and image remain insep¬ 
arable. As one gains a clearer pic¬ 
ture of the many environmental and 
biological forces at work in mental 
illness, the ancient fear of posses¬ 
sion and the possessed loses its 
force. One day, through research, 
the haunted faces of the mentally ill 
will disappear into artistic and 
medical history altogether. 
Marc Wortman 
Above: English illustrator George Cruishank 
depicted various forms of mental disorders in 
his popular caricatures. The Blue Devils of 
1836 shows the overwhelming weight of 
depression. As comic as the figure appears, 
the very real threat of suicide plagues him. 
Left: The 20th-century’ American artist Boris 
Artzybasheff continues the tradition repre¬ 
senting the mentally ill as besieged by terrify¬ 
ing outside forces. A detail from his 1947 
work Anxiety portrays the victim as trapped, 
unable to move. 
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SCOPE 
YCC launches 
new program in 
cancer genetics 
The Yale Cancer Center has estab¬ 
lished a new program in cancer 
genetics to help patients with the 
dilemmas raised by advances in 
genetic research. 
"Testing positive for genetic 
predisposition to cancer does not 
necessarily mean a patient will get 
cancer, but rather that the patient 
has a genetic mutation that 
increases the likelihood,” explains 
Allen Bale, M.D., director of the 
Cancer Genetics Program. 
“There is very little genetic 
testing being done now,” says 
Susan Mayne, Ph.D., associate 
director for cancer prevention and 
control at the Yale Cancer Center, 
the first Connecticut institution to 
offer a cancer genetics program. 
"For the most part, family histories 
have been relied upon to determine 
a course of action.” 
Initially, the Yale program is 
offering testing only to those peo¬ 
ple with a family history of cancer. 
But it is the role of the genetic 
counselor to help prospective 
patients decide whether they even 
want to have a test. 
“It’s important to educate 
patients before testing so they can 
decide what’s right for them,” 
says Yale Cancer Center coun¬ 
selor Ellen Matloff, M.S. “Some 
patients don't want to know—it 
would impair their quality of life. 
For others, knowledge is empow¬ 
ering; it helps them plan and 
make important life and lifestyle 
decisions.” She adds that the 
stress of not knowing is often the 
worst part. 
Dr. Mayne says that once a 
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genetic predisposition to cancer is 
determined, the big question is 
what to do with the knowledge. 
“Just knowing you have this 
genetic susceptibility doesn’t do 
much good if you can’t do any¬ 
thing about it. That’s why our can¬ 
cer prevention and control efforts 
and cancer genetics efforts are 
closely linked.” 
By focusing on families, 
researchers find broader implica¬ 
tions because these families may 
hold the key to the genetics of can¬ 
cer as a whole. In pursuit of under¬ 
standing how cancer develops and 
how to prevent and treat it, scien¬ 
tists at the Yale Cancer Center are 
trying to learn more about carriers 
with and without the disease. 
The study of genetic suscepti¬ 
bility also presents the challenge of 
defining effective approaches for 
counseling individuals from high- 
risk families concerning genetic 
testing. “We do not yet know the 
best way to counsel people with a 
familial predisposition to cancer,” 
says Dr. Mayne. “An approach that 
works for prenatal diagnostics, for 
example, may not be optimal when 
dealing with cancer. 
Medical van brings care 
to the community 
Across New Haven, a new 36- 
foot van is delivering medical 
care to residents who in the past 
may have fallen through the 
cracks of the health system. 
The new Community Health 
Care Van is the centerpiece of 
an innovative research and eval¬ 
uation project, one of the newest 
national models to provide 
health care to drug users and 
other medically underserved city 
residents, says Frederick L. 
Altice, M.D., assistant professor 
of medicine at Yale School of 
Medicine and a member of the 
Yale AIDS Program. 
With this new van, Dr. Altice 
Community 
Health Care 
Yale investigators clone 
a gene for skin cancer 
Researchers from the U.S., Aus¬ 
tralia, and Sweden have combined 
forces to isolate the gene for basal 
cell carcinoma of the skin, accord¬ 
ing to findings published recently 
in the journal Cell. These findings 
could lead to skin cream that 
would cure the disease, and to 
genetic testing for susceptibility to 
skin cancer. 
The newly identified gene, 
called PTCH, is essential for keep¬ 
ing skin cells under control. 
“Genetic mutation of PTCH is the 
key step in development of skin 
cancer,” says Allen E. Bale, 
M.D., senior author of the Cell 
paper and director of the Cancer 
Genetics Program at the Yale Can¬ 
cer Center. 
and his colleagues hope to dis¬ 
cover whether this care and other 
directed efforts will help decrease 
or alleviate emergency depart¬ 
ment visits for acute health care 
problems and increase the use of 
primary care services. The project 
is sponsored by the School of 
Medicine, the Hospital of St. 
Raphael, the City of New Haven 
and its health department, Yale- 
New Haven Hospital, the Hill 
Health Center, Fair Haven Commu¬ 
nity Health Clinic and the APT 
Foundation. 
“We aim to do preventive out¬ 
reach as a model to reflect the 
needs of the community,” says Dr. 
Altice. The van will travel through¬ 
out New Haven in tandem with the 
city’s Needle Exchange Program. 
The van also will be used by 
another Yale program, the Medical 
Residents Training Program, 
which provides medical services 
one day a week to individuals at 
city soup kitchens. 
Since the mobile medical 
This discovery paves the way 
for novel approaches to prevent¬ 
ing and treating basal cell carci¬ 
noma, according to David J. Lef- 
fell, M.D. HS '84-87, associate 
professor of dermatology at Yale 
and a co-author of the report. 
“Although it’s still several 
years away, it’s not unreasonable 
to imagine an ointment that, when 
applied to the skin, may control 
the growth of the cancer,” says Dr. 
Leffell. “Because skin cancers 
occur externally, a dose of a med¬ 
ication that can replace the func¬ 
tion of the faulty gene could be 
applied directly to the cancer 
while minimizing side effects.” 
In 1992, Dr. Bale began stud¬ 
ies on the nevoid basal cell carci¬ 
noma syndrome (NBCCS) gene, a 
gene connected to a rare heredi¬ 
tary disorder where sufferers 
develop thousands of skin cancers 
and may also have birth defects 
and childhood brain tumors. He 
mapped the NBCCS gene to 
human chromosome 9, and after 
sorting through 40 other genes, 
reported isolation of PTCH, a 
human gene similar to a previ¬ 
ously reported fruit fly gene. “No 
one had a clue that this gene had 
anything to do with human cancer, 
but some of the features in fruit 
flies were strangely similar to the 
birth defects in NBCCS,” says Dr. 
Bale, associate professor of genet¬ 
ics and medicine at Yale. 
The researchers found that 
individuals with NBCCS are 
born with a mutation of PTCH 
in all of their cells. Further inves¬ 
tigation revealed the same muta¬ 
tion in non-inherited tumors, 
which account for the vast major¬ 
ity of basal cell carcinomas. In 
those tumors, the mutation was 
health clinic program began in 
1993, more than 1,800 men and 
women between the ages of 20 
and 45 have been served. Dr. 
Altice hopes to more than double 
that amount with the new van. 
As part of this federally fund¬ 
ed project, the Yale team will fol¬ 
low 500 drug users and look at 
the way they use health care ser¬ 
vices. “We will see if people who 
have repeated interaction with the 
van change from episodic and 
fragmented care to primary 
care. We also will explore how dif¬ 
ferent people perceive health 
care, and how and why drug users 
use certain kinds of care,” adds 
Dr. Altice. 
The van and related aspects 
of the research and evaluation 
project are supported by a four- 
year, $3 million grant made to the 
Yale School of Medicine by the 
National Institute on Drug Abuse. 
Dr. Altice is this grant’s principal 
investigator. ■ 
! 1 
U.S. Rep. Rosa DeLauro congratulates 
Frederick L. Altice, M.D., assistant pro¬ 
fessor of medicine, at the dedication cer¬ 
emony for a new community health van 
serxing New Haven neighborhoods. The 
van, left, is the centerpiece of a project 
to provide health care to city residents 
who max not otherwise receive it. 
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often caused by exposure to ultra¬ 
violet light. 
A second Yale study, reported 
in the September 1996 issue of 
Nature Genetics, expanded on 
these findings. Assistant professor 
of pediatrics Mae Gailani. M.D., 
and colleagues reported a larger 
test of the notion that genetic muta¬ 
tions may cause non-inherited 
basal cell cancers. 
They discovered by means of a 
screening test that the gene was 
damaged in about a third of non- 
inherited basal cell tumors, and that 
these mutations had occurred 
within the tumors rather than being 
inherited. Then researchers took a 
closer look at the gene in two 
tumors where no genetic damage 
had been found. In both cases, the 
gene turned out to be mutated. 
According to Dr. Bale, the 
screening test probably overlooked 
most mutations in the gene. The 
gene may be damaged in most if 
not all non-inherited basal cell can¬ 
cers, he said. 
Cheryl Carlson’s sculpture of the pink 
breast cancer awareness ribbons serves as 
the basis for the pictorial cancellation 
used on the first day of issue of a new U.S. 
postal stamp. The stamp, of which one mil¬ 
lion have been printed, draws attention to 
the importance of early detection and 
treatment of breast cancer. Ms. Carlson, 
an East Lyme, Conn., woman who lost her 
battle with breast cancer in November 
1995, was honored at a first-day-of-issue 
ceremony at the Yale Cancer Center on 
June 15, which would have been her 45th 
birthday. ■ 
Medical, graduate 
schools streamline 
Ph.D. programs 
The School of Medicine, together 
with the Graduate School of Arts 
and Sciences, this fall initiated a 
combined, interdepartmental pro¬ 
gram for students who wish to pur¬ 
sue a Ph.D. degree in preparation 
for careers in the biological and 
biomedical sciences. 
Ira S. Mellman, Ph.D.. profes¬ 
sor of cell biology at the School of 
Medicine, has been named the first 
director of the Program in Biologi¬ 
cal and Biomedical Sciences 
(BBS), an amalgamation of 10 
major departments, sections and 
academic programs based at the 
School of Medicine. This program 
recognizes the excellence of the 
school’s research environment and 
the fact that research in the bio¬ 
medical sciences has become 
inherently interdisciplinary, no 
longer conforming to traditional 
departmental boundaries. It also 
coordinates programs and stream¬ 
lines the application process to 
attract outstanding students who 
are interested in the flexible and 
interdisciplinary program of study. 
More than 40 students entered 
the following interest-based tracks: 
genetics and development, cell 
biology and molecular physiology, 
neuroscience, molecular bio¬ 
physics, microbiology, immunol¬ 
ogy, pharmacology and molecular 
medicine, each of which draw 
their faculties from multiple 
departments. 
"Their first year is devoted to 
course work, hands-on training in 
high-technology areas, and a series 
of three laboratory rotations during 
which students are introduced to a 
wide range of research problems, 
faculty and methodological 
approaches,” says Dr. Mellman. 
“By the second year, students 
choose a mentor in whose labora¬ 
tory they perform their dissertation 
research.” 
Although degrees are ulti¬ 
mately awarded by existing depart¬ 
ments, the BBS program provides 
educational, administrative and 
social support for Ph.D. students. 
M.D.-Ph.D students also are inte¬ 
grated into this larger group during 
their laboratory research period. 
Conversely, BBS encourages its 
Ph.D. students to explore the 
emerging interface between funda¬ 
mental research and molecular 
medicine or human biology. 
Stipends and tuition for all students 
are provided from one of several 
sources, including NIH-sponsored 
training grants, private fellowships 
and endowed fellowships. 
Dr. Mellman is a Yale gradu¬ 
ate, having received his Ph.D. 
degree from the Department of 
Genetics in 1978. After spending 
three years as a fellow and assistant 
professor at Rockefeller Univer¬ 
sity, he returned to Yale and has 
been a faculty member ever since. 
For six years, he served as director 
of graduate studies in the Depart¬ 
ment of Cell Biology. 
Study shows that preemies 
fare better when fed earlier 
A new study suggests that feeding 
even the tiniest babies soon after 
birth helps stimulate a wide variety 
of important physical changes that 
promote growth and development. 
In a 12-center trial sponsored 
by the National Institute of Child 
Health and Human Development, 
researchers studied the effects of 
early feeding of milk or formula on 
1,665 premature infants, bom 
weighing between 1 to 3 pounds. 
They found babies under the age of 
nine days who received small 
amounts of dilute formula or breast 
milk through a nasogastric tube, 
gained weight faster than those 
who received no tube feedings. 
Delaying those feedings by as 
little as a week was associated with 
a lag in weight gain of 2 to 4 grams 
per day. 
"Keeping babies solely on 
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Researchers explore the 
quality control of the cell 
Within the body’s billions of 
cells exists a system so intri¬ 
cate that each protein manufac¬ 
tured must undergo a series of 
tests to ensure its quality. Yale 
cell biologists have taken on the 
challenge of unraveling this quality 
control system in an effort to 
better understand the cell’s 
behavior and its relationship to 
genetic diseases. 
According to Ari H. Helenius, 
Ph.D., professor and chairman of 
cell biology, the production of pro¬ 
teins in the human cell can be 
compared to a factory assembly 
line. “In a factory, before a new 
product is sent out, it has to pass 
quality control checks that are 
necessary to find error,” explains 
Dr. Helenius. “Similarly, when 
defects are discovered by the 
cell’s quality control, the proteins 
are noted and given time to cor¬ 
rect themselves. If no improve¬ 
ment occurs, the protein is 
removed and dismantled.” The 
intravenous feedings appears to 
result in atropy of the gastrointesti¬ 
nal tract, which usually doesn’t last 
long,” says Richard A. Ehrenkranz, 
M.D., HS ’72-74, professor of 
pediatrics at Yale and lead author 
of the study. He continues to say 
that when premature babies are fed 
small amounts of formula or breast 
milk from an early age, the feed¬ 
ings seem to prime the gastroin¬ 
testinal tract and make it more 
ready to accept full feedings of 
milk or formula. 
These findings were presented 
in June at the annual meeting of the 
American Pediatric Society, the 
European Society for Paediatric 
Research and the Society for Pedi¬ 
atric Research. 
system recycles the good compo¬ 
nents within the body. 
Also called architectural edit¬ 
ing, this system depends on the 
cell’s ability to recognize, retain 
and destroy incompletely assem¬ 
bled proteins, ensuring the struc¬ 
tural integrity of protein products. 
Sometimes, however, a functional 
protein with a minor defect is 
rejected resulting in more damage 
to the body than if the cell had 
allowed the slightly defective pro¬ 
tein through the system. 
When the blueprint for a given 
protein is defective, as in inherit¬ 
ed diseases such as cystic fibro¬ 
sis, some liver diseases and 
blood-clotting disorders, the pro¬ 
tein is destroyed, leaving no agent 
to perform necessary functions. 
Dr. Helenius says it is specifically 
these cases that make it so 
important for researchers to find 
ways of relaxing the stringency by 
which quality control works and 
thus, hopefully, eliminating the 
Research targets anxiety 
in children facing surgery 
A two-year study is under way at 
Yale focusing on the anxiety chil¬ 
dren suffer prior to surgery. 
According to Zeev N. Kain, 
M.D., assistant professor of anes¬ 
thesiology and pediatrics and head 
of this research, preoperative anxi¬ 
ety poses a threat to more than half 
a million children every year in the 
United States. 
"This psychological phenome¬ 
non may result in increased length 
of time to induce anesthesia, slow 
recovery from the anesthetic, slow 
wound-healing and a delayed 
release from the hospital,” says Dr. 
Ari H. Helenius, Ph.D. 
causes of such diseases. 
Using viral and cellular pro¬ 
teins as their tools, Dr. Helenius 
and his co-workers are analyzing 
the rules that govern the cell’s 
quality control system. They are 
identifying the various molecular 
players involved, and searching for 
drugs that could be used to regu¬ 
late the process in patients with 
hereditary diseases or infections. 
“We need to tell the quality control 
not to be so picky and to let cer¬ 
tain proteins go, even though the 
cell thinks it's the wrong thing to 
do. In certain cases, it will cause 
less difficulty to the body," says 
Dr. Helenius. ■ 
Kain. The children may also suffer 
long-term negative behavioral 
changes, including nightmares and 
other sleep disturbance, eating dis¬ 
orders and aggression against 
authority. 
Through this study. Dr. Kain 
hopes to better understand the root 
causes and risk factors for preoper¬ 
ative anxiety and discover ways to 
alleviate it so the psychological 
and physiological problems that 
children who undergo surgery face 
will not continue to grow. 
Collaborating with Dr. Kain 
are Linda C. Mayes, M.D., the 
Arnold Gesell Associate Professor 
of Child Development and Pedi- 
continued on page 40 ► 
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Defusing 
a time bomb 
At Yale, home of 
the nation’s first 
HHT clinic, there’s 
help for patients 
with rare bleeding 
syndrome. 
By John Green 
A century ago, a Parisian internist named Henri 
Rendu examined a patient who had been sent 
to him for recurrent bleeding. The cause, according 
to the referring physician, was hemophilia. 
A blood test, however, showed normal clotting, 
and a skeptical Dr. Rendu found blood vessels in 
the patient’s nose that were abnormal. Hemophilia 
was not the cause, he decided, and on Oct. 23, 
1896, he presented the case to a group of his 
colleagues as a new phenomenon, a rare syn¬ 
drome known today as hereditary hemorrhagic 
telangiectasia (HHT). 
Mistaking HHT for hemophilia was understand¬ 
able, says Robert I. White Jr., M.D., professor of 
diagnostic radiology, who founded the nation’s first 
clinic for HHT at Yale in 1988. “It’s a disease that 
masquerades as many things.” 
For some patients, unaware of the disorder 
and its sometimes-fatal consequences, HHT is a 
timebomb, says Dr. White, director of the Yale 
Vascular Malformation Clinical and Research 
Group. Its most common symptom is frequent 
nosebleeds. In addition to hemophilia, HHT is fre- 
Yale physicians and researchers at an international meeting in 
Edinburgh last May to mark the Rendu centennial, clockwise 
from bottom: Robert White, M.D.; Joel Wirth, M.D.; Joshua 
Korzenik, M.D.; and Pierre Fay ad, M.D. 
quently misdiagnosed as stroke, ulcers, epilepsy 
or anemia. 
The multi-disciplinary, clinical approach devel¬ 
oped at Yale is crucial to identifying and managing 
the disease, says Dr. White. Patients are screened 
for family history and obvious symptoms. If the dis¬ 
ease is suspected in the lungs or brain, the two 
most vulnerable organs in HHT, high-resolution 
computed tomography (CT) or magnetic resonance 
(MR) scans are used to confirm the diagnosis. 
Since 1988, Yale’s Vascular Malformation clin¬ 
ic has screened and treated approximately 250 
patients with HHT. "Although it’s difficult to diag¬ 
nose,” says Dr. White, “it’s very treatable and all 
the serious complications can be prevented.” A 
genetic test is in development. 
HHT, also known as Osler-Weber-Rendu Syn¬ 
drome, results from congenital malformations of 
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the blood vessels. These 
defects, called telangiec- 
tasias, are direct connec¬ 
tions between arteries and 
veins without intervening 
capillaries, as in the normal 
circulation. The telangiec- 
tasias are prone to hemor¬ 
rhage, and new ones form in 
critical target organs through¬ 
out the patient’s life. 
HHT is an autosomal 
dominant disorder, which 
means that a child born to a 
parent with HHT has a 50 
percent chance of inheriting the mutated gene and 
some form of the disease. Sir William Osier 
demonstrated the hereditary nature of the syn¬ 
drome and Frederick P. Weber added significantly 
to its description. It was previously estimated to 
affect some 5,000 Americans. But after recent 
population studies, the estimate has been revised 
upwards to as many as 50,000 Americans. 
Dr. White’s timebomb analogy is apt because 
in more than half of those affected, the symptoms 
can progress from minimal to mortal. By the age of 
30, most people with HHT have nosebleeds, which 
become more severe as they get older and often 
require blood transfusions in later life. The telang- 
iectasias that show up as relatively minor signs 
like red spots on tongue, lips and fingers often do 
not appear until after the age of 30. 
More deadly complications may develop. 
Approximately one-third of people with HHT devel¬ 
op gastrointestinal bleeding, one-fourth have 
abnormal vessels in the lungs, and close to 20 
percent develop a cerebral form of the disease 
that can lead to brain hemorrhage and stroke. 
Treatment strategies for HHT involve develop¬ 
ing new and better ways to stop bleeding, a prob¬ 
lem that is tackled from many angles at the multi¬ 
disciplinary clinic. Joshua Korzenik, M.D., instruc¬ 
tor of internal medicine, has developed a new way 
of treating gastrointestinal bleeding using a hor¬ 
mone effective in up to 50 percent of patients. 
And with Pierre Fayad, M.D., assistant professor of 
neurology, Dr. Korzenik is studying the effects of a 
soybean extract on controlling the frequent nose¬ 
bleeds associated with HHT. He is also studying 
whether lasers can be used to treat telangiectasia 
of the stomach and duodenum. 
Dr. White developed a technique for treating 
the lung manifestation of the disease, using sili¬ 
cone balloons containing radiologic dye to strategi¬ 
cally close circulation in areas prone to bleeding. 
Douglas Ross, M.D., assistant professor of 
surgery, is studying the 
effect of using skin grafts 
to stop the most severe 
nosebleeds. David Leffell, 
M.D., associate professor 
of dermatology, has had 
excellent results removing 
cosmetically prominent 
skin telangiectasias using 
tunable dye laser. Issam 
Awad, M.D., professor of 
neurosurgery, along with 
John Chaloupka, M.D., 
assistant professor of 
radiology, are studying 
methods of first blocking circulation to vascular 
malformations in the brain, then surgically remov¬ 
ing them. 
Other key members of the HHT clinic staff are 
Jeffrey Poliak, M.D., associate professor of radiol¬ 
ogy; John Persing, M.D., professor of surgery; Joel 
Wirth, M.D.; assistant professor of medicine; and 
Catherine Burdge, R.N., the clinical nurse coordi¬ 
nator who helps screen and track some 500 
patients involved with the center. 
The HHT Foundation International, established 
by Dr. White and others to reach and help patients 
worldwide, has evolved from 15 original members 
who visited Yale in 1990 into an active organiza¬ 
tion of more than 500. The group publishes an 
upbeat quarterly newsletter, Direct Connection, and 
maintains a World Wide Web site on the Internet 
(http://www.hht.org) and an electronic mail 
address (hhtinfo@hht.org). 
The foundation also sponsors an annual con¬ 
ference that this year brought 125 families to Salt 
Lake City, home of the nation’s second HHT center 
of excellence, at the University of Utah. To mark 
the Rendu centennial this year, an international 
meeting of HHT physicians and researchers was 
held in Edinburgh last May. Participants at both 
gatherings heard some very good news: 
researchers have found that HHT is caused by 
defects in genes on chromosomes 9 and 12 that 
are crucial to the formation of blood vessels. Sci¬ 
entists also have identified the biochemical mech¬ 
anism for HHT in some patients. 
With chapters in the Netherlands, Australia 
and Denmark, the foundation actively raises funds 
for research into the genetics, new diagnosis, 
treatment and management of HHT. ■ 
John Green is a free-lance writer in New London, Conn. 
Treatment strategies for 
HHT involve developing 
new and better ways to 
stop bleeding, a problem 
that is tackled from many 
angles at the multidisci¬ 
plinary clinic. 
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TO GIVE AWAY MONEY IS 
AN EASY MATTER AND IN 
ANY MAN’S POWER. BUT 
TO DECIDE TO WHOM TO 
GIVE IT, AND HOW LARGE 
AND WHEN, AND FOR 
WHAT PURPOSE AND 
HOW, IS NEITHER IN 
EVERY MAN’S POWER 
NOR AN EASY MATTER. 
Aristotle 
Assuming you would 
consider the School of 
Medicine as one of your 
intended beneficiaries, 
we stand ready to help you 
with when, for what purpose, 
and how. 
Planned giving 
is one of our specialties. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
atrics at Yale, and Marc H. Bornstein, 
Ph.D., chief of the child and family 
research section at the National Insti¬ 
tute of Child Health and Human 
Development in Bethesda, Md. 
The Arthur Vining Davis Foun¬ 
dations grant will support two com¬ 
panion studies conducted by Dr. 
Kain. The first seeks to determine the 
various factors that predispose par¬ 
ents and children to preoperative anx¬ 
iety. Based on this information, the 
second study will examine different 
types of programs to prepare children 
and their parents for surgery. 
Biomedical engineering 
supported by new grant 
With support from The Whitaker 
Foundation, a major new program in 
biomedical engineering has been 
established within Yale University’s 
Faculty of Engineering and its School 
of Medicine by consolidating sepa¬ 
rate activities in biomedical imaging, 
molecular bioengineering and tradi¬ 
tional biomedical engineering. 
Yale University President 
Richard C. Levin said: “Significant 
expansion of the undergraduate bio¬ 
medical engineering curriculum, as 
well as a cohesive graduate program, 
will greatly enhance Yale’s general 
strength in science and engineering. 
Within the School of Medicine, the 
expansion of biomedical engineering 
will influence the future careers of 
physicians trained at Yale and provide 
many of them with the opportunity to 
realize the potential applications of 
engineering within medicine.” 
Yale is at the forefront of many 
research areas in which engineering 
is applied to medicine, according to 
John C. Gore, Ph.D., professor of 
diagnostic radiology, who has a joint 
appointment in the applied physics 
department and is the grant’s princi¬ 
pal investigator. “This grant will 
accelerate the implementation of bio¬ 
medical engineering at Yale, expand 
its scope and provide the resources to 
achieve many of the aims of this 
major new initiative,” he said. 
Teaching graduate students 
engaged in applications of physics 
and engineering to medicine will be 
more formally organized. Dr. Gore 
notes. “More importantly,” he said, 
“these students will undertake 
research in a multidisciplinary envi¬ 
ronment on important research prob¬ 
lems in biomedical engineering.” 
The Whitaker Foundation grants 
made to Yale and seven other educa¬ 
tional research institutions are 
designed to help enhance biomedical 
engineering by developing perma¬ 
nent, high-quality programs that 
will benefit education and research in 
the field. 
Yale, Bridgeport hospitals 
establish partnership 
The parent corporations of Yale-New 
Haven Hospital and Bridgeport Hos¬ 
pital have completed an affiliation 
that will allow them to compete 
more effectively in managed care and 
will provide patients with broader 
access to high quality, cost-effective 
medical services. 
As part of the affiliation, the two 
hospitals will retain separate staffs, 
governing boards and financial struc¬ 
tures. “For our employees, this is a 
transparent change and will not make 
a difference day-to-day on their roles 
and activities,” says Joseph A. 
Zaccagnino, president and CEO of 
Yale-New Haven Hospital. “This is 
not a merger or acquisition.” 
There will, however, be a merg¬ 
ing of two physician residency pro¬ 
grams, in general surgery and a 
newly created residency for emer¬ 
gency medicine. 
The hospitals together employ 
8,600, with a medical staff of over 
close to 3,000. There are 900 beds at 
Yale-New Haven and 425 at Bridge¬ 
port; about 38,000 patients are dis¬ 
charged from Yale-New Haven annu¬ 
ally, and an additional 19,000 from 
Bridgeport. 
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FACULTY NEWS 
High honors for the 
discovery of snurps 
Cellular particle research 
brings Yale a second City 
of Medicine Award 
Joan A. Steitz, Ph.D., the Henry Ford II 
Professor of Molecular Biophysics and 
Biochemistry and a Howard Hughes 
Medical Institute investigator, was one 
of four medical researchers to receive 
the 1996 City of Medicine Award. 
Dr. Steitz was honored for her dis¬ 
covery of cellular particles that read the 
genetic code in cells to make proteins. 
Her work in identifying these small 
nuclear ribonucleoproteins, called snurps, 
Joan Steitz, Ph.D. served as a springboard for understanding 
the mechanics of gene expression. 
The awards program was established in 1988 to recognize out¬ 
standing achievements in medicine throughout the nation and the 
world. Recipients include six Nobel Laureates. Of the 33 recipients in 
nine years, two have been from Yale. Vincent T. DeVita Jr., M.D., HS 
’66, professor of medicine and director of the Yale Cancer Center, 
was a 1995 award winner. 
Stephan Ariyan, M.D., HS 
’70-76, M.B.A., clinical pro¬ 
fessor of plastic surgery and 
otolaryngology and former 
chief of plastic surgery, has 
been awarded the Essay prize 
from the Educational Founda¬ 
tion of the American Society of 
Plastic and Reconstructive Sur¬ 
geons. Dr. Ariyan presented Stephan 
the essay Restructuring of Ac a- Ariyan, M.D. 
demic Departments of Surgery 
at University Medical Centers: Administrative 
and Financial Considerations, at the society's 
annual meeting in Dallas in November. 
Bruce Fichandler, PA. ’73, lecturer in plastic 
surgery and director of admissions for the Yale 
Physician Associate program, was re-elected 
treasurer of the American Academy of Physi¬ 
cian Assistants (AAPA). His two-year term 
began in June. 
Two other Yale physician assistants were 
honored by the AAPA in May at its annual 
conference in New York City. J. Jeffrey 
Heinrich, Ed.D., P.A., lecturer in plastic 
surgery, was named civilian PA. of the 
year; and Shepard B. Stone, M.P.S., lecturer 
in anesthesiology, was named military PA. 
of the year. 
continued on page 44 ► 
Healing powers 
Among the speakers and special guests at the 
1996 Yale Sports Medicine Seminar in New 
Haven were Frank Jobe, M.D., of the Kerlan- 
Jobe Orthopaedic Clinic in Los Angeles, and 
Kartmut Krahl, M.D., Ph.D., an orthopaedic 
surgeon in Essen, Germany. From left, front 
row, are Dr. Jobe and Krahl, and Jacek 
Cholewicki, Ph.D., assistant professor or 
orthopaedics and rehabilitation at Yale. Rear, 
from left: Yale Sports Medicine Center physi¬ 
cians Marc T. Galloway, M.D., John 
Daigneault, M.D., Patrick Ruwe, M.D., and 
Director Peter Jokl, M.D. 
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Honoring Paul Beeson 
Those he trained, and those whose lives he touched, pay a last¬ 
ing tribute to the distinguished chairman emeritus of medicine. 
ated the importance of 
the dual roles of acade¬ 
mic chairman and chief 
of service. His hospital 
rounds, which were visi¬ 
ble and influential, con¬ 
veyed the powerful 
image of an intelligent, 
prudent physician who was caring, 
polite and dedicated to his individual 
patients. When Dr. Beeson left Yale in 
1965, the Department of Medicine at 
Yale was among the strongest in the 
country, and Yale-New Haven Hospital 
had become one of American medi¬ 
cine’s most desired internships. 
Dr. Beeson moved to Oxford as 
Nuffield Professor of Clinical Medicine 
in 1965. When he resigned his posi¬ 
tion in 1974, he accepted an appoint¬ 
ment as Distinguished Physician of the 
U.S. Veterans Administration in Seat¬ 
tle. Dr. Beeson co-edited, with Walsh- 
McDermott, the Cecil-Loeb Textbook of 
Medicine, was an editor of Harrison’s 
Textbook of Medicine, edited the Jour¬ 
nal of the American Geriatrics Society 
and co-edited the Oxford Companion 
to Medicine. He is a member of the 
National Academy of Sciences, a mas¬ 
ter of the American College of Physi¬ 
cians, and recipient of diverse honors 
and awards. He has received honorary 
doctor of science degrees from Emory, 
McGill and Albany and is an Honorary 
Knight Commander of the Order of the 
British Empire. 
Yale-New Haven Hospital officials 
say the Beeson Medical Service will 
play an essential role in meeting hos¬ 
pital goals by uniting community and 
university physicians in a common 
devotion to patients, students and 
physicians in training. In October, Dr. 
Beeson was named an honorary 
trustee of the Associates of the Har¬ 
vey Cushing/John Hay Whitney Med¬ 
ical Library. ■ 
Photographs by Harry Bishop 
The dedication of the Paul B. Bee¬ 
son Medical Service at Yale-New 
Haven Hospital in May was a chance 
for many to pay homage to a consum¬ 
mate medical practitioner and 
researcher who influenced a genera¬ 
tion of physicians, and whose values 
still shape the attitudes, decision-mak¬ 
ing and actions of physicians-in-train- 
ing today. 
“Naming the Medical Service at 
Yale-New Haven Hospital after Dr. Paul 
B. Beeson is a seminal event in our 
institutional history,” reads the dedi¬ 
cation. “Dr. Beeson, who unified and 
defined the position of chairman of the 
Medical School Clinical Department 
and chief of the Hospital Clinical Ser¬ 
vice during his 13 years at Yale, repre¬ 
sents the values of professional 
integrity, educational dedication, and 
the primacy of patient care that are 
being emphasized throughout our 
medical service." 
A Montana native, Paul Beeson 
graduated from McGill Medical School 
and completed a two-year rotating 
internship at the Hospital of the Uni¬ 
versity of Pennsylvania before joining 
his father in general practice in Ohio. 
In 1939, Dr. Beeson became Dr. Soma 
Weiss’ first chief resident at the Peter 
Bent Brigham Hospital, and in 1942 
joined Dr. Eugene Stead at Emory Uni¬ 
versity as an assistant professor of 
medicine. After Dr. Stead left for Duke 
in 1946, Dr. Beeson became profes¬ 
sor and chairman of the Department 
of Medicine at Emory, where he stud¬ 
ied the pathogenesis of fever and the 
dynamics of bacteremia in patients 
with subacute bacterial endocarditis. 
Dr. Beeson was named chair¬ 
man/chief of the Department of Medi¬ 
cine at Yale and Ensign Professor of 
Medicine in 1952. Dr. Beeson appreci- 
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Left: Participants in 
the inaugural sympo¬ 
sium come together 
for a photograph in 
the Medical Historical 
Library. Held for the 
first time in May 1996, 
The Beeson Sympo¬ 
sium is planned as an 
annual event. 
Above: Yale professor Howard M. Spiro, M.D., 
recruited by Dr. Beeson in 1955 to start the depart¬ 
ment's section of gastrointestinal medicine, chats with 
Lewis Landsberg, M.D. '64, HS '65-70, a Beeson 
trainee who is now the chairman of medicine at 
Northwestern University in Chicago. 
Above: Martin Gordon, 
M.D. '46, left, chairman of 
the medical library trustees, 
and Alvan R. Feinstein, 
M.D. HS '52-57, Sterling 
Professor of Medicine. 
Left: Ralph 1. Horwitz, 
M.D. chairman of the 
Department of Medicine 
and the Harold H. Hines Jr. 
Professor of Medicine and 
Epidemiology, listens to 
Dr. Lee’s comments on the 
language of the doctor- 
patient relationship. 
Above: Paul B. Beeson, M.D., who left an indelible mark at Yale 
as chairman of the Department of Medicine from 1952 to 1965, 
listens to the discussion at the first Beeson Symposium in the His¬ 
torical Library of Harvey Cushing/John Hay Whitney Medical 
Library’ in May. Seated next to Dr. Beeson are his wife, Barbara 
Beeson, and Richard V. Lee, M.D. '64, now professor of pedi¬ 
atrics at Buffalo Children's Hospital. 
Left: Yale professor John N. Forrest Jr., M.D., HS '64-70, who 
trained under Dr. Beeson and today heads the medical school’s 
Office of Student Research, provides an overview for participants 
at the symposium. 
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rhomas E. 
iughes, Ph.D. 
Thomas E. Hughes, Ph.D., 
assistant professor of oph¬ 
thalmology and visual sci¬ 
ence, will serve as a member 
of the Visual Science C 
Study Section, Division of 
Research Grants, for a three- 
year period. Study sections 
review grant applications 
submitted to the National 
Institutes of Health. 
Thomas R. Kosten, M.D., HS ’81, 
professor of psychiatry and director 
l 
of the division of substance abuse, 
has been named chief of psychiatry 
service at the VA Connecticut 
Healthcare System. In his new posi¬ 
tion, Dr. Kosten will be responsible 
for VA Connecticut's clinical, educa¬ 
tional and research programs in psy¬ 
chiatry at both the West Haven and 
Newington campuses. 
Marvin Moser, M.D., clinical pro¬ 
fessor of medicine, has been 
appointed a member of the Sixth 
Joint National Committee on 
Doctor,; how can I 
thank you?” 
H ow many times have you heard this question from your patients? Your answer can lead to a way to help the Yale School of Medicine. A gift from your patient to the School honors you and guarantees the continuation of our tradition of excellence in 
teaching and patient care into the 21st century. 
“Yale School of Medicine was and remains 
extremely important to me in the ongoing development of 
my busy practice. I am proud of my close relationship with the School, 
even though I am geographically far from New Haven. My patients 
regularly take an interest in my research and clinical activities, and I 
am more than happy to share with them my fondness 
for Yale in order to stimulate their interest in the School’s mission.” 
Dudley Seth Danoff, M.D. ’63, F.A.C.S. 
Beverly Hills, California 
“My patients know that I am a proud graduate of Yale 
School Of Medicine and an active participant in the teaching 
program. They also know that one of the best ways to make me 
happy is to give to my alma mater.” 
Mary Jane Minkin, M.D. 75 
New Haven, Connecticut 
Brochures promoting the School are available for 
display in your office, to generate the revenue 
needed to continue our standard of excellence. 
Free copies are available from: 
Bonnie Sargent 
Office of Development 
Yale University School of Medicine 
P.0. Box 7611 
New Haven, Connecticut 06519-1714 
Or call: 
203.785.6760 
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the Detection, Evaluation and 
Treatment of High Blood Pressure 
of the National Heart, Lung and 
Blood Institute. 
The Pew Charitable Trusts of 
Philadelphia has selected Hong Sun, 
Ph.D., assistant professor of genet¬ 
ics, as one of 22 Pew Scholars in the 
Biomedical Sciences for 1996. The 
$200,000 award, intended to encour¬ 
age scholars to be innovative in their 
research, will support Dr. Sun’s 
work in mitogen-activated protein 
kinases and cell signaling. 
o 
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Stephen G. Waxman, 
M.D., Ph.D. 
Yale neurologist elected 
to institute of Medicine 
Stephen G. Waxman, M.D., Ph.D., 
professor and chairman of neurology, 
has been elected to the Institute of 
Medicine, the health-care arm of the 
National Academy of Sciences. 
In addition to serving as profes¬ 
sor of neurology, neuroscience and 
pharmacology at Yale, Dr. Waxman 
founded and is the director of the 
PVA/EPVA Neuroscience Research 
Center, VA Connecticut Healthcare 
System on its West Haven campus. 
He is recognized internationally for 
elucidating the molecular architec¬ 
ture of nerve fibers and the glial cells 
that surround them, and the mecha¬ 
nisms by which nerve fibers in the 
brain and spinal cord adapt to injury. 
He has published more than 300 
scientific papers and edited five 
books on neuroscience. He is the 
author of Spinal Cord Compression 
and Correlative Neuroanatomy, and 
is the editor of The Neuroscientist. 
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NEW BOOKS 
Multivariable Analysis: An Introduc¬ 
tion, by Alvan R. Feinstein, M.D., 
HS ’52-54, Sterling Professor of 
Medicine and Epidemiology, Yale 
University Press 1996. 
Facing Death, edited by Howard M. 
Spiro, M.D., professor of medicine; 
Mary G. McCrea Curnen, M.D., 
Dr.P.H., clinical professor of epi¬ 
demiology and pediatrics; and Lee 
Palmer Wandel, associate profes¬ 
sor of history and religious stud¬ 
ies, Yale University Press 1996. 
Children are ... Images of Grace: A 
Pediatrician's Trilogy of Faith, 
Hope, and Love, by Diane M. 
Komp, M.D., professor of pedi¬ 
atrics, Zondervan Publishing 
House (Mich.) 1996. 
Dumplings: A Collection of Poems, 
by James W. Lancaster, M.D., HS 
’50-53, Lancaster (Fla.) 1996. 
A Practical Approach to Cardiac 
Arrhythmias, by Stephen C. Vlay, 
M.D. ’75, Little, Brown & Co. 
(Boston) 1996. 
Clinical Management of Hyperten¬ 
sion, by Marvin Moser, M.D., 
clinical professor of medicine, 
Professional Communications 
(N.Y.) 1996. 
Now I Know Better, edited by 
David Bachman, M.D., director of 
pediatric emergency medicine at 
the Children’s Hospital at Yale- 
New Haven, Millbrook Press 
(Conn.) 1996. 
Dear Bruno by Alice Trillin, a volun¬ 
teer at The Hole In The Wall Gang 
Camp affiliated with the Yale 
School of Medicine, The New 
Press (New York) 1996. 
Sexual Harassment in the Work¬ 
place and Academia: Psychiatric 
Issues, edited by Diane K. Shrier, 
M.D. ’64, American Psychiatric 
Press, Inc. (Washington) 1996. 
A Primer of Gynecologic Oncology 
by Robert C. Wallach, M.D. ’60, 
IDI Publications (Omaha) 1995. 
Skin Changes and Diseases in 
Pregnancy by Robert C. Wallach, 
M.D. ’60, and M. Harahap, Marcel 
Dekker Publisher (New York) 1996. 
Women’s Sexual Health by Ruth 
Steinberg, M.D., assistant clinical 
professor of obstetrics and gyne¬ 
cology, and Linda Robinson, Pen¬ 
guin (New York) 1996. 
Treatment Planning for Psy¬ 
chotherapists by Richard B. 
Makover, M.D., assistant clinical 
professor of psychiatry, American 
Psychiatric Press Inc. (Washing¬ 
ton) 1996. 
Transjugular Intrahepatic 
Portosystemic Stent Shunts 
(TIPS), Harold 0. Conn, M.D. ’72, 
HS '51-56, was the coordinating 
editor with J. Palmaz, J. Rosch and 
M. Rossle as coeditors, Igaku 
Shoin Medical Publishers (New 
York) 1996. 
A Charitable 
Annuity: 
The YSM gift 
that rates 
In exchange for a gift of 
$5,000 or more, the School of 
Medicine can offer you, or you 
and your spouse, a fixed annual 
income for life. 
Your age(s) and market 
rates of interest determine 
your income level. 
Current sample rates: 
Age(s) Rate 
One life 
55 4.8% 
66 5.9% 
77 8.2% 
Two lives 
66/65 4.9% 
75/74 5.9% 
82/79 7.1% 
Please allow us to tailor 
a proposal to your 
philanthropic 
and financial goals. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Light for the new millennium 
Class of 2000 a many-faceted group of students 
The following is adapted 
from Director of Admissions 
M. Lynne Wootton’s September 
report to the Medical School 
Council on the entering class. 
Not long ago, the Thousand 
Points of Light program was 
established. I would like to share 
with you information on our 
own 101 points of light—a term 
you will see these first-year 
students in the Class of 2000 cer¬ 
tainly deserve. 
That light first shone in many 
different places—in this hemi¬ 
sphere as well as in Europe, Asia, 
the Middle East and Africa. Our 
entering students have won numer¬ 
ous awards, prizes, scholarships, 
grants and fellowships, and more 
than 70 percent have already pub¬ 
lished and presented research find¬ 
ings, on topics ranging from 
Cloning the Whirligig Gene to 
The Disenchantment of Nature: 
The Naturalist Temper of Robert 
Lowell. 
They have given their time in 
shelters, nursing homes, cancer 
outreach centers, a home for pedi¬ 
atric AIDS patients, intensive care 
units, senior citizen centers, homes 
for teen-aged mothers and a 
domestic violence center here in 
New Haven. They have volun¬ 
teered as emergency medical tech¬ 
nicians (EMTs), translators. Big 
Brothers and Sisters, camp coun¬ 
selors for emotionally disturbed 
children, and firefighters. They 
have taught English to non-English 
speakers, jet skiing to 12-year-old 
campers and biochemistry to Yale 
students. One student helped start a 
program to provide cuddling and 
nurturing to newborns in over¬ 
crowded neonatal units. Another 
taught music to more than 400 
inner-city children. 
One student worked in a Chi¬ 
natown health clinic, another in a 
medical clinic in Haiti. A third is a 
writer who has published two nov¬ 
els and is under contract for four 
more. They are composers and 
arrangers, ballet and ballroom 
dancers, and choreographers. They 
sing gospel and enjoy jazz. One 
performed in a summer-stock the¬ 
ater group, another is a cantor, still 
another paints. One student was 
drafted by the Boston Bruins—but 
chose to come to New Haven 
instead! 
The story of one young man's 
road to Cedar Street helps to 
answer an often-asked question: 
What makes a Yale medical stu¬ 
dent? This medical student is 
exceptional, but no more so than 
his 100 colleagues. 
He earned a 4.0 GPA as an 
undergraduate majoring in both 
economics and political science, 
then did his premedical work five 
years later. He authored a section 
for a Lonely Planet guide to Brazil, 
and was the recipient of Rotary, 
Elks, Masons and Presidential 
Leadership scholarships. He was 
an Eagle Scout and wrote a thesis 
on U.S.-Cuban relations during the 
Castro era. 
While in college, he founded 
and owned a coffeehouse. He was 
one of three undergraduate stu¬ 
dents selected to teach and consult 
at the Wharton Small Business 
Development Center. An EMT, he 
volunteered as a victim's advocate 
for a Colorado county sheriff. 
He organized a mountain¬ 
climbing expedition to Venezuela, 
and secured sponsorship from four 
companies. He is a board member 
of the Search for Genghis Khan 
Expedition—a non-profit corpora¬ 
tion seeking the burial site of 
Genghis Khan and increase aware¬ 
ness of 13th-century and present- 
day Mongolia. He was nominated 
by undersea explorer Robert Bal¬ 
lard for membership in the 
Explorer’s Club, and was accepted 
in 1994. He raised over $100,000 to 
help low-income families establish 
businesses in an economically 
depressed area of Philadelphia. 
This aspiring physician volun¬ 
teered in Ecuador with Amigos de 
las Americas after nine months of 
training in language, culture and 
public health. During his three- 
month stay, he traveled to remote 
villages and vaccinated over 600 
people for yellow fever. He is now, 
together with 100 others, a first- 
year Yale medical student—all 
members of an extraordinary 
class—the Class of 2000. We wel¬ 
come all of you with great pride. 
more student news on page 48 ► 
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A welcome 
to medicine 
The white jacket that 101 first- 
year medical students in the 
Class of 2000 donned during ori¬ 
entation in August symbolizes 
their entry into a rich and satisfy¬ 
ing life of service to others. “I 
can’t think of any better way to 
spend a professional life than as a 
physician,” Robert H. Gifford, 
M.D., H.S. ’66-67, associate dean 
for education and student affairs, 
told the new students, their par¬ 
ents and friends at the Harkness 
ceremony. “To be able to combine 
a love for science with a concern 
for people is the ultimate privilege 
for any individual.” This ceremony 
was one of two major events for 
Top: Forrester A. Lee, M.D., associate pro¬ 
fessor of medicine and assistant dean for 
multicultural affairs, helps first-year med¬ 
ical student LaLisa Anderson into her white 
jacket during a ceremony welcoming the 
entering class to the profession of medicine. 
Above: Stephanie Eisenbarth, a first-year 
M.D./Ph.D. student, walks across Harkness 
Courty’ard after the White Jacket Ceremony. 
Below: The presentation of jackets 
followed remarks by Associate 
Dean Robert H. Gifford, M.D. 
the new students. More than 90 
percent of them and several of 
their spouses/significant others 
also attended an October retreat 
to enhance communication. They 
enjoyed being with colleagues in a 
relaxed atmosphere at the Her¬ 
itage Inn, took part in activities to 
heighten knowledge of themselves 
and others, and participated in 
exercises to develop more effec¬ 
tive communication skills with col¬ 
leagues, partners and patients in 
the medical community. ■ 
Contribute to the 
School of Medicine’s 
Future and Invest in 
Your Own 
Yale University’s life income 
program offers graduates of the 
School of Medicine the oppor¬ 
tunity to: 
■ Help ensure the future 
of a great institution 
• Receive quarterly 
income payments 
for life 
■ Increase your income 
from low-yielding stock with¬ 
out incurring capital gains 
taxes 
■ Reduce federal and 
state taxes 
Please call or write to see if 
you can use these benefits to 
the mutual advantage of you 
and the School of Medicine. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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A runner’s training inspires 
air-quality research in Iran 
In 1979 at the age of 7, Maryam 
Asgari found herself far from her 
native Iran and unable to return. 
When she did go back 14 
years later as a Yale medical stu¬ 
dent, the purpose of the trip was 
to renew family ties. But she 
made an observation that result¬ 
ed in a three-month study of air 
quality in Tehran and the sur¬ 
rounding countryside. Her 
research was the basis of her stu¬ 
dent thesis at Yale and for recom¬ 
mendations to scientists and offi¬ 
cials in Iran. 
Ms. Asgari, now in her final 
year of medical school at Yale, 
presented the findings of her 
study at Student Research Day 
last May, a year early. She also 
presented her research in poster 
form at the American Lung 
Association/American Thoracic 
Society International Conference 
in New Orleans. 
Ms. Asgari came to the Unit¬ 
ed States with her mother in 
1979 at the age of 7 to visit her 
brother, then a student at the Uni¬ 
versity of California at Berkeley. 
The revolution in Iran delayed 
their return for more than a 
decade. “We lived in California 
until I finished college at Stanford 
in 1992,” says Ms. Asgari. Her 
mother returned to Iran as 
Maryam began medical school at 
Yale. In 1993, she returned to a 
much-stabilized Iran after 14 
years abroad. 
In New Haven, before the jour¬ 
ney, Ms. Asgari had been running 
6 miles a day to train for a 
marathon. Two miles in Iran was 
enough to leave her short of 
breath and wheezing. “If someone 
like myself, in fairly good health, 
was affected by the air quality," 
she asked herself, “what was it 
like for people who were breathing 
this on a daily basis?” 
After that first visit, Ms. 
Asgari returned to New Haven and 
searched the literature for infor¬ 
mation on air quality and 
public health in Iran. She 
found very little. 
In collaboration with 
Yale faculty Arthur B. 
Dubois, M.D., and William 
Beckett, M.D., physician- 
scientists in environmen¬ 
tal health at the Yale-affili¬ 
ated John B. Pierce Laboratory, 
Ms. Asgari embarked on her own 
study. She collected the neces¬ 
sary equipment and supplies and 
set off to Iran, from June to Sep¬ 
tember of 1994. 
Her father, a physician, made 
introductions at the University of 
Tehran School of Public Health, 
where she gained access to 
patients and won the support of 
Iranian researchers. They helped 
her navigate the politics of Iran’s 
decentralized health system and 
its “houses of health,” communi¬ 
ty-based clinics where research 
may be conducted if one knows 
how to go about asking. 
Despite the doors opened to 
her as a native of Iran, Ms. Asgari 
encountered problems, starting at 
the airport with the confiscation 
of her air-monitoring equipment, 
which was held for a week, then 
returned to her. To conduct 
research in the houses of health, 
she was required to bring along 
an escort—married and male. 
She believes that the effort 
was well spent. The results of the 
tests among 400 children in 
Tehran and in rural villages 
showed the poor air quality was 
clearly detrimental to the chil¬ 
dren’s lung function. 
“We looked at several differ¬ 
ent variables to explain the differ¬ 
ence in lung function among the 
rural and urban children,” says 
Ms. Asgari. “We analyzed their 
nutritional status and the over¬ 
crowding situation among urban 
kids, but the only constant we 
found to explain lung detriment 
was the difference in air quality.” 
Maryam Asgari, left, now in her 
final year of medical school at Yale, 
stands next to the poster presenta¬ 
tion of her air-quality research, con¬ 
ducted in Iran. With her is Aina 
Puce, Ph.D., Ms. Asgari's adviser 
for another research project on 
brain imaging and perception. 
While Ms. Asgari found slight¬ 
ly higher rates of detriment among 
children in urban areas, she dis¬ 
covered that all the children in the 
study were affected by the poor 
air-quality. She limited the 
research to children because their 
lungs are still developing, making 
it easier to measure the detrimen¬ 
tal effects. 
Tehran is one of the world’s 
most polluted cities, she says, 
“but many things can be done to 
raise the air-quality standards—if 
the government would just pay 
more attention to this problem.” 
She hopes that her work will inter¬ 
est and inspire scientists in Iran, 
and lead to air-quality controls for 
factories, cars, trucks and trains. 
Ms. Asgari, who spent part of 
the summer on a clinical clerkship 
in obstetrics and gynecology in 
Ireland, will visit Surinam in South 
America this year for a primary 
care elective. She plans to train in 
dermatology and plastic surgery 
after graduating in May. ■ 
Rosalind D’Eugenio 
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Immunobiology student 
awarded fellowship 
Lynn Hannum, a third-year gradu¬ 
ate student in the department of 
laboratory medicine, has been 
awarded the 1996-1997 Richard K. 
Gershon Fellowship to encourage 
biomedical careers. 
Ms. Hannum, who works in 
the laboratory of Mark J. Schlom- 
chik, M.D., Ph.D., assistant profes¬ 
sor of laboratory medicine, con¬ 
centrates her research on better 
understanding the conditions 
required to maintain immunity to 
diseases, known as immunological 
“memory.” Memory cells develop 
during the initial immune response 
to an infectious agent and are 
responsible for rapid, effective 
clearance of that pathogen upon 
subsequent encounters. In particu¬ 
lar, Ms. Hannum focuses on the 
memory in B lymphocytes, the 
cells that produce antibodies. 
“We know that memory can be 
long-lasting,” explains Ms. Han¬ 
num, “since vaccination as a child 
can confer life-long immunity to 
some diseases. Still, we don't 
understand the mechanism by 
which memory cells persist over 
such long periods of time.” 
One theory she is examining is 
that the antibodies produced dur¬ 
ing an immune response are 
retained in the spleen and lymph 
nodes, and that periodic encounter 
with these stored antigens is neces¬ 
sary to re-stimulate memory B 
cells. To test this hypothesis, Ms. 
Hannum developed transgenic 
Physician Associate Program graduates 
32, honors first distinguished alumna 
Left: Dean Gerard N. Bur¬ 
row, M.D. ’58, and Elaine 
E. Grant, P.A., M.PH, 
assistant dean for the PA 
Program, congratulate Bar¬ 
deen Camp, P.A.-C, center, 
who received the program's 
first Distinguished Alumnus 
Award. Ms. Camp gradu¬ 
ated with honors as a mem¬ 
ber of the program’s first 
class in 1973, and today is 
manager of the hematol¬ 
ogy/oncology infusion ther¬ 
apy unit at the Hospital of 
St. Raphael in New Haven. 
She is one of526 indi¬ 
viduals who have completed 
the 24-month educational program in the medical model. Responsible to 
their supen’ising physicians, they practice in urban and rural settings in 
emergency rooms, hospitals, health maintenance organizations, clinics, and 
private and group practices throughout the United States. Thirty-two gradu¬ 
ates received their certificates at Commencement this year. 
mice which do not produce anti¬ 
bodies, and lack the proposed viral 
and bacterial fragments. “We are 
beginning to analyze immune 
responses in these transgenics to 
determine whether or not stored 
antigen is actually necessary for 
long-term maintenance of memory 
B cells.” 
The fellowship is named in 
memory of Dr. Richard K. Ger¬ 
shon, a Yale professor of pathol¬ 
ogy, immunology and biology 
who died in 1983. He was a 
leader in the exploration of the 
immune system. The fellowship 
is funded by contributions from 
Dr. Gershon’s family, friends 
and alumni. 
Ms. Hannum received her B.S. 
degree in 1987 from Bates College 
in Lewiston, Maine. 
Above: Surgeon and author Richard 
Selzer, M.D., above, addresses grad¬ 
uates of the Yale Physician Associate 
Program at their Commencement in 
August. Dr. Selzer, author of the best¬ 
selling Mortal Lessons and Down 
from Troy: A Doctor Comes of Age, 
sowed on the medical school faculty 
for 25 years, spoke to the graduates 
about the language of medicine. 
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alumni/ae news 
Opportunities abroad 
The new Office for International Health 
welcomes information from alumni/ae, 
faculty and friends of the School of Medi¬ 
cine on opportunities at international 
sites, ranging from clinical service oppor¬ 
tunities overseas in developing countries 
to research projects to which students or 
faculty could provide assistance. 
“The Office for International Health is 
committed to helping faculty and students 
network with overseas sites interested in 
Yale collaboration,” says Michele Barry, 
M.D., HS ’77-81, professor of medicine 
and director of this office. Any faculty, stu¬ 
dent or alumnus/a who has knowledge of a 
potential collaboration may contact Linda 
Limauro, the office’s administrative man¬ 
ager, at (203) 785-5937. 
This office, established in the spring 
of 1996, serves medical, nursing and pub¬ 
lic health students and faculty interested 
in global health issues. In September, a 
bimonthly seminar series was started. ■ 
Bradley R. 
Straatsma, M.D. 
Maxwell Bogin. M.D. '26, recently 
relinquished his position as class agent 
after decades of service, and now resides 
at the retirement community, 3030 Park 
[3030 Park Ave., Bridgeport, CT 06604], 
While somewhat limited in his physical 
activities, he is mentally and psychologi¬ 
cally as keen as ever. His daughter, 
Debby Bogin Cohen, of Boston, reports 
that a Bogin niece doing research in the 
Museum of the Jewish Diaspora in Tel 
Aviv found the citation that “among 
distinguished bearers of the Jewish fam¬ 
ily name Bogin includes the 20th-cen¬ 
tury American physician Maxwell 
Bogin." For decades. Dr. Bogin was 
chairman of pediatrics at Bridgeport 
Hospital, an affiliate of the School of 
Medicine. His wife, Edith, resides with 
him at 3030 Park. 
Morris A. Wessell, M.D. '43, HS '48- 
51, clinical professor of pediatrics, 
became the first recipient of the New 
London (Conn.) Native Son Award by 
his hometown Rotary Club. The club 
created this honor to recognize some¬ 
one who grew up in New London and 
accomplished much in his professional 
life elsewhere. Dr. Wessell also 
received the Paul Harris Lellowship. 
the highest honor given by the Rotary. 
R.M. Fasanella, M.D. '43, HS '43-44, 
chairman of ophthalmology at Yale 
from 1951 to 1961, writes to report 
on the careers of two of his former 
students: Bradley R. Straatsma, M.D. 
'51. has been named editor-in-chief of 
the American Journal of Ophthalmol¬ 
ogy. Dr. Straatsma formerly was direc¬ 
tor of the Jules Stein Eye Institute and 
professor and chairman of the depart¬ 
ment of ophthalmology at University of 
California-Los Angeles School of Med¬ 
icine. Javier Servat, M.D.. HS '62. a 
chief resident under Dr. Lasanella. has 
had a distinguished career in ophthal¬ 
mology in Trujillo, Peru. A coinciden¬ 
tal communication received from Dr. 
Servat is noted below. 
B. Herold Griffith, M.D. '48, HS 48- 
49, retired from the practice of plastic 
surgery in March. Dr. Griffith was pro¬ 
fessor of surgery from 1959 to 1996, 
and chief of plastic surgery from 1970 
to 1991, at Northwestern University 
Medical School in Chicago. He also 
was chairman of the American Board of 
Plastic Surgery from 1981 to 1982. 
Harry C. Miller, M.D. 54, of Great 
Palls, Va., and a summer resident of 
Canandaigua Lake, N.Y., is professor 
emeritus and former chair of the urol¬ 
ogy department at George Washington 
University Medical Center. 
William H. Hindle, M.D. ’56, has 
been appointed to the National Acad¬ 
emy of Sciences' Institute of Medi¬ 
cine’s Committee on Breast Cancer 
Research, the National Cancer Institute 
Breast PNA (fine-needle aspiration) 
subcommittee on training and creden- 
tialing, and the editorial advisory board 
of the medical journal Cancer Cyto- 
pathology. Dr. Hindle is professor of 
clinical obstetrics and gynecology at the 
University of Southern California 
School of Medicine and director of the 
Breast Diagnostic Center at Women’s 
and Children's Hospital. 
Brian Crowley, M.D. '57, president of 
the Washington (D.C.) Psychiatric Soci¬ 
ety, was recently named a life fellow of 
the American Psychiatric Association. 
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Marcia Kraft Goin, M.D. 58, Ph D., 
HS ’58-62, clinical professor of psy¬ 
chiatry at the University of Southern 
California (USC) School of Medicine, 
has been nominated as a trustee-at- 
large of the American Psychiatric 
Association. Dr. Goin is director of res¬ 
idency training in the psychiatric out¬ 
patient clinic at Los Angeles County/ 
USC Medical Center, and is in part- 
time private practice. 
Max Pepper, M.D., M.P.H. ’59, of 
Montague, Mass., retired professor and 
founding chair of community medicine 
at St. Louis University, is clinical pro¬ 
fessor of family and community health 
at Tufts University Medical School and 
consultant to the community-oriented 
primary care training program for 
internal medicine residents at Baystate 
Medical Center in Springfield, Mass. 
Dr. Pepper also traveled to Ramallah, 
near Jerusalem, to help Palestinian col¬ 
leagues launch a new graduate program 
in public health at Bir Zeit University 
for medical professionals from the 
West Bank and Gaza. He is also serv¬ 
ing a two-year term as president of the 
Physicians Forum. His wife, Anita 
Golden Pepper, M.P.H. ‘60, Ph.D. ’72, 
is also clinical professor at Tufts Med¬ 
ical School. 
Leon G. Smith, M.D. '56, HS ’59-62, 
chairman of medicine at Seton Hall 
University School of Graduate Medical 
Education, and director of medicine 
and chief of infectious diseases at Saint 
Michael’s Medical Center in Newark, 
N.J., was voted one of the top five 
infectious disease specialists in a New 
Jersey statewide poll published by the 
New Jersey Monthly. 
Javier Servat, M.D., HS ’62, in a 
recent letter to AYAM Vice President 
Nicholas Passarelli, M.D. ’59, HS ’59- 
65, reported on 34 years of practice and 
teaching at the Institute of Ophthalmol¬ 
ogy at the National University of Tru¬ 
jillo in Peru. As a tribute to his service 
and to his training of more than 80 resi¬ 
dents in ophthalmology from all 
throughout Latin America, the institute 
was recently renamed the Javier Servat 
Univajo Institute of Ophthalmology. 
Dr. Servat remembers his years of 
training at Yale fondly and sends salu¬ 
tations to all of his old friends. 
Juan Larah. M.D. ’82, was named 
director of Adult Medicine at the Mis¬ 
sion Community Health Clinic, which 
provides care to the under served His¬ 
panic community of San Francisco. 
Heidi Boerstler, Dr.P.H. ’87, M.P.H. 
’81, J.D., is department chair for health 
administration programs and a profes¬ 
sor at the College of Business and 
ALUMNI 
Alumni/ae of 
our medical 
school, achieving 
distinction in 
other academic 
centers, are fre¬ 
quent lecturers at 
department con¬ 
ferences on our 
campus. 
We wish to report of such visits 
briefly in such a column in order to 
inform classmates and colleagues of 
these events. Department chairmen 
and alumni/ae speakers are urged 
to inform Yale Medicine of such 
visits so that this mission may be 
accomplished. 
On April 25, Alvin E. Friedman- 
Kien, M.D. ’60, presented medical 
grand rounds and subsequent house 
staff colloquies on The Viral Etiol¬ 
ogy and Pathogenesis of Kaposi’s 
Sarcoma, and related aspects of the 
AIDS epidemic. Dr. Friedman-Kien 
is professor of dermatology and 
microbiology at New York Univer¬ 
sity Medical Center. He is an inter¬ 
national authority on Kaposi's sar¬ 
coma, and his research has centered 
Alvin Friedman- 
Kien, M.D. 
Administration at the University of 
Colorado in Denver. 
David Seifer. M.D., fellow in Ob/Gyn 
'89-91, has joined the Ohio State Uni¬ 
versity College of Medicine as director 
of the division of reproductive 
endocrinology and infertility. 
John T. Chang. M.D., M.P.H. ’95, has 
graduated from Northwestern Univer¬ 
sity Medical School and is a house- 
staff physician in internal medicine at 
Georgetown University Medical Cen¬ 
ter in Washington. Dr. Chang published 
an article in the September 1995 issue 
of CHEST. 
/ae on campus 
on the pathogenesis of viral and 
infectious agents in dermatologic 
disease and oncology. 
Dr. Friedman-Kien presented a 
comprehensive review of the history 
and pathogenesis of Kaposi’s sar¬ 
coma (KS) with a summary of the 
evolution of our knowledge since 
1981 in the era of AIDS. The associ¬ 
ation of this malignancy with the 
herpes virus and the ultimate identi¬ 
fication of human herpes virus 8 
(HHV8) as the probable etiologic 
agent of KS was described. The 
complex and enigmatic epidemiol¬ 
ogy and pathogenic elements in 
the expression of this malignancy 
were discussed. 
Dr. Friedman-Kien is, coinci¬ 
dentally, a renowned and eclectic 
collector of modern art and authority 
on artistic antiquities. His collec¬ 
tions are celebrated ones. A profile 
of Dr. Friedman-Kien on this subject 
appeared in the March 1996 issue of 
Art and Antiques. 
Nicholas P.R. Spinelti, M.D. ’44 
Consultant, Alumni Affairs 
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Richard L. Frank 
Richard L. Frank, M.D., died of a 
stroke in February in New York. He 
was 90. 
Dr. Frank graduated from Yale 
College in 1926 and received a 
master’s degree from Yale in 1930; 
he graduated from the Yale School 
of Medicine in 1931. Dr. Frank 
served in the Army during World 
War II. He completed his residency 
in psychiatry and child psychiatry 
at New York Psychiatric Institute at 
Columbia University, and from 
1945 to 1946 he taught psycho¬ 
analysis at the Long Island College 
of Medicine. 
Dr. Frank continued his train¬ 
ing in psychoanalysis and child 
analysis with the New York Psy¬ 
choanalytic Society. He later taught 
at Columbia University’s Psycho¬ 
analytic Clinic. Dr. Frank joined the 
faculty at Mount Sinai School of 
Medicine in New York, where he 
led the work that established the 
adolescent service in psychiatry. He 
was also in private practice in Man¬ 
hattan for more than 30 years. 
William F. Stephenson 
William F. Stephenson, M.D., died 
April 23 at his home in Denver. He 
was 72. 
Dr. Stephenson served in the 
medical corps during World War II. 
He graduated from the University 
of Oklahoma, and received his 
medical degree from Yale in 1952. 
Dr. Stephenson completed an 
internship on Staten Island, N.Y., 
and at the Public Health Service in 
Fort Worth, Texas. He completed 
residency training in psychiatry at 
the University of Colorado Health 
Sciences Center. 
Dr. Stephenson practiced psy¬ 
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chiatry in Denver for more than 30 
years and was a clinical instructor 
at the University of Colorado 
Health Sciences Center. 
Raymond S. Duff 
Raymond S. Duff, M.D., M.P.H., 
died on June 21 in Connecticut 
from complications from a stroke. 
He was 72. 
Dr. Duff served in the Army 
from 1943 to 1946. In 1948, he 
received a bachelor’s degree from 
the University of Maine. He gradu¬ 
ated from the Yale School of Medi¬ 
cine in 1952. Dr. Duff served a 
pediatric internship and residency 
at Yale-New Haven Hospital from 
1952 to 1955. In 1959, he received 
a master’s of public health degree 
from Yale. 
From 1955 to 1956, Dr. Duff 
was director of the Bureau of Med¬ 
ical Services for the New Haven 
Health Department. In 1956, he 
joined the Yale faculty as instructor 
in pediatrics and public health. 
He also was director of ambulatory 
services for Yale-New Haven 
Hospital. Dr. Duff retired from Yale 
in 1988 as professor emeritus of 
pediatrics. 
George A. Carden Jr. 
George A. Carden Jr., M.D., died at 
his home in New York City on Aug. 
10. He was 89. 
Dr. Carden received a bache¬ 
lor’s degree in 1931 and a medical 
degree in 1935, both from Yale. 
During World War II, he was a 
member of an American research 
team investigating tropical dis¬ 
eases, especially malaria, in both 
the laboratory and in the field. He 
served in 1945 as executive secre¬ 
tary to the Committee on Drugs and 
Medical Supplies of the National 
Research Council, and in 1946 was 
executive secretary to the National 
Academy of Sciences' Board of 
Coordination of Malaria Studies. 
In 1948, Dr. Carden was pre¬ 
sented with a presidential certifi¬ 
cate of merit for outstanding ser¬ 
vice toward the war effort as chief 
of the wartime Office of Scientific 
Research and Development’s 
malaria division. In 1982, he retired 
as a clinical professor of medicine 
at the Columbia University College 
of Physicians and Surgeons, after 
36 years on the clinical faculty. He 
practiced medicine at Columbia- 
Presbyterian Medical Center from 
1946 until his death. 
Yale established the George A. 
Carden Jr. Fellowship for research 
in virology and immunology in his 
honor. Dr. Carden also received a 
Distinguished Service Award in 
1992 from the Association of Yale 
Alumni in Medicine. 
IN MEMORIAM 
Robert M. Cushing, M.D. ’32 
June 20, 1996 
Hugh Richard Hoopes, M.P.H. ’79 
April 22, 1996 
Milton Malev, M.D. ’26 
November 16, 1995 
Lucien M. Pascucci, M.D. ’34 
July 2, 1995 
Milber Bedford Pope, M.P.H. ’70 
August 11, 1995 
Donald H. Schultz, M.D. ’52 
May 23, 1996 
Theodore H. Sills, M.D. ’27 
June 12, 1996 
Marc A. Weisblatt, M.P.H. ’91 
December 12, 1995 
alumni/ae affairs 
Expanding on a happy 
What makes a great reunion 
program a little bit better? 
Feedback from alumni/ae that lets 
us try a few new ideas, plus two 
days of great weather. Thanks to 
the excellent response to our 
alumni/ae survey in late 1995 (not 
to mention blue skies), this past 
June’s Alumni/ae Reunion Week¬ 
end program was a tremendous hit. 
As we plan the 1997 reunion, we 
would appreciate hearing more of 
your ideas and preferences for this 
special weekend in New Haven. 
The 1996 reunion was a happy 
mixture of traditional and new 
activities. On the Friday night, 
after a day of meetings and semi¬ 
nars around the medical campus, a 
convivial reception in the Histori¬ 
cal Library was hosted by Dean 
Gerard N. Burrow, M.D. ’58, fol¬ 
lowed by a Mexican-themed buffet 
dinner in the Harkness Courtyard. 
Shuttle vans whisked revelers 
to the Shubert Theater a few blocks 
away, to see comic legend Jerry 
Lewis in the touring musical pro¬ 
duction Damn Yankees. Other 
groups made their way from cam¬ 
pus to Yale Field to watch the New 
Haven Ravens AAA baseball club 
play the Portland Seadogs, an 
experience made all the more 
exciting by the hooting and stomp¬ 
ing of the Elm City’s younger 
fans (a collection of glove-wield¬ 
ing, 12-year-olds hoping to catch a 
fly ball). 
The next day we set up golfers 
with convenient tee-times at the 
Yale Golf Course and made free 
court time available at the Yale 
Tennis Center. And the weather 
was clear, hot and dry. 
Alumni/ae 
reunion 
weekend 
19 9 6 
These additions to the program 
were your suggestions and they 
complemented the traditional com¬ 
ponents of reunion—individual 
class programs, parties and semi¬ 
nars, as well as special presenta¬ 
tions by faculty. As always, the 
Friends of the 50th Dinner, hosted 
by the Association of Yale Alumni 
in Medicine (AYAM) at the Gradu¬ 
ates Club, was an evening of relax¬ 
ation and good cheer—and very 
short speeches. The dean did stand 
up and thank the Class of 1946 
for its record accomplishment of 
raising a reunion gift of more than 
$1 million. 
Seafood Newburg, beef ten¬ 
derloin and strawberry shortcake 
were also at their traditional places 
on the Saturday lunch buffet 
table—staples of comfort for many 
in this ever-changing world we live 
in! And while we can count on 
some familiarity in the menu this 
coming June, the backdrop for the 
meal will be dramatically different: 
The entire first floor of Harkness 
will be new, the result of a top-to- 
bottom renovation of the cafeteria 
into a food court with new seating, 
a private dining room and a recon¬ 
figured Spinelli Lounge. 
An important tradition that 
tradition 
was maintained in 1996 was the 
presentation of the Distinguished 
Alumni Service Award, to two 
recipients: Marie-Louise T. John¬ 
son, Ph.D., M.D. ’56, HS ’56-59; 
and Dwight F. Miller, M.D. ’56, 
HS ’58-59. Both Drs. Johnson and 
Miller are former presidents of the 
AYAM, and have worked tirelessly 
for the good of the school and all 
its alumni/ae. Continuing a rela¬ 
tively new tradition started in 
1994, Dean Burrow presented the 
Peter Parker Medal to Arthur 
Crovatto, M.D. ’54, HS ’54-61 
who stepped down this summer as 
director of alumni affairs. Dr. 
Crovatto remains closely involved 
with students as instructor of 
anatomy. 
Next year, Alumni/ae Reunion 
Weekend will be Friday and Satur¬ 
day, June 6 and 7. Since we will 
not mail a survey this year, I would 
be very grateful to hear from 
people at any time, by mail, fax, 
phone or e-mail. We are especially 
interested in finding ways to meet 
the needs and expectations of 
younger alumni/ae to encourage 
their participation. 
William K. Jenkins 
Managing Director 
Office of Alumni Affairs 
Write to Bill Jenkins at the Office 
of Alumni Affairs, PO. Box 7613, 
New Haven, CT06519-0613 (Tel: 
203-785-4674, Fax: 203-737- 
5153), or via e-mail at 
williain.jenkins@yale.edu 
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1941 
55TH REUNION 
By Willvs M. Monroe, M.D. 
Attending our 55th reunion, with 
spouses, were Peter Duncan, 
John Fenton, Fred Glike, Willys 
Monroe and Ed O’Connell. 
Willys, acting for class secretary 
Bob Ollayos (who was in northern 
Wisconsin at the time), took notes 
and reported on the activities of 
class members since our 50th 
reunion. He sadly announced the 
deaths of nine classmates since that 
occasion: Acpua, Areson, 
Helen P. Langner, M.D. '22, 
responds to a gift of flowers from 
Arthur C. Crovatto, M.D. '54. 
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Cheney, Ed Harvey, Lasell, Mur- 
fitt, Parrella, Simmonds and 
Rogers, leaving 24 still alive. We 
understand that Randy Bell was 
unable to attend the festivities 
owing to failing health. It also 
appears that the only one of us still 
active professionally is Peter Dun¬ 
can, who is pursuing a project in 
genetic research. If there are oth¬ 
ers, please make this known to Bob 
Ollayos or Willys Monroe. 
In honor of the 55th anniver¬ 
sary of our graduation, despite our 
diminishing numbers (but under 
the persuasive leadership of Peter 
Duncan), our class subscribed its 
largest gift ever to the Medical 
Alumni Fund. Although most of 
the returnees came from nearby, 
Willys and Louise Monroe came 
from Virginia. In fact, Louise con¬ 
ducted pediatric cardiology clinics 
in Roanoke, Va., on Friday, June 7, 
until noon and still made it to the 
barbecue supper at Harkness Hall 
that evening. Saturday’s activities 
for our class followed the tradi¬ 
tional pattern of morning medical 
seminars and the meeting of the 
Association of Yale Alumni in 
Medicine, followed by sherry and 
lunch on the Harkness lawn. But 
the day culminated in the “attitude 
adjustment” hour at the Graduates 
Club, with plenty of good fellow¬ 
ship and nostalgic reminiscences 
of days gone by, followed by a 
sumptuous dinner with Friends of 
the 50th. After dinner we said our 
fond farewells, promising to keep 
in touch and to return, God willing, 
in 2001 for our 60th. 
1946 
50TH REUNION 
By Franklin C. Behrle, M.D. 
On Friday, June 7, the Class of 
1946 assembled at the Colony Inn 
where an early afternoon cocktail 
party set the tone for a happy, hec¬ 
tic and high-calorie 50th reunion. 
Further fortified by the dean’s 
reception in the Historical Library, 
we wove our way to the New 
Haven Hotel where we encoun¬ 
tered our first of several sumptuous 
feasts, immediately followed by a 
smash performance by Jerry Lewis 
in Damn Yankees at the Shubert. 
Saturday morning brought us 
up to speed on state-of-the-art radi¬ 
ology and the state of the School 
of Medicine. At noon. Dean Bur¬ 
row, mind-boggled by the report of 
the windfall class gift, went for 
broke in providing the most lavish 
buffet the Harkness Hall tents have 
ever hosted. 
After a brief session for the 
class picture on the steps of Ster¬ 
ling (marked by a not-too-success- 
ful attempt to place us in the identi¬ 
cal positions of our original gradu¬ 
ation shot), we embarked on a rol¬ 
licking bus trip to the Gordon 
estate, the highlight of the trip 
being Betsy (Reilly) Sullivan’s 
skirmish with a plate of buffet 
Newburgh, which inevitably ended 
up in Jud Hoover’s lap. The after¬ 
noon at the Gordons’ placed 
another jewel in the crown of this 
established tradition and provided 
a much-needed chance to renew 
old ties in a warm and relaxed 
atmosphere. Hoover was the 
solitary sampler of the lake, osten¬ 
sibly to elute the remains of the 
Betsy buffet. 
The class dinner on Saturday 
night at the Graduates Club was 
nothing short of gourmet and was a 
fitting climax to the air of gemut- 
lichkeit prevailing throughout the 
weekend. Sunday morning rolled 
around with startling quickness. 
Amid parting salvos of “See you at 
the 55th,” the party was over. 
Those fortunate enough to 
make it were: Molly Albrink, Joe 
and Virginia Arminio, Bill and 
Joan Banfield, Tim and Phyllis 
Beck, Frank and Peg Behrle, 
Sandy Bluestein, Linus and Dusty 
Cave, Tom and Babette Coleman, 
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Tom and Harriet Doe, Marty and 
Evelyn Gordon, Jim and Ruth 
Harten, Jud Hoover, Jim and 
Micki Kleeman, Vinnie and 
Rosina Longo, Hugh MeLane, 
Jack and Laura Neville, Bob and 
Marge Owens, Vinnie and Babe 
Pepe, Julie Sachs, Don and Char¬ 
lotte Shedd, Dick and Mitzi 
Sisson, Bob and Mary Wagner, 
William P. Walsh (Class of 
’43)and Frances, Bill and Midori 
Wedemeyer, and Eli and Emma 
Sue Wing. 
We were most pleasantly sur¬ 
prised to welcome three widows: 
Rosalie Collier, Muriel Murphy 
and Betsy (Reilly) Sullivan. Sadly, 
the Whelans and their daughter, 
Sharon, John Morton, Ruth (Svi- 
borgsen) Kempe and Joe Morris 
were all looking forward to coming 
but had to cancel due to unforeseen 
circumstances. 
The class gift to Yale shot out 
all the lights—a grand total of 
$1,155,059 with 76 percent partici¬ 
pation. The previous high had 
been $350,000. A class act? 
1951 
45TH REUNION 
By John J. Sullivan, M.D. 
It was 1951 all over again—Fri¬ 
day, June 7th, we had all assem¬ 
bled during the day, registered and 
had been greeted by Lycurgus 
Davey, our AYAM president and 
Gerard Burrow, our dean. 
We had attended and enjoyed 
radiology chairman Bruce 
McClennan’s presentation The X- 
Ray: 100 Years Of Progress, an in- 
depth historical study. 
Now, conviviality took over 
and we were at the dean's recep¬ 
tion. Our next stop was Mory’s for 
cocktails and dinner. We were 
John and Ruth Berg, Jocelyn 
Malkin. Sid and Ina Furst. John 
and Betty Lou Haxo. Wally Mor¬ 
Reunion on a small scale 
The fourth, irregular, mid-term, New England mini-reunion for 
the Class of 1945 convened on Oct. 10, 1996, at the Publick 
House in Sturbridge, Mass. Eight classmates (Atwood, 
Breck, Daniels, Gardam, Jenney, Jones, Naumburg and Rein¬ 
er) and six wives attended. 
The class will hold its next mini-reunion April 5 to 9 at 
Howie-in-the-Hill, Fla. Ray Gagliardi has been planning this 
event for the entire class. Having celebrated our 50th reunion 
in 1995, the year 2000 looks a long way off—hence a mid¬ 
term meeting for this loyal and loving group. 
R.W. Breck, M.D. 
Left: Members of the Class of 1946 visit 
together during the Dean's Reception in 
the Medical Historical Library’, 50 years 
after their graduation from the School of 
Medicine. From right: Vincent Pepe, 
M.D., Julian A. Sachs, M.D., James N. 
Harten, M.D., and June Pepe. 
Below: John L. Sullivan, M.D., left, 
and John V. Haxo, M.D., members of 
the Class of 1951, share a happy 
moment during their 45th reunion. 
gan, Mai and Muriel Bagshaw. 
Carrold and Luanna Iverson. 
Lowell and lone Goodman. Tom 
and Barbara Amatruda, John and 
Mary Sullivan. Andy and Irene 
Wong, and A1 and Donna 
Mowlem. 
It was a casual, happy evening. 
There were two long tables. At the 
one I was at. the old boys and girls 
were having a delightful time. I 
glanced happily at the other long 
table. The group was even more 
excited. It was just what a reunion 
should be! 
The program on Saturday was 
again outstanding. Radiology was 
featured, all the way through the 
latest in teleradiology. It would 
make you proud of the old school. 
Again, it was time for convivi¬ 
ality—libations and dinner at the 
Graduates Club! Our group was 
now joined by Paul and Polly 
Bruch. Frank and Dolly Allen, 
and Brad and Ruth Straatsma. 
This party was even better. As 
Ernest Hemingway said: “We ate 
well and we drank well." 
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Sid Furst was the master of 
ceremonies. He remembered the 
15 classmates we had lost, and 
added the name of Mike Walken, 
our almost-classmate. We had a 
moment of silent prayer for our 
old friends. 
Sid reviewed our corres 
pondence from classmates unable 
to be with us. Tom Amatruda 
discussed plans for the 50th. 
We shall hear more from him later 
on this. 
The 50th sounds great. The 
one and only Lowell Goodman is 
forming a class band for this one, 
so stiffen up your embouchure. We 
all want another great affair. You 
have to come back. 
1956 
40TH REUNION 
By John H. Gardner, M.D. 
Thirty-two of us gathered in New 
Haven for our 40th reunion. Forty- 
eight percent of the living mem¬ 
bers of our class attended, a pretty 
good record for a 40th reunion. It 
was good to see some old friends 
at the unstructured class gathering 
Friday afternoon, but it was not 
very well attended. A fair number 
of us attended the teaching ses¬ 
sions on the past and future of 
radiology, and the meetings of the 
Association of Yale Alumni in 
Medicine, but attendance was cer¬ 
tainly best at the dinner meetings. 
Commencement + 70 
Elizabeth Ross Harrison, M.D. '26, attended reunion in June with her 
nephew, Ross G. Harrison III. Dr. Harrison's father, Ross Granville Harri¬ 
son, M.D., Ph.D., was a leader in the field of tissue culture and the first to 
develop a method for growing tumor cells in flasks. When the elder Dr. 
Harrison moved his family to New Haven in 1907from Johns Hopkins 
University in Baltimore, the family lived in the building on York Street that 
is now Mory’s. Dr. Harrison celebrated her 97th birthday this year. 
A high point of these reunions has 
always been the Friday evening 
informal dinner at Helen and 
Steve Downing’s house in Guil¬ 
ford, when one gets to relax with 
old friends and suffer through 
slides and movies of previous 
reunions. The more formal cock¬ 
tails and dinner at the New Haven 
Lawn Club on Saturday was some¬ 
what better attended and the cui¬ 
sine was very good, especially if 
one were lucky enough to obtain 
the entree requested through the 
alumni office. Bill Lewit and 
Charlie Zigun were only able to 
make it to the luncheon on Satur¬ 
day—sorry not to have seen more 
of them. 
This reunion was preceeded 
by a questionnaire which had been 
answered by 54 of us, or 81 per¬ 
cent—again an excellent record. 
Most of us are near or past the age 
of 65 and it is therefore not sur¬ 
prising that 20 of us have retired, 4 
more are on the verge, and 10 
more have sharply curtailed their 
professional duties, often by relin¬ 
quishing department chairman¬ 
ships, and sound as though they 
are enjoying the situation much 
better. That leaves only 20 of the 
respondents, 37 percent, who are 
still in the full-time active practice 
of medicine and planning to 
remain so. Perhaps the most thor¬ 
oughly retired is Bob McDivitt, 
who gives his address as the yacht 
Charade, out of Trinidad. Many 
respondents commented on the 
excellence of a Yale medical edu¬ 
cation and the joys of practicing 
medicine tempered somewhat, 
however, by the current tendency 
to have one's practice run by 
insurance companies. In the 
same spirit, spurred onward by 
the uniquely generous matching 
grant offered by Bill Hindle, 
our class made a substantial con¬ 
tribution to the Yale Medical 
Alumni Fund. We left New Haven 
with rekindled warmth of spirit 
and a desire to return in another 
five years. 
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35TH REUNION 
By Sally L. Marchesi, M.D. 
A dinner, hosted by Vincent T. and 
Sally Lockwood Marchesi and 
Robert I. and Ellen Levy, was held 
on Saturday evening at the March- 
esi’s Guilford home. Enjoying the 
evening were Robert S. and Joyce 
Briggs, David W. and Judith 
Brook, Lawrence T. Chiara- 
monte, Royal C. Hudson Jr., 
Joseph E. and Joanne Jasaitis, 
George M. and Christa Lordi, 
Anoush Miridjanian, Roy E. 
Ronke Jr., Robert N. Taub and 
Warren D, and Myra Widmann. 
Elaine Pitt sent her regrets. 
A poem of thanks was sent by 
George and Christa Lordi reflect¬ 
ing the feelings of the evening. 
Many thanks for 
... the view of the ocean and the bay, 
the poppies on the driveway; 
... the evening sun, 
many old friends for fun; 
...a house of warmth and delight, 
where childrens’ touches are 
still in sight; 
... some tales of intervening years, 
some changes, disappointments 
and cheers; 
... good cooking and great tastes, 
such organization didn’t go to 
waste; 
... these special moments we shall 
treasure, 
as proof of extending friend¬ 
ships ’ measure. 
1966 
30TH REUNION 
By Arne Youngberg, M.D. 
A small transcontinental contingent 
gathered in New Haven for our 
30th. Phil and Arlene Bernstein 
flew in from San Francisco. Gene 
Cassidy drove cross-country from 
the Iowa heartland. Joel and Cyn¬ 
thia Singer, Jim and Victoria Sans- 
ing, Jim and Pat Brown, Donald 
Cohen, and Arne and Patti Young- 
Distinguished alumni/ae 
Dwight F. Miller, M.D., and Marie-Louise T. Johnson, M.D., Ph.D., 
both members of the Class of 1956, received the Distinguished Alumni 
Sennce Award at reunion in June. Dr. Miller, a Connecticut pathologist, 
was president of the AYAM from 1984 to 1989. Dr. Johnson, a derma¬ 
tologist who treated patients and conducted research in Hiroshima, 
Japan, during the 1960s, was AYAM president from 1993 to 1995. 
berg popped in from various urban 
and rural areas in Connecticut. 
Our class dinner was in the 
Library Room at the Graduates 
Club on the New Haven Green and 
we had laughs and fond memories, 
sharing news of all our classmates. 
Our 35th reunion in 2001 will coin¬ 
cide with Yale’s 300th Anniver¬ 
sary—think about it. 
1971 
25TH REUNION 
By Barry Perlman, M.D. 
Graying but still largely unbowed, 
approximately 31 members of the 
Class of ’71 celebrated their 25th 
graduation reunion. The class din¬ 
ner, an excellent clambake, was 
held on Saturday evening, as it 
often has been in the past, at the 
beautiful home of John and Ellen 
Ebersole on Long Island Sound. A 
brunch was held on Sunday morn¬ 
ing at the home of Barbara 
Kinder, who planned the class 
reunion along with Elton Cahow, 
her husband, and Richard Moggio. 
Many of those who enjoyed the fes¬ 
tivities were “reunion groupies” 
who had attended most of the prior 
class gatherings. They were joined 
by several first-time attendees, 
including Sten Lofgren, Stuart 
Phillips, Tim Jette (who has left 
anesthesiology for psychiatry) and 
Steve Moffic. Geographically, too, 
the group arrived from all parts of 
the country and included John 
Cieply from Hawaii, Andy Cook 
from Maine, Doug Schmidt from 
Colorado, and Paul Vignola from 
Florida. As might be expected, the 
largest contingent in attendance 
was from Connecticut, Massachu¬ 
setts and New York. They included 
Albert Weihl (who has founded 
an emergency medicine residency 
at Yale), Richard Kaufman. 
Fred Cohn, Burns Woodward. 
John Patti and Barry Perlman 
(who was appointed chair of the 
New York State Mental Health Ser¬ 
vices Council by Gov. George 
Patakai, himself a graduate of Yale 
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College). Others who made the 
pilgrimage to New Haven were 
David Lippman (who had just 
recently returned from a self-con¬ 
ferred sabbatical of a year’s dura¬ 
tion with his family, during which 
time he spent some months practic¬ 
ing in New Zealand and he visited 
with Elizabeth Morgan), John 
Mills (who regaled us with adven¬ 
tures from his continuing military 
involvement), John Smiarowski 
(who has infiltrated New England 
culture into rural Louisiana), Rich 
Travers, Semeon Tsalbins, Lenny 
Eisenfeld, Jonathan Stewart, and 
Marian and Bruce Block (the 
only intra-class marriage and still 
going strong). 
Alumni/ae listen to a presentation on 100 
years of radiology at Yale by Bruce McLen¬ 
nan, M.D., chairman of diagnostic radiol¬ 
ogy. In the front row, from right, are Robert 
R. Wagner, M.D. ’46, Mary Wagner, Minn 
Sisson and Richard G. Sisson, M.D. '46. 
While the mood was bright, 
those who came together took the 
opportunity to offer condolences 
and support to Lenny Eisenfeld 
whose son tragically died in a ter¬ 
rorist bombing while studying in 
Israel earlier in the year. Long-term 
spouses were congratulated on 
their achievement and new spouses 
were warmly welcomed. Unlike 
prior reunions, proud talk was as 
much about the accomplishments 
of children who are beginning to 
take their place in the world as 
about the doings of the class mem¬ 
bers themselves. Beyond nostalgia. 
other prominent topics were 
news of those not present and 
changes in the landscape of medi¬ 
cine since graduation. 
1976 
20TH REUNION 
By Alfredo Axtmayer, M.D. 
Attending the 20th reunion were a 
select few, including Roger and 
Meredith Boshes, Peter Swanson, 
Ken Dobuler, Cindy Mann, and 
Pat and Alfredo Axtmayer. Quot¬ 
ing Roger: “I am completely 
bummed. Where are Cullen and 
Schottenfeld. Kremer, Sladky? 
The only good thing is the upgrad¬ 
ing of the wine at dinner, which 
was a lively, albeit intimate, meal.” 
He predicts the 25th will be big. He 
is practicing psychiatry and teach¬ 
ing psychiatry in Rhode Island. 
Ken Dobuler and Sue report 
their daughter, Zoe, is now a year 
old. He is chief of medicine at 
Griffin Hospital, continuing his 
pulmonary practice. His newfound 
aspiration is to become an expert 
sea kayaker, which he is doing now 
with dedication. 
Peter Swanson is still practic¬ 
ing family medicine in Shelton, 
Conn., and is searching for docu¬ 
mentation of our second-year show 
to present at the 25th reunion. Last 
we heard. Bob Taylor had the 
sound and Rick Morin had the 
film, so maybe we can get these 
together. 
Cindy Mann is still practicing 
pediatrics in New Haven at CHCP, 
which is no longer a closed-panel 
HMO. She is concerned now that 
she has to pay attention to the part 
of medicine she never liked. She is 
still in love with pediatrics and 
reports the adoption of her son, 
Michael, now 4 years old, from El 
Paso, who “is the light of my life.” 
She also wants those who didn't 
show up this year to know the 
seven of us who dined together had 
a great time talking about the rest 
of you! 
I keep wondering why I do this 
every five years, since we seem to 
be having diminishing returns. I 
continue to practice orthopaedics 
in the Meriden/Wallingford area, 
and do some limited work at Yale- 
New Haven and St. Raphael's. Am 
enjoying life with my wife, Pat, 
and my four children, Alfredo, 
Patrick, Aileen and Caitlin. 
1981 
1 5TH REUNION 
By Barbara Ross, M.D. 
Nine members of the Class of ’81, 
along with spouses and friends, 
returned to New Haven for our 
15th reunion. We got together for 
dinner at the Colonial Tymes 
restaurant, for what turned out to 
be great food and a comfortable 
place to catch up with each other. 
As before, our New York con¬ 
tingent was well represented. 
Dovelet Shashou and husband, 
Jon Trambert, hail from Riverdale. 
Dovelet practices pediatric oph¬ 
thalmology and is on the go with 
Steven, 6, and Emily, 3. Ines Car- 
rasquillo is also back in New 
York, practicing plastic surgery, 
after a brief stint in Florida. She 
much prefers the Big Apple. 
Frank Yeomans’ psychiatry prac¬ 
tice in the city focuses on the bor¬ 
derline patient, and he’s recently 
published a book on the subject. 
David Lebwohl and Sally have 
recently moved back to Connecti¬ 
cut and now live in the shoreline 
town of Madison—welcome to 
the suburbs! 
Other classmates had to travel 
a bit farther to reunion. Tony 
Urbano and Camille came back 
from Bethlehem, Pa., where Tony 
is an interventional cardiologist. 
Their children are Angela, 7, 
Camille, 5, and Anthony, 3. Susan 
Burdette lives in Montreal with 
husband, Victor Radoux, and step¬ 
daughter, Catherine, 11. Susan is a 
continued on page 62 ► 
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With honors 
Arthur C. Crovatto, M.D. ’54, awarded Peter Parker Medal 
Arthur C. Crovatto, M.D. ’54, 
who retired this year as direc¬ 
tor of alumni affairs, has been 
honored with the Peter Parker 
Medal for his service and special 
contributions to the school, and 
for his loyalty as an alumnus. 
The Parker Medal is named 
for the Yale medical missionary 
who devoted his life’s work to 
China, where his breakthrough 
achievements in transcultural rela¬ 
tions wrought truly historic 
changes in the worlds of medicine, 
religion and international diploma¬ 
cy in the mid-1800s. Peter Parker 
was a graduate of Yale College, 
Yale Medical College and Yale 
Divinity School. 
“Dr. Crovatto has done a 
superb job in building alumni/ae 
relations and has been the archi¬ 
tect of wonderful alumni/ae 
reunions during the past six 
years,” Dean Gerard N. Burrow, 
M.D. ’58, said as he presented 
the medal to Dr. Crovatto at 
reunion in June. “Arthur has 
been one of the driving forces in 
the anatomy lab and his anec¬ 
dotes to the students have figured 
prominently in the second-year 
class show.” The Class of 1999 
honored Dr. Crovatto with his own 
song (Art Crovatto, to the tune of 
the Eagles’ Desperado) in the 
1996 show. 
Born at home in Union City, 
N.J., Dr. Crovatto chose medicine 
as a goal early in life. Interviewed 
this summer, he recalled that his 
mother offered him two career 
choices—those of minister or 
physician. Possibly influenced by 
his godfather, a doctor, he chose 
the latter. From Union City, he was 
able to enjoy the pleasures of New 
York City for the cost of a 5-cent 
subway token, and recalls watch¬ 
ing in fascination as the Lincoln 
Tunnel connecting New Jersey and 
Manhattan was excavated. 
The first in his family to pro¬ 
ceed beyond grammar school, he 
entered Columbia University in 
1945, where he was a premed¬ 
ical student and a junior-varsity 
basketball player. He first visited 
New Haven for a game against 
Yale in the Payne Whitney Gymna¬ 
sium. He returned again for foot¬ 
ball games at the Yale Bowl, 
filled to capacity, trolley cars run¬ 
ning. In February 1946, he 
entered the Army. 
When he later interviewed 
for admission to the School of 
Medicine, he was welcomed by 
Bill Whalen, then a first-year 
medical student, and spent two 
hours touring the school. The 
friendly and inviting atmosphere 
he found, and the Yale System of 
medical education, galvanized his 
love of medicine and of Yale. He 
participated in the Aesculapian 
Student Frolic Dance, the pro¬ 
ceeds of which paid for the daily 
student-faculty teas (a wonderful 
aspect of the student life of the 
era), and he played on the medical 
school basketball team. 
During his internship, Arthur 
met Janet Herrold, who was pursu¬ 
ing a master’s degree at the Yale 
School of Nursing and graduated 
with the Class of 1955. They mar¬ 
ried in York, Pa., and moved there 
in 1961. He established a private 
practice as a urological surgeon, 
and served as chief of the division 
of urology at York Hospital. Dr. 
Crovatto was chairman of the York 
County Medical Society Scholar¬ 
ship Committee, which he and his 
colleagues founded in 1962. Free 
polio vaccinations were being 
offered at the time to the York 
community, and donations were 
collected in a bucket at the clinic. 
These proceeds became the core 
of the scholarship and loan fund 
which today makes annual awards 
of $30,000 to students aspiring to 
a career in medicine. 
After 29 years in York, the 
Arthur C. Crovatto, M.D. '54, left, receives 
the Peter Parker Medal from Dean Gerard 
N. Burrow, M.D. '58, at reunion in June. 
Crovattos returned to New Haven 
in 1990, and Dr. Crovatto 
assumed the directorship of the 
medical school Office of Alumni 
Affairs. Working with the medical 
students as an instructor in anato¬ 
my, he has enjoyed connecting 
these future alumni/ae to the 
Association of Yale Alumni in Medi¬ 
cine (AYAM). He and his wife have 
four children, two of whom now 
live on the Upper West Side of 
New York City. From his son’s 
apartment he can see his child¬ 
hood home of Union City. Five 
young grandchildren keep the 
Crovattos busy, and Dr. Crovatto is 
devoting time to tennis, gardening, 
the appreciation of basketball, 
and weekends at his summer 
home on Martha’s Vineyard. He 
remains connected to Yale and 
medicine, and to another genera¬ 
tion of aspiring physicians, as an 
instructor of anatomy. 
Bonnie Sargent 
Yale medicine 59 | 
H
arry
 B
ishop
 
Sharing light 
Was the Greek inscription above the door to Sterling about 
the handing down of knowledge, ora more collegial enterprise? 
A search of the past suggests the latter. 
Where the runners outwear each other 
but running with lampless hands. No man takes light from his brother 
till blind at the goal he stands. 
Swinburne, Hymn of Man 
AAM riAAIA 
AIAAOIOTIIN 
E 
As we crossed Cedar Street 
last fall on our way into Ster¬ 
ling Hall of Medicine, Bill Collins, 
M.D. ’47, asked if I could trans¬ 
late the Greek inscription on the 
architrave over the entry portal to 
the rotunda. Knowing nothing of 
the history of the portal and its 
architecture, my rendition was: 
Those having brightness (of 
knowledge) will pass it on to each 
other. This idea of sharing 
seemed quite appropriate to the 
collegial atmosphere that most of 
us experienced and enjoyed at the 
Yale School of Medicine. Col¬ 
leagues pointed out soon enough 
that the first word of the inscrip¬ 
tion referred not to brightness but 
to torches. 
But of course, for there above 
the inscription was the symbol of 
the torch with the owl of wisdom 
behind it, sculptured in the frieze 
as in an ancient Aesculapian tem¬ 
ple, clearly a fascination of the 
architect. This symbolism had to 
have an historical significance, so 
my answer to the original question 
only raised more questions. 
A visit to the Yale Medical His¬ 
torical Library produced two publi¬ 
cations showing the entry portal: 
The Yale Alumni Magazine of Janu¬ 
ary 1959 and the Yale Memorials 
from the Office of the Secretary, 
1963. In both, the rendition of the 
Greek inscription in English was 
as follows: Those who have torch¬ 
es shall pass them on to others. 
This translation did not seem sat¬ 
isfactory, as the last word of the 
inscription, AAAHAOIX, means 
not “to others" but “to each 
other” or “to one another." 
My next stop was at the Ster¬ 
ling Memorial Library on the main 
campus. There, the electronic text 
section provided, with just a few 
keystrokes on the computer, the 
source of the quotation. It flashed 
on the screen, identified as 
Republic, I 328 a 2. It was about 
horse racing! A novel idea it was, 
a relay race on horseback. Refer¬ 
ence was made to the Jowett 
translation, which proved to be: ... 
Will horsemen carry torches, 
and pass them one to another 
during the race? This literary 
translation is quite appropriate to 
the context of the passage, but a 
review of the original Greek text 
would permit, if we remove the 
question mark, a more literal 
translation known to us today: 
Those having torches will pass 
them on to one another. 
How were these words cho¬ 
sen for the entry portal of the Yale 
School of Medicine and the Insti¬ 
tute of Human Relations? There 
had to be a story. Researching 
the files of Dean Milton C. Winter- 
nitz, the entire story of the portal 
was revealed, finally, in the folder 
labeled Miscellaneous. 
Dean Milton Winternitz, who 
had instituted the medical 
school’s full-time faculty system, 
had felt for some time that the 
medical school was carrying a dis¬ 
proportionate share of the social 
problems of the community. With 
his friend, the 28-year old dean of 
the Law School, Robert M. 
Hutchins, the dean embarked 
upon an effort to bring multiple 
disciplines, including law, sociolo¬ 
gy, psychology, psychiatry, medi¬ 
cine and even engineering, to 
share in these sociological 
endeavors. The president of Yale 
University, James Rowland Angell, 
described the project as a com¬ 
munity of scholars. It was to be 
called the Institute of Human 
Relations, for which the dean had 
obtained a generous Rockefeller 
grant, both for its construction 
and its support for the next five 
years. Precursor to the the pre¬ 
sent-day Yale Psychiatic Institute, 
the Institute of Human Relations 
originally occupied the left side of 
Sterling Hall of Medicine. 
The architect chosen for the 
project was Grosvenor Atterbury, 
a member of the Yale College 
Class of 1891 and a close friend 
and classmate of Harvey Cushing, 
M.D. Among the items found were 
a letter from Mr. Atterbury to Dr. 
Winternitz and a reprint of the 
architect’s article, Hospitals 
and Esthetics (from the Journal of 
the American Medical 
Association, 1915). 
Searching through these 
items, one uncovers a clear expla¬ 
nation for a choice of the inscrip¬ 
tion. To Mr. Atterbury, the esthet¬ 
ics of the hospital were more a 
function of the art than of the sci¬ 
ence of architecture. He believed 
that there was a human side to 
every medical problem and that 
this was epitomized by the sen¬ 
tence suggested for the entrance 
to the Virchow Hospital in Berlin: 
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Architect Grosvenor Atterbury’s enchantment with the ancient Aescu- 
lapian temples of healing is seen in the sculptured frieze, above the 
inscription, at the portal to Sterling Hall of Medicine. The sculpture 
exhibits a small torch (the literal meaning in the singular of the first 
word of the inscription) behind which is the figure of an owl. The owl, 
the favorite bird of Athena/Minerva, was the bird of wisdom. 
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“In treating the patient, do not for¬ 
get the man." His admiration of 
this inscription probably motivated 
him to have a similarly telling 
inscription over the portal of 
entry of the Institute of Human 
Relations. 
In a letter to Dean Milton Win- 
tern itz dated November 13, 1930, 
Mr. Atterbury enclosed a copy of 
Hospitals and Esthetics and an 
explanation for the inscription. His 
translation of the quotation is 
close, but not quite literally correct: 
Carrying torches they passed them 
on, one to another. His interpreta¬ 
tion was that there are “times 
when in the brotherhood of all the 
arts and sciences one profession 
should take the torch from another, 
as did the Greek runners ... eager 
to advance it toward the goal.” This 
interpretation, like mine, implies a 
sharing or horizontal transmission 
of knowledge. He continues to say 
that.the quotation is taken from a 
description of ancient Olympic 
Games. He was unable to recall the 
author and suggested that the 
dean inquire of “one of the Greek 
Professors in the University." 
Dean Winternitz did write to 
Professor Austin M. Harmon, who 
replied promptly in a letter of 
November 18, 1930. Professor 
Harmon identified the source of the 
quotation and corrected Mr. Atter¬ 
bury’s translation thus: “Carrying 
torches, they will pass them on, 
one to another.” He described 
torch races as a feature of the 
Panathenaic Festival at Athens as 
there were no torch races in the 
Olympic Games. The last paragraph 
of Professor Harmon’s letter is wor¬ 
thy of quotation: 
“Since the torch race was a 
relay race, in which each team of 
runners passed a torch from hand 
to hand precisely as modern run¬ 
ners pass a short staff, and since 
it was the duty of each runner in 
the relay to keep alight the torch 
which he received and passed, the 
transmission of the torch, by 
repeated figurative use, has come 
to be almost synonymous with the 
transmission of learning from one 
generation to the other. In that 
sense, the words of Plato are 
applicable to the activity of any 
school in the University. It is diffi¬ 
cult, however, to share what seems 
to be the view of Mr. Atterbury that 
they adequately symbolize coopera¬ 
tion and are therefore especially 
applicable to the Institute of 
Human Relations. There was no 
exchange of torches in the race 
and the runner received from some¬ 
one else the torch that he kept 
lighted and passed on.” 
Conclusively, then, Professor 
Harmon makes it clear that the 
passing of the torch is a vertical 
transmission of knowledge from 
one generation to another and not 
a sharing or horizontal transmis¬ 
sion. To emphasize Professor Har¬ 
mon’s words that the object was 
that the torch “be kept lighted and 
passed on,” I quote the definition 
of the quotation from Brewer's 
Dictionary of Phrase and Fable 
first published in 1870: “To main¬ 
tain and transmit knowledge, 
learning, etc., to the succeeding 
generation.” 
Dean Winternitz accepted Mr. 
Atterbury’s proposal and reasons 
for the inscription, but being dean 
of the medical school, he also 
accepted Professor Harmon’s 
interpretation, which was so 
applicable to the medical school. 
He was right, for ironically the Insti¬ 
tute of Human Relations exists his¬ 
torically in name only while the 
inscription persists as a fitting 
expression of the mission of the 
Yale Medical School. 
Lycurgus M. Davey, M.D. '43 
President. AY AM 
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hematologist-oncologist at McGill 
University. Neil Gross lives in 
Bethesda now, and has set his sight 
on business school in the fall. And 
Alicia Barela gets the “longest 
journey” award, having traveled 
from California where she is in 
Ob/Gyn with the Kaiser healthcare 
system. She was accompanied by 
her son Robb—many of us remem¬ 
ber him as a toddler 15 years ago. 
Many thanks to all who submit¬ 
ted information for our reunion 
booklet—watch the mail for your 
copy. And I hope to see all at the 
20th reunion in 2001. 
1986 
1 OTH REUNION 
By Eric P. Suan, M.D. 
Fifteen members of the Class of 
1986 returned to New Haven to cel¬ 
ebrate the class’s 10th reunion. 
Most of the activities centered 
around food, drinks and good con¬ 
versation. A cool summer’s night 
was perfect for the Friday evening 
barbecue on the patio of Harkness 
Hall. Kudos to Mike Miller for 
arranging a tour of his old Harkness 
John H. Gardner III, M.D. '56, and his wife, 
Anne L. Gardner, right, visit an exhibit on 
A.C. Gilbert, M.D. '09, at the Eli Whitney 
Museum in Hamden, Conn., on a tour added 
this year to the reunion weekend events. 
Guiding them is Helaine Patterson, president 
of the museum and director of public infor¬ 
mation at the School of Medicine. 
dormitory room. A feast at Mory’s 
on Saturday completed the week¬ 
end's events. Oh yes, the lectures 
were very stimulating as always. In 
attendance were Catharine Arnold 
(now in medicine in New Haven), 
Cristina Brunet (Class of ’87) 
(medicine, New Haven), Sophie 
Cole (cardiology, San Francisco), 
Colleen Collins (primary care, 
Chelsea, Mass.), Amanda Dill 
(medicine, Danbury, Conn.), 
Daniel Fierer (research, NIH in 
Bethesda, Md ), Jeremy Holtzman 
(medicine, Minneapolis), Betty 
Klein (vitreoretinal surgery. Red¬ 
ding, Conn.), Cynthia (Hall) 
McCraven (Ob/Gyn, Cheshire, 
Conn.), Tim McGowen (pediatric 
orthopaedics, Winston-Salem, 
N.C.), Michael Miller (Pfizer, 
Alexandria, Va.), Ilena Norton 
(psychiatry, Denver, Colo.), Eric 
Suan (vitreoretinal surgery. Camp 
Hill, Pa.), Miriam Tatum (primary 
care, Derby, Vt.), Julia Whiteside- 
Michel (glaucoma, Little Rock, 
Ark ), and John Wysolmerski 
(endocrinology. New Haven). 
1991 
5TH REUNION 
By Frank Lobo, M.D. 
The Class of ’91, encompassing not 
only those who actually graduated 
in 1991, but also some who arrived 
at YSM in 1987, reunited, in part, 
over Alumni/ae Reunion Weekend. 
At the dean’s reception on Friday, 
Funda Meric (finishing research 
fellowship at NIH, returning to 
Michigan for chief year in general 
surgery), Rick Ihnat and Denise 
Kung Ihnat (attendings in internal 
medicine in St. Louis), and I con¬ 
gratulated each other on the kind¬ 
ness that time had shown us and 
traded any gossip that was available 
about our classmates. Rick already 
has turned down a chairmanship of 
a department—likely a ’91 first! At 
the barbeque later that evening, the 
ever great-looking wife and hus¬ 
band Gaetane Francis (Ob/Gyn 
attending in Greenwich) and Larry 
Hirsch (epilepsy fellowship at 
Columbia) arrived. The evening 
was warm, and so was the food. 
Saturday evening brought us 
together with the 50th reunion class 
for the Friends of the Fiftieth dinner 
at the Graduates Club. There we 
were joined by Dan Saal (finishing 
Ph.D. work in physiology, likely 
headed for psychiatry—behind the 
desk) and wife. Dr. Denise Alba. On 
the other side of the table, and just 
out of conversation range, was 
Peter Bernstein (perinatology fel¬ 
lowship at Einstein) and wife, Cath- 
leen Bernhart. Peter and Cathleen 
economized on reunion expenses 
by attending three at once (Yale 
College, YSM, and along with Gae¬ 
tane, Yale Ob/Gyn residency). The 
bar was welcoming, the food 
yummy and the company terrific, 
but the big hit was the Class of 
1991 Update booklet, featuring bios 
on those who returned the forms 
and world-premiere cartoons 
by Marc Agronin (assistant profes¬ 
sor of psychiatry at Minnesota). 
The enthusiasm for the Update 
has prompted a second mailing 
of forms, which should be 
arriving now, in order to make 
an addendum. 
On Sunday, reunion attendees 
indulged me by coming to my 
house for brunch. Although 
described in the invitation as a “ren¬ 
ovated” old house, it actually is 
somewhat short of that. Nonethe¬ 
less, the yard was large enough to 
contain the crowd, which swelled 
with the arrival of John Phillips 
(chief year in urology at Yale), 
Steve Ugent (finished dermatology 
at Tufts, now assistant professor at 
Boston U.), and Steve’s fiancee, Dr. 
Randy Berger. Finally, Carl Hen- 
ningson (finished Ph.D., matched 
at Penn for internal medicine) 
brought his infectious smile to the 
brunch. Bernstein, Ihnat and 
Phillips’ children were perfect 
angels and were overheard asking 
how old they would have to be to 
apply to Yale Medical School. 
Maybe by the 20th reunion. 
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Healing the world from home 
Yale medical alumni/ae learned 
of an innovative way to 
develop world medical aid without 
leaving their own hospitals, in a 
reunion presentation by William H. 
Rosenblatt, M.D., assistant profes¬ 
sor of anesthesiology and one of 
five winners of the 1996 Interna¬ 
tional Rolex Awards for Enterprise. 
Dr. Rosenblatt described the 
prize-winning REMEDY program, 
a system for recovering discarded 
surgical supplies from U.S. hospi¬ 
tals and donating the materials to 
developing countries. REMEDY, 
for Recovered Medical Equipment 
for the Developing World, was 
developed in 1991 at Yale and is 
now in place in more than 60 
hospitals throughout the United 
States, including Yale-New 
Haven Hospital. 
The program teaches hospitals 
a thoroughly tested protocol to 
recover discarded but unused oper¬ 
ating room supplies in affluent 
countries and distribute them 
through well-known charities to 
the needy in developing countries. 
Physicians, nurses and technicians 
thereby contribute to global health 
care during their daily routine, Dr. 
Rosenblatt told returning 
alumni/ae gathered in a Jane Ellen 
Hope seminar room in June. 
According to David G. Silver- 
man, M.D., professor of anesthesi¬ 
ology and vice president of REM¬ 
EDY, this program also includes a 
research component, whereby U.S. 
hospitals are able to learn cost- 
effective measures to save money 
and reduce waste. Drs. Silverman 
and Rosenblatt have published 
extensively on this issue, including 
articles in the Journal of the Amer¬ 
ican Medical Association. 
As standard practice, Ameri¬ 
can hospitals throw away surgical 
supplies prepared for operating 
room procedures—even if they 
remain intact—because they are 
no longer covered under the 
manufacturer’s single-use-only 
warranty. These supplies can 
then be sent to developing coun¬ 
tries, which have extremely lim¬ 
ited materials. 
In addition, REMEDY is 
looking at effective methods to 
donate materials overseas and 
developing communication sys¬ 
tems, including use of the Inter¬ 
net, about the materials that are 
available in the United States and 
that are needed in developing 
countries. 
“REMEDY, in cooperation 
with the Yale Office of Interna¬ 
tional Health, is developing AIRE- 
mail. Agencies for International 
Relief e-mail list. This list will be a 
free means by which not-for-profit 
agencies can offer donated goods 
or make urgent requests,” Dr. 
Rosenblatt says. “REMEDY 
already has filled one urgent 
request for a skin graft mesher in 
Belarusk and has distributed items 
for which REMEDY had no over¬ 
seas request,” he adds. 
“With funds from Rolex and 
other corporations, REMEDY is 
encouraging more hospitals to par¬ 
ticipate in this program,” Dr. 
Rosenblatt says. In the past, hospi¬ 
tals had approached REMEDY for 
programmatic information, and 
now REMEDY is able to request 
hospitals to join this global effort. 
To extend REMEDY’S work, 
the program has developed a link¬ 
age with the Albert Schweitzer 
Institute for the Humanities, based 
in Wallingford, Conn., to dissemi¬ 
nate the REMEDY program 
William H. Rosenblatt. M.D.. holds a tray of 
disposable items—still intact and sterile— 
recovered from the operating room at Yale- 
New Haven Hospital and bound for Albania 
and Nicaragua. No longer covered by the 
manufacturers' single-use-only warranties, 
the items are used in developing countries 
with limited materials. 
more widely in the United States 
and elsewhere. 
The Rolex awards program 
was created in 1976 to encourage a 
spirit of enterprise in individuals 
worldwide by providing them with 
the financial support and recogni¬ 
tion that they need to bring their 
original ideas to fruition. 
Dr. Rosenblatt and four others, 
selected from more than 2,500 
applications in 116 countries, each 
received $50,000 cash awards and 
solid gold Rolex chronometers at 
ceremonies in Geneva and New 
York City in May. 
Helaine Patterson 
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Reflections on 
the beginning 
of coeducation 
at Yale 
By Vivian Reznik, M.D. ’75 
s I reflect on my history at 
Yale—as a transfer student 
to Yale College in 1969, 
four years at Yale School of Medi¬ 
cine and a marriage to someone in 
the class of 1970—what I remember 
best is that first year of coeducation. 
I came to Yale College in the 
fall of 1969.1 was one of 40 women 
at Davenport College, all transfers 
from some other college—Sarah 
Lawrence in my case. We all came 
to New Haven in the spirit of a great 
adventure, few of us with specific 
goals. I remember thinking it was 
better than a junior year abroad. 
(Imagine choosing New Haven 
over Paris!) 
Some of us had lofty dreams— 
to become a Supreme Court justice, 
design great buildings, discover the 
bones of prehistoric man, win the 
Nobel prize. Others had more lim¬ 
ited aspirations—to meet a nice guy, 
fulfill a family legacy, get a good 
education. We didn't immediately 
break any barriers that first year. We 
didn't run the Yale Daily News, or 
start our own sports program, or get 
membership to Mory’s. Those 
changes would come from future 
classes. But we showed the institu¬ 
tion that women could be produc¬ 
tive, intellectual, interactive partici¬ 
pants without diverting the men in 
some sexual frenzy. 
We became lawyers (did we 
ever!), doctors, parents, writers, 
artists, filmmakers, judges, profes¬ 
sors, scientists and CEOs. We 
changed history and the environ- 
Vivian Reznick, M.D., a 1975 
graduate of the School of Medi¬ 
cine, is professor and vice chair 
of pediatrics at the University of 
California, San Diego School of 
Medicine. She returned to New 
Haven in May for the 25th-year 
reunion of the Yale College 
Class of 1971, the University’s 
first undergraduate class to 
include women. Yale School of 
Medicine has admitted women 
since 1916. 
ment at Yale. The administration of 
Yale at that time should be congrat¬ 
ulated not only for its vision but 
also for the way it achieved coedu¬ 
cation. Yale applied the same stan¬ 
dards it used for men and admitted 
women who had the capacity, desire 
and talent to change the world, 
whether through leadership, schol¬ 
arship or athleticism. Yale helped 
those women, as well as the men, 
discover their inner strength and 
taught them to use it productively. 
At Yale College, I was swept 
away by the world of 19th-century 
French literature. It was romantic, 
expansive, beautiful and inaccessi¬ 
ble. Did that help me become a bet¬ 
ter professor of pediatrics today? 
Maybe, because I remember how I 
felt daydreaming that I would never 
allow myself to become a Madame 
Bovary, or that I would always 
fight as did the revolutionaries in 
Les Miserable s, or hoping that 
our world was not as suffocating 
as that of Stendhal’s The Red and 
the Black. 
My liberal arts education awak¬ 
ened in me the idea that change is 
possible and perhaps inevitable. But 
the critical lesson I learned at Yale 
was that individuals change society. 
Perhaps that idea has been germi¬ 
nating in me through my years of 
scrambling to succeed at academic 
medicine, raising children and sur¬ 
viving managed care changes in 
medicine. But hopefully I have 
imparted that lesson to my children, 
students, interns, residents, peers 
and superiors. I have proceeded 
through these past 25 years as if it is 
my birthright to succeed. That atti¬ 
tude came in part from my parents 
but was refined, ignited and nur¬ 
tured at Yale. 
I think about young people I see 
now growing up in San Diego who 
feel that they have no future. No one 
may have ever told them that they 
are important, that they have inner 
talents and strengths that should and 
will be cultivated. This lack of self 
esteem is critical in the epidemic of 
teen violence, pregnancy and drug 
addiction in our society. Perhaps a 
Yale education cannot be promised 
to this large, youthful population. 
But the lessons we learned at Yale 
and the way in which we were 
treated as women and students 
there—with respect, honesty, 
commitment and enthusiasm— 
should serve as a model for youth 
development and our individual 
interactions with young people in 
our communities. YM 
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DEVELOPMENT 
Above: This depiction of an anatomy lesson 
from a 15th-century work in Johannes de 
Ketham’s Fasciculus Medicinae shows that 
dissection has been basic to medical educa¬ 
tion for centuries, although not always with 
the same attention to detail or degree of 
understanding. The picture of today's Yale 
students crowding around a cadaver will 
soon change. In the next century’s anatomy 
laboratory, the scene will incorporate 
advanced computer simulation, integrated 
with traditional dissection of real cadavers. 
Anatomy lesson 
The problem: limited and antiquated laboratory; 
space for the core course of a medical student’s 
first year. The answer: a teaching center grounded 
in tradition and the best in new technology. 
During an informal discussion at 
Alumni/ae Reunion Weekend this 
year, a group of alumni/ae from the 
'40s and '50s asked the dean what 
the school’s most important needs 
are right now. 
“Do you remember the 
anatomy laboratory when we were 
students?’’ Dean GerardN. Burrow, 
M.D. '58, responded dryly. “Well, it 
hasn’t changed a bit. ” 
ach morning during the 
school year, more than 130 
people can be found in the 
human anatomy laboratory standing 
elbow to elbow (or ulna to ulna), 
breathing in formaldehyde, squint¬ 
ing under old lamps, trying to get 
the most out of an important med¬ 
ical school rite of passage. Four or 
five students share each cadaver. 
The changing rooms are makeshift 
and shabby. The 101 medical stu¬ 
dents who entered Yale School of 
Medicine this fall are learning 
human anatomy in a laboratory 
that was originally built in the 
1930s to accommodate a class of 
about 50. Add in the students from 
the Physician Associate Program, 
plus the faculty, and the lab on Ster¬ 
ling Hall of Medicine’s third floor 
is crammed. 
Furthermore, the other basic 
science teaching labs scattered 
throughout the school are also inad¬ 
equate. Students and faculty need a 
central facility that is dedicated to 
teaching and learning, and w'hich 
incorporates modem technology. 
“It felt as if our medical educa¬ 
tion was being delayed by some¬ 
thing other than our own igno¬ 
rance,” student Alicia Arbaje said at 
the end of her first year in June. 
“Don’t get me wrong, I love it here. 
But honestly, the anatomy lab was 
hard to deal with. Just improving 
the ventilation would improve on 
student morale.” 
Dr. Burrow had more to say on 
the subject during a formal presen¬ 
tation at reunion weekend. “The old 
labs are beyond renovation,” he told 
the returning alumni/ae. "We have 
plans to build a new Student Labo¬ 
ratory and Teaching Center. It will 
feature modern anatomy labs, com¬ 
puter workstations, conference 
space and a lecture hall. But we 
need to have the funding commit¬ 
ments in hand in order to build it.” 
Medical students have studied 
human anatomy since antiquity— 
often with great difficulty. Since 
before the time of Hippocrates, reli¬ 
gious and cultural injunctions 
against dissection and autopsy have 
impeded the advance of the science 
Yale medicine 65 
The cadaver ceremony 
of medicine. Students at all medical 
schools in the early 1800s, including 
this one, paid grave robbers to obtain 
the cadavers they needed, causing 
more than a few conflicts with the 
local citizenry. In his book Doctors, 
The Biography of Medicine, Sherwin 
B. Nuland, M.D. ’55, wrote that it 
was Galen, the second-century 
Greek physician who “introduced 
physicians to the anatomical concept 
. . . that a detailed knowledge of the 
body’s structure is the foundation 
upon which understanding of disease 
must be based." Some 1,400 hun¬ 
dred years later in Italy, Dr. Nuland 
adds, Andreas Vesalius published De 
Humani Corporis Fabrica, and 
“paved the way for modern scientific 
medicine by presenting to the world 
the first accurate knowledge of 
human anatomy and a method by 
which it might be studied.” 
Today, in the Yale System of 
medical education, the study of 
anatomy, cell biology, microbiology, 
pathology, laboratory medicine and 
neurobiology provide the grounding 
for the clinical training that follows. 
Learning is driven by individual ini¬ 
tiative and close cooperation with 
one's colleagues and mentors. While 
scalpels, probes and Gray’s Anatomy 
are still in use, the teaching of 
anatomy and physiology is far from 
static. Technology is rapidly driving 
adaptation and change. 
Three-dimensional models, 
video microscopy and interactive 
computer tutorials are already 
employed at Yale, enhancing and 
complementing traditional learning 
methods. They fit perfectly in the 
Yale System that fosters self-motiva¬ 
tion and individual responsibility. 
"When we weren't in the 
anatomy lab, our class invaded the 
library computers,” says Ms. Arbaje, 
now a second-year student. “At peak 
time, that was difficult.” 
Experts now debate whether 
high-tech teaching methods of the 
future, such as virtual reality, will 
make the need for human cadavers 
and dissection labs obsolete. Most 
teachers agree that the human 
cadaver will never completely 
become superfluous. The new Stu¬ 
dent Laboratory and Teaching Cen¬ 
ter will include a discrete computer 
lab to incorporate new technologies 
to compliment the traditional 
cadaver dissection experience. 
The proposed Student Labora¬ 
tory and Teaching Center will bring 
together faculty, students and new 
technologies under one roof and 
ensure that Yale continues its leader¬ 
ship role in teaching and scholarship 
in the decades ahead. The center will 
At the end of the first year of study, in a cer¬ 
emony that is both poignant and life-affirm¬ 
ing, Yale medical students honor the people 
who helped teach them anatomy by donating 
their bodies to their medical education. They 
eulogize people they never met while they 
were alive, but whom they came to know in 
the most intimate detail through the tactile 
inspection of gallstones, coronary arteries, 
muscle fiber and arthritic joints. The dissec¬ 
tion of each cadaver reveals much about 
that individual, and about humanity in gen¬ 
eral. A good physician must be trained to be 
responsive to both. 
be constructed within the shell of a 
former industrial building, and will 
cost an estimated $6 million to com¬ 
plete. These plans are part of Yale 
University’s $ 1.5 billion capital 
campaign to restore and construct 
facilities throughout the campus. 
If the funds are raised by the end 
of the capital campaign next June, it 
is expected that the new center 
would be in operation by the fall of 
1999, in time for the anatomy lec¬ 
tures to the Class of 2003. Here is an 
opportunity for alumni/ae who are 
interested in making a major com¬ 
mitment to the campaign to desig¬ 
nate their gifts to the new Student 
Laboratory and Teaching Center. ■ 
Campaign for the Student Laboratory and Teaching Center 
Named Gift Opportunities 
To Name the Student Laboratory 
and Teaching Center 
Anatomy and Experimental Surgery 
$6 million David Davison 
Director, Individual Major Gifts 
(laboratory facilities) $2.5 million 
Lecture Hall 
Exhibition Hall and Atrium Lounge 
Computer/Telemedicine Lab 
Basic Science Teaching Labs (6) 
Cold Room 
Men’s Locker Room 
$1 million 
$500,000 
$250,000 
$100,000 (each) 
$75,000 
$50,000 
Write to David Davison at the Office 
of Medical Development, 100 
Church Street South, Suite 211, New 
Haven, Connecticut 06519, or via e- 
mail at david.davison @yale.edu 
Women’s Locker Room $50,000 
Faculty Office $50,000 
Model Storage $25,000 
Dissection Tables (36) $15,000 (each) 
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LETTERS 
Remembering Ray Duff 
To the editor: 
The death on June 21 of Raymond 
Duff, M.D. ’52, HS '52-55 (pedi¬ 
atrics)—postdoctoral fellow in 
pediatric cardiology '54-55 and 
professor emeritus of pediatrics— 
terminated the career of a valiant 
leader in improving the welfare of 
children everywhere. 
Few individuals delved into 
the intricacies of so many disci¬ 
plines with the determination and 
respect as he did: clinical pedi¬ 
atrics, pediatric cardiology, hospi¬ 
tal administration, neonatology, 
ethics, sociology, religion! He 
studied these diverse approaches. 
He was appreciated and respected 
by eminent members in each of 
these fields. He never shirked what 
he saw as his duty, which in 
essence was exemplified by his 
conviction that a “Responsible man 
does what needs to be done.” His 
idea of what “needed to be done” 
was at a higher level than most of 
us ever dreamed of! 
The book Sickness and Soci¬ 
ety, co-authored with Professor 
August Hollingshead of Yale Soci¬ 
ology Department and published in 
1968, opened the door for consid¬ 
eration of “who gets what kind of 
care where.” The conceptualiza¬ 
tions are as applicable now as 
when the study was undertaken 30 
years ago. Assessing Pediatric 
Practice, a study begun in 1970 
and edited for publication in 
1990 by Dr. C.D. Cook, deals 
with pediatric care in the New 
Haven community. 
Ray Duff liked the term 
“physician of record.” He always 
did what he thought was right and 
good for the patient and all con¬ 
cerned. Countless students, house 
officers and colleagues appreciated 
his “being there.” 
As a clinician, teacher, physi¬ 
cian of record, social scientist 
and ethicist, Ray Duff led the way. 
I doubt that anyone can achieve 
the eminent way in which he 
assumed this role. The least we can 
do is to try. 
Morris A. Wessel, M.D. ’43, 
HS ’48-51 
New Haven, Conn. 
No place for guns? 
To the editor: 
Dr. Sarah Knutti’s seeing “... no 
excuse for guns in the hands of the 
ordinary citizen,” (Letters, Spring 
1996) puts me in mind of the fol¬ 
lowing similar sentiment: “That 
ordinary persons of no official sta¬ 
tus be allowed to own firearms is 
antithetical to our new philosophy 
of freedom with order.” Reichs- 
fuhrer, A. Hitler. 
Chester Johnson, M.P.H. '68 
Santa Fe, N.M. 
Zimmerman’s day 
To the editor: 
I was very interested to read the 
obituary of Harry Zimmerman 
M.D. '27, HS '27-30, in your Fall 
1995 issue because I feel that I 
owed him a debt of gratitude. I 
am a general surgeon, active in 
practice in Meriden and Walling¬ 
ford 1946-1965 following comple¬ 
tion of my graduate training that 
included two years as assistant res¬ 
ident at what was then Yale-New 
Haven Hospital. The pathologist at 
the Meriden Hospital was Dr. Rolf 
Katzenstein who had been a stu¬ 
dent of Dr. Zimmerman. 
In my practice I was perform¬ 
ing surgery, at that time chiefly 
radical mastectomies, on many 
women with breast cancer. To help 
determine prognosis for these 
women we counted the lymph 
nodes removed (as many as 100 in 
some cases) and determined the 
percent that showed microscopic 
evidence of metastasis since we 
felt that the outlook for more dis¬ 
tant and undetected spread was 
dependent on the potential of the 
particular cancer for independent 
growth. Dr. Katzenstein suggested 
that there was an even better 
method to determine this potential 
that he had learned from Dr. Zim¬ 
merman. This was to take a small 
piece of the primary cancer and 
transplant it into the anterior cham¬ 
ber of a rabbit's eye. If the poten¬ 
tial was sufficient it would grow 
there and this could be determined 
by examining the eye after seven to 
Harry Zimmerman, M.D., center, watches a 
video presentation with fellow alumni/ae at 
reunion in 1994. 
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10 days. We began to perform this 
test, and if it proved positive it 
helped to make the decision to fol¬ 
low mastectomy with radiation 
therapy to the chest. 
Our results persuaded me of 
the advantage of this post-opera¬ 
tive irradiation which was con¬ 
firmed by the collected follow-up 
study on the treatment of breast 
cancer which I performed for what 
used to be The Cancer Study Com¬ 
mittee of the Connecticut Medical 
Society in conjunction with the 
State Health Department’s long¬ 
term follow-up on the treatment of 
all types of cancer under the direc¬ 
tion of Dr. Matthew Griswold. The 
5- and 10-year survivals on my 
patients were better than those 
reported by Dr. Cushman Haager- 
son who was a great champion of 
extensive lymph node removal. 
Unfortunately because we did not 
have available the best technical 
management for the control of the 
radiation therapy that is now avail¬ 
able we had some cases of compli¬ 
cations that included degrees of 
pulmonary fibrosis. Some cases of 
lymphedemia in the affected arm 
were probably due more to the 
extensive dissection, which in my 
later cases included the internal 
mammary nodes. 
Dr. Katzenstein died about 20 
years ago, but if he were alive 
How to reach us 
Yale Medicine welcomes 
news and commentary. 
Please send letters to the edi¬ 
tor and news items to Yale 
Medicine, P.D. Box 7612, 
New Haven, CT 06519-0612, 
or via electronic mail to 
ymm@yale.edu, and include 
a daytime telephone number. 
Submissions may be edited 
for length, style and content. 
would, I feel sure, join me in this 
little tribute to a great man. 
Allan J. Ryan, M.D., HS ’43-45 
Edina, Minn. 
Dr. Kashgarian replies: 
Dr. Katzenstein’s advice to 
Dr. Ryan probably came not from 
Dr. Zimmerman but from Dr. 
Harry Sylvester Nutting Greene, 
Anthony N. Brady Professor and 
Chairman of Pathology at that 
time. It was in 1938 that Dr. 
Greene first published in Science 
the method of heterologous trans¬ 
plantation of mammalian tumors to 
the anterior chamber of the guinea 
pig’s eye. He demonstrated that 
human malignant tumors, but not 
the normal tissue from which they 
were derived, were able to grow in 
an alien species and he reasoned 
that this was the biological demon¬ 
stration of the autonomous growth 
that characterizes malignancy. 
Being a pathologist, he was aware 
of the vagaries that exist in 
attempting to identify malignant 
potential merely by peering 
through the microscope and he felt 
that heterologous transplantation 
could be a true biological test for 
malignant potential. It is of interest 
that transplantation of human 
tumors to sites other than the ante¬ 
rior chamber in alien species 
required treatment with radiation 
or corticosteroids. The anterior 
chamber provided a uniquely pro¬ 
tective environment for tumors to 
grow since no adjuntive treatment 
was necessary. We now know that 
this is directly related to the cellu¬ 
lar immune response to tumors. 
Thus these early (in this age of 
molecular biology some would say 
crude descriptive) experiments 
identified two of the most impor¬ 
tant characteristics of malignancy 
and its behavior, neither of which 
have yet been fully elucidated, 
even today nearly 60 years after its 
first observation. 
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The Program for Humanities in Medicine 
Listed below are the remaining lectures in the 1996-1997 Humanities in 
Medicine series, held Thursdays at 5 p.m. in the Beaumont Room at the 
School of Medicine. Refreshments at 4:30 p.m. Free and open to all. 
January 9 
HEALING ART: DOCTOR LOOKING 
AT SCULPTURES 
Wayne O. Southwick, M.D. 
Professor Emeritus of Orthopaedics & Rehabilitation, 
Yale University School of Medicine 
March 20 
FROM PHARAOH TO DNA: CHANGING 
VIEWS OF CANCER 
David J. Leffell. M.D. 
Professor of Dermatology, Yale University School of 
Medicine 
January 23 
FALSE CHILDHOOD MEMORIES: 
EPIDEMICS OR BACKLASH? 
Sara Gamble, PhD 
Staff Psychologist, Traumatic Stress Institute, 
South Windsor, Connecticut 
January 30 
THE NUREMBERG CODE 50 
YEARS LATER 
David J. Rothman, PhD 
Bernard Schoenberg, Professor of Social Medicine, 
Columbia University, New York, New York 
February 6 
ART & THE CALLING: BEDSIDE 
STORIES 
David J. Elpern, M.D. 
Dermatologist, Williamstown, Massachusetts 
February 20 
“YOU LIE LIKE A DOCTOR!” 
PETRARCH’S ATTACK ON MEDICINE 
George A. Trone, MA 
Doctoral Candidate, Department of Italian, 
Yale University 
March 6 
BEING POSITIVE: THE LIVES OF 
MEN AND WOMEN WITH HIV 
Robert Klitzman, M.D. 
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AYAM Outreach Program 
To better communicate with our alumni/ae, the AYAM is pleased to announce 
The Outreach Program, an effort to enhance and expand direct contact with our members. 
REUNION WEEKEND 
Save the date: June 6 and 7 for the 
1997 Alumni Reunion Weekend. Yale 
University President Richard C. Levin will 
address alumni/ae at the Saturday annual 
meeting. Albert B. Deisseroth, M.D., Ph.D., 
chief of medical oncology, will make a pre¬ 
sentation on new gene-therapy initiatives in 
cancer treatment. See page 39 for details. 
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Soon, locating fellow alumni/ae will be easier 
with an updated Yale School of Medicine Alumni 
Directory, last published in 1992. Those who 
ordered the new directory will receive it soon by 
mail. New orders may be placed while supplies last 
by calling Harris Publishing at 1.800.877.6554. 
REGIONAL EVENTS 
Meet fellow alumni/ae face-to-face at a series 
of receptions around the nation. A May 17 wine¬ 
tasting and tour of North Salem Vineyard in 
Westchester County, N.Y. (hosted by George W. 
Naumburg Jr., M.D. ’45) follows recent events in 
Washington, San Diego, San Francisco, New Haven 
and Boston. 
MINI REUNIONS 
Members of the Class of 1945 are meeting for 
an informal April reunion in Florida. If you and 
classmates are planning a similar event, please call 
the Office of Alumni Affairs at 203.785.4674. 
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DISCOVERY 
Gene hunters 
Richard Lifton s search for the genes behind rare forms 
of hypertension is good news for more than 50 million people 
with high blood pressure. 
By Julie Miller 
Photographs by Peter Casolino Fifteen years ago, Richard P. Lifton, M.D., 
Ph.D., was puzzled by an observation he made 
while visiting a dialysis unit at Stanford Uni¬ 
versity, where he was a third-year medical student. 
Although 99 percent of Palo Alto's population was 
white, all of the patients in the dialysis unit younger 
than 40 were African American. 
“In the back of my mind, I wondered whether or 
not there was an inherited susceptibility among African 
Americans to end-stage kidney disease,” says Dr. 
Lifton, now associate professor of medicine and genet¬ 
ics at Yale School of Medicine and investigator at the 
Howard Hughes Medical Institute. 
Scientists at the time did not have the knowledge 
of human genetics that would have allowed them to 
explore possible links between genes and hyperten¬ 
sion, which can cause kidney failure. But Dr. Lifton’s 
experience at Stanford fed his curiosity and planted a 
seed that has led to important discoveries during the 
past five years about the genetic basis of hypertension. 
Today, armed with the powerful tools of molecular 
genetics, he leads a team of researchers who since 
1992 have found mutations in eight genes that alter 
blood pressure by changing salt and water reabsorption 
in the kidney. They have looked specifically at rare 
forms of disease, where blood pressure is remarkably 
high, with the strategy of applying these lessons to 
more common forms of hypertension affecting large 
numbers of people. And they are applying the same 
reasoning to better understand rare types of 
low blood pressure. 
Julie Miller is a free-lance writer in North Stonington, Conn. 
Fifty million Americans age 6 and older suffer 
from hypertension, according to the American Heart 
Association. Although the cause of most hypertension 
is unknown, it may lead to heart attack, stroke or kid¬ 
ney failure. In February of last year. Dr. Lifton was 
awarded a $4.5 million grant from the National Insti¬ 
tutes of Health (NIH) to fund a specialized center of 
research in the molecular genetics of hypertension. 
Scientists have long recognized a predisposition in 
some families to hypertension and other diseases 
affecting the heart, the kidneys and the cardiovascular 
system. Only in the last five years have they been able 
to use that information to identify the origins of those 
diseases, says Dr. Lifton. 
Using blood samples and a technique known as 
positional cloning, in which a gene causing a disease is 
identified by genetic mapping, Dr. Lifton’s team 
tracked the inheritance of the rare hypertension genes 
through approximately 300 families from around the 
world participating in the studies. In the last two years. 
Dr. Lifton’s research team has received 2,500 blood 
samples from 40 states and 17 countries, including 
Saudi Arabia and Israel. 
Richard P. Lifton, M.D., Ph.D., has focused attention on 
rare and severe forms of hypertension, with the ultimate 
goal of finding better treatments for the millions of peo¬ 
ple with more common types of high blood pressure. 
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Identifying the rare genes that 
cause severe disease can provide 
key insight into the molecular 
causes of more common forms of 
the same disease. These findings. 
Dr. Lifton says, will allow scien¬ 
tists to develop genetic tests that 
identify people with inherited sus¬ 
ceptibilities to hypertension and 
specific treatments to prevent 
the disease. 
At 42, with an occasional fleck 
of gray in his light brown hair. Dr. 
Lifton is again pursuing the ques¬ 
tion he pondered 15 years ago at 
Stanford and searching for genes 
that contribute to the development 
of end-stage kidney disease among 
young African Americans. Thus 
far, he and colleagues have located 
a large number of families with 
two or more members with end- 
stage kidney disease and have 
begun genetic analysis. 
The research team has identi¬ 
fied genes linked to two uncom¬ 
mon types of severe hypertension, 
glucocorticoid-remediable aldos¬ 
teronism (GRA) and Liddle’s syn¬ 
drome. GRA is the result of expres¬ 
sion of a key gene in the wrong 
part of the adrenal gland, leading to 
high levels of aldosterone, a steroid 
hormone that regulates the balance 
of salt and water in the body. 
Richard Shimkets, a graduate stu¬ 
dent in the lab, identified the gene 
mutation in Liddle’s syndrome, 
which activates the epithelial 
sodium channel in the nephron of 
the kidney, increasing the reab¬ 
sorption of salt and water and thus 
raising blood pressure. 
The nephrons, responsible for 
removing waste from the body’s 
blood supply and regulating the 
composition and volume of blood, 
are central to the hypertension 
studies. The outer cortex of the 
kidney contains more than a mil¬ 
lion nephrons, each made up of 
convoluted tubules and a glomeru¬ 
lus. The glomeruli, spheres of 
coiled blood vessels inside a thin, 
membranous sac, act as filter units. 
The arrangement of nephrons in 
the kidney, resembling the kernels 
of com on a cob, forms a large sur¬ 
face area for collecting fluid. 
The focus on severe hyperten¬ 
sion is highly useful to researchers 
because the effects of therapy are 
dramatically apparent in patients 
with high readings. "We’re cutting 
our teeth,” Dr. Lifton says, “on 
these relatively simple forms of 
high blood pressure.” Now, new 
findings suggest that variants in the 
gene encoding angiotensinogen 
contribute to more common forms 
of hypertension in the general pop¬ 
ulation as well. 
Angiotensinogen is a protein 
secreted by the liver that causes 
blood vessels to constrict. Changes 
in its level can raise or lower blood 
pressure. The identity of the func¬ 
tional variants, the magnitude of 
their effects on blood pressure, and 
their mode of action have not yet 
been defined. 
Above left: Blood samples are cata¬ 
loged by research associate Carol Nel¬ 
son-Williams, right. Graduate student 
Traci Mansfield, left, prepares patient 
DNAfor analysis by polymerase chain 
reaction, a technique used to narrow the 
chromosomal location of suspected 
gene mutations. 
Left: The painstaking process of identi¬ 
fying genes responsible for disease 
often begins with a single patient and 
widens to a study of the person's 
extended family. Anita Farhi, R.N., right, 
who oversees patient recruitment for Dr. 
Lifton’s studies, and Janet Budzinack 
hold a family tree outlining an inherited 
predisposition to Liddle’s syndrome, a 
rare form of hypertension. 
Most cases of hypertension are 
probably due to a combination of 
genetic and environmental factors, 
including diet and salt intake. Dr. 
Lifton says. “Our early ancestors 
evolved in the interior of sub-Saha¬ 
ran Africa, an extremely salt-poor 
environment,” he adds. “Genes 
that promoted the body’s conserva¬ 
tion of salt and water conferred a 
selective advantage.” Today, in the 
salt-rich environment of industrial¬ 
ized societies, those same genes 
now may contribute to hyperten¬ 
sion and other disease. 
Genetic susceptibilities to 
hypertension help explain why 
some people who eat salt do not 
develop high blood pressure. 
“We’re spending a lot of money in 
public health getting people to stop 
eating too much salt,” Dr. Lifton 
says. “We believe there are many 
Advances in genetics, 
says Dr. Lifton, have 
made “this phase 
of the understanding 
of human disease 
one of the most pro¬ 
ductive in the history 
of medicine. ” 
people for whom it doesn’t matter, 
as well as a subset in whom it may 
be a matter of life and death. 
“If we learn more about 
genetic susceptibility, then we 
can say, ‘You, feel free to eat the 
nachos (fat-free, of course). 
An ethical paradox 
While better understanding of 
the genetic basis of disease 
holds the hope of new diagnostic 
tests to identify people at risk 
early in life, it also raises compli¬ 
cated, troubling questions. 
“We need to consider whether 
making a genetic diagnosis will do 
more harm than good,” says 
Richard P. Lifton, M.D., Ph.D,, 
associate professor of medicine 
and genetics at Yale School of 
Medicine and investigator at the 
Howard Hughes Medical Institute. 
A person whose genetic test for 
Huntington’s disease is positive, 
for example, faces a slow death 
at a young age. “There’s slow 
deterioration in physical and men¬ 
tal capabilities. At present, we 
can’t do anything about it." 
People who learn they have 
the disease through genetic 
screening at least have time to 
plan and put their lives in order. 
Some may decide not to have chil¬ 
dren. There may be enormous dis¬ 
advantages, however, because 
the genetic information may be 
used against those who are seek¬ 
ing jobs or applying for health and 
life insurance. 
By contrast, patients with 
GRA (glucocorticoid-remediable 
aldosteronism), an inherited type 
of severe hypertension, face the 
same risks but have the benefit of 
available treatment. They, too, 
may have difficulty obtaining 
insurance. “You may be able to 
give patients information benefi¬ 
cial to their health,” Dr. Lifton 
says. “The paradox is that until 
recently this information could 
be used against the interests of 
the patient.” 
Some progress has been 
made in finding solutions to these 
problems. Health insurance 
should be easier to obtain and 
keep under a law signed recently 
by President Clinton. The Health 
Insurance Portability and Account¬ 
ability Act of 1996 prevents the 
But you, stick to the carrots.’” 
But are high-blood-pressure 
genes entirely responsible for that 
susceptibility? Among the families 
participating in Dr. Lifton's stud¬ 
ies, some members who inherited 
the mutated genes were nonethe¬ 
less free of hypertension. The clus¬ 
tering of these patients within par¬ 
ticular families suggested that they 
might also have inherited genes 
that protect them from developing 
hypertension. These observations 
prompted efforts to identify such 
blood-pressure-lowering genes. 
The researchers began with dis¬ 
eases causing life-threatening low 
blood pressure in children. 
Sue Chang, a nephrology fel¬ 
low in the lab, found that PHA-1, 
which causes life-threatening 
continued on page 7 ► 
loss or denial of insurance cover¬ 
age due to pre-existing medical 
conditions. “One important mes¬ 
sage is that we all have inherited 
susceptibilities to one disease or 
another, and we shouldn’t decide 
who is insurable and who is not 
on the basis of this kind of infor¬ 
mation,” Dr. Lifton says. 
Another question that arises 
is whether or not to inform partici¬ 
pants in scientific studies that 
they have inherited susceptibili¬ 
ties to fatal diseases. “We look to 
the individual for guidance,” says 
Maurice J. Mahoney, M.D., profes¬ 
sor of genetics, pediatrics, obstet¬ 
rics and gynecology. Dr. Mahoney 
is a member of the medical 
school’s Human Investigation 
Committee, which approves clini¬ 
cal research projects and handles 
issues involving the protection of 
human subjects. “If there are no 
benefits in the immediate future, 
we have to decide how important 
it would be to their health to know. 
We often will say there is no rea¬ 
son to inform them, although we 
give some leeway if they want the 
information.” ■ 
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Building on a tradition of kidney research 
One reason scientists at Yale 
have embraced the work of 
Richard P. Litton, M.D., Ph.D., is 
that it links a tradition of world- 
renowned research in kidney physi¬ 
ology directly to patient care. Dr. 
Litton became associate professor 
of medicine and genetics at the 
medical school in 1993 and inves¬ 
tigator at the Howard Hughes Med¬ 
ical Institute the following year. His 
collaboration with the Yale physiol¬ 
ogy group made it possible for him 
to identify gene mutations that 
alter blood pressure by changing 
salt and water reabsorption in 
the kidney. 
In discovering a number of the 
inherited factors that affect blood 
pressure, Dr. Lifton is building 
upon more than 70 years of excel¬ 
lence in kidney research at Yale. 
In 1921, John Peters, M.D., came 
to Yale from the Rockefeller Insti¬ 
tute in New York to establish a 
research program in metabolism. 
In the years that followed, the pro¬ 
gram attracted many gifted young 
investigators, who were inspired 
by Dr. Peters’ leadership in 
metabolism studies and skill 
in the laboratory. 
“Every medical student, 
whether he knows it or not, is a 
student of Peters,” wrote Donald 
D. Van Slyke, a chemist, who 
worked with Dr. Peters at the Rock¬ 
efeller Institute in the 1920s and 
enjoyed a friendship and collabora¬ 
tion with him for decades. “His 
contributions to the pathologic 
physiology of the circulatory, 
respiratory, excretory and endo¬ 
crine systems, of the metabolism 
of proteins, fats, carbohydrates, 
electrolytes and water have been 
integrated into the science 
of medicine." 
Dr. Peters played a primary 
role in the development of kidney 
research in America. He was at the 
forefront in applying basic science 
to problems in clinical medicine, a 
practice that continues at Yale 
today. His research group devel¬ 
oped new techniques of analyzing 
body fluids to measure the 
changes brought on by metabolic 
Left: Richard P. Lifton, M.D., Ph.D., talks 
with colleagues Gerhard H. Giebisch, 
M.D., and Peter S. Aronson, M.D. 
Dr. Lifton's work has provided a clinical 
link for more than 70 years of kidney 
physiology research at Yale, says Dr. 
Aronson, the chief of nephrology. 
disorders. Of particular interest 
were nutritional and endocrine dis¬ 
turbances, kidney disease and tox¬ 
emia of pregnancy. Along with his 
investigative work and teaching, 
Dr. Peters also devoted much of 
his attention to the overall care of 
his patients. 
As more was learned about 
metabolism during the 30 years 
after Dr. Peters’ arrival at Yale, it 
became clear that the kidney was 
crucial in maintaining the balance 
of fluids and electrolytes in the 
body. In addition to excreting 
waste products, the kidney con¬ 
trols acid/base balance and regu¬ 
lates transport of a number of 
electrolytes, such as sodium, chlo¬ 
ride and potassium. 
The period from the 1930s to 
the 1950s marked the beginning 
of quantitative kidney physiology, 
which involves measuring the 
amounts or proportions of sub¬ 
stances that are excreted. A para¬ 
meter of kidney function known as 
“clearance,” first introduced in 
1928, was used to characterize 
the excretion of urea by the kidney. 
Clearance studies by scientists 
including Robert W. Berliner, M.D., 
professor emeritus of physiology 
and medicine and former dean of 
the medical school, laid the foun¬ 
dation for the knowledge of renal 
transport of salt, water, bicarbon¬ 
ate, acid and potassium. Dr. 
Berliner conducted studies at the 
National Institutes of Health on 
the handling of potassium in the 
kidney and trained many people 
who later became section chiefs in 
nephrology across the nation. 
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According to Dr. Giebisch, Dr. 
Lifton's patient-focused research 
“gives us a new direction in which 
to look at a basic research level. ” 
Studies of the processes with¬ 
in the kidney that account for renal 
excretion, namely the transport of 
fluid and electrolytes across cell 
membranes along the nephron, 
began in the late 1950s. Gerhard 
H. Giebisch, M.D., Sterling Profes¬ 
sor of Cellular and Molecular Phys¬ 
iology, who came to the medical 
school in 1968, has spent his 
career studying renal function in 
single cells. Turning to molecular 
mechanisms, he is now examining 
the effect of genetic manipulation 
on the transport of ions across the 
cell membrane. 
In 1971, the medical school’s 
section of metabolism in the 
Department of Internal Medicine 
was divided into two parts, 
nephrology and endocrinology. 
Nephrology, a subspecialty devel¬ 
oped in the 1960s along with dial¬ 
ysis and kidney transplantation, 
encompasses faculty interested in 
kidney function and disease. John 
P. Hayslett, M.D., HS ’60-65, pro¬ 
fessor of medicine, became the 
first nephrology section chief. 
Research is progressing in a 
number of other areas of kidney 
physiology. As an example, Dr. 
Hayslett is studying sodium trans¬ 
port and sodium channels in the 
distal portion of the nephron. 
PeterS. Aronson, M.D., professor 
of medicine and cellular and mole¬ 
cular physiology and the present 
chief of nephrology, is characteriz¬ 
ing some of the proteins that 
transport sodium and chloride 
across cell membranes in the 
proximal tubule of the kidney. 
“I can envision a day when 
newborns are screened for genes 
that cause susceptibility to differ¬ 
ent sodium transport disorders, 
such as hypertension, and we 
develop interventions to prevent 
these,” says Dr. Aronson. 
The traditions established by 
Dr. Peters continue in kidney 
research today. Several current 
faculty members—Drs. Berliner, 
Giebisch, Aronson and Emile L. 
Boulpaep, M.D., professor of cellu¬ 
lar and molecular physiology— 
have been recipients of the most 
prestigious research honor in kid¬ 
ney physiology, the Homer Smith 
Award. Dr. Lifton is taking the 
research in a new direction, as he 
unravels the mystery of the role 
that genes encoding renal trans¬ 
porters play in clinical disorders. 
Says Dr. Aronson: “I can envision a 
day when newborns are screened for 
[disease-susceptibility] genes ... 
and we develop interventions to pre¬ 
vent these [disorders]. ’’ 
For example, “one of the 
potassium channels Dr. Giebisch 
has been working on we have just 
implicated in Bartter’s syndrome,” 
Dr. Lifton says, referring to a dis¬ 
ease in children that causes 
potassium wasting and lowers 
blood pressure. Adds Dr. Giebisch: 
“In this case, there is some 
aspect of the disease that we can¬ 
not explain with the current state 
of knowledge. This [information 
from the Lifton lab] gives us a new 
direction in which to look at a 
basic research level.” ■ 
continued from page 5 
dehydration and low blood pressure 
in newborns, is caused by mutations 
that decrease activity of the same 
sodium channel mutated in Liddle’s 
syndrome. David Simon. M.D.. a 
nephrology fellow and now assis¬ 
tant professor of medicine, found 
that Gitelman’s and Bartter’s syn¬ 
dromes, diseases that also cause low 
blood pressure, are caused by muta¬ 
tions in three different genes that are 
also involved in the reabsorption of 
salt by the kidney. 
“When we started work in this 
area,” says Dr. Lifton, “hyperten¬ 
sion was variously proposed to be a 
disease arising from primary abnor¬ 
malities in the brain, the heart, the 
blood vessels, the kidney or the 
adrenal gland. Intriguingly, all the 
mutations identified thus far change 
blood pressure by altering how 
much salt the kidney retains. These 
findings place renewed emphasis on 
the role of the kidney in blood pres¬ 
sure regulation.” 
“Dr. Lifton has done ground¬ 
breaking work in identifying the 
genetic causes of the extremes of 
blood pressure,” says Francis S. 
Collins, M.D.. Ph.D., director of the 
National Human Genome Research 
Institute in Bethesda, Md. "Thanks 
to his efforts, we are dramatically 
closer to a complete explanation of 
the heritable factors that determine 
blood pressure.” Dr. Collins was a 
postdoctoral fellow in genetics and 
pediatrics at the School of Medicine 
from 1981 to 1984. 
"Dr. Lifton’s findings may 
allow diagnostic tests to identify 
people at highest risk early in life, as 
well as new treatments based on a 
better understanding of the regula¬ 
tory pathways in the kidney,” adds 
Dr. Collins, who heads the Human 
Genome Project to map and 
sequence each of the approximately 
100,000 human genes. 
The genetic studies reflect a 
blending of clinical investigation, 
molecular genetics and collabora¬ 
tion with a close network of col¬ 
leagues in kidney research, includ- 
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The genetic studies 
reflect a blending of 
clinical investigation, 
molecular genetics 
and collaboration 
with a close network 
of colleagues in 
kidney research. 
While working as a nephrology fel¬ 
low in Dr. Lifton's laboratory, David 
Simon, M.D., identified three gene 
mutations responsible for rare forms 
of low blood pressure. 
ing John P. Hayslett, M.D., HS 
'60-65, professor of medicine in 
the section of nephrology; Peter S. 
Aronson, M.D., professor of medi¬ 
cine and cellular and molecular 
physiology and chief of nephrol¬ 
ogy; and Gerhard H. Giebisch, 
M.D., Sterling Professor of Cellular 
and Molecular Physiology. 
“I have a wonderful opportu¬ 
nity here at Yale to collaborate with 
the physiology groups,” Dr. Lifton 
says. “One consequence of the rev¬ 
olution in human genetics will be a 
renaissance in both basic and 
human physiology. We will be able 
to identify specific causes of dis¬ 
eases, make animal models of them, 
study their physiology in extensive 
molecular detail and bring this to 
the bedside.” 
For many years, Yale has been 
recognized as one of the world’s 
premier research centers in the 
basic science of kidney physiology, 
particularly the mechanisms by 
which the kidney regulates body 
salt content, says Dr. Aronson. 
“This research has now been 
linked by Dr. Lifton’s work to 
human disease.” 
Dr. Lifton came to Yale from 
Harvard in 1993 as an assistant pro¬ 
fessor of medicine. He became an 
associate professor and a Howard 
Hughes Medical Institute investiga¬ 
tor in 1994 and this year was named 
director of cardiovascular genetics 
at the medical school’s Boyer Cen¬ 
ter for Molecular Medicine and 
director of the Department of Inter¬ 
nal Medicine's Program in Molecu¬ 
lar Genetics. He serves on NIH 
advisory committees on large-scale 
sequencing of the human genome 
and the special emphasis panel for 
the study of the genetics of heart, 
lung and blood disease. He has pub¬ 
lished more than 50 journal articles, 
reviews and textbook chapters. 
At Yale, his teaching style is 
immensely popular. Rather than 
delivering a talk, he leads a discus¬ 
sion by constructing a problem and 
calling on his listeners to suggest 
answers. “When he’s discussing his 
research, he has tremendous enthu¬ 
siasm,” Dr. Aronson says. Adds Dr. 
Simon: “Even though I’ve heard 
the same talk many times, it’s 
always fresh.” 
The same energy is in the air in 
Dr. Lifton’s laboratory. His button- 
down shirts and khaki trousers 
blend with the informal dress of 
students who stop to talk with him. 
He listens intently as Holly Duncan 
Craig, a student in the M.D./Ph.D. 
program, brings him up-to-date on 
her work on genes related to vascu¬ 
lar malformations in the brain, 
which can cause stroke. Delighted 
with her progress, Dr. Lifton smiles 
and peppers his comments with, 
“That’s incredibly exciting ... that’s 
great... fantastic.” 
His fascination with genetics 
grew out of a curiosity about hered¬ 
ity that began in high school in sub¬ 
urban Washington, D.C. In college 
and later in graduate school, he 
began to understand that there were 
things to be learned from genetics 
that could be applied to human dis¬ 
ease. “The union between science 
and medicine seemed a very natural 
route to take,” he says. 
After receiving a bachelor’s 
degree with highest distinction in 
biology from Dartmouth College in 
1975, Dr. Lifton focused his gradu¬ 
ate study on the genetics of the fruit 
fly Drosophila melanogaster. He 
earned his medical degree in 1982 
and a doctorate in biochemistry in 
1986 from Stanford before training 
as a resident at Harvard Medical 
School and Brigham and Women’s 
Hospital in Boston. 
From the time he first became 
fascinated by heredity in a high 
school biology lab until he com¬ 
pleted his medical residency in 
1987, major changes had taken 
place in genetics. These started 
with the introduction of recombi¬ 
nant DNA technology in the early 
1970s by Stanley Cohen, M.D., and 
Herbert W. Boyer, Ph.D., the for¬ 
mer Yale postdoctoral fellow who 
endowed the molecular medicine 
building in which Dr. Lifton now 
pursues his research. The revolution 
in human genetics accelerated in 
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Dr. Lifton and research associate 
Carol Nelson-Williams study pho¬ 
tographs of children for signs of 
bone malformation that may be due 
to renal tubular acidosis. Dr. 
Lifton’s team is working to identify 
a gene mutation that may be linked 
to the disease. 
the early 1980s with new tech¬ 
niques for mapping genes. 
The human genome consists 
of 3 billion base pairs of genes, 
resembling beads on a string. 
Although the sequence of the 
beads, or their locations on the 
chromosomes, is remarkably simi¬ 
lar from one person to the next, the 
exact sequence can vary. Dr. 
Lifton explains. Comparison of the 
DNA sequences of two unrelated 
people will reveal differences in 
the DNA sequence in approxi¬ 
mately one of every 1,000 posi¬ 
tions. While all people share simi¬ 
larities, the cumulative effects of 
these small differences are 
believed to account for the diver¬ 
sity among humans. 
“These differences in DNA 
sequence permit us to follow 
the inheritance of any segment 
of the human genome through 
families,” says Dr. Lifton. “I had 
been interested in heredity for a 
long time. Now, I had training in 
medicine and the knowledge of 
molecular genetics that I could 
apply to the investigation of com¬ 
mon diseases that I saw in the hos¬ 
pital every day.” 
Dr. Lifton collaborates with 
scientists and clinicians world¬ 
wide, who help him locate the 
families who participate in his 
studies. DNA for the studies is 
extracted from blood samples from 
family members. Using detailed 
genetic maps. Dr. Lifton compares 
the inheritance of the disease to the 
inheritance of genetic markers 
spanning the genome, and looks 
for the portion of the genome that 
travels with the disease. Relatives 
who are healthy are as important to 
the studies as those with hyperten¬ 
that diagnosis and attributed her 
headaches to hypertension. “With 
genetic testing, we diagnosed her as 
having GRA, a rare form of severe 
hypertension. We went back 
through the family and found more 
relatives with this disease,” Dr. 
Lifton says. The girl and her rela¬ 
tives were treated with medication 
that counteracts the effects of the 
high levels of aldosterone in GRA. 
and they responded well. 
sion, he says. “You get information 
from knowing what gene they 
didn’t inherit.” 
An especially rewarding aspect 
of the research, he adds, is the con¬ 
tact with families who appreciate 
the search for solutions to these rare 
diseases. An 8-year-old girl had 
been suffering for three years from 
what her physician thought were 
migraine headaches. Another doc¬ 
tor who examined her questioned 
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Genetic clues to 
a brain disorder 
L.K. was 40 when she suffered a 
stroke. She had complained of 
headaches for some time, but 
none were as bad as that day 
when she could no longer move 
her left arm and leg. She felt 
numbness throughout her body 
and experienced double vision. 
She always feared she might suf¬ 
fer a stroke at a young age, espe¬ 
cially since strokes seemed to 
run in her family. 
Her father, grandfather and 
two uncles also experienced 
severe headaches. Her four 
cousins had strokes when they 
were in their 30s, and one died at 
the age of 38. The teen-age chil¬ 
dren of two cousins were diag¬ 
nosed with epilepsy. L.K.’s broth¬ 
er had a mild stroke and experi¬ 
enced double vision and difficulty 
walking a few weeks before her 
own stroke. Her sister was diag¬ 
nosed as harboring a brain lesion, 
and she, too, suffered from 
severe headaches. 
Neurosurgeon Issam A. Awad, AID., has collaborated with Dr. Lifton in genetic 
studies of cerebral cavernous malformation, an inherited disorder that can pre¬ 
cipitate stroke in young adults. 
Yale physicians used mag¬ 
netic resonance imaging to diag¬ 
nose her condition as cavernous 
malformation, an inherited vascu¬ 
lar disease of the brain. 
Six months after brain opera¬ 
tions for resection of the two cav¬ 
ernous malformations which had 
hemorrhaged, L.K. is able to play 
the organ and ride her exercise 
bicycle. She spends much of her 
time caring for and counseling 
numerous relatives with cav¬ 
ernous malformations. 
A team of researchers led by 
Richard P. Lifton, M.D., Ph.D., has 
identified a gene linked to this 
devastating disease. Dr. Lifton’s 
studies of cavernous malforma¬ 
tion were conducted in collabora¬ 
tion with Issam A. Awad, M.D., 
professor of neurosurgery, and 
Murat Gunel, M.D., a resident in 
neurosurgery and research fellow 
at the Boyer Center for Molecular 
Medicine. 
Cavernous malformations in the 
blood vessels of the brain are 
depicted in an artist’s rendering, a 
magnetic resonance image and a 
photograph. One in every 200 people 
is likely to have the disease, and 
many will not have warning symp¬ 
toms. Identification of the gene muta¬ 
tions responsible will allow those at 
risk to receive preventive treatment. 
“We found that this type of 
lesion exists in one out of every 
200 people. Some have symp¬ 
toms, and others do not,” says 
Dr. Awad. “It’s important for us to 
understand who will have this 
lesion and, of those people, who 
will bleed from it.” 
The researchers found that 
Hispanic Americans have a higher 
incidence of cavernous malforma¬ 
tion than do other ethnic groups. 
In fact, all cases among Hispanic 
Americans of Mexican descent 
were traced to the same mutation 
from an apparently common 
ancestor. The gene is probably 
related to abnormal formation of 
blood vessels in the brain, Dr. 
Awad says. The next step is to 
determine how the abnormal ves¬ 
sels occur and whether or not 
there is a second gene that 
makes some lesions bleed. 
Cavernous malformations 
cause headaches, seizures and 
cerebral hemorrhage. They 
account for up to a third of hemor¬ 
rhagic strokes in young people. 
Ultimately, these lesions can 
cause disability and death. 
“Identifying the gene provides 
a model for understanding, in bio¬ 
logical terms, how some patients 
are predisposed to stroke,” Dr. 
Awad says. "In a practical way, it 
will enable population screening 
for this lesion, with the aim of pre¬ 
venting stroke in these patients.”■ 
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Another participant in the 
studies, a 13-year-old boy, had 
lived with severe hypertension 
since infancy. He came to the hos¬ 
pital because of a seizure at the 
age of 6 weeks. His blood pres¬ 
sure was found to be 240/120, one 
of the highest ever recorded in a 
child of that age. The boy had 
been treated with enalapril and 
nifedipine, both medications 
for hypertension, but neither 
controlled his blood pressure 
effectively. 
Genetic studies showed that 
he had the characteristic mutation 
causing GRA. The genetic studies 
of his family revealed 24 relatives 
with the disease, six of whom had 
cerebral hemorrhages before age 
45. “This was the first case in 
which genetic testing was used to 
diagnose a specific cause of hyper¬ 
tension,” Dr. Lifton says. Affected 
family members have been suc¬ 
cessfully treated. 
A year after this discovery. 
Dr. Lifton gave a talk on GRA to 
a group of physicians at the Uni¬ 
versity of Toronto. Some of them 
had described the disease 25 years 
before. Also in the audience was 
the physician who had reported 
the first known case of GRA. 
Dr. Lifton came full circle at this 
meeting, first finding a patient 
with GRA and performing a clini¬ 
cal investigation and then con¬ 
tributing the results to the molecu¬ 
lar basis of the physician’s disease. 
“It was a lovely experience to 
listen to the people who had done a 
careful investigation 25 years pre¬ 
viously,” Dr. Lifton says. “We 
were able to bring new informa¬ 
tion to bear on problems that have 
been recognized for years.” 
When he began his work in 
genetics, Dr. Lifton says, many 
colleagues doubted that he would 
find genes that affect blood pres¬ 
sure, since there are so many sys¬ 
tems in the body that interact with 
one another. “Our understanding 
of physiology takes us only so far 
in identifying the fundamental 
mechanisms of disease. 
Top: Dr. Lifton listens to 
a progress report from 
researchers in his Boyer 
Center lab. 
Right: He leads a semi¬ 
nar on human genetics 
for internal medicine 
residents at the West 
Haven campus of the 
VA Connecticut Health¬ 
care System. 
‘'If we learn more about genetic susceptibility, 
then we can say, ‘You, feel free to eat the 
nachos ... but you, stick to the carrots. 
Richard P. Lifton, M.D., Ph.D. 
“It’s exciting to know that 
many diseases have an underlying 
genetic basis,” he adds. “Now we 
can identify their specific causes. 
That’s what makes this phase of 
the understanding of human dis¬ 
ease one of the most productive in 
the history of medicine.” 
Dr. Lifton’s pioneering work 
in molecular genetics has placed 
him in high demand, but he has 
resisted offers to move on. When 
he was invited to head a new car¬ 
diovascular research program on 
the West Coast earlier this year, 
he declined. Taking on an adminis¬ 
trative role at this point in his 
career, he says, would take him 
away from the work that drew 
him into the field—seeking 
answers to some of the fundamen¬ 
tal problems in clinical medicine. 
"This job is the one I always 
wanted,” he says. “The outstand¬ 
ing clinical medicine, genetics 
and physiology at Yale make the 
environment perfect for what I 
want to do.” YM 
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CANCER 
New rules 
of engagement 
By altering cell-to-cell communication, 
gene therapy has the potential to wage an information war 
against cancer at the molecular level. 
By John Green 
Photographs by Frank Poole Twist slowly ... He’s a runner, so he’s got hard 
bones, so you’re going to have to twist. Just 
slowly pull back the trochar ... otherwise we’re 
going to get a shooting pain.” 
Clad in a white coat, Albert Deisseroth is watching 
over a young cancer patient as a resident physician 
extracts a sample of bone marrow. The marrow will be 
tested to see whether the young man's leukemia has 
resurfaced after a period of remission. 
The patient gets a liberal dose of local anesthetic 
before the resident draws the marrow out through a 
rather wicked-looking needle inserted in the hipbone. 
In relaxed fashion. Dr. Deisseroth accomplishes at least 
three things at once: 
He imparts good biopsy technique to the resident, 
who is new to the procedure, gently prefacing each sug¬ 
gestion with the words: “What I usually do is ...” 
He steadily solicits the patient for feedback: 
“How are you doing, Mike? ... If you feel the faintest 
hint of any pain, let us know. If we do it slowly, there’s 
no pain.” 
And he keeps one eye on the lab technician to 
make sure she prepares the blood and marrow samples 
as he wants them: “Squirt it in. Shake it up. I’m afraid 
it’s gonna clot.” 
At the end of the session, Mike, a Yale graduate 
student who has endured the procedure in a variety of 
other clinics, hops off the table almost smiling. Today’s 
ordeal, the relief in his face suggests, was easier than it 
could have been. 
Albert Deisseroth's enthusiasm for gene therapy is tem¬ 
pered by the day-to-day hurdles of its development, yet he 
can’t help being excited by the future: “We have powerful 
new tools that will allow us to help people in ways we 
couldn’t before. ” 
Dr. Deisseroth, Yale’s newly arrived chief of med¬ 
ical oncology and the Ensign Professor of Medicine, 
acquired this gentle efficiency by performing bone 
marrow harvests for transplants six or seven times a 
week over a period of years. What he sees in the faces 
of patients and their families motivates him in his 
search for new cancer treatments, especially in the fast¬ 
growing field of gene therapy. “We are painfully aware 
of the importance of minimizing the time for imple¬ 
menting new therapies,” he says, “especially those that 
can help people who are facing potentially fatal dis¬ 
eases. It’s a major driving force.” 
A HISTORY OF INVENTION 
Albert B. Deisseroth, M.D., Ph.D.. has come to Yale to 
implement gene therapy, giving the university a major 
stake in an exciting and controversial new approach to 
cancer treatment. Recruited in 1995 by Vincent T. 
DeVita Jr., M.D., HS ’66, director of the Yale Cancer 
Center, and Ralph I. Horwitz, M.D., chairman of the 
Department of Internal Medicine, Dr. Deisseroth came 
to New Haven from the M.D. Anderson Cancer Center 
in Houston. There he served as chief of hematology and 
was principal investigator in a variety of promising 
gene therapy trials for patients with leukemia and can¬ 
cers of the ovary and breast. 
Dr. DeVita offers unqualified praise. “He’s an out¬ 
standing scientist and doctor, and a very inventive per¬ 
son who is always on the edge of the envelope,” he 
says. “Every time something new is happening, if you 
pick up the literature you'll see Dr. Deisseroth's name.” 
Dr. DeVita, director of the National Cancer Insti¬ 
tute (NCI) from 1980 to 1988, recalls that Dr. Deis¬ 
seroth was involved in hemoglobin synthesis in his 
early career, while training in molecular biology. 
John Green is a free-lance writer in New London. Conn. 
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Then he became “very much 
involved in chronic leukemias and 
the effect interferon had on them.” 
Dr. DeVita, who has known 
Dr. Deisseroth for two decades and 
worked with him at the NCI, 
recalls how some 20 years ago Dr. 
Deisseroth was the first person to 
set up autologous bone marrow 
transplantation—first in lab ani¬ 
mals and then in humans. The pro¬ 
cedure, says Dr. DeVita, “sat 
around a while before people 
picked up on it, and it's now 
become a very useful tool.” The 
procedure preserves a quantity of 
the cancer patient's stem cells 
through a bone marrow harvest, 
saving the cells from destruction 
by chemotherapy. Stem cells are 
progenitor cells which develop into 
the variety of blood cells that com¬ 
prise the immune system. 
After the toxic effects of 
chemotherapy have diminished, 
the stem cells are reintroduced to 
restore the patient’s immune sys¬ 
tem. The technique allows much- 
higher-than-normal doses of 
Three new clinical 
gene therapy studies 
to be launched 
this spring at Yale 
will target prostate, 
breast and 
ovarian cancers. 
chemotherapy agents, thereby 
increasing the survival of patients 
who would not benefit from con¬ 
ventional doses. This early work 
done with stem cells is the spring¬ 
board to a number of the strategies 
Dr. Deisseroth and his team are 
developing for clinical gene ther¬ 
apy trials at Yale. 
OPENING THE DOOR 
Gene therapy is a rapidly evolving 
approach to medicine that makes 
use of more than 20 years of 
genetic engineering techniques to 
attack disease in new ways. By 
altering cell-to-cell communica¬ 
tion, gene therapy has the potential 
to wage an information war against 
cancer at the molecular level. Ini¬ 
tially conceived of as a means to 
treat inherited disorders—either by 
replacing or inactivating harmful 
gene mutations—gene therapy is 
now being researched in trials for a 
wide range of diseases, including 
cancer, vascular disease, arthritis, 
neurodegenerative disorders, AIDS 
and other acquired diseases. There 
are currently more than 150 clini¬ 
cal gene therapy trials worldwide, 
including 125 protocols approved 
by the National Institutes of 
Health’s (NIH) Recombinant DNA 
Advisory Committee (RAC), 
which monitors gene therapy 
research in the United States. At 
the beginning of 1996, more than 
1,000 patients had been treated 
with some form of gene therapy. 
An example of a trial with 
encouraging results is Dr. Deis- 
seroth’s own work begun at M.D. 
Anderson. The trial tested a strat¬ 
egy for improving the body’s abil¬ 
ity to tolerate extremely high doses 
of chemotherapy agents used to 
treat breast and ovarian cancer. The 
method involves making an ally of 
a gene known to foil chemother¬ 
apy, the multi-drug resistance gene 
type 1. The MDR-1 gene produces 
a kind of “molecular pump” that 
has enabled cancer cells to rid 
themselves of the toxic drugs. 
One important key to the 
process of gene therapy is engi¬ 
neering a means of transmission, or 
vector, to carry a particular gene to 
the target cells. For the breast and 
ovarian trials. Dr. Deisseroth’s 
team engineered a vector that 
transfers the MDR-1 gene to 
healthy bone marrow cells, making 
them less vulnerable to the toxic 
effects of chemotherapy. “Albert’s 
study with the MDR-1 gene into 
stem cells in fact works,” Dr. 
DeVita says. “He shows that you 
can make the marrow resistant to 
chemotherapy.” 
Dr. Deisseroth brought two 
active gene therapy treatment pro¬ 
tocols with him to Yale from M.D. 
Anderson. In late January, he and 
colleagues were finishing the work 
necessary to launch three new clin¬ 
ical studies this spring. One of the 
new treatments being evaluated 
promises to make radiation therapy 
more effective in patients with 
prostate cancer. The second is 
designed to selectively kill off 
malignant cells in the marrow of 
patients with breast cancer, while 
the third would similarly cleanse 
tumor cells from the abdominal 
membrane of patients with ovarian 
In the “clean room” where viral 
vectors are designed for new treat¬ 
ments for prostate, breast and ovar¬ 
ian cancer. Dr. Deisseroth confers 
with post-doctoral fellows 
Thanyaphong Nanakorn, M.D., left, 
and Lianhua Yin, Ph.D. The racks 
contain frozen common cold 
viruses, altered so they cannot 
spread disease. Instead, these vec¬ 
tors are used to deliver a therapeu¬ 
tic gene to its target inside the body. 
cancer. Corresponding studies in 
laboratory animals were nearing 
completion in January, with espe¬ 
cially promising results in the 
prostate cancer trial, according to 
Dr. Deisseroth, who was prepar¬ 
ing to seek approval for human 
trials from the Food and Drug 
Administration and Yale’s Human 
Investigation Committee. 
THE NECESSARY VISION 
For the gene therapy field as a 
whole. Dr. Deisseroth says, the 
qualified successes of some of the 
early trials are only small steps 
toward a much larger goal. “For 
the past 50 years in cancer treat¬ 
ment,” he says, “we have been lim¬ 
ited to basically destructive treat¬ 
ments: We cut things out, burn 
them [with radiation] or destroy 
them with toxic chemicals. The 
problem is that these destructive 
treatments are not very selective, 
so they’re very toxic to the normal 
tissues.” 
Genetic therapy. Dr. Deis¬ 
seroth explains, has very different 
goals. “We want to use genetic 
modification to protect the normal 
tissues of the body, or to sensitize 
the tumor cells to the therapy, 
thereby improving the perfor¬ 
mance of existing methods of ther¬ 
apy. And ultimately we want to 
develop genetic therapy as a pri¬ 
marily corrective approach to treat¬ 
ment—without harm to patient.” 
Driving this, in his mind, are 
the dramatically rising costs of 
health care. By the year 2000, can¬ 
cer will be the leading consumer of 
the health care dollar in the U.S., 
he says, adding that much of the 
cost of cancer therapy is spent 
bringing patients through the very 
difficult, sometimes life-threaten¬ 
ing complications of therapy. 
Advances in molecular biol¬ 
ogy, genetics and bioengineering, 
he says, have “opened the door for 
corrective therapies—not only for 
cancer, but for all human diseases. 
“In terms of the national bud¬ 
get, nothing could be more useful 
Thanyaphong Nanakorn, M.D., 
cultures cells in a flask as part of 
the development of a vector for 
prostate cancer therapy. 
than to convert very expensive 
chronic therapy into single deci¬ 
sive therapeutic interventions that 
have a lifelong impact and that can 
be carried out simply—even out¬ 
side the hospital.” 
In the future. Dr. Deisseroth 
can imagine traditional lab tests 
being replaced by a profile of what 
he calls “the parts of the machin¬ 
ery,” the genes of the cell and their 
products. “If the products are not 
being produced normally, one 
could say, for example, ‘Element B 
is not working, we're going to 
replace it.' You give somebody a 
nose spray, and in goes a vector 
and takes care of it. In this vision 
of the future, the vectors, or what¬ 
ever methods of delivery are being 
utilized, can target themselves to 
specific cells or to specific loca¬ 
tions or addresses within the cells 
or within the genome and just 
replace the problem elements.” 
This kind of future-gazing 
inspires the progress of scientists 
who solve the day-to-day problems 
of gene therapy development and 
negotiate its inevitable blind alleys, 
but such vision may also cause 
problems. Patients and their fami¬ 
lies may grasp it as a promise of 
something just around the corner. 
And entrepreneurs of startup 
biotech and drug companies under 
pressure to raise millions in ven¬ 
ture capital are tempted to oversell 
the promise and understate the dif- 
yale medicine 15 
Eight days a week 
Albert Deisseroth brings a record of innovation, passion and 
scientific rigor to Yale’s application of gene therapy. 
Albert Deisseroth was born and 
raised in Middletown, N.Y., 
where he remembers “a distin¬ 
guished family physician who 
came to the house with a bag of 
pills and a three-piece suit and 
made me feel good.” His friend¬ 
ship with the family doctor kindled 
an interest in medicine. 
Dr. Deisseroth earned his 
undergraduate and medical 
degrees at the University of 
Rochester, where he also 
received a Ph.D. degree in bio¬ 
chemistry. He then served his 
residency at Harvard’s Beth Israel 
Hospital in Boston. From there he 
went to the National Institutes of 
Health as a clinical trainee and 
then chief resident physician in 
the National Heart Institute. It 
was during his sojourn there that 
Yale first came calling in the form 
of biology and genetics professor 
Frank H. Ruddle, Ph.D. 
Recalls Dr. Deisseroth: “I was 
sitting there—just a young investi¬ 
gator in the lab—and in walks 
Frank Ruddle, and says, ‘I read 
one of your papers. I’ve got things 
that we’ve made that could be 
useful to you in the project you’re 
working on. Let’s collaborate.’ 
And we did over about a three- 
year period.” 
So began a key period of 
accomplishment in Dr. Deis- 
seroth’s career. During this time 
he moved to Harvard’s Dana Far- 
ber Cancer Center as a clinical fel¬ 
low while continuing the collabora¬ 
tion at Yale. “Each week I’d com¬ 
plete all my clinical duties at Far- 
ber. Then I’d hop on the train on 
Friday night and come down from 
Boston to New Haven. And I’d 
work in Frank Ruddle’s biology lab 
all weekend and then go back on 
Sunday night to Boston. My wife 
and three children would see me 
off on the train every Friday night. 
This went on for a whole year.” 
The work paid off: “It was a 
major breakthrough in mapping 
the elements of the genetic mate¬ 
rial. Together we opened up a new 
way of mapping.” 
Dr. Deisseroth calls that early 
work at Yale “a very vivid imprint¬ 
ing experience.” And it was defi¬ 
nitely part of what drew him back. 
“Life is a struggle. When you get a 
chance to revisit an important 
period in your life, that’s always a 
very attractive option.” 
After the Farber, Dr. Deis¬ 
seroth was offered a job running 
a section at the National Cancer 
Institute, then headed by Dr. DeVi- 
ta. Dr. Deisseroth worked in bone 
marrow transplantation and inten¬ 
sive therapy, and began experi¬ 
ments introducing genetic ele¬ 
ments into cancer and normal 
cells to make therapy work better. 
A seven-year stint followed at 
At a weekly lab journal club. Dr. 
Deisseroth and his research team 
report on recent findings relevant to 
their oncology work. 
the University of California at San 
Francisco, where a colleague was 
Harold Varmus, M.D., now a 
Nobel laureate and current head 
of the NIH. Dr. Deisseroth’s last 
stop before his new post at Yale 
was the M.D. Anderson Cancer 
Center at the University of Texas 
in Houston, where he served as 
chief of hematology. 
Dr. Deisseroth’s wife, Louise, 
is a high school science teacher, 
and their three children have also 
all become scientists: Kate works 
at a Silicon Valley biotech compa¬ 
ny in California, Karl is a medical 
student at Stanford, and Karen is 
a graduate student in clinical psy¬ 
chology at Ohio State University. 
Reflecting on a life in science, 
Dr. Deisseroth recalls the opening 
of the Henry James novel Wash¬ 
ington Square, and the notion that 
“a physician is an individual 
grounded in the practical but 
touched by the light of science.” 
He decided early on that “! want¬ 
ed my life to not be directed to 
possessing things, but to be a 
vehicle through which things of 
value were created for others.” 
In response to a question 
about what he does to relax, Dr. 
Deisseroth replies, “I’m relaxed 
all the time. I’m so interested in 
what I’m doing that it becomes 
the central focus. When I wake 
up, no matter how late I’ve been 
up the night before, I drag myself 
out of bed, and I’m so interested 
in pursuing what I’ve been work¬ 
ing on that every minute of life is 
exciting for me. I don’t have to 
worry about going on vacation. 
My life is a vacation. There’s no 
downtime, [although] I’ve been 
stumped a lot of times by prob¬ 
lems I couldn’t solve. 
“I’ve been lucky to live my life 
in a time of great and momentous 
change. And that change is con¬ 
tinuing, and has driven my work 
forward from the very day I first 
set foot in medical school.” ■ 
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In the future, Dr. Deisseroth can imagine 
traditional lab tests being replaced by a profile 
of what he calls uthe parts of the machinery, ” 
the genes of the cell and their products. 
ficulties and timeframe of a new 
approach. So as with all new treat¬ 
ments, gene therapy is a source of 
controversy both within and out¬ 
side the research community. 
“There is no question that gene 
therapy will eventually prove itself 
as it matures over a period of years 
and decades,” says Dr. Deisseroth. 
“We have powerful new tools that 
will allow us to help people in 
ways we couldn’t before. How¬ 
ever, years of basic research and 
careful clinical trials will be 
required before these new treat¬ 
ments will be beneficial.” 
As for potential hazards, 
Dr. Deisseroth says the therapies 
he envisions will be safer than 
existing treatments. “We’re inter¬ 
ested in replacing a therapy [cur¬ 
rent chemotherapy] that is muta¬ 
genic and highly toxic and invasive 
with a harmless intervention that 
has a lifelong impact and no risk,” 
he says. 
“None of these vectors go into 
cells used in reproduction and fer¬ 
tilization; they go into the differen¬ 
tiated cells,” he adds. "There is no 
risk to the evolution of the human 
species because these interventions 
are not transmitted from generation 
to generation.” 
“WE HAVE EVERYTHING” 
Gene therapy by its nature must 
involve a wide-ranging team of 
clinicians and research scientists. 
And Yale has strength in many of 
the required disciplines. A team 
might include oncologists, molecu¬ 
lar and structural biologists, geneti¬ 
cists, immunologists, pharmacolo¬ 
gists, structural chemists, X-ray 
crystallographers and a variety of 
other bioengineering and biotech 
specialists. 
Says Dr. DeVita: “I think 
what attracted Dr. Deisseroth to 
Yale is similar to why I came: The 
science base here is extraordinary. 
We have a large number of very 
talented scientists in molecular 
biology and structural biology.” 
Dr. Deisseroth agrees: “You want 
to be at an institution where the 
best minds, the leading minds are 
available in the areas that are 
needed—and we’re basically there. 
We have everything.” 
How will these intellectual 
resources be applied to gene ther¬ 
apy? During the first half of 1997, 
a team will be working on what Dr. 
Deisseroth refers to as the “sensiti¬ 
zation” or “pro-drug activation” 
trial, a pre-clinical trial targeting 
breast cancer cells. One problem of 
treatments today involving autolo¬ 
gous bone marrow transplants is 
that in advanced breast cancer 
patients, tumor cells have metasta¬ 
sized to the marrow. So when har¬ 
vested stem cells are reintroduced, 
so may be the cancer. To combat 
this the team has designed a virus 
that infects the breast cancer cells 
in vitro but not the hematopoeic 
cells (stem cells). The introduced 
gene produces an enzyme and a 
protein which convert a fairly 
harmless drug (5 fluoro cytosine, 
or 5FC) that normally is used to 
treat fungal infections into a highly 
toxic substance—all within the 
genetically altered cancer cells. As 
Dr. Deisseroth puts it, “you just 
flood the petri dish culture with the 
drug and only the cancer cells will 
convert it to a deadly toxin.” 
Although this trial takes place out¬ 
side the body, its implication could 
be “broad and profound.” Says Dr. 
Deisseroth: “We’re thinking ahead 
to how we can develop something 
like this for the whole body and 
avoid all harmful therapies.” 
He immediately, though, offers 
the caveat: “It sounds great, but it's 
tough to implement.” One problem 
is producing enough of the viral 
particles to get the element in all 
the cancer cells in all parts of the 
body. Another problem is that this 
particular vector, although it doesn’t 
infect stem cells, would infect other 
cells of the body in vivo. Dr. Deis¬ 
seroth, though, looks forward to a 
successful in vitro trial that would 
offer a "proof of principle.” 
Another trial will target ovar¬ 
ian cancer, and a more specific 
viral vector has already been 
designed. When an ovarian cancer 
is removed, some microscopic 
amounts of the tumor cells remain 
in the peritoneum, the membrane 
that lines the walls of the abdomi¬ 
nal cavity. The viral vector devel¬ 
oped for this trial infects the nor¬ 
mal peritoneal cells as well as the 
ovarian cancer cells. But it will not 
produce the converting enzyme 
that changes the non-toxic drug to 
the toxin—unless it’s inside the 
Srinivasan Srimatkandada. Ph.D, 
develops a gel image as part of a 
related study. Much of the current 
work is directed toward making exist¬ 
ing therapies function better. 
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Special delivery, with the help of a virus 
Broadly defined, gene ther¬ 
apy sounds simple: alter a 
patient’s genes to achieve a ther¬ 
apeutic benefit. If you’re dealing 
with a genetic disorder, replace the 
mutated gene with the correct 
gene. If you want to cure a cancer, 
make a change in the cancer cell 
genes that allows you to kill them 
with a drug that’s harmless to nor¬ 
mal cells. 
The hard part is applying the 
theory to patients, but already 
there have been some qualified 
successes and the techniques are 
rapidly evolving. W. French Ander¬ 
son, M.D., is a gene therapy pio¬ 
neer in whose NIH laboratory 
Albert Deisseroth worked early in 
his career and whom he credits for 
kindling his interests in the field. 
In 1990, a team led by Dr. 
Anderson performed the first feder¬ 
ally approved gene therapy, an 
effort to help a 4-year-old girl with a 
genetic disorder that blocked pro¬ 
duction of a vital enzyme. The team 
genetically altered some of her 
white blood cells outside the body 
Siqing Fu, M.D., Ph.D., an expert in 
the design of viral vectors, came to 
Yale with Dr. Deisseroth from the 
M.D. Anderson Cancer Center in 
Houston. 
to produce the missing enzyme 
and then transfused the white cells 
back into her bloodstream. The 
treatment worked and she now 
leads a normal life, although she 
needs regular treatments as the 
altered white cells die off. 
At Yale, gene therapy re¬ 
searchers hope to improve treat¬ 
ments for cancer—either by in¬ 
creasing the efficacy of current 
therapies or developing new ones. 
All strategies of gene therapy 
require a means of altering genetic 
material in target cells. To do this, 
researchers have made an ally of 
an ancient enemy, the virus. Virus¬ 
es are tailor-made for the job 
because they have evolved to 
invade cells and then commandeer 
the cells’ genetic material for the 
manufacturing of more viruses. 
The process of tailoring viral 
vectors is an art in itself. At Yale’s 
new viral-vector production lab, 
postdoctoral associate Siqing Fu, 
M.D., Ph.D., is the vector designer 
who presides over the process. 
Dr. Fu came with Dr. Deisseroth 
from M.D. Anderson Cancer Cen¬ 
ter in Houston to continue their 
collaboration. 
Dr. Fu uses a variety of bio¬ 
chemical processes and gene 
splicing techniques to both cripple 
the virus so that it can’t replicate, 
and to attach to it the gene that will 
be delivered to the target cell. The 
viruses most often tapped to be 
vectors are the adenoviruses, 
associated with colds, and retro¬ 
viruses. 
Yale’s vector production facility 
was created last year in two rooms 
in Sterling Hail of Medicine, with an 
elaborate filtering apparatus and 
positive- and negative-air-pressure 
systems to keep dust out and vec¬ 
tor material in the lab. The FDA 
considers viral vectors to be drugs 
and tightly regulates the process. 
As a result, Dr. Fu says that devel¬ 
oping a vector can take as little as 
six months or longer than a year. ■ 
ovarian cancer cells. Developed at 
Stanford University, the vector is 
called a “tumor-specific transcrip¬ 
tional promoter.” 
Dr. Deisseroth sums up: “The 
gene doesn’t read out its product 
unless it’s in the cancer cell. So this 
is good, it's another step forward.” 
The third trial will target 
prostate cancer, also by using a 
viral vector to infect tumor cells. 
With the insertion of a new gene 
into the tumor cell, the drug 5FC is 
converted to the more toxic 5FU, 
making the cell more susceptible to 
radiation therapy. 
MELANOMA RESEARCH 
Yet another gene therapy team at 
Yale is targeting one of the fastest 
rising and deadliest of cancers. 
According to Sancy Leachman. 
M.D., Ph.D, if melanoma is 
detected early it is nearly 100 per¬ 
cent curable. Once it metastatizes 
to other parts of the body, the 
10-year survival rate drops to 
between 5 and 10 percent. That’s 
why. Dr. Leachman says, “you 
can’t find a more rewarding or 
important area of research in der¬ 
matology than melanoma.” Dr. 
Leachman, a molecular biologist 
who worked in Dr. Deisseroth’s 
laboratory last year, is an NIH fel¬ 
low in dermatology at Yale. 
Dr. Deisseroth and other senior 
investigators are attempting to har¬ 
ness the patient’s own immune sys¬ 
tem to fight metastatic melanoma. 
They designed a protocol for bone 
marrow transplantion with the 
desired effect of inducing a “graft- 
versus-tumor" reaction against the 
spreading melanoma cells. Accord¬ 
ing to this protocol, not yet tested, 
immune cells from the donor mar¬ 
row would attack the melanoma. 
By modifying the foreign immune 
cells genetically before transplan¬ 
tation, researchers also might be 
able to tag the foreign cells and 
selectively destroy them once the 
job is done. 
Dr. Leachman, who was 
involved in the design of the 
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Dr. Deisseroth with his laborary team: "There is no question, ’’ he says, 
“that gene therapy will eventually prove itself as it matures over a period of 
years and decades. ” 
melanoma protocol, says that Dr. 
Deisseroth “is one of the few peo¬ 
ple who really bridge the gap 
[between laboratory and clinic],” 
she adds. “You know you actually 
have the potential to treat patients 
with some of the most exciting and 
potentially helpful treatment regi¬ 
mens that are becoming available.” 
As to the quality of the 
research team: “The higher caliber 
principal investigator you have in a 
lab, the higher caliber postdocs you 
recruit, that’s just the way it works, 
so of course he’s got an excellent 
group of people working with 
him.” They have come to New 
Haven from as far away as China, 
Thailand, Spain, India and Korea. 
Among the gene therapy 
group’s members are Injae Chung, 
Ph.D.; Takuma Fujii, M.D., Ph.D.; 
Siqing Fu, M.D., Ph.D.; 
Thanyaphong Nanakorn, M.D.; 
Felix Garcia-Sanchez, Ph.D.; 
Srinivasan Srimatkandada, Ph.D.; 
Lianhua Yin, Ph.D.; and medical 
students Michael Wang and Matt 
Cooperberg. Dr. DeVita credits Dr. 
Deisseroth as being a key factor in 
the recent recruitment to the Can¬ 
cer Center of Edward Chu, M.D., 
“an outstanding molecular pharma¬ 
cologist,” and Frank Hsu, M.D., an 
immunologist who has developed a 
new approach to vaccination. 
HOPE, HYPE, HELP 
For a number of reasons, not the 
least of which is that it alters the 
genetic code in human cells, gene 
therapy is under intense scrutiny 
from the NIH and the Food and 
Drug Administration (FDA). The 
FDA, for instance, has developed 
stringent guidelines for the produc¬ 
tion of viral vectors to be used in 
humans. Yale has built for Dr. 
Deisseroth’s team a vector produc¬ 
tion facility (one of the few at an 
academic institution) according to 
the FDA guidelines. 
Last year, a scientific advisory 
panel convened by NIH Director 
Harold Varmus, M.D., reported 
that a swirl of hyperbole and exag¬ 
geration has created “the mistaken 
and widespread perception that 
gene therapy is further developed 
and more successful than it actu¬ 
ally is.” As co-chairman Stuart 
Orkin, M.D., told a reporter, 
“this is a young field with much 
in front of it, but there is no 
established efficacy of any gene 
therapy today.” 
Dr. Orkin and his colleagues 
questioned the efficacy of the gene 
viral vectors currently being used, 
saying "none is ideal or perhaps 
even nearly ideal” in its ability to 
transfer genes into the target cells. 
They criticized redundancy in 
experiments and “a lack of suitable 
controls,” while saving some of 
the harshest rebukes for the bio¬ 
tech industry: “Uncritical gene 
therapy reports [from companies] 
are used by industry to promote 
investment and perceived research 
dominance.” 
Nonetheless, the group sees 
“extraordinary potential for the 
long term" in gene therapy. The 
NIH currently grants about 2 per¬ 
cent, $200 million, of its annual 
budget to gene therapy projects 
and is a funding source for a por¬ 
tion of the work at Yale. What, if 
any, effect the recent critique will 
have on current grant proposals is 
still unknown. 
As far as the criticism within 
the research community goes, for 
Dr. DeVita it’s a case of deja vu. 
"There is usually about a decade of 
controversy surrounding [new 
fields in medicine), even the most 
promising of them,” he says. "In 
the case of gene therapy, there are 
people who say, ‘Well it can’t 
work, we shouldn't do it now, we 
Felix Garcia-Sanchez, Ph.D. 
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should wait until we know more 
before we do it.’” When Dr. DeVita 
and collegues introduced a new 
chemotherapy for Hodgkins disease 
two decades ago, critics were equally 
skeptical. But the four-drug combi¬ 
nation known as MOPP raised the 
survival rate for patients with 
advanced disease from near zero to 
65 percent. “So we’ve faced the 
same sort of thing in the past,” Dr. 
DeVita says. 
At the same time, neither he nor 
Dr. Deisseroth downplays the chal¬ 
lenges, hurdles and overall difficulty 
of the work ahead to realize even a 
small part of the promise of gene 
therapies. As Dr. Deisseroth puts it, 
“In the beginning of a field like this, 
the number of things that you don't 
know is very high and so the chances 
that you’ll not have a perfect system 
the first time out are also very high.” 
The hurdles facing gene therapy 
are not trivial, agrees Maurice J. 
Mahoney, M.D., professor of genet¬ 
ics, pediatrics, and obstetrics and 
gynecology. “The basic biologic 
problems are quite significant— 
inserting a gene at a place where it 
will be expressed and ensuring that 
expression continues over some rea¬ 
sonable length of time, and then per¬ 
haps having to repeat the therapy at 
intervals,” he says. “It seems very 
unlikely if you only transform one 
percent of cells that you are going to 
affect the course of a disease—at 
least for most disease states. But if 
you affect 10 percent you may be 
able to.” 
Will gene therapy research pay 
off? Dr. DeVita, while emphasizing 
that gene therapy is only one 
approach to cancer research and 
treatment at Yale, says, “Things are 
moving very fast and the tools are 
extraordinary. You can do things that 
are really quite unbelievable. When 
you used to make predictions—if 
you were enticed to make a predic¬ 
tion—it usually took longer. These 
days when you predict something it 
usually takes less time, not more. 
So my guess is that we’ll be able to 
find ways to make gene therapy a 
useful tool.” YM 
Eight questions 
Francis S. Collins, M.D., Ph.D., 
earned his doctorate at Yale in 
1977 and spent three years at 
the medical school as a postdoc¬ 
toral fellow in genetics and pedi¬ 
atrics. Today he heads the 
National Human Genome 
Research Institute (NHGRI) in 
Bethesda, Md., the federal insti¬ 
tute overseeing the effort to map 
the human genome. 
In November, Dr. Collins 
spoke at the annual meeting of 
the Association of American Med¬ 
ical Colleges in San Francisco on 
The Ethical and Social Implica¬ 
tions of the Human Genome Pro¬ 
ject. “If s exciting to have the abili¬ 
ty to predict who is individually at 
risk for which diseases. That is 
the kind of opportunity for individ¬ 
ualized preventive medicine that 
we have dreamed about,” he told 
the gathering of more than 3,000 
academic physicians and medical 
administrators from around the 
nation. But he posed a further 
question: “Are we ready for the 
consequences of that revolution?” 
To consider the question care¬ 
fully, Dr. Collins offered eight 
more: 
1. Will the complexity of whole 
genome biology overwhelm us? 
2. Will we successfully shepherd 
new genetic tests from research 
into clinical practice? 
3. Will effective legislative solu¬ 
tions to genetic discrimination be 
found? 
4. Can health care providers and 
the public become genetically liter¬ 
ate in time? 
5. Will the therapeutic promise of 
genetics be realized? 
6. Will the benefits of advances in 
genetics be available only to a 
privileged few? 
7. Will we succumb to genetic 
determinism? 
8. Will we arrive at consensus on 
the limits of genetic technology? 
In his discussion, Dr. Collins 
offered some answers and a hint 
of things to come as researchers 
around the world endeavor to 
record more than 3 billion bits of 
information about the estimated 
100,000 human genes. He said 
that many physicians may not be 
equipped to implement sophisti¬ 
cated new tests now available for 
susceptibility genes such as 
BRCA1 and BRCA2, which indicate 
a higher risk for developing breast 
cancer, and that many doctors are 
currently quite uncomfortable pro¬ 
viding genetic counseling to their 
patients. 
To increase the genetic litera¬ 
cy of both health care profession¬ 
als and the public, Dr. Collins said 
that a coalition convening this 
spring will help substantially by 
providing a clearing house for edu¬ 
cational materials. He expressed 
concern about genetic determin¬ 
ism, as science offers more evi¬ 
dence for the biological causes of 
both illness and behavior: “We 
have to work at not slipping into 
that narrow slot, the idea that 
‘genes are us.’” 
Finally, Dr. Collins spoke elo¬ 
quently of the need for laws to pro¬ 
tect individuals from genetic dis¬ 
crimination. “We are all walking 
around with four or five seriously 
misspelled genes,” he said. “We 
are all at risk of having that infor¬ 
mation used against us.”» 
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MILESTONES 
75 years of Yale pediatrics 
Medical school marks 
the occasion with 
dedication of new 
research center. 
A century ago, the industrial 
building at the comer of 
Howard and Congress 
avenues in New Haven was a rub¬ 
ber factory. A generation ago, it 
was the place women shopped for 
a bargain on coats. 
In November, a portion of 464 
Congress Ave. reopened as a 
dynamic new facility for research 
in pediatrics. Five state-of-the-art 
laboratories provide new space for 
eight principal investigators and 
their research teams, who are prob¬ 
ing research questions in areas 
from cancer genetics and genetic 
imprinting to the developmental 
biology of the immune system. 
The 17,000-square-foot Yale 
Child Health Research Center was 
dedicated Nov. 1 with a ribbon cut¬ 
ting by the mayor, medical school 
and hospital administrators, and 
community leaders from the Hill 
neighborhood that surrounds the 
new facility. 
The dedication also marked 75 
years of pediatrics at Yale. 
“The center will take an inter¬ 
disciplinary approach to improving 
the understanding of normal devel¬ 
opment and the abnormalities that 
continue to result in injury, handi¬ 
caps and death to children,” said 
Joseph B. Warshaw, M.D., chair¬ 
man and chief of pediatrics at Yale. 
Scientists in the Department of 
Pediatrics will interact with col¬ 
leagues in the departments of Biol¬ 
ogy, Cell Biology, Genetics, and 
Cellular and Molecular Physiol¬ 
ogy, the sections of Immunobiol¬ 
ogy and Neurobiology and other 
basic science programs, participat¬ 
ing in research designed along pro¬ 
grammatic lines. Yale medical fac¬ 
ulty are pursuing pediatric research 
projects: 
■ advancing our understanding of 
information processing in children 
with learning disabilities, using 
functional magnetic resonance 
imaging, and functionally defining 
male and female brain differences 
■ pioneering, using imaging tech¬ 
nologies, the diagnosis in congeni¬ 
tal heart disease prenatally 
■ carrying out molecular studies to 
define cystic fibrosis 
■ attempting to identify the gene 
that is defective in the disease 
hemochromatosis, a common 
Top: Tours of the Child Health Research 
Center were a hot ticket in November, 
when the 17,000-square-foot facility’ was 
dedicated during an open house and sci¬ 
entific symposium. 
Above: Immunology fellow Jose 
Calderon, M.D., and research assistant 
Beth Cooper are among two dozen people 
engaged in research in the center’s five 
state-of-the-art laboratories. 
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A history of 
advances in 
children’s health 
Seventy-five years ago last 
November, Yale launched one 
of the first departments of pedi¬ 
atrics in the country. Its mission 
was to increase clinical scholarship 
in pediatrics and to decrease the 
vulnerability of children to injury and 
disease. 
From the beginning in 1921, 
the Yale Department of Pediatrics 
has done a remarkable job of carry¬ 
ing out that mission. “It’s always 
had an impact, far out of proportion 
to its size, on American pediatrics," 
says Howard A. Pearson, M.D., who 
chaired the department from 1972 
to 1985. 
Today, many once-devastating 
diseases are under control, and 
effective programs that were once 
unheard of are standard. As the 
department marks its 75th anniver¬ 
sary, Dr. Pearson notes some of the 
ways in which, over the decades, 
department members have indeed 
had an impact. For instance, they: 
■ conducted pioneering work on 
the causes, prevention and treat¬ 
ment of rickets, a disease that in 
the 1920s affected thousands of 
American children, especially in 
cities like New Haven. 
■ encouraged the State of Connecti¬ 
cut to build a residential facility, 
the Southbury Training School, for 
mentally retarded youngsters. 
■ refined fluid and electrolyte ther¬ 
apy for diarrhea, long a major killer 
of children. 
■ brought about a better under¬ 
standing of polio. 
■ helped produce a vaccine against 
German measles. 
■ showed that the practice of pedi¬ 
atrics should include attention to 
psychological and social issues. 
■ demonstrated that rooming-in 
arrangements for new mothers and 
their babies served both better than 
did the long-standard practice of 
separating newborns from their 
mothers. 
■ revolutionized the care of prema¬ 
ture infants by showing that they 
could be safely cared for in nurs¬ 
eries that let staff and parents have 
more access instead of isolating 
them in cubicles, and established 
the country’s first modern inten¬ 
sive-care unit for premature infants. 
■ helped establish separate, appro¬ 
priate hospital facilities for 
children. 
■ helped to start and maintain 
New Haven’s Hill Health Center, 
where pediatrics is an important 
part of medical services for urban 
residents. 
■ launched the country’s first com¬ 
prehensive program for testing for 
sickle-cell anemia in newborns and 
demonstrated that mortality from 
the disease could be reduced. 
■ advanced knowledge in ped¬ 
iatric research through work at 
the Children’s Clinical Research 
Center and in other major programs 
at Yale. 
Joseph B. Warshaw, M.D., who 
has chaired the department since 
1987, calls it “poised to advance 
even further in the next 75 years.” 
The current explosion in molecular 
science, coupled with new technolo¬ 
gies, is giving pediatric researchers 
and practitioners “an improved 
understanding of what’s going on,” 
he says. 
Recent work in the department 
has helped make it possible to diag¬ 
nose many cases of congenital 
heart disease prenatally. Current 
topics under study include the mole¬ 
cular mechanisms of cystic fibrosis. 
“These projects and others,” he 
adds, “will be in the forefront as the 
growth of knowledge in pediatrics 
increases logarithmically.” ■ 
genetic disease that can cause 
liver and heart problems, arthritis 
and diabetes 
■ developing experimental models 
to examine gene therapy of a rare 
immune deficiency disease and 
examining the effect of this genetic 
defect on immune function 
■ studying the regulation of expres¬ 
sion of interferon-gamma, a key fac¬ 
tor in the immune response that is 
poorly produced by lymphocytes in 
newborns, in order to understand the 
basis of the susceptibility of new¬ 
borns to severe infections 
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Above: A view of the building at 464 
Congress Ave. as it appeared in the 
19th century, when it was a rubber fac¬ 
tory. Later the building became an out¬ 
let for women's apparel. The Child 
Health Research Center occupies 
renovated space on the second floor. 
22 Spring 1997 
■ studying how different proteins 
are transported to different areas 
within the cell, and attempting to 
dissect out the mechanisms by 
which protein trafficking is 
achieved in health, disrupted in dis¬ 
ease states, and restored during 
recovery 
■ studying how the expression of 
some genes is determined by 
whether they are inherited from the 
mother or the father and how this 
regulation may affect organ devel¬ 
opment, as well as the development 
of inherited diseases. YM 
Above: Joseph B. Warshaw, 
M.D., left, and Howard A. 
Pearson, M.D., are among the 
physicians who have chaired 
the department during its 75- 
year history. They are pictured 
before one of the center’s six 
murals created by New Haven 
public school students. Fourth- 
graders at the Lincoln-Bassett 
School made this colorful 
mosaic reproduction of Edward 
Hopper’s Railroad Sunset. 
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Above: Myron Genel, M.D., associate 
dean for government and community 
affairs, greets Courtland Seymour 
Wilson, executive director of the Hill 
Development Corp. 
Right: Mayor John DeStefano and 
other community leaders, including 
U.S. Rep. Rosa DeLauro, Alderman 
Tony Dawson and Hill Development 
Corp. Chairwoman Cathy Sutton 
Dawson, spoke at the dedication. 
John M. Leventhal, M.D., HS ’73-76, left, stands with the participants 
in the scientific symposium he organized to mark 75 years of pedi¬ 
atrics at Yale. From left: Dr. Leventhal, professor of pediatrics and in 
the Child Study Center; Richard P. Litton, M.D., Ph.D., associate pro¬ 
fessor of medicine (nephrology) and genetics at Yale and a Howard 
Hughes Medical Institute investigator; Nancy C. Andrews, M.D., Ph.D., 
assistant professor of pediatrics at Harvard Medical School; Michael 
S. Kramer, M.D., professor of pediatrics, epidemiology and biostatis¬ 
tics at McGill University School of Medicine; and Leon E. Rosenberg, 
M.D., HS ’73-76, former dean of the Yale School of Medicine and 
senior vice president, scientific affairs, at Bristol-Meyers Squibb. 
All the right moves 
Yale Sports Medicine Center moves to 
expanded quarters at One Long Wharf. 
With fanfare, food and an a 
cappella performance by a 
group of Yale undergraduates, the 
Yale Sports Medicine Center 
opened its doors in a new facility in 
November at One Long Wharf 
Drive in New Haven. 
The new location has expanded 
clinical facilities, including special¬ 
ized athletic splint, brace, orthotic 
and casting rooms, and on-site X- 
ray. A bioskiils laboratory and 
sports medicine library comple¬ 
ment the new center, which has 
twice the space of the previous Sar¬ 
gent Drive location. 
“The new sports medicine cen¬ 
ter allows us to provide state-of-the- 
art specialized medical care for all 
athletes at one location,” says Peter 
Jokl, M.D. ’68, HS '69-73, chief of 
sports medicine at both at the Yale 
School of Medicine and Yale-New 
Haven Hospital. Dr. Jokl served as 
medical commissioner for the 1995 
Special Olympics World Games. 
Four full-time physicians at 
the Yale Sports Medicine Center 
provide treatment for men and 
women who suffer musculoskele¬ 
tal injuries, both athletes and non¬ 
athletes alike. In addition, trainer 
O. William Dayton serves a 
vital role in this comprehensive 
program. 
High school coaches, athletic 
directors and school health-care 
providers in the Greater New 
Haven area got to see the new cen¬ 
ter first-hand at a seminar in 
December, taught by the sports 
medicine staff. 
Dr. Jokl says the program is 
“especially fortunate to be located 
adjacent to the physical therapy 
services of Gaylord Hospital,” 
which are next door. “Since reha¬ 
bilitation is often a key to recovery 
in orthopaedic injuries, it is great to 
have an outstanding physical ther¬ 
apy program so available.” ■ 
Above: John Daigneault, 
M.D., shows a series of 
magnetic resonance images 
to Linda Fischer, an ath¬ 
letic trainer who visited the 
Sports Medicine Center 
during a December semi¬ 
nar for coaches and train¬ 
ers in the community. 
Left: The center’s four full¬ 
time faculty physicians, 
from left: John Daigneault, 
-o Director Peter Jokl, 
| Patrick Ruwe and Marc 
on | Galloway. 
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Left: The Yale Sports Medicine 
Center's new home is on the sixth 
floor of the renovated One Long 
Wharf building, overlooking 
Long Island Sound. 
Above: Ceremonies during the 
Yale-Princeton weekend also 
marked the retirement of Carm 
Cozza, the legendary Yale football 
coach. At the Sports Medicine Cen¬ 
ter opening, he spoke apprecia¬ 
tively of the long relationship 
between the center and Yale athlet¬ 
ics. Behind him is a sculpture by 
former chairman and professor 
emeritus Wayne O. Southwick, 
M.D., which Dr. Southwick dedi¬ 
cated to the center. 
Above: Dr. Jokl greets Joseph A. Zaccagnino, center, president and 
chief executive officer of Yale-New Haven Hospital, and Paul H. John¬ 
son, president and chief executive officer of Gaylord Hospital in 
Wallingford, Conn. 
Left: At the opening 
reception, Gary E. 
Friedlaender, M.D., 
chairman of ortho¬ 
paedics and rehabilita¬ 
tion, spoke of the cen¬ 
ter \s growth and suc¬ 
cess since its founding 
a decade ago by Direc¬ 
tor Peter Jokl, M.D. 
(standing to his left). 
Above: The Yale College a cappella group 
Whim W Rhythm sing a football fight song at 
the opening, which coincided with the Yale- 
Princeton game. 
Right: Coach Cozza with O. William Dayton, 
Yale’s former head athletic trainer, who sees 
patients at the Sports Medicine Center. 
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GALLERY 
Painless 
150 years ago, the use of ether brought 
a fundamental change to medicine. 
By Marc Wortman 
How much will it hurt? These 
days, surgeons can answer 
their patients’ standard ques¬ 
tion precisely: not at all. But until 
Oct. 16, 1846, any invasive proce¬ 
dure was likely to hurt very much 
indeed. That was the day on which 
surgeons first demonstrated the use 
of inhaled ether as a general anes¬ 
thetic and liberated the surgical 
patient from pain—at least until the 
effects of the magic vapors wore off. 
This past Oct. 16, an interna¬ 
tional meeting in Boston marked the 
150th anniversary of that historic 
moment, now celebrated as Ether 
Day. On that date a century and a 
half ago at Massachusetts General 
Hospital, surgeon John Collins War¬ 
ren. M.D., operated on a patient 
anesthetized by Boston dentist 
William Thomas Green Morton 
using inhaled ether. “That was a 
thunderclap in medical history,” 
says Yale clinical 
professor of surgery 
and medical historian 
Sherwin B. Nuland, 
M.D. ’55, HS ’55-61, 
author of The Origins 
of Anesthesia. “Noth¬ 
ing was the same 
afterwards.” 
Not only for the 
surgeon. Prior to the 
first use of ether, alco¬ 
hol and the proverbial 
4 //£■/ 
Above: A young Hartford dentist, 
Horace Wells (1815-1848), received 
scant credit for his use of nitrous 
oxide for dental operations. 
biting the bullet were the only 
weapons in the pain-fighting arse¬ 
nal. Any surgery required a number 
of strong men on hand to restrain the 
patient. Needless to say, delicate 
surgery was inconceivable under 
such circumstances. 
Nicholas M. Greene, M.D., 
professor emeritus and former chair¬ 
man of anesthesiology at Yale, 
organized a milestone exhibit on 
anesthesia’s history this fall at the 
Harvey Cushing/John Hay Whitney 
Medical Library. 
While Dr. Morton is credited 
with introducing inhaled ether’s 
anesthetic properties to the world, 
Dr. Greene points out that Crawford 
W. Long, M.D., of Georgia began 
using ether in his surgical practice 
four years earlier, but did not pub¬ 
lish his findings until after Drs. War¬ 
ren and Morton had made their 
Top: Wick vaporizers controlled the 
respiratory volume passing through the 
vaporizer and thus the concentration of 
ether. This instrument was widely used 
for surgery during the 1940s and '50s. 
Above: The first public demonstration 
of surgery’ performed on an etherized 
patient was a “thunderclap ” in med¬ 
ical history. Surrounded by colleagues. 
Boston dentist William Thomas Green 
Morton gives the patient ether. 
demonstration in 1846. In fact, Hart¬ 
ford dentist Horace Wells should 
also be credited for the advance, 
since he had previously experi¬ 
mented with nitrous oxide inhalation 
in his practice. He shared the con¬ 
cept of inhalation anesthesia with 
Morton, who then brought it to the 
26 Spring 1997 
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Vol. XXXV. Wednesday, November 18, 1846. No. 16. 
INSENSIBILITY DURING SURGICAL OPERATIONS PRODUCED BY 
INHALATION. 
Read before the IJoston Society of Medical Improvement, Nov. Uth, I84G, an nbstraci having been 
previously read before the American Academy of Arts and Sciences, Nov. 3d, 1846. 
By Honry Jacob Bigelow, M.D., one of the Surgeons of the Massachusetts General Hospital. 
Left: The publication of the report of 
the first use of inhaled ether as an 
anesthetic, written by Henry Jacob 
Bigelow, M.D., a Harvard colleague 
of surgeon John Collins Warren, 
M.D., brought worldwide attention. 
attention of Dr. Warren. Dr. Warren’s 
announcement of the successful surgi¬ 
cal use of inhaled ether brought 
tremendous worldwide attention. It is 
regarded as the first major American 
contribution to medicine. 
The immediate effect of the dis¬ 
covery of anesthesia was in fact lim¬ 
ited and sometimes downright danger¬ 
ous. It would be another 40 years 
before the germ theory was pro¬ 
pounded, and many operations under¬ 
taken with the new freedom permitted 
by anesthesia resulted in deadly infec¬ 
tions and some wildly speculative sur¬ 
gical experiments. Wide objections to 
its use quickly arose. Other anesthet¬ 
ics were tried. Chloroform was dis¬ 
covered as an anesthetic in 1847, 
but quickly demonstrated the poten¬ 
tially lethal quality of a deep sleep 
as a number of early fatalities 
were reported. 
However, the great medical value 
of anesthesia was readily apparent and 
its use spread rapidly. Peter Parker, 
M.D., a Yale-trained physician and 
minister, went to China in 1837. Only 
a year after inhalation ether was first 
used by Dr. Warren at Massachusetts 
General, Dr. Parker performed an 
amputation in Canton using the gen¬ 
eral anesthetic. This is believed to be 
the first use of anesthesia in Asia. 
By the turn of the century, new 
forms of anesthesia were being devel¬ 
oped. Cocaine was first used by Sig¬ 
mund Freud’s assistant, Karl Koller, 
M.D., as a local anesthetic and alter¬ 
native to ether and chloroform. (Dr. 
Freud himself eventually would be 
proclaiming the wonderful pain- 
relieving qualities of cocaine.) Pro¬ 
caine, the first synthetic local anes¬ 
thetic, was introduced in 1902. 
Thiopental became the first widely 
used intravenously administered gen¬ 
eral anesthetic, beginning in 1935, 
allowing for much more precise mon¬ 
itoring of the anesthetic effect. 
While these landmark events 
have revolutionized the operating 
room, anesthesia as a medical spe¬ 
cialty was much slower in develop¬ 
ing. Only during the past half-century 
did it become a recognized medical 
specialty. Yale appointed Dr. Greene 
as its first professor of anesthesiology 
in 1955. He guided the field toward 
its emergence as an intellectual disci¬ 
pline in its own right. At the Boston 
Ether Day celebration, he was given 
the Massachusetts General Hospital 
Trustees Medal to honor his contribu¬ 
tions to the field. While the section of 
anesthesiology didn't become a 
department until 1971, it has since 
been recognized as among the best in 
the country, with 58 attendings, 56 
residents, six fellows and five nurses, 
in a program credited with numerous 
scientific and medical advances. 
“Finally,” says Dr. Nuland, “anesthe¬ 
sia has taken its place among our most 
meticulous specialties and the most 
technologically advanced of all.” ■ 
Above: Surgery was cptick and brutish 
before the advent of anesthesia. Av this 
18th-century engraving from the 
Clements C. Fry Print Collection at Yale 
shows, it took muscle to get the job done. 
Below: Dripping ether or chloroform 
on a cloth or mask such as these held 
over a patient's mouth and nose was 
the most widely used form of inducing 
anesthesia during the first century of 
its use. 
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SCOPE 
Yale expands partnership with New Haven city schools 
Leaders from the New Haven 
Public Schools and Yale Univer¬ 
sity signed an agreement in early 
December establishing a formal 
partnership to enrich educational 
opportunities for New Haven 
students. 
The partnership builds on work 
initiated in recent years between the 
Yale schools of medicine and nurs¬ 
ing and Career High School, which 
in 1998 will open a new regional 
facility on the Route 34 connector 
near the Yale medical complex. 
The high school offers concentra¬ 
tions in allied health, business 
and computing. 
“In creating this partnership, we 
recognize our common interests and 
shared educational responsibilities 
to our students, and today join 
together to form one intergenera- 
tional community of learners,” said 
Reginald Mayo, Ph.D., superinten¬ 
dent of schools in New Haven. He 
was joined by Yale Secretary Linda 
K. Lorimer, medical school Dean 
Gerard N. Burrow, M.D. ’58, HS 
’58-66, nursing school Dean Judith 
B. Krauss, R.N., and Career High 
School Principal Charles Williams. 
Since January of 1995, anesthe¬ 
siology professor J.G. Collins, 
Ph.D., has coordinated an effort to 
identify ways to share University 
resources with Career faculty as 
they move forward in their efforts to 
revise curriculum. Medical librari¬ 
ans at Yale have trained Career 
High teachers, students and the 
school librarian in use of the Inter¬ 
net and other electronic information 
reference tools. The library training 
program will continue during the 
coming school year, and Career fac¬ 
ulty now have full borrowing privi¬ 
leges at the medical library. 
“The partnership was designed 
to encourage more contact and 
informal communication between 
the students and staff at Career with 
medical and nursing students and 
faculty,” says partnership coordina¬ 
tor Claudia R. Merson. To that end, 
the Yale Medical Shuttle will 
expand its route to include regular 
stops at the new Career High School 
when it opens, and Yale participants 
will have access to the high school 
swimming pool and other sports and 
recreation facilities. 
Career students also have had 
opportunities to learn about a vari¬ 
ety of career options through partic¬ 
ipation in a medical careers course 
at the high school and internships at 
the medical and nursing schools, 
where Career students observe med¬ 
ical faculty and other health profes¬ 
sionals in research and clinical 
areas. Yale medical faculty and 
postdoctoral fellows also lecture at 
the high school on career options 
and paths. 
An educational program started 
in 1993 continues to best exemplify 
the kinds of enrichment that this 
partnership has been designed to 
produce. Career students come to 
the medical school for an innovative 
human anatomy program, con¬ 
ducted in the medical school’s 
human anatomy laboratory and 
taught by medical students and 
William B. Stewart, Ph.D., associ¬ 
ate professor of surgery and chief of 
the gross anatomy section, and his 
colleagues at Yale. The highly moti¬ 
vated Career students have learned 
more about human anatomy, earned 
higher grades and increased their 
interest in the sciences by partici¬ 
pating in this program. 
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Dr. Kessler’s appointment as dean was made 
as Yale Medicine was going to press. Additional 
coverage of the announcement is included in a 
Yale Medicine Bulletin mailed in early March. 
FDA commissioner 
becomes 15th dean 
President Richard C. Levin 
announced on Feb. 13 that David 
A. Kessler, M.D., J.D., commis¬ 
sioner of the U.S. Food and Drug 
Administration, will become dean of 
the Yale University School of Medi¬ 
cine, effective July 1. 
Dr. Kessler is a graduate of 
the Harvard Medical School, the 
University of Chicago Law School 
and Amherst College. Appointed 
in 1990, Kessler served as FDA com¬ 
missioner under Presidents Bush and 
Clinton. Before that. Dr. Kessler was 
medical director of the Hospital of 
the Albert Einstein College of Medi¬ 
cine from 1984 until 1990. 
During his six-year tenure at the 
FDA, Dr. Kessler successfully tack¬ 
led difficult issues as he sought to 
meet critical public health needs. 
Under his leadership, the FDA’s 
accomplishments were wide-rang¬ 
ing, from the introduction of the 
Nutrition Facts food labels to 
tobacco regulation, and from mam¬ 
mography standards to world-record 
times for drug approvals. During his 
tenure, the FDA reduced by 50 per¬ 
cent the median time required to 
evaluate new drugs it approved. 
“This is one of the great days of 
my life,” Dr. Kessler told more than 
450 people who filled Mary S. Hark- 
ness Auditorium for the announce¬ 
ment. “This is one of the world’s 
great institutions and it is a high 
honor to be your dean.” In his com¬ 
ments in Harkness and at a press 
conference that followed. 
Dr. Kessler repeatedly stressed the 
importance of delivering world- 
class care to people who cannot 
receive it elsewhere. “What is 
magic at other places,” he told a 
room full of reporters, “they have 
to be able to do here every day.” 
President Levin introduced the 
school’s 15th dean with the obser¬ 
vation that medicine is simultane¬ 
ously facing enormous challenge 
and opportunity. “It is a perfect 
time for us to have a dean with Dr. 
Kessler’s vision and intelligence, 
and openness to new ideas,” said 
President Levin. “I think this is the 
right man at the right time for taking 
the school forward.” 
To more applause. President 
Levin vowed that “the provost and I 
are going to make it possible for Dr. 
Kessler to do these things. We are 
supplying him with ample resources 
to develop new educational pro¬ 
grams, to take new clinical initia¬ 
tives, to recruit new and outstanding 
faculty, and to improve the quality of 
our laboratory facilities.” 
Gerard N. Burrow, M.D. ’58, 
dean of the School of Medicine since 
1992, will return to the medical fac¬ 
ulty and will serve as special advisor 
for health affairs to President Levin. 
He will also write a history of Yale 
medicine for the University’s 300th 
anniversary celebration in 2001. 
Dr. Kessler completed his 
internship and residency training in 
pediatrics at The Johns Hopkins 
Hospital. He has been elected a 
member of the Institute of Medicine, 
which is part of the National Acad- 
Top: Dr. Kessler addresses a packed 
Harkness Auditorium on Feb. 13. 
Above: Dr. Kessler and President 
Levin at a press conference following 
the announcement. 
emy of Sciences. Dr. Kessler's many 
honors have included the American 
Cancer Society’s Medal of Honor, 
the American Heart Association's 
National Public Affairs Special 
Recognition Award, the American 
Federation for AIDS Research Shel¬ 
don W. Andelson Public Policy 
Achievement Award, the American 
Academy of Pediatrics Excellence in 
Public Service Award, and the March 
of Dimes Franklin Delano Roosevelt 
Leadership Award. 
Dr. Kessler is married to Paulette 
Kessler, a lawyer, and they have two 
children, Elise, 14, and Ben. 11. ■ 
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Christopher J. McDougle, M.D. 
Yale contributes 
to new advances 
in autism research 
Three new studies, including two 
by Yale researchers, are opening the 
door to significant advances in the 
understanding and treatment of 
autism, according to an editorial in 
the November issue of the Archives 
of General Psychiatry. 
In the first of the three studies, 
Christopher J. McDougle, M.D., 
associate professor of psychiatry 
and in the Child Study Center, and 
colleagues studied 30 adults with 
autistic disorder. Half were given 
placebo, the other half were given 
a potent and selective serotonin 
reuptake inhibitor called fluvoxam- 
ine maleate. 
After 12 weeks, eight (53 per¬ 
cent) of the 15 patients in the flu- 
voxamine-treated group showed 
improvement, compared to none in 
the placebo group. 
The authors concluded that 
“fluvoxamine was superior to 
placebo in reducing repetitive 
thoughts and behavior, maladap¬ 
tive behavior, and aggression, 
and in improving some aspects 
of social relatedness, especially 
language use.” 
Other than mild sedation and 
gastrointestinal distress in a few 
patients, fluvoxamine was well tol¬ 
erated, according to the researchers. 
They say their results warrant con¬ 
trolled studies using fluvoxamine 
and other drugs of the same class 
in children and adolescents 
with autism. 
A second study, also by 
Dr. McDougle and colleagues, 
confirms a dysregulation in sero¬ 
tonin function in some patients 
with autism. 
The synthesis of serotonin is 
dependent upon the dietary intake 
of the essential amino acid trypto¬ 
phan, according to information 
cited in the study. Seventeen drug- 
free patients with autistic disorder 
received a 24-hour, low-tryptophan 
diet followed the next morning by 
an amino-acid drink. A second test 
was conducted with placebo in a 
randomized order. 
Other Yale authors of the two 
papers were Susan T. Naylor, R.N., 
M.S.N.; Donald J. Cohen, M.D. ’66; 
Fred R. Volkmar, M.D.; George R. 
Heninger, M.D.; and Lawrence H. 
Price, M.D., HS '78-82. 
In the third paper, researchers 
at Stanford University studied the 
involvement of the X chromosome 
in the etiology of autism. They 
found that while there was no mod¬ 
erate to strong gene effect causing 
autism on the X chromosome, 
smaller gene effects could not be 
excluded. 
Women’s Health 
Program at Yale 
designated a center 
of excellence 
The Women’s Health Program at 
Yale has been designated by the 
U.S. Department of Health and 
Human Services (HHS) as one of 
six National Centers of Excellence 
in Women’s Health to serve as 
models for improving the health 
care of American women. 
“This new center will strengthen 
and expand the Women’s Health 
Program at Yale that was estab¬ 
lished in 1992,” says program 
and center director Janet B. Hen- 
rich, M.D., associate professor 
of medicine and of obstetrics 
and gynecology. 
“Our program strives to 
improve the quality of health care 
for women, foster and generate 
research in women's health, better 
integrate women’s health and gen¬ 
der-related concepts into the med¬ 
ical school curriculum, and enhance 
the education and training of physi¬ 
cians in women's comprehensive 
care,” she says. 
With the national designation 
and $330,000 in federal support for 
women’s health, the Yale program 
will initially concentrate in two 
main areas: 
» Expansion of the interdisciplinary 
training and service model of com¬ 
prehensive, integrated patient care 
for New Haven-area women that 
started in 1995 in Yale-New Haven 
Hospital’s Primary Care Center. 
Physicians in internal medicine, 
obstetrics and gynecology, and 
psychiatry will collaborate on 
this project. 
■ Development of a framework to 
facilitate interdisciplinary research 
on women’s health. 
Coordinating the program’s 
research component is Carolyn M. 
Mazure, Ph.D., associate professor 
Janet B. Henrich, M.D. 
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of psychiatry and editor of the 
book Does Stress Cause Psychi¬ 
atric Illness? Dr. Mazure will help 
stimulate research in women’s 
health that will encompass the 
fields of clinical medicine, basic 
science, public health and behav¬ 
ioral science. 
According to HHS Secretary 
Donna E. Shalala, the national cen¬ 
ters, announced Oct. 1, “are just 
one step in a broad cooperative 
effort to improve our health 
research and services for women, 
and to improve the career 
prospects for women in the health 
professions.” 
Surgical technique may 
prompt heart disturbance 
Certain surgical techniques appear 
to increase the risk of atrial fibrilla¬ 
tion in patients after coronary 
artery bypass graft surgery 
(CABG), according to a study 
conducted at Yale and 23 other 
university-affiliated medical 
centers across the United States. 
In a study of 2,417 patients 
undergoing CABG surgery, an 
average of 27 percent of them 
experienced this common heart 
rhythm disorder. The condition 
more likely occurs in older male 
patients with a history of heart fail¬ 
ure, says Joseph P. Mathew, M.D., 
assistant professor of anesthesiol¬ 
ogy at the School of Medicine and 
the study’s first author. Dr. Mathew 
and his colleagues reported the 
findings in the Journal of the 
American Medical Association. 
“In an effort to decrease costs, 
people who have had CABG 
surgery often are discharged from 
the hospital as early as three to five 
days after their surgery, which is 
just about the same time that this 
common rhythm disturbance 
shows up,” says Dr. Mathew. “The 
occurrence of atrial fibrillation will 
limit these cost-containment 
efforts. In this era of decreasing 
reimbursement for medical costs, it 
is important that this heart rhythm 
Yale one of three 
centers testing new 
HIV therapy 
Yale physicians have begun clinical 
research on an anti-HIV therapy 
that uses a novel approach to fight 
the AIDS virus. Yale is one of three 
sites in the United States to study 
this new medication that a Japan¬ 
ese pharmaceutical company has 
developed. 
“This drug may provide an 
additional new treatment to the 
expanding and exciting array of HIV 
therapies,” says Gerald Friedland, 
M.D., director of the Yale AIDS Pro¬ 
gram and its Clinical Trials Unit. 
Researchers now understand 
that the virus that causes AIDS 
multiplies in the human body even 
early on in HIV infection, according 
to Dr. Friedland. Millions of viruses 
are produced daily in the human 
body and eventually render a per¬ 
son’s disease-fighting immune sys¬ 
tem helpless against infections. 
Gerald Friedland, M.D. 
Previous anti-HIV therapies, 
like AZT or the new protease 
inhibitors, act by interrupting one 
of two enzymes that help the virus 
multiply. The new therapy that Yale 
physicians are evaluating acts by 
preventing the virus from fusing 
with uninfected cells in the body 
and by preventing infected cells 
from fusing to uninfected cells, 
thereby limiting the ability of HIV to 
spread. The medication accumu¬ 
lates in the lymph nodes where the 
highest level of virus replication 
and infection of new cells occurs. 
In the Yale study, patients 
are being given the new medication 
once or twice a month in addition 
to their other HIV therapies, and 
health professionals are monitor¬ 
ing certain lymphocytes and 
viral counts. 
A yardstick for 
HIV prevention 
A team of Yale researchers will 
play a major role in a comprehen¬ 
sive analysis of programs designed 
to halt the spread of HIV, in an 
effort to test the effectiveness 
of different approaches to AIDS 
prevention. 
A novel component of the five- 
year project will be its reliance on 
techniques from operations 
research, statistics and economics 
to create mathematical models of 
the impact of HIV prevention pro¬ 
grams, according to School of Man¬ 
agement professor Edward Kaplan, 
Ph.D. Dr. Kaplan will collaborate 
with David Paltiel, Ph.D., assistant 
professor of health policy and man¬ 
agement in the Department of Epi¬ 
demiology and Public Health, and 
other Yale management and public 
health faculty, as well as col¬ 
leagues at two other universities. 
“Decisions regarding how 
much money to spend on HIV pre¬ 
vention programs are made hap¬ 
hazardly," Dr. Kaplan says. “Most 
prevention programs are not evalu¬ 
ated at all, those that are studied 
typically do not involve serious 
attempts to estimate the number 
of new infections prevented, and 
precious few studies report the 
actual costs of intervening. Yet, 
given that the goal of HIV preven¬ 
tion is, in fact, to prevent HIV infec¬ 
tions, one would think that a wiser 
approach would be to figure out 
how prevention dollars can be 
spent more effectively.” ■ 
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disturbance be identified and the 
patients treated before they go 
home,” Dr. Mathew says. 
Patients who develop atrial fib¬ 
rillation after CABG surgery spend 
an average of 13 extra hours in the 
intensive care unit and two extra 
days in the hospital. The extra time 
is usually needed to control the fast 
heart rate, to treat patients with 
blood-thinning medication, or to 
treat the complications associated 
with this condition. The current 
study indicates that the occurrence 
of atrial fibrillation after surgery 
was strongly associated with neuro¬ 
logical injury. 
Using approximate estimates of 
cost, the occurrence of atrial fibril¬ 
lation after this type of surgery 
increases the overall cost of surgery 
by at least $1,616, the researchers 
found. In the United States, where 
350,000 CABG surgeries annually 
are performed, the additional costs 
of the prolonged hospitalization, 
excluding treatment costs, is $153 
million per year. 
Prognosis excellent 
for children with 
Lyme disease 
Two Connecticut researchers 
reported in the New England Jour¬ 
nal of Medicine that the prognosis 
is excellent for children with Lyme 
disease who are promptly treated 
with antibiotics. 
Results of the study should put 
to rest many parents’ fears that their 
children who have Lyme disease 
will suffer chronic disease or dis¬ 
ability—even after treatment with 
antibiotics. 
The research was conducted by 
Eugene D. Shapiro, M.D., professor 
of pediatrics and of epidemiology 
at Yale, and Michael A. Gerber, 
M.D. ’74, professor of pediatrics at 
the University of Connecticut 
School of Medicine and director. 
Division of Pediatric Infectious 
Diseases, Connecticut Children's 
Medical Center. 
The study was conducted over 
20 months in five pediatric prac¬ 
tices in southeastern Connecticut. 
Children who went to the physi¬ 
cians’ offices and were diagnosed 
with Lyme disease were eligible for 
inclusion in the study. Two hundred 
and one patients enrolled in the 
study, which was reported in the 
journal’s Oct. 16 issue. 
All but four of the children 
were treated with a single course of 
conventional antibiotics for two to 
four weeks, and almost all began to 
feel better shortly after beginning 
therapy. At a two-month checkup, 
94 percent were free of Lyme dis¬ 
ease symptoms. About two years 
later, all patients were free of any 
objective evidence of either chronic 
or recurrent Lyme disease. 
Drs. Shapiro and Gerber said 
the non-specific symptoms associ¬ 
ated with Lyme disease play a role 
in the reactions of parents to the 
disease. Many fear that a short 
course of oral antibiotics—daily 
dosages for two to four weeks—is 
insufficient. Later, if the children 
complain of headaches, tiredness or 
aches and pains, the parents often 
believe the cause is recurrent or 
chronic Lyme disease. The scien¬ 
tific evidence shows these concerns 
are unfounded. 
Yale biochemists 
report new role 
of enzyme activity 
Two medical school biochemists 
have reported a new role for 
changes in the activity of the 
enzyme glycogen synthase (GSase) 
that reverses a long-held belief 
about its function. 
The Yale scientists have shown 
that the well-known changes in 
activity of GSase do not control the 
flow of carbohydrate synthesis 
through the enzyme, as has gener¬ 
ally been assumed, but instead help 
the enzyme to control the concen¬ 
trations of small molecules in the 
cell. The enzyme is changed when 
the flow through it changes in order 
to keep the other molecules in the 
cell at a constant level. 
This work has significant 
implications for other changes in 
enzyme activity, such as those stim¬ 
ulated by genetic engineering, the 
Yale researchers believe. In provid¬ 
ing an additional role for the bind¬ 
ing of phosphates to enzymes 
which changes its activity, this new 
Robert G. Shulman, Ph.D. 
research provides a base for under¬ 
standing the numerous phosphory¬ 
lations being reported. 
Robert G. Shulman, Ph.D., and 
Douglas L. Rothman. Ph.D., pre¬ 
sented their findings in the Pro¬ 
ceedings of the National Academy 
of Sciences. Dr. Shulman is profes¬ 
sor of molecular biophysics and 
biochemistry, while Dr. Rothman is 
associate professor of research in 
medicine. In conducting their 
research, they employed magnetic 
resonance spectroscopy techniques 
and mathematical models. 
‘‘We showed that the enzyme 
GSase does not control the rate of 
carbohydrate synthesis, as scientists 
have long believed, but rather that 
the flow is controlled at the first 
step, when glucose enters the mus¬ 
cle cell,” Dr. Shulman explains. 
“The activity of GSase is itself con¬ 
trolled by phosphorylation in order 
to maintain constant concentrations 
in the cell.” 
32 Spring 1997 
FACULTY NEWS 
Edward Chu, M.D., associate pro¬ 
fessor of medicine (oncology), has 
been named director of the newly 
established VA Cancer Center at 
the VA Connecticut Healthcare 
System in West Haven. Dr. Chu is 
chief of medical 
oncology-hema¬ 
tology at the VA 
and co-director 
of the Develop¬ 
mental Thera- 
| peutics Program 
? at the Yale Can- 
o 
I cer Center. 
Michael S. Conte, M.D., associate 
research scientist in surgery, 
received the fellowship award of 
the American Surgical Association 
Foundation for his research pro¬ 
posal on Endothelial Restoration 
and Vascular Remodeling. This 
national two-year fellowship is pre¬ 
sented annually to new faculty. 
NEW B 
The Yale Guide to 
Children’s Nutrition, 
William V. Tambor- 
lane, M.D., profes¬ 
sor of pediatrics, 
editor-in-chief, et 
al., Yale University 
Press 1997. 
Return from Madness, by 
Kathleen Degen, M.D., assis¬ 
tant clinical professor of psy¬ 
chiatry, and Ellen D. Nasper, 
Ph.D., assistant clinical pro¬ 
fessor of psychiatry, Jason 
Aronson Inc. (Penn.) 1996. 
James P. Comer, M.D., HS '64-67, Maurice 
Falk Professor in the Child Study Center and Psy¬ 
chiatry, whose School Development Program has 
become a model for improving the quality of 
American education, has received the 1996 Heinz 
Award in the category of the Human Condition. 
Dr. Comer’s program, which addresses the inner- 
city problems of drug abuse, teen-age pregnancy 
and crime, has made a decisive difference in the 
J role of public schools in many communities. The 
| Heinz Awards were established in memory of the 
I late U.S. Sen. John Heinz and measure the excel¬ 
lence of an individual’s achievements, as well as 
less tangible qualities such as intellectual curiosity, willingness to take 
risks, concern for humanity, optimism and commitment to making the 
world a better place. Dr. Comer also was presented an award for outstand¬ 
ing service to the field of education at Lehigh University’s College of 
Education Alumni Day, held in October in Pennsylvania. 
Joseph S. Elman, M.D., clinical 
instructor in ophthalmology and 
visual science, has been elected 
president of the Connecticut Soci¬ 
ety of Eye Physicians. 
0 0 K S 
Critical Operative Maneuvers 
in Urologic Surgery, by Harry 
C. Miller Jr., M.D. ’54, and 
George W-K. Yu, M.D., Mosby 
(St. Louis, Mo.) 1996. 
The Prostate Cancer Answer 
Book: An Unbiased Guide 
to Treatment Choices, by 
Marion Morra, associate 
director of the Yale Cancer 
Center and associate 
research scientist in epi¬ 
demiology and public health, 
and Eve Potts, Avon Books 
(New York) 1996. 
Michael D. Ezekowitz, M.D., 
Ph.D., professor of medicine (car¬ 
diovascular), addressed the Interna¬ 
tional Symposium on Atrial Flutter 
and Fibrillation in September in 
Heidelberg, Germany. His topic 
was Prevention of Stroke in 
Patients with Atrial Fibrillation. 
Frank Hsu, M.D., assistant profes¬ 
sor of medicine (oncology), has 
been appointed co-director of the 
Immunology Research Program at 
the Yale Cancer Center. Dr. Hsu's 
research interests focus on immuno¬ 
therapy of malignancies, especially 
regarding lymphoma. Much of his 
work centers on the use of vaccine 
therapies for various forms of cancer. 
The National Institutes of Health 
(NIH) working group on new inves¬ 
tigators met in September for the 
first time. John Krystal, M.D., 
associate professor of psychiatry, is 
one of the eight-member group des¬ 
ignated to review the current poli¬ 
cies and practices of the NIH for 
new investigators. 
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Harlan M. Krumholz, M.D., 
assistant professor of medicine 
(cardiology) and epidemiology, and 
director of the Center for Outcomes 
Research and Evaluation at Yale- 
New Haven Hospital, received a 
William Harvey Award for excel¬ 
lence in magazine writing on the 
subject of high blood pressure. The 
award is sponsored by the Ameri¬ 
can Medical Writers Association, 
the National Heart, Lung, and 
Blood Institute of the National 
Institutes of Health, and Bristol- 
Myers Squibb Co. 
Marion E. Morra, 
M.A., associate director 
of the Yale Cancer Cen¬ 
ter, received the Ameri¬ 
can Cancer Society’s 
Distinguished Service 
Award for her writing 
and production of sev¬ 
eral publications on 
cancer topics, and for 
her numerous contri¬ 
butions in relation to 
quality-of-life issues for cancer 
patients. 
Howard A. Pearson, M.D., pro¬ 
fessor emeritus of pediatrics, 
received the Distinguished Career 
Award from the American Society 
of Pediatric Hematology/Oncol¬ 
ogy at its ninth annual conference 
in Chicago in October. Dr. Pearson 
was recognized for his career in 
pediatrics and his identification of 
two diseases: chronic neutropenia, 
a congenital form of anemia; and 
Pearson syndrome, a blood disor¬ 
der caused by mitochondrial dis¬ 
ease. Pearson syndrome appears in 
infancy and is usually fatal. There 
have been 30 to 40 cases diagnosed 
around the world. 
Robert A. Rosenheck, M.D., HS 
’73-77, clinical professor of psychi¬ 
atry at Yale and director of the 
Northeast Program Evaluation 
Center of the VA Connecticut 
Healthcare System in West Haven, 
has been honored by the Vietnam 
Veterans Assistance Fund for his 
distinguished service to homeless 
veterans and veterans with serious 
mental illness. 
Tracy A. Smith-Leiker, Ph D., 
postdoctoral fellow in genetics, was 
honored in November at the Zeneca 
Pharmaceuticals Life Science Sym¬ 
posium. Dr. Smith-Leiker was a 
winner in the Burroughs Wellcome 
Fund Life Science Research Fel¬ 
lowship program, which recognizes 
the achievements of young scien¬ 
tists, for research on a protein 
involved in intercellular transport 
during Drosophila oogenesis. 
Merle Waxman, associate dean for 
academic development, received 
the Association of American Med¬ 
ical College’s (AAMC) 1996 
Women in 
Medicine 
Leadership 
Award in 
November. 
She is the first 
non-physician 
to receive the 
award since it 
was estab¬ 
lished four 
years ago. Ms. 
Waxman, who 
also serves as 
director of the 
Office for Women in Medicine and 
ombudsperson, was recognized by 
the AAMC for her institutional 
leadership at Yale, and for her 
role throughout the country as an 
advocate of women in medicine 
and science. 
Eiji Yanagisawa, M.D., HS ’56- 
59, clinical professor of otolaryn¬ 
gology, was the guest speaker at the 
97th annual meeting of the Otorhi- 
nolaryngological Society of Japan 
held last May in Fukuoka. His pre¬ 
sentation was titled Video Docu¬ 
mentation in Otorhinolaryngology. 
Lorrin Yee, M.D., associate 
research scientist in medicine, has 
joined the Yale Cancer Center’s 
developmental therapeutics team. 
Barry L. Zaret, M.D., Robert W. 
Berliner Professor of Medicine and 
Diagnostic Radiology, and his son, 
Elliot, were one of two pairs of 
Yale father-and-son exhibitors at 
the Greene Art Gallery & New 
England Sculptors’ Guild in Guil¬ 
ford, Conn., in September. The 
exhibit benefited the Neighborhood 
Music School of New Haven. 
ACE appointments 
Michael B. Bracken, Ph.D., 
professor of epidemiology 
and obstetrics and gynecolo¬ 
gy, was installed as presi¬ 
dent of the American College 
of Epidemiology in Balti¬ 
more. At the college’s recent 
annual meeting, fellowship 
status was conferred upon 
Robert W. Ryder, M.D., the 
John Rodman Paul Professor 
of Epidemiology and Medi¬ 
cine, and Susan T. Mayne, 
Ph.D., assistant professor of 
epidemiology. Audrey F. 
Saftlas, Ph.D., associate 
research scientist in epi¬ 
demiology, was elected as a 
member of the college. At 
the same meeting, Lisbet 
Lundsberg, Ph.D. ’95, asso¬ 
ciate research scientist in 
epidemiology, was awarded 
the Student Prize for her doc¬ 
toral thesis, Low to Moder¬ 
ate Drinking During Pregnan¬ 
cy and Intra-Uterine Growth 
Retardation, Low Birth 
Weight and Preterm 
Delivery. 
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Yale alumnus takes 
the reins at Tufts 
John T. Harrington, M.D. ’62, a 
nephrologist who has served as 
interim dean of Tufts University 
School of Medicine for the past 
year, has been appointed the 15th 
dean of the 103-year-old medical 
school by the university’s Board 
of Trustees. 
Dr. Harrington, who has been 
professor of medicine at Tufts since 
1979, was chosen after a year-long 
search. Before being appointed the 
medical school’s dean ad interim in 
November 1995, he had served 
as the school's academic dean 
since 1994. 
Tufts President John DiBiaggio 
called Dr. Harrington “uniquely 
qualified” to strengthen the univer¬ 
sity and the medical school’s rela¬ 
tionship with its teaching hospitals. 
He received his undergraduate 
degree from the College of the Holy 
Cross in Worcester, Mass., in 1958. 
A beloved teacher and mentor, Dr. 
Harrington has been cited for teach¬ 
ing excellence by seven of the med¬ 
ical school’s graduating classes and 
received the school's Distinguished 
Faculty Award in 1994. The new 
dean and his wife, Gertrude R. Har¬ 
rington, live in West Roxbury, 
Mass., where they raised seven 
children. 
Rocko M. Fasanella, M.D. 43, 
HS ’43-44, chief of ophthalmology 
at Yale from 1951 to 1961, was 
honored with a video tribute out¬ 
lining his contributions to medi¬ 
cine and the American Society of 
Ophthalmic Plastic and Recon¬ 
structive Surgery as part of the 
society’s 27th annual scientific 
symposium held in October. The 
purpose of the annual video tribute 
is to introduce a society colleague 
who has made major contributions 
to his profession. 
Edith M. Jurka, M.D. ’44, was 
the keynote speaker at an interna¬ 
tional conference on the applica¬ 
tion of the arts in psychiatric ther¬ 
apy in August. Her topic was Path¬ 
ways Through the Brain Which 
Lead to Enhancement of Intuition 
and Creativity’. The group of inter¬ 
national therapists, which included 
six from the United States, met in 
St. Petersburg, Russia; Vilnius, 
Lithuania; and Prague, Czech 
Republic. 
continued on next page ► 
Alumni/ae on campus 
On May 30, 1996, Robert A. 
Chase, M.D,, the Emile Holman 
Professor of Surgery at Stanford 
University, presented surgical grand 
rounds at Yale. The presentation 
was done in 3-D and was entitled 
Stereoscopy: History and Medical 
Applications. Dr. Chase graduated in the Class of ’47 
at the School of Medicine and completed his specialty 
training in surgery at the Yale-New Haven Hospital in 
1954. After military experiences in reconstructive and 
plastic surgery, he completed further training in that 
specialty and returned to Yale in 1957 to initiate its 
first Division of Plastic and Reconstructive Surgery. 
In 1963, Dr. Chase was appointed chairman of 
the Department of Surgery at Stanford and became 
the Emile Holman Professor of Surgery. He has spent 
the rest of his surgical career at Stanford, except for 
three years during which he served as president and 
director of the National Board of Medical Examiners. 
Currently, Dr. Chase serves as a professor in the 
anatomy division at Stanford. During his Yale visit, he 
had the opportunity to carry on seminars with house- 
staff and to visit with medical school faculty members 
from several departments. 
Dr. Chase is currently working on the development 
of computer-assisted interactive educational pro¬ 
grams within the computer laboratories which he 
helped to develop at Stanford. 
Nicholas P.R. Spinelli, M.D. ’44 
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David A. Page, M.D. ’56, writes to 
say that he is semi-retired in Savan¬ 
nah, Ga., “part time at the Georgia 
Eye Institute and part time on a 
golf course.” 
Charles Zigun, M.D. ’56, is 
resuming his long career in private 
psychiatric practice after a five- 
year appointment with the Con¬ 
necticut Department of Mental 
Health as an attending psychia¬ 
trist in the psychiatric intensive 
care unit. 
George E. Vazakas, M.D., HS 
'61-63, retired in July after 29 
years in private practice in urology. 
Dr. Vazakas will continue teaching 
University of Massachusetts med¬ 
ical students and surgical residents 
at Berkshire Medical Center in 
Pittsfield, Mass. 
Joseph F.J. Curi, M.D. 64, of 
Torrington, Conn., writes with 
news of his four children. His two 
oldest daughters, Anne and Sarah, 
are practicing attorneys in Boston. 
His younger children, Katheryn 
and Michael, both made U.S. Row¬ 
ing’s 1996 Collegiate All-America 
Team. Katheryn is an adolescent 
counselor and women’s novice 
crew coach at the University of 
Vermont. Michael is a senior at 
Yale College and varsity heavy¬ 
weight crew captain. He was 
accepted early admission to the 
University of Connecticut School 
of Medicine. 
M. Harvey Brenner, Ph.D. ’67, 
professor in behavioral sciences 
and health education at the Johns 
Hopkins University School of 
Hygiene and Public Health, was 
presented the American Public 
Health Association's Award for 
Excellence at the annual meeting in 
November in New York City. Dr. 
Brenner was recognized for his 
studies on relationships between 
economic factors and public health. 
Patricia D. Mail, M.P.H. ’67, 
writes to say, “Never give up!” 
Twenty-nine years after earning her 
master’s degree, she finally—on 
the third try—received a Ph.D. 
degree from the University of 
Maryland. Her research on Ameri¬ 
can Indians and Alcohol began at 
Yale and was her dissertation topic. 
Sidney C. Smith Jr., M.D. ’67, 
professor of medicine, chief of car¬ 
diology and director of the Acade¬ 
mic Center for Cardiovascular Dis¬ 
ease at the University of North Car¬ 
olina at Chapel Hill, was guest 
speaker at a special American 
Heart Association (AHA) presi¬ 
dent’s reception celebrating 
research, held at the Yale School of 
Medicine in October. Dr. Smith is 
past president of the AHA’s 
National Center. 
Harry S. Holcomb III, M.D. ’68, 
orthopaedic surgeon at Eastern 
Shore Physicians & Surgeons Inc. 
of Nassawadox, Va., addressed the 
16th annual Symposium on South¬ 
ern New England Maritime History 
in November. His talk chronicled 
Members of the Class of 1954 
met in Cambridge, England, for 
an interim reunion and confer¬ 
ence in September. Their head¬ 
quarters were in Lucy Cavendish 
College, just a short walk from 
the Backs of Cambridge colleges, 
where the group is pictured with 
King’s College Chapel (A.D. 
1485) in the distance. There was 
a meeting at the university’s hos¬ 
pital and, on one evening, Cam¬ 
bridge general practitioners and 
hospital specialists joined the 
group at a buffet supper. The 
Yale classmates toured the Cam¬ 
bridge colleges and gardens and 
made day trips to London, Ely 
and Lavenham, in addition to 
journeys to Bath, Scotland and 
Paris. In the picture are, seated 
left to right: JoAnn Vosskuhler, 
Eva Henriksen, Barbara Olson, 
John Rose, Barbara Pullen, 
Audrey Nora and Jeanne Davis. 
Standing, left to right: Phyllis 
Paule, Esther McMillin, Lowell 
Olson, Elizabeth Lockett, Donald 
Davis, Jack Vosskuhler, Richard 
Pullen, Janet Crovatto, Arthur 
Crovatto, James Nora and 
William Paule. 
Overseas reunion 
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A special report from Yale Medicine and the Yale Cancer Center 
In 1971, cancer was a 
black box. We could exam¬ 
ine it, turn it over in our 
hands, weigh it, but could 
not look inside. Today the 
lid of the box has been 
pried open, and we are 
gazing at an incredibly 
complex and beautiful 
piece of machinery, a 
facsimile if you will of a 
normal cell. The cancer 
cell has gone from a 
black box to a blueprint." 
Vincent T. DeVita Jr, md 
Director 
Yale Cancer Center 
years of progress 
since passage of the 
National Cancer Act 
on Dec. 23,1971 
We’ve come farther than we ever dreamed 
Twenty-five years ago. President Nixon 
signed a hard-fought yet momentous piece 
of legislation, the National Cancer Act. The 
new law launched a massive campaign of 
basic scientific research to better understand 
cancer, and it promoted the wide application 
of those discoveries to help patients. With 
new funding and independence, the National 
Cancer Institute (NCI) was expected to 
work vigorously and efficiently to reduce the 
suffering caused by a disease then considered 
to be fatal in most cases. 
Has the War on Cancer been successful? 
A quarter century later, the profound impact 
of the National Cancer Act is easily measured 
in human terms. More than 10 million 
survivors owe their lives to cancer research, 
and, among children, the results have been 
truly remarkable. Most cases of childhood 
leukemia are now curable and death rates 
for children’s cancers have declined by more 
than 62 percent since 1950, according to 
the NCI. 
Dramatic proof of the measure’s success 
came last November with a study in the 
journal Cancer. For the first time since 
record-keeping began in 1901, overall cancer 
mortality in the United States had dropped 
by 2.6 percent. This decline, observed during 
the years 1991 to 1995, is likely to continue 
well beyond the year 2000. 
“We have come farther than the people 
who framed the act ever dreamed,” says Yale 
Cancer Center Director Vincent T. DeVita 
Jr., MD, who headed the NCI for eight years 
under Presidents Carter and Reagan. The 
next 25 years, Dr. DeVita says, promise 
a more fundamental shift: the beginning of 
the end of cancer. 
While mortality rates for certain cancers 
have shown sharp declines in the past, 
appreciation ot those numbers otten was 
overshadowed by the rising cancer death toll 
overall. But now the field has shifted, says 
Dr. DeVita. “I think these declines are going 
to be steady and they will continue to 
deepen.You can attribute this reduction in 
mortality, and the remarkable molecular 
revolution we are now experiencing, to the 
foresight of those involved with framing 
the National Cancer Act.” 
Since its passage Dec. 23, 1971, the act 
has provided more than $30 billion for 
cancer research and treatment. At the time 
of passage, annual governmental funding 
for cancer was $176 million, a budget that 
today has expanded to approximately $2 
billion. Says Dr. DeVita, “It is probably one 
of the best investments ever made by the 
U.S. government.” 
Dr. DeVita joined the NCI in 1966, 
after his residency at Yale-New Haven 
Hospital. Six years later, he won the Albert 
and Mary Lasker Prize for Medicine, for 
development of the four-drug combination 
known as MOPP. This chemotherapy 
regimen raised the cure rate for patients with 
advanced Hodgkins disease from near zero 
to 65 percent. 
(continued on page 2) 
Present at the creation: The evolution of modern cancer research and treatment at Yale 
1943 
Yale gives birth to the field of chemotherapy 
with the work of Louis S. Goodman, md, 
Alfred Gilman, md, and Gustaf E. Lindskog, md, 
when they use nitrogen mustard in the 
treatment of a patient with lymphosarcoma. 
1953-1967 
Arnold D. Welch, md, PhD, chairman of 
pharmacology, and Paul Beeson, md, 
chairman of the department of medicine, 
help lay the groundwork for the field of 
medical oncology in the United States. 
1960s 
Drs. Welch and Beeson establish the 
first medical oncology department at 
a university under Dr. Paul Calabresi, 
MD, PhD. 
Yale forms statewide cancer network 
The Yale Oncology 
Network expands on 
a tradition begun in 
1941 with the establish¬ 
ment of the Connecticut 
Tumor Registry, the 
oldest defined-population 
cancer database. 
New treatments being pioneered at the Yale 
Cancer Center are now available to patients 
throughout Connecticut at medical centers 
participating in the newly formed Yale 
Oncology Network. The network is designed 
to combine the expertise of the Yale Cancer 
Center with that of community oncologists 
in all corners of the state. 
Danbury Hospital and Bridgeport 
Hospital are the first two affiliate cancer 
centers in the network. In addition, official 
partnerships have been formed with the 
Norwich Cancer Center and two medical 
practices, Hematology, Oncology, P.C. in 
Stamford and Northwestern Connecticut 
Oncology/Hematology Associates. Under 
the arrangement, many of the Yale Cancer 
Center’s clinical research trials are open 
to patients of these facilities and practices, 
allowing them to undergo treatment in a 
familiar setting and under the direction of 
their own physicians. 
Yale Cancer Center Director Vincent 
T. DeVita Jr., md, envisions an eventual 
network of about eight hospitals. “By 
coupling the powerful research engine at 
Yale with the sphere of influence of commu¬ 
nity affiliates,” he says, “advances in cancer 
care will be more readily available to 
patients all across Connecticut.” 
f 
l| 
Dr. DeVita with Dr. Jose 
Costa, deputy director 
of Yale Cancer Center. 
Dr. Costa directs the 
Critical Technologies 
Shared Resource, which 
is designed to bridge 
basic research knowledge 
with clinical medicine. 
"Through this program, 
patients will benefit from 
the most advanced 
cancer diagnostics," 
Dr. Costa says. 
“We’ve come farther than we 
(cont. from page 1) 
Dr. DeVita became director of the 
National Cancer Institute in 1980, a position 
he held until 1988. Director of Yale Cancer 
Center since 1993, he has assembled a 
team and organized programs to integrate 
the world-class basic research of Yale with 
advanced clinical treatments to benefit 
cancer patients in Connecticut and around 
the world. 
Much of the significance of the National 
Cancer Act arises from one unique feature: 
For the first time, there was a mandate to 
support the application of research, which 
expanded the NIH’s previous focus on basic 
research. In order to speed transfer of cancer 
research to the treatment of cancer patients, 
the National Cancer Act established compre¬ 
hensive cancer centers (there are 26 today) 
to perform basic research and transfer that 
research to the clinic. The Yale Cancer 
Center, founded in 1974, was one of the first 
of these “matrix” centers established at major 
medical schools in the United States. 
Many of the advances in cancer care have 
come directly from the ability to conduct 
ever dreamed” 
clinical trials, which were provided for in the 
act. And the results of that funding can be 
seen in the successful treatment of many 
types of cancers, including breast, colon, 
leukemias and Hodgkins disease. Many treat¬ 
ments now are less radical and less toxic and 
have fewer side effects. 
“The morbidity of the disease has changed 
radically because of clinical trials,” says 
Dr. DeVita, “and now we are also seeing the 
decrease in mortality.” 
Researchers are gaining a greater 
understanding of the differences in cellular 
mechanisms, and the actual genes that 
differentiate cancer cells from normal cells 
have become specific targets of treatments. 
In the future, these treatments will make 
cancer the most curable of chronic diseases, 
thanks in large part to the molecular biology 
revolution that was virtually funded by 
the National Cancer Act. 
“The tools now available for us to analyze 
the cancer cell machinery are breathtaking,” 
says Dr. DeVita. “Seeing cancer go from 
incurable to curable has been a great thrill.” 
1974 1975 1970s-1980s 1986 
Yale Comprehensive Cancer Center is 
established by the National Cancer 
Institute under the provisions of the 
1971 National Cancer Act. 
The Cancer Information Service is 
established by the NCI at Yale under 
the leadership of Marion Morra, SCD, 
who shapes the international cancer 
information field. 
Yale continues as an international 
leader in basic cancer research and 
drug development under the leader¬ 
ship of Directors Joseph R. Bertino, 
md, Jack W. Cole, md, and Alan C. 
Sartorelli, PhD. 
Yale recei' 
research i gGr 
becomes ( ok 
prevention jitlit 
Edward Chu: A marriage of science and nature 
Edward Chu, md, arrived at Yale in 1996 
alter working nearly 10 years at the National 
Cancer Institute, where his background 
in biochemical pharmacology led him to 
investigate how cancer drugs work and how 
cancer cells become resistant to certain 
medications. 
Dr. Chu’s research focuses on the anti- 
metabolites and fluoropyrimidines, major 
drugs used to treat colon and breast cancer. 
In particular, he applies molecular approaches 
to better understand why cancer cells be¬ 
come resistant to these agents. 
It may come as a surprise to some that Dr. 
Chu is interested in the development ot drugs 
with a natural and herbal base. But that is one 
component of his research. “Many of the 
anti-cancer agents now in use originally 
developed from natural products,” says Dr. 
Chu. Camptothecins, the most recent class of 
compounds to have demonstrated impressive 
clinical activity, come from the bark and 
wood of a tree found in China. A number of 
herbal medicines have recently been shown 
to have interesting anti-cancer properties. For 
example, the active ingredient inYun zhi, 
derived from the willow wood tree in China, 
recently was identified as a small protein mol¬ 
ecule that appears to have striking anti-cancer 
activity against a number of malignancies. 
“It is an exciting possibility,” says Dr. Chu, 
“that these agents may work, in part, by 
causing the cancer cells to differentiate into 
a state that is no longer malignant. It is also 
possible that they help to stimulate the body’s 
own immune system.” 
Susan Mayne: Prevention and 
For scientists pursuing state-of-the-art 
research in cancer prevention and control, 
Connecticut provides one of the best popu¬ 
lation laboratories anywhere in the world: 
It has a statewide cancer registry that has 
been in operation since 1935, a relatively 
large population concentrated in a small 
geographic region, and a wealth of resources 
at the Yale Cancer Center. 
This synergy attracted Susan T. Mayne, 
PhD, to Yale to broaden her research in the 
role diet may play in cancer causation. 
As assistant professor of epidemiology and 
the Cancer Center’s associate director for 
prevention. Dr. Mayne works with colleagues 
to isolate and assess the risk factors associated 
with cancer. A new tool, the Rapid Case 
Ascertainment Shared Resource, allows 
Yale Cancer Center investigators to identify 
cancer patients across Connecticut within 
a few weeks of their initial diagnosis. 
Following these patients from an early date 
provides valuable data to better understand 
what causes various cancers and how they 
may be prevented. 
public health 
For example, little is known about the 
role of environmental factors in breast cancer 
causation. Dr. Mayne is working with lead 
investigator Tongzhang Zheng, scd, assistant 
professor of epidemiology, to test the hypoth¬ 
esis that women with breast cancer have 
higher-than-normal levels of organochlorine 
compounds in their body fat. Drs. Zheng 
and Mayne, along with epidemiologist 
Robert Dubrow, md, PhD, and breast cancer 
surgeon Barbara Ward, md, are combining 
chemical analyses of women’s fat tissue with 
in-depth patient interviews focused on diet 
and lifestyle. 
For some cancers, the role of dietary 
patterns is unclear, suggesting a need for 
observational studies. One such project led 
by Harvey Risch, PhD, associate professor 
of epidemiology, is aimed at investigating the 
role of diet and other factors in a cancer 
that is rapidly increasing, adenocarcinoma of 
the esophagus. “These studies are needed 
to identify low- and high-risk behaviors,” 
says Dr. Mayne, “to set the stage for future 
prevention efforts.” 
1993 1995 1994-1997 
and 
icer 
Vincent! DeVita Jr., md, pioneer 
clinical oncologist and director of the 
National Cancer Institute from 1980 
to 1988, becomes the fourth director 
of Vale Cancer Center. 
The Yale Oncology Network is 
formed as a framework for statewide 
clinical trials conducted at Yale and 
medical centers around Connecticut. 
Dr. DeVita and Jose Costa, md, 
deputy director of Yale Cancer 
Center, establish a new program 
structure at Yale Cancer Center 
strongly linking basic and clinical 
research. 
Y lc ale Cancer Center 
The Yale Cancer Center is 
one of 26 comprehensive 
cancer centers designated 
by the National Cancer 
Institute. If you would like to 
support its programs, please 
write to Yale Cancer Center, 
Yale University School of 
Medicine. PO Box 208028, 
New Haven. CT 06520-8028 or 
telephone 203-785-2144. 
Quartermark is a special joint 
publication of Yale Medicine, 
the magazine of the Yale 
University School of 
Medicine, and the Yale 
Cancer Center. Contributors: 
Michael Fitzsousa, Judith 
Winslow, llene Shub Lefland, 
Pat Janowski. Design: 
Cheney & Company 
Albert Deisseroth: Cracking 
Each of us carries within our cells frag¬ 
ments of DNA that are less than perfect. 
Some of these errors in programming will 
result in cancer. 
What if we could correct those coded 
mistakes before a malignancy grows large 
enough to threaten life, or before it occurs? 
Perhaps even before birth itself? 
That is the long-term goal of Albert 
B. Deisseroth, MD, PhD, and his team of 
researchers and clinicians, who are pursuing 
promising leads in the burgeoning field of 
gene therapy. The development of a single 
treatment that lasts a lifetime may one day 
alter the field of cancer therapy at its core. 
genetic code 
The current gene therapy program at 
Yale is directed toward removing some of the 
obstacles to that long-term vision. Clinical 
trials will soon be launched for patients with 
breast, ovarian and prostate cancer, to test 
genetic interventions designed to improve 
chemotherapy and radiation treatments. 
“Gene therapy,” says Dr. Deisseroth, “will 
lead to drug discovery efforts and to a whole 
new generation of medications. The way 
human diseases are treated will dramatically 
change. It also may lead someday to better 
cancer prevention, by enabling clinicians to 
identify and repair gene defects before 
disease develops.” 
cancer’s 
Frank Hsu: A vaccine against 
The most common objective of a vaccine 
is prevention: getting a flu shot is supposed 
to protect against contracting the disease. 
Oncologist Frank Hsu, MD, is engaged in 
developing quite a different type of vaccine 
to fight cancer. 
Unlike standard vaccines, cancer 
vaccines are meant to be therapeutic. They 
are designed not to prevent cancer, but to 
help train the immune system to attack and 
destroy existing cancerous cells. At Stanford 
University, Dr. Hsu worked to develop and 
test this approach by incorporating pieces of 
cancerous cells into vaccines formulated to 
stimulate the immune system. Preliminary 
results from this work have shown promise 
cancer 
against non-Hodgkins lymphomas. 
At Yale, Dr. Hsu is working to refine and 
improve the vaccine techniques. Most of his 
work is focused on dendritic cells, which 
provoke a strong immune response in the 
body. In a clinical trial now under way, Dr. 
Hsu harvests blood cells from a patient, then 
isolates and purifies dendritic cell precursors 
from the blood. 
These precursors are mixed in culture 
with tumor proteins from the same patient. 
After a few days in culture, the dendritic cells 
mature and incorporate the tumor proteins. 
By returning these cells back to the patient 
these modified dendritic cells can then stim¬ 
ulate response against the cancerous tumor. 
the origin and operational expan¬ 
sion of the Benedict-Manson 
Transportation Co. of New Haven. 
Dr. Holcomb is a direct descendant 
of the Manson Family. 
Charles A. Dinarello, M.D. ’69, 
HS ’69-75, professor of medicine 
at the University of Colorado 
School of Medicine in Denver, 
received the Ludwig Heilmeyer 
Gold Medal for his contributions to 
progress in molecular biology for 
medicine. Until 1996, he was pro¬ 
fessor of medicine and pediatrics at 
Tufts University School of Medi¬ 
cine, where he established the 
Sheldon M. Wolff Professorship. 
Dr. Dinarello is past-vice president 
of the American Society of Clinical 
Investigation and president of the 
International Cytokine Society. In 
1993, he received the Ernst Jung 
Prize in Medicine and donated the 
$125,000 award to universities in 
the U.S. and Israel. 
Morris B. Mellion, M.D. ’70, has 
been named senior vice president 
of health care policy and chief 
medical officer at BlueCross 
BlueShield of Nebraska. Dr. Mel¬ 
lion is also clinical associate pro¬ 
fessor of family practice and 
orthopaedic surgery (sports medi¬ 
cine) at the University of Nebraska 
Medical Center, and serves as team 
physician for men’s and women's 
sports and as adjunct professor in 
the School of Health, Physical 
Education and Recreation at the 
University of Nebraska 
at Omaha. 
Stephan Ariyan, M.D., HS ’70-76, 
clinical professor of surgery (plas¬ 
tic) at Yale, was selected as the 
1996 National Visiting Professor 
for the Society of Head and Neck 
Surgeons. As national visiting pro¬ 
fessor, Dr. Ariyan has lectured at 
the universities of Toronto, Miami, 
Tennessee and Louisville. He pre¬ 
viously served as the society’s 
president from 1992 to 1993. 
Thomas W. Chapman, M.P.H. 
’71, chief executive officer of the 
George Washington University 
Hospital and senior vice president 
for network 
development 
of the George 
Washington 
Medical Cen¬ 
ter, has been 
presented the 
1996 Distin¬ 
guished 
Alumni 
Award by the 
Association 
of Yale 
Alumni in Public Health. The cere¬ 
mony was part of festivities at the 
Yale Club of New York City in 
November at a dinner, held during 
the American Public Health Asso¬ 
ciation annual meeting. 
Mr. Chapman also serves as a 
senior health advisor to the Clinton 
administration on health care 
reform. He is currently the national 
program officer for Opening 
Doors, a program to reduce socio¬ 
cultural barriers to health care 
sponsored by the Robert Wood 
Johnson Foundation and the Henry 
J. Kaiser Family Foundation. He 
also received the CEO of the Year 
Award from the American Hospital 
Association in 1989. 
Harvey Fernbach, M.D. ’71, 
M.P.H. ’71, of Washington, D.C., 
has a private psychiatry practice in 
Maryland and is a consultant for 
the American Psychiatric Associa¬ 
tion’s Council on Economic 
Affairs. Dr. Fernbach is also on the 
Medical and Chirurgical Faculty of 
Maryland and a member of the 
Physicians for National Health 
Program, which is involved in a 
national effort to establish a single¬ 
payer health care system. 
Michael A. Kaufman, M.D. 73, 
J.D., has been appointed medical 
officer and senior vice president of 
TO GIVE AWAY MONEY IS 
AN EASY MATTER AND IN 
ANY MAN’S POWER. BUT 
TO DECIDE TO WHOM TO 
GIVE IT, AND HOW LARGE 
AND WHEN, AND FOR 
WHAT PURPOSE AND 
HOW, IS NEITHER IN 
EVERY MAN’S POWER 
NOR AN EASY MATTER. 
Aristotle 
Assuming you would 
consider the School of 
Medicine as one of your 
intended beneficiaries, 
we stand ready to help you 
with when, for what purpose, 
and how. 
Planned giving 
is one of our specialties. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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BlueCross of California, the Cali¬ 
fornia operating subsidiary of Well¬ 
Point Health Networks Inc. 
Harry S. Romanowitz, M.D. '73, 
chairman of the department of 
pediatrics at Stamford (Conn.) 
Hospital, has been instrumental in 
founding the new Roslyn and 
Leslie Goldstein Children’s Health 
Center, an outpatient primary and 
specialty care pediatric clinic. 
Dr. Romanowitz was the keynote 
speaker at the center’s dedication. 
Stephen I. Kramer, M.D., HS ’78- 
83, was promoted to associate pro¬ 
fessor of psychiatry and behavioral 
medicine at Bow¬ 
man Gray School 
of Medicine in 
Winston-Salem, 
N.C., in Septem¬ 
ber. Dr. Kramer 
has been an assis¬ 
tant professor of 
psychiatry and 
behavioral medi¬ 
cine at Bowman 
since 1989. 
Shannon C. Kenney, M.D. ’79, HS 
'79-83, associate professor of medi¬ 
cine, was one of four recipients of 
the 1996 Philip and Ruth Hettleman 
Prizes for Artistic and Scholarly 
Achievement by Young Faculty at 
the University of North Carolina at 
Chapel Hill. Dr. Kenney is known 
worldwide among Epstein-Barr 
virus researchers as a leader in the 
field of regulation of viral gene 
expression. 
Thomas D. Fogel, M.D., HS '82- 
85, vice president of Coastal Radia¬ 
tion Oncology Medical Group in 
California, has been elected secre¬ 
tary of the 1996-97 Board of Direc¬ 
tors of the American Cancer Soci¬ 
ety’s California Division at the 50th 
annual meeting held at the Fairmont 
Hotel in San Francisco. Dr. Fogel 
Thomas D. Fogel M.D. 
also received the division’s annual 
Quality of Life Award for starting a 
prostate cancer support group for 
patients and families. 
Kristine M. Napier, M.P.H. 84, 
nutritional consultant and medical 
writer, was presented a William 
Harvey Award for excellence in 
magazine writing on the subject of 
cholesterol at the 21st annual South¬ 
eastern Conference on Cardiovascu¬ 
lar Health, hosted by the North Car¬ 
olina State Division of Health Pro¬ 
motion. The award is sponsored by 
American Medical Writers Associa¬ 
tion, the National Heart, Lung and 
Blood Institute of the National Insti¬ 
tutes of Health; and Bristol-Myers 
Squibb Co. Ms. Napier previously 
received a William Harvey Award 
in 1994. 
Larry Amsel, M.D. ’88, of New 
York City, has been awarded a 
$400,000 grant from the National 
Institutes of Health’s Human 
Genome Project to produce an edu¬ 
cational video for primary care clin¬ 
icians on caring for and counseling 
patients facing genetic tests and 
struggling with questions of testing 
for genetic risks. The project is in 
collaboration with the Hastings 
Center for Bioethics. 
Elan D. Louis, M.D. ’89, HS ’89- 
90, and Vinita Sehgal, M.D. ’90, 
both assistant professors at the Col¬ 
lege of Physicians and Surgeons, 
Columbia University, announce 
the birth of their son, Devin Natan, 
in August. 
Leila A. Mankarious, M.D. ’90, 
has joined the pediatric ear, nose 
and throat service at the Harvard 
Medical School, Massachusetts Eye 
and Ear Infirmary, in Boston. 
Margaret R. Stevens O’Neill, 
M.D. ’91, married Michael E. 
O'Neill, J.D. ’90, in June 1991, 
and moved to Baltimore, where 
she spent two years in internal 
medicine and three in dermatology 
at Johns Hopkins. Dr. Stevens 
O’Neill has now joined a private 
practice near Washington, D.C., 
while her husband is clerking for a 
Supreme Court justice. She would 
love to see her classmates if they 
are in the area. 
Deborah A. Dillon, M.D. ’92, a 
fellow in molecular pathology, was 
selected to received a $25,000 fel¬ 
lowship as part of the College of 
American Pathologists Foundation 
1996-1997 Scholars Award Pro¬ 
gram. Dr. Dillon’s research project 
will focus on the detection of tumor 
DNA in the blood of patients with 
tumors of the colon and pancreas. 
Kathryn M. Ryder, M.D. ’92, 
has been appointed assistant profes¬ 
sor of medicine at the University 
of Nevada School of Medicine. 
Dr. Ryder practices general internal 
medicine and is a diplomate of 
the American Board of Internal 
Medicine. 
Bruce G. Freeman, M.D., HS ’93- 
96, has joined Edward H. Gleich, 
M.D., HS ’75-77, at Shoreline Pedi¬ 
atrics and Adolescent Medicine, 
which has offices in Madison and 
Clinton, Conn. Dr. Freeman is 
engaged to Tina M. Roman, M.D., 
a resident in pediatrics at Yale-New 
Haven Hospital. 
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alumni reunion weekend 
PRELIMINARY SCHEDULE 
FRIDAY, JUNE 6, 1997 
8:00 a.m. to 7:00 p.m. 
MEDICAL SCHOOL ALUMNI/AE REGISTRATION 
Sterling Hall of Medicine, Rotunda 
1:00 to 2:30 p.m. 
SCHOOL OF MEDICINE ALUMNI FUND 
CLASS AGENTS AND REUNION GIFT CHAIRS LUNCHEON 
Sterling Hall of Medicine, Steiner Room 
1:00 to 2:45 p.m. 
YALE SCHOOL OF MEDICINE 
CLASS REUNION PROGRAM 
Hope Building 
3:00 to 4:00 p.m. 
ASSOCIATION OF YALE ALUMNI IN MEDICINE 
Executive Committee Meeting 
Sterling Hall of Medicine, Beaumont Room 
4:15 p.m. 
WELCOME TO REUNION 1997 
Greetings and Remarks 
Lycurgus M. Davey, M.D. ’43 March 
President, Association of Yale Alumni in Medicine 
Gerard N. Burrow, M.D. ’58 
Dean, School of Medicine 
YALE SCHOOL OF MEDICINE SPECIAL PRESENTATION 
Albert B. Deisseroth, M.D., Ph.D., 
Ensign Professor of Medicine 
Chief, Section of Medical Oncology 
Hope Building, Room 110 
5:15 p.m. 
DEAN’S RECEPTION 
Historical Library 
333 Cedar Street 
Open to all alumni/ae, faculty, students and guests 
6:15 p.m. 
BARBECUE/BUFFET 
Edward S. Harkness Hall 
367 Cedar Street 
Open to all alumni/ae, faculty, students and guests 
Pre-paid advance registration required 
SATURDAY, JUNE 7, 1997 
7:30 a.m. to 7:00 p.m. 
MEDICAL ALUMNI/AE REGISTRATION 
Sterling Hall of Medicine, Rotunda 
7:30 to 10:00 a.m. 
CONTINENTAL BREAKFAST 
Sterling Hall of Medicine, Beaumont Room 
9:45 to 11:00 a.m. 
FACULTY SEMINAR 
New Directions in the Treatment of Cancer 
Introduction: Albert B. Deisseroth, M.D., Ph.D. 
Participants: Edward Chu, M.D., Ph.D., 
Frank Hsu, M.D., Ph.D., and Barbara Burtness, M.D. 
Hope Building, Room 110 
11:15 a.m. 
ANNUAL MEETING OF THE ASSOCIATION 
OF YALE ALUMNI IN MEDICINE 
Welcome and Remarks 
Lycurgus M. Davey, M.D. ’43 March, 
President of the Association 
Greetings 
Richard C. Levin 
President, Yale University 
State of the School Address 
Gerard N. Burrow, M.D. ’58 
Dean, School of Medicine 
Alumni in Medicine Distinguished 
Service Award Presentation 
Brady Auditorium, 310 Cedar Street 
12:15 p.m. 
SHERRY 
12:30 p.m. 
BUFFET LUNCHEON 
Edward S. Harkness Hall, 367 Cedar Street 
2:45 p.m. 
GUIDED TOURS 
Yale Center for British Art 3:00 to 4:00 p.m. 
Historic Sections of New Haven 3:00 to 4:15 p.m. 
Yale-New Haven Children’s Hospital 
3:00 to 4:00p.m. 
For additional information, call 203-785-4674 
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OBITUARIES 
Ralph D. Alley 
Ralph D. Alley, M.D., died Sept. 7 
at his home in Loudonville, N.Y. He 
was 78. 
Born in India, the son of mis¬ 
sionary parents. Dr. Alley spent his 
first 15 years there and attended the 
Woodstock School at the base of 
the Himalayas. He graduated from 
the University of Virginia in 1939 
and from Yale School of Medicine 
in 1943. 
Dr. Alley served in the U.S. 
Navy as a medical officer aboard 
the LST 292 during the Normandy 
invasion of Omaha Beach on D- 
Day, June 6, 1944. He completed 
residencies in general and cardio- 
thoracic surgery at Yale-New 
Haven Hospital and, in 1952, 
moved to Albany. In 1954, he was 
the first surgeon to repair a trau¬ 
matic aneurysm of the aortic arch 
using external shunts developed in 
his surgical laboratory, and he 
became internationally known as a 
pioneer in cardiothoracic surgery. 
Dr. Alley, along with David S. 
Sheridan of Argyle, N.Y., invented 
numerous catheters and medical 
devices still widely used today. 
From 1973 to 1983, he was the 
head of the division of cardiotho¬ 
racic surgery at Albany Medical 
College and visiting professor on 
the faculty of the University of Vir¬ 
ginia. Dr. Alley was a founding 
member of the Society of Thoracic 
Surgeons and served as president in 
1976. He also served as regent to 
the American College of Surgeons 
for a nine-year period and was a 
member of the American Board of 
Thoracic Surgery. 
Louise Bates Ames 
Louise Bates Ames, born in Port¬ 
land, Maine, died from thyroid can¬ 
cer on Oct. 31 at the home of her 
granddaughter in Cincinnati. She 
was 88. 
Dr. Ames received her B.A. and 
M.A. degrees from the University 
of Maine and her Ph.D. degree from 
Yale University in 1936. She was 
on the staff of the Yale Clinic of 
Child Development from 1933 to 
1948 as a personal research assis¬ 
tant to Dr. Arnold Gesell. In 1950, 
she and two other collaborators of 
Dr. Gesell—Dr. Frances Ilg and Dr. 
Janet Rodell—established the 
Gesell Institute in Child Develop¬ 
ment in New Haven, which later 
became the Gesell Institute of 
Human Development. 
Dr. Ames was one of the first 
researchers to track the develop¬ 
mental phases of childhood. From 
1976 to 1985 she wrote a series of 
guides, beginning with Your One 
Year Old, that helped parents feel 
that they were on target even while 
their children seemed in turmoil. 
Dr. Ames wrote 25 books, 
many scientific articles and a syndi¬ 
cated newspaper column. She 
appeared on the Phil Donahue and 
Oprah Winfrey shows and, for a 
time, her own weekly television 
program. From 1944 to 1950, she 
was curator of Yale Films of Child 
Development. In 1991 she became 
a lecturer at the Yale Child Study 
Center and since 1993, an assistant 
professor emeritus at Yale. 
C. Elton Cahow 
C. Elton Cahow, M.D., died Jan. 2 
at his home in Branford, Conn. He 
was 65. 
Dr. Cahow was born in Fort 
Pierce, Fla. He graduated in 1952 
from Davidson College in North 
Carolina with a bachelor’s degree 
in chemistry and received a medical 
degree from the Cornell University 
School of Medicine in 1956. He 
served internships in both surgery 
and medicine at New York Hospi- 
tal-Cornell Medical Center and 
completed his residency in general 
and cardiothoracic surgery under 
the late Frank Glenn, M.D., at the 
New York Hospital. 
In 1963, Dr. Cahow joined the 
faculty at Yale as an instructor in 
the Department of Surgery. During 
his 33 years at Yale, he served from 
1964 to 1970 as assistant professor, 
from 1970 to 1977 as associate pro¬ 
fessor and from 1977 to 1987 as 
professor of surgery. In 1987, Dr. 
Cahow was named the William H. 
Carmalt Professor of Surgery and 
was also appointed vice chairman 
of the department and chief of the 
section of general surgery at the 
medical school and at Yale-New 
Haven Hospital. He was also pro¬ 
gram director of surgical residency 
at the hospital. 
Dr. Cahow’s wife, Barbara 
Kinder Cahow, M.D., is chief of 
surgery at the VA Connecticut 
Healthcare System in West Haven. 
In December, Dr. Kinder was 
40 Spring 1997 
named the William H. Carmalt Pro¬ 
fessor of Surgery. 
Although his clinical interests 
spanned the entire field of general 
surgery, he developed particular 
interest in the areas of liver, pancre¬ 
atic and biliary tract surgery. In 
recent years. Dr. Cahow embraced 
the techniques of laparoscopic 
surgery and became an interna¬ 
tional leader in the performance, 
critical evaluation and teaching of 
these techniques. He was a fellow 
of the American College of Sur¬ 
geons and belonged to a multitude 
of professional associations. He 
was past president of the Connecti¬ 
cut Society of the American Board 
of Surgeons. 
Memorial contributions may 
be made to the C. Elton Cahow 
Endowment Fund, c/o Larry 
Jerome, Senior Development Offi¬ 
cer for Medical Development, 100 
Church St. South, P.O. Box 7611, 
New Haven, CT 06519. A memor¬ 
ial service will be held May 23 in 
Battell Chapel. 
Louis A. Cohen 
Louis A. Cohen, Ph.D., of West 
Bethesda, Md., died after a heart 
attack Sept. 12 at a hospital in 
Edinburgh, Scotland, while attend¬ 
ing a conference. He was 70. 
Dr. Cohen, a Boston native, 
was a 1949 organic chemistry grad¬ 
uate of Northeastern University and 
received a doctorate in organic and 
biological chemistry from Massa¬ 
chusetts Institute of Technology. 
He was on the biochemistry faculty 
at Yale medical school from 1952 
to 1954. 
In 1955, he moved to 
Bethesda, Md., while working as 
an organic chemist for the National 
Institutes of Health (NIH). From 
1957 to 1960, he was an adjunct 
professor of chemistry at Howard 
University. Since 1966, Dr. Cohen 
had been director of the NIH’s 
Graduate School of the Foundation 
for Advanced Education in 
the Sciences. 
Donald S. Dock 
Donald Stone Dock, M.D., died 
Dec. 3 at Connecticut Hospice. He 
was 69. 
Bom in New York City, Dr. 
Dock was a graduate of Princeton 
University and the Johns Hopkins 
University School of Medicine. He 
had post-graduate training at Yale 
University and Harvard. Dr. Dock 
lived in Madison, Conn., for 26 
years before moving to Branford 
in 1986. 
He was a New Haven cardiolo¬ 
gist for 36 years, most recently 
with the Connecticut Heart Group. 
Dr. Dock was chief of medicine at 
the Hospital of Saint Raphael from 
1963 to 1981, except for the years 
1972 to 1974, when he was chief of 
medicine at the Atomic Bomb 
Casualty Commission in Hiroshima 
and Nagasaki, Japan. More 
recently. Dr. Dock was director of 
the coronary care unit, director of 
the Take Heart cardiac rehabilita¬ 
tion program and director of elec¬ 
trocardiography and Holter moni¬ 
tors at St. Raphael’s. He was a clin¬ 
ical professor of medicine at Yale 
and an associate fellow at Berkeley 
College. Dr. Dock was awarded the 
Dr. Oscar Roth Award in 1996 by 
Saint Raphael’s for his many years 
of dedication and service to his 
patients and to the hospital. 
William R. Goff 
William Richard Goff, Ph.D., of 
Branford, Conn., died Sept. 10 at 
Connecticut Hospice. He was 66. 
Dr. Goff was born in Provi¬ 
dence, R.I., and received a doctor¬ 
ate from the University of Virginia. 
He was professor emeritus of neu¬ 
rology and psychology at Yale 
School of Medicine and former 
director of the neuro-psychology 
laboratory at the VA Connecticut 
Healthcare System in West Haven. 
Dr. Goff helped design and build 
the first analog computer to 
study electrical activity of the 
human brain. 
A Charitable 
Annuity: 
The YSM gift 
that rates 
In exchange for a gift of 
$5,000 or more, the School of 
Medicine can offer you, or you 
and your spouse, a fixed annual 
income for life. 
Your age(s) and market 
rates of interest determine 
your income level. 
Current sample rates: 
Age(s) Rate 
One life 
55 4.8% 
66 5.9% 
77 8.2% 
Two lives 
66/65 4.9% 
75/74 5.9% 
82/79 7.1% 
Please allow us to tailor 
a proposal to your 
philanthropic 
and financial goals. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Contribute to the 
School of Medicine’s 
Future and Invest in 
Your Own 
Yale University's life income 
program offers graduates of the 
School of Medicine the oppor¬ 
tunity to: 
■ Help ensure the future 
of a great institution 
■ Receive quarterly 
income payments 
for life 
■ Increase your income 
from low-yielding stock with¬ 
out incurring capital gains 
taxes 
■ Reduce federal and 
state taxes 
Please call or write to see if 
you can use these benefits to 
the mutual advantage of you 
and the School of Medicine. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
At the time of his retirement in 
1986, he was professor of neurology 
at Yale and a research career scien¬ 
tist at the VA. 
Frederick R. Hine 
Frederick R. Hine, M.D., died Sept. 
12 at Duke University Medical Cen¬ 
ter in Durham, N.C. He was 70. 
Born in Cincinnati, Ohio, Dr. 
Hine received a bachelor’s degree 
from Yale in 1946 and graduated 
from the medical school in 1949. He 
was a psychiatric intern at Charity 
Hospital in New Orleans and a resi¬ 
dent at Tulane University School of 
Medicine, where he was later a 
member of the faculty. In 1953, he 
became affiliated with the Southeast 
Louisiana Hospital in Mandeville. 
In 1959, Dr. Hine joined the 
staff at Duke University and began a 
long tenure, beginning as an assis¬ 
tant professor of psychiatry, becom¬ 
ing an associate professor in 1963 
and full professor in 1971. During 
his 37 years at Duke, he was chair¬ 
man of the medical school training 
committee for the Department of 
Psychiatry from 1962 to 1974, and 
director of medical student educa¬ 
tion in psychiatry until the time of 
his death. He is the only three-time 
recipient of Duke University 
medical school’s Honored 
Teacher Award. 
J. Louis Jack 
J. Louis Jack, M.D., died Nov. 19 at 
his home in North Haven, Conn. He 
was 103. 
Dr. Jack, born in New York 
City, attended Brown University 
and graduated in 1915 from Rhode 
Island State College in Kingston, 
now known as the University of 
Rhode Island. He taught science and 
coached at East Providence High 
School. From 1917 to 1919, Dr. 
Jack served in France as a member 
of the Second Field Artillery. In 
1923, he graduated from Yale 
School of Medicine and interned at 
Bellevue and Staten Island hospitals 
in New York. He was a surgeon at 
the former Grace-New Haven Hos¬ 
pital, retiring in 1950, and was also 
in private practice with his brother, 
the late Gabriel J. Jack, M.D. 
In October 1948, his painting 
Young Men In Green was featured in 
TIME magazine. In 1992, on his 
100th birthday, he was honored with 
a Doctor of Humane Letters degree 
by the University of Rhode Island 
and was also the first recipient of 
its Distinguished Alumni Award 
in 1990. 
Warren R. Johnson 
Warren R. Johnson, M.D., died Aug. 
28 of cancer at his home in Fairway 
Falls, Pike Creek, Del. He was 65. 
Dr. Johnson graduated in 1953 
from Colby College in Waterville, 
Maine, and in 1957 from the Yale 
School of Medicine. He completed 
his pediatric internship and resi¬ 
dency at Delaware Hospital, Wilm¬ 
ington Medical Center, and was a 
fellow in pediatrics at Johns Hop¬ 
kins Hospital in Baltimore from 
1960 to 1961. Dr. Johnson served as 
secretary of the Delaware Hospital 
medical staff from 1963 to 1970, 
senior attending physician in the 
department of pediatrics from 1970 
to 1973, and chairman of the depart¬ 
ment of pediatrics credentials com¬ 
mittee from 1973 to 1980. Since 
then, he had been in private practice 
and was director of medical educa¬ 
tion for pediatrics at the Medical 
Center of Delaware. Dr. Johnson 
was also active in the Health Care of 
the Homeless Program at Henrietta 
Johnson Clinic. 
John W. King 
John Weaver King, M.D, Ph.D., 
died Oct. 9 at his Cleveland 
Heights, Ohio, home. He was 80. 
Born in Bakerton, Pa., Dr. King 
earned a master’s degree in dairy 
science from Pennsylvania State 
University and a doctorate in bacte- 
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riology from Yale in 1941 before 
completing his medical degree at 
Yale in 1944. After an internship in 
Philadelphia, he taught at the Ver¬ 
mont Medical School in Burlington 
for four years. In 1950, Dr. King 
joined the Cleveland Clinic, where 
his devotion to upgrading the labo¬ 
ratories led to the naming of the 
medical technology department 
after him following his retirement. 
He headed the hospital medical lab¬ 
oratory for the Cleveland Clinic 
Foundation and, in 1980, retired 
as director of the foundation’s 
blood banks. 
Dr. King served in the Army in 
active duty in San Antonio, Texas, 
during the 1950s and as a reservist 
in the 1970s. He was commanding 
officer of the 256th General Hospi¬ 
tal in Parma, Texas, from 1973 until 
he retired in 1975. 
Leonard Parente 
Leonard Parente, M.D., died Nov. 9 
in the Hospital of St. Raphael in 
New Haven. 
Dr. Parente was born in New 
Haven and received a bachelor’s 
degree from Yale in 1927. After 
earning his medical degree from 
Emory University, he completed an 
internship and residency in pedi¬ 
atrics, and entered private practice. 
In 1942, Dr. Parente earned an 
M.P.H. degree from Yale. He was a 
lecturer in public health at the med¬ 
ical school and director of health 
for the town of Hamden, Conn., for 
28 years. Dr. Parente was the first 
medical director of the Connecticut 
Department of Welfare. He was 
president of the Connecticut 
Public Health Association and 
a fellow of the American Public 
Health Association. 
Earl J. Rhoades 
Earl J. Rhoades, M.D., died Oct. 8 
in the Dover Rehabilitation and 
Living Center, Dover, N.H. He 
was 83. 
Dr. Rhoades was bom in West 
Pittston, Pa., and attended Lafayette 
and Wilkes colleges. He received an 
M.D. degree from Yale in 1943. 
After an internship at Henry Ford 
Hospital, he received further 
orthopaedic training at Northwest¬ 
ern University, the Bronx Veterans 
Administration Hospital and the 
Hospital for Special Surgery in 
New York City. He served as a cap¬ 
tain in the Army’s 375th 
Orthopaedic Detachment from 
1944 to 1947 and was chief of 
orthopaedics at Tripler Army Med¬ 
ical Center in Honolulu at the time 
of discharge. 
Dr. Rhoades was a specialist in 
orthopaedic surgery in New Haven 
for 32 years, attending at Yale-New 
Haven and St. Raphael’s hospitals. 
He served as an associate attending 
at Newington Children’s Hospital. 
Dr. Rhoades was also on the clinical 
faculty at Yale School of Medicine, 
a member of the Yale Orthopaedic 
Association and a past editor of the 
Yale Journal of Biology and Medi¬ 
cine. He lived in Woodbridge and 
Orange for many years before mov¬ 
ing to New Durham, N.H., in 1994. 
Murray Z. Rosenberg 
Murray Z. Rosenberg, M.D., died 
Sept. 1 at the home of his son in 
Asheville, N.C. He was 71. 
Dr. Rosenberg formerly lived 
in Storrs, Conn., and had a home in 
Longboat Key, Fla. He graduated in 
1946 from Harvard University and 
in 1949 from Yale School of Medi¬ 
cine. For 30 years until his retire¬ 
ment in 1986, Dr. Rosenberg served 
as chief of pathology and as direc¬ 
tor of the clinical laboratory at 
Windham Community Memorial 
Hospital in Willimantic, Conn. He 
also had clinical appointments at 
Yale University and the University 
of Connecticut medical schools. 
Dr. Rosenberg served in the 
U.S. Navy during World War II and 
served as an Army physician at the 
406th Laboratory in Tokyo from 
1951 to 1953. 
IN MEMORIAM 
Ralph D. Alley, M.D. '43 
September 7, 1996 
George A. Carden Jr., M.D. '35 
August 10, 1996 
Raymond S. Duff, M.D. ’52, M.P.H. ’59 
June 21, 1996 
Eugene Field, M.D., HS ’36 
May 1995 
Richard L. Frank, M.D. ’31 
February 10, 1996 
Frederick R. Hine, M.D. ’49 
September 12, 1996 
Warren R. Johnson, M.D. ’57 
August 28, 1996 
Ferdinand G. Kojis, M.D. '28 
April 1991 
Margaret J. Lindsay, M.P.H. ’68 
July 6, 1996 
Leonard Parente, M.D., M.P.H. ’42 
November 9, 1996 
Earl J. Rhoades, M.D. '43 
October 8, 1996 
Murray Z. Rosenberg, M.D. ’49 
September 1, 1996 
William F. Stephenson, M.D. ’52 
August 23, 1996 
David C. Sundmacker, M.P.H. ’75 
October 11, 1996 
Constance B. Thomas, M.P.H. '53 
August 28, 1996 
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Sarah A. Schleck 
Sarah Ann Schleck, Ph.D., died 
Nov. 16 at Duke University Medical 
Hospital. She was 45. 
Bom in Morristown, N.J., Dr. 
Schleck lived in Madison, Conn., 
from 1979 until moving to North 
Carolina in 1992. She received a 
B.A. degree from Mount Holyoke 
College in South Hadley, Mass., in 
1973. She received a master’s 
degree in 1985 and a Ph.D. degree 
in 1991, both from Yale School of 
Medicine's Department of Epidemi¬ 
ology and Public Health. Dr. 
Schleck worked as an associate in 
research and a laboratory supervisor 
at Yale. At the time of her death, she 
was the operating room scheduling 
coordinator for heart surgery at 
Duke University Medical Hospital. 
Dr. Schleck was past president 
of the Yale Epidemiology and Pub¬ 
lic Health Doctoral Student Organi¬ 
zation and had served on a Yale 
“Doctor,; how can I 
thank you?” 
ow many times have you heard this question from 
your patients? Your answer can lead to a way to 
help the Yale School of Medicine. A gift from your 
patient to the School honors you and guarantees 
the continuation of our tradition of excellence in 
teaching and patient care into the 2ist century. 
“Yale School of Medicine was and remains 
extremely important to me in the ongoing development of 
my busy practice. I am proud of my close relationship with the School, 
even though I am geographically far from New Haven. My patients 
regularly take an interest in my research and clinical activities, and I 
am more than happy to share with them my fondness 
for Yale in order to stimulate their interest in the School’s mission." 
Dudley Seth Danoff, M.D. ’63, F.A.C.S. 
Beverly Hills, California 
“My patients know that I am a proud graduate of Yale 
School of Medicine and an active participant in the teaching 
program. They also know that one of the best ways to make me 
happy is to give to my alma mater.” 
Mary Jane Minkin, M.D. 75 
New Haven, Connecticut 
Brochures promoting the School are available for 
display in your office, to generate the revenue 
needed to continue our standard of excellence. 
Free copies are available from: 
Bonnie Sargent 
Office of Development 
Yale University School of Medii 
P.0. Box 7611 
New Haven, Connecticut 06519- 
Or call: 
203.785.6760 
Graduate Professional Student 
Senate committee. 
Constance B. Thomas 
Constance Bancroft Thomas, M.N., 
M.P.H., died Aug. 28 at her home in 
Frederick, Md. She was 79. 
Mrs. Thomas, bom in New 
Haven, earned two master’s degrees 
from Yale University, one in nursing 
in 1944 and one in public health in 
1953. She received her bachelor’s 
degree in music from the University 
of Pennsylvania. Before her mar¬ 
riage, Mrs. Thomas worked as a 
public health educator for the Den¬ 
ver Tuberculosis Society and as a 
head nurse at Yale-New Haven Hos¬ 
pital and later at the State University 
of New York at Geneseo. 
Edward M. Wakeman 
Edward Maurice Wakeman, M.D., 
died Oct. 12 at the M.D. Anderson 
Hospital Cancer Center in Houston, 
Texas. 
Dr. Wakeman, bom in New 
Haven, was a graduate of Yale Col¬ 
lege and the University of Pennsyl¬ 
vania School of Medicine. Follow¬ 
ing an internship at the Mary Imo- 
gene Bassett Hospital in Cooper- 
stown, N.Y., and a tour in the Navy 
as a flight surgeon, he returned to 
New Haven for his pediatric resi¬ 
dency at Grace-New Haven Hospi¬ 
tal and was named chief resident in 
1962. Dr. Wakeman was in a private 
pediatrics practice in Guilford, 
Conn., for 33 years until the time of 
his death. He was a fellow of the 
American Academy of Pediatrics, 
an associate clinical professor of 
pediatrics at Yale and was recently 
named a member of the board of 
directors of Yale Preferred Health. 
Dr. Wakeman served on the 
Guilford Board of Education and 
founded the Guilford Center for 
Children, the first state-supported 
day care center for children in Con¬ 
necticut and served as chairman 
from 1971 to 1975. 
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From the dean of the School of Medicine 
Dean Gerard N. Burrow, M.D. '58 
As change touches our research-intensive medical school, it is reassur¬ 
ing to note that two rich traditions continue to prevail and even flour¬ 
ish. These are, of course, the Yale System of medical education, which 
remains the framework of our dynamic curriculum, and the original 
research that our students conduct for their theses, an academic require¬ 
ment at Yale for more than 150 years. 
During this transitional period for both the practice and profession of 
medicine, another impressive tradition continues as well, in the form of 
loyal support from Yale alumni/ae. 
Just as you and your classmates did, Yale medical students today excel 
in academics and community service. And your contributions to the 
School of Medicine help to support their education. 
Last year, your gifts and pledges to the Medical School Alumni Fund 
totaled more than $2 million. For this generosity, my deep appreciation 
goes to fund chairman Daniel L. Arons, M.D. ’67, his committee, the 
reunion gift chairs, class agents and to the hundreds of Yale alumni/ae who 
support this school. 
As dean of the Yale School of Medicine, I cherish the interactions with 
the students, our future alumni/ae, and delight in interactions with current 
Yale alumni/ae, who have given so much to our profession, the health of 
many who live in America, and to this school. 
From the chairman of the Medical School Alumni Fund 
This has been a very impressive 
year for the Yale Medical School 
Alumni Fund. I have enjoyed getting 
to know many of the volunteers and 
donors who are so loyal to our alma 
mater. Our support of the medical 
school has gained prominent recog¬ 
nition within the entire Yale Alumni 
Fund program, and I am very proud 
to serve as your representative. 
There is a great deal of excite¬ 
ment in the air as we are in the final 
year of Yale’s remarkable $1.5 bil¬ 
lion campaign. Hundreds of medical 
school graduates will be counted in 
the campaign honor roll, having 
made special reunion gifts toward 
the many worthy needs at the School 
of Medicine and having supported 
the Annual Fund generously each 
year. In particular, I am very grateful 
for those who have made contribu¬ 
tions toward the renovation of Hark- 
ness Hall and new student laboratory 
facilities. As Dean Burrow has told 
us, these two projects especially 
need alumni/ae backing, and it has 
been heartening to see so many grad¬ 
uates stepping forward to make the 
school an even better place for future 
generations of students. 
Thank you very much to more 
than 2.000 alumni/ae who made gifts 
or pledges in 1995-96. You brought 
us to 50 percent participation, help¬ 
ing us to be a leader among our peer 
institutions at Yale. Our reunion 
continued on next page ► Daniel L. Arons, M.D. '67 
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classes had an extraordinary year, raising 
more than $2 million. We were led by the 
Class of 1946, which achieved a reunion 
giving record of more than $1.1 million 
and reached the highest percentage of 
participation among reunion classes with 
80 percent. The Class of 1971 also had a 
great reunion gift effort, raising more 
than $300,000 for the school. 
I would like to recognize and thank 
the reunion gift chairs who did such great 
work to make all of this possible: John 
Ogilvie, M.D., for the classes of 1926, 
1931 and 1936; Peter Duncan, M.D., for 
1941; Frank Behrle, M.D., 1946; Arthur 
Pava, M.D., 1951; Dwight Miller, M.D., 
1956; Anoush Miridjanian, M.D., 1961; 
John Baxter, M.D., 1966; Richard Mog- 
gio, M.D., 1971; Alfredo Axtmayer, 
M.D.. 1976; Anthony Urbano, M.D., 
1981; Eric Suan, M.D., 1986. We are also 
grateful for the wonderful leadership of 
Andrew McGowan, M.D. '58, and the 
Reunion Gift Program Committee on the 
YSM Alumni Fund Board. 
Annual Fund gifts from alumni/ae 
and friends remain a vital source of fund¬ 
ing for the School of Medicine, and raised 
well over $400,000 last year to benefit 
current medical students. Thanks to the 
dedication and hard work of more than 
100 class agents, the school is able to 
make personal contact with its graduates 
to sustain this wonderful support. Special 
thanks go to Howard Minners, M.D. '57, 
the class agent who achieved the highest 
participation rate (for the second year in a 
row), with almost 90 percent of his group 
of classmates contributing. 
All of the donors for 1995-96 are 
listed with their classes, and those who 
made leadership contributions also are 
recognized in the Sterling Association 
listing. 
Please join me again this year in 
building the extraordinary legacy of the 
Yale Medical School Alumni Fund. 
Through our annual and reunion giving, 
we are making an important and tangible 
difference in the lives of current and 
future medical students as we give some¬ 
thing back to the school where we began 
our lives as physicians. 
Medical School Alumni Fund 
The names and data included on the fol¬ 
lowing pages reflect contributions made 
and endowment income accumulated 
between July 1, 1995, and June 30, 1996. 
The class members recognized made a gift 
to the fund during that period. Endowment 
income is not reflected in the class partici¬ 
pation percent. If we have inadvertently 
omitted your name, please accept our 
apologies and contact Mr. William K. 
Jenkins in care of this magazine so that 
we may correct this omission. 
1925 
Gift: $650 
Participation: 100% 
Samuel Reback 
1926 
Gift: $556 
Maxwell Bogin 
1927 
Gift: $1,452 
William C. Meredith 
1928 
Gift: $1,423 
Participation: 100% 
Edward R Kearney 
Nathan E. Ross 
1929 
Gift: $3,014 
Participation: 67% 
Olive Gates 
George S. Goldman 
John A. Hangen 
1930 
Gift: $702 
Knox H. Finley 
1931 
Gift: $6,427 
Participation: 50% 
Agent: 
Thomas C. Jaleski 
Reunion Gift 
Chairman: 
John B. Ogilvie 
Paul A. Harper 
Thomas C. Jaleski 
1932 
Gift: $3,213 
Participation: 38% 
Frank Carroll 
Lee E. Farr 
Myron E. Wegman 
1933 
Gift: $2,353 
Participation: 57% 
Agent: 
Fred W. Base 
Fred W. Buse 
Warren P. Cordes 
John G. Martin 
Francis M. Woods 
1934 
Gift: $5,290 
Participation: 57% 
Agent: 
John B. Ogilvie 
Joseph Budnitz 
Knowles B. Lawrence 
Herbert C. Miller 
John B. Ogilvie 
Harry Sherman 
1935 
Gift: $8,530 
Participation: 27% 
Agent: 
James Q. Haralambie 
H. Hoffman Groskloss 
James Q. Haralambie 
Samuel D. Kushlan 
1936 
Gift: $42,219 
Participation: 25% 
Agent: 
Nicholas D. D 'Esopo 
Reunion Gift Chairman: 
John B. Ogilvie 
Albert W. Diddle 
Margaret C. Gildea 
Philip M. LeCompte 
Stephen F. Nagyfy 
Margaret Sommers 
1937 
Gift: $12,133 
Participation: 53% 
Agent: 
Wilbur D. Johnston 
William G. Cooper Jr. 
Guido A. Deblasio 
Alfred E. King 
Dunham Kirkham 
Julia Mehlman- 
Greenhut 
James P. Morrill 
T. Dennie Pratt 
Morgan Sargent 
Albert D. Spicer 
John M. Thomas 
Jean Wells 
1938 
Gift: $6,498 
Participation: 60% 
Agent: 
Nelson K. Ordway 
Benjamin E. Lyons 
John J. McGillicuddy 
Nelson K. Ordway 
James Radcliffe Jr. 
George E. Roberge 
Theodore W. Steege 
Lester J. Wallman 
1939 
Gift: $164,743 
Participation: 76% 
Agent: 
Rebecca Z. Solomon 
Harold H. Coppersmith 
Norman L. Cressy 
William H. 
Druckemiller 
John P. Ferguson Jr. 
Joseph B. Forman 
S. Jerome Greenfield 
Arthur E. Laidlaw 
Margaret A. Lennox 
Buchthal 
James P. Murphy 
Douglas S. Riggs 
Ernest L. Sarason 
Bradford Simmons 
Rebecca Z. Solomon 
John D. Tobin 
Douglass W. Walker 
John H. Wentworth 
1940 
Gift: $7,040 
Participation: 65% 
Agent: 
James F. Ferguson Jr. 
Theodore E. Allen 
Joseph V. Baldwin 
Ronald S. Beckett 
Jack S. Blaisdell 
Wynant Dean 
Richard E. Dormont 
James F. Ferguson Jr. 
Eugene J. Fitzpatrick 
Henry D. Humphrey 
Donald G. Johnson 
Ira D. LeFevre Jr. 
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Paul D. MacLean 
Edward Martin 
Robert T. Rowe 
Lee S. Sannella 
Bryce A. Smith 
Patricia E. Wanning 
Helen H. Woods 
1941 
Gift: $31,320 
Participation: 65% 
Agent: 
Willys M. Monroe 
Reunion Gift Chairman: 
Peter Duncan 
Sophia C. Alway 
W. Randal Bell 
Charles B. Cheney 
Herbert W. Diefendorf 
Peter A. Duncan 
Lloyd D. Flint 
Frederick P. Glike 
Thomas S. Harvey 
William Lee 
Bjom Lih 
F. Eugene Martin 
Willys M. Monroe 
Edward B. O’Connell 
Robert W. Ollayos 
1942 
Gift: $20,400 
Participation: 74% 
Agent: 
Walter J. Burdette 
William E. Bloomer 
James M. Bunce 
Walter J. Burdette 
Robert E. Carroll 
Donald S. Childs Jr. 
Vincent J. Collins 
Hendrik DeKruif 
Davitt Felder 
William Harrison Jr. 
Leo Kellerman 
John R. Lincoln 
Samuel Ritvo 
Lois K. Rogers 
Charles F. Scholhamer 
Richmond W. Smith Jr. 
Carter Stilson 
Maurice Tulin 
Irving N. Wolfson 
1943-March 
Gift: $15,778 
Participation: 74% 
Agent: 
Dorothea R. Peck 
Ralph D. Alley 
John R. Brobeck 
Lycurgus M. Davey 
Gerard Fountain 
R. Leonard Kemler 
J, Philip Loge 
Henry E. Markley 
Dorothea R. Peck 
Edward F. Rabe 
Earl J. Rhoades 
Henry A. Riedel 
Bernard R. Rowen 
Marcus E. Sanford 
Edward H. Soule 
Hilliard Spitz 
Nicholas M. Stahl 
Oliver G. Stonington 
Sophie C. Trent-Stevens 
Morris A. Wessel 
Robert H. Wyatt 
1943-December 
Gift: $6,140 
Participation: 58% 
Agent: 
S. Brownlee Brinkley 
John R. Almklov 
David G. Borden 
Robert F. Bradley 
S. Brownlee Brinkley 
Henry B. Bruyn Jr. 
Thomas L. Bucky 
Jane B. Cadbury 
Donald G. Clark 
Hunter H. Comly 
Norman I. Condit 
Thomas D. Cook 
Ronald W. Cooke 
Joseph I. Epstein 
Robert H. Furman 
Henry H. Jones 
Joseph F. Kell 
Benjamin R. Robinson Jr. 
Donald W. Seldin 
W. Keasley Welch 
1944 
Gift: $88,138 
Participation: 83% 
Agent: 
Nicholas P.R. Spinelli 
Carl E. Andrews 
Edward J. Conway 
Robert E. Cooke 
John C. Coolidge 
George B. Corcoran Jr. 
Frank W. Countryman 
Charles H. Crothers 
Lawrence G. Crowley 
Sanford R. Dietrich 
John H. Doherty 
Robert W. Frelick 
Carol Goldenthal 
Howard B. Hamilton 
Robert I. Hinkley 
Donald H. Holden 
W. Raymond James 
Ward S. Jenkins 
Edith M. Jurka 
Harvey W. Kausel 
Jerome J. Kaye 
John W. King 
Frederick F. Krauskopf 
Edwin F. Lang Jr. 
Ronald E. Losee 
Ellen P. MacKenzie 
Katharine H. Martin 
Joseph Massaro 
A. Reese Matteson 
Russell R. Monroe 
Lawrence K. Pickett 
Laurence G. Roth 
Sarah P. Sherwood 
Nicholas P. Spinelli 
Priscilla D. Taft 
Anthony Varjabedian 
1945 
Gift: $21,651 
Participation: 67% 
Agent: 
Richard W. Breck 
George H. Allison 
Albert S. Atwood 
Richard W. Breck 
Louise H. Burr 
Alice S. Cary 
Thomas P. Cotter 
Richard R. Dyer 
Robert S. Easton 
Alice D. Friedman 
Raymond A. Gagliardi 
James D. Gardam 
Philip S. Good 
Herbert S. Hamed Jr. 
Isao Hirata Jr. 
O. Roger Hollan 
Hans R. Huessy 
Leland W. Jones 
Michael W. Lau 
William E. Laupus 
Mark M. Lindsey 
Charles U. Lowe 
James R. Mason 
Charles E. McLean 
George W. 
Naumburg Jr. 
Fitzhugh C. Pannill 
Charles E. Sherwood 
Joseph R. Stanton 
Kenneth C. Steele 
1946 
Gift: $1,155,059 
Participation: 80% 
Agents: 
Franklin C. Behrle 
Joe D. Morris 
Reunion Gift Chairman: 
Franklin C. Behrle 
Margaret J. Albrink 
Joseph A. Arminio 
William G. Banfield Jr. 
Aaron T. Beck 
Franklin C. Behrle 
Sanfurd G. Bluestein 
Linus W. Cave 
Thomas J. Coleman 
George C. Cusick 
Thomas A. Doe 
Edward F. Edinger 
Martin E. Gordon 
John C. Hoover 
Ruth S. Kempe 
Harold King 
James A. Kleeman 
Vincent J. Longo 
Hugh J. McLane 
Joe D. Morris 
John H. Morton 
John F. Neville Jr. 
Laura W. Neville 
Robert H. Owens 
Vincent Pepe 
David H. Riege 
Phillips E. Roth 
Julian A. Sachs 
Donald P. Shedd 
Richard G. Sisson 
R. Bruce Thayer 
Robert R. Wagner 
William P. Walsh 
William J. 
Wedemeyer Jr. 
Elihu S. Wing Jr. 
1947 
Gift: $37,838 
Participation: 77% 
Agents: 
George R. Barnes Jr. 
W. Roy Breg Jr. 
George R. Barnes Jr. 
Henry N. Blansfield 
John E. Bowers 
W. Roy Breg Jr. 
Rocco A. Calandruccio 
John L. Cannon 
Betty P. Carlin 
M. Richard Carlin 
John C. Carpenter 
Charles R. Cavanagh Jr. 
Robert A. Chase 
Amoz I. Chemoff 
William F. Collins Jr. 
Robert P. Darrow 
Archie L. Dean Jr. 
Owen W. Doyle 
Franklin H. Epstein 
Richard K. Friedlander 
Frank L. Golbranson 
Frank H. Horton 
Robert J. Kerin 
Brock Lynch 
Victor A. Machcinski 
William K. McClelland 
Robert F. Newton 
Myron K. Nobil 
Philip H. Philbin 
Olive E. Pitkin 
Irving Rudman 
Alvin Somberg 
Patricia B. Tudbury 
Ellis J. Van Slyck 
M. Henry Williams Jr. 
1948 
Gift: $6,300 
Participation: 64% 
Agent: 
Anne Godley 
George F. Batten 
Edith M. Beck 
Jonathan S. Bishop 
Richard S. Buker Jr. 
Elizabeth F. Eisner 
Albert A. Fisk 
Emil Frei 
Julian Frieden 
Anne Godley 
Paul S. Goldstein 
B. Herold Griffith 
Sylvia P. Griffiths 
Richard M. Hannah 
Ross R. Harcus 
Paul B. Koehler 
Robert E. Lempke 
John P. Morris 
John B. Morrison 
David E. Morton 
Richard C. Peterson 
George P. Rostel 
Lewis P. Rowland 
Benjamin F. Rush Jr. 
Jerome H. Shapiro 
William A. Sibley 
Jessie P. Spear 
Paul Talalay 
Wallace W. Turner 
Paul W. Weld 
1949 
Gift: $5,136 
Participation: 67% 
Agent: 
Daniel W. Elliott 
William G. Anlyan 
DeWitt C. Baldwin Jr. 
Jonathan S. Bishop 
Mary P. Couchman 
Phillip G. Couchman 
N. Joel Ehrenkranz 
Daniel W. Elliott 
Albert A. Fisk 
Eleanora C. Gordon 
Frederic W. Gray 
Daniel K. Halvorsen 
Jackson Harris 
Frederick R. Hine 
Gordon D. Jensen 
Benjamin A. Johnson 
Frank D. Law 
Orlando J. Miller 
Timothy F. Nolan Jr. 
Julian I. Pichel 
Charles L. Rennell Jr. 
Murray Z. Rosenberg 
Carl M. Russell 
Lawrence E. 
Shulman 
Martha Vaughan 
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Vernon T. Watley 
Mary-Agnes P. Wine 
1950 
Gift: $35,751 
Participation: 65% 
Agent: 
Jane B. Shumway 
Lyal D. Asay 
Sylvia L. Axelrod 
Malcolm A. Bagshaw 
John E. Borowy 
William H. Bucher 
Alvin Davis 
Claude W. Delia 
Marie C. Duncan 
Kent Ellis 
Thomas J. Ferraro Jr. 
Daniel Fine 
Lawrence R. Freedman 
David A. Frucht 
Carl A. Gagliardi 
Lucian S. Lapinski 
Janus C. Lindner 
Margaret S. Lyman 
Harold March 
Harry L. McClelland 
Robert T. McSherry 
John H. Meyers 
Orlando J. Miller 
Charles A. Nugent Jr. 
Robert T. Sceery 
Cynia B. Shimm 
Jane B. Shumway 
John S. Strauss 
Myra D. Tyler 
1951 
Gift: $110,013 
Participation: 49% 
Agent: 
Lowell I. Goodman 
Reunion Gift Chairman: 
Arthur A. Pava 
Frank R. Allen 
Thomas T. Amatruda Jr. 
Muriel H. Bagshaw 
John W. Berg 
Eleanor C. Bigley 
Paul R. Bruch 
John J. Egan 
Sidney S. Furst 
Lowell I. Goodman 
John T. Groel 
Robert N. Hamburger 
John V. Haxo 
Carrold K. Iverson 
Robert D. King 
Jocelyn S. Malkin 
Walter S. Morgan 
Albert R. Mowlem 
Richard S. Munford 
Ismail N. Nevin 
Alfred Owre Jr. 
Arthur A. Pava 
Harold M. Sterling 
John H. Sullivan 
Andrew S. Wong 
1952 
Gift: $6,134 
Participation: 70% 
Agent: 
Sidney N. Paly 
Maurice L. Bogdonoff 
Frank R. Coughlin Jr. 
Richard N. deNiord Jr. 
Richard D. Floyd 
Robert P. Gerety 
Marvin H. Goldberg 
Arthur P. Hustead 
William J. Johnson 
Thomas S. Kelly 
James K. Luce 
Joseph A. Montimurro 
N. Karle Mottet 
Robert L. Nolan 
Robert F. Owen 
Sidney N. Paly 
Robert G. Petersdorf 
Leon A. Phillips 
John M. Roberts 
Elizabeth M. Rush 
Leonard Rush 
Mary W. Schley 
Donald H. Schultz 
Robert B. Schultz 
John H. Wagner Jr. 
Doris L. Wethers 
John L. Wolff 
1953 
Gift: $20,647 
Participation: 65% 
Agent: 
Vincent L. Gott 
Seth F. Abramson 
Harold D. 
Bomstein Jr. 
Remi J. Cadoret 
William R. Chaffee 
Allen Chetrick 
Rex B. Conn 
John L. Doppman 
James P. Dunn 
Thomas O. Gentsch 
Vincent L. Gott 
Robert E. Hamlisch 
A. Daniel Hauser 
George L. Hoffmann 
David P. Holman 
Peter B. Hukill 
Richard R. Knowles 
Frederick M. Lane 
Hildegard M. Leslie 
Preston L. Leslie 
Robert N. Melnick 
Harvey M. Peck 
Warwick Potter Jr. 
Paul G. Quie 
Jose Ramirez-Rivera 
John C. Roberts 
Barbara F. Rosenberg 
Irwin K. Rosenberg 
Virginia C. Saft 
Richard A. Sinnott Jr. 
Ora K. Smith 
John F. Snyder 
Lynn C. Stoker 
William J. Vandervort 
William A. Wilson 
James F. Young 
1954 
Gift: $6,764 
Participation: 82% 
Agent: 
John K. Rose 
Frank P. Berg 
George W. Bostwick 
Richard J. Bouchard 
George N. Bowers Jr. 
Ralph K. Campbell 
John R. Cole 
Alan H. Covey 
Arthur C. Crovatto 
Donald D. Davis 
Walter J. Freeman 
Orlando F. Gabriele 
John A. Gariepy 
Edward J. Gerety 
Samuel T. Giammona 
Frank L. Gruskay 
Nicholas A. Halasz 
Katherine H. Halloran 
Robert P. Hatch 
Walker R. Heap Jr. 
Eva H. Henriksen 
Samuel J. Hunter 
Herbert S. Hurwitz 
Robert F. Hustead 
Robert J. Joy 
Robert M. Keith 
Donald S. Komfeld 
Lowell A. Kristensen 
Richard Lamb 
Harry C. Miller Jr. 
Paul N. Neufeld 
James J. Nora 
William S. Palmer 
William J. Paule 
Anthony V. Piccirillo 
Richard D. Pullen 
Jacques M. Quen 
John K. Rose 
Elihu M. Schimmel 
Leonard M. Silverman 
Robert L. Stein 
Martin B. Vita 
John W. Vosskuhler 
1955 
Gift: $27,040 
Participation: 55% 
Agent: 
Robert A. Kramer 
John B. Atwater 
John C. Bailar III 
George E. Becker 
E. Edward Bittar 
Jerome Bobruff 
Douglas G. Boyden 
Irwin M. Braverman 
Padraic Burns 
Paul Calabresi 
Joseph A. Camilleri 
Leo R. Cardillo 
Nicholas A. Coassin 
Pasquale J. Costa 
Robert G. Crounse 
John G. Daley 
Fred W. Doyle 
Leroy Engel 
Edwin G. Fernand 
Mahlon V. Freeman 
James C. Garlington 
Paul Gonick 
Dicran Goulian Jr. 
Ion Gresser 
Milton J. Hirshberg 
John H. Hodge 
D. Franklin Johnson Jr. 
Harry O. Kendall 
David R. Kessler 
Robert A. Kramer 
Edward A. Krull 
Roger Lester 
James Lum 
Alexander Maitland III 
Joseph S. McGuire Jr. 
David J. Nelligan 
James P. Nolan 
Edward J. Ottenheimer Jr. 
Robert H. Peters Jr. 
Robert A. Reich 
Paul J. Robinson 
Alan A. Stone 
Paul R. Stowell 
Vito J. Zupa 
1956 
Gift: $108,123 
Participation: 78% 
Agents: 
John H. Gardner III 
Donald J. Dalessio 
Reunion Gift Chairman: 
Dwight F. Miller 
Suzanne S. Becker 
Alvin D. Benjamin 
Levon Z. Boyajian 
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Thomas M. Brown 
Rosalie A. Burns 
John F. Carroll 
Joseph C. Cerny 
Edwin L. Child 
James C. Collias 
Chandler Dawson 
S. Evans Downing 
Mitchell Edson 
Gilbert M. Eisner 
Thomas F. Ferris 
John H. Gardner III 
Sumner H. Gochberg 
Val S. Greenfield 
Robert H. Groves 
Alan R. Gurwitt 
Armen C. Haig 
Joan M. Hardenbergh 
John H. Hart 
Robert L. Hill 
William H. Hindle 
Charles L. Hopper 
Marie-Louise T. Johnson 
George T. Kammerer 
Jerome O. Klein 
William V. Lewit 
Jacob Mainzer Jr. 
Preston C. Manning 
Dwight F. Miller 
Norman F. Moon 
Donald J. Nalebuff 
William M. Narva 
A. Frederick North Jr. 
William M. O’Brien 
David A. Page 
James R. Patrick 
George W. Paulson 
Robert L. Powell 
Stewart E. Pursel 
Robert J. Rice 
Robert Scheig 
James Scheuer 
Edward C. Senay 
Benjamin A. Shaver Jr. 
Donald W. Sherrick 
Daniel R. Silbert 
Bruce Trembly 
Theodore K. Tseu 
Marion B. Warbasse 
1957 
Gift: $32,325 
Participation: 70% 
Agents: 
Harry C. Briggs 
Howard A. Minners 
Donald Agostinelli 
Joseph S. Amenta 
Jack N. Blechner 
Richard I. Breuer 
Harry C. Briggs 
John P. Carey 
Albert K. Chun-Hoon 
Louis Z. Cooper 
Harold D. Cross 
Brian Crowley 
Thomas H. Danaher 
James R. Dorr 
Salvatore Falbo 
Elizabeth H. Forsyth 
Gary A. Fry 
Robert H. Glass 
Anne H. Good 
Jack P. Green 
Malcolm Hill 
Gilbert F. Hogan 
Warren R. Johnson 
Richard L. Kahler 
Stanley E. Kilty 
William L. Kissick 
Edgar H. Levin 
Jack Levin 
Bennett F. Markel 
Mark D. Marshall 
David E. Martin III 
Howard A. Minners 
Robert K. Modlin 
Hugh L. Moffet 
George A. Nelson Jr. 
Herbert A. Newman 
Thomas F. O'Brien Jr. 
Joseph S. Pagano 
Raymond E. Phillips 
Clifford B. Reifler 
Arnold Schoolman 
Stanley Simbonis 
Charles A. Slanetz Jr. 
Gilbert B. Solitare 
Donald C. Stahl 
Arthur Taub 
Romeo Vidone 
William J. Waskowitz 
James G. Zimmer 
1958 
Gift: $77,752 
Participation: 59% 
Agents: 
Andrew J. McGowan Jr. 
Paul A. Rudnick 
George K. Aghajanian 
Don P. Amren 
Joseph E. Angelo 
John P. Arnot 
Frederick Baekeland 
Peter A. Benson 
William C. Branscome 
A. Russell Brenneman 
Gerard N. Burrow 
Benjamin Bursten 
David A. Carlson 
John A. Carlston 
Joseph J. Cillo 
Robert V. Diserens 
Robert J. Donohue Jr. 
Lawrence Dubin 
Donald A. Duncan 
Joel C. Eberlin 
Philip R. Fazzone 
Michael E. Fishman 
Raymond A. Gaito 
Marcia K. Goin 
William M. Gould 
James Greenwald 
Charles A. Hall Jr. 
Stanley Harris 
Roger C. Herdman 
Michael Kashgarian 
Haskins K. Kashima 
Jay W. Kislak 
Morton M. Kligerman 
Theodore W. Lieberman 
Myron Lotz 
Jack W. Love 
Thomas J. Mauro Jr. 
Michael J. McCabe 
Andrew J. McGowan Jr. 
John A. Merritt Jr. 
Richard C. Miller 
Robert S. Neuwirth 
Carol F. Phillips 
David M. Pugh 
William B. Radcliffe 
Paul A. Rudnick 
Bruce H. Sklarew 
Edward L. Socolow 
Arlene Sweedler 
Raymond W. Turner 
Margaret S. Wenzel 
John P. Wood 
Pauline B. Wood 
Robert W. Wroblewski 
1959 
Gift: $19,573 
Participation: 56% 
Agents: 
Asa Barnes Jr. 
Muriel D. Wolf 
Scott I. Allen 
Carol J. Amick 
Robert M. Amick 
Asa Barnes Jr. 
Jack F. Bowers 
William C. Butterfield 
Edwin M. Clayton 
Sidney M. Cohen 
Martin Colodzin 
Ronald C. De Conti 
William L. Donegan 
Gerald Fenichel 
Robert L. Fisher 
Paul J. Friedman 
Eric Gillett 
Gerald B. Gordon 
W. Keith Hadley 
James H. Halsey Jr. 
H. Rodney Hartmann 
William H. Heydom 
C. Richard Hinckley 
Leonard Inker 
William J. Jablonski 
John J. Jasaitis 
Edvardas Kaminskas 
Herbert J. Kaufmann 
Kristaps J. Keggi 
David W. Kingsbury 
Parry B. Larsen 
Myron S. Lee 
Kathryn H. Lewis 
John C. Marsh 
Brian J. McGrath 
Peter M. Molloy 
James A. O'Neill Jr. 
Nicholas M. Passarelli 
Lincoln T. Potter 
James D. Prokop 
James R. Ralph 
David P. Reed 
Joseph D. Saccio 
Constantine J. Sakles 
Marc D. Schwartz 
Owen A. Shteir 
David B. Skinner 
Carl H. Smith 
Gene W. Spector 
James J. Stagnone 
Lisa A. Steiner 
John S. Strauss 
Leo H. Von Euler 
Robert B. Whitney Jr. 
Muriel D. Wolf 
1960 
Gift: $17,753 
Participation: 63% 
Agent: 
Thomas P. Kugelman 
Victor A. Altshul 
Alan W. Ames 
Jack D. Barchas 
Colin M. Bloor 
Stuart P. Bowne 
Donald P. Buebendorf 
Thomas E. Carson 
Francis D. Cogliano 
Neil R. Cooper 
Jon E. Courtney 
John M. Davis 
Malin Dollinger 
Caldwell B. Esselstyn Jr. 
Warren H. Fisher 
Paul J. Friedman 
Eugene C. Gaenslen Jr. 
Gary E. Gathman 
James I. Gilman 
Irving Guttenberg 
Daniel M. Jones 
William S. Kaden 
Eric P. Kindwall 
Frank J. Kleeman 
Susan T. Kleeman 
Thomas P. Kugelman 
Alcide M. LaNoue 
Edward R. Lang 
Robert Marcus 
Donald L. Miller 
Richard G. Morrill 
Buford L. Nichols Jr. 
Fred Palace 
Jerrold M. Post 
Martin L. Reite 
Albert M. Ross 
Daniel J. Rubin 
John J. Schrogie 
Ross L. Snyder Jr. 
Fred L. Stargardter 
Robert C. Wallach 
May Y. Wang 
Ronald A. Yankee 
1961 
Gift: $65,578 
Participation: 58% 
Agent: 
Robert S. Briggs 
Reunion Gift Chairman: 
Anoush Miridjanian 
Earl L. Baker 
Frank H. Baker 
Albert A. Bechtoldt Jr. 
Robert S. Briggs 
David W. Brook 
Ralph J. DePonte 
Orson R. Dee 
Paul D. Deiter 
Jon D. Dorman 
John E. Fenn 
Charles F. Gibbs 
David D. Griffith 
Walter J. Hierholzer Jr. 
Royal C. Hudson Jr. 
Louis D. Hunt 
Richard L. Keefe 
Robert I. Levy 
George M. Lordi 
Hugh J. Lurie 
Sally L. Marchesi 
Vincent T. Marchesi 
David B. Matloff 
Anoush Miridjanian 
Richard A. Moore 
John K. Pearce Jr. 
Elaine Pitt 
Bruce C. Robinson 
William M. Rogoway 
Roy E. Ronke Jr. 
Shaun Ruddy 
Thomas H. Sakoda 
Stanley G. Schade 
John H. St. Andre 
Robert N. Taub 
Franklin H. Top Jr. 
David E. Weaver 
Warren D. Widmann 
Murray Wittner 
1962 
Gift: $34,524 
Participation: 55% 
Agents: 
Fredric K. Cantor 
A. Richard Pschirrer 
Michael H. Alderman 
Charles B. Anderson 
Frederic P. Anderson 
Spencer J. Brody 
Fredric K. Cantor 
Ray A. Carlsen 
Thomas N. Chase 
Yale medicine 49 
Oliver T. Dann 
Arnold J. Eisenfeld 
I. Bruce Elfenbein 
Joseph D. Ferrone Jr. 
John W. Foreman 
Stephen J. Fricker 
John N. German 
David H. Groth 
Roderick C. Haff 
John H. Hageman 
John T. Harrington 
Patricia C. Hassakis 
Cornelis Heijn 
Gary Jacobson 
Walter W. Karney 
Glenn L. Kelly 
David E. Knoop 
Bernard Kosto 
Manuel J. Lipson 
Richard E. Marshall 
Allan L. Mattem 
Stanley E. Matyszewski 
David J. McConnell 
William A. Miller 
David D. Nicholas 
A. Richard Pschirrer 
Joseph Ross 
James A. Spencer 
Nancy A. Staley 
Larry L. Stewart 
Seth U. Thaler 
William F. Weber 
Stewart R. Wright 
1963 
Gift: $16,696 
Participation: 44% 
Agent: 
Craig H. Llewellyn 
Barbara R. Almond 
Miguel R. Alonso 
V. Richard Back 
Wayne D. Brenckman Jr. 
Charles W. Carl Jr. 
Theodore J. Chu 
Gordon S. Cohen 
John E. Conte Jr. 
James S. Dalsimer 
Dudley S. Danoff 
Andrew Edin 
John P. Eliopoulos 
Jon M. Fessel 
Alan L. Folsom 
David H. Fram 
William T. Friedewald 
David H. Fulmer 
Vincent F. Geremia Jr. 
Lee D. Goldberg 
Peter B. Gregory 
Benjamin K. Harris 
Stephen C. Joseph 
Brian C. Judd 
Harold P. Kaplan 
Constantine D.Kyropoulos 
Edward C. Larkin 
William B. Lehmann 
Craig H. Llewellyn 
Edward G. Lund Jr. 
John L. Mahoney 
Robert H. Margulis 
Herbert Y. Meltzer 
Robert E. Mueller 
Sheldon R. Pinnell 
Jay M. Pomerantz 
William F. Porter Jr. 
Berkeley L. Rich 
Gaylord Rockwell 
Thomas A. Savignano 
Alan E. Shapiro 
Marvin R. Skolnick 
Lee B. Talner 
Richard M. Thompson 
Thomas W. Tillack 
Peter V. Tishler 
Lawrence Tremonti 
Helen N. Walsh 
Peter G. Weiner 
Seth M. Weingarten 
James G. Wepsic 
Charles S. Wilson 
Edward F. Wilson 
Jerome A. Winer 
Alfred J. Wise 
1964 
Gift: $10,197 
Participation: 48% 
Agents: 
Berton W. Ashman 
Robert W. Lyons 
Berton W. Ashman 
Sidney M. Baker 
Philip Blume 
Anthony J. Bravo 
William V. Brown 
Thomas A. Cardella 
Joseph F. Curi 
Paul F. Dodd 
Anthony A. Ferrante 
Norman C. Fost 
Barry Gault 
Peter A. Gross 
John F. Haney 
Christopher W. Hauge 
Richard Hockman 
Lawrence Horwitz 
William J. Houghton 
Sue Y. Kimm 
William E. Knight 
Lewis Landsberg 
Richard V. Lee 
Thomas L. Lentz 
David B. Leof 
James S. Levine 
Paul R. Lightfoot Jr. 
Robert W. Lyons 
Andrew E. MacMahon 
William F. Matched 
Robert L. Mitchell 
Alan H. Morris 
James J. Murphy 
Donald A. O’Kieffe Jr. 
William B. Pratt 
Jack S. Rice Jr. 
Stanley J. Rosenberg 
Richard P. Saik 
SaulM. Schanberg 
Norman Scher 
A. Thomas Snoke 
Sigrid L. Tishler 
Lee Van Lenten 
Stephen Waltman 
Oscar Wand 
1965 
Gift: $45,553 
Participation: 62% 
Agent: 
David A. Hill 
Jon R. Almquist 
Susan A. Aoki 
Thomas T. Aoki 
John H. Austin 
Paul Balter 
Hector R. Bird 
Victor J. Burner 
Thomas B. Caldwell III 
David G. Campbell 
Grant L. Christian 
Robert M. Cohn 
Michael J. Cummings 
Carl Ellenberger Jr. 
David S. Fedson 
Robert I. Finkel 
Michael P. Flynn 
Richard 1. Frankel 
Christopher C. Gates 
Gary L. Gross 
James K. Gude 
Reid R. Heffner Jr. 
David A. Hill 
Carl E. Hunt 
Virginia B. Johnson 
Ronald J. Karpick 
Mohandas M. Kini 
Robert H. Koehl 
Richard J. Kozera 
Sandra C. Levine 
Mark W. Lischner 
Michael B. Mayor 
David Murdock 
Walter W. Noll 
A. Lawrence Ossias 
Robertson Parkman 
John A. Parrish 
Robert L. Pickens 
Alan N. Rachleff 
William A. Renert 
George B. Rowland 
John F. Schilke 
Margretta A.R. 
Seashore 
David P. Simmons 
Robert T. Solis 
Harlan Spitz 
Alan W. Stone 
Jonathan Titus 
Robert G. Weiner 
1966 
Gift: $93,220 
Participation: 53% 
Agents: 
Mary A. Houghton 
Gary L. Townsend 
Reunion Gift Chairman: 
John D. Baxter 
Benjamin F. Balme 
John D. Baxter 
Patricia Bazemore 
Robert P. Bazemore 
Frank C. Bell 
Philip Bernstein 
James E. Brown 
Eugene P. Cassidy 
Donald J. Cohen 
Thobum A. Dadisman Jr. 
Joseph A. Donadio 
Robert N. Frank 
Peter D. Gibbons 
Stanley I. Greenspan 
J. McLeod Griffiss 
Robert A. Gunn 
Henry G. Hanley 
Jay G. Hayden 
Mary A. Houghton 
Richard J. Howard 
Stuart M. Kotler 
Wilbur L. Kukes 
Lynne L. Levitsky 
Henry B. Mann 
David B. Melchinger 
Harold Mellin 
William Y. Moores 
Eli H. Newberger 
Edward J. O'Keefe 
William D. Peterson 
James D. Slavin Jr. 
Reynold Spector 
Parker J. Staples 
Lawrence J. Toder 
Arne S. Youngberg 
1967 
Gift: $16,943 
Participation: 58% 
Agent: 
Richard B. Swett 
Daniel L. Arons 
Arthur L. Beaudet 
Richard S. Bockman 
Arthur W. Boddie Jr. 
Daniel J. Booser 
Gary C. Burget 
William T. Cave Jr. 
Mary W. Clark 
Cynthia J. Curry 
Marian C. Davidson 
James L. Davis III 
James J. Dineen 
Timothy J. Dondero Jr. 
Alexander F. Dora 
James M. Dowaliby 
John A. Drews 
Peter R. Egbert 
Dennis G. Egnatz 
Herbert W. Felsenfeld 
Melvin V. Goldblat 
Richard J. Hart Jr. 
Richard L. Heppner 
Peter N. Herbert 
George P. Herr 
David L. Ingram 
Mary Jurbala 
J. Robert Kirkwood 
Melvyn Korobkin 
Carl E. Lane 
Anthony P. Lovell 
Carl K. Marling 
James V. Miller 
Stephen W. Miller 
Joseph L. Morris 
John O. Pastore 
William E. Perkins 
Daniel F. Phillips 
Brian F. Rigney 
Jonathan L. Saveli 
Alfred Q. Scheuer 
Stephen C. Schimpff 
Sidney C. Smith Jr. 
Helen L. Smits 
Lewis S. Solomon 
Robert S. Steinberg 
Richard B. Swett 
M. David Tilson III 
Karen H. Toker 
Robert A. Vogel 
Robert A. Vollero 
Joseph F. Walter 
Martin Wand 
Redford B. Williams Jr. 
Robert J. Winer 
Robert S. Young 
Ihor G. Zachary 
Peter M. Zeman 
1968 
Gift: $12,370 
Participation: 52% 
Agents: 
Rutledge W. Currie 
Donald O. Lyman 
Philip L. Barry 
Daniel I. Becker 
Bernard D. Beitman 
Grace J. Boxer 
William Catalona 
Donald R. Coustan 
Rutledge W. Currie 
Robert G. Dillard 
Edward M. Druy 
Barbara M. Egbert 
Alan G. Finesilver 
William F. Flynn 
Richard A. Getnick 
Mark G. Grand 
Leonard Grauer 
Ralph S. Greco 
John R. Hill 
Thomas R. Johnson 
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Peter Jokl 
William F. Keane 
Daniel E. Keim 
Peter A. Kirkpatrick 
Jeffrey S. Lee 
Marc E. Lippman 
Frank E. Lucente 
Donald O. Lyman 
Stephen I. Marglin 
Rodrigo Martinez 
John A. McCutchan 
Harmon Michelson 
David P. Millett 
Richard P. Mills 
Richard M. 
Morehead Jr. 
James B. Morris 
Peter Nicholas Jr. 
Margot Onek 
Henry F. Panek 
Jackson B. Pickett III 
Charles T. Post Jr. 
Ralph J. Rauch 
Joseph L. Renda 
Gordon H. Sasaki 
Peter W. Scherer 
Frederick C. Sherman 
Elizabeth M. Short 
Howard W. Siegel 
Gerald L. Springer 
Lee H. Strohl 
Edmund C. 
Tortolani Jr. 
James L. Weiss 
Per H. Wickstrom 
Creed W. Wood 
1969 
Gift: $413,410 
Participation: 56% 
Agent: 
Adrian M. Schnall 
Charles S. Angell 
David G. Ansel 
David W. Barry 
Robert E. Belliveau 
Donald H. Buchholz 
Thomas E. Ciesielski 
Joseph P. Cleary 
N. Roger Cooke 
Leo M. Cooney Jr. 
Richard J. Daly 
Michael W. Dennis 
Charles A. Dinarello 
Douglass T. Domoto 
Daniel M. Eichenbaum 
Ralph J. Falkenstein 
Gary S. Farnham 
B. Graeme Fincke 
Lesley F. Fishelman 
Anna S. Gail 
Royal J. Gay 
Sander G. Genser 
Robert O. Gordon 
John F. Hiatt 
Thomas C. Howard 
Lee M. Jampol 
Joel M. Kaufman 
Paul H. Kelker 
John J. Kelly Jr. 
Rowena Korobkin 
Lynn G. Lagerquist Jr. 
Michael R. Liebowitz 
Elliot M. Livstone 
C.E. Long III 
Robert L. Marier 
Arnold F. Mazur 
Ellen B. Milstone 
Thomas F. Minehan 
Bruce K. Nagle 
Lionel M. Nelson 
Nancy Olmsted 
Timothy A. Pedley 
Deborah A. Putnam 
Joseph D. Robinson 
Joseph M. Rochford 
Jonelle C. Rowe 
Dennis J. Rudzinski 
Lutz H. Schlicke 
Adrian M. Schnall 
David J. Schulak 
Andrew Schwartz 
Gerald J. Smallberg 
Robert J. Walat 
Stephen R. Webb 
Carolyn K. Wells 
1970 
Gift: $29,319 
Participation: 52% 
Agent: 
James R. Missett 
Elissa B. Arons 
John W. Blanton Jr. 
Paul E. Braun Jr. 
Henry Chessin 
M.J. Chusid 
Anne M. Curtis 
Michael H. Cynamon 
James E. DeLano Jr. 
Daniel F. Dedrick 
W. Montague Downs 
Jonathan Ecker 
Richard L. Edelson 
Robert A. Epstein 
Bruce A. Fabric 
Harvey Fembach 
Robert D. Gilbert 
Thomas H. Gouge 
Paul C. Hessler 
Jay H. Hoofnagle 
Jonathan D. Katz 
Gerard T. Kennealey 
Mark A. Korsten 
Thomas L. Lewis 
Robert B. Litman 
Anne W. Lucky 
Roger A. Mason 
Leonard M. Milstone 
James R. Missett 
William K. Mueller 
Lynn W. Reiser 
Bruce A. Reitz 
Joel F. Rubinstein 
Dennis E. Shield 
Stuart S. Shorr 
Richard A. St. Onge 
Robert S. Stem 
Daniel A. Symonds 
Ray W. Tripp III 
C. Brace Wenger 
Joellen Weme 
Daniel Wuensch 
Karl O. Wustrack 
Marc O. Yoshizumi 
1971 
Gift: $301,308 
Participation: 70% 
Agents: 
John L. Cieply 
Barbara K. Kinder 
Reunion Gift Chairman: 
Richard A. Moggio 
Judith L. Bader 
Gregory W. Bartha 
Michael J. Beierle 
Bruce Block 
Marian H. Block 
John L. Cieply 
Frederick L. Cohn 
Andrew D. Cook 
David Cossman 
Edward C. Cottle 
John S. Ebersole 
Leonard I. Eisenfeld 
Thomas Etkin 
Daniel E. Feldman 
Fred Finkelman 
John W. Foster Jr. 
Jared J. Gardner 
Richard B. Gloor 
Allan W. Graham 
Jerold A. Haber 
Michael J. Hart 
William W. Hay Jr. 
W. Robin Howe 
N. Timothy Jette 
Richard Katzman 
Robert M. Kessler 
Barbara K. Kinder 
Ralph J. Kirmser 
Stuart R. Kleeman 
Michael E. Klein 
William L. Krinsky 
Gary M. Lande 
Laurence W. Levinger 
David H. Lippman 
Robert A. Mackey 
William J. Mangione 
Samuel S. Masters 
Patrick T. Minihan 
Steven H. Moffic 
Richard A. Moggio 
Martin Paris 
John A. Patti 
Barry B. Perlman 
Stuart B. Phillips 
Michael C. Piercey 
Irving G. Raphael 
Joan M. Reese 
David M. Rinzler 
Douglas R. Schmidt 
John Smiarowski 
James P. Southwick 
Jonathan W. Stewart 
Daniel R. Synkowski 
Semeon G. Tsalbins 
Paul A. Vignola 
Robert B. Vranian 
Albert C. Weihl 
Jerold C. Woodhead 
Burns Woodward 
Daniel G. Wright 
1972 
Gift: $10,424 
Participation: 59% 
Agent: 
Harry L. Malech 
Robert D. Arbeit 
R. Michael Buckley Jr. 
Leonard H. Cohen 
Philip L. Cohen 
Norman M. Dinerman 
William H. Drackemiller Jr. 
M. Felix Freshwater 
John P. Fulkerson 
Robert D. Glassman 
Dorothy M. Gohdes 
Robert F. Goodman 
Andrew H. Greenhill 
Bruce B. Haak 
Thomas L. Horn 
Vernon H. Humbert Jr. 
Anthony H. Jackson 
Jesse B. Jupiter 
Frank M. Kahr 
Roy A. Kaplan 
Michael A. Kaufman 
Donald L. Kent 
Philip W. Lebowitz 
Theodore M. Levin 
Paul A. Lucky 
Harry L. Malech 
John E. Mayer Jr. 
Jeffrey S. Menkes 
Jerome H. Meyer 
David B. Moyer Jr. 
John P. O'Grady 
Edward J. Olinger 
Marc B. Osias 
William L. Risser 
Richard S. Robbins 
David H. Ronrond 
Philip M. Rothfeld 
Charles F. Scholhamer 
Frederick D. Stockwell 
Gary M. Strauss 
Lawrence P. Temkin 
Philip J. Weyman 
Brooke M. Wolf 
Michael W. Yogman 
Steven M. Zeldis 
1973 
Gift: $8,022 
Participation: 60% 
Agents: 
John F. McQuade 
Jerrold F. Rosenbaum 
David A. Adler 
David A. Baggish 
David N. Bailey 
Mary Ann 
Brunstetter-Shafer 
James N. Campbell 
Marvin M. Chassin 
William T. Choctaw 
F. Sessions Cole III 
Joseph M. Connors 
David L. Coulter 
Carolyn G. Dedrick 
Christopher M. Doran 
Jane H. Ferguson 
Richard J. Fingeroth 
Robert A. Florin 
Lee Goldman 
Gary V. Gordon 
Gary T. Grimes 
Neal Handel 
Frederick M. 
Henretig 
Jorge L. Hernandez 
Howard S. Honig 
John M. Kirkwood 
Michael S. Kramer 
Lynne M. Liptay 
George Lister Jr. 
Harold R. 
Mancusi-Ungaro Jr. 
John A. McDowell 
John F. McQuade 
Jerry Nagler 
James A. Neviackas 
Claes M. Nilsson 
David E. Peach 
John W. Popp Jr. 
Robert H. Posteraro 
Thomas J. Romano 
Harry S. Romanowitz 
Jerrold F. Rosenbaum 
John P. Sherck 
George D. Shoup 
Joseph F. Simeone 
Robert A. Sirota 
Carole H. Stashwick 
Charles F. Stroebel 
James F. Sullivan 
Thomas F. Sweeney 
Robert J. Ursano 
Christine A. Walsh 
Marc A. Weinberg 
Richard S. Young 
1974 
Gift: $8,275 
Participation: 49% 
Agents: 
Robert J. Schechter 
Amy Starr 
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Irving M. Asher 
Leonard I. Banco 
Ralph E. Binder 
Neil Blumberg 
Ronald C. Brown 
Peter J. Buchin 
Robert A. Caine 
Richard A. Cazen 
Richard F. Clarke 
Bert D. Collier Jr. 
Paul David 
Vincent A. Di Maria 
Irl L. Extein 
Allan B. Friedland 
Michael A. Gerber 
Harvey Gerhard 
Alan A. Halpern 
Robert F. Hempton 
Edward O. Janosko 
Robert M. Jarrett 
Robert C. Jimerson 
Marie T. Kelly 
Dahlia V. Kirkpatrick 
Robert M. Kolodner 
Saul Lande 
Edward L. Marut 
Andrew R. Mayrer 
James R. McMonagle 
Daniel A. Moros 
Marjorie A. Oda 
Richard C. Pasternak 
Andrew L. Ries 
David Z. Ritvo 
John D. Schrumpf 
Harry Shamoon 
Alan B. Silken 
Barry S. Solof 
Amy Starr 
James A. Strom 
George H. Talbot 
Carol C. Teitz 
Edward M. Wolin 
1975 
Gift: $9,713 
Participation: 27% 
Agents: 
Mary Jane Minkin 
Phillip J. Rich 
Yvonne L. Burnett 
William S. Bush 
Rodney J. Butch 
Chau V. Dang 
Jeffrey J. Davis 
Robert G. Drake Jr. 
Stanley W. Gale 
Elizabeth R. Gawron 
Alfred C. Gaymon 
Paul A. Johnson 
Kevin Kane 
George D. Knowles 
Richard J. 
Loewenstein 
Bruce McLucas 
Hyman J. Milstein 
Mary Jane Minkin 
Robert G. Nankin 
Andrew B. Newman 
Kwaku Ohene-Frempong 
George J. Pardos 
Mary L. Polan 
Vivian Reznik 
Philip J. Rich 
Robert S. Sandler 
Frederick S. Sherman 
Thomas W. Smith 
Morris J. Westfried 
Henry S. Willner 
David W. Wiltse 
1976 
Gift: $93,915 
Participation: 51% 
Agent: 
William K. Levy 
Reunion Gift Chairman: 
Alfredo L. Axtmayer 
Alfredo L. Axtmayer 
Alan B. Bloch 
Sharon L. Bonney 
Roger A. Boshes 
William D. Carlson 
Randall D. Cebul 
Helen Y. Chang 
Pauline Y. Chao 
Richard S. Childs Jr. 
Joseph Ciabattoni 
John D. Clemens 
Ellen C. Cooper 
Kenneth J. Dobuler 
Gary S. Dorfman 
John A. Elefteriades 
Geoffrey Etherington 
Richard A. Frank 
Susan R. Gaynon 
Ira H. Gewolb 
Rose H. Goldman 
Randall S. Hawkins 
Clarion E. Johnson 
JoelKabak 
David T. Kawanishi 
Richard D. Kayne 
Carol H. Lee 
William K. Levy 
Sidney Mandelbaum 
Cynthia F. Mann 
Josefina V. Marin 
Frederick C. Morin III 
Jon S. Morrow 
Richard L. Neubauer 
O’dell M. Owens 
N.T.S. Quao 
Daniel W. Rahn 
Paul R. Ramirez 
Emanuel R. Reinitz 
Mark C. Ruchntan 
Lawrence E. Samelson 
Richard S. Schottenfeld 
Charles R. Swenson 
Peter M. Ting 
Robert C. Ward 
John C. Wiles 
Jerome B. Zeldis 
Carol M. Ziminski 
1977 
Gift: $9,806 
Participation: 59% 
Agents: 
Maryheth Ezaki 
Ronald J. Vender 
Michael G. Adelberg 
Marcia C. Arent 
Phyllis August 
Diane M. Barnes 
George Bolen 
John J. Boronow 
Gerald M. Brody 
Richard D. Bucholz 
Christopher S. Clark 
Mark A. Dillingham 
Stuart B. Dubin 
Sybil E. Duchin 
Marybeth Ezaki 
Thomas W. Ferguson 
Anne H. Flitcraft 
James A. Fox 
Julia B. Frank 
Barbara K. Gehrett 
Gary G. Griffieth 
Steven R. Hahn 
Robert W. Hand 
Bruce L. Innis 
Howard K. Koh 
Wilhelmina C. Korevaar 
Don A. Marshall Jr. 
Margaret S. McKenna 
Robert J. Mitchell 
Alan S. Penziner 
Richard E. Peschel 
Theodore M. Pitts 
Jordan S. Pober 
Rachel Z. Ritvo 
Steven J. Scheinman 
Ricky M. Schneider 
Susan B. Schneider 
Simeon A. Schwartz 
Jeffrey L. Sklar 
Ronald J. Vender 
Steven L. Warsof 
Sharon R. Weinstein 
John E. Whitcomb 
J. Douglas White 
Daniel Wohlgelernter 
1978 
Gift: $7,445 
Participation: 51% 
Agents: 
Michael J. Anderson 
Duke E. Cameron 
Seth M. Powsner 
Kathy L. Ales 
Richard J. Baron 
Ronald J. Berenson 
Booker T. Bush Jr. 
Duke E. Cameron 
David F. Cawthon 
Jesse M. Cedarbaum 
Henry R. Desmarais 
Mark J. Di Nubile 
James N. Dreyfus 
Eric B. Einstein 
James T. Elder 
Emily A. Fine 
Mark L. Finklestein 
Eugene G. Fong 
Stuart M. Forman 
Maija G. Freimanis 
Robert A. Gelfand 
George M. Golenwsky 
Linda J. Hall 
Jeffrey N. Hausfeld 
Alexandra N. Helper 
Robert Hershfield 
Elizabeth S. Hodgson 
Anne A. Knowlton 
Robert L. Kraft 
Cynthia S. Kretschmar 
Sanford D. Markowitz 
Jose L. Martinez 
Robert K. McLellan 
Michael J. Mitchell 
Kurt K. Nakaoka 
Yvette L. Piovanetti 
Barbara H. Pober 
Seth M. Powsner 
Jeffrey D. Roth 
Sally Rudicel 
Neal D. Ryan 
Steven M. Shoum 
Donald C. Simonson 
Thomas J. Smith 
Gerson M. Stemstein 
Rebecca A. Taub 
Caroline R. Taylor 
Marcia J. Wade 
Jonathan D. Weinberg 
David L. Wessel 
Susan Wong 
1979 
Gift: $10,510 
Participation: 41% 
Agents: 
David E. Golan 
Cynthia A. Sherman 
Frederick R. Aronson 
Guthrie S. Birkhead III 
Gershwin T. Blyden 
J. Kenneth Burkus 
Stuart L. Bursten 
Sarah E. Carpenter 
Paul E. Collier 
Kerry Cooper 
Jeffrey N. Dornbusch 
Norman L. Elliott 
Lu-Jean Feng 
John A. Fox 
John J. Gargus 
David E. Golan 
Bruce Halperin 
Edward C. Halperin 
Arthur C. Johnson III 
Heather L. Johnson 
Leslie J. Katz 
Roxanne E. Kendall 
Jonathan Kolitz 
Forrester A. Lee Jr. 
Wing-Yin Leong 
Michael K. Lindsay 
Shirley McCarthy 
Timothy W. McKeithan 
S. Kwante Ofori-Kwakye 
Barbara A. Peters 
Jean Rosenthal 
Lynn K. Rudich 
Gary L. Schaer 
Eric A. Schwartz 
Cynthia A. Sherman 
Laurie Smaldone 
Pamela E. Smith 
Candace S. Thurston 
Duane C. Tucker 
Gary C. Vitale 
John T. Woo 
Jeffrey W. Work 
1980 
Gift: $5,503 
Participation: 44% 
Agents: 
Eduardo C. Alfonso 
Steven I. Rosenfeld 
David E. Adelberg 
Eduardo C. Alfonso 
Seth L. Alper 
Alan B. Astrow 
David A. August 
Milton F. Austin 
Jay M. Baraban 
Jean B. Bolognia 
Patricia C. Brown 
Michael W. Champeau 
Michael M. Chang 
Thomas F. Deering 
Deborah D. Desir 
Gary V. Desir 
Claudia Dinan 
Francis W. Drislane 
Stephen G. Emerson 
Paul A. Epstein 
Barbara G. Fallon 
Todd J. Garvin 
Marc F. Glickstein 
David J. Goldberg 
Jonathan L. Jacobs 
Barry M. Kacinski 
Mary C. Komei 
Ethan A. Lemer 
Theodore W. Marcy 
Suzanne M. Matsui 
Cesar R. Molina 
Eric J. Nestler 
Mark J. Ratain 
Steven I. Rosenfeld 
Alan E. Schlesinger 
Gerri A. Schulman 
John A. Selling 
Jeffrey N. Siegel 
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Hillel D. Skoff 
Leslie W. Sojka 
Kim R. Swartz 
James A. Talcott 
Joseph L. Tate 
Marcia R. Taylor 
Nancy T. Taylor 
Mary C. Wise 
Lawrence H. Young 
Raphael Zahler 
Laurel E. Zollars 
1981 
Gift: $33,949 
Participation: 45% 
Agent: 
Anthony M. Urbano 
Reunion Gift Chairman: 
Anthony M. Urbano 
Jane E. Asch 
Cynthia B. Aten 
Robert B. Bailey Jr. 
Alicia I. Barela 
Sherri L. Brown 
Patricia A. Burke 
Colleen Bursten 
Nelson J. Chao 
Chee C. Chow 
Francis Chui 
Marc D. Coltrera 
Jonathan M. Fine 
Paula M. Fracasso 
Robert S. Goldman 
Laurie J. Gordon 
Jeffrey A. Gruskay 
Alan Heimann 
Scott A. Hundahl 
Thomas Kievan 
Brian K. Kobilka 
Mark J. Koruda 
Richard E. Kravitz 
Thomas S. Kupper 
Elliot Lach 
Aiziz Laurent 
David E. Lebwohl 
Bernard Lewin 
Philip A. Lowry 
David Y. Lu 
Yvedt L. Matory 
Barton N. Milestone 
Robert M. Milstein 
David A. Paly 
Robert B. Portney 
Susan B. Radoux 
Barbara A. Roach 
Barbara A. Ross 
Dovelet Shashou 
Bernard H. Shen 
Martin H. Teicher 
Anthony M. Urbano 
Alan B. Wagshal 
David S. Weiss 
Stephen B. Wilson 
David H. Wohns 
Aizik L. Wolf 
John C. Wong 
1982 
Gift: $5,408 
Participation: 33% 
Agents: 
Muriel Cyrus 
Stephanie Wolf- 
Rosenblum 
Sylvia R. Beck 
Paula K. Braverman 
Thomas J. Brennan 
Muriel Cyrus 
Fred M. Drennan 
Liba E. Goldblum 
Daphne T. Hsu 
Henry D. Jampel 
Laurie B. Katz 
Patricia Kellner 
Teresa L. Massagli 
Kathleen A. Nolan 
Joyce A. O'Shaughnessy 
Christopher N. Otis 
Robert Pierattini 
Carrie A. Redlich 
Steven D. Resnick 
Robert J. Rizzo 
Paula C. Schlesinger 
William M. Sikov 
Lynn T. Tanoue 
Patrick J. Toth 
Albert L. Ungricht 
Stephanie Wolf- 
Rosenblum 
N. Bruce Yager 
Mary E. van der Velde 
1983 
Gift: $4,851 
Participation: 31 % 
Agents: 
David Schwartz 
Michael B. Tom 
Amos Bodner 
Robert E. Bookstein 
Michael Brines 
Elena Citkowitz 
Sean W. Dowling 
Dianne Edgar 
Tammy C. Harris 
Donald R. Johns 
William Kadish 
Robert M. Kotloff 
Ana M. Lamas 
Scott R. Lambert 
Charles Lim 
David Lindgren 
Frederic R. Martin 
Lois A. Morton 
David P. Norton 
Dan A. Oren 
Moshe Rubin 
Daniel Sabbeth 
Leonard B. Saltz 
Maria E. Schmidt 
Susan O. Seward 
Michael Silverberg 
Philip M. Spiro 
Nancy K. Terrell 
Pamela L. Zeitlin 
1984 
Gift: $5,000 
Participation: 43% 
Agents: 
Hingge Hsu 
Jay R. Kostman 
Martha R. Arden 
Deborah J. Arrindell 
David I. Astrachan 
Susan J. Baserga 
Leonard Bell 
Troyen A. Brennan 
Barbara A. Coda 
David J. Fillmore 
David A. Frank 
Paul Gagliardi 
Peter M. Glazer 
John L. Gwin Jr. 
Bruce G. Haffty 
Robert J. Havlik 
Sabra L. Jones 
Emilio J. Juncosa 
Jeffrey N. Katz 
Michel Kliot 
Daniel M. Kolansky 
Jay R. Kostman 
Philip R. Krause 
John H. Krystal 
Margaret L. Lancefield 
Richard L. Leff 
James G. Linakis 
Alison C. 
Lindsay-Beltzer 
Frederick A. Paola 
Dominic D. Pennachio 
Jill S. Ratain 
Terri L. Richardson 
William A. Rios 
Kenneth S. Rosenblum 
Paul B. Rothman 
Saul Sadka 
Ana M. Salazar 
Joshua D. Schor 
David A. Shrier 
Theodore A. Silver 
Edwina E. Simmons 
Michael Simons 
Paul M. Snyder 
Mark Stein 
Andrew L. Stemlicht 
Susan P. Tredwell 
1985 
Gift: $4,375 
Participation: 45% 
Agent: 
Fred Santoro 
Barry D. Bergquist 
J. Alexander Bodkin 
Jane E. Carter 
Elizabeth A. Chamey 
Alice S. Chi 
Bryan X. DeSouza 
Carol F. Farver 
Guy L. Fish 
Guy Fried 
Richard B. Garber 
Michael W. Gilbert 
Samuel D. Goos 
Daniel Greenwald 
Barbara J. Guillette 
Jacqueline Gutmann 
Robert S. Higgins 
Marie Hobart 
Stuart N. Isaacs 
Michael R. Johnson 
Robert L. Klitzman 
Ellen R. Kolarik 
Susan A. Korrick 
Shirley J. Lee 
Jonathan S. Lewin 
Ted W. Love 
Jeffrey A. Lowell 
Anthony Marks 
Mary C. Nakamura 
Jon C. Parker 
Richard G. Parker 
Leslye C. Pennypacker 
Samuel R. Pesin 
Anne Regenstein 
Richard A. Ruiz 
Greg A. Sachs 
Fred Santoro 
Edward B. Savage 
Gary L. Shapira 
Timothy A. Shapiro 
Robert C. Smith 
Louis J. Tesoro 
Yonina C. Weiss 
1986 
Gift: $20,817 
Participation: 41 % 
Agents: 
Eric Bernstein 
Clinton L. Undo 
Eric P. Suan 
Reunion Gift Chairman: 
Eric P. Suan 
Margaret N. Alexander 
Catharine A. Arnold 
David Atkins 
Samir M. Bhatt 
Richard L. Bridgewater 
Cristina M. Brunet 
Danilo D. Castro 
Paul Chang 
Raymond T. Chung 
Andrew R. Conn 
Suzanne D. Conzen 
Raymund S. Cuevo 
John A. Detre 
Amanda B. Dill 
Jay A. Gates 
Michael Grossbard 
Barbara J. Harvey 
Gary S. Hirshfield 
Jeremy L. Holtzman 
Robert A. Jackson 
Roberto Lewis- 
Fernandez 
Clinton L. Lindo 
Manuel B. Litchman 
Antoinette L. Lloyd 
Thomas J. Lynch Jr. 
Stacey Mandelbaum 
Cynthia A. McCraven 
Timothy W. McGowen 
Michael D. Miller 
Elizabeth A. Plotkin 
George M. Sachs 
Jeffrey G. Schneider 
Dae Y. Song 
Kimberlee A. Sorem 
Andrew W. Steele 
Eric P. Suan 
Steven J. Waisbren 
Terry Watnick 
Reginald O. Windom 
John J. Wysolmerski 
Alan Yamada 
1987 
Gift: $4,664 
Participation: 33% 
Agents: 
Subba R. Gollamudi 
Mindy G. Schuster 
Barry Weinstock 
Andrew N. Bazos 
Gregory M. Brown 
Michael J. Caplan 
Jerome H. Chin 
Richard Diana 
Ellen Dolnansky 
Robert Englander 
Eugene S. Fu 
Steve M. Gaskin 
John M. Gaziano 
Laurence A. Greenbaum 
Hugh C. Hemmings Jr. 
Robert J. Homer 
Amy C. Justice 
Rebecca E. Kadish 
Christopher King 
Joseph T. King Jr. 
Elliott Levy 
Kenneth E. Newhouse 
Patricia T. Powell 
Lauri R. Robertson 
Seth A. Rosenthal 
Patrick A. Ruwe 
Mindy G. Schuster 
Michael H. Solon 
Odett R. Stanley-Brown 
Richard P. Tierney 
Robert C. Urban Jr. 
Leslie Vogel 
Barry Weinstock 
Mark D. Widmann 
1988 
Gift: $3,891 
Participation: 36% 
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Agents: 
Michael E. Mockovak 
Susan A. Valley 
Hedayatollah Zaghi 
Larry Amsel 
Linda W. Armstrong 
Joi Barrett 
Jonathan A. Borden 
Martha Brochin 
Robert K. Brown 
Kathleen Carney- 
Godley 
Martin L. Chenevert 
Laura M. Dember 
Joshua E. Freedman 
Irene J. Freeman 
Jonathan S. Friedes 
Leslie K. Jacobsen 
Ellen Kommehl 
Frederick F. Lang Jr. 
Lisa C. Larkin 
Frederick Long 
Michael E. Mahig 
Elizabeth E. Mannick 
Theodore Miclau 
Kelle H. Moley 
Autry J. Parker Jr. 
Donna Richman 
Michael O. Rigsby 
Michael A. Rothschild 
Jonathan A. Sherman 
Mitchell J. Sklar 
Lenore K. Soodak 
Philip A. Stull 
Susan A. Valley 
Hedayatollah Zaghi 
1989 
Gift: $3,878 
Participation: 44% 
Agents: 
Stephen Bharucha 
Lewis Lipsey 
Melissa T. Myers 
Katherine A. Albert- 
Hemmings 
Jennifer F. Bock 
Susan K. Bonar 
Maura J. Brennan 
Ira Cheifetz 
Cherise M. Dyal 
Dina B. Eisinger 
Alexandra Flather- 
Morgan 
Craig E. Fleishman 
Yvonne 1. Frei 
Susan Garetz 
Virginia J. Greenbaum 
Adam L. Greene 
Colin K. Grissom 
Joni H. Hansson 
Lisa R. Ide 
Howard Kesselman 
Lawrence R. Kleinberg 
Robert L. Levin 
Amy Lewis 
Howard Morningstar 
Melissa T. Myers 
Viviann M. Rubin 
Thomas J. Silva 
Leslie M. Sims 
Stephen M. Smith 
Robert Spiera 
David M. Stier 
Sanjoy Sundaresan 
Amy A. Tyson 
Andrew T. Walker 
Marjorie S. Webster 
John T. Whalen 
Roger F. Widmann 
Christopher Wolf-Gould 
1990 
Gift: $1,881 
Participation: 30% 
Agents: 
Ercem S. Atillasoy 
Thomas J. Christopher 
Jonathan T. Foster 
Tracy D. Nelson 
Chancier N. Samy 
Roberto Soto 
Dan Stryer 
Susan G. Anderson 
Nancy R. Angoff 
Ercem S. Atillasoy 
Thomas J. Christopher 
Mark A. Dettelbach 
Mittie E. Doyle 
Jonathan T. Foster 
Douglas M. Freedman 
Alan S. Hilibrand 
Betty S. Kim 
Stephen Knight 
Toshiko F. Magnus 
Ira Meisels 
Mark A. Miller 
Tracy D. Nelson 
Erika H. Newton 
Jullie W. Pan 
Jane E. Rasmussen 
Chander N. Samy 
Andrew H. Schulick 
Daniel Stryer 
Karl G. Wagner Jr. 
Samuel C. Wang 
Marc J. Warman 
Siu-Long Yao 
Keith A. vom Eigen 
1991 
Gift: $6,560 
Participation: 30% 
Agents: 
Stephen Bell 
Carl Henningson 
Richard G. Ilmat 
FrankM. Lobo 
Karen Hsieh Lu 
Funda Meric 
Andrew F. Phillips 
John Phillips 
Reunion Gift Chairman: 
Frank M. Lobo 
Jeanne B. Ackman 
Marc E. Agronin 
William T. Andrews 
Mark G. Barad 
Stephen Bell 
Steven B. Care 
Jeffrey D. Carter 
Daryl K. Daniels 
Vivek David 
Sarah A. Davidson 
Scott E. Edwards 
Helen L. Egger 
Jean L. Fraser 
Bernice K. Glover 
Gwendolyn Grant 
Lawrence J. Hirsch 
Richard G. Ihnat 
Thomas S. Kupper 
James S. Levine 
Francis M. Lobo 
Charles Lu 
Karen Hsieh Lu 
Margaret R. O'Neill 
Robert Z. Orlowski 
Eleanor S. Poliak 
Pablo A. Quintela Jr. 
Marc A. Seltzer 
Robert M. Spillane 
Stacy B. Stryer 
Margaret M. Toth 
Paula I. Watnick 
Ellis L. Webster 
1992 
Gift: $1,135 
Participation: 23% 
Agents: 
Karen J. Anted 
J. Mathieu Massicotte 
Robin A. Perlmutter 
Darrick J. Alai mo 
Karen J. Antell 
Douglas M. Dahl 
Frederic W. Deleyiannis 
Ann S. Denehy 
Anne T. Egan 
Michael Girardi 
Andrew J. Griffith 
Israel R. Grossman 
Nancy L. Harthun 
Doris M. Iarovici 
Joanna Y. Jen 
Robert B. Johnson 
Alan B. Jotkowitz 
Lauren E. Krieger 
Joseph M. Massicotte 
Robin A. Perlmutter 
Kenneth E. Rosenzweig 
Mary E. Savage 
John L. Walsh 
Teresa L. Wooten 
James S. Yeh 
1993 
Gift: $1,270 
Participation: 28% 
Agents: 
Juan Bartolomei 
Ann Dolinsky 
Stephanie A. Falcone 
Robert lannone 
Julie Miner 
Anthony J. 
Adrignolo III 
Albert Assad 
Elizabeth S. Auld 
Michael C. Brown 
Sarah S. Demtrak 
William D. Dockery III 
Elizabeth D. Elguera 
Stephanie A. Falcone 
Christopher P. Fey 
Blair W. Fosburgh 
Lawrence B. Gardner 
Adriane M. Guerin 
Deborah M. Jotkowitz 
William F. King Jr. 
Lisa A. Kotler 
Elizabeth D. Le 
David M. Lee 
Matthew L. Lerner 
Gayle Lesnieski 
Michael C. Locker 
Samer Najjar 
Lisa J. Nelson 
Michael I. Oppenheim 
William R. Rodriguez 
Jaclyn A. Ryan 
Denver Sallee III 
David A. Tendler 
Antonio F. Vinals 
Joan M. Walker-Biskup 
Edward M. Weaver 
1994 
Gift: $760 
Participation: 17% 
Agents: 
Kevin E. Bishoff 
Constantino S. Pena 
David S. Aghassi 
Kevin E. Bishoff 
Emily J. Davidson 
Katherine E. Dee 
Emil D. Engels 
Kirk R. Essenmacher 
Anuj Gupta 
Victoria L. Holloway 
Debra H. Howard 
Lauren D. Hyman 
Robert lannone 
Michael G. Kaiser 
Constantino S. Pena 
Marc N. Potenza 
Karen M. Rosewater 
Martina M. Schulz 
Heather K. Stanley- 
Christian 
1995 
Gift: $680 
Participation: 30% 
Agents: 
Jeffrey I. Algazy 
Alice Y. Chang 
Steven L. Craig 
Steven M. Kawut 
Hyun W. Bae 
Alice Y. Chang 
Cheng-Chieh Chuang 
Steven L. Craig 
Sameer P. Desai 
Barbara M. Garcia Pena 
Timothy J. Hong 
Walter O. Jackson 
Stephanie A. Kapfer 
Steven M. Kawut 
Larry T. Khoo 
Margot B. Kushel 
Benjamin H. LeBlanc 
Alex L. Madlener 
Dorothy R. Novick 
Nicholas A. Schwartz 
K.R. Shen 
Mary R. Shoemaker 
Lawrence W. Solomon 
Dara E. Thomas 
Kenneth P. Vives 
Former House Officers 
Neville Alleyne 
Frederick L. Altice 
Floyd L. Atkins 
John M. Aversa 
Ronald J. Bailey 
Arnold M. Baskin 
Malcolm S. Beinfield 
Michael R. Berman 
Jacques L. Bonnet- 
Eymard 
Hubert B. Bradbum Jr. 
Christine Brahney 
Myron Brand 
Richard A. Brand Jr. 
Ronald W. Braun 
John M. Brogden 
Sorin J. Brull 
Julian H. Capps II 
Richard S. Casden 
Scott Evans Casper 
Richard A. Chase 
Chang Song Choi 
Charles R. Clark 
James C. Cobey 
Edward J. Collins Jr. 
Harold O. Conn 
Frederick G. Dalzell 
Marlene De Maio 
Ralph J. De Vito 
Donald S. Dock 
John M. Duncan Jr. 
Pierre B. Fay ad 
Dale J. Federico 
Jeffrey C. Femyhough 
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The Historical Library of the Harvey Cushing/John Hay Whitney Medical Library. 
Louis B. Fierman 
Stephen V. Flagg 
John S. Goetcheus 
John W. Goldkrand 
Jacob D. Goldstein 
Isaac Goodrich 
Scott Andrew Hoffinger 
Eric A. Hyson 
Robert Gordon Kalb 
Moreson H. Kaplan 
David J. Keller 
Dae Un Kim 
Robert Kim 
Arthur H. Knowlton 
Kenneth M. Kramer 
Gail Landy 
Randi Leavitt 
John D. Lewis 
Donald T. McAllister 
William McCullough 
John R McGovern 
Robert M. McLean 
Jan Evans Patterson 
Thomas F. Patterson 
Stanley M. Polansky 
David Poverman 
Gary Price 
Jane E. Rasmussen 
Gordon V.K. Reid 
David L. Rimm 
Patrick A. Ruwe 
Herbert S. Sacks 
Enzo J. Sella 
Carlton C. Sexton 
Thomas E. Shaffer 
Robert E. Silverman 
Sanan Simarak 
Leon G. Smith 
Stephanie S. Spangler 
V.I. Sreenivas 
Robert A. Stanton 
Barry S. Strauch 
Herbert Suesserman 
Herbert Tabor 
Franklin T. Wetzel 
Douglas G. Wright 
Leonard H. Zamore 
Joseph H. Zelson 
Bernard Zuckerman 
Parents 
Anne M. Asher 
Gail Steinmetz Broder 
Frederic D. Brown 
Howard Chin 
Judy Coppola 
Mr. & Mrs. Kenneth T. 
Doran 
Mrs. Vincent A. Doroszka 
Dorothy M. Ference 
Max Finkelman 
Conrad Fischer 
Jenifer Rawson Grant 
Dr. Myron Greengold 
Wei Jen Hsia 
Dr. Earl Hellerstein 
F. Warren Heilman 
Gloria F. Holmes 
Kenneth P. Kinney 
Sean Lynch 
Natesh Magge 
Virginia G. Mannick 
Harry Meisels 
Mr. & Mrs. Lewis Nankin 
Mr. & Mrs. Victor M. 
Newman 
Cecile Portney 
R. Donald Reich 
Harold & Frances 
Sampson 
Henry S. Sanematsu 
Leon G. Smith. M.D. 
Argyle Stoute, M.D. 
David D. Strachan 
Jack Weingold 
Friends 
Irwin Abouaf 
Mr. & Mrs. Donald E. 
Adams 
Thomas H.G. Aitken 
Mr. & Mrs. Mark 
Anderson 
Sally C. Anderson 
James W. Andrews 
Nancy H. Andrews 
Ellen Hope Angus 
Kathleen M. Annicelli 
Charles S. Atzbach 
Sally T. Bailey 
Diana Balmori 
Fred L. Barber 
Waddell Barnes, M.D. 
Mr. & Mrs. Morton 
Barrow 
Mr. & Mrs. Jack Barry 
Ms. Kerry A. Bartolini 
Mrs. Arnold M. Baskin 
Dr. & Mrs. Ramon A. 
Batson 
Randy S. Berger 
Billie Anne Berman 
Mr. & Mrs. John P. 
Beveridge 
David F. Bindelglass, M.D. 
Margaret T. Bixler 
Mr. & Mrs. William 
Bolling 
Stanley N. Botwinik 
Malcolm B. 
Bowers Jr., M.D. 
Mr. & Mrs. Joseph L. 
Bowes 
Timothy Brandt 
Robert B. Brooks 
John W. Browder 
William Brown 
Dr. Sonja Buckley 
Grace T. Burket 
Maryanne Y. Butler 
Dr. & Mrs. Harold Byrdy 
Edwin C. Cadman, M.D. 
C. Elton Cahow, M.D. 
Esther Capasse 
Geraldine B. Carroll 
Christopher Carrozzella, 
Esq. 
Andrew M. Casden 
Mr. & Mrs. C. Nick 
Catrini 
Salvador Chaparo 
Ana Maria Chiesa 
Horacio P. Chiesa 
Horachio P. Chiesa Galy 
Mr. & Mrs. Harry E. 
Chinn 
L. Dawn Christian, 
D.D.S. 
William Chudnovsky 
Joanne Chvisuk 
Mr. & Mrs. Charles 
Ciambriello 
Pasqual Civitillo 
Mr. & Mrs. Charles A. 
Clancy 
Mr. & Mrs. Donald Clum 
Jeanne F. Cobey 
Mr. & Mrs. James G. 
Coclin 
Mrs. Henry Cohen 
Louis Cohen 
LeBaron C. Colt Jr. 
James P. Comer, M.D. 
Jamie Condon 
Joseph P. Conte 
Melvin P. Coolidge, M.D. 
Carole L. Cooper 
James E. Coppage 
Mr. & Mrs. Sidney Corob 
Emily S. Coventry 
David E. Crabb 
Edward T. Creamer Jr. 
Mr. & Mrs. Joseph 
Cristiano 
Mr. & Mrs. John M. 
Cunningham 
Edward D'Amico 
Nancy M. Daly 
Mel Damelio 
Dr. & Mrs. J. Sanford 
Davis 
Robert V. Dawe, M.D. 
Mr. & Mrs. Peter 
Delehanty 
Priscilla F. Delehanty 
Robert Delnickas 
Edward F. Delvecchio 
Mary Dimando 
Mikel T. Dodd & Lauren 
Biszewski 
Mr. & Mrs. Joseph J. 
Dolan 
William T. Donohue 
Phyllis G. Donzelli 
Rev. and Mrs. Raymond 
Downs 
Mr. & Mrs. Donald J. 
Doyle 
Thomas P. Duffy, M.D. 
Kathleeen L. Dunn 
Mr. & Mrs. Stanley K. 
Durkin Jr. 
Jerry Ehrenwald 
Mrs. Gunnar O. Eng 
Mr. & Mrs. Frank C. 
Ennever Jr. 
Mrs. Ellin F. Ente 
Lucretia Faulk 
Patricia A. Faulkner 
John Ferranti 
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Lori-Ann Fickie 
Mr. & Mrs. Peter W. Finck 
David S. Fischer 
Stephen Fleck. M.D. 
Ruth K. Forgione 
Mr. & Mrs. Edward L. 
Forte 
Cheri Fox 
Dr. & Mrs. Gerald 
Freedman 
Karen J. Freedman 
Robert J. Freeman 
Flarry I. Freund 
Mrs. James T. Friss 
Prof. Joseph S. Fruton 
Paula A. Furo 
Karyn Gabbinelli 
Laurie A. Gagne 
Mr. & Mrs. Charles W. 
Gannon 
Alphonse F. Gencarelli 
Gary Gerard, M.D. 
Mrs. John R. Geyer 
Nancy P. Gillis 
Mr. & Mrs. Thomas S. 
Giuffrida 
Theodore P. Giuliano 
William W.L. Glenn. M.D. 
Mr. & Mrs. Asher 
Gluckman 
Arlene S. Gold 
Estelle K. Goldman 
Dr. Herbert 1. Goldman 
Mr. & Mrs. Irving M. 
Goldman 
Arthur Goldzweig, Esq. 
Daniel Goleman 
Mr. & Mrs. Donald E. 
Goodrich 
Mr. & Mrs. John H. 
Gorman 
Anton Graham 
Beverly M. Grasso 
Maurice D. Grasso 
Ruth E. Greenblatt 
Mr. & Mrs. Charles A. 
Grillo 
John M. Grobman, M.D. 
Florence S. Grodin 
Mr. & Mrs. Zola Grona 
Barbara S. Gross 
Jeffrey L. Gross, M.D. 
Eileen Rockefeller 
Growald 
Helen D. Haller 
Michael B. Hammond 
Mr. & Mrs. Paul M. 
Harpin 
Sylvia Heisman 
Herbert Hermele, M.D. 
Fred H. Hibberd 
Tommy Hilfiger 
Donald & Audrey Hill 
Philip & Rose Hoffer 
Holocaust Survivorsof 
New Haven 
Mr. & Mrs. William M. 
Homich 
Lillian S. Howard 
Joseph T. Hughes 
Alice Hummel 
Mr. & Mrs. James J. 
Imbrogno 
Janet Impellitteri 
Raymond J. 
lppolito, M.D. 
Virginia B. Isakson 
Susan B.Jacobson 
Daniel James 
Robert L. James 
Henry A. Jensen 
Mr. & Mrs. Robert Jess 
Ann M. Johnson 
Earl or Jean Johnson 
Mrs. Charles S. Judd Jr. 
Foster Kay, M.D. 
Mr. & Mrs. Dan Kearney 
Kenneth M. Kearns, M.D. 
Mr. & Mrs. Thomas Keefe 
Thomas J. Keenan, M.D. 
Robert S. Keller 
Nancy M. Kenny 
Tina Khentigan 
Mrs. Charles P. Kingsland 
Susan T. Kirchhof 
Lucille S. Kirsch 
Gerald H. Knecht 
Vincent A. Koblish 
Uwe Koepke, Ph.D., M.D. 
Lindsay P. Koester 
Mr. & Mrs. Jay B. 
Korman 
Mr. & Mrs. Jerome D. 
Korman 
Dawne M. Kornhass 
Pearl A. Kramer 
Shelley G. Kreiger 
Pamela Kriger-Feinberg 
R.S. Kronheim 
Dorothy P. Kuehl 
Robert Lapham 
Michael Lavoie 
Leonard H. LeMarri 
Mrs. Elliot Lehman 
Aaron B. Lerner, 
M.D., Ph.D. 
Eleanor M. Leventhal 
Morton A. Levin 
Po-Huang Liang 
Karlys Merry Lightheart 
Richard S. Lovelace 
Mrs. Leslie A. Lowerson 
Elizabeth B.T. Lozier 
Richard H. Lustberg 
John M. Lyons 
Jean Magi 
Daniel C. Maguire 
Edyth W. Maibrunn 
Veronica M. Malcomson 
Mr. & Mrs. Peter L. 
Malkin 
Candida Mancusi 
Ted Mann 
Anthony Marino 
Doris McDermott 
Mr. & Mrs. N. Heath 
McDowell 
Geraldine B. McGinty 
Estelle McKiernan 
Mr. & Mrs. Roger 
McMahon 
Mr. & Mrs. Joseph F. 
McVerry 
Mr. & Mrs. Steen M. 
Melby 
The Mendillo Family 
Foundation Inc. 
Nicole Meo 
Ronald C. Merrell 
Helen Messina 
Arthur Meyer 
Mr. & Mrs. Salvatore 
Milardo 
Richard J. Miller 
Mr. & Mrs. Steve Milligan 
Mr. & Mrs. I.E. Millstone 
Murray A. Morrison, M.D. 
Mr. & Mrs. Thomas P. 
Nacinovich 
Amelia J. Nash 
Mrs. Nathaniel L. 
Nathanson 
Charles Needham, M.D. 
Ruth & Naomi Nelson 
Mr. & Mrs. Brian J. 
Newman 
Jason D. Newman 
Thomas C. Nichol 
Judith S. Novak 
Mr. & Mrs. Henry W. 
O'Brien 
John M. O'Leary 
Mr. & Mrs. William L. Ohr 
Katharine Odell 
Carole A. Orlosk 
Dianne Fina Otteson 
Anne M. Pacelli 
Mr. & Mrs. Harry Panzer 
Irene Papaminas 
Paul S. Pariser 
Je Guk Park 
Ellen M. Paternoster 
Mr.& Mrs. Joseph F. 
Pauloski Sr. 
George F. Pavarini Sr. 
Lisa Pearsall 
James & Dorothea Pelkey 
Edith Perelmutter 
Elizabeth M. Pfriem 
Mr. & Mrs. Philip P. 
Piskura 
C.L. Polite 
Mr. & Mrs. Stewart G. 
Pollock 
George G. Posener 
Nancy R. Pugsley 
Anna Rabinowitz 
John F. Raycroft, M.D. 
Mr. & Mrs. Christopher J. 
Regan 
Robert S. Reger 
Jean K. Regnier 
Mr. & Mrs. Ronald Reis 
Mildred Renert 
Mr. & Mrs. John M. 
Reshotnik 
Dana A. Ricker 
Mr. & Mrs. Morton 
Rietberg 
Mr. & Mrs. David 
Rockefeller 
Robert A. Roda 
Luis F. Rodriguez 
William J. Roos Jr. 
Mr. & Mrs. Arthur J. Root 
Rev. Ruby M. Rose 
Roger D. Rosenfeldt 
Richard & Hinda 
Rosenthal 
Victoria Roth 
Prof. Shoichi Royama 
Barbara Rubin 
David T. Russell 
Russell J. Ryan 
Nona C. Saling 
Hector Sandoval 
Charles V. Schaefer Jr. 
Lori Schmidt 
Mr. & Mrs. Alfred Schnog 
Mrs. Norbert Schnog 
Bette Scovil 
Barbara S. Segaloff 
Mr. & Mrs. Wally Seidon 
Arthur M. Seigel, M.D. 
Toni Mendez Shapiro 
Bernard Shectman 
Marc Sheerin 
S.K. Shenay 
Mary C. Shortelle 
Stanley Paul Shuler 
Craig M. Sidoti 
Suzanne E. Siegel 
Mr. & Mrs. Edward A. 
Silver 
Bruce Singer 
Nicholas Skovran 
Rosalind Slifkin 
Barbara R. Smith 
Walter Sofian 
Jonathan Sonneborn 
Mr. & Mrs. James V. 
Sorrentino 
Mr. & Mrs. Howard B. 
Sosin 
Mr. & Mrs. John F. 
Spellman 
Constance E. Spencer 
Mrs. F. Donald Sperry 
Howard M. Spiro, M.D. 
Mr. & Mrs. David Squires 
Tracey C. St. Louis 
Carmella Stankiewicz 
Mr. & Mrs. Bernard 
Starkey 
Mr. & Mrs. Charles 
Starkey 
Mr. & Mrs. James Starkey 
Mr. & Mrs. Walter 
Starkey 
Helene L. Stearns 
Nina Stearns-Surfus 
Deborah J. Steeves 
Elizabeth K. Steiner. M.D. 
Helen Z. Steinkraus 
Mr. & Mrs. Ronald 
Stevens 
Sadie Stren 
A. Walter Stubner 
Anne M.Svoboda 
Brian Sweeney 
Cynthia Sweeney 
Alma Mary Tait 
Dr. & Mrs. T.E.H. Talma 
Trudy L. Talner 
Mr. & Mrs. Barney 
Tarinelli 
Fleurette Thibodeau 
Anthony M. Timpanelli 
Ernest C. Todd 
Lisa A. Todd 
Adin M. Tooker 
Richard J. Toole 
Mr. & Mrs. Louis R. 
Tortora 
Robert Traurig 
R. Leanne Trout 
Mr. & Mrs. John E. Ulicki 
Helen Ullman 
Behrouz Vafa 
Janine Vautaret- 
Marconnet 
Lisetta J. Verrastro 
Irene Voynick 
Magdalena W. Wagner 
Mr. & Mrs. George J. 
Wallace 
Dr. James K. Wallman 
George D. Ward 
William A. Ward 
Eileen M. Weingarten 
Marion U. Weinstein 
Seth P. Weinstein 
Prof. Stanley Weinstein 
Mr. & Mrs. Gunther Weiss 
Faye Whaley 
Diane M. Whelan 
Harold T. White 
Martha White 
Mr. & Mrs. Russell 
Wilkinson 
Scott R. Williams 
Arthur J. Willner 
Irwin & Margo Winkler 
Mr. & Mrs. Billy R. 
Woolbright 
Leonard H. Zamore, M.D. 
Marilyn Zimmerman 
Mrs. Sarah B. Zusman 
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STERLING ASSOCIATION 
STERLING ASSOCIATION 
The School of Medicine Alumni Fund’s 
Sterling Association recognizes donors who 
have made gifts at the following levels: 
Benefactor $ 50,000 and above 
Sponsor 25,000-49,999 
Patron 10,000-24,999 
Fellow 5,000-9,999 
Associate 1,000-4,999 
Member 200 - 999 
Benefactor 
Alumni/ae 
John D. Baxter ’66 
Sanfurd G. Bluestein '46 
Thomas J. Coleman ’46 
John A. Elefteriades ’76 
John P. Ferguson Jr. '39 
Martin E. Gordon ’46 
Robert N. Hamburger ’ 51 
Liselotte & Samuel S. Herman 
M.P.H. ’48 
William H. Hindle ’56 
Morton M. Kligerman ’58 
Margaret A. Lennox 
Buchthal ’39 
Richard A. Moggio ’71 
Joe D. Morris '46 
Nicholas PR. Spinelli ’44 
Robert R. Wagner '46 
William J. Wedemeyer Jr. ’46 
Friends 
Sabra M. Hamilton Foundation 
Tommy & Susan Hilfiger 
Estate of Marion G. Howard 
Thomas J. Keenan, M.D. 
Ted Mann 
George G. Posener 
Alma Mary Tait 
Irene Voynick 
Sponsor 
Alumni/ae 
Frederic P. Anderson ’62 
John W. Foster Jr. ’71 
Mohandas M. Kini ’65 
Willys M. Monroe ’41 
Myron K. Nobil ’47 
Friends 
Phil N. Allen Charitable Trust 
Harry I. Freund 
Mary P. Hines 
Po-Huang Liang 
Mr. & Mrs. David Rockefeller 
Luis F. Rodriguez 
Nona C. Saling 
Christopher Timpanelli 
& family 
Patron 
Alumni/ae 
Carl E. Andrews ’44 
Alfredo L. Axtmayer ’76 
Gregory W. Bartha ’71 
Franklin C. Behrle ’46 
Bruce Block ’71 
& Marion H. Block ’71 
Harold D. Bornstein Jr. ’53 
Rosalie A. Bums ’56 
Paul Calabresi ’55 
Pasquale J. Costa ’55 
Anne M. Curtis '70 
Claude W. Delia’50 
Lee E. Farr’32 
John E. Fenn ’61 
William P. Ferretti M.P.H. '71 
Lowell I. Goodman '51 
William Harrison Jr. '42 
Barbara K. Kinder ’71 
William L. Kissick ’57 
Patrick T. Minihan ’71 
Anoush Miridjanian ’61 
Morgan Sargent ’37 
Albert C. Weihl ’71 
AizikL. Wolf’81 
Robert H. Wyatt '43 
Friends 
Nancy M. Daly 
Dr. & Mrs. J. Sanford Davis 
Mr. & Mrs. Dundas I. Flaherty 
James A. & Jane C. Folger 
Foundation 
Fred H. Hibberd 
Robert L. James 
Mr. & Mrs. Steve Milligan 
Mr. & Mrs. I.E. Millstone 
Amelia J. Nash 
Elizabeth K. Steiner, M.D. 
Seth P. Weinstein 
Fellow 
Alumni/ae 
Frank C. Bell ’66 
John L. Cieply ’71 
Donald J. Cohen ’66 
Frederick L. Cohn ’71 
Allan W. Graham ’71 
William D. Harkins M.P.H. ’68 
Michael J. Hart ’71 
Thomas C. Jaleski ’31 
Marie-Louise T. Johnson '56 
Thomas Kievan '81 
William E. Laupus ’45 
Benjamin E. Lyons ’38 
A. Frederick North Jr. ’56 
Nancy Olmsted ’69 
John A. Patti ’71 
Vincent Pepe '46 
Michael C. Piercey ’71 
Jerrold M. Post ’60 
Irving G. Raphael ’71 
William A. Renert ’65 
Julian A. Sachs ’46 
Mary Jo P. Shepard M.P.H. ’76 
John Smiarowski ’71 
Charles D. Spangler M.P.H. ’42 
Kenneth C. Steele ’45 
Franklin H. Top Jr. ’61 
Paul A. Vignola ’71 
Robert B. Vranian ’71 
Warren D. Widmann ’61 
Former House Officers 
Richard A. Chase 
V.I. Sreenivas 
Friends 
Fred L. Barber 
Ana Maria Chiesa 
Carole L. Cooper 
Mikel T. Dodd & Lauren 
Biszewski 
Jerry Ehrenwald 
Philip & Rose Hoffer 
Earl & Jean Johnson 
Arthur Meyer 
Richard J. Miller 
Ruth & Naomi Nelson 
James & Dorothea Pelkey 
Elizabeth M. Pfriem 
Richard & Hinda Rosenthal 
Victoria Roth 
Charles V. Schaefer Jr. 
Magdalena W. Wagner 
Irwin & Margo Winkler 
Associate 
Alumni/ae 
Seth F. Abramson ’53 
Michael G. Adelberg ’77 
Theodore E. Allen ’40 
Ralph D. Alley ’43 
Thomas T. Amatruda Jr. ’51 
Carol J. Amick ’59 
Robert M. Amick ’59 
Elissa B. Arons ’70 
David Atkins ’86 
Alicia I. Barela ’81 
Aaron T. Beck '46 
Suzanne S. Becker’56 
Philip Bernstein ’66 
John E. Borowy ’50 
Thomas J. Brennan ’82 
Richard L. Bridgewater ’86 
Robert S. Briggs ’61 
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Class of 1946 Sets Reunion 
Gift Campaign Record 
The Class of 1946 broke the $1 million barri¬ 
er and set a new record for reunion gift cam¬ 
paigns in the School of Medicine. A total of 
$1,155,059 was counted in gifts and 
pledges, with a participation rate of 80 per¬ 
cent. Leadership gifts included a charitable 
remainder trust in the amount of $590,000 
established by Dr. and Mrs. William J. Wede- 
meyer Jr.; two current gifts by Dr. Sanfurd G. 
Bluestein for unrestricted use and for HHT 
research in diagnostic radiology; and a gift of 
$67,405 to Yale’s Pooled Income Fund from 
Dr. Robert R. Wagner. ■ 
David W. Brook '61 
James E. Brown '66 
Gerard N. Burrow '58 
Rocco A. Calandruccio '47 
Fredric K. Cantor '62 
John A. Carlston '58 
Randall D. Cebul '76 
Helen Y. Chang'76 
Paul Chang '86 
Joseph Ciabattoni ’76 
Andrew D. Cook '71 
David Cossman '71 
Lawrence G. Crowley '44 
Michael J. Cummings '65 
Rutledge W. Currie '68 
Paul D. Deiter '61 
Herbeit W. Diefendorf '41 
Thomas A. Doe '46 
Malin Dollinger '60 
Robert J. Donohue Jr. '58 
S. Evans Downing '56 
Fred W. Doyle '55 
Owen W. Doyle '47 
William H. Druckemiller '39 
John S. Ebersole ’71 
Jonathan Ecker ’70 
Mitchell Edson '56 
Elizabeth F. Eisner '48 
Lee E. Farr '32 
Fred Finkelman '71 
Michael P. Flynn ’65 
Eugene C. Gaenslen Jr. '60 
Olive Gates '29 
Peter D. Gibbons '66 
Richard B. Gloor '71 
Anne Godley '48 
Carol Goldenthal '44 
Thomas H. Gouge '70 
Leonard Grauer'68 
Ralph S. Greco '68 
Peter B. Gregory '63 
Peter A. Gross '64 
Joan M. Hardenbergh '56 
Armen C. Haig '56 
Randall S. Hawkins '76 
John V. Haxo '51 
Jay H. Hoofnagle '70 
John C. Hoover '46 
W. Robin Howe '71 
Royal C. Hudson Jr. '61 
N. Timothy Jette '71 
Jonathan D. Katz '70 
Richard Katzman '71 
Harvey W. Kausel '44 
Ruth S. Kempe '46 
Alfred E. King '37 
Stuart R. Kleeman '71 
Jerome O. Klein '56 
Lucian S. Lapinski '50 
Hildegard M. Leslie '53 
Preston L. Leslie '53 
Lynne L. Levitsky '66 
William K. Levy '76 
Bernard Lewin '81 
Michael K. Lindsay '79 
Manuel B. Litchman '86 
Vincent J. Longo '46 
George M. Lordi '61 
Edward G. Lund Jr. '63 
Margaret S. Lyman '50 
Robert W. Lyons '64 
Sidney Mandelbaum '16 
Preston C. Manning '56 
Robert Marcus '60 
Edward L. Marut '74 
Harry L. McClelland '50 
Hugh J. McLane '46 
Jerome H. Meyer '12 
Dwight F. Miller '56 
Orlando J. Miller "49 
Robert L. Mitchell '64 
Steven H. Moffic'71 
William Y. Moores '66 
Albert R. Mowlem '51 
Robert E. Mueller '63 
William K. Mueller '70 
Donald J. Nalebuff '56 
Robert G. Nankin 75 
George W. Naumburg Jr. '45 
Richard L. Neubauer '16 
Andrew B. Newman '75 
James A. O’Neill Jr. ’59 
Margaret R. O'Neill '91 
Marjorie A. Oda '74 
S. Kwame Ofori-Kwakye '19 
John B. Ogilvie ’34 
O'dell M. Owens '16 
David A. Paly '81 
Martin Paris '71 
George W. Paulson '56 
Arthur A. Pava '51 
John K. Pearce Jr. '61 
Alan S. Penziner 'll 
Robert G. Petersdorf '52 
Charles T. Post Jr. '68 
Stewart E. Pursel ’56 
James R. Ralph ’59 
Emanuel R. Reinitz ’76 
John M. Roberts ’52 
Nathan E. Ross '28 
MarkC. Ruchman '16 
Shaun Ruddy '61 
Thomas H. Sakoda '61 
Leonard B. Saltz '83 
Stanley G. Schade '61 
Robert Scheig ’56 
Douglas R. Schmidt '71 
Bernard H. Shen '81 
Harry Sherman '34 
Richard G. Sisson '46 
David B. Skinner ’59 
Ora K. Smith '53 
A. Thomas Snoke '64 
Michael H. Solon ’87 
John H. St. Andre '61 
Amy Starr '74 
Robert S. Steinberg '67 
Harold M. Sterling ’51 
Gerson M. Stemstein '78 
Charles R. Swenson '16 
Priscilla D. Taft '44 
Martin H. Teicher '81 
Seth U. Thaler ’62 
Peter M. Ting ’76 
Bruce Trembly '56 
Theodore K. Tseu ’56 
Raymond W. Turner '58 
Ronald J. Vender 'll 
Leo H. Von Euler'59 
Marcia J. Wade '78 
Joseph F. Walter ’67 
Robert C. Ward ’76 
W. Keasley Welch '43 
Morris J. Westfried '75 
Ronald A. Yankee '60 
James F. Young ’53 
Arne S. Youngberg ’66 
Former House Officers 
Jacob D. Goldstein 
John P. McGovern 
Parents 
Mrs. Vincent A. Doroszka 
Conrad Fischer 
F. Warren Heilman 
Argyle Stoute, M.D. 
Friends 
Thomas H.G. Aitken 
James W. Andrews 
Kathleen M. Annicelli 
Dr. & Mrs. Ramon A. Batson 
Randy S. Berger 
Malcolm B. Bowers Jr., M.D. 
John W. Browder 
Geraldine B Carroll 
Mr. & Mrs. C. Nick Catrini 
Horacio P. Chiesa 
Horachio P. Chiesa Galy 
Mrs. Henry Cohen 
James P. Comer, M.D. 
Melvin P. Coolidge, M.D. 
Mr. & Mrs. Sidney Corob 
Robert Delnickas 
Rev. & Mrs. Raymond Downs 
Mrs. Ellin F. Ente 
Lori-Ann Fickie 
Robert J. Freeman 
Mrs. James T. Friss 
Professor Joseph S. Fruton 
Nancy P. Gillis 
Mr. & Mrs. Thomas S. 
Giuffrida 
Theodore Paul Giuliano 
Mr. & Mrs. Asher Gluckman 
Daniel Goleman 
Eileen Rockefeller Growald 
Sylvia Heisman 
Donald & Audrey Hill 
Joseph T. Hughes 
Daniel James 
Lucille S. Kirsch 
Mrs. Elliot Lehman 
Eleanor M. Leventhal 
Richard H. Lustberg 
Geraldine B. McGinty 
Ronald C. Merrell 
Mr. & Mrs. Brian J. Newman 
Judith S. Novak 
Anne M. Pacelli 
George F. Pavarini Sr. 
Mildred Renert 
Mr. & Mrs. Alfred Schnog 
Arthur M. Seigel, M.D. 
Walter Sofian 
Jonathan Sonnebom 
Mr. & Mrs. James V. Sorrentino 
Mr. & Mrs. John F. Spellman 
Howard M. Spiro, M.D. 
Helen Z. Steinkraus 
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Anne M.Svoboda 
Trudy L. Talner 
Anthony M. Timpanelli 
R. Leanne Trout 
George D. Ward 
Faye Whaley 
Harold T. White 
Martha White 
Mr. & Mrs. Russell Wilkinson 
Member 
Alumni/ae 
David E. Adelberg ’80 
George K. Aghajanian '58 
Donald Agostinelli ’57 
Margaret J. Albrink ’46 
Michael H. Alderman ’62 
Kathy L. Ales ’78 
Margaret N. Alexander '86 
Frank R. Allen 51 ’ 
George H. Allison ’45 
Jon R. Almquist ’65 
Miguel R. Alonso ’63 
Victor A. Altshul ’60 
Sophia C. Alway ’41 
Joseph E. Angelo '58 
David G. Ansel ’69 
Martha R. Arden ’84 
Joseph A. Arminio ’46 
Catharine A. Arnold ’86 
Daniel L. Arons ’67 
Frederick R. Aronson ’79 
Deborah J. Arrindell ’84 
Jane E. Asch ’81 
Irving M. Asher ’74 
Berton W. Ashman '64 
David I. Astrachan ’84 
Cynthia B. Aten ’81 
Albert S. Atwood ’45 
Phyllis August ’77 
Milton F. Austin '80 
Judith L. Bader ’71 
David A. Baggish ’73 
Muriel H. Bagshaw ’51 
John C. Bailar III ’55 
David N. Bailey ’73 
Earl L. Baker '61 
Sidney M. Baker ’64 
Paul Balter ’65 
William G. Banfield Jr. ’46 
Jack D. Barchas '60 
Asa Barnes Jr. '59 
George R. Barnes Jr. ’47 
Richard J. Baron ’78 
Andrew N. Bazos ’87 
Albert A. Bechtoldt Jr. '61 
Daniel I. Becker ’68 
Ronald S. Beckett ’40 
Ronald J. Berenson ’78 
Frank P. Berg '54 
John W. Berg ’51 
Samir M. Bhatt ’86 
Eleanor C. Bigley ’51 
Jonathan S. Bishop ’48 
Jonathan S. Bishop ’49 
Henry N. Blansfield ’47 
Jack N. Blechner ’57 
Neil Blumberg ’74 
Jerome Bobruff ’55 
Richard S. Bockman ’67 
J. Alexander Bodkin ’85 
Maurice L. Bogdonoff ’52 
Maxwell Bogin '26 
George Bolen ’77 
Sharon L. Bonney ’76 
Robert E. Bookstein '83 
David G. Borden ’43 
Roger A. Boshes’76 
Richard J. Bouchard ’54 
Stuart P. Bowne ’60 
Levon Z. Boyajian ’56 
Douglas G. Boyden ’55 
W. Roy Breg Jr. ’47 
TroyenA. Brennan ’84 
Richard I. Breuer ’57 
Ronald C. Brown ’74 
William H. Bucher’50 
Donald P. Buebendorf ’60 
Richard S. Buker Jr. '48 
Patricia A. Burke ’81 
J. Kenneth Burkus ’79 
Padraic Burns ’55 
Williams. Bush’75 
Remi J. Cadoret '53 
John L. Cannon ’47 
Charles W. Carl Jr. ’63 
Ray A. Carlsen ’62 
David A. Carlson ’58 
John F. Carroll '56 
Jeffrey D. Carter ’91 
Alice S. Cary '45 
Eugene P. Cassidy ’66 
Danilo D. Castro ’86 
Charles R. Cavanagh Jr. ’47 
Linus W. Cave ’46 
Richard A. Cazen '74 
Joseph C. Cemy ’56 
William R. Chaffee ’53 
Michael W. Champeau ’80 
Michael M. Chang ’80 
Robert A. Chase '47 
Thomas N. Chase ’62 
Alice S. Chi ’85 
Richard S. Childs Jr. '76 
Jerome H. Chin ’87 
Albert K. Chun-Hoon ’57 
Raymond T. Chung ’86 
Joseph J. Cillo ’58 
Elena Citkowitz ’83 
Mary W. Clark ’67 
John D. Clemens ’76 
Robert M. Cohn ’65 
John R. Cole ’54 
James C. Collias ’56 
William F. Collins Jr. ’47 
Martin Colodzin ’59 
Marc D. Coltrera ’81 
Edward J. Conway ’44 
Thomas D. Cook ’43 
Ronald W. Cooke ’43 
John C. Coolidge '44 
Kerry Cooper '79 
Edward C. Cottle ’71 
David L. Coulter ’73 
Frank W. Countryman ’44 
Jon E. Courtney ’60 
Arthur C. Crovatto ’54 
Brian Crowley '57 
Joseph F. Curi ’64 
Cynthia J. Curry ’67 
Richard J. Daly '69 
Oliver T. Dann ’62 
Robert P. Darrow '47 
Lycurgus M. Davey ’43 
Alvin Davis ’50 
James L. Davis III ’67 
Jeffrey J. Davis ’75 
Chandler Dawson '56 
James E. DeLano Jr. ’70 
Bryan X. DeSouza '85 
Wynant Dean ’40 
Orson R. Dee ’61 
Michael W. Dennis ’69 
John A. Detre '86 
James J. Dineen ’67 
Paul F. Dodd ’64 
John H. Doherty ’44 
Joseph A. Donadio ’66 
Gary S. Dorfman ’76 
Richard E. Dormont ’40 
Jeffrey N. Dornbusch '79 
James R. Dorr ’57 
James M. Dowaliby ’67 
Sean W. Dowling ’83 
Fred M. Drennan ’82 
John A. Drews ’67 
Stuart B. Dubin '77 
Peter A. Duncan ’41 
Cherise M. Dyal '89 
Robert S. Easton ’45 
Dianne Edgar’83 
Andrew Edin ’63 
Scott E. Edwards ’91 
Helen L. Egger ’91 
N. Joel Ehrenkranz ’49 
Gilbert M. Eisner ’56 
I. Bruce Elfenbein ’62 
John P. Eliopoulos ’63 
Carl Ellenberger Jr. ’65 
Daniel W. Elliott ’49 
Norman L. Elliott ’79 
Kent Ellis '50 
Leroy Engel ’55 
Franklin H. Epstein ’47 
Irl L. Extein ’74 
Marybeth Ezaki ’77 
Tommy and Susan Hilfiger 
fund MS research 
Tommy Hilfiger’s name is recognized 
around the world for his popular men’s 
and women’s fashions. His company is also 
well-known for its support of charitable 
organizations, such as the Fresh Air Fund in 
New York. Tommy Hilfiger and his wife, 
Susan, have personally committed them¬ 
selves to biomedical research. Among other 
activities, they have made a gift of $50,000 
to support a research fellowship in the Yale 
Multiple Sclerosis Program. 
Mr. Hilfiger’s sister, Dorothy Clapp, who 
has multiple sclerosis, is a participant in 
clinical treatment studies sponsored by Yale 
under the direction of Joseph B. Guarnac- 
cia, M.D., co-director of the Yale MS Pro¬ 
gram. She has also worked with patients 
and their families to ease the devastating 
effects of this disease. 
The Hilfiger family helped the Yale MS 
Program become the fifth participating aca¬ 
demic center in the Nancy Davis Center 
Without Walls, a unique collaboration creat¬ 
ed and supported by the Nancy Davis Foun¬ 
dation for MS. ■ 
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MEMORIALS 
Deceased medical alumni/ae and friends may be memorialized by a 
gift at any time to the School of Medicine Alumni Fund endowment 
in the name and class of the person so honored. The next-of-kin of a 
deceased medical alumnus/a is advised about the In Memoriam Pro¬ 
gram by a mailing from New Haven some weeks after the School of 
Medicine receives notification of the death. The letter of information 
includes a copy of the Testament of Remembrance, in which the names 
of all persons so memorialized are listed in the medical section by 
class, thus establishing a lasting memorial. Your inquiries and interest 
are welcome. 
YALE UNIVERSITY 
Office of the Alumni Fund-Memorials 
Rev. James R. Blanning and 
Rev. William E. Bliss, directors 
P.O. Box 1890 
New Haven, CT 06508-1890 
(203)432-5853 
Deceased alumni and friends 
so honored in 1995-1996 were: 
Alfred E. Bacon ’49 
Lester W. Burket ’36 
Charles B. Cheney ’41 
Vincent A. Doroszka '30 
David Paul Dunn ’60 
James Philip Dunn ’53 
Gunnar O. Eng ’49 
Kevin N. Hennessey ’68 
Robert Corlett Howard ’49 
Charles Sheldon Judd ’46 
Sidney L. Lasell '41 
Charles L. Mache Jr. '47 
John C. Mendillo ’30 
Herbert C. Miller ’34 
Kenneth R. Morgan ’42 
Edward Nichols '38 
Edward T. O’Donnell ’34 
Edward W. Pinkham Jr. ’38 
Max R. Smimow ’06 
Lewis Thorne ’36 
Philip Caeser Viscidi ’42 
Darrell G. Voorhees ’39 
Wesley Watson ’43 
Harry M. Zimmerman ’27 
Salvatore Falho ’57 
Ralph J. Falkenstein '69 
Carol F. Farver ’85 
Philip R. Fazzone ’58 
Davitt Felder ’42 
Herbert W. Felsenfeld ’67 
Lu-Jean Feng ’79 
Gerald Fenichel ’59 
Thomas J. Ferraro Jr. '50 
Thomas F. Ferris ’56 
Jonathan M. Fine ’81 
Alan G. Finesilver '68 
Richard J. Fingeroth ’73 
Robert I. Finkel ’65 
Knox H. Finley ’30 
Lesley F. Fishelman '69 
Robert L. Fisher '59 
William F. Flynn '68 
Alan L. Folsom '63 
John W. Foreman ’62 
Robert N. Frank ’66 
Jean L. Fraser’91 
Lawrence R. Freedman '50 
Robert W. Frelick ’44 
M. Felix Freshwater ’72 
Guy Fried ’85 
Jonathan S. Friedes '88 
Alice D. Friedman ’45 
Paul J. Friedman ’60 
Paul J. Friedman ’59 
David H. Fulmer ’63 
Sidney S. Furst '51 
Raymond A. Gagliardi '45 
Raymond A. Gaito ’58 
Jared J. Gardner '71 
John H. Gardner III ’56 
John A. Gariepy ’54 
Jay A. Gates ’86 
Barry Gault '64 
Elizabeth R. Gawron ’75 
Royal J. Gay ’69 
Alfred C. Gaymon ’75 
Susan R. Gaynon ’76 
Sander G. Genser ’69 
Michael A. Gerber ’74 
Vincent F. Geremia Jr. '63 
John N. German '62 
Margaret C. Gildea ’36 
Bernice K. Glover '91 
Sumner H. Gochberg ’56 
Dorothy M. Gohdes ’72 
David E. Golan ’79 
Lee Goldman ’73 
Anne H. Good ’57 
Eleanora C. Gordon '49 
Gary V. Gordon ’73 
Gwendolyn Grant ’91 
S. Jerome Greenfield ’39 
Andrew H. Greenhill ’72 
Stanley I. Greenspan '66 
James Greenwald ’58 
J. McLeod Griffiss '66 
B. Herold Griffith ’48 
David D. Griffith ’61 
Gary T. Grimes ’73 
David H. Groth ’62 
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The Office of Alumni Affairs, as part of its new Outreach Program, sponsored a reception in San Francisco in November 
1996 during the annual meeting of the Association of American Medical Colleges. Brothers John A. Anlyan, M.D. '45, 
right, and William G. Anlyan, M.D. '49, second from left, are pictured with Dean Gerard N. Burrow, M.D. '58, left, and 
John’s wife, Betty. 
Robert H. Groves ’56 
James K. Gude ’65 
Robert A. Gunn '66 
Irving Guttenberg ’60 
John L. Gwin Jr. ’84 
Bruce B. Haak '72 
Linda J. Hall ’78 
James H. Halsey Jr. '59 
John A. Hangen ’29 
Henry G. Hanley ’66 
James Q. Haralambie ’35 
Ross R. Harcus '48 
Paul A. Harper ’31 
John T. Harrington ’62 
Stanley Harris ’58 
John H. Hart '56 
Richard J. Hart Jr. ’67 
Barbara J. Harvey ’86 
Patricia C. Hassakis '62 
Christopher W. Hauge '64 
A. Daniel Hauser '53 
William W. Hay Jr. ’71 
Jay G. Hayden '66 
Richard L. Heppner '67 
Peter N. Herbert '67 
George P. Herr '67 
William H. Heydom '59 
David A. Hill '65 
C. Richard Hinckley '59 
Lawrence J. Hirsch ’91 
Gary S. Hirshfield "86 
Elizabeth S. Hodgson '78 
Gilbert F. Hogan '57 
O. Roger Hollan '45 
Charles L. Hopper '56 
Thomas L. Horn '72 
Mary A. Houghton '66 
William J. Houghton '64 
Thomas C. Howard '69 
Daphne T. Hsu '82 
Vernon H. Humbert Jr. '72 
Carl E. Hunt '65 
Herbert S. Hurwitz '54 
Richard G. Ihnat '91 
Leonard Inker '59 
Carrold K. Iverson '51 
Jonathan L. Jacobs '80 
W. Raymond James '44 
Robert M. Jarrett ’74 
Arthur C. Johnson III '79 
Benjamin A. Johnson '49 
Paul A. Johnson '75 
Thomas R. Johnson ’68 
Virginia B. Johnson ’65 
William J. Johnson ’52 
Daniel M. Jones ’60 
Henry H. Jones ’43 
Brian C. Judd ’63 
Emilio J. Juncosa ’84 
Amy C. Justice ’87 
Rebecca E. Kadish ’87 
Richard L. Kahler '57 
George T. Kammerer '56 
Kevin Kane '75 
Harold P. Kaplan '63 
Roy A. Kaplan '12 
Walter W. Kamey '62 
Ronald J. Karpick '65 
Michael Kashgarian '58 
Michael A. Kaufman ’72 
Richard L. Keefe '61 
Robert M. Keith '54 
Leo Kellerman '42 
R. Leonard Kemler '43 
Donald L. Kent ’72 
Robert J. Kerin '47 
David R. Kessler ’55 
Harold King '46 
Joseph T. King Jr. '87 
Robert D. King ’51 
David W. Kingsbury '59 
J. Robert Kirkwood '67 
Ralph J. Kirmser '71 
Jay W. Kislak’58 
James A. Kleeman ’46 
George D. Knowles ’75 
Richard R. Knowles ’53 
Anne A. Knowlton ’78 
Paul B. Koehler ’48 
Howard K. Koh ’77 
WilhelminaC. Korevaar '77 
Donald S. Komfeld '54 
Melvyn Korobkin '67 
Mark A. Korsten '70 
Robert A. Kramer '55 
Frederick F. Krauskopf '44 
Edward A. Krull '55 
Thomas P. Kugelman "60 
Thomas S. Kupper ’81 
Samuel D. Kushlan ’35 
Constantine D. Kyropoulos '63 
Lynn G. Lagerquist Jr. ’69 
Scott R. Lambert '83 
Saul Lande '74 
Lewis Landsberg '64 
Edward R. Lang '60 
Michael W. Lau '45 
Frank D. Law '49 
Philip W. Lebowitz '72 
Carol H. Lee '76 
Forrester A. Lee Jr. '79 
Richard V. Lee '64 
Jack Levin '57 
James S. Levine '64 
Sandra C. Levine '65 
William V. Lewit '56 
Theodore W. Lieberman '58 
Michael R. Liebowitz '69 
Paul R. Lightfoot Jr. ’64 
Bjorn Lih ’41 
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Harris Brothers Support 
Yale Child Study Center 
Two brothers, both Yale College graduates, 
pledged a $4 million gift to construct a new 
facility and support programs at the Yale 
Child Study Center. The gift from Irving B. 
Harris, Yale College Class of ’31, and Nei- 
son Harris, Yale College ’36, will help con¬ 
struct the Neison and Irving Harris building, 
a new wing attached to the center. 
David Lindgren ’83 
Janus C. Lindner '50 
Clinton L. Lindo ’86 
Elliot M. Livstone ’69 
Francis M. Lobo ’91 
J. Philip Loge '43 
Jack W. Love ’58 
Anthony P. Lovell '67 
Jeffrey A. Lowell '85 
Frank E. Lucente '68 
James Lum '55 
Hugh J. Lurie '61 
Brock Lynch '47 
Michael E. Mahig ’88 
John L. Mahoney ’63 
Jocelyn S. Malkin ’51 
Stacey Mandelbaum ’86 
William J. Mangione ’71 
Harold March ’50 
Vincent T. Marchesi ’61 
Robert H. Margulis ’63 
Robert L. Marier '69 
Josefina V. Marin ’76 
John C. Marsh ’59 
Edward Martin ’40 
Frederic R. Martin '83 
John G. Martin ’33 
Jose L. Martinez ’78 
Teresa L. Massagli ’82 
William F. Matched ’64 
David B. Matloff’61 
Allan L. Mattem '62 
A. Reese Matteson '44 
Stanley E. Matyszewski '62 
Thomas J. Mauro Jr. ’58 
William K. McClelland '47 
Cynthia A. McCraven ’86 
John A. McDowell ’73 
Andrew J. McGowan Jr. '58 
Timothy W. McGowen ’86 
Joseph S. McGuire Jr. ’55 
Robert K. McLellan ’78 
John F. McQuade ’73 
Harold Mellin ’66 
Herbert Y. Meltzer ’63 
Barton N. Milestone ’81 
Donald L. Miller ’60 
Harry C. Miller Jr. '54 
Mark A. Miller'90 
Michael D. Miller’86 
Richard C. Miller’58 
Stephen W. Miller ’67 
William A. Miller’62 
Richard P. Mills ’68 
Hyman J. Milstein ’75 
Robert K. Modlin '57 
Hugh L. Moffet ’57 
Cesar R. Molina ’80 
Russell R. Monroe '44 
Norman F. Moon ’56 
Richard A. Moore '61 
Frederick C. Morin III '76 
Joseph L. Morris '67 
Jon S. Morrow '76 
David E. Morton ’48 
N. Karle Mottet ’52 
James J. Murphy '64 
Jerry Nagler '73 
Stephen F. Nagyfy ’36 
William M. Narva ’56 
George A. Nelson Jr. ’57 
Paul N. Neufeld '54 
John F. Neville Jr. ’46 
Laura W. Neville ’46 
Ismail N. Nevin '51 
Kenneth E. Newhouse '87 
James P. Nolan ’55 
Timothy F. Nolan Jr. ’49 
Walter W. Noll ’65 
David P. Norton ’83 
Edward B. O’Connell ’41 
John P. O'Grady ’72 
Donald A. O'Kieffe Jr. ’64 
Joyce A. O’Shaughnessy ’82 
Kwaku Ohene-Frempong ’75 
Robert W. Ollayos ’41 
Margot Onek ’68 
Nelson K. Ordway ’38 
A. Lawrence Ossias ’65 
Robert H. Owens ’46 
David A. Page ’56 
Fred Palace ’60 
Sidney N. Paly ’52 
Henry F. Panek ’68 
Robertson Parkman '65 
Nicholas M. Passarelli ’59 
John O. Pastore '67 
James R. Patrick ’56 
Timothy A. Pedley ’69 
Barry B. Perlman ’71 
Richard E. Peschel '77 
Barbara A. Peters ’79 
Richard C. Peterson ’48 
Carol F. Phillips '58 
Leon A. Phillips ’52 
Julian I. Pichel ’49 
Lawrence K. Pickett '44 
Sheldon R. Pinnell ’63 
Olive E. Pitkin '47 
Elizabeth A. Plotkin ’86 
Robert L. Powell ’56 
William B. Pratt '64 
James D. Prokop ’59 
David M. Pugh ’58 
Richard D. Pullen ’54 
Susan B. Radoux ’81 
Daniel W. Rahn ’76 
Paul R. Ramirez ’76 
Jose Ramirez-Rivera ’53 
David M. Raskind '24 
Carrie A. Redlich ’82 
Clifford B. Reifler ’57 
Lynn W. Reiser ’70 
Bruce A. Reitz ’70 
Jack S. Rice Jr. ’64 
Henry A. Riedel '43 
Brian F. Rigney ’67 
William A. Rios '84 
Samuel Ritvo ’42 
Barbara A. Roach ’81 
Richard S. Robbins ’72 
Joseph D. Robinson '69 
Joseph M. Rochford '69 
Lois K. Rogers ’42 
Thomas J. Romano ’73 
Roy E. Ronke Jr. ’61 
John K. Rose ’54 
Albert M. Ross ’60 
Paul A. Rudnick '58 
Benjamin F. Rush Jr. '48 
Carl M. Russell ’49 
George M. Sachs '86 
Virginia C. Saft ’53 
Gary L. Schaer ’79 
James Scheuer ’56 
Stephen C. Schimpff ’67 
Mary W. Schley '52 
Ricky M. Schneider ’77 
Charles F. Scholhamer '72 
Richard S. Schottenfeld ’76 
John J. Schrogie ’60 
David J. Schulak ’69 
Donald H. Schultz ’52 
Russell B. Scobie ’29 
Margretta A.R. Seashore '65 
Donald W. Seldin ’43 
Jerome H. Shapiro ’48 
Dovelet Shashou ’81 
Donald P. Shedd ’46 
Cynthia A. Sherman ’79 
Jonathan A. Sherman ’88 
Charles E. Sherwood ’45 
Sarah P. Sherwood ’44 
Cynia B. Shimm ’50 
Stuart S. Shorr ’70 
Jane B. Shumway ’50 
Leonard M. Silverman ’54 
Donald C. Simonson ’78 
Richard A. Sinnott Jr. ’53 
HillelD. Skoff’80 
Laurie Smaldone ’79 
Gerald J. Smallberg ’69 
Pamela E. Smith ’79 
Sidney C. Smith Jr. ’67 
Thomas W. Smith '15 
Helen L. Smits ’67 
Robert T. Solis ’65 
Kimberlee A. Sorem ’86 
Edward H. Soule '43 
James P. Southwick ’71 
Gene W. Spector ’59 
James A. Spencer ’62 
Robert Spiera ’89 
Robert M. Spillane ’91 
Hilliard Spitz '43 
Richard A. St. Onge ’70 
Donald C. Stahl '51 
Nicholas M. Stahl ’43 
Nancy A. Staley ’62 
Fred L. Stargardter ’60 
Mark Stein ’84 
Robert L. Stein ’54 
Ted Mann Foundation Funds 
Lymphoma Research 
The Ted Mann Foundation pledged 
$500,000 over five years to establish 
the Ted Mann Lymphoma Research Pro¬ 
gram Fund in the Yale Cancer Center. Mr. 
Mann, producer and founder of Mann 
Theaters in California, supports a variety 
of education and medical research caus¬ 
es through the foundation. 
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Friends Jonathan W. Stewart ’71 
Lee H. Strohl ’68 
Eric P. Suan ’86 
James F. Sullivan ’73 
Thomas F. Sweeney '73 
Richard B. Swett ’67 
Daniel R. Synkowski ’71 
Paul Talalay ’48 
Lee B. Talner ’63 
Robert N. Taub ’61 
Caroline R. Taylor ’78 
Carol C. Teitz ’74 
Lawrence P. Temkin ’72 
R. Bruce Thayer '46 
Jonathan Titus ’65 
Patrick J. Toth '82 
Susan P. Tredwell ’84 
Lawrence Tremonti '63 
Ray W. Tripp III '70 
Semeon G. Tsalbins ’71 
Patricia B. Tudbury ’47 
Maurice Tulin ’42 
Albert L. Ungricht ’82 
Anthony M. Urbano ’81 
Ellis J. Van Slyck '47 
Martha Vaughan '49 
Gary C. Vitale ’79 
Robert A. Vollero '67 
John W. Vosskuhler ’54 
Karl G. Wagner Jr. '90 
Helen N. Walsh ’63 
William P. Walsh ’46 
Martin Wand ’67 
May Y. Wang '60 
Patricia E. Wanning ’40 
Steven L. Warsof ’77 
Stephen R. Webb ’69 
Myron E. Wegman ’32 
Marc A. Weinberg ’73 
Peter G. Weiner ’63 
Robert G. Weiner ’65 
Seth M. Weingarten ’63 
James L. Weiss '68 
Carolyn K. Wells '69 
C. Bruce Wenger ’70 
James G. Wepsic ’63 
Doris L. Wethers ’52 
Robert B. Whitney Jr. ’59 
Per H. Wickstrom ’68 
Henry S. Willner ’75 
ElihuS. Wing Jr. ’46 
Alfred J. Wise ’63 
Daniel Wohlgelemter ’77 
David H. Wohns ’81 
Brooke M. Wolf ’72 
Stephanie Wolf- 
Rosenblum '82 
John L. Wolff ’52 
Irving N. Wolfson ’42 
Edward M. Wolin ’74 
Andrew S. Wong ’51 
Jeffrey W. Work ’79 
Stewart R. Wright ’62 
Karl O. Wustrack ’70 
John J. Wysolmerski ’86 
Marc O. Yoshizumi ’70 
Richard S. Young ’73 
Pamela L. Zeitlin ’83 
Steven M. Zeldis ’72 
Former House Officers 
Frederick L. Altice 
Christine Brahney 
Ronald W. Braun 
Richard S. Casden 
Edward J. Collins Jr. 
Harold O. Conn 
John W. Goldkrand 
Herbert S. Sacks 
Sanan Simarak 
Leon G. Smith 
Robert A. Stanton 
Parents 
R. Donald Reich 
Henry S. 
Sanematsu 
Mr. & Mrs. Mark Anderson 
Ellen Hope Angus 
Diana Balmori 
Waddell Barnes, M.D. 
Timothy Brandt 
William Brown 
Dr. Sonja Buckley 
Grace T. Burket 
Edwin C. Cadman, M.D. 
L. Dawn Christian, D.D.S. 
Joanne Chvisuk 
Mr. & Mrs. Charles Ciambrielh 
David E. Crabb 
Thomas P. Duffy, M.D. 
David S. Fischer 
Cheri Fox 
Karyn Gabbinelli 
Alphonse F. Gencarelli 
Gary Gerard, M.D. 
Arthur Goldzweig, Esq. 
Beverly M. Grasso 
Maurice D. Grasso 
Holocaust Survivors of 
New Haven 
Helen D. Haller 
Michael B. Hammond 
Mr. & Mrs. James J. Imbrogno 
Mrs. Charles S. Judd Jr. 
Foster Kay, M.D. 
Nancy M. Kenny 
Uwe Koepke, Ph.D., M.D. 
Mr. & Mrs. Jay B. Korman 
Robert Lapham 
Aaron B. Lerner, M.D., Ph.D 
Richard S. Lovelace 
The Mendillo Family 
Foundation Inc. 
Daniel C. Maguire 
Edyth W. Maibrunn 
Mr. & Mrs. Peter L. Malkin 
Candida Mancusi 
Charles Needham, M.D. 
Jason D. Newman 
Katharine Odell 
John M. O’Leary 
Mr. & Mrs. Harry Panzer 
Je Guk Park 
Anna Rabinowitz 
Mr. & Mrs. Ronald Reis 
Dana A. Ricker 
Robert A. Roda 
Roger D. Rosenfeldt 
Mrs. Norbert Schnog 
Suzanne E. Siegel 
Mr. & Mrs. Howard B. Sosin 
Mr. & Mrs. Ronald Stevens 
Sadie Stren 
A. Walter Stubner 
Dr. & Mrs. T.E.H. Talma 
Ernest C. Todd 
Robert Traurig 
Behrouz Vafa 
Leonard H. Zamore. M.D. 
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EPH ALUMNl/AE FUND 
From the dean for public health 
The faculty and students join me in thanking our 
alunmi/ae for their outstanding support this year 
for financial aid through the EPH Alumni Fund. We 
have an extraordinary group of students, many of 
whom have great financial needs. Being able to help 
them relieve some of their financial burdens is very 
rewarding. 
We have opened the new student center across the 
street from the Laboratory of Epidemiology and Public 
Health. It includes the Student Affairs and Career Ser¬ 
vices offices, a student lounge, computer facilities and 
a magnificent new library. Moving those activities has 
allowed us to develop the first floor of the main build¬ 
ing with new classrooms and a thoroughly renovated 
Winslow Auditorium. 
The faculty is implementing our strategic plan, 
including needed revisions of the curriculum. The first 
classes in our new Health Management and Regulatory 
Affairs programs are here and doing well. We are 
strengthening our relationships with other schools at 
Yale and the cross-fertilization of ideas makes EPH a 
lively place. We are also recruiting several new faculty 
in a wide range of areas. 
But as we enjoy academic life, we cannot forget 
the enormous public health problems facing popula¬ 
tions close to us in the city of New Haven and as far 
away as the most distant point on the globe. It is on 
these problems that we must focus our educational and 
research activities and programs. 
On behalf of the entire school, I extend our grati¬ 
tude to those alumni/ae who have generously sup¬ 
ported our efforts. 
Michael H. Merson, M.D. 
Dean for Public Health 
From the chairman of 
the Public Health Alumni Fund 
This spring at our alumni 
weekend we will cele¬ 
brate the 50th anniversary of 
organized alumni/ae involve¬ 
ment in Epidemiology and 
Public Health at Yale. 
Throughout all of these 
years, we have shared a tradi¬ 
tion of loyalty and devotion 
to EPH. The enthusiasm of 
our dean, the new renovation 
of the student and teaching 
facilities and the heightened 
activity of our faculty—in research and service areas 
such as emerging infectious disease, managed care and 
urban health—have increased the visibility of public 
health at Yale. 
One result has been the recruitment of an outstand¬ 
ing group of master’s and doctoral students who repre¬ 
sent our real investment in the field. Alumni/ae gen¬ 
erosity has made financial support available to many of 
these students who could otherwise not attend Yale. In 
fact, last year our level of alumni/ae participation in 
giving was at an all-time high of 41 percent, and EPH 
gifts and pledges to the Annual Fund and Yale’s capital 
campaign totaled more than $400,000. 
I want to express my congratulations and sincere 
thanks to everyone who worked on these fund-raising 
activities, as well as to those who so generously con¬ 
tributed. Adequate financial aid for students remains 
our most important financial priority as we address the 
challenges of educating students for the demands of 
public health in the future. If EPH is guided by our 
mission to train leaders, we must be able to attract and 
retain the very best students and allow them to plan 
careers that address the needs of the field. As EPH 
alumni/ae and public health professionals, we all 
appreciate the importance of this mission. It is fitting, 
in this next anniversary year, that we renew our com¬ 
mitment to advancing the field by continuing our sup¬ 
port of those who will be our future colleagues. 
Eric W. Mood, M.P.H. ’43 
Chairman 
Public Health Alumni Fund 
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The names and data included on the following 
pages reflect contributions made and endow¬ 
ment income accumulated between July 1, 
1995, and June 30,1996. The class members 
recognized made a gift to the find during that 
period. Endowment income is not reflected in 
the class participation percent. If we have 
inadvertently omitted your name, please 
accept our apologies and contact Mr. William 
K. Jenkins in care of this magazine so that we 
may correct this omission. 
1933 
Gift: $20 
Participation: 33% 
Miriam M. Campbell 
1934 
Gift: $1,338 
Participation: 100% 
Iwao M. Moriyama 
1937 
Gift: $100 
Participation: 50% 
Howard West 
1938 
Gift: $185 
Participation: 100% 
Willard H. Boynton 
Andrew S. Wong 
1941 
Gift: $1,376 
Participation: 50% 
Margaret H. Hyde Moore 
Roslyn L. MacNish 
1942 
Gift: $5,455 
Participation: 100% 
Agent: 
Eric W. Mood 
Henry F. Canby 
Leonard Parente 
Charles D. Spangler 
1943 
Gift: $1,327 
Participation: 75% 
Agent: 
Eric W. Mood 
Julius Elston 
Carolyn S. Koffler 
Eric W. Mood 
Amelia F. Roe 
Miriam H. Rohde 
Adele P. Schlosser 
1944 
Gift: $1,078 
Participation: 67% 
Agent: 
Eric W. Mood 
Paul E. Gagnon 
Jean F. Heston 
Jane Y. Parker 
Einar H. Raysor 
1945 
Gift: $200 
Participation: 56% 
Roslyn R. Bilford 
Naomi Barer Golden 
Mrs. Joe Bales Graber 
Lois M. Jund 
Hazel M. Whitesel 
1946 
Gift: $600 
Participation: 33% 
Dorothy B. Hamilton 
D. Patricia Nelson 
1947 
Gift: $3,390 
Participation: 58% 
Sidney S. Chipman 
Anne E. Fulton 
Lillian L. Konick 
Leah Lehrer 
Jean M. Pinder 
Cecil G. Sheps 
Samuel Zibit 
1948 
Gift: $120,875 
Participation: 62% 
Agent: 
Samuel S. Herman 
John B. Dibeler 
Mary L. Ellis 
Joseph Hanford Gerber 
Samuel S. Herman 
Mrs. Richard E. Johnson 
Beatrice H. Kaasch 
Dorothea S. LaBelle 
Hiram Sibley 
1949 
Gift: $1,150 
Participation: 69% 
Agent: 
Edgar L. Geibel 
Eleanor C. Connolly 
Edgar L. Geibel 
Eleanor P. Kostant 
Edmund R. Mattos 
M. Christine R. Owre 
William B. Parsons 
Joyce L. Reiss 
Elizabeth Robinton 
Ernest M. Sable 
Mary T. Springer 
Kathryn K. Venning 
1950 
Gift: $1,987 
Participation: 62% 
Agent: 
Eric W. Mood 
Dorothy Reese Bloomfield 
Ida M. Bucher 
Austin J. Evans 
Jerome M. Glassman 
Dorothy R. Granoff 
Eugene K. Harris 
Frances K. Reynolds 
Nathan M. Simon 
1951 
Gift: $640 
Participation: 42% 
Norton G. Chaucer 
Homer Hopkins Jr. 
Robert L. Johnson 
Virginia E. Torres 
James M.A. Weiss 
1952 
Gift: $3,255 
Participation: 47% 
Agent: 
Yolande F. Lyon 
Mary M. Del Piero 
Howard Dunphy 
Joanna Adele Henry 
Malcolm C. Hope 
Charles Holway Lawrance 
Helen Kardys Loria 
Yolande Lyon 
Brena B. Wolff 
1953 
Gift: $865 
Participation: 45% 
Abraham Cutcher 
Cecilia Frances 
Di Cicco 
Barbara J. Lee 
Milton H. Sisselman 
Constance B. Thomas 
1954 
Gift: $610 
Pa rticipation: 71% 
Agent: 
Eric W. Mood 
Donald R. Cowan 
Jo Ann G. Graves 
Alvin Hamburg 
William A. Markey 
Ruth M. Taber 
1955 
Gift: $465 
Participation: 67% 
Agent: 
Frances R. Ogasawara 
Lester M. Bornstein 
Amy L. Cawley 
Evelyn S. Farnsworth 
Morris London 
Mary McC. Mogan 
Frances R. Ogasawara 
Gerald Rosenblatt 
Daniel E. Ross 
1956 
Gift: $2,705 
Participation: 75% 
Agent: 
David D. Boyd 
Ruth D. Bartling 
Dorothy Carol 
Blumer 
David D. Boyd 
Marvin H. Burton 
Lois Blatchford Fuller 
Kathleen H. Howe 
John E. Ives 
Paul I. Kaufman 
John F. Mullett 
Julia R. Nole 
Mary K. Ochiai 
George R. Walker 
1957 
Gift: $2,025 
Participation: 53% 
Agent: 
Edward R. DeLouise 
Anne M. Anzola 
Lee de Cady Jr. 
William A. Clermont 
Edward R. DeLouise 
Sheldon Selig King 
Shirley T. Steidel 
Paul W. Sternlof 
Patricia A. Viscosi 
1958 
Gift: $4,845 
Participation: 55% 
Agent: 
Joseph Scorpion 
Eduardo Anzola 
Josephine Blanchett 
Helen H. Davenport 
Normand E. Girard 
Patricia P. Grimaila 
Philip B. Hallen 
J. Philip Keeve 
Edward H. Noroian 
Joseph A. Scorpion 
Mary K. Spiker 
Irene N. Sweeny 
Robert Kenneth Wood 
1959 
Gift: $965 
Participation: 40% 
Agent: 
Dorothy M. Wilson 
Marvin A. Lavenhar 
Hugh J. Maher 
Feme G. Moore 
Ellwyn D. Spiker 
Mattie Lee D. Wade 
Kenneth J. Williams 
1960 
Gift: $2,205 
Participation: 53% 
Charles W. Burchard 
Kathryn L. D'Amico 
Wouter Ekker 
Maxine Geeslin 
Rose A. Iannotta 
John J. Kwasnowski 
Salvatore Miano 
R. John C. Pearson 
Hannah Clark Russell 
1961 
Gift: $3,425 
Participation: 71% 
Agent: 
Joseph T. Prekup 
Gordon R. Beem 
Mary S. Blackburn 
Martin Donabedian 
Alfred E. Fletcher 
Yoh Ok Lee 
Helen M. O’Connell 
Margaret P. Parker 
Joseph T. Prekup 
Angela M. Russo 
William R. Slivka 
1962 
Gift: $1,050 
Participation: 22% 
Thomas A. Blumenthal 
Thomas R. Mayhugh 
1963 
Gift: $3,125 
Participation: 47% 
Jordan Braverman 
Hamp Coley 
Raul R. Cuadrado 
Stephen F. Davie 
Frank M. Isbell 
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Edward M. Kenney 
Jean M. Maynard 
Samuel B. Webb Jr. 
1964 
Gift: $2,755 
Participation: 39% 
Agent: 
Allen Cohen 
James J. Culhane 
Katherine Maria Detre 
Martin Hirsch 
Carter L. Marshall 
Estelle Siker 
Monroe W. Spero 
Claudewell Sidney 
Thomas 
1965 
Gift: $2,225 
Participation: 50% 
Edgar W. Francisco III 
Monte Nelson Frazier 
James F. Jekel 
Michael E. Kove 
Peter J. Levin 
Charlotte Miller 
Mary K. Murphy 
Francia M. Pagano 
Elliot A. Segal 
Viola J. Spinelli 
Alice J. Turek 
Sarah L. Turner 
David S. Weiner 
1966 
Gift: $1,820 
Participation: 36% 
Richard W. Benfer 
Allen Cohen 
Anne B. Collart 
Richard H. Ferraro 
Jennifer L. Kelsey 
Robert C. Lowrie Jr. 
Mrs. Birch H. 
Milliken 
Nancy Alfred Persily 
Gary J. Robinson 
1967 
Gift: $4,341 
Participation: 59% 
Agent: 
James M. Malloy 
Gerard M. Barber 
Rosalie M. Berberian 
Caroline Fong-Cheng 
Ann Gomez 
Joel Kavet 
Dennis J. Magid 
Patricia D. Mail 
James M. Malloy 
Joseph A. Mangiafico 
Charles Petrillo Jr. 
Nancy Ruth Phillips 
Bruce J. Steinhardt 
Elgin Wayne Watkins 
Irma Willner 
Robert L. Woodward 
1968 
Gift: $12,910 
Participation: 53% 
Sonia M. Colon 
Joseph L. Dorsey 
Elizabeth Schwartz Elliot 
Robert R. Everett 
L. Carol Fernow 
Carl R. Fischer 
Michael J. Geaney Jr. 
Francis J. Greaney 
William D. Harkins 
Chester H. Johnson 
R. Elizabeth Leif 
Margaret J. Lindsay 
Jean C. MacCorison 
John M. Patton 
Richard L. Petrelli 
Cornell Scott 
Doreen P. Sharabati 
Martha F. Steel 
Doris Storms 
Elizabeth C. Wright 
1969 
Gift: $2,773 
Participation: 45% 
Susan S. Addiss 
Janet A. Albrecht 
Jean Parker Cobb 
Victor Crown 
James M. Dawson Jr. 
Charles W. Felix 
Sister Mary Anne 
Fitzmaurice 
Sharon A. Garcia 
David P. Johnson 
Samuel P. Korper 
John N. Parker 
Samuel D. Rowley 
Marva Serotkin 
Edward P. Tantorski 
Wanda Vierthaler 
1970 
Gift: $12,820 
Participation: 56% 
Robert G. Alexander 
Susan W. Balter 
Katherine Benesch 
Arthur A. Berarducci 
Michael B. Bracken 
Hamilton B. Brown Jr. 
Shan Cretin 
Ruth C. Edelson 
Walter M. Gawlak 
Robert S. Gureasko 
Martin James Kandes 
J. Kevin Kinsella 
Shirley O. Labium 
Scott W. Lite 
Russell F. Martin 
C.P. Noel McCarthy 
Andrea W. Nevins 
Peter Orris 
Saro Palmeri 
William L. Pedersen 
Carol B. Phillipy 
Nancy Norton Reitz 
Stephen Skorcz 
Joseph A. Zaccagnino 
1971 
Gift: $17,460 
Participation: 52% 
John Bihldorff 
Evelyn J. Bromet 
Willard Cates Jr. 
Katrina H. Clark 
Dale A. Culp 
Chester L. Davis II 
Harvey Fembach 
William P. Ferretti 
Anne-Marie Foltz 
Marilyn S. Halper 
Dennis R. Hamilton 
Wanda Hatmaker Decker 
Mohamed Ismail Johnson 
William P. Koughan Jr. 
Joseph S. McManus 
Nancy P. Mogielnicki 
Wan Hin Ooi 
Carol L. Paul 
Marcia Russell Prado 
John M. Ryan 
Anna Caroline Schildroth 
Jane Silver 
Rev. Robert E. Steele 
David L. Stockton 
Victor J. Tucci 
Judith Whitcomb 
1972 
Gift: $6,085 
Participation: 67% 
Agent: 
Dorothy J. Nicoll Lewis 
David P. Barone 
Stephen B. Baruch 
Steven H. Beloff 
Michael L. Benjamin 
Frances L. Bushnell 
Paul G. Bushnell 
C. Gene Cayten 
Catherine A. Connolly 
John A. Drew 
James P. or 
Anne S. Fenhagen 
Daphne Dej. Gemmill 
Susanne Harris 
Russell E. Holmes 
Selby Campbell Jacobs 
Dorothy N. Lewis 
Steven M. Lipsius 
Marilyn Marie Massey 
Eugene A. Richardson 
Sergio Ruschel 
Jo Ann Silverstein 
Joyce R. Waksman 
Owen L. Wood 
Carol H. Simpson Yee 
1973 
Gift: $8,575 
Participation: 57% 
Agent: 
Gaty D. Sax 
Emily M. Barclay 
Eva Danielsson Cohen 
Bernice E. Coleman 
Etekamba E. Ekwo 
Bruce Goldman 
Schula Russell Hobbs 
Helen B. Hubert 
Shirley A. Jackson 
James L. Mason 
Dennis P. May 
Dwight N. McNeill 
Stanley D. Miller 
George A. Million 
Eugene C. Nelson 
Marjorie E. Nelson 
Eugene Robertson 
Gary Dean Sax 
Janet B. Schoenberg 
Andrew Edmund Slaby 
Alice S. Stark 
Thomas J. Stranova 
Irene Trowell-Harris 
Larry S. Webber 
Bonnie C. Yankaskas 
Carl J. Zack 
1974 
Gift: $3,033 
Participation: 44% 
Agent: 
Thomas A. Benoit 
Gregory Belok 
Thomas A. Benoit 
Ian B. Berger 
Roger H. Bernier 
Olga Brown-Vanderpool 
Beth G. Crocker 
Robin Gilleland 
Elizabeth M. Helming 
George L. Kelley 
Evelyn B. Mostow 
Edward J. Mullen 
Thomas P. Pipicelli 
Shirley M. Pripstein 
Nils R. Richardson 
Elaine Ron 
Donald R. Showalter 
Abigail L. Smith 
Meredith E. Spear 
J. Lawrence Tanenbaum 
1975 
Gift: $6,355 
Participation: 42% 
Agent: 
Linda K. Broker 
Christine P. Antaya 
Edith N. Baum 
Ralph E. Binder 
Gerald E. Bisbee Jr. 
Linda K. Broker 
Ann C. Cunningham 
Linda K. Demlo 
Jack A. Eiferman 
Joyce H. Glazer 
Gerard R. Goulet 
William J. Grego Jr. 
Donna Brown Grossman 
Anne H. Hall 
Mary F. Johnson 
Barbara R. Unterman 
Jones 
James E. Knoben 
Matthew A. Kurs 
Stuart L. Lefkowich 
Sheldon M. Levy 
Marsha Alex Lubick 
Hillary Dernby Malafronte 
Laurence F. McMahon Jr. 
Dennis W. Mesenhimer 
Mary W. Palshaw 
Dale P. Sandler 
Edward V. Sargent 
Nancy E. Stroup 
Raymond Chiu-Ping Tang 
John H. Tobin 
Maura M. Tobin 
Franziska U. Ulrich 
Vera B. Walline 
1976 
Gift: $15,860 
Participation: 55% 
Agent: 
Elaine P. Anderson 
Elaine P. Anderson 
William F. Appicelli 
Helen Y.Y. Chang 
Janet Cobey 
Mary P. Cowmeadow 
Darryl E. Crompton 
Agueda N. Deans 
Joanna M. Erikson 
Paul H. Etkind 
Robert H. Frazier 
Berton D. Freedman 
Wendy Corn Friedman 
Annette B. Garofalo 
Linda J. Goodhart 
Karen A. Gordon 
Cleve Lee Killingsworth 
Janina Levy 
Eric Malz 
Robert C. Marquardt 
Karen E. McClelland 
Lawrence V. Meagher Jr. 
Gino A. Nalli 
Arthur J. Orloske 
Ruth Fitch Quah 
Robert Risdon Schwarz 
Mary Jo P. Shepard 
Martha Ann Teitelbaum 
Gladys A. Williams 
Thomas S. Wingardner Jr. 
Frances L. de Peyster 
1977 
Gift: $9,227 
Participation: 42% 
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Richard B. Burford Jr. 
Patrick F. Carone 
Jeffrey Allen Cassis 
Steven R. Cohen 
Bruce D. Cummings 
Marsha E. Dunn 
Gerard J. Foley 
Joanne Godley 
Travis K. Hedrick 
Susan J. Kennedy 
Teri J. Klein 
Ronald F. FaPensee 
Wendy K. Lefkowich 
Angela Manns 
Polly W. Marvin 
Rosanne B. McTyre 
Sharon A. Mulgrew 
Kristin K. O’Connor 
Veronica C. Oestreicher 
Harris Pastides 
Finda Mendelsohn Pottem 
Marilynn S. Robinson 
Deborah Rose 
Fynne E. Rosenwald 
Abby Rothschild 
Carroll Schilling 
Susan M. Silverman 
Gail M. Sullivan 
Virginia R. Towle 
Leon F. Vinci 
Ellen J. Waldman 
Paula Y. Yaney Gambill 
1978 
Gift: $10,650 
Participation: 57% 
Agent: 
Ann T. Freedman 
Vijaya V. Bapat 
Kathleen M. Berman 
William Harvey Blitz 
Alan B. Bloch 
Bradford A. Buxton 
Constance C. D’Atri 
Robert J. Fensterheim 
Ann T. Freedman 
Janice R. Gold 
Celestine Grace 
Olympia Hadjimichael 
Nancy G. Hildreth 
Stephen W. Hildreth 
Jane E. Hill 
David W. Houck 
William A. Howard 
Jean Crum Jones 
Margaret Fong Karis 
Amy Schein Kondo 
Rosalyn S. Fiss 
Christopher M. Maylahn 
Robert K. McFellan 
H. James Myers 
Marguerite Nelligan 
Patricia Fynn Noeker 
Peter F. O'Connor 
David W. Osborne 
Elizabeth L. Pantelick 
Trudee C. Parenteau 
Ellen D. Rothberg 
Karen C. Schneider 
Michelle D. Schoenberger 
Robert E. Schwartz 
Roberta Jo Shapiro 
Patricia A. Shea 
Alan J. Siniscalchi 
Marie Stoeckel 
Rolando Antonio Thorne 
Bernadette S. Vissani 
R. Bradford Walker 
Fucy Ellen Weiger 
Karen W. Wolchuck-Sher 
1979 
Gift: $13,985 
Participation: 47% 
Agent: 
Ralph Tartaglione Jr. 
Virginia P. Bainbridge 
Marianne Berwick 
Joann N. Bodurtha 
Jonathan Brenn 
Dennis A. Brogan 
Christopher M. Cannon 
Elizabeth S. Carter 
Ralph J. Cobum 
James F. Consedine II 
Susan De Renzo 
Frances D. Dwyer 
Terry Edelstein 
Nurit Erger 
Lynn Fielden-Smith 
Laura Meisler Finkelstein 
Delores A. Franks 
Judith B. Gancher 
Shelley Helfer-Amira 
Karen G. Hellenbrand 
Joseph D. Henn-Demayo 
Lucinda H. Hogarty 
Susan Kananovich 
Phillip S. Katz 
Karen A. Kmetzo 
Paul Anthony Kowalski 
Benjamin Krevsky 
Renee S. Leary 
William McCune IV 
Patricia J. Moore-Pastides 
Laure C. Nichols 
Helen O'Brien 
S. Kwame Ofori-Kwakye 
Betty J. Reid 
Lisa Klar Rosenfeld 
George B. Rowland 
William E. Schweizer III 
Audrey P. Silvey 
Ilene B. Wachs Fache 
Jonas Zucker 
1980 
Gift: $8,925 
Participation: 47% 
Phillip R. Aaron 
Frederick R. Aronson 
Diane Denis Aye 
Curtis S. Breslin 
Antoinette M. Brooke 
Gary L. Busack 
Sheila L. Conneen 
Martha G. Dale 
Anne Morrison Danaher 
Alfred E. Fasulo Jr. 
Audrey L. Fetter 
Barbara H. Granger- 
Russota 
Ellen B. Greif 
John Halleran 
Samuel S. Hamilton 
James P. Harisiades 
Virginia S. Humphrey 
Johanna C. Hunt 
Helen E. Kelly 
Michael J. Kremer 
Robert V. Levine 
Paul A. Locke 
Leroy F. Ludwig 
Kristina Obom Maldarelli 
Steven Morrow 
Glenn S. Newsome 
Benita J. O’Colmain 
Jane Ungate O'Connor 
Ann L. Prestipino 
Christina P. Quinn 
James E. Rawlings 
Christie Michele Reed 
Jeri Ann Rose 
Beth F. Schaier 
Susan L. Schwartz 
Kathleen F. Scribner 
Lydia A. Selling 
Marsha L. Silverman 
Judith S. Stavisky 
Carolyn K. Wells 
Tal Ben-Dashan Widdes 
1981 
Gift: $10,015 
Participation: 43% 
Agents: 
Angelo J. DeVita 
Barbara Gaugler 
Pennebaker 
Robert M. Anderson Jr. 
Barbara M. Aufiero 
Heidi Boerstler 
Janet L. Brandsma 
Harold J. Burdo Jr. 
Lionel K. Chadwick 
Patricia J. Checko 
Rollin C. Chew 
Angelo J. Devita 
Richard T. Forsley 
Robert Fox 
Peggy A. Gallup 
Marie F. Gavula 
Louis M. Gonzalez 
Joan Urquhart Goodman 
Roslyn Hamilton-McGraw 
Gerlinde B. Kehlenbach 
Cindy F. Kleiman 
Thomas J. Krause 
Charles R. Lawson 
Neal A. Lustig 
Katherine M. McCormack 
William R. McLaughlin 
Blackford Middleton 
Marlee D. Mooney 
Ellen Gallagher Parsons 
Frederick V. Peterson Jr. 
Idalia Ramos-Sanchez 
Kimberly Chauncey 
Shadur 
Elizabeth N. Shapiro 
Karin Swanson 
Keith D. Tait 
Kathleen R. Yager 
Nancy C. Yedlin 
1982 
Gift: $10,860 
Participation: 36% 
Agent: 
Jean Milton Ellis 
Jamie L. Amaral 
Gretchen D. Biemesderfer 
Francis L. Crowley 
Kathleen K. Devine 
Jean M. Ellis 
Paul Garbe 
James L. Hadler 
Denise Heinemann 
George R. Hession Jr. 
Karla A. Hitchcock 
Nancy Pitt Hopkins 
Catherine Sullivan Jaquith 
Constance M. Jarowey 
Annette Kenney 
David P. Klarberg 
Susan Eberle Levy 
George J. Mandes 
Linda F. McCaig 
William F. McKeon 
Tsuneki Mizuta 
David L. Mork 
Susan G. Rice 
Christopher J. Rogers 
Scott David Stratton 
Michele T. Visconti 
Sandra Michaelson 
Warren 
Maud Helen White 
Theodore J. Witek Jr. 
Jill Okrent Zaheer 
1983 
Gift: $7,824 
Participation: 40% 
Agents: 
Jeffrey Hughes 
Marybeth McNemey 
Barbara W. Abraham 
Gail Ellen Alexander 
Joseph A. Amatruda Jr. 
Carolyn R. Anderman 
Lisa A. Bowie 
Benjamin Obi 
Chukwumah 
Eileen Conlon 
Linda K. Contreras 
Peggi Matzkin Czinger 
Lorraine Denicola 
Mark L. Dembert 
Robert A. Duncan 
D.J. Safiya Edwards 
Eileen McDonald Egan 
Ellen M. Ginzler 
Judith S. Goldstein 
Trerotola 
James D. Gonzales 
Halesteen Graham 
Daniel A. Graybill 
Virginia C. Hiland 
James M. Lehane III 
Allen F. Levy 
Scott K. Mock 
Judith F. Nelson 
Suzanne Nutt 
Barbra G. Rabson 
Keith A. Radcliffe 
Julie A. Russem 
Lynn St. Germaine 
Saphire 
PaulM. Schur 
Ina L. Silverman 
Claudia Smith 
Elizabeth C.H. 
Stevenson 
James G. Uberti 
Nancy K. Wright 
1984 
Gift: $7,170 
Participation: 39% 
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Agent: 
Leslie A. Batch 
Deborah J. Arrindell 
Leslie A. Balch 
John R. Beecher 
Rhonda L. Bohn 
Troyen A. Brennan 
Timothy J. Callahan 
Jean G. Concannon 
Rudy Glen Davis 
Christopher Fenger 
Jean L. Freeman 
Marcia Lipkind Hirsch 
Suzanne S. Horn 
Sarah M. Horwitz 
Robert C. Hughes 
Gregory R. Huth 
Catherine S. Jackson 
Mehrdad Jalali 
Georgia Jennings 
J. Kutcher-Henchel 
Andrea McCrensky- 
Krerner 
Stephen T. McGarvey 
Marta E. Moret 
Lloyd M. Mueller 
Cathy F. Nager 
Donna Niedzwiecki 
Theresa Marie O'Connor 
Jessica L. Richer 
Stephen Marc Schwartz 
Phillip J. Screen 
Dennis G. Shrauger 
Robin Kupfer Spencer 
Pamela Parise Suan 
Marie Ann Tobin 
Carey Vames 
1985 
Gift: $4,660 
Participation: 32% 
Agents: 
Katherine S. Fitzpatrick 
Joan M. Cleary Miron 
Lisa R. Anthony 
Christine D. Berman 
William P. Buick 
Rene S. Cabral-Daniels 
Lawrence M. Chesny 
Joan M. Cleary Miron 
Kathleen M. Craig 
Loretta Dipietro 
Marjorie M. Eichler 
Grace P. Erickson 
Katherine S. Fitzpatrick 
Elizabeth Hale Frayne 
Barbara K. Gottlieb-Ware 
Tatsuyuki Kakuma 
Julie M. Marshall 
P. Douglas McConatha 
Rona Janis Mogil 
Beverly-Jane Perry 
Adrian J. Pinsince 
Martha J. Santini 
Eric Scalettar 
James V. Soscia 
David Steffen 
Heidi Roberta Sulis 
Anne Harmon Sweeney 
Samuel P. Wertheimer 
Nathan D. Wong 
Terry Martin Zingman 
1986 
Gift: $7,734 
Participation: 34% 
Agents: 
Incht B. Ahluwalia 
AricR. Wilt 
Indu B. Ahluwalia 
Maria Rosario G. Araneta 
Judith Ann Bell 
Andrea Lee Boissevain 
Lewis P. Bower Jr. 
Marijane L. Carey 
Julia E. Clark 
Reid M. Davis 
A. Richard Dooley Jr. 
John M. Esdaile 
Nancy E. Fithian 
Robert B. Goetzinger Jr. 
Stephen B. Gruber 
Michael S. Huncharek 
Denise R. Lewis 
David C. Lowy 
Adrienne Marks 
Karen C.P. Milliken 
Bernadette M. Mosellie 
Daphne M. Nielsen 
Tracey M. Orloff 
Clare F. Pegues 
Philip O. Renzullo 
Maria J. Schymura 
Janet M. Sgro 
Carrie Shepard 
Eric Triffin 
Marie Irene Tsivitis 
Katherine Burdick Wilson 
Lynn D. Wilson 
Nancy Borstelman Winer 
1987 
Gift: $14,425 
Participation: 29% 
Agents: 
Hilda Chaski Adams 
Elizabeth A. Wennar 
Hilda Chaski Adams 
Margaret B. Corbae 
Barbara L. Decesare 
Meg B. Domino 
Robin N. Eastman 
Cecelia Edwards- 
Randolph 
Stephen A. Frayne 
Bridgid M. Garrison 
John Ginnetti Jr. 
Elizabeth Grottole 
Carol Guardiano 
Priscilla Ann Halloran 
Sara A. Holdcroft 
Michael T. Koff 
Mary Ann Lillie 
Laurie B. Logan 
Deirdre McDonald 
John C. McLaughlin 
Barbara J. Moggio 
Maureen Brady Moran 
Joseph J. Napolitano 
Mark J. Pereira 
Lynn Pezak Malloy 
Elizabeth J. Philippe 
Anita A. Roth 
Judith Natale Sabino 
Catherine Leda Seibyl 
Mary C. Sherwin 
Peter C. Tortora 
Joel A. Wasserman 
1988 
Gift: $6,885 
Participation: 30% 
Agent: 
Joseph Della Plica 
Ellen S. Bass 
Giselle Charlotte Bleecker 
Jayne Bonner-Gary 
Sharon Marie Christie 
James Joseph Cullen 
April R. Dworetz 
Sylvia Blackburn Farrell 
Aden Carlos Jackson 
Ellen Lucy Kraftsow 
Lydia Jeanne Landis 
Mark William Legnini 
Paul Alan Lindia 
Saifuddin Taiyeb Mama 
Susan S. Merrill 
Carolyn Andrea Nunley 
Mary E. Haesche Okero 
Madhusudan G. Rao 
Carrie A. Redlich 
Lawrence Vincent Silvia 
Carol Ann Strycharz 
Howard S. Teitelbaum 
Thomas Aaron 
Wellington 
Lisa Wilson-Foley 
Darlene Uten 
Zimmermann 
1989 
Gift: $6,635 
Participation: 27% 
Agent: 
Joy Misako St. Germain 
Christine Appel 
Holly Anne Ardito 
Judy Gardner Audette 
Perry David Cohn 
Marybeth Durkin 
Agnes B. Edwards 
Michael Joseph Gillespie 
Elizabeth Harrison Hadley 
Clifton Ping Lee 
Lydia M. Lodynsky 
Angela S. Mattie 
Kathleen Louise Moore 
Joanne Susan Mosca 
Deena Beth Myers 
David Dean Peete 
Elizabeth Ann Platz 
Theresa L. Raphael 
Joseph Robinson 
Robert P. Sbriglio 
Nipon Sermpanich 
William Benjamin Shatz 
Joy Misako St. Germain 
James Gordon Trexler 
Sophie Helene 
Tworkowski 
Whei-Kuo Wu 
1990 
Gift: $8,015 
Participation: 36% 
Agent: 
Jennifer Jennings Miller 
Lorraine M. Almo 
Ethan N. Arnold 
Alisa M. Bellantonio 
Linda V. Bergonzi King 
Andrew K. Bhak 
Phyllis F. Boynton 
Patricia Campbell 
Michael Anthony 
Carrozza 
Nicholas A. Daniels 
Jerilyn A. Deveau 
Deborah L. Fulton-Kehoe 
Donna Mae Gruskay 
Brenda Y. Hernandez 
Jennifer W. Hincks 
Reynolds 
Alfredo A. Lardizabal 
John Martin Lavin 
Barbara A. Leonard 
Susan Patricia Lustig 
Rebecca J. Mark 
Julie Ann Medulan 
Janet Amy Munroe 
Karyn J. Nair 
Angela B. Nimsgem 
Rochelle Enid Oberwetter 
Karen A. Oliver 
Gary D. Perlman 
Edward M. Rafalski 
Jeanne Marie Danzi Scinto 
Heralio G. Serrano 
Brian Yong-Seop Shin 
Salim Ramzan Ali Surani 
Stacey H. Wills 
1991 
Gift: $7,513 
Participation: 30% 
Agent: 
Patricia J. DeFelice 
Benjamin O. Adetola 
Lisa A. Amerino 
Sharon Lee Carlton 
Barbara A. Casey 
Sandra S. Childress 
Maureen P. Corry 
Patricia J. DeFelice 
Dymphna J. Egglin 
Seth R. Frank 
Brenda J. Goldstein 
Catherine M. Heer 
Rani A. Hoff 
Katie B. Horton 
Timothy A. Jacobs 
Kathryn S. Katz 
Anne M. Lane 
Sally J. Malech 
Laura Elizabeth Mitchell 
Andrea Mary Orane 
Andrew P. Owens 
Louise P. Roumagoux 
Sanjeev K. Srivastava 
Stacy M. Susman 
Mitchell S. Tepper 
Victoria Valdez 
Lucie L. Wilkins 
Patreece T. Williams 
1992 
Gift: $2,665 
Participation: 21% 
Melissa Paige Barby- 
Byers 
Donald G. Cofrancesco 
Murat Dayanikili 
Shannon Green Hanson 
Nancy A. Malone 
Lisa Newell 
David Max Senior 
Steave Hon-Shen Su 
William D. Wamester 
William Robert White 
1993 
Gift: $1,270 
Participation: 22% 
Deirdre D. Hardrick 
David L. Katz 
Chinaro M. Kennedy 
Lynn M. O’Connor 
Mark B. Russi 
Nadeem S. Siddiqui 
1994 
Gift: $3,350 
Participation: 18% 
Kathleen A. Cameron 
Linda C. Degutis 
Cynthia D. Ho 
Robyn M. Hoffmann 
Ellis K. Johnson 
Gwendolyn A. Myers 
Eric H. Opin 
Mary-Elizabeth M. Reeve 
Helaine E. Resnick 
Kenneth C. Rondello 
Nicole T.C. Vecchi 
1995 
Gift: $1,135 
Participation: 21% 
Agent: 
Nicole Herczfeld 
Donna J. Boehm 
Michelle L. Canham 
Suzanne C. Fickett 
Shelley D. Geballe 
Julie Huang 
Brad M. Ingegneri 
Saima Iqbal 
Marjan Javanbakht 
Unni K. Karunakara 
Elizabeth G. Kemper 
Bonnie D. Kerker 
Hans-Helmut Koenig 
Rama G. Melkote 
Friends 
Frederic Holtzberg 
Michael H. Merson 
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alumni/ae affairs 
Reaching out 
The impressive honor roll of names 
that precedes this page is testa¬ 
ment to the support that alumni/ae 
and friends of the School of Medicine 
have provided in just a single year. 
There are dozens of other ways, 
too, that alumni/ae strengthen the 
school and its programs every day. 
Many of those efforts are focused 
on students and the school’s educa¬ 
tional program. For example, 
alumni/ae on the clinical faculty vol¬ 
unteer their time to teach medical stu¬ 
dents in lectures and small groups. 
Alumni/ae endow academic chairs, 
fellowships and special programs. 
And in smaller ways, too, alumni/ae 
support the activities and spirit of 
medical students. At this writing in 
late February, the Second-Year Show 
is gearing up with support from 
alumni/ae who bought ads in the pro¬ 
gram. Likewise, the yearbook went to 
press this month with similar 
alumni/ae backing. 
The cycle of giving does not end 
there. Yale medical students are cer¬ 
tainly among the nation’s most gener¬ 
ous with their time and resources. 
Students have initiated community 
service programs, ranging from 
The HOPE Project, which brings 
medical care to people at New Haven 
shelters, to the ASAP initiative, in 
which medical students spend time 
in city schools talking to pupils about 
substance abuse. An extraordinary 
number of first- and second-year 
students volunteer in one of these 
many programs. 
Last fall, in what has become an 
annual tradition, the students staged 
the fourth Hunger and Homelessness 
Auction, raising more than $13,000 
for the benefit of New Haven area 
shelters, soup kitchens and other 
community programs. Students and 
other auction-goers paid top dollar for 
the chance to go bowling with the 
directors of student affairs and admis¬ 
sions, or for three days roughing it at 
Dr. Tom Lentz’s Vermont cabin. 
This kind of outreach eventually 
comes full circle, as students graduate 
and become alumni/ae themselves. 
By encouraging alumni/ae to nurture 
the next generation of physicians and 
scientists and to remain in touch with 
one another, we are strengthening a 
community that is greater than the 
sum of its parts. 
AYAM President Lycurgus “Bill” 
Davey, M.D. ’43 March, and I invite 
you to become involved in the AYAM 
Outreach Program, which is 
described on the inside front cover of 
this magazine. Watch the mail for 
announcements of regional receptions 
and programs near you. We hope to 
see you at these events, and we 
encourage you to order the new Yale 
School of Medicine Alumni Direc¬ 
tory. We also hope you will make 
every effort to attend reunion this 
year on June 6 and 7, even if your 
class reunion year (ending in a 2 or 7) 
isn't here yet. This year’s program 
will be fantastic, with a presentation 
by gene therapist Albert B. Deis- 
seroth, M.D., Ph.D., (who is profiled 
on Page 12) and a chance to tour the 
school and medical center and his¬ 
toric New Haven. 
We look forward to seeing you in 
New Haven or in your hometown. 
William K. Jenkins 
Managing Director 
Office of Alumni Affairs 
Write to William Jenkins at the Office 
of Alumni Affairs, P.O. Box 7613, 
New Haven, CT 06519, or via e-mail 
at william.jenkins @yale. edu 
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Mission statement 
Defining a family financial philosophy is the first step toward effective planning. 
' Because of constant harassment by 
investment sales personnel your phone 
call is being screened. If your call is 
personal and you would like a 
response, please leave a message. 
Thank you. ” 
The above is taken verbatim 
from the home answering 
machine of a Yale medical alum¬ 
nus who graduated more than 30 
years ago. He is a surgeon with 
an active practice. Like many suc¬ 
cessful professionals, he is beset 
by junk phone calls from sales 
people trying to pitch their com¬ 
pany’s product. 
Usually, this means life insur¬ 
ance, mutual funds or advice on 
investing. Most of these calls are 
made by young college graduates 
working on commission for well- 
known brokerage houses. The 
callers get a phone, a desk and a 
list of names and numbers provided 
by direct marketing firms that 
collect information from numer¬ 
ous sources. 
This is a real nuisance for 
many people, but a very serious 
interference for a physician on-call 
who expects to hear from patients 
or colleagues. 
MATTERS OF TRUST 
The Yale alumnus who uses his 
message machine to block sales 
calls has found a way to deal with 
this aggravation. However, many 
people are not immune to quacks 
posing as competent investment 
advisors. One retired physician in 
her 80s who has her financial plan¬ 
ning in good order (thanks to a 
skilled and reputable financial 
planner), went to a “free seminar" 
on how to set up living trusts to 
avoid probate. A high-pressure 
salesman promised to help her set 
up a trust with assets that, she later 
found out, she could not legally use 
for that purpose. The physician 
gave him a $250 deposit on the 
spot. Fortunately, she consulted 
her trusted financial planner for 
advice. He intervened and got the 
money back. 
The general advice that this 
financial advisor gives is as fol- 
70 Spring 1997 
lows: “Get professional help you 
can trust. Work out your objectives 
before you take action, but don’t 
procrastinate.” 
LIFE PLANNING 
Most Yale alumni/ae are not likely 
to confide in strangers about their 
investments and estate plans (or 
lack thereof). However, the exis¬ 
tence of bothersome callers should 
not become an excuse to avoid 
seeking out competent help to put 
your financial house in order. Even 
the most successful and savvy 
investor may not have a coordi¬ 
nated overall financial plan that 
takes advantage of opportunities to 
maximize retirement income 
stream, minimize the estate tax 
burden for children, or guarantee 
college funds for grandchildren. 
“I know I need to make out a 
will,” said one alumnus to a Yale 
development officer on three sepa¬ 
rate occasions over a period of a 
year and a half. “I just can’t seem 
to face my own mortality.” Amaz¬ 
ingly, an estimated 70 percent of 
Americans do not have a will. 
“People think that estate plan¬ 
ning means death planning,” says 
Tom Rogerson of State Street 
Global Advisors, “and they want to 
avoid the subject. Actually it’s life 
planning.” Mr. Rogerson’s point is 
that a good estate plan should ben¬ 
efit you while you are alive, as well 
Do-it-yourself guide to stopping 
junk mail and phone calls. 
Yale School of Medicine has a 
policy never to rent or share its 
list of names, addresses and 
phone numbers with any outside 
person or company: reputable 
or not. For information on how 
you can stop junk solicitations 
of all kinds, try this Internet 
website: 
www.obviously.com/junkmail — 
or contact the National Fraud 
Information Center at 
1-800-876-7060, or via e-mail 
at nfic@internetMCI.com 
as provide for the disposition of 
your property when you are 
through using it. A good plan can 
increase current income, assure 
financial security during retirement 
or disability, minimize taxes, cut 
costs and reduce aggravation. 
Planning is for people with a lot 
to live for. 
State Street Global Advisors is 
making a series of presentations on 
estate planning exclusively for 
Yale alumni/ae around the country. 
The AYAM sponsored a presenta¬ 
tion in New Haven in December 
that was attended by 45 medical 
alumni/ae, spouses and friends. 
Several of those present had been 
to seminars put on by other institu¬ 
tions, so it was a demanding and 
attentive audience. 
The primary points of the 
State Street Global Advisors 
seminar are: 
■ Determine your goals and 
objectives. 
■ Get expert help and formulate a 
plan that accomplishes those goals 
and objectives. 
■ Recognize that planning is a team 
effort that should include your 
attorney, your accountant and your 
investment counselor. 
TO GRAT OR NOT TO GRAT 
Some people think that reducing 
taxes is the only goal, but it is best 
not to let that consideration distort 
your real objectives. If it is one of 
your goals to be charitable, and the 
time is right, you may wish to 
include a development officer on 
your planning team. There are sim¬ 
ple ways to afford to be more gen¬ 
erous, such as by donating appreci¬ 
ated securities instead of cash. 
The acronymns GRAT and 
CRUT are simply jargon used to 
describe different kinds of trusts. 
Choosing among these and other 
financial planning vehicles is a 
matter of finding the best means to 
reach the desired end. The more 
important first step is determining 
a family financial philosophy that 
will define your values—a per- 
The AYAM is sponsoring 
a series of estate planning 
seminars by State Street Global 
Advisors, designed as a financial 
planning sen’ice to alumni/ae, 
with find-raising issues rele¬ 
gated to the background. 
No one is solicited for a gif 
at these events. 
For more information, contact: 
William Jenkins 
Office of Alumni Affairs 
(203)785-3304 
or David Davison 
Office of Medical Development 
(203)785-5577 
sonal mission statement that helps 
you map out good decisions. 
For example, some wealthy 
people who could arrange to give 
their children a free ride for life, 
don't. They might have a philoso¬ 
phy that includes paying for their 
children's education, but no more, 
expecting each child to make it in 
the world on merit and initiative. In 
their estate plans, they might fund 
a charitable family foundation that 
their children would be responsible 
for administering. Their goal is to 
enable the family to work together 
to preserve a legacy of philan¬ 
thropy in the community. 
To begin to develop your fam¬ 
ily financial philosophy, ask your¬ 
self some life planning questions. 
What are my values? What do I 
want to accomplish with my 
assets? How do I want to benefit 
my spouse, my children or grand¬ 
children—now and later? 
David Davison 
Director, Individual Major Gifts 
Write to David Davison at the 
Office of Medical Development, 
100 Church Street South, Suite 211, 
New Haven, CT 06519, or via e- 
mail at david.davison@yale.edu 
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LETTERS 
The organ bind 
To the editor: 
As a Yale alum, husband of a liver 
transplant recipient of 10 years, and 
co-founder with that recipient of a 
chapter of TRIO (the 
Transplant Recipi¬ 
ents International 
Organization), I was 
extremely pleased 
to see your Summer 
1996 issue [cover 
story. Second 
chance at life.] 
It wonderfully sup¬ 
ports our message 
that transplanta¬ 
tion works. Your 
plea for organ 
donation is most welcome, for 
without donation, transplantation 
will not have the opportunity 
to work. 
Signing a donor card, although 
in many states a legally binding 
document, is not enough. No doctor 
will violate the wish of the family 
of the departed, no matter what. 
Thus we plead for everyone to dis¬ 
cuss their wish with their family 
before the tragedy occurs. This is 
How to reach us 
Yale Medicine welcomes 
news and commentary. 
Please send letters to the edi¬ 
tor and news items to Yale 
Medicine, P.O. Box 7612, 
New Haven, CT 06519-0612, 
or via electronic mail to 
ymm@yale.edu, and include 
a daytime telephone number. 
Submissions may be edited 
for length, style and content. 
vital. The emergency room is no 
place to consider the gift of life for 
the first time. Without donors, (or 
until artificial or xenographic trans¬ 
plants become practical) thousands 
who could live will not. 
I was, however, troubled by the 
comment that people are “ ... asked 
for consent to use the organs of a 
dying person.” That is never done. 
Consent is only asked for the use of 
the organs of those who are in fact 
dead and whose organs at that time 
are being maintained in a viable 
state by mechanical means. The 
usual term is “brain dead," an 
unfortunate and misleading term. It 
is important for potential donor 
families to know that their loved 
one is in fact dead, that no one 
involved with their care has had 
anything to do with the process of 
potentially using their organs, 
and their “left-over items” are 
actually capable of saving the life 
of another. 
Donal R. Treffeisen, M.Eng. ’52 
Transplant Recipients 
International Organization 
New York 
Let us be precise 
To the editor: 
I was seated in the waiting room. 
Knowing no doctor’s appointment 
ever starts on time, I looked for 
reading matter more interesting 
than the paperback I had with me. 
Then I spotted Ycde Medicine with a 
tick on the cover featuring Lyme 
disease. I know Lyme disease cases 
actually were first found in La 
Crosse, Wise., but Lyme, Conn., 
scooped the pool with the investi¬ 
gators at the Ivy League schools. 
My eyes stopped on page 15. 
Oh, my fur and whiskers! “Ticks, 
like other insects, have a decided 
sense of taste.” Perhaps, but ticks 
and mites are not insects, not even 
in New Haven. This Midwestern 
native, product of the University 
of Wisconsin, cannot ignore 
this statement. 
Yes, ticks and insects are both 
arthropods, a large phylum, but the 
class Insecta have 6 legs, and 3 
body segments, head, thorax and 
abdomen. Ticks have 8 legs, 2 body 
segments, a cephalothorax and 
abdomen. Ticks, mites and scorpi¬ 
ons are the class Arachnoidea. 
Ticks and insects are as closely 
related as ticks and lobsters. 
M.H. Schmidt, M.D. 
Marshall, Wise. 
Ticks most definitely are not 
insects. Unfortunately one such 
reference slipped into print. 
Apologies to entomologists (and 
ticks) everywhere. 
Extra credit 
To the editor: 
I was gratified to read your com¬ 
ment in the Fall/Winter 1996 issue 
of Yale Medicine. Harry Greene, 
not Harry Zimmerman, did the het¬ 
erologous tumor transplantation. 
In 1947-49,1 did my thesis 
with Harry Greene [the Anthony N. 
Brady Professor of Pathology from 
1949 until his death in 1969], trans¬ 
planting embryonic chicken giz¬ 
zard to anterior chambers of guinea 
pig eyes. In recent years I have 
been amused at work coming out of 
Boston concerning tumor angio¬ 
genesis. This would be nothing new 
to Harry. Credit should go where 
credit is due. 
Richard D. Otis, M.D. ’49 
East Falmouth, Mass. 
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Continuing Medical 
Education at Yale 
June 2 
Monday 
Update in Hepatology 
Course Director: Victor J. Navarro, M.D. 
Assessment and implementation of current therapies for hepatitis C and new 
diagnostic categorizations and therapies for autoimmune liver diseases. 
Jane Ellen Hope Building, Room 110 
A 
June 13 Yale Alumni in Ophthalmology: 
Friday The Yale Spring Symposium 
Course Directors: Craig A. Sklar, M.D. and M. Bruce Shields, M.D. B 
A broad range of topics in ophthalmology including treatment of retinal disease, 
contemporary cornea surgery, neuro-ophthalmology, oculoplastics, strabismus and 
glaucoma basic and clinical research. 
New Haven Lawn Club, New Haven, CT 
July 12-13 
Saturday- 
Sunday 
Medical Problems in the Performing Arts 
Course Director: Martin W. Sklaire, M.D. 
Traumatic injuries in musicians (special focus on the hand, and 
ear, nose & throat), performance anxiety, and alternative medicine. 
Yale Summer School of Music, Norfolk, CT 
C 
August 11-13 
Monday- 
Wednesday 
7th Annual Cardiovascular Symposium 
Atrial Fibrillation: The Arrhythmia of the Elderly 
Course Director: Michael D. Ezekowitz, MBCHB, Ph.D. 
Mechanisms of atrial fibrillation, and relevant treatment approaches. 
Jane Ellen Hope Building, Room 110 
D 
August 15 1997 Annual Yale Sports Medicine Seminar 
Friday Women in Sports 
Course Director: Peter Jokl, M.D. E 
Focus will be on epidemiology and treatment. Special presentation on National 
Institutes of Health’s role in studying and assessing the impact of athletic activities 
on female health. 
Mary S. Harkness Auditorium 
For information, contact the Office of Postgraduate and Continuing Education,Yale University School 
of Medicine, 333 Cedar Street, P.0. Box 208052, New Haven 06520-8052; Tel: (203) 785-4578 
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PATIENT LOAD IS UP 
ALUMNI BULLETIN OF THE SCHOOL OF MEDICINE 
SUMMER 1997 
g US 
BUT WITH CHANGES 
COME NEW OPPORTUNITIES 
TO BETTER EDUCATE 
THE NEXT GENERATION 
OF PHYSICIANS 
Continuing Medical 
Education at Yale 
Sept. 6-7 Yale at Mystic: An Ultrasound Review 
Sat-Sun Course Director: Kenneth J.W. Taylor, M.D., Ph.D. 
Mystic Hilton, Mystic, Conn. 
Sept. 6-13 The Third Anaesthesia & Critical Care Symposium 
Sat-Sat Course Director: Sorin Brull, M.D. 
Killarney, Ireland 
Sept. 13 Glaucoma Symposium 
Saturday Program Chairman: M. Bruce Shields, M.D. 
Marriott, Rocky Hill, Conn. 
Sept. 18-21 The 21st Yale Physician Assistant Certification/Recertification 
Thurs-Sun Preparatory Conference 
Course Coordinator: Christiane Nockels, P.A. 
Mary S. Harkness Auditorium, New Haven 
Sept. 20 First Annual Michael S. Voynick Neuro-Oncology Symposium 
Saturday Course Director: Joseph M. Piepmeier, M.D. 
Jane Ellen Hope Building, New Haven 
Oct. 9 7th Annual Dual Diagnosis Committee Conference 
Thurs Course Director: Douglas Ziedonis, M.D. 
Jewish Community Center, New Haven 
Oct. 31 Diabetes Complications: Mechanisms and Management 
Friday Course Director: Rosa Hendler, M.D. 
New Haven Lawn Club, New Haven 
Nov. 14 Uveitis Update 
Friday Program Chairman: I. Willard Abrahams, M.D. 
Boardman Building, Room 307, New Haven 
Dec. 12 Advances in HIV Therapeutics 
Friday Course Director: Gerald Friedland, M.D. 
Mary S. Harkness Auditorium, New Haven 
A 
B 
C 
D 
E 
F 
G 
H 
I 
For information, contact the Office of Postgraduate and Continuing Education,Yale University School 
of Medicine, 333 Cedar St., P.0. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
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Managed care has cut into the clinical 
income that helps support medical 
schools such as Yale’s, and it threatens 
to limit the number of patients that 
students and residents may see as part 
of their education. The challenge is 
also an opportunity to reassess and 
improve teaching. 
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EDUCATION Medical students are acutely aware of 
the mounting influence of economics 
upon physicians, says Steve Kavic, 
M.D. ’p7, who graduated in May. 
“ There’s no question, ” he says, “that 
the style of medicine I’ll practice 
will be very different from that of 
my father’s and grandfather’s 
generations. ” 
Lessons in 
managed care 
Say what you will about the assault on medical education by a changing economy. 
Managed care has Yale and other academic medical centers reassessing 
the way they do business. 
By Marc Wortman 
Speaking to a team of community physicians last fall, one longtime 
Yale faculty member joked ruefully, “Were thinking about changing 
the name from the School of Medicine to the School for Health Care 
Cost-Containment. Were hoping eventually to squeeze the medical 
part out altogether.” He may have been exaggerating wildly to make 
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a point, but as anyone around a 
medical school can testify, cost- 
containment has indeed taken its 
place as part ol the curriculum. 
Faculty and administrators at Yale 
once focused solely on preparing 
students and residents to treat 
patients while carrying out their 
own clinical practices and research. 
These days, the School of Medicine 
must not only teach them how best 
to care for patients, but also how to 
care for them while keeping an eye 
fixed firmly on costs. 
As a result, says Dean Gerard 
N. Burrow, M.D. ’58, “There has 
been a fundamental and profound 
change in the way we go about our 
business. Diminishing clinical 
income and diminishing research 
support,” he says, “are forcing 
medical service delivery and costs— 
has forced across-the-board rethink¬ 
ing of how Yale goes about training 
its students and residents to be the 
physicians of tomorrow. No depart¬ 
ment or clinical program has been 
untouched, and many have em¬ 
barked on major reorganization. 
The need for these changes results in 
part because the in-patient hospital 
unit—the longstanding principal 
training ground for medical students 
and residents—is no longer the 
comprehensive training center it 
was. More and more medicine takes 
place in ambulatory settings, and 
students and trainees must be where 
the patients are. 
Because medical education has 
been supported for decades by 
clinical revenue generated by faculty, 
centers around the country, says 
Dr. Burrow: “Every medical school 
dean in the United States is search¬ 
ing for a new funding paradigm.” 
THE MARKET’S IMPACT 
The story of the rise of managed 
care has been widely told, but what 
is less well-known is its impact on 
medical education. With medical 
costs spiraling upwards with no 
systemic economic brake, market 
controls were asserted over the 
freedoms physicians previously 
enjoyed to direct patient care—and 
effectively set their own fees. Fears 
of potential liability, along with the 
absence of economic oversight, often 
led fee-for-service physicians to pre- 
“There has been a fundamental and profound change in the way 
we go about our business.” 
medical schools to abandon the 
privileged monastic life of the ivory 
tower for the secular world.” [On 
July 1, Dean Burrow will become 
special advisor for health affairs to 
Yale President Richard C. Levin, 
and David A. Kessler, M.D., former 
commissioner of the U.S. Food and 
Drug Administration, will assume 
the deanship.j 
The move from academic 
isolation to the rough-and-tumble 
reality of modern medical practice 
reflects the swiftly changing environ¬ 
ment for health care delivery around 
the nation and at Yale. The advent 
of managed care—the term most 
often used to describe the reorgani¬ 
zation of managerial control of 
Marc Wortman is a free-lance writer 
in New Haven. 
managed health care and its cost¬ 
cutting agenda have quickly under¬ 
mined the funding basis for teaching 
programs across the United States, 
especially in areas where managed 
care has become the dominant 
insurance model. Faculty and 
administrators at Yale and elsewhere 
are sounding the alarm as they look 
for new ways to support teaching. 
“Managed care,” says Joseph B. 
Warshaw, M.D., chair of the 
Department of Pediatrics and the 
medical school’s deputy dean for 
clinical affairs, “has the potential to 
wreak havoc on medical schools. 
And, in many cases, it is extracting 
money from the health care system 
that would otherwise be available for 
patient care and medical education.” 
Yale faces many of the same difficul¬ 
ties as other academic medical 
scribe high-cost tests and procedures 
of marginal medical benefit. Hospi¬ 
tal-based care proved especially 
prone to upward price pressures. 
Health care spending reached astro¬ 
nomical levels, with no end in sight. 
Jumping at the opportunity to 
control costs presented by changes 
in insurance laws during the late 
1980s and the early part of this 
decade, employers rapidly moved 
employees out of traditional fee-for- 
service individual insurance coverage 
and into health care plans, such as 
health maintenance organizations 
(HMOs) and other managed care 
plans. There, physicians work as 
paid employees or profit-sharing 
associates answering to administra¬ 
tors responsible for containing costs. 
Continued on page 10 
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The future of managed care 
If we’re fortunate, insurers will see that the health of medical schools, 
not to mention patients, is in their best interest. 
By Gerard N. Burrow, M.D. ’58 
wptimal care is cost-effective 
care" is a statement that underlies 
the interest in managed care. 
Unfortunately, at present, cost is 
being managed rather than care. 
The dollar amount of patient care is 
called the medical-loss ratio by the 
managed care companies, a 
pejorative term. As the managed 
care companies drive down this 
ratio, drive-by deliveries and $12 
million bonuses for the CEO are 
the result. 
In the United States, the costs 
of medical care had been increasing 
at a level that could not be sus¬ 
tained, and change was necessary. 
While the Clinton Health Care Reform 
plan was directed toward cost- 
containment to control this increase, 
the plan also was directed toward 
access for 45 million Americans 
without health insurance. The 
ultimate failure of the Clinton plan 
stimulated the rapid incursion of 
managed care companies, which 
have successfully managed cost, 
albeit at the expense of quality, 
but have net at all addressed the 
problem of access. 
The health of the public and the 
pathophysiology of the individual 
patient represent a continuum. 
However, in the past, this concept 
has been given lip service rather 
than serious attention. A positive 
aspect of managed care is that 
there is a premium on wellness and 
a resulting financial advantage in 
preventive medicine. Unfortunately, 
under the current system of man¬ 
aged care, patients change providers 
so frequently that there is little 
financial advantage for the provider 
to emphasize the preventive aspects 
of health care. 
Managed care, as presently 
constituted with the intense down¬ 
ward pressure on clinical income, 
presents a real threat to medical 
schools. The managed care organiza¬ 
tions have been reluctant to provide 
teaching opportunities because of 
increased cost, and have been 
equally unwilling to support medical 
education in general. At Yale, we 
have estimated that the faculty 
donates about $15 million from its 
clinical income to pay for education 
and the under-recovered costs of 
research. As the reimbursement 
decreases, faculty members have 
increasing difficulty supporting 
themselves, much less donating 
clinical income for education 
and research. 
Yale School of Medicine requires 
sufficient patients for teaching and 
research, sufficient academic control 
to carry out teaching and research 
and, from somewhere, sufficient 
resources to support education 
and research. The managed care 
organizations must play a role in this 
support. If they continue to ignore 
the issues of access and medical 
education, managed care organiza¬ 
tions will ultimately wither. 
Dean Gerard N. Burrow, M.D. fS, 
becomes the David Paige Smith Professor 
of Medicine and special advisor for health 
affairs to President Levin on Jidy i. 
FRANK POOLE 
A range of voices Here and on 
the pages that follow, 10 short 
commentaries shed light on the 
effects of economic change upon 
the teaching of medicine. These 
opinions and analyses come from 
physicians and leaders in academic 
medicine and public health, a 
student, a U.S. senator, and two 
executives in managed health care. 
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Doing the right thing 
We need to safeguard academic values from the distractions of finance. 
By Joseph B. Warshaw, M.D. 
Academic medicine in the United 
States faces a conflict of values 
that threatens our contribution to 
the health enterprise, and to 
American society more broadly. 
We are forgetting who we are and 
why we are. We are in danger of 
becoming part of a culture of 
commercialism in medicine and in 
the biologic sciences that threatens 
core values of our tradition: teach¬ 
ing to educate, carrying out 
research for the pure exhilaration 
of discovery, and practicing medi¬ 
cine because of our commitment 
to serve the public, especially the 
underserved of our communities. 
These pressures are coming 
from the financial constraints 
imposed by managed care and an 
increasingly competitive clinical 
and research environment. In res¬ 
ponse, medical schools should 
indeed have sound, efficient, and 
competitive practice operations that 
provide the revenues to support 
medical education and clinical 
research. In many respects, how¬ 
ever, we have gone over the cliff 
and have reached a level of destruc¬ 
tive preoccupation with the busi¬ 
ness of practice. Academic discus¬ 
sions among chairmen about 
issues relating to education, 
research and innovative programs 
of care increasingly take a back 
seat to an almost compulsive 
fixation on managed care, physician 
networks, price competition, and 
clinical income in a capitated 
environment. Our faculties are 
taking sabbaticals in the business 
school rather than the biology 
department. 
Why, at a time when our 
students show so much promise 
and there is so much excitement in 
medicine, is there such a serious 
threat to our values? One of our 
major problems is the need to 
sustain huge academic programs, 
the result of the phenomenal growth 
that has occurred over the past 
30 to 40 years. 
The money that medical 
schools receive from clinical activi¬ 
ties alone has increased from $28 
million in 1960 to $14.5 billion in 
the late 1990s. From 1960 to 1990, 
medical school revenues grew at 
more than twice the rate of other 
U.S. institutions of higher education, 
due in large part to clinical income 
opportunity. We have benefited 
enormously from these clinical 
revenues, and we contributed to and 
bear some responsibility for a 
health care system in which costs 
were viewed as running amok. 
While managed care has slowed 
the rate of increase in health costs, 
the values behind this trend are 
not those of academic medicine. 
Commercial managed care organiza¬ 
tions and their officers have ex¬ 
tracted huge profits from the health 
care system, and they have bene¬ 
fited enormously from the educa¬ 
tional programs, clinical research 
and medical innovation that have 
originated in our medical schools. 
Yet they have contributed relatively 
little to the academic enterprise 
itself. There is little incentive for the 
companies to invest. 
There are recent additional 
pressures on academic health 
centers, with perhaps a new zenith 
“Terms such as gate¬ 
keeper, covered lives 
and provider should 
be abolished from 
our vocabularies. 
We are physicians, 
caring for patients.” 
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reached by the audits on Medicare 
billing being conducted by the Office 
of the Inspector General and the 
implicit presumption that American 
medical schools have defrauded 
the American public of hundreds 
of millions of dollars in excessive 
charges. Audit squads are now 
extracting huge back payments and 
penalties from our nation’s schools. 
This not only risks damage to the 
American medical educational 
establishment, but also creates a 
public mistrust that is unfounded. 
All of this has contributed to our 
new academic commercial vocabu¬ 
lary and a quest for dollars that is 
distorting our mission and our 
values. We need to refocus and 
remember that we do not build our 
medical school practices to sustain 
the business of medicine, but rather 
as the means by which we meet 
our mission of service, education, 
and scholarship. 
So what can we do? There are 
a number of steps that we can take. 
► First, we must create some 
distance between the business of 
medicine and the practice of 
medicine. We are spending too 
much academic energy on the 
former. Our medical school prac¬ 
tices should be centralized, competi¬ 
tive vehicles for care that are 
professionally managed, with service 
and performance standards that 
can compete with the private sector 
and which support, not detract from, 
our academic responsibilities. 
We are about to launch a new 
integrated group practice that will 
be organized as an “arms-length,” 
not-for-profit corporation, in which 
all medical practice activities of 
the school will be carried out. The 
practice will be responsible for all 
contracting and credentialing, for 
setting performance standards and 
for funds flow to the school and 
departments. While there may be 
some financial margin coming to the 
departments from the practice, we 
anticipate that, in this very competi¬ 
tive health care marketplace, 
revenues generated will be used 
primarily to support the physicians 
in the practice itself. The goal of the 
practice will be to provide the 
patient base necessary for our 
medical education and clinical 
research. 
► Given the explosive growth in 
faculty size over the past 30 years, 
we must carefully evaluate the size 
of our programs. It is likely that 
many of them have grown beyond 
our abilities to support them and, in 
many cases, beyond what is 
required for our academic mission. 
Right-sizing will, in many instances, 
mean a downsizing of our faculty. 
Critical mass will be achieved both 
through programmatic development 
and by collaborations across 
traditional departmental boundaries 
and with community physicians in 
the clinical areas. 
For managed care organizations 
to bear some of the responsibility 
for sustaining the medical enter¬ 
prise, our system needs a tax on 
gross revenues of these organiza¬ 
tions as a kind of reinvestment 
capital to support medical educa¬ 
tion and clinical research. Post¬ 
graduate medical education has in 
large part been funded by monies 
linked to Medicare reimbursements. 
We need new paradigms for the 
distribution of the direct and indirect 
costs of medical education that 
have traditionally gone to hospitals 
as a component of Medicare 
reimbursement. Allocation of these 
monies to medical schools for 
support of the faculty actually 
providing education for postgradu¬ 
ate medical education would ease 
financial pressure to our schools. 
► Our medical students and 
house staff must be educated 
about issues in medical economics 
and practice structure and organiza¬ 
tion in a way that reinforces the 
traditional values inherent in the 
physician-patient relationship. These 
are the values that resulted in the 
overturning of gag rules for physi¬ 
cians in HMOs that forbade them 
from discussing treatment options 
with their patients. It was practicing 
physicians and enlightened consum¬ 
ers who challenged inappropriate 
limits on hospitalization after 
mastectomy and delivery, and other 
restrictions imposed by HMOs 
seemingly more interested in profits 
than in quality. It is surprising how 
complacent the broader medical 
community has been. 
► We should reject the notion 
that patients are clients or custom¬ 
ers. Terms such as gatekeeper, 
covered lives and provider should 
be abolished from our vocabularies. 
We are physicians, caring for 
patients. We must convey to our 
students the values that make 
medicine the caring profession, and 
those values should be no different 
under managed care. We must 
continue to emphasize the values 
inherent in the doctor-patient 
relationship. 
Most importantly, we should be 
mindful of why we do what we do. 
Why are we physicians and medical 
scientists? What attracted us to 
medicine? In most cases, it was not 
to do battle with insurance compa¬ 
nies and HMOs. We must continue 
to practice the values that attracted 
us to medicine, those values that 
always put the patient first and give 
us joy from our students and from 
discovery. The values of medicine 
have served society well. We must 
protect them. 
Joseph B. Wars haw, M.D., is deputy dean 
for clinical affairs and chairman of the 
Department of Pediatrics. 
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For the next generation of doctors, 
a chance to make change count 
Graduating students 
with Dr. Gifford at 
Commencement in 
May. “Somehow, ” he 
told the class 0/1997, 
“your generation must 
find a way to convince 
our leaders and 
political representatives 
that health care is not 
just another product. ” 
The following is excerpted from 
the commencement address 
delivered in May by Robert H. 
Gifford, M.D., HS '65-66, associ¬ 
ate dean for medical education 
and student affairs. 
I don’t have to tell you that it’s an 
unsettled time in American medicine. 
There are a lot of negative feelings 
and tensions out there, I am sorry to 
say. But we had better get used to 
the fact that our profession will no 
longer be business as usual. The 
individual, fee-for-service, unrestricted, 
entrepreneurial system that my 
generation so short-sightedly fostered 
and protected essentially broke 
the bank. It simply couldn’t go on. 
Something had to be done to contain, 
and even to reduce, the ever-escalat¬ 
ing costs of medical care. And, like 
it or not, managed care has been 
the answer, and it’s not likely to go 
away soon. 
You have an opportunity to do 
something about it. But my genera¬ 
tion has so resisted the concept of 
managed care that we have failed to 
embrace the enormous potential for 
better health care that it might offer, 
and we have failed to take respon¬ 
sible leadership in its explosive 
development and management. 
We have allowed it to be sold out to 
big business, where the profit motive 
has undermined the quality-of-care 
motive and where health care has 
become a huge new business venture 
to make fortunes for corporate 
executives and shareholders. The 
result of this corporate takeover by 
primarily nonmedical people has been 
indiscriminate cost-cutting in a fiercely 
competitive market, an almost total 
disregard for the care of the poor 
and, at times, an assembly-line-like 
depersonalization of health care. 
In fact, one of the major objections to 
managed care as it is now evolving 
under business management is that 
physicians are losing control of the 
precious doctor-patient relationship 
that has defined us for so many years 
and which was one of the major 
reasons that we went into medicine in 
the first place. 
But is the concept of managed 
care really all bad? Isn’t it possible 
that we might be damning the whole 
because of some of its flawed parts? 
Isn’t it possible that we may be so 
preoccupied with its most egregious 
negative feature that we have 
overlooked its many positive virtues? 
We seem to have developed an 
almost automatic negative response 
to managed care. 
Our anger and distrust at the 
corporate takeover of medicine has 
caused many of us to lose perspec¬ 
tive about the good that managed 
care might otherwise be able to offer 
if responsible, cost-effective, quality 
care ever became the driving force. 
In fact, there is much to be said in 
support of the concept of managed 
care that could be markedly better 
than what we have had. 
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“There has never 
been a more exciting 
time in biomedical 
science. It is 
going to be a time 
for enlightened 
leadership.” 
The opportunities of managed 
care have never been better to 
provide more of our citizens with 
comprehensive health care. It is a 
concept made to order for an empha¬ 
sis on primary care and for the 
development of long-overdue, effective 
programs of preventive medicine 
through routine screening and better 
immunizations. It also promises to 
centralize medical-record-keeping and 
foster new opportunities for clinical 
research. The opportunities to cut 
costs legitimately are also greatly 
enhanced by managed care. Costs 
can be significantly reduced by 
practicing evidence-based medicine, 
by centralizing services, by utilizing 
health care teams, by reducing 
redundancy, and by increasing 
efficiency. There have been outstand¬ 
ing examples of well-run managed 
care organizations in this country 
where quality-of-care has been 
central, but unfortunately, many of 
those are now being bought out by 
huge corporate structures where 
profit, once again, will be the 
driving force. 
Somehow, your generation must 
find a way to convince our leaders 
and political representatives that 
health care is not just another 
product like automobiles or comput¬ 
ers, and should not be just another 
entry on the listings in the stock 
exchange. The principal beneficiaries 
of a managed care business should 
be the patients, not the owners. 
To help restructure the goals and 
financing of managed care will be one 
of your greatest challenges in the 
years ahead. 
Although cost-cutting will be 
essential under any system, this 
preoccupation with cost reduction has 
come just at a time when medical 
education must further expand into 
the ambulatory setting outside of the 
teaching hospital. Unfortunately, the 
education of medical students and 
residents has been consciously and 
specifically excluded from most 
managed care organizations, under 
the belief that they bear no responsi¬ 
bility for medical education and that it 
would be too expensive to take it on. 
Since there are no available funds to 
pay for this kind of training, it will 
remain a major problem for medical 
education at all levels, and also will 
require creative solutions from you in 
the years ahead. 
Managed care has also come at 
a time of unprecedented research 
advances in technology and human 
biology, many of which hold out 
phenomenal possibilities for the 
treatment of disease and the mainte¬ 
nance of health, but which by their 
nature will be very expensive. There 
has never been a more exciting time 
in biomedical science. Physicians and 
the public will demand to have these 
new discoveries applied. But, unless 
they can be shown to save money, 
they are likely to come into deadly 
ethical and financial conflict with the 
current limits being placed on spend¬ 
ing by managed care. It is going to be 
a time for enlightened leadership, and 
I hope that you will be up to it. 
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Continued from page 4 
Fees are often based on total patient 
population rather than on services 
performed, placing a premium on 
lower-cost forms of care and a focus 
on prevention. Between 1985 and 
1995, the number of Americans 
enrolled in HMOs tripled to 58 
million. Another 91 million now 
belong to preferred provider organi¬ 
zations (PPOs), a looser form of 
managed care. 
As a result, the rise in medical 
costs has indeed slowed dramatically 
around the nation and at Yale, with 
massive decreases in hospitalizations 
credited for much of the change. 
Market-bound health care plans 
have proved far more resistant to 
paying the relatively high cost of 
hospitalization and certain high-tech 
medical procedures, forcing medical 
providers to seek lower-cost settings 
for service delivery. Physicians now 
undertake less expensive procedures 
or must receive approval for order¬ 
ing tests and procedures from an 
administrator. To the chagrin of 
utDoc,’ they say, we’ve 
us money.’” 
many in the medical community, 
as a profit incentive has entered the 
system, administrators and share¬ 
holders battle to keep costs down 
and returns high. In many cases, 
clinicians have changed the style 
of their medical practices to increase 
the number of patients seen and 
have had to decrease the amount 
of time and service provided to 
individuals. Group practices, 
HMOs and associated ambulatory 
clinics, as well as day-surgery 
centers, medical hotels, home-care, 
hospices and day hospitals, have 
come to dominate the practice 
of medicine. 
Amid the changes, no one is 
quite sure what to do about medical 
education. Most health care plans 
would consider educating future 
physicians and supporting clinical 
research at best part of what they 
call the medical-loss ratio, that is, 
money spent providing service and 
not profit. Phis causes serious 
dilemmas for medical schools. 
Robert H. Gifford, M.D., HS 
’66-67, associate dean for medical 
education and student affairs, is 
partly responsible for seeking out 
clinical training settings for third- 
and fourth-year medical students. 
As he looks for new ambulatory 
clinics to take on students, he says 
he has heard a similar refrain from 
several HMOs: ‘“Doc,’ they say, 
'we’ve got a bottom line to meet. 
Teaching costs us money.’” Yale 
must struggle—and in some cases 
pay—to place students into real- 
world settings to learn medicine. 
Flistorically, medical education 
at Yale has been carried out by most 
faculty as an activity supported by 
their primary work as clinicians and 
researchers. They taught or pro¬ 
vided teaching facilities because 
they enjoyed doing it and found it 
rewarding, while it also enhanced 
their professional reputation, freed 
them from bureaucratic hassles, 
kept them at the forefront of 
medical science and gave them 
access to a medical and intellectual 
community of enormous depth and 
breadth. Now, a managed care 
organization is urging the physician 
to move each patient as rapidly as 
possible through the system. 
“The pressure to spend all your 
working moments in practice rather 
than teaching and research is real,” 
says Dr. Burrow, himself a clinical 
practitioner in endocrinology and a 
leading expert in thyroid disease. 
Given the time-consuming demands 
of education, students can only 
decrease the physician’s efficiency. 
A conflict of cultures has 
ensued within medicine. “Educa¬ 
tion can’t be rushed,” says David J. 
Leffell, M.D., B.S. ’77, HS ’84-87, 
associate professor of dermatology 
and surgery. He is medical director 
of the Yale Faculty Practice, the 
umbrella organization for the 
clinical faculty practices in 16 of 
the medical school’s departments. 
“If there is increased pressure on the 
physician, something has to give. 
I worry that it will probably be 
education.” 
To ensure that this does not 
happen ultimately, and that its 
physicians remain in charge of 
medical decision-making, the school 
has taken steps to bolster its posi¬ 
tion in the changing health care 
economy. In 1995, it established a 
managed care organization of its 
own in partnership with Yale-New 
Haven Hospital’s parent corpora¬ 
tion, Yale New Haven Health. The 
new entity, Yale Preferred Health, 
was launched in response to the 
introduction of Medicaid managed 
care in Connecticut, which threat¬ 
ened the traditional access Medicaid 
patients had to Yale services. 
Continued on page 12 
got a bottom line to meet. Teaching costs 
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That was then. This is now 
It is up to physicians to strengthen the teaching of medicine. 
By David J. Leffell, M.D. 
IVIedical education is a complex, 
integrative process. It involves not 
only the acquisition of knowledge, 
but also the development of skill in 
its application and the cultivation of 
wisdom in its execution. It is 
typically a gentle, ongoing process 
that is increasingly ill-fitted to the 
rigid and inflexible demands of the 
medical care environment. 
The traditional clinical teaching 
encounter, in which several 
patients might be seen and evalu¬ 
ated in morning clinic, with ample 
time for discussion among several 
faculty members and students, is 
quickly becoming a relic of the 
past. Increasingly, we are being 
forced to compress the transmission 
of knowledge, skill and wisdom into 
time intervals that more resemble 
med-bites, analogous to sound-bites, 
than the interactive episodes that 
foster disposition to inquiry. And 
guess what? The payers don’t care. 
It is therefore left to us, who are 
most committed to teaching the next 
generation of physicians, to be 
creative, innovative and flexible in 
finding new ways to teach the 
practice of medicine. In fact, the 
challenge to medical education goes 
beyond the constriction of time 
available for teaching. The challenge 
extends to the very degree of clinical 
activity permitted students and 
residents. A third-year resident 
remarked recently that the biggest 
concern among her peers is the fact 
that they are “not allowed to do 
anything anymore." This, a direct 
consequence of aggressive enforce¬ 
ment of teaching-physician billing 
regulations, is likely to affect pro¬ 
foundly our ability to train residents, 
especially when it comes to proce¬ 
dural activities. 
Yale must take a leadership role 
in helping to define how medical 
education can accommodate the 
legitimate concerns of government 
and the pressures of the changing 
marketplace. Managing education 
must remain as much a priority as 
managing care. 
David J. Leffell, M.D., HS ’84-87, 
associate professor of dermatology and 
surgery, is medical director of the Yale 
Faculty Practice. 
“It is left to us to be 
creative, innovative 
and flexible in 
finding new ways 
to teach.” 
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The plan has succeeded in 
enrolling almost 25 percent of 
Medicaid patients in New Haven 
and its surrounding towns, and up 
to 10 percent statewide, says Ellen 
Skinner, director of managed care 
and marketing for the Yale Faculty 
Practice. Now it is courting employ¬ 
ers throughout the region with the 
goal of continued growth. In early 
May, Yale Preferred Health an¬ 
nounced plans to merge with 
Farmington-based HealthChoice, 
the managed care organization of 
Hartford's St. Francis Hospital, to 
create the largest provider-owned 
health care plan in Connecticut. 
“The faculty have to 
run faster and see 
more patients. 
They have less time 
for teaching.1’ 
Since November 1994, Yale New 
Haven Health has owned a 50 
percent share of HealthChoice. 
To further meet the economic 
challenges, Yale is developing 
networks of providers through 
agreements with specialty and 
primary care practices across 
Connecticut and even into Rhode 
Island and New York. These 
networks, particularly in cardiology, 
oncology and psychiatry, will help 
ensure an adequate flow of patients 
to the medical center for teaching, 
and will bolster clinical revenues by 
aggressively negotiating contracts 
with managed care organizations. 
The school also is considering the 
migration of the Faculty Practice 
physicians into a new, free-standing 
entity that will enable quicker 
decision-making while reducing 
the school’s financial risk. “We are 
being aggressive about ensuring 
access to patients for teaching,” 
says Dr. Feffell. “Our core mission 
is at stake, so we can’t afford to 
be passive.” 
MOVING PAST THE HOSPITAL 
Financing for medical education 
historically has been cobbled 
together from a variety of sources 
not solely dedicated to training the 
next generation of doctors. In a 
sense, the budget for medical 
education has been the cream 
skimmed off the top of the ad¬ 
vanced medical and research services 
provided at the medical center. Out 
of the School of Medicine’s $434 
million budget for 1995-96, less than 
$17 million came from student 
tuition. A little over 40 percent of 
the remaining amount was covered 
by overhead charged to faculty 
clinical practices, while 53 percent 
came from overhead charged against 
faculty research grants and con¬ 
tracts. A small percentage also comes 
from endowment income. In other 
words, says Dr. Gifford, “For years, 
students were educated by someone 
paid to do something else.” 
The two major sources of 
income, clinical revenue and 
research funding, remain stable for 
the time being, but all indications 
are that both will decline in the 
future. At the same time, access for 
students and residents to both 
faculty and patients is becoming 
more restricted. “The handwriting,” 
Dr. Gifford says, “is on the wall. 
It used to work fine. Now, it’s not so 
fine. The faculty have to run faster 
and see more patients. They have 
less time for teaching. That is even 
Continued on page 14 
The private sector 
must help with 
the training of 
physicians 
By Edwin C. Cadman, M.D. 
When funds for training physicians 
were included in the Medicare 
budget in 1965, the federal govern¬ 
ment opened a new chapter in 
American medicine and made an 
open-ended commitment to help pay 
the costs of training hospital interns, 
residents and fellows after their 
graduation from medical school. 
In addition to usual inflationary 
increases, two factors have in¬ 
creased the costs more dramatically 
than economists had predicted— 
a more than doubling of medical 
school graduates annually (from 
7,500 in 1965 to 17,000 today) 
and an influx of foreign medical 
graduates. The average cost to the 
federal government is $70,000 per 
trainee, and with nearly 100,000 
trainees, the dollars are substantial. 
Of the $10 billion spent annually 
training physicians, $7 billion comes 
from the federal government. 
As a cost-saving measure, the 
government wishes to reduce its 
payment to support graduate 
education for physicians. A current 
pilot program developed by the 
Health Care Financing Administration 
(HCFA) in February will gradually 
eliminate funds for 25 percent of all 
resident physicians over the next five 
years in New York. It is likely that 
this, or a similar proposal, will be 
enacted in the future that will affect 
the entire country. 
Reducing these federal pay¬ 
ments will have a substantial effect 
on those hospitals that have made a 
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Medical education. Dr. Cadman argues, is a shared 
responsibility that benefits the nation as a whole. 
would also bear this additional cost 
of education. We feel that this 
educational responsibility is a 
shared one with the country and, 
therefore, we favor a universal 
educational pool, the source of 
funds for which should come from 
those who benefit from a high-quality 
physician workforce—namely all 
health care providers, the insur- 
ance/HMO industry, the states 
(teaching hospitals provide a 
disproportionate share of care to 
the uninsured) and the federal 
government. 
The private sector must assume 
a greater responsibility in preserving 
the national resource of excellence 
in physician education, since the 
ultimate beneficiaries of a highly 
competent physician workforce are 
the citizens of this country. Without 
a universal payment methodology for 
training doctors, the burden would 
reside in communities such as ours, 
which would be required to accept 
the complete financial obligation. 
Edwin C. Cadman, M.D., is chief of 
staff and senior vice president of medical 
affairs at Yale-New Haven Hospital 
and professor of medicine at the School 
of Medicine. 
major commitment to education. 
Yale-New Haven Hospital has 
approximately 500 residents and 
200 fellows. Our total direct costs 
related to resident training exceed 
$25 million, primarily in salaries and 
benefits to support both residents 
and faculty. We currently receive 
Medicare reimbursement of only 
$5.7 million. (The formula for 
Medicare reimbursement for direct 
costs is related to the percent of 
Medicare patients cared for at the 
training hospital.) In addition, 
Medicare reimburses teaching 
hospitals to compensate for the 
indirect costs associated with 
teaching, such as overhead related 
to medical records, complexity of 
cases, on-call rooms for residents 
who stay overnight in the hospital 
(we have 110), conference rooms 
and additional computer resources. 
Clearly, should the federal 
government choose to eliminate 
reimbursement of educational 
costs for post-graduate education 
of physicians, the impact would 
be greatest among the 100 or 
so hospitals that train the majority 
of our nation’s new generation 
of doctors. 
We are deeply devoted to our 
educational mission, and we desire 
to remain a center for educational 
excellence. Therefore, if we were to 
fund this education mission by 
ourselves, the cost of care here 
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Single-payer system may be 
the only cure 
By John C. Marsh, M.D. ’59 
While some may argue that we 
need only let the marketplace take 
care of medical practice and the 
problems will sort themselves out, 
I am not persuaded that we have 
made progress in the last few years. 
As for the impact that managed 
care has had on the practice of 
medicine, the current situation 
is deplorable. 
Increasing numbers of patients 
and physicians (and I speak as one 
belonging to both categories) are 
being moved around in systems of 
increasing complexity and inconsis¬ 
tency. Patients are being forced to 
leave established physician relation¬ 
ships because of a change in 
insurance plan at their or their 
spouses’ place of employment. 
I have had the experience of both 
gaining new patients and losing old 
ones for this reason. The physician- 
patient relationship has about as 
much stability as that between a 
professional athlete and his team 
during the period of free agency. 
While 45 million people have no 
access to medical care, top CEOs of 
managed care plans pocket millions 
in bonuses and salaries. Medicine 
has become a commodity, subject to 
low bids, incentives to physicians for 
non-referral, and even to gag rules. 
Clinical research and medical 
education have become step¬ 
children, even orphans, in the current 
system. I recently experienced the 
refusal by an insurance company of 
support for a patient with a unique 
cancer (carcinoid) for a specific, 
uniquely suitable form of therapy 
(radioactive somatostatin analog). 
This is similar to radioactive iodine 
for thyroid cancer, but it was 
I 
rejected because it was a Phase I 
clinical trial. 
Nonprofit hospitals are being 
absorbed by huge organizations and 
becoming for-profit organizations, 
reducing still further the opportuni¬ 
ties for uninsured patients to receive 
care and for medical education for 
house staff and medical students. 
What can be done? Physicians 
and the general public must agree 
on specific goals and convince 
politicians of their merit. These 
should include equal access to 
medical care by all citizens and free 
choice of physicians by all. This will 
probably mean a single-payer 
system, similar to that practiced in 
Canada. In such a system, pricing for 
medical services would be regulated 
by the government and would be 
universal. I am aware of the objec¬ 
tions, especially from physicians, 
but, I ask, would such a system be 
worse, and less fair than the current 
hodgepodge of inconsistencies 
and inequities? 
John C. Marsh, M.D. yy, is a Yale 
oncologist and professor of medicine. 
Continued from page 12 
more true out in the community. 
The one thing lost too often 
is teaching.” 
While faculty time and financial 
support are being squeezed, the 
setting for medical education also 
has had to change. “A lot of figuring 
out what's wrong is done long before 
the patient arrives in the hospital,” 
says Dr. Gifford. “If you restrict 
education to the hospital, you miss 
way more than half of the patient’s 
story.” For medical schools, this 
has been a particular challenge. 
“Hospitals made it easy for us,” 
says Dr. Gifford. “Patients were 
accessible. There was time for 
students to be involved and it didn’t 
cost the hospital or the doctor 
anything.” Says Faculty Practice 
director Dr. Leffell: “You can’t lose 
money anymore.” 
Dr. Burrow estimates that 
clinical faculty already donate $15 
million worth of time to the school 
annually. Still more is being de¬ 
manded of them. “We have a 
dedicated group of people who have 
taken a personal hit,” says Deputy 
Dean Warshaw. Some resent the loss 
of freedom and the decrease in 
income that managed care has 
demanded. Indeed, some faculty 
members have opted out of medical 
education altogether. 
A TIME OF ADJUSTMENT 
The large majority of faculty 
members, however, have been 
coping with the changing nature of 
their profession—and have changed 
their practices, courses and depart¬ 
ments to meet the new demands. 
For medical students at Yale, 
preparation for managed care now 
begins in the very first days on 
campus. Thanks in part to a $2.5 
million grant from the Robert Wood 
Johnson Foundation, the curricu- 
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lum has undergone a major review 
and reorganization. Formerly 
separate and overlapping rather than 
complementary, departmental 
offerings are now integrated to bring 
basic science and clinical medicine 
into closer relationship. Several 
courses for first-year students have 
been coordinated to create what is 
called the Medicine, Society and 
Public Health Program, to help 
them better understand the forces 
and issues underlying contemporary 
medical practice. For Steve Kavic, 
“Hospitals made it 
easy for us .. .There 
was time for students 
to be involved and it 
didn’t cost the 
hospital or the doctor 
anything.” 
M.D. ’97, who graduated from the 
School of Medicine in May and is 
starting his surgical residency at 
YNHH this summer, the training in 
the business of medicine was a 
necessary evil. “You’re caught,” he 
says. “As a student you want to learn 
only medicine, but you have to learn 
the bytes, bits and buzzwords of 
managed care. It’s very clear to all of 
us students that it’s an important 
part of medicine and will only 
become more important.” 
Some things, however, do not 
change. The school’s unique, 155- 
year-old thesis requirement, accord¬ 
ing to Dr. Gifford, remains “sacro¬ 
sanct and will continue so.” But the 
settings in which students receive 
much of their clinical education are 
diversifying rapidly. Numerous new 
affiliations with HMOs share the 
Focus on 
prevention 
will aid medical 
students and their 
future patients 
By Michael H. Merson, M.D. 
Two phenomena occurring in the 
health care world are having a 
profound effect on medical 
education. 
The first is the realization that, 
despite our extraordinary progress 
in the development of new medical 
technologies and more effective 
drugs, we cannot deal effectively 
with communicable and non-commu¬ 
nicable diseases, such as AIDS and 
hypertension, through treatment 
alone. We have demonstrated that 
prevention—achieved through health 
promotion programs and appropriate 
public health laws and policies— 
can have a dramatic impact on 
such diseases. 
The second is that managed 
care, in the ideal, puts enormous 
stock in the role of prevention and in 
confronting health issues on a 
population basis—rather than 
looking only at treatment of individu¬ 
als. The very phrase “health mainte¬ 
nance organization" implies maintain¬ 
ing good health as a priority. The 
best way of reducing health care 
costs is to prevent disease from 
occurring at all. 
Here at Yale, Epidemiology and 
Public Health is responsible for 
teaching epidemiology, biostatistics 
and prevention to medical students. 
Our task is to help ensure that all 
medical school graduates, regardless 
of their specialty, enter their resi¬ 
dency training with a population- 
based perspective, so they can both 
HARRY BISHOP 
treat disease and guide all their 
patients on how to stay healthy in 
the increasingly “managed” health 
care environment. We encourage 
students with a strong interest in 
acute or chronic disease epidemiol¬ 
ogy or public health policy to enter 
our master’s program. We believe 
that all medical doctors of the future 
will, one way or another, need to be 
practitioners of good public health. 
Michael H. Merson, M.D,, is dean for 
public health and chairman of the 
Department of Epidemiology and 
Public Health. 
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goal of assuring sufficient ambula¬ 
tory clerkships lor third- and lourth- 
year students. 
Within Yale's individual depart¬ 
mental residency training programs, 
managed care has necessitated 
radical restructuring. Since Medicare 
was created in 1965, it has provided a 
salary to support all residents. The 
expectation is that residency pro¬ 
grams will lace significant cuts to 
help reduce the Medicare budget. 
Not all view change as a threat to 
quality. “You can't make improve¬ 
ment without change,’’ says Edwin 
C. Cadman, M.D., chief of staff and 
senior vice president lor medical 
alfairs at YNHH and prolessor of 
medicine. He is director ol the 
hospital’s residency training pro¬ 
grams, covering 500 residents and 
200 fellows training in subspecialty 
areas. “These are opportunities for 
improvement.” 
Changes in Medicare have 
lorced attending physicians to 
supervise daily care—to approve the 
tests and treatments that formerly 
were the residents’ responsibilities. 
While this may assure better 
oversight, it greatly taxes the 
teaching possibilities within resi¬ 
dency programs. “The simple things 
in the past were the domain of 
nurses and trainees,” says Ronald C. 
time and the impending decrease in 
support Irom the lederal govern¬ 
ment, according to Dr. Merrell, 
“Residency programs will have to 
shilt, close or taper. We need to 
figure out another formula.” Adds 
Dr. Cadman: “Our responsibility is 
to make sure the change is lor the 
better, not the worse.” Several 
departments have already scaled 
back the size of their residency 
programs. 
One way to reduce costs is to 
improve the delivery of care while 
finding cost-saving means to reduce 
duplication of services and stop 
waste. Efficiency has become the 
watchword for the school as a 
whole. Yale Faculty Practice director 
Dr. Leffell says, “There are things 
we’ve done out of habit that we need 
to stop. Managed care is making us 
look in the mirror.” 
CHANGE AND OPPORTUNITY 
Throughout the School ol Medi¬ 
cine, clinical training programs have 
been reorganized to reduce costs and 
reflect the new realities ol medical 
practice. “We are changing drasti¬ 
cally,” says Dr. Merrell, echoing his 
fellow department heads. “We’re 
training a dilferent kind of practitio- 
and reorganized previous clinical 
operations to meet the changing 
demands. “Over half our patients 
come in the same day as their 
surgery,” says Roberta Hines, M.D., 
HS ’78-84, chair of anesthesiology. 
“We now have a pre-admission 
testing center. It’s educational for 
patients and residents, and has 
management benefits for us 
as well.” 
Not all departments have found 
the changes beneficial. Some have 
struggled to deal with truly global 
changes in treatment practices. In 
psychiatry, for instance, some 
facilities that once treated patients in 
a hospital setting lor 90 days or 
more now have average stays ol 
seven to 10 days, as dictated by 
managed care companies’ rules. 
Department chair Benjamin S. 
Bunney, M.D., the Charles B.G. 
Murphy Professor ol Psychiatry and 
professor of pharmacology, says, “It 
often takes more than seven days for 
the disorders we treat to respond to 
medication, and we cannot predict 
who will respond and who won’t. 
We also used to work with the 
patient’s lamily and community 
environment. We have very little 
time lor that now.” 
The transition now under way 
may be enormously difficult and the 
uIn managed care, the devil is in the detail. A large number of points 
that are not clinically critical but financially important must now be 
managed by the attending physician.” 
Merrell, M.D., chair and Lampman 
Professor of Surgery. “In managed 
care, the devil is in the detail. A 
large number ol points that are not 
clinically critical but financially 
important must now be managed by 
the attending physician.” Given the 
squeeze on attending physicians’ 
ner. We re training surgeons to work 
in a managed care environment and 
to be accountable for consumption 
of resources and to work as part of a 
large group. We’re sharply focused 
on outcome." 
Individual academic depart¬ 
ments have established new services 
outcome unclear, but some believe it 
is healthy for medicine. Theodore 
Marmor, Ph.D., author of Under- 
standing Health Care Reform and 
other books on health policy, is a 
professor of politics and public 
policy at the Yale School of Manage¬ 
ment. “It may be painful but, in the 
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Sorry, 
your time is up 
By Angelo Volandes 
Please pay on your way out. 
That was my subtle hint to 
patrons to vacate the restaurant 
booth for the next hungry bunch. 
My dad gave me three booths at our 
Manhattan restaurant to wait on 
during the busy lunch hour, and I 
quickly learned that, given limited 
seats and time, the more customers 
I served, the more money I could 
make. It’s ironic that today as a 
medical student the same principle 
will be used to determine my income 
as a future physician. 
Many physicians under managed 
care will be paid more if they see 
more patients and will receive 
bonuses for spared medical proce¬ 
dures. While that may make logical 
business sense, it seems at odds 
with the basic tenets of medicine. 
The unique problems of a particular 
patient may require added effort 
and time. 
New issues complicating the 
patient-physician relationship are 
bound to surface when salaries are 
tied to patient care. Will patient care 
be compromised in our hastiness to 
squeeze in extra bodies? Will certain 
patients become stigmatized if their 
health care consumes an inordinate 
amount of time? It would be naive to 
think that somehow physicians are 
immune to the personal financial 
incentives by which non-medical 
professions often function. 
Clinical teaching is now suffused 
with issues of economics. Rarely 
does a week pass whereby a mentor 
fails to mention that an HMO would 
look askance at the list of proce¬ 
dures ordered, or that the amount of 
time spent on a patient is simply not 
realistic, given the number of pa- 
“Managed care has 
altered the teaching 
of medicine to 
students at a 
fundamental level.” 
tients to be seen. Often frustrated, 
I ask myself: Toward what purpose? 
The call to medical efficiency, and 
thus the popularity of HMOs, is 
based in part on concerns about 
equitable health care, namely the 
45 million Americans who are 
without access. Are any of the 
savings redistributed to those 
45 million? If there has been any 
redistribution of resources, it is to 
the executives and stockholders of 
insurance companies. Why should 
quality time with a patient be 
subjugated to the demands of a 
profit-interested business? 
Managed care has altered the 
teaching of medicine to students at 
a fundamental level. It is dishearten 
ing to think that the next generation 
of physicians will not have the 
freedom that previous generations 
enjoyed to exercise sound clinical 
judgment. Telling a patient that you 
have to cut his or her visit short 
because of the HMO has more dire 
consequences than the indigestion 
experienced from an unexpectedly 
hastened luncheon. 
Angelo Volandes is entering his fourth 
year at the School of Medicine. 
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long run, it’s good for education. 
It encourages people to think about 
the worth of medical education on 
its own rather than as a by-product 
of service delivery. Treating the 
educational activity within a context 
of a budget is better than having it 
clawed and scratched away on the 
periphery of care and treatment.” 
One thing is clear: the changes 
have already been enormous and 
have only begun. For resident Steve 
Kavic, setting out on his career in 
surgery, this evolution has been part 
of his education at Yale. “There’s no 
question that the style of medicine 
I’ll practice will be very different 
from that of my father’s and 
grandfather’s generations,” he says. 
But medicine has always adjusted to 
the changing realities of the society 
it serves. For Dr. Kavic, that makes a 
career in medicine an especially 
inviting opportunity. “I’m very 
happy with my career choice.” YM 
Redefining the relationship between managed care 
organizations and academic medical centers 
By Mike Cardillo and Nicholas A. Hanchak, M.D. 
IVIanaged care has triggered far- 
reaching changes in the way health 
care is provided and financed. More 
efficient management of costs and 
an emphasis on preventive health 
care and disease management have 
been important positive contribu¬ 
tions. Still, new financial arrange¬ 
ments have created challenges for 
academic medical institutions 
seeking to fulfill their mission of 
excellence in patient care, education 
and research. 
Although the agendas of 
managed care organizations and 
academic medical centers appear to 
be in conflict, we share an interest in 
using the best programs possible to 
improve the quality and affordability 
of care. We likewise share an 
interest in preserving the medical 
education and research that have 
made American health care the best 
in the world. By combining our 
strengths, we can improve the 
quality of health care while also 
delivering it efficiently so it can be 
widely afforded. 
One reason our interests are 
coming together is the development 
of integrated delivery systems (IDSs), 
which are strategic alignments of 
academic medical centers, commu¬ 
nity-based providers and physicians. 
By virtue of their role in managing 
the health of defined patient 
populations, the mission of IDSs 
combines the delivery of acute care 
with an emphasis on disease 
prevention and health maintenance. 
These networks can benefit from 
alliances with managed care organi¬ 
zations, which are already armed 
with information systems and 
targeted interventions that support 
disease prevention and manage¬ 
ment of chronic disease across the 
continuum of care. 
Member-based payment models, 
as opposed to fee-for-service 
payments, encourage IDSs to 
achieve cost savings by delivering 
care more efficiently and promoting 
health management. The resulting 
savings can be used to support 
medical education and research to 
the same or even greater extent that 
excess fee-for-service revenues have 
in the past. 
In addition, partnerships 
between academic medical centers 
and managed care organizations can 
contribute to the training of medical 
students. Because we view such 
partnerships as critical to the future 
of our health care system, Aetna U.S. 
Nicholas A. Hanchak, M.D. 
Healthcare established the Aca¬ 
demic Medicine and Managed Care 
Forum. Representatives from 
academic medical centers including 
Yale, teaching hospitals, and man¬ 
aged care organizations convene to 
discuss issues such as the funding 
of graduate medical education, 
medical research, and managed 
Medicare and Medicaid. Together 
we can find solutions that preserve 
the excellence of our medical 
education and research and fulfill 
the promise of managed care and 
academic medicine—to improve the 
quality and efficiency of health care 
in America. 
Mike Cardillo is president of Aetna 
U.S. Healthcare; Nicholas A. Hanchak, 
M.D., is president of Aetna subsidiary 
U.S. Quality Algorithms, Inc. 
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“A good from 
which everyone 
benefits” 
The following is excerpted from the 
floor speech given by U.S. Sen. 
Daniel Patrick Moynihan, D-N.Y., on 
Jan. 21, introducing a bill to create 
a Medical Education Trust Fund 
financed by Medicare, Medicaid and 
the private sector. The trust fund 
would provide support to America’s 
medical schools and teaching 
hospitals, which Senator Moynihan 
describes as threatened by 
increasing competition and the 
growth of managed care. Payments 
from the trust fund would average 
$17 billion each year, roughly 
doubling the federal commitment to 
medical education. The legislation 
is still pending. 
IVIedical education is one of 
America’s most precious public 
resources. Within our increasingly 
competitive health care system, it is 
rapidly becoming a public good— 
that is, a good from which everyone 
benefits but for which no one is 
willing to pay. Therefore, it would be 
explicitly financed with contributions 
from all sectors of the health care 
system, not just the Medicare Pro¬ 
gram as is the case today. The 
fiscal pressures of a competitive 
health market are increasingly 
closing off traditional implicit 
revenue sources (such as additional 
payments from private payers) that 
have supported medical schools, 
graduate medical education and 
research until now. 
The Medical Education Trust 
Fund established in the legislation I 
have just reintroduced would receive 
funding from three sources broadly 
representing the entire health care 
system: a 1.5 percent tax on health 
insurance premiums (the private 
sector’s contribution), Medicare and 
Medicaid (the latter two sources 
comprising the public sector’s 
contribution). The relative contribu¬ 
tion from each of these sources will 
be in rough proportion to the 
medical education costs attribut¬ 
able to their respective covered 
populations. 
This legislation is only a first 
step. It establishes the principle 
that, as a public good, medical 
education should be supported by 
dedicated, long-term federal funding. 
To ensure that the United States 
continues to lead the world in the 
quality of its medical education and 
its health system as a whole, the 
legislation would also create a 
Medical Education Advisory Commis¬ 
sion to conduct a thorough study 
and make recommendations, 
including the potential use of 
demonstration projects, regarding 
the following: alternative and 
U.S. Sen. Daniel Patrick Moynihan 
additional sources of medical 
education financing; alternative 
methodologies for financing medical 
education; policies designed to 
maintain superior research and 
educational capacities in an 
increasingly competitive health 
system; the appropriate role of 
medical schools in graduate 
medical education; and policies 
designed to expand eligibility for 
graduate medical education pay¬ 
ments to institutions other than 
teaching hospitals. 
Mr. President, the services 
provided by this nation’s teaching 
hospitals and medical schools— 
ground-breaking research, highly 
skilled medical care, and the 
training of tomorrow’s physicians— 
are vitally important and must be 
protected in this time of intense 
economic competition in the 
health system. 
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Yale surgeon and historian Sherwin Nuland explored the troubling medical and 
personal issues surrounding death in ways never done before in the best-selling 
1994 book How We Die. His new book, The Wisdom of the Body, applies his multiple 
talents to a new understanding of 
How we live 
By Marc Wortman 
Photographs by Gale Zucker 
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Few of us ever experience a truly radical change in 
our lives. Sherwin Nuland has. Twice. The first 
came early in his life, when, as an n-year-old, he 
watched his mother die of colon cancer, turning his 
household and his life upside down. “All that I have 
become,” he has written, “and much that I have not 
become, I trace directly or indirectly to her death.” 
The second change would come a half-century later 
when the surgeon and clinical professor wrote How We 
Die: Reflections on Life’s Final Chapter. Published early in 
1994, it became an instant bestseller. The book’s crystal- 
clear explanations of the physiological conditions leading 
to death and deeply felt, personal narratives of deaths he 
had witnessed struck an unsuspected nerve in the reading 
public, a craving for understanding and perspective 
about the often obscure and much-feared physical reality 
of modern death and dying. The book sold hundreds of 
thousands of copies, spending a total of 34 weeks on the 
hardcover and paperback New York Times bestseller lists. 
It won the 1994 National Book Award for nonfiction and 
made Dr. Nuland a high-profile writer and a frequently 
heard voice on end-of-life issues. 
Those questions aren’t the result of idle speculation. 
They come at the end of a long career devoted to caring 
and operating on thousands of patients and learning as 
much as possible about how to help them. “I loved being 
a doctor,” he says. “Caring for the sick validated me. 
Being a writer is secondary to the thousands of hours I 
spent at the bedside.” 
Dr. Nuland retired from active surgical practice at 
the beginning of 1992, on the very day he began writing 
How We Die. He continues to serve on faculty commit¬ 
tees, advises students on their thesis work and meets 
frequently with groups at Yale and elsewhere. He now 
spends large parts of his days researching at the Medical 
Historical Library, or writing at home in the recently 
restored neo-Colonial house just outside New Haven 
that he shares with his wife, actress Sarah Peterson, and 
their two teen-age children. (He also has two grown 
children from a previous marriage.) Sitting in his serene, 
book-lined study, he is a slim, robust man with a pierc¬ 
ing look in his blue eyes. He appears younger than his 66 
years. “I’m very egotistical about my physical self,” he 
admits with a laugh. He credits regular games of tennis, a 
“We have 75 trillion cells in our bodies,” Dr. Nuland says. “Every one 
of them has something going on constantly. Why don’t things 
go wrong? Why don’t we die?” 
Given the book’s obvious subject, however, many 
readers overlooked an important emphasis: Despite 
being what could be termed a layman’s anatomy of 
death, How We Die also amounts to a remarkable portrait 
of human life in both its physiological and spiritual 
glories. The book again and again points out how, even 
in the throes of dying, the human body and mind are 
astoundingly resistant to their biological demise. Dr. 
Nuland’s true concern in How We Die is not death but, 
in many respects, just the opposite. Much of what he 
explains is the human body’s vast power to ward off 
death in all but the most overwhelming circumstances— 
and the ways in which death fits into the wider patterns 
of human development. Published this spring, his new 
book, The Wisdom of the Body, explores this idea, provid¬ 
ing a biological explanation for the endurance and 
development of human life. 
“We have 75 trillion cells in our bodies,” Dr. Nuland 
says. “Every one of them has something going on con¬ 
stantly. Why don’t things go wrong? Why don’t we die?” 
daily regimen of push-ups, and a young family for his 
hardy physical condition. He also recognizes his luck in 
the roll of the genetic dice: “People in my family die of 
cancer, or live unscathed to late age." So far, he appears 
to be on the fortunate path. He sits forward on one of 
the two small couches near a fireplace in his study where 
he carries out interviews. The National Book Award 
certificate is displayed on the mantel. 
In his 1988 book on the history of medicine, Doctors: 
The Biography of Medicine, he wrote that, “The story of 
medicine is ... the story of my professional life.” While 
he has stopped his medical practice, he finally has a 
chance to try to understand what those years in the 
operating room meant. Writing, he finds, is his way ol 
knowing what he thinks about the life he has experi¬ 
enced. “I’m like a little kid,” he says. “I want to find out 
things and then share it with others.” His writings reflect 
an astounding amount of knowledge in a wide variety of 
fields, and the hundreds oi books lining his wall evidence 
a mind of extraordinary reach. Since the 1980s, Dr. 
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Nuland has edited the Classics of 
Medicine Library, a series of hand¬ 
some gilt-edged and leather-bound 
reissues of every major work in 
medical history, all with his intro¬ 
ductions. When asked about his 
polymathic pursuits, he demurs, 
“1 have always felt I was not well- 
educated. Virtually from the cradle, 
I have wanted to learn more.” 
Always a reader in medical 
history, he began researching, 
editing and writing for the Classics 
of Medicine series during the early 
1980s. In the odd free moments 
he found at the medical center, he 
would run over from the hospital to 
the Medical Historical Library at 
the School of Medicine’s Harvey 
Cushing/John Hay Whitney 
Medical Library, one of the greatest 
collections of its kind in the world. 
Now retired, Ferenc Gyorgyey 
directed the Historical Library for 
many years and worked closely with 
Dr. Nuland, serving as translator on 
a volume in the History of Medicine 
series. They are now close friends. 
Mr. Gyorgyey says, “He has a 
fantastic brain. He works at incred¬ 
ible speed, and he brings a fresh 
perception to things. He has the 
courage to build a hypothesis, and 
he’s not afraid that something 
Shep Nuland in the Medical Historical 
Library, where he spends much of his 
time researching. Page 20: At home in 
his study a few miles away, Dr. Nuland 
works amid stacks of books and papers. 
He usually speaks his words as he sets 
them out in longhand. 
unpleasant will come out of it. If 
he believes in something, he will 
tell it.” 
One of the most embracing of 
those hypotheses grew directly out 
of his professional experiences as a 
surgeon and the most personal 
aspects of his own life. “Biology and 
the human condition are the same 
Continued on page 24 
| 
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From The Wisdom of the Body 
The following passages are 
taken from the introduction to 
The Wisdom of the Body, by 
Sherwin B. Nuland, M.D. 
Centuries ago, when little was 
known of science, the mystery of 
the body’s internal machinery 
enthralled ordinary people and 
tantalized the educated. It seemed 
a miracle, this bustling edifice of 
thought and action—beyond the 
capacity of mere mortals to compre¬ 
hend, and yet providing here and 
there a hint that the inscrutable 
might somehow be understood if 
only properly directed efforts were 
made. In time, the right direction 
was indeed found and the efforts 
were rewarded, yet the tantalizing 
and the mystery not only did not 
lessen; they actually grew. The more 
became known, the more miracu¬ 
lous seemed the intricacies of the 
whole and the more urgent the drive 
to expand our knowledge of organs 
and tissues. 
As knowledge grew of cells and 
the turbulence of chemistry within 
them, it became evident that the 
seeming chaos of our tissues has 
about it an overarching purpose— 
in this sense, not a theological or 
philosophic purpose, but one based 
on the simple biological principle of 
survival. If an organism is to survive, 
every activity within it must in some 
way be part of the effort. Moreover, 
it is imperative that there be total 
coordination if the outcome is to be 
the singular momentum that is 
ongoing life. 
The integration of all parts of 
this effort has a seeming wisdom 
about it, by which the multiplicity of 
processes is somehow guided into 
a harmonious whole. The essence of 
success is the dynamism that 
allows each cell to respond instanta¬ 
neously to even the most minor 
threat to its integrity and therefore 
to the integrity of the entire organ¬ 
ism. There can be no chemical 
complacency. A high degree of 
radical readiness—to the point of 
instability, in fact—is required to 
allow the immediate change that 
corrects a tendency toward imbal¬ 
ance. Every disturbance sets off 
the calling forth of compensatory 
mechanisms that neutralize it. Our 
steadiness is a dynamic equilibrium. 
To coordinate all of the instabili¬ 
ties in all of the cells requires that 
the far-flung parts of an organism 
be in constant communication with 
one another, over long distances 
as well as locally. In the scale of 
animals that includes humankind, 
this is accomplished by messages 
sent via nerves, in the form of 
electrical energy we call impulses; 
via the bloodstream, in the form of 
the chemicals we call hormones; 
and—to nearby groups of cells— 
via the specialized substances we 
call local signaling molecules. 
As each of these methods of 
communication was discovered, 
researchers became increasingly 
impressed with how well integrated 
is the entire array of apparently 
disparate activities. They came to 
recognize the inherent wisdom of 
the body. Not only did they recog¬ 
nize it; the term also began to 
appear in their writings. 
The first scientist to use the 
metaphor of wisdom to characterize 
the body’s seemingly intuitive 
integration of its diverse faculties 
was Ernest Starling, one of the two 
codiscoverers of hormones. Deliver¬ 
ing the prestigious Harveian Oration 
of the Royal College of Physicians 
in 1923, he spoke of the regulation 
of bodily processes, their adaptabil¬ 
ity, and the contribution of hor¬ 
mones toward integrating them into 
a single unified system. For his 
epigraph, Starling chose a verse 
from the Book of Job (38:36): 
“Who hath put wisdom in the inward 
parts? or who hath given under¬ 
standing to the heart?" 
He entitled his oration “The 
Wisdom of the Body.” 
There is a certain irony in 
Professor Starling’s epigraph. In the 
Hebrew original, the word translated 
as “heart” is sechvi, a term so 
distinctive that this is the only place 
in the entire Bible where it occurs; 
and the term’s precise definition has 
been the focus of much learned 
discussion. According to some 
rabbinical authorities, it is equiva¬ 
lent to “mind,” perhaps from the 
belief, shared with Aristotle, that the 
heart is the seat of the mind. The 
wonder of the human body is not 
only the wisdom of its physiology 
but also the breadth of its mind. 
Nine years after Starling's 
oration, the great explicator of the 
body’s automatic control over 
vegetative functions (such as 
digestion, circulation, and tempera¬ 
ture control) Walter B. Cannon, of 
Harvard University, used the same 
title for a popular book he wrote. He 
chose to follow Starling’s lead as a 
way of recognizing the contribution 
made by the English scientist to the 
understanding of the body’s regula¬ 
tory mechanisms. In the introduc¬ 
tion to his book, Cannon quoted the 
French physiologist Charles Richet, 
who in 1900 had stated that “in¬ 
stability is the necessary condition 
for the stability of the organism.” 
A stable system is not a system 
that never changes. It is a system 
that constantly and instantly 
adjusts and readjusts in order to 
maintain such a state of being that 
all necessary functions are permit¬ 
ted to operate at maximal efficiency. 
Stability demands change to 
compensate for changing circum¬ 
stances. Ultimately, then, stability 
depends on instability. 
“The Wisdom of the Body” was 
to appear one more time, as the 
title of the fourth of a series of 
twelve Gifford Lectures presented by 
Sir Charles Sherrington at the 
University of Edinburgh in 1937- 
1938, several years after he won a 
Nobel Prize for his studies of the 
ways in which the nervous system 
coordinates bodily functions. He 
began the fourth lecture by suggest¬ 
ing to his audience that they see 
the human body as he did after a 
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long career of studying it: “Wonder 
is the mood in which I would ask to 
approach it for the moment." The 
lectures have been collected into a 
single volume which encapsulates 
the quest on which Sherrington 
based his life's work; it is called 
Man on His Nature. 
The book you are holding is 
written by yet another man awe¬ 
struck with the amazement that is 
us. I offer it not in imitation of the 
great scientists who have preceded 
me, but in homage to their vision. 
It is my thesis that we are 
greater than the sum of our biologi¬ 
cal parts. Not only that, but we have 
it in us to be still better than we 
are—and the choice lies to a 
significant degree in our own hands, 
as I have tried to demonstrate by 
telling the stories of people whom I 
have been privileged to know during 
my surgical career. 
No matter how similar our parts 
to those of other animals, there are 
to be found within them some char¬ 
acteristics that make us uniquely 
human. Whether as overtly evident 
as the power of the brain that has 
been given us or as taken for grant¬ 
ed as certain adaptations within our 
skeletal system, we are possessed 
of elements that make us different 
from any other living thing that has 
ever existed on this earth. 
If this is true of our bodies, how 
much more must it be true of the 
qualities of emotion and thought 
that we alone of all the animal 
kingdom possess? Although fo¬ 
cused primarily within the coordinat¬ 
ing tissues of the brain, powers 
such as these originate in the 
contributions of every segment of 
us. Like everything else about 
human function, the myriad frag¬ 
ments that coalesce to form human 
feeling arise from the workings of 
the physical structure that has been 
given to us. The uniquely human 
mind is a property of the organic 
characteristics of the uniquely 
human body, just as all function is 
the accompaniment of the physical 
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structure from which it arises. There 
is no duality of mind and body—all 
is one. Were it possible for Rene 
Descartes to reappear at this hour, 
today’s neuroscience would quickly 
convince him of the unity. In that 
one, which is the summation of our 
humanness, I include the quality 
that I find most remarkable, the 
quality which above all else makes 
us distinctively what we are. By this, 
I mean a biologically inherent 
particularity that is both miracle and 
mystery, the particularity I choose to 
call the human spirit. 
Notwithstanding the tragedies 
that humankind has visited on itself 
individually and collectively, and the 
havoc we have wreaked on our 
planet, we have become endowed 
nevertheless with a transcendent 
quality that expands generation 
upon generation, overcoming even 
our tendency toward self-destruc¬ 
tion. That quality, which I call spirit, 
has permeated our civilization and 
created the moral and esthetic 
nutriment by which we are sus¬ 
tained. It is a nutriment, I believe, 
largely of our own making. Without 
it, we would wither and lose our way 
in the wilderness. 
As I define it, the human spirit 
is a quality of human life, the result 
of living, nature-driven forces of 
discovery and creativeness; the 
human spirit is a quality that Homo 
sapiens by trial and error gradually 
found within itself over the course of 
millennia and bequeathed to each 
succeeding generation, fashioning it 
and refashioning it—strengthened 
ever anew—from the organic 
structure into which our species 
evolved so many thousands of 
years ago. It lives while we live; it 
dies when we die. Whatever else of 
a man may remain to join the 
consciousness of eternity, this 
magnificence I call the human spirit 
does not exist a moment beyond 
the moment of death. It is neither 
soul nor shade—it is the essence 
of human life. 
Excerpts from The Wisdom of the Body 
copyright ©1997 by Sherwin B. Nuland. 
Reprinted with permission of Alfred A. 
Knopf Inc. 
to me,” he says. His eyes brighten at 
the notion that our biological 
existence has evolved to thrive 
despite constant threats from 
virtually every direction. “I live in 
awe of human physiology. The body 
is a wondrous mechanism with so 
many fail-safe devices. We are 
always in danger of death, and yet 
we don’t die until old age or massive 
infection or trauma.” With life¬ 
saving redundancy in virtually every 
organ system, the body has an 
How We Die shows 
just how much it 
really takes to kill a 
person. The Wisdom 
of the Body shows 
how capable our 
biology is to develop 
and maintain itself. 
innate capacity for nearly instanta¬ 
neous communication and correc¬ 
tion when any life-threatening event 
occurs. Instability is an environmen¬ 
tal constant—the world is always 
changing—yet the body is continu¬ 
ously restoring the necessary 
equilibrium to the whole that 
promotes survival. Hormonal, 
neural and intercellular reactions 
course throughout the body, 
integrating into a single, self- 
sustaining organism. 
How We Die shows just how 
much it really takes to kill a person. 
The Wisdom of the Body shows how 
capable our biology is to develop 
and maintain itself. All of these 
biological functions taken together 
can be directly equated with what 
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would generally be seen as the 
evolutionally highest-order capabil¬ 
ity: wisdom. 
In The Wisdom of the Body, 
Dr. Nuland explains: “If an organ¬ 
ism is to survive, every activity 
within it must in some way be part 
of the effort. Moreover, it is impera¬ 
tive that there be total coordination 
if the outcome is to be the singular 
momentum that is ongoing life. 
The integration ol all parts of this 
effort has a seeming wisdom about 
it, by which the multiplicity of 
processes is somehow guided into a 
harmonious whole.” 
As he writes in the prologue to 
The Wisdom of the Body, he, like 
many others who have studied 
human biology, finds that a won¬ 
drous wisdom governs the body. 
This is something Dr. Nuland 
believes we know with our bodies, 
if not always with our minds. It 
governs our lives. And it is even 
found in the types of more spiritual 
questions that we ask about life. The 
very title ol the book evolves from 
early questions about the relation¬ 
ship between biology and the 
human spirit. The words originate 
in the Book of Job: “Who hath put 
wisdom in the inward parts?” The 
words were taken up earlier in this 
century by other medical writers, 
starting with Ernest Starling. He 
used them as the title of a lecture he 
gave in 1923 on the role of hormones 
in integrating bodily processes into a 
unified system. Then, in 1932, 
Walter B. Cannon, a Harvard 
physician who had helped explain 
Dr. Nuland chats with longtime friend 
and colleague Robert J. Levine, M.D., 
a medical ethicist and chairman of the 
Human Investigation Committee. 
the body’s control over basic func¬ 
tions such as circulation and 
digestion, used it as the title of a 
popular book on the body’s regula¬ 
tory mechanisms. Finally, Nobel 
laureate Sir Charles Sherrington so 
titled a lecture he gave as part of a 
series of talks in 1937-1938, building 
on his studies of the nervous 
system’s coordination of bodily 
functions. Dr. Nuland says, “All 
three men and I have been fasci¬ 
nated by the wonders of human 
biology and the human mind.” 
He extends the notion of bodily 
wisdom to equate those higher-order 
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qualities that make us human with 
basic biological functions. “What 
we are in the human spirit,’ he says, 
“is simply a reflection of our cellular 
life." Life is in constant conflict 
with the forces that would destroy 
it—and we endure by building an 
order that prevents or reduces the 
Yiddish moniker in the Jewish 
village of Eastern Europe from 
which his family came. Most people 
who know him personally call him 
“Shep.” “Sherwin” was a name his 
mother, Vitsches, heard in a Broad¬ 
way show tune and then gave to the 
officials when she enrolled her son 
the small living room between the 
two bedrooms while the life of the 
family swirled around him. Dr. 
Nuland has an uncanny ability to 
focus closely on whatever matter is 
before him, perhaps a skill learned 
in the chaos of that teeming house¬ 
hold and community. 
“Knowledge makes me feel part of something larger. I have an 
immigrants mentality: Nothing is ever enough.” 
threat of death. Our communal 
lives celebrate this biological fact. 
“We create a culture that is a 
reflection of the biological victory 
over death,” he says. “Beauty is the 
order and evidence of our ability to 
stay alive.” The book traces out this 
notion, beginning at the cellular 
level and following it through 
various physiological systems, and 
finally to the brain and then the 
human spirit. “The human spirit,” 
he says, “is the essence of the book. 
There’s a biological basis for the 
human spirit.” 
Memoir is very much at the 
core of Dr. Nuland’s writings about 
biology, and, not surprisingly, his 
biological theory for human whole¬ 
ness grows in part out of a child¬ 
hood in which the struggle for 
survival was continuous and death a 
very real threat. However, the cele¬ 
bration of life was also a constant. 
Dr. Nuland spent his childhood in a 
four-room tenement apartment in a 
teeming immigrant neighborhood 
in the Bronx. He shared that tiny 
space with an aunt, his parents, his 
brother, a cousin for a period and 
his grandmother. Yiddish was the 
household language. His parents 
could neither read nor write 
English. Even his name was what he 
terms “an afterthought.” Everyone 
called him “Shepsel,” a common 
in school. For the young boy, his 
mother’s death caused enormous 
grief and set him on a course to 
fight disease through medicine. 
After his mother’s death—his 
father labored from early in the 
morning until late at night in the 
garment industry—the crowded 
household was left in the charge of 
his elderly grandmother. “Bubbeh” 
as he affectionately called her, raised 
the boys until, at age 96, she too 
died when the future surgeon and 
author was 18 and a precocious 
college student at New York Univer¬ 
sity. His description of the elderly 
yet extraordinarily strong woman’s 
physical decline and the series of 
strokes that eventually killed her is 
among the most moving chapters in 
How We Die. 
No member of his family had 
ever had formal schooling other 
than for religious purposes. “Our 
household valued learning,” he 
recalls, “even though no one had 
any. It was not learning for the sake 
of achievement, but for developing a 
sense of oneself.” To this day, he 
avers, “Knowledge makes me feel 
part of something larger. I have an 
immigrant’s mentality: Nothing is 
ever enough. I’m always in a search 
to understand more.” He remem¬ 
bers well spending each evening 
studying at a folding card table in 
Gifted with a photographic 
memory capable of comprehending 
and retaining large chunks of 
material at a glance (“I studied in 
college by photographing’ pages 
and they stayed in my mind”), he 
came to the Yale School of Medicine 
in 1951, graduating in 1955. He 
remained in New Haven as a 
surgical resident, between 1955 and 
1961, at what was then Grace-New 
Haven and is now Yale-New Haven 
Hospital. He was in the same 
surgical residency group as another 
promising young surgeon, Richard 
Selzer, M.D., and succeeded him as 
chief resident. The following year’s 
surgical residents included Bernie 
Siegel, M.D. The trio remained in 
New Haven as general surgeons and 
at Yale as clinical professors. While 
Dr. Nuland went into practice by 
himself, Drs. Selzer and Siegel 
worked together for 20 years. All 
three crossed paths regularly in the 
operating rooms. 
Each made his mark as a 
surgeon, but together they have 
gone on to something that may be 
unprecedented among American 
surgeons. Although many individual 
physicians have certainly become 
famous writers, never have three 
close surgical associates found fame 
as writers. “It’s unique,” says Dr. 
Selzer, author of several nonfiction 
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books, including Confessions of a 
Knife and, most recently, Raising the 
Dead. “The surgeons of Yale have 
turned out to be writers. Surgeons 
are supposed to be mute as grass, 
and here we are singing arias.” 
All three have now retired from 
active medical practice to devote 
themselves to their writing and 
related activities. 
Each of the three writes in an 
entirely different vein than the 
others. “I don’t think any jealousy 
exists among the three of us,” says 
Dr. Selzer. His work mines the 
literary possibilities in his experi¬ 
ences. “I’m a 19th-century throw¬ 
back,” he says. “I write for the 
language.” With a vast following, 
Dr. Siegel is author of the best¬ 
selling Love, Medicine and Miracles 
and other works aimed at changing 
attitudes in cancer patients as a 
means of curing or helping them to 
cope with their diseases. He also 
heads a national self-help organiza¬ 
tion called ECaP, Exceptional 
Cancer Patients, that supports 
cancer patients and their families in 
bringing changes to their lives. 
“The only one of us who is a literary 
talent is Dick,” says Dr. Nuland, 
who recalls being impressed by Dr. 
Selzer’s command of language even 
when they were residents. “I used to 
poses: one to learn, the other is to 
find out what I think about what 
I’ve learned. Siegel writes to get his 
message out. I’m a little in between 
Siegel and Selzer. There’s something 
in us that makes writing our life’s 
blood at this point.” Adds Dr. 
Selzer: “It was to surgery that we 
bound ourselves, but writing was 
our destiny.” 
That destiny has made them 
public figures, on occasion in open 
conflict with each other. Dr. Siegel 
recalls that Dr. Nuland went on 
Oprah Winfrey’s television talk 
show a decade ago to argue against 
Dr. Siegel’s work with cancer 
patients. “I got criticized,” says 
Dr. Siegel, “for what was seen as 
the guilt, shame and blame I was 
causing.” The Oprah experience 
still resonates with Dr. Siegel, who 
felt his work had been misrepre¬ 
sented. “He doesn’t have a photo¬ 
graphic memory,” he says, “because 
he misquoted me.” He terms 
Dr. Nuland the most intellectual 
and least emotional of the three, 
and suggests that he devote his 
next book “to miracles and things 
you can’t explain.” Despite these 
differences, Dr. Siegel believes 
that the three have grown much 
closer in their outlooks in recent 
years. “The key,” he says, “is 
deal with death is helping people 
to live.” 
While Dr. Nuland may still 
disagree with Dr. Siegel’s ap¬ 
proaches, he has indeed found 
himself, through his medical 
experience, needing to bring wider 
knowledge and understanding about 
the wonders of life. “All of us,” he 
says, “need to be aware that we are a 
magnificent mystery. There is a 
treasure everywhere we look. We can 
study all the embryology we want, 
but every time a kid comes out, it’s a 
brand-new miracle.” 
Dr. Nuland fears that modern 
medicine has, in part, lost sight of 
the humanity of its patients and the 
human spirit he believes essential to 
medical practice. He has written 
articles criticizing the biotechnically 
based and managed-care-induced 
move to apply objective standards of 
evidence to each case. He believes 
this undermines the human essence 
of the doctor-patient relationship. 
He says, “The physician’s art of 
taking a patient’s history and 
developing a sense of who it is 
they’re taking care of is being lost.” 
He asserts that a surgeon should 
grasp the individual wisdom of each 
body being treated. “Basic decisions 
now are coming from secondary 
sources—what the literature says. 
“The surgeons of Yale have turned out to be writers,” says colleague 
Richard Selzer, M.D. “Surgeons are supposed to be mute as grass, and 
here we are singing arias.” 
read Dick’s patient charts just for 
the writing.” Given the rigors of a 
surgical practice, however, none of 
the three began writing seriously 
until reaching his 40s. 
Dr. Nuland explains the varying 
intentions among the remarkable 
threesome: “I write for two pur- 
humanizing education. Selzer 
helped me see my patients as people. 
Out of that came a way of helping 
people. That’s the path we’ve each 
taken now. All three of us feel that 
we can do more with words than 
with a knife.” Dr. Siegel says of 
How We Die, “Helping people to 
Medicine should be about individu¬ 
alization of diagnosis, care and 
follow-up. Objectification under¬ 
mines this.” 
Death and end-of-life issues 
remain an important concern. He 
blames medicine’s ethos for some of 
the great difficulties modern society 
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has in dealing with death. The 
profession’s constant need to 
diagnose and treat mistrusts the 
body’s own wisdom at the end of 
life. “Dying is very hard,’’ he says. 
“However, the dreadfulness of death 
is to a significant extent due to 
attempts to stave it off. At certain 
points we have to step back, and 
death won't he so bad.” 
Dr. Nuland knows death 
intimately. Hoiv We Die begins with 
the drama surrounding the death 
from myocardial infarction—a 
massive heart attack—of his very 
first patient as a medical student at 
Yale, including his own despair 
when his heroic efforts at open-chest 
heart massage failed to revive the 
man. Closing the circle, he brings 
the book to its uneasy conclusion 
with reflections provoked by the 
1989 colon-cancer death in New 
York of his beloved older brother 
Harvey—and memories of their 
mother’s death of the same disease. 
Many readers have experienced an 
anguish similar to Dr. Nuland’s own 
about the questionable medical and 
personal decisions he made to 
extend a battle, on behalf of his 
brother, that he knew could not 
be won. 
It is the humane character of 
Dr. Nuland's own response to his 
brother’s and others’ deaths that has 
led thousands of readers to call or 
write him about the book and their 
own experiences with the deaths of 
loved ones. Three years after the 
book appeared, he continues to hear 
daily from readers. “It has become a 
ministry,” he says. “People just need 
to talk about death." 
The lessons Dr. Nuland takes 
from the life he has led—-and its 
coming end one day in death—is 
that “because of that ending, we 
have a necessity to soak up the 
goodness available to us every day. 
Our lives are sprinkled with sorrow, 
but we transcend those periods. I’ve 
had my sorrows, but somehow 
things roll back." Those who have 
read his books—or been under his 
medical care—know that our ability 
to overcome even our deepest losses, 
too, comes from the wisdom of the 
body. It’s a wisdom to which he has 
devoted a lifetime. YM 
At work in his study, Dr. Nuland is 
reminded by the poster of a lecture he 
gave in China on two successive 
days. ‘At the second, there was standing 
room only and I was very impressed 
with my popularity, ” he says. “ When 
I got home, I asked a friend to translate 
the poster. It says, among other things, 
‘Attendance mandatory. 
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INTERVIEW: ROBERTA HINES, M.D. 
Mission critical 
The field of anesthesiology looks beyond its traditional role in the OR and finds the 
future lies also in intensive care, pain management and, unexpectedly, prevention. 
FRANK POOLE 
Roberta L. Hines, M.D., an energetic and enthusi¬ 
astic champion of anesthesiology, became chair 
of the Department of Anesthesiology at Yale 
School of Medicine and chief of anesthesiology at Yale- 
New Haven Hospital (YNHH) in the fall of 1995. This 
outstanding clinician, educator and clinical investigator 
has seen the field of anesthesiology take a more global 
approach to patient care, expand pain management and 
offer diverse practice opportunities for young men 
and women. 
A New Hampshire native, Dr. Hines came to Yale in 
1978 as a surgical intern after receiving a degree from 
Dartmouth Medical School. Following internship, she 
completed residency training at YNHH in surgery and 
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Previous page: Roberta L. Hines, M.D., in an operating room at Yale-New Haven 
Hospital, leads a department of 72 attending and 76 resident physicians. 
Above: The department opened its pre-admission testing center in 1997, directed 
by Richard Wiklnnd, M.D., to better prepare patients for surgery. The screening 
that takes place there ofien reveals conditions, such as hypertension, that might 
otherwise go undetected and untreated. 
anesthesiology, serving one year as 
chief resident in anesthesiology. She 
joined the Yale faculty as an instruc¬ 
tor in 1982, and in May 1994 she was 
named professor upon her appoint¬ 
ment as acting department chair. 
Dr. Hines’ research interests 
include critical care medicine, right 
ventricular function of the heart, 
cardiovascular and respiratory 
physiology, platelet function, new 
inotropic agents and renal function. 
This work parallels Dr. Hines’ work 
at YNHH, where she has served as 
director of the recovery room, 
cardiothoracic anesthesia and the 
cardiothoracic intensive care unit. 
The department that Dr. Hines 
leads comprises 72 attending and 56 
resident physicians, one physician 
associate and six certified registered 
nurse anesthetists, and provides 
anesthesia services annually for more 
than 30,000 surgical procedures. 
When the section of anesthesiology 
was established as part of the 
Department of Surgery in 1955, 
there were six attending physicians 
and five residents; by 1971 it had 
become a department. 
Dr. Hines spoke recently with 
Helaine Patterson, director of 
the Office of Public Information. 
A portion ol their conversation 
follows. 
WHAT CHALLENGES ARE FACING 
ANESTHESIOLOGY TODAY? 
Anesthesiology is at a critical point 
in its identity as a specialty. Tradi¬ 
tionally, we have identified our role 
as intraoperative physicians. We’ve 
spent so much time in the operating 
room—obviously important—in 
reducing overall operative mortality 
and allowing surgical subspecialties 
to develop. That’s the good news. 
But the downside is that the 
specialty’s growth has been ham¬ 
pered by the fact that we were not 
really known by many other special¬ 
ists except surgeons, so the full 
breadth and the intensity of what we 
do has not been appreciated by 
internists and pediatricians. Only 
within the last 10 years—when 
many of us have begun to look 
outside the operating room for new 
avenues to expand anesthesiology— 
have other medical specialties and 
the population, in general, begun to 
appreciate what we do. The classic 
line, put people to sleep, has become 
a very small part of what we do. 
We are, in a true sense, 
intensivists, caring lor severely ill 
patients, managing multisystem 
diseases and relieving pain. Most 
people don’t understand the other 
aspects of anesthesiologists’ work. 
Much of what we do outside the 
operating room has just begun to 
become focused, particularly in pain 
management, intensive care and 
pre-admission testing. Many 
anesthesiologists also are taking a 
more primary care role. That’s going 
to raise people’s eyebrows, and 
they’re going to say, “What is 
someone who’s really in tertiary care 
doing giving primary care to the 
sickest patients?” 
WHAT, IN FACT, ARE 
ANESTHESIOLOGISTS DOING IN 
PRIMARY CARE? 
This developed as more and more 
of our patients—more than 40 
percent—are coming into the 
hospital either the day or morning 
of surgery. It became clear that we 
couldn’t see patients who are ill or 
have multisystem organ disease at 
6 o’clock in the morning and have 
them appropriately prepared by 
7:30 a.m. for their surgery. As a 
specialty, we said that’s unaccept¬ 
able. We couldn’t understand 
people’s medical conditions and get 
them optimized, so the field of 
preoperative testing and evaluation 
developed. 
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In October 1995, we opened our 
anesthesia pre-admission testing 
center with the premise that we 
would want to see everyone, doing 
thorough history and physical 
examinations, reviewing the appro¬ 
priateness of laboratory evaluations, 
and optimizing their care in a 
prospective fashion—seeing patients 
seven to 10 days before surgery so 
they could come back at 6:30 a.m. 
and have their surgery at 7:30 a.m. 
the same day. 
In assuming that role, we’ve 
taken a much more primary care 
role. We’re now identifying people’s 
primary hypertension—diseases that 
people didn’t know they had. Many 
of these people didn’t have a primary 
care physician. A case in point: A 
67-year-old gentleman who didn’t 
go to the doctor regularly was 
referred by a surgeon for hernia 
repair. We were the first people to 
identify that patient’s profound 
diastolic hypertension and to 
control blood pressure with the aid 
of our cardiologist. We not only 
lessened the likelihood of adverse 
events occurring during the proce- 
“We’re now 
identifying 
people’s primary 
hypertension— 
diseases that people 
didn’t know they 
had. Many of these 
people didn’t have 
a primary care 
physician.” 
dure, but we also impacted his 
longevity and other factors by 
identifying a fairly significant 
cardiovascular risk factor that no 
one ever knew he had. 
WITH THE ADVENT OF 
LAPAROSCOPIC SURGERY, DO 
ANESTHESIOLOGISTS HAVE A 
NEW OR DIFFERENT ROLE? 
The role is not really different, 
but again it’s a challenge. When 
laparoscopic surgery began, we 
thought that patients were going to 
do better because the surgery was 
less invasive and that they would go 
home sooner. The patients would 
come in, be healthy, have their 
gallbladders taken out laparo- 
scopically, and go home. We’ve 
begun to realize that our surgeons 
are getting so proficient with 
laparoscopic procedures that we re 
no longer seeing just healthy 
patients. Were seeing sicker patients 
for laparoscopy, and we re beginning 
to realize that, just like before, the 
surgical procedure may simplify 
some aspects of anesthetic manage¬ 
ment. Dealing with patients with 
advanced medical conditions, our 
role is much greater in maintaining 
those patients in an optimal state 
for the surgeons to do their proce¬ 
dures, because special physiologic 
derangements occur with laparo¬ 
scopic surgery that aren’t a major 
concern in healthy patients. In sick 
patients, particularly those with 
cardiovascular disease, they can be 
quite profound. 
SHIFTING AWAY FROM CLINICAL 
PRACTICES IN ANESTHESIOLOGY, 
PLEASE DESCRIBE CURRENT 
CLINICAL RESEARCH IN 
ANESTHESIOLOGY AT YALE. 
One of the hottest areas is appropri¬ 
ate testing for patients undergoing 
surgical procedures, and how to 
optimally match testing with the 
procedures. Part of the interest has 
been cost-motivated, and we now 
do things in a more structured 
fashion. Ongoing research here 
specifically has looked at tests a 
particular patient would need for a 
particular surgery. Does every 
patient need an electrocardiogram 
(EKG)? Does that affect outcome? 
We’ve recently revised our 
policy. We’ve been able to show that 
a large group of patients don’t need 
routine bloodwork or routine 
electrocardiograms. Basically, people 
thought it was heresy to discard 
those practices, but we’ve been able 
to show that there’s no increase in 
anesthetic complications if appropri¬ 
ate guidelines are followed. 
Similarly, we’re looking at other 
laboratory tests and more specifi¬ 
cally matching them with outcomes 
in patient diseases and, therefore, 
taking an epidemiological ap¬ 
proach—once again, working in an 
area where anesthesiologists tradi¬ 
tionally would not. We’re making 
choices every day with testing 
modalities, and we’re repeating them 
in a more structured, systematic, 
research approach based upon 
patients’ histories, exercise tolerance 
and other disease states, particularly 
emphasizing patients with cardiovas¬ 
cular disease. Does everybody who 
has angina need a stress test? Does 
everybody need invasive testing to 
evaluate cardiac disease before 
coming for surgery? We clearly 
know that’s not true, and we can 
stratify those patients who then 
need to move on to catheterization 
or certain medications versus those 
who could be taken to the operating 
room on their already-charted 
medical management. We’ve made 
decision trees based upon ongoing 
epidemiological work. 
The other area akin to pre¬ 
admission testing is in pediatrics, 
where controversy has focused on 
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parental presence during pediatric 
anesthesia and anxiety-related issues 
with parental presence. Zeev Kain, 
M.D., director of pediatric anesthe¬ 
siology, has been working with 
Linda C. Mayes, M.D., in the Child 
Study Center, on a battery of issues 
related to preoperative anxiety and 
ways to reduce it in parents and 
children. Dr. Kain published data 
showing that parental presence may 
not always be good during pediatric 
inductions—a conclusion that, once 
again, has forced us to evaluate our 
old norms. The old school of 
thought was that parents would 
quiet their children. He’s shown in 
children less than four years of age 
that the presence of parents— 
particularly if the parents are 
anxious—actually increased the 
need for anesthetic agent and 
increased anxiety during awakening. 
His ideas are interesting and clearly 
controversial. Most children’s 
hospitals like to say that parents can 
be present, and clearly we do at Yale, 
but situations may arise where 
having parents present is not best 
for their children. Having child 
psychiatry involved in anesthesiol¬ 
ogy is another area one wouldn’t 
have imagined, historically. 
IN WHAT OTHER AREAS ARE 
YALE ANESTHESIOLOGISTS 
CONDUCTING CLINICAL 
RESEARCH? 
We are very active in cardiac 
anesthesia because that parallels our 
clinical activities. We re a leading 
center in cardiac surgery, which 
extends itself into anesthesia. Were 
one of a handful of centers around 
the country that routinely does 
intraoperative transesophageal 
echocardiography. This is an 
advanced method of imaging the 
heart while surgery is actually taking 
place. We have taken the same 
principles and technology that 
“Without Luke 
Kitahatas discovery 
... pain management 
as we know it today 
would not exist.” 
cardiologists use to evaluate cardiac 
function and brought that into the 
operating room. This provides 
instantaneous appreciation of what 
cardiac performance is during 
cardiac surgery and helps our 
surgical colleagues judge the 
adequacy of their valve replacement. 
Does the patient need a replace¬ 
ment? Can he or she have a repair? 
We work with them in a close 
relationship to formulate their 
surgical plan and give them an idea 
of how successful they can expect it 
to be. It’s a more sensitive indicator 
that a patient is having problems 
during cardiac surgery based upon 
information we get from this 
monitor than we’ve ever had before. 
That’s clearly innovative, and we 
were actually the first anesthesia 
department in the country to report 
on the use of this modality in the 
operating room. Paul G. Barash, 
M.D., professor of anesthesiology, 
reported that work in 1984, and we 
now use it for all adult cardiac cases. 
WHAT’S HAPPENING IN BASIC 
RESEARCH? 
Luke M. Kitahata, M.D., the 
professor of anesthesiology who 
founded Yale’s pain center, contin¬ 
ues to be an international leader in 
spinal opiate receptors and research 
in pain management. He is world- 
renowned for being one of the first 
investigators to come up with the 
notion that we could take medicines 
that we traditionally used, like 
morphine and other opiates, and 
put them in the spinal cord directly 
to affect it. At a much lower dose, 
these medicines have exquisite and 
sensitive pain relief. Dr. Kitahata’s 
basic science work led to the entire 
field of patient-controlled analgesia 
using opiates and epidural opiates. 
Without his discovery that anesthe¬ 
siologists can put opiates in the 
central nervous system, reduce the 
amount given to patients, and 
thereby reduce the potential for side 
effects of respiratory depression, 
urinary retention, nausea, vomiting 
and other negatives, pain manage¬ 
ment as we know it today would 
not exist. 
IS PAIN MANAGEMENT ALSO 
MOVING FROM THE OPERATING 
ROOM AND POST-OPERATIVE 
CARE INTO OTHER AREAS OF 
PATIENT CARE? 
Pain management has divided itself 
into two factions. Acute pain 
management focuses more on the 
time of surgery and deals with the 
pain in surgical incisions and related 
issues. The second area takes a 
multidisciplinary center approach to 
manage chronic pain syndromes, 
such as reflex sympathetic dystrophy 
(a chronic syndrome that occurs 
following work-related injuries or 
trauma) and low-back pain. 
Our Center for Pain Manage¬ 
ment, located at Temple Medical 
Center in New Haven, has physi¬ 
cians from neurology and psychia¬ 
try, psychologists, as well as anesthe¬ 
siologists who have special creden¬ 
tials in pain management. Here, 
we diagnose the patients’ pain. 
But because many chronic pain 
syndromes are difficult to diagnose 
from a traditional view, we are 
looking at new modalities specifi¬ 
cally to help diagnose more 
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complex pain processes, and then, 
secondarily, look at new ways to 
treat them, maybe even non- 
pharmacologically. 
Lloyd Saberski, M.D., associate 
clinical professor of anesthesiology, 
performs a procedure called 
epiduroscopy. With this procedure, 
new and innovative diagnostic 
techniques for the management of 
back pain have been developed. In 
addition, he and his colleagues are 
looking at whether certain syn¬ 
dromes previously thought to affect 
only peripheral nerves may have a 
central etiology. With pain syn¬ 
dromes, particularly in the extremi¬ 
ties, many people have thought 
they couldn’t possibly be mediated 
by something going on in the 
central nervous system, and that it 
had to be at that specific location. 
As we know, low-back pain has 
been very difficult to treat by 
surgery and traditional pain man¬ 
agement. In spite of surgery and 
narcotics, the patient may not get 
much symptomatic relief. Anatomi¬ 
cally, the surgeon goes in, takes out 
the disc, and things look like they 
ought to be fine. But the patient still 
has incapacitating pain, can't go 
back to work, has weakness in his or 
her legs or other problems. It may 
be that, indeed, more than the 
anatomical component is occurring. 
These are the patients that may 
benefit from epiduroscopy. 
“Pain, ”says Dr. Hines, “is still the 
largest black box. ’’Above she consults 
with Lloyd Saberski, M.D., a faculty 
member at the department’s Center for 
Pain Management, where clinical 
research is helping to uncover the 
sometimes-mysterious pathology 
behind symptoms. 
Pain management, in the 
sophisticated sense as we know it, 
has developed within the last io 
years. Pain is the area that, I 
think, is still the largest black box. 
We’ve been traditionally focused on 
treating the symptoms, making 
patients feel better. Now were 
taking a step back to examine the 
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real pathology causing this pain 
and to understand the complex 
mechanisms eliciting pain in order 
to interrupt those pathways. 
WITH THE POPULATION AGING 
AND BABY BOOMERS TURNING 50, 
SURGERY IS BEING PERFORMED AT 
A LATER AGE. IS THIS PRESENTING 
MORE CHALLENGES AND RISKS 
FOR ANESTHESIOLOGY? 
It clearly is. Because of patients’ 
ages, they get significant cardiovas¬ 
cular disease. Even patients who 
aren’t coming for cardiovascular 
surgery present an issue because 
they have to be managed as if they 
have significant cardiac disease, and 
it changes our approach to inter¬ 
operative management and moni¬ 
toring them. That also has been part 
of the impetus for us to see these 
patients earlier in our pre-admission 
testing center to make sure their 
underlying cardiac conditions, high 
blood pressure, diabetes or other 
factors are well under control. 
One of the newest areas of interest, 
as you can imagine, is geriatrics in 
anesthesiology because patients over 
70 present some unusual problems, 
such as greater risk for hypothermia 
and a decreased ability to metabo¬ 
lize drugs. 
WHO WILL TREAT THESE PATIENTS 
AND OTHERS? WHAT IS THE 
PHYSICIAN SUPPLY IN 
ANESTHESIOLOGY? WHO’S 
INTERESTED? ARE MORE WOMEN 
ENTERING THE FIELD? 
I should preface this by saying that 
you’re obviously getting one 
woman’s opinion: I’m very optimis¬ 
tic, but not all my colleagues share 
my optimism. The data shows that 
we have been training too many 
physicians and too many anesthesi¬ 
ologists in general. We have finally 
recognized that and taken good 
steps toward bringing the profes¬ 
sional pendulum back. Moving 
into a much more perioperative 
approach clearly has helped. If we 
traditionally were going to keep our 
focus in the operating room, the 
number and kind of physicians 
that we train would be very differ¬ 
ent from sending people out into 
the intensive care units, pain 
centers and pre-admission testing 
centers. Since the specialty has 
evolved and grown, it has aided that 
supply situation. We’re putting 
different kinds of people into the 
specialty and helping with issues of 
resident training. 
Zeev Kain, M.D., left, and colleagues 
have found evidence that questions some 
long-held beliefs about children 
undergoing surgery. In some cases, 
especially among children younger than 
four years, parental presence may 
increase the child’s anxiety before and 
after surgery and increase the need for 
anesthetic agent. 
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We do not need to train 1,400 
anesthesiologists every year, which is 
the number we’ve been training 
nationally for several years. Realisti¬ 
cally, we need to train between 800 
and 900 per year, and the model is 
set that people are going to move 
out of the operating room and into 
perioperative management, pain 
management or ICU as part of their 
practice techniques. 
I also see a different outlook 
for people entering the field. Their 
interests are much broader. They 
possess an eager sense to look at all 
aspects of patient management, not 
just traditional anesthesia in the 
operating room. They have greater 
interest in basic science and under¬ 
standing the modalities of pain 
management. We’re seeing a differ¬ 
ent kind of individual coming into 
anesthesia, one with more diversi¬ 
fied interests. They still have a keen 
interest in clinical anesthesia, but 
now clinical anesthesia with some¬ 
thing added—that little bit of basic 
science, pain management or ICU 
care. This is positive and will help us 
develop into multidisciplinary 
practice, where we’ve been for many 
years in the operating room. Now 
we’re multidisciplinary out of the 
operating room. 
I’m very, very optimistic. 
Applications from people interested 
in anesthesia last year are beginning 
to take an upswing. We’ve done a 
good job of marketing ourselves and 
letting people know that things are 
not the doom and gloom that were 
painted a few years ago. We are 
seeing a more diverse group of 
people interested in the specialty, 
particularly with women coming in. 
WHY ARE MORE WOMEN 
ENTERING THE FIELD? 
The major reason has been the 
increased visibility of female role 
models in academic anesthesia. 
This, combined with the specialty’s 
multidisciplinary nature, allows a 
great deal of career flexibility. 
Opportunities exist to combine 
conventional kinds of practice with 
the newer, expanded areas of the 
specialty. A person can tailor 
practice, spending 50 percent of 
his or her time in the operating 
room and the other 50 percent 
in ICU or in pain management. 
It also provides an opportunity 
to develop a practice that utilizes 
all aspects of one’s medical and 
surgical expertise. 
IS MANAGED CARE HAVING 
A MAJOR IMPACT ON 
ANESTHESIOLOGY? 
In the operating room, we are being 
forced to practice in a more effi¬ 
ciency-based model. The major 
impact is on activities outside of the 
operating room. We no longer are 
getting reimbursed at the same level 
for pain management, pre-admis¬ 
sion testing and intensive care work. 
IT SEEMS, THOUGH, THAT THE 
PROFESSION IS SHOWING THAT 
THESE ACTIVITIES ARE EXTREMELY 
VALUABLE. 
They’re phenomenally valuable, but 
the insurers don’t always see things 
as we do in terms of value-added. 
One of the difficult situations that 
we re facing is that we’re getting 
paid less for those outside-of-the- 
operating-room activities. Just at the 
time when we’re blossoming outside 
of the OR, people want us to return 
to the OR, or at least they’re telling 
us that they’re not going to pay us 
for activities that we do outside of 
the OR. That’s a real challenge for 
the department, which is commit¬ 
ted to maintaining those outside 
activities. We’re not going to 
retrench into the OR only, so one of 
the most difficult juggling matches 
for me is how we can maintain our 
academic presence outside of the 
OR in a fiscally responsible way. 
LAST OCTOBER, ANESTHESIA 
CELEBRATED THE 150th 
ANNIVERSARY OF THE FIRST USE 
OF ETHER. COULD YOU PROJECT 
WHAT ANESTHESIA MAY BE LIKE IN 
THE FUTURE? 
In pain management, we’re clearly 
going to see great development, 
both in finding the mechanisms for 
some pain syndromes and in 
identifying the mechanisms and 
developing specific and sophisti¬ 
cated ways to treat them. More 
specific modalities, pharmacologi¬ 
cally, may not have any pain relief 
properties per se, but they may 
prevent the transmission of the 
painful stimulus, offering an 
entirely new approach to pain 
management. 
OTHER ADVANCES? 
The other area where we re going to 
have a great impact as anesthesiolo¬ 
gists is in patient outcome following 
surgery. We’ve already had a dra¬ 
matic impact in reducing death 
during surgery, but what we haven’t 
done as well as we will over the next 
few years is in looking at much 
more specific endpoints. With the 
physiological work going on in our 
perioperative group, we will be able 
to treat more specifically renal 
dysfunction and mesenteric dys¬ 
function, some of those more 
specific end-organ problems that we 
haven’t been able to focus our 
attention on. 
I see us getting much more 
directed and pre-emptive. In the 
past we’ve said, “This is a problem, 
let’s work at treating the problem 
when the patient has it.’’ Now we’re 
saying we’ve done that very well. We 
need to look at the mechanisms for 
YALE MEDICINE 35 
these problems and prevent them 
from happening. I see us taking a 
much more basic and scientific 
approach to some modalities. 
I also think that we’re going to 
see in the near future that very 
healthy patients probably aren’t 
going to come into hospitals any 
more for their anesthesia. There is 
an increasing interest in the mode 
of office-based anesthesia. The 
geography of where we provide 
anesthesia, I believe, is going to 
change, and people who practice in 
hospital settings are going to be 
treating sicker and sicker patients, 
with more complex and sophisti¬ 
cated disease processes. 
WILL A NEW FIELD OF 
AMBULATORY ANESTHESIOLOGY 
EVOLVE? 
Not a new field, but an expansion 
and diversification of our present 
role. This is best demonstrated by 
looking at the areas outside of the 
traditional operating room setting 
where anesthesia is being per¬ 
formed. Such areas include: radiol¬ 
ogy, radiation therapy and 
electroconvulsant therapy. People 
are actively looking at whether we 
can safely give anesthesia for 
arthroscopy in physicians’ offices. 
Does everyone who comes for an 
arthroscopy have to come into the 
hospital? That may not be the case. 
Similarly, can we provide some 
gynecological anesthesia in the 
office for in vitro fertilization, or do 
patients have to come into the 
hospital OR? We re just begin¬ 
ning—with the epidemiological 
evidence that we’ve gotten with 
outcome studies in our pre-admis¬ 
sion testing area—to see whether we 
can safely perform anesthesia in 
nonhospital locations. That will be 
the issue. 
My concern is that managed 
care will want us to do that because 
“I m very, very 
optimistic. We’ve 
done a good job of 
marketing ourselves 
and letting people 
know that things 
are not the doom 
and gloom that 
were painted a 
few years ago.” 
it’s less expensive. But, as physicians, 
we will have to be the patients’ 
advocates. We need to get that data 
and assess whether it really is as safe 
to give anesthesia for arthroscopy in 
the office as it is to give it in an out¬ 
patient anesthesia facility with a 
recovery area and nurses trained to 
monitor those patients. As we move 
outside of traditional operating- 
room anesthesia, we have to take 
what we’ve learned and see whether 
it can be modified appropriately. 
These principles clearly can’t be 
abandoned. 
My concern is that people are 
going to say that just because 
anesthesiologists are not in the 
operating room, we don’t need to do 
all the things that we’ve learned over 
the last 150 years. That challenge will 
provide us with our next opportu¬ 
nity to demonstrate our excellence 
and commitment to patient care. YM 
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Through the past, darkly 
Lessons from an earlier American drug epidemic show hyperbole, not fact, 
often dominates public discourse. 
By Michael Fitzsousa 
Photographs by Harold Shapiro 
In the early 1970s, medical historian David F. Musto, 
M.D., MA ’6i, HS ’64-67, charted new territory 
with his book The American Disease, a history of 
illegal drug use in the United States that toppled as¬ 
sumptions about substance abuse, law and public policy. 
It would be a decade before the next major book on the 
topic was published, and more than 20 years before the 
number of researchers in the field would grow large 
enough to warrant a major conference. 
That moment came last fall, when 15 scholars from 
around the nation gathered in New Haven for Historical 
Perspectives on the Use and Abuse of Illicit Drugs in the 
United States. Chaired by Dr. Musto, professor of child 
psychiatry and of the history of medicine at Yale, the 
meeting brought together senior scholars David F 
Courtwright, Ph.D., author of the 1982 book Dark 
Paradise; Peter Bourne, M.D., drug czar under President 
Carter and author of a recent Carter biography; John C. 
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Learning the rules of political football 
iter G. Bourne, M.D., witnessed 
the collision of drugs and politics 
first-hand as director of the U.S. 
Office of Drug Abuse Policy during 
the Carter years. First recruited by 
then-Georgia Gov. Jimmy Carter 
while on the psychiatry faculty at 
Emory University, Dr. Bourne quickly 
learned just how crucial a savvy 
understanding of politics is to 
making progress in drug policy. 
At the Yale conference last 
October, he told a story illustrating 
this point. “I started off with the 
rather naive view that, if you had 
access to the president, you could 
do whatever you wanted,” said Dr. 
Bourne, author of Jimmy Carter: A 
Comprehensive Biography from 
Plains to Post-Presidency, published 
in February. But he recalled one 
early meeting between President 
Carter and California state Sen. 
(and ’60s radical) Tom Hayden, in 
which Mr. Hayden steadily berated 
the president for failure to exert 
more power over corporations. 
"Carter finally said, ‘Listen, I’m 
just the President of the United 
States. I don’t have that much 
power!”’ Dr. Bourne recalled, 
smiling. “And I thought, if the 
president does not have the power 
to achieve what he wants, how 
can I? ... If you can’t propose things 
that will draw support, or at least 
co-opt the opposition, you really 
don’t get anywhere.” He concluded 
that one of the greatest obstacles 
was the entrenched interests of 
career administrators. “The sub¬ 
stance of the issue was really very 
secondary to their goal of building 
political power,” said Dr. Bourne. 
“For example, I thought the DEA 
[Drug Enforcement Agency] would be 
overjoyed to see declining rates of 
overdose mortality, but that was the 
last thing they wanted. They wanted 
the threat to grow and grow and 
grow so their budget would grow 
and grow and grow.” 
But even that explanation can 
be elaborated upon. Dr. Musto 
recalled that while interviewing Harry 
J. Anslinger, the federal narcotics 
commissioner from 1930 to 1962, 
he asked why the Narcotics Bureau 
never used social scientists to 
estimate the number of addicts. 
Mr. Anslinger replied that that 
number was “dynamite” and the 
Bureau was not about to let its 
estimation escape control. "If the 
number went up, we weren’t doing 
our job,” Mr. Anslinger said, “and if 
it went down, our budget was in 
danger.” As a result, Dr. Musto 
concluded, many of the estimates 
in the Anslinger era remained 
remarkably stable. 
When he was named drug czar under President Jimmy Carter, Peter Bourne, M.D., 
thought that anything was possible. He quickly learned how politics interfered with 
discussion of the substance of issues. 
“[Declining overdose 
mortality] was the 
last thing they 
wanted. They wanted 
the threat to grow 
and grow and grow 
so their budget 
would grow and 
grow and grow.” 
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Burnham, Ph.D., professor of 
history ar Ohio Srare University; 
and Ruth C. Engs, Ed.D., professor 
of applied health science at Indiana 
University. A dozen more historians 
delivered papers on topics ranging 
from Captain Hobsons Horror Stones 
to Women and Addiction in the 
United States to Opiate Use in the 
Jazz Age. 
Drug abuse has been a powerful 
political issue in the U.S. for more 
than ioo years, and several of the 
conference presenters described the 
remarkable rhetoric used at both 
ends of the spectrum for political 
gain. “For many people,’ says Dr. 
Musto, “there is no sense of history 
about drugs; many are not aware 
that this is our second drug epi¬ 
demic this century.” (The first one 
Michael Fitzsousa is the editor of 
Yale Medicine. 
peaked between the years 1900 and 
1920 and produced the Harrison Act 
of 1914, restricting what had been an 
open trade in opiates and cocaine.) 
Joseph Spillane, Ph.D., assistant 
professor of history at the University 
of Florida, oudined this early period 
in his paper on Cocaine Before 
Prohibition: Patterns of Use in the 
United States 1880-1915. Jill Jonnes, 
Ph.D., a journalist and the author 
of Hep Cats, Narcs, and Pipe Dreams: 
A History of America's Romance with 
Illegal Drugs, detailed the spread of 
drug culture in post-World War II 
Baltimore. 
In both these periods, as in the 
more recent past, law enforcement 
agencies have sought greater author¬ 
ity to control drugs. At times, they 
consolidated power by exaggerating 
the dangers of illicit drug use, Dr. 
Musto and his colleagues argue. 
“The talk hasn’t changed much since 
Ruth Engs, Ph.D., of Indiana 
University, has proposed that there are 
recurrent cycles of “clean living” 
movements in the United States that 
especially target drugs and alcohol. 
Page 37: David F. Musto, M.D., 
moderated discussion among 15 scholars 
from across the United States. 
the 1920s,” Susan L. Speaker, Ph.D., 
of Bucknell University said during 
her account of the crusade of Capt. 
Richmond P. Hobson, who drew 
much of his own anti-narcotics 
rhetoric from the temperance 
movement of the 19th century. On 
the other side of the debate, advo¬ 
cates of a more lenient drug polity 
also have favored hyperbole over 
scientific and historical accuracy. 
“The historian is often caught 
in the middle,” Dr. Musto says. 
“Trvins; to be accurate makes both J O 
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Scholars met in the 
Beaumont Room to 
present papers and 
discuss the history of 
illicit drug use in the 
United States, a field 
that began two 
decades ago with the 
publication of Dr. 
Musto’s The American 
Disease. 
sides uneasy. Neither can under¬ 
stand why, after studying it for so 
many years, you don't agree with 
their side. There’s a religious inten¬ 
sity in the polarization that occurs 
over drug policy.” 
In uncovering primary source 
material, drug-policy historians have 
demonstrated that: 
► The power of laws to control 
drug use has been more modest than 
had been assumed in the decades 
before the 1960s. 
► The use of illicit drugs has 
had great swings, with the peaks and 
valleys relatively far apart. The 
period from one low point to the 
next may be a lifetime. 
► Widespread use of a drug 
can fall dramatically ii it is perceived 
to be dangerous. 
► Americans oscillate from 
viewing illicit drugs as a useful tool 
for self-realization to seeing them as 
so dangerous that any use would 
reduce one’s full potential. “The 
underlying theme,” Dr. Musto says, 
“is maximizing one’s individual 
“There’s a religious 
intensity in the 
polarization that 
occurs over drug 
policy.” 
potential, either by using drugs 
or abstaining.” 
► Drug use is viewed as an 
epidemic especially when the 
middle class is affected. On the 
other hand, drug use frequently has 
had a false or exaggerated link with 
ethnic minorities, “and this link 
intensifies the punishments man¬ 
dated by laws.” 
A second conference is planned 
for 1998 to further encourage 
collaboration among researchers in 
this growing discipline. (The 1996 
conference was sponsored by the 
Section of the History of Medicine, 
the Yale Child Study Center and 
the National Institute on Drug 
Abuse.) “It’s just beginning as a 
field. These [scholars] delve into 
areas where there’s no one else to 
talk to among most history facul¬ 
ties,” says Dr. Musto. “It has been 
good to facilitate this kind of 
contact and cooperation." 
For those who came to New 
Haven, the conference was a chance 
to meet the pioneer scholars of the 
field. Dr. Courtwright, whose 
Dark Paradise was the second book 
published on the topic, said Dr. 
Musto was “the first person to go 
into the archives, look at the 
evidence using primary sources and 
write a balanced account of U.S. 
drug policy.” Added Dr. Burnham: 
“This conference is a tribute to 
David Musto and his work." YM 
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GALLERY 
An earlier epidemic 
For Americans born 
after World War I, 
it may come as a 
surprise that the experi¬ 
ence with now-illicit 
drugs is rooted further 
back in history than the 
psychedelic 1960s or even 
the 1950s heroin epidemic 
of Claude Brown’s 
Manchild in the Promised 
Land. Turn-of-the- 
century advertisements 
show the public’s early 
embrace of narcotics, 
including heroin and 
cocaine; portraits of anti¬ 
drug crusaders give a 
human face to the harsh 
rhetoric of temperance 
and punitive movements 
against drug use. 
Source: David F. Musto, M.D. 
Above: Capt. Richmond Pearson Hobson, a naval hero of the 
Spanish-American War, campaigned against alcohol until the 
success of Prohibition, and then turned his energies against 
heroin and later marijuana. 
B H V e R ' 
PHARMACEUTICAL PRODUCTS. I 
Wr arc turn- wilding to Physicians through- | 
(Mil flu- United States literature and sam- ; 
ASPIRIN 
The substitute for the Salicylate-, ugreea- 
ble of taste, free from unpleasant after¬ 
effects. 
HEROIN 
The Sedative tor Coughs, 
HEROIN HYDROCHLORIDE 
Its water-soluble salt, J 
You will have call for them. Crier 
a supply from your jotber. 
FARBEHFABRIKEN OF ELBERFELD CO. 
40 Stone Street, New York, 
Heroin and Aspirin were 
trademarks of the Bayer Co., 
which introduced the drugs 
to the medical profession in 
1898 and 1899, respectively. 
Ownership of the names 
was lost in the afiermath 
of World War I. 
In 1889, coca wine was 
recommended for baseball 
players and other athletes. 
The most popular coca wine, 
vin Mariani, offered a discount 
to clergy and orphanages. 
Above: Harry J. Anslinger, head of the Federal Bureau 
of Narcotics for three decades, testifying before Congress 
in the early 1960s. He had a profound faith in the 
deterrent effect severe penalties had upon drug use. 
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SCOPE 
Neurosurgery 
becomes a department 
Dennis Spencer named first 
chairman and chiefi The School of Medicine and Yale-New Haven 
Hospital (YNHH) have established a Depart¬ 
ment of Neurosurgery and named Dennis D. 
Spencer, M.D., to be the first leader of this free-standing 
department. Neurosurgery previously had been a section 
within the Department of Surgery. 
Dr. Spencer, also the Harvey and Kate Cushing 
Professor of Neurosurgery at Yale and an attending 
surgeon at YNHH, is internationally known for the 
surgical treatment of neurological diseases causing 
medically intractable epilepsy. 
I he new department’s program encompasses 
epilepsy surgery, neuro-oncology, neuropsychology, 
neurovascular surgery, pediatric neurosurgery, stereotac¬ 
tic radiosurgery, and stereotactic and functional neuro¬ 
surgery. The Functional Imaging/Neuropsychology 
Laboratory supports many of these activities. 
Dr. Spencer envisions that in future years neurosur¬ 
gery at Yale will provide an environment in which basic 
discovery remains the driving force, increasingly high 
standards of patient care will be the expected outcome, 
and the highest quality of education will result. “As our 
laculty neurosurgeons and surgeons-in-training deliver 
increasingly complex treatments for patients with many 
neurological diseases, they will combine clinical and 
basic science experience to provide a unique appreciation 
and understanding of the human nervous system and its 
disorders,” the new chair/chief predicts. 
Neurosurgery at Yale was organized in 1918 under 
Drs. Samuel Harvey and William German. Both men 
trained under Dr. Harvey Cushing, considered to be the 
father of American neurosurgery. In 1934, Dr. Cushing 
and Dr. Louise Eisenhardt, a longtime collaborator in 
neuropathology, came to Yale, which was developing a 
strong tradition in surgery of the nervous system. Later 
in the decade, Dr. Cushing, with two other colleagues, 
established the Medical Historical Library. 
Neurosurgery continued 
to expand at Yale, and during 
the 1940s a three-year train¬ 
ing program was formalized 
at the New Haven Hospital. 
Dr. John Fulton, a Yale 
neurophysiologist, conceived 
the idea of a journal and in 
1944 he published the first 
issue of the Journal of Neuro¬ 
surgery with Dr. Eisenhardt 
as editor. 
Dr. Spencer became head of neurosurgery in 1987, 
replacing Dr. William F. Collins, chief from 1967, who 
had become chairman of the Department of Surgery in 
1985. Dr. Spencer developed a widely used surgical 
approach for patients with temporal lobe epilepsy and, 
together with D. Eugene Redmond, Jr., M.D., Yale 
prolessor of psychiatry, pioneered stereotactic cellular 
replacement therapy for patients with Parkinson’s disease. 
Dr. Spencer also directs the surgical component of 
the comprehensive Yale Epilepsy Program, in which 
faculty and fellows conduct research, train surgeons and 
other health professionals, and treat patients from 
throughout the world. The interdisciplinary epilepsy 
program embraces neurosurgery, neurology, neuropsy¬ 
chology, psychiatry, social work and neuroradiology. 
Dr. Spencer has centered his own research on the 
neurobiologic study of human tissue involved in epilepsy. 
In this work, he and his colleagues have employed in 
vivo and in vitro electrophysiology, microdialysis, 
confocal ana electron microscopy studies, molecular 
biology and magnetic resonance spectroscopy to examine 
brain tissue removed during surgery. Laboratory discov¬ 
eries have helped to define the pathogenesis of human 
epilepsy and to place basic research into the context of 
human disease. 
A native of Iowa, Dr. Spencer received a B.S. degree 
in 1967 from Grinnell College in Iowa, a B.M.S. degree 
in 1969 from the University of South Dakota Medical 
School, and an M.D. degree in 1971 from the Washing¬ 
ton University School of Medicine. He completed his 
six-year neurosurgery residency training and his fellow¬ 
ship at Yale in 1977, the same year he joined the Yale 
medical school faculty and YNHH medical staff. 
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Routine care and oral 
medication reduce spread 
of HIV to infants 
Pregnant women who are infected 
with the AIDS-causing virus may 
dramatically reduce the rate of 
transmission of the virus to their 
unborn infants if they receive 
routine obstetrical care and take the 
medication zidovudine orally during 
their pregnancy, according to Yale 
University School of Medicine 
researchers. 
The Yale findings, reported in 
the Journal of Acquired Immune 
Deficiency Syndromes and Human 
Retrovirology, represent a different 
way of counseling, testing and 
treating pregnant women who are 
infected with the human immuno¬ 
deficiency virus (HIV) causing AIDS, 
says Warren A. Andiman, M.D., 
HS ’76, professor of pediatrics. 
From 1990 to 1993, a total of 
267 infants were born to 245 HIV- 
infected mothers who were treated 
at Yale-New Haven Hospital’s high- 
risk obstetrical unit during their 
pregnancy with the medication 
zidovudine (AZT). The rate of HIV 
infection transmitted from the 
mothers to their babies was reduced 
from 19 percent to 5 percent, Dr. 
Andiman says. 
The study is one of a handful of 
U.S. studies that have begun to 
show this same phenomenon, notes 
Dr. Andiman. “Our results are more 
robust because all of the data were 
collected at a single institution, 
where delivery of care was uniform.” 
The study bolsters efforts “to 
encourage widespread, perhaps 
universal, education and counseling 
about HIV infection,” Dr. Andiman 
concludes. “All women of childbear¬ 
ing age need to be offered an oppor¬ 
tunity to be tested for HIV. Those 
found to be infected should then be 
offered treatment with AZT.” 
The research also contains 
tremendous implications in prevent¬ 
ing the transmission of HIV from 
mothers to children. This approach 
is especially significant for pregnant 
women in developing countries, 
where neither financial resources nor 
the technical sophistication exists to 
undertake a rigorous program of 
administering intravenous medica¬ 
tions during labor and delivery. 
Oral AZT costs approximately 
$1.50 per pill, so five 100 mg pills a 
day would cost only $7.50 per day 
to prevent infection in a child. 
Compared with the tens of thou¬ 
sands of dollars needed to treat an 
HIV-infected infant for life, oral 
AZT taken daily during the last part 
of pregnancy represents a cost of less 
than $1,000. 
This research was supported, in 
part, by grants from the National 
Institute of Allergy and Infectious 
Diseases and the National Institute 
on Drug Abuse. 
Co-authors with Dr. Andiman 
Medicine at NASA 
F ER CASOLINO 
Left: Daniel S. Goldin, administrator 
of the National Aeronautics and Space 
Administration (NASA), gave the 
keynote address at the annual meeting 
of the Associates of the Cushing/Whitney 
Medical Library in April. Above: He 
attends the opening of the exhibit 
Medical Benefits of Aerospace 
Research with Martin E. Gordon, 
M.D. ’46, chairman of the Associates 
and clinical professor of medicine. The 
exhibit, at the medical library during 
April and May, highlighted NASA 
contributions to medicine, including 
advanced imaging and monitoring 
techniques and telemedicine initiatives 
to deliver care to remote regions. 
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are B. Joyce Simpson, R.N., 
a research nurse and administrative 
coordinator of the pediatric AIDS 
program in the department of 
nursing at YNHH, and Eugene D. 
Shapiro, M.D., professor of pediat¬ 
rics and of epidemiology and public 
health at Yale medical school and an 
attending physician at YNHH. 
“Kangaroo Care” may help 
infants born prematurely 
Premature infants may get a boost if 
their parents spend an extended 
period each day holding them close. 
To explore this idea, health profes¬ 
sionals in pediatric neonatology at 
the School of Medicine and Yale- 
New Haven Children’s Hospital, 
along with colleagues at the Yale 
Child Study Center, are evaluating a 
new technique designed to promote 
the growth of infants with very low 
birth weights. 
Kangaroo Care for Premature 
Infants, or skin-to-skin care, was 
first pioneered in 1979 in Bogota, 
Colombia, in an effort to reduce the 
mortality among premature infants. 
Wearing only a diaper, the infant is 
placed on a parent’s chest and 
remains in that position for up to 
several hours per day. 
“We are comparing it to our 
standard parent-infant interaction to 
see if some of the same developmen¬ 
tal complications that occur in 
preterm babies can be decreased 
through a few hours of skin-to-skin 
contact each day,” says Richard A. 
Ehrenkranz, M.D., HS ’72-74, 
professor of pediatrics and of 
obstetrics and gynecology, who 
directs the three-year study funded 
by a $4,500 gift from Ronald 
McDonald House Charities. 
Adds colleague Michael D. 
Kaplan, M.D., a research fellow at 
the Child Study Center: “This 
allows us to learn more about 
mechanisms of growth in the early 
neonatal period, and it gives parents 
an opportunity to provide direct 
care for their infants and increase 
feelings of competence.” 
Other researchers include Mario 
Rojas, M.D., a neonatology fellow, 
and Linda C. Mayes, M.D., the 
Arnold Gesell Associate Professor of 
Child Psychiatry, Pediatrics and 
Psychology. 
Asthma research expands at Yale 
sthma is so common now 
that it has become a major health 
care issue,” says Jack A. Elias, M.D., 
director of the new Specialized 
Center of Research to understand 
the causes of asthma. “In the last 
15 years, asthma has become an 
increasingly severe health problem, 
even reaching epidemic proportions.” 
Approximately 15 million children 
and adults in the United States 
suffer from asthma, and its fre¬ 
quency appears to be particularly 
prominent in inner-city areas. Since 
the early 1980s, national statistics 
show that the prevalence of and 
death rates due to asthma have 
increased by approximately 40 
percent. 
Dr. Elias, professor of medicine 
and chief of pulmonary and critical 
care medicine at the School of 
Medicine, heads a multidisciplinary 
team of Yale physicians in internal 
medicine, pulmonary medicine, 
critical care medicine, and occupa¬ 
tional and environmental medicine. 
They join scientists from the section 
of immunobiology, the departments 
of pathology, laboratory medicine 
and comparative medicine, and the 
John B. Pierce Laboratory to con¬ 
duct studies designed to under¬ 
stand the inflammation in airways of 
patients with asthma. 
The research’s major focus 
deals with the cellular and molecu¬ 
lar biology of asthma. “Our research 
centers on three main themes,” Dr. 
Elias notes. “The first is the study of 
cytokines, small proteins that cells 
make to communicate with one 
another. Secondly, we are exploring 
certain kinds of cells, called T 
lymphocytes, which are small cells 
that are considered to be the 
‘orchestra leaders’ of the inflamma¬ 
tory response in the airways of 
people with asthma. 
“Thirdly, intense studies will be 
undertaken of a particular type of 
occupational asthma seen in 
patients who are exposed to 
chemicals frequently found in 
plastics and spray paint. A subset of 
people are sensitive to and experi¬ 
ence asthma attacks when they 
come in contact with these chemi¬ 
cals. A particularly high frequency of 
this type of asthma has been noted 
in sick patients who are auto-body 
workers in Connecticut. 
“We hope that these molecular 
studies will lead to an improved 
understanding of the basic science 
of asthma and to the development 
of improved treatments for it,” Dr. 
Elias says. “The ultimate goal of all 
of the studies will be to generate 
the type of knowledge upon which 
new treatments for asthma can 
be based.” 
To conduct this research the 
National Heart, Lung and Blood 
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Public lectures examine 
21st-century germs 
Exotic-sounding microorganisms 
like hanta and ebola viruses, mad 
cow disease and hemorrhagic 
fevers have commanded attention 
in newspapers, novels and films. 
This spring, Yale medical faculty 
presented medical perspectives on 
these global-village germs in an 
eight-evening lecture series, titled 
Pathogens 2000: Rising Tides of 
Virulent Diseases, to more than 
100 individuals. 
“The pathogens or germs of 
today and tomorrow present 
problems that are just as complex as 
those of previous centuries,” said 
James D. Kenney, M.D., associate 
Institute, a component of the 
National Institutes of Health, 
selected Yale as one of seven sites 
in the United States for a research 
center and awarded $8.6 million to 
the school over the next five years. 
The Yale Asthma Research 
Program encompasses six major 
projects, with these leaders: 
► Interleukin-11 in Viral 
Asthma. Dr. Elias. These studies 
investigate the role that the 
cytokine interleukin-11 plays in viral 
infections and the mechanism by 
which viral infections lead to 
asthma attacks. 
► Regulation of Th2 Effector 
Function in the Airways. Kim 
Bottomly, Ph.D., professor of 
immunobiology and biology and 
associate investigator at the Howard 
Hughes Medical Institute. These 
studies investigate the processes 
that regulate the generation and 
function of a specific lymphocyte 
population, known as Th2 lympho¬ 
cytes, and the role that they play in 
mediating asthma. 
dean for postgraduate and continu¬ 
ing medical education. “Our global 
society faces new vulnerabilities due 
to these microorganisms, some of 
which are resistant to medication, 
suppress the human immune 
system, and can pose threats of 
epidemic proportion.” Educational 
support for the Pathogens 2000 series 
was provided by The Patrick and 
Catherine Weldon Donaghue 
Medical Research Foundation, based 
in Hartford, Conn. 
Speakers and topics included 
Jose R. Santana, M.D., internal 
medicine resident physician, Diseases 
of Travelers: Unexplained Pulmonary 
Hemorrhage in Nicaragua; Lynn 
Tanoue, M.D., assistant professor of 
medicine, Viral Pneumonias: Your 
Last Breath; Robert W. Ryder, M.D., 
John Rodman Paul Professor of 
Epidemiology and Medicine, 
Emerging Hemorrhagic Fevers: The 
Crimson Tide; Frank J. Bia, M.D., 
professor of medicine and laboratory 
medicine, Parasites for the 21st 
Century; Howard Levitin, M.D., 
professor of medicine, Chronic 
Fatigue Syndrome: Still the Enigma; 
Robert T. Schoen, M.D., associate 
clinical professor of medicine, Tick- 
Borne Diseases: Present Siege; Michael 
O. Rigsby, M.D., assistant professor 
of medicine, The New Threat of 
Tuberculosis: Biological and Social 
Modifiers; and John Booss, M.D., 
associate professor of neurology and 
laboratory medicine, The Vulnerable 
Brain: Prions and AIDS. 
► Molecular Analysis of IL-5 
Gene Transcription. Anuradha Ray 
Ph.D., assistant professor of 
medicine (pulmonary). Dr. Ray's 
study is focusing on a cytokine 
called interleukin-5 (IL-5) that plays 
an important role in asthma. 
Interleukin-5 recruits a particular 
type of white blood cells, called 
eosinophils, to the lungs of people 
with asthma. These cells are 
believed to be responsible for many 
of the manifestations of asthma. 
Her studies are designed to deter¬ 
mine what processes regulate the 
production of interleukin-5. 
► Transgenic Modeling of 
Airway Inflammation in Asthma. 
Dr. Elias. This study is centering on 
the use of transgenic technology, in 
which human genes can be im¬ 
planted into laboratory mice. These 
studies will allow Dr. Elias and his 
colleagues to determine which 
genes are likely to generate asthma¬ 
like features, such as inflammation, 
wheezing and mucous production, 
that people with asthma experience. 
► Cytokines and Adhesion 
Molecules in Hapten-Induced 
Airways Hyperresponsiveness. 
Gregory P. Geba, M.D., assistant 
professor of medicine (pulmonary). 
This study is concentrating on the 
development of a new model of 
asthma in laboratory mice, based 
on generating a delayed form of 
airway inflammation. Dr. Geba and 
his colleagues will be determining 
what triggers the inflammatory 
response and what turns it off. 
In addition, they will explore the 
mechanisms by which inflammatory 
cells enter the airways of these 
animals. 
► T Cells in the Pathogenesis 
of Human Isocyanate Asthma. 
Carrie A. Redlich, M.D., associate 
professor of medicine (occupational 
and environmental medicine). This 
research is designed to study the 
mechanisms of inflammation in the 
airways of adults exposed to 
chemicals used in the auto-body 
industry in Connecticut. 
—Helaine Patterson 
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Two days, two surgeons general 
The two physicians to hold the post of U.S. Surgeon General most 
recently visited the School of Medicine this winter, drawing 
standing-room-only crowds of students, faculty and administrators 
at their respective presentations on two consecutive days. These 
high-profile, outspoken individuals continue to command the 
attention of both the public and the Yale medical community. 
Joycelyn Elders, M.D., who stepped down as surgeon general in 
1994, addressed the topic Medical Education and Personal 
Responsibilities. She frankly told the hundreds gathered in Sterling 
Hall’s Mary S. Harkness Auditorium, “We’ve got the best doctors 
and the best nurses. We all know we have those things. But we do 
not have the best health. Health is more than the absence of 
disease.” The previous day, at Yale’s Medical School Council, 
C. Everett Koop, M.D., Sc.D., who frequently speaks out on contem¬ 
porary health issues, described the educational program of the 
Koop Institute, based at Dartmouth. This summer, Dr. Koop adds 
yet another position to his active schedule when he becomes 
visiting professor of public 
health (health policy) in the 
Department of Epidemiol¬ 
ogy and Public Health 
at Yale. 
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A new vision for ophthalmology 
Bruce Shields becomes chairman and first Sears professor 
The new chair of the 
Department of Ophthal¬ 
mology and Visual Science, 
M. Bruce Shields, M.D., credits his 
early interest in the field to two 
uncles who were ophthalmologists. 
He was attracted, he says, “because 
ophthalmology combines medical 
and surgical aspects, and also deals 
with a wide range of patients, from 
children to the elderly. 
“As a physician,” he says, “you 
can establish long-term relationships 
with patients, just as family physi¬ 
cians do, getting to know them 
and helping them deal with their 
visual conditions.” 
This spring, the Yale Corpora¬ 
tion voted Dr. Shields to become 
the first recipient of the Marvin L. 
Sears Professorship. Drs. Shields 
and Sears, both internationally 
known leaders in ophthalmology, 
share a strong professional interest 
in the multifaceted problem of 
glaucoma, a condition in which 
individuals lose their vision because 
of abnormally high pressure in the 
eye. There are more than ioo types 
of glaucoma, and approximately i to 
2 percent of the population suffer 
from it. 
Dr. Shields, who also is chief of 
ophthalmology at Yale-New Haven 
Hospital, joined the medical faculty 
in November after serving 22 years 
as a faculty member at Duke 
University, as staff surgeon at the 
Durham, N.C., Veterans Affairs 
Medical Center, and as a consultant 
at the Veterans Affairs Medical 
Center at Asheville. He trained at 
Duke, completing his residency 
there in 1974. 
Dr. Shields, who succeeds Dr. 
Sears as chairman, plans to build 
on the strengths of the department 
that Dr. Sears created in 1971 and 
led until 1993. During his chairman¬ 
ship, the Yale Eye Center opened at 
330 Cedar St. Here, the Boardman 
Building houses clinical services, 
and the Brady Laboratory and 
Brady/Boardman connector 
provide adjoining space for basic 
science vision research and visual 
neurobiology. 
Dr. Sears, now in his 36th year 
at Yale, continues to teach clinical 
medicine to resident physicians and 
basic research to postdoctoral 
fellows, treat patients, and direct his 
own research laboratory studies. His 
work in adrenergic pharmacology 
resulted in the development and 
approval of timolol, which has 
become the mainstay for the 
medical therapy of glaucoma. 
Foundations, professional colleagues 
and grateful patients contributed 
funds toward establishing the Sears 
professorship. 
Dr. Shields, a native of 
Okmulgee, Okla., received a B.S. 
degree in 1962 from Phillips Univer¬ 
sity in Enid, Okla., and an M.D. 
M. Bruce Shields, M.D. 
degree in 1966 from Oklahoma 
University School of Medicine. He 
took a one-year rotating internship 
at the U.S. Naval Hospital in 
Philadelphia and served three years 
in the U.S. Navy, being discharged 
in 1970 as a lieutenant commander. 
He completed his residency in 
ophthalmology at Duke University 
and a fellowship in glaucoma at the 
Massachusetts Eye and Ear Infir¬ 
mary in Boston. 
During his career, Dr. Shields 
has centered his clinical practice, 
research and teaching on glaucoma 
and directed Duke’s glaucoma 
service. In recent years, he has been 
Continued on page 50 
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Orthopaedics chair 
follows mentor as the first 
Southwick professor 
Gary E. Friedlaender, M.D., chair 
of the Department of Orthopaedics 
and Rehabilitation, has been 
named the first Wayne O. 
Southwick Professor of Ortho¬ 
paedics and Rehabilitation, an 
endowed professorship established 
last year in honor of one of his 
mentors. 
The Wayne O. Southwick 
Professorship, the first endowed 
chair in the department of ortho¬ 
paedics and rehabilitation, was 
established through contributions 
from Dr. Southwick’s former 
trainees, colleagues, friends and 
patients. Dr. Southwick, who 
became chief of orthopaedic surgery 
at Yale in 1958, was named professor 
emeritus of orthopaedics and 
rehabilitation in 1993. 
Dr. Friedlaender, who also is 
chief of orthopaedics and rehabilita¬ 
tion at Yale-New Haven Hospital 
(YNHH), specializes in oncology 
reconstruction. He and his Yale 
colleagues pioneered a bone trans¬ 
plant procedure that has helped 
spare the limbs of hundreds of 
individuals who have had cancer, 
other diseases or injuries. An expert 
on the influence of chemotherapy 
and radiation therapy on intact 
bone, fracture repair and bone 
grafts, immune responses to bone 
transplants, and the safe and 
efficient banking of bone for 
transplantation, Dr. Friedlaender 
founded the Yale Bone Bank and 
served as its first director from 1979 
to 1988. He has written extensively 
on tissue banking, fracture healing 
and bone allografts, and coedited 
three textbooks on these subjects. 
A 1969 graduate of the Univer¬ 
sity of Michigan School of Medi¬ 
cine, Dr. Friedlaender completed his 
internship and assistant surgical 
resident training at the University of 
Michigan Medical Center. He first 
came to Yale in 1972 as a National 
Institutes of Health postdoctoral 
research fellow in orthopaedic 
surgery, oncology and immunology. 
After completing his orthopaedic 
residency training at Newington 
Children’s Hospital and YNHH in 
1974, he became director of the 
Naval Medical Research Institute’s 
Tissue Bank Division, a post he 
held until 1976. 
Dr. Friedlaender became an 
instructor in surgery (orthopaedics) 
in 1974 and was promoted to 
assistant professor in 1976, associate 
professor in 1979 and professor of 
surgery in 1984. He became profes¬ 
sor of orthopaedics and rehabilita¬ 
tion and the first chair of the 
department of orthopaedics and 
rehabilitation when it was estab¬ 
lished in 1986. He has been director 
of orthopaedic research at the 
medical school since 1981 and has 
directed the orthopaedic oncology 
and transplantation immunobiology 
research laboratory since 1976. 
Dr. Friedlaender serves as a 
surgical consultant at several area 
hospitals and an adviser to many 
national and international organiza¬ 
tions. Last year, he received a 
Distinguished Service Award from 
the American Association of Tissue 
Banks. He has been awarded fellow¬ 
ships and grants from the National 
Cancer Institute and the Ortho¬ 
paedic Research and Education 
Foundation, among others. 
Surgeon Barbara Kinder 
appointed to Carmalt chair 
Barbara Kinder, M.D. ’71, HS ’71- 
76, a specialist in endocrine surgery 
and chief of surgery at the West 
Haven campus of the VA Connecti¬ 
cut Healthcare System, has been 
named the William H. Carmalt 
Professor of Surgery. 
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Dr. Kinder, who has spent her 
entire career at Yale, completed her 
internship and residency training in 
surgery at Yale-New Haven Hospital 
and also was a postdoctoral fellow in 
pharmacology. She became an 
instructor in surgery at the medical 
school in 1976, was promoted to 
assistant professor a year later, and 
became professor of surgery in 1990. 
She served as chief of surgery 
for Yale University Health Services 
from 1985 to 1989 and chief of the 
division of endocrine surgery in the 
medical school’s Department of 
Surgery from 1987 to 1992. She has 
been chief of surgery at the VA 
since 1989. 
Dr. Kinder has authored or co¬ 
authored numerous articles pub¬ 
lished in medical and scientific 
journals on topics both in her field 
(such as hyperparathyroidism and 
thyroid cancer) and about her field 
(such as the differences that male 
and female surgeons experience 
during their careers). When she was 
appointed to her VA post, she was 
one of fewer than a dozen female 
chiefs of surgery at VA hospitals 
nationwide. 
Dr. Kinder is a founding 
member of both the American and 
International Associations of 
Endocrine Surgeons. She also is a 
member of the New England 
Surgical Society, Eastern Surgical 
Society, The Endocrine Society, 
Connecticut Society of American 
Board Surgeons, New England 
Cancer Society and the Association 
of VA Surgeons, among others. She 
is a fellow of the American College 
of Surgeons; her other honors 
include the Leah Lowenstein Award 
for medical student teaching in 1987 
and the Association of Women 
Surgeons’ Distinguished Members 
Award in 1996. 
The Carmalt chair previously 
was held by Dr. Kinder’s late 
husband, C. Elton Cahow, M.D., 
who died Jan. 2. 
Psychiatrist Bradley 
Peterson holds Meers- 
Jameson chair 
Bradley S. Peterson, M.D., director 
of neuroimaging and of clinical 
research at the Child Study Center, 
has been named the Elizabeth Meers 
and House Jameson Assistant 
Professor in Child Psychiatry. 
Dr. Peterson has focused his 
research on the neuroimaging of 
developmental neuropsychiatric 
disorders, the role of risk and 
protective factors in developmental 
psychopathologies, and the neurobi¬ 
ology and treatment of Tourette’s 
syndrome and obsessive-compulsive 
disorder. In addition, he is interested 
in exploring the psychoanalytic 
perspectives of these disorders. 
A 1987 graduate of the Univer¬ 
sity of Wisconsin Medical School, 
Dr. Peterson came to the Child 
Study Center as a National Institute 
of Mental Health postdoctoral 
research fellow in 1990 after com¬ 
pleting his general psychiatry 
residency training at Massachusetts 
General Hospital. From 1992 to 
1994, he continued work at the 
Child Study Center on a child 
psychiatry clinical fellowship. He 
was named director of neuroimaging 
at the center in 1993 and became 
an assistant professor of child 
psychiatry there a year later, when 
he was also named director of 
clinical research. 
Dr. Peterson has authored or 
co-authored more than two dozen 
articles for medical journals, many 
of which deal with the pathogenesis 
and treatment of Tourette’s syn¬ 
drome. He also has written chapters 
in a number of books, including 
Advances in Neurology, the second 
edition of the Handbook of Child 
and Adolescent Psychiatry (in press) 
and Treatment Resistant Obsessive- 
Compulsive Disorder (also in press). 
He authored a chapter for Child 
Psychiatry Clinics of North America: 
Neuroimaging (in press), which he 
also edited. 
Since coming to Yale, Dr. 
Peterson has received numerous 
awards for his research. These 
include two Eli Lilly Pilot Research 
Awards from the American Academy 
of Child and Adolescent Psychiatry, 
the Dean’s Young Faculty Award 
from the School of Medicine, and 
Independent Investigator awards 
from the March of Dimes Birth 
Defects Foundation, the Tourette 
Syndrome Association, the Dana 
Foundation and Janssen 
Pharmaceutica. In addition, he has 
been presented a Young Investigator 
Award from the National Associa¬ 
tion for Research on Schizophrenia 
and Depression and a Career 
Development Award from the 
National Institutes of Health. 
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developing glaucoma treatments 
involving the application of laser 
technology in which he concen¬ 
trates on treating the most advanced 
types of glaucoma. 
A prolific author, Dr. Shields 
has written more than 25 chapters 
and 130 scientific journal articles. 
However, his best-known work is 
the Textbook of Glaucoma, now in its 
fourth U.S. edition. It also has been 
translated into German, Japanese, 
Portuguese and Spanish. 
Dr. Shields serves as president of 
the American Glaucoma Society, a 
director of the American Board of 
Dr. Shields plans to 
place a major 
emphasis on the 
educational programs 
at Yale for both 
students and 
physicians-in- 
training. 
Ophthalmology, and a member of 
the program committees for the 
American Academy of Ophthalmol¬ 
ogy and the Association for Research 
in Vision and Ophthalmology. 
In the years ahead, Dr. Shields, 
who considers himself first and 
foremost to be an educator, plans to 
place a major emphasis on the 
educational programs at Yale for 
both students and physicians-in- 
training, and to provide quality 
continuing medical education for 
community ophthalmologists. 
—Helaine Patterson 
At Dartmouth, a preview of historic things to come 
Dartmouth has called upon a Yale 
medical professor and two luminar¬ 
ies from Yale’s alumni body for a 
three-day international symposium 
this fall to celebrate Dartmouth 
Medical School’s bicentennial. 
Pasko T. Rakic, M.D., Sc.D., 
chair of Yale’s Section of Neurobiol¬ 
ogy and the Dorys McConnell 
Duberg Professor of Neuroscience; 
Francis S. Collins, Ph.D., who 
earned his doctorate in physical 
chemistry at Yale, was a fellow in 
genetics and pediatrics at the 
medical school, and now heads the 
National Human Genome Research 
Institute; and Daniel J. Callahan, 
Ph.D., who earned his B.A. degree 
from Yale and is a noted medical 
ethicist and director of the Hastings 
Institute, will be among more than 
two dozen major figures from 
science, medicine, ethics, and 
related fields taking part in the 
Dartmouth symposium. 
Dartmouth Medical School’s 
founder, Dr. Nathan Smith, left 
Hanover, N.H., in 1813 to become 
one of the founding faculty mem¬ 
bers of the Yale School of Medicine. 
Dr. Smith’s standing in the medical 
community of that day is captured 
in the statement of a member of the 
Yale faculty who said Dr. Smith “was 
more extensively known than any 
other medical man in New England, 
or indeed than any man in any 
profession.” That was high praise 
indeed for the son of a farmer who 
had till that point spent his entire 
career in rural northern New 
England. Dr. Smith actually had a 
hand in the founding of no less than 
four New England medical schools, 
later being active in the establish¬ 
ment of medical schools at Bowdoin 
and the University of Vermont. 
The Dartmouth symposium, 
Great Issues for Medicine in the 21st 
Century: A Consideration of the 
Ethical and Social Issues Arising 
Out of Advances in the Biomedical 
Sciences, will take place Sept. 5 to 7 
in Hanover, N.H. Half-day sessions 
will focus on genetics, neuroscience, 
health care and world population. 
Dr. Rakic is chair of the session on 
neuroscience and will deliver an 
address titled The Importance of 
Being Well Placed and Havitig the 
Right Connections. Dr. Collins will 
be one of several people delivering 
addresses in the genetics session. 
And Dr. Callahan is among half a 
« f 
m 
Nathan Smith, by Ulysses Dow Tenney. 
dozen individuals representing 
different perspectives on the health 
care community who will participate 
in a panel discussion on the ration¬ 
ing of health care. 
There is no registration or 
admission charge for attendance at 
the symposium, and it has been 
certified for AMA Category I CME 
credit. Those wishing more informa¬ 
tion about the full program for 
Dartmouth’s Bicentennial Sympo¬ 
sium may call the Dartmouth 
Medical School Bicentennial Office 
at (603) 650-4037. 
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He saved the day; now he’s a knight 
Yale physiologist Boulpaep honored by King of Belgium 
In Belgium, a knight is correctly 
called chevalier in French, or 
ridder in Dutch. So might 
people address Emile L. Boulpaep, 
M.D., as Chevalier Boulpaep? 
“In principle, yes, but I hope 
they don’t,” says Dr. Boulpaep. 
A genial professor of cellular and 
molecular physiology at the School 
of Medicine, he was knighted last 
summer by King Albert II of Bel¬ 
gium, who customarily grants 
titles of nobility. Last year, the 
King honored only n individuals 
with titles. 
The title of knight honors 
Dr. Boulpaep for his work with the 
Belgian American Educational 
Foundation Inc., which has pro¬ 
vided nearly 3,000 graduate and 
postdoctoral fellowships for Bel¬ 
gians and Americans. The Belgian 
title—rarely given to anyone outside 
Belgium—also presents him with a 
challenge rarely faced by anyone in 
the United Sates: the need to come 
up with a coat of arms and a motto. 
The foundation is a successor to 
the Commission for Relief in 
Belgium (C.R.B.), organized by 
Herbert Hoover during World War I 
Emile L. Boulepaep, M.D., and his 
salamander-adorned coat of arms. 
to aid a hungry nation deprived of 
food during the German occupa¬ 
tion. After the 1918 Armistice, the 
commission’s remaining funds were 
used to rebuild Belgian universities 
and to launch the fellowship 
program. “The foundation is the 
daughter of the C.R.B.,” says Dr. 
Boulpaep. Although he’s been a 
resident of the United States for 30 
years, he remains a citizen of 
_ __ 
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Belgium, where America still reaps 
the good will sown by the post-war 
relief effort. 
Dr. Boulpaep first came to the 
United States in 1964 on a Belgian 
American Education Foundation 
fellowship. When the foundation 
faced financial problems a few years 
later, he led efforts to revamp its 
organization and add to its assets. 
He has been involved ever since, 
taking on tasks from interviewing 
prospective fellows to serving— 
since 1976—as president. “I wanted 
to save this foundation,” he says. 
In 20 years as the foundation’s 
president, he has increased its 
assets tenfold. 
Dr. Boulpaep talks of the “good 
understanding” that the foundation 
has fostered between Belgium and 
the United States, and of the many 
fellows who have become leaders in 
science, business and other fields. 
Four fellows went on to become 
prime ministers of Belgium; two 
have won Nobel prizes. ► 
AAAS members honored 
for contributions 
to science 
The American Association for the 
Advancement of Science (AAAS) 
elected 283 members as fellows. 
The following individuals from the 
School of Medicine were recognized 
for their contributions to medical 
science at the Fellows Forum in 
February during the AAAS 
Annual Meeting in Seattle: Emile L. 
Boulpaep, M.D., professor of 
cellular and molecular physiology; 
Edwin C. Cadman, M.D., 
professor of medicine and senior 
vice president of medical affairs 
and chief of staff at Yale-New 
Haven Hospital; Peter Jatlow, M.D., 
professor of laboratory medicine 
and psychiatry; Keith A. Joiner, 
M.D., professor of medicine and 
epidemiology (microbiology); 
Michael Kashgarian, M.D., 
professor of pathology and 
biology; Robert J. Levine, M.D., 
professor of medicine and chairman 
of the Human Investigation 
Committee; and Vincent T. 
Marchesi, M.D., the Anthony N. 
Brady professor of pathology, cell 
biology and biology. 
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Since his knighthood was 
announced by royal decree on 
Belgian Independence Day, July 21, 
1996, Dr. Boulpaep has been busy as 
usual, directing medical studies in his 
department, co-editing a new 
physiology textbook, and conduct¬ 
ing kidney research. In November he 
traveled to Belgium to meet with the 
Council of the Nobility, a group that 
has helped him create his motto and 
coat ol arms. The motto can be in 
French, Dutch or Latin; he’s chosen 
Latin (which he studied in school). 
His motto is Educatio Iungit Popidos, 
which translates as education unites 
people. “The foundation is a link 
between two countries. 
His coat of arms incorporates the 
themes of education and medicine, 
with three rings in the center repre¬ 
senting the three roles of a university: 
teaching, research and service. 
His coat of arms also includes a 
salamander—functionally, to 
represent his research in physiology 
(“I’m known as the guy who uses 
salamanders as a model to work with 
and to study renal/kidney function.”) 
“Symbolically, the salamander in 
Europe is the symbol ol fire,” Dr. 
Boulpaep explains. “It is thought that 
the salamander can separate good fire 
from bad fire, and this animal is 
associated with distinguishing good 
from bad—just as is done in the 
interpretation of scientific data and 
in the evaluation of students.” 
In heraldry, the background is 
symbolic, too. His coat of arms’ 
background is blue for Yale. The 
council artists have created some¬ 
thing that “looks like a coat of arms, 
not like objects placed together 
surrealistically.” 
Meanwhile, Chevalier Boulpaep, 
who anticipates receiving his coat of 
arms this summer, is pleased with the 
way that his Yale colleagues address 
him. “They still call me Emile,” 
he says. 
Myron Genel, M.D., prolessor ol 
pediatrics and associate dean for 
government and community affairs, 
was one of the speakers at the 
American Medical Association’s 1997 
National Leadership Conlerence in 
Philadelphia in March. Dr. Genel’s 
topic was The Role of the American 
Medical Association in Support of 
Clinical Research. 
Robert J. Levine, M.D., professor 
ol medicine and chairman of the 
Human Investigation Committee, 
led a delegation 
of the Citizen 
Ambassador 
Program on 
Medical Ethics 
on a 15-day visit 
to the Czech 
Republic, 
Poland and 
Hungary in 
September. This 
predominately American group of 
physicians and other health profes¬ 
sionals, lawyers and clergy met with 
their Central European counterparts 
to exchange information and 
perspectives. 
Theodore Lidz, M.D., Sterling 
Professor Emeritus of Psychiatry, 
received the 1997 Distinguished 
Service Award Irom the American 
College of Psychiatrists in March. 
In accepting the award, Dr. Lidz 
said that he viewed his selection as 
“an affirmation ol the importance 
of psychotherapy and sociotherapy, 
and particularly the critical role ol 
the family in understanding and 
treating patients,” especially those 
with schizophrenic disorders. 
Ira S. Mellman, Ph.D. ’78, profes¬ 
sor of cell biology and director of 
the Biological and Biomedical 
Sciences Program, lectured in 
52. 
January at the National Institutes of 
Health. His topic was Cell Biology of 
Antigen Presentation: MHC Class II 
Transport, Dendritic Cell Develop¬ 
ment, and Other Strange Tales. 
Marvin Moser, M.D., clinical 
professor of medicine, is the keynote 
speaker at a 10-month series of 
hypertension symposia, which began 
in February. The symposia are 
sponsored by the National Heart 
Lung & Blood Institute and are 
being held in cities throughout the 
United States, including Boston, 
Chicago, Los Angeles, Houston, 
Indianapolis, Seattle and Miami. 
Dr. Moser has been the senior 
medical consultant for the past 
23 years. 
Howard A. Pearson, M.D., 
professor of pediatrics, received 
the distinguished career award last 
fall from the American Society of 
Pediatric Hematology/Oncology. 
The award is given in recognition 
of outstanding service and signifi¬ 
cant scientific contributions to 
the understanding and treatment 
of blood diseases and cancer 
in children. 
Wilfred Reguero, M.D., clinical 
professor of obstetrics and gynecol¬ 
ogy, was recipient of the first 
Wyeth-Ayerst Hera Gold Award 
for Improvement in Women’s and 
Children’s Health Outcomes. The 
presentation was made during the 
Zitter Group’s 1996 Congress on 
Health Outcomes and Accountabil¬ 
ity in November in San Francisco. 
Dr. Reguero, who is chairman of 
the Department of Obstetrics and 
Gynecology at the Hospital of 
Saint Raphael, was honored for the 
Project MotherCare Neighborhood 
Mobile Clinic. 
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‘Physician: Impossible’ 
With stage talent to rival their MCAT scores, the second-year class proves that nearly 
anything can he accomplished. Only dont give up that career in medicine just yet. 
Photographs by Peter Casolino 
It has become as predictable a 
part of second year as the 
national board exams in June 
and premonitions of life on the 
wards. For medical students, the 
second-year show is the exhilarating 
product of time and effort that 
culminates in two rollicking perfor¬ 
mances each spring semester. 
For faculty and administrators, 
the experience is even more hair- 
raising, since it is tradition to 
lampoon the most familiar and 
respected figures on campus. For 
the audience (even for those who 
miss half the inside jokes) the 
second-year show is unfailingly 
entertaining. 
This year’s offering by the Class 
of 1999, Physician: Impossible, took 
the shape of an episode of the tele¬ 
vision series Nova documenting 
the making of a physician. Kerri 
Cavanaugh, playing the part of the 
filmmaker, led viewers through the 
admissions process, first-year classes, 
anatomy, Dr. Emile Boulpaep’s 
shower, Match Day and a 12-step 
meeting of Academicians Anony¬ 
mous. And as now seems obligatory, 
they satirized one faculty member in 
particular with the following (to the 
tune of Rogers and Harnrnersteins The cast prays in supplication, with a nod to The Sound of Music, while singing 
How Do You Solve a Problem Like How Do You Solve a Problem Like Frank Bia? 
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Cast members occupy a backstage corner of Harkness Auditorium before the 
premiere of Physician: Impossible in February. Clockwise from rear: Geoff 
Emerson, Michelle Sanders, Richard Torres, Alison Days, Gilbert Ortega 
and Danica Barron. 
Maria? From the musical 
The Sound of Music): 
...He tells jokes that we all like 
And he seems to like the mike 
He could keep us all in lecture for a year. 
Cause his slides are nice and gory, 
And we know his whole life story: 
He’s from Cornell, 
He did real well, 
Now he’s here. 
(refrain) 
How do you solve a problem like Frank Bia 
Dr. Bia, a much-beloved teacher with a 
reputation for being a ham, then hopped up 
on stage and tap-danced. 
In a skit titled My Fair Angela, Shahram 
Salami counsels Jessica Harberer (as legal eagle 
and pronounced Southerner Angela Holder) on 
how to speak proper English. 
Josh Broder, left, and choreographer Sherri Sandifer in the opening 
number, (Never Seen a) Place Like Yale, sung to the tune of a song 
from the musical Aladdin. 
Matt Cooperberg, left, co-producer Jose Prince, right, 
and fellow cast members look for their places during 
the final rehearsal. 
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Camille Hylton, right front, and the chorus launch into the dance number, 
Miss Histology (to the tune of the Miss America Pageant theme). 
“Hello 
Harkness, my 
old friend, ” 
sings David 
Gershfield (as 
Art Garfunkle), 
accompanied by 
Richard Torres 
(as Paul Simon) 
in The Sounds 
of Sirens. 
Cynthia A. Brandt, M.D., M.P.H., 
fellow in medical informatics, 
received the Best Traditional Poster 
Award from the American Medical 
Informatics Association (AMIA). 
The award and a check for $250 
were presented at the 1996 AMIA 
Annual Fall Symposium in Wash¬ 
ington. Dr. Brandt’s poster was 
Visualizing Immunization Logic in a 
Rule-Based Expert System. 
Ruth A. Potee, Class of 1998, has 
been awarded the 1996 Family 
Medicine Interest Group (FMIG) 
Leadership Award by the American 
Academy of Family Physicians 
during its annual National Congress 
of Family Practice Residents and 
National Congress of Student 
Members meeting held in Kansas 
City, Mo., in August 1996. The 
award recognizes medical students 
for their outstanding leadership 
abilities and invaluable contribu¬ 
tions to their local FMIG. 
Becoming Gay: The Journey 
to Self Acceptance, by 
Richard A. Isay, M.D. ’61, FIS 
'62-65, Pantheon Books 
(New York) 1997. 
But the real show-stopper, 
according to co-producer Jose 
Prince, was the surprise appearance 
Saturday evening by Deans Gerard 
N. Burrow and Robert Gifford, who 
played themselves in one of the 
show’s three twist endings. In this 
version, the school is revealed to be 
a front for the federal witness pro¬ 
tection program, run locally by the 
two deans. Their scene ends with 
the two of them sunning themselves 
on a beach, waxing nostalgic about 
good old New Haven. 
“We sure had it great,” mused 
Dr. Gifford. “Yes,” Dr. Burrow 
replied, “but after an appearance in 
the second-year show, I just had to 
call it quits.” 
—Michael Fitzsousa 
Waiting for a Miracle: Schools Are Not 
the Problem, by James P. Comer, M.D., 
HS ’64-67, Maurice Falk Professor in 
the Child Study Center and Psychiatry, 
Dutton (New York) Fall 1997 
The Cancer Chemotherapy Hand¬ 
book, Fifth Edition, by David S. 
Fischer, M.D., clinical professor of 
medicine, Mosby (St. Louis, Mo.) 1997. 
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Yale student edits 
national newsletter 
Medical students are primary readers 
of paper or electronic versions of IMpact 
As editor of IMpact, Yale medical student Nirav Shah entices readers 
with an electronic version of the newsletter on the Internet. 
^A^hat can happen when medical 
students try to organize a commu¬ 
nity gun-exchange program? When 
employers have access to employ¬ 
ees’ computerized medical records? 
When an experienced physician is 
called to a scene that, as he puts it, 
“could weaken you at the knees”? 
Nirav R. Shah, who this fall will 
begin his fourth year as a Yale 
medical student, hopes that his 
fellow students around the country 
will consider these matters—and 
read about them in IMpact, the 
Internal Medicine Newsletter for 
Medical Students, established in 
1994 to show medical students 
that internal medicine is an exciting 
and meaningful career. 
IMpact, a quarterly newsletter, 
covers all kinds of issues related to 
"internal medicine and medicine in 
general,” says Mr. Shah, who 
became editor about two years ago. 
IMpact was then fairly new, and he 
set out to increase circulation by 
consistently offering interesting, 
relevant and accessible material. 
He soon added an electronic 
edition to the regular eight-page 
printed one. He put the printed 
version of IMpact on the Internet, 
he says, because online reading is 
convenient—indeed, downright 
natural—for today’s medical stu¬ 
dents. (The Internet address is: 
http://www.acponline.org/journals/ 
impact/impmenu.htm). He points 
out that many have used computers 
since they were youngsters, and 
they’re familiar with facilities—like 
his own Harkness dormitory at 
Yale—that are linked to the informa¬ 
tion superhighway. 
“Medicine itself is moving 
toward more dissemination of 
information online,” he notes, adding 
that the American College of 
Physicians (ACP), which sponsors 
IMpact, was moving parts of the 
Annals of Internal Medicine onto the 
World Wide Web when he proposed 
the electronic version. 
Each issue of IMpact has a 
theme, such as innovations in 
medical education, computers in 
medicine, or student activism. 
Generally, each includes feature 
articles, Questions and Answers, 
Significant Figures (statistics) and 
Humanities. (Mr. Shah says, “It’s too 
easy to forget the humanistic side 
when you’re studying science at 
3 a.m.”) He also writes an Editor’s 
Letter on the theme of each issue. 
“I try to do ‘pro-and-con,’ then say, 
This is what I think’,” he says. 
“Editors have to take a stand.” 
He includes material from Yale 
medical faculty and especially 
students, as well as from the ACP. 
“I get submissions from medical 
students from all around the world 
via e-mail,” he says. 
Mr. Shah’s first issue featured a 
fourth-year medical student’s report 
on how Yale was revamping curricu¬ 
lum in the first two years. In the 
issue on computers, his Editor's 
Letter noted that computerized 
patient records could be misused, 
but he stressed that good medical 
care requires good information and 
called for measures (like better 
software) to protect confidentiality. 
The activism issue included 
one student’s report on a successful 
program to feed the hungry and 
another's wry account of an ardu¬ 
ous—and unsuccessful—effort to run 
a community gun-exchange program 
as part of local crime prevention 
efforts. A recent humanities piece 
focused on a story about a doctor 
who received a call from a patient 
who had just committed murder. 
Mr. Shah, whose parents are 
from Bombay, grew up near Buffalo, 
N.Y. He plans a career of research 
and practice in internal medicine. 
He’s pleased that IMpact’s print 
circulation is now more than 10,000 
per issue, that 200 users accessed 
the electronic table of contents in 
one recent month, and that so far 
more than 250 medical students 
have joined the American College of 
Physicians as a result of the 
electronic edition’s offer of free 
membership. 
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“Lift Every Voice” 
Photographs by Michael Marsland 
Actor, playwright and civil rights 
activist Ossie Davis, right, 
spoke to students and faculty 
who filled Mary S. Harkness 
Auditorium in recognition of 
Martin Luther King Jr. Day in 
January. Mr. Davis, author of the 
Tony Award-winning play Purlie 
Victorious, has appeared in 
Raisin in the Sun and I’m Not 
Rappaport on Broadway, The 
Client and four films by Spike 
Lee, including Do the Right 
Thing. He spoke about his life 
as an actor closely involved in 
the civil rights movement in an 
address titled Scenes from Our 
Story: We Are Still Marching, 
following a performance by the 
Yale undergraduate singing 
group Shades, middle right. 
Mr. Davis is 
greeted by James P. 
Comer, M.D., 
M.P.H., a friend of 
many years and the 
Maurice Falk 
Professor of Child 
Psychiatry. 
Robert H. Gifford, M.D., associate dean for medical 
education and student affairs, presents one of 11 
Distinguished Community Service Awards during 
the observance. Among the recipients were medical 
and public health students AJ. Babineau, Kathryn 
Cunningham, Alison Days, Benjamin Doolittle, 
Dionne Otey, Scott Porter, Neda Sharghi and 
Obinwanne Ugwonali. 
Third-year 
medical student 
Sherri Sandifer 
plays and sings 
the African 
American anthem 
Lift Every Voice 
to close the 
program. 
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ALUMNI/AE NEWS 
Marier named dean at LSU 
Robert L. Marier, M.D. ’69, medical director 
and chief administrative officer at the Medical Center of 
Louisiana, has been appointed dean ot Louisiana State 
University (LSU) School oi Medicine in New Orleans. 
Dr. Marier, who assumed the deanship last Novem¬ 
ber after serving for a year as acting dean, graduated 
from Yale School ol Medicine in 1969 before taking his 
residency in internal medicine at Massachusetts General 
Hospital. He returned to Yale as a postdoctoral fellow in 
inlectious disease from 1974 to 1975. He served in the 
U.S. Public Health Service as an epidemic intelligence 
officer at the U.S. Centers lor Disease Control before 
joining the Yale faculty as assistant professor of medicine 
from 1975 to 1978. 
Dr. Marier moved to New Orleans in 1978 to join 
the medicine faculty at LSU. He also served as associate 
dean and chairman of the 
Department oi Public 
Health and Preventive 
Medicine. Dr. Marier, 
whose undergraduate 
degree is from Boston 
College, earned a master’s 
degree in health services 
administration from the 
Tulane School of Public 
Health in 1990. 
He was a founding 
member of United 
Services for AIDS in Louisiana and has served on the 
Governor’s Commission on Telecommunications and the 
Louisiana Health Care Commission. He and his wife, 
Joanne, are the parents ol two daughters, Rebecca 
and Alicia. 
Beck Institute honors a founder 
of cognitive therapy 
Aaron T. Beck, M.D. ’46, professor emeritus and direc¬ 
tor ol the Center for Cognitive Therapy at the University 
ol Pennsylvania, was honored by the department ol 
psychology of Assumption College in Worcester, Mass., 
with the establishment of the Aaron T. Beck Institute for 
Cognitive Studies. The Beck Institute will sponsor 
education and training projects in cognitive therapeutic 
skills for students and postgraduate professionals. 
Dr. Beck established an international reputation as 
a lounder of cognitive therapy by pioneering the 
formulation of cognitive models of various psychiatric 
disorders and by developing and testing specific psycho¬ 
therapeutic applications to the disorders. His research in 
psychopathology has identified specific risk factors lor 
suicide and specific psychological configurations in 
depression, anxiety disorders and personality disorders. 
Three of the various inventories and questionnaires that 
Dr. Beck developed are among the most widely used in 
research and clinical practice: the Beck Depression 
Aaron T. Beck, M. D., in a 
portrait at the University of 
Pennsylvania School of 
Medicine. 
Inventory, Beck Hopelessness Scale, and Beck Suicide 
Ideation Scale. 
Annual conlerences at the new institute will address 
research and therapeutic developments in cognitive 
therapy, as well as ethical and moral issues faced by both 
therapists and clients. For the community at large, the 
institute will strive to provide information that illumi¬ 
nates the contributions ol cognitive factors to the 
resolution oi problems in living. 
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40s 
Earl J. Simburg, M.D., HS 41-43, 
was appointed to the Mental Health 
Advisory Committee of the Hem¬ 
lock Society in November. He also 
was awarded a Meritorious Service 
Award by the Community of the 
Alta Bates Medical Center in 
Berkeley, Calif., at its annual 
meeting in February, and was 
reappointed to a three-year term on 
the Alta Bates Foundation Board 
of Trustees. 
Donald W. Seldin, M.D. 43, HS 
’43-46, Sc.D.H. ’88, was profiled 
in a recent issue of Science. The 
article recounts how his efforts in 
mentoring talented students at the 
University of Texas Southwestern 
Medical School at Dallas, his vision 
of the school as a top research 
center, and his commitment to 
excellence were major factors in 
Southwestern’s rise from an obscure, 
eight-year-old medical school in 1951 
to the front rank of medical schools 
and university research centers. Dr. 
Seldin retired in 1987 after 36 years 
of service and now serves as a part- 
time advisor to the school. 
Edith M. Jurka, M.D. 44, was a 
featured speaker at the first Interna¬ 
tional Conference on the Psychology 
of Consciousness in April in 
Monterey, Calif. Her talk was titled 
Brain Determinants of Personality 
Characteristics. 
Reese A. Matteson, M.D. ’44, 
reports his impending retirement 
from his ENT practice in Danville, 
Ill. He is enjoying travel, having 
recently returned from Thailand and 
Nepal. A trip to Poland, Slovakia 
and Hungary is in the works. 
Samuel D. Kushlan, M.D. ’35, HS 
’35-37, passes along this note 
from Raymond A. Gagliardi, M.D. 
’45, HS ’48-51, of Boca Raton, Fla. 
“Though retired from practice, I 
continue as historian of the Ameri¬ 
can Roentgen Ray Society (ARRS). 
I have just published, as editor-in- 
chief, the third volume of History of 
the Radiologic Sciences. [Chairman] 
Bruce McClennan from Yale was 
editor of the volume of Diagnosis 
(the others being Radiation Oncology 
and Radiation Physics). Ray orga¬ 
nized a mini reunion for classmates 
of 1945 in Orlando on April 6. 
O. Roger Hollan, M.D. ’45, 
HS ’45-46, has been honored by 
the establishment of a professorship 
in his name at the University of 
Texas Health Science Center in 
San Antonio. 
50s 
Leonard S. Krassner, M.S. ’51, 
M.D., HS ’57-59, recently marked 
10 years as medical director at 
Choate Rosemary Hall in 
Wallingford, Conn. Dr. Krassner 
continues to serve as president of 
Yale Alumni in Pediatrics. 
Joseph S. Pagano, M.D. ’57, the 
Lineberger Professor of Cancer 
Research and director of the 
Lineberger Comprehensive Cancer 
Center at the University of North 
Carolina (UNC) at Chapel Hill, 
received the 1996 North Carolina 
Award in Science, the state’s highest 
civilian honor. The award was 
presented by Gov. Jim Hunt. Dr. 
Pagano was cited for his internation¬ 
ally recognized research into viruses 
and human cancer, for founding the 
UNC cancer center, and for his 
leadership of cancer initiatives. 
Donald H. Harter, M.D., HS and 
postdoctoral fellow ’57-58, is a senior 
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scientific officer for the Howard 
Hughes Medical Institute (HHMI), 
director of the HHMI’s National 
Institutes of Health Research 
Scholars Program, and clinical 
professor of neurology at George 
Washington University School 
of Medicine. 
60s 
Carl R. Fischer, M.P.H. '68, 
executive director of the Medical 
College of Virginia Hospitals for the 
past ii years, was elected chairman 
of the board of the University 
HealthSystem Consortium (UHC), 
a national alliance of 77 academic 
health centers. Mr. Fischer has been 
an active member of the consortium 
since its inception, most recently 
serving a second term as chair of one 
of its governing committees. 
Charles A. Dinarello, M.D. 69, 
HS ’69-75, professor of medicine at 
Alumni/ae on campus 
Lewis Landsberg, M.D. ’64, HS 
’65-70, was guest speaker at 
Medical Grand Rounds in Febru¬ 
ary. Dr. Landsberg discussed 
Obesity-Related Hypertension and 
the Insulin Resistance Syndrome. 
Informal teaching sessions followed 
with house officers and attending 
staff throughout the day. 
Since 1990, Dr. Landsberg has 
been the Irving S. Cutter Professor 
and chairman of the Department 
of Medicine at Northwestern 
University Medical School in 
Chicago, where he was director of 
the Center for Endocrinology from 
1990 to 1993. From 1972, he served 
the University of Colorado School 
of Medicine, was awarded the 
Ludwig Heilmeyer Gold Medal for 
his contributions to cytokine 
biology in internal medicine. The 
medal, presented at the annual 
meeting of the Heilmeyer Society 
last November, is the highest award 
granted by this organization of 
internal medicine professors in 
Germany, Austria and Switzerland. 
Dr. Dinarello has published more 
than 400 original research articles 
on cytokines, particularly on 
interleukin-i. He serves on the AIDS 
Program Advisory Council of the 
National Institutes of Health and 
the Board of Scientific Advisors of 
the National Institute of Allergy and 
Infectious Diseases. 
70s 
Robert J. Lerer, M.D., HS ’70-73, 
an Ohio pediatrician and board 
member of Caring Partners Interna¬ 
on the faculty at Harvard Medical 
School, becoming professor of 
medicine there in 1986. His 
research has focused on catechola¬ 
mines and the sympatho-adrenal 
system, as well as nutrition, obesity 
and hypertension. 
Dr. Landsberg’s son, Judd W. 
Landsberg, M.D. ’96, is a resident 
in medicine at the Yale-New Haven 
Hospital. [See related alumni/ae 
news item on opposite page.] 
—Nicholas P.R. Spinelli, M.D. ’44 
Send news of alumni/ae on campus to 
Dr. Spinelli in care of the Office of Alumni 
Affairs, P.O. Box 7613, New Haven, CT 
06519-0613. 
tional, has traveled during the last 
five years as a medical missionary to 
Nicaragua, Cuba, Russia, India and 
China. He also set up programs to 
provide ongoing care to children 
with disabilities and handicaps in 
Mexico and India. Dr. Lerer was one 
of the original founders of the Fair 
Haven Community Clinic in New 
Haven in 1971. 
Frederick L. Greene, M.D., HS 
’70-76, professor of surgery at the 
University of South Carolina School 
of Medicine, was awarded the 1996 
Distinguished Service Award by the 
Columbia (S.C.) Medical Society 
for his introduction of an anti¬ 
violence program into that city’s 
school system. 
John R Docherty, M.D., HS 
’71-74, professor and administrator 
at New York Hospital-Cornell 
Medical Center, was named chief 
medical officer and executive vice 
president of Merit Behavioral Care 
Corp. in Park Ridge, N.J., a 
managed behavioral health care 
organization. 
Jerry H. Morewitz, M.D., post¬ 
doctoral fellow ’77-79, director of 
geriatric psychiatry at Eastern 
Virginia Medical School in Norfolk, 
was named chairman of its depart¬ 
ment of psychiatry and behavioral 
sciences in January. Dr. Morewitz 
had served as interim vice chairman 
of the department since 1994. 
Paul E. Collier, M.D. ’79, was a 
speaker at the Society for Clinical 
Vascular Surgery in Sewickley, Pa., 
in March. His topics were: How 
Essential Is the Intensive Care Unit 
after Carotid EndarterectomyI; 
Do Clinical Pathways for Major 
Vascular Surgery Improve Outcomes 
and Reduce Costs?; Office Removal 
of Silastic Catheters and Ports Is 
Safe and Cost Effective; and Are 
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Preoperative Antibiotics Administered 
Preoperatively? 
80s 
Eric Holm, P.A. 
’80, was elected 
to the board of 
trustees of the 
new clinician-led, 
multi-specialty 
group practice 
created by the 
reorganization of Harvard Pilgrim 
Health Care’s Health Centers 
Division in Metro Boston. Mr. 
Holms is a physician associate in 
orthopaedics at the Copley and Post 
Office Square Health Centers. 
Marian T. Hannan, M.P.H. ’81, is 
president-elect of the Association of 
Rheumatology Health Professionals, 
a division of the American College 
of Rheumatology, and also senior 
research associate at the Hebrew 
Rehabilitation Center for the Aged 
in Boston. 
Glenn C. Isaacson, M.D., HS 82- 
83, has been appointed professor and 
chairman of the Department of 
Otorhinolaryngology at Temple 
University Health Sciences Center 
in Philadelphia. Dr. Isaacson was 
appointed deputy chair of otorhino- 
laryngology/bronchoesophagology 
at Temple in 1993, and was named 
acting chairman of the department 
in 1995. 
90s 
control in Vietnam in 1993 and 
Port-au-Prince, Haiti, in 1994 and 
1995. Dr. Jacobs is profiled in Who’s 
Who in America, in Medicine, and in 
the South and Southwest. He and his 
wife, Carolyn, adopted a daughter, 
Jenny, in Hanoi in 1993. 
Sujai D. Nath, M.D., HS 92-95, in 
private practice of general neurology, 
has joined the medical staff of South 
Florida Baptist Hospital in Plant City. 
Joseph Kwangho Choo, M.D. 93, 
married Je Un Kim in December in 
Memorial Church at Harvard 
University. Dr. Choo completed his 
residency in internal medicine at 
Brigham and Women's Hospital and 
has begun a fellowship at Massachu¬ 
setts General Hospital. 
Debra Howard, M.D. ’94, and 
Adam Schussheim, M.D., were 
married in December. Dr. Howard is 
an assistant chief resident in internal 
medicine at New York Hospital- 
Cornell Medical Center, and in July 
begins an endocrinology and me¬ 
tabolism fellowship at Columbia- 
Presbyterian Medical Center. 
Andreas Klein, M.D. ’95, and his 
wife, Jen, announce the birth of 
their son, Aaron Rothwell Cameron 
Klein, on April 1, 1996, in Boston, 
where Dr. Klein is a junior resident 
at the New England Medical Center. 
Judd W. Landsberg, M.D. 96, a 
resident in internal medicine at Yale- 
New Haven Hospital, was married 
last year in Houston to Sarita I. 
Ordonez, a recent graduate of New 
York University School of Taw. 
Timothy A. Jacobs, Ph.D., M.P.H. 
’91, ofTampa, Fla., is a consultant in 
international public health and 
infectious disease epidemiology. He 
practiced public health and disease 
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OBITUARIES 
Anne S. Bittker 
Anne Stern Bittker, 78, a former 
Yale Medicine editor and School of 
Medicine public relations officer, 
died Feb. 2 at Connecticut Hospice 
in Branford. She was 78. 
Mrs. Bittker received a 
bachelor’s degree from Connecticut 
College and began a career in 
advertising and public relations in 
New York City. She later worked for 
Research Publications Inc. and was 
a public relations officer for the 
New Haven Foundation. The wife 
of Boris I. Bittker, Sterling Professor 
Emeritus of Law at Yale, Mrs. 
Bittker joined the news bureau of 
Yale School of Medicine in 1966. 
From 1968 to 1970, she was associate 
managing editor of Yale Medicine. 
Howard D. Christiansen 
Howard D. Christiansen, M.P.H., 
of Moreland, Idaho, died Dec. 21 
of an apparent heart attack. At the 
time of death, he and his wife, 
Morita, were serving a mission for 
the Church of Jesus Christ of 
Latter-day Saints in Indianapolis. 
He was 63. 
Dr. Christiansen received a 
bachelor’s degree in agronomy from 
Brigham Young University and, in 
1967, a master’s degree in public 
health from the Yale School of 
Medicine. He worked in the nuclear 
weapons industry for various 
contractors of the Department of 
Energy. For two years, he worked 
for the Montana Board of Health, 
retiring in 1995. 
Arthur L. Coleman, Jr. 
Arthur L. Coleman Jr., M.D., of 
Clean, N.Y., died on Dec. 23. He 
was 73. 
Dr. Coleman graduated from 
Phillips Academy Andover in 1941, 
Amherst College in 1945 and the 
Yale School of Medicine in 1948. 
He completed his radiology and 
pediatrics internships at Lenox Hill 
Hospital in New York City and his 
residency at the Mallinckrodt 
Institute of Radiology and Barnes 
Hospital in St. Louis. He served 
in the U.S. Army Medical Corps. 
Dr. Coleman was the director of 
radiology in several New York 
hospitals, including the French- 
Polyclinic and Sisters of Charity. 
Frank H. D’Andrea 
Frank H. D’Andrea, M.D., died 
on Nov. 27 in Shoreham, Vt. He 
was 90. 
Dr. D’Andrea was accepted into 
Yale University at age 16 and 
received a bachelor’s degree in 1926 
at the age of 19. He continued on at 
Yale and received a medical degree 
in 1929. After interning at Stamford 
Hospital in Connecticut, he began 
his anesthesiology practice in 1935. 
He was one of the first 100 board- 
certified anesthesiologists in the 
country. Dr. D’Andrea was director 
of the anesthesia departments at 
both Stamford and St. Joseph’s 
hospitals and was a consultant for 
Greenwich and Norwalk hospitals. 
He served as chairman of the 
medical board at Stamford Hospital 
and Southwestern Connecticut 
Rehabilitation Center. 
Dr. D’Andrea retired from 
practice in 1974, moving to Ver¬ 
mont with his daughter and her 
family. He then served as a volun¬ 
teer medical missionary with the 
Catholic Medical Mission Board for 
10 years, teaching anesthesiology 
and practicing medicine in Papua, 
New Guinea; Guyana; and Colom¬ 
bia. In 1995 Dr. D’Andrea’s achieve¬ 
ments were honored in a video 
celebrating the 100th anniversary of 
Stamford Hospital, with which he 
was affiliated for 45 years. 
Iza Sznejerson Erlich 
Iza Sznejerson Erlich, M.S.W., died 
Feb. 9 at Yale-New Haven Hospital. 
She was 77. 
Mrs. Erlich, an assistant clinical 
professor of psychiatry in social 
work in the Department of Psychia¬ 
try, was born in Russia and raised in 
Poland, immigrating to the U.S. at 
the outbreak of World War II. She 
received bachelor’s and master’s 
degrees in psychology from the New 
School for Social Research in New 
York City. She then earned a 
master’s degree in social work at the 
University of Washington School of 
Social Work. From 1963 to 1983 she 
was a psychotherapist with Yale 
University Health Services in the 
Department of Mental Health. In 
1983 she graduated from Western 
New England Institute for Psycho¬ 
analysis, where she became the first 
social worker to be admitted for 
psychoanalytic training. After 
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graduating from the institute, she 
went into private practice as a 
psychoanalyst in New Haven. 
Sarah M. Ferguson 
Sarah M. Ferguson, died 
Nov. 23 at Hartford Hospital in 
Connecticut. She was 85. 
Miss Ferguson received a 
bachelor’s degree in nursing from 
Columbia University, an R.N. 
degree from Boston Children’s 
Hospital, and then a master’s degree 
in public health in 1955 from the 
Yale School of Medicine. She was 
head of pediatric services for 
Cornell Medical Center in New 
York City for 20 years. Miss 
Ferguson also worked as a visiting 
nurse in Connecticut. In 1987 she 
was honored as Woman of the Year 
for Rocky Hill, Conn. 
Paul F. Finlayson 
Paul F. Finlayson, M.D., M.P.H., 
died March 1 at his home in 
Wahroonga, Australia. He was 60. 
Dr. Finlayson received a 
medical degree and a diploma in 
psychological medicine from the 
University of Sydney, and a master’s 
degree in public health from Yale in 
1972. In 1989 he was awarded a 
doctorate in medicine from Sydney 
University. Dr. Finlayson worked as 
a staff psychiatrist for public 
hospitals for 36 years until his early 
retirement in 1994 because of ill 
health. At the time of his death, he 
was a clinical senior lecturer in 
psychiatry for the University of 
Sydney Medical School and a 
consultant psychiatrist. Dr. 
Finlayson pioneered and worked on 
three unique community programs: 
the Ku-ring-gai Neighbourhood 
Service, the Grief Support Tele¬ 
phone Service and Dial-A-Mum 
Telephone Support Service for 
people in distress. In a recent list of 
the Queen’s Birthday Honours, he 
was recorded among the Members 
of the Order of Australia. 
J. Wister Meigs 
J. Wister Meigs, M.D., of North 
Branford, Conn., died March 19 at 
the Evergreen Woods Health 
Center. He was 82. 
Dr. Meigs was a 1936 graduate 
of Princeton University and in 1940 
received a medical degree from 
Harvard Medical School. He 
completed his internship at Pennsyl¬ 
vania Hospital in Philadelphia and 
his residency at Massachusetts 
General Hospital. From 1945 to 
1947, Dr. Meigs served in the office 
of the surgeon general of the Army 
as a major attached to the industrial 
hygiene laboratory. In 1947 he 
joined the faculty of Yale as an 
instructor in the Department of 
Epidemiology and Public Health 
and served as director of residency 
training in preventive medicine 
while at Yale. Between 1953 and 
1968, Dr. Meigs was chief of 
medical services to the New Haven 
Works of the U.S. Steel Corp. 
During the mid-1970s, his 
studies in occupational medicine led 
to a six-month research trip to Japan 
to work at the Atomic Bomb 
Casualty Commission. After 1973, 
Dr. Meigs’ work focused mostly on 
cancer epidemiology. He became 
director of the Connecticut Cancer 
Epidemiology Unit at Yale, where he 
expanded the use of the Connecticut 
Tumor Registry as a source of reliable 
data for cancer researchers. Dr. Meigs 
also worked as a consultant on safety 
and health to the United Illuminat¬ 
ing Co., the Upjohn Co. and the 
Olin Corp., and was a founder of the 
Occupational Medical Association 
of Connecticut. 
TO GIVE AWAY MONEY IS 
AN EASY MATTER AND IN 
ANY MAN’S POWER. BUT 
TO DECIDE TO WHOM TO 
GIVE IT, AND HOW LARGE 
AND WHEN, AND FOR 
WHAT PURPOSE AND HOW, 
IS NEITHER IN EVERY 
MAN’S POWER NOR AN 
EASY MATTER. 
Aristotle 
Assuming you would 
consider the School of 
Medicine as one of your 
intended beneficiaries, 
we stand ready to help you with 
when, for what purpose, and 
how. 
Planned giving 
is one of our specialties. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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David M. Pugh 
David M. Pugh, M.D., died Jan. 29 
at his home in Mission, Kan. He 
was 67. 
After receiving his bachelor’s 
degree from the University of 
Rochester in 1951, he served as an 
officer during the Korean conflict. 
Dr. Pugh received his medical 
degree from Yale in 1958. He 
completed his internship at 
Bethesda Naval Hospital and his 
residency and a cardiology fellow¬ 
ship at the University of Washing¬ 
ton. Dr. Pugh had been a professor 
of cardiology at Kansas University 
Medical Center since 1964. He was 
instrumental in starting CPR 
training in the Kansas City area and 
in training medical professionals in 
advanced cardiac life support. 
Edward H. Soule 
Edward H. Soule, M.D., died 
Dec. 1 at his home in Rochester, 
Minn. He was 80. 
Dr. Soule received a bachelor’s 
degree from Bowdoin College in 
Maine in 1939, a medical degree 
from Yale in 1943, and completed 
his internship at Maine General 
Hospital in Portland in 1944. From 
1944 to 1946, he served in the Navy 
Medical Corps. After his discharge, 
he returned to Maine General 
Hospital as a resident in pathology. 
In 1948 Dr. Soule became a resident 
in pathology at the Mayo Clinic 
and entered the Mayo Graduate 
School of Medicine. He served as an 
assistant to the staff from 1951 to 
1952, and was appointed to the 
permanent staff as a consultant in 
surgical pathology in 1952, a post he 
held until his retirement. Dr. Soule 
joined the faculty of the Mayo 
Graduate School of Medicine in 
1956 and was promoted to assistant 
professor in 1959 and associate 
professor in 1964. From 1969 until 
his retirement, he was a professor 
of pathology and head of a section 
of surgical pathology. 
Robert K. Watson 
Robert K. Watson, Ph.D., died Feb. 
21 at Yale-New Haven Hospital. 
He was 55. 
Dr. Watson received a bachelor’s 
degree in psychology from Antioch 
College in Ohio in 1964 and a 
Ph.D. degree in clinical psychology 
from the University of Chicago in 
1972. He opened the first sleep 
disorders center in Connecticut at 
Griffin Hospital in Derby in 1980 
and, in 1983, opened the New 
Haven Sleep Disorders Center. Dr. 
Watson held a clinical appointment 
at Yale in the Department of 
Medicine from 1988 to 1992 and was 
a lecturer in the Department of 
Psychiatry from 1983 until his death. 
Benjamin Wiznia 
Benjamin Wiznia, M.S.W., died 
Feb. 22 at Yale-New Haven Hospi¬ 
tal. He was 86. 
Mr. Wiznia emigrated from 
Poland to the United States in the 
early 1920s. He graduated from City 
College of New York and received a 
master’s degree in history from 
Columbia University and a master’s 
degree in social work from Fordham 
University. Mr. Wiznia was a 
psychiatric social worker for nearly 
50 years. Early in his career, he 
worked on American Indian 
reservations in Arizona and, subse¬ 
quently, with the Veterans Adminis¬ 
tration there. He was the chief 
psychiatric social worker at the VA 
Connecticut HealthCare System’s 
West Haven campus and a clinical 
instructor of psychiatry at the Yale 
School of Medicine. 
IN MEMORIAM 
Arthur L. Coleman Jr., M.D. ’48 
December 23, 1996 
Frank H. D’Andrea, M.D. ’29 
November 27, 1996 
Kent Ellis, M.D. ’50 
December 1, 1996 
Sarah M. Ferguson, M.P.H. ’55 
November 23, 1996 
Alice Dershimer Friedman, M.D. ’45 
February 5, 1997 
Henry H. Henstell, M.D. ’33 
December 26, 1996 
Sidney Hurwitz, M.D. ’54, HS ’69-71 
November 13, 1993 
Louise G. Hutchins, M.D. ’36 
September 3, 1996 
Louis Jack, M.D. ’23 
November 19, 1996 
Gerald R. Nowlis, M.D. ’48 
September 30, 1996 
Dorothy G. Pederson, M.P.H. ’55 
September 18, 1996 
Edward Hersey Soule, M.D. ’43 
December 1, 1996 
64 SUMMER 1997 
ALUMNI AFFAIRS 
A letter from the AYAM president 
By Lycurgus Davey, M.D. ’43M 
It is with reflective pleasure that 
I view my past two years as 
president of the Association of 
Yale Alumni in Medicine (AYAM). 
The term started on a note of 
uncertainty within the Office of 
Alumni Affairs. Art Crovatto, M.D. 
’54, H.S. ’54-61, was stepping down 
as director. As an alumnus, he 
showed both a special dedication to 
the medical students—our future 
alums—and a faculty for promoting 
greater communication among 
alumni groups. We feared a real gap 
in our activities would be created 
with his leaving. Bill Jenkins came 
over from the Office of Develop¬ 
ment and filled in that gap with 
such energy, enthusiasm, expertise 
and cooperative spirit that he fairly 
blew away all doubts. His long 
hours of work and effort have put 
an indelible personal stamp on 
the results. 
In our Executive Committee 
meetings, attended by upwards of 
20 people three times a year, we’ve 
noticed growing attendance and a 
wider geographical mix, with 
attendees more often traveling from 
afar. For me, the most refreshing 
part of these meetings has been the 
presentations by the president of the 
Student Council, Alicia Arbaje ’99. 
The exceptional quality of Yale 
medical students is exemplified by 
their activism. Another special 
group at the meetings are the 
medical school representatives to the 
Association of Yale Alumni convoca¬ 
tions on the main campus. 
The alumni affairs office still 
has a desk for our consultant and 
former director, Nick Spinelli, M.D. 
’44. On Mondays, he is joined with 
a degree of regularity by Jack 
Ogilvie, M.D. ’34, along with Sam 
Kushlan, M.D. ’35, chairman of 
bequests and endowment on the 
Alumni Fund Board. Their com¬ 
bined wisdom represent an impor¬ 
tant contribution to our efforts to 
improve contact and service to 
all alumni. 
Contact with alumni has been 
enhanced by the Outreach Program, 
which was launched in Boston in 
the spring of 1995. Meetings have 
extended west to San Francisco and 
San Diego, south to Orlando, and 
locally in New Haven and West¬ 
chester County, N.Y. Except for a 
tremendous turnout in Washington, 
D.C., these gatherings have been 
intimate in scale with camaraderie, 
spirit and general good feeling. 
This program has been my favorite, 
as I could share with others my 
gratitude and obligation to the 
school for fostering, in our medical 
education, the ideals and principles 
that have boosted our professional 
lives a cut above others. 
No effort was made to solicit 
funds at these gatherings, as this was 
not our duty, but neither were the 
more pressing needs of the school 
kept secret. When Dean Gerard 
Burrow was able to be present, he 
reported on the state of the school 
and usually mentioned in passing 
the crying need to refurbish the 
Harkness dormitory as well as the 
antiquated anatomy laboratories. 
They have changed from their 
origins in the 1930s only in being 
more crowded, with well over too 
students cramped in the same stuffy 
space that once housed 50. 
For our day-to-day needs, 
thanks must be extended to Patty 
DiNatale who has filled in ably in 
the past six months for the ailing 
Connie Tolliver, the perennial 
mother of all alumni activities. 
Connie is recovering nicely from a 
stroke suffered in January of this 
year—fortunately not a severe one. 
With the aid of a rehabilitation 
program, an early return to the 
office may be possible. 
Finally, I must express my pride 
and pleasure in having served as 
your president. With justifiable 
confidence built on long association, 
I pass on the “torch” to my succes¬ 
sor, Nicholas M. Passarelli, M.D. 
’59, HS ’59-65. 
Lycurgus “Bill”Davey, M.D. ’43M 
is the outgoing president of the 
Association of Yale Alumni in 
Medicine. 
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Grateful patients, grateful doctors 
Stethoscope, syringe, scalpel, clamp, tin cap. 
This brochure was 
conceived by Andrew 
McGowan, M.D. ’78, and 
created in consultation 
with the board of directors 
of the Yale Alumni Fund 
in Medicine. The brochures 
are available free by 
contacting: Bonnie Sargent, 
Office of Development, P.O. Box 
7611, New Haven, CT 06719. 
E-mail bonnie.sargent@yale.edu 
or call (207) 787-6760. 
By David Davison 
May I have $110 million please? 
(Pause) 
Yes. 
t was probably not this simple 
for Jon Huntsman, a cancer 
patient who expressed his grati¬ 
tude to his physician by contribut¬ 
ing this record-breaking sum a few 
years ago to fund a building now 
known, not surprisingly, as the 
Huntsman Cancer Institute at the 
University of Utah. 
A more likely scenario in today’s 
world was experienced recently by 
Alan W. Stone, M.D. ’65, a Wash¬ 
ington, D.C., internist, who was 
asked by a patient, “Doctor, what is 
your favorite charity?” In the past, 
Dr. Stone had been unsure how to 
respond. On this occasion, he pulled 
out of his desk drawer a brochure 
titled Your Doctor Graduated from 
Yale University School of Medicine 
and mailed it to his patient. In a 
straightforward and low-key style, 
the brochure provides information 
about making a donation to the 
David Davison is director of 
development for the School of 
Medicine. Write to him at the Office 
of Medical Development, 100 Church 
Street South, Suite 211, New Haven, 
CT 06719, or via e-mail at 
da vid. da viso n @yale. edu. 
school. It acted almost Kjmgjm 
as a third party 
between Dr. Stone 
and his patient. The 
result was a $1,000 
contribution sent to 
Yale School of 
Medicine by a 
grateful patient. Mj, 
Is the 
doctor-patient Jwlg! i ' |L 
relationship 
contaminated by 
such an exchange? Since it was 
the patient who brought up the 
subject, Dr. Stone saw no problem. 
“In that circumstance I was com¬ 
fortable answering ‘Yale School of 
Medicine.’ I found it was helpful to 
have the brochure available. It’s 
something tangible to use.” 
The brochure served Dr. Stone 
and the patient/donor as a useful 
tool, explaining the reasons why a 
donation to Yale is worthwhile, 
representing the school’s message of 
need for support of its teaching and 
research missions, and providing the 
simple but essential details about 
where to send a gift. 
In certain circumstances, it can 
be helpful to both the doctor and 
the patient for the third-party 
intermediary to be a volunteer or a 
professional development officer. 
Judith Winslow, associate director of 
the Yale Cancer Center, has had the 
unusual experience of acting first in 
the role of grateful patient, then as a 
dedicated volunteer, and finally, this 
past year, as a full-time professional 
development officer. Ms. Winslow, 
who was treated successfully for 
fibrosarcoma more than 20 years 
ago, helped found the Patient to 
Patient group at Memorial Sloan- 
Kettering Hospital and served on 
the board of its fund-raising auxil¬ 
iary. When Vincent T. DeVita Jr., 
M.D., director of the Yale Cancer 
Center, decided he wanted a full¬ 
time development specialist to help 
increase fund-raising activity for 
cancer research, he invited Ms. 
Winslow to join his team. 
As a development officer 
representing the school and the 
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Yale Cancer Center, she can ask 
appropriate and essential questions 
that might be awkward for the 
physician to ask the grateful patient, 
or vice versa. For example, a patient 
might not want to ask the doctor 
about either the tax advantages of- a 
particular method of giving, or the 
gift recognition policies and oppor¬ 
tunities provided by Yale. Tax breaks 
and public praise are probably not 
the reason the person wants to make 
a gift, but with the right answers 
available through a tactful inter¬ 
preter like Judith Winslow, a more 
generous gift can result that benefits 
everyone involved. 
While the nuances and intima¬ 
cies of the doctor-patient relation¬ 
ship cannot be generalized, there 
often may be very appropriate times 
to ask for gifts. What if a physician 
has a very trusting, long-term 
relationship with a patient, and 
knows that the patient’s family is 
generous and philanthropic in the 
community. When and how is it 
okay to ask? 
“If a patient undergoing 
treatment brings up the subject of a 
contribution with the physician, 
then it’s appropriate,” Ms. Winslow 
offers. “If time has passed since suc¬ 
cessful treatment, and a physician is 
trying to fund expanded research in 
his laboratory, for example, it might 
be fine to reach out to former 
patients and ask for help.” 
Volunteer support groups are 
often formed to provide platforms 
for activity and outlets for people 
dedicated to supporting biomedical 
research and patient care. Benefit 
dinners, charity auctions and 
theater parties are the common 
result. 
Once in a while, gratitude 
walks through the door unan¬ 
nounced. Early this year, George 
Zepko walked into the Develop¬ 
ment Office and introduced 
himself. Seven years ago, suffering 
from Marfan syndrome, he received 
a new ascending aorta and aortic 
valve from Dr. John Elefteriades. 
Dr. Lawrence S. Cohen was, and 
still is, his cardiologist. Now Mr. 
Zepko wanted assistance in devising 
the best tax-wise strategy for leaving 
a large portion of his estate to Yale 
in honor of his doctors. The 
development officer asked him what 
had motivated the decision. He 
replied, “It’s my way of thanking 
Dr. Cohen and Dr. Elefteriades for 
what they have done for me.” 
Much of the time, a patient’s 
interest and generosity is more than 
a case of personal gratitude. It can 
be a long-term involvement devel¬ 
oped through an understanding of 
the needs and the opportunity to 
cure disease. 
Stephen G. Waxman, M.D., 
Ph.D., chairman of the Department 
of Neurology, has received support 
from grateful patients and their 
families since before coming to Yale 
from Stanford in 1986. He points 
out his responsibility to communi¬ 
cate in depth with each patient 
about their disease, and emphasizes 
the ongoing dialogue that often 
develops with chronic-disease 
patients. For example, multiple 
sclerosis (MS) patients need to know 
about upcoming drug-trial options, 
as well as the long-range potential 
for research progress. Dr. Waxman 
has taken the time to keep former 
patients regularly informed about 
the progress of his own research in 
MS and spinal-cord injury. In special 
cases, where patients have asked for 
more information regarding gift 
possibilities, he has involved the 
Development Office to write 
proposals and make personal visits. 
“Yale physicians give the best 
care possible to every patient, 
irrespective of the ability to pay,” 
says Dr. Waxman. “No one thinks 
about gifts or gratitude. However, 
we educate patients about their 
disease and about the importance of 
training and research in medicine. 
When it’s appropriate, we let 
patients and families know that if 
they wish, they can help in the effort 
to advance the frontiers. We’ve 
found that once they understand 
that progress is being made, they 
often want to become partners.” 
Gratitude, obviously, cuts both 
ways for Dr. Waxman and Yale. 
“The gifts of private individuals, 
including patients, are invaluable to 
our research efforts. We couldn’t 
succeed without that help.” 
Left: From the last will and testament of 
Elizabeth S. Nixdorff, who died in 1974- 
Dr. German, a renowned professor at Yale 
(and father of John German, M.D. '62), 
had treated her husband. When she 
created her will in 1966, she consulted her 
personal physician, Nicholas P.R. Spinelli, 
M.D. ’44, who helped her decide to fund 
a professorship at Yale. 
ARTICLE THIRD. 
(b) I give and bequeath the sum of FIVE HUNDRED THOUSAND 
DOLLARS ($500,000) to establish and maintain a professorship 
in neurosurgery in the Yale University School of Medicine. 
This bequest is made in memory of my late husband, CHARLES 
EDWARD NIXDORFF, and the net income therefrom to be expended 
to establish and maintain a professorship in recognition of 
the many contributions to medicine of DR. WILLIAM J. GERMAN; 
accordingly, it is my request that the holder of this profes¬ 
sorship shall be designated by the University as THE NIXDORFF- 
GERMAN PROFESSOR OF NEUROSURGERY. 
YALE MEDICINE 67. 
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letters Association of Yale 
Alumni in Medicine 
It’s a Yale thing 
To the editor: 
I read with interest your article 
about the free clinic in San Fran¬ 
cisco started by two Yale medical 
school graduates (Pure Medicine, 
Fall/Winter 1996). You may be 
interested to know that about the 
time the Drs. Gibbs started their 
clinic, I started one in Biddeford, 
Maine. I am a graduate of Yale 
College 1956 and the medical school 
i960. I have also had two sons 
graduate from Yale College, in 
1986 and 1994. 
Our clinic is slightly different 
from that of the Drs. Gibbs in that 
our staff is all volunteer, and we 
are open three evenings a week. 
We see only patients without health 
insurance and we provide free 
general medical care on site as well 
as free non-narcotic medications. 
I have enclosed a recent article 
from Parade magazine about our 
How to reach us 
Yale Medicine welcomes news and 
commentary. Please send letters to 
the editor and news items to 
Yale Medicine, P.O. Box 76x2, 
New Haven, CT 06519-0612, or via 
electronic mail to ymm@yale.edu, 
and include a daytime telephone 
number. Submissions may be edited 
for length, style and content. 
clinic, as well as a copy of our 
annua! report. 
I much enjoyed your clear and 
concise article. Perhaps free clinics 
are a Yale thing. 
Francis J. Klee man, M.D. 56o 
Biddeford, Maine 
Officers 
Nicholas M. Passarelli, M.D. ’59 
President 
Gilbert F. Hogan, M.D. ’57 
Vice President 
Peter N. Herbert, M.D. ’67 
Secretary 
Lycurgus M. Davey, M.D. ’43 
Past President 
Executive Committee 
Joseph F.J. Curi, M.D. ’64 
Mary V. Digangi, M.D. ’64 
John W. Foster, Jr., M.D. ’71 
R. Leonard Kemler, M.D. ’43 
Robert J. Kerin, M.D. ’47 
Jocelyn S. Malkin, M.D. ’51 
Dwight F. Miller, M.D. ’56 
Donald E. Moore, M.D., M.P.H. ’81 
Lynn W. Reiser, M.D. ’7° 
Ex-officio 
David A. Kessler, M.D. 
Dean 
William K. Jenkins 
Managing Director, Alumni Affairs 
Daniel L. Arons, M.D. ’67 
Chair, YSM Alumni Fund 
Samuel D. Kushlan, M.D. ’35 
YSM Bequest and Endowment 
Representatives to the 
Association of Yale Alumni 
Frank R. Coughlin, Jr., M.D. b2 
Martin E. Gordon, M.D. ’46 
Michael Kashgarian, M.D. ’58 
Benjamin E. Lyons, M.D. ’38 
James D. Prokop, M.D. ’59 
Theoharis C. Theoharides, M.D., Ph.D. ’83 
AYAM Representative, 
Medical School Council 
William K. Jenkins 
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COMING NEXT ISSUE 
Avenues 
for innovation 
Yale’s position on the commercial¬ 
ization of university-based scientific 
research has evolved from modest 
support to active encouragement in 
recent years. Now, with a new 
branch of the University’s Office of 
Cooperative Research on the 
medical campus, biomedical 
discoveries made at Yale are more 
likely than ever to be developed for 
the practical advantage of patients. 
Commencement 
and the ’97 Match 
Medical and public health graduates 
marched forth under a clear blue sky in 
May, as Commencement exercises 
recognized the best and the brightest. 
Residency placement results on Match 
Day also brought good news for many. 
The complete list next issue. 
New dean speaks at EPH opening 
David A. Kessler, M.D., above right, talks with Dean for Public Health 
Michael H. Merson, M.D., before the dedication of renovated space for 
Epidemiology and Public Health in early June, as Yale Medicine went 
to press. Dr. Kessler, who addressed the public health assembly and met 
alumni/ae at a reception later in the day in the Medical Historical 
Library, becomes the 19th dean of the School of Medicine on July i. 
Additional coverage in the Fall issue of Yale Medicine. 
Reunion fun 
What does it take to get 
a reunion rolling? 
This June it was 
The Cellmates, a 
band of rocking Yale 
researchers that includes 
BBS Program Director 
Ira Mellman, Ph.D., 
left, on bass and 
Pharmacology Chair 
Leonard Kaczmarek, 
Ph.D., on guitar. 
Above: Members of the 
Class of 195y pose for a 
photograph on the steps 
of Sterling Hall of 
Medicine at the end of 
Alumni Reunion 
Weekend. 
PHOTOGRAPHS BY PETER CASOLINO 
Yale Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
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Good Ideas cover story 
After years of skepticism and modest support for partnerships with 
industry, Yale has thoroughly reinvented its approach to the commercialization 
of University research. Ideas hatched at the medical school have spawned more 
than three dozen startup companies and contributed significantly to the 
University’s patent royalties in recent years. But more importantly, new 
therapies based on these innovations will reach patients faster. 
By Karen Schmidt 
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Profile: David W. Barry 
Leader of the teams that developed the AIDS drug AZT and the anti-viral 
acyclovir, alumnus David W. Barry left industry giant Glaxo Wellcome to 
launch his own pharmaceutical company in North Carolina’s Research 
Triangle. In the pipeline: a stable of promising anti-cancer and anti-viral 
drugs, including five for HIV. 
By Terrence Noland 
20 Notes From a Navajo Winter 
The landscape and people of northeastern Arizona bring a Yale medical student 
face to face with new concepts of health and medicine—and an appreciation 
for the complexities of delivering care in a remote setting. 
By Gregory Raskin ’p8 
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D r v e n 
Yales expanded 
Office of Cooperative 
Research links the realms 
of academia and industryy 
translating scientific 
discoveries into better care 
for patients and support 
for future research. 
By Karen Schmidt 
Photographs by Frank Poole 
When cell biologist Ira Mellman, second from left, uncovered new 
knowledge about the properties of dendritic cells, Jon Soderstrom, 
Ben Muskin and Gregory Gardiner, from left, of the Office of 
Cooperative Research saw the seed of a new business venture. 
w. Ira Mellman, Ph.D., and his colleagues 
began studying the biology of dendritic cells and their 
role in the immune system, like most basic scientists 
they didn’t have a specific clinical goal in mind. 
“We got involved because they looked like interest¬ 
ing cell-biologic creatures,” says Dr. Mellman, professor 
of cell biology and director ol the Program in Biological 
and Biomedical Sciences. Dendritic cells change shape 
and function dramatically as they develop through dis¬ 
tinct stages, first capturing a loreign protein, then taking 
information about the invader to the lymph nodes to 
educate T-cells. “They play a critical role in initiating the 
immune response,” Dr. Mellman says. 
It became clear that the ability to control the devel¬ 
opment of dendritic cells might lead to new therapies to 
treat autoimmune disorders such as rheumatoid arthritis 
and Crohn’s disease. The next step, Dr. Mellman 
thought, would be a genomic study to determine “what 
genes were being turned on and turned off at each of the 
three stages of dendritic cell development.” That re¬ 
quires highly specialized technology, so he approached a 
genomics company and spoke to a pharmaceutical firm 
about funding the work. 
But when Gregory E. Gardiner, Ph.D., director ol 
the University’s Office of Cooperative Research, heard 
about the work, he proposed a different approach to the 
funding. Dr. Gardiner suggested establishing a new drug 
discovery company based on Dr. Mellman's techniques 
for exploiting dendritic cells’ unique properties. The 
Office of Cooperative Research has already drafted a 
business plan for Dendritic Cell Sciences Inc., and is 
working on securing investors. 
When Dr. Gardiner arrived in February 1996 from a 
position as group director of research and development 
operations for Pfizer Central Research in Groton, 
Conn., he brought scientific expertise and more than 
two decades of experience in the pharmaceutical indus¬ 
try. His goal: to promote the University’s intellectual as- 
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“We got involved 
because they looked like 
interesting cell-biologic 
creatures. ... They play a 
critical role in initiating 
the immune response, ” 
Recent discoveries about dendritic cells, Ira Mellman says, may lead 
to better treatments for autoimmune disorders such as rheumatoid 
arthritis and Crohn’s disease. 
sets and find the best ways to manage and develop them. 
The idea is to take the discoveries and inventions 
hatched inside the halls of academia and put them out 
in the world where they can earn the University some 
revenue, and more importantly, do some good. 
“One reason a major research university like Yale 
must concern itself with technology transfer has to do 
with revenues, to be sure,” says Yale Provost Alison F. 
Richard, Ph.D. “But of equal importance is the value 
of making discoveries quickly available to the benefit 
of society.” 
For example, Stephen G. Waxman, M.D., Ph.D., 
chair of the neurology department, is working on tech¬ 
nology that could be used to treat cerebral edema and 
glioma, a kind of brain cancer. “If we’re going to use 
society’s dollars, we should try to deliver something for 
society,” says Dr. Waxman, professor of neurology, 
pharmacology and neurobiology. The marketplace, he 
adds, is often the vehicle that brings new discoveries to 
the public. “If you discover penicillin and keep it in the 
laboratory, it can’t benefit society. It is important to 
Karen Schmidt is a New Haven-based writer specializing 
in science and medicine and a student in the Department 
of Epidemiology and Public Health. 
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have a bridge that can take laboratory results and, with 
appropriate academic safeguards, carry them into the 
clinical domain.” 
NURTURE AND NATURE 
“University researchers have always wanted their results, 
their ideas, their discoveries, to flower in the commu¬ 
nity,” says Carolyn W. Slayman, Ph.D., deputy dean for 
academic and scientific affairs at the medical school. In 
the past it was publication in a journal, not commercial¬ 
ization, that served as the transfer point. “You put your 
results out there and you hoped people would see them 
and use it.” 
That doesn’t work anymore, Dr. Gardiner says. If a 
company can’t be assured of exclusive rights to a new in¬ 
vention, it has no incentive to spend, say, $350 million 
to bring a new drug to the market. That reality has led 
academic scientists into a sometimes unfamiliar world of 
patents, licensing, start-up companies and venture capi¬ 
tal. But some universities, including Yale, have been slow 
to embrace the idea that academia can work with indus¬ 
try without losing sight of its educational mission. 
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“In my 27 years at Yale, I have seen a very gradual 
evolution in the attitudes of the University’s scientists, 
engineers and administration toward the commercializa¬ 
tion of University-based scientific research,” says Yale 
President Richard C. Levin, “an evolution of attitudes 
from skepticism, to modest support, to active encour¬ 
agement.” Former medical school Dean Leon E. 
Rosenberg, M.D., HS ’63, now senior vice president for 
scientific affairs at Bristol-Myers Squibb Co., has 
observed the same progression. “I think that Yale was 
certainly very cautious about the involvement of its 
faculty with the private, for-profit world.” 
Involvement with business was not supposed to be 
the scientist’s role in society, says Alan C. Sartorelli, 
Ph.D., the Alfred Gilman Professor of Pharmacology. 
Instead, the scientist was encouraged to cultivate a kind 
of noble detachment. “We were supposed to be pure 
and they not so pure because they were interested in 
money,” he says. 
“Our mission is primarily an educational one, ” says OCR leader Gregory 
Gardiner. “As long as any business arrangement furthers that mission in more than 
just a monetary way, we’ll consider it. ” 
The right chemistry 
Sometimes the idea for a new 
therapeutic compound comes from a 
biologist. Sometimes the idea comes 
from a medicinal chemist. At Yale, 
close collaboration between the two 
has led to the design of some 
remarkable drugs. 
From the first antiviral com¬ 
pound, discovered by William H. 
Prusoff, Ph.D., professor emeritus 
and senior research scientist, to the 
more recent anti-AIDS drug d4T, 
licensed to Bristol-Myers Squibb Co. 
in 1986 and now marketed under 
the brand name Zerit, Yale research 
has benefited from such a collabora¬ 
tion. Zerit, a reverse transcriptase 
inhibitor, grew from a collaboration 
between Dr. Prusoff and the late Tai- 
Shun Lin, Ph.D., a medicinal chemist. 
In 1985, Dr. Prusoff and Dr. Lin 
began investigating whether the 
compound would inhibit the growth 
of HIV. 
“It’s an interactive process,” 
says Yung-Chi Cheng, Ph.D., the 
Henry Bronson Professor of Pharma¬ 
cology, professor of medicine, and 
director of the Developmental 
Therapeutics program of the Yale 
Cancer Center. The program links 
researchers from labs throughout 
the medical school. Licensed 
inventions in just the past few years 
include an anti-hepatitis B compound 
that is in Phase III clinical trials, two 
anti-cancer treatments in Phase I 
clinical trials, and two other antivirals 
expected to go into clinical trials 
within a year, Dr. Cheng says. 
Dr. Cheng stresses the 
importance of maintaining the 
department’s strength in chemistry. 
“Our chemistry strength is weaken¬ 
ing,” he says. “The situation needs 
to be addressed in order to continue 
discovering compounds.” 
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"In my 27 years at Yale, I have seen a very gradual evolution in the 
attitudes ... toward the commercialization of University-based 
scientific research, an evolution of attitudes from skepticism, to 
modest support, to active encouragement.” 
Yale President Richard C. Levin 
But two of Yale’s biggest biomedical successes in 
recent years were developed in close partnership with 
industry: the anti-AIDS drug Zerit and Lyme disease 
vaccines lor people and animals. The newly expanded 
Office of Cooperative Research, which now has a branch 
in the Sterling Hall ol Medicine, has been working 
closely with Yale scientists to develop and, where 
appropriate, commercialize their discoveries. 
For example, the office is formulating a business 
plan for a drug discovery company based on the work of 
Prolessor Yung-Chi Cheng, Ph.D., the Henry Bronson 
Prolessor of Pharmacology, professor ol medicine, and 
director ol the Developmental Therapeutics program ol 
the Yale Cancer Center. Dr. Cheng’s work on antiviral 
drugs has already led to numerous patents, and his 
current work could lead to antiviral agents that could be 
used against hepatitis, herpes, Epstein-Barr virus and 
cytomegalovirus. 
Richard L. Edelson, M.D. ’70, chairman ol the 
Department of Dermatology, is continuing work on 
improving a photopheresis treatment for a type ol 
lymphoma; his new discoveries about the process ol 
photopheresis could lead to treatments for leukemia and 
chronic inflammatory and autoimmune diseases. 
Technology transfer is the only practical way to take 
these discoveries out ol the lab and into a clinical setting 
where they may someday help treat patients, says Jon 
Soderstrom, Ph.D., associate director of the Office ol 
Cooperative Research and one ol three people who staff 
the medical school branch. 
“If we re doing research in the life sciences, I would 
say we have an obligation to see it receives the broadest 
exposure possible,” Dr. Soderstrom says. The office’s job 
is to link the worlds ol business and academia, and to 
take the burden off scientists, who may not have the 
business savvy to know which strategy is best to develop 
a particular discovery. 
“The scientists,” Dr. Soderstrom says, “can continue 
to be the scientists.” 
FROM ACADEMIA TO INDUSTRY 
Yale scientists have been studying Lyme disease since the 
malady was identified here in 1975. But when the team 
working on a Lyme vaccine was ready to move into 
clinical trials, it was time to transfer the technology out 
of academia and into the private sector. It wasn’t just a 
matter ol money, says team member Richard A. Flavell, 
Ph.D., chief of immunobiology and a Howard Hughes 
Medical Institute investigator. It was common sense. 
Deputy dean Carolyn Slayman with OCR representatives 
Soderstrom, left, and Muskin. “ They have been so successful at 
generating interest among the faculty that they have more potential 
startup companies than there is space for in New Haven. ” 
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“We did what you should do and can do in a 
university. We proved the concept to be correct,” says 
Dr. Flavell. After showing the vaccine worked in ani¬ 
mals, it was up to a pharmaceutical company— 
SmithKline Beecham, in this case—to handle the 
clinical trials and regulatory approvals. 
“I want to be doing research,” Dr. Flavell says, as 
opposed to “writing the standard operating procedures 
for how a drug should be made.” Dr. Flavell, who 
previously served as chief scientific officer and vice 
president for research and development at Biogen, one 
of the first biotechnology companies, knows the tech¬ 
nology transfer field from both sides. 
“The university is the place where basic research is 
done, and it’s not the place where applied research is 
done,” he says. “Most basic research is done in universi¬ 
ties, so technology transfer is an essential component 
of the development of applications of publicly 
funded research. It’s a natural process, and it should 
be encouraged.” 
But even top research universities like Yale have 
been reluctant to tackle the complicated financial and 
ethical issues that may crop up when discoveries made 
on campus succeed commercially. University administra¬ 
tions may be concerned that a faculty member’s commit¬ 
ment to an outside, private enterprise could mean less 
time and energy devoted to classroom, clinical or 
scholarly pursuits. 
The reluctance could also stem from unfamiliarity 
with industry. Until about a quarter-century ago, 
biologists didn’t have to concern themselves with 
conflicts of interest or conflicts of commitment because 
commercialization was often not even a possibility, Dr. 
Flavell says. The reason was simple: Unlike engineers or 
chemists, “biologists had never been involved in any¬ 
thing that would lead to a commercial product,” he says. 
Even though great discoveries, such as the structure 
of DNA, were being made, until gene cloning became 
possible in the early 1970s there was a general belief that 
molecular biology would not lead to anything truly 
useful. “Biologists just weren’t used to that kind of 
thing,” he says. 
In addition, until 1980 federal law gave universities 
only limited rights to license inventions that resulted 
Cumulative Royalty income to Yale University, 1977-1997 (in millions of dollars) 
30 —I 
Most of the growth is 
attributable to Zerit, an 
AIDS drug discovered at Yale 
that has been used to treat 
hundreds of thousands of 
people with HIV. 
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from government-funded research. Says Dr. Gardiner: 
“What really started the university technology transfer 
offices going is that the federal government said univer¬ 
sities can take title to a patent.” 
The Bayh-Dole amendments, enacted by Congress 
in the early 1980s, led to the establishment of technology 
transfer offices, including Yale’s. But the offices carried a 
heavy burden of paperwork and tended to focus on 
regulatory compliance instead of business development. 
“The Bayh-Dole amendments have had the net 
effect of causing all invention disclosures to be treated 
equally,” Dr. Gardiner said in a presentation to the Yale 
Corporation in February. But all inventions are not 
alike: Of more than 850 invention disclosures made at 
Yale since the office was established, 75 percent of the 
revenue earned through fiscal 1997 (close to $30 million) 
was generated by just 10 inventions. 
Instead of treating all discoveries the same, the new 
model of technology transfer is designed to actively 
identify the best opportunities for academic/private 
partnerships. The technology transfer office works 
closely with Yale scientists to find potentially marketable 
discoveries, then develops a plan. 
“There’s a broader approach to how ideas and 
discoveries should flow from a university to the corpo¬ 
rate world,” says Dr. Slayman, the deputy dean who 
works closely with the office. The technology transfer 
office also is able to provide an essential degree of 
business sophistication. “Yale has to be known as a place 
to be taken very seriously.” 
The best way to develop a particular discovery may 
be a traditional licensing arrangement. It may involve 
contract research with a pharmaceutical company, or a 
corporate alliance to benefit both a company and the 
university. And the best way to market a discovery may 
be with a brand-new business venture, funded by 
outside venture capital. “We’re essentially trying to 
perform a business development function,” Dr. 
Soderstrom says. 
Jeff Collinson, managing partner of Collinson 
Howe & Lennox in Stamford, is an investor in Neuro¬ 
gen and Alexion, two companies based on Yale discover¬ 
ies. Both of those ventures, he says, were established 
with little or no help from the University. “There was 
really no interface with technology transfer on either of 
those investments,” says Mr. Collinson, a 1963 Yale 
College graduate. 
Now there is more of an effort to facilitate the 
process. “They’re far more proactive than they were,” 
he says. “There is a focal point, a catalyst to make these 
things happen, an organization to surface potentially 
fundable technologies.” 
Science and business require two very different sets 
of skills, and the Office of Cooperative Research staff is 
equipped to bridge the gap. Dr. Soderstrom says that 
when a scientist comes to him with a new discovery 
“the question I have to ask is, what can I do with it?” 
Dr. Soderstrom has to determine first how to keep 
potential competitors away from a discovery. Then he 
has to figure out what product or service might result 
WHO’S WHO AT OCR 
When Gregory E. Gardiner, Ph.D., 
took the helm of the Office of 
Cooperative Research in 1996, he 
brought expertise from both the 
corporate and scientific worlds. 
As group director of research 
and development operations for 
Pfizer Central Research in Groton, 
Conn., Dr. Gardiner designed and 
implemented Pfizer’s external 
biotechnology investment strategy. 
Since his job at Pfizer was to 
evaluate potential licensing and 
research opportunities for the 
company’s pharmaceutical busi¬ 
ness, Dr. Gardiner already had 
extensive hands-on experience 
building partnerships between 
universities and industry. 
Dr. Gardiner has impressive 
research credentials as well: He 
holds a doctorate in physical 
chemistry from Fordham University 
and was a Sterling Fellow in Chemis¬ 
try at Yale from 1969 to 1972, 
before joining Pfizer in 1974. 
Dr. Gardiner’s appointment 
was quickly followed by an expan¬ 
sion of the office and the opening 
of a branch in the medical school. 
Staffing that office are Jon 
Soderstrom, Ph.D., who came to 
Yale from Oak Ridge National 
Laboratory, and R. Bennett Muskin, 
who was vice president and director 
of JCL Clinical Research Corp. in 
Knoxville, Tenn., a small biotechnol¬ 
ogy company. 
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from it and, finally, whether the need for the product or 
service is large enough to pay for its development. The 
idea, he says, is to translate a discovery into something 
that makes sense in terms of a product. It isn’t always 
easy for the scientist to determine what might form the 
basis for a profitable business. 
“You see all sorts of ideas,” Mr. Collinson says, “and 
a number of them are quite interesting. But they don't 
all form the basis for starting a company.” He is looking 
for discoveries that have a good chance of producing 
salable goods or services, ones that will offer an investor 
a good return. “From the perspective of a scientist in 
his lab, that’s a difficult distinction,” he says. But Dr. 
Gardiner and his staff have a good sense of a discovery’s 
business potential, says Mr. Collinson. “It’s a useful 
screening process.” 
RECRUIT, RETAIN, REWARD 
A strong, business-like program to find partners to 
develop technology offers clear financial rewards for 
the University. What may be less clear are the ways 
that program can help recruit, retain and reward 
faculty members. 
“Our best and brightest faculty need technology 
transfer,” says Louis Berneman, managing director of the 
Center for Technology Transfer at the University of 
Pennsylvania. “They want to see the results of their 
research benefit the public.” 
The income can also help support continuing 
research, both by established professors, junior faculty 
and students. “Here’s a source of money for us as a 
university to assist young people, as well as to help 
more senior people who need carry-over grant funds,” 
says Dr. Sartorelli. 
Development of Yale-based businesses benefits the 
city and state, too. “Yale’s intentions are to be an active, 
helpful and contributing partner in the growth of the 
high-tech industry in our state,” Yale President Levin 
says. “Although the commercialization of new research 
discoveries cannot always be transformed into more local 
jobs, Yale is generating new economic vitality near the 
University." Yale scientists have established eight public 
companies and more than 30 private companies, em¬ 
ploying more than 750 people; about 25 of the compa¬ 
nies are located in greater New Haven. 
Keeping companies in the city is one objective of 
the Office of Cooperative Research. A lack of space is a 
problem that could be greatly alleviated by the develop¬ 
ment of a new business incubator on land in the Route 
34 corridor, a project that's still in the pre-planning 
stages. A technology incubator provides a supportive 
environment to attract and retain young, start-up firms, 
usually offering tax and other incentives. Science Park, 
Gregory E. Gardiner Jon Soderstrom R. Bennett Muskin John S. Swartley 
Dr. Soderstrom, who holds 
a Ph.D. in Psychology/Industrial 
Engineering from Northwestern 
University, worked as director 
of program development and, 
before that, director of technology 
licensing in Oak Ridge’s Technology 
Transfer office. 
Mr. Muskin holds a degree in 
physics and engineering and did 
graduate work in biomedical engi¬ 
neering at Drexel University. Mr. 
Muskin brings to the office first¬ 
hand experience as an entrepreneur 
in technology-based health care 
companies. Prior to joining Yale, he 
put together the business plan and 
financing for his first company in 
1991 and later licensed the technol¬ 
ogy to a leading medical device and 
supply company. Subsequent to this 
experience, Mr. Muskin was re¬ 
cruited to be the director of busi¬ 
ness development and strategic 
planning for two small biotechnology 
companies specializing in 
immunodiagnostics. 
The newest member of the 
office's medical school staff is 
John S. Swartley, Ph.D., who arrived 
in September. He left the Emory 
Medical School faculty, where he 
studied the genetics of bacterial 
pathogens. He also consulted for 
Emory’s technology transfer office. 
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A fertile 
ground 
for new 
technology 
Yale has always been a fertile 
source for new technology, but 
medical scientists have scored a 
couple of major successes in 
recent years. 
Two of the biggest suc¬ 
cesses—the anti-AIDS drug Zerit 
and Lyme disease vaccine under 
development—might never have 
happened if not for partnerships 
with pharmaceutical companies. 
Both the reverse transcriptase 
inhibitor Zerit (d4T) and the Lyme 
disease vaccine required enormous 
amounts of capital to bring them 
through development and to the 
market (a process still under way in 
the case of the Lyme vaccine). 
Since new ventures don't have that 
kind of capital, both of those 
discoveries were licensed to large 
drug companies—Bristol-Myers 
Squibb for Zerit and SmithKIine 
Beecham for the Lyme disease 
vaccine. Both companies had the 
capital and the necessary experi¬ 
ence to develop the drugs. 
Licensing to existing compa¬ 
nies isn’t always the best way to 
bring a discovery to market, though. 
Eight public companies and more 
than 30 private ones have been 
formed over the years to develop 
Yale technology. The publicly 
traded firms are valued at more 
than $1 billion, and include: Enzo 
Biochem, Neurogen, GeneLabs 
Technologies, Ariad Pharmaceu¬ 
ticals, Alexion, Vion Pharmaceu¬ 
ticals, Sparta Pharmaceuticals, 
and Innovir Laboratories. 
Neurogen is an example of a 
company that developed Yale 
intellectual assets through 
venture capital. “When the 
founders left Yale, they didn’t 
even have a patentable invention 
to license,” said Office of Coop¬ 
erative Research Director Gregory 
E. Gardiner, Ph.D., speaking in 
February to the Yale Corporation. 
“But they did have some excel¬ 
lent ideas about GABA receptors 
which could lead to new drugs in 
at least four different therapeutic 
categories.” 
The ideas needed to be 
proven in a research-intensive 
environment, Dr. Gardiner says, 
and the move paid off: Eight 
years later, Neurogen has four 
drugs in clinical development and 
at least three more in the 
immediate pipeline. 
Among the private 
companies developed with Yale 
technology are: 
► Analytica of Branford, founded 
by the discoverers of 
electrospray mass spectrom¬ 
etry, a key biotechnology tool 
► Genaissance Pharmaceuti¬ 
cals, a company that applies 
DNA sequencing to drug 
discovery, which started in 
Science Park in 1993 and 
continues to grow 
► CuraGen, a New Haven 
bioinformatics company 
started with four people in 
1993 that has since seen 
employment rise to 100 
► Exelixis, a developmental 
biology company in 
Cambridge, Mass. 
► Gene Logic, a genomics 
company started in New 
Haven and recently relocated 
to Baltimore 
► International Biotechnologies, 
a medical imaging company 
located in Science Park that 
went public but was acquired 
by Kodak in 1995 
► Molecular Diagnostics, a 
biotech diagnostics venture 
started in 1980 in West 
Haven and acquired by 
Bayer in 1989. 
The development of new 
companies can be expected to 
continue at a steady pace, says 
Jon Soderstrom, Ph.D., the OCR’s 
associate director. About another 
10 companies are now in 
development, with two “fairly far 
along in the process,” Dr. 
Soderstrom says. 
The work of Yale scientists was the 
basis for Zerit, above, one of the new 
generation of highly effective AIDS 
medications. Medical school investigators 
also invented a vaccine for Lyme disease, 
which is spread by the deer tick, Ixodes 
scapularis, background. 
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a technology incubator and research park with close ties 
to Yale, is a model for that sort of development. Located 
in a state-designated Enterprise Zone in New Haven, 
Science Park is home to about ioo companies that 
employ 2,000 people. 
“Greg and his staff have been so successful at generat¬ 
ing interest among the faculty that they have more 
potential startup companies than there is space for in 
New Haven,” Dr. Slayman says. “The most visible thing 
that could happen in the future, besides the steady 
growth, would be if we could successfully develop the 
Route 34 corridor.” 
“Yale University, working closely with the city and 
state, intends to step up to the plate and do its part to 
generate new business opportunities in the New Haven 
area,” says Dr. Richard, the provost. “There truly is local 
urgency to Yale’s engagement in technology transfer in 
order to generate revenue and jobs.” 
Even if the Route 34 complex spurs new businesses 
to start up nearby, and even if Yale has a strong connec¬ 
tion to many of the companies, University officials 
are clear that business interests will not be allowed to 
overshadow Yale’s primary mission, which is academics. 
“Yale remains deeply committed to student educa¬ 
tion, which we consider to be our central responsibility 
and defining mission,” Dr. Richard says. “One of the 
tensions in forming industrial collaborations is to make 
sure they enhance rather than detract from student 
education.” But alliances with industry can enhance 
education by exposing students to the latest technologies 
and lab techniques, and better prepare students for 
careers in the pharmaceutical and biotechnology 
industries. “It’s less a case of academia adopting an 
industrial approach to education,” she says, “than it is 
a case of industry adopting an academic approach to 
scientific discovery.” 
“Our mission is primarily an educational one,” 
Dr. Gardiner says. “As long as any business arrangement 
furthers that mission in more than just a monetary way, 
we’ll consider it.” 
Though some may worry that faculty members 
could get caught in conflicts when they work too closely 
with moneymaking enterprises, policies on conflict of 
interest and conflict of commitment are strictly spelled 
out, Dr. Slayman says. 
The policy lists some examples that would be a clear 
violation: If a scientist uses a Yale laboratory to do 
product-testing research, paid for by a company in 
which he is a 20 percent owner and founder, seeking to 
validate advertising claims made about a product sold 
by that company; if a clinician makes patient referrals 
to a diagnostic company in which she or her immediate 
family has a significant ownership interest; or if a 
faculty member steers a graduate toward a research 
project that could substantially enhance the value of a 
company in which the faculty member has a significant 
ownership interest. 
Some situations would be allowed with proper 
disclosure and oversight, such as if a scientist who is a 
member of a company’s scientific advisory board 
conducts research sponsored by that company. The 
clearly defined policies alleviate concerns by letting 
faculty members know what’s appropriate and what isn’t. 
“I think it’s healthy that we’ve put these mechanisms in 
place,” Dr. Slayman says. 
The real concern, Dr. Gardiner says, would be if 
scientists lacking business savvy tried to start companies 
completely on their own to commercialize discoveries. 
“The companies we’re talking about have sophisticated 
investors who put money into them,” he says. With 
plenty of attorneys and other professionals monitoring 
operations, the potential for problems is greatly reduced. 
THE FUTURE 
Looking ahead, Dr. Soderstrom projects conservatively 
that new businesses will be formed at a judicious rate of 
about three a year. “We are going to focus a lot of time 
and energy on spinning out companies,” he says. 
So far, Dr. Gardiner says, technology transfer has 
not had an enormous impact on the University’s research 
budget. The royalties for the fiscal year that ended June 
30, 1997, totaled about $13.5 million—equal to about 5 
percent of the university’s $280 million research budget, 
and up from about 2 percent the previous fiscal year. 
The average for all U.S. universities stands at about 1 
percent, Dr. Gardiner says. 
“When you get in the neighborhood of 10 percent, 
you can say, ‘I’m having an impact,’ ” Dr. Gardiner says. 
“I think we ought to try to get to 10 percent, then look 
and see, has this been good for the University?” 
With experience, the difference between the mission 
of industry and the mission of a university will become 
more clearly defined, Dr. Flavell says. “Drawing a clear 
line will allow for a more flexible attitude toward 
technology transfer.” 
Neurology chair Stephen Waxman agrees. “I’d like 
to see closer interactions between Yale and industry, but 
they have to be structured in a way that enhances and 
respects the academic mandate,” he says. “If structured 
in the right way, the interface can benefit our patients 
and our trainees, as well as the University.” YM 
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From Salmonella, 
a potential 
cancer treatment Yale researchers, Vion take 
a novel approach to 
gene therapy. 
0 of the technologies to emerge 
from Yale recently is a potential gene 
therapy agent for cancer treatment. School 
of Medicine researchers John M. Pawelek, 
Ph.D. and K. Brooks Low, Ph.D. have 
worked hand-in-hand with David 
Bermudes, Ph.D., and a team of scientists 
at New Haven-based Vion Pharmaceuticals 
Inc. to prepare their invention for possible 
clinical trials. 
The Yale technology, licensed to Vion 
December 1995 and named TAPET 
(for tumor amplified protein expression 
therapy), is one of the first uses of a bacterium, rather 
than a virus, as the mechanism for delivering genes 
to cells. 
The Yale concept, described in the Oct. 15 issue 
of the journal Cancer Research, involves the use of 
engineered strains of the common Salmonella bacte¬ 
rium, the same bacterium that, in its unaltered or 
wild-type form, can cause food poisoning and septic 
shock. The altered Salmonella, stripped of its 
pathogenicity, is nonetheless able to target solid 
tumors in laboratory animals in a fashion similar to 
the wild-type parent, according to Dr. Pawelek, senior 
research scientist in dermatology and a lecturer 
in pharmacology. 
The view inside a melanoma tumor, as seen through the electron 
microscope. A tumor-bearing mouse was injected with Salmonella. 
After 24 hours the bacteria were located within the tumor, where 
they had multiplied. Salmonella were found both inside and outside 
the melanoma cell. Also seen are melanosomes, pigment-laden 
granules characteristic of melanoma cells. 
i g 
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The three inventors 
of the engineered 
Salmonella vector; 
from left: K. Brooks Low, 
Ph.DDavid Bermudes, 
Ph.D.; and John M. 
Pawelek, Ph.D. 
“In fact," he says, “we can now significantly 
prolong the life of mice with melanoma by injecting 
them with our attenuated bacteria. Although as few as 
10 wild-type Salmonella are sufficient to kill a mouse, 
we can inject 10 million cells of our attenuated strains 
and the mice show no symptoms of infection. After 
the Salmonella are introduced into the mouse blood¬ 
stream, they seek out tumors, multiply selectively 
there in great numbers, and—by mechanisms yet to 
be unraveled—dramatically slow the rate of tumor 
growth and prolong life. Furthermore, because the 
bacteria multiply within the tumor itself, anti-tumor 
genes that we introduce genetically into the bacteria 
also are multiplied.” 
The use of engineered Salmonella, says gene 
therapist Albert B. Deisseroth, M.D., Ph.D., chief of 
the section of medical oncology and associate director 
of the Yale Cancer Center, “could represent a powerful 
new approach to cancer therapy. They have geneti¬ 
cally transformed a pathogenic bacterium into one 
that is safe in laboratory animals, yet still retains its 
tumor-targeting properties.” 
Dr. Pawelek, a cancer biologist who studies 
melanoma; Dr. Bermudes, a parasitologist; and Dr. 
Low, a bacterial geneticist and professor of research 
in therapeutic radiology, began collaborating in late 
1992 on this project when a University of Massachu¬ 
setts colleague introduced Dr. Pawelek to Dr. 
Bermudes, who was then a Yale associate research 
scientist working only three floors above him in the 
Infectious Diseases Section of Internal Medicine. Dr. 
Bermudes became interested in Dr. Pawelek’s views 
on an old theory on how metastatic cancer cells seem 
to behave like white blood cells as they spread 
through the body, and encouraged Dr. Pawelek to 
pursue the theory experimentally. 
After a few weeks Dr. Bermudes returned to Dr. 
Pawelek with an idea for a new type of therapy: the 
use of white-blood-cell-specific parasites to seek out 
cancer cells. They tested several parasites for their 
ability to infect human melanoma cells in culture, and 
soon settled on further work with Salmonella. 
Approached because of his expertise in bacterial 
genetics, Dr. Low was supportive and also favored 
testing the potential of Salmonella in this way. Within 
weeks, Dr. Pawelek began a sabbatical in Dr. Low’s 
lab, where the trio pursued the development of safe 
Salmonella as an anti-cancer vector. A few months 
later they obtained their first laboratory animal data, 
and Terrence W. Doyle, Ph.D., vice president for 
research and development at Vion, became interested 
in the Yale-developed technology. Vion entered into a 
license agreement with Yale in December 1995, 
assisted with the patent filing and employed Dr. 
Bermudes as associate director of biology in Septem¬ 
ber 1995. Vion has also supported this and other 
research at Yale through grants. 
“We are obviously most excited about the potential 
use of this technology for human cancer therapy,” Dr. 
Pawelek says. “We’ve made the Salmonella both safe 
and effective for laboratory animals, and now the 
challenge is to do the same for humans. The safety 
issue seems under control, and the potential effective¬ 
ness seems highly promising.” 
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PROFILE 
David W. Barry 
Leader of the team that discovered AZT, a former Burroughs Wellcome 
executive strikes out on his own in pursuit of new 
anti-viral treatments. 
By Terrance Noland 
Photographs by Corey Lowenstein 
Early in his career as a physician-scientist, David W. Barry, M.D. ’69, 
H.S. 69-72, survived two close calls with tropical viruses. In the first, 
he was exposed to the African arbovirus Germiston, a strain of 
bunyamwera, and briefly lapsed into a coma. A week later, he returned 
to work. In the second, two of his colleagues were infected by the virus 
that causes deadly Lassa fever. One colleague died, but doctors saved the 
other with serum from the blood of a nurse who had survived the disease 
in Africa. 
For Dr. Barry, his co-worker’s recovery was a revelation. “It was,” he says 
today, “a very tangible demonstration that viral infections could be treated. 
Back in those days, people looked at serious virus infections a lot like we look 
at metastatic cancer now. They just sort of gave up.” 
That attitude has changed with advances in research and drug develop¬ 
ment over the past three decades. In fact, Dr. Barry, 54, has made a career— 
and now a business—of developing treatments for viruses once thought 
untreatable. Consider his track record. At Burroughs Wellcome, where he 
eventually headed worldwide research and development for British parent 
Wellcome PLC, he developed the herpes drug acyclovir, the first blockbuster 
anti-viral. He also led the team that discovered AZT, the first treatment for 
HIV. Now chairman and CEO ofTriangle Pharmaceuticals Inc., a Durham, 
N.C.-based company he started two years ago, he is developing a stable of 
promising anti-cancer and anti-viral drugs, including five for HIV. 
“Even as a young resident it was clear he had the potential to make a 
contribution to society. And he has done that,” says Yale professor of 
Terrance Noland is managing editor ^/ Business North Carolina magazine 
in Charlotte. 
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medicine Vincent A. Andriole, M.D. ’57, Dr. Barry’s 
attending physician during his internship and residency 
at Yale-New Haven Hospital. Dr. Barry graduated 
from the School of Medicine in 1969 and from Yale 
College in 1965. 
Perhaps better than anyone, Dr. Barry has mastered 
the blending of benevolence with business in the field of 
drug development. From the start of his career, he was 
attracted to what he calls the “tough nuts to crack” in 
illnesses. “I just wasn’t interested in drugs that treat 
trivial diseases, even though that’s where the biggest 
markets were at the time.” Dr. Barry helped prove more 
consequential drugs could be lucrative, too. Acyclovir’s 
sales reached as high as $1.3 billion a year, and AZT’s 
profits spurred many other drug companies to develop 
their own HIV treatments. “Now it’s very clear that in 
those areas where there is the biggest human need, 
there’s likely to be the biggest return on investment. 
If you can find a treatment for cancer, you will make 
money. It’s only fairly recently that it has coincided.” 
His new company is a perfect example. Though 
Triangle is still in its infancy and won’t have a product 
on the market for at least two years, Dr. Barry has 
managed to raise $98 million in public and private 
David W. Barry, M.D., 
decided to start his own 
company, Triangle 
Pharmaceuticals Inc., 
after industry giant 
Glaxo merged in 199$ 
with Burroughs 
Wellcome, where 
Dr. Barry headed 
worldwide research and 
development. Dr. Barry 
holds a model showing 
the molecular structure 
of FTC, the company’s 
anti-viral nucleoside 
analogue, which is 
being evaluated for 
the treatment of HIV 
and hepatitis B. 
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capital. One reason? The products in its pipeline. They 
have shown potential against such serious diseases as 
HIV, herpes, hepatitis B, and lung and brain cancer—all 
lucrative markets Or drug development. 
I here’s another reason investors have been keen on 
Triangle. Dr. Barry has assembled a remarkable team. 
His 43-person staff: includes several key players who 
helped him build Wellcome into an anti-viral power¬ 
house. Among them: Phil Furman, Ph.D., one of Dr. 
Barry’s four AZT co-inventors; Nick Ellis, Ph.D., former 
AZT global brand director; and Franck Rousseau, M.D., 
former director of infectious diseases and HIV clinical 
research at Wellcome France. 
At Wellcome, Dr. Barry had a reputation as an 
innovative and strong-willed leader who wasn’t afraid to 
butt heads with other executives. He got away with it 
because of the results he delivered. His group's anti-viral 
work helped turn the company into a drug power¬ 
house—something he’s not shy about pointing out. 
Today, no one in the pharmaceutical industry can claim 
a longer track record in AIDS drug development. 
“Hands down,” says David Molowa, a biotech analyst 
with Bear, Stearns & Co. in New York, “he’s Mr. HIV.” 
With much of the same team in place at Triangle, 
Dr. Barry is ready to repeat history. “David is the kind 
of guy who simply succeeds,” says fellow Yale alumnus 
Joseph S. Pagano, M.D. ’57, a friend and the director of 
the University of North Carolina’s cancer center in 
nearby Chapel Hill. “He is a very canny man.” 
“QUADRUPLE A” 
Initially, Dr. Barry’s interest in medicine was sparked by 
his frequent bouts of illness as child. Growing up in the 
mill town of Nashua in southern New Hampshire, he 
developed rheumatic fever at age 6. That was followed 
by a case of scarlet fever. 
As an undergraduate, he attended Yale College. 
He majored in French literature but took several science 
classes, including organic chemistry and advanced 
biology. “They seemed interesting and I did well in 
them” he recalls. After graduating magna cum laude, 
he chose medicine over literature for graduate studies. 
“I thought I’d be a better doctor than a writer” he quips. 
Dr. Barry credits the School of Medicine’s 
thesis requirement with “getting me set off in my 
career in science and virology.” His topic? How quickly 
certain viral vaccines protect experimental animals 
from infection. 
When he graduated from medical school in 1969, he 
took his internship and residency at Yale-New Haven 
Hospital, specializing in internal medicine. There he 
continued his virology research, 
working with renowned Yale scien¬ 
tist Gueh-Djen Edith Hsiung, 
Ph.D., now professor emeritus of 
laboratory medicine. They were 
testing the drug IdUrd, a herpes eye- 
infection treatment developed by 
Yale professor emeritus William 
Prusoff, Ph.D., to see if it worked 
against brain infections. 
“It subsequently turned out not 
to work,” Dr. Barry says. “But it was 
a tremendous learning experience to 
be at the forefront of a new thera¬ 
peutic area. Until that time, most 
people thought viruses were 
untreatable. And Yale was the place 
that thought, 'No, they probably are 
treatable.’ And that was a tremen¬ 
dous help to me. By the time I left 
residency, I had been exposed to the 
best of virology in America and 
probably the world.” 
At Yale, Barry also got interested 
in clinical work through his exposure 
As CEO, Dr. Barry assembled a team of top researchers from his group at Burroughs 
Wellcome, among them Phil Furman, Ph.D., one of the four co-inventors of AZT. 
He also recruited Chris A. Rallis, in background, to be Triangle’s vice president for 
business development and its general counsel and secretary. 
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to two top infectious-disease clinicians. Dr. Andriole 
and Elisha Atkins, M.D., professor emeritus of medi¬ 
cine. Dr. Andriole recalls Barry as an “outstanding 
resident. He was very bright and worked very hard.” 
He also remembers his intensity: “Quadruple A person¬ 
ality. He always was that way.” Dr. Andriole used to get 
him to lighten up some by cracking jokes. “There were 
times when I could get him to laugh, and his laugh was 
a small smile on his face. One side of his mouth would 
go up a little higher than the other. When I saw that, 
I knew I had gotten him to relax a little bit.” 
FROM THE FDA TO WELLCOME 
Dr. Barry considered doing postdoctoral work in Dr. 
Andriole’s lab, but when he Finished his residency in 
1972, the Vietnam War was still raging. “My brother had 
just come back from Vietnam and said it really wasn’t a 
great place to be,” he says. “So I was looking for alterna¬ 
tives.” He found one. He joined the Food and Drug 
Administration’s Bureau of Biologies. That fulfilled his 
draft requirement. The bureau was in need of an expert 
on yellow fever, and Dr. Barry had studied the disease 
for his thesis. The next year, he became deputy director 
of the bureau’s virology division. 
But Dr. Barry’s career there faltered in 1976, after 
leading the FDA’s role in a swine-flu immunization 
program conducted by the Centers for Disease Control 
and Prevention. When the vaccine caused neurological 
damage in some people, Dr. Barry saw the handwriting 
on the wall. “They didn’t throw me out, but it was clear 
my chances for promotion were limited." 
In 1977 he joined Burroughs Wellcome, based in 
Research Triangle Park, N.C. A year later he was made 
head of clinical investigation. At the time, the company 
had a herpes drug in early pre-clinical stages. One of his 
first tasks was to develop it. That drug was acyclovir, the 
hugely successful anti-viral agent. 
In 1983, after becoming head of the virology depart¬ 
ment, he led Burroughs Wellcome’s push into finding an 
AIDS treatment. At the time, few other drug companies 
were interested in pursuing the market. “Nobody thought 
anybody would make any money on it whatsoever,” 
Dr. Barry says. “When we started, it was a relatively rare 
disease affecting a disenfranchised population.” 
Dr. Barry organized a team that began working with 
a similar retrovirus that grew in mice. They began 
testing compounds against it. The breakthrough came in 
November 1984. A Burroughs Wellcome scientist came 
to Dr. Barry’s office with news: The compound she was 
David W. Barry, M.D 
Chairman and chief executive officer, Triangle 
Pharmaceuticals, Durham! N.C. 
Yale College, Class of 1965 
Yale School of Medicine, Class of 1969 
Intern and resident, Yale-New Haven Hospital, 
1969-72 
Married to Gracia Chin Barry (Mount Holyoke 
’66); father of two adult children 
Avid fly fisherman and quail hunter, owns two 
English pointers 
Member Yale School of Medicine Dean’s 
Advisory Council since 1988 
testing had eliminated the virus in her petri dishes. 
It was AZT, a compound made from herring sperm that 
Burroughs Wellcome had first tried against bacterial 
infections. At first the researcher couldn’t believe her 
eyes. “She said, ‘Maybe I forgot to put the virus in it,’ ” 
Dr. Barry recalls. But they repeated the experiment and 
found the compound worked in even smaller amounts. 
Dr. Barry and his staff uncorked a bottle of white 
wine to celebrate. There was little time to revel. Working 
closely with the FDA, they raced the drug through the 
clinical and review stages in only 22 months. They 
presented their data to the FDA in September 1986 and 
got approval for AZT’s commercial use in March 1987. 
The team’s efforts became a model for fast-track approval 
of breakthrough treatments for life-threatening diseases. 
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HUNG IN EFFIGY 
Rather than being celebrated. Dr. Barry and his group ran 
into a storm of controversy at first. At $10,000 a year, the 
initial price of the drug angered AIDS activists. Dr. Barry, 
promoted to vice president of research in 1986, was a 
visible target. When the group Act Up stormed the floor 
of the New York Stock Exchange in protest in 1989, they 
hung him in effigy. As AZT’s price came down, the 
controversy faded some. Dr. Barry and the man who led 
the stock-exchange demonstration, Peter Staley, are now 
friends and have participated together in case studies of 
the issue at Harvard Business School. 
With the success of acyclovir and AZT, Wellcome’s 
sales swelled. In 1994, Dr. Barry was named director of 
worldwide research, development and medical affairs. 
He oversaw 3,200 researchers. Some thought he was on 
track to become the next CEO. 
That all changed in March 1995. That’s when British 
rival Glaxo bought Wellcome, creating Glaxo Wellcome. 
Glaxo had its own research czar, and Dr. Barry was 
offered a secondary position. He turned it down, taking 
a sizeable retirement package instead. “Wellcome had a 
way of thinking that I liked,” he told Business North 
Carolina magazine last year. “It was always trying to do 
the impossible, to handle the most difficult diseases in 
the world. Glaxo was different. They were focused on 
certain areas that were less life-threatening, where they 
produced incremental medical improvements and 
significant financial returns. I still wanted to go and cure 
the incurable diseases.” 
Using venture capital and money from his separa¬ 
tion package, Dr. Barry started Triangle in July 1995. 
With a steady stream of employees leaving Glaxo 
Wellcome after the merger, he had a deep talent pool to 
choose from in staffing his company. His first 12 em¬ 
ployees were all former Wellcome people. Last Novem¬ 
ber, he took the company public. Since then, the stock 
price has doubled from $10 to $20 per share in late 
September. (Dr. Barry’s share of the company, 6.5 
percent, is worth about $20 million.) 
Dr. Barry is aiming to run Triangle as a full-fledged 
pharmaceutical company, offering a diversified slate of 
products that it will develop and market itself. That’s 
unlike many biotech startups, often built around one 
promising compound. It’s an ambitious goal for such a 
small company, but Dr. Barry is counting on finding 
ways to streamline operations, such as contracting out 
manufacturing and some clinical work. 
The company will also save time and money by 
bypassing the inventing stage. Instead, it will acquire 
compounds. This summer, for instance, Triangle beefed 
up its stable of products by buying Avid Corp., a small 
Philadelphia drug-research company. The main draw 
was rights to a protease-inhibitor HIV drug Avid has 
had in early-stage clinical trials. 
That gives Triangle eight products. Its furthest 
one along is the HIV drug MKC-442, a nonnucleoside 
reverse transcriptase inhibitor. “It inhibits the key 
enzyme of the virus, but chemically is different from 
things like AZT and 3TC.” Two other HIV drugs, 
CS-92, similar to AZT, and FTC, also a nucleoside 
analogue, are scheduled to begin clinical trials 
this year. 
MANY LINES OF ATTACK 
The reason Dr. Barry has so many HIV treatments in 
development is that he doubts any one drug will ever 
conquer the disease. At Burroughs Wellcome in the early 
1990s, he was one of the early proponents of combina¬ 
tion therapy, in which two or three drugs are given at a 
time and new ones are rotated in as soon as patients 
develop resistance. That is now generally considered the 
best way to treat HIV. 
Even with 11 HIV drugs on the market, there will be 
a need for many more, Dr. Barry says. “Because they’re 
used in combination and because each one of the drugs 
has some disadvantage—either toxicity, intolerance, 
efficacy, drug resistance, drug-drug interactions—there’s 
plenty of room for improvement.” 
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For example, he is hoping his MKC-442 won’t cause 
the kind of rashes common with similar treatments. 
Early tests in patients have been promising, both in 
terms of effectiveness and low rates of rashes. “We know 
that the dose we tested so far, when used alone, will 
make the virus fall immediately 90 percent or more in 
about 80 percent of the patients,” Dr. Barry says. 
Starting later this year, Triangle plans to test the com¬ 
pound to see how well it works with other drugs. If that 
goes well. Dr. Barry expects to get approval by late 1999, 
at the earliest. 
Also scheduled for clinical trials this year is Triangle’s 
alanosine, a brain- and lung-cancer drug. The VA 
Connecticut Healthcare System’s West Haven campus is 
slated to take part in that trial. Dr. Barry says he’d like to 
find more anti-cancer agents to develop but is interested 
only in those that are selective—that will harm the 
tumor but not the body. “Anti-cancer therapy is just 
starting to get into that area,” he says. “I see that we are 
tive. “Academic people are very, very conscious of their 
need to be precise." 
He has also heard the criticism in recent years that 
drug companies, particularly those with HIV treat¬ 
ments, are price-gouging patients. The cost is indeed 
high. Most HIV combination regimens run about 
$13,000 to $15,000 a year. But Dr. Barry defends the 
high cost. For one thing, the drugs are expensive to 
make. For another, their effectiveness has brought down 
hospitalization costs considerably. 
Besides, he argues, profits are what push companies 
to develop new treatments. “Profit motive is clearly the 
reason there are now 11 drugs on the market and why 
combination therapy is making such a great improve¬ 
ment in people’s lives. You’re changing the whole face of 
the disease from being rapidly fatal to one where we’re 
talking realistically about decades of health. And all of 
that is based on companies getting involved and making 
profits. That’s a pretty straightforward equation.” 
“You need the research, which universities provide, to really be able to 
understand the basic mechanisms of whats wrong. And once you’ve 
got a tentative idea of how to fix it, you really need the industrial 
partner to bring the scientific concept to a reality.” 
starting to have enough science, a lot of it generated at 
Yale, to show that it is possible to take advantage of 
subtle differences in the way tumors metabolize things 
and normal cells do. Metastatic cancer in the future is 
going to be less and less a certain and rapid death 
sentence.” 
Many ol Triangle’s compounds were discovered by 
scientists at Emory University and the University of 
California at San Diego, which now have royalty 
agreements with the company. Dr. Barry thinks such 
links are critical. “We provide—that is, industry and 
academia—two different and needed aspects. You need 
the research, which universities provide, to really be able 
to under-stand the basic mechanisms of what’s wrong. 
And once you’ve got a tentative idea of how to fix it, you 
really need the industrial partner to bring the scientific 
concept to a reality.” 
Their relationship, he says, “should be as close as 
possible.” He sees great value in private companies 
sponsoring university research. And though he has heard 
the arguments about potential conflicts of interest, he 
doubts such cooperation makes studies any less objec- 
Companies are also attracted to the HIV market 
by its growth. In 1995 the market was about $250 
million worldwide. Last year it quadrupled to just over 
$1 billion. This year it could hit $2 billion. The main 
reason: Increased effectiveness and reduced side-effects 
have caused more people to seek treatment. Little more 
than a year ago, 20 percent of those infected were 
getting treated. Now it’s 30 percent to 40 percent, 
Dr. Barry says. 
So what can we expect to see next in the war on 
AIDS? “The biggest issue now is thinking about the 
long-term management of AIDS. We’ve got short-term, 
year-level management under our belts pretty well, but 
now, more and more, there will be new strategies to 
approach decades-long management. It may be using 
drugs that counteract the resistance of other drugs. It 
may be treating more aggressively or slightly less aggres¬ 
sively early on. It’s hard to say. But that will be the talk 
in AIDS over the next couple of years.” 
And it’s safe to say, David Barry will be doing much 
of the talking. YM 
YALE MEDICINE 19 
EDUCATION 
In the sparsely populated canyon country 
of northeastern Arizona, a medical 
student makes discoveries about life on a 
different scale (and finds a little piece 
of Ne w Haven). 
By Gregory Raskin 
from a 
Navajo 
winter 
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It’s not that you can’t get there from here. You can, 
but it’s not easy. 
It is entirely possible to take a commercial flight to 
the edges of the Navajo Nation—a Native American 
reservation approximately the size of West Virginia that 
encompasses parts of Utah, Arizona and New Mexico. 
This positions you more than too miles from Chinle, 
Ariz., your final destination, which falls smack dab in 
the center of the reservation. From there, you can take a 
bus (one trip daily, approximate time to Chinle: four 
hours) or rent a car. 
If you take the bus, which doesn’t run on week¬ 
ends, you’re pretty much stranded when you arrive, 
because Chinle [pronounced CHIN-lee] lies in the 
absolute middle of nowhere. In fact, it’s farther than 
that; go to the middle of nowhere, take a right, and 
drive for another hour—now you’re in Chinle. Of 
course, when you’re 24 years old renting a car is not an 
option, so if you’re my age and want to get there from 
here you have to pack up your own car, get some good 
music and hit the road. This was my plan exactly as I set 
out last New Year’s Day to begin a month-long elective 
in primary care at the Indian Health Service (IHS) 
hospital in Chinle. 
After spending six straight years in New Haven (I was an 
undergraduate just down the road at Yale College), I 
knew by the middle of the second year of medical school 
that I would be aching for a break come winter of 1997. 
I thought I would go somewhere warm after a brutal 
winter last year. Also, I calculated that by placing myself 
in Arizona in March I would be poised to see some 
Grapefruit League spring training games. Baseball and 
Gregory Raskin is a fourth-year medical student at Yale. 
sun in wintertime, plus a great experience in rural 
medicine—it seemed perfect. Alas, all the spots in 
March were filled when I inquired the previous year, 
so I settled for a baseball-free January slot in Chinle, a 
small town at nearly 6,000 feet in elevation. No spring 
training, no warm weather, but definitely a whole 
different ballgame. 
By the time I finally left for this out-of-New-Haven 
experience in the middle of my third year, I was raring 
to go. I was in search of many answers. What was the 
reservation like, and how was it different Irom what I 
had known? Could I retain my (admittedly tenuous) 
sanity so far from the frenzied confines of the Northeast? 
What would it be like to drive thousands of miles alone, 
across plains, deserts and the mighty Mississippi? How 
long could I go without a bagel? With these questions in 
mind, along with the distant exhortations of Horace 
Greeley ringing in my ear, this young man went west. 
Left: The snow-dusted Canyon de Chelly is only a few miles from 
the center of Chinle, Ariz., where the author found a new perspective 
on medicine. 
The journey started with questions about culture, and one 
imponderable: How long could I go without a bageli 
YALE MEDICINE 
The Navajo Nation reservation is entirely open range: 
cows and horses and sheep graze anywhere they please. 
What this means for Navajo ranchers is that they must 
brand their livestock, herd them communally, and then 
sort them from time to time when animals are to be 
sold, shorn or slaughtered. What this means to the 
intrepid traveler is that one must be careful while driving 
on the reservation because it is extremely common to see 
animals walking on the road. Who wins in a battle 
between my little red Honda Civic, barreling 70 miles 
an hour up Arizona Route 191, and a half-ton cow 
chewing its cud on the double yellow line? No one. 
And the open range does not spare the towns on the 
reservation, which means that finding a parking space at 
The Silver Coin launderette involves avoiding the horses 
strolling casually across the parking lot. Coupled with 
the innumerable stray dogs that roam the town in search 
of food or perhaps something to do, Chinle can seem 
like one part zoo, one part obstacle course. I’m con¬ 
vinced that—assuming this nickname has not been 
taken already by another city or town—Chinle could be 
known as The Stray Dog Capital of the World. From 
any random vantage point in the parking lot of the local 
supermarket it was usually possible to spot at least a 
couple of ownerless mutts; my personal record was six. 
Of course, these are country dogs—they couldn’t sniff 
in New Haven. 
Aside from the launderette, Chinle contains a 
supermarket, a post office, three fast-food restaurants, 
a few gas stations, several other stores and the Chinle 
Comprehensive Healthcare Facility, where I worked. 
A road sign at the city limits displays a transliterated 
Navajo greeting: Yd’dt’eeh. The back of the sign says 
Hdgoonee’, Navajo for goodbye. 
During my time in Chinle I lived in a small house 
adjacent to the hospital with a physical therapy student 
from Virginia. The house and the hospital sit on a 
plateau above the main road. Out the back window of 
the house lies a plain on which horses and cows graze, 
and beyond looms a mesa—snow-covered during my 
month-long stay. Though the street directly in front of 
our house was paved, it quickly turned to ice and mud a 
few hundred feet away. Driving home always presented 
the intriguing possibility of getting stuck. 
The hospital itself is a relatively modern facility in 
the process of being outfitted with a new computer 
system. I spent mornings in the outpatient clinic, 
seeing both children and adults for urgent visits and 
follow-up appointments. Sore throats and back pain are 
as common out there as at Yale-New Haven. Dozens of 
The commercial 
strip running 
through the center 
of Chinle is the 
center of Chinle. 
A few fast-food 
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up the business 
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serves a population 
spread out over 
many hundreds of 
square miles. 
22 
patients are seen each morning and afternoon, some 
of whom have traveled for more than an hour to come 
to the clinic. 
The other half of my day was usually spent in the 
emergency room, sewing up lacerations and learning 
how to cast broken bones. Between patients, I got to 
know the ER staff fairly well, an interesting mix of 
Navajo and non-Indian health care workers. The 
emergency medical technicians are Navajo and provide 
ambulance transport from the field (for example, from 
motor vehicle collisions), translation for the non- 
Navajo-speaking staff (all the physicians in the hospital), 
and patient screening in the ER. The nurses in the ER 
are either non-Navajo employees of the National Health 
Service or Navajo women trained locally. There is an 
attending physician in the ER at all times—the one with 
whom I spent most of my time was a former trauma 
surgeon from Los Angeles who claimed to have “seen 
everything.” Patients who have medical problems too 
difficult to be handled by the Chinle hospital are sent by 
helicopter or small plane to larger hospitals in Albuquer¬ 
que, Phoenix or Denver. 
The language barrier was the first of several challenges to 
medical care that I did not foresee. As mentioned above, 
English is not the Navajos’ first language. The younger 
generations learn English in school and speak it; the 
older people do not and require a translator. But the 
translator has to turn English medical terms into a 
language with literally thousands upon thousands of 
verb conjugations, a language that even declines nouns. 
During World War II, Navajo men drafted into the 
Army were employed to transmit radio messages in the 
Pacific Theater. The language is so complex that it 
served as a code the Japanese were never able to crack. 
In New Haven many of my patients speak Spanish, a 
language in which I have at least mediocre proficiency; 
I can usually be sure to get my point across. On the 
reservation I had to have faith in my translators. 
Coupled with the language gap was a different 
view of physiology held by the Navajo people I met. 
On more than one occasion, I provided the second 
opinion after a patient had already visited a traditional 
medicine man. (Bizarrely, I treated a medicine man in 
the ER once, the entire time managing to stifle my urge 
to utter the line “Medicine Man, heal thyself.”) As a 
former molecular biophysics and biochemistry major in 
college and a man who lists magnetic resonance angiog¬ 
raphy and spiral computed tomography as two of his 
favorite things in the world, traditional Navajo beliefs 
about the workings of the human body hinging on a 
sense of balance and beauty in the universe seemed as 
foreign to me as their language. Consequently, I often 
was uncertain how my patients understood my ques¬ 
tions, explanations and advice. 
Patient compliance is clearly a challenge for the 
IHS, not only for cultural and linguistic reasons, but 
also for physical ones. While some Navajos live in the 
town near the hospital, many more have homes far from 
the town, miles even from a paved road. Addresses are 
listed in the medical records with descriptions like “Six 
miles NW of Antelope House Overlook, left side of 
road”or, my favorite, “29 miles NW of Pinon Trading 
Post, blue hogan with dirt roof, right side of road.” 
It’s not as though I could call my patients to see if they 
were OK or were taking their medicine—most don’t 
have telephones. 
In bad weather, 29 miles of dirt road equals insur¬ 
mountable mud and ice. Despite a patient’s best inten¬ 
tions, he or she will not be able to make his hyperten¬ 
sion follow-up appointment, perhaps for a week. 
The IHS hospital in Chinle, better known as the Chinle Comprehensive Health Care Facility. A place to learn about 
lacerations, broken bones and the Navajo approach to life and health. 
In inclement weather the clinic can be nearly empty. 
When the roads finally clear up, the waiting room packs 
wall to wall. During one particularly bad snowstorm 
while I was there, the National Guard was called in to 
help people get out ol their homes. 
Learning the ways of the whites has had an impact on 
the Navajos’ health in detrimental as well as positive 
ways. While access to medical care and technology 
undoubtedly has been beneficial, the Navajos seem to 
have fallen prey to some seductive yet decadent parts 
of our society. These days, because of their diet and 
lifestyle, the Navajo have one ol the country’s highest 
incidences ol diabetes, a disease all but absent Irom the 
reservation 60 years ago. In Chinle all three restaurants 
serve fast lood, and there is probably more canned meat 
in aisle six of the Chinle supermarket than in the entire 
state of Connecticut. Canned meat doesn’t need refrig¬ 
eration, impossible for Navajos without electricity. 
Although it is illegal to buy, sell or consume alcohol on 
the reservation, alcoholism is another scourge. The 
problem is severe enough that the supermarket stocks 
hairspray, vanilla extract and mouthwash (items contain¬ 
ing alcohol) behind a special counter. Purchase ol these 
items requires the blessing ol a highly wary store clerk. 
Furthermore, the reservation is one of the poorest 
areas in the country. Unemployment compounds the 
problems of alcoholism and poor diet of the younger 
generations and can often lead to depression and despair. 
But the difference that I found between the poverty on 
the reservation and the poverty that cripples much of 
urban America is that the family structures remain 
intact. In U.S. cities, people who are poor and troubled 
by alcoholism, drug addiction or psychiatric problems 
often find themselves out on the street. In the Navajo 
Nation, large families take care of their own. If a family 
member ends up battling alcoholism, someone will 
inevitably come down to the supermarket parking lot, 
transport the sleeping relative home and tuck him into 
bed. Somehow it seems to make the poverty—while 
certainly still a desperate situation—slightly more 
tolerable, knowing that your family will be there to 
catch you should you fall. 
Another distinctive facet of the Navajo culture is that it 
is a term of respect to call older people “grandmother’’ 
and “grandfather” when you address them. It was 
proper, then, to “give 500 mg ol Tylenol to the grandma 
in Bed Four.” I’m pretty sure that if you addressed my 
own grandmother in this manner, she would kick you 
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in the teeth and then instruct you to take your own 
damn Tylenol. 
It is well known that medical charts are littered with 
acronyms and condensed wording for common prob¬ 
lems. In Chinle, while sore throats are quite prevalent, 
they have a few problems that I had never before 
encountered; these problems might just merit their own 
abbreviations. In one week, I tended to two patients 
who arrived in the emergency room, one FOH or “Fell 
Off Horse.” I also saw a 75-year-old grandmother who 
came in BKWTS, which you might think rather un¬ 
likely, given her advanced age, provided you knew that 
BKWTS stood for “Broke Knee While Tending 
Sheep.’’Apparently she slipped on the ice, fell on a rock, 
and fractured her patella, an injury that I could not see 
happening to my aforementioned, Reebok-wearing, 
contract-bridge-playing grandma in Livingston, N.J. 
Before I left for the trip, I was under the impression 
that the landscape out west would be beautiful. Driving 
through Arizona along Interstate 40, I was not so sure. 
The scenery is indisputably impressive. Snow-covered 
red mesas jut abruptly into the skyline along the infinite 
horizon, and bizarre rock formations—Rough Rock 
and Round Rock are two towns north of Chinle, while 
Window Rock is the Navajo Nation capital—have been 
tortured from the earth by time, rivers and wind. The 
clean air and blue sky invariably produce a sense of 
majesty in anyone who has lived in a city penned in by 
soot, tenements and highway interchanges. But I 
found that the landscape was too vast, too intimidating 
to be beautiful. Driving on endless roads (Chinle is 
over an hour’s drive north of I-40) in my compact car, 
I felt alienated, as though I were merely an afterthought 
to nature. 
I think this gave me a little sense of the way the 
Navajo language and culture have developed, which also 
points to the problems of providing medical care for this 
population. My life—with its landscape of skyscrapers, 
indoor parking lots and domed sports arenas, its sounds 
of sirens and jackhammers, its smells of gasoline and 
Dunkin’ Donuts—seems as different from a Navajo’s life 
as English does from the Navajo language. 
In the Navajo language, nature reigns supreme. 
It does not make sense to say in Navajo that “the boy 
drank the water,”or even “the water was drunk by the 
boy.” Instead, the closest English translation to the act of 
drinking water is “the water let the boy drink it.” In my 
tiny car, with my little car radio blaring out tunes that 
could seem deafening in the driver’s seat but wouldn’t 
have carried for 100 yards into the vast plains, I felt like 
the road (not a natural phenomenon, to be sure, but 
representative) let me drive on it. 
By the end of the trip, I developed an appreciation for 
the complexities of the Navajo Nation and the difficulty 
of providing health care across long distances and varied 
cultures. To be sure, understanding the problem is but 
the first step to creating a solution. I ruminated on this 
during the long drive home, and can claim not to have 
been bored in the least despite the thousands of miles. 
Of the many questions I had set out to answer, 
there was one I couldn’t. Isolated as it is, the Chinle 
supermarket’s frozen-food section is copiously stocked 
with Lender’s bagels (one ol New Haven’s many contri¬ 
butions to the world). My bagel-deprivation study thus 
will have to wait until I make my way to a more remote 
corner of the globe. 
I wonder, could I drive to Nepal? YM 
YALE MEDICINE *5 
r 
4 
Medicine 
at the movies 
Paul Muni starred 
as the medical- 
scientist-hero in 
the Academy 
Award-winni ng 
The Story of 
Louis Pasteur. 
Hollywood's fascination with the 
healing profession is fertile ground 
for a series of history of 
medicine seminars. 
With horrific images of a mental institution. 
The Snake Pit represents one of the first attacks on 
the public image of the medical community. 
By Marc Wortman 
In the climactic scenes of the 1931 film 
Arrowsmith, the driven medical 
researcher-hero, played by Ronald 
Coleman, is testing his new and promising 
plague vaccine in a disease-ridden tropical 
village. Hewing to a Hollywood version of 
the scientific method, he injects half the 
villagers with the vaccine while the other 
half go without. He faces a moral dilemma 
upon realizing that the vaccine may indeed 
work. If it does, those who went without 
could have been saved, but will instead 
surely die. Torn between his quasi-religious calling of 
advancing scientific knowledge and his moral imperative 
as a doctor to save lives, he abandons his experiment and 
gives the vaccine to all the villagers. Doing so, however, 
likely ruins his research findings 
and perhaps his career. 
That basic clash of medical cultures—between 
medicine as rigorous, authoritative and sometimes 
inhumane science and as personal devotion to saving 
lives—marks hundreds of films Hollywood has made 
exploring the role of medicine in American society. 
Arrowsmith is remarkable because it is one of the earliest 
feature films to portray that conflict so unambiguously. 
Through the 1950s, whether in the laboratory or the 
clinic, medicine as shown on the silver screen was almost 
always a saintly calling. Physicians and scientists were 
carrying on a heroic battle against disease on behall of 
people from all walks of life. Then a gradual but pro¬ 
found shift took place. Along with the scientific power 
of medicine and the social authority of its practitioners, 
Hollywood showed there also came potential for great 
corruption and a chilling loss of humanity among 
physicians. “Now,” says John Harley Warner, Ph.D., 
professor of the history of medicine, “you walk into any 
video store and you’ll find scores of villain doctors. 
There’s the doctor-experimenter—in a nonconsensual 
way—the doctor-slasher, the doctor-patient-abuser.’’ 
That historical transformation of the image of the 
physician is just one aspect of the representation of 
medicine in film covered by Dr. Warner and Charles 
Andrew Morgan III, M.D., associate professor of 
psychiatry, in a seminar they taught together this year to 
some two dozen medical students, residents and fellows, 
on Medicine at the Movies: Historical Perspectives on Film 
and the Culture of American Medicine. (They expect to 
repeat the course soon.) 
It wasn’t just a chance for participants to kick back 
and watch movies, but an opportunity to explore their 
own place in the wider culture. “Popular perceptions of 
the profession as a whole are profoundly influenced by 
Hollywood,” says Dr. Warner. In watching films ranging 
from Thomas Edison’s pioneering public health films on 
tuberculosis, such as Hope (1912), to medical-scientist-as- 
hero films like The Story of Louis Pasteur (1936), to more 
recent versions of the potential abuses of medical care, 
including One Flew Over 
the Cuckoo's Nest (1975), 
the Yale students had a 
chance to reflect on how 
their chosen field is 
viewed in the popular 
eye. “Accuracy isn’t the 
issue,” says Dr. Warner. 
“You might want to say, 
‘That’s not what we’re 
like,’ but the depictions 
are very powerful.” 
Viewing the repre¬ 
sentation of medicine in 
film gave the students an 
opportunity to reflect on 
how the public perceives 
their powers and how 
much those powers grow 
out of real capabilities. 
“Where does the 
physician’s authority 
come from?” Dr. Warner 
wanted students to ask. 
“It’s too easy to fall back 
solely on the belief in the 
power to heal. As these 
films show, it’s as much a 
function of changes in 
culture. It’s not only in 
medicine. It’s out there in 
American culture.” YM 
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Thomas Edison’s Motion Picture Studio released several 
dramatic films aimed at improving public health. Here, the 
director instructs the actors in Hope, released in 1912, one 
of the first films to present an image of the physician. 
care giving. 
MUST-SEE MOVIES 
FOR PHYSICIANS 
Arrowsmith (1931) 
Men in White (1934) 
The Story of Louis Pasteur (1936) 
Dr. Ehrlich’s Magic Bullet (1940) 
Madame Curie (1943) 
Sister Kenny (1946) 
The Snake Pit (1948) 
The Magnificent Obsession (1954) 
The Hospital (1971) 
Coma (1978) 
THE BUST 
Doctor X (1932) 
The Body Snatcher (1945) 
Suddenly Last Summer (1959) 
Freud (1962) 
M*A*S*H (1970) 
The Elephant Man (1980) 
Zelig (1983) 
The Doctor and the Devils (1985) 
Flatliners (1990) 
Lorenzo’s Oil (1992) 
Source: John Harley Warner, Ph.D. 
SCOPE 
comes to New Haven 
Trading Washington 
for the Ivy League, 
the medical school's 15th 
dean gets his bearings 
and begins to fix his gaze 
“squarely ahead. " 
The first day was a whirlwind 
tour of sorts, down the 
hallways of Sterling Hall of 
Medicine and beyond, across Cedar 
Street and into laboratories and 
departmental offices, even the coffee 
nook oft the rotunda at the School 
of Medicine’s main entrance. 
David A. Kessler, M.D., Yale’s 
15th dean of medicine, took office 
July 1 and spent his first days 
introducing himself to students, 
faculty and staff. “It’s been two 
weeks of getting to know every¬ 
body,” he said in mid-July, unpack¬ 
ing boxes in the stark white sur¬ 
roundings of his freshly painted 
office on the second floor of 
Sterling’s C-Wing. The shelves held 
one book (Principles and Practice of 
Oncology, 5th edition), the desk 
empty except for a computer 
equipped with headset and micro¬ 
phone. “You can tell by looking 
around,” he said smiling, “that I’ve 
spent very little time in this office.” 
Accompanying Dr. Kessler on 
his impromptu rounds were two 
newly appointed senior administra¬ 
tors: Irwin M. Birnbaum, who 
served for 15 years as chief financial 
officer at Montefiore Medical 
Center in New York and became the 
medical school’s first chief operating 
officer on July 1; and Ruth J. Katz, a 
public health expert and attorney 
with extensive federal government 
experience, who was named assis¬ 
tant dean for administration. 
(See Faculty News, Page 37). 
“We’re enormously fortunate to 
have both of them with us,” said 
Dr. Kessler, who stepped down as 
Food and Drug Administration 
commissioner in February after six 
years in office. He has remained in 
the public eye as co-chairman of a 
congressional panel that evaluated 
the proposed $368.5 billion tobacco 
settlement announced in June. 
Above: Dean David A. Kessler, 
M.D., unpacks books in his 
office in Sterling Hall of 
Medicine in early July. 
Right: The dean meets with 
college students visiting Yale for 
a program organized by the 
medical school's Office of 
Multicultual Affairs. 
Dr. Kessler 
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“By joining forces with the existing 
team here,” he said, “especially 
deputy deans Carolyn Slayman 
and Joseph Warshaw, we re begin¬ 
ning to understand the breadth and 
scope of this institution and the 
challenges, and to fix our gaze 
squarely ahead.” 
Dr. Kessler said he planned to 
discuss his outlook on the school 
and priorities for his deanship in an 
interview later this fall. He briefly 
described the challenges ahead as 
falling in the categories “fiscal, 
facilities and scientific—building on 
the extremely strong basic science 
tradition and translating those 
discoveries into the clinic.” 
Regarding finances, “There are 
significant infrastructure issues that 
absolutely have to be addressed,” he 
added. The school also is sorting 
out a shortfall in clinical revenues 
related to the introduction of a new 
computer billing system in 1996 and 
to diminished reimbursement under 
managed care. 
In the first weeks of his five- 
year term, however, Dr. Kessler was 
focused on students and faculty, 
attending a lunch one day with a 
group of minority medical and 
public health students, and meeting 
the next with department chairs and 
faculty. The last week in July, on a 
trip organized by Ms. Katz, a group 
of 10 students accompanied him to 
Washington as he testified before 
Congress on the proposed tobacco 
settlement. “It was incredible,” 
third-year medical student Gregory 
Raskin said of the experience. (See 
Student News, Page 42) (Coinci¬ 
dentally, Dr. Kessler’s co-chair on 
the tobacco panel, former Surgeon 
General C. Everett Koop, M.D., 
began a one-year term as a visiting 
professor in Yale’s Department of 
Epidemiology and Public Health, 
also on July 1.) 
Continued, on Page 30 
Lyme researchers roll out new tool against ticks 
Ticks beware: That gentle, doe-eyed 
creature you planned to feast upon 
may be hosting your last meal. 
Lyme disease researchers in five 
states will use deer as a magnet for 
ticks as part of a $2 million experi¬ 
ment that has the potential to 
dramatically reduce or even elimi¬ 
nate new cases of Lyme disease. 
Last year, physicians across the 
United States reported more than 
18,000 new cases of the debilitating 
affliction, which causes joint pain 
and can damage the heart and 
nervous system. Most cases of 
Lyme disease are treated successfully 
with antibiotics. 
The five-year program, spon¬ 
sored by the U.S. Department of 
Agriculture, targets deer as a critical 
link in the tick life cycle and 
subsequent bacterial infection that 
occurs when the tick takes its blood 
meal from humans. At specially 
designed feeding stations in Rhode 
Island, Connecticut, New York, 
New Jersey and Maryland, the deer 
will brush up against paint rollers 
coated with pesticide, which in turn 
will kill the ticks that feed on deer. 
The results of the program will 
not be clear until 1999 or 2000, 
because the deer tick has a two-year 
life cycle, says Durland Fish, Ph.D., 
the project coordinator and a 
research scientist in epidemiology 
and public health. But, he says, 
based on a similar program in Texas 
targeting tick-borne illness among 
cattle, the potential is enormous. In 
the Texas study, the tick population 
dropped by 90 percent. 
A Lyme disease vaccine 
created by Yale medical faculty and 
developed by SmithKline Beecham 
Inc. was shown effective in clinical 
trials earlier this year, as was a 
separately developed vaccine also 
tested at Yale. SmithKline submitted 
its application to the FDA in 
September. 
Michael Fitzsousa 
EPH scientist Durland Fish, Ph.D., above, and colleagues in five states are using deer to 
target Lyme disease-causing ticks. 
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During a meeting with administrators 
this summer. Dr. Kessler talks with 
Bruce I. McClennan, M.D., professor 
and chair of diagnostic radiology. 
Continued from Page 29 
Dr. Kessler said his role as an 
anti-tobacco advocate is clearly 
secondary to his responsibilities as 
dean. (As FDA chief, he succeeded in 
banning the sale of tobacco to 
minors and in classifying nicotine as 
an addictive substance subject to 
FDA regulation, a policy upheld in 
federal court in April.) “Issues don't 
go away overnight,” he said, “espe¬ 
cially important issues on which one 
has worked for years, but it is not 
where I am focused now. My primary 
focus is being dean here at Yale." 
While he vowed to make “no 
speeches, no pronouncements” 
during his first month as dean, Dr. 
Kessler did have occasion to address 
public health and medical alumni/ 
Yale scientists exploring neurobiology of autism 
The National Institute of Child 
Health and Human Development 
(NICHD) has selected Yale as one 
of three universities to initiate a 
major research project on the 
neurobiology of autism, the most 
severe developmental disorder of 
childhood. To conduct this research, 
the NICHD has awarded $5.3 
million to the School of Medicine 
over the next five years. 
Autism, which arises as a result 
of neurobiological factors, affects 
the development and behavior ol 
one in 1,000 children. Although the 
disorder results from some insult to 
the developing brain, its cause or 
causes remain unknown. Less 
information is known about other 
pervasive developmental disorders, 
such as Asperger’s syndrome, which 
shares several features with autism. 
“We hope that this research will 
provide greater understanding ol 
autism and also enable us to develop 
improved treatment,” says Fred R. 
Volkmar, M.D., the Harris Associ¬ 
ate Professor of Child Psychiatry, 
Pediatrics and Psychology, who will 
direct the research program. 
In most cases, infants who are 
born with this disorder lack the 
usual disposition to form social 
relationships. Profound deficits in 
social interaction and communica¬ 
tion are associated with unusual 
behaviors such as repetitive move¬ 
ments, difficulties in dealing with 
change, and abnormal responses to 
the non-social environment. 
The new grant builds upon five 
decades of autism research and 
treatment within the Yale Child 
Study Center, according to center 
Director Donald J. Cohen, M.D. 
'66, the Irving B. Harris Professor of 
Child Psychiatry. He says that the 
project, “the largest research com¬ 
mitment in the history of the field, 
is truly welcomed by parents and 
ae several weeks before arriving, as 
a speaker at the dedication ol new 
EPH facilities in early June. (See 
Alumni News, Page 54.) There, he 
spoke of retaining the resolution of 
youthful idealism and quoted the 
educator Horace Mann, “who said 
that you should be ashamed to die 
until you have won some victory 
for humanity. He could have been 
talking about the road that you 
have chosen.” 
“I am thrilled,” he added, “to be 
coming to Yale to be part of training 
of the next generation, who will be 
able to try and make a difference in 
people’s lives, who know that there 
are no miracles in the promotion of 
the public welfare, only hard work 
and compassion.” 
Michael Fitzsousa 
Fred R. Volkmar, M.D. 
advocates, who appreciate that only 
through such study can the progno¬ 
sis of autism really be improved.” 
Faculty at the Child Study 
Center will join colleagues at the 
University of Chicago and Univer¬ 
sity of California at Los Angeles 
(UCLA) to conduct studies on the 
molecular and family genetics of 
autism and its related conditions 
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and of brain imaging projects. The 
scientists also will study develop¬ 
mental changes when individuals 
with autism receive treatment. 
“Even though early intervention 
and detection have improved the 
outcome, the human and financial 
costs of autism and related condi¬ 
tions remain very high,” says Dr. 
Volkmar, who will collaborate with 
Catherine Lord, Ph.D., at the 
University of Chicago, and Susan 
Smalley, Ph.D., at UCLA. “Since our 
research focuses on addressing the 
neurobiological factors which cause 
autism and related disorders, we will 
conduct work that ranges from the 
level of the gene to the brain and the 
expression of these conditions 
behaviorally in individuals.” 
Researchers will concentrate on 
four interrelated areas: 
Role of genetic factors in autism. 
Genetic factors play a role in at least 
some cases of autism. As part of this 
project, Edwin Cooke, M.D., of the 
University of Chicago; David L. 
Pauls, Ph.D., associate professor in 
the Yale Child Study Center; and 
Dr. Smalley of UCLA will attempt 
to identify the gene or genes 
involved in some cases of autism by 
studying families in which more 
than one child has autism or closely 
related conditions. 
Data will be pooled with an 
international genetic study of 
autism directed by Professor 
Michael Rutter of the University of 
London. Collaborating with him 
will be several Yale medical profes¬ 
sionals, including Domenic V. 
Cicchetti, Ph.D., senior research 
scientist in psychiatry and in the 
Child Study Center; Ami Klin, 
Ph.D., assistant professor in the 
Child Study Center; Robert 
Schultz, Ph.D., assistant professor 
in the Child Study Center, and 
Drs. Cohen and Pauls. 
Related genetic and psychiatric 
conditions in family members of 
persons with autism and Asperger’s 
syndrome, a condition similar to 
autism. Drs. Pauls and Smalley will 
assess the relationship of other 
conditions, such as Tourette's 
syndrome, obsessive-compulsive 
disorder and depression, to autism 
and Asperger’s syndrome in patients 
and family members. Previous 
research has suggested that family 
members may be at increased risk 
ior some of these conditions. 
Asperger’s syndrome, however, 
seems to be associated with a 
different developmental profile, 
including more preserved language 
skills. Related problems also appear 
more frequently in family members. 
Neuroimaging of brain areas 
that may be involved in autism. 
Jennifer Levitt, M.D., (UCLA) and 
Dr. Schultz hope to identify ways in 
which the brain processes informa¬ 
tion differently in individuals with 
autism and other conditions. They 
plan to use both structural and 
functional brain imaging methods 
to examine anatomical brain 
differences. 
Ways in which the development of 
individuals with autism develop and 
change as they are treated. Drs. Lord, 
Klin, and Volkmar will assess the 
range of outcomes and patterns of 
these individuals’ developmental 
course as they relate to intensity of 
intervention, age at diagnosis and 
other clinical factors. 
Longer steroid treatment helps some spinal patients 
A Yale-led, national study of spinal 
cord injuries has concluded that 
extending the standard steroid 
treatment an extra day improves the 
odds for patients who do not receive 
medication right away. 
Michael B. Bracken, Ph.D., 
professor of epidemiology and of 
obstetrics and gynecology, led the 
scientists and physicians from 16 
centers in the National Acute Spinal 
Cord Injury Study (NASCIS III). 
They reported that giving the 
steroid methylprednisolone for 48 
hours results in improved function 
in patients with spinal cord injury— 
if treatment begins within three to 
eight hours after injury. Standard 
treatment is 24 hours. 
The study, funded primarily by 
the National Institute of Neurologi¬ 
cal Disorders and Stroke (NINDS), 
and in part by Pharmacia and 
Upjohn Inc., was published in the 
May 28 issue of the Journal of the 
American Medical Association. 
The study compared three 
treatments: methylprednisolone 
given over a 48-hour period; an 
antioxidant drug, tirilazad mesylate, 
administered over a 48-hour period; 
and, as a control, 24-hour treatment 
Michael B. Bracken, Ph. D. 
with methylprednisolone. Nearly 
500 patients were evaluated in 
emergency rooms in New Haven 
and throughout the United States 
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and again six weeks and six months 
later as part of the randomized, 
controlled trial. 
Patients who began treatment 
three to eight hours after injury 
showed significantly better long¬ 
term recovery if they received 
methylprednisolone for 48 hours 
than if they received it for 24 hours, 
or if they received tirilazad. Patients 
who were treated within the first 
three hours after injury, however, 
showed about the same degree of 
recovery regardless of which drug 
they received or how long they 
received it. Researchers found that 
patients who received tirilazad three 
to eight hours after injury developed 
slightly fewer complications than 
patients in either methylpredniso¬ 
lone group, but they did not regain 
as much of their physical ability. 
“Based on these results, we 
recommend that patients receive 
24 hours of methylprednisolone if 
treatment is begun within three 
hours after injury," says Dr. 
Bracken, the report's lead author. 
“If patients cannot be treated within 
the first three hours, however, they 
should receive methylprednisolone 
for 48 hours.” 
The researchers measured 
improvements in patients’ ability to 
move, perceive sensation, and take 
care of themselves without assis¬ 
tance. Approximately 60 percent of 
patients treated with 48-hour 
methylprednisolone starting at three 
to eight hours recovered a substan¬ 
tial degree of independence, com¬ 
pared with nearly 40 percent of 
those given the standard treatment 
or tirilazad. Ultimately, recovery 
also depended upon the extent of 
the initial injury. 
Scientists believe both medica¬ 
tions work by interfering with a 
kind of secondary damage, called 
lipid peroxidation, that eats away at 
highly vulnerable cell membranes. 
They think this secondary damage 
becomes more difficult to interpret 
the longer initial treatment is 
delayed, which may explain why 
extending methylprednisolone 
treatment is useful in patients 
treated three hours or more after 
injury. While tirilazad and methyl¬ 
prednisolone are both powerful 
inhibitors of lipid peroxidation, 
methylprednisolone may inhibit 
other kinds of secondary damage, 
such as the release of chemicals that 
cause inflammation, the researchers 
say. “Researchers still need to 
discover if tirilazad given in differ¬ 
ent doses, and perhaps for a longer 
period, could be more effective,” 
says Dr. Bracken. 
Scientists probe links between PCP, schizophrenia and dopamine 
Scientists at the School of Medicine 
have taken a major step toward 
understanding cognitive deficits in 
sufferers of schizophrenia. Their 
findings were reported in the Aug. 
15 issue of the journal Science. 
Robert H. Roth, Ph.D., 
professor of psychiatry and pharma¬ 
cology, led a neuroscience research 
team that studied the behavior of 
African green monkeys that were 
given repeated doses of phencyclid¬ 
ine (PCP), a drug that is often 
abused by humans. They found that 
PCP induces similar cognitive 
dysfunction as that found in 
patients diagnosed with schizophre¬ 
nia. The team found the schizophre¬ 
nia medication clozapine successful 
in partially reversing the cognitive 
dysfunction in primates treated 
with PCP. 
“The results of this study open 
up countless possibilities for future 
treatment strategies,” says Dr. Roth. 
“It could lead to better drugs for 
cognitive brain dysfunction and poor 
response inhibition, which are com¬ 
mon symptoms of schizophrenia.” 
Team members include J. David 
Jentsch, a graduate student in 
neurobiology; D. Eugene Redmond 
Jr., M.D., professor of psychiatry 
and neurosurgery; John D. 
Elsworth, Ph.D., research scientist 
in psychiatry; Kenneth D. 
Youngren, a graduate student in 
neuroscience; and Dr. Roth. 
“Until now, researchers have 
used only acute doses of PCP in 
their studies of behavioral effects 
brought on by PCP injections into 
laboratory animals,” says Mr. 
Jentsch, the report’s first author. 
“We used chronic or repeated doses 
of PCP to more closely parallel the 
same symptoms of schizophrenia 
that a PCP abuser develops.” 
The scientists showed that 
cognitive deficits are associated 
with an alteration of the neurotrans¬ 
mitter dopamine, already linked 
to schizophrenia. 
The team found that primates 
treated with PCP were significantly 
less successful at retrieving bananas 
from a transparent box than saline- 
treated primates, indicating poor 
response inhibition. The scientists 
looked for chemical changes in 
PCP-treated primates by measuring 
the amounts of dopamine in their 
brains. “We saw a reduction of 
dopamine in the dorsolateral 
prefrontal cortex, the brain area 
responsible for working memory, 
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and the prelimbic cortex, a brain 
section thought to control behav¬ 
ioral inhibition,” says Mr. Jentsch. 
“There is a strong link between 
the degree of inhibition of dopam¬ 
ine and in the degree of cognitive 
dysfunction.” 
When the primates treated with 
PCP were given the drug clozapine, 
they showed a marked improvement 
in the object retrieval task. The 
results are similar to the effects of 
clozapine that have been observed 
in schizophrenic individuals. 
Karen Peart 
Access to Internet 2 will speed ‘Visible Human collaboration 
The Yale Center for Advanced 
Instructional Media (C/AIM) at the 
School of Medicine will be among 
the first programs to benefit from 
Yale’s participation in Internet 2, a 
nationwide consortium of ioo 
research universities involved in the 
development of a new computer 
network more than ioo times faster 
than the Internet. 
Yale will receive $350,000 
from the National Science Founda¬ 
tion over the next two years to 
connect to the very high speed 
Backbone Network Service (vBNS), 
which now links 64 research 
institutions across the United 
States. The University will spend an 
equal amount upgrading the 
campus network. 
The faster connection to 
vBNS—the basis for the Internet 2 
consortium, of which Yale is a 
charter member—will enable 
collaboration among institutions in 
such bandwidth-hungry fields as 
genetic mapping and sequencing, 
modeling of weather systems, and 
high-resolution imaging for medi¬ 
cine, scientific research and the arts. 
The collaboration between 
C/AIM, established in 1987 to 
develop new media for medical 
education, and the National 
Library of Medicine (NLM) was 
one of three programs cited in 
Yale’s grant application. Staff at 
C/AIM have been limited by 
connection speed in their work 
with NLM colleagues conducting 
detailed image analysis for the 
Visible Human Project, according 
to C/AIM academic director C. 
Carl Jaffe, M.D. The Visible 
Human Project is a 40-gigabyte 
collection of three-dimensional 
digital images of male and female 
human bodies compiled from 
microscopic studies of cadavers. 
Two other Yale projects will 
make early use of the vBNS connec¬ 
tion. One, Computational Neuro¬ 
science and Optical Imaging of Visual 
Cortex, is a collaboration between 
Steven W. Zucker, professor of 
computer science and electrical 
engineering, and colleagues at the 
University of California at San 
Francisco. The second will bring 
together physicists engaged in 
particle research at Yale and sites in 
Illinois, New York, California and 
Switzerland. Other prospective 
vBNS applications at Yale include a 
project in which neuroscience and 
neurobiology professor Gordon M. 
Shepherd, M.D., D.Phil., professor 
of neuroscience and neurobiology, 
will share maps of neural activity 
patterns with his colleagues at other 
institutions, showing how neurons 
E. Carl Jaffe, M.D. 
School of Medicine 
faculty are collaborators 
on the Visible Human 
Project, a massive 
online database of 
anatomical images. 
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in olfactory bulbs react to specific 
odors. His group also is participat¬ 
ing in the multi-agency Human 
Brain Project, under which research¬ 
ers are creating databases lor the 
sharing and archiving of a wide 
range of neuroscience data. 
Many other projects are ex¬ 
pected to receive vBNS access once 
installation is complete and its 
availability becomes more widely 
known. The service will increase 
network speed from the current 
average 1.5 million bits per second 
(bps) to as much as 622 million bps, 
with an eventual capacity of 2.4 
billion bps. By comparison, the 
typical computer modem runs at 
only 28,800 bps. 
Michael Fitzsousa 
City children learn the basics of bicycle safety, helmet use 
A School of 
Medicine initiative 
launched during 
the summer may 
save lives by 
teaching young 
bicyclists safety 
skills and promot¬ 
ing helmet use 
among children in 
New Haven. 
The Commu¬ 
nity Foundation for 
Greater New Haven awarded 
$10,000 to the New Haven Re¬ 
gional Injury Prevention Program 
(NHRIPP), part of the Department 
of Surgery’s section of emergency 
medicine, to implement the 
FreeWheels project developed by 
NHRIPP co-director Linda 
Degutis, Dr. PH. 
Bicycle-related injury is a major 
cause of death throughout the 
United States, especially among 
children ages 5 to 19. These injuries 
account for over 900 deaths, 20,000 
hospital admissions and 580,000 
emergency department visits 
nationwide each year. 
Despite a 1993 Connecticut law 
requiring children under age 12 to 
wear helmets when bicycling, many 
continue to ride without helmets, 
putting themselves at risk for serious 
head injury. “This grant provides a 
great opportunity to devise new and 
creative ways to prevent head injuries 
in children,’’ says Dr. Degutis, 
assistant professor of surgery. 
Dr. Degutis explored different 
ways to reach city children with 
the bicycle safety message and 
came up with the FreeWheels 
project. During the first phase, 
which took place this past summer, 
135 children attending New Haven 
summer day camps were provided 
with bicycle helmets and given a 
four-hour class on helmet usage, 
basic rules of the road, signaling and 
other cycling skills. A pre-test 
measured their knowledge of bicycle 
safety and a post-test measured what 
they had learned by participating in 
the program. 
The course, based on two 
national bicycle skills and safety 
programs, was taught by a certified 
bicycle safety instructor with the 
assistance of four local teen-agers, 
whose participation was key. “It was 
important for the younger children 
participating in the program to get 
instruction from teens because 
they’re looked up to as role models,” 
says Laura L. Fawcett, NHRIPP 
program coordinator. “If they see 
older children wearing helmets, 
they’ll begin to view helmets as a 
natural part of riding bicycles.” 
Karen Peart 
Linda Degutis, Dr. P.H. 
Yale-New Haven announces alliance in Greenwich 
Greenwich Health Care System, the 
parent corporation for Greenwich 
Hospital, and Yale New Haven 
Health System, the state’s largest 
integrated health care delivery and 
financing system, have announced an 
agreement to form a strategic alliance. 
Under the proposed affiliation 
agreement, Greenwich Hospital will 
preserve its local direction while 
gaining improved access to high- 
quality clinical support for its key 
programs. The affiliation also 
strengthens its long-established 
collaborative arrangements with 
Yale-New Haven Hospital and the 
Yale University School of Medicine. 
The most recent example of this is 
Greenwich Hospital’s association 
earlier this year with the Yale 
Cancer Center’s Oncology Network, 
in which cancer patients gain access 
Yale New Haven Health 
to advanced cancer treatments 
under the direction of their own 
local Greenwich physicians. 
The alliance with Greenwich is 
similar to the one between Bridge¬ 
port Hospital and the Yale New 
Haven Health System, which was 
completed in July 1996. The boards 
of directors and medical staffs will 
remain separate. 
Tom Urtz 
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At Childrens Hospital, bring in the clowns 
A troupe of professional clowns 
has moved into Yale-New Haven 
Children’s Hospital and added new 
meaning to the phrase alternative 
medicine. 
The Big Apple Circus Clown 
Care Unit, which took up residence 
in July, has introduced such unor¬ 
thodox treatments as red nose 
transplants, kitty cat scans and 
chocolate milk transfusions. The 
program, unique to Connecticut, is 
based upon similar Big Apple 
Circus units in Boston, Washington 
and New York. 
Professionally trained clowns 
visit the hospital three days a week, 
cheering children with juggling, 
mime, magic and music. Their 
special medical treatments include 
an eye exam using two rubber 
chickens (one large, one small), a 
cardiac accelerator (a hairy spider) 
and plate-spinning platelet tests. 
“Sick children need to laugh. 
That’s what brought us into the 
hospital. Once we got in there, we 
realized that parents of sick children 
need to laugh and that staff who are 
taking care of sick children need to 
laugh as well,” says Michael 
Christensen, co-founder of the Big 
Apple Circus and originator of the 
hospital program. 
Funding for the Clown Care 
Unit was provided through the 
Greenwich-based Garrett B. Smith 
Foundation, established by Scott 
and Heidi Smith in memory of their 
son Garrett, who was treated for 
cancer at Yale-New Haven 
Children’s Hospital. 
Ken Best 
Excellence in the Robert G. Fenley 
Writing Awards-Medical Science Writing 
competition for his Spring 1996 article 
Lowly Worm, High Stakes. It described 
the impact of hookworm disease, which 
can be especially devastating to 
children, in developing countries around 
the globe. The article explained how 
research by Yale scientist Peter Hotez, 
M.D., Ph.D., and colleagues might 
interrupt the cycle of infection. 
Yale Medicine also won two Merit 
Awards in the National Health Informa¬ 
tion Awards Competition for the 
magazine’s Special Reports series. 
The judges recognized the Spring 
1996 Special Report by writer Marc 
Wortman on Lyme disease research 
and treatment at Yale (where the 
disease was first identified in 
1975) and the Summer 
1996 Special Report by 
Mr. Fitzsousa on 
transplantation and 
organ donation. 
The Special Report 
series was launched in 
1995 to bring medicine 
and health news from Yale 
to a wider audience and to 
stimulate interest in and 
support for medical school 
programs and initiatives. 
Yale Medicine 
wins four awards 
Fall brought good news to Yale 
Medicine in the form of four national 
awards for coverage during 1996. 
On Nov. 1, Mary Kathleen Figaro, 
M.D. ’96, received an Award of Distinc¬ 
tion from the Association of 
American Medical Colleges’ 
Group on Institutional 
Advancement (AAMC/GIA) for 
her Summer 1996 article 
The Beginning, Again. Her first- 
person story was the final 
installment in a four-year 
series chronicling a student’s 
journey though medical school. 
Dr. Figaro is a second-year 
resident in internal medicine at 
The New York Hospital-Cornell 
Medical Center. 
Editor Michael Fitzsousa 
received the AAMC/GIA Award of 
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Eating disorders expert proposes fat tax on foods 
NEW BOOKS 
Burgers, fries and other high-fat 
foods consumed literally by the 
ton are making Americans sick and 
should be slapped with a high-fat 
supertax, says Kelly D. Brownell, 
Ph.D., director of the Yale 
University Center for Eating and 
Weight Disorders. 
“A whopping 7 percent of 
Americans eat at McDonald’s on 
any given day and the average child 
sees 10,000 food commercials a year 
on television, 95 percent of them for 
candy, fast food, soft drinks and 
sugared cereals,” says Dr. Brownell, 
professor of psychology and of 
epidemiology and public health. He 
notes that obese children have more 
than six times the risk of becoming 
overweight adults. “Is it any wonder 
that the prevalence of obesity in 
America has increased 25 percent in 
the last 15 years alone to an unprec¬ 
edented level of 35 percent of 
women and 31 percent of men?” 
In a recent issue of the journal 
Addictive Behavior, Dr. Brownell 
and graduate student E. Katherine 
Battle underscore the public health 
significance of obesity and recom¬ 
mend policies that would subsidize 
healthy foods, tax unhealthy foods, 
and funnel the proceeds into 
nutrition education and public 
exercise programs. 
“The next new frontier to be 
explored in the eating disorders and 
obesity field is that of prevention 
rather than treatment. The policy 
arena is an area of enormous 
potential, Dr. Brownell says. 
“Legislation and regulations aimed 
at the price structure of foods, 
opportunities and incentives for 
increased physical activity, and 
control of exposure to messages 
leading to unhealthy eating could 
have a considerable public health 
impact—at very little cost.” 
Obesity exacts a public health 
toll of approximately $40 billion a 
year due to higher rates of heart 
disease, cancer, diabetes, hyperten¬ 
sion and stroke. Instead of blaming 
the victims, society should recognize 
that Americans are being seduced 
by “our toxic food environment,” 
which offers up “a diet that is high 
in fat, high in calories, delicious, 
widely available and low in cost,” 
according to Dr. Brownell. 
Therefore, food should be 
regarded as a potential disease- 
causing agent, just like tobacco or 
alcohol, the researchers conclude. 
“Junk-food advertisements should 
be regulated and excise taxes 
imposed on high-fat foods, just as 
they are on tobacco and alcohol,” 
Dr. Brownell says. “Taxing ciga¬ 
rettes has a clear and predictable 
impact on sales and per capita 
consumption, so it would seem 
logical that a high-fat tax, combined 
with increased physical activity, 
might have a positive effect on 
eating disorders and obesity.” 
The Yale researchers advocate 
that revenues from a high-fat tax be 
used to provide more opportunities 
and incentives for physical activity 
in the community, such as bicycle 
paths, recreation centers and 
exercise programs. A food tax also 
could help fund nutrition education 
programs in public schools. 
Cynthia Atwood 
The Best Interests of the Child 
by Albert J. Solnit, M.D.; Sterling 
Professor Emeritus and senior 
research scientist in the Child Study 
Center; Free Press (New York) 1996. 
Biochemistry and Disease: Bridging 
Basic Science and Clinical Practice 
by Robert M. Cohn, M.D. ’65, and 
Karl S. Roth, M.D.; Williams & 
Wilkins (Baltimore) 1996. 
Epidemiology, Biostatistics and 
Preventive Medicine by James F. 
Jekel, M.D., M.P.H., the C.-E.A. 
Winslow Professor of Public Health; 
Joann G. Elmore, M.D., M.P.H., 
assistant professor of 
medicine; and David L. 
Katz, M.D., M.P.H., 
lecturer in epidemiology 
and public health; W.B. 
Saunders Company 
(Philadelphia) 1996. 
The Ethical Way: 
Challenges and Solutions for 
Managed Behavioral Healthcare 
by H. Steven Moffic, M.D. ’71; 
Jossey-Bass (San Francisco) 1997. 
Handbook of Autism and Pervasive 
Developmental Disorders edited by 
Donald J. Cohen, M.D. ’66, Director 
of the Yale Child Study Center and 
Irving B. Harris Professor of Child 
Psychiatry, and Fred R. Volkmar, 
M.D., the Harris Associate Professor 
of Child Psychiatry in the Child Study 
Center; Wiley Publishers (New York) 
Second edition 1997. 
Spiritual Passages: Embracing Life’s 
Sacred Journey by Drew Leder, M.D. 
'86; Putnam/Jeremy P. Tarcher 
(New York) 1997. 
The Therapist Is the Therapy by Louis 
B. Fierman, M.D., HS ’53; Jason 
Aronson Inc. (Northvale, N.J.) 1997. 
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FACULTY NEWS 
Dean makes 2 senior appointments 
Dean David A. Kessler, 
M.D., announced the 
appointment of two senior 
administrators in July. 
Irwin M. Birnbaum, who 
served for 15 years as chief financial 
officer at Montefiore Medical 
Center and since 1986 as a health 
care attorney and partner in the 
New York City offices of Proskauer 
Rose LLP, became the school’s 
new chief operating officer. Mr. 
Birnbaum is responsible for all of 
the school’s financial, business and 
operating aspects, ranging from the 
budget to the Yale Faculty Practice. 
Pie also will be a key interface with 
the Yale New Haven Health Care 
System, in going forward with the 
health care system to meet the 
enormous challenges of the changes 
taking place in health care delivery 
and health care education. 
Ruth J. Katz, a public health 
expert who was counsel to the 
Subcommittee on Health and the 
Environment, Committee on 
Energy and Commerce in the U.S. 
House of Representatives, was 
named assistant dean for adminis¬ 
tration, with responsibility for day- 
to-day administrative programs of 
the dean’s office. Ms. Katz, who has 
lectured on public health policy, 
and health care policy and politics 
at several universities, including 
Harvard and Johns Hopkins, also 
anticipates teaching in the depart¬ 
ment of epidemiology and public 
health at Yale. 
Mr. Birnbaum, who was awarded 
a B.S. degree in 1956 from Brooklyn 
College and a J.D. degree in 1961 
from New York University School of 
Law, started his career in hospital 
administration as a budget officer at 
Montefiore in 1962. By 1970, he had 
been named chief financial olficer, a 
position he held until he left in 1986. 
As a senior member of Proskauer 
Rose’s health law group, he has 
represented hospitals, hospital medical 
staff, physician practice groups, and a 
range of health care organizations 
across the country. Among his 
publications is the four-volume 
Treatise on Health Care Law, which 
he co-edited. 
Ms. Katz served as counsel to 
the Health Subcommittee between 
November 1982 and January 1995, 
analyzing policy, developing and 
drafting legislation, and managing 
the subcommittee’s considerations 
of such issues as the National 
Institutes of Health, Medicaid, 
maternal and child health, repro¬ 
ductive health and long-term care. 
During a four-month leave, starting 
in November 1992, she served as a 
member of the Clinton-Core 
Transition Team for Health Care 
Policy. She has worked as a legisla¬ 
tive aide for health affairs in the 
Office of U.S. Rep. James H. 
Scheuer (D-N.Y.), and a policy 
analyst and staff attorney for the 
U.S. Department of Health and 
Human Services’ Select Panel for 
the Promotion of Child Health. She 
also has served as director of public 
health programs at the Henry J. 
Kaiser Family Foundation. 
An Atlantic City, N.J., native, 
Ms. Katz received a B.A. degree, 
magna cum laude, in 1973 from the 
University of Pennsylvania, a J.D. 
degree in 1977 from Emory Univer¬ 
sity, and an M.P.H. degree in 1980 
from Harvard University. 
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Yale scientists chosen as HHMI 
investigators 
rhe Howard Hughes Medical 
Institute (HHMI) has announced 
that two Yale medical school 
scientists are among the 70 research¬ 
ers selected in a national competi¬ 
tion to become HHMI investiga¬ 
tors. I he appointments bring the 
number of HHMI investigators at 
Yale to 21. 
The Yale researchers are 
Gerald I. Shulman, M.D associate 
professor of medicine (endocrine) 
and of cellular and molecular 
physiology; and Tian Xu, Ph.D, 
assistant professor of genetics. 
HHMI also selected two Yale 
faculty based on Science Hill, 
Jennifer Anne Doudna, Ph.D., 
assistant professor of molecular 
biophysics and biochemistry, and 
G. Shirleen Roeder, Ph.D., 
professor of biology. HHMI is the 
Gerald I. Shulman 
Tian Xu 
largest philanthropic organization in 
the United States. “Their selection 
was the result of an intensely 
competitive process and is a tribute 
to their ability and promise as 
research scientists.” 
HHMI investigators conduct 
biomedical research in five areas: 
cell biology, genetics, immunology, 
neuroscience and structural biology. 
In recent years they have made 
significant discoveries related to 
obesity, AIDS, cancer, diabetes, 
hypertension, cardiac arrhythmias, 
cystic fibrosis, muscular dystrophy 
and many other medical problems. 
HHMI, which was founded in 1953 
and is headquartered in Chevy 
Chase, Md., enters into long-term 
research agreements with universi¬ 
ties and other academic research 
organizations where its investigators 
hold faculty appointments. HHMI 
investigators conduct their scientific 
research in institute laboratories 
located on the various campuses. 
Biochemists join National Academy 
of Sciences 
Book fund 
honors professor 
The Harvey Cushing/John Hay 
Whitney Medical library has 
received a gift to establish a 
book fund honoring Leonard 
R. Farber, M.D., clinical 
professor of medicine. The 
donor, who wished to remain 
anonymous, is the husband of 
one of Dr. Farber’s patients 
and made this gift in apprecia¬ 
tion for the care given his wife 
during her final illness. 
Books purchased will 
contain bookplates crediting 
the Leonard R. Farber, M.D., 
Book Fund. Such funds enable 
the library to acquire books 
and periodicals that could not 
be purchased from the 
library’s operating budget. 
Three medical school 
biochemists were elected 
recently to the National 
Academy of Sciences, 
bringing the total number 
of Yale University research¬ 
ers who are academy 
members to 62. The three 
new members are: Donald 
M, Engelman, Ph.D., and 
Dieter G. Soli, Ph.D., 
both of whom are profes¬ 
sors of molecular biophys¬ 
ics and biochemistry 
(MB&B); and Peter B. 
Moore, Ph.D., professor of 
chemistry and of molecular 
biophysics and biochemis¬ 
try. A fourth Yale scientist, 
chemist and physicist John 
C. Tully, Ph.D., also was 
elected to the academy’s 
membership. 
The three MB&B 
researchers use molecular 
imaging to reveal how key 
proteins transcribe genetic 
information, how genetic 
code is deciphered, and 
how that deciphered code is 
translated into the proteins 
of human cells. Dr. 
Engelman is working with 
cell membrane proteins to 
understand how the one¬ 
dimensional information 
found in gene sequences is 
converted through protein 
folding into three-dimen¬ 
sional molecules. Dr. 
Moore studies the structure 
and function of RNA 
molecules and ribonucle- 
oproteins. Dr. Soil’s 
research focuses on genetic, 
molecular biological and 
biochemical studies of the 
function of transfer RNAs 
in various organisms. 
The academy, a private 
organization of scientists 
and engineers dedicated to 
the furtherance of science 
for the general welfare, has 
advised the federal govern¬ 
ment since its establish¬ 
ment in 1863. 
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Dr. Burrow assumes new roles as advisor, professor, historian 
Gerard N, Burrow, M.D. ’58, who has 
completed his term as 14th dean of 
the School of Medicine, was named 
the David Paige Smith Professor of 
Medicine by vote of the Yale Corpora¬ 
tion. Yale President Richard C. Levin 
announced the appointment in June 
at the annual meeting of the Asso¬ 
ciation of Yale Alumni in Medicine. 
Dr. Burrow, who will serve the 
University as special advisor on 
health affairs to President Levin, is 
working on a history of the School 
of Medicine, one of a series of six 
books commissioned for Yale’s 
300th anniversary in 2001. In 
addition, he was appointed a senior 
advisor to the World Health 
Organisation’s Programme on 
Maternal and Newborn Health/ 
Safe Motherhood. 
The Smith professorship, 
established by an anonymous 
bequest in 1912, focuses on the 
theory and practice of medicine. Mr. 
Smith, who died in 1880, received a 
B.A. degee in 1851 from Yale College. 
A graduate of 
the Yale School of 
Medicine and a 
member of its faculty 
for 15 years, Dr. 
Burrow returned to 
Yale in 1992 from the 
University of California 
at San Diego, where 
he served as vice 
chancellor for health 
sciences and dean of g 
the School of Medi- 8 < 
cine for four-and-a- g 
half years. In addition s 
to his leadership in American 
academic medicine, Dr. Burrow 
possesses extensive experience in 
the Canadian healthcare system. He 
spent 12 years in Toronto as physi¬ 
cian-in-chief and director of the 
division of endocrinology and 
metabolism at Toronto General 
Hospital, and the Sir John and Lady 
Eaton Professor and chair of the 
department of medicine at the 
University of Toronto. 
Alumni!ae attending the AYAM reunion 
in June rise to give Dr. Burrow a standing 
ovation. 
As an endocrinologist, Dr. 
Burrow has centered his research 
interests on the thyroid, emphasizing 
how the growth of the gland is 
controlled. His clinical interests have 
centered on thyroid disease in 
pregnant women, particularly the 
treatment of hyperthyroidism. 
Hematologist awarded endowed chair 
The Yale Corporation has named 
Nancy Berliner, M.D. ’79, the first 
Arthur H. and Isabel Bunker 
Associate Professor of Medicine 
(Hematology). The new chair was 
created in memory of businessman 
Arthur H. Bunker, a 1916 graduate 
of Yale’s Sheffield Scientific School, 
and his wife, journalist Isabel 
Leighton Bunker. Mr. Bunker, a 
partner with Lehman Brothers and 
chairman of American Metal 
Climax Corp., died of leukemia in 
1964. The new chair in hematology 
was established through a bequest 
from the estate of Isabel Bunker, a 
magazine and science writer who 
passed away earlier this year. 
Dr. Berliner has been examin¬ 
ing the molecular basis of granulo¬ 
cyte differentiation in bone-marrow 
cells to gain insights into the factors 
leading to the development of acute 
leukemia. She and her laboratory 
colleagues also are focusing on the 
genetic mechanisms governing 
enzymes in the blood that are 
believed to contribute to tissue 
remodeling in inflammatory injury 
and repair, and to tumor metastases. 
A 1975 summa cum laude 
graduate of Yale College, Dr. 
Berliner earned her medical degree 
at Yale in 1979, winning prizes for 
best thesis and best qualifications 
for a successful practitioner. She 
took her residency training at the 
Peter Bent Brigham Hospital and 
Brigham and Women’s Hospital in 
Boston, and served as an instructor 
at Harvard Medical School for a 
year before joining the Yale faculty 
as an assistant professor in 1986. In 
addition to her professorship in 
hematology, Dr. Berliner also holds 
an appointment in the Department 
of Genetics. She has been honored 
by the National Cancer Institute, 
the American Cancer Society and 
the Leukemia Society of America. 
She was vice president of the 
American Society for Clinical 
Investigation in 1995. 
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FACULTY NOTES 
Michael B. Bracken, Ph.D., head 
of the chronic disease epidemiology 
division ol the Department of 
Epidemiology and Public Health and 
prolessor of obstetrics and gynecol¬ 
ogy, spoke belore the Royal College 
ol Surgeons ol Canada in May. His 
topic was the pharmacologic treat¬ 
ment ol acute spinal cord injury and 
the results ol the recently completed 
third National Acute Spinal Cord 
Injury Trial, which he directed. 
J.G. Collins, Ph.D., and Steven 
Marans, Ph.D., were recipients ol 
1997 Ivy Awards presented in May at 
the annual Elm-Ivy Awards Lun¬ 
cheon hosted by the City ol New 
Haven and Yale University. 
Dr. Collins is associate professor 
ol anesthesiology. As past-chairman 
ol Connecticut United for Research 
Excellence Inc., he has helped focus 
the state’s interests in the field of 
biotechnology and has spurred the 
development of educational pro¬ 
grams for elementary and secondary 
school students. He also helped craft 
a partnership among the Yale Schools 
of Medicine and Nursing and New 
Haven’s Career High School. 
Dr. Marans is primary leader lor 
the Child Development-Community 
Policing Program, which integrates 
the resources of the Yale Child Study 
Center and the New Haven Depart¬ 
ment of Police Service. The 
program’s goals are to improve the 
skills of law enforcement personnel 
in responding to situations where 
children are exposed to violence and 
to develop research that will 
strengthen public policy and clinical 
care. The U.S. Justice Department 
has provided funds to replicate the 
program in four other cities across 
the United States. 
A Yale surgical team visited the 
Nasser Institute in Cairo, where team 
members perlormed 16 major cardiac 
operations in six operating sessions 
in March. Future visits are planned 
as part ol a program to transfer 
Yale expertise to the region. 
The multidisciplinary team was 
led by John A. Elefteriades, M.D., 
pro lessor and chief of cardiothoracic 
surgery, and included anesthesiolo¬ 
gist Jane Fitch, M.D., and 
cardiothoracic surgeon Robert 
Gottner, M.D. Dr. Elefteriades was 
honorary lecturer at the 5th Alpe- 
Adria Cardiology Symposium at the 
University of Grax in Austria in May 
and served as visiting professor at the 
University Hospital ol Wales in July. 
Also in July, Dr. Elefteriades and 
Graeme L. Hammond, M.D., 
professor of surgery (cardiothoracic), 
lectured at the First International 
Congress on Thorax in Athens. 
Myron Genel, M.D., associate dean 
for government and community 
affairs, has been elected to the board 
of directors of ResearchlAmerica. 
The national organization was 
founded eight years ago to build 
support lor medical research. 
Dr. Genel’s three-year term 
began in March. 
Peter Igarashi, M.D., associate 
professor of medicine, will serve as a 
member of the General Medicine B 
Study Section, Division of Research 
Grants for the National Institutes of 
Health (NIH) Department of Health 
and Human Services lor a three- 
and-a-hall-year term that began in 
January. Study sections review grant 
applications submitted to the NIH. 
Charles S. Kleinman, M.D., 
professor of pediatrics, diagnostic 
radiology, and obstetrics and gyne¬ 
cology, was awarded a citation for 
distinguished academic achievement 
by the Alumni Association of the 
New York Medical College in May 
lor his dedication to the health and 
lile of children and their families. 
Marc I. Lorber, M.D., professor ol 
surgery (transplantation) and chief of 
the section of organ transplantation 
and immunology, was elected 
treasurer ol the American Society of 
Transplant Surgeons at its 23rd 
annual scientific meeting held in 
Chicago in May. 
James C. Rosser Jr., M.D., assistant 
prolessor ol surgery, was nominated 
for a Computerworld Smithsonian 
Award for his Operation Outreach. 
The project is a combination of CD- 
ROM multimedia tutorials, objec¬ 
tive-based skill training and remote 
guidance, which Dr. Rosser created 
to promote the teaching and practice 
of minimally invasive surgery. 
The project became part of the 
Smithsonian Institution’s Permanent 
Research Collection ol Inlormation 
Technology Innovation at the 
National Museum of American 
History in June. 
Maria J. Trumpler, Ph.D., assistant 
professor of the History of Medicine, 
was the primary consultant for The 
Body and Its Image: Art, Technology, 
and Medical Knowledge, an exhibi¬ 
tion at Dartmouth College’s Hood 
Museum ol Art. The exhibit explores 
how representations of human 
anatomy and disease have changed 
and developed since the 16th century 
and how they have affected the 
practice of medicine. Dr. Trumpler 
also presented a slide lecture at the 
museum entitled Gender and the 
Body in Anatomy and Pathology 
Textbooks, 1500-1990. 
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Emperor s new clues? 
A medical sleuth searches 
for the secret of Napoleons 
death and finds there 
isn’t one. 
By Rachel Engers 
The death mask of Napoleon 
Bonaparte that belongs to 
Philip F. Corso, M.D., 
captures in haunting detail the face 
of the emperor, with its hooked 
nose and asymmetrical mouth, 
but gives no hint of the cause of 
his demise. 
Alive, Napoleon was the subject 
of intense medical scrutiny. From 
1815, the time of his exile to a rocky, 
barren isle in the southeast Atlantic, 
until his death in 1821, Napoleon was 
chronically ill, attended by no fewer 
than four physicians. 
In death, the emperor, his body 
still sealed in a series of four coffins, 
has become a topic of medical debate 
and mystery. Dr. Corso, a 1948 
graduate of Yale College and assistant 
clinical professor of surgery (plastic) 
at the School of Medicine, has 
turned the question of how he died 
into a life’s avocation. 
One theory holds that Napoleon 
was the victim of arsenic poisoning, 
murdered by Count Charles de 
Montholon, the French general and 
aide-de-camp who accompanied him 
in exile to the island of St. Helena. 
Among the alleged motives: 
Montholon was a major beneficiary 
of Napoleon’s estate and may have 
harbored bitterness over the 
emperor’s rumored affair with 
Montholon’s wife. While investigat¬ 
ing this thesis, Dr. Corso consulted 
Philip F. Corso, M.D., a Yale College graduate who serves on the medical school’s clinical 
faculty, holds a 19th-century death mask from his collection of Napoleona. 
with the Federal Bureau of Investiga¬ 
tion as well as one of the world’s 
leading authorities on arsenic 
poisoning, Dr. Thomas Hindmarsh 
of the biochemistry laboratory at 
Ottowa General Hospital. 
After researching the medical 
accounts and autopsy reports 
recorded by Napoleon’s doctors, as 
well as the results of atomic absorp¬ 
tion testing that determined the level 
of arsenic in strands of Napoleon’s 
hair, Dr. Corso came to the same 
conclusion as Napoleon’s physicians: 
The emperor was not murdered, but 
died of stomach cancer complicated 
by a perforating ulcer. 
Dr. Corso, now emeritus chief 
of plastic surgery at Norwalk and 
Bridgeport hospitals and St. 
Vincent’s Medical Center in Bridge¬ 
port and the emeritus president of 
the Connecticut Society of Plastic 
and Reconstructive Surgeons, has 
devoted much of the past 25 years to 
the study of the French emperor. 
His home in Fairfield County, 
Conn., is flush with Napoleona, 
including letters in Napoleon’s own 
hand, Napoleonic coins, and 
sketches, paintings and statues of 
the emperor. He is writing a book, 
tentatively titled The Death of 
Napoleon: A Medical Inquest, with 
the aim of settling the controversy 
definitively by proving that Napo¬ 
leon died from natural causes. 
“The whole idea of conspiracy 
lives on forever,” he admits resign¬ 
edly. But to those scholars who insist 
Napoleon was done in, he responds, 
“It’s much easier to write a book 
when everyone is dead and no one 
is there to question you strongly.” 
For Dr. Corso, the first solution to 
this Napoleonic mystery was the 
correct one. 
Rachel Engers is a writer based in 
Hartford. 
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STUDENT NEWS 
A window on health policy 
(Through which our 
student correspondent leaps 
head-first fior a behind-the- 
scenes look at the tobacco 
settlement debate.) 
By Gregory Raskin 
Being an active medical 
student, and in the business 
of being in close contact 
with the Office of Student Affairs— 
even though I am admittedly treated 
with skepticism and something just 
short of revulsion when I go to 
bother them—I saw nothing unusual 
when I was paged by those fine folks 
from Harkness early one Monday 
morning in July. Returning the page, 
I was extremely surprised to find 
out that Dean David Kessler and 
Assistant Dean Ruth Katz were 
taking io students to Washington 
that very evening for a crash course 
on the making of federal health 
policy. If I sprang into action, I 
would get to be one of those stu¬ 
dents. (Later, on the flight home, as 
we students were sitting around 
wondering how we had been lucky 
Gregory Raskin is a fourth-year 
medical student at Yale. Notes From 
a Navajo Winter, his account of a 
month-long elective in primary care 
at the Indian Health Service hospital 
in Arizona, appears on Page 20. 
enough to have been chosen, I 
offered that the Student Affairs 
Office was probably ecstatic over the 
possibility of a 24-hour window in 
which they could be assured I would 
not come and harangue them.) 
After a dash to J. Press for a tie 
worthy of Our Nation’s Capital and 
an emergency meeting with a cobbler 
(my size-12 penny loafers, which I 
have had since the eighth grade, had 
developed an unsightly and cavern¬ 
ous hole on the left sole), I raced to 
school to meet the group. Dean 
Kessler, Ms. Katz, seven fellow 
medical students and two public 
health students got to know each 
other on the small turboprop shuttle, 
which was ferrying only two other 
people to National Airport, giving 
it the feeling of a private charter. 
The students checked into a hotel 
on Capitol Hill and went out for a 
late dinner of Ethiopian food. 
Early the next morning, the 
students met over breakfast to discuss 
the briefing material that had greeted 
us at check-in the night before. We 
perused the recommendations of the 
Koop/Kessler report on the proposed 
tobacco settlement, which was the 
unifying theme for our daylong 
experience. Next we walked to the 
Hart Senate Building on Capitol Hill 
for a wonderful session led by Ms. 
Katz titled Seminar on Federal 
Legislative Process. The meeting was 
held in the Senate Judiciary 
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Committees conference room. As 
portraits of past chairmen (all the 
way from Martin Van Buren to 
Orrin Hatch) gazed down on us, 
Ms. Katz took us through the entire 
ordeal: from the smallest inkling of a 
bill in a senators or representative’s 
mind, through the various subcom¬ 
mittees, to the floor of Congress, to 
the presidents desk and back again, 
if necessary. 
Emboldened with our new 
knowledge of government, we 
attended the Commerce Committee 
oversight hearings regarding the 
tobacco settlement. Staunchly on the 
side of public health, we smiled at 
the compelling arguments of Drs. 
Kessler and Koop, whose testimony 
spoke to the faults of the settlement. 
We jeered silently when selected 
senators came out on the side of 
Big Tobacco. 
Most senators started off by 
saying something obvious, benign 
and noncontroversial, like that they 
were morally outraged and despon¬ 
dent to find out that children in 
America were smoking cigarettes. 
I was surprised to see several senators 
far more interested in their constitu¬ 
ents (tobacco farmers, they claimed, 
but I suspected Big Tobacco cam¬ 
paign donors) than in the public 
health of our nation. Also, it ap¬ 
peared that, despite having large 
staffs of countless legislative aides, 
many of the senators seemed misin¬ 
formed regarding the particulars of 
both the tobacco settlement and 
the public health risks of smoking. 
We left the hearing after the testi¬ 
mony of Michael Moore, the 
Mississippi attorney general spear¬ 
heading the settlement. 
After a quick interview with the 
New Haven Register (I was even 
quoted in the following day’s paper), 
we students and Ms. Katz headed 
over to the editorial offices of the 
Washington Post for a lunch meeting. 
John Schwartz, the Posh main writer 
on the tobacco issue, discussed his 
take on the morning session in the 
Senate. We talked about the role of 
the media in helping to shape public 
health policy. With a deadline 
looming large, we were sent scurry¬ 
ing from the Post building and over 
to the White House. 
I had been to the White House 
once before, for a tour with my 
family. This time, though, it would 
be for a meeting in the Old Execu¬ 
tive Office Building, where the vice 
president has his office and many 
presidential staffers work. We walked 
through the interior of the build¬ 
ing—whose 20-foot ceilings, pink 
pillars and huge spiral staircases 
could have been designed by Lewis 
Carroll—to a dark conference room. 
Waiting for us in the appropriately 
not smoke-filled back room were 
Dean Kessler, Dr. Koop and an 
adviser to the president. The meeting 
seemed to have two purposes: the 
adviser explained the president’s role 
in the tobacco issue, and then the 14 
of us had a discussion about what 
message the students thought 
President Clinton should bring to 
the people. Of course, we were 
appropriately unanimous in the 
preeminence of public health to steer 
our government. Even if we hadn’t 
agreed, it’s probably not that easy to 
argue with C. Everett Koop. 
By the end of the day, as we 
walked out into the humid D.C. 
sunshine, we were all pretty worn 
out. We had learned about the 
tobacco issue as a model for federal 
health policy and viewed it from 
many angles: that of the public 
health community, the legislature, 
the media and even the executive 
branch. When I popped into the 
Office of Student Affairs the next 
day to tell them how the trip went, 
I could tell by the looks on their 
faces they were already hard at work, 
trying to think of another excuse to 
send me away from New Haven. 
STUDENT NOTES 
Alison Days was awarded the 
Novastis Award (previously known 
at the Ciba-Geigy Award) at the 
Student/Faculty Tea in May for 
laudable extracurricular activity 
within the community. She received 
a complete set of the Netter Atlas. 
Pezhman Eliaszadeh, a graduate 
student in public health, was one 
of 10 outstanding college students 
throughout the U.S. to receive a 
$1,000 Public Service Scholarship. 
These awards are donated by the 
Federal Physicians Association (FPA) 
in honor of Dr. Gerold Van der 
Vlugt, past president of the FPA, and 
are designated for students planning 
a health-related government career. 
David Gershfield was presented the 
Marguerite Rush Lerner Award at 
the Student/Faculty Tea in May for 
his poem entitled Retrospection. 
Jason R. Klenoff was awarded the 
Alpha Omega Alpha Honor Medical 
Society Student Research Fellowship 
Award in the amount of $3,000 for 
his research entitled Developmental 
Morphometries of Olfactory Receptor 
Axonal Arbors. Supporting faculty 
mentor Charles A. Greer, Ph.D., 
associate professor of surgery 
(neurosurgery) and neurobiology, 
was recognized as well. 
Rachel 
Villanueva 
was one of 50 
outstanding 
young medical 
professionals 
presented the 
American 
Medical Association (AMA)/Glaxo 
Wellcome Achievement Award by 
the AMA at its annual national 
leadership conference in March. 
Dr. Villanueva was recognized for 
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her work as president of 
the Student National 
Medical Association. 
For the nth year, Yale has 
received a generous gilt 
from the Howard Hughes 
Medical Institute to 
support graduate medical 
education in the biological 
sciences. This year’s gilt 
amounts to $330,000. A 
portion of the funds has 
been used to create 
graduate fellowships, held 
in 1996-97 by jin Xie 
(molecular biophysics and 
biochemistry), Karl 
Hagland (microbiology), 
and Qiu-Xing Jiang and 
Leon Isales-Suarez 
(cellular and molecular 
physiology). The remain¬ 
der is contributing to the 
stipends of 200 students 
throughout the biological 
sciences at Yale. 
At the 1997 national 
convention of the Ameri¬ 
can Medical Student 
Association (AMSA) in 
Orlando, Yale medical 
students were among those 
presenting award-winning 
research abstracts. Daniel 
Coghlin presented his 
work, Discussing Advance 
Directives in the Outpatient 
Setting: Who Wants to Talk 
About It Any way? at the 
presentation of Medical 
Student Projects & 
Research session sponsored 
by the National Health 
Service Corps. The 
following students’ work 
was presented at the Basic 
and Clinical Science poster 
session, which is sponsored 
by AMSA, the National 
Institutes of Health and 
the Association of Ameri¬ 
can Medical Colleges: 
Alan Cheng, Novel 
Strategies in Retroviral- 
Mediated Gene Correction 
of SCID; Jessica Haberer, 
Epitope Mapping of the 
L.pifanoi Amastigote 
Antigen P-4 Involved in 
T-cell Responsiveness to 
Human Cutaneous Leish¬ 
maniasis' Abike James, 
A Critical Analysis of 
Interpregnancy Intervals as 
an Explanation for the 
Persistent Disparities in 
Small for Gestational Age 
Births Between Black and 
White Women; and Mark 
Skirgaudas, Expression of 
Angiogenesis Factors and 
Selected Vascular Wall 
Matrix Proteins in Intracra¬ 
nial Saccular Aneurysms. 
Volunteers and performers 
are needed for the 1998 
Peter A.T. Grannum 
Scholarship Jamboree, a 
variety show consisting of 
poetry, singing and ethnic 
dances. The 1997 jambo¬ 
ree, sponsored by the 
Student National Medical 
Association, raised $10,000 
for scholarships to be given 
to New Haven high school 
sophomores or juniors. 
Students interested in the 
1998 jamboree may contact 
third-year M.D./Ph.D. 
student Helena Hansen 
at 772-2239. 
The letter, please 
Match Day, an annual exercise in anxiety, 
ends with smiles all around. 
Cheers and toasts filled the Ebbert Lounge on Match Day 
last March as the members of the Class of 1997 opened 
long-anticipated letters from the National Resident Match¬ 
ing Program. Inside was the answer to the question that 
hovers over most of fourth year: Where will I train? 
The Match uses a weighted formula to pair graduating 
students with residency programs around the country. After 
applications, visits and interviews, students and residency 
programs each submit ranked choices, with a computer 
sorting out the matches. Some 20,209 first-year residency 
positions were offered in the 1997 Match, with more than 
13,550 U.S. medical school seniors and 3,430 interna¬ 
tional medical school graduates securing positions. As has 
been the case for the third consecutive year, more than half 
the nation’s graduating seniors will pursue training in one 
of the generalist specialties for at least the first year of 
residency, reflecting an increasing trend toward primary 
care training. Among the Yale graduates, more than half are 
entering subspecialty training programs this year. 
Marc Wortman 
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1997 residency 
placements for Yale 
medical students 
The Office of Student Affairs has 
provided the following list, which 
outlines the results of the National 
Resident Matching Program for Yale's 
medical school graduates. 
ARIZONA 
Good Samaritan Hospital, Phoenix 
Frank Moya, transitional 
CALIFORNIA 
California Pacific Medical Center, 
San Francisco 
Mark Skirgaudas, medicine 
Childrens Hospital, Oakland 
K. Leslie Avery, pediatrics 
Kaiser Foundation Hospital, San Francisco 
Jeffrey Tseng, medicine 
Los Angeles County-University of Southern 
California Medical Center 
Mark Spicer, neurosurgery 
Stanford Health Services 
Melissa Berhow, general surgery 
Kristina Crothers, internal medicine 
Matthew Klein, plastic surgeiy 
Adetokunbo Oyelese, neurosurgery 
Daniel Saal, psychiatry 
Susan Wolf, dermatology 
University of California—Irvine Medical 
Center 
Monique Lawrence, emergency medicine 
University of California—Los Angeles 
Medical Center 
Daniel Lee, diagnostic radiology 
Joseph Wu, internal medicine 
University of California—San Diego 
Medical Center 
Susannah Ehret, medicine/pediatrics 
Anil Panackal, internal medicine 
Alexander Rivkin, otolaryngology, surgery 
University of California—San Francisco 
Andrew Haskell, orthopaedics 
Mark Skirgaudas, diagnostic radiology 
CONNECTICUT 
Hospital of Saint Raphael 
Laertes Manuelidis, medicine 
KentTa, transitional 
Susan Wolf, medicine 
Middlesex Hospital, Middletown 
David Walker, family practice 
Yale-New Haven Hospital 
Maryam Asgari, dermatology (research) 
John Beiner, orthopaedics 
Sumeet Bhanot, otolaryngology, surgery 
Robert Camp, pathology 
Malabika De, internal medicine 
Nina Fisher, dermatology 
Janette Gaw, general surgery 
Jason Gold, general surgery 
Jonathan Grauer, orthopaedics 
Anu Gupta, internal medicine 
Basem Jassin, otolaryngology, surgery 
Stephen Kavic, general surgery 
Chang Soo Kim, plastic surgery 
Kathryn Leinhardt, internal medicine 
Dana Loo, internal medicine 
Raburn Mallory, internal medicine 
Laertes Manuelidis, dermatology 
Frank Moya, ophthalmology 
Helena Nolasco, internal medicine 
Mark Rubinstein, medicine 
Lisa Sanders, internal medicine/primary 
FLORIDA 
Jackson Memorial Hospital, Miami 
Richard Pigeon, orthopaedics 
Urjeet Patel, left, and Chang Soo Kim toast the 
good news. Dr. Patel matched in otolaryngology 
and surgery at Washington University and 
Bames-Jewish Hospital in St. Louis. Dr. Kim 
was selected for his plastic surgery residency at 
Yale-New Haven Hospital. 
GEORGIA 
Emory University School of Medicine, 
Atlanta 
Peter Ferren, psychiatry 
Christiana Muntzel, pediatrics 
LOUISIANA 
Earl K. Long Medical Center, Baton Rouge 
Carlos Caceres, medicine 
Tulane University School of Medicine, 
New Orleans 
Shawn Nakamura, orthopaedics 
MARYLAND 
Johns Hopkins Hospital 
Tamara Dildy, emergency medicine 
University of Maryland, Baltimore 
Katherine Day, otolaryngology, surgery 
MASSACHUSETTS 
Beth Israel Deaconess Medical Center, 
Boston 
Carlos Caceres, idiagnostic radiology 
Daniella Courban, obstetrics and gynecology 
Eric Fan, internal medicine 
Nina Fisher, medicine 
Jeffrey Meyerhardt, internal medicine 
Boston Combined Residency Program in 
Pediatrics (Children’s Hospital) 
Kelly Cant, pediatrics 
Boston Medical Center 
Winifred Agard, emergency medicine 
Wendy Kuohung, obstetrics and gynecology 
Brigham & Women’s Hospital, Boston 
Anthony Aizer, internal medicine 
Michael Fischer, internal medicine/primary 
Joshua Fogelman, medicine 
Pieter Pil, general surgery 
Deaconess Hospital, Boston 
Winifred Agard, medicine 
Willis Chou, internal medicine 
Jeremiah O’Regan, medicine 
Harvard Combined Medicine/Pediatrics 
Program (Massachusetts General 
Hospital), Boston 
Carole Smarth, medicine/pediatrics 
Harvard Longwood Psychiatry, Boston 
Michele Baker, psychiatry 
Massachusetts General Hospital, Boston 
Jill Fischer, pediatrics 
Peter Siekmeier, psychiatry 
MISSOURI 
Barnes-Jewish Hospital, St. Louis 
Urjeet Patel, surgery 
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Monique Lawrence, now in the University 
of California-Irvine Medical Center’s 
emergency medicine program, shares a hug 
with a friend upon hearing the news. 
Behind them is Kevin Daly of the Class of 
1998, who has Match Day to look forward 
to as a fourth-year student next March. 
Nirit Weiss, lefi, of the Class of1998 joins 
a delighted Susannah Ehret, who learned 
of her placement at the University of 
California-San Diego Medical Center for 
a residency in medicine and pediatrics. 
Washington University, St. Louis 
Urjeet Patel, otolaryngology 
NEW JERSEY 
St. Barnabas Medical Center, Livingston 
Lisa Park, transitional 
NEW MEXICO 
University of New Mexico School of 
Medicine, Albuquerque 
Basia Holub, emergency medicine 
NEW YORK 
Beth Israel Medical Center 
Janel Hackney, medicine 
Einstein/Jacobi Medical Center, Bronx 
Noah Scheinfeld, dermatology 
Einstein/Montefiore Medical Center, Bronx 
Rani Spudich, plastic surgery 
Lenox Hill Hospital 
Amos Dare, surgery 
Daniel Lee, medicine 
Manhattan Eye, Ear & Throat 
Lisa Park, ophthalmology 
The Mount Sinai Hospital 
Bradley Ekstrand, internal medicine 
The New York Hospital 
Celia Golden, internal medicine 
Rachel Rothschild, pediatrics 
Rachel Villanueva, obstetrics and gynecology 
New York University Medical Center 
Joshua Fogelman, dermatology 
David Meyer, general surgery 
Presbyterian Hospital, New York 
Brigitte Kerpsack, pediatrics 
St. Vincents Hospital, New York 
Noah Scheinfeld, medicine 
SUNY—Buffalo Affiliated Hospitals 
Amos Dare, neurosurgery 
SUNY—Buffalo/Graduate Medical Center 
Julian Anthony, surgery, urology 
PENNSYLVANIA 
Abington Memorial Hospital 
Elizabeth Benstock, medicine 
Childrens Hospital, Philadelphia 
Jennifer Femiano, pediatrics 
Eric Frehm, pediatrics 
Hospital of the University of Pennsylvania, 
Philadelphia 
Phillip Cheng, internal medicine 
Stanford Peng, internal medicine 
Rachel Rapaport, general surgery 
Amal Sawires, internal medicine 
Thomas Jefferson University Hospital, 
Philadelph ia 
Jerome Zink, surgery, urology 
Elizabeth Benstock, dermatology 
University Health Center of Pittsburgh 
Abike James, obstetrics and gynecology 
RHODE ISLAND 
Memorial Hospital, Pawtucket 
Christopher Bositis, family practice 
Rhode Island Hospital/Brown University, 
Providence 
Jane Kim, plastic surgeiy 
TEXAS 
University of Texas Health Science Center, 
San Antonio 
W. Randy King, general surgery 
VIRGINIA 
University of Virginia, Charlottesville 
Santosh Krishnan, general surgery 
Julia MacRae, plastic surgery 
WASHINGTON 
Tacoma Family Medicine 
Karen Kiang, family practice 
University of Washington Affiliated 
Hospitals, Seattle 
Andrea Edwards, internal medicine 
Shelagh Houghton, internal medicine 
Dana Meinke, internal medicine 
Jeremiah O’Regan, diagnostic radiology 
Jeffrey Tseng, diagnostic radiology 
Some names appear twice because the 
graduate is entering a one-year program before 
beginning a specialty residency. 
The transitional designation is a one-year 
program with three-month rotations in 
different specialties. 
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Questions 
that open 
new fields 
Scientific authority is often 
not the last word, aspriring 
scientists learn on Student 
Research Day. 
When Judah Folkman, M.D., first 
proposed his novel theories of 
tumor growth, many leading investi¬ 
gators of the day scorned his work. 
Eventually they were forced to 
acknowledge the validity of his 
findings on the crucial role blood 
vessels play in tumor growth, which 
proved to be the basis of an entirely 
new area of biology. Learning about 
his experiences was just the sort of 
inspiration the many aspiring 
researchers among Yale’s medical 
students needed for their own 
required student research projects. 
They had the chance to examine the 
work of graduating students and to 
hear Dr. Folkman first-hand when he 
delivered the Lee E. Farr Lecture to 
close out the annual Student 
Research Day in May. 
Student Research Day also 
gave Dr. Folkman, the Julia Dyckman 
Andrus Professor of Pediatric 
Surgery at Children’s Hospital in 
Boston, a chance to learn what 
some of tomorrow’s challengers of 
scientific authority have been doing. 
The findings from original research 
pursued by some 45 medical and 
public health students were dis¬ 
played on posters or presented 
orally. Student Research Day 
celebrates the conclusion of the 
students’ original research and 
thesis projects. Required research 
projects have been a continuous 
For many. Student Research Day marks the formal entry of medical students 
into the research community. 
part of the Yale System since 1839, 
making it the longest-standing 
requirement of its kind among the 
nation’s medical schools. Past 
projects have frequently pointed 
students in what prove to be lifelong 
career directions. 
Prior to delivering his talk on 
Strategies for the Discovery of 
Endogenous Inhibitors of Angiogen¬ 
esis, Dr. Folkman listened to 
presentations by five students 
selected by the Thesis Awards 
Committee for special honors. 
They were: 
► Anthony Aizer, Genetic Variants of 
the Angiotensinogen Gene and 
Their Effects on Blood Pressure 
Regulation Among People of 
African Descent 
► K. Leslie Avery, Containing the 
Backlash against Managed Care 
Limits: A Rational Approach 
Towards Legislating Mandated 
Health Benefits Coverage 
► Kelly Cant, Genetic and Biochemi¬ 
cal Characterization of Drosophila 
Singed, a Homolog of the Actin 
Bundling Protein Fascin 
► Michael A. Fischer, Excess Sample 
Size and the Delta Wobble' in 
Randomized Controlled Trials 
► Dana Meinke, Tat-dependent 
Regulation of 3’-End Processing 
Efficiency in HIV-1 
Marc Wortman 
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Only beginning his research, Robert Kadoko, Class of 2000, learns 
from Wendy Kuohung what she found in her biochemical work in 
obstetrics and gynecology. 
Carolyn W. Slayman, Ph.D., deputy dean for academic and scientific 
affairs, and Bruce I. McClennan, M.D., chair of the Department of 
Diagnostic Radiology, listen as Julia MacRae, left, explains her study 
of REMEDY, an international program founded at Yale to redistribute 
medical supplies to developing nations. 
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Pictured with John N. Forrest Jr., M.D.; Farr lecturer Judah 
Folkman, M.D.; and associate dean of medical education and student 
affairs Robert Gifford, M.D., are five students honored for their 
outstanding theses. From left, they are: Anthony Aizer, Dana Meinke, 
K. Leslie Avery, Kelly Cant and Michael Fischer. 
Lee E. Farr, M.D., a pioneer in the field of nuclear 
medicine and a 1933 graduate of the School of 
Medicine, died on July 16. Dr. Farr established the 
annual lectureship that has brought Nobel laureates 
and other distinguished physicians and scientists to 
campus on Student Research Day each year since 
1988. Dr. Farr and his wife, Miriam, pictured above 
on Student Research Day 1996, often traveled to 
New Haven from their home in Walnut Creek, 
Calif., to attend the lecture, but they were unable to 
do so this May due to his failing health. These pages 
are dedicated to his memory. 
Dr. Farr’s obituary appears on Page 70. 
Farr lecturer Judah Folkman, M.D., left, and John N. Forrest, M.D., 
director of the OJfice of Student Research, pause among the posters. 
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COMMENCEMENT 1997 
A time for enlightened leadership 
The members of the Class 0/1997 face unprecedented challenges as they graduate. 
But there has never been a more exciting time in biomedical science. 
Dana Loo, right, shares her delight at finishing her medical degree with ipp6 YSM graduate 
Julie Rothstein. 
Commencement is a time to 
both celebrate accomplish 
ment and take a big step 
toward the future. For the members 
of the Class of 1997, that step is 
filled with exceptional uncertainty. 
In his Commencement address 
May 26, Robert H. Gifford, M.D., 
HS ’65-66, associate dean for 
medical education and student 
affairs, warned of the potential for 
“deadly ethical and Financial conflict 
with the current limits being placed 
on spending by managed care.” 
It was in the spirit of overcoming 
conflict that he called upon the 
Class of 1997 to be creative in their 
approach to this problem as they 
embarked upon their careers. “It is 
going to be a time for enlightened 
leadership,” he said, “and I hope 
you will be up to it.” 
Whatever thorny issues may lie 
ahead, there was no conflict, only 
smiles, apparent as 97 medical 
students were awarded diplomas 
under a tent in Edward S. Harkness 
Hall Courtyard. The class was the 
last to receive its diplomas from 
Dean Gerard N. Burrow, M.D. ’58, 
who has returned to the faculty 
(See Faculty News, Page 37). As is 
custom, many students and profes¬ 
sors were honored for their achieve¬ 
ments. At the University Com¬ 
mencement exercises on Old 
Campus, Alfred G. Gilman, a 1962 
graduate of Yale College and 1994 
Nobel laureate in medicine, was 
awarded an honorary doctor of 
medical sciences degree. 
Marc Wortman 
Class co-president Heather Lynch presents Robert H. Gijford, 
M.D., HS ’6j, with the class yearbook dedicated to him. 
The much-loved Dr. Gijford had planned to leave his post as 
dean of medical education and student affairs at the end of the 
academic year, but he was asked by Dean David A. Kessler, M.D., 
to stay on for an additional year. 
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The color and pageantry of Commencement include a bouquet and smiles for family and 
friends as Tamara R. Dildy parades into the Harkness Hall Courtyard. 
Tamara R. Dildy, Society for 
Academic Emergency Medicine 
Award 
Stephen M. Kavic, Connecticut 
Society of Board Surgeons Prize 
Adetokunbo A. Oyelese and Rachel 
Villanueva, Peter A.T. Grannum 
Award 
Rachel R. Rothschild, Lauren 
Weinstein Award 
David E. Walker, Connecticut 
Academy of Family Physicians 
Award 
Danica Barron and Michelle Pinto, 
Milton C. Winternitz Prize in 
Pathology 
Urjeet Patel, Endocrine Society 
Medical Student Achievement 
Award 
From left. Commencement marshals 
Lawrence S. Cohen, M.D. ’yo, HS ’ 
65, Robert H. Gifford, M.D., HS '6y, 
James Jekel, M.D., and Gary Friedlander, 
M.D., sing out during the University 
Commencement ceremony on Old Campus. 
Student honors 
and prizes 
Santosh N. Krishnan, Parker Prize 
Benjamin R. Doolittle, Miriam 
Kathleen Dasey Award 
Joshua P. Fogelman, Norma Bailey 
Berniker Prize 
Anthony Aizer, Jeffrey A. 
Meyerhardt and Rachel 
Villanueva, Dean’s Prize lor 
Community Service 
David B. Meyer, Campbell Prize 
Phillip M. Cheng, Perkins Prize 
Stephen M. Kavic and Rachel 
Rapaport, Merck Book Awards 
John M. Beiner, Lange Book Award 
Kelly Cant and Adetokunbo A. 
Oyelese, M.D./Ph.D. Award 
Rachel Villanueva, Connecticut 
Society of American Board of 
Obstetricians and Gynecologists 
Prize 
Brigitte F. Kerpsack, New England 
Pediatric Society Prize 
Thesis prizes 
Malabika De and Jeffrey A. 
Meyerhardt, American Cancer 
Society Prize 
Shelagh A. Houghton, Peter F. 
Curran Prize 
Phillip M. Cheng, Ferris Prize 
Dana S. Meinke, William U. 
Gardner Thesis Prize 
Abike T. James, Nicholas J. 
Giarman Prize 
Maryam M. Asgari, International 
Health Prize 
David E. Walker, Keese Prize 
K. Leslie Avery, Dr. Harold H. 
Lamport Biomedical Research 
Prize 
Kelly Cant, M.D./Ph.D. Thesis 
Prize 
Jeffrey R. Tseng, Dr. Louis H. 
Nahum Prize 
Michael A. Fischer, John P. Peters 
Prize 
Peter J. Siekmeier, Lidz Prize in 
Psychiatry 
Anthony Aizer, Louis G. Welt Prize 
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Faculty Honors 
Each year, faculty are honored for 
particular contributions to the 
education and lives of the graduat¬ 
ing class. The recipients of the 
Class of 1997 prizes were: 
► Bohmfalk Prize: James Jekel, 
M.D., the C.-E.A. Winslow 
Professor of 
Public Health, 
and Vincent 
Quagliarello, 
M.D., associate 
professor of 
medicine, were 
honored for 
outstanding contributions to 
the teaching program, Dr. Jekel 
for his clinical teaching, Dr. 
Quagliarello for his efforts in the 
basic sciences. 
► The Francis Gilman Blake Award: 
Thomas Duffy, M.D., professor 
of medicine and in the Cancer 
Center, was recognized as the 
most outstanding teacher in the 
medical sciences. 
► The Betsy Winters House Staff 
Award: This honor, which went to 
Pauline Chen, M.D., honors the 
member of the house staff of Yale- 
New Haven Hospital who has 
made the most significant contri¬ 
bution to the education of the 
students, as designated by the 
graduating class. 
► The Leah M. Lowenstein Award: 
Women’s health expert Janet B. 
Henrich, M.D., 
associate profes¬ 
sor of medicine 
and obstetrics 
and gynecology, 
received the prize 
for being the 
full-time faculty 
member whose work represents 
the highest degree of excellence in 
nonsexist education. Dr. Henrich 
also directs the Women’s Health 
Program at Yale and serves as a 
master ofTrumbull College. 
► American Medical Women’s 
Association Gender Equity 
Award: Presented to medical 
faculty around the country, this 
prize honors faculty who have 
promoted gender-fair environ¬ 
ment for education and training. 
Shanta Kapadia, M.D., lecturer in 
surgery (gross 
anatomy), and 
Laura Ment, 
M.D., professor 
of pediatric 
neurology, shared 
the 1997 prize. 
► Dean’s Medical Education Farr 
Prize: Faculty who have made 
special efforts to organize, coordi¬ 
nate and implement successful 
courses and clerkships receive this 
honor. This year’s recipients: 
Walter N. Kernanjr., M.D., 
assistant professor of medicine, 
and Frederick 
Haeseler, M.D., 
associate clinical 
professor of 
medicine. 
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Jeffrey Meyerhardt feels the warmth of completing his Yale tnedical studies. 
Following 
presentation of 
degrees, graduates, 
from left, Daniella 
Courban, Kristina 
Crothers, Amos 
Dare, Katherine 
Day and Malabika 
De, recite the Yale 
Physicians Oath 
authored by Alan C. 
Mermann, M.D., 
the school chaplain 
and clinical 
professor of 
pediatrics. 
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COMMENCEMENT 1997: EPH 
A time-honored celebration 
Photographs by Melanie Stengel 
w 1th its roots in medieval pageantry and its graduates moving 
toward a new millenium, com¬ 
mencement 1997 lor the graduates 
ol Epidemiology and Public Health 
(EPH) was a festival of ancient 
pomp and circumstance and a time 
for more sober thoughts about the 
challenges they face after leaving 
Yale. Dean for Public Health 
Michael H. Merson, M.D., con¬ 
ferred master’s of public health 
degrees upon 93 students. Ten 
graduates received doctor of phi¬ 
losophy degrees. James F. Jekel, 
M.D., who has retired as the C.- 
E.A. Winslow Professor of Public 
Asifa Nurani delivered the student address to an audience of several hundred 
parents, friends and students. 
Health and is a 1965 EPH alumnus, 
gave the (acuity address during the 
ceremony held on the lawn outside 
the Laboratory of Epidemiology 
and Public Health. 
James F. Jekel 
Facidty share the joy of students. Here, Peter 
Hotez, M.D., Ph.D., associate professor 
of epidemiology, shows his pride in the 
achievement ofNeda Shargi, whose student 
research focused on Dr. Hotez’s hookworm 
vaccine project. 
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Elena Lingas, recipient of the E. Richard Weinerman Fellowship for her involvement in social 
and political justice efforts, was the EPH banner-bearer. 
Faculty and 
student awards 
The recipient of- this year’s Award 
for Excellence in Teaching at EPH 
had a slight problem getting to 
the stage on Commencement 
Day to pick it up. She was across 
town, receiving her own doctoral 
degree from the Graduate School 
of Arts and Sciences. Nonetheless, 
Elizabeth Bradley, Ph.D., M.B.A, 
admired by students for her 
teaching style as an assistant 
professor of epidemology and 
public health in the division of 
Health, Policy and Administration, 
might have been able to hear the 
applause that rose from the tent 
at EPH. 
Student awards announced at 
Commencement this year were: 
► The Wilbur G. Downs Interna¬ 
tional Travel Fellowships: 
Kathryne Baisley, Nora Labiano- 
Abello, Pia MacDonald, Asifa 
Nurani, Veronica Pinell-Salles and 
Lara Vu received support to 
undertake research on public 
health problems in developing 
countries. 
► Kathleen Hara Howe Scholarship: 
Garth Rauscher received this 
award, given to an incoming 
student who enrolls mid-career or 
several years after receiving a 
baccalaureate degree. 
► Merit Scholarships: April Bell, 
Stella Chang and Meike 
Hensmann were recognized for 
their outstanding work. 
► Richard H. Schlesinger Fellow¬ 
ships: Marcus Heifetz, Alice Ruby 
and Teri Schreiner were chosen on 
the basis of their academic 
achievements and interest in 
community-based public health. 
► John Devereaux Thompson 
Scholarships: Hyun-Ju Lee, 
From left: Yu- Ting Lin, Ya-Pei Liu, 
Jennifer Meltzer, Garth Rausher and 
Winfield Ellis Rehmus listen during the 
ceremony under the tent. 
Spring brought Keqin Qi a Ph.D. degree 
and a bundle in the form of her infant 
son, Raymond. 
Jennifer Meltzer and Romericus 
Stewart were selected based upon 
their interest in health policy or 
management. 
► E. Richard Weinerman Fellow¬ 
ships: April Bell, Romeo Caringal, 
Kiran Cherla, Elena Lingas, 
Veronica Pinell-Salles and Alice 
Ruby were chosen for their 
commitment to social justice, 
awareness oi community needs 
and involvement in social and 
political action. 
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ALUMNI/AE NEWS 
’40s 
Richard W. Breck, M.D. 45 
March, forwards the following news 
from classmate Fred O’Connell, 
M.D. “Sandy and I had a wonderful 
time at the reunion with a mixture 
of joy and sadness that we left—joy 
at being able to be and it was with 
you again, if only so briefly, and 
sadness at having to part. One of 
my seven daughters, the youngest, 
said when her older sisters were 
always leaving for school ‘the 
trouble with this world is that there 
are too many goodbyes and not 
enough hellos.’ Too true! Well, it 
was a wonderful reunion/renewal 
and we will long remember all of 
you as you were at Howie in the 
Hills—remarkable you all still 
looked young and vital, just like 
those days when the earth was green 
and we were young and callow 
fellows. We had a great trip, driving 
all over Germany, Austria, Bavaria, 
Switzerland, Italy, with a day in 
Brussels. Came back exhausted from 
jet lag but full of memories of 
fabulous places and nice people.’’ 
Joseph R. Stanton, M.D. 45, has 
donated his vast library on life 
issues to the Sisters for Life in 
New York City, a new religious 
order of women established to 
assist pregnant women. A library 
has been built in a former bomb 
shelter at the convent and was 
dedicated The Dr. Joseph R. 
Stanton Human Life Issues and 
Resource Center. Dr. Stanton 
also co-authored a restatement 
of the Hippocratic Oath entitled 
A Modern Hippocratic Oath. 
William G. Anlyan, M.D. 49, B.S. 
’45, chancellor emeritus of Duke 
University and a trustee of the Duke 
Endowment, was presented the 
Lifetime Achievement Award by 
Research!America at its first Re¬ 
search Advocacy Awards dinner in 
March in Washington, D.C. Dr. 
Anlyan was honored for his career 
accomplishments and his lifetime 
commitment to improving health 
and well-being. 
’50s 
James C. Garlington, M.D. 55, 
traveled to Africa in February 
with the Association of Yale 
Alumni Educational Programs on 
the East Africa safari. “A must for 
animal lovers and adventurers,” 
says Dr. Garlington. 
Harold J. Fallon Jr., B.A. 53, M.D. 
’57, associate dean for graduate 
medical education and professor of 
medicine at the University of 
Alabama School of Medicine in 
Birmingham, has assumed his 
responsibilities as chair of the Board 
of Regents of the American College 
of Physicians (ACP). His one-year 
term began during the ACP’s 78th 
annual session in March in Philadel¬ 
phia. An ACP Regent since 1991, 
Dr. Fallon was awarded mastership 
in ACP in 1989, an honor reserved 
for highly distinguished internists. 
Joyce D. Gryboski, M.D. ’57, HS 
’57-60, professor emeritus of 
pediatrics at Yale, was presented the 
1966 Schwachman Award of the 
North American Society for Pediat¬ 
ric Gastroenterology and Nutrition 
for her accomplishments in the field 
of pediatric gastroenterology. 
Gene W. Spector, M.D. ’59, a 
radiologist in private practice in St. 
Louis, is opening his third imaging 
center with its own magnet. 
’60s 
Augustus A. White III M.D., 
Dr.Med.Sci., HS ’63-66, professor 
of orthopaedic surgery at Harvard 
Medical School and the Harvard/ 
MIT Division of Health Sciences 
and Technology, and orthopaedic 
surgeon-in-chief, emeritus, at Beth 
Israel-Deaconess Medical Center, 
was awarded an honorary Doctor of 
Medical Science degree from Brown 
University on the 40th anniversary 
of his college graduation. 
Julian Katz, M.D., a post-doctoral 
fellow in internal medicine at Yale 
from 1965 to 1967, was installed as 
the 136th president of the Philadel¬ 
phia County Medical Society in 
June at the Union League of 
Philadelphia. 
Julian Katz 
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William G. Baxt, M.D. ’67, chair 
of emergency medicine at the 
University of Pennsylvania Medical 
Center and associate editor of 
Annals of Emergency Medicine, has 
been appointed to the Board of 
Trustees of the Children’s Seashore 
House, Philadelphia Center for 
Health Care Sciences. 
David P. Millett, M.D. '68, FAA 
Southern Regional Flight Surgeon, 
a fellow of the Aerospace Medical 
Association and a trustee of the 
Civil Aviation Medical Association, 
made two presentations at the 68th 
annual scientific meeting of the 
Aerospace Medical Association in 
Chicago in May. His topics were 
The Stresses of Commercial Flight and 
Medical In-Flight Emergencies and 
Oxygen Systems and Their Use in 
Commercial Aviation. Dr. Millett is 
retired from both the Air Force and 
from Eastern Airlines, where he was 
director of flight medicine. 
’70s 
Frederick L. Greene, M.D., HS 
’70-76, director of surgical oncology 
at the University of South Carolina 
since 1980 and tenured professor of 
surgery since 1987, has been named 
chairman of the Department of 
General Surgery at the Carolinas 
Medical Center in Charlotte, N.C. 
Elizabeth Morgan, M.D. ’71, HS 
’71-77, writes from Washington: 
“Have now returned from seven 
years’ exile in New Zealand and a 
decade of career disruption as a 
result of family court disruption of 
my life. I am now able to resume 
my career, I hope, and with good 
fortune to be able to combine my 
interests in surgery and severe 
physical trauma with those in 
psychology and severe psychological 
trauma.” Dr. Morgan, who was 
profiled in the Summer 1990 issue 
of Yale Medicine, spent 25 months in 
prison for refusing to reveal the 
whereabouts of her daughter, who 
she alleged was abused by the girl’s 
father. Dr. Morgan left the United 
States from 1989 to 1997. 
Siang Yong Tan, M.D., J.D., HS 
’71, professor of medicine at the 
University of Hawaii John A. Burns 
School of Medicine in Honolulu, 
and director of both medical 
education and the ethics center 
for the St. Francis Medical Center, 
was appointed governor of the 
Hawaii chapter of the American 
College of Physicians (ACP) during 
the society’s 78th annual session in 
March in Philadelphia. Dr. Tan 
was elected for a four-year term 
and also represents ACP members 
on the National ACP Board 
of Governors. 
Charles E. Putman, M.D., senior 
vice president for research adminis¬ 
tration and policy at Duke Univer¬ 
sity, was elected to the Oak Ridge 
Associated Universities (ORAU) 
Board ol Directors at the 52nd 
meeting of the ORAU Council 
of Sponsoring Institutions. Dr. 
Putman was an assistant and 
associate professor of radiology 
and internal medicine at Yale 
from 1973 to 1977. 
Morris A. Flaum, M.D., M.B.A., 
HS ’74-77, chairman of internal 
medicine at St. Joseph Mercy 
Hospital in Ann Arbor, Mich., 
has been named senior vice presi¬ 
dent of medical and academic affairs 
for Mercy Health Partners in 
Toledo, Ohio. 
O’dell M. Owens, M.D. ’76, 
M.P.H. ’76, director of reproductive 
endocrinology at Cincinnati’s 
Christ Hospital, delivered the main 
address during June commencement 
exercises at the University of 
Cincinnati. During the ceremony, 
he was awarded an honorary Doctor 
of Humane Letters degree. 
O’dellM. Owens, M.D. ’j6 
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Neurosurgeon elected to Yale Corporation 
Nationally renowned neurosur¬ 
geon Dr. Benjamin S. Carson 
was elected in May as alumni 
trustee of the Yale Corporation 
in a worldwide balloting of 
University alumni/ae. 
Dr. Carson, who graduated 
from Yale College in 1973, has 
achieved recognition both for his « 
skill as a surgeon and as an g 
inspiring role model for disad- » 
x 
vantaged young people. He 
heads the department of 
pediatric neurosurgery at the 
Johns Hopkins Medical Institutions and is associate 
professor of neurosurgery, oncology, plastic surgery 
and pediatrics at the Johns Hopkins 
School of Medicine. 
Two years ago, Dr. Carson and his 
wife, Lacena, a 1975 Yale graduate, 
founded the USA Scholars Fund, a national 
program that makes annual awards to 
students in grades 1 to 12 who both have 
the highest marks in their schools and 
who participate in community activities or 
demonstrate humane concern. 
Dr. Carson has been recognized by 
the Alpha Omega Medical Honor Society, 
the Academy of Achievement, and by the 
Horatio Alger Society of Distinguished 
Americans. In 1996 he received an honorary Doctor 
of Medical Sciences degree from Yale University. 
Patrick F. Carone, M.D., M.P.H. 
’77, director of psychiatry at Long 
Island’s Mercy Medical Center, was 
appointed in April to chair the New 
York State Board for Professional 
Medical Conduct. Dr. Carone, first 
appointed to the board in 1993, has 
served on numerous hearing panels 
and is a member of the Physician 
Retraining Subcommittee and the 
Advisory Committee. 
K. Randall Young Jr., M.D., HS 
’78-85, writes to say: “After three 
years at the National Institute of 
Allergy and Infectious Diseases, 
I joined the faculty here at the 
University of Alabama at Birming¬ 
ham, where I direct the Division 
of Pulmonary and Critical Care 
Medicine and hold the Ben 
Vaughan Branscomb Chair in 
Medicine in Respiratory Diseases.” 
He has been in touch with house 
staff colleagues Shawn Skerrett, Bob 
Silverman and Randi Leavitt. “If 
anyone gets down to the heart of 
Dixie (as it says on Alabama’s license 
plates), we ll show them the best of 
Southern hospitality.” 
’80s 
Aziz L. Laurent, M.D. ’81, staff 
physician in the student health 
center at the University of Texas at 
Austin, is a principal investigator for 
Phase I drug studies at Pharmaco 
International. Dr. Laurent also is 
house physician for the Four 
Seasons hotel in Austin and a 
member of the ethics committee of 
the Travis County Medical Society. 
Jed B. Gorlin, M.D. ’82, was 
named associate medical director of 
Memorial Blood Centers of Minne¬ 
sota in July. 
Amanda Dill, M.D. 86, was 
elected a fellow of the American 
College of Physicians last 
November. 
Leo K. Mills, M.D., post-doctoral 
fellow in internal medicine (cardiol¬ 
ogy) from 1988 to 1991, is a cardiolo¬ 
gist at Green River Heart Institute 
in Owensboro, Ky. 
’90s 
Chai Kulsakdinun, M.D. ’93, a 
resident in orthopaedic surgery at 
Yale-New Haven Hospital, and Julie 
Wang, B.A. ’87, an investment 
banker, were married on May 30 at 
the Loeb Boathouse in Central Park 
in New York. 
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ALUMNI REUNION WEEKEND 1997 
As world changes, reunion remains a constant 
If you attended Alumni Reunion 
Weekend this past June, you 
may have noticed that the event 
followed a pattern that has become 
comfortably familiar: handshakes, 
hugs, strawberry shortcake, nostal¬ 
gia, photos of children and grand¬ 
children, applause for reunion gift 
chairmen and class volunteers—and 
a standing ovation for Helen 
Langner, M.D. ’22, at age 105 our 
most senior alumna! As you will 
read in detail in the following 
reports, it was a truly memorable 
and special weekend for everyone. 
All of us here hope that if your 
class is celebrating a five-year 
reunion next June—and even if it 
isn’t—that you will join us for this 
special weekend. Here is a rundown 
of what happened this year: 
More than 250 alumni/ae and 
guests attended. The weekend 
started with seminars where class¬ 
mates discussed the paths of their 
careers and their thoughts and 
opinions on the future of medicine, 
remembering fondly the Yale System 
of medical education. The formal 
welcome and introduction were 
presented by Lycurgus M. Davey, 
M.D. ’43 March, president of the 
Association of Yale Alumni in 
Medicine (AYAM). Outgoing Dean 
Gerard N. Burrow, M.D. ’58, 
welcomed the group and introduced 
Albert B. Deisseroth, M.D., Ph.D., 
chief of the section of medical 
oncology and associate director of 
the Yale Cancer Center, who 
discussed The Revolution in Genetics 
and Health Care. After the dean’s 
reception in the Historical Library, 
the group was off to the Harkness 
Hall courtyard, where the patio 
had been transformed for a New 
England-style clambake that 
featured lobster and shrimp. 
Entertainment was provided by The 
Cellmates, a rock band composed 
of Yale scientists and researchers. 
Saturday morning’s program 
began with a faculty seminar on 
New Directions in Treatment of 
Cancer. Participants included Dr. 
Deisseroth; Edward Chu, M.D., 
Ph.D.; Frank Hsu, M.D., Ph.D.; 
and Barbara Burtness, M.D. 
Following the seminar, the annual 
meeting of the Association of Yale 
Alumni in Medicine was held. The 
group was honored to have greet¬ 
ings and remarks from Yale Presi¬ 
dent Richard C. Levin. Dr. Burrow 
gave his final State of the School 
address and reviewed his years as 
dean. The meeting concluded with 
the presentation of the Distin¬ 
guished Alumni Service Awards to 
Dr. Davey and John W. Foster, 
M.D. ’71. Both Dr. Davey and Dr. 
Foster have devoted much of their 
time and energy to the Alumni 
Association and the Alumni Fund. 
Saturday evening found the 
reunion classes spread out among 
various restaurants and private 
homes for their class dinners. The 
Friends of the 50th dinner was held 
at the Graduate Club, honoring the 
Class of 1947. Also in attendance 
were graduates senior to their 50th 
reunion year, members of the five- 
year-reunion class, and members of 
the administration. It was a evening 
of lighthearted conviviality, high¬ 
lighted by members of the class 
playing the piano—and one tap 
dancing for the group during dessert. 
Plans for next year’s reunion 
weekend, scheduled for June 5 and 
6, are now under way. Alumni/ae 
who graduated in years ending in a 
3 or an 8 will be celebrating their 
anniversaries. We look forward to 
seeing you in New Haven. 
William K. Jenkins 
Managing Director, Office of Alumni Affairs 
The new slate of 
AYAM officers, 
from left: President 
Nicholas M. 
Passarelli, M.D. 
ft; Secretary Peter 
N. Herbert, M.D. 
'6y; Vice President 
Gilbert F. Hogan, 
M.D. ft; and Past 
President Lycurgus 
M. Davey, M.D. 
43 March. 
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REUNION REPORTS 
1922 
75th reunion 
By Helen P. Langner, M.D. 
I always attend the Yale Alumni 
Reunion and this year was my big 
75th Reunion, which made it more 
special for me. 
1 look forward to and always 
enjoy meeting and having conversa¬ 
tion with the distinguished scien¬ 
tists who have made noteworthy 
research findings. The scientific 
seminars that are presented, report¬ 
ing their more recent developments 
in research, are one of the highlights 
of my day. 
The company and conversation 
of my alumni is always pleasant and 
enlightening. By the day’s end I feel 
up-to-date on all of the Yale activi¬ 
ties and what is expected to come. 
After a long, wonderful day, I return 
home with all my memories to 
recuperate. Then it is back to my 
interests of conservation and natural 
resources. My main interests always 
were science and medicine and they 
remain so. 
1937 
60th reunion 
By Albert D. Spicer; M.D., D.M.D. 
The Class of 1937 consists of 18 
living members. I enthusiastically 
hoped to contact enough members 
for a fair representation of the class 
at our 60th reunion. I made a few 
calls, but received no commitments. 
There always seemed to be one 
reason or another why they prob¬ 
ably wouldn’t be able to attend. The 
outlook was not very encouraging 
since there were only three of us at 
the 55th reunion: Wilbur Johnston, 
Dennie Pratt and myself. Wilbur 
lives in New Haven and at the 
present time is not too well. Dennie 
Pratt, who lives in Bass Harbor, 
Maine, telephoned me to say he 
would not be able to come. 
I personally have been suffering 
recently from an unsolved neuro¬ 
logical disorder that is partially 
disabling my left hand and arm. 
It must be that old age is creeping 
up on the Class of 1937! I sincerely 
regret that the Class of 1937 was not 
represented this year. 
1942 
55th reunion 
By Samuel Ritvo, M.D. 
The reunion was an enjoyable 
experience in every respect except 
for the small turnout of the Class of 
1942. The program coordinated by 
the alumni association provided a 
gala setting with interesting talks on 
the cutting edge of medical science, 
followed by Dean Burrow’s recep¬ 
tion with an opportunity to greet 
Dr. David Kessler, the incoming 
dean. The excellent New England 
clambake, which followed, was 
further enlivened by the faculty 
rock band playing and singing their 
“molecular biological neuro¬ 
scientific” creations. At the reunion 
dinner at the Graduate Club on 
Saturday, we were the oldest class, 
represented by Bill Harrison, 
Leo Kellerman, IrvWolfson, my 
wife, Lucille, and me. Jim Bunce 
attended the Friday activities, but 
could not be there Saturday. Moe 
Tulin, who reported by telephone, 
keeps up a keen interest in medi¬ 
cine. He particularly enjoys having a 
Helen P. Langner, M.D. '22, receives an 
ovation and bouquet of flowers during the 
annual meeting of the Association of Yale 
Alumni in Medicine in June. 
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seat designated for him as the senior 
member of the medical staff when 
he attends grand rounds at his old 
hospital. We are grateful to whom¬ 
ever had the idea of seating the 
three members of the youngest 
class, 1992, at the same table. It 
was refreshing to partake of their 
enthusiasm for what they were 
doing. All our class members who 
attended are retired, enjoying their 
special interests, except for me. I am 
fortunate to be in a field (psychiatry 
and psychoanalysis) where I can 
continue to practice and to teach at 
the Yale Child Study Center, where 
I enjoy the stimulation provided by 
students and colleagues. 
1947 
50th reunion 
By Philip H. Philbin, M.D. 
Our class experienced what was 
easily the most enjoyable of all of 
our reunions. The good times 
began at registration, which was 
painlessly expeditious and where 
many familiar, albeit somewhat 
different, faces started to shape up. 
The name tags were very helpful in 
lots of cases! 
Friday evening we met at 
Mory’s for lifestyle updates, a good 
deal of reminiscing and a great 
dinner. There were no speeches, no 
assigned seats—a very informal 
affair. Bob Chase presented a 
videotape he’d produced from 
classmates’ photos current and past. 
It was a delight and served as a 
springboard ior a multitude of 
comments, some memorable, some 
best forgotten! Bob had copies for 
all. This was a very generous task in 
time and expense on his part, and 
many thanks were extended. As we 
were leaving, we encountered the 
’92 Whiffenpoofs assembled with 
their Great Mug on high. Happily 
responsive to requests, they were 
truly outstanding, an unexpected 
bonus, a proper conclusion for a 
notable occasion. 
The program at the medical 
school and the luncheon that 
followed on Saturday were ex¬ 
tremely well received. At that time 
the class picture, shepherded by a 
nervous but tolerant (almost 
weeping) photographer, was com¬ 
pleted despite several acerbic 
From left: Evelyn Gordon, Martin E. 
Gordon, M.D. ’46, and Lucille Ritvo. 
remarks on the part of some of the 
participants. 
Saturday night the good times 
went on at the Graduate Club. 
Preceding dinner were cocktails, 
conversation and exquisite music, 
the latter thanks to Vic 
Machcinski, the official class 
pianist. During dinner, between 
courses, Dean Burrow and Drs. 
Davey and Spinelli spoke briefly. 
Drs. Olive Pitkin Tamm, Jack 
Cannon, Frank Epstein and Bill 
Collins then captivated the audi¬ 
ence with comments that can only 
be described as hysterical rather 
than historical. Moving to the 
ballroom after the repast, the group 
was fortunate that classmate Brock 
Lynch had agreed to a dance 
exhibition accompanied by a sing- 
along by those present. Dancing is 
stressful enough; trying to dance 
during the resultant cacophony 
would tax anyone’s concentration! 
Brock hung in there, did a profes¬ 
sional, totally enjoyable perfor¬ 
mance. The night seemed a happy 
time for everyone. 
On a gorgeous, sunny Sunday 
morning Bob and Martha Newton 
opened their beautiful home to the 
class for the perfect reunion finale— 
Brock Lynch, M.D. ’47, left, catches up 
with Rocco M. Fasanella, M.D. ’44, HS ft, 
during the Dean’s Reception in the Medical 
Historical Library during reunion weekend. 
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a tasty, informal brunch under the 
most attractive of circumstances. It 
was another grand memory of our 
50th, which I’m sure we ll recall 
many times. The class owes a debt 
of thanks to Bob Newton, Bob 
Kerin and those thoughtful, ever 
helpful staffers in the alumni office. 
Those of the Class of 1947 
attending our 50th were George 
and Ellie Barnes, Hank Blansfield 
and Lorraine, Roy and Margaret 
Breg, Jack Cannon and Doris, Jack 
Carpenter and Casey, Charlie 
Cavanaugh and Elizabeth, Bob and 
Ann Chase, the Chernoffs, Amos 
and Renate; Bill Collins and Gwen, 
the Darrows, Bob and Sue; Jean 
Daugherty, Frank and Sherrie 
Epstein, Dick Friedlander and 
Nancy, Frank and Ann Horton, 
Bob and Claire Kerin, Anton 
Lethin and Bonnie Ayers. Mary, 
Brad Colwell’s widow, was nice to 
come. Also present were Dick Levy 
and his wife, Barbara; Brock 
Lynch, Vic and Barb Machcinski, 
Willie McClelland and Jean, Bob 
and Martha Newton, Mike Nobil 
and Gwen, Phil and Jo Philbin, 
Irving (Billy) Rudman, Ellis Van 
Slyck with his wife, Ann; Olive 
Pitkin Tamm, Hank Williams and 
last, but certainly not least, Root 
and Marie Ziegra. 
Bill Thompson, Rocco 
Calandruccio, Dick and Betty 
Carlin, Archie Dean, Arthur 
Chapman, Steve Gehrs and Pat 
Tudbury tried their best, but just 
couldn’t make it. Hope we see all of 
them next time. 
1952 
45th reunion 
By Frank Coughlin, M.D. 
Forty-five years and one day after 
our diplomas were presented to us, 
signed by President Alfred Whitney 
Griswold, 11 of 27 living classmates, 
out of our original 66 students, 
returned to Yale. Over two days we 
enjoyed a delightful reacquaintance 
with our school, our fellow students 
In the 
steps of 
Peter Parker 
Arthur Ebbert Jr., M.D., 
received the Peter Parker 
Medal during reunion for his 
long and remarkable service 
to the School of Medicine. 
Dr. Ebbert, a former deputy 
dean and founding editor 
of Yale Medicine magazine, 
is professor emeritus of 
medicine. The medal, 
awarded periodically by 
the dean, is named after 
the Rev. Peter Parker, an 
1834 Yale medical graduate 
and missionary who 
established the first Western 
hospital in China. 
and our shared stories, enthusiasms 
and experiences. Actually our happy 
band of reunion celebrants con¬ 
sisted of 17 persons: Maurice L. 
Bogdonofif, Prank R. and Barbara 
Coughlin Jr., Richard D. and 
Mary Botts Lloyd, Arthur P. and 
Catherine Hustead, Joseph A. and 
Sarah Montimurro, Robert L. and 
Janiece Nolan, Robert F. and Edith 
Trugly Owen, Robert G. 
Petersdorf, John M. Roberts and 
Louise Regan, and John L. Wolff. 
In preparation for the reunion, 
John Wagner, class secretary, 
assembled and distributed a folio of 
Class of 1952 profiles contributed by 
24 of our classmates. Most of our 
class have retired from active 
medical teaching and practice after 
busy careers with active community 
and family lives. The folio memori¬ 
alized seven others who had died 
since 1992: Siggie Centerwall, Bill 
Minturn, Bill Klatchko, Bob 
Zeppa, Bill Stephenson, Don 
Schultz and Ray Duff. Dick and 
Ruth de Niord Jr. were unable to 
attend this year. 
With the able support of the 
Alumni Affairs Office we partici¬ 
pated in a program that showed us 
something new and helped us to 
appreciate something old: The Yale 
System is alive and well! Students are 
selected on the basis of intelligence, 
performance and compassion; 
students come from diverse back¬ 
grounds and share a commitment to 
excellence and life-long learning. 
Uniformly, we came to the conclu¬ 
sion that we were fortunate to have 
the opportunity to commence our 
life’s work at Yale University School 
of Medicine. 
On the first day of class reunion 
we assembled in the Hope Building. 
Each of us reviewed something 
about our careers, our impressions 
of Yale, and our hopes and concerns 
for the direction in which the 
school will move in this era of 
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managed care, advanced medical 
technology and electronic commu¬ 
nication. In the afternoon we were 
welcomed by AYAM president Bill 
Davey. Outgoing Dean Gerard N. 
Burrow, M.D. ’58, then spoke to us 
optimistically about the state of the 
school. We enjoyed Professor Albert 
B. Deisseroth’s dramatic presenta¬ 
tion on the Revolution in Genetics 
and Health Care. 
After the Dean’s Reception in 
the Historical Library, which looks 
pleasingly familiar, we adjourned to 
a New England clambake. 
On the following day after 
breakfast, we attended a faculty 
seminar led by Professor Deisseroth, 
and then concluded the morning 
with the annual meeting of the 
AYAM led by Bill Davey (who was 
Dr. Bill German’s chief neurosurgi¬ 
cal resident when we were in our 
clinical years!). At the meeting, 
questions were asked and answered 
concerning school finances, the Yale 
System, student selection and 
performance, and the school’s need 
for alumni support. 
Our final evening together as a 
class featured a class dinner at 
Barkie’s restaurant. This provided 
another opportunity to renew old 
friendships, to share life stories and 
to talk about Yale. 
We came away refreshed and 
appreciative of the good fortune 
that brought us to a superb place of 
education at the early stage of our 
adult lives and the knowledge that 
Yale continues to offer others the 
same opportunity today. 
1957 
40th reunion 
By Jack Levin, M.D. 
The Class of 1957 held its 40th 
reunion activities on Saturday, 
June 7. We had our traditional class 
meeting, following luncheon at 
Harkness Hall, on Saturday after¬ 
noon in a pleasant room in the Hope 
Building. Hal Fallon (a dean at the 
University of Alabama School of 
Medicine), Stan Kilty (public health 
and HMOs), and Ron Fishbein 
(life as a surgeon in private practice) 
thoughtfully shared their interesting 
professional experiences with us. A 
sad moment was spent remembering 
the eight members of the class who 
had passed away. 
In contrast to the two previous 
reunions, the weather was clear and 
pleasant, adding to the great success 
of a new event—an excellent clam¬ 
bake in the courtyard of Harkness 
Hall on Friday evening—and to the 
enjoyment of the class dinner on 
Saturday evening, held at the 
Stony Creek home of a cousin of 
Carol Hogan. 
The following classmates were 
present: Vince and Daria Andriole; 
Jane Battaglia and her granddaugh¬ 
ter, Jessica Harris; Jack and Barbara 
Blechner; Richard and Laurel 
Breuer; Harry and JoAnn Briggs; 
Ed Eyerman and Janet Vitt; Hal and 
Jo Ann Fallon; Bob and Joan 
Fishbein; Ron and Estelle Fishbein; 
Tony and Mary Fons; Liz and Ben 
Forsyth; Gil and Carol Hogan; 
Dick Kahler; Stan and Carol Kilty; 
Bill and Priscilla Kissick; Jack 
Levin; Howie and Gretchen 
Minners; Bob and Jill Modlin; 
Herb and Ann Newman; Ray 
Phillips; Cliff and Barbara Reifler; 
Mel and Marianne Roberts; Don 
Stahl; Bill and Barbara Waskowitz. 
As usual, Carol and Gil Hogan 
provided a lovely evening, in a very 
attractive setting overlooking the 
Thimble Islands. The food was good 
and plentiful, and everyone enjoyed 
the opportunity for extensive conver¬ 
sations with their classmates. Over 
one-third of those who attended 
were retired, emphasizing that 40 
Contribute to the 
School of Medicine’s 
Future and Invest in 
Your Own 
Yale University’s life income 
program offers graduates of the 
School of Medicine the oppor¬ 
tunity to: 
■ Help ensure the future 
of a great institution 
■ Receive quarterly 
income payments 
for life 
■ Increase your income 
from low-yielding stock with¬ 
out incurring capital gains 
taxes 
■ Reduce federal and 
state taxes 
Please call or write to see if you 
can use these benefits to the 
mutual advantage of you and 
the School of Medicine. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Distinguished by service 
Lycurgus M. Davey, M.D., ’43 March, left, and John W Foster Jr., M.D. 
’71, HS ’72-76, above, received the Distinguished Alumni Service Award 
during reunion in June. 
Dr. Davey, who worked for legendary neurosurgeon Harvey Cushing as a 
Yale undergraduate, was lauded as “a living bridge to a golden era of 
medicine at Yale. "He practiced neurosurgery in New Haven for five 
decades and was president oftheAYAM from 1993 to 1997. 
Dr. Foster, chief of radiology at Westerly Hospital in Rhode Island, served 
the school for many years, most recently as chair of the YSM Alumni 
Fund, and remains an active member of the AYAM executive committee. 
years had actually passed since 
graduation. 
I am planning to prepare an 
updated class book that will provide 
current addresses and telephone 
numbers. With retirement, many 
members of the class have moved and 
can no longer be found at their usual 
locations. In addition, it might he 
very helpful to know who now lives 
(or has a vacation home) in places 
one might be visiting! If anyone has 
news that they would like to have in¬ 
cluded in this publication, please 
write to me at 87 Shore View Av¬ 
enue, San Francisco, CA 94121. 
1962 
35th reunion 
By Michael Alderman, M.D. 
In New Haven for fun, laughs, 
memories, good food and some 
serious talk were Bill and Anne 
Miller, John and Trudy 
Harrington (John is now dean of 
Tuffs Medical School), Arnold and 
Nancy Eisenfeld, John and Carol 
German, Steve and Kate Fricker, 
Fred and Jane Cantor, Dave Seil 
(Dave had a video he had made 
from old class pictures of our 
fourth-year picnic—everyone had 
more hair), Jim and Joyce Spencer, 
Stan and Maureen Matyszewski, 
Dick and Peggy Pschirrer (thanks 
for being the on-site hosts!), Bruce 
Elfenbein, (Bruce came up by train 
from Philadelphia Saturday just to 
join us for dinner) and Alan and 
Rhona Fieberson. Mickey Aider- 
man had expected to join us but the 
pressure of an early morning 
departure for Europe kept him away 
at the last minute. 
Several classmates (Manny 
Fipson, Glenn Kelly and Tom 
Chase) had family and/or practice 
commitments that prevented them 
from traveling to New Haven. John 
Godley had a daughter graduating 
from medical school in Chicago. 
Tom Dann wrote that his oldest 
child, Sara, is a second-year resident 
in child psychiatry at Johns Hopkins 
and his youngest child is in high 
school. Pat Hassakis sent her best 
wishes and regrets from Santa 
Monica. Dick Collins was moving 
from the U.S. Embassy in New 
Delhi to the U.S. consulate in Hong 
Kong. The week before reunion, 
while on vacation, John Foreman 
was thrown from a horse and suf¬ 
fered back injuries; luckily he has re¬ 
turned to the practice of pediatrics 
with a body brace and gadgets that 
enable him to get around. 
Not many of us got to New 
Haven this year for our 35th Re¬ 
union. Five years seems such a long 
time until the 40th, so some of us 
thought that a reunion midway 
might be in order—in sunnier 
climes, of course. Perhaps that will 
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persuade more of you to join us. 
We missed the rest of you and 
trust that you are well and thriving. 
Let us hear from you! 
1967 
30th reunion 
By Janies Dowaliby III, M.D. 
At our five-year reunion in 1972 we 
started talking Friday noon and did 
not slow down until Saturday 
midnight. It was as if we had never 
been apart, as if we had just come in 
from anatomy or pathology and had 
sat down to have a beer and talk 
over the day. The ease with which 
we slipped back into a comfortable 
and confiding relationship with 
each other was astonishing—and 
gratifying. 
Twenty-five years after that first 
reunion I am no longer surprised, 
but I am still gratified. Now I know 
that it happens every time. At our 
30-year reunion we started talking 
Friday noon and did not slow down 
until Saturday midnight. Tony 
Lovell says that we have the Yale 
System to thank. Since we were not 
set in grim competition with each 
other, we spent the first two years 
working together, helping each 
other and forging bonds of confi¬ 
dence and friendship. I suspect that 
he is right. In any event, it is clear 
that those bonds are powerful and 
indissoluble. 
There were 27 present for our 
30th: Dan and Elissa Arons, Rich¬ 
ard Bockman, Mary Williams 
Clark and her husband, Jerry Lee 
King; Alex Dora, Jim and JoAnne 
Dowaliby, John Drews, Richard 
and Lilian Hart, Peter and Maureen 
Herbert, Tony and Kathy Lovell, 
Bill Perkins, Brian and Robin 
Rigney, Stephen and Carol 
Schimpff, Helen Smits and her 
husband, Roger LeCompte; Dick 
Swett and his daughter, Diana; 
Bob Young, Ihor Zachary and 
Peter Zeman. 
The mood was a little different 
this time, a little more earnest, as be¬ 
fits our age. After all, we’re all about 
55 years old now (except for 
Dowaliby, who against all advice 
stubbornly persists in remaining 13 
years older than the rest). Time’s 
wing has brushed us all. Two of the 
members are retired on disability. 
Another is about to have surgery 
for prostate cancer, and a fourth 
has just been diagnosed as having 
significant valvular heart disease. 
There was a flurry of informal con¬ 
sultations as we sought to confirm 
our down-home physicians’ opin¬ 
ions with classmates—the people we 
really trust. 
Above all, the talk, the endless 
talk. Of children, of work, of the 
medical climate, of retirement, of 
travel, of adventure. When our din¬ 
ner on Saturday night in the private 
back room at Adriana’s was over and 
the talking had finally wound down, 
the furniture in the main dining 
room was stacked up and the restau¬ 
rant staff were quietly waiting for us 
to leave so that they could shampoo 
the carpets. It was a little before 
midnight. Everyone had to get up 
and head for home in the morning. 
We had not run out of things to 
talk about. I can assure you of that. 
We never will. 
1972 
25th reunion 
By Harry L. Malech, M.D. 
June 1997 marked a quarter-century 
since our class finished what already 
is an ancient historical version of 
the Yale “new” curriculum. The 
25th-year reunion of our class was 
A Charitable 
Annuity: 
The YSM gift 
that rates 
In exchange for a gift of $5,000 
or more, the School of Medi¬ 
cine can offer you, or you and 
your spouse, a fixed annual 
income for life. 
Your age(s) and market 
rates of interest determine 
your income level. 
Current sample rates: 
Age(s) Rate 
One life 
55 5.0% 
66 6.1% 
77 8.3% 
Two lives 
66/65 5.0% 
75/74 6.1% 
82/79 7.3% 
Please allow us to tailor 
a proposal to your 
philanthropic 
and financial goals. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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very well attended. Though not 
everyone could participate in all the 
events, I am pleased to report that 
30 of our classmates (more than a 
third of our class) were in atten¬ 
dance at one or more reunion 
events. Felix Freshwater’s generous 
matching gift challenge to our class 
provided a special theme and 
significance to our reunion. I also 
was impressed with the enthusiasm 
of a large group of our fellow 
classmates, particularly the leader¬ 
ship of Don Kent, for taking on 
this challenging opportunity both 
to help the medical school and at 
the same time use this occasion 
to renew old friendships among 
our classmates. 
There were excellent reunion 
lectures on Friday and Saturday. 
Among those seen attending the lec¬ 
tures were Mary Charlson and Fred 
Hyde. Jesse Jupiter gave a lecture to 
members of the orthopaedics and re¬ 
habilitation department during his 
reunion visit. Following the lectures 
of Saturday morning, there was a 
chance to meet over a buffet lun¬ 
cheon at Harkness. It was interesting 
to note that a number of our class¬ 
mates have children who are under¬ 
graduates at Yale, thus providing ex¬ 
tra opportunities to give generously 
to Yale. These include Mark Osias, 
Philip Cohen and Harry Malech. 
Phil did note that because he had 
twins at Yale he had a special deal 
on paying tuition in that he only 
needed one stamp to send both 
tuition checks. 
Some others seen at the lunch 
were Steven Zeldis, Tony Jackson, 
Michael Charney and Fred 
Henretig. Dick Robbins and Helen 
were there, and it was so much fun 
to be able to appreciate his timing 
and humor again as he joked about 
his home state of Georgia. Later that 
afternoon we all migrated to Bruce 
Haak’s home on a beautiful point 
overlooking Long Island Sound at 
the end ofTwin Coves Road in 
Madison. We are very grateful to the 
Haaks for their hospitality, provid¬ 
ing a comfortable and informal 
gathering for at least 20 classmates 
and some spouses. 
Some of those at Bruce’s house 
included Paul and Ann Lucky, 
Charles Scholhamer, Larry and 
Barbara Temkin, Marc and Lesley 
Osias, John Fulkerson, Bob and 
Louise Glassman, Lenny and Linda 
Cohen, Mike and Sally Buckley, 
Dave Moyer and Bob Goodman. 
In the evening, we had an excellent 
dinner at the Graduate Club. It was 
so popular that we needed to 
squeeze in a few extra place settings 
and chairs. Some of those in atten¬ 
dance at the dinner were Dorothy 
Gohdes and Neil Kaminsky, Don 
and Ellen Kent, Phil and Susan 
Lebowitz, Phil and Barbara 
Rothfeld, Gary and Meda Strauss, 
Bill Druckemiller, Dave Moyer 
and Frank Kahr. 
1977 
20th reunion 
By Attilio V. Granata, M.D. 
The special festivities of the Class of 
1977’s 20th reunion took place at 
Mory’s on Saturday evening, June 7. 
After drinks in the library, a small 
but hearty number of classmates 
and spouses met for dinner in the 
Captain’s Room. Julia Frank 
brought the album of snapshots 
from our second-year show, 
Mefistofollies, in December 1974. 
(For younger alumni, in our day we 
had three semesters of basic science 
and introductory clinical medicine, 
then began our clerkships in the 
middle of the second year!) 
After posing for our official class 
photo (plus 20 years), dinner found 
us all easily renewing the camarade¬ 
rie of our medical school days. Talk 
ranged from juggling family issues 
to managed care to the whereabouts 
of other classmates. 
Present were: Gerald Brody 
(and wife, Pat), Harriet Comite, 
Sybil Duchin (and husband, Art), 
Julia Frank, Attilio Granata (and 
wife, Claudia Dinan, YMS ’80), 
Alan Penziner (and wife, Pat), 
and Gail Sullivan (and husband, 
Victor Peplau). Those present 
heard regrets sent from Steve 
Scheinman (who promises to 
attend the 25th), Alice Matoba, 
Margaret McKenna (in the middle 
of moving to D.C.), and Marybeth 
Ezaki. Time moves swiftly, but the 
recollection of old friends and good 
times adds a unique dimension of 
meaning. We promise an all-out ef¬ 
fort to break all attendance records 
for the 25th! 
1982 
15th reunion 
By Stephanie Wolf-Rosenblum, 
M.D. 
A small but enthusiasic group from 
the Yale School of Medicine Class of 
1982 met to celebrate their 15th 
reunion in June. Hats off to Lynn 
Tanoue and Carrie Redlich for 
planning the weekend’s events, 
which began with a clambake Friday 
night. On Saturday, classmates and 
their families enjoyed an afternoon 
of sun and tennis at the Ridgetop 
Club in Hamden, followed by 
dinner at Scoozi’s in New Haven 
while the kids had a massive pajama 
party at Carrie’s. The weekend 
culminated with brunch at Lynn’s on 
Sunday. The weekend’s participants 
included: Lynn Tanoue (pulmonary 
and critical care faculty at Yale), 
Daphne Hsu (pediatric cardiology 
faculty at Columbia), Jed Gorlin 
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(about to assume the helm at the 
Blood Centers of Minnesota), Patty 
Kellner (family practice, University 
Heights in Cleveland), Jessica 
Herzstein (occupational medicine/ 
toxicology consultant, Massachu¬ 
setts), Carrie Redlich (occupational 
and pulmonary medicine faculty at 
Yale), JeffTepler (hemotology/ 
oncology at New York Hospital, 
womens health), Stu Gardner 
(pediatric practice, Connecticut), 
and Stephanie Wolf Rosenblum 
(pulmonary/critical care/sleep and 
medical director, Lahey Hitchcock, 
New Hampshire). Prize for longest 
distance traveled goes to Bert 
Ungricht (ophthalmology, Salt Lake 
City). There in spirit were Paula 
Braverman (pediatrics in Philadel¬ 
phia, recovering from surgery), and 
Dan Odenheimer (Israel). 
We are looking forward to a 
record crowd at our 20th in the 
year 2002! In the meantime, a 
partial list of e-mail addresses has 
been tabulated. For information, 
or to add your name, contact 
me at: Stephanie. Wolf¬ 
Rosenblum @Hitchcock. org. 
1987 
10th reunion 
By Barry Weinstock, M.D. 
The Class of 1987 met informally 
during the day on Friday, enjoying 
the reception in the Medical 
Historical Library. Many enjoyed 
the clambake in front of Harkness 
Hall. On Saturday most re-explored 
Yale and then convened at Mory’s 
for a dinner of exchanging stories, 
pictures of children and e-mail 
addresses. Andy Bazos and his wife, 
Ann, recently finished renovating a 
250-year-old home and are now 
ready to start thinking about kids. 
Andy is an orthopaedist practicing 
in New York and Connecticut. Nick 
Burke and his wife, Sue, described 
life with their three children in 
Minneapolis, where Nick is busy as 
a cardiologist. Pat Ruwe and his 
wife, Stacy, joined the festivities. Pat 
is assistant professor of orthopaedics 
and rehabilitation at Yale. Rich 
Diana also is an orthopaedist in the 
New Haven area but could not 
attend the reunion. Joe King and 
Amy Justice attended from Cleve¬ 
land, where Amy is doing HIV 
research and primary care while Joe 
is a busy neurosurgeon. They have a 
io-month-old boy. Linda and Jon 
Lewin also arrived from Cleveland 
to join the class for dinner along 
with Mike Solon, who is practicing 
primary care in the Baltimore area. 
Donna Klimowicz is a psychiatrist 
in south Jersey and is busy raising a 
3-year-old with her husband, Rick. 
Tarik Ramahi couldn't attend the 
reunion but is assistant professor of 
medicine/cardiology at Yale, 
specializing in heart failure and 
transplantation. Steve Gaskin and 
his wife, Diane, are busy raising four 
children in Charlotte, N.C., where 
Steve is an emergency-room physi¬ 
cian. Larry Amsel is handling in¬ 
patient psychiatry at Columbia in 
New York, where Leslie Vogel is 
taking care of out-patient psychiatry. 
Leslie and her husband, Luciano, 
attended the reunion with their 
daughter, Paola. Lisa Straus at¬ 
tended and is practicing primary care 
in New York. Rebecca Kadish is an 
anesthesiologist in New Hampshire. 
Eric Jankelovits is an anesthesiolo¬ 
gist in Stamford, Conn. He and his 
wife, Monica, have two little girls. 
Although Eric could not attend the 
reunion, I did track him down on I- 
95 by cellular phone and enjoyed a 
quick visit with him at a McDonalds! 
Seth Rosenthal won the award for 
longest trip (from California, where 
he is practicing radiation oncology). 
Mark Widmann and his wife, Kim, 
TO GIVE AWAY MONEY IS 
AN EASY MATTER AND IN 
ANY MAN’S POWER. BUT 
TO DECIDE TO WHOM TO 
GIVE IT, AND HOW LARGE 
AND WHEN, AND FOR 
WHAT PURPOSE AND HOW, 
IS NEITHER IN EVERY 
MAN’S POWER NOR AN 
EASY MATTER. 
Aristotle 
Assuming you would 
consider the School of 
Medicine as one of your 
intended beneficiaries, 
we stand ready to help you with 
when, for what purpose, and 
how. 
Planned giving 
is one of our specialties. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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won the best excuse award for not 
attending the reunion. Kim gave 
birth to Sara Hirsh Widmann on 
May 28, 1997—all 6 lb, 6 oz of her. 
Mike Gaziano and his wife, Ann, 
attended the reunion from Boston, 
but unfortunately spent much of the 
trip caring for their children, who 
both had colds. Mike reports that 
Matthew Miller and John Keaney 
are both alive and well and living in 
Boston, but were unable to attend 
the reunion this year. John is a 
cardiologist at Boston University. 
Mindy Schuster is practicing 
infectious disease at Penn. Barry 
Weinstock is a cardiologist in 
Florida. He and his wife, Jodi, have 
two sons. Goals for future reunions 
are more and better programming 
and better attendance. We also will 
be trying to establish a Class of 1987 
e-mail directory. If you have an e- 
mail address, send it to Barry 
Weinstock at bweinstock@csi.com. 
I apologize in advance for any 
omissions or errors! 
1992 
5th reunion 
By Robin A. Perlmutter, M.D. 
There were only three I992’ers at 
our fifth-year reunion dinner 
(Elizabeth A. Mullen, Tom 
Davenport and Robin Perlmutter) 
because rumor had it the other 97 
were on call. Mike and Nancy 
(Dingott) Girardi attended the 
weekend with their little boy, but 
left before the class dinner. We 
enjoyed meeting members of the 
Class of 1942 (our dinner compan¬ 
ions) and realized that their experi¬ 
ences at Yale were pretty similar to 
ours. The Yale System may look a 
little different than it did in 1942, 
but it’s still alive and kicking. 
I have some news of the class, 
which is strictly via the grapevine, so 
the details are shaky, if not down¬ 
right fictitious. I apologize in ad¬ 
vance for any omissions (or commis¬ 
sions). Since graduation, the 
following have gotten married: 
Mimi Blaurock, Jeb Blaugrund, 
Barry Birch, Jim Chang and 
Harriet Roeder, John Barash, Sara 
Dobbs, Stephanie Goodman, 
Suresh Karne, Bob Johnson, Chai 
Kulsakdinun (I saw the announce¬ 
ment in the New York Times, so it 
must be true), Julie Lund, Dan 
Philbin, Sean Roddy (REALLY!!), 
and Fred Welt. New parents since 
graduation include: Ahmed Abou- 
Zamzam (daughter Aida), Rick 
Alaimo (son), Karen Antell and 
Mitch Saltzberg (son Ethan), Ken 
Rosenzweig and Stacey Berg 
Rosenzweig (daughter Olivia), 
Nancy and Mike Girardi (son), 
Nahum Goldberg (daughter 
Shoshana joins big sister), Laura 
Marks (son Jake), Julie Lund (son 
Will), Nate Schmiechen (twins 
Alexandra and Zoe), Bill Sharpe 
(son), Claudia Showalter Reynders 
(twins really recently), Annie Towe 
Egan (twin sons), and Teri Wooten 
Daily (daughter Emma). Also, con¬ 
gratulations to Anne Wolf on her 
recent engagement. 
If anyone has more accurate or 
additional news of our class and 
wants to share it, e-mail me (Robin) 
at mta. dr.perr@mahbosp. org. 
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REUNION: EPIDEMIOLOGY AND PUBLIC HEALTH 
Buildings matter 
At the dedication of renovated facilties for EPH, a commitment to the future. 
During reunion festivities in 
early June, the alumni/ae, 
faculty and students of 
Epidemiology and Public Health 
found added cause for celebration in 
the dedication of renovated facilities 
in the Laboratory of Epidemiology 
and Public Health (LEPH) and at 
47 College Place. 
The renovation produced 
comfortable new space for a student 
center, library, computer rooms and 
a redesigned C.-E.A. Winslow 
Auditorium, as well as office 
renovations on the first three floors 
of LEPH. Several hundred members 
of the EPH, medical school and 
New Haven communities turned 
out to mark the occasion, high¬ 
lighted by the cutting of both a 
ribbon and a cake, the latter taking 
the distinctive form of the towering 
LEPH building. 
The program began with an 
invocation by the Rev. Bonita 
Grubbs, M.P.H. ’85, and remarks by 
EPH Dean Michael H. Merson, 
M.D.; Yale President Richard C. 
Levin; then-Dean Gerard N. 
Burrow, M.D. ’58; and incoming 
Dean David A. Kessler, M.D. 
Later in the day, awards were 
presented by Travis Hedrick, 
M.P.H. ’77, Ph.D., president of the 
Association of Yale Alumni in 
Public Health. Longtime alumni/ae 
leader and retired EPH faculty 
member Eric Mood, LLD, M.P.H 
’43, received the Distinguished 
Service Award. An emotional and 
joyful tribute to the late John D. 
Thompson, M.S. ’50, included 
reminiscences by Jack O’Connor, 
M.P.H. ’57; Joel Kavet, M.P.H. ’67, 
Sc.D.; and Rosemary Hurzeler, 
M.P.H. 77. 
A special retirement observance 
honored James F. Jekel, M.D., 
M.P.H. ’65, who served as the 
C.-E.A. Winslow Professor of Public 
Health. Dr. Jekel spoke at the EPH 
commencement in May and re¬ 
ceived the Bohmfalk teaching award 
at the medical school ceremony. 
(Culinary) art 
imitates life 
Every celebration needs a 
cake, and the dedication of 
renovated EPH facilities in 
June was no exception. 
EPH Dean and Chairman 
Michael H. Merson, M.D., 
cut both the cake and the 
proverbial blue ribbon, the 
latter with the help of 
outgoing medical school 
dean Gerard N. Burrow, 
M.D. ’$8, now the David 
Paige Smith Professor of 
Medicine and special advisor 
to President Levin. 
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Speakers for the day’s final 
program, Retrospectives: Missions and 
Milestones During the Last 50 Years at 
EPH, included former EPH chairs 
Robert McCollum, M.D., D.P.H., 
and Adrian Ostfeld, M.D., and 
alumni/ae David Pearson, Ph.D., 
’70; Rosemary Stevens, Ph.D. ’68; 
Jennifer Kelsey, Ph.D. ’69; Kathleen 
Howe, M.P.H. ’56; and George 
Silver, M.D., M.P.H. ’69; professor 
emeritus of public health and a 
former HEW undersecretary. 
Listening to the tribute to 
John D. Thompson, from 
left: Darlene Zimmerman, 
M.P.H. 88; Gerlinde 
Herman-Kehlenback, 
M.P.H. 81; Dorothy M. 
Horstmann, M.D., John 
Rodman Paul Professor 
Emeritus of Epidemiology 
and a senior research 
scientist in epidemiology; 
James Niederman, M.D., 
recently retired clinical 
professor of epidemiology 
and public health; and 
Arthur Ebbert, M.D., 
former deputy dean of the 
medical school. 
Cardiologist Forrester Lee, M.D., assistant 
dean for multicultural affairs, and 
Courtland Seymour Wilson, executive 
director oj the Hill Development Corp. 
Medical school Dean David A. Kessler, 
M.D., spoke with former Connecticut health 
commissioner Susan Addiss, M.P.H. ’69. 
David Pearson, Ph.D. Jo, former associate dean for public health, was among the speakers 
discussing EPH milestones over the past 90 years. He is now chairman of Health Policy and 
Management at the University of New Hampshire. 
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Excerpts from the dedication ceremony 
“These newly renovated facilities are 
not the school of public health. 
That school exists in the minds, and 
the hearts, and the spirits of all of 
you who are participating in this 
fine institution. On the other hand, 
it would be naive to suggest that 
buildings don’t matter. ... The new 
and renovated facilities are symbolic 
of Yale’s recommitment to research 
and education in the field of 
epidemiology and public health. ... 
It has been enormously hearten¬ 
ing from the other side of town to 
watch what Mike [Merson] has been 
able to do in a very brief period 
with the school, the energy he has 
brought to it, the tremendous 
commitment, the opening up to an 
international horizon. He has 
shown extraordinary leadership. 
I know that you all believe that. 
I think great times are ahead for 
the school." 
President Richard C. Levin 
Travis Hedrick, M.P.H. 77, Pb.D., 
president of the Association of Yale Alumni 
in Public Health, presents the Distinguished 
Service Award to Eric Mood, LLD, 
M.P.H. ’43. 
“By the time a person reaches my 
age, he is supposed to have lost the 
urgency of his ideals. Reality is 
supposed to have dulled the sharp 
edge of his resolution. But it hasn’t 
worked that way with me and I 
know it hasn’t worked that way with 
you. I’d like each of you to turn 
back the clock for a moment; I’d 
like all of you to think back to the 
time when you took your first step 
on the road to public health as a 
profession. I’d like you to think 
what motivated you then. ... It 
certainly wasn’t social prestige, and 
it certainly wasn’t the money. It was 
simply a desire to make a difference 
in people’s lives, to do some good in 
the world. 
Horace Mann, the educator, 
said that you should be ashamed to 
die until you have won some victory 
for humanity. He could have been 
talking about the road that you have 
chosen. ... Accomplishments in the 
field of public health, as in any hu¬ 
manitarian endeavor, rest in the 
Kathleen Howe, M.P.H. ’36, presents the 
Distinguished Alumni Award medallion to 
Adriana Natale, M.D., in recognition of 
the contribution of Dr. Natale’s late 
husband, John D. Thompson, M.S. '30. 
simple recognition that problems 
can be solved if we are willing to 
face our responsibility. It doesn’t 
matter whether your degree is an 
M.P.H., a doctor of public health, 
an M.D., or a Ph.D. in nursing. ... 
The lines between medicine and 
public health should be nonexistent. 
Prevention knows no boundaries, 
infectious disease knows no bound¬ 
aries, the death and disability from 
tobacco knows no boundaries. ... 
The public health challenges of 
today are no less formidable than 
those of years past. In this country 
polio, diphtheria and rickets have 
been replaced by heart disease, can¬ 
cer and stroke. Our professions cry 
out for men and women who view 
public health not as a profession, 
but as their calling, who are willing 
to touch what others see as untouch¬ 
able, who are willing to sign up for 
nothing less than the Churchillian 
promise of blood, toil, sweat and 
tears in return for nothing more 
than the privilege of promoting the 
common good.” 
Dean David A. Kessler, M.D. 
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W. Randal Bell 
W. Randal Bell, M.D., formerly of 
Marblehead, Mass., died April i of 
metastatic prostate cancer at his 
home in Peterborough, N.H. He 
was 85. 
Born in Brooklyn, N.Y., Dr. 
Bell graduated from Rensselaer 
Polytechnic Institute and received 
his medical degree from Yale in 
1941. After a year’s internship at 
New Haven Hospital, he spent four 
years in the Army medical corps on 
the West Coast and with the 313th 
General Hospital in the Philippines, 
retiring as a major. 
For 30 years, Dr. Bell was a 
pediatrician in Massachusetts. He 
was chief of staff at North Shore 
Children’s Hospital, where he was 
an active participant in the building 
of a new hospital facility. He also 
was on the staff at Salem Hospital 
and the former Mary Alley Hospital 
in Marblehead. 
After retiring, Dr. Bell worked 
with Dr. Robert Grassi, seeing 
patients at Monadnock Community 
Hospital in Peterborough, and with 
the Visiting Nurse Association and 
Crotched Mountain Rehabilitation 
Center. 
Philip S. Brezina 
Philip S. Brezina, M.D., of Bristol, 
Conn., and East Orleans, Mass., 
died June 10. He was 82. 
Dr. Brezina received a bachelor 
of arts degree from Trinity College 
in Hartford in 1936 and his medical 
degree from Yale in 1940. He 
OBITUARIES 
completed a six-year surgical 
residency in New Haven and served 
as chief surgical resident. In 1946 
Dr. Brezina opened a general 
surgery practice in Bristol and did 
pioneering work in vascular surgery. 
He also served as chief of surgery at 
Bristol Hospital for more than 30 
years. In 1965 he volunteered his 
surgical skills at the Albert 
Schweitzer Hospital in Haiti. 
Dr. Brezina and his wife, 
Frances, traveled worldwide pursu¬ 
ing their special interest in birds. 
He was an avid fisherman and a 
master at fly tying. 
Lee E. Farr 
Lee E. Farr, M.D., one of the 
nation’s preeminent physicians in 
nuclear and environmental medi¬ 
cine, died of cancer in Walnut 
Creek, Calif., on July 16. He was 89. 
A native of Albuquerque, N.M., 
Dr. Farr was a 1929 graduate of Yale 
College. He received his M.D. 
degree from the School of Medicine 
in 1933 and remained as an assistant 
professor of pediatrics. In 1934 he 
was appointed an associate in 
medicine at the Hospital of the 
Rockefeller Institute for Medical 
Research in New York City. From 
1940 to 1949 he served as director of 
research and physician-in-chief at 
the Alfred I. DuPont Institute of the 
Nemours Foundation in 
Wilmington, Del., where he 
researched and developed a treat¬ 
ment for nephrosis in children. 
In 1949 Dr. Farr was named 
medical director, chairman of the 
medical department and physician- 
in-chief of the Medical Research 
Center at Brookhaven National 
Laboratory in Upton, N.Y. While at 
Brookhaven, he pioneered the 
design and construction of the 
world’s first nuclear reactor built 
and used primarily for medical 
purposes. 
In 1962 the University of Texas 
in Houston appointed Dr. Farr chief 
of the section of nuclear medicine at 
M.D. Anderson Hospital and 
Tumor Institute, and as professor of 
nuclear and environmental medi¬ 
cine and chairman of the Depart¬ 
ment of Environmental Health at 
the University of Texas School of 
Public Health. 
In 1968, the California State 
Department of Public Health 
appointed Dr. Farr chief of emer¬ 
gency health services and head of 
disaster health services. He worked 
to establish the California Bureau 
of Emergency Medical Services 
and was named its first chief in 
1970, a post he held until his 
retirement in 1973. 
During World War II, Dr. Farr 
served with the Navy as a medical 
officer aboard the U.S.S. Tryon, an 
armed hospital transport ship in 
the Pacific assigned to remove 
casualties from Guadalcanal. Dr. 
Farr was a consultant to the Navy 
and to the Atomic Energy Commis¬ 
sion and was a member of the U.S. 
Delegation to the International 
Conference on Atomic Energy in 
Geneva in 1955. 
He also was selected in 1955 to 
be a member of the advisory 
committee to the Atomic Bomb 
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Casualty Commission, analyzing 
medical effects on atomic bomb 
victims. He served as its chairman 
from 1955 to 1968. 
Dr. Farr was awarded the Gold 
Cross Order of Phoenix by Queen 
Frederika of Greece in i960 for his 
consulting work in nuclear medi¬ 
cine. West Germany bestowed the 
Order of Merit upon him in 1963. 
He authored more than 200 papers 
and articles on nuclear medicine, 
nuclear reactors, protein metabo¬ 
lism, emergency medical services, 
and radioactive and chemical 
environmental contaminants. 
Franklin M. Foote 
Franklin M. Foote, M.D., Dr.P.H., 
formerly of Wethersfield, Conn., 
died June 29 at Fairview Manor in 
Pittsfield, Mass. He was 89. 
Dr. Foote was a graduate of 
Yale, where he earned three de¬ 
grees—bachelor of science in 1930, 
doctor of medicine in 1933 and 
doctor of public health in 1935. He 
was certified in public health by the 
American Board of Preventive 
Medicine in 1949. Dr. Foote served 
in the Army medical corps during 
World War II and for many years in 
the Army Reserve before retiring as 
a colonel. 
Dr. Foote was executive director 
of the National Society for the 
Prevention of Blindness in New 
York City before his appointment in 
1959 as Connecticut’s health com¬ 
missioner. He served in that posi¬ 
tion for 15 years under three differ¬ 
ent governors. 
Dr. Foote had been honored by 
the New England Public Health 
Association, the Connecticut Public 
Health Association and the Con¬ 
necticut Society for the Prevention 
of Blindness. He was also made a 
Paul Harris Fellow by the Rotary 
Club of Hartford. 
George L. Hoffman 
George L. Hoffman, M.D., of 
Scottsdale, Ariz., died May 16. 
He was 71. 
Born in Pittsburgh, Dr. 
Hoffman studied at the Virginia 
Military Institute and the University 
of Pittsburgh before graduating 
from Haverford College. He served 
as a second lieutenant during World 
War II, the youngest commissioned 
officer in the Army, according to his 
family. In 1953 he graduated from 
Yale School of Medicine. Dr. 
Hoffman was an intern in Philadel¬ 
phia, where he met his wife, Jewel 
Delores Hunt, a nurse. In 1954 he 
served a surgical residency at the 
Cleveland Clinic Hospital. 
In 1958 Dr. Hoffman moved to 
Mesa, Ariz., where he was a well- 
known and respected surgeon until 
his retirement several years ago. He 
was chief of staff at Mesa Lutheran 
Hospital and a member of the 
Arizona Board of Medical Examin¬ 
ers. Dr. Hoffman served as president 
of the Maricopa County Medical 
Society, the Arizona Chapter of the 
American College of Surgeons and 
the Phoenix Surgical Society. His 
most outstanding honor was 
election to the Board of Regents of 
the American College of Surgeons 
in 1975. 
Dr. Hoffman owned a dude 
ranch in Yavapai County for 15 years 
and brought his family there to 
escape city life and experience the 
West of times past. He retired in 
1993 and moved to Scottsdale, 
where he enjoyed riding his horse 
and playing tennis daily. 
Hans R. Huessy 
Hans R. Huessy, M.D., died May 9 
from complications of a brain 
aneurysm at his home in Jericho, 
Vt. He was 75. 
Dr. Huessy was one of the 
first researchers to recognize that 
the behavior patterns observed in 
children with attention deficit 
disorder continued through life, 
and that the disorder presented 
symptoms in males that were very 
different from those in females. 
A maverick in his profession, he 
was also one of its most outspoken 
critics, opposing the influence 
of psychoanalysis on American 
psychiatry. 
Born in Frankfurt am Main, 
Germany, Dr. Huessy came to the 
United States in 1934 at the age of 
13, when his father became an 
instructor at Harvard University. 
Dr. Huessy graduated from 
Dartmouth College in 1942, 
received his M.D. degree from Yale 
in 1945 and interned in pediatrics at 
the Johns Hopkins Hospital. He 
was a psychiatric resident and staff 
psychiatrist for the U.S. Public 
Health Service before receiving a 
master of science degree from the 
University of Colorado in 1951. 
Dr. Huessy was a lieutenant 
colonel and senior surgeon, serving 
Colorado, Utah, Idaho, Wyoming 
and Montana. He returned to 
Vermont in 1958 and began a 30- 
year career with Spring Lake Ranch, 
a therapeutic community in 
Cuttingsville. 
In i960 Dr. Huessy began 
teaching at the University of 
Vermont Medical School. He 
became a full professor in 1967 and 
chaired the Department of Psychia¬ 
try from 1967 to 1970. Between 
1967 and 1971 he headed the Inter- 
University Forum for Educators in 
Community Psychiatry. He was a 
fellow of the American Public 
Health Association and of the 
American Psychiatric Association. 
Dr. Huessy retired from the medical 
school in 1985, but continued 
consulting work with St. Lawrence 
Psychiatric Center in Ogdensburg, 
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N.Y., and several halfway houses 
throughout the state. 
Dr. Huessy was an avid skier 
and became the youngest U.S. 
amateur certified ski instructor. He 
was a justice of the peace in Jericho 
from 1958 to 1967. 
Robert H. Jordan 
Robert H. Jordan, M.D., formerly 
of North Haven, Conn., died April 
11 at his home in Juno Beach, Fla. 
He was 88. 
Dr. Jordan was a graduate of the 
University of Richmond and the 
Medical College of Virginia. He 
served his internship at Chesapeake 
and Ohio Hospital in Huntington, 
W. Va., from 1933 to 1934 and took 
his residency at Pinecrest Sani¬ 
tarium in Farmingdale, N.Y., and 
the former Grace Hospital in New 
Haven from 1936 to 1937. He served 
in the Army Medical Corps from 
1942 to 1946. 
Dr. Jordan was a practicing 
physician in New Haven from 1938 
until his retirement in 1980. He 
was also a clinical instructor in 
medicine at the School of Medicine. 
After retirement from private 
practice, he served at Connecticut 
Hospice in Branford from 1980 
until 1982, when he moved to Juno 
Beach. He was a former president of 
the Connecticut Society of the 
American Board of Internists, a 
fellow of the American College of 
Physicians and the American 
College of Chest Physicians, and a 
diplomate of the American Board 
of Internal Medicine. 
Edward R Kearney 
Edward P. Kearney, M.D., died June 
21 at his home in Montclair, N.J. 
He was 95. 
Dr. Kearney was a 1924 gradu- 
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ate of the College of the Holy Cross 
and, in 1928, from Yale School of 
Medicine. During World War II he 
served in the 57th Signal Battalion 
of the Army Medical Corps in 
Africa, Italy and France. He was 
awarded the Purple Heart twice. 
Dr. Kearney was director of the 
medical staff at St. Vincent’s 
Hospital in Montclair and main¬ 
tained a private practice there for 35 
years before retiring in 1962. He was 
honored as a Knight of St. Gregory 
in i960 at the Sacred Heart Cathe¬ 
dral in Newark. 
Norman J. Kelman 
Norman J. Kelman, M.D., formerly 
of Wallingford and Branford, 
Conn., died April 20 from leukemia 
at his home in New York City. He 
was 82. 
Dr. Kelman graduated Phi Beta 
Kappa from Wesleyan University in 
Middletown, Conn., and earned a 
master of arts degree from Colum¬ 
bia University and an M.D. degree 
from Harvard Medical School. 
During World War II, he served as a 
major in the Army and was assigned 
to Gen. George C. Patton’s division 
when it entered Berlin. 
After the war, Dr. Kelman 
began a private practice in New 
York and studied under Dr. Karen 
Horney at the American Institute of 
Psychoanalysis. He taught at the 
institute for more than 50 years and 
served as an assistant dean and 
board member. He also played a 
major part in the formation of the 
New York School of Psychoanalysis 
in the 1950s. 
Dr. Kelman taught at other 
institutions, including the New 
School for Social Research, Albert 
Einstein College of Medicine, the 
University of Miami Medical School 
and, from 1958 to 1959, the Yale 
School of Medicine. 
George L.H. Le Bouvier 
George L.H. Le Bouvier, M.D., of 
Portland, Ore., died March 12 
following a stroke. He was 75. 
Born in Constantinople, Dr. Le 
Bouvier was educated at Oxford 
University, St. Bart’s in London and 
the University of Glasgow. At Yale, 
he was a research associate in 
epidemiology from 1966 to 1970 
and a senior research associate in 
epidemiology from 1970 to 1977. 
He also served on the faculty at the 
University of Glasgow. 
Dr. Le Bouvier retired in 1977 
to the island of Maui, where he 
pursued his interest in plants and 
trees and learned to speak the 
Hawaiian language. He moved to 
Portland in 1992 and was an active 
volunteer at the Hoyt Arboretum 
and the Rose Test Gardens. 
Morgan Sargent 
Morgan Sargent, M.D., formerly of 
Quincy, Mass., died May 30 of 
pulmonary stenosis at the Harbor 
House Nursing Home in Hingham, 
Mass. He was 87. 
Born in Quincy, Dr. Sargent 
graduated in 1932 from Williams 
College and in 1937 from Yale 
School of Medicine. He served his 
internship at Hartford Hospital for 
two years and at Pondville Hospital 
in Massachusetts for one year. From 
1941 to 1946 he was chief of surgery 
at the Don CeSar Rehabilitation 
Hospital in St. Petersburg, Fla., for 
the Army Air Corps. 
Dr. Sargent practiced medicine 
in Quincy from the 1940s until his 
retirement in 1986. He was also 
chief of surgery at Quincy Hospital 
from 1946 to i960 and chief of 
staff at the hospital for many years. 
Dr. Sargent was a past president 
and longtime director of the 
City of Quincy Hospital Corp., 
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a director at the former Quincy 
Savings Bank, a trustee of the 
Delcevare King Trust and the John 
Quincy Adams Foundation, and 
director and past president of the 
Rice-Eventide Home. 
Clyde A. Swift 
Clyde A. Swift, M.D., of Guilford, 
Conn., died April 15 at Connecticut 
Hospice in Branford. He was 67. 
Dr. Swift served in the U.S. 
Marine Corps, 2nd division, during 
World War II and in the Massachu¬ 
setts Air National Guard. He 
received a bachelor of science degree 
in 1954 from Bates College and an 
M.D. degree in 1958 from Tufts 
University. Dr. Swift served his 
internship and residence at 
Dartmouth-Hitchcock Medical 
Center in Hanover, N.H. 
He held positions at Glen Falls 
(N.Y.) Hospital, and at Memorial 
Hospital of Martinsville and Henry 
County, Va., before joining the 
faculty in anesthesiology at Yale 
School of Medicine in 1982. While 
at Yale, he was a member of the 
Impaired Physician Committee of 
the Connecticut State Medical 
Society, the Committee on Physi¬ 
cian Health of the New Haven 
Medical Society and was chairman 
of the Yale Medical Center Task 
Force on the Impaired Health 
Care Provider. 
R. Bruce Thayer 
Ralph B. Thayer, M.D., died June 
11 at his home in Enfield, Conn. 
He was 75. 
Dr. Thayer graduated from 
Bowdoin College in 1943 and from 
Yale School of Medicine in 1946. 
As an Army veteran of World War 
II he served as a captain in the 
medical corps. 
As a family physician, Dr. 
Thayer practiced in the Enfield and 
Somers area from 1949 to 1968. He 
served in various positions with 
Blue Cross & Blue Shield of 
Connecticut from 1968 until his 
retirement as senior vice president 
in 1984. 
Dr. Thayer was a former trustee 
of the Connecticut Medical 
Services and a member of the 
American Medical Association, 
the Connecticut State Medical 
Society and the Tolland County 
Medical Association. He was a 
former member and president of the 
medical staff at Johnson Memorial 
Hospital in Stafford. 
Laura B. Weed 
Laura B. Weed, M.D., died on 
March 29 in Burlington, Vt. 
She was 75. 
Born in Cleveland, Dr. Weed 
graduated from Vassar College in 
1943 and from Yale School of 
Medicine in 1947. At Peter Bent 
Brigham Hospital in Boston, she 
made important contributions to 
medical research on the metabolic 
response to surgery. In Bangor, 
Maine, and in Cleveland she 
worked on developing medical 
record systems and on providing 
clinical care to the underserved 
and the poor. Dr. Weed was one 
of the founders and principals of 
The Given Health Care Center in 
Burlington in 1970, and was 
instrumental in building one of 
Vermont’s first rural healthcare 
facilities, the Grand Isle Health 
Center. 
She was an associate professor 
of medicine at the University of 
Vermont College of Medicine. 
IN MEMORIAM 
W. Randal Bell, M.D. ’41 
April 1, 1997 
Philip S. Brezina, M.D. ’40, 
HS ’40-46 
June 10, 1997 
Gyla E. Brooks, M.P.H. ’60 
March 1, 1997 
Hans R. Huessy, M.D. ’45 
May 9, 1997 
Arthur J. Orloske, M.P.H. ’76 
January 21, 1997 
Morgan Sargent, M.D. ’37 
May 70, 1997 
Eugene Smith, M.D. ’44 
March 13, 1997 
Robert L. Stein, M.D. ’54 
May 10, 1997 
R. Bruce Thayer, M.D. ’46 
June 11, 1997 
Laura B. Weed, M.D. ’47 
March 29, 1997 
Malvin F. White, M.D. ’39 
April 8, 1996 
Peter T. Wotton, M.P.H. ’67 
November 3, 1996 
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DEVELOPMENT 
Non-profit or not? 
Managed care, a flurry of mergers, and the growth of for-profit health care has left the 
public confused about academic medicine. Where does this leave philanthropy? 
By David Davison 
Yale School of Medicine is renowned as one of the 
world’s great research institutions. The school’s 
deep and extensive commitment to community 
service and care for the people of New Haven and the 
surrounding region may be less well known. 
Each morning on National Public Radio’s Morning 
Edition program, the local announcer acknowledges 
the support of a few select organizations, including 
the following: 
Yale-New Haven Hospital, caring for Connecticut’s 
citizens for 171 years. Yale-New Haven Hospital is a 
non-profit organization. 
This is not an incidental tag line. People often are 
not aware that the hospital is a not-for-profit, tax-exempt 
charitable organization, as is the School of Medicine. 
Both entities are big, complex and changing with the 
times, all the while retaining their charitable missions. 
Both raise funds to help provide health care to the 
community and to conduct research and training. 
The hospital recognizes the need to make the point to 
its local constituency. 
Decades ago—before the explosive growth of medical 
centers, health insurance and government programs— 
voluntary hospitals operated under fewer regulations. 
Many clearly served the community by providing what at 
the time was called charity care to the poor. Last year, 
Yale-New Haven Hospital provided more than $25 
million in free care and uncompensated services. Today, 
David Davison is director of development for the School of 
Medicine. Write to him at the Office of Medical Development, 
100 Church Street South, Suite 211, New Haven, CT 06519-1/14, 
or via e-mail: david.davison@yale.edu. 
The New Haven Dispensary, known today as the ]ane Ellen Hope 
Building, was erected in 1901. It provided care for poor children and 
became the Ambulatory Service of the Department of Pediatrics in 
1922. Currently it is used for lectures and meetings. 
large academic medical centers don’t always take credit for 
the free services they provide. With an estimated 45 
million Americans uninsured and falling reimbursement 
rates from Medicaid, Medicare and managed care, a lot of 
unreimbursed care is being delivered. 
In health care, everyone knows that the times are 
rapidly changing. According to the American Hospital 
Association, nearly 1,200 hospitals have been sold or 
merged with other institutions in the past two years. 
Thirty percent of those transactions involved for-profit 
institutions. Medical schools have even struck deals with 
for-profit corporations. Tulane School of Medicine has a 
complex agreement with Columbia/HCA that essentially 
puts the health care delivery management side of the 
business in the hands of a for-profit entity, while leaving 
teaching and research under the continued control of 
the academic leaders and non-profit board members. 
74 FALL 1997 
H
A
R
V
EY
 
C
U
SH
IN
G
/J
O
H
N
 
HA
Y 
W
H
IT
N
EY
 
M
ED
IC
A
L 
LI
B
R
A
R
Y
 
These mega-mergers are occurring as patients, physicians 
and insurance payers are reorienting their relationships 
with each other. 
Where does this leave philanthropy? It is definitely 
not a good idea for hospitals and medical schools to 
assume that the traditions of charitable giving will always 
endure. According to the Chronicle of Philanthropy, donors 
are questioning the philanthropic process at large health 
care institutions, especially if there is real or imagined 
potential that it might become a profit-making business. 
Some donors are reportedly demanding that hospitals 
return donations that were made years before. 
Yale School of Medicine has been around since 
1813, the hospital since 1826. Neither is changing its 
identity or mission, and both institutions rely on dona¬ 
tions to accomplish their goals in patient care, research 
and teaching. 
The not-for-profit status of our institutions cannot be 
taken for granted. It must be made clear to the public, in 
compelling ways, that we have critically important goals 
for teaching, research and the delivery of care. 
We must broadcast the news about our research 
programs, and our commitment to improving health care 
in the community. For example, Yale medical students 
and faculty volunteer their time to deliver a variety ol 
outreach services such as free vaccines and immunizations 
for children, substance abuse prevention in New Haven 
Citizens of New Haven awaiting treatment at the New Haven 
Dispensary (c. 1920). The charity care it provided was made possible 
in part by grants from the charitable Community Chest and from 
other donors. 
Schools, the AIDS Care Program for children and 
families, and free care lor the homeless. 
In other words: good old-fashioned care, provided 
regardless of the patient's ability to pay. 
What the public thinks 
To obtain some useful data on 
public perceptions, a comprehensive 
survey was commissioned by the 
Association of American Medical 
Colleges last year. 
It turns out that the public 
does care about teaching and 
research in general. Survey respon¬ 
dents were asked whether they 
thought the following statement 
was true or false: 
“New drugs, medical devices, 
and surgical techniques not only 
improve the quality of health care, 
they can also save money for you 
and your family.” Sixty-seven percent 
said true. 
People responded in similar 
fashion to statements defining 
medical schools and teaching 
hospitals as the “backbone of 
innovation” that play a “critical 
role ... training doctors in cutting- 
edge knowledge.” 
Yet the survey showed that 
most Americans don’t understand 
how these institutions function, 
or the role of medical faculty and 
students in providing care and 
conducting research. It is not 
clear to the public that revenues 
for the research and teaching 
missions are shrinking, as well as 
the funds that are needed to 
provide free care. 
As for the public’s appreciation 
of our free-care mission: 55 percent 
of respondents believed that an 
academic medical center “provides 
health care services for low income 
people who otherwise could NOT 
afford care.” Only 39 percent of 
those respondents living in cities 
where there are academic medical 
centers believed that their local 
institutions were not-for-profit. 
A large segment of the public 
needs to know more about the 
array of community service 
programs at the School of Medicine, 
and the free medical care provided 
by our dedicated faculty 
and students. 
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LETTERS 
Divine inspiration 
To the editor: 
Your issue on managed care and 
medical education (Lessons in 
Managed Care, Summer 1997) un¬ 
derscores the fact that medical care 
has been infiltrated by a new group 
of decision-makers who lack medical 
training. These events signal a 
stinging rebuke, inflicted by the 
marketplace, on the recent practice 
of medicine. 
I bis has brought an end to 
what may be termed “the laissez-care 
era of medicine,” a time when a 
patient’s care and welfare were a 
doctor’s sole concern. Sadly, those 
responsible for this achievement had 
an ostrich's view of cost-contain¬ 
ment. As a result, responsibility for 
patient care is now shared. 
All of this brings to mind the 
fifth book of The Iliad, in which 
Homer described a wound suffered 
by Aeneas (apparently an open frac¬ 
ture of the hip and a crush injury to 
the acetabulum). 
Aeneas’ management may give 
us our first glimpse of an early 
HMO prototype since, from the 
start, his care was seen to by medical 
and non-medical personnel. It was 
initiated by Apollo, the patron deity 
of medicine, who removed the pa¬ 
tient from the battlefield to the 
sanctuary of his temple. Further care 
was rendered by Artemis, the twin 
sister of Apollo, and Leto, their 
mother, who “healed his wound and 
restored his strength completely.” 
All those involved in the care of 
Aeneas were endowed with divine 
attributes, a gift that helps in the 
care of humans. The difference to¬ 
day is that while managed care 
administrators often are not physi¬ 
cians, neither are they gods. We 
should leave medical decisions to 
doctors—mere mortals, to be sure, 
but highly trained ones—while be¬ 
ing certain as physicians to address 
the cost issues that gave rise to 
managed care. 
Perhaps our dilemma may af¬ 
ford an opportunity for us to be¬ 
come more efficient on the federal 
level—namely to consolidate exist¬ 
ing resources, such as the Veterans 
Affairs health system. Medicare and 
Medicaid. The VA system might be 
expanded to care for all patients 
funded with federal monies. And if 
these same facilities were made avail¬ 
able to the nation’s 45 million unin¬ 
sured, a large step would be achieved 
in streamlining medical care. 
While divine inspiration pre¬ 
vailed in Homer’s day, today we may 
have to rely upon human adapta¬ 
tion. Laissez-care is gone. 
Robert J. Kerin, M.D. ’47 
Milford, Conn. 
Lobsters, indeed! 
To the editor: 
I was ready to ignore the tick vs. 
insect slip in your Lyme disease ar¬ 
ticle, because in the popular press, 
ticks are often lumped with insects 
in the Aristotelian-derived sense of 
“entoma”; however, Dr. M.H. 
Schmidt’s letter (Let Us Be Precise, 
Spring 1997) has compounded the 
problem and forced me to write. 
Ticks, mites, scorpions, spiders 
and their relatives are in the class 
How to reach us 
Yale Medicine welcomes news 
and commentary. Please send 
letters to the editor and news 
items to Yale Medicine, P.O. 
Box 7612, New Haven, CT 
06519-0612, or via electronic 
mail to ymm@yale.edu, and 
include a daytime telephone 
number. Submissions may 
be edited for length, style 
and content. 
Arachnida. The ending “-oidea” 
refers only to superfamily designa¬ 
tions. Furthermore, although spiders 
and scorpions do have two body 
segments, a cephalothorax and 
abdomen, mites and ticks do not. 
Mites and ticks, which comprise the 
subclass Acari, have a single body 
that is not separated into discrete 
sections. The mouthparts are at¬ 
tached directly to the compact, 
oval, round, or cylindrical body of 
the arthropod. The fusion of the 
various body parts is suggested by 
the presence of sutures and annula- 
tions, but no distinct separations 
are easily visible. 
Finally, to be more precise, ticks 
are more closely related to lobsters 
than to insects! 
William L. Krinsky, M.D. ’71, Ph.D. 
Division of Entomology 
Peabody Museum of Natural History 
New Haven, Conn. 
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THE PROGRAM FOR HUMANITIES IN MEDICINE 
Lectures at 5 PM on Thursday in the BEAUMONT ROOM, Yale University School Medicine, 
333 Cedar Street, New Haven. Refreshments at 4:30 PM. The lectures are free and open to the public. 
For more information, call Howard Spiro or Clara Gyorgyey at (203) 783-3494. 
DECEMBER 4 
SIR WILFRED THOMASON GRENFELL, 
THE LABRADOR DOCTOR 
Charles P. Stetson, BS 
Chairman, US Fund for Leadership Training 
Southport, Connecticut 
DECEMBER 18 
CHAOS THEORY & FRACTALS IN MEDICINE, 
MUSIC & ART 
Ary Goldberger, MD 
Associate Professor of Medicine 
Harvard Medical School 
Boston, Massachusetts 
JANUARY 8 
HOW TO STAY HUMAN IN MEDICINE: 
THE HOUSE OF GOD & MOUNT MISERY 
Steven J. Bergman (Samuel Shem), MD, PhD 
Writer, Comic & Psychiatrist 
Harvard Medical School 
Boston, Massachusetts 
JANUARY 22 
‘HOW I GOT TO BE WFLAT I WANTED TO BE” 
Morris Wessel, MD 
Clinical Professor Emeritus of Pediatrics 
Yale University School of Medicine 
FEBRUARY 5 
OVER THE RIVER THROUGH THE WOODS: 
TAKING THE MEDICAL HIGH ROAD 
THE BAYER LECTURE 
Richard “Buzz” Goodstein, MD 
Vice President for Scientific Relations 
Bayer, Pharmaceutical Division 
West Haven, Connecticut 
FEBRUARY 19 
THE BEAUTY OF MY ANOMALOUS NATURE: 
A BOOK OF MEMORIES KY PETER NADAS 
Ivan Sanders, PhD, Professor of English 
Suffolk Community College & The New School 
New York, New York 
MARCH 5 
HISTORY OF MEDICINE & HEALING IN SOUTH ASIA* 
Maneeshal Lai, PhD 
Visiting Professor, History of Medicine 
University of Wisconsin 
Madison, Wisconsin 
MARCH 12 
THE BEST-KEPT SECRET: WOMEN IN VIETNAM 
Linda S. Schwartz, RN, MSN 
Doctoral Candidate 
Yale University School of Medicine, EPH 
MARCH 19 
MEDICINE ON TRIAL: COURTROOM STORIES 
OF MEDICINE, LAW & MORALITY 
Hon. Barry R. Schaller, JD 
Judge, Connecticut Appellate Court 
Hartford, Connecticut 
MARCH 26 
“ONE WORD: THE POETRY OF MEDICINE” 
THE ROBERT PENN WARREN LECTURE 
MarkJ. Straus, MD 
Professor of Medicine & Poet 
New York Medical College 
New York, New York 
APRIL 9 
OLD MAPS: GUIDES TO THE GEOGRAPHY 
OF THE EARTH, BODY & MIND 
Harold L. Osher, MD 
Cardiologist, Cartographer 
& Director of Osher Map Library 
University of Southern Maine 
Portland, Maine 
APRIL 16 
SENSIBILITY, MEDICINE & THE SPECTACLE OF THE 
BREAST IN THE 18TH-CENTURY NOVELS 
Nina A. Prytula, MPhil 
Doctoral Candidate, Department of English 
Yale University 
APRIL 30 
RICHARD SELZER: POET OF THE BODY 
Mahala Yates Stripling, PhD 
Texas Christian University 
Fort Worth, Texas 
MAY 7 
JAMES JOYCE: MANIC GENIUS & THE FAMILY TRIANGLE 
James R. Merikangas, MD 
Clinical Professor of Psychiatry & Neurology 
Yale University School of Medicine 
MAY 14 
THE EMERGING OF A PHOTOGRAPHIC EYE 
Barbara Young, MD 
Assistant Professor Emeritus of Psychiatry 
& Photographer 
Johns Hopkins University 
Baltimore, Maryland 
*Co-sponsored by the Office of Multicultural Affairs 
Yale University School of Medicine 
Yale Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
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Can paralysis be reversed? The conventional 
wisdom says no, but recent findings by a 
team ol Yale neurologists provides new 
hope that spinal cord injury may be 
treatable in the not-too-distant future. _ 
rage 20 
By Rachel Engers 
12 Navigating the spinal cord 
Yale Medicine 
Alumni Bulletin of the 
i Yale University School of Medicine 
Winter/Spring 1998 
Volume 32, No. 1 
20 
Page 12 
Music and medicine 
Meet the Cellmates, that biorocking band of Yale scientists. 
Like many of their medical school colleagues, their interests 
in music, science and healing tend to overlap. 
By Karen Schmidt 
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A century ago, the modern 
science of medical imaging was 
born when Roentgen discovered 
the X-ray. Now, new methods 
are revealing the intricate 
details of function in addition 
to anatomical structure. 
By Marc Wortman 
Page 16 
An early alumnus, 
Page 11 
A welcome to medicine, Page 52 
Yale Medicine on the web Yale Medicine makes its debut 
on the World Wide Web this spring. Look for this and future 
issues along with links to additional resources at the 
following address: http://info.med.yale.edu/external/pubs 
As always, we can be reached via e-mail at ymm@yale.edu. 
SCOPE 
Federal audit shows Yale’s Medicare billing 
practices in good health The Office of Inspector General of the U.S. Depart¬ 
ment ol Health and Human Services (HHS) has 
given the School ol Medicine a clean bill of health 
regarding its Medicare billing practices at Yale-New 
Haven Hospital. The School of Medicine was 
one ol 49 institutions nationwide notified 
that they would be audited under the 
HHS Physicians at Teaching Hospitals 
(PATH) audit program. 
Under Medicare rules, teaching 
physicians are permitted to bill for 
care they directly provide to patients. 
In addition, il the care is provided by a 
resident, the teaching physician super¬ 
vising the resident can bill for those ser¬ 
vices only if he or she is sufficiently involved in the 
care, and if that involvement is appropriately docu¬ 
mented. How much involvement was sufficient and 
what kind of documentation was required were matters 
of debate and confusion until HHS adopted new regula¬ 
tions in 1996 that attempted to clarify these issues. 
The HHS PATH audit program has focused on 
Medicare payments to teaching physicians in academic 
medical centers lor care provided before the new regula¬ 
tions were issued. Many academic medical centers have 
complained that the PATH audits are unfairly 
.pplying the new rules retroactively, 
finding innocent errors caused by 
confusion and unfairly calling 
them fraud. 
The audit at Yale began in 
August 1996, and auditors re¬ 
viewed a sample of Medicare 
payments to Yale School of Medi¬ 
cine for patients seen by Yale faculty 
physicians in 1994. The HHS auditors’ 
conclusion: Yale is in compliance. “The 
results of this audit show Yale’s commitment 
to compliance,” said Dean David A. Kessler, 
M.D. “Compliance is difficult at times because the rules 
and regulations are complex and sometimes unclear. 
For Yale to have come through this audit so well is a 
tribute to the doctors and administrators at the School 
of Medicine.” 
Urban health program 
broadens community 
outreach efforts 
The U.S. Department of Health and 
Human Services’ Health Resources and 
Services Administration (HRSA) has 
awarded nearly half a million dollars to 
the Yale Urban Health Program over a 
three-year period. One of 16 Public 
Health Special Projects funded by 
HRSA this year, the Urban Health 
Program will use the grant to expand 
collaborations within the Yale medical 
center, the University and the greater 
New Haven area. 
The grant allows the program’s leaders 
to expand curricula and create new pro¬ 
grams, including student internships 
and a minority fellows program. Funds 
will also be used to sponsor the second 
annual Urban Health Lecture Series, 
which began in late October. Lecture 
topics include The Effects of Pesticides on 
Children, School Health, Prevention of 
HIV Among Drug Users in New Haven, 
and Prenatal Cocaine Exposure. 
According to Nora E. Groce, Ph.D., 
assistant professor of public health, the 
lecture series highlights some critical 
issues facing the urban community 
today, including violence prevention, 
homelessness and abuse. 
“The HRSA grant will help us get 
some of the most talented and moti¬ 
vated public health, medical and nurs¬ 
ing students working together to im¬ 
prove the well-being of people in urban 
communities,” says Dr. Groce, principal 
investigator for the grant and one of 
three co-direcrors of the Urban Health 
Program. 
The Urban Health Program, created 
in 1995 with a planning grant from the 
Pew Charitable Trusts, fosters interac¬ 
tion between students at Yale, faculty 
and the community. According to 
Dr. Groce, the program aims to bring 
more community practitioners into the 
University to share their experiences 
and expertise. 
Executive advisors include Michael 
H. Merson, M.D., dean for public 
health; Ralph I. Horwitz, M.D., chair of 
internal medicine; and Margaret Grey, 
Dr.P.H., associate dean for research and 
doctoral studies at the School of Nurs¬ 
ing. The co-directors include Dr. Groce, 
Patrick G. O’Connor, M.D., M.P.H., 
associate professor, general medicine, 
and Martha Swartz, R.N., M.S., associ¬ 
ate professor of nursing. The program’s 
coordinating director is Wanda 
Anderson Harris, M.Ed., M.P.A. 
“We want the program to produce a 
generation of students who can leave 
Yale with invaluable experiences on the 
cutting edge of urban health chal¬ 
lenges,” says Wanda Harris. 
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Study documents 
dumping of psychiatric 
patients 
Two-thirds of psychiatric hospitals pro¬ 
viding inpatient mental health care in 
the United States are reported to dump 
patients for economic reasons, according 
to a Yale/Harvard study published in the 
journal Health Services Research. 
Patient dumping is the practice by 
which hospitals transfer unprofitable 
patients, specifically those without in¬ 
surance coverage, to public hospitals 
and community mental health centers 
(CMHCs), which are required by law to 
care for these patients after private fi¬ 
nancial resources have been exhausted. 
This is the first national analysis of the 
factors that promote or constrain eco¬ 
nomically motivated transfers of patients 
in relation to competitive pressures, hos¬ 
pital ownership and managed care prac¬ 
tices. 
“This form of patient dumping ap¬ 
pears to be substantially exacerbated by 
increased competition among hospitals 
and reductions in the capacity of state- 
run psychiatric hospitals,” Mark J. 
Schlesinger, Ph.D., associate professor 
of public health at Yale, and colleagues 
from Harvard University’s Kennedy 
School of Government wrote in the 
journal’s December issue. 
In addition to tax exemptions, the 
primary way hospitals subsidize care for 
patients without coverage is through 
profits made by treating insured pa¬ 
tients. This practice has become increas¬ 
ingly difficult in recent years with the 
growth of managed care and other meth¬ 
ods implemented to reduce the cost of 
health care delivery, such as the use of 
the prospective payment system for 
Medicare and other insurers, utilization 
review by insurance companies, and re¬ 
duced public compensation pools. 
The researchers found that 25 percent 
of the survey respondents (directors of 
CMHCs) reported a great deal of 
dumping occurred in their service area, 
with slightly more than half of those pa¬ 
tients transferred on economic grounds. 
Twenty-two percent of the CMHCs re¬ 
ported substantial adverse effects on 
their agencies due to dumping. Seventy- 
five percent reported that transfers based 
on economic grounds were more likely 
to occur from for-profit hospitals. 
About face 
The brain’s prefrontal cortex may hold 
the key to our ability to recognize 
and remember one another. 
Patricia S. Goldman-Rakic, Ph.D., 
professor of neurobiology, and 
her colleagues have pinpointed an 
area of the brain that retrieves informa¬ 
tion about faces and facial expressions 
from memory. Their findings were 
reported in the Nov. 7 issue of the 
journal Science. 
The research team showed macaque 
monkeys pictures of human faces and 
objects, and measured the electrical 
impulses in different areas of the brain. 
Research results showed that neurons 
clustered in an area of the inferior pre¬ 
frontal cortex responded only to pic¬ 
tures of faces and to no other stimuli. 
The team further found that the pre¬ 
frontal cortex was able to maintain in¬ 
formation about the faces even after the 
stimuli were removed. 
Scientists know that the prefrontal 
cortex is the most advanced part of the 
human brain and is responsible for cog¬ 
nitive functions such as memory, rea¬ 
soning, mental computation and lan¬ 
guages, but it has been unclear how the 
prefrontal cortex processes information. 
“This study has revealed that infor¬ 
mation related to faces is processed in a 
specific region of the prefrontal cortex,” 
says Dr. Goldman-Rakic, the study’s 
principal investigator. “This shows not 
only that the prefrontal cortex is modu¬ 
lar and specialized by domain, but that 
each of its neurons has a dedicated 
function, since individual neurons code 
individual types of information—for 
example, different faces.” 
Past studies of brain function have 
focused mostly on sensory and motor 
areas, which have been found to be 
modular and specialized. Some scientists 
have theorized that the prefrontal cortex 
might function in a different way. 
Seamas P. O Scalaidhe, Ph.D., associate 
research scientist in neurobiology and 
the study’s first author, points out that 
in this respect, the organization of the 
prefrontal cortex resembles that of other 
brain areas. 
Researchers measured and compared neural 
activity as the subject looked at a rendering 
of a face, above left, and at a non-face image. 
“Our study indicates that the pre¬ 
frontal cortex is modular, like other 
brain areas that have been more closely 
examined,” says Dr. O Scalaidhe. “This 
research has brought us closer to under¬ 
standing how the higher centers of the 
human brain work.” 
Dr. Goldman-Rakic’s team included 
Dr. O Scalaidhe and Fraser A.W. 
Wilson, Ph.D., now an assistant profes¬ 
sor at the University of Arizona. The 
National Institute of Mental Health 
and the McDonnell Foundation funded 
the study. 
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Yale, Scirex Corp. open 
unit for psychiatric 
drug research 
The Department of Psychiatry and 
SciREX Corp. have announced a new 
collaboration to conduct clinical re¬ 
search on potential new drugs for psy¬ 
chiatric disorders. The Scirex Clinical 
Research Unit at Yale, which opened 
Nov. io in a 6,000 square-foot facility 
at 320 Congress Ave., will conduct 
studies of central nervous system- 
focused drugs. 
“New treatments for psychiatric disor¬ 
ders are desperately needed, and the 
complexity of drug approval require¬ 
ments is significant, says Michael 
Choukas, Scirex s president and chief 
executive officer. “By collaborating with 
full-time Yale faculty psychiatrists, we 
hope to speed clinical drug development 
This is only a test 
Patients have questions, Yale 
When faced with medical tests, 
patients and their families 
generally have questions ga¬ 
lore. Yale faculty have teamed up to pro¬ 
vide answers in a new book, The Yale 
University School of Medicine Patient’s 
Guide to Medical Tests, published in 
December by Houghton Mifflin Co. 
The book's 620 pages are packed 
with information on common and not- 
so-common diagnostic procedures. 
Each of its 29 chapters is written by a 
Yale School of Medicine full-time 
faculty physician who specializes in 
the field being covered. 
“The book helps patients through the 
diagnostic process; it lets them and their 
families know what the process is, what 
to expect, how to prepare,” says Barry L. 
Zaret, M.D., the book’s senior editor. 
“We want to demystify the process and 
help patients to be a greater part of 
that process.” 
The associate editors are Peter 1. 
Jatlow, M.D., HS ’65, professor and 
chairman of laboratory medicine, and 
Lee D. Katz, M.D., HS '86, associate 
professor of radiology and director of 
and potentially reduce the time it takes 
for new therapeutic discoveries to reach 
the market.” 
Scirex, a contract research organiza¬ 
tion headquartered in Blue Bell, Pa., 
performs drug development services 
for pharmaceutical and biotechnology 
companies. The company will work 
closely with Yale psychiatry faculty 
members to plan and conduct central 
nervous system clinical studies. Faculty 
expertise centers on basic neuroscience, 
molecular neurobiology and genetics, 
neuropsychopharmacology and clinical 
biological psychiatry. Current research 
projects concentrate on depression, 
anxiety disorders including post-trau¬ 
matic stress disorder, obsessive compul¬ 
sive disorders, schizophrenia and sub¬ 
stance abuse. 
“University medical schools have tra¬ 
ditionally been the proving ground tor 
physicians have answers. 
diagnostic imaging. Dr. Zaret, the 
Robert W. Berliner Professor of Medi¬ 
cine and chief of cardiovascular medi¬ 
cine, also was an editor of The Yale Uni¬ 
versity School of Medicine Heart Book, 
published five years ago. 
The book’s first section covers topics 
important to all readers. It discusses pa¬ 
tients’ rights and informed consent, ex¬ 
amines the role of screening, and pro¬ 
vides overviews of current diagnostic 
imaging techniques (like CT scans) and 
laboratory tests, from finger-stick blood 
tests to bone marrow biopsies. The sec¬ 
ond section deals with testing as it re¬ 
lates to specific organs, organ systems or 
diseases, or to groups of people, such as 
children or women. 
The authors explain how particular 
systems work, what happens when they 
don’t work right, what doctors look for, 
and how they go about looking. They 
include short case histories, describe 
common disorders, and list signs and 
symptoms that indicate problems. 
Tests are presented in a logical se¬ 
quence, from the simplest to the most 
complicated. Dr. Zaret notes. Newer 
some of the most revolutionary new ad¬ 
vances in medical science. Yet over the 
past decade, health care management 
and dwindling government dollars have 
eroded the financial base needed to sup¬ 
port this critical work,” says Benjamin 
S. Bunney, M.D., chairman of the De¬ 
partment of Psychiatry and the Charles 
B.G. Murphy Professor of Psychiatry 
and Pharmacology. 
“By working together, we gain not 
only the freedom to search for new dis¬ 
coveries, but also earlier access to novel 
therapeutic compounds which could 
lead to increased understanding of both 
normal and diseased brain function,' he 
said. “Ultimately, our patients will bene¬ 
fit because our combined efforts may 
result in decreasing the time it takes 
for new therapeutic discoveries to reach 
the market.” 
The Yale University 
School of Medicine 
Patient’s Guide 
to Medical Tests 
Detailed Descriptions 
of the Most Common 
DIAGNOSTlC PROCEDURES 
T The most valuable screening tests 
for every age and stage of life 
T What you should know before 
undergoing a test 
\ Advice from the doctors, nurses, and 
technicians who actually perform the tests 
T A guide to helpful home tests 
Barry L. Zaret, M.D., Senior Editor 
Peter I. Jatlow, M.D., & Lee D. Katz, M.D.. Associate Editors 
tests—often, more specific or less inva¬ 
sive than older ones—are regularly 
pointed out. Charts supply basic infor¬ 
mation, such as where the test is done, 
how long it takes, what equipment is 
used, what discomfort or pain may 
occur, what risks or complications 
may be involved, and the average cost 
(lower than $100, $100 to 500, or more 
than $500). 
“The book is very comprehensive,” 
says Dr. Zaret, “and it’s designed to be 
exquisitely reader-friendly.” 
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Breaking bread with Every other Thursday throughout 
the academic year, students, fac¬ 
ulty and staff file into the Beau¬ 
mont Room for an experience that is 
half culinary and half food for thought. 
During its lunch-hour meetings, Medi¬ 
cal School Council hosts sessions on ev¬ 
ery topic from curriculum development 
to cancer research to the latest in com¬ 
puter-based teaching. 
Last fall this elegant, wood-paneled 
room was the place to be for dean- 
watchers. In October and November, 
Dean David A. Kessler, M.D., and two 
newly appointed top administrators 
made presentations to overflow crowds. 
“If ever there was a case for new facili¬ 
ties, I think you’ve made it,” the dean 
joked as they squeezed into the first of 
the two sessions. “There’s not a lot of 
oxygen left, but come on in.” 
Dr. Kessler and Ruth J. Katz, J.D., 
M.P.H., the new associate dean for ad¬ 
ministration, spoke Oct. 16, followed 
Nov. 20 by Irwin M. Birnbaum, J.D., 
the school’s new chief operating officer. 
They introduced themselves, discussed 
some of the school’s most pressing is¬ 
sues, and answered questions about 
school finances, faculty appointments, 
teaching, clinical care and student life. 
“I am here, I believe, to serve the col¬ 
lective wisdom, and I want to be doing 
what you want me to be doing, focusing 
on the things you think I should be fo¬ 
cusing on,” Dr. Kessler told the group. 
“I’m good at getting things done, but 
what we get done needs to come from 
those who have the best ideas—whether 
it’s someone in the mailroom, a first- 
year student, or someone on the senior 
faculty. The best ideas deserve the 
most attention.” 
In order for Yale to remain at the 
forefront of American medicine, “there 
are some major infrastructure issues that 
we need to address,” he said, referring to 
the school’s operating deficits over the 
past two years. Yale has seen a decline in 
clinical income under managed care 
compounded by problems with the 
school’s computerized billing system. 
On the positive side, the federal office 
of the Inspector General gave the school 
a clean bill of health in November sub¬ 
sequent to an audit regarding its Medi- 
the new brass 
care billing practices, and 
NIH grant income rose 
nearly 8 percent this year 
with larger growth an¬ 
ticipated in future years. 
“This is a great institu¬ 
tion, and it has a long 
history,” Dr. Kessler said. 
“And we will do well, 
better than well. But we 
have to get certain things 
in order, so I am spend¬ 
ing a portion of my time 
on the fiscal side of the 
house, making sure this 
place is vibrant and can 
compete with the best, 
and have the resources to 
do that.” 
The medical school 
needs additional space, 
including a new anatomy 
lab and new research 
quarters, issues that will 
be addressed in a facilities 
plan now being formu¬ 
lated, he said. New build¬ 
ings are part of that plan, 
as well as renovations of 
existing space following 
the model of the physiol¬ 
ogy wing of Sterling Hall 
of Medicine that was 
completed in the fall. (See Page 8.) Other 
priorities for the medical school include 
aggressive searches for a number of de¬ 
partment chairs, recruitment of senior 
women to the faculty, new fund-raising 
initiatives, and improvements for students. 
“I take our responsibility to teach very 
seriously,” Dr. Kessler said, “I care less 
about what we teach as opposed to how 
we teach. There is a core of knowledge 
that keeps changing. You’re not going to 
learn everything. But I’d like everybody 
to be well trained. There is no reason to 
sit in any lecture, go to any course that 
isn’t excellent here.” 
Dr. Kessler and Ms. Katz, a former 
congressional counsel and an expert in 
health policy, have been meeting with 
students to discuss financial aid, hous¬ 
ing, security and other issues. Since ar¬ 
riving in July, Ms. Katz has coordinated 
the formation of new student affairs 
committees, served as the liaison be¬ 
tween the medical school and the 
VA Connecticut Healthcare Sys¬ 
tem in West Haven, and worked 
on several fund-raising projects. 
“On a daily basis, I work with 
the department chairs and fac¬ 
ulty members to help address the 
issues they face in getting their 
own jobs done,” she said. “In 
brief, I work to make the dean’s 
office the user-friendly place it 
can and should be.” 
Mr. Birnbaum, who Dr. 
Kessler introduced as “the best in 
the field of medical and hospital 
finance,” was the long-time chief 
financial officer of New York’s 
Montefiore Medical Center. 
He recalled meeting Dr. Kessler 
there in 1982, when Dr. Kessler 
was applying for the job of spe¬ 
cial assistant to the president. “In 
came a guy with red hair and a 
scraggly red beard, and I asked 
him, ‘Why do you want this 
job?’ He told me that in 10 or 15 
years, he wanted to be the head 
of a major medical center or 
dean of a medical school.” 
Along the way, Mr. Birnbaum 
said, Dr. Kessler was sidetracked. 
They prepared together for Dr. 
Kessler’s Senate confirmation 
testimony before he was sworn in 
as U.S. food and drug commis¬ 
sioner in 1990. After Dr. Kessler an¬ 
nounced in late 1996 that he would 
leave the Food and Drug Administra¬ 
tion, and accepted the deanship at Yale, 
he phoned Mr. Birnbaum in late March 
1997 to ask him to come to New Haven. 
“The No. 1 reason 1 wanted to do it was 
David Kessler,” Mr. Birnbaum said. “He 
just wants to make change, and make 
change in the right direction. I wanted 
to be a part of it.” 
Mr. Birnbaum said the financial 
challenges to the medical school are 
significant but manageable. Beyond the 
bottom-line concerns, he said, are fun¬ 
damental questions about how to edu¬ 
cate students and residents in the era 
of managed care, when patients are 
discharged earlier from the hospital. 
“The question is not whether Yale will 
survive. Yale will not only survive, it 
will thrive,” he said. “The changes will 
be in how we teach.” 
Irwin M. Birnbaum 
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University of California professor named dean of nursing school Catherine Lynch Gilliss, D.N.Sc., 
chair of the Department of Fam¬ 
ily Health Care Nursing at the 
University of California, San Francisco, 
has been named dean of the Yale School 
of Nursing for a five-year term begin¬ 
ning July i. She will succeed Judith B. 
Krauss, M.S.N., who joined the nursing 
school faculty 26 years ago and has 
served as dean for nearly 13 years. 
Dr. Gilliss, a certified adult nurse 
practitioner, has taught at the University 
of California since 1984, where she re¬ 
ceived her doctor of nursing science de¬ 
gree and completed a postdoctoral fel¬ 
lowship. She previously held teaching 
positions at several universities includ¬ 
ing The Catholic University of America 
in Washington, D.C., the University of 
Maryland and the University of Port¬ 
land, where she serves as a trustee. 
Grant from insurer funds 
two outcomes research 
projects 
Insurance giant Aetna Inc. has awarded 
more than $750,000 to the School of 
Medicine to fund research aimed at im¬ 
proving health outcomes. The grants are 
among $6 million awarded to 13 institu¬ 
tions through the company’s Quality 
Care Research Fund. 
The two grants are as follows: 
► $468,066 to the School of Medi¬ 
cine and Yale New Haven Health 
System in collaboration with Aetna sub¬ 
sidiary U.S. Quality Algorithms to com¬ 
pare managed care and tee-for-service 
insurance in the care and outcomes of 
elderly patients with heart attacks. This 
study will build on the Cooperative 
Cardiovascular Project (CCP), a na¬ 
tional Medicare quality improvement 
project, to compare tests, procedures, 
specialty care, readmissions and mortal¬ 
ity among those elderly heart attack 
patients treated under managed care 
and those treated under traditional fee- 
for-service. 
“Managed care is emerging as an im¬ 
portant system of administering medical 
Catherine L. Gilliss 
Her research has focused on innova¬ 
tive models of nursing intervention for 
patients and their families, especially 
care to the elderly individuals, and this 
grant will allow us to evaluate how well 
it serves elderly patients after heart at¬ 
tacks,” said Harlan M. Krumholz, 
M.D., who will lead the study. Dr. 
Krumholz is associate professor of medi¬ 
cine (cardiology) and director of the 
Center for Outcomes Research at Yale- 
New Haven Hospital. 
► $300,000 to the School of Medi¬ 
cine to study the effectiveness of Bright 
Beginnings. This volunteer-based 
mentoring program that encourages vul¬ 
nerable, young mothers to develop 
healthy lifestyles for themselves and 
their children and to make good use of 
illness prevention resources. The study 
will examine the effectiveness of this 
broad-based, parent support program by 
evaluating such measures as completion 
of well-baby check-ups, inappropriate 
use of the emergency department, the 
number of preventable injuries and each 
mother’s sense of parenting competency. 
“We believe that Bright Beginnings 
could serve as a model to help alleviate 
some of the substantial health problems 
faced by underserved, inner-city chil¬ 
dren and their families,” said John M. 
Leventhal, M.D., HS ’76, professor of 
during recovery from life-threatening 
illnesses such as coronary bypass surgery. 
Most recently, she completed an enu- 
merative study of the primary care work 
force in the state of California. 
During her tenure, Dean Krauss has 
made several key appointments to the 
faculty and overseen the expansion of 
the school’s research programs. A new 
doctoral program was added in 1994, 
and the school moved to newly reno¬ 
vated state-of-the-art teaching facilities 
in 1995. In addition, the school has 
strengthened and developed new clinical 
partnerships with several clinical agen¬ 
cies throughout Connecticut. A noted 
authority on the care of people with 
serious and persistent mental disorders, 
Dean Krauss will return to a teaching 
and mental health policy role on 
the faculty. 
pediatrics and medical director of the 
program, which has served 115 families 
in greater New Haven during the past 
three years. Added Elizabeth Demir, 
chair of the Bright Beginnings advisory 
committee: “This Aetna grant will allow 
us to expand the number of successful 
matches between mothers and mentors 
this promising program can sustain each 
year and, if study results substantiate 
our early findings, we should be able to 
attract continued funding.” 
The program was launched in 1995 
by the Friends of the Children’s Hospi¬ 
tal, a volunteer organization affiliated 
with the Department of Pediatrics. 
Psychiatric hospitals 
may be deluged 
with sex offenders 
When convicted sex offenders finish 
serving prison time, many of them will 
go directly from a jail cell to a psychiat¬ 
ric ward. A June 1997 U.S. Supreme 
Court ruling says that prisoners who fit 
the profile of “sexually violent preda- 
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tors” will immediately be committed to 
hospitals for psychiatric care. 
At an estimated annual cost of be¬ 
tween $60,000 to $130,000 per patient, 
this will drain a psychiatric system that 
is already strapped for funds, says 
Howard V. Zonana, M.D., professor of 
psychiatry at the medical school and 
clinical lecturer at Yale Law School. 
“Society certainly has a right to be 
protected from sexual violence,” says 
Dr. Zonana, who chairs the American 
Psychiatric Association’s Task Force on 
Sexually Dangerous Offenders. “But I 
am also concerned with the enormous 
cost and the impact on the quality of 
care this ruling will have on patients 
with severe incapacitating mental 
illnesses whose ability to survive in 
the community requires extensive 
resources.” 
According to Dr. Zonana, whose 
views were expressed in the Nov. 14 issue 
of the journal Science, treatment for sex 
offenders requires maximum-security fa¬ 
cilities that are not usually found in hos¬ 
pital settings. 
“If sex offenders are unable to control 
their behavior, they should be given 
longer prison terms and those who need 
psychiatric treatment should have it 
available before the end of their criminal 
sentences,” says Dr. Zonana. 
The U.$. Supreme Court ruling 
found that “sexually violent predators” 
can be hospitalized after and only after 
they have served their entire criminal 
sentence. Dr. Zonana maintains that 
these statutes provide a very low thresh¬ 
old for people to be determined men¬ 
tally ill. The court’s decision makes it 
possible for sex offenders to be hospital¬ 
ized based on remote past behavior and 
any mental abnormality or personality 
disorder that makes them likely to re¬ 
peat their behavior. 
According to Dr. Zonana, this issue 
raises tough questions such as what 
mental illnesses or conditions are suffi¬ 
cient to meet the sexually violent preda¬ 
tor requirement. 
“This law is so broadly drawn that 
rapists who display anti-social behavior 
or traits could be hospitalized,” says 
Dr. Zonana. “This is transforming 
criminal behavior into mental illness, 
further stigmatizing the mentally ill 
and serving a primary function of pre¬ 
ventive detention.” 
EPH, Hospice Institute 
work to improve 
access to care 
The John D. Thompson Hospice Insti¬ 
tute in Branford, Conn., and experts 
from Yale’s Department of Epidemiol¬ 
ogy and Public Health have launched a 
three-year educational program to im¬ 
prove access to palliative care for the 
terminally ill. 
“Our partnership with Yale will pro¬ 
vide a much-needed educational effort 
about hospice and palliative care,” says 
Rosemary Johnson-Hurzeler, R.N., 
M.P.H. ’75, the institute’s president and 
chief executive officer. “The care pro¬ 
vided, as well as the related educational 
and research programs, will focus on 
life, not death,” she adds. 
According to Elizabeth H. Bradley, 
Ph.D., assistant professor of public 
health at Yale, the project is offering a 
formal education program to physicians, 
nurses and other health care providers at 
acute-care hospitals in Connecticut. 
“We will measure the impact of the edu¬ 
cational program on medical profession¬ 
als’ knowledge and attitudes about hos¬ 
pice, as well as utilization of hospice 
services,” says Dr. Bradley, research di¬ 
rector for the hospice project. The edu¬ 
cational program was designed by the 
John D. Thompson Hospice Institute 
for Education, Training and Research 
Inc. (named for a late Yale EPH faculty 
member) and its affiliate, the Connecti¬ 
cut Hospice, the nation’s first hospice 
program. In future years, the two groups 
anticipate making this educational 
program available to all hospitals in 
Connecticut. 
Physician’s award will support 
As a patient’s life comes to an end, 
physicians and care providers are 
faced with the unique task of 
tending to the spiritual as well as medi¬ 
cal needs of their patients. Yale physi¬ 
cian Peter A. Selwyn, M.D., M.P.H., as¬ 
sociate director of Yale’s AIDS Program 
and associate professor of medicine, has 
dedicated a significant part of his career 
to improving end-of-life care for AIDS 
patients. In September, he was one of 12 
physicians chosen to receive the Faculty 
Scholars Award from the Open Society 
Institute’s Project on Death in America 
(PDIA), funded by the financier 
George Soros. 
Dr. Selwyn will receive up to $65,000 
for three years from PDIA, a nationwide 
program aimed at advancing medical 
education, awareness and clinical care in 
end-of-life care. Dr. Selwyn will use the 
award to help develop curricula at the 
School of Medicine on end-of-life care. 
He will also help develop a model clini¬ 
cal program at Leeway, a 30-bed skilled 
nursing facility for people with HIV 
and AIDS in New Haven, where he is 
medical director. 
“Despite recent advances in therapy, 
the AIDS epidemic is still affecting 
people in the prime of their lives with a 
life-threatening illness,” says Dr. 
end-of-life AIDS care 
Peter A. Selwyn 
Selwyn. “This grant will aid in the im¬ 
provement and development of new 
strategies for end-of-life care and to help 
increase awareness about this often over¬ 
looked area of medicine for doctors in 
training.” 
Dr. Selwyn has chronicled his experi¬ 
ences in a book of memoirs entitled Sur¬ 
viving the Fall: The Personal Journey of 
an AIDS Doctor, to be published by Yale 
University Press this spring. The book 
explores the early days of the AIDS epi¬ 
demic, when Dr. Selwyn worked at 
Montefiore Medical Center in New 
York City, and focuses on the ways in 
which working with dying patients led 
him to come to terms with his own per¬ 
sonal history of grief and loss. 
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“This is something I got very good at 
in Washington,” Dean David A. 
Kessler, M.D., above left, joked as he 
joined in the ribbon-cutting cer¬ 
emony celebrating the renovation of 
15,000 square feet in the Department 
of Cellular and Molecular Physiology. 
The $4.9 million project, the first of 
several that are anticipated to reno¬ 
vate existing space in the medical 
school’s main building originally 
constructed in 1924, was supported, 
in part, by a $1.5 million grant from 
the National Science Foundation. 
Architecturally, the renovation 
changed a series of small, often oddly 
shaped rooms into six larger flexible 
laboratory modules, two flexible 
core facilities (one for microscopy 
and another for graphics), and several 
smaller laboratory support spaces, 
including cold room, equipment 
rooms and biological and radioactive 
waste storage areas. With Dr. Kessler 
are, above from left: Virginia M. 
Chapman, department Chair 
Walter F. Boron, M.D., Ph.D., John 
Giovannone, former Dean Gerard 
N. Burrow, M.D., architect Barry 
Svigals, and John Bollier. Listening 
to the dedication were former Dean 
Robert W. Berliner, M.D., far left, 
and Emile L. Boulepaep, M.D., both 
members of the physiology faculty. 
Study explores 
connections between 
menopause and mood 
1 he number ol women experiencing 
menopause is expected to triple over the 
next decade, causing an increased de¬ 
mand for more effective treatment oi 
symptoms such as mood changes. To 
address this situation, Angela Cappiello, 
M.D., Ph.D., chief oi the Menopause 
Mood Disorders Clinic and co-director 
ol the Behavioral Gynecology Program 
at the School of Medicine, has launched 
a series ol studies on mood disorders in 
menopausal women that may offer relief 
for some symptoms ol menopause. 
“My goal is to understand the con¬ 
nection between the brain and the 
female hormone estrogen,” says Dr. 
Cappiello, whose study is funded by 
the Lilly Center for Women’s Health. 
“Female hormones may protect women 
front stress. Loss ol estrogen could cause 
women to be more vulnerable to stress- 
iul life changes that usually occur 
around the time of menopause, includ¬ 
ing changes in employment, marriage, 
and children leaving home.’’ 
Dr. Cappiello is studying how healthy 
menopausal women respond to a seroto¬ 
nin depletion induced by a low tryp¬ 
tophan diet. She expects that meno¬ 
pausal women treated with estrogen will 
have a more stable mood and will be less 
sensitive to the mood changes of a low 
tryptophan diet. In addition. Dr. 
Cappiello is also testing whether the 
most effective treatment for depressed 
menopausal women is estrogen alone, 
fluoxetine (Prozac) alone, or the combi¬ 
nation of both fluoxetine and estrogen. 
“If we can prove that estrogen regu¬ 
lates serotonin (unction, then that will 
be a big finding,” says Dr. Cappiello. 
An estimated 30 million women are 
expected to reach menopause in the 
next 10 years, and more than one-third 
of a woman’s life is post-menopausal, 
according to Dr. Cappiello. Previous re¬ 
search has shown that estrogen regulates 
brain activity and that loss of estrogen 
can affect mood and behavior. Approxi¬ 
mately 85 percent of women have some 
kind of reaction to estrogen loss, such as 
mood changes, depression, hot flashes 
and insomnia. Fifteen percent of 
menopausal women suffer from more 
severe symptoms. 
“We want women to know that treat¬ 
ment is available,” says Dr. Cappiello 
who will use her study to inform 
women that they do not have to suffer 
in silence. “Research on menopause is 
relatively new. It is getting more 
attention because more and more 
women are becoming menopausal and 
there is greater interest in women’s 
health issues.” 
The Menopause Mood Disorders 
Clinic is part of the Yale Behavioral Gy¬ 
necology Program operated jointly by 
the departments of Psychiatry and of 
Obstetrics and Gynecology at the 
School of Medicine. 
Contributors: Helaine Patterson, 
Karen Peart, Michael Fitzsousa, Judith 
Winslow, Cynthia Atwood, llene Shub 
Lefland, Susan Alksnis and Carolyn 
Battista. 
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New research finds link between religion 
and health in the elderly 
For the elderly, religion may do 
more than ease the soul. In fact, 
attendance at religious services 
may actually improve physical health 
and psychological well-being. That ac¬ 
cording to two new reports, co-authored 
by Stanislav V. Kasl, Ph.D., professor of 
epidemiology in the Department of Epi¬ 
demiology and Public Health, and Ellen 
Idler, Ph.D., associate professor of soci¬ 
ology at Rutgers’ Institute for Health, 
Health Care Policy and Aging Research. 
The reports reveal the findings of a 
12-year study conducted by 
Yale public health faculty and 
funded by the National Insti¬ 
tute on Aging (NLA). The 
study sampled 2,812 people 
age 65 and over from Protes¬ 
tant, Catholic, Jewish and 
other religious backgrounds in 
New Haven. Subjects were in¬ 
terviewed annually from 1982 
to 1989 and again in 1994. 
The two reports were pub¬ 
lished in the Nov. 15 issue of 
the Journal of Gerontology. The 
first report, Religion Among 
Disabled and Nondisabled Per¬ 
sons I: Cross-sectional Patterns in Health 
Practices, Social Activities and Well-being, 
explores the impact of participating 
in religious services on risky health 
behaviors, friendships and family ties, 
and depression. 
The three major findings for elderly 
people who participated in religious 
services are: 
► Lower frequency of unhealthy be¬ 
haviors: Subjects are healthier because 
they are more likely to engage in good 
health habits, such as exercise, and are 
less likely to have participated in risky 
behaviors, such as excessive smoking 
and heavy drinking, due in part to 
social and behavioral guidelines set 
forth and reinforced by the religious 
organizations. 
► Stronger support systems and so¬ 
cial ties: Subjects reported more friend¬ 
ships, closer relationships with more 
family members, and participation in 
more leisure activities, such as visits to 
museums and sporting events. In addi¬ 
tion, they were more likely to have cel¬ 
ebrated the winter holidays with more 
than one group of people. 
► Improved emotional well-being: 
Subjects reported increased feelings of 
optimism and happiness and fewer 
symptoms of depression. The impact 
was the greatest for people experiencing 
functional disability due to chronic ill¬ 
ness. Functional disability is defined as 
difficulty handling such daily activities 
as climbing stairs, using the toilet or 
carrying groceries. 
The report is important because it 
measured many other kinds of resources 
in elderly people’s lives, and found that 
attendance at religious services was con¬ 
sistently associated with most of these 
resources. “Attendance acted as a linch¬ 
pin because it was associated with better 
overall health practices, more friends 
and relatives, more social activities 
and higher levels of well-being,” notes 
Dr. Idler. 
The second report, Religion Among 
Disabled and Nondisabled Persons II: 
Attendance at Religious Services as a 
Predictor of the Course of Disability, ex¬ 
plores how religious involvement can in¬ 
fluence changes in physical health over a 
12-year period. These findings show that 
attendance at religious services was a 
good predictor of functional ability in 
later life by comparing a person’s func¬ 
tional ability in 1982 to the changes that 
occurred during each follow-up year. 
“Over the long-term, people who had 
better health levels in 1982 and contin¬ 
ued attending religious services were 
able to maintain higher levels of func¬ 
tioning and psychological health 
through 1988,” says Dr. Idler, who re¬ 
ceived a Ph.D. degree in 1985 from Yale. 
“Even after we took out the other 
variables such as friendship, leisure ac¬ 
tivities and social support, there was still 
evidence that attendance at religious ser¬ 
vices had a positive impact on health, 
particularly for those who experienced 
some level of disability at the beginning 
of the survey,” she adds. Some of the 
subgroups studied, such as 
people who already had some 
disability, continued to experi¬ 
ence the positive effects 
through 1994, but the overall 
numbers were lower due to a 
decline in the subject pool. 
“There were so many reasons 
for thinking that we should ex¬ 
pect better health among 
people who are religiously in¬ 
volved, but until now it wasn’t 
anything we were able to 
quantify,” says Dr. Idler. 
“We also found that it wasn’t a 
person’s individual feelings of 
religiousness that made the difference, it 
was acting as part of the larger worship 
group that fostered positive health.” 
“This study is important because it 
has a large representative sample of 
community-living elderly, a longitudinal 
follow-up to study changes over time 
and rigorous statistical adjustments for 
the influence of many other variables so 
that the unique effect of religiousness 
can be better identified,” adds Yale’s 
Dr. Kasl. 
The study was commissioned as part 
of the NIA-Established Populations for 
the Epidemiologic Study of the Elderly, 
which included separate studies con¬ 
ducted by Harvard University, Duke 
University and the University of Iowa. 
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When house calls 
were horse calls 
Saddlebags 
tell the story 
of a physician’s 
day in the early 
19th century. 
Above: A portrait of Dr. Bissell, and his signature, taken from his copy of a 
medical journal. Below: Medicines of the time would have included emetics 
and cathartics, which Dr. Bissell kept in small glass bottles or wrapped in paper, 
tied with string and labeled in his own hand. 
By John Curtis 
Photographs by Terry Dagradi 
Biomedical Communications In a box in an office at the Medical Historical Library 
sit a pair of leather saddlebags, stiff with age, frayed 
from use and still holding some of the nostrums and 
powders that made up a physician’s pharmacopoeia in 
the first half of the 19th century. 
Small glass bottles and yellowed paper packets con¬ 
tain such remedies as ergot to strengthen uterine con¬ 
tractions during childbirth and Peruvian bark to treat 
fevers. They belonged to Asaph Leavitt Bissell, M.D., 
one of Yale’s earliest medical graduates. Dr. Bissell, a 
member of the school’s second class, practiced in 
Suffield, Conn., a tobacco-farming community where 
his parents had once lived and where his family still 
plays a prominent role. Charles Bissell Jr., the physician’s 
great-great-grandson and a member of the Yale College 
Class of 1945W, surmises that the saddlebags were always 
near the door ready for use. “He would hop on his 
horse,” says Mr. Bissell, a present-day resident of 
Suffield, “and go out to take care of someone." 
After Asaph Bissell’s death in 1850, the saddlebags 
were handed down from father to son until 1996, when 
Mr. Bissell donated them to the medical school. “I 
thought it was the appropriate place to have them.” 
Asaph Bissell was born in 1791 in Hanover, N.H., 
and began medical studies at Dartmouth in 1811. Two 
years later he went to New Haven with Dr. Nathan 
Smith, who had been lured away from Dartmouth to 
become the founding dean of the medical faculty at Yale. 
Dr. Bissell graduated in 1815. 
According to John Harley Warner, Ph.D., professor 
of the history of medicine, a medical kit of the time 
“would have included emetics and cathartics, and 
purgatives like calomel. It would probably have included 
some opiates. I would be very surprised if he wouldn’t 
have had a lancet for letting blood [although no instru¬ 
ments remain in the bags today]. Anything having to do 
with surgery would have been very superficial.” 
According to Historical Librarian Toby Appel, 
Ph.D., the bags will join surgical instruments and other 
artifacts of medical history on display there. YM 
John Curtis is a staff writer. 
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Navigating the spinal 
Myelinated healthy axons, above, and demyelinated 
axons, right, as they appear after injury to the spinal 
cord. Determining how to restore this protective coat¬ 
ing to injured nerve cells is central to Yale’s spinal 
cord research effort. 
12 
Once injured, the spinal cord cannot heal—at least that’s what medicine 
has long believed. Now Yale scientists are mapping this terra incognita 
and providing real hope to people with paralysis. 
cord 
By Rachel Engers 
riginating in the brain, 
stretching down the back and 
extending its reach through the 
peripheral nerves to every part of the 
body from the toes to the fingertips, 
the spinal cord is the body’s informa¬ 
tion highway. Despite its importance, 
it is smaller than one might expect: 
just 18 inches long and about half an 
inch wide. It’s also quite vulnerable. 
All it takes is a motor vehicle acci¬ 
dent or a miscalculated dive into a 
swimming pool for the spinal cord to 
be compressed or twisted. In an in¬ 
stant, sensation and movement may 
cease altogether. 
Each year in the United States, 
spinal cord injury deprives close to 
14,000 people of the ability to walk, 
to use their arms and hands, or in 
some cases, to breathe unaided. Of 
the approximately 250,000 Ameri¬ 
cans who are paralyzed, a dispropor¬ 
tionate number have been injured in 
the prime of their lives. Many, like 
actor Christopher Reeve, who was 
paralyzed from the neck down after 
falling from a horse in 1995, are trau¬ 
matized at the peak of an active and 
vigorous life. 
Although physicians have be¬ 
lieved for thousands of years that an 
injured spinal cord could not be repaired, new scientific 
evidence indicates that this might not be true. “For 
about the past 10 years,” says Stephen G. Waxman, 
M.D., Ph.D., professor and chair of the Department of 
Neurology, “we have had the sense that restoration of 
function after spinal cord injury is not an unrealistic 
goal.” Applying new understanding of how nerve cells 
Rachel Engers is a writer in Simsbury, Conn. 
Neurology chair and center Director Stephen Waxman: “The goal of repairing the injured 
spinal cord, at least in some patients, is a realistic one.” 
die and how they might he re¬ 
vived, Yale scientists have made 
important steps toward the goal of 
someday reversing paralysis. 
Much of this work has been 
done in partnership with the Para¬ 
lyzed Veterans of America and its 
largest chapter, the Eastern Para¬ 
lyzed Veterans Association. In co¬ 
operation with the federal Depart¬ 
ment of Veterans Affairs, these two 
groups helped establish the PVA/ 
EPVA Center for Neuroscience 
and Regeneration Research at Yale, 
which opened in 1988 at the VA 
medical facility in West Haven. 
In the decade that has followed, 
PVA/EPVA Center scientists have 
gained ground in several areas. 
They demonstrated that damage 
to the protective coating of nerve 
cells plays a key role in producing 
paralysis after spinal cord injury, 
and have focused their efforts on finding ways to restore 
nerve function where this myelin layer has been stripped 
away. They also uncovered the molecular mechanism by 
which remissions occur in patients with multiple sclero¬ 
sis, a disease that also attacks the protective coating of 
nerve cells. And they have developed the basis for new 
treatments for pain and muscle spasticity specific to spi¬ 
nal cord injury. The major goal of the program is to re¬ 
store total function in individuals who have sustained 
spinal cord injuries. Along the way, this research pro¬ 
gram is aimed at finding ways to improve quality of life 
for patients while the search for a cure progresses. 
A DECADE OF ADVANCES 
These milestones and others were celebrated during a 
two-day program in late September marking 10 years of 
collaboration among Yale, the VA, and the PVA and 
EPVA. Speaking to more than 100 members of the veter¬ 
ans groups who came to New Haven for the event, Dr. 
Waxman said their support has provided not only fund¬ 
ing but, through interaction between patients and scien¬ 
tists, motivation to work hard for a breakthrough. “We 
don’t yet have a cure in hand,” he told the group, “but 
we’ve made enough progress that I know we will come 
up with more effective treatments. A cure is now a 
realistic goal.” 
Because scientists thought that nerves in the central 
nervous system (unlike those in the peripheral nervous 
system) were incapable of regrowing after injury, they 
believed the only way to restore function would be to re¬ 
build an entire spinal cord, surely a formidable task. 
Recent discoveries at Yale and around the world have 
changed that picture significantly. In 1988, Dr. Waxman 
put together two crucial pieces of information that, 
while previously known, had never been connected. One 
was the observation that among paralyzed patients, some 
nerve cells were found to survive at the site of injury— 
even in patients who had no function below the injury. 
The second was the knowledge that myelin was part of 
the puzzle in paralysis. 
Myelin is a fatty sheath that insulates nerve cells and 
speeds the conduction of impulses along the spinal cord. 
When a spinal cord is damaged, some axons are severed. 
Others survive, but their myelin is stripped away. Dr. 
Waxman set out to find why the surviving axons were 
unable to function, and, in doing so, made the connec¬ 
tion to the critical role of myelin in spinal cord injury. 
His research showed that nerve fibers within the spinal 
cord work somewhat like electrical cords—when their 
protective coating is removed, conduction is impaired. 
He discovered that it is this demyelination that prevents 
the surviving axons from properly carrying information. 
“In addition to the strategy of regrowing axons, this dis¬ 
covery opened up the possibility of repairing existing 
ones,” says Dr. Waxman, the Helen Wilshire Walsh 
Director of the PVA/EPVA Center. “Damage to the my¬ 
elin had been talked about even in 1906, but had been 
buried in the literature.” This finding focused attention 
on the goal of restoring nerve impulse conduction in de- 
myelinated axons, an approach to promoting functional 
recovery in spinal cord injury. 
Is the theory correct? To find out, scientists at Yale 
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are experimenting with ways to mend the damaged my¬ 
elin sheath in an injured spinal cord. Jeffery D. Kocsis, 
Ph.D., associate director of the PVA/EPVA Center and a 
professor of neurology and neurobiology, has 
carried out studies using the transplantation of 
glial cells to stimulate the renewed production 
of myelin and restore the conduction of electri¬ 
cal impulses through the nerve cells. Glia, 
whose name is derived from the Greek word 
for glue, are cells that fill in the spaces in the 
nervous system not occupied by nerve cells. 
Outnumbering nerve cells io to one, glia pro¬ 
vide support for nerve cells, with complex 
functions ranging from producing myelin to 
regulating the metabolism. 
Dr. Kocsis began work on the transplanta¬ 
tion of cells four years ago. His interest was 
sparked by other research done in the 1980s in 
France and England showing that when glial 
cells were injected into the spinal cords of my¬ 
elin-deficient rats, the cells produced anatomi¬ 
cally correct myelin. “When I learned of the re¬ 
search, I wondered if the myelin would work 
properly,” says Dr. Kocsis. To find out, he bred 
his own colony of myelin-deficient rats at the 
PVA/EPVA Center and injected two types of 
cultured glial cells—oligodendrocytes and as¬ 
trocytes—into their spinal cords. He found 
that injecting glial cells not only produced myelin but 
restored impulse conduction. 
Now, Dr. Kocsis is looking for ways to make this 
discovery useful to humans with spinal cord injuries. 
His research was spurred on by an important finding 
made by William F. Blakemore, D.V.M., a fellow col¬ 
laborator in The Myelin Project. (This Washington- 
based organization was founded by Augusto and 
Michaela Odone of Fairfax, Va., after their son con¬ 
tracted adrenoleuko-dystrophy, a myelin-attacking dis¬ 
ease. The 1992 film Lorenzo’s Oil was based on their 
story.) Dr. Blakemore, of the University of Cambridge, 
found a way to demyelinate the spinal cord of a rat and 
this paved the way for Dr. Kocsis and others to experi¬ 
ment with the insertion of cells from the central and 
peripheral nervous systems, as well as genetically engi¬ 
neered cells. In these experiments, Dr. Kocsis found that 
extensive remyelination occurred when Schwann cells 
(from the peripheral nervous system) were mixed with 
astrocytes (from the brain). 
The newest and most exciting aspect of this research 
is focused on the olfactory ensheathing cell, a peripheral 
glial cell located in the nose. “These cells are unique,” 
Dr. Kocsis says. “Under different conditions, they can 
differentiate either into Schwann cells or astrocytes. We 
have found that they make myelin and migrate tremen- 
Joel Black is associate director of the PVA/EPVA Center. 
Jenny Fjell, below, is a predoctoral fellow who came to Yale 
from Karolinska Institute in Sweden, another of the world’s 
leading centers for spinal cord injury research. 
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Jeffery Kocsis found that injecting glial cells into the spinal cords 
of rats not only produced new myelin but also restored impulse 
conduction. 
dously.” This is encouraging because it may mean that 
only one type of cell is needed to restore myelin (elimi¬ 
nating the cumbersome process of mixing Schwann cells 
and astrocytes, as well as the need tor the removal of as¬ 
trocytes trom the brain via a biopsy). Dr. Kocsis is also 
collaborating with Alexion Pharmaceuticals in New 
Haven to develop transgenic pig cells for transplantation 
into human spinal cords. 
CLUES ABOUT MS 
Multiple sclerosis, a disease that affects more than 
300,000 people in this country and an estimated 2.5 mil¬ 
lion worldwide, also results from neurological damage. 
As with spinal cord injury, the myelin surrounding the 
axons is destroyed, preventing them from transmitting 
signals to the brain. But unlike most neurological dis¬ 
eases, in which injury to the brain or spinal cord is gen¬ 
erally irreversible, multiple sclerosis (MS) often includes 
remissions in which patients regain lost vision or move¬ 
ment spontaneously. Scientists have long been mystified 
as to the causes of these remissions. 
A team of researchers, assembled by Dr. Waxman at 
the PVA/EPVA Center, has dissected nerve fibers mol¬ 
ecule by molecule to identify the molecular basis for MS 
remission. They found that injured nerve fibers can heal 
themselves by inserting new sodium channels into the 
cell membranes. These sodium channels act like molecu¬ 
lar batteries, powering the flow of impulses through the 
nerve fibers despite the absence of myelin at the site of 
injury. “We are trying to determine where the sodium 
channels are produced and how they are redistributed af- 
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ter injury,” says Joel A. Black, Ph.D., associate director 
of the PVA/EPVA Center. The next step is to find a way 
to induce the insertion of these critical sodium channels 
into demyelinated nerve fibers. “My job,” says Dr. 
Black, “is to tell the physiologists what I find so that 
they can design a drug.” Success in this area may be 
applicable to those with paralyzing spinal cord injuries 
as well. “It’s just a matter of time before we make signifi¬ 
cant advances that improve the lives of people with 
spinal cord injuries,” says Dr. Black. 
Another strategy has emerged from the work of Drs. 
Kocsis, Waxman and colleagues. They have furthered the 
development of a drug called 4-aminopyridine (4-AP), 
which improves impulse conduction in damaged nerve 
fibers. The drug, now in Phase III clinical trials for mul¬ 
tiple sclerosis, works to reverse symptoms such as weak¬ 
ness and visual loss in MS patients. Early clinical trials 
have started to test 4-AP’s benefits for patients with spi¬ 
nal cord injury. These initial studies suggest that treat¬ 
ment with 4-AP may reduce pain and spasticity. “The 
patients who have responded to 4-AP know it is not go¬ 
ing to cure them, but it appears to improve the quality 
of their lives,” says Dr. Kocsis. These inquiries into pain 
and spasticity were prompted by discussions with mem¬ 
bers of the PVA, who had approached Dr. Waxman’s 
team several years ago in search of answers. 
Although it is not a cure and despite side effects that 
may include trembling and seizures, 4-AP has been met 
with enthusiasm. “We feel that science is on the verge of 
a breakthrough, especially with 4-AP, which has really 
meant a lot to those of us with spinal cord injuries,” says 
Kenneth Huber, president of the PVA, which funded 
early studies on 4-AP. “The return that some people have 
experienced has given us a great deal of hope.” 
Scientists at the PVA/EPVA Center and in Yale’s 
Department of Pharmacology played an important role 
in the development of 4-AP by identifying the molecules 
that prevent nerve impulses from traveling through the 
spinal cord in the aftermath of an injury. In axons, nerve 
activity is modulated by specialized molecules called 
potassium channels, which were discovered in the 1950s 
by Nobel prize winners Alan Hodgkin and Sir Andrew 
Huxley. Hodgkin and Huxley did their research on 
squids, which have very large nerve fibers. Three decades 
later, Yale researchers showed that, in mammals, the 
potassium channels are located beneath the myelin, 
which covers and masks them. 
Working in separate laboratories at Yale but commu¬ 
nicating closely, the PVA/EPVA Center’s team and J. 
Murdoch Ritchie, Ph.D., the Eugene Higgins Professor 
of Pharmacology, showed that when axons lose their my¬ 
elin, these potassium channel molecules are exposed and 
halt nerve conduction, acting as “locked brakes.” This 
CONTINUED ON PAGE 19 
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Solutions to pain 
Unlike a broken arm or leg, a dam¬ 
aged spinal cord does not stop hurt¬ 
ing once the body heals. An esti¬ 
mated 60 percent of those with 
spinal cord injuries suffer from 
chronic pain for which there is cur¬ 
rently no treatment. At the PVA/EPVA 
Center, Marco A. Rizzo, M.D., Ph.D., 
assistant professor of neurology, and 
Sulayman Dib-Hajj, Ph.D., an associ¬ 
ate research scientist, are part of a 
team that is developing the basis for 
drugs that will end post-spinal cord 
injury pain, again exploiting the prop¬ 
erties of sodium channels. 
After injury, the genes that pro¬ 
duce some types of sodium chan¬ 
nels are turned on, producing too 
many of these channels. The genes 
for other sodium channels are 
turned off, and these channels 
disappear. The work of Dr. Rizzo 
and Dr. Dib-Hajj suggests that this 
change is a root cause of pain. 
Unlike potassium channels, which 
Marco Rizzo Sulayman Dib-Hajj 
block the transmission of impulses 
after injury, sodium channels pro¬ 
duce an abnormal “repetitive firing” 
of impulses. The challenge now is to 
identify the varying types of sodium 
channels and determine how to in¬ 
hibit those that trigger pain. Two 
dozen sodium channels have been 
identified in organisms from jellyfish 
to humans, and scientists believe 
there may be many more. Using com¬ 
puterized sequence analysis, Dr. Dib- 
Hajj has studied their development 
over the course of evolution, charting 
the differences that are evident be¬ 
tween species. “We can learn a lot 
by comparing the sequences,” he ex¬ 
plains. “The idea is that if function is 
conserved over evolutionary time, we 
may be able to identify a similarly 
conserved amino acid sequence and 
determine experimentally if it under¬ 
lies that function of the protein. 
Which amino acid residues cause 
the sodium channel to open and 
close or to be fast or slow? These 
are important issues for rational 
drug design that targets specific 
channels." 
In addition to pain, most patients 
with spinal cord injuries and MS ex¬ 
perience debilitating muscle spasms 
caused by damage to axons in the 
spinal cord. Scientists at Yale are 
examining the physiological basis 
for spasticity and are developing 
the basis for new drugs to alter the 
opening of sodium channels or 
modulate the level of GABA, a neu¬ 
rotransmitter produced by the body 
that prevents hyperactive uninhibited 
nerve activity. 
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Background: Astrocytes, the star-shaped gtial celts that outnumber 
nerve cells in the spinal cord 10 to 1, traditionally have been thought 
responsible for scarring. Yale scientists have produced new evidence 
that these cells play a role in restoring nerve conduction. 
Laboratory meets 
real life A broken spinal cord cannot be 
healed. Case closed. That was 
the message James Peters re¬ 
ceived from physicians when his spi¬ 
nal cord was injured during an explo¬ 
sion at an army base in 1967. Until 
recently, he and other paralyzed vet¬ 
erans had no reason to believe they 
would ever walk again. 
“Now, there is a renewed sense of 
hope,” said Mr. Peters, executive di¬ 
rector of the Eastern Paralyzed Veter¬ 
ans Association, who recently visited 
the laboratories at the PVA/EPVA 
Center for Neuroscience and Regen¬ 
eration Research at Yale. “The tunnel 
now has a light.” 
Located on the West Haven cam¬ 
pus of the VA Connecticut Healthcare 
System, the PVA/EPVA Center was 
founded as a collaborative effort 
among the University, the Paralyzed 
Veterans of America, the Eastern 
Paralyzed Veterans Association, and 
the Department of Veterans Affairs in 
1987. It opened the following year. 
During two days of lectures, tours 
and gatherings at Yale and the VA 
campus in late September, the 
founding partners celebrated a de¬ 
cade of advances in neuroscience 
research. As part of the celebration, 
Stephen G. Waxman, M.D., Ph.D., 
gave the first annual Helen Wilshire 
Walsh lecture, From Molecules to 
Man: Approaching a New Neurology 
of the Spinal Cord, summarizing the 
discoveries at the PVA/EPVA Center 
that are bringing a cure for spinal 
cord injuries closer. 
Hearing Dr. Waxman explain how 
lengthy and complicated the process 
of discovery can be actually was en¬ 
couraging to Chris A. Timpanelli, an 
attorney in Stratford, Conn., who was 
diagnosed with multiple sclerosis 10 
years ago. “Some people would be 
disheartened by this,” he says, “but I 
look at it another way. We are lucky 
to have people this dedicated. Know¬ 
ing this has been more therapeutic 
than any drug.” 
Currently, about 30 scientists 
work at the PVA/EPVA Center. More 
than 50 scientists have trained 
there, many continuing their own spi¬ 
nal cord research in laboratories 
around the world. “The work of this 
lab is very relevant to the clinic and 
the concerns of patients. That’s what 
attracted me as a student,” Mark 
Baccei, who was explaining his stud¬ 
ies on calcium channels, told the visi¬ 
tors. He is a third-year graduate stu¬ 
dent in the interdisciplinary neuro¬ 
science program at Yale. Martin 
Young, treasurer of the EPVA, was 
one of those listening. “I know of no 
place in the world,” he said, “where 
they are doing this as intensively as 
at Yale." 
The partnership between scien¬ 
tists and non-scientists has been 
beneficial to both groups. “When 
we’re working at the bench, designing 
an experiment or building a model, 
we are thinking in very abstract ways. 
But when we are interacting with 
people, it gives us a better perspec¬ 
tive,” said associate research scien¬ 
tist Sulayman Dib-Hajj, Ph.D. “It’s not 
just science for the sake of science, 
but science that may eventually 
lead to improvements in the lives 
of people with these injuries. This is 
a very powerful motivation.” 
Last fall’s celebration of the PVA/EPVA Cen¬ 
ter was a chance for scientists to discuss 
their work with members of the two veterans 
organizations, and to listen to their views and 
ideas. Sulayman Dib-Hajj, left, and Karen 
Lankford, below, were among those explaining 
recent research findings. Below left: Joseph 
Segarra, right, president of the EPVA, talks 
with Stephen Waxman, left, Peter Addesso 
and IVlary Segarra during a tour of the lab. 
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discovery provided a target—if the potassium chan¬ 
nels could be turned off, the brakes would no 
longer be locked. The drug 4-AP turns off these un¬ 
masked potassium channels, thereby improving 
transmission of impulses and restoring some lost 
functions. 
STOPPING CELL DEATH 
One of the latest and most innovative investiga¬ 
tions at the PVA/EPVA Center involves the preven¬ 
tion of nerve cell damage before it occurs. When 
the spinal cord is traumatized, nerve cells die, but 
not all at once. 
Research at the PVA/EPVA Center has indi¬ 
cated that cell death is caused by a process akin to 
sabotage. The initial blow to the spinal cord kills 
some cells instantaneously and then sets off some 
secondary processes which cause the body to attack 
itself. An abnormal influx of calcium, a byproduct 
of the first round of cell death, gnaws away at 
nearby nerve cells. Death occurs in waves, taking 
hours or even days to complete. The timing of cell 
destruction, however, leaves a window of opportu¬ 
nity in which damage might be limited. Yale scien¬ 
tists have targeted the specific molecules that release 
calcium to the axons and are working to develop 
the foundation for drugs which will inhibit these 
molecules and stem the tide of calcium at the time 
of injury. If this research is successful, scientists may 
be able to prevent a spinal cord injury from result¬ 
ing in paraplegia or quadriplegia by intervening in 
the process of cell death and “rescuing” nerve cells. 
In the last decade, advances at the PVA/EPVA 
Center at Yale and other research institutions 
around the world have been made on such a broad 
front that the field of neurology is undergoing a 
dramatic change. “Traditionally, neurology has been 
an intellectually beautiful discipline, but we did not 
have therapies,” says Dr. Waxman. “A neurologist 
would go through a meticulous mental exercise and 
arrive at a diagnosis. But, we would have nothing 
to offer the patient, and that has to change.” 
Dr. Waxman believes that neuroscientists will 
very soon be able to help patients in ways that were 
once thought impossible. He is optimistic that 
within the next decade researchers at Yale or else¬ 
where will find a vaccine for MS and a cure for spi¬ 
nal cord injuries. “We’re approaching a new—and 
much more hopeful neurology of the spinal cord,” 
Dr. Waxman says. “The goal of repairing the in¬ 
jured spinal cord, at least in some patients, is a 
realistic one and we’re moving as fast as we can in 
this direction.” YM 
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A celebration of progress A 
Michael Delaney, past president of the PVA, 
talks to a fellow visitor to Yale during the 
celebration last fall of the 10th anniversary 
of the PVA/EPVA Center. 
Yale President Richard C. Levin, left, with ► 
PVA President Kenneth Huber, right, and 
Executive Director Gordon Mansfield. 
Stephen Waxman, left, and Langdon Clarke 
at the announcement of the Helen Wilshire 
Walsh Directorship at the PVA/EPVA Center 
for Neuroscience and Regeneration Re¬ 
search. Dr. Waxman gave the first annual 
lecture in Mrs. Walsh’s honor as part of the 
program celebrating the 10-year partnership 
that built and continues to support the ► 
center. The endowment was established 
through a bequest from the estate of Mrs. 
Walsh, an advocate of research in spinal 
cord injury who supported the work of the 
PVA, the EPVA and Yale for many years. 
Mr. Clarke, grandson of the late Mrs. Walsh, 
was instrumental in creating the endow¬ 
ment and directing the use of the funds 
for research in neurology at Yale. 
Last year Yale University honored the execu¬ 
tive director of EPVA by naming the James 
J. Peters Conference Room at Yale in the 
PVA/EPVA Center for Neuroscience and 
Regeneration Research. The plaque that 
commemorates the occasion reads: “Jim 
Peters is a repository of knowledge and a 
source of inspiration. He is central to the ► 
battle against spinal cord dysfunction.” 
Center Director Stephen Waxman hosted a 
dinner at the Yale Club of New York in June. 
From left, Gerard Kelly, deputy executive 
director; Vivian Beyda, Dr.P.H., director of 
research and education; Joseph Segarra, 
president; Dr. Waxman, and Mr. Peters. 
Stephen Waxman, backed by the founders 
of the PVA/EPVA Center. From left: Gerard 
Kelly, John Bollinger, Joseph Segarra, Paul 
Hoffman, Kenneth Huber, Gordon Mansfield 
and James Peters. 
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Music 
and 
me 
Musical aptitude and a gift for 
healing coincide more often than one 
might imagine. 
By Karen Schmidt 
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What was the first human music? A whistled 
imitation of a bird call? A rhythmic pound¬ 
ing that mimicked a heartbeat or hoof beat? 
A croon to soothe a crying baby or comfort a sick friend? 
Music was probably born of the natural rhythms of 
life. So it shouldn’t come as a surprise when people who 
dedicate themselves to life science release their creative 
energy in music. 
Both music and medicine are strict disciplines, even 
though one is considered an art and one a science. Both 
demand practitioners who learn complex skills, practice 
them exhaustively, then impose a set of rules on what’s 
naturally messy—a disease, an injury, a series of unre¬ 
lated sounds. And both require enormous dedication, 
so much that it would seem impossible for one person 
to do both. 
But some scientists manage. They realize medicine 
and music aren’t mutually exclusive. Not only can the 
two disciplines coexist; given the right conditions, they 
can coalesce. 
ROCKING RESEARCHERS 
Consider the lyrics of the original love song/lab song 
She’s a Knockoutby Ira Mellman, Ph.D., bass player for 
Yale’s biorocking band, the Cellmates. “She knows how 
to get into your genes/And what recombination means. 
She’s got the magic touch/And I need her oh so much. 
She’s a knockout.” 
Only a medical scientist is likely to catch the refer¬ 
ence to an experimental mouse known as a “knockout,” 
but an average listener would still hear a love song. 
“It’s kind of an interesting niche,” says Dr. Mellman, 
professor of cell biology and director of the Program in 
Biological and Biomedical Sciences. “You write about 
what you know.” 
Dr. Mellman’s musical colleague Richard A. Flavell, 
Ph.D., chief of the Section of Immunobiology and a 
Howard Hughes Medical Institute investigator, writes 
songs that are more unabashedly scientific. Dr. Flavell 
has penned the ROl Blues, tracking the trials of an in¬ 
vestigator trying to win a National Institutes of Health 
grant, Molecular Millionaire, about a postdoc who 
wants to earn big money doing biotechnology research, 
and DNA, to the tune of the Sex Pistols’ punk-rock 
anthem EMI. 
Though the Cellmates call their niche biorock, the 
six-member group doesn’t limit itself to its own biologi- 
Karen Schmidt is a writer in New Haven and a first-year 
graduate student in Epidemiology and Public Health. 
cally inspired music. Thanks to a mix of musical cultures 
and generations, they play everything from Jerry Lee 
Lewis to The Pretenders to Phish, a contemporary band 
that contributed the tunes Golgi Apparatus and Down 
With Disease to the Cellmates’ repertoire. 
Their venues have ranged from departmental parties 
to the American Museum of Natural History in Wash¬ 
ington, the site of the 1995 annual meeting of the Ameri¬ 
can Society for Cell Biology. “We do it because it’s won¬ 
derful fun. It’s incredible fun,” says Dr. Flavell, a leading 
Lyme disease researcher. “It’s an enormous release.” 
In addition to Drs. Mellman and Flavell, the group 
includes guitarist Leonard K. Kaczmarek, Ph.D., chair 
of the Department of Pharmacology; drummer William 
M. Philbrick, Ph.D., associate professor of medicine; 
lead vocalist Tamar Boursalian, an immunobiology 
graduate student; and the group’s only non-scientist, 
Madlyn Flavell (Richard’s wife) on keyboards. 
Since the band members are best known for their 
lab work, audiences aren’t always sure what they’re going 
to see and hear. “People have expectations that it will be 
just useless,” Dr. Flavell says. But since the members 
have strong musical backgrounds, the band’s sound is re¬ 
markably sophisticated. “The level of musicianship is 
very good,” Dr. Mellman says. “Enough of us have done 
this professionally or close to professionally that we 
know what the expectations are.” 
Dr. Mellman trained as a classical musician from 
childhood, and went to Oberlin College in Ohio to con¬ 
tinue his music studies. During his college years, he fre¬ 
quently traveled to New York to play saxophone in re¬ 
cording studio gigs, produced songs, and played with a 
group he calls “the best managed and best produced 
band that never made it.” 
But on a tour playing with Paul Anka’s orchestra, 
Dr. Mellman decided he didn’t want to be a professional 
musician if it meant ending up like some of his col¬ 
leagues. “You could see that they were automatons, they 
were dead, and I did not want that.” He quit the music 
program, and ended up majoring in biology. 
Dr. Kaczmarek began playing guitar while he was 
growing up in London. He once played Albert Hall, 
and as a member of a group called The Exiles, opened 
for Eric Clapton at the London club Eel Pie Island. 
“The trouble is, there were so many bands in 
London in the ’60s. It was incredibly competitive,” 
Dr. Kaczmarek says. So he decided against music as a 
career. “It’s easier to be a scientist playing music on the 
side than a musician doing science on the side.” 
Dr. Flavell started playing guitar as a teen-ager in 
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Mitosis 
i. 
There was a girl from a midwest town, 
She didn’t smile, she didn't frown 
When other children went out to play 
She stayed inside and watched the 
cells all day 
This made her momma very sad, 
It made her poppa very mad, 
To see their beautiful little girl 
Have the cells become her whole world 
But with the cells she did stay 
On the microscope she all day 
What she watching was lots of fun, 
She see mitosis, mon! 
And she say: 
Chorus 
One cell will get you two cells, 
Two cells will get you four 
Unless one dies then, 
You have just three cells 
But these make six cells 
Before your eyes 
II. 
The girl she grow now day by day 
Until a Ph.D. she did say, 
Is just the very right thing for me 
If a scientist I am to be 
Leonard Kaczmarek, left, is chair 
of pharmacology at Yale. Cellmate 
Richard Flavell heads the immuno¬ 
biology section and is co-inventor of 
a Lyme disease vaccine. Both came 
to the United States from England, 
where they performed in rock bands 
during the 1960s. 
So she went to San Francisco, 
All the way from O-hi-o 
She took a bike, she took a train, 
Still she got there all the same 
When she saw those hills so high, 
And the bridges that touched the sky, 
It brought a tear right to her eye, 
But she say: 
Chorus 
III. 
Lots of people she got to know, 
Lots of cells in San Francisco, 
The cell divisions she got to see, 
Were more beautiful than the sea 
This made her momma very proud 
Her poppa too would sing out loud 
Still it made her kind of sad, 
For the life she never had 
Her university the best in the land 
She wanted more or she'd throw it 
in the can 
So she joined a rock and roll band, 
She’s singing: 
Chorus 
— Ira Mellman 
The Cellmates may lose lead singer 
Tamar Boursalian, right front, later 
this year when she completes her 
graduate studies. “Unfortunately,” 
jokes one of the senior Cellmates, 
“none of us is on her thesis 
committee.” 
Norfolk, England, and formed his first band at age 15. 
“We were pretty awful,” he admits. His bands improved 
over the years, and one even played on the same bill as 
The Animals. But Dr. Flavell says he never seriously 
considered a career in music, and grew away from it dur¬ 
ing his postdoc years. 
Then in the mid-’8os, he bought a new guitar and 
set up a recording studio in his home in Boston so he 
and his wife, Madlyn, could record music together with 
occasional vocal help from their children. 
Some time after Dr. Flavell arrived at Yale, he 
learned that both Dr. Mellman and Dr. Kaczmarek had 
played professionally and invited them to dinner. “The 
ulterior motive,” Dr. Mellman recalls, “was to play.” 
The Cellmates’ first real performance was a New 
Year’s Eve party, Dr. Flavell recalls. Eventually the band 
replaced its mechanical rhythm box with Dr. Philbrick 
on drums, and recruited Ms. Boursalian as a vocalist. 
“It just clicked,” says Dr. Mellman, who describes her as 
the best singer he’s ever performed with. “It was obvious 
that if we wanted to work on it, it could be more than 
just junk.” 
The Cellmates played at immunology and neuro¬ 
science parties and retreats. The first national gig came a 
couple of years ago, at the official opening of the Massa¬ 
chusetts Institute of Technology’s new biology building. 
“That was fun,” Dr. Flavell says. “We actually had the 
faculty of MIT singing a chorus on the stage.” Since 
then, they’ve played at a retreat for the drug company 
Merck, an anniversary party for Princeton’s molecular 
biology department, and at the 1996 Cold Spring Har¬ 
bor Symposium, where James Watson himself (of the 
team that discovered the structure of DNA) enjoyed 
rocking to the music. The musicians even get paid for 
their work—usually more, Dr. Kaczmarek says, than 
they’re paid for giving scientific talks. “The idea of hav¬ 
ing scientists play music is rarer than having scientists 
give talks,” he says. 
Though they only manage to rehearse every few 
weeks and play about six times a year, the Cellmates 
hope to keep going, and possibly make a real recording. 
“It’s a very good outlet,” Dr. Mellman says. “You have 
to pay attention. It’s one of the few things you can do that 
just wipes the slate clean, reformats the hard disk.” 
A PHYSICAL EXPERIENCE 
A singer—the one musician whose own body acts as 
the instrument—may come closest to linking music 
and biology. 
“Music, when it really works, is a physical experi¬ 
ence,” says Kyle D. Pruett, M.D., a child psychiatrist at 
Yale’s Child Study Center. “It takes over your entire body.” 
Dr. Pruett, a professional tenor who has performed 
throughout the region, discovered the phenomenon while 
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singing centuries-old music in a madrigal group in high 
school. “When you get it right, even if you’re 15 years old, 
it’s not an experience your body forgets,’’ he says. 
And Dr. Pruett says the musician’s need to listen and 
be patient has helped “incredibly” in his medical prac¬ 
tice. He even saw the disciplines merge neatly years ago 
before one of his first opera performances, Benjamin 
Britten’s Prodigal Son. Another performer, a young boy 
suffering from stage fright, had locked himself in a bath¬ 
room before the show, and Dr. Pruett managed to con¬ 
vince him to perform. 
“I think after that experience,” he says, “I had 
become convinced there was a way for me to become 
a good doctor and a good musician.” 
Dr. Pruett grew up in an Indiana household in 
which “music was a given, it was not an add-on.” He 
started singing in a church choir as a boy, and studied 
voice with the choir director. In high school, he sang in 
the madrigal group and performed musical comedy. At 
the same time, his interest in biology was sparked by a 
CONTINUED ON PAGE 25 
Kyle Pruett, a child psychiatrist well known for his work on father¬ 
hood, also sings opera and performs professionally. He recently 
collaborated with composer Fenno Heath and soprano Judith Caldwell 
on the CD I’ll Sing and Ever Shall: Songs for Judy and Kyle. “There are 
occasionally moments,” he says of his choice of career and avocation, 
“where I wonder, ‘What if I had not tried to ride both these horses?’” 
The ear’s amplifier 
Using sound and music to study the delicate workings of hair cells 
may provide answers about hearing loss. 
The body’s musical sense might 
go all the way down to the 
cellular level. 
Well, maybe it isn’t music in the 
traditional sense. But Joseph 
Santos-Sacchi, Ph.D., professor of 
surgery (otolaryngology) and of neu¬ 
robiology, is studying cells in the in¬ 
ner ear that seem to dance in re¬ 
sponse to music. He even has a 
videotape of the cylindrical cells 
dancing to the sound of the William 
Tell Overture. 
“This cell movement is unique. 
It’s unlike any other movement found 
in the body.” says Dr. Santos-Sacchi 
(who denies any real musical talent 
but has a saxophone, clarinet and 
keyboards at home.) Since hair cells 
allow us to hear, understanding how 
this unusual dancing movement re¬ 
lates to cell function could be a key 
to eventually unlocking treatments 
for certain forms of hearing loss. 
When hair cells in the inner ear 
detect a mechanical disturbance—a 
sound wave—they respond by send¬ 
ing information about the sound to 
the auditory nerve and on to the 
brain. There are two types of hair 
cells: inner and outer. 
“Most of the information you hear 
comes from the inner hair cells,” he 
says. But Dr. Santos-Sacchi studies 
the outer hair cells, which have very 
few direct connections to the audi¬ 
tory nerve but still play a role in 
sound reception. 
The outer hair cells seem to actu¬ 
ally change their length—by chang¬ 
ing the surface area of their cell 
membranes—in response to sound. 
“Presumably, they start jumping up 
and down,” he says. “At least, that’s 
what happens in vitro." 
Dr. Santos-Sacchi takes the outer 
hair cells from guinea pigs and stud¬ 
ies the electrical signals that corre¬ 
spond to the cells’ motion. If the re¬ 
searchers can figure out how to 
modulate that motility, it may be a 
step towards understanding how the 
outer hair cells work. 
That’s important because the 
outer hair cells seem to be part of a 
sort of “cochlear amplifier” that uses 
a mechanical feedback mechanism 
to boost the vibration of the basilar 
membrane of the cochlea. 
Outer hair cells tend to be the 
first to go in response to any insult, 
such as disease or loud noises. They 
don’t regenerate in mammals, so the 
result can be hearing loss. 
“Presumably, the way that works,” 
Dr. Santos-Sacchi says, “is that the 
inner hair cells are no longer getting 
that boost.” 
At Norfolk festival, the hills are alive with remedies 
Yale physicians, musicians target problems of performance. The physical sensations of fear 
are familiar to all of us: the dry 
mouth, queasy stomach, 
pounding heart and shaky muscles. 
Kyle D. Pruett, M.D., describes it 
as the sympathetic nervous 
system’s primitive fight-or-flight re¬ 
sponse, as the human body pre¬ 
pares for the moment when the 
campfire goes out and the circling 
saber-toothed tiger decides to strike. 
But that cascade of symptoms is 
precisely the last thing a musician 
wants in the moments before a per¬ 
formance, when small-muscle coordi¬ 
nation is critical. 
“You do not want Pleistocene-era 
feelings flowing through your body,” 
Dr. Pruett, a clinical professor at the 
Yale Child Study Center and a profes¬ 
sional tenor, told a group of fellow 
physicians and performers last sum¬ 
mer. Dr. Pruett was one of the 
speakers and coordinators for the 
fourth annual Medical Problems in 
the Performing Arts conference, held 
at the Norfolk Chamber Music Festi¬ 
val in northwestern Connecticut in 
collaboration with the Yale Summer 
School of Music. 
Dr. Pruett talked about perfor¬ 
mance anxiety or, as he prefers to 
call it, performance awareness. It’s 
one of the most disabling health 
problems a performer can face, and 
can cripple a career if left untreated. 
The conference was designed to ex¬ 
plore performance anxiety and other 
medical problems that plague per¬ 
forming artists, especially musicians. 
These “small-muscle Olympians,” as 
Dr. Pruett calls them, suffer from 
health problems ranging from ten¬ 
dinitis to hearing loss, and as a 
group of patients, tend to be ne¬ 
glected. 
“It’s basically a misunderstood, 
undertreated group," says Peter Jokl, 
M.D. ’68, HS ’69-73, professor of 
orthopaedics and rehabilitation 
and chief of the section of sports 
medicine. 
Dr. Jokl, Dr. Pruett and Martin W. 
Sklaire, M.D., HS '62, coordinated 
the conference, along with festival 
manager Elaine Carroll and director 
Joan Panetti. The sponsors were the 
Yale Summer School of Music, the 
Child Study Center and the sports 
medicine section. 
About 10 years ago, Dr. Sklaire, 
clinical professor of pediatrics, took 
a course in Aspen, Colo., about medi¬ 
cal injuries to performers. As an 
amateur piano, clarinet and cello 
player, he had some idea of the 
physical stresses musicians face. As 
a specialist in pediatric and adoles¬ 
cent medicine with extensive experi¬ 
ence in sports medicine, he saw a 
clear connection. “A lot of injuries to 
musicians are similar to injuries to 
athletes,” many stemming from over¬ 
use, Dr. Sklaire says. 
The very act of playing an instru¬ 
ment can force the body into unnatu¬ 
ral positions, Dr. Sklaire says. “If 
you’re spending enough time, you’re 
going to have aches and pains as a 
result,” he says. For professional 
musicians whose livelihoods depend 
on playing, injuries can be more than 
a nuisance. 
Paul W. Brown, M.D., clinical pro¬ 
fessor of orthopaedics and rehabili¬ 
tation and of plastic surgery, spoke 
at the conference about some of the 
upper extremity problems musicians 
can face. These include overuse inju¬ 
ries, such as tendinitis, nerve com¬ 
pression or entrapment, and focal 
dystonia, the loss of control over an 
individual or group of muscles. 
In some cases, a cure can be as 
simple as a small change in practice 
habits, such as taking regular rests, 
or a change in musical technique. 
Dr. Brown described one patient, a 
French horn player, who had been 
complaining of arm pain. He found 
she was gripping her instrument 
white-knuckle tight. “The cure here 
was not medical,” he explained. “It Otolaryngologist David Astrachan works with performers at Norfolk on ways to prevent 
and manage ear, nose and throat injuries. Hearing loss tops the list. 
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was just a matter of changing her 
musical technique." 
Some cases are more difficult, 
as when the only real treatment is 
rest, “which professional musicians 
don’t take kindly to at all,” he said. 
Part of the reason musicians may be 
undertreated is that their livelihood 
is threatened: They don’t want to be 
told they have to stop playing. On 
the other hand, musicians tend to be 
highly motivated, hardworking and in¬ 
terested in their own treatment, pre¬ 
cisely because the stakes are so 
high, Dr. Brown said. 
David I. Astrachan, M.D. '84, a 
clinical instructor in otolaryngology, 
talked about ear, nose and throat in¬ 
juries to performers. One of the 
most serious health problems 
among musicians can be hearing 
loss. It’s most common in percus¬ 
sionists and violinists, but can affect 
anyone in an orchestra, and it's of¬ 
ten irreversible, he said. 
Wind instruments can peak at 
123 decibels. “That’s jet aircraft 
noise,” Dr. Astrachan said. Using ear¬ 
plugs can reduce the noise by 25 
decibels. “That can be all you need 
to take a potentially damaging sound 
and make it less damaging,” he 
said; musicians who don't want to 
use earplugs in performance are 
encouraged to at least use them 
in rehearsals. 
The conference also included a 
panel discussion with members of 
the Vermeer String Quartet, which 
performed at the festival the night 
before the conference. Afternoon 
workshops examined hearing prob¬ 
lems, rehabilitation of hand injuries, 
and relaxation techniques. 
Though attendance at the confer¬ 
ence has been modest, Dr. Sklaire 
says he and his colleagues want to 
continue organizing it. “I think we’re 
all committed to perpetuating this,” 
he says. 
“As an academic institution, this 
is the type of thing we should do,” Dr. 
Jokl says. “A university should be a 
repository of this kind of knowledge.” 
CONTINUED FROM PAGE 23 
teacher who “taught science with the passion of a Shakespearean actor.” 
“He had such respect for science as a discipline and, really, an art,” 
Dr. Pruett says. 
Dr. Pruett came to Yale College and majored in history and music. “I 
didn’t see any point in doing medicine twice. I would do college once and 
medicine in medical school,” he says. He continued to sing, and traveled to 
Europe with the Yale Glee Club in his junior year. He was invited to sing in 
Europe, but was told he would have to work harder at his music. “So I spent 
a summer thinking about it very seriously,” he says. “But, in the end, the 
service commitment had deeper roots in me.” 
While in medical school at Tufts University, he got a position singing in 
an Episcopal church. “I think it kept me sane,” he says. “It was such a heal¬ 
ing environment for me compared to medical school.” When he returned to 
Yale for his residency, he went back to his old music teacher, and began sing¬ 
ing opera. “I didn’t like opera,” he admits. “I liked lieder and musical com¬ 
edy and oratory and sacred music.” Now, most of his musical work is in op¬ 
era, which he describes as “a true mega-art form.” Though Dr. Pruett says he 
loves being a physician, he sometimes wonders what a musical career might 
have been like. “There are occasionally moments,” he says, “where I wonder, 
‘What if I had not tried to ride both of these horses?’ ” 
ORDER AND EXPRESSION 
As the most mathematical of the arts, music seems to hold a particular fasci¬ 
nation for scientific thinkers seeking the creative without straying too far 
from the rational. 
“There is certainly creativity in medicine, in the thinking process,” says 
Fredric O. Finklestein, M.D., a nephrologist and clinical professor of medi¬ 
cine. But that creativity is constrained by the structures of science. For a 
physician, it is often difficult if not impossible to get “that spark of original¬ 
ity” that happens in the arts, he says. 
Dr. Finklestein majored in history of music as part of Yale’s undergradu¬ 
ate Class of 1963, doing pre-med work at the same time. His senior thesis 
addressed the creative process in 20th-century music and how composers im¬ 
posed a variety of rigorous external forms to achieve freedom of expression. 
Though Dr. Finklestein still plays piano and clarinet, he doesn’t per¬ 
form. He sees music as a creative respite from his clinical work, and says he 
doesn’t regret choosing medicine over music as a career. “I really enjoy medi¬ 
cine. I really love the work, so I don’t really have second thoughts about it in 
that sense.” 
Besides, he sees a clear link between the two fields. Both require rigor, 
practice and discipline. “In medicine we have to pay endless attention to de¬ 
tail,” Dr. Finklestein says. “If you’re seeing a patient, you have to impose this 
external rigorousness on taking the history and the physical.” 
Only after gathering that information can the creative part of medicine 
begin, leading to the diagnosis. “You have to have an ordered framework in 
order to have this creative expression,” he says. But even in that process, the 
freedom must be tempered. “You have to impose these external forms on 
what you do.” 
He compares the rigor of medicine to what the great, early 20th-century 
composer Igor Stravinsky said about music: Freedom of expression in music 
can only be achieved by imposing strict form. Stravinsky, who was born in 
1882, explained it like this: “The more art is controlled, limited, worked 
over,” he wrote, “the more it is free.” YM 
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To create this composite of the body. Alexander 
Tsiaras assembled photographic slices from the 
Visible Man images, then rotated and manipulated 
the data set to achieve the desired effect. 
Opposite: The lungs, liver, intestines and skeleton 
are visualized in this composite of the upper body. 
Armed with powerful new 
imaging devices, clinicians and 
researchers can peer into the 
body more clearly than ever 
before. What they are seeing 
is revolutionizing 
medicine. 
By Marc Wortman 
It 
M* 
When something goes seriously wrong 
inside the body, there’s only one 
course of action: look inside, identify 
the problem and then figure out how best to fix it. 
For most of medical history, that crucial first step 
of making a correct diagnosis 
has required penetrating the 
living person’s sealed physi¬ 
ological system, inherently a 
dangerous and complex sur¬ 
gical process. Then, a cen¬ 
tury ago, the arrival of the X- 
ray gave medicine the ability 
to see through the body’s sur¬ 
face without cutting it open. 
While X-ray images in 
various forms continue to be 
one of medicine’s diagnostic 
mainstays, they offer a lim¬ 
ited, static portrait of the liv¬ 
ing human organism. Over 
the last io years, imaging 
technology has traveled light 
years from the world in which X-rays were the 
only means of looking into humans without 
resorting to the knife. An explosion of advances 
in other forms of imaging technology has given 
physicians new eyes, allowing them to peer into 
the most minute recesses of the body and observe 
dynamic physiological and biochemical processes 
in action. As a result, for the first time clinicians 
and researchers can ask biological questions 
directly and watch the living, fully awake body 
as it responds. 
Marc Wortman, a regular contributor to Yale Medicine, 
received an award of merit in the National Health Information 
Awards Competition for his 1996 article on Lyme disease. 
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“Radiologists are like abstract expressionists,'’ 
says Alexander Tsiaras, the LIFE magazine photog¬ 
rapher whose work illustrates this issue's cover 
story on advances in medical imaging. “They have 
a special talent for looking at a fragment of infor¬ 
mation in two dimensions and extrapolating it to 
three. In their mind’s eye, they can create a whole 
from a single section or slice.” 
Mr. Tsiaras’ art is more dazzling to the eye than 
the workaday images that radiologists use to diag¬ 
nose disease and guide treatment. But advances 
in imaging technology, a field that traces its ori¬ 
gins to the discovery of the X-ray in 1895, are 
closing the gap between the of ten-cryptic images 
that are a radiologist’s stock-in-trade and the 
artist’s more comprehensible, if less concrete, ren¬ 
dering of anatomy. 
Working with specialists in other disciplines— 
surgery, neurology, psychiatry, computer science, 
physics, photography and the graphic arts—radi¬ 
ologists are developing ways to better visualize 
the body, its structures and its metabolism. New 
techniques such as helical CT, PET and functional 
MRI (See An Imaging Glossary), and the overlaying 
of these images into composites, are beginning 
to resemble the high-tech special effects of 
Hollywood. 
“Art and diagnostic imaging converge daily and 
will do so increasingly in the next century,” says 
department Chair Bruce L. McClennan, M.D. 
“There’s a long tradition of artists who combine 
physical reality with the ideal, and the desire to 
find beauty in the real world as it exists in flesh 
and blood.” 
It is this last quality, says surgery Chair Ronald 
C. Merrell, M.D., that distinguishes Mr. Tsiaras’ 
data-derived images from the work of many artists. 
“You can go back to his original image and reinter¬ 
pret it yourself. It’s all there in his database.” 
This highly graphic and accessible presentation 
of anatomy, he adds, provides a common language 
for imaging specialists and surgeons. “His visual¬ 
ization of actual structures could be enlightening 
to diagnostic radiologists, and his translation of 
radiographic images makes radiology far more 
comprehensible to surgeons. It could potentially 
do some great good.” 
Mr. Tsiaras spent six months last year collabo¬ 
rating with the Department of Surgery, through a 
grant from NASA, to promote the visualization of 
abstract disease processes and human anatomy. 
He is the founder and principal in the New York 
City-based Anatomical Travelogue, and the author 
of Body Voyage: A Three-Dimensional Tour of a Real 
Human Body (1997, Warner Books). 
Michael Fitzsousa, Editor 
2,8 
For patients, this has meant vast improvements in care and 
raised hopes for better diagnosis and cure where none existed be¬ 
fore. From knee injuries to Parkinson’s disease, the advanced imag¬ 
ing technology provides a means of rapidly and precisely measuring 
the extent of tissue damage and locating functional disturbances. 
Armed with such knowledge, specialists can then choose the least 
invasive and most effective treatment option. There is less need for 
exploratory surgery, less possibility of causing inadvertent harm 
and increased likelihood of rapid recovery. 
Investigators in a wide range of fields now employ a great 
wealth of advanced imaging tools—computed tomography, func¬ 
tional magnetic resonance imaging, single photon emission com¬ 
puted tomography, and positron emission tomography scans. (See 
An Imaging Glossary.) Through the eyes of this technology, investi¬ 
gators can visualize human physiology in action and, increasingly, 
explain how it works at the most basic levels, from thought to 
movement. “Most people think of imaging as something static,” 
says Bruce L. McClennan, M.D., chair of the medical school De¬ 
partment of Diagnostic Radiology and chief of diagnostic imaging 
at Yale-New Haven Hospital. “But those days are gone forever. 
More and more, physicians want not just form but function. 
And we can deliver it. It’s brought about a revolution in how we 
practice medicine. Already we’ve cut down drastically on the use 
of X-rays and X-ray films, and they’ll virtually disappear in the 
next century. And that’s just the beginning. 
“Just one example: we’re now developing interventional imag¬ 
ing magnets to do medical procedures while the patient is actually 
inside the magnet. The information will be right there for the clini¬ 
cian. For the patient, it means less waiting, more accurate diagnosis 
and treatment, less surgery and swifter recovery.” 
For researchers, seeing the body through the new imaging de¬ 
vices has begun to answer ages-old questions about what actually 
goes on in almost every imaginable bodily functions. Anatomical 
structures and their respective biological functions can be studied 
simultaneously. For example, the contracting walls of the heart and 
the firing cells in the brain can be observed in action so that nor¬ 
mal and abnormal behaviors of the body’s essential functions can 
be charted and compared. Equipped with the findings, physicians 
and scientists can develop new therapies for disorders. The observ¬ 
ing eye of the investigator can zoom without resistance through 
every passage and wall in the body to uncover otherwise hidden 
disease processes. The imaging technology needed to do this is 
enormously complex, yet its effect is to simplify treatment and 
greatly ease and speed the healing process. 
While the diagnostic imaging field is now so wide that no in¬ 
stitution can command a full range of applications, Yale is a leader 
in an exceptionally high number. An especially important area is 
breast needle localization, in which biopsies of suspicious lumps 
can be accomplished with much greater accuracy. This may prove 
to be an invaluable tool for cancer patients, most importantly 
in the diagnosis of breast cancer. “Breast imaging,” says Dr. 
McClennan, “is a huge problem facing our field.” Eventually, he 
believes, the emerging capability to image breast tissue accurately 
while simultaneously removing suspicious lumps “will obviate the 
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need to go to the operating room. Were going to even¬ 
tually eliminate the knife.” 
Improvements in high-speed diagnostic imaging 
tools have already saved many lives, countless hours of 
suffering, and enormous amounts of money by shorten¬ 
ing the time needed to come up with an explanation for 
patients’ woes. One recent example is a new kidney 
stone diagnostic procedure, developed at Yale, that has 
eliminated the need for long waits to 
determine the cause of severe side 
pain. (See Throwing Stones.) Patients 
who only three years ago would have 
endured as much as 24 hours of un¬ 
relieved suffering before the source 
of their pain could be determined 
and treatment begun can now begin 
Better imaging techniques, says department Chair Bruce L. McClennan, 
“have brought about a revolution in the way we practice medicine.” 
treatment within five minutes of arrival in 
the Emergency Department. 
Many of the advances have been made 
possible by the application of computing 
technology to imaging devices. In its turn, 
the computerization of diagnostic imaging 
is rapidly reshaping the nature of medical 
communications. Yale is part of a nation¬ 
wide movement exploring the possibilities 
for computer networking among physi¬ 
cians, allowing for faster diagnosis, the 
sharing of information between specialists 
and clinicians over long distances and im¬ 
proved storage of patient data. 
While the newer imaging technologies 
have opened up new possibilities for inves¬ 
tigation and improved clinical care, they 
also serve the recent priorities of managed 
care for holding down costs for therapies 
and preventing more serious, and more ex¬ 
pensive, medical problems. For instance, 
advances made possible by imaging tech¬ 
nology, such as the high-speed diagnosis of 
kidney stones and needle localization biop¬ 
sies, reduce time patients need to spend in 
the hospital and often end the need for 
multiple and redundant procedures. They 
On January 27,1896, Yale 
physicist Arthur W. Wright, 
above, made the first X-ray 
image in the United States 
after Wilhelm Conrad 
Roentgen’s discovery in 
Wurzburg the month be¬ 
fore. Within days, American 
physicians were using the 
new technology to peer in¬ 
side the human body, re¬ 
vealing buckshot, for ex¬ 
ample, in the hand of a 
New York attorney injured 
in a hunting accident. 
u[With the next generation of 
imaging applications] the 
information will be right there for 
the clinician. For the patient, it 
means less waiting, more accurate 
diagnosis and treatment, less 
surgery and swifter recovery.” 
— Bruce L. McClennan 
also potentially lower the number of patients whose con¬ 
ditions worsen, resulting in the need lor extended care. 
WATCHING THE BRAIN WORK 
In the federally designated Decade ol the Brain, it is in¬ 
side the skull that the frontiers of medicine have been 
pushed furthest by applications of imaging technology. 
Perhaps more than any other institution, Yale is noted 
for using its imaging technology to learn more about 
how the brain functions. Investigators are mapping out 
brain structures and exploring the biochemistry of many 
fundamental mental processes, such as memory, vision, 
reading, attention, hearing and even smell, as well as dis¬ 
orders in those processes. These conditions include dys¬ 
lexia, schizophrenia, autism and brain trauma from 
stroke, alcoholism and epilepsy. “Brain imaging has be¬ 
come one of the hottest fields in the biological sciences. 
There are always new applications for MR being found,” 
says medical physicist R. Todd Constable, Ph.D., an as¬ 
sistant professor of diagnostic radiology, who works 
closely with clinicians on magnetic resonance imaging 
(MRI) projects. “Our research imager is swamped. It’s 
tough to book time.” 
Irena Tocino, opposite 
page, head of the radiology 
department’s breast 
imaging section, has 
demonstrated new uses 
of magnetic resonance 
imaging in detecting 
tumors. The original X-ray 
film, right, suggested 
the presence of a small 
cancer but was not 
conclusive. The subsequent 
MR image, center, was easy 
to interpret and allowed a 
definitive diagnosis, says 
Dr. Tocino. A breast biopsy 
confirmed the diagnosis. 
An imaging glossary 
Looking into the human body 
without opening it up has 
been a tool for medicine for 
more than a century. Expos¬ 
ing film to X-ray beams 
passed through the body pro¬ 
vided readable images of 
solid structures like bones 
and masses of dense, soft 
tissue, such as muscle and 
brain. In many ways, the ba¬ 
sic concepts in imaging tech¬ 
nology have changed remark¬ 
ably little. 
Discovered by Wilhelm 
Conrad Roentgen in 1895, 
X-rays are beams of radia¬ 
tion that pass through differ¬ 
ent kinds of tissue in varying 
amounts. On photographic 
film, air and soft tissue will 
register in different shades of 
black while bone will show up 
as white. In dense organs 
like breast tissue, a radiolo¬ 
gist will read the film for 
subtle gradations to spot 
anomalies that are potential 
indicators of disease. 
Computed tomography 
(CT) takes an X-ray camera 
and spins it about the 
subject’s body to take a 
cross-sectional image, or 
slice. The X-rays from the CT 
scanner are picked up by 
sensors linked to a computer 
that generates a highly de¬ 
tailed video image. A signifi¬ 
cant technical advance, a he¬ 
lical CT scanner moves over 
the patient, taking rapid, 
overlapping images of large 
portions of the body. When 
rendered on the computer, 
the images can be viewed 
from any angle and perspec¬ 
tive. For instance, tours 
through a virtual, 3D image 
of an organ allow physicians 
to study areas of the body re¬ 
quiring reconstructive surgery 
prior to operating or to in¬ 
spect precancerous polyps in 
the colon to determine appro¬ 
priate treatment. 
Using pharmaceuticals 
“tagged" with nuclear trace 
elements, single photon 
emission computed tomog¬ 
raphy (SPECT) and positron 
emission tomography (PET) 
scanners can detect and 
measure the site, speed and 
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Much of that work involves mapping out brain 
anatomy and function. In order to observe the brain in 
action, study subjects enter the machine and then are 
given a battery of tests while their brain activity is im¬ 
aged and recorded. “Any task you can perform on a 
computer or a video player,” says John C. Gore, Ph.D., 
director of the NMR Physics Research Group and pro¬ 
fessor of diagnostic radiology and applied physics, “can 
be projected, controlled and recorded.” Study subjects 
lie down inside the functional MRI (fMRI) machine, 
which is specially outfitted for research. It may have a 
video screen placed just outside it from which images are 
then reflected through a series of mirrors to the supine 
subject. Headphones can be used for delivering sound 
tasks, or an air circulation system for olfactory studies. 
Anyone who has undergone an MR scan knows the 
magnet’s hollow rhythmic beat can be unnerving. Sub¬ 
jects can’t move about inside the tube and anyone prone 
to claustrophobia would be better off skipping the exer¬ 
cise. While the subjects perform tasks, whether it’s bend¬ 
ing a finger or reading a word, their brain activity can 
then be imaged and sites mapped for specific activities, 
from muscle activation to language usage. 
With all that data as a baseline for normal brain 
Antibodies surround breast cancer cells, above, in 
an image captured by a confocai laser scanning 
electron microscope. 
quantity of absorption of the 
radiopharmaceutical. The 
minute change can be re¬ 
corded to show, for instance, 
the body repairing tiny frac¬ 
tures in bone structure or the 
rate of uptake of neurotrans¬ 
mitters in the brain. Yale re¬ 
searchers have used PET 
and SPECT to develop a 
new method for detecting 
Parkinson’s disease prior to 
the onset of the shaking and 
other behavioral symptoms 
associated with it. Physicians 
can now begin treatment 
early enough, in many cases, 
to prevent the most devas¬ 
tating symptoms altogether. 
The advent of Magnetic 
Resonance Imaging (MRI)— 
first used clinically in 1986, 
followed by a giant leap for¬ 
ward with the arrival of func¬ 
tional MRI (fMRI) in 1990— 
made the dynamism of life 
visible for the first time with¬ 
out significantly interfering 
with that dynamic. The tube¬ 
shaped magnet of the MRI 
machine creates a massive 
yet harmless magnetic field 
around the body that causes 
hydrogen atoms to line up 
uniformly. When the magnetic 
field is switched off, the at¬ 
oms relax back to their nor¬ 
mal patterns, giving off de¬ 
tectable signals as they do. 
A computer records the pro¬ 
cess, which occurs at varying 
rates depending on the tis¬ 
sue, and then generates 
highly detailed images. Radi¬ 
ologists can set the magnet 
for study of anatomy through 
sensitivity to tissue or they 
can observe function, or 
metabolic activity, through 
sensitivity to blood oxygen¬ 
ation. When a portion of the 
brain is activated, an fMRI 
scan can detect increased 
blood flow. By overlaying an 
anatomical with a functional 
study, researchers can map 
out which sites in the brain 
serve to control different ac¬ 
tivities, or they can compare 
function in a normal brain 
versus that of a person with 
a mental illness or such dis¬ 
orders as learning disabilities 
or autism. 
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Using a new technique for rapid, total-body MRI, the entire human 
body can be imaged in as little as 18 seconds. 
anatomy and function, investigators then begin to ob¬ 
serve differences in the brains of those with cognitive 
and mental disorders, from learning disabilities, post- 
traumatic stress syndrome and epilepsy to schizophrenia, 
alcoholism and stroke. (See What the Brain Thinks While 
Reading) The investigators hope eventually to develop 
reliable diagnostic tools and therapies for these disorders 
that remain among the most difficult to diagnose and 
most resistant to treatment. 
Already, neurosurgeons and neurologists have begun 
to find practical tools derived from these experimental 
studies. For instance, Dennis Spencer, M.D., the Harvey 
and Kate Cushing Professor and chair of neurosurgery, 
has been testing fMRI as a noninvasive, extremely rapid 
method of examining the brain prior to surgery. Patients 
with seizure disorders or tumors who need surgery may 
soon be able to have their brain anatomy mapped out 
without the extended preoperative procedures that are 
now necessary. (See Peeling Back the Skull without a 
Knife) The potential savings in time, money and pain are 
almost incalculable. 
Stroke is another area in which new applications of 
imaging technology hold great promise. By understand¬ 
ing which areas of the brain have been damaged by 
trauma or stroke, more appropriate therapies can be 
prescribed for individuals. Assistant professor of 
neuroradiology Robert K. Fulbright, M.D., director of 
clinical fMRI, has shown that stroke, epileptic seizures 
and other neuronal activity change the way water mol¬ 
ecules move in the brain. Diffusion weighted imaging, 
an MRI technique that measures these changes, is now 
regarded as the most sensitive way to detect stroke in pa¬ 
tients during the first few hours after symptoms occur. 
Actual scanning can take less than a minute, with results 
following within a half hour. “We can rule out hemor¬ 
rhages and tumors and detect stroke very, very early. 
This gives us a tool for rapid treatment and for develop¬ 
ing new treatments. New drugs are now in development 
to limit damage from, or even prevent stroke.” 
NEW WAYS TO IMPROVE CARE 
The advantages for clinical care and medical research the 
newer technologies offer are easy to imagine. The reality 
of their application is much tougher. 
Much about how MRI works is simply not under¬ 
stood, and the process of getting readable images from 
machines can be enormously complex. It’s not like an 
X-ray in which the tube shoots, film gets exposed to ra¬ 
diation on the other side of the body and a photographic 
negative of anatomical structures follows. Even the most 
basic MRI scan requires a highly specialized team to op¬ 
erate it and process the data emerging from it. The more 
Imaging techniques have been used to diag¬ 
nose cancer since the application of the X-ray. 
Now, the digital reconstruction of data gener¬ 
ated by helical CT provides a view of structures 
from a vantage point inside the body. This 
frame from a virtual flythrough of the colon 
reveals a 1-centimeter polyp. 
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complex the question the less certain are the data and 
the more post-processing must take place to clarify just 
what the eye of the scanner has seen. “You don’t just get 
an area of the brain to light up,” says medical physicist 
Dr. Constable of studies of brain activation. “Nobody 
knows why functional MRI works or why images 
change,” adds Dr. Gore. 
That is why many of the frontiers of diagnostic im¬ 
aging are being explored as much by physicists as by ra¬ 
diologists. Dr. Gore, who is himself a physicist, directs a 
large team comprising physicists, neuroscientists, radi¬ 
ologists and computer scientists who work with re¬ 
searchers throughout the School of Medicine and indeed 
the entire University using MRI for their research. Bio¬ 
logical investigators need Gore’s group to help them de¬ 
velop imaging methods and then explain just what it is 
they’re seeing. Says Dr. Gore: “We continually find that 
what we think are simple tasks—like listening to a tone 
in the ear for example—may also evoke a transient re¬ 
sponse in areas of the brain that we were not expecting. ” 
Figuring out what causes those responses and eliminat¬ 
ing “noise” from small movements or individual varia¬ 
tions in brain structure require complex calculations. 
The future of imaging technology promises to alter 
medicine radically, from diagnostic and treatment meth¬ 
ods to administration of care. Some of the most specula¬ 
tive uses already developed for the new imaging tech¬ 
nologies seem to have jumped from the screens of 
science fiction movies. 
Eventually, patients will very likely be able to walk 
into a clinic, get a complete body scan in a matter of 
minutes, have it diagnosed for problems and then stored 
away for future reference. Kevin M. Johnson, M.D., a 
diagnostic radiologist doing MR research, has already 
perfected a new technique for rapid total body MRI, in 
which a patient’s entire body can be imaged without 
great blurring in as little as a scant 18 seconds. Using an 
adaptation to the scanner, Johnson can move his study 
subjects on a sliding table swiftly through the MRI ma¬ 
chine, getting 180 cross-sectional images along the way. 
The complete picture gives a much wider scope for diag¬ 
nosis than current procedures. The images can also be 
stacked for animated tours. While many questions re¬ 
main, Dr. Johnson believes that the new technique is es¬ 
pecially promising for detecting the spread of cancers, 
which now is usually done in limited regions using a CT 
(computed tomography) body scanner and an ingested 
or injected nuclear tracer. “We can do a workup faster 
and with less inconvenience and suffering for the pa¬ 
tient,” says Dr. Johnson, assistant professor of diagnostic 
radiology. “And you get to see the entire body and not 
just a limited area.” He believes that, when coupled with 
existing tests, the rapid total body MRI will eventually 
provide better cancer detection. 
What the brain thinks 
while reading If men and women sometimes seem like they come 
from different planets, the difference in how their 
brains go about reading may help explain just how far 
apart those planets are. Husband-and-wife team of pedi¬ 
atric neurologist Bennett A. Shaywitz, M.D., and develop¬ 
mental pediatrician Sally E. 
Shaywitz, M.D., together with 
their team of investigators, 
electrified the neuroscientific 
world when they reported in 
1995 in the journal Nature 
that female subjects had ar¬ 
eas in both brain hemispheres 
active during reading while 
male subjects had only one. 
This was the first time func¬ 
tional differences in the brains of men and women had 
been shown. While it demonstrates important anatomi¬ 
cal differences between the brains, it also may help ex¬ 
plain why neurologists report that women with strokes 
tend to recover language abilities more rapidly than men. 
The Shaywitzs’ finding was in fact a byproduct of a 
much larger investigation of reading and language usage 
designed to identify neurological differences in the 
brains of non-impaired readers and those with dyslexia. 
“We’re developing a much more in-depth picture of how 
the brain works in non-impaired readers and people with 
reading difficulties,” says Robert K. Fulbright, M.D., direc¬ 
tor of clinical fMRI and a collaborator with the Shaywitzs. 
Use of language for reading is an enormously com¬ 
plex mental activity involving motor-speech areas and 
language reception regions in the brain. Investigators 
ask study subjects to sound out nonsense words pro¬ 
jected on a screen that is reflected to them while they 
undergo functional imaging. Areas of activation are then 
overlapped with anatomical scans. The results of each 
subject are “averaged" out to create a common brain 
space to account for individual differences in size and 
anatomy. The researchers are analyzing the data to de¬ 
termine differences between non-impaired readers and 
those with disabilities. Eventually, clinicians will diagnose 
children with various learning disabilities early on and be¬ 
gin treatment to prevent a lifetime of difficulties. “Read¬ 
ing disability is a circumscribed deficit surrounded by 
strengths,” says Dr. Sally Shaywitz, professor of pediat¬ 
rics and a faculty member in the Child Study Center. 
[Bennett Shaywitz is a professor with appointments in 
pediatrics, neurology and the Child Study Center.] “You 
need to identify those strengths, make the child aware 
of those strengths, and then maximize them to help 
overcome the disability.” 
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The three-dimensional quality of computer ani¬ 
mated graphics has given viewers playing video games or 
watching movies a feeling of entering into a world of 
virtual reality. A similar experience is now possible in 
traveling at high speed through the body. Where now a 
viewing scope must be inserted into the partially anes¬ 
thetized body and passed through the colon, aortic ves¬ 
sels or bronchial tubes until an obstruction is encoun¬ 
tered, radiologists will soon rely upon virtual equiva¬ 
lents. And the virtual tour will be a better diagnostic 
tool than current invasive procedures. Colorized, ani¬ 
mated, volumetric renderings on the computer of CT 
scans provide a realistic image of the interior of the 
body’s passages. Using a joystick, the viewer can travel 
up and down or zoom in on sites, such as polyps, ath¬ 
erosclerotic plaque buildup or ulcers. There are major 
Peeling back the 
skull without a knife Understanding what transpires 
inside another person’s 
head may be difficult for 
anyone, but for a surgeon about to 
operate on the brain, that knowledge 
can be a matter of life and death. 
New applications of functional MRI 
may make it a far less dangerous 
process. 
For the past decade, patients 
undergoing brain surgery have bene¬ 
fited from a procedure pioneered at 
Yale. Before removing tumors, vascu¬ 
lar malformations or other lesions 
that might cause seizure disorders, 
surgeons must carefully map the 
surface of the brain to pinpoint 
areas vital to language, and the 
organization of motor function, sen¬ 
sation and vision. Prior to surgery, 
the surgeon removes a portion of 
the patient’s skull and lays a grid of 
electrodes over the cortex, the outer 
layer of gray matter at the brain’s 
surface. The fully conscious patient 
then completes a series of tasks, 
during which critical regions of the 
cortex are identified and mapped 
as areas to avoid during surgery. 
The entire process lasts about a 
week and takes place in the Yale 
Epilepsy Unit. 
The chairman of the Department 
of Neurosurgery, Dennis D. Spencer, 
M.D., is exploring the use of the fMRI 
to achieve results superior to those 
from the electrode grid. A one-hour 
fMRI exam may eventually replace 
the week-long monitoring process 
that is now the state of the art, says 
medical physicist R. Todd Constable, 
Neurosurgeon Dennis Spencer prepares 
to lay down a grid of electrodes on the 
exposed surface of the brain during a pro¬ 
cedure that will map functional locations 
to be avoided during epilepsy surgery. 
Ph.D., an assistant professor who is 
working on the imaging technology 
with Dr. Spencer. To test this capabil¬ 
ity, the research team is correlating 
fMRI data with the already-proven 
electrode techniques. Says Dr. 
Spencer: "Surgeons will eventually be 
able to understand where language 
is controlled without having to invade 
the brain and physically map it.” 
The map shown above left is produced 
from data gathered during a week of ob¬ 
servation and EEG recording. The color 
outlines indicate areas of the cortex that 
control motor function (red), language and 
speech (yellow) and sensory ability (blue). 
The area outlined in black shows sur¬ 
geons where they can most safely operate 
to remove the epileptic focus without 
causing a permanent neurological deficit. 
Spencer and colleagues are now using 
functional MRI studies like the one above 
to map the brain non-invasively. 
advantages to the virtual colonoscopy, angioscopy 
and bronchoscopy beside not subjecting patients to 
unpleasant, invasive and potentially hazardous pro¬ 
cedures. When an obstruction is encountered that 
would halt an actual physical exam, the virtual ex¬ 
amination simply passes right through it. Using 
color processing, blood can be “drained” from the 
heart and vessels to examine walls and valves, 
Function over form 
Positron emission tomography (PET) is es¬ 
pecially useful as a tool to visualize me¬ 
tabolism, to see not only the form of a 
structure but its function as well. The im¬ 
age at left allowed surgeons to diagnose a 
brain tumor without opening the skull. The 
patient had been treated for a previous tu¬ 
mor, and the dark area could have been 
dead tissue from the prior radiation 
therapy. PET imaging detected metabolic 
activity consistent with a new tumor. 
“Only PET can show that difference,” says 
VA PET Center Director Robert Soufer. 
A virtual image bank Images of all sorts can be digi¬ 
tized, then manipulated, com¬ 
pressed, archived and sent be¬ 
tween computer workstations over 
huge distances at speeds limited 
only by the bandwidth of the line. 
For radiology and all aspects of 
medicine dependent on its services, 
that means a revolution in service 
delivery is about to take place. Over 
the next several years, Yale-New 
Haven Hospital plans to put its own 
imaging systems online and link into 
a network within the center. It will 
very likely be accessible to physi¬ 
cians outside the hospital who hold 
authorization codes as well. The Pic¬ 
ture Archiving and Communications 
System, or PACS, will allow referring 
physicians and radiologists to down¬ 
load and discuss patient images at 
their workstations simultaneously. 
When radiology goes online, medi¬ 
cine will change dramatically. 
“PACS and teleradiology,” says 
Howard P. Forman, M.D., vice chair 
for finance and administration in 
the Department of Diagnostic 
Radiology, “will make more of a 
change in medical practice in the 
next 10 years than anything else 
now on the horizon.” 
PACS will go a long way toward 
making the computerized world of 
medicine, now only partially imple¬ 
mented, complete. “We can call up 
any number of images anyplace, any¬ 
time,” says Pradeep Mutalik, M.D., 
while sitting at a double monitor 
workstation specially designed for di¬ 
agnostic imaging. Dr. Mutalik, along 
with fellow associate research scien¬ 
tist Vladimir P. Neklesa, M.D., is in 
charge of bringing PACS online at 
Yale. Eventually, teams of radiologists 
based at the medical center will re¬ 
view images sent from satellite sites, 
clinics and private practices through¬ 
out a large region. 
The completion of PACS will elimi¬ 
nate the need for storing medical 
film. Where now a vast film archive 
holds medical records—with only the 
most recent images kept at the hos¬ 
pital and the rest warehoused off¬ 
site—a theoretically infinitely ex¬ 
pandable digital-storage system will 
keep images at constant ready. Wor¬ 
ries about confidentiality appear mis¬ 
placed. One of the major complaints 
all physicians make today is 
that when they need patient 
images, all too often they’re 
simply not to be found. Says 
Dr. Mutalik of PACS-based 
storage: “Unlike film, where 
there is only one copy, it 
doesn’t sprout legs and walk 
away.” Only those with au¬ 
thorization will be able to en¬ 
ter the secure Web site or 
the PACS system. For those 
physicians, however, image 
retrieval will be almost in¬ 
stantaneous, even for much 
older images. Eventually, all 
of an individual’s medical 
records could be down¬ 
loaded onto a “smart card” 
that the person might carry 
like a credit card. 
Yale-New Haven Hospital 
already has a partial network estab¬ 
lished within the hospital. Funding is 
in place to begin creating the com¬ 
plete PACS. As with any investment 
in new high-tech systems, the risks 
of undertaking the $8-10 million 
build-out of the system are substan¬ 
tial. Some pioneering hospitals cre¬ 
ated early versions of PACS before 
the technology was adequately de¬ 
veloped, and soon had to scrap the 
whole thing. “Timing is everything,” 
says Dr. Neklesa. “We think now is a 
good time to get in.” Department of 
Diagnostic Radiology chair Bruce L. 
McClennan, M.D., agrees: “We’ll be 
able to display, store and share infor¬ 
mation in a high-speed, secure fash¬ 
ion. The clinical networking revolution 
is here.” 
For Vladimir Neklesa, right, and Pradeep Mutalik, the 
future of radiology does not require film. 
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Throwing stones Every day in any large emer¬ 
gency department around the 
country at least one person, 
and usually far more, arrives in 
terrible agony caused by a sharp 
pain in the side. Getting a correct 
diagnosis for the source of the pain 
is the first, all-important, step in 
relieving the misery. The likeliest 
cause for most cases of what 
physicians call “acute flank pain” is 
a kidney stone. Hardened collections 
of mineral salts, literally rocks, build 
up in the kidneys and then enter the 
For the past six decades, physicans have relied on a technique called intravenous pyelogram, left, 
to determine treatment for patients arriving with a sharp pain in the side. The problem was that 
IVP can take as long as 24 hours for results. Four years ago, Yale physicians developed a faster, 
more precise technique—made possible by the advent of helical CT—that in five minutes can dis¬ 
tinguish between a kidney stone, indicated by the arrow above left, and an aortic aneurysm, 
above right. In the case of the aneurysm, immediate surgery saved the patient’s life. 
ureters, the tubes that run from 
the kidneys to the bladder. These 
kidney stones can get stuck, block¬ 
ing urine flow and causing a horrific 
pain that has been likened to child¬ 
birth in its severity. The trouble is 
that other possible causes for 
such pain—from appendicitis to 
tumorous masses—while less likely, 
are not rare. Until doctors find the 
actual cause of the pain, there is 
virtually nothing they can do to 
help. Pain relief medication might ac¬ 
tually make matters worse in some 
cases or even prevent correct 
diagnosis. 
For 60 years, physicians had only 
one method at hand for deciphering 
whether the pain originated with a 
blockage caused by a kidney stone, 
or not. They injected patients intrave¬ 
nously with an iodine solution that is 
rapidly excreted by the kidneys, and 
which then would appear white when 
exposed to X-rays. If there was a 
blockage, the stone itself might not 
be visible, but the distended section 
of ureter above it would be, giving 
which would otherwise be obscured, for damage. Even¬ 
tually, a completely animated, virtual tour of the body 
may be possible. “The potential is great,” says James 
Brink, M.D., vice chair for clinical affairs and associate 
professor of diagnostic radiology, who is working with 
the technology. “Is it ready for primetime? It’s too early 
to tell.” 
IMAGES WITHOUT FILM 
The most far-reaching impact from diagnostic imaging 
advances, however, may be through communication 
technology. Digitizing imaging allows for high-speed 
computer link ups among specialists and clinicians. 
Doctors on opposite sides of the world will be able to 
work together to come up with the best diagnosis and 
treatment lor patients. Digital imaging also reduces the 
space needed for storage of images and the number of 
personnel necessary for maintaining film archives. At 
the same time, it enhances access by allowing those 
with appropriate entry codes to download information. 
“Theoretically,” says Pradeep G. Mutalik, M.D., who 
is director of radiology information technology and is 
developing medical communications systems for the 
Department of Diagnostic Radiology, “the day has ar¬ 
rived when we can dispense with film.” Already some 
military hospitals have gone entirely filmless. Since 1993, 
digital transfer of images has been possible to the inten¬ 
sive care units at Yale-New Haven Hospital. Eventually, 
the entire hospital complex will be wired for digital in¬ 
formation sharing. 
Dr. Mutalik and his colleague Vladimir P. Neklesa, 
M.D., are responsible for setting up Yale’s Picture 
Archiving and Communications System (PACS), includ¬ 
ing a Web-based system in which authorized physicians 
will be able to log on from their office workstation and 
download archived images. (See A Virtual Image Bank) 
The future of radiology as a profession and medicine 
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physicians some good evidence 
about the site and potential danger 
represented by a stone. If it wasn’t a 
stone, then other procedures could 
begin, such as exploratory surgery, to 
figure out what was wrong. Depend¬ 
ing on the degree of obstruction, it 
would take anywhere from 10 min¬ 
utes to 24 hours to get a clear pic¬ 
ture of the ureters. Moreover, in a 
small number of cases, patients de¬ 
veloped adverse reactions to the in¬ 
jected contrast material, and in rare 
cases, those reactions were life- 
threatening. Even when the pictures 
came in, at best, this long-standard 
diagnostic method, called intrave¬ 
nous pyelogram (IVP), provided only 
a partial map to the stone. Whether 
urologists should try an intervention 
of some sort or just wait to let the 
stone pass on its own was often a 
matter of educated guess work. 
Then, in 1993, Yale-New Haven Hos¬ 
pital acquired a new helical com¬ 
puted tomography (CT) scanner. 
A standard CT scanner employs a 
doughnut-shape X-ray camera 
adapted to a computer to achieve 
high-resolution images quickly. It 
takes from three to five seconds to 
make each image, or cross-sectional 
slice, with any extended region of 
the body, such as a flank being ex¬ 
amined for a source of pain, requir¬ 
ing 20 to 30 minutes. The patient 
needs to hold completely still 
throughout. As such, it wasn’t a prac¬ 
tical tool for figuring out why a pa¬ 
tient was writhing in agony. The new 
helical CT scanner, however, took the 
basic CT technology and sped it up 
enormously. A partial body scan that 
previously took a half-hour can now 
be completed in less than a minute. 
Beginning that summer, a team of 
Yale radiologists and urologists, 
headed up by Robert C. Smith, M.D., 
associate professor in the Depart¬ 
ment of Diagnostic Radiology, took 
patients arriving with symptoms of 
kidney stones and ran them through 
the new helical CT machine. They 
then compared them with a similar 
number who underwent a standard 
diagnostic procedure. Kidney stones 
will never look the same again. With¬ 
out using any contrast material, soft 
tissue appears gray and all stones 
white under CT scans. “We not only 
see the blockage,” says Dr. Smith, 
“we can see the stone perfectly fine 
as well. We were able to see the 
stone in virtually every case.” And 
the helical CT scan could detect 
appendicitis, masses in ovaries 
and other less common sources 
of flank pain. 
Over the next two years, Dr. 
Smith’s team performed helical CT 
scans on more than 800 patients 
experiencing acute flank pain. Diag¬ 
nostic accuracy proved higher than 
IVR and the scans provided much 
more exact information about the 
size and location of any stones that 
were found, making treatment deci¬ 
sions more effective. Patients who 
once may have waited more than a 
day in the hospital before diagnosis 
could be made now start treatment 
in a matter of minutes. “Usually,” 
says Dr. Smith, “we have an answer 
within five minutes. No matter how 
you look at it, CT is more accurate 
and faster, and there is no known 
harm other than the necessary low- 
level radiation exposure." As a result 
of the Yale study, helical CT scan is 
now the standard diagnostic proce¬ 
dure for flank pain in most major 
hospitals around the world. 
as a whole will be radically altered by so-called 
“teleradiology,” in which radiologists will provide service 
to a large region from a single center. “People now see 
the world through their computers,” says Howard P. 
Forman, M.D., vice chair for finance and administration 
in diagnostic radiology. “We constantly ask ourselves, 
How can we deliver information and images to physi¬ 
cians in a seamless manner?” 
SOFTWARE VERSUS HARDWARE 
While the tremendous value of many of the technologies 
is now readily apparent, not all high-tech medical equip¬ 
ment has proven its worth. For many years, promising 
and extremely expensive new imaging technology 
seemed to arrive at the medical marketplace every few 
months. Medical centers invested huge sums to acquire 
advanced equipment and systems, in some cases only to 
see it superseded within months. The almost crazed pace 
“It used to be a new technology 
came along and we looked for 
ways to apply it. Now, we develop 
applications from the technology 
that has stabilized. The cutting 
edge has slowed down.” 
— Howard P. Forman 
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Imaging the eye 
New diagnostic tool offers 
insight into glaucoma 
Laser technology that produces 
a three-dimensional image of 
the optic nerve may help oph¬ 
thalmologists detect the subtle 
changes that signal the earliest 
stages of glaucoma. The process, 
known as confocal scanning laser 
tomography, is undergoing clinical 
trials at Yale and the University of 
California at Los Angeles. 
Glaucoma is a condition in which 
people lose their vision because of 
abnormally high pressure in the eye. 
The pressure is the result of fluid 
buildup caused by blockage in the 
drainage channel between the back 
of the cornea and the iris. 
"Early detection and appropriate 
treatment are the only methods of 
preventing blindness due to glau¬ 
coma. Both depend on our ability to 
analyze the optic nerve to determine 
if early atrophy is taking place,” says 
M. Bruce Shields, M.D., chair of the 
Department of Ophthalmology and 
Visual Science at Yale School of 
Medicine. His collaborator is Joseph 
Caprioli, M.D., HS '83, who left Yale 
last year to become director of the 
Glaucoma Division of the Jules Stein 
Eye Institute at UCLA School of 
Medicine. “There never has been 
technology sophisticated enough for 
early diagnosis and careful follow¬ 
up,” says Dr. Shields. “That is what 
this laser offers." 
The purpose of the Yale-UCLA 
study is to build scientific evidence 
confirming that the confocal scan¬ 
ning laser is able to reveal optic 
nerve damage more accurately than 
current methods. The scanning laser 
would aid in screening patients for 
glaucoma and guiding treatment of 
those with established disease more 
precisely. The optic nerve contains 
nearly a million fibers that send vi¬ 
sual signals from the retina to the 
Confocal laser scanning produces detailed images of the optic nerve head, which is only 1.5 
millimeters in diameter. Computer analysis of the data generated during scanning provides 
information critical to the management of glaucoma. 
brain. Although glaucoma encom¬ 
passes a large group of disorders, 
the common denominator is gradual 
deterioration of the optic nerve, lead¬ 
ing to blindness. 
The visible end of the nerve, re¬ 
ferred to as the optic nerve head, 
may be compared to the eraser end 
of a pencil, Dr. Shields explains. The 
nerve extends backward from the 
eye to the brain, and the portion that 
can be seen resembles a disc. As 
nerve fibers die, changes occur in 
the contour of the optic nerve head. 
The actual loss of nerve fiber 
bundles and a posterior deformity— 
in which the disc bows backward, 
creating a cup-like malformation— 
are two changes that may be visible. 
During examination with the con¬ 
focal scanning laser, the patient’s 
head rests in a device similar to a 
slit lamp, the standard instrument in 
every ophthalmologist’s office. The 
laser is housed in a camera-like de¬ 
vice in front of the patient’s eye. The 
beam is focused on a small portion 
of tissue in the eye. The reflected 
light passes through an opening said 
to be confocal to the laser focus, so 
that the photodetector “sees” only 
the small area. The beam scans 
back and forth across the nerve. 
Probing deeper with each scan, it 
completes 32 images of nerve tis¬ 
sue in one second. The laser is at¬ 
tached to a computer, which ana¬ 
lyzes data and integrates the im¬ 
ages into a three-dimensional model 
on a monitor. 
For more than a decade, begin¬ 
ning in the 1980s, Dr. Shields and 
Dr. Caprioli corresponded with each 
other about the separate studies 
they were conducting in glaucoma. 
During that time, Dr. Shields was a 
faculty member at Duke University 
and Dr. Caprioli was director of the 
glaucoma service at Yale. They first 
discussed collaborating on clinical 
measurements of optic nerve dam¬ 
age in late 1996 and early 1997. 
Dr. Shields, who also is chief of 
ophthalmology at Yale-New Haven 
Hospital, recently completed a term 
as president of the American Glau¬ 
coma Society. He is author of the 
Textbook of Glaucoma, now in its 
fourth U.S. edition. The book has 
been translated into German, Japa¬ 
nese, Portuguese and Spanish. 
Scientists at about a dozen insti¬ 
tutions around the world, including 
Japan and Finland, are conducting 
research similar to the Yale-UCLA 
study, says Dr. Shields. “Even though 
we feel strongly that this new tech¬ 
nology does offer something we 
don't have today,” he adds, “we 
need long-term clinical trials to 
prove its value.” 
Julie Miller 
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“The powers that be say, ‘How much faster is it?’ ‘How much cheaper?’ 
Were constantly sorting out the hype from what will really bear fruit.” 
— Bruce McClennan 
of imaging technology development that took place in 
the 1980s has slowed considerably as the hardware revo¬ 
lution seems to have crested for the moment. Most re¬ 
cent advances have come about through development of 
software, new applications of existing technologies and 
the convergence of a variety of techniques rather than 
the creation of another new generation of machines. 
“It used to be,” explains Dr. Forman, “the field devel¬ 
oped things in what could be seen as a backward way. 
A new technology came along and we looked for ways 
to apply it. Now, we develop applications from the 
technology that has stabilized. The cutting edge has 
slowed down.” 
Part of that slowing has occurred because of eco¬ 
nomics. The arrival of managed care has meant that the 
high cost of purchasing high-tech care systems must be 
justified through improved patient outcomes over exist¬ 
ing forms of treatment. With a new, high-power fMRI 
machine costing more than $4 million just to purchase 
and millions more to operate, clinicians and researchers 
need to prove that it will not only provide better clinical 
outcomes for patients, but will pay its own way. Clini¬ 
cians must now think both like healers and like business 
managers. Says department chair Dr. McClennan: “It’s a 
different world. The assessment of technology is much 
more demanding because there is such a constraint on 
resources. The powers that be say, ‘How much faster is 
it?’ ‘How much cheaper?’ and ‘Show me the outcome 
studies before I’ll spend a dollar.’ We re constantly sort¬ 
ing out the hype from what will really bear fruit.” 
Given the enormous costs of equipment and the 
rapid sweep of technological change in diagnostic imag¬ 
ing, the risks of doing a high-tech belly flop are great. 
The School of Medicine is continuously bombarded by 
companies seeking testing and adaptation of their equip¬ 
ment. The capabilities claimed by the manufacturers of 
these new technological wonders sometimes vastly out¬ 
pace reality. There are occasions when new systems can 
do more than the current state of patient care and aca¬ 
demic research actually demand. Says Dr. McClennan: 
“We need to ask, where is the technology leading us and 
who is in charge? The challenge is to keep medicine and 
technology married and not get distracted.” Like most 
marriages, the road has sometimes been bumpy, but it’s 
a marriage that all believe will continue. YM 
Magnetic resonance images of the brain, shown 
above, along with electrophysiology recordings, 
are used to identify the approximate locations of 
seizure-generating brain tissue. Using a stereotac¬ 
tic frame, the tissue to be studied is targeted (in¬ 
tersection of yellow lines) and a trajectory plot¬ 
ted. An electrode may then be inserted precisely. 
Healthy Control Parkinson’s Disease 
P% 
Essential Tremor 
• 
Progressive Supranuclear 
Palsy 
These SPECT images of the brain pinpoint 
locations where dopamine transport occurs. 
The images compare healthy individuals to 
patients with Parkinson’s disease and two other 
disorders in which dopamine tranfer is impaired, 
progressive supranuclear palsy and essential 
tremor. The technique is being evaluated for the 
diagnosis and monitoring of Parkinson's and 
related diseases. 
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FACULTY NEWS 
Faculty join Institute of Medicine 
Three medical school faculty 
members are among the 60 
new members elected to the 
Institute of Medicine. They are: 
► Mark R. Cullen, M.D. ’76, pro¬ 
fessor of medicine (occupational and 
environmental medicine) and of pub¬ 
lic health, and director of the Yale 
Occupational and Environmental 
Medicine Program. Dr. Cullen has 
centered his work on strategies for 
investigation of toxic agents causing 
health effects in humans. Two of his 
current research areas focus on occu¬ 
pational asthma, particularly due to 
diisocyanates, and host factors in 
asbestos-related pulmonary fibrosis 
and lung cancer. 
► Ralph 1. Horwitz, M.D., the 
Harold H. Hines Jr. Professor of 
Medicine and Epidemiology and 
chair of the Department of Internal 
Medicine. Dr. Horwitz has conducted 
clinical research on a wide range of 
topics, including the link between 
Reye’s syndrome and aspirin, heart 
attacks, asthma and the use of inhal¬ 
ers, prostate gland and surgical treat¬ 
ment, and the epidemiologic aspects 
of disease. 
George Miller 
Mark 
► George Miller Jr., M.D., the John 
F. Enders Professor of Pediatric Infec¬ 
tious Diseases and professor of epidemi¬ 
ology and of molecular biophysics and 
biochemistry. Dr. Miller concentrates 
his research on tumor viruses, including 
the Epstein-Barr and Kaposi’s sarcoma 
viruses. 
FACULTY N 
James J. Abrahams, M.D., associate 
professor of diagnostic radiology and 
surgery (otolaryngology), presented an 
abstract titled Augmentation Procedures 
of the Jaw in Patients with Inadequate 
Bone for Dental Implants: Radiographic 
Appearance, at the annual meeting of the 
Radiological Society of North America 
in Chicago in December. 
Hoffman-LaRoche Symposium held in 
September at the National Museum of 
American History in Washington. Dr. 
Burrow’s talk was titled Preparing for the 
Information Age in Health Care. 
Liza Cariago-Lo, M.S., Ed.D., has 
been named director of the Office of 
Multicultural Affairs and will work un¬ 
der the direction of Assistant Dean 
Forrester A. Lee, M.D. ’79. 
Gerard N. Burrow, M.D. ’58, the 
David Paige Smith Professor of Medi¬ 
cine (endocrinology) and special advisor 
to the president for health affairs, was 
among the speakers at a Smithsonian/ 
J.G. Collins, Ph.D., professor of anes¬ 
thesiology and lecturer in pharmacology, 
and D. Helaine Patterson, director of 
medical school public information, are 
among seven individuals selected to be- 
Ralph I. Horwitz 
come the first fellows of Connecticut 
United for Research Excellence Inc. 
(CURE). Dr. Collins was recognized for 
his efforts, inspiration, leadership and 
vision as a past chair of CURE and his 
role as founding father of BioRAP, a life 
sciences learning publication for middle 
school students sponsored by CURE. 
Ms. Patterson was recognized for her 
public relations advice and editorial 
oversight on many CURE publications. 
James P. Comer, M.D., HS ’64-67, the 
Maurice Falk Professor in the Child 
Study Center and Department of Psy¬ 
chiatry and director of the School De¬ 
velopment Program, was one of three 
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recipients of the Camille O. Cosby- 
World of Children Award in November. 
The award, given by the Judge Baker 
Children’s Center in Boston, is named 
in honor of the wife of entertainer 
Bill Cosby and recognizes outstanding 
achievement in improving the lives of 
disadvantaged children. The other two 
recipients were children’s advocate 
Tipper Gore and BankBoston CEO 
Chad Gifford. 
Vincent T. DeVita, M.D., director of 
the Yale Cancer Center and professor of 
medicine (oncology) and epidemiology 
and public health, received the Key to 
the Cure Award at the Cure for Lym¬ 
phoma Foundation’s third annual Caba¬ 
ret for a Cure dinner in November at 
the Plaza Hotel in New York City. He 
was also presented the Presidential 
Award from the New England Cancer 
Society at its annual meeting this fall in 
New Haven. 
John Elefteriad.es, M.D. ’72, professor 
and chief of cardiothoracic surgery, was 
named College Governor-Elect for Con¬ 
necticut by the Board ofTrustees of the 
American College of Cardiology. After a 
one-year term, he will become College 
Governor for the state until the year 
2002. Dr. Elefteriades also served as vis¬ 
iting professor in August in Japan, 
where he spoke on minimally invasive 
cardiac surgery and left ventricular re¬ 
modeling by aneurysmectomy and 
Batista operations. 
Janine Evans, M.D., assistant professor 
of medicine (rheumatology), has been 
appointed medical director of the Yale- 
New Haven Physician Hospital Organi¬ 
zation and the Yale-New Haven Medical 
Staff Independent Practice Association 
(IPA). In this dual role, Dr. Evans will 
collaborate with Yale University, Yale 
Faculty Practice and community physi¬ 
cians on the IPA to coordinate effective 
medical management, utilization and 
quality assurance in the delivery of 
health care. She will also work with phy¬ 
sicians to develop programs and policies 
that support high-quality, cost-effective 
health care to the patients who are cov¬ 
ered through health plans that have con¬ 
tracted with the Yale New Haven 
Health System. 
Bruce C. Fichandler, PA-C ’73, physi¬ 
cian assistant in surgery, lecturer in sur¬ 
gery (plastic), and director of admissions 
for the Yale Physician Associate (PA) 
Program, was presented the Second 
Annual Alumni Award at PA graduation 
ceremonies in August. He also received 
the Jack Cole Society Award for his 
significant contributions in support of 
the physician associate profession. 
Society namesake Jack W. Cole, M.D., 
former chair of surgery and a founder of 
the PA Program, gave the Commence¬ 
ment address. 
Myron Genel, M.D., associate dean for 
government and community affairs and 
professor of pediatrics, was re-elected to 
the American Medical Association’s Sci¬ 
entific Council and named to its execu¬ 
tive committee by the AMA House of 
Delegates at the annual meeting in June. 
Gerhard H. 
Giebisch, 
M.D., Sterling 
Professor of 
Cellular and 
Molecular 
Physiology, 
was awarded 
an honorary 
doctorate from 
the University Gerhard H. Giebisch 
of Vienna in 
June. The award was given in conjunc¬ 
tion with a symposium entitled Renal 
Electrolyte Metabolism Physiology and 
Pathophysiology, on the occasion of Dr. 
Giebisch’s 70th birthday. The event 
was organized by John P. Geibel, M.D., 
Ph.D., associate professor of surgery 
(gastroenterology) at Yale, and Jurg 
Graf, M.D., of the department of gen¬ 
eral and experimental pathology at the 
University of Austria. Speakers from 
Yale included Walter F. Boron, M.D., 
Ph.D., professor and chairman of cellu¬ 
lar and molecular physiology, and 
Peter S. Aronson, M.D., C.N.H. 
Long Professor of Internal Medicine 
(nephrology) and of cellular and mo¬ 
lecular physiology, and chief of the sec¬ 
tion of nephrology. 
Thomas M. Gill, M.D., assistant pro¬ 
fessor of medicine (geriatrics), was one 
of 10 junior faculty to receive the Paul 
Alumnus Bruce Fichandler with Elaine Grant, 
assistant dean and director of the Physician 
Associate Program. 
Beeson Physician Faculty Scholars in 
Aging Research Award from The Ameri¬ 
can Federation for Aging Research. This 
$450,000 award is funded by the John 
A. Hartford Foundation, the Common¬ 
wealth Fund, and the Alliance for Aging 
Research on behalf of donor friends. 
He also received a $240,000 Generalist 
Physician Faculty Scholars Award from 
The Robert Wood Johnson Foundation, 
the nation’s largest philanthropy de¬ 
voted exclusively to health and health 
care. Both awards will support Dr. Gill’s 
research on identifying the precipitating 
events leading to new dependence in ac¬ 
tivities of daily living among frail, com¬ 
munity-living elderly persons. “This re¬ 
search,” says Dr. Gill, “will lead to an 
improved understanding of the dis¬ 
abling process and, in turn, will enable 
investigators to better design effective 
and efficient strategies to prevent, slow 
or reverse functional decline.” 
Caleb Gonzalez, 
M.D., professor 
of ophthalmol¬ 
ogy, was one of 
five pediatric 
ophthalmologists 
to receive the 
Honor Award 
from the Ameri¬ 
can Association 
for Pediatric Ophthalmology and Stra¬ 
bismus (AAPOS) at its annual meeting 
in April in Charleston, S.C. This award 
Caleb Gonzalez 
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is to recognize outstanding achievement 
and distinguished service to the 
AAPOS. Dr. Gonzalez received a similar 
honor in 1992 from the American Acad¬ 
emy of Ophthalmology. 
Martin E. Gordon, M.D. ’46, clinical 
professor of medicine and chairman of 
the Board of Trustees of the Associates 
of the Harvey Cushing/John Hay 
Whitney Medical Library, was one of 
the three Deans of the Academy, finalist 
judges for more than 600 entries to the 
American Medical Association’s 1997 
International Health and Medical Film 
Competition in November in San Fran¬ 
cisco. Dr. Gordon was a John Muir Film 
Festival winner in 1976 and has received 
numerous other awards as a director/ 
producer of medical films. 
Charles A. Greer, Ph.D., professor of 
neurosurgery and neurobiology, orga¬ 
nized and chaired the joint meeting of 
the International Symposium on Olfac¬ 
tion and Taste XXI and the Association 
for Chemoreception XIX meeting in 
San Diego. The joint meeting, which 
occurs every 12 years in the U.S., was 
the largest to date and included 652 pre¬ 
sentations from around the world. 
Pasko Rakic, M.D., chairman and 
Dorys McConnell Duberg Professor of 
Neurobiology, was honored during the 
meeting with the 19th Givaudan-Roure 
Lectureship. 
Donald W. Kohn, M.D., clinical pro¬ 
fessor of surgery (dental) and pediatrics, 
and chief of dentistry at Yale-New 
Haven Hospital, was named president 
of the International Association of Pedi¬ 
atric Dentistry at the Association’s XVI 
Congress in Buenos Aires in September. 
Keat-Jin Lee, M.D., associate clinical 
professor of surgery (otolaryngology), 
spoke on the Advanced Points of Ear 
Surgery at the annual Chilean Congress 
of Ear, Nose, Throat Conference in 
Chile in November. He is also Secre¬ 
tary-Treasurer of the American Academy 
of Otolaryngology until 1999. 
Richard H. Mattson, M.D. ’53, profes¬ 
sor of neurology and vice chair for aca¬ 
demic affairs, was honored with the 
1997 Clinical Investi¬ 
gator Award by the 
American Epilepsy 
Society/Milken Fam¬ 
ily Foundation Epi¬ 
lepsy Research Award 
Program. The award 
was given in Boston 
in December for his Richard H. Mattson 
epilepsy research over 
a 35-year period. In another presenta¬ 
tion, Dr. Mattson was awarded the 
Novartis Epileptology Prize for 1997 at 
the 22nd International Epilepsy Con¬ 
gress in Dublin last July. The prize was 
given in recognition of his outstanding 
achievements in the field of epilepsy 
with a particular interest in researching 
the optimal use of anti-epileptic drugs. 
Dr. Mattson was also selected as the 
Hans Berger Lecturer at the 25th Hans 
Berger Symposium in June. This honor 
was based on early work on sleep depri¬ 
vation, as well as on intensive CCTV/ 
EEG monitoring studies. 
The Albert Schweitzer Institute for the 
Humanities sponsored James R. 
Merikangas, M.D., lecturer in psychia¬ 
try and attending in psychiatry and 
neurology at Yale-New Haven Hospital, 
to present seminars in child psychiatry 
and neurology to the faculties of Vilnius 
University Center for Children with 
Developmental Disorders in Lithuania 
and the universities ofTartu and Tallinn 
in Estonia. These seminars, funded 
by the Open Society Institute/Soros 
Foundation, were held from June 27 
to July 3, 1997. 
Marvin Moser, M.D., clinical professor 
of medicine, was recognized for out¬ 
standing contributions to hypertension 
New chair for Cell Biology 
When Pietro De Camilli, M.D., returned to Italy in 1981 after three years as a 
postdoctoral fellow and assistant professor at the School of Medicine, chairing 
a department at Yale was the furthest thing from his mind. But events brought 
him back to New Haven in 1987, and last Nov. 1, after another decade on the 
faculty, he assumed the leadership of the Department of Cell Biology for a two- 
year term. Since his postdoctoral days in the late 1970s, he has focused his re¬ 
search on synapses, the junctions which transmit information between neurons 
in the brain. “These studies have a direct impact in the fields of neurological 
and psychiatric diseases, but also have general relevance in cell biology,” says 
Dr. De Camilli, who studied medicine and endocrinology at the universities of 
Milan and Pavia. Dr. De Camilli is a Howard Hughes Medical Institute investigator 
and serves on the boards of a half-dozen journals including the Journal of Neuro¬ 
science. The department has 11 primary investigators and 43 graduate students. 
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NEW BO K S treatment and control by the National 
Heart, Lung & Blood Institute at the 
25th anniversary dinner of the National 
High Blood Pressure Education Pro¬ 
gram in November in Washington. 
Dr. Moser has been the senior medical 
consultant to the national program for 
24 years. 
Eric J. Nestler, M.D. ’83, Ph.D. ’82, 
professor of psychiatry, neurobiology, 
and pharmacology, and Benjamin S. 
Bunney, M.D., the chair and Charles 
B.G. Murphy Professor of Psychiatry 
and professor of pharmacology, partici¬ 
pated in the Consensus Development 
Conference on Effective Medical Treat¬ 
ment oi Heroin Addiction in November 
at the National Institutes of Health in 
Bethesda, Md. 
Herbert S. Sacks, M.D. ’52, clinical 
professor of child and adolescent psy¬ 
chiatry at the Child Study Center, be¬ 
came president of the 42,000-member 
American Psychiatric Association in 
July. Dr. Sacks will use his office to 
speak out on behalf of children and for 
reforms in the juvenile justice system. 
Gerald I. Shulman, M.D., Ph.D., pro¬ 
fessor of medicine (endocrinology), and 
of cellular and molecular physiology, 
was one of two researchers awarded the 
Boehringer Mannheim and the Juvenile 
Diabetes Foundation International Dia¬ 
betes Care Research Award for 1997. 
The $100,000 prize, presented at the In¬ 
ternational Diabetes Federation Meeting 
in July in Helskini, is awarded to stimu¬ 
late innovation in the field of diabetes 
research leading to practical advances in 
prevention, detection, treatment and 
cure for diabetes and its complications. 
Scott W. Wolfe, M.D., associate profes¬ 
sor of orthopaedic surgery and director 
of the orthopaedic and rehabilitation 
department’s hand and upper extremity 
service, is the recipient of the 1997-1998 
Bunnell Traveling Fellowship in Hand 
Surgery, awarded annually by the 
American Society for Surgery of the 
Hand. This award provides funds for 
travel to international and/or domestic 
medical centers to pursue educational 
interests in the study of the hand. Dr. 
Wolfe will report on his educational ex¬ 
perience at the 1997-1998 residents and 
fellows conference and annual meeting 
of the society. 
Eiji Yanagisawa, M.D., clinical profes¬ 
sor of surgery (otolaryngology), was 
guest of honor at the 77th Annual 
Scientific Meeting of the American 
Broncho-Esophagological Association 
in Scottsdale, Ariz., last May. He also 
served as one of two judges from the 
United States at the World Video Festi¬ 
val held in conjunction with the XVIth 
World Congress of Otorhinolaryngol¬ 
ogy and Head and Neck Surgery in 
Sydney, Australia, last March. In Febru¬ 
ary 1997, he was guest lecturer at the 
International Symposium on Endo¬ 
scopic Surgery in Otolaryngology in 
Mexico City. 
Rallying the Whole Village: The Comer 
Process for Reforming Education edited by 
James P. Comer, M.D., HS ’64-67, 
Maurice Falk Professor of Psychiatry; 
Norris M. Haynes, 
Ph.D., associate 
professor; Edward 
T. Joyner, Ed.D., 
M.A.T., lecturer; 
and Michael Ben- 
Avie, M.A., 
M.Phil., associate 
research scientist, 
all in the Child 
Study Center, 
Teachers College 
Press (N.Y.) 1996. 
Some Chose to Stay: Faith and Ethics in 
a Time of Plague by Alan C. Mermann, 
M.D., M.Div. ’79, medical school chap¬ 
lain and clinical professor of pediatrics, 
Humanities Press (N.J.) 1997. 
Sports and Exercise for Children with 
Chronic Health Conditions edited by 
Barry Goldberg, M.D., HS ’71, director 
of sports medicine at the University 
Health Services, clinical professor of 
pediatrics. Human Kinetics Publishers, 
Inc. (Ill.) 1995. 
Reverie and Interpretation: Sensing 
Something Human by Thomas H. 
Ogden, M.D. ’72, Jason Aronson Inc. 
(N.J.) 1997. 
The Yale University School of Medicine 
Patient’s Guide to Medical Tests by faculty 
members at the Yale University School 
of Medicine. Senior editor Barry L. 
Zaret, M.D. is Robert W. Berliner 
Professor of Medicine and professor of 
diagnostic radiology. Peter 1. Jatlow, 
M.D., HS ’65, professor oflaboratory 
medicine and psychiatry, and Lee D. 
Katz, M.D., HS ’86, associate professor 
of diagnostic radiology, orthopaedics 
and rehabilitation and medicine, are 
associate editors. Houghton Mifflin 
Company (Boston/N.Y.) 1997. 
Entrance to Sterling Hall of Medicine, Winter 1998 
Rallying the 
Whole Village 
The Comer Process for 
Reforming Education 
James P. Comer 
Norris M, Haynes 
Edward T. Joyner 
Michael Ben-Avie 
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Medical school chaplain promotes 
a curriculum of caring 
By Carolyn Battista 
Medical school chaplain Alan Mermann's new 
book explores the importance of the human 
connection in medicine. 
It’s a rare medical school that has its 
own chaplain, especially a chaplain 
who frequents the anatomy lab and 
writes about Albert Camus. But at Yale, 
that personage is Alan C. Mermann, 
M.D., M.Div. ’79 who trained and 
practiced as a pediatrician and is now a 
clinical professor of pediatrics. He’s also 
an author whose varied writings include 
a new book of essays entitled Some 
Chose to Stay: Faith and Ethics in a Time 
of Plague, published in December by 
Humanities Press. 
Ordained as a minister in 1979 
after 25 years in pediatric practice, 
Dr. Mermann says that he often visits 
the first-year anatomy lab, “just to be 
there.” He knows how hard it is for 
young medical students to deal with 
that first cadaver. His essays describe 
his own experiences in finding a foun¬ 
dation on which to build a life of con¬ 
viction and commitment. This is the 
focus of much of his work at the medi¬ 
cal school, where he teaches, listens, 
counsels and involves students in eye¬ 
opening activities. 
He points out that at Yale, where stu¬ 
dents may hold any, or no, religious be¬ 
liefs, his work usually has little to do 
with formal religion. It has everything 
to do with helping students understand 
what it means—and what it takes—to 
be a good doctor. 
Students want to become “caring, 
compassionate physicians,” he says, but 
they worry about losing compassion as 
they train in hectic hospital settings 
(where the patient may seem less a per¬ 
son than the subject of clinical labora¬ 
tory reports). He aims to help students 
keep on caring. 
One essay in his new book deals with 
Albert Camus’ 1956 novel, The Plague. A 
major character is a physician who never 
abandons the plague victims, and Dr. 
Mermann points out that a major 
theme is how important it is to be with 
and for people. “This is something that 
can be taught,” he says. “You can learn 
how to do it, and it’s something that 
should constantly be a part of medical 
education.” His essay goes on to de¬ 
scribe his seminar in which first-year 
medical students are paired with seri¬ 
ously ill patients—often, people who are 
dying. It’s a seminar with much to teach 
about being with and for others. “The 
patients teach the students,” he says. 
As chairman of the pediatric bioethics 
committee at Yale-New Haven Hospital, 
Dr. Mermann also includes students in 
meetings where parents and physicians 
discuss painfully difficult decisions—-for 
example, how long to provide extended 
life support when a 3-year-old has suf¬ 
fered serious brain damage in a car acci¬ 
dent. “We just sit and talk, until all 
comments and opinions have been 
voiced,” he says. “It can take a while.” 
Students learn that in medicine, there 
often are no easy answers. 
He also hopes to show students that 
medicine is not something to practice 
competitively. Collegiality and the shar¬ 
ing of knowledge are most important. 
“We’re in this together,” he tells them. 
His essays touch on many books—in¬ 
cluding the Bible, Walden and Cry, the 
Beloved Country—that along with vari¬ 
ous experiences have shown him what 
needs to be done. He tells of his deci¬ 
sions to become a pediatrician and a 
minister, and to take action amidst 
such plagues as disease, poverty, racism 
and war. 
He hopes that his work can help stu¬ 
dents awaken to what lies around and 
before them. “Physicians,” he says, 
“need to be alert.” 
Carolyn Battista is a writer in Waterford, 
Conn. 
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For the new dean, a welcome to Yale 
Symposium stresses crucial links between science and health 
Four of Yale’s leading research scientists and physicians 
presented findings and an overview of their work at an 
October symposium welcoming David A. Kessler, 
M.D., to the school as dean. On a day focused on the applica¬ 
tion of research to clinical medicine, their reports were fol¬ 
lowed by a discussion among leaders of several of the world’s 
top private-sector research operations. 
Advancing the Public’s Health Through Research included 
presentations by Marie E. Egan, M.D., assistant professor of 
pediatrics (respiratory); Erol Fikrig, M.D., associate professor 
of medicine (rheumatology); David B. Simon, M.D., assistant 
professor of medicine (nephrology); and Tian Xu, Ph.D., as¬ 
sistant professor of genetics and an investigator at the Howard 
Hughes Medical Institute. It was moderated by Richard P. 
Lifton, M.D., Ph.D., professor of medicine, genetics and mo¬ 
lecular biophysics and biochemistry, and an investigator at the 
Howard Hughes Medical Institute. 
The presentations—on work related to cystic fibrosis, 
Lyme disease, hypertension and cancer—were followed by a 
roundtable discussion by senior research executives at five 
major pharmaceutical and technology companies. The speak¬ 
ers—Michael J. Berendt, Ph.D., of Bayer Corp.; George M. 
Milne, Ph.D., of Pfizer; Peter Mueller, Ph.D., of Boehringer- 
Ingelheim, Inc.; Mark C. Rogers, Ph.D., of Perkin Elmer; and 
Peter S. Ringrose, Ph.D., of Bristol-Myers Squibb—discussed 
Creating a Positive Relationship Between Academia and Indus¬ 
try: Promise and Challenges. The discussion was moderated by 
Gregory E. Gardiner, Ph.D., director of the Yale Office of 
Cooperative Research. 
At the end of the day, Dr. Kessler shared some of his 
thoughts about what it means to be dean at this juncture in 
the school’s history, and what it means to pursue scientific 
discovery at an academic health center. His remarks follow. 
“The days are gone when any one 
aspect of a great university could 
successfully exist without a 
passionate interaction of all the 
parts with the whole.” 
Dean Kessler spoke of a new unity: “We must bind 
ourselves together.” 
Remarks by David A. Kessler, M.D. 
It gives me enormous pleasure to stand before you as the 15th 
dean of the Yale School of Medicine. It is an honor to have 
been chosen to lead this institution into the next century. 
There is no better place I’d rather be than here at Yale. I am 
particularly honored to stand here tonight among two of our 
former distinguished deans, Jerry Burrow and Bob Berliner. 
I accept the responsibility of continuing their stewardship. 
It is a source of satisfaction to know that I have come to a 
place that has maintained its standards of excellence in a 
world of ever-changing perspectives. But it is also an exciting 
challenge to contemplate the work that lies ahead. For excel¬ 
lence is elastic, it knows no limits, and it is maintained not 
only by the preservation of the best of the past, but by the 
need to dare, and the willingness to embrace both innovation 
and experimentation. 
Excellence is a reflection of spiritual wealth, and the conser¬ 
vation of that wealth is a notion that is cherished at Yale. This 
Yale idea of excellence is composed of two impulses that are 
interwoven. The first is the diversity of our institution, our 
schools and the departments within them, each intellectually 
independent and protective of that independence. The second 
is the universal purpose of the institution as a whole, which 
binds together the various parts and makes them greater than 
each would be standing alone. 
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Aristotle said that man is by 
nature a social animal. We go to 
schools, we marry, have families, 
join churches and clubs together in dis¬ 
crete bundles that are stabilized, for the 
most part, by a morality of our own 
making. This morality, this moral glue 
that binds us together, comes from di¬ 
verse sources. It comes from within us, 
from family teaching, from our religious 
institutions and our centers of learning. 
But it also comes from a central pur¬ 
pose, a shared goal that can be achieved 
when the parts of the whole are meshed 
together and working toward that end. 
In a great university, there must be a 
sense of union between the diverse 
parts and the whole. But this union is 
something that we are inclined to dis¬ 
trust. We tend to fear that a common 
identity or a common cause might con¬ 
ceal important differences between us, 
might repress our particular interests 
and principles. We are tempted to with¬ 
draw behind parochial barricades, pre¬ 
ferring a smaller loyalty to that of a 
larger and seemingly impersonal power. 
And when this happens, when the 
privileges of the parts become more im¬ 
portant than the larger structure of the 
institution, then the glow of our excel¬ 
lence is dimmed, and we are all the los¬ 
ers. Without in any way diminishing the 
independent methods of any school, 
department or individual, we must bind 
ourselves together. 
In short, we must be one. For the 
days are gone when any one aspect of a 
great university could successfully exist 
without a passionate interaction of all 
the parts with the whole. 
The basic science departments and 
the clinical departments. 
The health system, the hospital, and 
the medical school. 
The community physicians and the 
full-time faculty. 
The School of Public Health and the 
School of Medicine. 
The School of Management and the 
Faculty of Arts and Sciences. 
And the medical school within the 
University. 
All of these parts of the whole must 
share a united vision of the future that 
focuses on what we want to accomplish. 
Without that communal outlook, we 
will never attain our highest goals. With 
it, there are no limits. 
I have come to Yale from the public 
sector. 1 always have been, and will con¬ 
tinue to be, a staunch supporter of pub¬ 
lic service. But 1 must tell you that the 
transition from the public sector to the 
private has presented me with fewer 
problems than I would have thought, 
for 1 see no difference in the goals that 
occupied me there, and the commit¬ 
ments that will occupy me here. I am 
speaking about the commitment to pre¬ 
serve and strengthen the health of the 
public through discovery, through the 
care of patients, and through the educa¬ 
tion of our future physicians. 
But none of these commitments is at¬ 
tainable without a strong team to strive 
toward the common goal. My thanks go 
out the deputy deans, Joe Warshaw and 
Carolyn Slayman, for their strong sup¬ 
port and dedication during the transi¬ 
tion period and for their willingness to 
continue in their most important ca¬ 
pacities; to the chairs, faculty and stu¬ 
dents who made me feel at home from 
the very first day; to our provost, Alison 
Richard; to our deputy provost, 
Stephanie Spangler. 
I learned in Washington that an 
agency head could get things done. 
But I also learned that when an 
agency head linked up with the presi¬ 
dent, you could tackle the impossible. 
And I believe it is the same way at Yale. 
It is no secret that I came to Yale in 
major part because of Rick Levin. Any 
one dean can accomplish only so much. 
A dean and a president, working to¬ 
gether, is something all together differ¬ 
ent; working together to sustain the 
greatness of what is Yale. 
The highest of our goals resides in the 
position of the Yale School of Medicine 
as a truly great research institution. Sci¬ 
ence exists in a continuing state of revi¬ 
sion and progression, and it is this quest 
for new knowledge that drives us toward 
goals of excellence in our basic and 
clinical research endeavors. 
At the scientific symposium this after¬ 
noon, we learned from several of our 
junior faculty about the broad range of 
their research pursuits—from the role of 
a regulatory protein in cystic fibrosis, to 
new treatments for Lyme disease, to in¬ 
sights into the pathophysiology, diag¬ 
nostics, and therapeutics of high and 
low blood pressure, to discoveries in the 
genetics of tumor suppression. 
Decades ago, we did not have the 
tools to study the underlying mecha¬ 
nisms of human disease. So we drew 
lines between basic sciences and clinical 
research. Those lines are being erased by 
advances of scientific understanding. 
To truly erase the lines between basic 
and clinical science, we must include a 
vision of expanded clinical excellence. 
We must advance the clinical agenda of 
the medical school across a broad front 
to fulfill our mission of providing exem¬ 
plary models of care to the public and of 
educating our students at every level. To 
that end, I am committed to continuing 
to build the most outstanding clinical 
faculty who are focused on the study of 
human disease. I am committed to 
working with our partners in the hospi¬ 
tal and health system to advance jointly 
an agenda of clinical excellence at the 
medical center. 
During this year’s White Coat 
Ceremony, I told the first-year 
class that, as we all know, a 
doctor does not become a healer by vir¬ 
tue of a medical degree. I told them that 
each one of them will be a healer if the 
identifiable purposes of their lives are 
forever bound up with the relief of suf¬ 
fering, with the forestalling of death, 
and the creation of conditions that are 
conducive to a more flourishing exist¬ 
ence for their patients. 
I am committed to making the name 
of the Yale School of Medicine synony¬ 
mous with clinical innovation and ex¬ 
emplary clinical practice. 1 will work 
with the clinical leadership to support 
that vision—not at the expense of our 
basic sciences, but in support of them. 
In short, excellence across the board; ex¬ 
cellence in every endeavor, in everything 
we do. The excellence of the Yale com¬ 
mitment to the educational process is of 
great comfort to me, mainly because we 
have an outstanding faculty, and out¬ 
standing students are attracted to such 
men and women. 
1 want our young doctors to be de¬ 
voted forever to a life in medicine. I 
want them to shine in a reflection of the 
excellence that is Yale. 
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ALUMNI/AE NEWS 
Tobacco-control advocate named public 
health chief in Massachusetts 
Howard Kyongju Koh, M.D. ’77, B.A. 
’73. M.P.H., began his dudes as com¬ 
missioner of public health in Massachu¬ 
setts in September. Dr. Koh, former 
director of cancer prevention and con¬ 
trol at Boston University Medical 
Center and a professor at the BU 
schools of medicine and public health, 
has been a prominent leader of anti¬ 
smoking efforts in Massachusetts. He 
helped coordinate tobacco control ac¬ 
tivities in Massachusetts that are cred¬ 
ited for a rapid decline in cigarette con¬ 
sumption (at a rate three times faster 
than the national average). 
He also helped launch a national 
program of skin cancer screenings, 
which have now reached more than a 
million people. Dr. Koh has concen¬ 
trated expertise in malignant melanoma, 
cancer prevention and control, and 
Asian-American health issues. He and 
his wife, Dr. Claudia Anne Arrigg, 
live in Andover, Mass., with their 
three children. Howard Kyongju Koh 
CLASS N 
’30s 
Myron E. Wegman, M.D. ’32, HS ’32- 
36, a fellow of the American Academy of 
Pediatrics and dean emeritus of the Uni¬ 
versity of Michigan School of Public 
Health, received the 1997 E.H. 
Christopherson Lectureship Award at 
the November meeting of the American 
Academy of Pediatrics. The award is 
given annually to one individual in rec¬ 
ognition of his or her outstanding con¬ 
tributions to international child health. 
’40s 
Class secretary Albert S. Atwood, M.D. 
’45, and his wife, Harriet, made a trip 
with class agent Richard W. Breck, 
M.D. ’45, and his wife, Verne, to 
Westchester County’s only winery. They 
visited proprietors George W. 
Naumburg Jr., M.D. ’45, and his wife, 
Michelle, at their North Salem Vine¬ 
yard, said Dr. Breck, who reports: “The 
grapes had just been picked, and even 
the white grape juice was delicious.” 
Robert E. Carroll, M.D. 42, B.A. ’38, 
emeritus professor of clinical ortho¬ 
paedic surgery at the Columbia Univer¬ 
sity College of Physicians and Surgeons, 
was presented the Distinguished Service 
Award at a commencement ceremony in 
May for his outstanding contributions 
to the medical school, hospital and the 
specialty of surgery of the hand. Colum¬ 
bia has established the Robert E. Carroll 
Professorship in Surgery of the Hand in 
the Department of Orthopaedic Sur¬ 
gery. Funds for this chair were provided 
by Dr. Carroll’s friends and family. 
Jerome H. Shapiro, M.D. 48, of Bos¬ 
ton, was awarded a Gold Medal by the 
Radiological Society of North America 
in December 1996 for his contributions 
to teaching and his initiation of stan¬ 
dards in radiology representing excel¬ 
lence in the field of radiology. 
Robert R. Wagner, M.D. ’46, recently 
retired as chair of the department of 
microbiology at the University of 
Virginia School of Medicine. His suc¬ 
cessor, J. Thomas Parsons, Ph.D., and 
his colleagues in the basic sciences, have 
initiated an effort to create the Robert 
R. Wagner Endowed Fellowship Fund 
to benefit graduate students in the basic 
sciences. Dr. Wagner and his wife, 
Mary, live in Charlottesville, Va. 
Morris A. Wessell, M.D. ’43, clinical 
professor of pediatrics, has been 
awarded the C. Anderson Aldrich 
Award in Child Development by the 
American Academy of Pediatrics (AAP). 
The annual award, presented in Novem¬ 
ber at the annual meeting of the AAP’s 
section of developmental and behavioral 
pediatrics in New Orleans, seeks to 
honor a pediatrician whose work with 
children and their development has 
been ground-breaking. Since the first 
award was presented in 1964 there have 
been 36 honorees, 17 with ties to Yale. 
’50s 
Paul Calabresi, 
M.D. ’55, has been 
appointed to Tufts 
University’s Board 
of Overseers for 
the School of 
Medicine, which Paul Calabresi 
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advises the university’s president and 
trustees. Dr. Calabresi is professor of 
medicine (oncology) at Brown Univer¬ 
sity and a member of President Clinton’s 
Cancer Panel. In 1995, he received the 
St. George Medal for distinguished ser¬ 
vice in cancer control by the American 
Cancer Society. He is also a master of 
the American College of Physicians and 
a member of the Institute of Medicine 
of the National Academy of Sciences. 
Robert E. Shope, M.D., HS 54-58, 
served as a member of President 
Clinton’s roundtable discussion on cli¬ 
mate change July 24 at the White 
House. Dr. Shope, professor of pathol¬ 
ogy, microbiology and immunology at 
the University of Texas Medical Branch, 
has devoted his career to the study of 
tropical diseases. He was a faculty mem¬ 
ber in epidemiology at Yale from 1965 
to 1995 and also served as the director 
of medical education in the [department 
of Epidemiology and Public Health 
and director of the Yale Arbovirus 
Research Unit. 
’60s 
Victor J. Burner, M.D. ’65, B.A. 59, of 
Pasadena, Calif., shares news of a musi¬ 
cal trip abroad. He recently toured 
southern China with the Pasadena 
String Quartet, performing in the con¬ 
servatories of Canton and Heng Yang. 
He writes: “You would think we were 
rock stars by our heroic reception! ” 
Philip J. DiSaia, M.D., HS ’67, chief 
of the division of gynecologic oncology 
at the University of California at Irvine, 
has been elected vice president of the 
American Board of Obstetrics and Gy¬ 
necology. He will serve as chairman of 
the board’s policy committee and con¬ 
tinue to serve as member of the execu¬ 
tive committee. 
James J. Murphy, M.D. ’64, has retired 
as chief of radiology at the Asheville 
(N.C.) Veterans Medical Center after 25 
years of federal service. 
R. John C. Pearson, M.P.H. ’60, HS 
’61-62, stepped down as chairman of 
community medicine at the West Vir¬ 
ginia University Health Science Center/ 
Morgantown in September 1996 and 
took a sabbatical to travel to South Af¬ 
rica from June to October 1997. 
Reynold 
Spector, M.D. 
’66, has been 
named executive 
vice president of 
clinical sciences 
at Merck Re¬ 
search Laborato¬ 
ries in Rahway, 
N.J. Dr. Spector 
joined Merck in 
1987 as executive 
director of clinical sciences. He was 
promoted to vice president in 1991 and 
senior vice president in 1994. In 1991 
he received the prestigious Harry Gold 
Award from the American Society of 
Pharmacology and Experimental 
Therapeutics for his research and 
teaching activities. 
’70s 
David A. Adler, M.D. ’73, professor of 
psychiatry at Tufts University School of 
Medicine (TUSM), received a five-year 
National Institute of Mental Health 
grant to study ways of improving detec¬ 
tion and treatment of depression in pri¬ 
mary care practices. He also recently 
completed a term as chairman of the 
TUSM faculty senate and is chairman 
Reynold Spector 
Victor Burner and fellow members of the 
Pasadena String Quartet thread their way 
by boat though the mountains of Gweilin, 
China, last spring. 
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of the publication board at the Group 
for the Advancement of Psychiatry. Dr. 
Adler is senior psychiatrist and director 
at the Mental Health Services Research 
Group at New England Medical Center. 
Richard Doud Bey, M.D. ’79, and his 
wife, Cheryl, of Winston-Salem, N.C., 
are the parents of a new daughter, Maris 
McCammon Bey, born Oct. 30. 
James R. Gonzales, M.P.H. ’78, of 
Nutley, N.J., chief operating officer and 
executive vice president of the East Or¬ 
ange General Hospital, has advanced to 
diplomate status in the American Col¬ 
lege of Healthcare Executives. 
Frederick L, Greene, M.D., HS ’70-76, 
has been named chairman of the depart¬ 
ment of general surgery and program di¬ 
rector of the surgical residency program 
at Carolinas Medical Center in Char¬ 
lotte, N.C. Dr. Green was previously 
professor of surgery at the University of 
South Carolina in Columbia. 
Anthony V. 
Proto, M.D. ’71, 
chairman of the 
department of ra¬ 
diology at the 
Medical College 
of Virginia, Vir¬ 
ginia Common¬ 
wealth University Anthony V. Proto 
in Richmond, has 
been named editor of Radiology by the 
Radiological Society of North America. 
The journal is celebrating its 75th year. 
’80s 
Evangeline Franklin, M.D. ’82, M.P.H. 
’82, recently left University MEDNET 
in Cleveland to become network medi¬ 
cal director at Aetna/U.S. Healthcare 
in Louisiana and Arkansas. At 
MEDNET, she worked as director of 
the immediate care department, as 
medical director of the call center, 
which she implemented for computer¬ 
ized telephone triage, and as chair of 
the Clinical Practices Council. 
William A. Petit Jr., M.D., HS ’85-89, 
of Plainville, Conn., has been named 
medical director of the Joslin Center for 
Diabetes at New Britain General Hospi¬ 
tal and director of the section of endo¬ 
crinology, metabolism and diabetes. 
Jonathan A.S. Sherman, who attended 
the School of Medicine for three years 
as a member of the Class of 1988, 
phoned as Yale Medicine was going to 
press to report that his loving wife 
Karen Avenoso died of cancer Feb. 25. 
She was a graduate of Dartmouth Col¬ 
lege, a Rhodes scholar and a reporter for 
the Boston Globe. Mr. Sherman, who 
went on to graduate from Harvard Busi¬ 
ness School, is a senior manager of mar¬ 
keting at Johnson & Johnson and lives 
in Westfield, N.J. 
Institute of Medicine adds Yale alumni/ae 
to its rolls 
Four Yale University School of Medicine 
alumni/ae have been elected to the Insti¬ 
tute of Medicine. 
Three of the new members are 
Jennifer R. Niebyl, M.D. ’67, professor 
and head of the department of obstetrics 
and gynecology at the University of 
Iowa Hospitals and Clinics in Iowa 
City; Helen L. Smits, M.D. ’67, 
president and medical director of 
HealthRight Inc. in Meriden, Conn.; 
and Mark R. Cullen, M.D. ’76, 
(See Faculty News). In addition, Aaron 
T. Beck, M.D. ’46, the University 
Professor Emeritus of Psychiatry at the 
University of Pennsylvania School of 
Medicine, was elected to senior mem¬ 
bership. [Dr. Beck also received the 
Cummings PSYCHE Award in Septem¬ 
ber from the Nicholas & Dorothy 
Cummings Foundation, which cited 
him as “one of the major figures of 
20th-century psychotherapy.” The 
award, made in cooperation with the 
Institute for Behavioral Healthcare in 
Portola Valley, Calif, included a cash 
prize of $50,000 and a bronze statute 
of the Greek goddess Psyche.] Jennifer R. Niebyl 
Alumni Fund Report will include campaign highlights 
The 1996-97 annual report of the Medical School 
Alumni Fund will be published separately and mailed 
this spring. It will include a final report on the School 
of Medicine portion of the campaign ...and for Yale. 
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Kim A. Eagle, M.D., HS ’79-8}, was 
guest lecturer at Medical Grand Rounds 
on Nov. 20, where his topic was The 
Perspective Cardiac Evaluation of Patients 
Preoperatively. Dr. Eagle is the Albion 
Walter Hewlett Professor of Medicine 
(Section of Cardiology) at the Univer¬ 
sity of Michigan School of Medicine. 
Following his Yale training, he com¬ 
pleted a cardiology fellowship at 
Harvard University and remained on 
the faculty in Cambridge until moving 
to Michigan in 1994. Dr. Eagle also pre¬ 
sented at Cardiology Grand Rounds, 
where a dialogue on health care in the 
current setting of managed care ensued. 
Dr. Eagle reminisced on The Environ¬ 
ment for Learning the Tradition of 
Training, which warmly colored the 
recollection of his New Haven years. 
Dr. Eagle has published and lectured 
extensively on preoperative cardiovascu¬ 
lar evaluation procedure prior to cardiac 
or non-cardiac surgery. In the evolving 
era of managed health care, Dr. Eagle 
has been part of a Consultative Task 
Force of the American Heart Associa¬ 
tion attempting to provide practice 
guidelines in this area. 
Paul A. Khavari, M.D., Ph.D. ’88, HS 
’88-90, was the Neville & Lucille Kirsch 
Guest Lecturer Dec. 3 in the Depart¬ 
ment of Dermatology. Dr. Khavara, 
assistant professor of dermatology at 
Stanford, spoke on Cutaneous Gene 
Therapy, then delivered grand rounds on 
Gene Regulatory Mechanisms of Epithelial 
Growth. His special interests include 
insights into gene therapy, molecular 
mechanisms of disease and molecular 
foundations of anti-cancer therapies. 
The recipient of many awards while at 
Yale and since, Dr. Khavari is an advi¬ 
sory member of many national derma¬ 
tology organizations and at NIH. He 
has published widely in the dermatology 
literature. 
The late Dr. Neville Kirsch, HS ’40-42, 
whom the department honored with the 
annual lectureship, had a long and dis¬ 
tinguished career both in New York and 
at the Hartford area hospitals before his 
death in 1991. Besides having had an ac¬ 
tive consultative practice he published 
widely in the medical literature. Publi¬ 
cations included studies of foreign body 
granulomas and veterinary dermatology. 
The lectureship is sponsored by his wife 
Lucille Kirsch in memory of his vigor¬ 
ous teaching and clinical career. 
Send news of Alumni/ae On Campus 
to Nicholas P.R. Spinelli, M.D. ’44, in 
care of Yale Medicine. 
Alumni/ae Summit 
Dean David A. Kessler, M.D., above right, met with alumni at the Oct. 25 
meeting of the Association of Yale Alumni in Medicine. The informal discus¬ 
sion ranged from the dean’s thoughts about Yale and current affairs in medi¬ 
cine and health to ways in which alumni/ae leaders can help mobilize sup¬ 
port for increased financial aid. Above: AYAM members listen as Samuei D. 
Kushlan, M.D. ’35, asks Dr. Kessler a question. Right: Also joining in the dis¬ 
cussion were Jocelyn S. Malkin, M.D. ’51, and Howard Minners, M.D. ’57, both 
of whom traveled from Washington to attend the meeting. 
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STUDENT NEWS 
Auction raises funds for 
homeless shelters and 
food pantries 
The Fifth Annual Hunger and Homelessness Benefit 
Auction raised more than $20,000 for New Haven 
homeless shelters and food pantries. Proceeds from 
the Nov. 21 event were donated to Life Haven, FISH of 
Greater New Haven, Loaves and Fishes, Rachel’s Table, the 
Downtown Evening Soup Kitchen and the Community 
Health Care Van. Some noteworthy bids: Last minute 
negotiating and $500 dollars bought Dean David A. 
Kessler, M.D., and Director of Admissions Lynne Wootton 
parts in thesecond-year show. For $1,250 six students will 
spend a long weekend in the Martha’s Vineyard summer 
home of Drs. Keith Joiner and Jo Ellen Schweinle. Four 
students, their wallets $1,100 lighter, will tour the White 
House Oval Office and meet with U.S. Rep. Henry 
Waxman. One lucky winner will have her dog jogged (yes, 
jogged) five times for a mere $20. Strangely, no one bid on 
the “Fish Tank Servicing,” in which fish and tank were 
not included. 
—Gregory Raskin, Class of 1998 
Second-year student Melissa S. Ellis makes an offer. 
S T U D E N T N 0 T E S 
Rajani P, Nadkarni, M.D., postdoctoral fellow in oncology 
and hematology at Yale, has joined the oncology and hematol¬ 
ogy practice of Drs. Sorcinelli and Tansino of Meriden, Conn. 
Jing Zang Tao, M.D., a postdoctoral fellow in diagnostic radi¬ 
ology, is working with Kevin Johnson, M.D. in nuclear mag¬ 
netic resonance. 
Above left: Robert H. Gifford, M.D., associate dean for medical educa¬ 
tion and student affairs, takes a bid during the Fifth Annual Hunger and 
Homelessness Benefit Auction last November in Mary S. Harkness Audi¬ 
torium. The event raised more than $20,000 for New Haven homeless 
shelters and food pantries. 
Left: Second-year medical student Jennifer L. Dorosz, left, and Anne F. 
Pistell, assistant dean for student affairs at EPH, solicit bids for a bottle 
of wine at the auction. 
51 
School of Medicine Dean David A. Kessler, M.D., helps first-year medical student Emmanuelle M. 
Clerisme into the white jacket that signifies service to others at the White Coat Ceremony held 
at the start of the academic year. Merle Waxman, associate dean for academic development, 
looks on. 
Photographs by Gale Zucker 
The Class of 2001 required 101 seats for the 
students from five continents. They’re the first 
class to enter the school under Dr. Kessler’s 
tenure as dean. 
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Freshmen Sandeep Bansal, Fred Aslan, Monica E. Lopez, Steven A. Farmer and Analene J. 
Pentopoulos gather at the end of the ceremony. 
The White Coat 
Ceremony is a 
first-year student’s 
initiation into 
medicine. 
Aaron S. Covey with his mother, Susan Covey. 
Frederick C. Cobey, with his father, James C. 
Cobey, a house staff officer here from 1973 
to 1976. 
First-year student Avery S. Grauer smiles with 
her father, Leonard Grauer, M.D., a 1968 
graduate of the School of Medicine. Ms. 
Grauer’s brother, Jonathan, received his Yale 
M.D. degree in 1997 and is a resident in 
orthopaedics at Yale-New Haven Hospital. 
Andrea L. Ciaranello, Damani A. Piggott, Karl A. 
Lozanne and Vivian A. Lombillo applaud Dr. 
Kessler’s remarks at the annual ceremony, a 
welcome to the profession of medicine. “You are 
a healer,” Dr. Kessler told the incoming class, “if 
the relationship between you and your patient is 
a covenant of faith, not a business contract, an 
article of trust, not an exchange of services.” 
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Cost vs. caring 
A medical students financial dilemma 
Tuition ($) Total ($) 
■11,750.19>C5 
20,650.32,910 
22,000.33,435 
■ 23,300.35,825 
24.700  37,700 
26.700  40,515 
By Ashish Patel 
Before last spring’s Medical Stu¬ 
dent Council elections, the can¬ 
didates were asked to name the 
issue of highest concern to the student 
body. The answer that resonated with 
every student was financial aid. When 
the new dean, David A. Kessler, M.D., 
asked the same question at the start of 
this academic year, the answer again was 
financial aid. When members of the 
Student Council presented their report 
to the Association of Yale Alumni in 
Medicine in late September, once again 
they pointed to the urgent need lor Yale 
to seriously look at a medical student’s 
financial burden. 
Medical students at Yale face an in¬ 
creasing and ominous threat of excessive 
indebtedness that may very well affect 
their choice of a professional field of 
medicine. Lack of financial aid funds 
also puts Yale at a competitive disadvan¬ 
tage among its peer institutions. 
The cost of medical education has 
continually risen. Ten years ago, the cost 
of attending Yale was $21,239 Per year 
for tuition, room, board and related 
expenses. Today that figure has nearly 
doubled, to $40,515. Tuition alone for 
the current academic year rose by 
$2,000 to $26,700, an increase of 
8 percent. 
Students meet these costs using 
personal savings, family contributions, 
scholarship grants established by 
alumni/ae, and loans. A majority have 
little savings, if any, especially after the 
first year of medical school. Most have 
left their parents’ home and do not re¬ 
ceive the family contribution that the 
Ashish Patel, a second-year student, is 
president of the Medical Student 
Council. 
Rise in medical school cost 
Year 
85/86 ..7  
93/94  
94/95  
95/96. 
96/97 . 
97/98  
Source: YSM Financial Aid Office 
school factors into its calculations. 
Grant money is limited. Furthermore, 
medical students are discouraged from 
working because of the intensity of the 
program, though some do work to 
meet expenses. 
More than half the cost of a Yale 
medical education, therefore, is bor¬ 
rowed. When members of the Class of 
1997 walked off Harkness Courtyard af¬ 
ter Commencement last May, they car¬ 
ried an average debt of $76,644. The 
largest debt owed by a member of the 
class was $159,855. Over the course of a 
10-year repayment schedule with inter¬ 
est, a student ultimately pays more than 
half a million dollars. 
What appears to make this level of 
debt justifiable is a false assumption 
made by policy-makers within the fed¬ 
eral government. They assume that all 
medical students will earn an extraordi¬ 
narily large income directly out of 
school. The U.S. Department of Health 
and Human Services has eliminated all 
educational loans based on need. Only 
those students who give up the freedom 
to choose their field by signing on to a 
primary care practice receive loans with 
deferment support. The federal Stafford 
loan program has stopped its loan defer¬ 
ment during the residency years with 
the result that many residents are hard 
pressed to keep up with their payments. 
The most disturbing concern stems 
from the rapidly changing face of man¬ 
aged care medicine. On average, a resi¬ 
dent or a fellow earns $35,000 annually. 
Yale medical graduates generally train 
for four to seven years past their medical 
school education. Once this training is 
complete, the young physicians are ex¬ 
pected to cope with a managed care en¬ 
vironment that has already squeezed out 
every possible penny from income. 
With an estimated physician surplus of 
more than 30 percent under managed 
care, even the once-safe assumption of 
guaranteed employment is no longer 
valid. What promises to remain is a 
huge indebtedness on the part of the 
students, which still has to be paid. 
The greatest threat to a young 
physician’s career—being forced to con¬ 
sider cost in choosing a field of medi¬ 
cine—stems from such a difficult finan¬ 
cial scenario. Yale School of Medicine 
has always been fortunate to attract 
highly qualified students who are dedi¬ 
cated to the profession of healing. Yale 
students are expected, and for the most 
part do, choose their fields based on 
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their interest and motivation. One has 
to wonder, however, whether it is pos¬ 
sible to make a residency decision with¬ 
out considering financial compensation. 
More importantly, is it really possible to 
practice medicine in one of the noblest 
fashions, such as practicing in an 
underserved area, after incurring formi¬ 
dable education debts? 
The proof that the financial burden is 
a real concern comes from the fact that 
many medical schools have already 
taken steps to alleviate the problem by 
actively bolstering their financial aid 
program. Most schools not only draw 
on their endowment, as Yale does, but 
actively fund financial aid through their 
operating budgets, something Yale does 
not do. The University of Pennsylvania 
is working to make much of its program 
tuition free by the year 2005. Consider¬ 
ing the fact that tuition accounts for less 
than 5 percent of the typical medical 
school’s budget (4 percent at Yale), this 
revolutionary goal is not impossible. 
Free tuition may not be necessary. 
What is required, however, is a serious 
effort outlining specific cost-reduction 
objectives. The funds currently available 
for financial aid all come from the en¬ 
dowment established in part by our gen¬ 
erous alumni/ae. Those who choose to 
give to Yale School of Medicine may 
consider financial aid as a prime option. 
Until our endowment rises, we are faced 
with the fact that spending everything 
we can from the current endowment for 
financial aid is inadequate in keeping 
Yale competitive. 
Those of us who love Yale School of 
Medicine came to Yale for the enthusi¬ 
asm and energy of student life at 
school. This energy has to be constantly 
nourished, for without it, the spirit of 
Yale Medicine cannot survive. To keep 
this energy alive, something has to be 
done to help the financial costs incurred 
by the students. Tuition increases have 
to be halted and financial aid has to 
be increased. 
Average debt for Class of ’97 
Yale Stamford Harvard Cornell Washington Johns 
Univ Hopkins 
Yale scholarships compared to other medical schools 
$14,000 
$12,000 
$10,000 
$8,000 
$6,000 
$4,000 
$2,000 
$0 
Source: YSM Financial Aid Office 
$12,048 
Yale Stamford Johns Duke Cornell Columbia Rochester Harvard Penn Washington 
Hopkins Univ 
Contribute to the 
School of Medicine’s 
Future and Invest in 
Your Own 
Yale University’s life income 
program offers graduates of the 
School of Medicine the oppor¬ 
tunity to: 
■ Help ensure the future 
of a great institution 
■ Receive quarterly 
income payments 
for life 
■ Increase your income 
from low-yielding stock with¬ 
out incurring capital gains 
taxes 
• Reduce federal and 
state taxes 
Please call or write to see if 
you can use these benefits to 
the mutual advantage of you 
and the School of Medicine. 
Yale University 
School of Medicine 
Office of Planned Giving 
P.O. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Looking ahead, giving back 
Common dreams and feelings of gratitude connect the generations 
By David Davison The dilemma ol managing 
financial stress along with 
the demands ol preparing for 
a career in medicine is a theme that 
spans the generations. As Ashish 
Patel describes in the preceding 
commentary, most of todays stu¬ 
dents are saddled with many tens of 
thousands of dollars ol debt. It is a 
serious problem and a story that 
should resonate with many Yale 
School of Medicine alumni/ae. 
And while figures from the 
1940s might seem quaint today, 
some alumni/ae ol that era can recall 
$600 tuition bills that they could 
not alford to meet. After all, these 
were the war years and the economy 
was still coming out of the Great 
Depression. The scholarships they 
received got them through medical 
school and into the medical profes¬ 
sion. It is not surprising that when it 
comes to directing their gifts to the 
school, many alumni/ae—from all 
eras—want to support financial aid. 
There is probably no more pure ves¬ 
sel into which an alumnus can 
choose to pour a contribution. 
Today, with tuition rates rising, 
the pressure on students to finance 
their medical education can seriously 
affect the course ol their careers, 
starting with their choice of medical 
schools. Yale’s own research shows 
David Davison is director of 
development at the School of Medicine. 
Write to him at the Office of Medical 
Development, P.0. Box 7611, New 
Haven, CT 06519-1714, or via e-mail: 
david.davison@yale.edu. 
that students who prefer to come to 
Yale are accepting offers from other 
medical schools because of better fi¬ 
nancial aid packages. On the na¬ 
tional level, research indicates that 
when burdened by a large debt, 
many young physicians forego a 
promising career in research and 
teaching in order to make an income 
that will enable them to pay off their 
heavy loans much sooner. 
Dean David A. Kessler, M.D., is 
working with a student-run commit¬ 
tee to address the need lor providing 
more financial aid. At a meeting of 
the Association of Yale Alumni in 
Medicine in October, he made it 
clear that this is an urgent priority. 
“We have about $1.4 million 
available from endowment for finan¬ 
cial aid,” Dr. Kessler said, “but that 
is not nearly enough. We need to 
raise more to stay competitive with 
other medical schools.” 
Yale School of Medicine is 
among the best in the world, but in 
the category of scholarships and 
loans available to students, it falls 
short compared to other prominent 
institutions such as Columbia, Johns 
Hopkins, Stanford and Harvard. 
Each ol those schools has approxi¬ 
mately three times as much funding 
available for financial aid. Yale ad¬ 
mits students strictly on merit and 
offers financial aid solely based on 
need. Schools that can offer students 
a tuition-free education make it dif¬ 
ficult to compete for the best and 
the brightest. 
To help celebrate their 50th re¬ 
union, members of the Class of 1944 
combined several major gifts to ini¬ 
tiate a scholarship endowment. The 
Class of 1959 did the same for its 
35th reunion. A gift of $75,000 is 
needed to establish a named scholar¬ 
ship fund, although many are at 
much higher levels. Recent examples 
of new named lunds include the 
Freshwater/Class of 1972 Scholarship 
Fund and the Donna and Jack 
Ogilvie Scholarship Fund. “We need 
to make sure that the best and 
brightest candidates are not dis¬ 
suaded Irom attending Yale because 
of the prospect of a large debt,” Felix 
Freshwater, M.D. ’72, wrote in an 
appeal letter to his classmates. 
“When tuition rose during my 
years as a student, Yale gave me a 
loan so I could afford to continue 
my studies and graduate,” said 
Nicholas Passarelli, M.D. ’59. “My 
classmates and I are attuned to the 
needs of today’s students and we 
want to perpetuate the tradition of 
giving.” 
The legacy of a Yale medical 
education is passed on in many 
ways, through teaching and training. 
A legacy of gratitude and generosity 
also connects students and alumni/ 
ae across the generations. The aspira¬ 
tion to become a physician, and 
the deep feeling of gratitude for 
the opportunity, remain a common 
experience. 
The students who benefit from 
scholarship funds regularly commu¬ 
nicate with our donors. The follow¬ 
ing is an excerpt from a letter sent to 
Dr. Passarelli, that was shared with 
fellow members of the Class of 1959 
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who contributed to the class scholar¬ 
ship fund. The student grew up de¬ 
termined to help humankind, but 
she lacked the financial means to at¬ 
tend college and medical school 
without help. 
Since I was a young child, my dream 
was always of medicine—and Yale. 
... You have provided me with much 
needed scholarship funding in the 
quest of my dreams. You have done 
this while requesting nothing in 
return. However, I offer you this 
promise: I intend to return scholar¬ 
ship money to Yale University School 
of Medicine once I become finan¬ 
cially situated. ...I know that there 
are others like myself who want only 
to be given the means to obtain 
their dream. 
THE PROGRAM FOR HUMANITIES IN MEDICINE 
Lectures at 5 pm on Thursday in the BEAUMONT ROOM, Yale University 
School Medicine, 333 Cedar Street, New Haven. Refreshments at 4:30 pm. 
The lectures are free and open to the public. For more information, call 
Howard Spiro or Clara Gyorgyey at (203) 785-5494. 
APRIL 9 
OLD MAPS: GUIDES TO THE GEOGRAPHY 
OFTHE EARTH, BODY & MIND 
Harold L. Osher, MD 
Cardiologist, Cartographer 
& Director of Osher Map Library 
University of Southern Maine 
Portland, Maine 
APRIL 16 
SENSIBILITY, MEDICINE &THE SPECTACLE OFTHE BREAST 
IN THE 18TH-CENTURY NOVELS 
Nina A. Prytula, MPhil 
Doctoral Candidate, Department of English 
Yale University 
APRIL 30 
RICHARD SELZER: POET OFTHE BODY 
Mahaia Yates Stripling, PhD 
Texas Christian University 
Fort Worth, Texas 
MAY 7 
JAMES JOYCE: MANIC GENIUS &THE FAMILY TRIANGLE 
James R Merikangas, MD 
Clinical Professor of Psychiatry & Neurology 
Yale University School of Medicine 
MAY 14 
THE EMERGING OF A PHOTOGRAPHIC EYE 
Barbara Young, M D 
Assistant Professor Emeritus of Psychiatry & Photographer 
John Hopkins University 
Baltimore, Maryland 
TO GIVE AWAY MONEY IS 
AN EASY MATTER AND IN 
ANY MAN’S POWER. BUT 
TO DECIDE TO WHOM TO 
GIVE IT, AND HOW LARGE 
AND WHEN, AND FOR 
WHAT PURPOSE AND HOW, 
IS NEITHER IN EVERY 
MAN’S POWER NOR AN 
EASY MATTER. 
Aristotle 
Assuming you would 
consider the School of 
Medicine as one of your 
intended beneficiaries, 
we stand ready to help you with 
when, for what purpose, and 
how. 
Planned giving 
is one of our specialties. 
Yale University 
School of Medicine 
Office of Planned Giving 
RO. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Clarence W. Bushnell 
Clarence W. Bushnell, of 
Bridgeport, Conn., died Oct. 28. He 
was 81. 
Mr. Bushnell was born in 
Lowville, N.Y., and received his 
nursing degree from Hudson River 
State Hospital in New York in 1937 
before serving in the Coast Guard 
during World War II. In 1947 he 
earned his bachelor’s degree from 
New York University and in 1951 re¬ 
ceived a master’s degree in public 
health from Yale. 
From 1951 to 1962, he was the 
assistant administrator lor Massa¬ 
chusetts Memorial Hospital in Bos¬ 
ton. From 1962 to 1981, he served 
as administrator lor Bridgeport Hos¬ 
pital in Connecticut and, from 1963 
to 1981, was a lecturer in public 
health and hospital administration 
at Yale. 
Edward C. Curnen Jr. 
Edward Charles Curnen Jr., M.D., 
ol Bethany, Conn., died Dec. 1 at 
the age ol 88. 
Born in Yonkers, N.Y., Dr. 
Curnen graduated from Yale College 
in 1931 and received his medical de¬ 
gree from Harvard in 1935. He 
served his internship and residency 
at the Infant’s and Children’s Hospi¬ 
tal in Boston and was a research fel¬ 
low at Harvard. In 1939, he joined 
the staff ol Rockefeller Institute for 
Medical Research, now Rockefeller 
University. 
Dr. Curnen served in the Naval 
Reserve Medical Corps during 
World War II and retired as com¬ 
mander. He joined the faculty at 
Yale after the war, as assistant profes¬ 
sor of preventive medicine and 
worked with the Yale Poliomyelities 
Study Unit. Dr. Curnen was director 
of the bacteriology laboratories at 
Grace-New Haven Hospital until 
1952 and also was a fellow at Yale’s 
Berkeley College. 
In 1952, he joined the University 
of North Carolina at Chapel Hill as 
the First professor and chairman ol 
its new pediatrics department. In 
i960, Dr. Curnen became the 
Carpentier Professor and chairman 
of the department of pediatrics at 
the Columbia College ol Physicians 
and Surgeons and director ol Babies 
Hospital. He was a fellow of the 
American Academy of Pediatrics 
and also served as chairman ol its 
committee on the control of infec¬ 
tious diseases. 
Gladys J. Goldman 
Gladys Jacoby Goldman, M.P.H., of 
Clinton, Conn., died Oct. 3 at Yale- 
New Haven Hospital. She was 87. 
Mrs. Goldman was born in 
Woodside, N.Y. She received her 
master’s degree in public health from 
Yale in 1947 and taught nursing in 
New Haven for many years. She was 
also a department head at New York 
Hospital/Cornell Medical Center. 
Louis Gluck 
Louis Gluck, M.D., died of cancer 
on Nov. 29 at Saddleback Memorial 
Hospital in Laguna Hills, Calif. 
He was 73. 
Born in Newark, N.J., Dr. 
Gluck graduated from Rutgers Uni¬ 
versity in 1948 and received his 
medical degree from the University 
of Chicago. He joined the faculty at 
Yale in i960 as an assistant professor 
ol pediatrics and was associate pro¬ 
fessor of pediatrics from 1964 until 
1968, when he moved to the Univer¬ 
sity of Miami. While at Yale he de¬ 
veloped a new design for a nursery 
for premature infants and ill full- 
term babies. Dr. Gluck’s design for a 
neonatal intensive care unit was one 
big open room, Filled with incuba¬ 
tors, enabling intensive management 
ol newborns. 
Dr. Gluck also helped develop a 
test of the amniotic fluid to deter¬ 
mine whether the lungs ol a fetus 
were mature. He later developed a 
similar intensive-care program at 
the University of California at San 
Diego. Dr. Gluck was also a profes¬ 
sor at the College of Medicine at the 
University of California at Irvine. 
John C. Haley 
John C. Haley, M.D., died Sept. 13 
at his home in Cheshire, Conn. 
He was 83. 
Dr. Haley, born in Long Beach, 
Calif., graduated from Yale College 
in 1937 and received his medical de¬ 
gree from Yale in 1941. During 
World War II, he served as a flight 
surgeon in the Army Air Corps. 
Dr. Haley interned at Massachu¬ 
setts Memorial Hospital in Boston 
from 1940 to 1941, was a senior in¬ 
tern at Montreal General Hospital 
until 1942 and served his residency 
in obstetrics and gynecology at 
Grace-New Haven Hospital from 
1945 until 1948. He joined the fac¬ 
ulty at Yale medical school as a clini¬ 
cal instructor of obstetrics and gyne¬ 
cology in 1951, became clinical 
associate in 1974 and advanced to as¬ 
sistant clinical professor in 1974. 
Kathleen H. Howe 
Kathleen Hara Howe, M.P.H., died 
Dec. 3 of cancer at Connecticut 
Hospice in Branford. She was 85. 
Born in Ontario, Dr. Howe 
graduated from Rollins College in 
1933 and earned her master’s degree 
in public health from Yale in 1956. 
After graduation she joined the fac¬ 
ulty at Yale and until 1979 served as 
an assistant professor and assistant 
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dean in the Department of Epidemi¬ 
ology and Pubic Health. After her 
retirement a scholarship fund was es¬ 
tablished in her name. In 1990 she 
was awarded the Yale Medal and was 
later honored by President Bush as 
one of the “thousand points of light” 
for her volunteerism with Connecti¬ 
cut Hospice from 1979 to 1997. 
Mrs. Howe was the first recipi¬ 
ent of the Distinguished Alumni/ae 
Award in 1988 from the Association 
of Yale Alumni of Public Health. 
She also received the Chairman’s 
Award of the Yale Alumni Fund, the 
Rotary Club Community Service 
Award, and the Ira V. Hiscock 
Award of the Connecticut Public 
Health Association. 
Franklin Hutchinson III 
Franklin Hutchinson III, M.D., died 
Oct. 24 at Yale-New Haven Hospi¬ 
tal. He was 77. 
A native of Brooklyn, N.Y., Dr. 
Hutchinson received his bachelor’s 
degree in 1942 from the Massachu¬ 
setts Institute of Technology and his 
Ph.D. degree in physics in 1948 from 
Yale. He joined the radiation labora¬ 
tory at MIT during World War II, 
developing radar technology for the 
military. Dr. Hutchinson holds three 
patents in microwave electronics. 
He began his 42-year tenure at 
Yale in 1948 as an instructor in radi¬ 
ology and biophysics. Dr. 
Hutchinson became assistant profes¬ 
sor of physics in 1951, associate pro¬ 
fessor of biophysics in 1957, and pro¬ 
fessor of biophysics in i960. He 
served as chairman of the biophysics 
department for eight years, as well as 
director of graduate studies and di¬ 
rector of undergraduate studies in 
biophysics. Dr. Hutchinson retired 
as professor emeritus in 1990. 
He was also a consultant in radi¬ 
ology at Yale-New Haven Hospital 
and had been a member of the advi¬ 
sory committee of the Atomic Bomb 
Casualty Commission. A fellow of 
Jonathan Edwards College, he 
played the French horn with the 
New Haven Symphony Orchestra. 
Dr. Hutchinson continued his 
research in mutagenesis as part of 
the radiology laboratory at the 
School of Medicine until his death. 
Warren M. Jones 
Warren Mead Jones, M.D., died 
July 31 at in home in Flourtown, Pa. 
He was 72. 
Born in West Pittston, Pa., Dr. 
Jones received his bachelor’s degree 
from Lafayette College, his law de¬ 
gree from the University of Pennsyl¬ 
vania and, in 1961, his medical de¬ 
gree from Yale. 
Dr. Jones was an ophthalmolo¬ 
gist in Flourtown. He was past presi¬ 
dent of the Montgomery County 
Medical Society and was a liaison 
between the Pennsylvania Medical 
Society and the Pennsylvania Bar As¬ 
sociation. 
Thomas J. Keenan 
Thomas J. Keenan, M.D., of Ply¬ 
mouth and Duxbury, Mass., died 
Oct. 15 in Jordan Hospital in Ply¬ 
mouth. He was 71. 
Born in Glenrock, Wyo., Dr. 
Keenan served in the Navy before 
graduating from Whittier College in 
Spokane, Wash. He received his 
medical degree in 1957 from the 
Medical College of Wisconsin. He 
interned at St. Mary’s Hospital in 
San Francisco and served his resi¬ 
dency in anesthesiology at Massa¬ 
chusetts General Hospital in Boston. 
During that residency, Dr. Keenan 
was on the house staff of Yale-New 
Haven Hospital. In 1959 he joined 
the staff and was a clinical anesthesi¬ 
ologist at Massachusetts General 
Hospital. Dr. Keenan was on the 
staff of the Massachusetts Eye and 
Ear Infirmary from 1969 until his 
retirement. 
A Charitable 
Annuity: 
The YSM gift 
that rates 
In exchange for a gift of 
$5,000 or more, the School of 
Medicine can offer you, or you 
and your spouse, a fixed annual 
income for life. 
Your age(s) and market 
rates of interest determine 
your income level. 
Current sample rates* 
Age(s) Rate 
One life 
55 4.5% 
66 5.6% 
77 7.8% 
Two lives 
66/65 4.6% 
75/74 5.6% 
82/79 6.9% 
* Yale will maintain these rates until 
at least May 311998. 
Please allow us to tailor 
a proposal to your 
philanthropic 
and financial goals. 
Yale University 
School of Medicine 
Office of Planned Giving 
RO. Box 2038 
New Haven, CT 06521-2038 
1-800-445-6086 
Fax: 1-203-432-7901 
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Henry V. Kogut 
Henry V. Kogut, M.D., of Stratford, 
Conn., died Oct. 18 in Bridgeport 
Hospital. He was 79. 
Born in Bridgeport, Dr. Kogut 
received his medical degree from 
New York Medical College and com¬ 
pleted a residency in ophthalmology 
at Yale in 1948. During World War 
II, he was a captain in the Army, 
serving as a flight surgeon in the 
United States and Germany. 
Dr. Kogut practiced ophthal¬ 
mology in Bridgeport and Stratford 
for 49 years. In 1979, he received the 
Physician Recognition Award from 
the American Medical Association. 
Dr. Kogut was also a fellow of the 
American College of Surgeons, the 
American Academy of Ophthalmol¬ 
ogy, and the American Society of 
Contemporary Ophthalmology. 
Helen P. Langner 
The School of Medicine’s oldest 
alumna, Helen P. Langner, M.D., 
died Dec. 10 at her home in Milford, 
Conn. She was 105. 
Born in Meriden, Conn., the 
oldest of six children, Dr. Langner 
grew up in Milford and graduated 
from Milford High School in 1910. 
She attended Hunter College in 
New York at a time when no 
Connecticut college would open its 
doors to her as a woman. After 
graduating from Hunter in 1914, 
she taught high school biology in 
New York. 
She returned to Connecticut 
and was admitted to the Yale School 
of Medicine. The only woman in her 
class, Dr. Langner received her medi¬ 
cal degree from Yale in 1922. She was 
the fourth woman to graduate from 
the medical school. 
She took her residency training 
at a state hospital on Wards Island in 
New York City, before traveling 
around the United States to set up 
child guidance clinics. In 1929, she 
joined the faculty at Vassar College 
in Poughkeepsie, N.Y., where she 
was the head of undergraduate 
health. She later established a private 
psychiatry practice in New York 
City, commuting from her home in 
Milford. In addition to seeing pri¬ 
vate patients, she treated patients at 
New York Hospital Cornell Medical 
Center and worked part time in the 
New York City school system. 
In 1970 at age 78, she retired 
from full-time practice but contin¬ 
ued to see patients well into her 90s. 
She served as a consultant both to 
the Milford health department and 
at Milford Hospital. She returned 
annually to the School of Medicine 
for Alumni Reunion Weekend, cel¬ 
ebrating her 75th reunion last June. 
Her report from the event was pub- 
Doctor,; how can I 
thank you?” 
H 
ow many times have you heard this question from 
your patients? Your answer can lead to a way to 
help the Yale School of Medicine. A gift from your 
patient to the School honors you and guarantees 
the continuation of our tradition of excellence in 
teaching and patient care into the 21st century. 
“Yale School of Medicine was and remains 
extremely important to me in the ongoing development of 
my busy practice. I am proud of my close relationship with the School, 
even though I am geographically far from New Haven. My patients 
regularly take an interest in my research and clinical activities, and I 
am more than happy to share with them my fondness 
for Yale in order to stimulate their interest in the School’s mission.” 
Dudley Seth Danoff, M.D. ’63, F.A.C.S. 
Beverly Hills, California 
“My patients know that I am a proud graduate of Yale 
School Of Medicine and an active participant in the teaching 
program. They also know that one of the best ways to make me 
happy is to give to my alma mater.” 
Mary Jane Minkin, M.D. 75 
New Haven, Connecticut 
Brochures promoting the School are available for 
display in your office, to generate the revenue 
needed to continue our standard of excellence. 
Free copies are available from: 
Bonnie Sargent 
Office of Development 
Yale University School of Medicine 
P.0. Box 7611 
New Haven, Connecticut 06519-1714 
Or call: 
203.785.6760 
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lished in the Fall 1997 issue of 
Yale Medicine. 
Dr. Langner dedicated herself to 
environmental causes, including 
projects to improve the Milford har¬ 
bor and to create a nature preserve in 
the salt marshes at nearby Smith’s 
Point. The area is now a federal 
wildlife preserve and borders the 
Audubon Coastal Center. 
In 1994, she was inducted as an 
honorary member of the Class of 
1998 by then-Dean Gerard N. 
Burrow, M.D. ’58. At a memorial 
service for Dr. Langner Feb. 9, her 
second Yale medical diploma was 
presented posthumously and ac¬ 
cepted by her younger brother, 
Gustave Langner, 95. 
James D. Prokop 
James D. Prokop, M.D., died Dec. 1 
of cardiac arrest at Greenwich Hos¬ 
pital. He was 64. 
Born in Bridgeport, Conn., Dr. 
Prokop graduated from Yale College 
in 1955 and from the School of 
Medicine in 1959. He served his in¬ 
ternship and residency, and was chief 
resident of neurosurgery at New 
York Hospital Cornell Medical Cen¬ 
ter from 1959 to 1961. Dr. Prokop 
was clinical associate at the National 
Institute of Neurological Diseases 
and Blindness in Bethesda, Md., 
from 1961 until 1963. 
Dr. Prokop was director of the 
Department of Neurosurgery at 
Stamford Hospital and St. Joseph 
Medical Center from 1976 to 1981. 
He also headed neurosurgery at 
Stamford Hospital in 1994-95. 
Luther George Simjian 
Luther George Simjian, the first di¬ 
rector of the School of Medicine’s 
Photography Department and the 
inventor of dozens of devices, some 
of them for medicine, died Oct. 23 
at his home in Fort Lauderdale, Fla. 
He was 92. 
Mr. Simjian was born in Turkey 
to well-to-do parents of Armenian 
descent. According to a 1934 Wash¬ 
ington Post article, his mother and 
three sisters were massacred in Tur¬ 
key and he was separated from his 
father. He came to the United States 
in the early 1920s, settling in New 
Haven with an uncle, and eventually 
was reunited with his father. 
Mr. Simjian worked as a pho¬ 
tographer at Yale, where he had 
hoped to pursue an interest in medi¬ 
cine. But his success as a photogra¬ 
pher and inventor swept aside his 
medical aspirations. He eventually 
patented nearly 200 inventions, in¬ 
cluding an autofocus camera in 1932, 
a color X-ray machine in 1934, an 
early flight simulator, a teleprompter 
and a mechanical precursor to the 
automatic teller machine. 
According to Richard G. Snyder, 
the current president of Reflectone 
Inc., the Tampa, Fla., company Mr. 
Simjian founded in Connecticut in 
1939, Mr. Simjian was considered 
“the second Thomas A. Edison” in 
many quarters. His medical inven¬ 
tions included a supersonic explor¬ 
ing device for ultrasound and the 
color X-ray machine, which assigned 
color values to varying shades of 
gray. He also envisioned linking the 
machine electronically to remote 
sites, making the diagnostic images 
available to physicians hundreds of 
miles away. In 1978, he received the 
Eli Whitney Award from the Con¬ 
necticut Patent Law Association. 
The Photography Department he di¬ 
rected is known today as Biomedical 
Communications. 
Joseph R. Stanton 
Joseph Robert Stanton, M.D., 
L.L.D., of Needham, Mass., died 
Sept. 9 at Needham nursing home in 
Wingate. He was 77. 
Born in Brighton, Mass., Dr. 
Stanton was stricken with polio as a 
teen-ager and did not pursue his 
dream of becoming a surgeon. He 
graduated from Boston College in 
1942 and received his medical degree 
from Yale in 1945 and his L.L.D. 
from St. Anselm College in 1973. Dr. 
Stanton was on the staff of Boston 
University School of Medicine from 
1946 to 1951. He then joined the staff 
of Tufts University School of Medi¬ 
cine as an instructor until 1958 and 
as associate clinical professor of 
medicine from 1958 until his retire¬ 
ment in 1985. Dr. Stanton devoted 
his energies to internal medicine and 
research on hypertension. 
In 1970, after the New York 
State legislature legalized abortion, 
he became active in the anti-abor¬ 
tion movement. Dr. Stanton 
founded the Massachusetts Citizens 
for Life and the Value of Life Com¬ 
mittee of Massachusetts. He was 
also chief archivist and historian of 
Massachusetts Citizens for Life. 
G. Pierce Taylor 
Grosvenor Pierce Taylor, M.P.H., of 
Shelburne, Mass., died June 7 at 
Franklin Medical Center in 
Greenfield, Mass. He was 79. 
Mr. Taylor graduated from 
Amherst College in 1942, then re¬ 
turned to work on his family’s apple 
orchards in Shelburne. He later took 
a job as a purchasing agent for Pro¬ 
fessional Equipment Co. of New 
Haven, Conn., and received his 
master’s degree in public health from 
Yale in 1961. Mr. Taylor then served 
as administrator of the Southwestern 
Michigan Hospital Council and as 
executive director of the Connecti¬ 
cut Hospital Planning Commission. 
He retired in 1974. 
Seth U. Thaler 
Seth U. Thaler, M.D., died Aug. 20 
at Arden Hill Hospital in Goshen, 
N.Y. He was 59. 
Born in New York City, Dr. 
Thaler graduated from Amherst Col¬ 
lege and received his medical degree 
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from Yale in 1962. He practiced oto¬ 
laryngology in Goshen lor many 
years. Dr. Thaler also was medical 
director at Arden Hill Hospital and a 
lellow ol the American College ol 
Surgeons and the American Associa¬ 
tion ol Otolaryngologists. 
Robert E. Waugh 
Robert E. Waugh, M.D., ol 
Farmington, Conn., died Aug. 1. 
He was 64. 
Born in Willimantic, Conn., 
Dr. Waugh was a graduate of 
Dartmouth College and received his 
medical degree from Yale in 1959. He 
was an intern at University of Cali¬ 
fornia at Los Angeles, and took his 
residency training in anesthesiology 
at Grace-New Haven Hospital from 
1961 to 1962. 
Dr. Waugh served two years in 
the Navy as an anesthesiologist at 
the Portsmouth Naval Hospital in 
Virginia. In 1964, he joined the staff 
ol New Britain (Conn.) General 
Hospital and at the time of his re¬ 
tirement in 1991 was the medical di¬ 
rector of its ambulatory surgery unit. 
Inez E. Wilber 
Inez Edith Wilber, M.D., died May 
10 at a nursing home in La Jolla, 
Calif., after sulfering a stroke. She 
was 93. 
Dr. Wilber was born in Los An¬ 
geles and was raised in Needles, Calif. 
She received her medical degree from 
the University of Michigan in 1932 
and served her internship and resi¬ 
dency at Yale Irom 1932 to 1935. She 
practiced ophthalmology in Washing¬ 
ton, D.C., from 1939 until she retired 
and moved to California in 1977. 
Dr. Wilber was a district gover¬ 
nor ol the women’s professional or¬ 
ganization Zonta International and a 
member of the American Associa¬ 
tion of University Women. 
IN MEMORIAM 
The School of Medicine has received 
notification ol the death of the 
loliowing persons: 
William B. Barry, M.D., Med ’36 
August 27, 1997 
Frank A. Carone, M.D. ’52 
October 3, 1997 
Jean Parker Cobb, M.P.H. ’69 
May 10, 1996 
Marvin B. Day, M.D., Med ’38 
July 24, 1997 
Lee E. Farr, M.D. ’33 
July 16, 1997 
George T. Furlong, M.P.H. ’53 
October 2, 1997 
Gladys Jacoby Goldman, M.P.H. ’47 
October 3, 1997 
John C. Haley, M.D. ’40 
September 13, 1997 
Warren Mead Jones, M.D. ’61 
July 31, 1997 
Perry W. Nadig, M.D., HS ’54-57 
March 12, 1997 
Marion Redmond, M.P.H. ’41 
October 21, 1992 
Dorothy A. Rice, M.P.H. ’77 
December 23, 1993 
Edwin D. Rogers, M.D. ’41 
May 9, 1995 
Joseph R. Stanton, M.D.’45 
September 9, 1997 
Meritt W. Stark, M.D., HS ’43-44 
October 20, 1997 
Seth U. Thaler, M.D. ’62 
August 20, 1997 
Robert E. Waugh, M.D. ’59 
August 11, 1997 
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F R I DAY, JUNE 5 
t> School of Medicine Alumni Fund Class Agents and Reunion Gift Chairs Luncheon 
D> Class Reunion Programs 
l> Association of Yale Alumni in Medicine Executive Committee Meeting 
t> Opening Remarks 
Nicholas M. Passarelli, M.D. ’59, President, AYAM 
David A. Kessler, M.D., Dean, School of Medicine 
\> Special Presentation 
The Yale System, its Evolution, Strengths and Problems 
Robert H. Gifford, M.D., Associate Dean for Medical Education 
and Student Affairs 
t> Dean’s Reception 
O New England Clambake 
FRIDAY AND SATURDAY, JUNE 5 AND 6, 1998 
SYMPOSIUM HONORING 
JOHN P. PETERS, M.D. 
John Punnett Peters, M.D., 
(1887-1955) was a legendary 
member of the Yale medical 
faculty, revered for his skill 
and warmth with patients as 
well as the new scientific 
ground he broke, especially 
in the area of metabolism. 
The seminar will explore 
these contributions to 
medicine, as well as the 
political controversy that surrounded Dr. Peters, 
an early advocate of socialized medicine who 
was targeted by conservatives in the late 1940s 
and early '50s. 
TOPICS 
The Committee of 430 Physicians 
George D. Lundberg, M.D. 
Editor in Chief 
Journal of the American Medical Association 
John Peters, McCarthyism and the 
Supreme Court Decision 
Catherine G. Roraback, LL.B/48 
Attorney-at-Law 
Canaan, Conn. 
Contributions to Nephrology 
Franklin H. Epstein, M.D. '47 
Professor of Medicine 
Harvard Medical School and Beth Israel Hospital 
Contributions to Diabetes Mellitus 
Phillip Gorden, M.D., HS '61-66 
Director 
National Institute of Diabetes and Digestive 
and Kidney Diseases 
Reflections of a Student of Peters 
Donald W. Seldin, M.D. '43 
Professor of Internal Medicine 
University of Texas Southwest Medical Center 
SATURDAY, JUNE 6 
I> Annual Meeting of the Association of Yale Alumni in Medicine 
Greetings by Nicholas M. Passarelli, M.D. ’59, President, AYAM 
Remarks: Dean David A. Kessler, M.D. 
Presentation of the Distinguished Alumni Service Award 
t> Sherry/Buffet Luncheon 
t> Guided Tours 
Yale University Art Gallery 
Historic Sections of New Haven/Eli Whitney Museum 
Yale-New Haven Children’s Hospital/Medical Center 
D> Individual Class Parties and Dinners for the five-year 
reunion classes 
D> Friends of the 50th Dinner (Honoring the Classes of 1948, 
1933’ 1938, 1943. and 1993) 
FOR INFORMATION, CONTACT 
William K. Jenkins, Managing Director 
Office of Alumni Affairs 
P.O. Box 7613, New Haven, CT 06519-0613 
(203) 785-4674, FAX (203) 737-5H3 
LETTERS 
One nation, two views 
To the Editor: 
I spent a month on the same Navajo 
reservation as Gregory Raskin [Notes 
From a Navajo Winter, Fall 1997]. I 
found parts of his description dis¬ 
concerting because it seemed at 
times as though he were looking 
down on the people he was treating. 
I must assume that the percep¬ 
tions differ because I have been a cli¬ 
nician for 15 years, and he is still in 
the learning process. I was sad to 
leave New Mexico. The Indian 
Health Service, a branch of the U.S. 
Public Health Service, is medicine as 
it used to be practiced, as I believe it 
was meant to be practiced. It is com¬ 
pletely patient-care oriented, with 
emphasis on the word care. Every¬ 
thing about the system is designed 
for the convenience of the cli¬ 
entele. Every clerk and secre¬ 
tary makes certain the “grand¬ 
mother” won’t wait in line 
and gets kind, courteous, effi¬ 
cient treatment. Each Navajo 
has a family practitioner over¬ 
seeing the totality of his or her 
care. Sub-specialists are utilized ap¬ 
propriately, and all are represented 
on-site. 
There is no insurance company 
involved—no denial of treatment, 
medication, hospitalization, or 
surgery if the clinician has deemed 
it appropriate. If a postop or post¬ 
partum patient needs a week to re¬ 
cover in-house before the long ride 
home, there is no utilization review 
worker to say otherwise. Social 
workers are amply available to be 
sure the home stay is safe. Medicines 
are dispensed directly in the clinic, 
eliminating middleman markup and 
another trip for the patient to get it 
as is the case with the pharmacy sys¬ 
tem. The full range of preventative 
and rehabilitative services are avail¬ 
able on-site. This is government-run 
health care—the entity we all sup¬ 
posedly fear. 
As far as the Navajos themselves, 
I found them to be marvelous pa¬ 
tients. The majority are farmers and 
ranchers, living a busy and 
physically demanding out¬ 
door existence. They are 
strong individually and 
communally, with good 
self-esteem. I he transla¬ 
tors pose no problem at 
all. It turned out that most 
of the elderly understood me 
perfectly, but preferred the comfort 
of speaking in their own language. 
Compliance was no better or worse 
than among patients anywhere else. 
Because illegal drug use is so 
rare, there is very little of the crime, 
violence and secondary diseases re- 
How to reach us 
Yale Medicine welcomes news 
and commentary. Please send 
letters to the editor and news 
items to Yale Medicine, P.0. Box 
7612, New Haven, CT 06519- 
0612, or via electronic mail to 
ymm@yale.edu, and include a 
daytime telephone number. 
Submissions may be edited for 
length, style and content. 
lated to the drug culture that so bur¬ 
dens our inner cities here. I learned 
much from their grace, dignity, co¬ 
hesiveness and natural wisdom. I 
can’t wait to return for another stint 
of service in March, and am taking 
with me another Yale medical stu¬ 
dent. My family only fears that I 
may not return. 
Susan Richman, M.D., HS ’79-83 
Assistant Clinical Professor 
Obstetrics and Gynecology 
To the Editor: 
Gregory Raskin’s Notes From a 
Navajo Winter was terrific because of 
its common-sense approach to the 
big questions, especially “How long 
could I go without a bagel?” (I may 
be biased in this.) I can confirm that 
Nepal, at least regarding the Lender’s 
product, is a bagel-free zone. 
Murray Lender 
Chairman 
H. Lenders & Sons 
Woodbridge, Conn. 
Doctor, see thyself 
To the Editor: 
I enjoyed reading Medicine at the 
Movies in the Special Report edition 
of Yale Medicine [Fall 1997]. I suggest 
you add another film to the sug¬ 
gested list for doctors and those in 
training to view. The Doctor with 
William Hurt tells the story of a 
physician who is stricken with can¬ 
cer and has to endure all the indigni¬ 
ties that his patients endure in his 
hospital. The experience changes his 
perspective and understanding of 
sick people. I believe all doctors 
should participate in this vicarious 
experience. 
Joan Gourley 
Milford, Conn. 
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Continuing Medical 
Education at Yale 
June 3 11th Annual Lyme Disease Conference A 
Wednesday Course Director: Robert Schoen, M.D. 
Focus on clinical topics and scientific advances 
Mary S. Harkness Auditorium 
June 19 Yale Ophthalmology Spring Symposium: B 
Friday The Distinguished Alumnus Lecture by Lee Jampol, M.D., Professor & Chairman 
Northwestern University Department of Ophthalmology 
Course Directors: Craig Sklar, M.D., and Bruce Shields, M.D. 
New Haven Lawn Club, New Haven, CT 
September 12,13 
Saturday - Sunday 
Yale at Mystic: An Ultrasound Review 
Course Director: Kenneth J.W. Taylor, M.D., Ph.D. 
Furthering acquaintance with the most useful applications 
for the latest technical advances in diagnostic ultrasound 
Mystic Hilton, Mystic, CT 
September 17 20 22nd Yale Physician Assistant Certification/ 
Thursday - Sunday Recertification Preparatory Conference 
Course Coordinator: Christiana Nockels, P.A. 
Mary S. Harkness Auditorium 
October 23, 24 Health and Spirituality Conference 
Friday - Saturday Co-sponsors: Albert Schweitzer Institute for the Humanities and 
the Program for Humanities in Medicine at Yale 
Jane Ellen Hope Building, Room 110 
ongoing Pain Management Programs 
Course Director: Lloyd Saberski, M.D. 
Individually tailored tutorials for physicians in the clinical management of pain 
Center for Pain Management, 40 Temple St., New Haven, CT 
c 
D 
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F 
For information, contact the Office of Postgraduate and Continuing Education,Yaie University School 
of Medicine, 333 Cedar St., P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
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First Lady praises Child Study Center Program In an April 30 address at Harkness Audito¬ 
rium during a symposium celebrating the 
30th anniversary of the School Develop¬ 
ment Program, First Lady Hillary Rodham 
Clinton praised the program's founder, James P. 
Comer, M.D. Dr. Comer, whose model has been 
implemented in more than 700 schools across 
the country, is the Maurice Falk Professor of 
Child Psychiatry In the Child Study Center. Mrs. 
Clinton recognized his “lifelong vision, passion 
and mission to make us understand what edu¬ 
cation is really all about. Today we celebrate a 
man who has committed his personal and 
professional life and the work of this center to 
fulfilling that vision.” In her 20-minute speech, 
Mrs. Clinton recalled her research on the 
medical and legal issues surrounding child 
abuse while she was in law school, and lauded 
the Child Study Center, in which she was a 
fellow working with Albert J. Solnit, M.D., and 
the late Sally Provence, M.D. “The impact of 
the center’s work can be seen in improved 
test scores and higher self esteem in schools 
nationwide,” said Mrs. Clinton, who wrote about 
her experience as a center fellow in her recent 
book, It Takes a Village. 
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A life of engagement 
Until her death last December at 105, Helen Langner was the 
school’s oldest graduate. “If you live long enough,” she told friends, 
“you get recognition, whether you deserve it or not.” In her case, 
the recognition spanned a century and marked an exceptional life. 
By John Curtis 
"'“'Uitcr, diir) 
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How do gender differences affect the progress and treatment of 
disease? It’s often hard to say, since for decades women were excluded 
from many clinical trials. A new Yale program in women’s health 
research will explore this largely uncharted territory. 
By Michael Fitzsousa 
A path for prevention 
When 20,000 of the world’s top AIDS researchers gathered in Geneva 
in late June, one clear message emerged: Prevention is still better than 
any cure. That belief is the foundation for the Center for Interdiscipli¬ 
nary Research on AIDS, launched last fall with the participation of 
six Yale schools and $10.8 million in federal funding. £ 
22 Factoring in gender 
By John Curtis 
42 Hunting down HIV 
A Yale professor has engineered a virus 
that attacks and destroys HIV in cell 
culture. Other scientists at the School of 
Medicine are responsible for drugs that slow 
the onset of AIDS and reduce the side effects 
of medication. 
A new era in AIDS treatment 
People with HIV are living longer as 
protease and reverse transcriptase 
inhibitors thwart the onset of AIDS. 
Despite drug resistance and other 
complexities, these new agents have 
changed the way physicians care for 
their patients. Page 33 
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Dispatch from the front lines 
Caring for people with AIDS helped 
author Peter Selwyn come to terms with 
a death in his own family. Page 38 
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LETTERS 
Rule of law, not men 
To the Editor: 
As a graduate ol Yale College but not 
the medical school, I was pleased to 
begin receiving Yale Medicine. How¬ 
ever, drawing upon my Yale education 
as a major in American history, 1 have 
always believed in the American tradi¬ 
tion stating that we are a nation of 
laws, not men. 
Thus, 1 read with interest the ar¬ 
ticle and the quotation attributed to 
the medical school’s new dean in your 
Fall 1997 issue. As a non-smoking 
physician, I share Dr. Kessler’s view of 
smoking and the tobacco companies. 
However, the deals being forced on 
the tobacco companies are unconstitu¬ 
tional and an attack on the rule of law. 
In a recent issue of The Freeman, 
Robert A. Levy makes the case that 
we can’t ignore the constitutional in¬ 
firmities just because the industry 
consents to them; that tobacco is not 
a special case and that other industries 
should be fearful; that prohibition as 
favored by Drs. Kessler and Koop 
would lead to a black market; that in 
fact cigarette smokers already pay 
more through the taxes on their ciga- 
The AYAM makes web debut 
At the Association of Yale Alumni in 
Medicine website, you will find informa¬ 
tion about the activities, goals, and struc¬ 
ture of the AYAM and the Yale School of 
Medicine Alumni Affairs Office. The site 
contains a brief history of the School of 
Medicine, the history and goals of the 
AYAM, AYAM constitution, a listing of the 
alumni officers, class secretaries, staff, 
outreach program and events. Visit us at 
http://www.med.yale.edu/ayam 
Yale Medicine on the web 
Yale Medicine and other medical school 
publications can be found on the 
World Wide Web at http:// 
info.med.yale.edu/ymm 
rettes than the cost for their care; and 
that Congress should first eliminate all 
subsidies to tobacco before resorting 
to a legislated settlement. 
I hope that Dean Kessler will en¬ 
courage those in training to under¬ 
stand that a superb education with 
free choice and not a paternalistic atti¬ 
tude is the essence of a Yale education. 
Robert H. Potts Jr., M.D. 
Copper Mountain, Colo. 
To tell the truth 
To the Editor: 
I came across your very nice article 
on the history of radiology at Yale 
[.Medicines new eyes, Winter/Spring 
1998]. I applaud your department, its 
innovations and your enthusiasm lor 
its capabilities. At the same time, I 
question the statements you make on 
attributing “the first X-ray image in 
the United States” to Yale physicist 
Arthur W. Wright. Sometimes issues 
like this are a matter of semantics. 
Although we attribute the “discovery” 
of X-rays and the first image to 
Roentgen, Crookes (and others) 
actually made X-rays and inadvert¬ 
ently exposed X-ray plates in his labo¬ 
ratory well before Roentgen developed 
an understanding of what was going 
on. As you may be aware, Crookes 
thought the gelatin plates were defec¬ 
tive and repeatedly returned them to 
Ilford, England’s largest manufacturer 
ol photographic plates, with a vitriolic 
note. It took a scientist of Roentgen’s 
caliber to realize what was occurring 
and to publish an account of his ex¬ 
periments. Hence, we attribute this 
great discovery to Roentgen. 
It is much the same with the first 
(clinical) X-ray in the United States. 
After reading a detailed description of 
Roentgen’s discovery of the X-ray in 
the New York Sun, a prominent local 
man and a member ol the Dartmouth 
scientific society, Howard H. Langell, 
inspired Frank Austin, an assistant in 
the Dartmouth physics laboratory, to 
test a dozen or so Crookes vacuum 
tubes in the Dartmouth collection to 
see if any of them would produce X- 
rays. It was probably on or before the 
very date you describe, Jan. 27, that 
Langell and Austin produced images 
of coins and keys in a wooden box 
and perhaps even of Austin’s hand. 
They then reported this event to 
Edwin Frost, a professor of astronomy 
at Dartmouth. 
On Monday, Feb. 3, Edwin’s 
brother, Gilman Frost, M.D., chief of 
staff at the Mary Hitchcock Memorial 
Hospital, brought 14-year-old Eddie 
McCarthy to the physics building at 
Dartmouth college. Eddie had fallen a 
week or so before while skating on the 
Connecticut River and had a clinical 
diagnosis ol a “colies” fracture. Utiliz¬ 
ing the tube that Austin had experi¬ 
mented with, the Frost brothers pro¬ 
ceeded to produce an X-ray of 
How to reach us 
Yale Medicine welcomes news and com¬ 
mentary. Please send letters to the edi¬ 
tor and news items to Yale Medicine, P.O. 
Box 7612, New Haven, CT 06519-0612, 
or via electronic mail to ymm@yale.edu, 
and include a daytime telephone number. 
Submissions may be edited for length, 
style and content. 
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McCarthy’s wrist showing the frac¬ 
ture. Frost reported this in an article 
dated Feb. 4 and submitted it to the 
journal Science. Reports in the same 
issue of Science by Drs. Pupin of Co¬ 
lumbia and Goodspeed of Pennsylva¬ 
nia described clinical X-rays that were 
made three and five days later. 
If Yale’s physicist, Arthur Wright, 
pre-empted the Dartmouth group, 
it remains unreported and unsub¬ 
stantiated, at least in the scientific 
literature. The Dartmouth group 
went one step further. The taking 
of the first clinical X-ray in America 
was captured by photographer Henry 
H. Barrett and so remains the first 
scientific experiment recorded by 
photographic means. 
In a word, from Vox Clamantis in 
deserto, “strong on the Tux’, weak on 
the ‘Veritas’.” 
Peter K. Spiegel, M.D. 
Professor and Chair 
Department of Diagnostic Radiology 
Dartmouth-Hitchcock Medical Center 
Lebanon, N.H. 
You’re both right 
To the Editor: 
Because of my mixed medical heritage 
(B.M.S. Dartmouth Medical School, 
M.D. Harvard Medical School, and 
ophthalmology residency at Yale), I re¬ 
ceive the alumni bulletins of all three 
institutions. I read with great interest 
your excellent article Medicines new 
eyes. I was greatly impressed by the 
claim that Yale physicist Arthur W. 
Wright made the first X-ray image in 
the United States on Jan. 27, 1896, 
just one day after an article entitled 
The New Photography appeared in the 
New York Sun newspaper describing 
Roentgen’s discovery of X-rays on 
November 8,1895. 
In the Winter 1995 issue of 
Dartmouth Medicine an article ap¬ 
peared describing the first clinical Y- 
ray in America: of the wrist of Eddie 
McCarthy, a 14-year-old boy who fell 
while ice skating on the Connecticut 
River in Hanover, N.H. This first 
clinical Y-ray was taken at Reed Hall 
at Dartmouth College on Feb. 3, 1896, 
and reported in an article published in 
Science dated Feb. 4, 1896. Physics 
professor Edwin Frost (and brother 
of Dr. Gilman Frost, a professor at 
Dartmouth Medical School and 
physician of Eddie McCarthy) wrote: 
“It was possible yesterday to test the 
method on a broken arm. After an 
exposure of 20 minutes, the plate on 
development showed the fracture in 
the ulna very distinctively. Comment 
upon the numerous applications of 
the new method in the sciences and 
arts would be superfluous.” 
Yale’s first X-ray image combined 
with Dartmouth's first clinical X-ray 
shows that these two institutions were 
(and continue to be) on the cutting 
edge of medical technology. It should 
also be remembered that Dartmouth 
and Yale share a common heritage, 
that of Nathan Smith, founder of 
Dartmouth Medical School in 1797 
and co-founder of Yale Medical 
School over a decade later. 
John D. Bullock, M.D. 
Professor and Chair 
Department of Ophthalmology 
Wright State University School of Medicine 
Dayton, Ohio 
Class agent syndrome 
To the Editor: 
A syndrome described in the Decem¬ 
ber 1997 Atlantic Monthly attracted 
my gaze. Now I know what causes my 
swollen legs: economy class syndrome, 
interestingly first described by Profes¬ 
sor Jennett of Glasgow University! 
As an American of Scottish descent, 
I now understand the connection be¬ 
tween my ethnic heritage, the legend¬ 
ary gift for thrift and my puffy ankles 
after a bargain flight. 
Another, which I call class agent 
syndrome, much more pleasant, is 
often seen in Yale medical alumni class 
agents after many years on the job. 
This condition may be experienced all 
year, depending on correspondence 
with classmates, but predominates 
each fall and peaks sharply every five 
years. Manifestations: frequent memo¬ 
ries and thoughts (even dreams) of 
classmates, living and dead. Enjoyable. 
Seriously desire to know if other class 
agents have noted same. 
Richard W. Breck, M.D. '45 
Wallingford, Conn. 
From the Edito 
Thanks for the magazines 
he magazine you are holding 
would be a good deal less inter¬ 
esting were it not for a person 
whose association with Yale began as 
a lanky freshman in Berkeley College 
42 years ago. Many people have 
helped make Yale Medicine a better 
publication during the last four years, 
but Robert Feldman, B.A. ’60, J.D. 
’63, is the one who made it possible. 
In the spring of 1994, he returned 
to Yale to oversee the medical school’s 
development, alumni affairs and pub¬ 
lic information activities. During the 
months that followed, Bob made it a 
priority to nurture the Alumni Bulletin 
of the School of Medicine into a lively 
and varied school magazine, while still 
making it a better alumni publication 
through expanded class notes, cover¬ 
age of alumni activities, and as a 
forum for alumni communication. 
This spring he left New Haven to 
become associate vice chancellor of 
Vanderbilt University in Nashville. 
It’s hard to imagine him trading 
Mory’s for the Grand Ole Opry but 
then again you don’t have to. Not 
only does he remain tried-and-true 
Yale blue, but, without doubt, he’ll 
take to Tennessee and it will take to 
him. We wish him good luck and 
good cheer. 
Michael Fitzsousa 
YALE MEDICINE 3 
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Yale spins off five biotech firms 
Until a decade ago, Yale’s participation in technol¬ 
ogy transfer, the movement of basic science ad¬ 
vances into the commercial marketplace, was 
negligible. That has changed dramatically {Yale Medicine, 
Fall 1997), and the change delights budget makers, 
among others. Two years ago, Yale’s annual income from 
royalties and licenses for University-developed projects 
had grown to $3 million. Yale expects those earnings to 
soar phenomenally, reaching $38 million for the fiscal 
year that ended June 30 and placing it among a handful 
of the universities leading in annual royalty and licensing 
income. More than three-quarters of the income has 
come from royalties from the AIDS medication Zerit, 
developed at Yale. A Yale-developed Lyme disease 
vaccine is expected to boost royalty income further in 
the coming years. 
There’s more good news. The Office of Cooperative 
Research has announced the formation of five new bio¬ 
technology companies based on spin-off technologies 
from School of Medicine research. 
Each of the new ventures plans to es¬ 
tablish research and development fa¬ 
cilities in the New Haven area, creat¬ 
ing an anticipated 70 or more new 
jobs in their first year of operations. 
“Yale is taking a more active role 
in forming new ventures in an effort 
to make sure the New Haven area 
reaps economic benefits from the 
University’s research.” says Gregory 
E. Gardiner, Ph.D., director of the 
According to results of a poll 
released in April, biomedical 
research and biotechnology 
industry have the strong sup¬ 
port of the vast majority of 
Connecticut residents. Most 
would even be willing to pay a 
surcharge on various health 
services or increased taxes if 
the money went to biomedical 
research. The survey was com¬ 
missioned by the national bio¬ 
medical research-advocacy or¬ 
ganization ResearchlAmerica 
and released by Connecticut 
United for Research Excel¬ 
lence, Inc. (CURE), coalition 
supporting biomedical re¬ 
search and education. Among 
its findings, the poll indicated 
that 80 percent of the respon¬ 
dents said they are more likely 
to think a hospital is “good" if 
they know it is engaged in re¬ 
search and training of medical 
students and residents. 
Office of Cooperative Research. “Aside from creating 
new jobs, the five companies are developing drugs and 
diagnostic techniques that have the potential to signifi¬ 
cantly benefit human health throughout the world.” 
The five new companies formed in partnership with 
Yale are: 
Molecular Staging Inc., which is generating DNA 
amplification techniques useful for detecting, 
characterizing and assessing the severity, or stage, 
of disease. MSI will focus on developing new and 
more powerful technologies for diagnosing cancer 
and infectious diseases. 
polyGenomics Inc., which is developing methods for 
analyzing population genetics to discover new genes 
using many of the same techniques employed by 
Molecular Staging. This could help researchers find 
the causes of complex diseases that involve defects in 
a number of genes, including psychiatric disorders 
such as panic disorders and schizophrenia and 
hypertension-associated kidney failure. 
Transmolecular Sciences Inc., which is relocating 
to New Haven from the University of Alabama at 
Birmingham. The company is studying neuro¬ 
transmitters involved in chronic pain as targets for 
developing powerful non-narcotic analgesic agents. 
The firm is also focusing on the diagnosis, imaging 
and treatment of malignant brain tumors. 
L2 Diagnostics, which was established with School of 
Medicine investment funds as a spin-off from its own 
Lyme/Lupus Diagnostics Laboratory. The new diag¬ 
nostic methods developed by the laboratory will help 
distinguish patients infected with Lyme disease from 
those who have been vaccinated. In May, an FDA 
advisory panel recommended approval of a Yale- 
developed vaccine. 
Cellular Genomics, which will explore ways in which 
changing patterns of gene expression affect how a cell 
looks and behaves. By focusing in on cells of the im¬ 
mune system, the company hopes to find new ways 
to treat autoimmune diseases such as juvenile-onset 
diabetes and multiple sclerosis, and to prevent 
transplant rejection. 
Formation of the new companies exceeds the 
University’s goals of spinning off three to four 
biotech companies each year, according to Jon 
Soderstrom, Ph.D., associate director of the Office 
of Cooperative Research. 
4 SUMMER 1998 
Budget, space concerns addressed in school’s 
strategic facilities plan 
When David A. Kessler, M.D., began speaking with 
faculty and top administrators in early 1997 before 
coming to the School of Medicine as dean, he 
found two issues on everyone’s mind: a mounting budget 
deficit and a critical shortage of space that threatened the 
school’s ability to recruit and retain the best faculty and stu¬ 
dents. Both problems demanded immediate attention, and, 
as the new dean soon learned, they were intricately linked. 
“Depending on how you calculate, the school had a 
deficit of $23 million or more for the 1997-98 budget year,” 
Dr. Kessler said in an interview in late June. Flaws in the 
school’s computerized billing system, combined with lower 
revenues from managed care, had contributed to the deficit. 
The lack of laboratory space had been recognized since at 
least 1989, when then-Dean Leon E. Rosenberg, M.D., 
formed a committee to address the issue, but plans for a 
new building stalled in the mid-1990s. A second committee, 
chaired by faculty members Carolyn W. Slayman, Ph.D., 
and Arthur E. Broadus, M.D., was formed to consider 
educational and programmatic goals in greater detail before 
new construction was proposed. 
Dean Kessler, with the participation of the school’s lead¬ 
ership, set about the task of crafting solutions to both prob¬ 
lems, spending much of his first year at Yale quietly analyz¬ 
ing the circumstances that produced them. The result of 
that process was apparent in two state-of-the-school presen¬ 
tations in late spring and early summer. In a series of meet¬ 
ings with department chairs, senior faculty, administrators 
and, ultimately, the Yale Corporation, the dean released 
a detailed account of the school’s finances and presented a 
plan to balance the budget by Jan. 1, 1999, six months 
earlier than he promised when he took office. Then in June, 
Dr. Kessler proposed a strategic facilities plan to meet a 
large portion of the school’s space needs. After reviewing the 
draft proposal at its June 19 meeting, the Yale Corporation 
approved funds to begin the formal planning process for 
renovations and new construction. 
The centerpiece of the plan is a proposed building at the 
corner of Congress Avenue and Cedar Street that would 
provide 139,000 square feet of laboratory space for disease- 
oriented research. The $160 million complex, one of the 
largest building projects ever undertaken at Yale, also would 
house a Magnetic Resonance Center to enable expansion of 
Yale’s cutting-edge capability in imaging, which is driving 
advanced research in nearly every discipline. Also included 
is space for offices, animal care, laboratory support and a 
teaching facility to replace the school’s overcrowded and 
outmoded gross anatomy laboratory in Sterling Hall of 
Medicine. State-of-the-art teaching laboratories and ciass- 
The need for additional 
research space has been a 
long-standing concern at the 
medical school, and faculty, 
administration and staff are 
looking forward to a proposed 
expansion of laboratory 
facilities. "This is about more 
than bricks and mortar,” says 
Dean David Kessler, right. 
“It's about people and ideas, 
and the creation of an environ¬ 
ment for research.” 
room space are also part of the new construction, which 
would total 201,000 net square feet. 
Still in the earliest stages of development, the plan will 
require the approval of city planning agencies and in-depth 
discussion by the medical school, the University and their 
New Haven partners, including the mayor, Board of 
Aldermen and the Hill Development Corporation. Once 
planning is complete, the school will return to the Yale 
Corporation for approval of construction funding. The 
project is only possible, Dean Kessler said, if the school 
secures significant funds from philanthropic sources. 
A portion of that total already has been committed by 
foundations and private donors. 
According to Dr. Kessler, balancing the budget was 
and will remain the key to University support. “Getting 
our fiscal house in order was the first step toward 
gaining the backing of the Corporation. They asked 
some hard questions and thanks to the chairs, the deputy 
deans, the faculty and the administration, we were well- 
prepared,” Dean Kessler said. “The key to this is living 
up to our responsibility.” 
Balancing the budget has been an across-the-board 
effort, with strategic cuts in the coming year’s expenses 
YALE MEDICINE 5 
M
IC
H
A
E
L
 
M
A
R
SL
A
N
D
 
"More than ever this is an opportunity for us to ensure that Yale creates the 
environment for collaboration between basic and clinical scientists around 
disease-oriented research.” 
Ralph I. Horwitz, M.D. 
Chair of Internal Medicine 
made by the departments, administra¬ 
tive offices and the Yale Psychiatric 
Institute, one of the clinical entities 
hardest hit by managed health 
care. “It required the entire school 
coming together,” Dr. Kessler said. 
“The chairs did it, the senior leader¬ 
ship in the faculty did it, and it 
wasn’t without hardship. It took 
real sacrifice.” 
Driving the strategic facilities plan 
is a concise statement of four aca¬ 
demic goals for the coming decade 
that places increased emphasis on the 
clinical enterprise. The goals are to 
strengthen disease-related research in 
the clinical departments, to sustain 
the high quality of basic science re¬ 
search, to promote research in epide¬ 
miology and public health, and to 
upgrade core facilities needed for bio¬ 
medical research throughout the 
University. The plan also calls for 
capital spending for renovations of 
$50 million a year for the next 10 years 
and outlines a process for upgrading 
and filling in space vacated by the 
laboratories that would move to the 
new building. That “backfill” plan ul¬ 
timately will group together research¬ 
ers from various departments who 
share scientific and clinical interests. 
Renovation of the Laboratory of 
Epidemiology and Public Health 
will also continue. Other important 
priorities include upgrading the space 
of the Yale Cancer Center in coopera¬ 
tion with Yale-New Haven Hospital, 
making improvements to the Yale 
Physicians Building, and expanding 
the space available for clinical 
neurosciences. 
The Department of Internal Medi¬ 
cine, which faces perhaps the most se¬ 
vere shortage of space, would benefit 
significantly from the new building, 
which would house programs in eight 
areas, according to the facilities plan. 
However, the building is not envi¬ 
sioned as a departmental structure, Dr. 
Kessler said, but rather as one orga¬ 
nized around program goals, similar to 
the Boyer Center for Molecular Medi¬ 
cine, which was completed in 1991. 
“More than ever this is an opportu¬ 
nity for us to ensure that Yale creates 
the environment for collaboration be¬ 
tween basic and clinical scientists 
around disease-oriented research,” said 
Ralph I. Horwitz, M.D., chair of In¬ 
ternal Medicine. “It will enable the 
school to remain at the forefront, and 
to recruit and retain the world-class 
physician-scientists needed to pursue 
this research.” 
According to Sally E. Shaywitz, 
M.D., a leading brain researcher and 
pediatrician who specializes in the 
study of dyslexia, the Congress Avenue 
Building’s proposed magnetic reso¬ 
nance facility would effectively double 
the medical school’s current capacity 
to image brain activity. “It means we 
can enter the next century,” said 
Dr. Shaywitz, who in 1995 with her 
colleague and husband Bennett A. 
Shaywitz, M.D., produced the first 
evidence of gender differences in brain 
activity. “It means we can do the kind 
of work that will allow us to under¬ 
stand better how people think and 
learn and read—and to learn why 
some very bright people have diffi¬ 
culty learning to read.” 
Robert H. Gifford, M.D., HS ’67, 
deputy dean for education, said that 
the teaching component of the pro¬ 
posed building “will make a huge dif¬ 
ference for students, in particular dur¬ 
ing the first two years of medical 
school." The school’s current anatomy 
laboratory, built in the 1930s to ac¬ 
commodate a class of 50, has been 
stretched past capacity for decades and 
now, and is currently used by 130 
medical and physician associate stu¬ 
dents. “We will have an anatomy lab 
that is state-of-the-art, rather than one 
of the oldest in the nation.” The new 
building would also consolidate other 
student teaching facilities now scat¬ 
tered across the campus. 
For Dr. Kessler, who would like 
the see the new building completed 
in four years, the strategic facilities 
plan is about “more than bricks and 
mortar. It is not about a building. 
It’s about people and ideas, and the 
creation o! an environment for re¬ 
search,” he said. “By having the 
clear sense of focus on disease, I 
think we will see real advances that 
impact both individuals and the 
health of the public. Our goal is to 
advance the scientific basis of the 
practice of medicine.” 
He recalled talking about the plan 
with W. Maxwell Cowan, M.D., 
Ph.D., vice president and chief scien¬ 
tific officer of the Howard Hughes 
Medical Institute, when Dr. Cowan 
visited Yale recently. “We took a walk 
and I showed him the site where we 
envision all this happening. I told him 
it was an ambitious plan, and not 
without difficulty,” Dr. Kessler said. 
“Max turned to me and said, ‘David, 
this may well be the best investment 
Yale will ever make.’ ” 
6 SUMMER 1998 
Lab testing may allow earlier 
cancer diagnosis 
If promising research at the Yale Cancer 
Center is proven effective, a simple 
blood or tissue test may be able to pro¬ 
vide earlier diagnosis of breast cancer 
than is now possible with mammo¬ 
grams. To pursue this new technology, 
the Cancer Center last fall established 
a new specialized laboratory with 
$500,000 in seed money provided 
by Los Angeles philanthropist 
Marcia Israel. 
Investigators are developing new 
tests capable of detecting very small 
clusters of cells before they become vis¬ 
ible on a mammogram. New technolo¬ 
gies already make it possible to deter¬ 
mine mutations in single cells as well as 
in genetic material extracted from a 
very small number of cells. The bio¬ 
logical materials obtained through such 
methods as fine needle aspiration can 
then be analyzed with great sensitivity 
and specificity for the genetic alter¬ 
ations that are the hallmark of cancer¬ 
ous cells. New technologies also make 
it possible to look for mutated cancer 
molecules in the blood of patients. 
“Researchers at the Yale Cancer 
Center have hopes not only of improv¬ 
ing the detection of small cancers, but 
also of being able to identify women 
whose breast tissue is about to become 
cancerous,” said Jose Costa, M.D., the 
Cancer Center deputy director under 
whose supervision the new laboratory 
falls. “These are the patients on whom 
we will ultimately want to test new 
cancer-preventing therapies.” 
Worry about Lyme disease 
may be worse than the illness 
Lyme disease was first identified and 
named by researchers at Yale more than 
a decade ago. Now, Yale investigators 
have shown that fear of Lyme disease 
may in some cases cause more prob¬ 
lems than the disease itself. According 
to a study published in the Annals of 
Internal Medicine in March, anxiety 
about possibly getting Lyme disease 
following a deer tick bite can result in 
over-treatment by doctors and is associ¬ 
ated with a high incidence of depres¬ 
sion and stress among patients. That 
worry is often unfounded and may re¬ 
sult in harm, especially from overuse of 
antibiotics. 
Lyme disease is caused by bacteria 
spread through extended feeding on 
human blood by the tiny deer tick. The 
tick must be embedded in the flesh for 
at least 24 hours to spread the bacteria 
into the host. In the vast majority of 
cases, an infected bite will cause a bull’s 
eye rash. Lyme disease can cause flu¬ 
like symptoms, swelling of the knees 
and, in very unusual cases, arthritis, 
facial paralysis and neurological disor¬ 
ders. A single course of antibiotics 
usually eradicates the disease and even 
later-stage manifestations normally 
respond to antibiotic therapy. 
According to the Yale study, 
however, many patients don’t 
believe it, or believe they 
have the disease when 
they do not. Out of 209 *! 
patients evaluated for this 
infectious disorder, 60 percent 
turned out not to have Lyme disease at 
all. Yet they still made an average of 
seven visits to the doctor, had four 
blood tests and underwent 42 days of 
antibiotic treatment. 
High levels of depression (42 per¬ 
cent) and stress (45 percent) were 
present in those who turned out not to 
have the disease and more than half 
reported adverse drug reactions after 
taking antibiotics. Assistant professor 
of medicine M. Carrington Reid, 
M.D., who co-authored the study with 
clinical professor of medicine Robert T. 
Schoen, M.D., says, “Were not helping 
these patients if we simply give them a 
label of Lyme disease.” The study 
points to the need for better informa¬ 
tion for patients and physicians about 
Lyme disease. 
Bringing public health education to a changing China 
The explosive growth of the economy 
of the People’s Republic of China 
brings with it many benefits—and a 
set of daunting new public health 
challenges. Already closely allied with 
efforts to improve public health edu¬ 
cation in China, Yale faculty and stu¬ 
dent efforts will expand significantly 
as a result of a five-year, $400,000 
grant from The Procter & Gamble 
Co. The funds will support a collabo¬ 
ration between the Department of 
Epidemiology and Public Health and 
Beijing’s 10-year-old Union School of 
Public Health, the nation’s first gradu¬ 
ate-level public health training pro¬ 
gram. The main focus of the collabo¬ 
ration will be on strengthening the 
Union School curriculum in public 
health law, health economics, environ¬ 
mental health, smoking control and 
other areas. The grant will also fund 
summer internships in China for Yale 
students in public health. 
Those students will face a broad 
range of problems. “Fundamental 
political and economic changes,” says 
Michael H. Merson, M.D., dean of 
public health and director of the Yale- 
Union collaboration, “are presenting 
China with not only many health 
risks associated with developing 
nations—such as infectious and para¬ 
sitic diseases—but also rising rates of 
diseases associated with lifestyle 
changes, including cancer, heart dis¬ 
ease and sexually transmitted diseases 
such as AIDS. In addition, 70 percent 
of adult men in China smoke, creat¬ 
ing a huge need for anti-smoking 
campaigns organized by public health 
workers.” 
Yale first collaborated with Union 
School in 1996 when University fac¬ 
ulty helped develop a public health 
law curriculum. Part of the new col¬ 
laboration will involve refining that 
curriculum and disseminating it to 
faculties at some 30 other public 
health schools in China. Procter & 
Gamble’s chairman and chief execu¬ 
tive officer, John E. Pepper, is a mem¬ 
ber of the Yale Corporation, the gov¬ 
erning board of the University. 
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Discovery of how a brain tumor travels may pave way to treatment 
Yale researchers have discovered a 
molecule that speeds the growth and 
spread of a form of brain cancer that 
afflicts some 20,000 Americans annu¬ 
ally and proves lethal in half of the 
cases within 18 months. Glioma, as 
the form of cancerous brain tumors is 
termed, is particularly resistant to 
standard treatments such as surgery 
because its cells zoom through normal 
brain tissue to other sites where new 
tumors can grow rapidly. According to 
a study directed by neurobiologist 
Susan Hockfleld, Ph.D., gliomas 
move through healthy brain tissue 
with the help of a tumor-specific pro¬ 
tein, which acts like a set of wheels on 
the cancer cells. The researchers hope 
that a therapy that blocks the function 
of the protein molecule, called brain- 
enriched hyaluronan binding protein 
(BEHAB), or reduces a tumor cell’s 
ability to generate it, may slow 
tumor progression. 
Dr. Hockfeld’s study, which was 
published in the April 1 issue of The 
Journal of Neuroscience, provides the 
first clear understanding of how glioma 
cells invade healthy brain tissue. The 
work also resulted in a new animal 
model for the disease that can be used 
to evaluate future therapies. “One ap¬ 
proach to controlling the cancer,” says 
Dr. Hockfield, the new dean of the 
Graduate School of Arts and Sciences, 
“would be to block the glioma cells’ 
ability to travel, without harming 
healthy cells.” She notes that BEHAB 
may prove a prime candidate for this 
type of therapy because it exists in 
glioma tumors but not in other kinds 
of brain tumors or tissue in the body. 
When a fragment of BEHAB protein is ex¬ 
pressed in experimental brain tumors (dark 
mass at upper right), the tumors show a 
marked increase in their ability to invade the 
neighboring normal brain tissue (lighter re¬ 
gion). The clusters of dark tumor cells are 
found scattered throughout the normal tis¬ 
sue shortly after they are grafted into the 
host brain. When the BEHAB protein is not 
expressed in these tumor cells, they do not 
invade the normal tissue. 
Wider use of medication 
could prevent many strokes 
An irregular heartbeat, or atrial 
fibrillation, affects some 2.5 million 
Americans. Clot formation associated 
with atrial fibrillation is believed to 
be a contributing factor in about 15 
percent of the 740,000 strokes that 
occur each year in the United States, 
yet very few of the people who would 
benefit from a medication to treat 
atrial fibrillation receive it. According 
to a study directed by Lawrence M. 
Brass, M.D., professor of neurology 
and chief of the neurology service at 
the VA Connecticut Healthcare 
System in West Haven, only 38 
percent of patients who had atrial 
fibrillation received warfarin, a blood 
thinner used to reduce the tendency 
for blood to form clots. Researchers 
believe that if more patients took 
warfarin, tens of thousands of strokes 
could be prevented, saving thousands 
of lives each year. “We have a medica¬ 
tion that has been shown to be highly 
effective,” says Dr. Brass, “but we 
have found that the medical commu¬ 
nity is not getting this therapy to all of 
the patients who need it.” The results 
of the study appeared in the Decem¬ 
ber issue of Stroke and are part of the 
Already an important tool for public 
health investigators, the World Wide 
Web now offers a new site for one- 
stop local research in the field: 
New Haven Health. The Cushing/ 
Whitney Medical Library received a 
grant from the National 
Library of Medicine this 
past winter “to create a pub¬ 
licly accessible Web site that 
will function as a central re¬ 
pository for information 
about public health in the 
greater New Haven area. 
The Web site includes vital 
and health statistics, current 
and historical public health 
documents, community 
organization listings, aids 
in the search for related 
ongoing efforts to enhance clinical 
practice in the Center for Outcomes 
Research and Evaluation at Yale-New 
Haven Hospital, Dr. Brass says. 
non-digital holdings, and historical 
images. Browsers will find links to re¬ 
lated sites and a listserv for the discus¬ 
sion of public health research. Go to 
<http://www.med.yale.edu/ 
newhavenhealth/>. 
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Yale physicians link up with Everest expedition 
In May, several dozen seasoned 
climbers set their sites on 
Everest, the world’s highest moun¬ 
tain. As one group labored up the 
treacherous and often deadly slopes, 
Yale physicians made medical history 
in an experiment linking the remote 
expedition to the clinical resources of 
a medical center 8,000 miles away. 
Vincent Grasso, M.D., a postdoc¬ 
toral associate in the Department of 
Surgery, directed care at Everest as 
colleagues in New Haven monitored 
the climbers’ adjustment to high alti¬ 
tude and thin air. Vest-like biopacks 
transmitted vital data from the slopes 
of the 29,028-foot mountain to the 
base camp at 17,000 feet, relaying 
the information to Yale by satellite 
phone and the Internet. A video con¬ 
nection allowed the two groups of phy¬ 
sicians to talk face to face as, for ex¬ 
ample, Dr. Grasso examined a sherpa 
guide who was experiencing abdomi¬ 
nal pain. Taking full advantage of the 
technology, images from a portable ul¬ 
trasound unit were transmitted simul¬ 
taneously allowing Dr. Grasso and the 
New Haven-based team to rule out 
major illness. 
“This exercise will allow us to get a 
better understanding of changes in 
people’s bodies as they are going 
through altitude changes. Hopefully 
we will begin recognizing predictive 
patterns,” says Peter B. Angood, M.D., 
assistant professor of surgery and 
New Haven-based medical director for 
the expedition. Dr. Angood and other 
Yale researchers participated in daily 
videoconferences with the expedition 
team and scientists at the MIT Media 
Lab, the U.S. Army, NASA and AT&T. In 
addition to testing the biopacks, the 
climbers have installed meteorological 
devices to transmit weather reports 
from Everest’s slopes and global posi¬ 
tioning equipment to measure the 
mountain’s subtle shifts in elevation. 
Dr. Ronald Merrell, chairman of 
surgery and director of the Yale 
Commercial Space Center, and Dr. 
Richard Satava, professor of surgery 
and a leading expert in telemedicine, 
initiated the Everest expedition’s 
medical experiments. 
Right: Vincent Grasso and climbing sherpa Ang 
Sherring talk to physicians at Yale from the 
base camp at Mt. Everest. 
Above: The New Haven team, led by Peter Angood, second from 
left, listen and watch from a medical school conference room. 
For detailed maps, photographs and reports from the expedition 
see <http://yalesurgery.med.yale.edu/CSC/everest.htm> and 
<http://everest.mountainzone.com/98/> on the World Wide Web. 
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“Tobacco Wars” began with a simple question: Why not? On a Wednesday evening in 
early April, David Kessler is 
telling the story of The Tobacco 
Wars to a room full of about 50 
people. The account is equal parts 
public health analysis, investigative 
journalism and detective story, with a 
few elements that are decidedly cloak- 
and-dagger: an informant code-named 
Cigarette, industry documents leaked 
in a plain white envelope, and pains¬ 
taking searches through patents and 
customs declarations. 
The opening chapter takes place in 
Washington, where as Food and Drug 
Administration commissioner in 1991, 
Dr. Kessler asked his staff why the 
FDA did not regulate tobacco. After 
all, it was clearly an addictive sub¬ 
stance responsible for as many as 
400,000 deaths a year in the United 
States alone. Why not try to prevent 
illness and death? Because 90 percent 
of smokers started in their teens, he 
also saw it as a pediatric health con¬ 
cern. Why not try to prevent young 
people from starting? The answer 
was direct, he recalls. “ ‘Because that’s 
one industry you can’t take on. It’s 
too powerful.’ ’’ 
Seven years later, the conventional 
wisdom has changed. The tobacco 
companies have offered to pay $368.5 
billion to settle a series of class-action 
lawsuits (a deal that subsequently fell 
Attention deficit study 
finds no evidence of 
overdiagnosis 
The number of children being 
diagnosed and treated for attention 
deficit/hyperactivity disorder 
(ADHD) has risen sharply in recent 
years, and parents and child-health 
advocates have raised concerns about 
possible overdiagnosis of the disorder. 
The Council on Scientific Affairs of 
the American Medical Association 
reviewed studies in the field over 
1 o 
apart as Congress sought a higher 
amount and curbs on immunity from 
future litigation). Dr. Kessler has left 
Washington to become dean of the 
School of Medicine, remaining vocal 
on the issue and advocating, along 
with former surgeon general C. 
Everett Koop, for a tough settlement. 
Tonight, Dr. Kessler talks about the 
tobacco wars as a faculty member en¬ 
gaging a class. “How do you look at 
the problem?” he asks the audience at 
the Slifka Center for Jewish Life at 
Yale. “What do you have to show?” 
From a regulatory standpoint, the 
problem was to define tobacco as a 
drug and place it under FDA jurisdic¬ 
tion. What stymied regulators was the 
definition of a drug as an article other 
than food that is intended to affect 
the function or structure of the body. 
“It took us two years to think 
through the question of how to ap¬ 
proach that definition. What we con¬ 
cluded, and it was a subtle difference 
that made all the difference in the 
world, was that the article was the 
nicotine,” Dr. Kessler says, noting 
that one of the definition’s key words 
is intended. “The physiological effects 
of nicotine on the central nervous 
system certainly are sufficient to 
affect the structure and function of 
the body. You have to show intent, 
the manufacturer’s intent. How do 
more than the last two decades 
and concluded that those worries 
are unfounded. The council’s chair- 
elect, Myron Genel, M.D., professor 
of pediatrics and associate dean of 
government and community affairs 
at the School of Medicine, says, 
“The preponderance of evidence is 
that ADHD is not diagnosed lightly. 
ADHD is one of the best studied 
and characterized disorders.” 
For the council’s report, which 
appeared in the April 8 issue of The 
Journal of the American Medical 
you go about doing that?” 
The search began with industry 
patents to develop nicotine substitutes 
and add nicotine to wrappings and fil¬ 
ters. Although the industry officials 
insisted they were not manipulating 
nicotine, a study of low-tar cigarettes 
suggested otherwise. The industry said 
that nicotine was linked to tar. If tar 
levels were high, nicotine levels would 
be high, the industry claimed. But the 
FDA found that one maker’s ultralight 
cigarettes, for example, had more 
nicotine than the same brand’s regular 
cigarettes. “I would argue that can’t 
happen without some degree of ma¬ 
nipulation,” Dr. Kessler says. 
But a theory is not proof. An im¬ 
portant bit of evidence came from a 
surprising source, a tobacco lobbyist 
bragging at a Washington reception 
that the FDA was looking in the 
wrong places. “What he said was, ‘It 
all begins in the fields,’ ” Dr. Kessler 
says. “What he didn’t realize was that 
the person standing next to him 
would call us the next day.” 
That information and another tip 
led the FDA to foreign patents and to 
Brazil, where an American company 
was developing genetically engineered 
tobacco with twice the normal con¬ 
centration of nicotine. The industry 
claimed the new tobacco was simply a 
blending device. 
Association {JAMA), studies published 
from 1975 through March 1997 were 
reviewed and analyzed. The council 
found little evidence of widespread 
overdiagnosis or misdiagnosis of 
ADHD, or of widespread over¬ 
prescription of Ritalin, the most 
commonly prescribed drug for 
treatment of ADHD. 
The council concluded: 
“Epidemiologic studies using stan¬ 
dardized diagnostic criteria suggest 
that 3 percent to 6 percent of the 
school-aged population may have 
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David Kessler answers questions after speaking at the Slifka Center in April. 
“The strongest evidence was yet to 
come and it focused on industry 
knowledge of tobacco products,” 
Dr. Kessler says. Documents from the 
1960s proved that tobacco officials 
knew nicotine was addictive. Others 
from the 1970s proved the tobacco 
industry was marketing to young 
people. “Realistically,” reads an indus¬ 
try memo, “if our company is to 
survive and prosper over the long 
term we must get our share of the 
youth market.” 
In 1996, the FDA declared nicotine 
a drug and placed restrictions on to¬ 
bacco ads and sales. A year later, the 
industry struck a deal with 41 state at¬ 
torneys general who were suing to re¬ 
cover smoking-related health care 
costs. The industry would agree to pay 
$368.5 billion over 25 years to settle 
the claims, but would be immune 
from future class-action suits. Dr. 
Kessler and Dr. Koop, a visiting pro¬ 
fessor of public health at Yale last year, 
called that deal too weak. Sen. John 
McCain, an Arizona Republican who 
chairs the Senate Commerce Com¬ 
mittee, proposed tougher restrictions in¬ 
cluding a $i.io-per-pack price hike to be 
phased in over five years; a $516 billion 
payment from the industry; no ban on 
lawsuits; and additional penalties if 
companies failed to reduce youth smok¬ 
ing. That proposal, approved by the 
commerce committee in a 19-1 vote, led 
the tobacco industry to walk out on the 
previous settlement. 
Dr. Kessler learned of the walkout 
a few hours before giving his talk at 
the Slifka Center. “Congress,” he tells 
the audience, “does not have to ask 
the industry for permission to act.” 
Congressional efforts to craft some 
type of settlement fell apart, however, 
leaving states to negotiate individually 
with the tobacco industry. 
He closes his talk with the recollec¬ 
tion of the question that was consid¬ 
ered naive. “Everyone at that time 
said it was a fool’s errand,” Dr. Kessler 
says. Tonight, this once-invincible 
industry is on the defense, hard- 
pressed even to find candidates who 
will accept its campaign contribu¬ 
tions. In Dr. Kessler’s eyes, it was 
persistence and preparation—as well 
as imagination—that made the differ¬ 
ence. “Sometimes, just sometimes,” 
he says, “you can take on the 
impossible.” 
ADHD. The percentage of U.S. 
youth being treated for ADHD is 
at most at the lower end of this 
prevalence range.” 
A brain structure that keeps 
confusion at bay 
Animals are constantly gathering sig¬ 
nals from the surrounding environ¬ 
ment, yet somehow they learn to fo¬ 
cus on stimuli important to survival 
and to ignore, or fail to learn to re¬ 
spond to, other stimuli. Otherwise, a 
survival-threatening confusion could 
result. A team of investigators, includ¬ 
ing Yale neuroscientist Jeansok J. Kim, 
Ph.D., has found a neurological expla¬ 
nation for this phenomenon called 
blocking, and has identified the brain 
structure involved in the blocking 
process. Dr. Kim and colleagues found 
that when they chemically severed a 
brain structure called the inferior olive 
in rabbits, blocking disappeared and 
the animals responded to redundant 
and irrelevant stimuli. 
“In order to adapt to its environ¬ 
ment,” says Dr. Kim, an assistant pro¬ 
fessor of psychology, “an animal must 
respond selectively to stimuli that reli¬ 
ably predict biologically significant 
events, such as food availability. In the 
interest of efficiency and simplicity, 
animals must avoid forming associa¬ 
tions with other stimuli that provide 
no new information. Blocking appears 
to circumvent such redundant learn¬ 
ing.” The study appeared in the 
journal Science. 
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New Haven’s mayor visits 
medical school 
New Haven and Yale University have 
never had better relations. Mayor 
John DeStefano told students and 
faculty during a visit to the medical 
school March 5. “ 1 he University 
and the city understand their need 
to grow together,” he said at a Medi¬ 
cal School Council lunch in the 
Beaumont Room. “1 feel better about 
understanding each other and sup¬ 
porting each other than I have in 
my lifetime.” 
Noting that the largest taxpayers 
and employers in two neighboring 
communities are a pharmaceutical 
company and a medical research com¬ 
pany, he cited the 
importance of the 
medical school to 
the region’s and 
the city’s economy. 
“I think that find¬ 
ing a way to grow 
the medical school 
towards the central 
campus of Yale is a good idea.” 
Mr. DeStefano said he has plans for 
developing downtown New Haven 
and Long Wharf. “I think you’re 
going to see the growth south of 
Howard Avenue towards Church 
Street South and the train station,” 
he said. He is also trying to improve 
transportation by promoting ferry ser¬ 
vice to Long Island, a fast rail link to 
New York City and an expanded run¬ 
way at Tweed-New Haven Airport. 
A lack of space, an unwarranted 
image as crime-ridden, and a dispro¬ 
portionate share of social ills such as 
poverty have hobbled development in 
New Haven, he said. Since the 1950s 
the city has lost residents and busi¬ 
nesses to the suburbs. Restrictive zon¬ 
ing laws and the lack of affordable 
housing in the suburbs and a higher 
proportion of multi-family dwellings 
in the city lead to a larger concentra¬ 
tion of poor people in the city, he 
said. Median income, which in 1950 
was about the same in the city and its 
suburbs, has shifted. For every dollar 
of income in neighboring towns, New 
Haven has 67 cents. “The fact of 
John DeStefano 
Linda Friedlaender and Irwin Braverman developed a tutorial that uses paintings at the Yale 
Center for British Art to train students to notice clinical details that are often overlooked. 
“In the old days, before the advent of modern medical imaging technology, doctors had to 
rely on the connection between the eyes and the brain,” Braverman says. “I hope this tutorial 
can restore some of those skills.” 
Using art to sharpen 
observational skills 
Medical education took an artistic 
turn for a group of Yale students 
this past spring. Professor Irwin M. 
Braverman, M.D. ’55, and museum 
curator Linda Friedlaender combined 
their expertise to produce a tutorial 
using works of art to sharpen the 
observational skills of aspiring 
physicians. 
In a collaboration between the 
medical school and the Yale Center 
for British Art, 56 medical students 
spent time looking at selected paint¬ 
ings, described them for the group 
and made thoughtful judgments 
about what was being communicated 
visually. Students were assigned a 
painting and given time to observe 
and study it—“like a rash that has 
been framed,” says Dr. Braverman, 
a dermatologist. 
The goal of the exercise is to pro¬ 
duce more careful observers by train¬ 
ing students to decode an object’s 
meaning and to extract useful infor¬ 
mation. Physicians with superior ob¬ 
servational skills ask the questions 
necessary to diagnose illness without 
relying excessively on tests, says Dr. 
Braverman, adding, “Doctors have to 
be taught to pick up on details that 
are often overlooked.” 
He came upon the idea last 
November while thinking of ways to 
teach his dermatology residents to no¬ 
tice more in the clinic. He discussed 
the idea with Mrs. Friedlaender, cura¬ 
tor of education at the Yale Center for 
British Art, who had been thinking 
about the same kind of observational 
exercise for residents in the Depart¬ 
ment of Orthopaedics and Rehabilita¬ 
tion, chaired by her husband, Gary E. 
Friedlaender, M.D. 
The students who participated in 
the tutorial found it to be a significant 
step in their training. “Like very de¬ 
tailed paintings, the human body is 
complex,” says Leo Kim, a first-year 
student. “Learning to look at, and re¬ 
ally see, all the details of a painting 
helps in diagnosing patients.” 
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housing segregation and the racial and 
economic isolation that flows out of 
that is a real challenge,” he said. 
On top of its economic woes, the 
city is unfairly portrayed as a place ol 
crime and that keeps people away, he 
said. He said that in 1994, Bridgeport 
had 54 murders, nine of which made 
the front page of the newspapers. 
Hartford had 61 murders, with seven 
making the front page. All but one of 
New Haven’s 34 murders that year 
were front-page news. ’‘New Haven is 
the murder capital of the state not be¬ 
cause we had the most murders,” Mr. 
DeStefano said, “but because we did 
the best job of publicizing them.” 
Since 1990 crime has dropped by 
nearly 40 percent, Mayor DeStefano 
said, noting that in early 1998 the 
city’s murder rate was the lowest in 
generations. “Real growth will occur 
when we move past perceptions and 
ignorance,” he said. 
Child Study Center aids 
Arkansas town after 
shootings 
The day after four girls and a teacher 
were shot to death at a middle school 
in Arkansas, Yale psychologist Steven 
Marans, Ph.D., was on a plane. 
Two boys, ages 11 and 13, were ac¬ 
cused of setting off a fire alarm on 
March 25, then ambushing school¬ 
mates as they ran from the building. 
As the small city of Jonesboro tried to 
make sense of the incident, one of 
nearly a dozen violent outbursts in 
schools around the nation this past 
school year, Dr. Marans was sum¬ 
moned as an observer and consultant. 
The reason was Yale’s Child Devel¬ 
opment-Community Policing Pro¬ 
gram, a unique collaboration between 
mental health professionals at the 
Child Study Center and New Haven’s 
police department. The CDCP Pro¬ 
gram, which provides counseling and 
other support to children who have 
witnessed violence, has been replicated 
in four U.S. cities with funding from 
the U.S. Department of Justice. 
“The partnership between mental 
health and law enforcement in 
New Haven has given us a unique 
opportunity to think about violence 
from many perspectives,” says Dr. 
Marans, who helped launch the 
program in 1991 with center Director 
Donald J. Cohen, M.D. ’66, and 
city police leaders. “We have gained 
an awful lot of experience over the 
last seven years.” 
During his two days in Jonesboro, 
Dr. Marans talked with counselors, 
parents, teachers and students and at¬ 
tended a meeting of about 500 stu¬ 
dents and parents. “They have a very 
arduous task at hand, which is to 
mourn the loss of life and to mourn 
their loss of friends and children,” says 
Dr. Marans, the Harris Assistant Pro¬ 
fessor of Child Psychoanalysis. Those 
who saw the shootings or lost friends 
may experience depression, eating and 
sleeping disorders, a sense of disbelief, 
psychological numbing and a degree 
of fearfulness. Children may be more 
clinging and dependent and needy 
than they are typically. 
The town of 50,000 people is left 
to wonder why two children would set 
out to kill other children. “Having the 
easy availability of guns and inad¬ 
equate supervision has been a potent 
and lethal combination. But every 
human being has anger and feelings 
of rage at times and longings for at¬ 
tention. Those feelings that are com¬ 
mon to all of us do not typically find 
expression in murdering one another,” 
says Dr. Marans. “We know this 
behavior is not typical in the majority 
of children, and our children need to 
know that as well.” 
Steven Marans 
Exercise science soars on 
human powered wings 
As a physiologist, Ethan Nadel, Ph.D., 
knows a great deal about what happens 
to the body during exertion and the 
causes of fatigue. Even he didn’t know 
just what to expect, however, when he 
helped to plan a world-record, human- 
powered flight. In his March 27 lec¬ 
ture, Dr. Nadel, professor of cellular 
and molecular physiology and of epi¬ 
demiology and director of the Yale- 
affiliated John B. Pierce Laboratory, 
described the challenges planners faced 
when preparing the pilot 10 years ago 
for Project Daedalus, a modern day 
reenactment of the mythical Greek 
inventor Daedulus’ 74-mile passage 
between the Greek islands of Crete 
and Santorini. Dr. Nadel selected the 
pilot team and developed a drink to 
prevent dehydration and boost the 
pilot’s energy supply during the gruel¬ 
ing but ultimately successful flight. 
His talk inaugurated a new series of 
campus lectures, along with a new 
summer research internship program 
for seven Yale College students, spon¬ 
sored by Gatorade Inc. 
Cardiologists combine 
to form statewide 
network 
In today’s managed care world, con¬ 
solidation of health care delivery ser¬ 
vices is the order of the day, including 
the practices of Yale faculty members. 
The Yale Cardiology Network, a 
faculty-practice organization, has 
merged with CardioNet of Connecti¬ 
cut, LLC, a community-practice 
group, to form a statewide heart-care 
network. Its more than 90 university- 
and community-based physicians, car¬ 
diologists and cardiac surgeons also 
serve parts of Rhode Island and New 
York. The network, the first of its kind 
in Connecticut, will operate under the 
name of the Yale Cardiology Network 
and will be headed by an executive 
committee chaired by Barry Zaret, 
M.D., chief of the section of cardio¬ 
vascular medicine. 
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A genetic intervention for 
children with rare disease 
Yale investigators are evaluating a po¬ 
tential therapy lor Canavan disease, a 
rare neurological disorder in children 
that is usually fatal. Eight children 
have been cared for at Yale this year as 
part of a clinical trial to test the safety 
of the treatment, which uses gene 
therapy techniques to replace a critical 
enzyme in the brain. 
Children with Canavan disease 
cannot hold their heads up, have 
trouble eating and may suffer seizures. 
Few live past the age of io. The 
genetic disease strikes children of 
all ethnic groups, occurring most 
frequently among Ashkenazi Jews. 
According to Margretta R. 
Seashore, M.D., the principal investi¬ 
gator in the study, the current phase 
of the trial will assess its safety. Yale’s 
Human Investigation Committee 
and its Biosafety Committee are also 
monitoring the study. A ninth child 
is undergoing the therapy at Thomas 
Jefferson University Hospital in 
Philadelphia. If the procedure proves 
safe, the FDA may allow researchers 
to add six more children to the trial. 
Although the Phase I trial is fo¬ 
cused on the safety of the procedure, 
researchers are watching for signs of 
improvement in the children. “It’s re¬ 
ally too early to know whether we’ve 
got some encouraging signs of thera¬ 
peutic effect,” said Maurice J. 
Mahoney, M.D., a member of the 
Human Investigation Committee. 
The only reported side effect among 
the children has been a high fever that 
is typical of gene therapies and easily 
treated, said Dr. Seashore, professor of 
genetics and pediatrics. 
Treatment starts with the insertion 
of a 2-inch-wide rubber reservoir 
under the scalp. A slender catheter 
carries the gene to synthesize asparto- 
acylase (ASPA), an enzyme missing in 
Canavan disease, into the ventricle of 
the brain. Although researchers are 
still trying to understand the exact 
mechanism, without ASPA a chemical 
called N-acetylaspartic acid builds 
up and myelin, the “white matter” 
that protects nerves and allows 
messages to be transmitted to and 
from the brain, becomes deficient. 
Researchers hope their therapy will 
stimulate the brain to produce ASPA 
and slow down or reverse the progress 
of the disease. 
Parents recognize that the therapy 
is experimental and may not help 
their children. “There will either be a 
benefit or there will be nothing,” said 
Howard Gluckman of Johannesburg, 
South Africa, who calls his son, 
Asher, 9, the granddaddy of the 
group. The youngest child in the 
group is 19 months. “At least they’re 
not in danger from the procedure.” 
“It’s a first step,” said Matthew 
During, M.D., a visiting professor 
at the medical school who conducted 
previous gene therapy trials in 
New Zealand. “It gives us a level 
of comfort and confidence in 
moving forward. 
Probing the hazards of 
autobody work 
Walk into an autobody shop and you 
may be greeted by a curious cocktail 
of chemical fumes. Posted signs keep 
customers out of work areas, but paint¬ 
ers and repairers must stay in that envi¬ 
ronment for hours each day. Although 
most shops take safety precautions, 
research shows that exposure to chemi¬ 
cals in autobody paint can trigger 
respiratory ailments. 
To determine how exposure to a class 
of chemicals known as isocyanates 
causes asthma, researchers at Yale’s 
Occupational and Environmental Medi¬ 
cine Program have launched a study of 
shops in two Connecticut counties. The 
study, called the Survey of Painters and 
Repairers in Autobodies by Yale, or 
SPRAY, is also directed at finding better 
ways of protecting workers’ health. 
Workers in autobody shops are ex¬ 
posed to many potentially harmful 
materials, such as paints and solvents. 
Paints often contain isocyanates, which 
are highly reactive chemicals known to 
induce respiratory symptoms and 
asthma. According to Mark R. Cullen, 
M.D., director of the Occupational and 
Environmental Medicine Program and 
the study’s principal investigator, isocy¬ 
anates account for the highest number 
of reported cases of occupational asthma 
in the United States and other devel¬ 
oped countries. Approximately 5 to 10 
percent of workers exposed to isocyan¬ 
ates may be affected nationally. 
SPRAY, which is funded by a 
cn 
Focus on fitness 
The Yale Conference on Women’s Health & Fitness in May brought to¬ 
gether some of the nation’s leading experts on physical activity, meno¬ 
pause, cancer and nutrition to discuss the latest findings for the treat¬ 
ment of women and the diseases that affect their health. Keynote 
addresses were given by Stephen Blair, director of epidemiology and clini¬ 
cal applications at the Cooper Institute for Aerobics Research in Dallas 
and author of the surgeon general’s report on physical activity; and 
Rebecca and Ruthann Lobo, co-authors of Home Team: of Mothers, 
Daughters & American Champions. The Lobos spoke about how they 
handled Rebecca’s success on the basketball court and Ruthann’s battle 
with breast cancer. Pictured at a reception at the Yale Sports Medicine 
Center are (back row, from left) Larry Matthews, Ph.D., conference co¬ 
chair; Rebecca and Ruthann Lobo; and (front row, from left) conference 
co-chairs Ann Cowlin and Peggy DeZinno. 
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case Yale appeals verdict in Dr. Doe 
In December a New Haven jury 
awarded $12.2 million to a former 
medical resident who became HIV¬ 
positive after an accidental needle stick 
in 1988. The resident, known in court 
documents as “Dr. Doe,” sued Yale, al¬ 
leging that inadequate training and su¬ 
pervision caused the accident. The Uni¬ 
versity is appealing the verdict. 
Dr. Doe, then 25, was a first-year 
resident seven weeks into her internship 
at Yale-New Haven Hospital when she 
pricked her right thumb while inserting 
a line into the artery of a patient with 
AIDS. Dr. Doe said she had tried the 
five-year, $2 million grant from the 
National Institute for Occupational 
Safety and Health, provides participat¬ 
ing autobody shops with free industrial 
hygiene evaluations. Yale researchers 
evaluate the working environments in 
several shops for isocyanate exposure, 
make recommendations to reduce their 
exposure to chemicals, and give workers 
free respiratory health evaluations. 
A “natural” tan to beat the sun 
With skin cancer rates soaring, derma¬ 
tologists have been warning people to 
protect themselves from the sun, but 
the popularity of tanning means the 
advice often goes unheeded. Thanks to 
a new cosmetic tanning lotion devel¬ 
oped by Yale senior research scientist 
John M. Pawelek, Ph.D., tanners will 
soon be able to get that sun-soaked 
look without sitting under the sun or 
in a tanning booth. 
Dr. Pawelek’s medical research focuses 
on therapies for melanoma and other 
forms of skin cancer. While doing basic 
research with professor of dermatology 
Jean Bolognia, M.D., on melanocytes, 
the pigment cells that color skin and pro¬ 
vide protection from the sun, he came 
upon a method for producing a water 
soluble form of melanin derived from the 
aloe vera plant. The extract, which is 
chemically indistinguishable from natural 
human melanin, immediately changes 
the skin’s color to a natural-looking 
procedure only three times before the 
accident and that the supervising physi¬ 
cian, a third-year resident, failed to 
monitor the procedure properly. 
The University is challenging the 
jury’s verdict in two areas. First, its ap¬ 
peal argues that Connecticut law does 
not recognize such a claim for educa¬ 
tional malpractice. It also argues that 
the University should not be held liable 
because, as an employee and resident at 
Yale-New Haven Hospital, Dr. Doe’s 
exclusive remedy is a workers’ compen¬ 
sation claim rather than a civil suit. Dr. 
Doe is already receiving workers’ corn- 
tanned hue and has skin cancer-protec¬ 
tive qualities similar to real melanin. 
In an added bonus, it also has re¬ 
markable chameleon-like characteris¬ 
tics that cause it to blend its hue to 
that of the individual’s surrounding 
skin. To Dr. Pawelek’s surprise, follow¬ 
ing early publicity about the product, 
he has received a flood of inquiries 
from people who suffer from vitiligo, 
a skin disorder causing a progressive 
loss of pigmentation cells that affects 
1 percent of the world’s population. 
San-Mar Laboratories Inc., which li¬ 
censed the discovery from Yale, will be 
producing cosmetic products contain¬ 
ing it for marketing worldwide before 
year’s end “It may prevent many cases 
of skin cancer,” says Dr. Pawelek “and 
should bring relief to at least some 
people with vitiligo.’’ 
Confronting violence 
in the home 
Domestic violence is rarely thought of 
as a public health issue, yet it has a 
massive impact on the health care sys¬ 
tem, accounting, for instance, for more 
than a third of all women seeking 
emergency treatment from U.S. hospi¬ 
tals. Understanding the phenomenon 
and seeking ways to reduce its inci¬ 
dence were among the topics explored 
at the third annual Domestic Violence 
Seminar Series, held this spring by the 
Department of Epidemiology and 
pensation benefits through the hospital. 
Both sides in the case expect to file 
briefs this summer and present argu¬ 
ments later this year. 
As of December 1996, 52 health care 
workers around the country had ac¬ 
quired HIV through occupational 
transmission, 24 of whom developed 
AIDS, according to the federal Centers 
for Disease Control and Prevention 
(CDC) in Atlanta. Another 111 may 
have acquired HIV on the job, but the 
source of transmission hasn’t been de¬ 
termined in those cases, according to 
the CDC. 
Public Health. The series is part of the 
Pew Urban Health Program, a research 
and teaching collaboration among stu¬ 
dents and faculty from the schools of 
medicine, public health and nursing. 
Addressing an audience of Yale 
and New Haven community members, 
the three principal speakers focused on 
different aspects of the issue of domes¬ 
tic violence. Sujata Warrier, Ph.D., di¬ 
rector of the New York City Program 
of the New York State Office for the 
Prevention of Domestic Violence, 
spoke about ways to assist victims 
from a variety of ethnic and social 
backgrounds. Donna Edward, J.D., 
executive director of the National 
Network to End Domestic Violence, 
discussed new federal legislation aimed 
at curbing violence against women. 
Yolanda Haywood, M.D., an associate 
professor of emergency medicine at 
George Washington University 
Medical Center, who treats domestic 
violence victims, was herself in an 
abusive relationship. By recounting the 
struggles she faced in leaving that 
violent situation, she sought to provide 
attendees with a clearer understanding 
of the complex motivations that under¬ 
lie domestic violence. 
Contributors: Susan Alksnis, 
Cynthia Atwood, John Curtis, 
Michael Fitzsousa, Katie Krauss, 
Helaine Patterson, Karen Peart, 
Marc Wortman. 
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Opening doors to women in medicine 
required changing many minds and 
one bathroom. 
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Lack of women’s bathrooms at the School of Medicine building at 150 York Street, above, since 
torn down, would help keep women out until Henry Farnam offered to build one, allowing his 
daughter and two other women to gain admission in 1916. Mr. Farnam, a Yale economics professor, 
wrote this letter, top, to Yale president Arthur Hadley offering to provide the funds to build the 
needed women’s bathroom. 
After graduating, Dr. Louise Farnam, above left, spent ten years as a medical missionary and 
practitioner at the Yale-affiliated Yali Hospital in China. When she removed a bad tooth from the 
mouth of Chinese leader Chiang Kai-shek, she got her picture on the cover of the program’s 
journal. After Louise Farnam and two other women entered in 1916, the next medical school 
class accepted only one woman, Ella Clay Wakeman, pictured at left with her classmates. 
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Many factors stymied the arrival of women at the 
Yale School of Medicine, including societal 
roles, self-assessment and certainly prejudice 
among men on the faculty and in the wider University 
community. By 1916, however, only one thing seemed to 
stand in the way of women gaining admission: the lack 
of proper bathroom facilities for women. It would take a 
father’s money and influence and a daughter’s determi¬ 
nation to overcome that last barrier. 
While Johns Hopkins University was founded as a 
coeducational institution in 1893, most other prestigious 
Eastern medical schools were slow to welcome female 
students. According to research on women in medicine 
that Susan J. Baserga, M.D., Ph.D. ’88, pursued as a Yale 
College undergraduate, Yale would wait nearly a quarter 
century before admitting women. Harvard held out the 
longest, until 1945. 
By the turn of the century, however, women could 
study in the Yale Graduate School, and Vassar College 
graduate Louise Farnam took a Ph.D. in physiological 
chemistry there in 1916. An exceptional student, she 
was also intent on studying medicine so that she could 
travel as a medical missionary to China. “She had 
incredible fortitude,” says Dr. Baserga, herself now an 
assistant professor of therapeutic radiology and genetics. 
“She was very religious and was driven by her faith. 
Fortunately, she also had a philanthropist father.” 
Louise Farnam came from a family with close ties to 
Yale, going back to the early 1700s and continuing 
with her father, Henry Farnam. Farnam pere was a 
Yale graduate, a professor of economics, a New Haven 
and Yale benefactor, and a member of the board 
overseeing New Haven Hospital. 
When his eldest daughter announced her intention 
to study medicine at what, until then, had been an 
all-male medical school, the medical school informed 
her that an insurmountable barrier prevented her 
enrollment. There was no women's bathroom in the 
school, which was then housed in a building, since torn 
down, at 150 York Street. Whether the issue of the 
bathroom was a genuine obstacle to the presence of 
women in the school—or a last ditch effort to keep 
them out—isn’t clear from the historical record, 
according to Dr. Baserga. 
Marc Wortman is a freelance writer. 
Susan J. Baserga 
Apparently some behind the scenes wrangling did 
ensue and in a letter of March 31, 1916, to then-Yale 
president Arthur Hadley, Professor Farnam, recognizing 
the matter of the lack of facilities was “considered a seri¬ 
ous one,” offered to pay for “suitable lavatory arrange¬ 
ments.” President Hadley agreed, and, in the next term, 
Louise Farnam and two other women, Helen May 
Scoville and Lillian Lydia Nye, became the first women 
admitted to the School of Medicine. Dr. Farnam gradu¬ 
ated in 1920, winning the Campbell Gold Prize for the 
highest rank in examinations. After further training at 
Johns Hopkins, she spent the next ten years at the new 
medical school and hospital established by the Yale- 
China Association, Yali, in Changsha. 
The year following Dr. Farnam’s admission to 
Yale saw only one woman, Ella Clay Wakeman, in 
the class. Female graduates of the era were well 
aware of the story behind the school’s lone women’s 
bathroom, which was quickly dubbed the Louise 
Farnam Memorial. 
Women continued to be admitted to the School 
of Medicine after those first classes in numbers kept 
deliberately small by the school. Other than during 
World War II, until the 1960s no class counted more 
than 10 percent women among its members. Helen P. 
Langner, M.D., who graduated in 1922, was the school's 
oldest alumna when she died last December at age 105 
(See A life of engagement). 
Louise Farnam would be pleased with her legacy. 
Today, the right of women to enter the School of 
Medicine without prejudice is beyond challenge. In fact, 
this year’s graduating class was the first ever to arrive at 
Yale with more women than men among its members. 
“Physicians like Dr. Farnam and Dr. Langner helped 
pave the way for many younger women,” says Merle 
Waxman, M.A., associate dean and director of the 
Office of Women in Medicine. “I think they and their 
contemporaries took great pride in that.” 
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A of engagement 
Helen Langner entered medicine 80 years ago, as the doors of the profession 
were first opening to women. She made good use of her 1922 Yale degree. 
By John Curtis 
SUMMER 1998 
As a medical student, Helen Langner, in white hat, second from left, 
became close friends with Ella Wakeman, right, who had entered the 
School of Medicine a year earlier, and Ella's brothers Maurice and 
Edward. The woman at the left is unidentified. 
Left: Helen Langner, Yale’s oldest living graduate until her death last 
December at age 105, witnessed a century of dramatic change in 
medicine but held fast to old-fashioned common sense. She told 
friends the key to longevity was to have a reason for living. 
When Helen P. Langner, M.D. ’22, died last 
December at age 105, one of her many friends 
observed that the least remarkable thing about 
her was her age. “I think she was bewildered by the 
accolades, the things that people said about her,” said 
Helen Trainor, a nurse-psychotherapist who trained 
and worked with Dr. Langner from 1983 until her death. 
“Her answer was, ‘If you live long enough you get 
recognition, whether you deserve it or not.’ ” 
Dr. Langner’s life spanned nearly all of the 20th cen¬ 
tury and was filled with accomplishments that had noth¬ 
ing to do with her years but everything to do with her 
times. She was the fourth woman to graduate from the 
Yale School of Medicine. She marched in one of the first 
women’s suffrage rallies. She was an early practitioner in 
the emerging field of child psychiatry. And at Yale medi¬ 
cal school reunions and other ceremonial events, she was 
honored and celebrated as the school’s oldest alumna. 
She died just a few months before she was to receive 
her second medical diploma from Yale as an honorary 
member of the Class of 1998, the first Yale medical 
class to enter with more women than men. Dr. Langner 
was inducted with the class four years ago at the White 
Coat Ceremony welcoming students to the profession 
of medicine. 
Who was this frail centenarian who radiated not 
only wisdom, but common sense and calm? Friends and 
colleagues remember a slight, white-haired woman who 
believed having good reasons for living was the key to 
longevity, and who kept her mind active even as her 
body came to rely on canes, walkers and finally a wheel¬ 
chair. She continued working until she was well into her 
90s. Invitations to meetings and reunions at Yale often 
came with offers, which she rejected, of a car and driver 
to collect her and take her home. She preferred walking 
from her house on Shipyard Lane in nearby Milford, 
Conn., to the center of town, where she could take the 
bus to New Haven. She routinely walked the three-quar¬ 
ters of a mile from her white two-story house overlook¬ 
ing the harbor to Milford Hospital and the city health 
department, where she began a second career at the age 
of 78. “To see her there was to feel all was right with the 
world ... as long as she was in it,” said Alan Jepson, 
Milford’s city clerk. 
John Curtis is a staff writer. 
EARLY OBSTACLES 
Dr. Langner marched in an early suffrage rally, but no 
one recalls her expressing anger or bitterness at the ob¬ 
stacles she faced as a woman in medicine. She believed 
hard work would see her through. “The first hurdle was 
finding a medical school that would accept you,” said 
Susan J. Baserga, M.D., Ph.D. ’88, who has written 
about the history of women in medicine (See Gallery) 
and who knew Dr. Langner. “The problem after that 
was getting a residency because there weren’t too many 
programs that accepted women.” 
Her path to a career in psychiatry began during 
World War I when she had an administrative job at St. 
Luke’s Hospital in New York City. She’d gone to New 
York a few years earlier to attend Hunter College, which, 
unlike colleges in Connecticut, accepted women. After 
graduation in 1914 she taught high school biology, work 
that didn’t satisfy her, before moving on to the hospital. 
She considered a career in nursing, but her father urged 
her to apply to the Yale medical school, which had be¬ 
gun to accept women. 
For the next four years she lived at the home in 
Milford where she’d grown up, the first and only daugh¬ 
ter of a baker and his wife, and big sister to five brothers. 
Every morning she caught an early train from Milford to 
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New Haven, walked from Union Station to her classes, 
and then returned home in the afternoon to study late 
into the night. In the little time she had for recreation, 
she sailed on Long Island Sound or listened to operas 
like The Magic Flute and Die Fledermaus. When she 
came home to visit during her undergraduate days in 
New York, her mother, who also loved opera, would slip 
her an extra dollar so she could attend a performance, 
her brother Gustave Langner remembered. 
Although she was the only woman in her medical 
school class, friends say she felt supported by her fellow 
students, particularly Edward and Maurice Wakeman, 
twin brothers whose lather was a physician and whose 
sister, Ella, had entered the school the year before. 
Maurice died while doing research in Africa, but 
Dr. Langner maintained her friendship with Edward 
and Ella. From medical school Dr. Langner went to a 
residency at Wards Island, a state mental hospital in 
New York City. 
It was made clear to Dr. Langner in her first job 
after her residency, setting up child guidance clinics 
around the country, that a man was preferred. Fine, she 
said. She offered to start the clinics, then step aside if a 
man came along. After a few months in Richmond, Va., 
she went to a privately funded clinic in Indianapolis, 
where she stayed two years until the stock market 
craned and funding ran out. 
She took over as director of undergraduate health 
services at Vassar College when her predecessor took a 
maternity leave. Although Dr. Langner never married, 
she was a strong advocate not only for women in medi¬ 
cine, but also for women who combined family and pro¬ 
fession. Dr. Langner told Merle Waxman, director of the 
medical school’s Office for Women in Medicine, that 
she was very excited about the increasing numbers of 
women entering the field. “She greatly admired women 
who devoted their careers to science and to medicine, 
Ms. Waxman says. “She was a strong supporter of the 
concept of an Office for Women in Medicine here, and 
was an important friend of the office.” 
After io years at Vassar, her interest in psychiatry led 
her to New York City, a private practice and an appoint¬ 
ment at The New York Hospital-Cornell Medical Cen¬ 
ter. She opened her office the month Japan attacked 
Pearl Harbor. She also moved into the family home 
overlooking the harbor at Milford and commuted to 
New York by train. Friends wonder if child psychiatry 
appealed to Dr. Langner because of her role as the older 
sister who had a hand in raising her five brothers. Even 
as a centenarian, friends say, she drew children to her be¬ 
cause she listened to them. “Kids won’t go near people 
they sense aren’t receptive,” says Ms. Trainor. “They 
After graduation from 
medical school in 
1922, Dr. Langner 
trained in psychiatry 
in New York City, 
then worked to es¬ 
tablish child guid¬ 
ance clinics around 
the United States be¬ 
fore becoming direc¬ 
tor of health services 
at Vassar College. 
This undated portrait 
of Helen Langner was 
taken during her days 
in New York City, 
when she had her 
own psychiatric prac¬ 
tice and worked at 
Cornell-New York 
Medical Center. 
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seem to be able to pick out the people who are warm 
and safe and approachable. She was very approachable.” 
Ms. Trainor recalls how Dr. Langner helped a 5- 
year-old boy, the son of friends, who had been diagnosed 
as hyperactive. Dr. Langner saw the boy not as a patient, 
but as a guest in her home. She encouraged curiosity in 
children, and like all children who visited her, the boy 
was allowed to explore the house. Dr. Langner con¬ 
cluded that he had too long an attention span to be 
hyperactive. “In her inimitable way,” Ms. Trainor says, 
“she did not say the diagnosis was wrong. She just sug¬ 
gested that this was a situation that could be remedied 
by setting certain limits.” 
A Milford woman took her io-year-old son to 
Dr. Langner for counseling about 25 years ago. “He was 
daydreaming, off in another world,” says the woman. 
The boy also had slight difficulties with hand-eye 
coordination. “She played games with him and learned 
about his abilities and weaknesses.” Dr. Langner, she 
says, played to the boy’s strengths with advice to take up 
“big muscle” activities such as swimming and running. 
“We had to know his limitations so we didn’t push him 
into things he shouldn’t be pushed into,” the boy’s 
mother says. 
While she was gentle and flexible, she could also be 
quite firm. “I sat behind a screen one time at Wards Is¬ 
land when she was discharging a patient,” her brother 
said, recalling an incident that occurred more than half a 
century ago. “She laid it into the husband who was go¬ 
ing to take his wife home and told him what he was go¬ 
ing to have to do so she wouldn’t have to come back to 
the hospital. He was very meek and mild, ‘Yes, Doctor. 
Yes, Doctor. I will, Doctor.’ I was grinning ear to ear 
behind the screen.” 
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Dr. Langner closed the chapter on her second career 
at Milford’s hospital and health department at the age of 
98. During the preceding two decades she had accepted 
no payment for her work, and it was only with difficulty 
that George Kraus, M.D., M.P.H. ’51, director of 
Milford’s health department, convinced her to let him 
pay her licensing fees and professional dues. 
“She saw people with problems who could not af¬ 
ford private psychiatric care,” Dr. Kraus said, adding 
that she was particularly helpful with elderly patients. 
“She would tell them that she was a psychiatrist who 
came to examine them. But they regarded her as a 
friend and a helper. As a result we were able to elicit 
information that we could otherwise not get.” 
Even after her second retirement, she tried to keep 
up with medical practices by reading medical journals 
and attending conferences and reunions. “I would bring 
a case to her and the next time I saw her she would 
have found an article in a journal that pertained to 
that particular case,” recalled Ms. Trainor, for whom 
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In 1994, Dr. Langner entered medical school for the second 
time, joining the Class of 1998 as an honorary member at 
age 102 during the traditional White Coat Ceremony. She 
did not live long enough to attend commencement but her 
brother Gustave accepted her honorary degree at a memo¬ 
rial service in February. 
Dr. Langner was a mentor. “She would have read it, 
given it to me to read and then we would discuss that 
particular article.” 
In her hometown Dr. Langner became an ardent 
preservationist, campaigning to save historic buildings 
and the harbor and sound where she’d sailed in her 
youth. “Every time they were going to demolish an old 
building in Milford that had historical significance,” said 
Nicholas P. Spinelli, M.D. ’44, “there she was. She al¬ 
ways had a petition: ‘You will not destroy this place.’ ” 
Dr. Langner was renowned as the oldest resident of 
Milford and the only survivor of her medical school 
class. Newspapers often carried stories about her and 
Cable News Network featured her in a report about 
centenarians. Although her longevity brought a degree 
of celebrity, it was her vibrant, active mind that drew 
people to her. “I suddenly was aware of this little old 
lady in the back of the room at reunions,” recalled 
Dr. Spinelli, the medical school’s former director of 
alumni affairs, who remembers meeting Dr. Langner 
about 15 years ago. “She was 90 going on 25. You 
would talk to her and you thought she was a college 
student planning to go to medical school next year, 
she was so enthusiastic.” 
And while she never liked to be fussed over, about 
80 friends, relatives and colleagues gathered at the First 
United Church of Christ in Milford in early February to 
remember her. Youngest brother Gustave, 94, accepted 
the honorary degree that would have come to his sister 
in May. Speaking at the memorial service, Deputy Dean 
Robert PL Gifford, HS ’67, said that her contribution to 
education was profound. “She became an inspiration to 
hundreds of medical students, particularly women.” EE] 
In 1997 Dr. Langner returned to Yale for her 75th reunion. She was 
the only surviving member of the Class of 1922. “The company and 
conversation of my alumni is always pleasant and enlightening," 
she wrote in her class report. “After a long, wonderful day, I return 
home with all my memories to recuperate.” 
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Carolyn Mazure directs the newly established 
Ethel F. Donaghue Women’s Health 
Investigator Program at Yale. 
Factoring 
in 
Yale research on womens healthy bolstered by 
a landmark $6.5 million grant, draws 
together scientists from many disciplines. 
By Michael Fitzsousa 
Until 1993, when Congress passed legislation 
changing the way clinical trials are conducted, it 
was possible to bring a drug or device to market 
without including women in its evaluation. For many 
years, it was the rule, rather than the exception, to ex¬ 
clude women from the studies that are required to prove 
the safety and effectiveness of new treatments. 
Two seemingly reasonable ideas in particular con¬ 
tributed to this gap in data. One was that women of 
child-bearing age should not be exposed to experimental 
risk. The other was that the hormonal changes associ¬ 
ated with the reproductive cycle would add a level of 
complexity to trials that would be unmanageable. Yet ex¬ 
cluding women has left major areas of human health un¬ 
explored, says Carolyn M. Mazure, Ph.D., a professor of 
psychiatry who heads the research arm of the Women’s 
Health Program at Yale. “It is essential to study women,” 
she says, “because the treatments and procedures devel¬ 
oped on men may not always be appropriate for 
women.” And while cyclic variation does bring complex¬ 
ity to many research questions, scientific methods have 
evolved to better handle that complexity. In fact, since 
enactment of the 1993 legislation, the inclusion of 
women in trials must be carefully considered when 
federal dollars are used. 
Just how far has the issue evolved during the past 
decade? At Yale, one indication came in February with 
the announcement of a $6.5 million grant for women’s 
health research. The five-year award from The Patrick 
and Catherine Weldon Donaghue Medical Research 
Foundation ofWest Hartford, Conn., will support 
interdisciplinary research that advances knowledge in 
women’s health. One of the most exciting aspects of the 
new program is its potential to bring together research¬ 
ers from a wide range of scientific fields, each with a 
unique perspective on how gender may factor into 
disease processes and health. “We don’t want people to 
think that women’s health must be a separate area of 
research,” says Dr. Mazure, who directs the Ethel F. 
Donaghue Women’s Health Investigator Program at 
Yale, the new entity created by the grant. “Instead, the 
hope is that more and more investigators will think 
Michael Fitzsousa is the editor of Yale Medicine. 
Dr. Mazure with members of the Donaghue Program staff, from left: 
Data manager Paul Falzer, Ph.D., research assistant Beth Ruff and 
program coordinator Mona Gregg. 
about gender in the research they are actively pursuing, 
and think more about research collaborations to answer 
relevant questions.” 
AN EVOLUTION 
The Donaghue funding was announced at a press con¬ 
ference in Yale’s Medical Historical Library, a balconied 
room with a 50-foot ceiling, leather sofas, reading tables, 
a massive stone fireplace and books lining every square 
foot of wall space. “This is the perfect setting for this 
special event,” Dean David A. Kessler, M.D., told the 
group. “Research has always been central to the school’s 
academic mission. That commitment will continue 
to be at the very core of all we do here in the future.” 
The Donaghue support, he added, provides the oppor¬ 
tunity to expand that commitment “while building on 
an already exemplary program in women’s health.” 
In addition to its research component, the Women’s 
Health Program at Yale has developed new models for 
patient care and the training of physicians, and in 1996 
was designated by the U.S. Public Health Service as one 
of the first six Centers of Excellence for women’s health 
nationally. According to Director Janet B. Henrich, 
M.D., advances in women’s health overall will depend to 
a large extent on good science. “We want to add to the 
knowledge base,” she says, “with the ultimate goal of 
improving care for women. The goal is to integrate these 
elegant findings from the laboratory into practice.” 
During late winter and spring, Donaghue program 
staff sent out requests for applications to researchers 
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around the medical school, University and at each of the 
Yale-affiliated hospitals. In total, 81 applications were 
submitted by investigators in 15 medical school depart¬ 
ments and other corners of Yale including the School of 
Nursing, departments of chemistry, sociology and psy¬ 
chology, the Institute for Social and Policy Studies and 
the John B. Pierce Laboratory. “If we were able to fund 
all of them,” says Dr. Mazure, “we would need $10 mil¬ 
lion.” Among the topics: the influence of sex-related 
hormones in a variety of disorders including cardiovas¬ 
cular disease and osteoporosis, the molecular mecha¬ 
nisms of breast, cervical and ovarian cancer, gender 
differences in surgical recovery, HIV risk behavior in 
women, the relationship between health and employ¬ 
ment in women, the relationship of breast cancer to en¬ 
vironmental exposure variables, and the biological basis 
for a variety of psychiatric conditions that women expe¬ 
rience at a higher rates than men, such as depression, 
eating disorders and post-traumatic stress disorder 
following abuse. The program’s scientific review com¬ 
mittee was to meet in July, with the first awards expected 
in August. Subsequent requests for research applications 
will go out each year to encourage new work. 
big difference in terms of comfort and morbidity.” 
Another researcher who received program support is 
endocrinologist Karl L. Insogna, M.D., who studies the 
underlying mechanisms of osteoporosis. This weakening 
of the skeleton, more common among women than 
men, occurs at a rate three to four times faster after 
menopause than in younger women. Hormone replace¬ 
ment therapy has been proven to slow and even halt 
the damage. Because estrogen therapy is known to 
carry health risks as well as benefits, the search is under 
way for more specific agents that might interfere with 
bone breakdown. 
For the last several years, Dr. Insogna and colleagues 
have been working to explain the mechanism by which 
bone loss occurs. Starting with the knowledge that 
parathyroid hormone (PTH) regulates bone breakdown 
and the metabolism of calcium, they looked for clues to 
how estrogen is involved in that process. Last year they 
identified a molecule produced by osteoblasts, the cells 
that form bone tissue, that appears to play an important 
role. Interleuken-6 (IL-6), says Dr. Insogna, is required 
in order for parathyroid hormone to break down bone. 
With support from the Women’s Health Program, he 
“It is essential to study women, because the treatments and procedures 
developed on men may not always be appropriate for women.” 
THREE PILOT PROJECTS 
Even before the Donaghue program was announced in 
February, women’s health research at Yale was off and 
running, supported by modest startup grants during the 
1997'9% academic year. Three of those projects, co-spon- 
sored by the Department of Diagnostic Radiology, the 
Claude D. Pepper Older Americans Independence Cen¬ 
ter and the Yale Liver Center, illustrate the kinds of re¬ 
search topics Dr. Mazure and her colleagues hope to 
shed light on. 
Diagnostic radiologist Liane E. Philpotts, M.D., saw 
a difficult clinical problem affecting breast cancer pa¬ 
tients and has used the women’s health funding to look 
for a solution to improve diagnosis and quality of life. 
Because the disease often spreads to the axillary nodes 
(glands in the armpit), patients usually have the nodes 
removed surgically as a precaution. The complications of 
surgery include swelling, significant pain and decreased 
range of motion. Dr. Philpotts is evaluating how well 
magnetic resonance imaging may be able to show the 
spread of cancer cells to the nodes. “If we can say they 
look fine, maybe we won’t have to take them out in the 
future,” she says. “To the patient, it could make a fairly 
and his colleagues published data correlating high 
blood levels of IL-6 with higher rates of bone breakdown 
in women with disturbances in parathyroid function 
and are chasing down new leads that may one day 
improve treatment. 
Allen E. Bale, M.D., associate professor of genetics, 
is searching for genes associated with hereditary breast 
cancer. He has developed automated technology for 
determining the DNA sequence of BRCAi and BRCA2, 
two genes that are frequently altered in families with 
breast cancer. In analyzing a large series of breast cancer 
kindreds, he found that a significant number lacked mu¬ 
tations in these genes, and he is searching for new genes 
that may underlie the disease. 
One possible candidate is the gene for Cowden syn¬ 
drome, a rare disorder associated with breast, thyroid 
and skin cancer. Dr. Bale thinks that mild mutations in 
the Cowden syndrome gene might cause breast cancer 
alone without thyroid or skin disease. “Beside the 
Cowden gene, there must be other genes we haven’t yet 
discovered,” says Dr. Bale. “We’re continuing to look for 
them so we can offer diagnostic testing and early detec¬ 
tion of breast cancer to more families.” 
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A SHORT HISTORY 
Women’s health came into focus at Yale in the early 
1990s, as more women entered the faculty and as Yale 
practitioners in internal medicine, obstetrics and gyne¬ 
cology, and other specialties began discussing the need 
for a streamlined clinical service where women could 
receive care in a more coordinated fashion. At about the 
same time, the issue of women’s health was coming 
sharply into locus in Washington. The General Account¬ 
ing Office issued a detailed report in 1990 documenting 
the disparity between women and men as subjects in 
federally funded clinical research. The same year, the 
National Institutes of Health created the Office of 
Research on Women’s Health, followed in 1991 by the 
establishment of the Office of Women’s Health at the 
U.S. Public Health Service. Meanwhile, the N1H was 
launching the Women’s Health Initiative, a long-term 
study of more than 100,000 women that will seek to 
document the causes of disease and premature death in 
women from all social and economic groups. 
Dr. Kessler, who was the Food and Drug Adminis¬ 
tration commissioner from 1990 to 1997, recalls asking 
his staff in the early ’90s, “ ‘Should we have required 
women to be included in the clinical trials?’ Some of the 
agency’s best reviewers said no, that the pharmacokinet¬ 
ics and pharmacodynamics of the drugs worked the 
same in men as in women,” Dr. Kessler recalls. “But 
later, as more studies were done, they started looking at 
the data and saying it really did make a difference.” 
Perhaps the most influential piece of legislation relevant 
to women’s health is contained in the NIH Revitaliza¬ 
tion Act of 1993, which requires that an appropriate 
number of women be included in clinical trials that are 
federally funded. One of the people who shepherded the 
act through Congress was Ruth J. Katz, J.D., M.P.H., 
now the School of Medicine’s associate dean for admin¬ 
istration. As counsel to the U.S. House of Representa¬ 
tives subcommittee on health and the environment, she 
organized the hearings for the act and helped write the 
legislation that President Clinton signed into law. When 
she arrived at Yale last July, one of the first projects she 
was given was to help pull together the agreement that 
became the basis for the Donaghue Foundation grant. 
The Donaghue research initiative is a key compo¬ 
nent of a highly active Yale program that drew the atten¬ 
tion of Health and Human Services Secretary Donna 
Shalala, who named it one of the first six Centers of 
Excellence in Women’s Health. This spring, the designa¬ 
tion and funding were renewed for a second 18-month 
period, allowing the faculty here to focus in greater 
depth on issues concerning patient care and physician 
education as well as research. 
Ruth Katz and Raymond Andrews talk before the press conference 
announcing the establishment of the Ethel F. Donaghue Women’s 
Health Investigator Program at Yale. Mr. Andrews is a trustee of the 
Patrick arid Catherine Weldon Donaghue Medical Research 
Foundation, which is providing $6.5 million in funding. 
In its first incarnation as the Women’s Health Initia¬ 
tive at Yale, the program provided a one-stop service ca¬ 
tering to women throughout New Haven and Fairfield 
counties. Led by Dr. Henrich and Florence Comite, 
M.D. ’76, HS ’76-78, it also brought together a diverse 
group at the medical center who were focused on 
women’s health issues and who began discussing the 
framework for a broader program. Gerard N. Burrow, 
M.D. ’58, then the medical school dean and now a spe¬ 
cial advisor to President Levin for health affairs, saw a 
need to combine the clinical progress with advances in 
education and research. “The exclusion of women was 
so ingrained,” he recalls ol his own research training in 
the 1950s, “that even as students working in the lab, we 
were told not to include female mice.” But over the last 
several decades that attitude has changed, and not only 
in the lab. Yale established the Office of Women in 
Medicine in 1975 and began actively recruiting women 
to the faculty and student body. Four years ago, the 
medical school enrolled more women than men in its 
entering class for the first time in its history. “The last 
20 years,” says Merle Waxman, M.A., associate dean and 
director of the Office of Women in Medicine, “has seen 
the dissolution of many of the barriers that hindered the 
entry of women into some of the specialties.” As a result, 
says Dr. Henrich, more women are in a position to pur- 
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Janet Henrich leads the Women’s Health Program at Yale and teaches an undergraduate course in 
women's health at Yale College. 
sue research that is relevant to women, which may in 
part explain the groundswell of interest that bubbled to 
the surface in 1990. 
According to Dr. Henrich, who spent 18 months 
at the NIH working with the Office of Research on 
Women’s Health, one of the major challenges in deliver¬ 
ing care to women stems from a division that dates 
hack 75 years or more. “There’s a fragmentation that 
has developed more around women than around men, 
with both internal medicine and obstetrics and gynecol- 
ogy providing primary care,” she says. “What this has 
done is separate reproductive and non-reproductive 
issues in a way that became institutionalized early in 
the century.” This schism produces gaps in care due to 
a lack of communication, Dr. Henrich says. “There’s 
been a lot of talk about developing a women’s health 
specialty,” she adds. “I have a strong bias against that 
because 1 think it would only lead to greater fragmenta¬ 
tion of care. We need the expertise of diverse specialties.” 
In early 1996, the Yale activities were reorganized as 
the Women’s Health Program at Yale, with Dr. Henrich 
as its leader. She and many of her medical school and 
hospital colleagues have spent long hours hashing out 
new methods for organizing women’s care. A committee 
chaired by ob/gyn associate professor Ervin E. Jones, 
M.D., Ph.D., and assistant clinical professor of psychia¬ 
try Robert M. Rohrbaugh, M.D., is developing a pro¬ 
posal for a required medical school clerkship in women’s 
health that would draw from the departments of Inter¬ 
nal Medicine, Obstetrics and Gynecology, and Psychia¬ 
try. Similar plans are being considered for residency 
training. “The idea,” says Dr. Henrich, “is to have the 
internal medicine residents learn more about reproduc¬ 
tive issues and the ob/gyn residents better prepared to 
recognize and treat hypertension, diabetes and thyroid 
disease. The goal is to increase the knowledge base.” 
That seems to be happening at Yale over a relatively 
short period of time. Lawrence S. Cohen, M.D., HS 
’58-65, a cardiology professor and special advisor to the 
dean, was among those involved in the school’s early 
discussions of women health and served on the commit¬ 
tee appointed by Dean Burrow in 1992. “They’ve more 
than exceeded the expectations in a very short period of 
time. Women’s health is off to a great start.” The true 
test of the research program’s success, says director 
Mazure, will be seen in the clinical setting several years 
down the road. “Politically, a lot has happened to move 
this all forward,” she says, “but the science has changed, 
too. Everybody knows that with most diseases, there isn’t 
just one factor that influences onset or treatment out¬ 
come—rather there are many factors. Now we have tools 
to understand multiple variables in health outcomes.” 
What will be the practical value of this investment in 
research? “There’s the promise of very significant transfer 
of this knowledge to clinicians and to the community,” 
says Dr. Mazure. “This initial funding will help us 
generate a lot of new research that can change both the 
health and health care of women. ” QE] 
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The Program for 
Humanities in Medicine 
1998-1999 LECTURE SERIES 
Lectures, free and open to the 
public, begin at 5 p.m. in the 
Beaumont Room, 333 Cedar 
Street. Refreshments at 4:30 p.m. 
For information call Howard Spiro or 
Clara Gyorgyey at (203) 785-5494. 
SEPTEMBER 24 
Medicine, Ethics & the Third Reich 
John J. Michalczyk, Ph.D. 
Professor of Fine Arts & Films 
Boston College 
OCTOBER 8 
AIDS & the Poetry of Healing 
Rafael Campo, M.D. 
Associate Professor of Medicine 
Harvard Medical School 
OCTOBER 22 
The Artists’ Vision: An Ophthalmologist 
Looks at Art 
Vincent A. deLuise, M.D. 
Clinical Assistant Professor of Ophthalmology 
Yale University School of Medicine 
NOVEMBER 5 
Freud’s Dream Theory— 
One Hundred Years Later 
Harry Fiss, Ph.D. 
Professor or Psychology 
University of Hartford 
NOVEMBER 19 
Call For The Doctor: 
A History of Country Blues Piano 
M. David Tilson, M.D. 
Professor of Surgery 
Columbia University School of Medicine 
DECEMBER 3 
“Bellevue”: Machinations of an 
Urban Hospital 
Mark Siegel, M.D. 
Clinical Professor of Internal Medicine 
New York University Medical Center 
DECEMBER 10 
The Human Encounters in Medicine 
The McGovern Lecture 
John Stone, M.D. 
Professor of Cardiology 
Emory University School of Medicine 
DECEMBER 17 
Covert Communication in Clinics, 
Classrooms, Corporations & Courtrooms 
The Bayer Lecture 
Robert Rosenthal, Ph.D. 
Edgar Pierce Professor of Psychology 
Harvard Medical School 
JANUARY 7 
Conflict In Classical Arabic Medicine 
Dimitri Gutas, Ph.D. 
Professor of Arabic Languages & Literature 
Yale University 
JANUARY 21 
From Quarantine to Condoms: 
HIV Control in Cuba* 
Helena Hansen, MS 
M.D./Ph.D. Candidate 
Yale University School of Medicine 
JANUARY 28 
My Brother, Madness & Survival: 
Memoir 
Jay Neugeboren, Ph.D. 
Professor of English/Writer in Residence 
University of Massachusetts 
FEBRUARY 4 
Hygeia Revisited: Lessons to Comfort 
Michael Berman, M.D. 
Clinical Professor of Obstetrics & Gynecology 
Yale University School of Medicine 
FEBRUARY 11 
Young Cushing: The Right Stuff 
Robert M. Crowell, M.D. 
Professor of Neurosurgery 
University of Massachusetts Medical School 
FEBRUARY 25 
Match Day: Stories of Adoption 
& Reunion 
Morris A. Wessel, M.D. 
Clinical Professor Emeritus of Pediatrics 
Yale University School of Medicine 
Diana K.R. Jowdy, MA 
Ph.D. Candidate 
American Culture 
University of Michigan 
MARCH 4 
Cultural Competence? Immigrant 
Patients American Doctors 
The Robert Penn Warren Lecture 
Anne Fadiman, BA 
Editor of The American Scholar 
MARCH 18 
Eye of Doctors: Enhancing Observational 
Skills With Fine Arts 
Irwin M. Braverman, M.D. 
Professor of Dermatology 
Yale University School of Medicine 
APRIL 1 
Meeting the Challenge of 
Alternative Medicine 
Joseph J. Jacobs M.D., MBA 
Former Director 
Office of Alternative Medicine at NIH 
APRIL 15 
When a Patient Wants to Die 
Charles F. McKhann, M.D. 
Professor of Surgery 
Yale University School of Medicine 
APRIL 29 
Forty Years of Medical Education at Yale 
Howard Levitin, M.D. 
Professor of Internal Medicine 
Yale University School of Medicine 
MAY 6 
Carlo Levi, MD & the Italian Anti-Fascist 
Movement 
Harvey Mandell, M.D. 
Retired Internist 
David Ward, Ph.D. 
Associate Professor of Italian 
Wellesley College 
MAY 13 
A Surprise 
Jacques Pepin, MA 
Master Chef, Columnist, Author, Teacher 
PBS-TV Host 
Note: Lectures marked by an asterisk (*) are co¬ 
sponsored by the Office of Multiclutural Affairs. 
PUBLIC HEALTH 
A ptit> for 
prevention 
With better treatments for HIV infection and increasing hope for a cure, 
are we becoming complacent about the spread of AIDS? Not if the architects 
of Yales new interdisciplinary research center have a say in the matter. 
By John Curtis 
In a vacant apartment building in Hartford’s Charter 
Oak neighborhood, within walking distance of 
Connecticut’s state capitol and several of the world’s 
largest insurance companies, anthropologist D. Scott 
Wilson, Ph.D., points the toe of his boot at a spent 
syringe. The last person to use it has bent the needle to 
prevent its re-use and the possibility of infection with 
HIV. “You see this a lot, which is a very good thing,” 
says Dr. Wilson, an AIDS prevention researcher working 
on a Yale-affiliated research project. Also strewn amid 
the glass and rubbish are small plastic bottles that once 
contained bleach or water and were part of needle-clean¬ 
ing kits that Dr. Wilson and his colleague, outreach 
worker Maria Martinez, hand out on the streets. 
They are one of two teams that roam abandoned 
buildings, crack houses and shooting galleries in Hart¬ 
ford, with the aim of learning the rules that govern be¬ 
havior there. Ultimately they hope to persuade drug us¬ 
ers to adapt those rules to include HIV prevention 
methods. Their work is one of lour projects under the 
umbrella ol Yale’s Center for Interdisciplinary Research 
on AIDS, or CIRA. Established last September with a 
$10.8 million grant Irom the National Institute of Men¬ 
tal Health and the National Institute on Drug Abuse, 
CIRA is a four-year effort centered in the Department 
John Curtis is a staff writer. 
Above: Human immunodeficiency virus, seen through the elec¬ 
tron microscope, has infected 30.6 million people worldwide 
over the last two decades, and caused 11.7 million deaths. 
Right: Maria Martinez, an outreach worker, and Scott Wilson, 
an anthropologist, walk through abandoned buildings, crack 
houses and shooting galleries to make contacts and observe 
the social interactions of people using drugs. They hope to 
learn enough about behavior in high-risk drug sites to devise 
measures to prevent HIV infection. 
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“Preventing infection,” Michael Merson says, “is still better 
than any cure.” 
ol Epidemiology and Public Health, an accredited 
school of public health. Its goal is to change risky behav¬ 
iors and stem the spread of AIDS. Yale’s CIRA joins 
centers at UCLA, Columbia University, the Medical 
College of Wisconsin and the University of California 
at San Francisco as the fifth federally funded AIDS 
prevention center in the country. While most of CIRA’s 
research will take place in Connecticut, the center is 
expected to develop prevention strategies that can be 
applied throughout the country and world. 
“ There is still a potential for the epidemic to spread 
even more dramatically than it has already in some 
populations,” says CIRA Director Michael H. Merson, 
M.D. “In many ways the worst is still to come.” 
The former head of the World Health Organization’s 
Geneva-based Global Programme on AIDS, Dr. Merson 
became Yale’s first dean of public health in 1995. Since 
his return to the United States, he has sounded a 
persistent warning that advances in the treatment of 
HIV, while a great step forward, carry with them the 
risk of complacency. 
Around the world, an estimated 30.6 million people 
live with AIDS or HIV infection, most of whom prob¬ 
ably have no idea they are infected. Since the epidemic 
began, 11.7 million people have died of AIDS, according 
to UNAIDS, the worldwide AIDS program of the 
United Nations. T he bulk of the world’s cases are in sub- 
Saharan Africa, where an estimated 20.8 million people 
have been infected. Every day, UNAIDS reports, 16,000 
people become infected with HIV. More than 90 percent 
of those new infections occur in developing countries. 
In Africa, the hardest-hit continent, AIDS travels pre¬ 
dominantly through heterosexual contact. In Botswana 
last year, 43 percent of pregnant women tested in one 
urban center were HIV-positive. One in five adults in 
Zimbabwe are believed to be HIV-positive. 
China, Asia’s largest country, is facing two epidemics, 
one among drug users in the southwestern part of the 
country and another among heterosexuals along the 
coast where prostitution is re-emerging. In Thailand, 
there is evidence of a drop in new infections, thanks to 
prevention efforts that promote condom use, discourage 
visits to sex workers and offer young women opportuni¬ 
ties other than commercial sex. 
Although doctors have vastly better weapons to fight 
it, including new anti-viral treatments developed at Yale 
(See Hunting down HIV), AIDS remains a deadly dis¬ 
ease. In the United States, 820,000 people were living 
with HIV or AIDS as of the 
end of 1997, according to 
UNAIDS. According to the 
organization’s Report on the 
Global HIV/AIDS Epidemic, 
released in June at an interna¬ 
tional conference in Geneva, 
an estimated 410,000 people 
have died of AIDS in the 
United States. For most of the 
1990s, acquired immune defi¬ 
ciency syndrome was the lead¬ 
ing killer of people between 25 
and 44. Now, with the first ef¬ 
fective therapies in place, AIDS 
has dropped to second place, 
below accidents. But the path 
of the infection has shifted as 
well. “The epidemic in the 
United States had been con¬ 
fined historically to gay men. 
It’s becoming more and more 
Among young people, a sense of immortality 
Although young people are acutely 
aware of the risks of HIV infection, 
most believe it won’t happen to 
them, according to a survey of 12- to 34- 
year-olds conducted by CIRA researchers. 
That attitude prevails even though 20 
percent of them have lost a friend or 
acquaintance to AIDS. 
While only slightly more than half of 
the young people surveyed used con¬ 
doms, almost 90 percent said they were 
not at risk of HIV infection. The survey, 
released in December by Yale and the 
MTV music television network, queried 
770 people on their attitudes toward 
sex, health and AIDS. 
"This study tells us that, despite the 
information that’s out there, young people 
have not internalized the dangers of AIDS, 
drugs, alcohol and other health-related 
risks,” says Michael H. Merson, M.D., dean 
of public health and director of CIRA. 
The study found that 45 percent of 
unmarried respondents have engaged in 
sex one or more times without using con¬ 
doms. Of those unmarried respondents 
fewer than half use condoms when they 
have sex with a new person and 23 per¬ 
cent fail to use birth control. Yet 63 per¬ 
cent of the total survey cited condoms 
and safe sex as ways to prevent AIDS. 
Fifty-three percent of respondents used 
a condom the last time they had sex. 
Although only 2 percent of whites 
considered themselves at risk for the 
virus, 16 percent of Hispanics and 11 
percent of African Americans said they 
were vulnerable to HIV infection. 
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Researchers at six of Yale’s graduate and professional schools have joined forces under the umbrella of CIRA to find 
ways to limit the spread of AIDS. Headed by Michael Merson, left, a physician whose life’s work has been in public health, 
and Peter Salovey, right, a psychologist, CIRA brings together 55 researchers in disciplines ranging from medicine to 
anthropology to law to management science. 
an epidemic of injecting drug users and their sex part¬ 
ners,” Dr. Merson says. The net effect, he says, will be 
more and more heterosexual transmission. 
A FOCUS ON BEHAVIOR 
Avoiding AIDS is as simple, and complicated, as avoid¬ 
ing risky behaviors. In the United States, blood screen¬ 
ing has virtually eliminated transfusions as a factor in 
the spread of HIV. Except among infants born to HIV- 
infected mothers—an increasingly rare occurrence in the 
United States due to the use of antiviral drugs by preg¬ 
nant women—transmission has become a function of 
behavior, occurring through unprotected sex or needle 
sharing. Yet for those at most risk of contracting AIDS, 
preventing HIV infection often takes a back seat to daily 
survival—finding a place to sleep, getting a meal or 
procuring drugs. 
CIRA’s four initial projects are designed to help 
people who appear to be most vulnerable to HIV infec¬ 
tion—the inner-city poor, adolescents and drug users. 
The anthropologists and outreach workers in Hartford 
hope to devise prevention measures for high-risk drug 
use sites. A team of psychologists is developing messages 
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Among those most vulnerable to HIV infection are injecting drug users, adolescents, minorities—and women. Susan, 28, 
and her daughter, Anna, were diagnosed HIV-positive in 1994. She believes she was infected by a former boyfriend in 1988. 
With her daughter and husband, Roy, Susan posed for this photograph from the book A Positive Life [1997, Running Press, 
Philadelphia], The collection of interviews by River Huston and photographs by Mary Berridge, who holds a masters degree 
in fine arts from Yale, tells the stories of women with HIV. 
to change risky sexual behavior and evaluating which 
approaches are most likely to succeed. Another team is 
looking for ways to prevent both pregnancy and sexually 
transmitted disease in teenagers. The fourth team is 
studying needle exchange programs to determine 
whether their benefits, such as reduced risk of infection 
and increased access to treatment, travel beyond the 
immediate participants. 
Ellen Stover, Ph.D., director of the division of mental 
disorders, behavioral research and AIDS at the NIMH in 
Bethesda, Md., says that CIRA stands out because of its 
focus on drug users and adolescents. “It’s unique and it’s 
where the direction oi research is going,” she said. “In 
the AIDS area, we have always encouraged behavioral 
scientists to work with public health experts and infec¬ 
tious disease experts.” 
INVOLVING THE COMMUNITY 
The CIRA team includes psychologists, epidemiologists, 
anthropologists, lawyers, molecular virologists, ethicists, 
a management expert and physicians. “To really under¬ 
stand how we’re going to prevent HIV, you have to look 
at it from various perspectives,” he says. CIRA has cre¬ 
ated a community advisory committee whose members 
include community leaders who also serve on an execu¬ 
tive committee that advises the center on policy and re¬ 
search priorities. Dominick Maldonado, an AIDS educa¬ 
tion coordinator for the City of New Haven, is 
chairman of CIRA’s community advisory committee. 
“In the past,” he says, “research was done and those of 
us in the community felt like guinea pigs.” This time 
things are different. Mr. Maldonado and Matthew F. 
Lopes, M.RH. ’77, a member of the Mayor’s Task Force 
on AIDS and member of CIRA’s executive committee, 
see a real effort to involve local groups. “We hope that 
we will come up with some interesting and novel ways 
of prevention that will be demonstrated to a wider 
population,” says Mr. Lopes, director of the AIDS 
division at the city health department, “not just in 
New Haven, but around the country.” 
Statistics compiled by Connecticut’s health depart- 
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A new era in AIDS treatment In the 17 years he’s been treating 
people with AIDS, never has Gerald H. 
Friedland, M.D., been more optimistic. 
New therapies such as protease and re¬ 
verse transcriptase inhibitors are thwart¬ 
ing the onset of full-biown AIDS in HIV-in¬ 
fected people, slowing the progress of 
the disease and offering patients more 
hope than ever before. 
Those therapies, however, have 
changed the way doctors care for people 
with AIDS and shifted treatment strate¬ 
gies to outpatient and community set¬ 
tings. “Because there are fewer deaths 
and because people are living longer, in 
some ways the clinical burden of care, 
the resources needed to produce care, 
have increased,” says Dr. Friedland, 
director of the Yale AIDS Program since 
1991. “The benefit of these therapies is 
very dependent upon all the clinical sys¬ 
tems that have been put in place to care 
for people with HIV disease. It’s not just 
writing a prescription and that's it. You 
need a whole system of care to help 
people benefit.” 
Dr. Friedland first encountered AIDS at 
Montefiore Hospital in the Bronx in 1981, 
when he saw injecting drug users mani¬ 
festing the symptoms of an illness then 
believed to afflict only gay men. At Monte¬ 
fiore he brought not just physicians and 
nurses into the care of AIDS patients, but 
social workers, mental health workers, 
clergy and others. That same multidis¬ 
ciplinary approach is at work at the Yale 
program, which opened in 1983 and was 
the first clinic dedicated to AIDS in the 
state. In addition to clinical care for HIV¬ 
positive patients the program offers 
counseling, testing and outreach pro¬ 
grams and does prevention work in city 
schools. There’s also a community health 
care van carrying counselors and out¬ 
reach workers into New Haven’s neighbor¬ 
hoods. Physicians and other research 
staff are performing clinical trials of new 
anti-retroviral therapies and studying the 
interactions of 
anti-retroviral 
agents and 
methadone 
in substance 
abuse 
programs. 
“This is a 
wonderful time 
in the history 
of the AIDS 
epidemic in 
the United 
States," says 
Dr. Friedland, professor of medicine and 
epidemiology. “There are potent and ef¬ 
fective therapies. They are very compli¬ 
cated and difficult but their benefit is un¬ 
questioned at this point in preserving 
and prolonging life. However, difficulties in 
providing therapies to all who can benefit 
from them remain, as does their still un¬ 
known durability. This is a time for intensi¬ 
fied therapeutic effort, not relaxation.” 
Gerald H. Friedland 
Odds for children at risk for AIDS begin to improve One of the mysteries of HIV is why 
it doesn’t surface in all the chil¬ 
dren born to infected mothers. 
Even at its worst, notes Warren A. 
Andiman, M.D., professor of pediatrics 
and epidemiology, it only struck about 
20 percent of children of HIV-positive 
mothers. Prevention programs and use 
of AZT have reduced the figure in New 
Haven from between 16 and 18 percent 
to about 2 percent. 
A related riddle is why some strains of 
the virus found in the mother emerge in 
the child and others don’t. “Is there a 
pattern to the kind of strain that a baby 
gets from among the strains that the 
mother has? Is there a selective process 
that goes on which determines whether 
a certain kind of virus is being transmit¬ 
ted from the mother to the baby?” Dr. 
Andiman asks. “It will be useful to learn 
something about how rapidly the virus 
changes. It would give us a sense of 
when an intervention might still be worth¬ 
while. You would want to provide therapy 
before the virus becomes very virulent." 
Dr. Andiman directs the pediatric AIDS 
program at Yale-New Haven Hospital and 
is studying the virus to find ways to pre¬ 
vent and treat infection. His research led 
him to participate in an international 
study evaluating Caesarean section as a 
means of protecting newborns from infec¬ 
tion. Many infections occur during pas¬ 
sage through the birth canal. 
A current laboratory-based study ex¬ 
plores how biological characteristics of 
the virus affect clinical outcomes. Are 
there specific behaviors of the virus that 
determine whether an infected child suf¬ 
fers a rapid progression of disease or be¬ 
comes a long-term survivor? If so, can 
less virulent strains of the virus be iso¬ 
lated and used in vaccines? Or can differ¬ 
ent viruses with useful traits be com¬ 
bined into a single vaccine? 
The 75 HIV-infected children in the 
AIDS program are part of a long-term ob¬ 
servational study to determine their sur¬ 
vival and to find out what opportunistic 
diseases emerge. “These kids are fol¬ 
lowed primarily to provide clinical care. 
At the same time we have very careful 
observation of the history of the disease. 
The primary reason for seeing them is to 
take care of them, not because we’re 
doing the study," he says. 
Children with AIDS suffer learning dis¬ 
abilities, problems with motor functions 
and cognitive skills, cognitive retardation, 
fungal infections of the esophagus and 
various viral and bacterial infections. The 
problem becomes one of managing the 
disease, far more difficult in children than 
adults. “The medicines taste nasty. The 
pills are very big. There are side effects,” 
says Dr. Andiman. “We have a lot of kids 
in their early teenage years who were in¬ 
fected when they were infants, with many 
medical problems. Most of them are not 
robust children." But he adds, “It has truly 
turned into a chronic disease. If children 
don’t succumb to the disease in the first 
three years of life, they really become 
long-term survivors.” 
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CIRA’s four projects 
When Public Health Dean Michael 
Merson began discussing AIDS 
prevention with colleagues at 
Yale several years ago, it occurred to him 
that prevention research had to follow the 
path of the epidemic. A disease that had 
already mobilized the gay community, 
AIDS was becoming an ever-increasing 
threat to the poor, minorities, women and 
injecting drug users. The four projects 
that ultimately became the focus of the 
Center for Interdisciplinary Research 
on AIDS are concentrating on those 
at-risk groups. 
CIRA stands out for its interdiscipli¬ 
nary approach, bringing together physi¬ 
cians, psychologists, anthropologists, 
lawyers, statisticians and others to work 
toward the common goal of preventing 
AIDS. "If you really want to have effective 
prevention measures," Dr. Merson says, 
“you need the skills of all those people." 
Message framing 
Convincing the most vulnerable to avoid 
risky sexual activity is the task of Peter 
Salovey, Ph.D., a Yale psychologist who 
with colleague John D. Mayer developed 
the theory of emotional intelligence 
popularized in a recent book by author 
Daniel Goleman. 
“Clearly our traditional AIDS messages 
aren't reaching certain people," says Dr. 
Salovey, professor of psychology and of 
epidemiology and public health. “The field 
has done a lot of work on delivering edu¬ 
cational messages to people about HIV 
and safer sex, but they have not paid at¬ 
tention to the nature of those messages.” 
Dr. Salovey, who is also the co-director 
of CIRA, is conducting a study based on 
prospect theory, which proposes that 
both negative- and positive-framed mes¬ 
sages can work in different situations. For 
example, Dr. Salovey theorizes that ac¬ 
centuating the negative works best for 
detection behavior: If you don’t get a 
blood test, you won't find out you are sick 
and get the treatment you need. Positive 
messages, he believes, will work best for 
prevention behaviors: Wear a condom 
and you'll stay healthy. 
His study, which comprises three ex¬ 
periments, will compare the effects of 
four videos about detection measures, in¬ 
cluding HIV-testing, and prevention behav¬ 
iors, such as condom use. Each experi¬ 
ment will follow about 500 poor Latina 
and African-American women recruited at 
community health centers in New Haven 
to determine whether positive- or nega¬ 
tive-framed videos work best and whether 
participants take HIV tests, abstain from 
risky sex or use condoms as a result. 
High-risk drug sites 
Anthropologists and outreach workers in 
Hartford want to find out whether there 
are rules of conduct in places where 
people use drugs—crack houses, shoot¬ 
ing galleries and abandoned buildings. 
“Can we make use of the fact that there 
are rules to establish other rules for AIDS 
prevention?” asks Margaret R. Weeks, 
Ph.D., associate director of the Institute 
for Community Research and director of 
this project. The Hispanic Health Council 
in Hartford is also working on the project. 
The institute and the council are each 
providing an anthropologist and an out- 
Michael Merson 
elRA 
reach worker to probe drug networks in 
the city. Could people who control drug 
sites distribute clean needles or discour¬ 
age needle sharing? The research will 
take place over three years at 16 sites 
where people use drugs. “Typically we go 
with them to the site to see how they are 
using drugs and what goes on there," 
says D. Scott Wilson, Ph.D., one of the 
anthropologists working on the study. 
Benefits of needle exchange 
A related project will track the spread of 
benefits from needle exchange programs. 
Studies have shown that needle ex¬ 
changes slow the spread of HIV and 
hepatitis B, draw drug users into treat¬ 
ment programs and serve as a vehicle to 
disseminate information about AIDS. The 
researchers want to determine how 
deeply those benefits penetrate into 
communities of drug users. 
“We already know the people who 
use the exchange benefit from it," says 
ment show increased rates of heterosexual infection 
and infection through intravenous drug use. Injecting 
drug users made up 51 percent of the 9,941 AIDS cases 
reported in Connecticut as of the end of May. That 
percentage is twice the national average. Men having 
sex with men constituted 24 percent of the cases and 
heterosexual intercourse was the mode of transmission 
in 15 percent, according to the state Department of 
Public Health. 
Since 1990 white males have dropped from 48 percent 
to 38 percent of the state’s AIDS cases among men. Afri¬ 
can Americans account for 38 percent of the AIDS cases 
in men, an increase from 35 percent reported in 1990. 
Of females with AIDS, 47 percent are African American, 
fewer than the 51 percent reported in 1990, but up from 
the 1994 rate of 44 percent. Hispanic women make up 
25 percent of the state’s women with AIDS. 
“This is increasingly a disease of minority popula- 
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The Road Less Traveled 
Not every 8o-year-old is at risk behind the wheel. How can we fine-tune 
driving skills —and predict who may have a problem? 
For many Americans, the automobile is a 
symbol of independence and an essential link 
with the outside world. Yet as people age, 
driving can become hazardous for them and 
others. Richard A. Marottoli, M.D., M.P.H., 
and Emily D. Richardson, Ph.D., are develop¬ 
ing ways to assess and improve driving skills in 
older persons at risk of having accidents. 
In earlier studies of predictors of driving 
difficulty, they demonstrated that people who 
have foot problems, don’t walk regularly and 
perform poorly on tests of visual attention are 
at higher risk of having crashes or 
moving violations. 
Driving impairment is a special concern 
because of its impact on others. “There are 
safety implications not just for the driver, but 
also potentially for the general public,” says 
Dr. Marottoli, associate professor of medicine 
at Yale and senior research associate at the VA 
Connecticut Healthcare System. “In general, 
older people do a very good job of knowing 
when to stop and when to cut back on their 
driving. It requires some creativity to come 
up with strategies people can use to maintain 
their mobility if they have to stop driving.” 
In a study funded by the NIH, the research¬ 
ers are trying to determine whether improv¬ 
ing physical abilities will help prolong safe 
driving among older persons. Dr. Marottoli is 
also refining predictors so physicians can use 
them to identify candidates for more detailed 
testing. Dr. Richardson, an associate research 
scientist in medicine, is studying ways to im¬ 
prove visual attention, by training participants 
to respond to stimuli on a computer screen. 
“If we can improve visual attention, does that 
translate into improved driving performance?” 
she asks. She hopes the training will improve 
poor dnving habits such as changing lanes 
without first checking left and right. 
“The goal of our research,” says Dr. 
Richardson, “is to identify and correct factors 
that contribute to driving problems so that 
older persons, can, if possible, continue to 
drive safely.” 
For Older Patients, Attention to the Many Facets of Good Health 
We hope you’ll enjoy this inaugural issue of the Yale 
Letter on Aging, a new publication launched by the 
School of Medicine to provide up-to-date information 
about health care for older patients. As are many geriatri¬ 
cians, I am frequently asked, “What exactly is geriatrics?” 
This question is perhaps best illustrated by an example. 
If an 8o-year-old man tells his cardiologist that he’s been 
having chest pain, the cardiologist will attempt to diag¬ 
nose the cause of the pain, then prescribe the appropri¬ 
ate treatments. Before deciding how to pursue the causes 
of the chest pain, the geriatrician will consider the man’s 
other health problems and factors such as family sup¬ 
port, socioeconomic constraints and psychological is¬ 
sues. In other words, the geriatrician is concerned with 
a patient’s overall functioning and well-being, as well 
as the diagnosis and treatment of individual diseases. 
Older adults often have multiple chronic diseases and 
experience difficulty with one or more activities of daily 
life. Rather than working atone, therefore, as do most 
other physicians, geriatricians often use an interdiscipli¬ 
nary approach, working with a coordinated team of 
nurses, social workers, physical therapists, occupational 
therapists and others. 
A second question I am fre¬ 
quently asked is, “Why is interest 
in geriatrics increasing?” The an¬ 
swer is simple—the baby boomers. 
Now well into middle age, baby 
boomers are caring for their 
increasingly frail parents while 
facing their own aging. This 
increased awareness of, and 
interest in, aging has coincided 
with an emerging understanding of the management and 
prevention of many of the diseases, impairments and 
disabilities faced by older persons. Problems such as fall¬ 
ing, chronic pain, urinary incontinence and sleeplessness, 
which only a decade ago were considered inevitable parts 
of aging, are now readily diagnosable and preventable. 
While much remains to be learned, geriatricians, through 
the benefits of research and training, are increasingly 
equipped to help older persons age successfully. 
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By Mary E. Tinetti, M.D. 
Mary E. Tinetti, M.D., is Chief of the Section of Geriatrics 
at Yale University School of Medicine and Yale-New 
Haven Hospital. 
Predictors of driving difficulty include 
foot problems, infrequent walking 
and poor performance on tests of 
visual attention. 
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Back in the Swing 
A broken hip, says the conventional wisdom, is the start of a downward spiral. 
But new research on elder disability holds clues to reversing that trend. 
Eating well, keeping in shape and remaining 
mentally active are factors that help older 
people recover basic activities of daily living 
such as walking, bathing, dressing and getting 
out of bed. In a 1997 study of people who had 
lost such abilities due to illness or accident, 
Thomas M. Gill, M.D., found that 28 percent 
regained independent functions over two 
years. “There is a misperception that once 
older people become disabled it’s a ticket to a 
nursing home,” says Dr. Gill, assistant profes¬ 
sor of medicine. 
Although age played a decisive role in pre¬ 
dicting exactly who would recover, Dr. Gill 
identified other important factors in the study, 
the first to attempt to identify factors other 
than age. Dr. Gill and colleagues looked into 
diet, physical condition and cognitive func¬ 
tion, and found that only 5 percent of those 
over age 85 recovered independence, but 28 
percent of those between 72 and 85 years 
learned to bathe, walk and perform other 
functions on their own again. 
Now Dr. Gill, with support from the NIH- 
funded Yale Pepper Center, is working on a 
prevention plan that focuses on muscle 
strength, balance and gait training, the use of 
adaptive devices and removal of environmen¬ 
tal hazards. He plans to study 160 older per¬ 
sons, half of whom will be enrolled in a pre¬ 
ventive care program. Researchers will assess 
participants’ balance, strength, range of mo¬ 
tion, ability to walk and ability to move from 
sitting to standing. “If someone takes longer 
than 10 seconds to walk 10 feet forward and 
10 feet back at a rapid pace,” says Dr. Gill, 
“that places them at much greater risk for 
becoming disabled. This simple walking test 
is one of the best markers of frailty.” 
Another study will follow 500 to 600 older 
persons living in the New Haven area for two 
years to determine why people become dis¬ 
abled. Initial evaluations will assess partici¬ 
pants’ risks for becoming disabled. “Some 
people at low risk become disabled and some 
people at high risk do not,” Dr. Gill says. 
“We have gained a lot of knowledge in terms 
of what puts older persons at risk of beconnng 
disabled. Now we need to figure out why 
they become disabled.” 
Teaching Geriatrics 
Physicians-in-training learn to look for details that make a difference 
in the care of older patients. 
Margaret A. Drickamer, M.D., says she knows 
her teaching has reached students when they 
call for advice on treating older patients. 
“Those questions wouldn’t even have gotten 
asked before the geriatrics rotation,” she says 
of the queries she receives from interns who 
have gone on to other rotations or clinics. 
Those questions, in turn, mean a more sensi¬ 
tive approach to caring for the multiple 
problems of older persons. “Taking care of a 
90-year-old is different from taking care of a 
40-year-old, whether you’re an ophthalmolo¬ 
gist or a dietician,” says Dr. Drickamer, an as¬ 
sociate professor of medicine who teaches ge¬ 
riatrics and ethics and heads the geriatrics unit 
at the VA Connecticut Healthcare System. 
Because geriatric cases so often involve sev¬ 
eral problems occurring at once, they require 
an approach that inverts the conventional 
medical wisdom of seeking out the unifying 
cause for all the ailments. Instead, geriatricians 
must look at the symptoms, sometimes treat¬ 
ing them independently of their underlying 
cause. “In geriatrics we try to find out what is 
threatening the patient’s equilibrium and what 
the contributing causes are,” Dr. Drickamer 
says. “Which of those can we alter?” 
In their geriatric rotations residents and 
medical students, Dr. Drickamer says, learn 
two facets of caring for older persons. First, 
physicians must focus on the problems, such 
as falling, cognitive decline or inability to per¬ 
form certain activities of daily living. The next 
> 5 
Older people who remain active are 
most likely to recover from injury 
and illness. 
Physicians-in-training need to look 
beyond symptoms, says Margaret 
Drickamer, right. “Rather than focusing 
on illness or disease, they need to find 
out what’s bothering their patient.” 
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Keeping Older Patients 
Healthy in the Hospital 
An independent, 78-year-old woman enters 
the hospital for treatment of angina. The 
treatment is successful but on the second day 
of her stay she becomes delirious. By the 
fourth day she is incontinent. By the ninth day 
she can no longer walk or care for herself. 
Her decline is largely due to complications 
of care such as prolonged bed rest and side 
effects from medication. 
“Our goal is to improve hospital care for 
older patients,” says Sharon K. Inouye, M.D., 
M.P.H., associate professor of medicine, 
who in 1995 launched Elder Life, an inter¬ 
disciplinary program designed to prevent 
physical and mental decline among older 
hospital patients. The program relies on a staff 
that includes Elder Life specialists, geriatric 
nurse specialists, a geriatric chaplain, geriatri¬ 
cians, rehabilitation specialists, dieticians 
and pharmacists. 
Two years after the program began, 
Dr. Inouye and her colleagues reported that 
patients in the Elder Life program were less 
likely to be re-hospitalized or to enter a 
nursing home and more likely to maintain 
functional abilities. Last October Yale-New 
Haven Hospital’s board approved Elder Life 
as a permanent program. The program serves 
Would the Patient Rather be 
Older patients must often choose between the 
security of a hospital and the comforts of 
home, when it comes to treatment of acute 
illnesses. Most want treatment at the place that 
offers the best chance of survival, according to 
a recent study by Terri L. Fried, M.D., and 
colleagues. Dr. Fried, assistant professor of 
medicine, found that if survivability is en¬ 
sured, slightly more than half of the older 
people she studied prefer hospital treatment. 
Although preference for location should 
play a role in treatment decisions, “it’s often at 
the bottom of the list in terms of deciding fac¬ 
tors,” says Dr. Fried. The availability of ser¬ 
vices and the potential outcomes rank as the 
highest priority when patients consider where 
At Yale-New Haven Hospital, Elder Life 
volunteers spend time with patients and 
help them with meals and questions. 
about 800 older people a year. 
At the heart of the program are about 40 
volunteers who chat and walk with patients, 
assist at meal time, and help them get answers 
to their questions. Patients can refer to an 
orientation board in their rooms listing the 
names of their doctors, nurses and volunteers. 
Also noted is a schedule of the day’s activities. 
“They really have a sense of what’s going to 
happen that day,” says Leslie Hurst, M.S., an 
Elder Life specialist who coordinates activities 
for patients. “It’s very reassuring to people.” 
they want to receive treatment. Next on the 
list of factors are patients’ perceptions about 
the process of care. Their social support, 
religious beliefs, self-reliance and past experi¬ 
ences with illness help shape those percep¬ 
tions. Some people prefer being at home with 
friends and family at hand, while others choose 
the hospital so they won’t be a burden on 
loved ones. Patients tend to feel, however, 
that treatment at home can only be a “low- 
intensity service,” which is not necessarily 
true, given the increased availability of tech¬ 
nology in the home. Dr. Fried says. She be¬ 
lieves physicians need to determine what pa¬ 
tients “want in terms of both the process of 
care and its outcomes. We’ve got to ask.” 
at Home? Not Always. 
Facts About Aging 
[> A child born in 1900 could expect 
to live 47 years. A child born in 
1997 has a life expectancy of 
76.2 years. 
[> Every 15 seconds a baby boomer 
in this country turns 50. 
t> One of the fastest growing 
segments of the older population 
is the 100-plus age group. 
The number of centenarians 
has increased 16-fold since 1940, 
from 3,700 to 61,000 today. 
[> The 13 percent of the population 
that is 65 or older accounts for 
44 percent of all days spent in a 
hospital, 40 percent of all visits 
to physicians and a third of the 
nation’s health care expenditures. 
t> Effective strategies against 
many disorders common to 
older persons, such as dementia, 
urinary incontinence, osteoporosis 
and falls, could yield huge 
financial savings while enhancing 
well-being. 
In her research, Terri Fried found that 
older patients like both the security 
of hospitals and the familiarity of 
home care. 
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PROFILE Briefly Noted 
Case Manager 
older persons leads to 
In the early 1980s Nanne 
Scholhamer, M.S.W., saw a pattern in 
some of the families who came into 
the Emergency Department at Yale- 
New Haven Hospital. “It was a 
worn-out family saying: ‘We can’t 
do this any more. We have been 
up three nights with Mom, who is 
incontinent, agitated and not sleep¬ 
ing,’” says Ms. Scholhamer, a 
social worker and case manager. 
Ms. Scholhamer cared for older 
patients in nursing homes before 
starting her career at Yale-New 
Haven Hospital almost two decades 
ago. Working in the Emergency 
Department, she saw the opportunity 
to help older patients and their 
caregivers by organizing their care around a formal program in geriatrics. 
Along with Leo M. Cooney, M.D., Andrea Schaffner, M.D., and Ronald 
L. Miller, M.D., Ms. Scholhamer helped establish what is today the 
Dorothy Adler Geriatric Assessment Center, the hospital’s outpatient 
facility for older persons. 
“What we proposed to do was find a preventive approach to treating 
older persons rather than reacting to situations,” says Ms. Scholhamer. 
Many of the people who come to the Adler Center need help for de¬ 
mentia and its symptoms. The center staff also helps persons and families 
address financial, legal and behavioral issues related to aging, and to plan 
for the management of care. 
An essential element of treatment, says Ms. Scholhamer, is the 
acknowledgement that the psychological and physical problems that 
afflict some older persons also affect their families. “We often identify 
depression in the caregiver,” she says. “How do you juggle a full-time 
career and three teenagers and a husband and your mom? How do you 
form a division of labor with your siblings so you are not the anointed 
one, the only one providing care?” 
As a case manager, Ms. Scholhamer assesses patients’ mental faculties, 
determines how well they function and interviews family members to 
identify problems. Can patients cook their own meals? Can he or she 
move from a chair to a bed? Ms. Scholhamer presents her evaluation to 
a physician, and together they craft a plan of care that often includes 
referrals to social service agencies. “What happens between visits to the 
Adler Center is that the case manager is in very close contact with the 
family at home,” she says. “What we have come to learn and to realize 
is that one of the most important things is educating and supporting 
the caregiving system.” 
Nanne Scholhamer, 
A simple observation about 
a new model of care. 
Nanne Scholhamer helps families 
care for older relatives—and 
themselves. 
Sharon K. Inouye, M.D., 
associate professor of medicine, was 
presented the 1998 Otsuka/American 
Geriatrics Society (AGS) Outstanding 
Scientific Achievement for Clinical In¬ 
vestigation Award by the AGS at its 
annual meeting in May in New York. 
Dr. Inouye was recognized for her 
achievements in clinical research, 
addressing the health care problems 
of older adults as a physician inves¬ 
tigator who is actively involved in 
direct patient care. 
Thomas M. Gill, M.D., has been 
named to the editorial board of the 
Journal of the American Geriatrics 
Society. Dr. Gill, an assistant profes¬ 
sor of medicine, began his three- 
year term on the board July 1. He 
has also recently been named a 
Robert Wood lohnson scholar, a 
Paul Beeson faculty scholar in aging, 
and an NIH academic awardee. 
Terri L. Fried, M.D., has received two 
grants to support a project called 
A Longitudinal Study of Communica¬ 
tion and Preferences in End-of-Life 
Care. This study of older patients, 
their families and physicians will ex¬ 
amine communication about progno¬ 
sis and treatment alternatives as 
well as the treatment preferences of 
patient and family regarding end-of- 
life care. Dr. Fried received the VA 
Health Services Research Career De¬ 
velopment Award and a grant from 
the Paul Beeson Physician Faculty 
Scholars in Aging Research Program. 
Mary E. Tinetti, M.D. and Terri L. 
Fried, M.D., are among the authors 
of When the Patient Cannot Come to 
the Doctor: A Medical House Calls 
Program, published recently in the 
Journal of the American Geriatric 
Society. This paper describes pa¬ 
tients in the medical house calls 
program and the medical problems 
that could be handled in the home 
and those that required transfer to 
the hospital. 
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Strengthening the Weakest Links 
The leg bone-like all the others-is connected to quality of life. 
The classroom is an inpatient corridor at the 
VA Connecticut Healthcare System campus 
in West Haven, a few miles from the Yale 
School of Medicine. 
Leo M. Cooney Jr., M.D., has asked an 80 
year-old patient to walk up and down the hall¬ 
way. The older man is helping to train a group 
of 10 residents, interns, nursing students and 
physicians who observe his balance and gait. 
“There are a couple of things to notice,” 
says Dr. Cooney, the Humana Professor of 
Medicine. “He is always leading with his right 
leg and following with his left, but the more 
he walks, the less time he is spending on his 
right leg.” Later, after a bedside examination, 
Dr. Cooney speculates that a nerve root prob¬ 
lem in the patient’s back is causing his limp. 
The examination is typical of Dr. Cooney’s 
approach to musculoskeletal problems in older 
patients. “My focus is on why a person is hav¬ 
ing problems getting in and out of bed, walk¬ 
ing, brushing their teeth, combing their hair, 
using their upper and lower extremities.” 
These are among what are called activities of 
daily living, ADLs in the jargon of geriatric 
medicine. Treating older persons is often a 
battle to maintain ADLs in order to maintain 
the patient’s independence. “If you can’t get 
out of a bed or chair by yourself then it’s very 
difficult to be by yourself all day long.” 
Dr. Cooney focuses on the functions of the 
bones, muscles and joints that drive the body’s 
movements. Understanding those purely me¬ 
chanical issues may suggest solutions to more 
general problems and have a far-reaching im¬ 
pact on the quality of life. “The real issue is 
not whether they need a walker or a cane or a 
crutch,” Dr. Cooney says. “It’s whether they 
can get by without another person being there 
all the time.” 
He begins his examinations at bedside. In 
this case he has asked the patient at the VA a 
series of questions about his ability to move 
and whether he gets dizzy when he stands up. 
Then he watches for clues to what’s wrong. 
“You watch them try to get off the chair. You 
watch them get off the bed. You watch them 
walk,” says Dr. Cooney, who is chiefof the 
Section of General Internal Medicine and di¬ 
rector of care coordination and the Continu¬ 
ing Care Unit at Yale-New Haven Hospital. 
Therapy, he says, varies with the patient 
and the ailment. “The key challenge is not 
what therapeutic models you’re going to 
use. It’s to identify the larger causes of the 
patient’s dysfunction.” In this case therapy 
is, to a large degree, in the patient’s hands. 
He will have to adhere to a regimen of physi¬ 
cal therapy, adjust to using a wheelchair and 
adapt his home to accommodate his lack of 
mobility. “Sometimes we can fix things,” 
says Dr. Cooney. “Probably 90 percent of 
the time things are not fixable. They are 
things that need to be identified so we can 
make plans for the family or the patient to 
help care for him or herself.” 
<1 2 
step is to select the appropriate in- or outpa¬ 
tient treatment for the patient. 
Geriatricians work as part of a team that 
includes physicians, social workers, clinical 
fellows, and nurse practitioners. Many people 
in those areas are seeking training in geriatrics, 
Dr. Drickamer says. “I think they realize 
that once in practice, they will need to know 
how to take care of a geriatric population,” 
she says. 
For physicians, training begins in medical 
school, where third-year students study geri¬ 
atrics during their outpatient rotation. As se¬ 
niors they may take an elective in geriatrics. 
In their first and third years, residents have a 
four-week geriatric rotation. Yale also offers a 
geriatric fellowship that starts with a year of 
clinical geriatrics followed by up to two years 
of geriatrics research. 
“We teach people how to take care of 
people in different settings—nursing homes, 
subacute care settings, homes, hospices,” 
Dr. Drickamer says. “Rather than focusing 
on an illness or a disease, they need to find 
out what’s bothering their patient, what’s 
putting that patient at risk and finding causes 
for that.” 
Leo Cooney looks to the bones 
and muscles for clues to 
dysfunction. 
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Basement stairs, multiple medications and slippery baths all increase the risk of a fall. 
Before the Fall 
Common-sense approach can help prevent this most common of injuries 
and preserve an older person’s independence. 
Each year in the United States, more than a 
third of older persons fall. One in 10 of those 
falls causes a serious injury. But even if no 
injuries result, a fall can damage an older 
person’s confidence in his or her ability 
to function. 
“Quite often it can be the beginning of loss 
of functional independence,” says Mary E. 
Tinetti, M.D., professor of medicine and Epi¬ 
demiology and Public Health. “People who 
have had a fall are much more likely to come 
to the emergency room, to be admitted to the 
hospital, or to use nursing homes or home 
services.” Like all geriatricians. Dr. Tinetti’s 
goal is to keep older persons as independent as 
possible. For the past eight years she has stud¬ 
ied why and how falls occur, and has devel¬ 
oped a protocol of simple measures that have 
been found to reduce falls by 30 percent. 
Fall prevention starts with an inventory 
of risk factors in the home, including the 
presence of stairs, throw rugs and step stools. 
Dr. Tinetti assesses the patient’s hearing, 
balance, gait, blood pressure and list of 
medications. Individual treatment plans 
may include a removal of environmental 
hazards and a change in medications. Physical 
therapists teach patients how to do exercises 
at home that improve balance, strength 
and walking. 
The team also recommends simple and 
inexpensive measures to prevent falls. For 
example, an older person whose washing 
machine is in the basement is encouraged to 
bundle dirty clothes in a bag and throw it 
down the stairs. Clean laundry should be 
placed in small piles and moved up the stain 
step by step. Home improvements include 
placing grab bars in strategic locations such as 
the bathroom and eliminating glare by remov¬ 
ing direct lighting. 
“We wanted to select things that people 
can do pretty readily and inexpensively,” 
Dr. Tinetti says. 
«8MB ■■■ ^ 
Peter Salovey Margaret Weeks Robert Heimer Jeannette Ickovics 
Robert Heimer, Ph.D., associate professor 
of epidemiology. “There’s no question 
about that. The question is, ‘Is this benefit 
available only to people who come and ex¬ 
change needles directly?’ " Using color- 
banded syringes that will be distributed to 
150 injecting drug users in Hartford, 150 
in Oakland and 240 in Chicago, they’ll 
track usage patterns over four years. They 
plan to follow a total of 5 million needles 
from index participants in exchanges to a 
second level of drug users who don’t par¬ 
ticipate but know people who do. They will 
continue to track the needles to see 
whether they penetrate a third level of 
drug users who neither use the exchange 
directly nor know anyone who does. 
Dr. Heimer and Edward H. Kaplan, 
Ph.D., professor of management sciences 
and of public health, previously concluded 
that New Haven’s needle exchange pro¬ 
gram reduced the rate of new infections 
by a third. In one of the first federally 
funded studies of needle exchanges, they 
logged when and where needles were dis¬ 
tributed, who received them, when and 
where they were returned and who re¬ 
turned them. They then checked the used 
syringes for HIV. They found that a 
needle’s street life dropped from about 
two weeks to a few days and that usage 
dropped from an average of eight to 
12 times per needle to between one 
and five times. The study also showed 
lower percentages of syringes with blood 
from HIV-infected people and hepatitis 
B-infected people. Dr. Heimer’s research 
has shown that the virus can survive in 
a syringe for up to a month, depending 
on how much blood is in the syringe 
and how much of the virus is present 
in the blood. 
“What is left to do," he says, “is to 
determine who benefits and who doesn’t 
from needle exchange programs, to 
determine where operations can be 
improved to maximize their impact, and 
to create enhanced needle exchange 
programs that target people who are 
at highest risk.” 
Pregnancy and disease 
Jeannette R. Ickovics, Ph.D., is examining 
how adolescent relationships bear on 
pregnancy, risky sexual behavior and 
sexually transmitted diseases. Her study 
focuses on 600 girls ranging in age from 
14 to 19, half of whom will be pregnant. 
“I think the question, particularly for ado¬ 
lescents, is whether or not pregnancy is 
by choice, by chance or by coercion," says 
Dr. Ickovics, assistant professor of epide¬ 
miology and psychology. “The very behav¬ 
ior that put them at risk for pregnancy— 
unprotected intercourse—also puts them 
at risk for sexually transmitted diseases.” 
She plans to recruit the subjects 
of her study at hospitals or health cen¬ 
ters in Hartford, Bridgeport and New 
Haven. Dr. Ickovics said she will ask how 
many sexual partners they’ve had, how 
often they have sex and whether the 
sex was protected. 
“Past behavior is the best predictor 
for future behavior,” Dr. Ickovics says. 
The study will follow the teens over two 
years to determine whether those who 
are pregnant become pregnant again 
and whether others become pregnant 
for the first time. 
“We certainly hope to use the infor¬ 
mation to develop interventions that will 
limit and reduce the risk of adolescent 
women for both pregnancy and sexually 
transmitted diseases.” 
tions,” says Gerald H. Friedland, M.D., who directs 
the Yale AIDS Program, a treatment center for people 
with AIDS. He has been tracking the disease since the 
early 1980s, when as a physician at Montefiore Hospital 
in the Bronx, he was among the first to notice it among 
drug users. “The epidemic in New Haven and the 
entire Northeast has been an epidemic of vulnerable 
populations. That is increasingly the character of the 
epidemic nationally.” 
As HIV spreads through a marginalized population, 
Dr. Merson finds a disturbing lack ol political will to 
implement proven prevention strategies. Politicians 
won’t support needle exchange programs for fear of be¬ 
ing perceived as soft on drugs (See Politics 1; science 0). 
The teaching of safe sex in schools raises social and reli¬ 
gious objections. All this, Dr. Merson notes, while tele¬ 
vision news anchors open their broadcasts with specula¬ 
tion about oral sex in the Oval Office. “Good public 
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health policy is based on science. Unlortunately, when it 
comes to AIDS, science has too often been ignored," he 
says, adding that AIDS never surlaced as an issue in the 
1996 presidential campaign. “It was the leading cause of 
death in our young people and neither candidate wanted 
to talk about it.” 
With those concerns in mind early in his tenure at 
Yale, Dr. Merson began discussing AIDS with colleagues 
in various disciplines. Yale had already been at the fore¬ 
front of treatment programs with the Yale AIDS Pro¬ 
gram, and Yale researchers had conducted one of the 
first federally funded studies to evaluate the efficacy 
of needle exchange programs as an AIDS prevention 
measure, but Dr. Merson felt even more could be done. 
He found enthusiasm for an AIDS prevention project 
among his colleagues, but also some doubts that the 
federal government would fund another AIDS center. 
Dr. Merson persisted, got an encouraging response to his 
initial proposal from the NIMH, and submitted a plan. 
Last September Yale President Richard C. Levin an¬ 
nounced the $10.8 million grant from the NIMH and 
NIDA. The funding will keep CIRA going for about 
four years, but those involved foresee a life beyond that. 
“Our vision for the center was that we would continue 
to have 15 to 20 domestic and international projects as¬ 
sociated with it in one way or another, for a decade or 
more,” Dr. Merson said. “I would hope we could serve 
as an international resource in HIV prevention.” Among 
the projects envisioned are training in prevention re¬ 
search for scientists, developing research capabilities at 
community-based organizations and analyzing policies 
that relate to HIV prevention. 
Adults and children estimated to be living with AIDS 
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CIRA combines the efforts of more than 55 research¬ 
ers from six Yale schools and departments as well as two 
Hartford-based partners, the Institute for Community 
Research and the Hispanic Health Council. Activities 
are centered around four major research projects and 
three “cores,” organizational units that support the 
work. One core handles administrative chores, another 
compiles the data collected and the third explores legal 
and ethical issues. Researchers are also working on 13 
projects affiliated with CIRA, including studies of drug 
abuse among children and high-risk behavior of drug us¬ 
ers infected with HIV. 
Keeping everything organized falls to Caroline Roan, 
associate director of the center. She is in charge ol set¬ 
ting up CIRA’s infrastructure. “When I started, I was 
working on a laptop sitting on the floor,” she says. She 
relies on e-mail and telephones to keep people in touch, 
but also schedules regular committee meetings, brown 
bag lunches and evening seminars. 
SHARING IDEAS 
The interdisciplinary nature of the project becomes ap¬ 
parent at an evening seminar in mid-February. As Peter 
Salovey, Ph.D., a psychologist who is co-director of 
CIRA and director of the project on framing persuasive 
messages, is explaining how to get the message out on 
risky sex, needles, condom use and HIV testing, Edward 
H. Kaplan, Ph.D., a management sciences expert who 
led the study of New Haven’s needle exchange program, 
picks up a piece of chalk and begins to apply math¬ 
ematical modeling to Dr. Salovey’s theories. The topic is 
the not-always-logical thought process behind risky 
sexual behavior. Wearing a condom will produce a fairly 
certain result, says Dr. Kaplan. Not wearing a condom 
offers two possible results—getting infected or not get¬ 
ting infected. He charts the possibilities on a blackboard 
and begins writing formulas. “It could be perfectly ratio¬ 
nal for people not to use condoms if risk is perceived 
as small,” Dr. Kaplan concludes. 
At a CIRA conference in late May, Alvin Novick, 
M.D., professor of ecology and evolutionary biology 
and director of the center’s law, policy and ethics core, 
leads a discussion on surveillance of AIDS cases and 
HIV infections. He poses a rhetorical question: Does the 
public health benefit of tracking cases ol HIV infection 
outweigh individual rights to privacy? 
Some states report only cases of AIDS, while others 
report cases of HIV infection. Fear of having their names 
on a list of those infected with HIV has made people re¬ 
luctant to get tested for the virus. There are valid scien- 
Drug use in Eastern Europe has led to a rapid increase in the inci¬ 
dence of HIV infection since the breakup of the Soviet Union. Most 
cases are found among drug users and their sex partners. CIRA is 
about to begin a five-year, $2 million program to bring Russian 
scientists to New Haven for training in HIV prevention research. 
tific reasons to compile such a list, Dr. Novick says, but 
equally compelling privacy issues. “You want to count 
people who are infected. 7’hey’re all going to need health 
care. They’re all potentially infectious to others,’’ he 
adds. “You could mandate the testing of everyone and 
then you’d have perfect surveillance. We would have to 
ask eventually whether it was the least invasive.” 
At CIRA’s first brown bag lunch in February, another 
ethical question surfaces. The topic is informed consent. 
How do researchers secure the cooperation of people 
they’re studying, explain what they’re doing and spell 
out their rights? “They have to know the purpose of 
what you are doing,” says Robert J. Levine, M.D., HS 
’63, professor of medicine and co-director ol the law, 
policy and ethics core, who leads the discussion. “They 
have to understand the risks. They have to understand 
the benefits. They have to know the alternatives.” The 
discussion turns to another question. Can researchers 
Page 40 I 
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EXCERPT 
Dispatch from the front lines 
In his new book, Yale physician Peter Selwyn describes the early days of the epidemic. 
si i r\ TV 111ST 
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Fresh out of Harvard Medical School in 1981, Peter A. Selwyn, 
M.D., began his career at the Montefiore Medical Center in the 
Bronx. As an intern he saw the AIDS epidemic run rampant 
through a community already challenged by poverty and drug 
addiction. In Surviving the Fall: The Personal Journey of an AIDS 
Doctor, published this spring by Yale University Press, Dr. Selwyn 
describes his experiences, the people he treated and how their 
lives, and deaths, helped him confront grief in his own life. 
Dr. Selwyn, associate professor of medicine and of epidemiology and public 
health, came to Yale in 1992 as associate director of the Yale AIDS Program. 
He is the medical director of Leeway, a 30-bed skilled nursing facility for AIDS 
patients, many of whom are in the late stages of the disease. The center, which 
opened in October 1995, recently received state health department approval to 
add 10 beds, which will be geared to the special needs of patients with HIV and 
co-existing mental illness. 
Dr. Selwyn recently received a faculty scholar’s award from the Project on 
Death in America of the Open Society Institute, which is intended to enhance 
end-of-life care, teaching and research at Yale-New Haven Hospital and Yale 
School of Medicine. 
I have become an "AIDS doctor,” an 
outcome I never could have antici¬ 
pated when I graduated from medical 
school in 1981. I have been involved in 
the care of more than a thousand pa¬ 
tients with HIV infection, and for almost 
ten years these have been my only pa¬ 
tients. I have been fundamentally 
changed by this experience, and my his¬ 
tory is now indelibly linked with the faces 
and histories of my patients, especially 
the many hundreds who have died. This 
story is their story, and mine. 
The beginning of the AIDS epidemic 
in the Bronx in the early 1980s was a 
time without recent precedent, a time 
when a fatal blood-borne disease spread, 
without warning and with grim efficiency 
through an unsuspecting and vulnerable 
population. This same insidious pattern 
was unfolding in Harlem, Brooklyn, and 
many other poor, inner-city communities 
in the United States and around the 
world. In these communities AIDS was 
affecting poor, minority populations, pri¬ 
marily intravenous drug users, their sex¬ 
ual partners, and children, in addition to 
gay men. I have long felt that this history 
and these stories need to be told, to help 
honor and take notice of all the uncele¬ 
brated men, women, and children who 
lived and died with this unforgiving 
plague. Statistics have been described 
as human beings with the tears washed 
off. In this narrative, I have tried to re¬ 
store some humanity to the statistics. 
This book describes both the first 
wave of the AIDS epidemic in the Bronx 
and the gradual process by which I also 
became aware of my own unfinished busi¬ 
ness. Absorbed in the pain and losses of 
my patients and their families, I slowly be¬ 
gan to acknowledge the grief that I had 
carried unknowingly for decades following 
the sudden death—and apparent sui- 
Excerpted from Surviving the Fall: The Personal 
Journey of an AIDS Doctor by Peter A. Selwyn, 
M.D. Copyright © 1998 by Peter A. Selwyn. 
Reproduced by permission of Yale University Press 
[http://www.yale.edu/yup/]. All rights reserved. 
cide—of my father when I was an infant. 
Surrounded by dying young parents, I 
slowly came to understand, for the first 
time in my life, what it meant to have a 
father, and to be one. This process of 
awakening led me to come to terms with 
my personal history, along with the 
stigma and the family secrets that it had 
engendered, and finally, with my own role 
as a son, as a husband, as a father to 
two young children, and as a physician. It 
was, for me, a journey of healing in the 
midst of the epidemic, a reclaiming of life 
in the midst of death. 
I remember Nelson most vividly, less be¬ 
cause we shared the same birthday than 
for the gentle sweetness of his soul. In 
our population of methadone program pa¬ 
tients, in which the patients with the 
most extreme personality disorders 
seemed to require the most attention, 
Nelson stood out in his sincerity, thought¬ 
fulness, and calm. Unlike many other pa¬ 
tients, he had an emotional maturity that 
enabled him to talk about his fears, con¬ 
cerns, and feelings about the disease 
without taking refuge in further drug use 
or other escapes. Sometimes, working 
with our patient population, it was easy to 
become overwhelmed with this sea of 
neediness, and with the feeling that no 
matter what you did, it would never be 
enough. Nelson was not like that, and as 
a result he tended to draw staff to him in 
a way that made it clear that they were 
getting as much emotional support and 
positive energy from him as they were 
giving in return. 
His wife, Marilinda, who accompanied 
him to all of his medical visits, was also 
gentle, composed, and a model of grace 
under pressure. Their only child, Manuel, 
was 12, and it was clear that his parents 
had been successful thus far in protect¬ 
ing him from the overriding influence of 
the street, in their neighborhood not far 
from Yankee Stadium, south of the Cross- 
Bronx Expressway. This close-knit family 
of father, mother, and only child stirred 
something in me that I did not identify 
consciously at the time. It was an image 
of the ideal family that I had never experi¬ 
enced, or had experienced only too briefly 
before it was erased from my memory. 
Nelson was the first patient for whom 
I wrote a prescription for AZT, the first 
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week that the drug became available, in 
spring 1987. I remember carefully writing 
the words on the prescription, foreseeing 
that this would be the first of thousands 
of such prescriptions that I would write. 
Nelson and I had both been anticipating 
the arrival of AZT, and indeed for every¬ 
one involved in the epidemic at the time 
this was a momentous event: it repre¬ 
sented, for the first time,the possibility 
that this virus could be treated. Every¬ 
thing that we had done up to then was 
supportive care. With the advent of AZT, 
we were at last fighting back at the virus 
itself, however crudely or ineffectively. 
Both of us knew, at the moment I 
handed him the prescription, that this 
would probably not be enough to keep 
him alive much longer, that this was prob¬ 
ably going to be, for him, too little too 
late. Yet for both of us, at that same 
moment, AIDS suddenly lost a little bit 
of its terror and mystery. 
After doing well on AZT for about six 
months, Nelson started to fail, first losing 
weight, then starting to lose his balance 
and coordination, and then becoming 
more apathetic and withdrawn. One day, 
he had a seizure in the clinic and was 
rushed to the North Central Bronx Hospi¬ 
tal emergency room, where a CAT scan re¬ 
vealed a large circular lesion in one of the 
frontal lobes of his brain. This was likely 
either cerebral toxoplasmosis or lym¬ 
phoma but the diagnosis could be made 
only be performing a brain biopsy. At that 
time, it was virtually impossible to find 
surgical consult- ants at our hospital who 
were willing to perform procedures on 
AIDS patients, and this case was no 
exception. In addition, both Nelson and 
his wife had decided that if he were to 
become sick again, they would not want 
further aggressive treatment if the quality 
of his life would be unlikely to improve. 
We treated him empirically for a week 
with medication that would be effective 
against toxoplasmosis, if that were in 
fact his diagnosis, but he showed no 
improvement. His mental status contin¬ 
ued to decline, and he began to slip in 
and out of consciousness. 
The last time I saw him, I sat by his 
bedside and took his hand. He opened 
his eyes, smiled weakly, said, "Thank you 
for being here,” and squeezed my hand 
briefly. Marilinda, who had been sitting 
nearby, began to cry softly. I talked with 
her a little while and then watched as 
she gave him a sponge bath. I had never 
been to a baptism, but there was some¬ 
thing sacred about the way she washed 
his body with such long, methodical, and 
loving movements; it seemed as if she 
knew that this would be the last time she 
would touch his living body, and that she 
wanted to linger over it all the more. He 
died in his sleep that night. 
A few months before his final illness, 
Nelson had told me that he had one un¬ 
fulfilled wish: to return to Puerto Rico and 
ride his motorcycle again. He had an old 
Harley-Davidson, which he had restored 
from parts and kept stored in a friend’s 
garage on the island. He giggled as he 
conjured up the image of himself, already 
beginning to look a little emaciated, rac¬ 
ing over hills and around steep mountain 
bends near his family’s home in the cen¬ 
tral coffee-growing region of Maricao. Not 
being certain that he could tolerate such 
a trip, but realizing that it was important 
for him to go regardless, we arranged for 
Nelson to have enough medication for 
several weeks, and local medical backup 
if he needed it. He sent me a postcard 
and returned several weeks later, bronzed 
from the sun and laughing, saying matter- 
of-factly that there was nothing else he 
had left to do. (I remember thinking at 
the time how wonderful it must be to 
have that feeling.) It was soon after that 
trip that he began to descend rapidly into 
his final illness. 
I went to Nelson’s funeral one rainy 
evening, at a small funeral parlor in East 
Harlem. He was lying in an open coffin in a 
room with red velour walls and dark 
wooden chairs. I approached the casket, 
stood and bowed my head for a moment 
and saw that they had done a nice job 
preparing him. He was wearing a pressed 
dark brown suit, hair neatly combed, 
hands clasped in front holding a rosary. I 
wondered, as I always do in such situa¬ 
tions, where he really was at the moment, 
and wished him well wherever he was. I 
turned away from the casket, saw 
Marilinda, gave her a hug, and then no¬ 
ticed his parents, whom I had briefly met 
in the hospital. Nelson’s father, misty-eyed, 
pressed my hands clumsily between his 
and said in Spanish, "Thank you, we will 
never forget what you did for our son.’’ 
These words, spoken to me from a father 
about his son, touching on death, and re¬ 
membrance, and love, moved me greatly 
and reaffirmed for me as I walked out into 
the night that I had chosen the work I 
needed to do. I still did not realize how 
close to home these words would come in 
my own life, how much they would touch 
my long-dormant feelings about the loss of 
my father and his memory. Words from a 
father about his son, spoken in gratitude 
to another man’s son who had grown up 
without his father. As I watched this family 
confront the loss of its father, husband, 
and son—seeing Nelson’s life reflected in 
relation to his survivors—it stirred some¬ 
thing in me that was both numb and pain¬ 
ful, something which would eventually lead 
me back to my childhood history. 
Yale physician Peter Selwyn examines a patient at Leeway, a skilled nursing facility in New 
Haven for people with AIDS, where he is medical director. 
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guarantee confidentiality to drug 
risers who have reason to fear the 
law? What obligations do they have 
to report illegal activities to authori¬ 
ties? “These are not the sorts of is¬ 
sues that have clear answers,” says 
Dr. Levine, chairman of the medical 
school’s Human Investigation 
Committee. He and others note 
that CIRA is covered by a federal 
certificate that guarantees interview 
subjects confidentiality. 
During an interview in her 
Hartford office, Margaret R. Weeks, 
Ph.D., associate director of the In¬ 
stitute for Community Research 
and director of CIRA’s study of 
high-risk drug sites, says researchers 
are required to report child abuse. 
They will also act in life-threatening 
situations, such as overdosing. 
“Often it’s a judgment call out in 
the field,” she says. Outreach work¬ 
ers will also make referrals lor drug 
users who seek treatment and will 
offer health kits. “The benefits of 
understanding these places, in order 
to protect health for the public 
good, justifies our research. If we go 
in there to intervene, either to im¬ 
pose the law upon them or impose 
something else upon them, we undo 
our ability to do research.” 
Page 44 
Peter Salovey describes prospect theory 
during a presentation at a CIRA meeting. 
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Mobile health unit 
extends AIDS care In 1993, an 18-foot van loaded with cli¬ 
nicians, social workers, counselors 
and outreach workers began winding 
its way down New Haven’s streets to offer 
medical services, HIV testing and coun¬ 
seling and referrals to substance abuse 
programs. The van, since replaced by a 
36-foot model with two exam rooms, a 
counseling room and a waiting area, is 
linked to the city’s needle exchange pro¬ 
gram. Funded by a $3 million grant from 
the National Institute on Drug Abuse, the 
health care van's operation is a collabora¬ 
tion among the medical school, the City 
of New Haven, Yale-New Haven Hospital 
and the Hospital of St. Raphael, and sev¬ 
eral community health centers. Although 
it operates in conjunction with the city’s 
needle exchange program, it has sepa¬ 
rate funding. 
“We traveled everywhere the needle 
exchange went,” says Frederick L. Altice, 
M.D., HS ’87, director of the van project. 
“I realized this would be an important 
method to provide medical care and pre¬ 
vention services to drug users.” It also 
provides medical care to people who are 
homeless and lack medical insurance, 
providing acute care and referrals to com¬ 
munity-based health care providers. In its 
first three years of operation the van 
treated more than 1,800 people, many of 
whom had HIV/AIDS. 
Prison program offers 
opportunities for 
prevention One of the ironies of the criminal 
justice system is that it brings 
many people into contact with 
regu-lar health care for the first time in 
their lives, says Frederick L. Altice, M.D., 
HS '87, assistant professor of medicine 
and a CIRA-affiliated researcher. Because 
they’re under constant penal surveillance, 
they can also be placed under close 
medical watch. 
“It’s an important opportunity to de¬ 
tect disease and to initiate treatment," 
says Dr. Altice, who has served in recent 
years as a consultant to Connecticut’s 
Department of Corrections, treating in¬ 
mates with AIDS. “For those who are at 
risk for HIV and are still negative, it’s a 
place where HIV risk reduction interven¬ 
tions should be introduced, in order to 
decrease their risk for getting HIV at a 
later time.” 
Cases of AIDS, he says, can be found 
in prisons at a significantly higher rate 
than in the general population. “The war 
on drugs has basically instituted wide¬ 
spread mandatory sentences on drug 
users and it is drug users who are at 
risk for HIV,” he says. “It’s the behavior 
that’s occurring just before people 
come in to prison that is the riskiest. 
It is unprotected sex and sharing of 
injection equipment.” 
Nationwide, according to Bureau of 
justice statistics, AIDS cases were six 
times more prevalent in the prison popu¬ 
lation than in the general population. At 
the end of 1995, there were 5,099 con¬ 
firmed AIDS cases in prisons, and AIDS 
was the cause of 34 percent of all in¬ 
mate deaths. Unfortunately, most cases 
of HIV go undetected within the prison 
system, Dr. Altice says. 
Dr. Altice has developed programs 
that link HIV-infected inmates to commu¬ 
nity health care when they leave prison. 
“The most basic and difficult problems 
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A 36-foot health 
care van, dedicated 
in 1996, follows a 
route through New 
Haven to provide 
medical care, HIV 
testing and counsel¬ 
ing and referrals to 
substance abuse 
programs. 
such as stable housing and food,” Dr. 
Altice says, "are things that destabilize our 
patients when they return to the commu¬ 
nity. Stable housing remains one of the 
most crucial and unavailable unmet needs. 
The best we can do is get them into a shel¬ 
ter. Sometimes you have to put a Band-Aid 
on one wound while you’re dealing with 
other wounds, such as accessing drug 
treatment and medical care." 
Nursing research 
improves care locally 
and around the world Yale AIDS researchers from the 
School of Nursing can be found in¬ 
terviewing sex workers in Thai broth¬ 
els and drug users in Poland, conducting 
clinical trials to prevent gynecologic com¬ 
plications in New Haven women infected 
with HIV, and teaching AIDS treatment and 
prevention to nurses in China and Vietnam. 
“What became apparent from the earli¬ 
est days of the epidemic,” says Ann Will¬ 
iams, M.S.N. '81, “was that nursing care 
made a huge difference. In the begin¬ 
ning—and it’s still true for most of the 
world—exquisite nursing care was all we 
had to offer people with HIV. Now, with the 
promise of long-term survival on the hori¬ 
zon for many, our focus is shifting from 
acute symptom management to interven¬ 
tions directed at the problems raised by 
living with a chronic condition." 
Professor Williams is principle investi¬ 
gator for the School of Nursing-based 
GRACE project, or Gynecologic Regimens 
Addressing Candida Events. GRACE was 
funded by the National Institute for Nurs¬ 
ing Research to examine the efficacy of 
three nursing interventions to prevent 
Candida vaginitis, a common and dis¬ 
tressing problem for women with AIDS. 
“Now that the study is complete,” she 
says, ‘‘we are turning our attention to new 
challenges such as strategies to improve 
medication adherence and screening for 
anal cancer. Neither of these issues were 
on our radar screen earlier, when our goal 
was limited to helping people feel better 
and live as long as possible." 
Professor Williams, who also serves 
as an advisor for School of Medicine stu¬ 
dents, was pleased that the dissertation 
research for the nursing school’s first 
doctoral graduate, Wantana Limkulpong, 
D.N.Sc. ’98, was a study of safer-sex 
practices among commercial sex workers 
in Thailand. Ms. Limkulpong discovered 
that although knowledge levels were 
high, financial pressures and lack of 
self-confidence prevented many women 
from initiating condom use. Limkulpong 
is returning to a faculty post at Mahidol 
University in Bangkok, where she will 
continue her research. 
The Nursing School’s global reach is 
extended by its collaborations with the 
Yale-China Association. Under one such 
project, Jane Burgess, director of the YSN- 
based Connecticut AIDS Education and 
Training Center, traveled to Hunan Prov¬ 
ince in May. In a program supported by 
the World AIDS Foundation, Ms. Burgess 
and Professor Williams, along with Nancy 
Angoff, M.P.H. ’81, M.D. '90, are conduct¬ 
ing a series of workshops to prepare 
Chinese nurses to respond to the 
growing threat of an HIV epidemic in the 
world’s most populous country. In asso¬ 
ciation with the workshops, Professor 
Williams and Dr. Angoff will study HIV 
seroprevalence in a storefront STD clinic 
in Changsha. Although HIV testing is not 
widely available, a skyrocketing incidence 
of anogenital HPV infections and genital 
ulcer disease suggests that the risk is 
extremely high. 
Closer to home, Professor Williams 
and Dr. Angoff are looking at strategies to 
improve patient-provider communication 
about end of life care and advance direc¬ 
tives. The range of AIDS nursing research 
under way at the School of Nursing illus¬ 
trates the global challenge posed by this 
epidemic and the importance of strong 
interdisciplinary collaborations. 
For college students, 
a focus on safer sex Every fall incoming 
freshmen can ex¬ 
pect invitations to 
one of 36 safer-sex work¬ 
shops held during their 
first week of school. 
Also offered at cultural 
houses, fraternities and 
sororities, the workshops 
are led by 27 peer edu¬ 
cators who talk about 
the risks of unprotected sex, which in¬ 
clude sexually transmitted diseases and 
pregnancy. Overseeing the program is 
Sally Rinaldi, R.N., M.P.H. ’82, who coordi¬ 
nates health education programs for Yale 
University Health Services. 
“Mostly we talk about why students 
need this information, why it is impor¬ 
tant,” Ms. Rinaldi says. “You may not 
need it today, but you might need it down 
the road. Even if you feel you don’t need 
the information for yourself you might 
need it for your roommate or your friends." 
She relies on health advocates among 
graduate students to inform their peers, 
who are more scattered in housing. 
Every year, health educators hand out 
about 40,000 condoms to graduate and 
undergraduate students. Undergraduates 
can get them from freshmen counselors 
or peer educators. On Valentine’s Day the 
program gives away safe sex kits which 
include condoms, lubricant, information 
on how to use them and information 
on abstinence. 
“We always include information about 
abstinence," says Ms. Rinaldi. “There 
are people who are sexually active and 
people who plan to abstain. It's not 
always the same for everyone.” 
Sally Rinaldi 
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DISCOVERY 
Hunting down HIV 
Yale research produced two of the current crop of AIDS drugs and a promising new line of inquiry. 
It may take a virus to kill a virus, if genetic approach is proven effective. 
By John Curtis 
It is perhaps testimony to HIV's resil¬ 
ience and versatility that physicians 
celebrate drugs that do no more than 
slow the virus’s progress in the human 
body. HIV hides and mutates in order to 
dodge the medications sent to stop it. 
And while these agents are limited in 
their therapeutic value, so far they have 
provided the only hope in the treatment 
of AIDS. 
Researchers at Yale have played key 
roles in developing two of these com¬ 
pounds, the reverse transcriptase inhibi¬ 
tor d4T, known commercially as Zerit, and 
3TC, known as Epivir. Both are key ingre¬ 
dients of the so-called drug cocktail that 
has fundamentally changed the nature of 
AIDS therapy during the past three years. 
They not only inhibit the reverse tran¬ 
scriptase enzyme, but more importantly, 
by terminal incorporation into the growing 
proviral DNA, a precursor to the virus, 
they prevent the reproduction of the vi¬ 
rus. These compounds are frequently 
combined with other inhibitors which in¬ 
hibit the viral enzyme protease, whose 
activity is essential for the formation of 
an infectious virus. 
In addition to contributing to tradi¬ 
tional, small-molecule pharmaceutical 
development, Yale scientists are exploring 
new avenues in the fight against AIDS, 
in particular the potential of biological 
agents to effect a cure. One novel ap¬ 
proach has resulted in a genetically 
engineered virus that attacks and kills 
HIV-infected cells in culture while leaving 
other cells unharmed. Whether it will do 
so in humans, or even animals, remains 
to be evaluated. 
William Prusoff, Ph.D., professor 
emeritus of pharmacology, has spent a 
45-year career at Yale investigating poten¬ 
tial antiviral and anticancer compounds, 
part of the traditional, small-molecule ap¬ 
proach. In the late 1950s he synthesized 
idoxurine, an analog of thymidine, which 
William Prusoff and his late collaborator, Tai-Shun Lin, discovered that d4T, although it was a 
poor anticancer agent, could slow the production of HIV. 
Zerit (d4T) 
Yung-Chi (Tommy) Cheng’s laboratory looks 
for ways to reduce the toxicity of drugs that 
work against AIDS. He found that 3TC could 
reduce side effects when used in 
combination with AZT. 
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was the first antiviral compound ap¬ 
proved by the FDA for therapy in humans. 
It was used to treat herpes infection of 
the eye. Dr. Prusoff and his long-time col¬ 
laborator, the late Tai-Shun Lin, Ph.D., dis¬ 
covered in the 1980s that a thymidine 
analog, reported in scientific literature as 
a poor anticancer agent, was very effec¬ 
tive in slowing the production of HIV. This 
compound is known as d4T or stavudine. 
How does d4T work? “It gets incorpo¬ 
rated into the growing viral DNA chain 
and synthesis of proviral DNA is 
stopped,” Dr. Prusoff says. HIV’s mecha¬ 
nism for reproducing is simply turned off. 
Bristol-Myers Squibb developed the 
drug under the trade name Zerit and 
brought it to market in 1994. Almost 
single-handedly, d4T has boosted Yale’s 
annual patent royalty income nearly ten¬ 
fold, to $34 million for the year ending 
June 30. [AZT, the first medication shown 
to slow the progress of HIV, was created 
by a Burroughs Wellcome team led by 
Yale alumnus David W. Barry, M.D. '69, HS 
’69-72. (Yale Medicine, Fall 1997)] 
“They are very potent in decreasing 
the viral load in the bloodstream,” says 
Dr. Prusoff, referring to the limitations 
of the currently available anti-viral 
medications, “but you don’t really elimi¬ 
nate the viral load in the cell where the 
virus is hiding. This is critical for an 
eventual cure.” 
The combination approach 
Two hurdles in AIDS pharmacology are 
toxicity and drug resistance. As with can¬ 
cer chemotherapy, AIDS medications can 
make people very sick. For example, d4T 
can cause peripheral neuropathy, tingling, 
numbness and pain in the extremities; 
ddl can cause lethal pancreatitis; and 
AZT is toxic to the bone marrow and can 
cause anemia, headaches and nausea. In 
addition, HIV often mutates when chal¬ 
lenged by a single therapeutic agent, cre¬ 
ating drug-resistant strains of the virus 
that foil treatment. By prescribing AIDS 
drugs in combinations, the physician can 
reduce individual dosages and minimize 
both side effects and the potential for re¬ 
sistance. “There are dozens of different 
combinations,” Dr. Prusoff says. “Resis¬ 
tance develops to all of those com¬ 
pounds.” Resistance to d4T has been 
found with laboratory strains of HIV, but 
mutant forms resistant to d4T have not 
been observed in patients being treated 
with d4T, Prusoff says. 
John Rose converted a cattle virus into a hunter and destroyer of HIV-infected human 
T-cells in culture. 
(3) gpl20/41, a 
protein produced 
by HIV, attracts 
the altered virus 
to the surface 
of the T-cell 
(1) Altered VSV with human CD4 and 
CXCR4 receptor molecules 
Stalking HIV 
John Rose and his collaborators altered a 
cattle virus known as VSV so that it seeks 
out human cells infected with HIV. They in¬ 
serted into VSV the human genes that pro¬ 
duce CD4 and CXCR4, receptor molecules 
where HIV begins its infection. With those 
receptor molecules (1) in place, the altered 
virus, (2), is drawn to gpl20/41 (3), a pro¬ 
tein produced by HIV that appears on the 
surface of infected human cells. VSV attacks 
and destroys only HIV-infected cells while 
ignoring healthy cells. In tissue cultures the 
engineered VSV has reduced the viral load 
by 10,000-fold. The new virus (4) reproduces, 
going on to attack other HIV-infected cells. 
(2) Altered VSV seeks out HIV- 
infected T-cell in culture 
Yung-Chi (Tommy) Cheng, Ph.D., the 
Henry Bronson Professor of Pharmacol¬ 
ogy, has worked on a parallel course to 
Dr. Prusoff. While Dr. Prusoff found drugs 
that work against AIDS, Dr. Cheng has 
sought ways to reduce their toxicity. Long¬ 
term usage, Dr. Cheng says, leads to a 
decline in the mitochondrial DNA of cer¬ 
tain organs, affecting their ability to func¬ 
tion properly. After a month or two of use, 
anti-retroviral agents such as AZT, ddl 
and DDC can cause problems in nerves, 
(4) Budding VSV separates from T-cell 
to attack other HIV-infected cells 
“If we know the mechanism for the 
toxicity, we may be able to prevent the 
toxicity by either making a new compound 
or by combination with other drugs,” says 
Dr. Cheng, whose laboratory team studies 
the behaviors of virus-specific proteins in 
order to exploit them. "The next question 
is, ‘Can we find a drug that will be active 
against the virus but will have no toxicity 
the pancreas, muscles and the liver. to the mitochondrial DNA?’ 
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That drug turned out to be 3TC, a compound that has 
positive and negative forms that mirror one another. Origi¬ 
nally synthesized by a Canadian researcher and identified 
as an antiviral agent, samples were sent to Dr. Cheng for 
study of its toxicity. He found that 3TC’s negative form re¬ 
duced side effects when used in combination with AZT. The 
combination increases 3TC’s efficiency at inhibiting reverse 
transcriptase, an enzyme HIV uses to reproduce its genetic 
material. Dr. Cheng identified 3TC as an agent that would 
be less toxic to mitochondrial DNA than DDC, ddl or d4T. 
"We are increasing the antiviral effects, decreasing the 
side effects. This may be a key mechanism of the combina¬ 
tion protocol against HIV," he says. “In the meantime we 
also discovered the same compound is active against the 
hepatitis B virus. The results were very promising.” So far, 
3TC has been approved for HIV treatment and is in clinical 
trials for use against hepatitis B. 
Search and destroy 
A new approach to AIDS may grow out of work led by John 
K. Rose, Ph.D., professor of pathology and cell biology. The 
agent he developed, based on a common virus found in 
cattle, has killed HIV-infected cells in culture. Scientists in 
the Rose lab are trying to develop a form of the engineered 
virus that will work against SIV, the simian form of HIV, for 
use in animal trials. If it is proven safe and effective in ani¬ 
mals, human trials could follow. 
Dr. Rose’s discovery was the result of efforts to deter¬ 
mine how viruses are constructed. “Once we know that, it 
becomes possible to change the components,” he says. 
The strategy was to trick HIV-infected cells into binding with 
another virus that would destroy them. He exploited the 
affinity between an HIV protein and its human targets— 
molecules on the surface of T-cells that allow HIV to enter 
and infect them. Infection begins when the HIV protein, 
gpl20/41, is drawn to the receptor molecule CD4 and 
the co-receptor molecule CXCR4. “What we did was to 
reverse that process,” Dr. Rose says. 
Dr. Rose deleted glycoprotein genes from the cattle virus 
known as vesicular stomatitis virus (VSV) and replaced 
them with the human genes that produce CD4 and CXCR4. 
With gpl20/41 on human cell surfaces as its prey, the re¬ 
ceptor-laden virus becomes a hunter drawn to HIV-infected 
cells like a magnet. “It doesn't completely eliminate HIV," Dr. 
Rose says. “It reduces the viral load 10,000-fold in tissue 
culture cells. In the best of all possible worlds it might pre¬ 
vent people from progressing to AIDS.” 
He also sees the possibility of developing an AIDS vac¬ 
cine, using recombinant VSV as a vaccine vector. “You can 
create a live virus vaccine, which might express protein from 
a virus that you want to immunize against.” Dr. Rose's group 
has already shown that VSV vectors expressing influenza 
virus proteins can protect against influenza. 
“The ideal situation," says Dr. Prusoff, “would be to de¬ 
velop a vaccine to prevent infection and at the same time 
find drugs which not only decrease the virus in the blood 
stream, but also get in to the hiding places of the virus in 
the various parts of the body. Eventually the source of the 
virus will be killed and you prevent new infections from 
taking place." 
4 4 
i Page 41 
ON THE STREET 
"Outreach workers. Kits and condoms,” shouts Dr. 
Wilson, one of: the anthropologists studying drug sites, 
as he and Ms. Martinez climb the stairs of an abandoned 
building back in Hartford’s Charter Oak neighborhood. 
Before leaving their office, they stuff their pockets and 
shoulder bags with condoms and kits that include 
small vials of bleach and water for cleaning needles. 
They also carry flashlights to help them find their way 
through abandoned buildings and avoid needles, feces 
and debris. 
The condoms and bleaching kits serve two functions. 
They provide an opportunity for outreach workers to 
introduce themselves to drug users. But as an AIDS 
prevention tool, bleaching has a mixed record. It 
requires filling the syringe with bleach and holding 
the bleach inside for 30 seconds, then repeating the 
process three times. After bleaching, the needle should 
be rinsed with water. If done correctly, the procedure 
disinfects the needle and syringe, but some addicts 
don’t hold the bleach inside for the required 30 seconds. 
Although they’re not always used properly, Dr. Wilson 
believes there is a benefit to distributing the kits. 
“If anyone’s using them at all," he says, “it’s better 
than no one using them.” 
What researchers and, indeed, the entire CIRA 
project are up against becomes clear on Irving Street in 
Hartford’s Upper Albany neighborhood. On a busy 
street corner between a police substation and a commu¬ 
nity health center the signs of drugs are all about. “Got a 
Two teams, each with an anthropologist and an outreach worker, are 
studying the rules that govern drug use in abandoned buildings and 
other sites in Hartford. They hope to slow the spread of HIV by con¬ 
vincing drug users not to share needles. Maria Martinez, Glenn Scott, 
Scott Wilson and Stephen Cabral visit an abandoned building in the 
Charter Oak neighborhood. 
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kit? Got a couple of rubbers?” two men ask as they 
approach anthropologist Stephen Cabral, Ph.D., and 
his colleague, outreach worker Glenn Scott. Both work 
at the Hispanic Health Council and are working on 
the high-risk drug sites project in Hartford. A moment 
later, a stocky man of medium height walks by. “I got 
what you need! ” he says, assuming strangers have come 
to the neighborhood for only one thing. He doesn’t miss 
a beat when he learns he has offered drugs to outreach 
workers. He smiles, shrugs his shoulders and turns 
down their offer of free condoms. He lingers to tell 
them that the last time he took them his girlfriend ac¬ 
cused him of cheating. Meanwhile Mr. Scott talks with 
Jeffrey, a tall, skinny man on his way to a Chinese take¬ 
out restaurant. Jeffrey has been in and out of drug treat¬ 
ment programs and laments some of the losses in his 
life, particularly a once-fine wardrobe. “I know what I’m 
doing is wrong,” says Jeffrey. “I’ve got to find something 
to replace it with.” 
Down a side street Dr. Cabral and Mr. Scott wait 
outside a garage. Inside are two men who a few minutes 
earlier approached them on the street to ask for bleach¬ 
ing kits. One of the men comes out, and, embarrassed, 
says he and the other man are only using the garage to 
relieve themselves. After they have gone, Dr. Cabral and 
Mr. Scott look around to find the floor littered with 
pastel-colored glassine envelopes that once contained 
heroin. Before leaving, Mr. Scott places a fresh bleach¬ 
ing kit on top of some broken furniture in the hope that 
someone will use it. 
The kit remains as a symbol of CIRA’s goal—evaluat¬ 
ing and implementing prevention measures that will 
stop the spread of AIDS. “Hopefully,” says Dr. Merson, 
“we can make a real difference in the nation in how we 
deal with this disease.” SMI 
Politics 1; science 0 Evidence of the political nature of AIDS prevention 
became apparent in April. The Clinton administration 
acknowledged what research has long established; 
needle exchange programs reduce the spread of HIV 
infection, serve as a conduit into treatment programs and 
don’t encourage drug abuse. Yet despite the scientific evi¬ 
dence, the federal govern¬ 
ment would not fund needle 
exchanges, officials decided. 
“It’s politics rather than 
science driving policy,” Dr. 
Merson said. “It’s but an¬ 
other example of why this 
epidemic continues to grow 
and be as serious as it is.” 
Robert Heimer, Ph.D., 
whose 1990 study with 
Edward H. Kaplan, Ph.D., found that needle exchanges 
reduced HIV infection by 30 percent, also decried the 
decision. “It is quite clear from the scientific evidence that 
needle exchanges can slow the transmission of HIV and 
other infectious diseases as well as serve as a conduit for 
getting people into substance abuse treatment,” Dr. Heimer 
said. “The foolishness has gone on long enough. When 
politics goes ahead of public health everybody suffers." 
Laws governing syringes and needle exchanges vary 
from state to state. Eight states prohibit dispensing sy¬ 
ringes without a prescription and another 10 place restric¬ 
tions on the sale of syringes without a prescription. In all 
but a few states, laws barring drug paraphernalia make 
possession of needles a crime. The 110 needle exchanges 
operating in the United States do so under a variety of 
legal conditions. Six states and the District of Columbia 
have created exemptions to paraphernalia laws to allow 
needle exchanges. Other states tolerate them and in some 
states the needle exchanges operate illegally. None of them 
receive federal funding. 
Clinton Endorses 
Needle Exchanges 
But Not Funding 
By Amy Goldstein 
IPushin/pon Post Staff Writer 
The Clinton administration declared yesterday that 
needle exchange programs can help curb the AIDS 
epidemic without fostering the use of illegal drugs, huL. 
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Medical school 
creates new deputy 
dean position for 
education 
Robert H. Gifford, M.D., H.S. 
67, who has served as associate 
dean for medical education 
and student affairs for the past 12 
years, became the School of 
Medicine’s first deputy dean for 
education on July 1. 
The appointment was announced 
by Dean David A. Kessler, M.D., who 
said the new position stresses the im¬ 
portance of education among the 
school’s three core missions. Deputy 
dean positions for research and patient 
care were created in 1995. “There 
should be no doubt that the teaching 
and educational mission of the school 
is certainly on a par with both clinical 
affairs and scientific affairs,” Dean 
Kessler said. “Nor is there doubt in 
anyone’s mind that Bob Gifford is the 
Robert Gifford 
person to move that mission forward." 
Dr. Gifford, who is delaying his re¬ 
tirement for a second time, will serve 
in the new position for a year. During 
that year he will establish a framework 
for the post while a nationwide search 
is conducted for a successor. He will 
also set and prioritize goals and evalu¬ 
ate the school’s needs in the area of 
education. Dr. Gifford’s previous re¬ 
sponsibilities, education and student 
affairs, will be divided under the new 
plan and an internal search has already 
been launched to fill the associate 
dean position. 
Dr. Gifford had planned to retire 
in June 1997 to begin a new career as a 
biology teacher in an inner-city school 
district. Dr. Kessler, however, asked 
him to remain during the 1997-98 aca¬ 
demic year to ease the transition to a 
new administration. This spring Dr. 
Gifford decided to stay on for one 
more year as deputy dean. 
He received his medical degree 
from Tufts University School of Medi¬ 
cine in 1961. He interned at Boston 
City Hospital and was a senior assis¬ 
tant resident at Yale-New Haven Hos¬ 
pital from 1966 to 1967. In 1969, he 
was appointed assistant professor of 
medicine at Yale. Three years later he 
was appointed associate professor of 
clinical medicine and in 1976 became 
a professor of medicine. In 1985 he 
was named associate dean for educa¬ 
tion and student affairs. 
Neurobiologist selected to lead graduate school 
Susan Hockfield, Ph.D., profes¬ 
sor of neurobiology at the 
School of Medicine, has been 
appointed dean of the Graduate 
School of Arts and Sciences, Yale 
President Richard C. Levin has 
announced. 
The Graduate School of Arts and 
Sciences is the largest of Yale’s 11 
graduate and professional schools. 
As dean, Dr. Hockfield will oversee 
academic and administrative policies 
for the school and its 2,300 students. 
She succeeds Thomas Appelquist, the 
Eugene Higgins Professor of Physics, 
who returned to his teaching and 
research responsibilities on July 1. 
Dr. Hockfield served as director of 
graduate studies for the section of 
neurobiology from 1986 to 1994, and 
has been involved with improving 
graduate training in the biological and 
biomedical sciences throughout her 
tenure at Yale. She has served on the 
executive committee of the graduate 
school and on a committee to improve 
linkages among the biomedical sci¬ 
ences. She has also had a role in the 
development of the new Biological 
and Biomedical Sciences Graduate 
Program, a collaboration among most 
of the biological science departments 
of the University. 
Dr. Hockfield, who joined Yale as 
an assistant 
professor in 
1985, said, 
“I am deeply 
honored to 
be entrusted 
with the chal¬ 
lenge of guid¬ 
ing one of the 
world’s finest 
graduate 
schools. Yale awarded the nation’s 
first doctoral degree more than a cen¬ 
tury ago, and I am eager to work with 
our gifted students and dedicated fac¬ 
ulty toward more ‘firsts’ for graduate 
education at Yale.” 
Susan Hockfield 
4 6 SUMMER 1998 
FACULTY N 
Vincent T. DeVitaJr., M.D., director 
of the Yale Cancer Center and profes¬ 
sor of internal medicine (oncology) 
and of epidemiology and public 
health, has been awarded the 
Commendatore Order of Merit of the 
Republic of Italy. The medal, a high 
honor bestowed by the Italian govern¬ 
ment, was presented at a ceremony in 
March at the Yale Club in New York. 
Dr. DeVita received the award for his 
significant contributions to the treat¬ 
ment and cure of cancer in Italy, the 
United States and throughout the 
world. Dr. DeVita also was named to 
serve on the Scientific Advisory Coun¬ 
cil of the Doris Duke Clinical Scien¬ 
tist Award Program of the Doris Duke 
Charitable Foundation. The newly- 
established program is designed to fill 
a gap in funding young investigators 
for clinical research in cancer, heart 
disease and AIDS. Dr. DeVita is one 
of two nationally known cancer ex¬ 
perts who have been invited to sit on 
the council. 
Robert M. Donaldson Jr., M.D., 
David Paige Smith Emeritus Professor 
of Medicine, was honored in April 
when the VA Connecticut Healthcare 
System West Haven Campus named 
the new education center in his honor 
for his contribution to education in 
the service ol patients. 
John A. Elefteriades, M.D., professor 
and chief of cardiothoracic surgery, 
was elected a founding director of the 
Heritage Foundation, which subsumes 
the former New York, Connecticut and 
New Jersey Chapters of the American 
Heart Association. He is the only sur¬ 
geon on the board. Dr. Elefteriades 
also delivered an honorary address on 
the Perspectives of the Thoracic Aorta 
from the Yale Center for Thoracic Aortic 
Disease in Tokyo in February at the 
joint meeting of the Asian Cardiovas¬ 
cular Society and the Japanese Society 
for Cardiovascular Surgery. 
The American Association for the Ad¬ 
vancement of Science (AAAS) elected 
as fellows in the Section of Medical 
Peter M. Glazer, M.D., associ¬ 
ate professor of therapeutic radi¬ 
ology, received the Michael Fry 
Young Investigator award at the 
annual meeting of the Radiation 
Research Society in April. This is 
the most prestigious award made 
by the society. 
Sharon K. Inouye, M.D., 
M.P.H., associate professor of 
medicine, was presented the 
1998 Otsuka/American Geriat¬ 
rics Society (AGS) Outstanding 
Scientific Achievement for 
Clinical Investigation Award by 
the AGS at their annual meeting 
in May in New York. Dr. Inouye 
was recognized for her achieve¬ 
ments in clinical research ad¬ 
dressing health care problems of 
older adults as a physician inves¬ 
tigator who is actively involved 
in direct patient care. 
Michael Kashgarian, M.D., 
professor of pathology and 
biology, received the James 
Colangelo Achievement Award 
by the National Kidney Founda¬ 
tion of Connecti¬ 
cut in May. The 
award recognizes 
medical profession¬ 
als who have sub¬ 
stantially improved 
the quality of 
Michael Kashgarian c 1 lire ror renal or 
urologic patients. Dr. Kashgarian is 
editor-in-chief of Yale Medicine. 
Sciences, Myron Genel, M.D., associ¬ 
ate dean for government and commu¬ 
nity affairs and professor of pediatrics/ 
pediatric endocrinology; Martin E. 
Gordon, M.D. ’46, clinical professor 
of medicine; and Karl L. Insogna, 
M.D., associate professor of internal 
medicine (endocrinology); and in 
the Section of Biological Sciences, 
Walter F. Boron, M.D., chair 
and professor of cellular and 
molecular physiology. The pre¬ 
sentation was made at the 
AAAS annual meeting in 
February in Philadelphia. 
Among the speakers at the 
Philadelphia meeting were 
Keith A. Joiner, M.D., profes¬ 
sor of internal medicine (infec¬ 
tious disease), cell biology, and 
epidemiology and public health; 
Gregory E. McCarthy, M.D., 
M.P.H., associate professor of 
neurosurgery and neurology; 
and Richard M. Satava, M.D., 
professor of surgery (general). 
Moment of reflection 
In a ceremony Feb. 11 in the Beaumont Room 
University officials unveiled a portrait of Gerard 
N. Burrow, M.D., '58, H.S. ’66, who stepped 
down last year after five years as dean of the 
School of Medicine. New Haven artist Steven R. 
DiGiovanni painted the portrait. Dr. Burrow met 
the artist at the Creative Arts Workshop where 
the former dean does metal sculpture. During 
their sessions, Mr. DiGiovanni set up a mirror so 
Dr. Burrow could watch him paint. Addressing 
the crowd that gathered in the Beaumont Room 
for the unveiling, University Provost Alison F. 
Richard, Ph.D., said: “Thanks to the artist and 
to the subject I think people will pause and say, 
‘He looks like a really wonderful person,’ and 
they’ll be right.” Added current Dean David A. 
Kessler, M.D.: “As the 14th dean of Yale School 
of Medicine, Dean Burrow personified a tradi¬ 
tion of excellence with a degree of great and 
distinguished service that we all can admire.” 
Fourteenth Dean Gerard Burrow, his face reflected by 
portrait glass, stands before his likeness at the 
unveiling ceremony. 
4 7 YALE MEDICINE 
Daniel M. Koenigsberg, M.D., asso¬ 
ciate clinical professor in rhe Child 
Study Center, was promoted to vice 
chairman of psychiatry at the Hospital 
of St. Raphael, where he is also section 
chief of the hospital’s child and ado¬ 
lescent psychiatry division. 
Robert G. LaCamera, M.D., clinical 
professor of pediatrics and pediatric 
nurse practitioner program (primary 
care), was presented the second 
annual Children’s Health and 
Wellbeing Award by ConnectiCare 
Inc. Dr. LaCamera, who retired from 
private practice last year as a New 
Haven pediatrician devoted to caring 
for children with disabilities. He has 
also been the medical director of the 
Easter Seal-Goodwill Industries 
Rehabilitation Center in New Haven 
since 1956. 
Richard R Lifton, M.D., Ph.D., 
professor of medicine, genetics and 
molecular biophysics and biochemis¬ 
try, has been named this year’s recipi¬ 
ent of the Homer Smith Award of the 
American Society of Nephrology for 
his laboratory’s research into the mo¬ 
lecular genetics of hypertension and 
kidney disease. The award, the 
society’s highest scientific prize, was 
announced this month and will be 
presented at the society’s annual meet¬ 
ing in Philadelphia in October. Dr. 
Lifton received his M.D. degree from 
Stanford University in 1982 and re¬ 
ceived his Ph.D. there in 1986. He 
joined the Yale faculty in 1993 as an 
assistant professor of medicine and 
Richard Lifton, right, works at a gene 
loader in his laboratory with Chris Bositis, 
a former student. 
genetics. His laboratory uses genetic 
approaches to identify inherited 
causes of hypertension, renal and 
cardiovascular disease. To date the 
group has identified the molecular 
basis of a dozen such diseases, which 
have provided important insight 
into disease causation, diagnosis 
and treatment. 
Bruce McClennan, M.D., professor 
of diagnostic radiology, was elected 
secretary of the American Roentgen 
Ray Society at the society’s 98th 
annual scientific and education meet¬ 
ing in San Francisco in April. Dr. 
McClennan began his five-year term 
April 30. The American Roentgen 
Ray Society was founded in 1900 and 
is dedicated to the goal of educating 
radiologists and to the advancement 
of medicine through radiology and its 
allied sciences. 
The Yale Cancer Center has inaugu¬ 
rated a revolutionary bone marrow 
transplantation procedure between 
partially mismatched, related donors. 
Joseph R McGuirk, D.O., associate 
research scientist in internal medicine 
(oncology), has been named assistant 
director for Allogeneic Bone Marrow 
and Stem Cell Transplantation at the 
Yale Cancer Center. 
Ira Mellman, Ph.D., professor of cell 
biology and immunology and director 
of the Program in Biological and Bio¬ 
medical Sciences, has been awarded the 
Newton-Abraham Visiting Professor¬ 
ship in Medical, Biological and Chemi¬ 
cal Sciences at the University of Oxford 
for the 1998-1999 academic year. Dr. 
Mellman plans to travel to England 
several times to deliver a series of pub¬ 
lic and scientific lectures at the Sir 
William Dunn School of Pathology. 
Previous recipients of the professorship 
include James D. Watson, Ph.D. 
Victor J. Navarro, M.D., assistant 
professor of medicine, was honored in 
April by the American Liver Founda¬ 
tion for his contributions to the work 
of its Connecticut chapter. 
Kyle D. Pruett, M.D., clinical profes¬ 
sor of child psychiatry at the Yale 
Child Study Center and the School of 
Nursing, has been named president of 
Zero to Three, a national nonprofit 
organization of pediatricians and child 
development specialists who share 
new knowledge about children’s early 
development with parents, policy 
Portrait of a pioneer 
A portrait recently added to the walls of the School of Medicine honors Dorothy M. Horstmann, 
M.D., Sc.D., the John Rodman Paul Professor Emeritus of Epidemiology and Pediatrics. In 1961 
she was the first woman named as a professor and eight years later was named to the endowed 
professorship. The portrait is a color photograph, taken by James C. Niederman, M.D., H.S. ’50, 
clinical professor of epidemiology, that has been printed on linen rather than photographic paper. 
The framed portrait hangs near the Beaumont Room on the second floor of the Sterling Hall of 
Medicine. Dr. Horstmann came to Yale in 1942 as the Commonwealth Fund Fellow in preventive 
medicine. She worked with Dr. Paul, for whom her endowed chair was named. In 1944 she re¬ 
turned to the University of California at San Francisco, where she pursued her medical studies, 
and joined the Yale faculty in 1945. She played a major role in developing and evaluating vac¬ 
cines for poliomyelitis and German measles. 
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One less car on the road 
For the past four years Raymond Aten, Ph.D., a re¬ 
search scientist in obstetrics and gynecology, has 
commuted to work from his home in Hamden on a 
bicycle. The state of Connecticut recently named 
him Commuter of the Month for his example. 
“It’s sort of an ideal commute,” Dr. Aten says of 
his four-mile, 15-minute trip from the Whitneyville 
section of Hamden. “I can make it in about the 
same time as someone driving.” Dressed in 
shorts, T-shirt, helmet and goggles equipped with 
a rear-view mirror, Dr. Aten carries in his saddle¬ 
bags a change of clothes, paperwork, a spare in¬ 
ner tube, reflective gear for night driving and a 
laptop computer. He rides his bicycle to work 
year-round, regardless of the weather. “It’s one 
less car on the road,” says Dr. Aten, who is presi¬ 
dent of the Connecticut Bicycle Coalition. 
makers and other professionals. Dr. 
Pruett is nationally known for his 
work with traumatized children and 
for research on how fathers influence 
their young children’s development. 
Dr. Pruett says the issues of quality 
medical and day care will be a primary 
focus of his work for Zero to Three, 
which is under the auspices of the 
National Center for Infants, Toddlers 
and Families. 
Carolyn W. Slayman, Ph.D., Sterling 
Professor of Genetics and Cellular and 
Molecular Physiology and deputy 
dean for academic and scientific af¬ 
talk about are the matters that mean the 
most to us. The shame that has no vent 
in words makes other organs weep.” 
According to Dr. Spiro, current officials 
of the University of Vienna are attempt¬ 
ing to recover information that has 
either been hidden or destroyed and 
trying to locate former faculty who 
were interned and exiled. “There is a 
new generation that has taken over,” 
says Dr. Spiro, “and they are not afraid 
to look into these atrocities.” 
David C. Ward, Ph.D., professor of 
genetics and molecular biophysics and 
biochemistry, was one of three Yale re¬ 
searchers inducted into the National 
Academy of Sciences in April. Dr. 
Ward has developed techniques called 
fluorescence in situ hybridization, 
known as FISH, that are widely used to 
analyze human chromosomes as well as 
to detect infectious, genetic and cancer¬ 
ous diseases. Among his accomplish¬ 
ments is the complete genetic mapping 
of chromosome 12, which contains 
genes implicated in a variety of dis¬ 
eases, including diabetes and several 
forms oi cancer. Dr. Ward received his 
Ph.D. degree from Rockefeller Univer¬ 
sity in 1969 and was a Leukemia 
Society of America Fellow 1969-1971 
at Imperial Cancer Research Fund, 
London. He joined the Yale faculty 
in 1971. The National Academy of 
Sciences, a private organization of sci¬ 
entists and engineers dedicated to the 
furtherance of science for the general 
welfare, was established in 1863. 
• • • 
John C. Baldwin, M.D., former 
professor and chief of cardiothoracic 
surgery at Yale, has been named dean 
oi Dartmouth Medical School and 
vice president for health affairs, 
effective July 1. Dr. Baldwin is the 
DeBakey-Bard professor and chair of 
the Department oi Surgery at Baylor 
College oi Medicine and chief of 
Surgical Services at the Methodist 
Hospital in Houston. 
fairs, has been appointed to a 15 mem¬ 
ber panel that will analyze the peer-re¬ 
view system at the National Institutes 
of Health. The system includes study 
sections which evaluate and score 
most grant applications submitted by 
researchers at colleges and universities. 
Recommendations from the panel are 
expected to be made within a year. 
Howard M. Spiro, M.D., director of 
the Program for Humanities in Medi¬ 
cine and professor of internal medicine 
(digestive diseases), was among noted 
speakers at a March 2 convocation in 
Vienna marking the 60th anniversary of 
the dismissal of Jewish faculty members 
from the Vienna Medical School. In his 
address, The Silence ofWords, Dr. Spiro 
said, “the things that we avoid and don’t 
Dean David A. Kessler, 
M.D., right, was the key¬ 
note speaker at the 
spring meeting of the 
New York Academy of 
Medicine. His topic was 
The Tobacco Wars, chroni¬ 
cling the FDA’s efforts to 
regulate tobacco (See 
Scope, page 10). The pre¬ 
vious year’s speaker was 
former Surgeon General 
C. Everett Koop. Left, 
Academy President 
Jeremiah A. Barondess, 
M.D., thanks Dr. Kessler 
at the podium. 
NEW BOOKS 
recognizing, treating, 
and preventing eh 
and adolescent depression 
.d 
Against the Spirit of System: The French 
Impulse in Nineteenth-Century Ameri¬ 
can Medicine by John Harley Warner, 
Ph.D., professor of history of medi¬ 
cine and American studies, Princeton 
University Press (N.J.) 1998. 
Antoine Lavoisier: The Next Crucial 
Year or, the Sources of His Quantitative 
Method in Chemistry by Frederic 
Lawrence Holmes, Ph.D., Avalon 
Professor of the History of Medicine, 
Princeton University Press (N.J.) 1998. 
Biochemistry and Disease: Bridging 
Basic Science and Clinical Practice by 
Robert M. Cohn, M.D. ’65 and Karl 
S. Roth, M.D., Williams & Wilkins 
(Baltimore, Md.) 1996. 
Captain of Death: The Story ofTuber- 
culosis by Thomas M. Daniel, M.D., 
B.S. ’51, University of Rochester Press 
(N.Y.) 1997. 
Chain of Custody by Harry A. Levy, 
M.D., M.P.H. ’82, Random House 
(N.Y.) 1998. 
Help Me, I’m Sad: Recognizing, Treat¬ 
ing, and Preventing Childhood and 
Adolescent Depression by David G. 
Fassler, M.D. ’82, Viking Penguin 
(N.Y.) 1997. 
Improve, Perfect, and Perpetuate: 
Dr. Nathan Smith and Early American 
Medical Education by the late Oliver 
S. Hayward, M.D., and Constance E. 
Putnam, University Press of New 
England (N.H.) 1998. 
New Treatments in Opiate Dependence 
edited by Susan M. Stine, M.D., 
Ph.D., assistant clinical professor of 
psychiatry and director of the Opiate 
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Treatment Program and Thomas R. 
Kosten, M.D., HS ’81, professor of 
psychiatry and chief of psychiatry 
both at the VA Connecticut 
Healthcare System in West Haven, 
Guilford Press (N.Y.) 1997. 
The Portraitby Charles Atkins, M.D., 
assistant clinical professor of psychia¬ 
try, St. Martin’s Press (N.Y.) 1998. 
Skin Signs of Systemic Disease by Irwin 
M. Braverman, M.D. ’55, HS ’56, 
professor of dermatology and in the 
Cancer Center, W.B. Saunders Co. 
(Penn.) third edition 1997. 
Surviving the Fall: The Personal Journey 
of an AIDS Doctor by Peter A. Selwyn, 
M.D., associate professor of medicine 
in the AIDS Program, Yale University 
Press 1998. 
Terror in the Medical Office by 
Norman F. Moon, M.D. ’56, Kabel 
Publishers (Rockville, Md.) 1998. 
The Therapeutic Narrative: Fictional 
Relationships and the Process of Psycho¬ 
logical Change by Barbara Almond, 
M.D. ’63 and Richard Almond, M.D. 
’63, HS ’66, Praeger Division of 
Greenwood Publishing Group 
(Westport, Conn.) 1996. 
The Therapeutic Perspective: Medical 
Practice, Knowledge, and Identity in 
America, i820-i88y by John Harley 
Warner, Ph.D., professor of history 
of medicine and American studies, 
Princeton University Press (N.J.) 
paperback edition 1998. 
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New associate dean leads medical school’s 
advancement program 
Jane E. Reynolds, Ed.M., who 
established a national reputation 
as dean of admission at Amherst 
College over the past nine years, has 
been appointed associate dean at the 
School of Medicine. She will oversee 
the school’s program in institutional 
advancement with responsibility 
for development, alumni affairs 
and publications. 
“I cannot imagine having anyone 
more effective and more experienced 
on our team,” Dean David A. Kessler, 
M.D., said in announcing her ap¬ 
pointment. “I am thrilled she decided 
to come to Yale.” 
Ms. Reynolds holds an Ed.M. 
degree from Harvard in administra¬ 
tion, planning and social policy, and 
a B.A. from the College of the Holy 
Cross. Over the past 20 years, she has 
held increasingly responsible positions 
at Harvard, Trinity College, Tufts 
University and Amherst, where she 
led the admissions program from 1989 
to 1998. According to Dr. Kessler, 
whom she met at Amherst when he 
received an honorary degree from 
his alma mater, “She helped diversify 
the student body at Amherst and en¬ 
couraged an international approach 
to recruitment.” 
The next several months will be a 
period of assessment and action, Ms. 
Reynolds said. As this issue of Yale 
Medicine went to press, medical 
school administrators were pleased to 
hear that the Yale Corporation had 
given preliminary approval for a stra¬ 
tegic facilities plan for the School of 
Medicine. The centerpiece of the plan 
is a proposal for a new Congress 
Avenue Building providing modern 
laboratory space for disease-specific 
research, a state-of-the-art anatomy 
laboratory and histology labs, and 
core facility space for expanded capa¬ 
bility in magnetic resonance imaging. 
(See Scope.) 
Other likely fund-raising goals, 
Ms. Reynolds said, will be to increase 
the amount of financial aid available 
to students, and to establish addi¬ 
tional endowed chairs to mark the 
University’s 300th anniversary in 2001. 
Dean Kessler said her background 
in admissions and the reputation she 
has established nationally and interna¬ 
tionally, will serve her well in her Yale 
role. “She is one of the most respected 
figures in the admissions world and 
we’re lucky to have her here,” he said. 
Ms. Reynolds, who says she was 
drawn to Yale “by David Kessler’s in¬ 
tellectual energy and his vision for the 
school,” is eager to apply that experi¬ 
ence. “The most kindred talents are 
being a spokesperson for an institu¬ 
tion, being able to understand what 
makes an institution tick, and getting 
out to the appropriate constituency to 
tell that story,” she says. “You have to 
be able to relate to a wide variety of 
publics to achieve the goal.” 
In her new position, Ms. Reynolds 
will work closely with Charles J. 
Pagnam, who became the University’s 
vice president for development on 
Jan. 1. Mr. Pagnam, one of seven 
officers of the university, began his 
career in development in 1977, when 
he joined The Campaign for Yale. 
Mr. Pagnam assumed increasing 
responsibilities over the subsequent 
two decades and in 1995 became 
director of development for the 
University. He played a pivotal role 
in the “... and for Yale” campaign, 
which raised $1.7 billion over a five- 
year period ending June 30, 1997. 
He succeeds Terry Holcombe, who 
retired at the end of last year. 
Jane Reynolds 
Although the University is in 
strong financial shape, Mr. Pagnam 
said it needs to raise about $200 mil¬ 
lion every year. “We still have to raise 
significant money to continue the 
project of refurbishing the facilities,” 
he said, adding that another top prior¬ 
ity is financial aid for students. 
He is aware of the medical school’s 
financial needs as well, he says, and 
plans to work out a dynamic develop¬ 
ment strategy with Ms. Reynolds. Part 
of his job is to coordinate fund-raising 
efforts among the college and Yale’s 11 
graduate and professional schools. 
As a Hamden native and current 
resident of North Haven, Mr. Pagnam 
also takes an active interest in New 
Haven affairs. “It is to our benefit to 
have a very healthy city,” he says. “It’s 
not a matter of remembering what 
New Haven was like. It’s more what 
New Haven can be. It’s a small com¬ 
munity that cares about itself.” 
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Just what the doctor ordered 
With The Rx Files, the second-year class writes a prescription 
for (kind) humiliation and high honors. 
No cow was too sacred for the 
Class of 2000, as it lam¬ 
pooned deans, beloved faculty 
members and lowly first-year students 
with equal relish in the second-year 
show, The Rx Files. Not even the 
lunchtime food vendors on Cedar 
Street were spared their barbs. 
The plot followed the exploits of 
fictional FBI agents Mulder and 
Scully from The Rx Files as they 
tracked down a missing collection of 
brains (The Cushing Brain Tumor 
Registry) and made bizarre discoveries 
about the faculty and student body. 
First-year students, the agents re¬ 
ported, lack reproductive organs. 
Anatomy professors are weird. 
As always, being satirized was the 
highest tribute. From its opening 
moments, the show set its sights on 
Robert H. Gifford, M.D., HS ’67, 
who has served for 
more than a decade 
as associate dean of 
medical education 
and student affairs. 
“Dr. Gifford, you 
will be sorely missed. 
(We think this time 
he might really mean 
it.),” the program read, 
referring to what had 
been his second ex¬ 
pected retirement at the 
end of the school year. 
As it happens, he 
didn’t. (See Faculty news) 
Other faculty members, including 
William Stewart, Frank Bia, John 
Rizzolo and Emil Boulpeap, joined in 
a videotaped spoof of the comic film 
The Full Monty. The professors tried 
out for a dance team to raise money to 
balance the medical school’s budget. 
Dean Kessler and Dr. Gifford gave 
thumbs up or down on the wannabe 
dancers, later portrayed on stage 
by students. 
The cast pounced on the English 
pronunciation of Pietro De Camilli, 
the recently appointed chair of the 
Department of Cell Biology, who was 
born in Italy. “What are you saying? 
Is it GTP or GDP?” asked student 
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1) Students take on infectious disease—the administrative section, that is, while performing 
Master of the Bugs, from the second act of The Rx Files. 2) John Abraham portrays Robert 
Gifford and Darren Lish portrays David Kessler in a musical number from the second-year-show. 
3) Alison Gruen plays a game show hostess in a gentle parody spoofing Arthur Crovatto’s 
anatomy instruction. 4) The real David Kessler dances a la Michael Flatley in a segment titled 
Deans of the Dance. 5) Not even the food vendors on Cedar Street escaped ribbing from the 
cast of The Rx Files, who poked fun while singing No Greasy, No Oily with apologies to Bobby 
McFerrin. 
Natalie Holt, playing agent Scully. 
But even she has trouble with medical 
jargon from native speakers of 
English. “I can’t take it any more!” 
she screams during a scene set at a 
faculty tea in the Beaumont Room. 
“I haven’t understood a single word 
anybody has said here tonight!’’ 
A scene on Cedar Street poked fun 
while it paid tribute to the vendors 
who offer food at lunchtime from 
their mobile stands. The cast sang 
No Greasy, No Oily to the tune of 
Don’t Worry, Be Happy. 
Bean curd make your mouth a 
water? 
You get two pieces for a quarter. 
No greasy. No oily. 
The yaki soba on my right 
Eat it, you get a parasite. 
No greasy. No oily. 
After Dr. Gifford, Dr. Kessler was 
the target of countless gags and one- 
liners on his work to regulate tobacco 
as commissioner of the Food and 
Drug Administration. Student 
Darren Lish, portraying Dr. Kessler 
on stage, leaned back in his chair and 
lit a cigarette. 
Dr. Kessler appeared as himself in 
one of the show’s final scenes, imper¬ 
sonating bare-chested prancer Michael 
Flatley in a parody of the traveling ex¬ 
travaganza Lord of the Dance. With 22 
dancers clad in black and step-dancing 
around them Dr. Kessler swirled direc¬ 
tor of admissions Lynne M. Wootton 
around the stage in a number called 
Deans of the Dance. 
The show’s finale had the entire 
Class of 2000, dressed in their white 
jackets, taking the stage and singing 
Do You Hear the Beepers Ring.I to the 
tune of Do You Hear the People Sing?' 
from the musical Les Miserables-. 
Do you hear the beepers ring loud in 
the middle of the night? 
It is the music of a people who are 
turning wrong to right 
For the students on the wards there is 
a redness in their eyes 
Before the longest call will end and 
the sun will rise. 
Linda Maxwell, who produced the 
show with Lalisa Anderson, called it 
one of the most memorable experi¬ 
ences of medical school. It is a last 
chance for second-year students to get 
to know each other before they split 
up into teams for their third-year hos¬ 
pital rotations. “We saw people really 
come out of their shells,” Ms. Maxwell 
said. “People really put their hearts 
into it.” 
STUDENT N 
The Medical Student Council elected 
new officers in April: For president, 
Sharon Chekijian, A.B., Smith 
College; for vice president, Jen Chow, 
B.S., B.A., University of Arizona; 
and for treasurer, Rockman Ferrigno, 
B.A., Fairfield University. The three 
first-year students delivered speeches 
at the April 1 meeting prior to 
the election. 
Joanne Band, was awarded the 
1997 Paul H. D'Amour Founder’s 
Fellowship by Big Y Foods Inc. The 
award honors the most academically 
outstanding graduate student in Big 
Y’s marketing area and includes a 
$1,000 stipend. 
Two students received awards for 
creative writing and community 
service at a faculty/student tea in the 
Beaumont Room on May 5. Maie 
Rahman St. John, a sixth-year stu¬ 
dent in the M.D./Ph.D. program re¬ 
ceived the Lerner Award and $250 for 
her poem about her travels around the 
world as a child. The late Marguerite 
Rush Lerner, a professor of clinical 
dermatology who also wrote children’s 
stories, established the Lerner Award. 
Caroline Harada, a first-year student, 
accepted the Novartis Pharmaceuticals 
Corp. Award on behalf of COVS, the 
Committee on Volunteer Services, 
which she chairs. The annual award, a 
complete io-volume set of the Netter 
Atlas, recognizes community service 
by students. The COVS coordinates 
volunteer efforts by students in public 
health, nursing and medicine. 
Award-winning students Maie Rahman St. 
John and Caroline Harada with Deputy Dean 
Robert Gifford. 
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Match Day reveals a trend toward generalism 
Cheers and applause erupted a 
few minutes before noon as the 
stack of envelopes made its way 
from the registrar’s office into the 
mailroom in Edward S. Harkness Hall. 
Inside were residency assignments, keys 
to the futures of a throng of waiting 
fourth-year students. 
As part of the National Residency 
Matching Program, medical students all 
around the United States learned of their 
placements simultaneously on March 18. 
According to Deputy Dean for Education 
Robert H. Gifford, M.D., 60 percent of the 
Yale students received their first choice 
of residency and 80 percent got one of 
their top three choices. Registrar Cynthia 
A. Andrien said only six of the 104 se¬ 
niors didn't participate in this year's 
match. Three chose not to participate and 
three are entering the military, she said. 
How important was the match? 
"Residency determines where you train, 
how you train, who trains you and what 
opportunities are available to you,” said 
Joseph Skowron, who placed in ortho¬ 
paedics at Harvard. 
Placements this year reflected a trend 
at Yale away from the most highly special- 
Top: Tobias Lee and 
Sheela Magge peer in 
their mailboxes for the 
letters that will spell 
their future for the next 
two or three years. 
Middle: Victoria 
Catenacci smiles to 
learn she has been 
accepted at Yale, where 
she wanted to study 
internal medicine. 
Right: Scott Porter 
hugs a friend as they 
get the news of their 
assignments. 
ized programs and toward residencies in 
internal medicine and pediatrics. Forty 
percent of this year’s seniors went into 
three-year medicine programs, up from 
22 percent last year. Pediatrics drew 17 
percent of the current graduating class, 
up from 8 percent last year. 
“I do think there’s a recognition on 
the part of students that there’s more 
and more of a need for people in the 
primary care specialties,” Dr. Gifford 
said. “Some of the highly specialized 
areas are overpopulated. Managed care 
is using them less and using primary 
care doctors more." 
As noon struck, the waiting students 
cheered, hugged and otherwise released 
the tension and anxiety of the morning. 
Victoria A. Catenacci was thrilled to be 
staying at Yale in internal medicine. “I 
like the program. I like the people. I’m 
very happy here,” she said. Said Childsy 
Robinson before opening her letter: “I’m 
very excited. I’ve been telling myself over 
and over that I can be happy anywhere." 
She got her first choice: pediatrics 
at Stanford. 
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1998 residency placements for Yale medical students 
The Office of Student Affairs has provided the following list, which outlines the results of the 
National Resident Matching Program for Yale’s medical school graduates. 
CALIFORNIA 
LAC-USC Medical Center 
Gregory Chin, surgery, otolaryngology 
San Diego Naval Base 
Helen Chun, internal medicine 
Stanford Health Services 
Chrysalyne Del ling, medicine 
Mark Homicz, surgery 
Kent Huston, internal medicine 
Michelle Parker, emergency medicine 
Childsy Robinson, pediatrics 
UCLA Medical Center 
Matthew Bui, urology 
University of California (Davis) 
Medical Center, Sacramento 
Kevin Daly, emergency medicine 
University of California - San Diego 
Mark Homicz, otolaryngology 
Jessica Kingston, obstetrics and 
gynecology 
University of California - San Francisco 
Te Ning Chang, plastic surgery 
Karen Earle, internal medicine 
Peter Hunt, internal medicine 
Lisa Lipschitz, obstetrics and 
gynecology 
Sushrut Waikar, internal medicine 
UCSF/Mt. Zion Medical Center 
Anna Bloxham, internal medicine/ 
primary 
COLORADO 
University of Colorado School of 
Medicine, Denver 
Henry Fischer, internal medicine 
Paul Pottinger, internal medicine 
CONNECTICUT 
Griffin Hospital, Derby 
Brandy McMahon, medicine 
Hospital of Saint Raphael, New Haven 
Kendall Lee, medicine 
Jason Oliphant, medicine 
Yale-New Haven Hospital 
Victoria Catenacci, internal medicine 
Monica Chacon, pediatrics 
David Chang, plastic surgery 
Marcoli Cyrille, internal medicine 
Jennifer Eras, internal medicine 
Andrew Gumbs, general surgery 
Charles Hong, internal medicine 
Hahnah Kasowski, surgery, 
neurosurgery 
Lynda Kauls, pediatrics, dermatology 
Susan Kim, internal medicine 
Jason Klenoff, surgery, otolaryngology 
Srinivas Rao, internal medicine 
Jeffrey Reynolds, internal medicine 
Nirav Shah, internal medicine 
Lisa Surer, internal medicine 
Mona Zain, internal medicine 
GEORGIA 
Emory University School of Medicine, 
Atlanta 
Reshma Chugani, pediatrics 
MARYLAND 
Johns Hopkins Hospital, Baltimore 
Hans Agrawal, pediatrics 
Kamal Bharucha, pediatrics 
Alan Cheng, internal medicine 
Nirit Weiss, surgery, neurosurgery 
Tong-Yi Yao, pediatrics 
MASSACHUSETTS 
Beth Israel Deaconess Medical Center, 
Boston 
Katherine Auerswald, internal 
medicine 
Bernice Ruo, internal medicine 
Boston Combined Residency Program 
in Pediatrics (Children’s Hospital) 
Sheela Magge, pediatrics 
Nicole Ullrich, pediatrics 
Boston University Medical Center 
Tobias Lee, internal medicineI 
primary 
Brigham & Women’s Hospital, Boston 
Daniel Hurwitz, medicine 
Linda Lee, internal medicine 
Gregory Schwartz, internal medicineI 
primary 
Cambridge Hospital 
Pieter Cohen, internal medicine/ 
primary 
Harvard/Children’s Hospital, Boston 
Monica Chacon, pediatric neurology 
Nicole Ullrich, pediatric neurology 
Harvard Medical School, Boston 
James O’Holleran, orthopaedics 
Joseph Skowron, orthopaedics 
Massachusetts General Hospital, 
Boston 
Joanne Band, pediatrics 
Kendall Lee, neurology 
Brandy McMahon, anesthesiology 
Olivia Okereke, medicine 
Massachusetts General Hospital/ 
McLean, Boston 
Olivia Okereke, psychiatry 
Lisa Price, psychiatry 
Mount Auburn, Cambridge 
Lisa Price, medicine 
MICHIGAN 
University of Michigan Hospitals, 
Ann Arbor 
Christi Cavaliere, plastic surgery 
Catherine Curtin, plastic surgery 
MISSISSIPPI 
Kessler Air Force Base, Gulf Coast 
Michael Yerkey, internal medicine 
MISSOURI 
Barnes-Jewish Hospital, St. Louis 
Jason Oliphant, diagnostic radiology 
YALE MEDICINE 
NEW YORK 
Einstein/Montefiore Medical Center, 
Bronx 
Sydney Butts, surgery; otolaryngology 
Marcia Dover, medicine, neurology 
Hospital lor Special Surgery, New York 
Russel Huang, orthopaedics 
Ashley Wivel, orthopaedics 
Mary Intogene Bassett, Cooperstown 
Eric Shmookler, medicine 
1 he Mount Sinai Hospital, New York 
James Borin, surgery, urology 
Naomi Donnelley, internal medicine 
The New York Hospital 
Gary Brendel, psychiatry 
Russel Huang, surgery 
William Pao, internal medicine 
Ashley Wivel, surgery 
New York University Medical Center 
Chrysalyne Delling, dermatology 
Gregory Raskin, internal medicine 
Presbyterian Hospital, New York 
Marjory Alabre, internal medicine 
Mauricio Garrido, general surgery 
Kimara Leibowitz, pediatrics 
NORTH CAROLINA 
Carolinas Medical Center, Charlotte 
Scott Porter, orthopaedics 
Duke University Medical Center, 
Durham 
Todd Atkinson, orthopaedics 
William Duvall, internal medicine 
Jaimie Nathan, general surgery 
Eleanor Rhee, obstetrics and 
gynecology 
University of North Carolina Hospital, 
Chapel Hill 
Amy Taylor, pediatrics 
OHIO 
Surnma Health System/Neoucom, 
Akron 
Marc Jones, transitional 
University Hospitals of Cleveland 
Andrew Kroger, pediatrics 
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Monica Chacon, Maurice Garrido and John Forman welcome the news of their assignments 
with hugs and smiles. 
PENNSYLVANIA TEXAS 
Allegheny University Hospital, 
Philadelphia 
Merle Carter, general surgery 
Children’s Hospital of Philadelphia 
Daniel Coghlin, pediatrics 
Barbara McGee, pediatrics 
Samir Shah, pediatrics 
Hospital of the University of 
Pennsylvania, Philadelphia 
Naomi Botkin, internal medicine 
Henry Chen, internal medicine 
Carl Edelen, internal medicine 
Kent Hu, internal medicine 
Ellen Komisaruk, obstetrics and 
gynecology 
Joanne Quinones, obstetrics and 
gynecology 
University Health Center - Pittsburgh 
Makunda Abdul, obstetrics and 
gynecology 
Kent Chou, orthopaedics 
Joon Yung Lee, orthopaedics 
Wills Eye Hospital, Philadelphia 
Marc Jones, ophthalmology 
University of Texas SW Medical 
School, Dallas 
Tara Bruce, obstetrics and gynecology 
Daniel Hurwitz, dermatology 
Patricia Stanford, pediatrics 
WASHINGTON 
University of Washington Affiliated 
Hospitals, Seattle 
Michelle Barton, pediatrics 
Albert Chong, general surgery 
John Forman, internal medicine 
Robert Kalus, internal medicine 
Heather Lynch, pediatrics 
University of Washington, Seattle 
Seth Schwartz, surgery, otolaryngology 
Some names appear twice because the graduate 
is entering a one-year program before beginning 
a specialty residency. 
The transitional designation is a one-year 
program with three-month rotations in 
different specialties. 
SUMMER 1998 
ALUMNI NEWS 
A focus on clinical research 
Lawrence E. Shulman, Ph.D. 45, M.D. 49, retired 
from rhe NIH in 1994 after serving for nine years 
as the first director of the National Institute of 
Arthritis and Musculoskeletal and Skin Diseases. Shortly 
thereafter, NIH Director Harold E. Varmus, M.D., ap¬ 
pointed him as NIH emissary for clinical research to the 
academic health centers. “My assignment,” Dr. Shulman 
reports, “was to hold in-depth discussions to learn the 
views, concerns and suggestions to strengthen clinical 
research in the nation.” 
Dr. Shulman visited 21 medical schools including 
Yale, where he met with then-Dean Gerard N. Burrow, 
M.D. ’58, and several members of the faculty. During his 
travels he evaluated current support mechanisms and for¬ 
mulated recommendations for new programs. Then in 
April of this year, the NIH announced the establishment 
of three new award categories for developing talented 
and skilled clinical researchers: the mentored, patient- 
oriented research career de¬ 
velopment award, the mid¬ 
career investigator award in 
patient-oriented research, 
and the clinical research 
curriculum award. 
“There’s been a growing 
concern by many that 
clinical research has not 
developed and fared as 
well as has basic laboratory 
research," says Dr. 
Shulman, who received a 
mastership from the American College of Physicians last 
March. “These new programs should provide a major 
investment by which discoveries from the laboratory 
may be translated into new and effective treatments 
for patients.” 
Lawrence E. Shulman 
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’30s 
Harvey Chenault, M.D., HS 
’39-41, of Paris, Ky., retired from 
practice as a neurosurgeon approxi¬ 
mately 10 years ago. He says that 
he is now relaxing in the quiet 
of the country and fishing in a 
man-made lake he built on his 
16-acre homestead. 
’40s 
Thomas L. Bucky, M.D. ’43, HS 
’44-49, ofWeston, Conn., retired 
from practice in 1996 after 40 years. 
Dr. Bucky and his wife, Doris, 
enjoy traveling to Florida to visit 
their two grandchildren. Last fall 
they also spent two weeks in Venice 
and Padua, Italy. He says that he is 
grateful for his Yale education and 
is relaxing and reflecting in his 
retirement years. 
Robert E. Cooke, M.D. 44, HS 
'44-50, in retirement in Florida, 
remains active with the Kennedy 
Foundation in Washington which 
has guided federal legislation on the 
care of mentally retarded children. 
Robert W. Frelick, M.D. 44, HS 
’44-45, remains active in retirement 
as a member of the advisory board 
of the National Cancer Institute. 
Dr. Frelick received a grant for 
smoking prevention/cessation in a 
target high school in Wilmington, 
Del. His wife Jane, ’44 Nursing, 
remains active after three major 
joint replacements, tutoring 
G.E.D. students and supervising 
smoking cessation among prisoners. 
Howard B. Hamilton, M.D. ’44, 
retired, lectures on Japanese litera¬ 
ture and the Noh Theater as an 
American resource person for the 
Japan Society. He is currently 
assisting the Library of Congress in 
digitizing 12,000 slides on these 
topics for the Internet. 
Edith M. Jurka, M.D. ’44, is active 
on the lecture circuit on topics in 
Noetic Medicine and has conducted 
symposia on intuitive reasoning 
and creativity. 
Jerome J. Kaye, M.D. ’44, reports 
that his daughter, Judy, is currently 
performing the historic character 
of Emma Goldman in the musical 
Ragtime on Broadway. Judy received 
a Tony award some years ago for her 
role in the Phantom of the Opera. 
David E. Morton, M.D. ’48, HS 
’49-55, retired in 1993, is working on 
his second novel. The first con¬ 
tained a major scene at Yale-New 
Haven Hospital. He and his wife, 
Kayoko, visited Italy in September 
just missing the great Assisi earth¬ 
quakes. They traveled to Nagano, 
Japan in February where Kayoko 
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was nurse-interpreter at the Winter 
Olympic Games. 
’50s 
Robert N. Hamburger, M.D. 51, 
HS ’53-54, received his fourth 
patent in July 1997, titled Allergen 
Detector: System and Method. Dr. 
Hamburger celebrated his 75th 
birthday in January, skiing and 
flying in Alta, Borego, Mexico, and 
San Diego (La Jolla), Calif. He and 
his wife Sonia attended the Associa¬ 
tion ol Yale Alumni Education 
Program, Ancient Civilizations of 
Peru, in September and thought it 
was an exceptional and wonderful 
experience. 
Michael Kashgarian, M.D. 58, 
professor of pathology and biology, 
has been elected to the board of 
governors of the Association of Yale 
Alumni. He is the only medical 
school faculty member currently 
named to the board, which has 21 
members and four officers. The 
members serve staggered terms, 
with seven members elected each 
year. Dr. Kashgarian begins his 
three-year term July 1. In addition 
to general governance, the board 
elects AYA officers and selects 
nominees for the position of alumni 
fellow to the Yale Corporation. 
Jack Levin, M.D. 57, HS ’57-65, is 
on sabbatical at the Institut des 
Vaisseaux et du Sang in Paris, 
France, studying megakaryocytes 
and the regulation of platelet 
production. 
Norman F. Moon, M.D. ’56, writes 
to say he has retired from his full¬ 
time orthopaedic surgery practice 
and has written of his experiences as 
a treating physician in a book, 
Terror in the Medical Office, pub¬ 
lished this year by Kabel Publishers 
in Rockville, Md. Dr. Moon says 
that the publishers, of which Karel 
Bedrich Absolon, Ph.D., M.D. 52, 
is president, have been excellent to 
deal with. 
David Weinstein, M.D., HS 59- 
60, writes that as he approaches 
age 70, he is still working 9 to 5, 
five days per week, in the practice 
of developmental medicine, neurol¬ 
ogy and epilepsy. Dr. Weinstein 
dabbles in neuroscience, conscious¬ 
ness and cognition. He sold his 
boat but is enjoying being a grand¬ 
parent and comments that his 
grown children are all respectable 
members of society. 
’60s 
Robert L. Capizzi, M.D., HS 66- 
69, was honored by the establish¬ 
ment of the Robert L. Capizzi 
Professorship in Medicine at 
Jefferson Medical College. The 
professorship was made possible by 
a portion of a $3 million gift given 
by Mrs. Samuel M.V. Hamilton to 
Thomas Jefferson University to 
honor three physicians who cared 
for her late husband. 
James J. Murphy, M.D. ’64, retired 
in September from his position as 
chief of radiology at the Asheville 
Veterans Medical Center in 
Asheville, N.C., after 25 years of 
federal service. 
Timothy A. Pedley, M.D. 69, has 
been appointed the Henry and Lucy 
Moses Professor of Neurology and 
chairman of the department of 
neurology at Columbia University. 
He will also serve as director of the 
neurology service and neurologist- 
in-chief of the Neurological Insti¬ 
tute of Presbyterian Hospital, 
Columbia-Presbyterian Medical 
Center in New York City. 
Edward F. Wilson, M.D. 63, after 
nine years as full-time medical ex¬ 
aminer in Portland, Ore., moved to 
Delaware County, Pa., in February 
as part-time medical examiner. Prior 
to Oregon, Dr. Wilson worked two 
years in Pesamar, Pakistan and 
Abha, Saudi Arabia; 15 years in 
Eugene, Ore., in hospital pathology 
and as county medical examiner; 
two years in Utah as deputy chief 
medical examiner; and his first two 
years in Baltimore, Md., as assistant 
state medical examiner. 
Armenia’s health minister 
Gagik Stamboltsian, M.D., HS '90-91, was appointed 
minister of health of Armenia in last July by President Levon 
Ter-Petrossian. Dr. Stamboltsian is chief of the Armenian 
General Benevolent Union Plastic and Reconstructive Surgery 
Center (PRSC). The PRSC, of which Dr. Stamboltsian remains 
chief, was established after the 1988 earthquake in Armenia 
in collaboration with Stephen Ariyan, M.D., HS '70-76, then 
professor and chief of plastic surgery at Yale. Dr. Stamboltsian 
was a member of a team of two surgeons, two anesthesiolo¬ 
gists and 10 nurses that spent 12 months in training at Yale 
from 1990 to 1991. The unit opened in 1992. Since taking on 
his new role as minister of health he has continued to help 
reconstruct the wounds of victims of the earthquake. 
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Records and tools of Harvey Cushing, M.D., are on display in the foyer outside the Cushing/ 
Whitney Medical Library. Out of Sight, Not Out of Mind: Renaissance of the Cushing Brain Tumor 
Registry, includes photographs and hospital records from more than 2,000 neurosurgical case 
studies from 1898 to 1936. 
’70s 
Francis S. Collins, M.D., Ph.D. 
74, postdoctoral fellow ’81-84 in 
human genetics and pediatrics, 
Director of the National Human 
Genome Research Institute, led a 
slate of speakers at the first AMA 
Genetics conference in New 
Orleans, La. on March 13-15. 
The title of the conference was 
Genetics Medicine and the 
Practicing Physician. 
Edward S. Curry, M.D. 78, 
chief of pediatrics at the Kaiser 
Permanente Fontana Medical 
Center, was appointed to the board 
of directors ofThe Southern 
California Permanente Medical 
Group in March. Dr. Curry is a 
fellow in the American Academy 
of Pediatrics. 
Michael K. Lindsay, M.D. ’79, 
associate professor of obstetrics and 
gynecology at Emory University 
School of Medicine, was named 
director of the division of maternal 
fetal medicine in January. 
Harry S. Romanowitz, M.D. ’73, is 
the recipient of Student Health 
Services of Stamford Hospital’s 
award for outstanding contributions 
to the health and well-being of 
the children of Stamford, Conn. 
He helped found and develop 
Stamford’s School-Based Health 
Center Program. Dr. Romanowitz 
was also appointed by Governor 
John Rowland as a permanent 
member of Connecticut’s Child 
Advocate Advisory Committee. 
Barry Solof, M.D. ’74, of Los 
Angeles, is currently the medical 
director of Outpatient Chemical 
Dependency Service at New Begin¬ 
nings Hospital in Lakewood, 
medical director of the Washington 
Medical Center Recovery Unit in 
Culver City, and the medical 
director of Pride Solutions in Los 
Angeles, Calif. 
Richard N.W. Wohns, M.D. ’77, a 
practicing neurosurgeon in Tacoma, 
Wash., graduated from the Execu¬ 
tive MBA Program at the University 
of Washington in June 1997. 
’80s 
Joseph Caprioli, M.D., HS ’79-83, 
professor of ophthalmology at the 
University of California, Los 
Angeles School of Medicine, was 
awarded the 1997 Lewis Rudin 
Glaucoma Prize by the New York 
Academy of Medicine for outstand¬ 
ing glaucoma research published in 
1996. Dr. Caprioli received the 
$50,000 prize for his research paper 
Investigative Ophthalmology and 
Visual Science, which explored the 
possibility that the body’s own 
defense mechanisms could help 
protect the optic nerve cells against 
damage during times of stress. 
Francis L. Crowley, M.P.H. ’82, 
was appointed director of the public 
health department for the Town of 
Groton, Conn., in October. 
Richard D. Gibbs, M.D. 86, 
and Patricia H. Gibbs, M.D. 87, 
HS ’87-90, founders of the San 
Francisco Free Clinic, were named 
California Family Physicians of 
the Year in February by the Public 
Outreach Committee of the 
California Academy of Family 
Practice Board of Directors. 
The award is a high honor in 
primary care medicine and this is 
the first time that the award has 
been given jointly to two physicians 
and the first time to a husband 
and wife team. The mission of the 
clinic, founded in 1993, is to take 
care of patients without insurance, 
families caught between welfare 
and employer-provided health 
insurance. 
Robert O. Kenet, M.D. ’81, Ph.D. 
’83, and Stephanie Seligman were 
married in December at the Carlyle 
Hotel in New York City. 
David R. Marks, M.D. ’89, has 
been hired as a health reporter for 
WVIT Channel 30, the NBC tele¬ 
vision station in Connecticut. He 
contributes two to three stories a 
week for the station while maintain¬ 
ing a practice as medical director of 
the New England Center lor Head¬ 
ache in Stamford, Conn. He was 
also a recent guest on the Today 
Showw\\eve he discussed new 
treatments for migraines. 
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N CAMPUS Phillip Chung-Ming Yang, M.D. 
’89, is completing a cardiology 
fellowship at Stanford University. 
Dr. Yang was married in August 
1997 to Mariko Yoshihara. 
Sonya S. 
Erickson, M.D., 
’91, associate in 
the department 
of obstetrics and 
gynecology at 
the University of 
Iowa College of 
Medicine, was 
one of 20 
physicians 
named to the first class ol the 
Association ol Professors of Gyne¬ 
cology and Obstetrics/Solvay 
Pharmaceuticals Educational 
Schools Development Program 
participants. The 15-month pro¬ 
gram, which began in January, is 
designed to help OB/GYN profes¬ 
sors teach women’s health more 
effectively and focuses on four 
major components: curriculum and 
instruction; measurement and 
evaluation; research and statistics; 
and leadership and management. 
James Hicks, M.D. ’91, HS ’92-95, 
is completing a fellowship in 
forensic psychiatry at New York 
University. 
90s 
Sonya S. Erickson 
James C. Rosser Jr., IV!.D., right, director of endo- 
laparoscopic surgery and assistant professor of 
surgery, gave a talk on 21st Century Solutions 
to Challenging Healthcare Problems at a Feb. 24 
reception for the Association of Yale Alumni in 
Medicine. With accompanying videos, Dr. Rosser 
described his application of modern communica¬ 
tions technology to surgery. From a studio in New 
Haven, he has supervised procedures in Ohio and 
Hawaii. He has also developed software that lets 
medical staff transmit information from house calls 
to the office via a laptop computer and a portable 
telephone. His technology is in use in a mobile 
van that brings health care to remote villages in 
Ecuador and Honduras. 
James C. Rosser Jr. 
ALUMNI 
Lee Goldman, M.D. ’73, M.P.H. ’73, 
the Julius R. Krevans Distinguished 
Professor of Medicine, associate dean 
for clinical affairs and the chair of 
the department of medicine at 
the University of California, San 
Francisco, was presented the Out¬ 
standing Alumnus Award by Yale 
Cardiovascular Medicine at the annual 
Friendly Hearts Award Dinner last 
Fall. Dr. Goldman has also been 
named the new editor-in-chief of the 
American Journal of Medicine by the 
Association of Professors of Medicine 
Search Committee. 
Stephen H. Moffic, M.D. ’71, 
executive vice chair for managed care 
at the Medical College of Wisconsin, 
Department of Psychiatry and 
Behavioral Medicine, presented at 
Yale’s Department of Psychiatry 
Grand Rounds in December on the 
topic The Ethical Practice of Managed 
Care: Is There A Way. Dr. Moffic has 
also published a book titled The 
Ethical Way: Challenges and Solutions 
for Managed Behavioral Healthcare. 
Pedro Rossello, 
M.D. ’70, gover¬ 
nor of Puerto 
Rico, made the 
case for the 
island’s statehood 
during an address 
at the School of 
Law March 28. 
He spoke at a 
two-day conference titled Foreign in a 
Domestic Sense: Reflections on the Cen¬ 
tenary of the United States Acquisition 
of Puerto Rico. 
This fall voters on the island are ex¬ 
pected to vote in a referendum on the 
island’s status. They may choose 
among the current commonwealth 
status, statehood and independence. 
Dr. Rossello, now in his second 
term as governor, argued that as a state 
Puerto Rico would create a bilingual 
and bicultural bridge between the 
United States and emerging markets 
Pedro Rossello 
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in Latin America. Statehood, he ar¬ 
gued, would convert Puerto Rico from 
a “disenfranchised outpost into an 
ever more valuable asset.” 
Gualberto Ruano, 
M.D. ’93, Ph.D. ’89, 
co-founder, chief ex¬ 
ecutive officer and 
chief scientific officer 
of Genaissance 
Pharmaceuticals Inc. 
in New Haven, was 
a speaker at the Yale-New Haven 
Biotechnology Enterprise Forum 
series in April. The forum was spon¬ 
sored by The Biotech Committee of 
Greater Haven and the Yale University 
Office of Cooperative Research. Dr. 
Ruano’s topic was Genomic Strategies 
and Drug Discovery. 
An announcement of a research 
and development collaboration 
agreement between Genaissance 
Pharmaceuticals, Inc. and Terrapin 
Technologies of San Francisco was 
made in February at the Second 
Annual Cambridge Healthtech 
Institute Conference on Gene Func¬ 
tional Analysis in San Francisco. 
Mary Ann Shafer, M.D. ’73, profes¬ 
sor of pediatrics at the University 
of California at San Francisco and 
accociate director of adolescent medi¬ 
cine at the University of California, 
was a guest at a tea in February at the 
Yale Calhoun College master’s house. 
She is also medical director at the 
Mission High School Clinic. 
Dr. Shafer’s academic and clinical 
activities have focused on the interre¬ 
lationships among risky behaviors of 
adolescents and young adults, includ¬ 
ing such problems as sexually trans¬ 
mitted diseases (STD), alcohol abuse 
and eating disorders. She has devel¬ 
oped STD and other risk prevention 
programs for high school students and 
military personnel and acts as a con¬ 
sultants to the Center for Disease 
Control, the military and the Califor¬ 
nia State Department of Health re¬ 
garding STD/HIV prevention. 
The American Academy of Pediat¬ 
rics awarded Dr. Shafer its Adele D. 
Hoffmann Award for her work in 
adolescent health. 
Send news of Alumni/ae on Campus to Nicholas 
PR. Spinelli, M.D. '44, in care of the Office of 
Alumni Affairs, P.O. Box 7613, New Haven, CT 
06519-0613. 
Gualberto Ruano 
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Dean Kessler in Washington 
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Washington, D.C. A reception will follow Dr. Kessler’s lecture, which is 
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Cathedral Ave., NW, Washington, D.C. 20016 or the Alumni Affairs office 
at (203) 785-4674. 
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OBITUARIES 
CLIFFORD C. BEEBE 
Clifford C. Beebe, M.P.H., formerly 
of Milford, Conn., died Feb. 6 at the 
Masonic Home and Hospital in 
Wallingford. He was 89. 
Born in New Haven, Mr. Beebe 
received a bachelor’s degree from 
Lafayette College in Easton, Pa., a 
master’s degree in public health from 
Yale in 1946 and a master’s degree in 
education from the University of 
Bridgeport. He was a consultant for 31 
years at the Connecticut Department 
of Education in the vocational reha¬ 
bilitation department until he retired 
in 1975. 
MAXWELL BOGIN 
Maxwell Bogin, M.D., a prominent 
Connecticut pediatrician, died Dec. 2. 
He was 95. 
Dr. Bogin graduated from Yale 
College in 1923 and the School of 
Medicine in 1926. He was chief of 
pediatrics at Bridgeport Hospital from 
1948 to 1967 and a former state chair¬ 
man of the Connecticut Chapter of 
the Academy of Pediatrics and presi¬ 
dent of the Hezekiah Beardsley 
Pediatric Society. 
In 1978 the Department of Pediat¬ 
rics of Bridgeport Hospital instituted 
the annual Maxwell Bogin, M.D., 
Lectureship in Pediatrics, which car¬ 
ries course credit for health profes¬ 
sionals. Dr. Bogin served as chairman 
of the medical advisory board of the 
Rehabilitation Center of Fairfield 
County and as consultant in pediatrics 
to the Connecticut State Department 
of Health. He was a founding partner 
of the Children’s Medical Group in 
Bridgeport and supervised pediatric 
clinics in Easton and Monroe. He was 
also a member of the Fairfield County 
Medical Association, the Connecticut 
State Medical Society, and the Ameri¬ 
can Medical Association. 
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THOMAS E. CARSON 
Thomas E. Carson, M.D., died Oct. 
1, 1997, after an apparent heart attack 
at his home in North Warren, Pa. He 
was 63. 
Dr. Carson graduated from Yale 
College in 1956 and the School of 
Medicine in i960. He completed his 
internships at Strong Memorial 
Hospital in Rochester, N.Y., and 
McKeesport Hospital in Pennsylvania. 
He was on the staff and medical direc¬ 
tor at Warren State Hospital for the 
last 15 years and had previously 
worked at Torrance State Hospital 
in Pennsylvania. 
Dr. Carson was a member and dea¬ 
con of the First Presbyterian Church. 
He was a past board member of the 
American Cancer Society’s Warren 
County Unit and a member of the 
Warren County Medical Society. 
STANLEY M.K. CHUNG 
Stanley M.K. Chung, M.D., of 
Honolulu, Hawaii, died April 21. 
He was 62. 
Dr. Chung was a graduate of 
Northwestern University and earned 
his medical degree from Yale in i960. 
He began his postgraduate training at 
the Cornell Medical Center and was a 
fellow in orthopaedic surgery at the 
Mayo Clinic. He completed his resi¬ 
dency in orthopaedic surgery at the 
University of Pennsylvania. While in 
Philadelphia, Dr. Chung was picked 
by C. Everett Koop, M.D., as a mem¬ 
ber of the first team to separate con¬ 
joined twins. 
Dr. Chung, who devoted much of 
his career to treating children, became 
a member of the medical staff at the 
Kapiolani Medical Center for Women 
and Children in 1978. He was named 
chief of the Medical Center’s depart¬ 
ment of pediatric surgery in 1989, and 
in 1992 he served as chairman of or¬ 
thopaedics in the surgery department. 
Dr. Chung was also an associate pro¬ 
fessor of surgery at the University of 
Hawaii John Burns School of Medi¬ 
cine and served two years as an Air 
Force captain. 
WARREN P. CORDES 
Warren Platts Cordes, M.D., formerly 
of Chatham, Mass., died Feb. 11 in 
Raleigh, N.C. He was 93. 
Dr. Cordes was born in 
Northhampton, Mass., and was a 
graduate of Colgate University. He re¬ 
ceived his medical degree from Yale in 
1933. He served in the Massachusetts 
National Guard from 1936 to 1939 and 
also in the U.S. Navy Medical Corps 
during World War II, stationed at 
New Caledonia in the South Pacific, 
reaching the rank of commander. 
In 1950, Dr. Cordes was appointed 
superintendent of the Gardner State 
Hospital. His specialties were psychia¬ 
try and neurology. He retired in 1973. 
Dr. Cordes was a member of the 
Massachusetts Medical Society for 50 
years. He was also active in both the 
Boy Scouts of America and the Massa¬ 
chusetts Archeological Society. 
WILLIAM H. DRUCKEMILLER SR. 
William H. Druckemiller Sr., M.D., 
died Sept. 25 at his home in Fairview, 
Pa. He was 83. 
Dr. Druckemiller, born in Sunbury, 
Pa., graduated from Bucknell Univer¬ 
sity in 1935 and received his medical 
degree from Yale in 1939. He served as 
a general surgeon in the U.S. Navy 
and then as a neurosurgeon from 
1946 to i960. He was chief of neuro¬ 
surgery at the National Naval Medical 
Center in Bethesda, Md., and retired 
from the Navy in i960 with the rank 
of captain. 
Dr. Druckemiller entered private 
practice in Erie, Pa., and was chief of 
neurosurgery at Saint Vincent Health 
Center from i960 to 1977. He also 
served as chief military consultant of 
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the National Aeronautics and Space 
Administration’s Mercury Project 
from 1958 to i960. 
SUMMER GOLDENTHAL 
Summer Goldenthal, M.D., formerly 
of New Haven, died April 24 at the 
Brian Health Care Center in 
Canton, Ga. 
Dr. Goldenthal, a World War II 
Army veteran, graduated from the 
School of Medicine in 1951 and served 
his residency at Yale-New Haven Hos¬ 
pital and at Johns Hopkins. He was a 
clinical instructor at Yale in 1956 and 
on the staff at Grace-New Haven 
Hospital. In 1959 he set up a private 
radiology practice in New Haven. He 
was also a radiologist for the Fannin 
Regional Hospital in Blue Ridge, Ga., 
and the Copper Basin Medical Center 
in Copperhill, Tenn. 
H. PATTERSON HARRIS JR. 
H. Patterson Harris Jr., M.D., 
M.P.H., of Southport, Conn., died 
Jan. 5 at Bridgeport Hospital in 
Bridgeport, Conn. He was 87. 
Born in Baltimore, Dr. Harris re¬ 
ceived a bachelor’s degree from Yale 
University in 1932, a medical degree 
from Duke University School of 
Medicine in 1938, and a master’s de¬ 
gree in public health from Yale in 
1965. He served as assistant supervisor 
at Fairfield Hills Hospital in 
Newtown, Conn. 
Dr. Harris had recently retired as 
medical examiner in Fairfield, and 
prior to that was a school physician, 
the director of public health for 
Fairfield, and a medical internist 
in private practice for more than 
20 years. 
ISAO HIRATA JR. 
Isao Hirata Jr., M.D., died Feb. 25 at 
Providence Hospital of Columbia, 
S.C. He was 74. 
Dr. Hirata, who was born and 
raised in New Haven, earned a 
bachelor’s degree from Yale in 1943, 
and received his medical degree in 
1945 at the age of 21. Dr. Hirata was a 
member of the Alpha Omega Alpha 
Honor Society. He completed his resi¬ 
dency in general surgery at Grace- 
New Haven Hospital in 1950 and 
practiced in New Haven. 
Dr. Hirata was secretary ol the 
medical staff at Yale-New Haven Hos¬ 
pital from 1956 to 1972, and the Yale 
football team physician from 1956 to 
1971. While at Yale he held the posi¬ 
tions of surgeon in chief of the 
University’s department of health and 
assistant clinical prolessor at the 
School of Medicine. In 1972 he ac¬ 
cepted the position of director of stu¬ 
dent health services at the University 
of South Carolina, which he held un¬ 
til he retired in 1988. He served as 
president of the American College 
Health Association from 1979-80. 
Dr. Hirata, whose Japanese-born 
father was a 1912 graduate of the 
medical school, told classmates at his 
50th that he was glad to have been at 
Yale during World War II, when lile 
in the United States was difficult for 
Japanese-Americans. Following the 
war, he served in the Army until 
1953, at which time he returned to 
New Haven. 
Forty-five years after the war 
ended, Dr. Hirata saw classmate Alice 
Shepard Cary, M.D., at their 1990 
class reunion in New Haven. Dr. Cary 
had lived in Kyoto for most of those 
45 years, moving to Japan just after 
the war. He told her that he had fam¬ 
ily in Japan he had never met. She of¬ 
fered to look them up. 
Besides not speaking Japanese, the 
largest obstacle to finding the other 
branch of Hiratas was that Dr. Hirata 
knew next to nothing about them. 
“During the war, my parents were so 
sensitive that they did not want ever 
to talk about the family in Japan,” he 
said in a 1995 Yale Medicine interview. 
“My mother wouldn’t tell me any¬ 
thing about my relatives. She didn’t 
even want to admit we had any.” And 
so the matter rested for decades. 
When Dr. Cary returned home to 
Japan after the reunion, she took with 
her the few details Dr. Hirata had 
gathered: The family was from the 
southern city of Fukuoka; one of his 
father’s brothers was a physician and 
two others had been in the Japanese 
navy and army. She was able to locate 
members of the family, and in 1992 
Dr. Hirata and his wife, Mary Keeler 
Hirata, were reunited with his Japa¬ 
nese relatives and learned of his re¬ 
markable ancestry ol 20 generations of 
physicians. At a banquet in his honor 
with 40 of his relatives, he listened to 
his cousin tell the story of the first 
Hirata healers in the mid-i6oos. 
HERBERT S. HURWITZ 
Herbert S. Hurwitz, M.D., of 
Scarsdale, N.Y., died Dec. 20. He 
was 68. 
Dr. Hurwitz graduated from 
Harvard College in 1950 and from the 
Yale School of Medicine in 1954. He 
completed his internship and resi¬ 
dency at the Johns Hopkins Hospital 
and Boston Children’s Hospital. 
After military service in Bordeaux, 
France, Dr. Hurwitz entered private 
pediatric practice in White Plains, 
N.Y., from which he retired in 1992. 
Dr. Hurwitz was on the staff ol the 
White Plains Hospital Medical Center 
and St. Agnes Hospital. He was a fac¬ 
ulty member at Babies Hospital, Co¬ 
lumbia University, and the State Uni¬ 
versity of New York at Purchase. 
Dr. Hurwitz was a recognized poi¬ 
soning prevention expert and the New 
York area chairman of the American 
Academy of Pediatrics Accident Pre¬ 
vention Committee, which was re¬ 
sponsible for the development and 
implementation of child-resistant 
bottle caps for medical packaging. He 
played a prominent role in the crusade 
for legislation and public education to 
ensure universal acceptance of this 
safety device. 
Dr. Hurwitz was a past president of 
the Harvard Club of Westchester 
County, N.Y. 
WILLIAM P. KOUGHAN 
William P. Koughan, M.P.H., died on 
April 6. He was 56. 
Mr. Koughan graduated from 
Boston College and received a master’s 
degree in public health from Yale in 
1971. He served lor four years as vice 
president of Lawrence General Hospi¬ 
tal in Lawrence, Mass. 
Mr. Koughan served 10 years as ex¬ 
ecutive director ol Wing Memorial 
Hospital and Medical Centers and 
president and CEO ol Wing Health 
Systems in Palmer, Mass. During his 
tenure at Wing Memorial Hospital, he 
expanded access to health care services 
within the greater Quaboag Valley. He 
brought primary care to the towns 
surrounding Palmer, beginning in 
1976 and was instrumental in the 
foundation of Palmer ambulance. 
He also served as president and 
CEO at North Hills Passavant Health 
Corporation in Pittsburgh, Pa., and 
president and CEO of Horizon 
Health System, Inc. in Bethlehem, Pa. 
In 1991 he moved to Watertown, N.Y., 
to serve as president and CEO of 
Samaritan Health Systems. 
PAUL R. LIGHTFOOT 
Paul R. Lightfoot, M.D., of 
Claremont, Calif, died April 4. 
He was 59. 
Dr. Lightfoot graduated from 
Fordham College in New York in i960 
and received his medical degree from 
Yale in 1964. He worked throughout 
his career at Kaiser Hospital in 
Fontana, Calif, serving as chief, 
director and chairman of critical care 
in the department of cardiology. 
OLGA A.G. LITTLE 
Olga A. Gavriluk Little, M.D., died in 
Willimantic, Conn., on Nov. 30. She 
was 87. 
Dr. Little received her medical de¬ 
gree from Boston University, com¬ 
pleted an internship in pediatrics at 
Yale from 1935 to 1937, continued her 
post-graduate training in psychiatry at 
Fairfield Hills Hospital in Newtown, 
Conn. She and her husband, Mervyn, 
met in medical school and worked to¬ 
gether throughout their careers. In 
1954 they helped found Natchaug 
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Hospital and served as medical direc¬ 
tor and president for years. 
ROBERT R. MCDONNELL 
Robert R. McDonnell, M.D., of New 
Haven, Conn., died Dec. 11 in New 
Haven. He was 78. 
Dr. McDonnell graduated from 
Colby College in Waterville, Maine, 
in 1942 and received his medical de¬ 
gree Lorn lelferson Medical College in 
Philadelphia in 1945. He was a captain 
in the Army from 1946 to 1948 and he 
completed residencies in neurosurgery 
at New Haven Hospital and at the 
Hartford Hospital from 1948 to 1952. 
Dr. McDonnell was an attending 
physician at Yale-New Haven Hospital 
and the Hospital of Saint Raphael 
from 1952 until his retirement in 
December 1996. He also served as 
treasurer of the Connecticut State 
Medical Society and was a member 
of the New England Neurological 
Society and the American Medical 
Association. 
STEPHEN F. NAGYFY 
Stephen F. Nagyfy, M.D., died Dec. 
28, at Wilson Memorial Hospital in 
Johnson City, N.Y. He was 86. 
Dr. Nagyfy received his bachelor’s 
degree from Yale in 1932 and his medi¬ 
cal degree from the School of Medi¬ 
cine in 1936. He later taught at Iowa 
State University. During World War 
II, Dr. Nagyfy served in the Navy as a 
lieutenant commander in the Medical 
Corps. He moved to Binghamton, 
N.Y., after the war and served as phy¬ 
sician for the Endicott Johnson Corp. 
Dr. Nagyfy later went into private 
practice associated with Wilson Me¬ 
morial Hospital-UHS and also served 
as chairman of obstetrics and gynecol¬ 
ogy. He retired in 1985. 
PAUL A. O’CONNOR 
Paul A. O’Connor, M.D., of 
Hackettstown, N.J., died Jan. 2 at 
Mountainside Hospital in Glen 
Ridge, N.J. He was 89. 
Dr. O’Connor received a bachelor’s 
degree from the University of Notre 
Dame in 1931 and his medical degree 
from Yale in 1935. He served his in¬ 
ternship at Martland Medical Center 
in Newark, N.J. During World War II 
he was a lieutenant commander in the 
Navy Medical Corps. 
Dr. O’Connor practiced general 
surgery in Newark for 52 years before 
retiring in 1989. He was on the staff at 
St. Michael’s Medical Center and the 
Presbyterian Hospital, both in New¬ 
ark, and St. Mary’s Hospital in Or¬ 
ange. He also served as the senior 
police surgeon for the Newark Police 
Department from 1954 to 1992. 
Dr. O’Connor, nicknamed Ducky, 
was a halfback on the 1929 and 1930 
Notre Dame national championship 
football teams under the legendary 
coach Knute Rockne. He played him¬ 
self as a football player in the motion 
picture Spirit of Notre Dame, which 
was released in the 1940s. 
NELSON K. ORDWAY 
Nelson K. Ordway, M.D., died of 
prostate/bladder cancer on Dec. 31 in 
Scottsdale, Ariz. He was 85. 
Dr. Ordway, a native of Maine, at¬ 
tended Yale College and was a 1938 
graduate of the School of Medicine. 
His postgraduate training was done at 
the New Haven Hospital and the 
Hospital of the University of Pennsyl¬ 
vania. During World War II he was a 
research assistant in pathology at Yale, 
where he conducted research on de¬ 
fenses against chemical warfare. In 
1945 he joined the pediatrics faculty at 
Yale as an instructor. In 1947, he was 
invited to help a fellow Yale alumnus, 
Myron E. Wegman, M.D. ’32, 
M.P.H., rebuild the pediatrics depart¬ 
ment at Louisiana State University 
Medical School in New Orleans and 
became department chair in 1952. 
According to Dr. Wegman, 
“Nelson brought to our budding de¬ 
partment a dimension of Yale-bred 
laboratory competence and research 
that led us to fantasize about building 
a miniature New Haven in New 
Orleans.” But while at LSU, Dr. 
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Ordway ran afoul of then-rampant 
McCarthyism when he rose to the de¬ 
fense of a colleague who had refused 
to sign a loyalty oath. Dr. Ordway 
maintained that political views were 
irrelevant to his colleagues compe¬ 
tence as a teacher. The colleague was 
forced to resign and Dr. Ordway was 
told that pediatrics would receive no 
funding as long as he remained chair¬ 
man. He then joined the faculty of the 
University of North Carolina and re¬ 
turned to Yale in 1958 as professor 
of pediatrics. 
In 1967, he served a year as a 
Rockefeller Foundation visiting pro¬ 
fessor at the Universidad del Valle, in 
Cali, Colombia, then moved to the 
University of Oklahoma, where he re¬ 
mained until 1974. He periodically 
taught and lectured in Latin America. 
Throughout his career, he placed an 
emphasis on direct care of infants and 
children. The chance to do more of 
this led him to join the Indian Health 
Service in 1974, first in Gallup, N.M., 
and then in Phoenix, Ariz., where he 
eventually retired in 1985. 
Dr. Ordway, as a member of Physi¬ 
cians for Social Responsibility, was ar¬ 
rested protesting against continued 
testing of nuclear weapons in Arizona. 
He was a lover of music and an avid 
hiker who at 16 climbed the Jungfrau 
in the Swiss Alps. At age 64, he 
trekked with granddaughter Nancy in 
the Himalayas to a level of almost 
19,000 feet. He was still camping, 
with the aid of a walker, within a few 
months of his death. 
GERALD B. SHATTUCK 
Gerald B. Shattuck, M.D., of 
Portsmouth, N.H., died Dec. 7. 
He was 74. 
Dr. Shattuck received a bachelor’s 
degree from Dartmouth College in 
1943 and a medical degree from Yale 
in 1946. He was a pediatric intern 
and assistant resident at the University 
of Rochester Strong Memorial Hospi¬ 
tal in N.Y. from 1946 to 1949, and an 
assistant at Harvard Medical School 
from 1949 to 1950. Dr. Shattuck was 
on the clinical faculty at Harvard and 
at the Children’s Hospital in Boston 
from 1950 to i960. He also taught at 
the University of New Hampshire’s 
School of Allied Health Services, the 
University of Southern Maine, 
and New Hampshire Vocational 
Technical Institute. 
Dr. Shattuck practiced pediatrics in 
Portsmouth from 1950 until 1986 and 
was chief of medical staff, medical 
services and pediatrics at Portsmouth 
Regional Hospital. He was also a se¬ 
nior pediatrician for Kron Medical 
Corp. in Chapel Hill, N.C., from 
1986 to 1988. 
HUGH A. SMITH 
Hugh Allan Smith, M.D., of 
Damariscotta Mills, Maine, died Jan. 
5 at Heritage Manor, Winthrop. 
He was 88. 
Dr. Smith received his bachelor’s 
degree from Western Reserve Univer¬ 
sity in 1932 and earned his medical de¬ 
gree in 1936 from Yale. From 1936 to 
1940, he completed his residency in 
radiology at Strong Memorial Hospi¬ 
tal in Rochester, N.Y., and, from 1940 
to 1942, served as an instructor in ra¬ 
diology at Yale. He then entered pri¬ 
vate practice in Hartford, Conn. 
In 1946 Dr. Smith moved to 
Maine, where he practiced as an asso¬ 
ciate radiologist at Eastern Maine 
General Hospital and, in 1949, he was 
named chief of the department of ra¬ 
diology. He held the post until 1972 
and continued to serve the depart¬ 
ment until his retirement in 1977. 
BENJAMIN M. SPOCK 
Benjamin M. Spock, M.D., who revo¬ 
lutionized the child-rearing philoso¬ 
phy of his day by encouraging parents 
to show their children both affection 
and firmness, died March 15 at the 
age of 94. 
A 1925 graduate of Yale College, 
Dr. Spock completed the first two 
years of medical school at Yale. He 
came to national prominence in 1946 
with the publication of Baby and 
Child Care. In his book, which has 
sold 50 million copies around the 
world, Dr. Spock explained the 
different stages of child development 
so parents could act on that knowl¬ 
edge. He challenged then-current 
notions that parents should neither 
coddle nor kiss their children. Two 
decades later, he linked pediatrics and 
politics by denouncing nuclear weap¬ 
ons and the war in Vietnam, stands 
that brought him to a federal court in 
1968. His conviction on charges of 
helping young men avoid the draft 
was reversed on appeal. Vice President 
Spiro Agnew and others blamed the 
youth revolt of the 1960s on his 
“permissive” child rearing advice, 
but parents and pediatricians saw a 
doctor who offered practical advice 
in simple terms. 
Morris A. Wessel, M.D. ’43, met 
Dr. Spock in 1947 at the Mayo Clinic, 
where Dr. Wessel had a fellowship. He 
recalls: “If you were seeing a child and 
having some difficulty about what was 
going on, he would come in and talk 
to the parent and make some sense 
out ol it. I wanted to be that kind ol 
pediatrician." According to Dr. 
Wessel, Dr. Spock came to defy the 
upper-crust culture into which he was 
born in New Haven in 1903. His fa¬ 
ther was a lawyer ior a railroad com¬ 
pany. “His moral feelings about the 
war and nuclear weapons were not the 
pattern of New England aristocrats,” 
Dr. Wessel said. 
He started his medical studies at 
Yale, but after two years switched to 
the Columbia University College of 
Physicians and Surgeons. Alter serving 
as a psychiatrist in the naval reserve 
during World War II, he completed 
writing his book. 
“He liberated families from the 
kind of rigid authoritarianism that so 
characterized child rearing in the first 
decades of this century,” said Joseph 
Warshaw, M.D., deputy dean and 
chair of pediatrics at the School of 
Medicine. “So much ol what he did 
and what he talked about became part 
of the conventional wisdom that it is 
hard to really appreciate the impact 
that he had. He basically empowered 
families to use common sense and 
take a more relaxed approach.” 
OLIVER G. STONINGTON 
Oliver G. Stonington, M.D., of 
Breckenridge, Colo., died of cancer 
Feb. 4. He was 82. 
Born in Staten Island, N.Y., Dr. 
Stonington graduated in 1933 from 
St. Paul’s School in Concord, N.H. 
and went to Princeton University. 
In 1939, he took a pre-medical year at 
Harvard University and then went on 
to graduate from Yale School of Medi¬ 
cine in 1943. Dr. Stonington did his 
residency training in urologic surgery 
as an Army captain at Hines Veterans 
Hospital in Chicago. 
In 1956, Dr. Stonington joined the 
faculty of the Colorado University 
Health Sciences Center in Denver. 
During his tenure as professor, he was 
honored nine times as the Outstand¬ 
ing Clinical Teacher of the Year. Dr. 
Stonington also received the American 
Urologic Association Award for Most 
Outstanding Research in 1975 for his 
work on prostate cancer. He retired in 
1977 as head of urology in the Depart¬ 
ment of Surgery at CU. Always active 
in sports. Dr. Stonington celebrated 
his 80th birthday skiing. 
ARTHUR A. WARD JR. 
Arthur A. Ward Jr., M.D., of Seattle, 
Wash., died Dec. 23 of complications 
following surgery. He was 81. 
Dr. Ward was born in Ceylon 
(present-day Sri Lanka) and came to 
the United States at the age of 15. He 
graduated from Yale College in 1938 
and from the School of Medicine in 
1942. Dr. Ward did his residency at 
Montreal Neurological Institute, then 
taught at Yale as an instructor in 
physiology in 1945. He also taught at 
the University of Illinois and the 
University of Louisville. 
In 1948, Dr. Ward was invited to 
develop a neurological division at the 
University of Washington Medical 
School. Without even a building, he 
helped design the laboratories and 
created the research and teaching pro¬ 
grams. He then developed the clinical 
program. Gradually he set up the epi¬ 
lepsy center for research. In 1965, the 
division became a department with 
Dr. Ward serving as chair until 1981. 
In 1976, Dr. Ward founded the 
UW’s Northwest Regional Epilepsy 
Center, which he directed until 1986. 
He was chief of the Neurosurgical Ser¬ 
vice at UW and Harborview Medical 
Center. Dr. Ward was president of the 
American Academy of Neurological 
Surgery and editor of the journal 
Epilepsia. 
PATRICIA WANNING WATSON 
Patricia Wanning Watson, M.D., of 
New Paltz, N.Y., died Dec. 19, at her 
home. She was 85. 
Dr. Watson, born in Cambridge, 
Mass., graduated from Radcliffe 
College and received her medical de¬ 
gree from Yale in 1940. She practiced 
as a pediatrician in Boston, then took 
time out to raise four children. Dr. 
Watson worked as a specialist in or¬ 
ganic causes of mental disorders and 
in bio-feedback in Kingston, N.Y. 
She had a lifetime interest in the brain 
and the mind. 
BETSEY CUSHING WHITNEY 
Betsey Cushing Whitney, the philan¬ 
thropist who in 1985 provided $8 
million to expand the Yale Medical 
Library in honor of her father and 
her husband, died March 25 at the 
age of 89. 
Her father was Harvey Cushing, 
M.D., the pioneering neurosurgeon 
and graduate of Yale College who 
came to the medical school to teach 
in 1933. Her husband was John Hay 
Whitney, known as Jock, a 1924 Yale 
College alumnus and fellow who pub¬ 
lished the Herald- Tribune, served as 
ambassador to Great Britain, backed 
Hollywood movies and Broadway 
shows, raced horses and collected art. 
After Mr. Whitney died in 1982, 
Mrs. Whitney sought a way to bring 
together in memoriam her husband 
and her father, who had never met, ac¬ 
cording to her daughter Kate Whitney 
of New York City. Her endowment 
of the Harvey Cushing/John Hay 
Whitney Medical Library was at that 
time the largest individual gift to the 
school. “It was wonderful to be with 
her when she went to the opening, 
and to have her see the students al¬ 
ready in the library and using the li¬ 
brary. It was very, very gratifying to 
her that she brought this about,” said 
Kate Whitney. “The thing that cap¬ 
tured my mother’s involvement was 
her excitement and her desire to be in¬ 
volved in the actual design and the de¬ 
tails of the new building for the li¬ 
brary and the renovation of some of 
the old spaces. It gave her enormous 
pleasure to be a part of that.” 
In endowing the library, Mrs. 
Whitney carried on a family philan¬ 
thropic tradition. Her husband hon¬ 
ored his father by donating funds to 
pay for Payne Whitney Gym. Her fa¬ 
ther, along with his friends and col¬ 
leagues John F. Fulton, M.D., and 
Arnold C. Klebs, M.D., bequeathed 
rare medical manuscripts and books to 
the library. The resulting collection 
was the nucleus of the Medical His¬ 
torical Library, which opened in 1941. 
Dr. Cushing’s design for the library, a 
Y-shaped wing that jutted from the 
back of Sterling Hall of Medicine, was 
adopted and completed after he died 
in 1939. The design of the new library 
maintained that concept. 
Mrs. Whitney was born in 1908, 
the second of three daughters. She 
also had two brothers. In 1930 Mrs. 
Whitney married James Roosevelt, 
the oldest son of Franklin Delano 
Roosevelt. Their marriage produced 
two daughters, Sara and Kate, but 
ended in divorce. In 1942, Mrs. 
Whitney married John Hay Whitney. 
Mrs. Whitney was said to be 
President Roosevelt’s favorite daugh¬ 
ter-in-law and she frequently served 
as a hostess at White House functions. 
In 1983 she established the Greentree 
Foundation, named after her 438-acre 
estate on Long Island’s Gold Coast. 
The foundation assisted local 
community groups. 
In 1995, she returned to the medi¬ 
cal school for an exhibit of surgical 
tools, papers and photographs from 
her father’s archives and collection. 
“She came up in a wheelchair and ac¬ 
tually stood and went around all the 
cases,” recalled former Dean Gerard 
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N. Burrow, M.D. ’58, who described 
Mrs. Whitney as “an absolutely 
wonderful woman.” 
GEORGE L. WILSON 
George L. Wilson, M.D., of Naples, 
Fla., and Derby, Conn., died on May 
2 at his home in Naples. He was 75. 
Born in Everett, Mass., Dr. Wilson 
attended Harvard University and re¬ 
ceived his medical degree from Tufts 
University in 1947. He was a corps- 
man at Chelsea Naval Hospital during 
World War II and served as a Naval 
surgeon in Korea and Japan during 
the Korean conflict. 
Dr. Wilson practiced thoracic sur¬ 
gery at the Hospital of St. Raphael in 
New Haven from 1956 until his retire¬ 
ment in 1992. He was also a clinical 
instructor of thoracic surgery at Yale. 
He served on the Board of Trustees 
and was president of the Medical Staff 
at the Hospital of St. Raphael. He was 
also on the Board at Quinnipiac 
College and was a member of the 
parents council at Davidson College. 
CHARLES ZIGUN 
Charles Zigun, M.D., of Fairfield, 
Conn., died March 5 in Bridgeport 
Hospital. He was 68. 
Born in Bridgeport, Dr. Zigun was 
a graduate of Yale College in 1952 and 
the School of Medicine in 1956. He 
was in private practice in Fairfield for 
over 30 years and was affiliated with 
the greater Bridgeport Mental Health 
Center as a staff psychiatrist for five 
years. Dr. Zigun was a past president 
of the Congregation Rodeph Sholom, 
the Jewish Family Service and the 
Connecticut Region of the United 
Synagogue of America. 
YALE MEDICINE 
IN MEMORIAM 
The School of Medicine has received notification of the death of the following persons: 
John B. Barnes, M.D. ’79 
September 16, 1997 
Clifford C. Beebe, M.P.H. ’46 
February 7, 1998 
Maxwell Bogin, M.D. ’26 
December 2, 1997 
WynthaT. Boothe, M.P.H. ’61 
February 14, 1995 
Ormond Y Brody, M.D. ’60 
August 13, 1996 
Lewis H. Bronson Jr., M.D. ’37 
April 1, 1988 
Clarence William Bushnell, M.P.H. ’51 
October 28, 1997 
Cynthia D. Buder, M.P.H. ’76 
February 6, 1991 
Thomas E. Carson, M.D. ’60 
October 1, 1997 
George B. Corcoran Jr., M.D. ’44 
August 28, 1997 
Warren P. Cordes, M.D. ’33 
February 11, 1998 
William H. Druckemiller, M.D. ’39 
September 25, 1997 
H. Patterson Harris Jr., M.D., 
M.P.H. ’65 
January 5, 1998 
Isao Hirata Jr., M.D. ’45 
February 25, 1998 
George L. Hoffmann, M.D. ’53 
May 16, 1997 
Kathleen H. Howe, M.P.H. ’56 
December 3, 1997 
Herbert S. Hurwitz, M.D. ’54 
December 20, 1997 
Henry V. Kogut, M.D., HS ’48 
October 18, 1997 
Olga A.G. Litde, M.D., HS ’37 
November 30, 1997 
D. Bruce McLean, Med ’36 
January 26, 1998 
Frances S. Miller, M.P.H. ’39 
June 16, 1996 
Stephen F. Nagyfy, M.D. ’36 
December 28, 1997 
Paul A. O’Connor, M.D. ’35 
January 2, 1998 
Nelson K. Ordway, M.D. ’38 
December 31,1997 
Joseph T. Prekup, M.P.H. ’61 
January 1, 1997 
James D. Prokop, M.D. ’59 
December 1, 1997 
Joseph P. Rossi, M.D., HS ’60 
June 7, 1996 
Roger N. Ryley, M.D. ’39 
November 1, 1992 
Gerald B. Shattuck, M.D. ’46 
December 7, 1997 
Hugh Allen Smith, M.D. ’36 
January 5, 1998 
Benjamin Spock, M.D., Med ’29 
March 15, 1998 
Myra D. Tyler, M.D. ’50 
January 13, 1998 
Patricia E. Wanning, M.D. ’40 
December 19, 1997 
Arthur A. Ward Jr., M.D. ’42 
December 23, 1997 
Jane L. White, M.P.H. ’43 
October 10, 1997 
Richard Y Worthington, M.D. ’38 
November 29, 1997 
Charles Zigun, M.D. ’56 
March 5, 1998 
The designation Med. indicates the deceased at¬ 
tended the School of Medicine for a portion of his 
or her education. 
6 7 
BOOK END 
The four humors weren’t that funny 
Laughter, they say, is the best medicine. 
But can laughter cure Methicillin-Resis- 
tanr Staphylococcus Aureus? Let me put 
that another way ... 
Once, when I was a young boy, there lived 
an alarming bit of eczema on my face. I 
itched, I whined, and my annoyed mother was 
forced ro drag me to the doctor’s office. Upon 
inspecting my grill, the pediatrician looked at 
my mother gravely, shook his head, and dead- 
panned: “I rhink we’ll have to amputate.” 
Petrified, I turned to my mother. Strangely, 
she was smiling. I was confused for a moment, 
but then I understood. This man, my doctor, had just made 
a joke under what was surely the gravest of circumstances. 
He had wielded his irony and slain two unhappy people. In 
their places were a smirking mom and a beaming, reverent 
(although still quite blemished) boy. 
Can you see that this real-life example points to an 
important issue? If you are thinking, “Yes! Eczema can be 
cured by amputation,” you may have missed the point 
entirely. Also, you are hopefully not a dermatologist. What 
you should have gleaned is that humor in medicine has an 
important role, one that is often overlooked. 
Toward the beginning of my clinical training, I was ner¬ 
vous around my patients. I ended up being very serious, 
both out of anxiety and respect. However, being serious all 
the time is not inherent to my character, and 1 think by try¬ 
ing to act a certain way I ended up appearing even more 
awkward than I really am. While medical school at Yale 
stresses the importance of the doctor-patient relationship, 
I never appreciated how humor can be used to one’s advan¬ 
tage. It can distract a patient who is self-absorbed and de¬ 
pressed, help a patient to be on your side, and may turn a 
stressful situation into one of friendly rapport. 
As my clinical training progressed, I developed a differ¬ 
ent way to think about respect. I feel that doctors should 
regard patients as though they are normal people. This is 
sometimes hard for a beginning medical student. I think 
that the majority of my patients do better when they do not 
feel they are being treated as extremely fragile. On rhe other 
hand, one cannot be perceived as cavalier or immature. 
Humor walks a razor’s edge: ir is vital to feel out the situa¬ 
tion to determine whether or not, in the words of Woody 
Allen, “This is not the right crowd for this joke.” In short, 
don’t tell a knee-slapper to a guy with patellar tendinitis. 
I also have the particular concern that I tend to write 
often—in forums where plenty of people can read what I 
write—and I don’t want to be disrespectful. 
For example, when I rotated through surgery, 
we amputated an unfortunate gentleman’s 
toe which had become gangrenous. Would 
the patient whose toe I amputated appreciate 
it if he knew I was telling the above amputa¬ 
tion-related humorous anecdote? Is it OK, 
but only if he never finds out? Should I hang 
up my word processor forever? Because of 
such erhical dilemmas, future columns of 
mine dealing with possibly taboo subjects 
will appear under the pseudonym “Galen,” 
or possibly “Assistant Dean for Admissions 
Thomas Lentz.” 
Humor in medicine can also have value that goes beyond 
the obvious. In a word: cost-effectiveness. HMO executives 
and even the hospital president will be eating out of your 
latex-gloved hands when your cheery parients leave the 
hospital in record time. Numerous studies have shown 
shorter hospital stays for patients treated by funny doctors 
than for those who have brooding doctors who wear black, 
quote Soren Kierkegaard and pipe Wagner into their 
hospital ward. 
You’re thinking, fine, this will work if I’m a genuinely 
funny person, but what about my colleagues who are dull as 
a three-week-old scalpel? HMOs will still approve. If you’re 
not that funny but still attempt humorous intervention, 
you may drive your patients from the hospital, saving 
society countless dollars. If all else fails, feel free to try a 
variation of the following (nearly foolproof) gag: 
After a medical conference where attendees were plied 
with material from pharmaceutical firms, I ended up with a 
sample capsule from a drug company. It looks just like a 
normal blue and white capsule, except that it’s about 8 
inches long and 3 inches in diameter. Occasionally I’ll put it 
in my breast pocket, enter a patient’s room, say “Good 
morning, Mrs. (ones, it’s time for your medicine,” and then 
produce this enormous pill. 
Usually this is met by a laugh, although I’m sure to scout 
out my audience before I try such a trick. I never do it on 
anyone who’s recently had abdominal sutures. 
I wouldn’t want to split any sides. 
Gregory Raskin, M.D. '98, invites all interested physicians 
to call him up for more good gags to use on the job. He is a 
first-year resident in internal medicine at New York University 
Medical Center. 
By 
Gregory Raskin 
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Continuing Medical 
Education at Yale 
Sept. 12,13 Yale at Mystic: An Ultrasound Review A 
Saturday-Sunday Course Director: Kenneth J. Taylor, M.D., Ph.D. 
Furthering acquaintance with the most useful applications of the latest 
technical advances in diagnostic ultrasound 
Mystic Hilton, Mystic, CT 
Sept. 16 20 The 22nd Yale Physician Assistant Certification/ 
Recertification Preparatory Conference 
Wednesday-Sunday Course Coordinator: Christiane G. Nockels, P.A. 
Omni Hotel, New Haven, CT 
Sept. 25 Death of Neurons 
Friday Course Director: Pierre Fayad, M.D. 
Harkness Auditorium 
B 
C 
Oct. 1, 2 
Thursday-Friday 
AIDS Conference 
Course Director: Gerald H. Friedland, M.D. 
Omni Hotel, New Haven, CT 
Oct. 10 Second Annual Michael S. Voynick Lecture in Neuro-Oncology 
Saturday Course Director: Joseph M. Piepmeier, M.D. 
Hope 110 
Oct. 14 
Wednesday 
8th Annual Dual Diagnosis Committee Conference 
Course Director: Douglas Ziedonis, M.D. 
Harkness Auditorium 
D 
E 
F 
Oct. 16,17 
Friday-Saturday 
Digestive Disease Review for the Primary Care Provider 
Course Director: Victor J. Navarro, M.D. 
Harkness Auditorium 
G 
Oct. 23, 24 Health and Spirituality Conference H 
Friday-Saturday Albert Schweitzer Institute for the Humanities 
Directed to a multidisciplinary audience of practitioners and graduate students in 
medicine, divinity, public health and social work. Dedicated to the memory of 
Dr. Albert Schweitzer’s son-in-law, Dr. David Miller. 
Hope 110 
For information, contact the Office of Postgraduate and Continuing Education, Yale University School of 
Medicine, 333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
Yale Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
Use the reply form 
in the Passport, 
listing over 40 
AYA Educational 
Programs. 
Get it by calling 
1-800-456-9253 
Flag the 
programs 
you want; 
travel and 
learn with 
Yale Faculty 
The Amazon and the Orinoco: 
South America's Wild Rivers 
April 2-17, 1999 
rvAaVa 
0UTe 
[sAavc'f1 7-19 
1999 
Faces 
JYssocT iaO°n °'L'{:'X 
Discovering the Leeward 
Islands 
January 30-February 6, 1999 
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Found in translation 
A cell is a cell is a cell, researchers say, as Drosophila, yeast 
and other model organisms yield clues to human illness— 
and increasingly suggest paths to improved treatments. 
Translational research at Yale has been enriched by unusually 
good crosstalk between basic scientists and clinicians. 
page 14 
By Neeraja Sankaran 
Hl’HiHiliH 
A vision for vision 
Two years into his tenure as chair, 
Bruce Shields is building a new 
program around disorders of the retina 
and tackling the financial challenges 
presented by managed care. Against 
this backdrop: spectacular work in 
basic visual science, a new laser center 
and other advances in treatment. 
By Julie Miller 
Interview: Dennis Spencer 
The leader of Yale’s newly created Department of 
Neurosurgery is as comfortable astride a Harley- 
Davidson as in the operating room charting new 
territory in the treatment of epilepsy. 
By Marc Wortman 
Reunion 1998 
I he Yale System and a look back at the career of 
legendary Yale professor John Peters occupied center 
stage at Alumni Reunion Weekend this year. 
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LETTERS 
Yale should divest itself 
of tobacco stocks 
To the Editor: 
It was discouraging to learn of the Yale 
Corporation’s April decision not to 
divest its considerable holdings in 
tobacco stocks. I urge the medical 
school to lobby in favor of divestiture. 
Physicians need to be more 
outspoken about the dangers of alco¬ 
hol and cigarettes. The late Dr. John 
Knowles, former president of the 
Rockefeller Foundation, said we could 
cut the nation’s health bill by 50 per¬ 
cent if everyone stopped smoking 
and drinking! 
My father graduated from the 
School of Medicine in 1934 and our 
family enjoys your magazine. 
Edward T. O’Donnell Jr. 
Wilmington, Del. 
Longevity and talent 
To the Editor: 
Like Helen Langner (A Life of Engage¬ 
ment, Summer 1998), I grew up in 
Milford and know the Langner family. 
While Helen was admired and re¬ 
vered, she was not the only talented 
member of the family. Her “kid 
brother” Gustave, now 94, who was 
consulted for your article, is a com¬ 
petitive swimmer and still wins senior 
titles internationally. If Dr. Langner 
were of the modern generation, she 
would probably say: “Our talent must 
he in our genes.” 
David Rosenbaum, B.A. '47 
Milford, Conn. 
How to reach us 
Yale Medicine welcomes news and com¬ 
mentary. Please send letters to the edi¬ 
tor and news items to Yale Medicine, P.0. 
Box 7612, New Haven, CT 06519-0612, 
or via electronic mail to ymm@yale.edu, 
and include a daytime telephone number. 
Submissions will be edited for length, 
style and content. 
Early X-rays, continued 
To the Editor: 
Missing from the extended debate on 
whether Yale or Dartmouth produced 
the first X-ray after Roentgen (Letters, 
Summer 1998) is one significant piece 
of information. 
Peter Spiegel wrote, “If Yale’s 
physicist, Arthur Wright pre-empted 
the Dartmouth group, it remains un¬ 
reported and unsubstantiated, at least 
in the scientific literature.” In fact. 
Dr. Wright’s report was published in 
the Feb. 1, 1896, issue of Engineering 
and Mining Journal and in Electrical 
Engineer ot February 5. 
Wright wrote an additional report 
with more experiments in the March 
issue of the American Journal of 
Science. It is ironic that Wright’s report 
antedated a report from Harvard by 
four days. 
Raymond A. Gagliardi, MD '45, HS ’48-51 
Historian, the American Roentgen Ray Society 
Bloomfield Hills, Mich. 
Class act 
To the Editor: 
Thank you for the most recent update 
on the traditional second year class 
show. It has been almost 30 years since 
the Class of 1972 performed in Guaiac 
Positive to rave reviews. After all these 
years the memories of the skits, the 
songs and the class shenanigans di¬ 
rected toward the “New Curriculum” 
of 1968 stand out as some of the most 
unforgettable and enjoyable episodes 
of my Yale experience. (How often 
in a medical career does one get to 
lampoon his professors, portray 
immunologist Byron Waksman and 
be applauded at the same time?) 
Kudos and congratulations to the 
most recent keepers of the tradition. 
Indeed, I hope that in 2028 the cur¬ 
rent class can look back on this bond¬ 
ing experience with their colleagues 
with the same fondness and joy that 
my classmates and I share now. 
Lawrence P. Temkin, M.D. '12, HS '72-77 
Tucson, Ariz. 
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SCOPE 
For a world of emerging diseases, 
a revived program in microbiology 
Jorge Galan Three decades ago, it seemed that modern medicine 
had virtually eliminated many infectious diseases. 
Armed with antibiotics, vaccines and a sense of vic¬ 
tory in the war against microbes, medical schools began to 
look at the discipline of microbiology in a different light, 
and in 1972 Yale joined others in disbanding its department. 
By the 1980s, however, such deadly microbes as HIV, 
Ebola, Marburg, and Legionnaires’ disease surfaced to re¬ 
mind physicians that infectious diseases were still alive and 
represented very real public health threats. Moreover, some 
of the older pathogens had developed resistance to drugs 
that had once been effective. 
With this in mind, faculty at the School of Medicine be¬ 
gan work several years ago to reestablish a formal program 
in the microbiology of infectious disease. In July, those 
plans came to fruition with the appointment of Jorge E. 
Galan, D.V.M., Ph.D., as the first chair of a new Section of 
Microbial Pathogenesis. Support for the program came 
from The Esther A. and Joseph Klingenstein Fund Inc. and 
the Lucille P. Markey Charitable Trust. 
“Times change,” Dr. Galan said in an interview. “With 
the new emerging infections, and with others making a 
comeback as you would expect in any kind of biological 
cycle, there is a new interest in infectious disease. I hope 
that interest is here to stay.” 
Microbial Pathogenesis is the fifth autonomous section 
at the medical school and the first created since 1988, when 
the Section of Immunobiology was founded. Dr. Galan and 
his colleagues will focus their research on the interactions 
that occur between pathogens and their hosts, an increas¬ 
ingly rich and fruitful area of research. The section also will 
become the academic and administrative home to a four- 
year-old graduate track in microbiology now administered 
as part of the Biomedical and Biological Sciences Program. 
The microbiology track, which has 25 students this year, 
was created in anticipation of the new section’s founding. 
Dr. Galan and his two colleagues in the section, Craig R. 
Roy, Ph.D., and Norma W. Andrews, Ph.D., will 
carry out research on bacteria and parasites and 
teach first- and second-year medical students. In ad¬ 
dition, the new chair plans to apply for a training 
grant to further strengthen the microbiology track. 
Over the next few years, the section is expected to 
grow to a total of six faculty members. 
Caroline W. Slayman, Ph.D., deputy dean for 
academic and scientific affairs and chair of the task 
force that recommended the section, said Dr. Galan 
was selected as chair because he is one of the world’s 
leading researchers in the area of bacterial patho¬ 
gens. “His selection,” she said, “reflects the feeling of 
the search committee that the real challenge is to 
work with pathogens and study their interactions 
with their host cells.” 
Keith A. Joiner, M.D., professor of medicine and epide¬ 
miology, and a member of the search committee, said Dr. 
Galan was recruited not only for his work in bacterial 
pathogenesis, but also for his broad scientific perspective, 
which will facilitate interactions with colleagues in related 
fields such as cell biology, immunology, epidemiology, in¬ 
fectious diseases and structural biology. 
Dr. Andrews, a faculty member in cell biology for the 
past four years, is an authority on parasite-host interactions. 
Dr. Roy worked in the same department as Dr. Galan at the 
State University of New York at Stony Brook and was re¬ 
cruited to Yale to continue his research on bacterial patho¬ 
genesis. Using Legionella pneumophila as a medium. Dr. Roy 
studies mechanisms by which bacteria subvert the normal 
functioning of human cells. 
Dr. Galan believes the idea that infectious diseases will 
one day be completely eradicated is mistaken. “We will 
never, ever be able to conquer infectious diseases,” he said. 
“We may learn how to deal with a given pathogen but even¬ 
tually other pathogens will emerge. This is going to be a 
battle forever, there is no question about it.” 
Norma Andrews 
Physician associates 
gain their master’s 
Starting next year, graduates of the 
physician associate program will re¬ 
ceive master’s degrees instead of the 
graduate professional degree now 
awarded. The Yale Corporation 
approved the change in June in recog¬ 
nition of the program’s curriculum, 
long considered to be of master’s level. 
mnunn 
The Class of 1999 will be the first 
since the program started in 1971 to 
receive master’s degrees. 
The change comes, says Elaine E. 
Grant, PA-C, M.P.H. ’92, assistant 
dean and director of the physician 
associate program, as the profession 
debates whether a degree or a title is 
more appropriate. Students themselves 
have made their preference clear. “We 
started seeing more and more students 
choosing other schools to get a 
master’s,” Ms. Grant says. 
Four years ago, in response to new 
standards for accreditation, the cur¬ 
riculum was amended to include re¬ 
search methodology, biostatistics and 
epidemiology. The 25-month course 
includes 10 months of classroom stud¬ 
ies and 15 months of clinical training. 
For graduation, students must success¬ 
fully complete 12 four-week rotations, 
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Lyme disease vaccines prove effective Clinical trials conducted at Yale 
over the past two years have 
proven the effectiveness of two 
Lyme disease vaccines—one developed 
by Yale faculty—the first such drugs 
of their kind. Advisory panels have 
now endorsed both vaccines and the 
pharmaceutical companies that own 
the drugs are awaiting FDA approval 
to begin marketing them. 
In studies at Yale and other centers 
involving more than 20,000 people 
over two Lyme disease seasons, the 
vaccines were found to prevent the 
disease in a majority of cases. The Yale 
vaccine, LYMErix, was found to pre¬ 
vent 76 percent after three injections. 
SmithKline Beecham has obtained ex¬ 
clusive licensing to the Yale vaccine. 
ImuLyme, a vaccine developed 
by Pasteur Merieux Connaught of 
Swiffwater, Pa., was found to prevent 
Lyme disease in 68 percent of cases 
after two injections and 92 percent of 
cases after a third dose. Differences in 
efficacy between the two vaccines 
could be due to varying methods of 
surveillance. ImuLyme excluded 
people over 65, while LYMErix in¬ 
cluded all adult age groups. 
The results of the studies were 
published in the July 23 issue of The 
New England Journal of Medicine. 
“These two studies demonstrate 
that vaccination can be an important 
new approach to preventing Lyme dis¬ 
ease, which is the most common tick- 
Stephen Malawista, left, and Robert Schoen 
respond to reporters’ questions during a 
press conference on Lyme disease. 
borne disease in the United States,” 
said Robert T. Schoen, M.D., clinical 
professor of internal medicine and a 
member of the team that studied the 
Yale vaccine. 
Lyme disease was first identified by 
Yale researchers Stephen E. Malawista, 
M.D., and Allen C. Steere, M.D., in 
1975. The vaccine was derived from 
basic research performed at the School 
of Medicine by a team including 
Richard A. Flavell, Ph.D., professor 
and chair, section of immunobiology, 
Fred S. Kantor, M.D., the Paul B. 
Beeson Professor of Medicine, Erol 
Fikrig, M.D., associate professor of 
medicine, and Stephen W. Barthold, 
“Ticked off” about Lyme disease treatment: 
While physicians discussed therapies, vaccines and 
research at a Yale symposium on Lyme disease in 
early June, several dozen people took to Cedar 
Street to protest what they called improper diagno¬ 
sis and treatment of the tick-borne illness by Yale 
clinicians and researchers. According to the protest¬ 
ers, who carried placards and distributed flyers say¬ 
ing they were "ticked off” at Yale, medical school 
physicians minimize the severity and frequency of 
the illness. “Many of us have gone undiagnosed and 
untreated because of the Yale protocol,” said 
Maureen Albertson of Bridgeport. 
Physicians at Yale have maintained that many 
cases of Lyme disease cannot be verified. "Lyme dis¬ 
ease has become a magnet for people who do not 
feel well," said Stephen E. Malawista, M.D., a profes¬ 
sor of medicine and one of two researchers who 
identified Lyme disease in 1975. “No one doubts 
that they are suffering. The question is whether they 
are suffering from Lyme disease. There is a differ¬ 
ence between hope or belief and hard clinical evi¬ 
dence. A danger is that some other condition will be 
ignored while the possibility of Lyme disease, how¬ 
ever remote, is being endlessly pursued.” 
D.V.M., Ph.D. This work was sup¬ 
ported by grants from the National 
Institute of Health and the Centers for 
Disease Control, as well as a generous 
grant from the Mathers Foundation. 
Both vaccines stimulate immune 
responses to produce antibodies 
against Lyme disease. The vaccines not 
only provide immunity, but also may 
kill the spirochete, the bacterium in 
the mid gut of the tick that causes 
Lyme disease. 
which expose them to primary and 
emergency care. To ensure that stu¬ 
dents understand the profession they 
are entering, Ms. Grant said appli¬ 
cants must have worked as emergency 
medical technicians, nurses, hospital 
volunteers, research assistants or medi¬ 
cal technicians or had other health 
care experience. 
Physician associates, generally 
known as physician assistants, are li¬ 
censed health care professionals who 
work with physicians. In most states 
they are licensed to prescribe medica¬ 
tions and most work in primary care. 
The Yale program’s first class of five 
students graduated in 1973; in August, 
36 students in the Class of 2000 began 
their studies. Students learn to take 
medical histories, perform physical 
examinations, order and interpret lab 
tests, diagnose and treat illnesses, assist 
in surgery and counsel patients. “The 
profession has been successful because 
the generalist educational component 
has allowed the profession to be flex¬ 
ible in fulfilling the health care needs 
of the country,” Ms. Grant said. 
“Physician associates have been able 
to shift as needs have shifted.” 
11 grants awarded 
to advance research 
in women’s health 
The Ethel F. Donaghue Women’s 
Health Investigator Program at Yale 
announced its first round of grants in 
August for studies of women’s health. 
These are the first awards made since 
the program received a $6.5 million 
grant in February from The Patrick 
and Catherine Weldon Donaghue 
Medical Research Foundation. The 
new program was created to advance 
women’s health research and develop 
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new cutting edge areas of investigation 
that will result in direct practical ben¬ 
efit for women. 
“These projects represent a wide 
variety of research interests in women’s 
health, and provide an exciting cor¬ 
nerstone for our program,” said 
Carolyn Mazure, Ph.D., professor of 
psychiatry and director of the research 
program. “The funded areas of study 
address unanswered questions in 
women’s health and begin the process 
of changing both the health and 
health care of women.” 
1998 DONAGHUE WOMEN’S HEALTH 
INVESTIGATOR AWARD RECIPIENTS 
► Aydin Arici, M.D., associate pro¬ 
fessor of obstetrics and gynecology, 
will study how estrogen protects the 
blood vessel walls from degeneration 
in women with cardiovascular disease. 
The goal is to develop a better under¬ 
A high school link to the 
Human Genome Project With the help of a Yale geneti¬ 
cist, some New Haven-area 
high school students have 
been advancing the frontiers of mo¬ 
lecular biology. For the past year and a 
half Yale geneticist Wesley Bonds Jr., 
Ph.D., has worked with the students 
from the Sacred Heart Academy in 
Hamden and their teacher to teach 
DNA sequencing. Since then the stu¬ 
dents themselves have gone on to 
teach sequencing workshops to teach¬ 
ers and other students, attended the 
International Conference on Gene 
Mapping and Sequencing and estab¬ 
lished what may be the country’s first 
high school gene bank. 
“The students are getting a unique, 
hands-on introduction to modern 
molecular biology,” says Dr. Bonds, an 
associate research scientist in genetics. 
“DNA sequencing is the perfect way 
to introduce students to scientific 
experiments because it is repetitive 
work and can be easily evaluated.” 
Sister Mary Jane Paolella, a biology 
teacher at the school, first became in¬ 
terested in teaching DNA sequencing 
edge will enhance the use of these 
agents in clinical settings, and hope¬ 
fully improve the outcome of patients 
suffering from ovarian cancer. 
► Marc Galloway, M.D., associate 
professor of orthopaedics and rehabili¬ 
tation, is investigating how to improve 
the surgical recovery of women 
athletes who undergo knee surgery. 
Laboratory studies suggest that pain 
threshold and immune responses vary 
according to the menstrual cycle. 
This study will determine if surgical 
outcomes can be improved by corre¬ 
lating surgical procedures with the 
time of the menstrual cycle. The study 
will also examine differences in social 
support and adherence to exercise 
regimens for men and women, both 
of which have been shown to influ¬ 
ence the rate of recovery. 
Bruce G. Haffty, M.D., associate 
professor of therapeutic radiology, is 
to her students in March of 1997. She 
had read about a researcher at the 
University of Washington in Seattle 
who taught high school students to se¬ 
quence chromosome fragments. That 
researcher put her in touch with Dr. 
Bonds here in New Haven. The ef¬ 
forts of Dr. Bonds and Sister Paolella 
have been incorporated into a course 
on biotechnology, with 11 students 
this academic year. Those 11 students 
have learned to mentor students and 
teachers from urban and suburban 
high schools at the marathon sequenc¬ 
ing days they offer twice a year. They 
are also part of the High School Hu¬ 
man Genome Project, a miniature of 
the National Human Genome Project, 
which is working to map all of the 3.2 
billion pairs of DNA molecules that 
comprise the human genome. 
“The same sequencing theories and 
problems in finding a gene are identi¬ 
cal to the national project,” says Dr. 
Bonds. “The students are doing the 
same things, but on a smaller scale 
with less equipment.” 
DNA sequencing is a unique teach¬ 
ing tool, Dr. Bonds believes, in that it 
allows students to use current research 
techniques to understand biological 
Wesley Bonds Jr. and Sister Mary Jane 
Paolella, a biology teacher at Sacred Heart 
Academy in nearby Hamden, Conn., have cre¬ 
ated an innovative course in gene sequenc¬ 
ing that is part of the High School Human 
Genome Project. 
systems usually approached in other 
ways. Because DNA sequences are now 
readily available over the Internet, 
Sister Paolella and Dr. Bonds believe 
that many other high schools should 
be able to involve themselves in geno¬ 
mics, even if they don’t have access to 
sequencing equipment themselves. 
“Our hope is to get other high 
schools and universities working to¬ 
gether to change the focus of high 
school biology,” says Sister Paolella. 
standing of the molecular mechanisms 
of estrogen action, which may lead to 
development of improved estrogenic 
substances providing more targeted 
cardiovascular interventions for 
women. 
► Linda M. Bartoshuk, Ph.D., pro¬ 
fessor of surgery, will study burning 
mouth syndrome, an intense oral pain 
that afflicts about one in six post¬ 
menopausal women. The study will 
identify and characterize those at risk, 
and test a drug therapy which may 
provide effective treatment to ease the 
pain of this syndrome. 
► Priscilla S. Dannies, Ph.D., profes¬ 
sor of pharmacology, is seeking ways 
to improve the survival rate of women 
suffering from ovarian cancer. Specifi¬ 
cally, she will study whether certain 
estrogen antagonists combined with 
chemotherapeutic agents can induce 
ovarian cancer cell death. This knowl¬ 
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trying to determine whether women 
who carry the genetic mutations 
BRCAi and BRCA2 have a higher risk 
of local recurrences in conservatively- 
treated breast cancer. The results will 
provide information to women diag¬ 
nosed with early stage breast cancer 
who carry the genetic mutations, so 
they can make more informed deci¬ 
sions about options lor treatment. 
Harvey Kliman, M.D., Ph.D., a 
research scientist in obstetrics and 
gynecology, is seeking predictors of 
successful embryo implantation in 
infertile couples. More than 10 
percent of reproductive age couples 
suffer from infertility, and in 20 
to 25 percent of such couples there 
is no proven cause. Implantation 
success predictors are likely to lead 
to a better understanding of the causes 
of infertility in women and to 
improved efficacy and reliability 
of embryo transfer. 
John M. Leventhal, M.D., profes¬ 
sor ot pediatrics, is studying whether a 
volunteer-based, home-visit program 
can improve the health, social func¬ 
tioning, and parenting of young in¬ 
ner-city mothers. Trained volunteers, 
who will be matched with pregnant 
women between the ages 15 to 25 who 
are receiving care at Yale-New Haven 
Hospital, will provide practical advice 
about parenting and meeting the 
mother’s social and economic needs. 
Ihe study will determine if this type 
of intervention can improve the 
success of these young mothers. 
Mark J. Mamula, Ph.D., associate 
professor ot medicine (rheumatology), 
is investigating systemic lupus erythe¬ 
matosus (SLE), an immunologic 
disease of unknown causes that afflicts 
primarily women. The study will 
examine how specific cellular proteins 
or antigens become targeted for attack 
by the immune system. Dr. Mamula 
hopes to identify autoantigenic candi¬ 
dates that may initiate this autoim¬ 
mune cascade and provide a first step 
for intervention in this disease. 
Nina S. Stachenfeld, Ph.D., re¬ 
search scientist in the John B. Pierce 
Laboratory, is examining the actions 
of estrogen and progesterone on the 
systems that regulate body fluid bal¬ 
ance. Researchers suspect that female 
sex hormones increase disease suscep¬ 
tibility and progression in post-meno¬ 
pausal women. Understanding of 
body fluid regulation could lead to the 
eventual prevention or treatment of a 
variety of chronic diseases that specifi¬ 
cally affect women. 
► Suzanne Swan, Ph.D., associate 
research scientist in the department 
of psychiatry, plans to study the 
conditions under which women use 
violence in domestic relationships. 
Evidence suggests women become 
violent in self-defense, out of fear, 
and as a response to violence perpe¬ 
trated against them; however, such 
action often results in more violent 
retaliation. Dr. Swan hopes to 
understand these patterns in order 
to develop and implement domestic 
violence intervention and prevention 
programs for women. 
Viola Vaccarino, M.D., Ph.D., 
assistant professor of epidemiology 
and public health, will study whether 
women benefit from coronary bypass 
surgery to the same extent as men in 
terms of symptom relief and func¬ 
tional and psychosocial recovery. 
This study will improve the ability 
of healthcare professionals to counsel 
female patients, enhance decision¬ 
making for women considering bypass 
surgery, and develop interventions to 
improve women’s recovery after 
bypass surgery. 
These projects are led by Yale 
investigators with collaborators across 
departments and disciplines, in 
conjunction with researchers front 
other major institutions, and with 
the help of community clinicians. 
I he program will publish its second 
request for applications this fall. 
Estrogen studies 
yield hope of breast 
cancer treatment 
Yale University researchers have 
visualized in atomic detail how two 
important female sex hormones, 
progesterone and estrogen, bind to 
their receptors—an accomplishment 
that could help scientists design better 
medications to treat breast cancer, ease 
the symptoms of menopause and 
prevent unwanted pregnancies. 
The Yale scientists’ data are 
available to the worldwide research 
community through the Protein 
Data Bank at Brookhaven National 
Laboratories on Long Island. Paul B. 
Sigler, M.D., Ph.D., professor of mo¬ 
lecular biophysics and biochemistry, 
and his colleagues are the first to make 
the structure of the estrogen-receptor 
complex available to scientists 
through the data bank. 
Dr. Sigler’s detailed atomic 
comparison of the estrogen and 
progesterone receptors binding— 
prepared in collaboration with 
Yale graduate student David M. 
Tanenbaum and postdoctoral 
associates Shawn P. Williams, Ph.D., 
and Yong Wang, Ph.D.—was pub¬ 
lished in the May 26 issue of the 
Proceedings of the National Academy 
of Sciences. A separate report by Dr. 
Sigler and Dr. Williams on the proges¬ 
terone receptor alone was published 
May 28 in the journal Nature. 
Drugs such as tamoxifin and 
raloxifene that bind to the estrogen 
receptor and block the uptake of 
estrogen have been shown in recent 
studies to be effective in treating and 
even preventing breast cancer. How¬ 
ever, even more effective estrogen 
blockers could be created using the 
three-dimensional, computerized 
“snapshot” of the estrogen receptor 
captured at Yale, said Dr. Sigler, a 
Howard Hughes Medical Institute 
investigator at Yale. Tailor-made medi¬ 
cations that improve the uptake of 
estrogen instead of blocking it could 
help relieve menopausal symptoms. 
“Our work with the progesterone 
receptor has given us by far the 
highest resolution, that is, the 
clearest look we have ever had, of 
the chemistry that underlies a steroid 
binding to its receptor,” said Dr. 
Sigler. Using a technique called 
X-ray crystallography, the researchers 
generated an image of progesterone 
bound snugly in its receptor’s specific 
binding pocket at a resolution of 
1.8 angstroms, which is roughly the 
distance between two atoms. 
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Weighing privacy and 
progress, Congress 
considers limits on 
patient data 
Advances in genedc screening abilities 
have put the medical world on alert 
about threats to patient privacy. In 
August, Sen. Christopher Dodd, D- 
Conn., came to the medical school to 
ask faculty about ways to ensure the 
privacy of genetic records. 
Sen. Dodd, who is sponsoring leg¬ 
islation that would bar insurers and 
employers from discriminating based 
on genetic predisposition to disease, 
told reporters, “The last thing I would 
want is any suggestion that we are try¬ 
ing to limit the importance of moving 
forward with genetic technology.” 
Several faculty members who met 
with Sen. Dodd agreed. Maurice J. 
Mahoney, M.D., J.D., prolessor of 
genetics, pediatrics and obstetrics and 
gynecology, pointed to the importance 
of the flow of information to physi¬ 
cians and family members. “One has 
to reach a balance,” he said. “We don’t 
want to inhibit that kind of flow. If 
we develop a culture in which we are 
fearful of the consequences of sharing 
information within the profession, 
that is to the detriment of health care. 
On the other hand, I have fears about 
allowing medical information to flow 
freely in the economic structures of 
our society and government.” 
Sen. Dodd told the gathering, 
“It seems to me we ought to be able 
to strike a balance here in pursuing 
that, while, at the same time, offering 
people some sense of security that this 
information is not going to be used to 
deprive them of insurance or employ¬ 
ment.” According to Sen. Dodd, 
discussions with constituents showed 
strong concerns about privacy. “The 
public response to that issue dwarfed 
every other issue.” 
Also present at the press conference 
were patients and families concerned 
about the potential economic and 
professional consequences of the 
genetic diseases they carry. Peter 
Przybylski said his n-year-old daugh¬ 
ter Ashley has carbamoyl phosphate 
8 ► 
Building a town-gown partnership, from high school 
to medical school 
New Haven Mayor John DeStefano visits a science lab on the first 
day of school at the new Hill Regional Allied Health and Business 
Career High School. 
A five-year collabora¬ 
tion between Yale 
University and 
New Haven’s Career High 
School entered a new phase 
in September, as students 
and teachers moved to a 
new building a few blocks 
away from the medical cen¬ 
ter. The proximity, as well 
as a new shuttle bus, will 
bring students closer to the 
anatomy classes they take 
and their internships at the 
medical school and Yale- 
New Haven Hospital. 
Career High—or Hill 
Regional Allied Health and 
Business Career High 
School, as the school will 
be known in its new building—was 
created in 1983 to introduce students 
to careers in health, business and 
computer technology. Until this year 
the magnet school and its 450 students 
occupied a former elementary school 
on Wooster Square that was originally 
built to handle only 300 students. 
The new 165,000-square-foot building 
at 140 Legion Ave. opened this year 
with 600 students. It will admit a full 
complement of 750 next year. 
The school’s relationship with 
Yale began in 1993 when Career 
students came to the medical school 
for anatomy lessons given by medical 
students and William B. Stewart, 
Ph.D., associate professor of surgery 
and section chief for anatomy and ex¬ 
perimental surgery. Since then it has 
grown into a multifaceted program 
that two years ago became a formal 
partnership. The School of Nursing has 
provided mentors and internships, and 
medical library staff have trained teach¬ 
ers in the use of the Internet. This past 
summer 15 Career students participated 
in a two-week program on the campus 
of the medical school, living in 
Harkness Hall and studying biology 
and chemistry with faculty from the 
medical school, Yale College and the 
New Haven public schools. Medical 
faculty and staff have advised Career 
staff on computer networks and 
laboratory equipment. The new 
school will have 650 networked 
computers with links to the Yale 
computer network. 
“What’s exciting about the partner¬ 
ship is that it goes beyond simply try¬ 
ing to inspire kids to become a physi¬ 
cian or a nurse or researcher,” says 
Claudia Merson, Ed.M., Coordinator 
of Career High School Partnership at 
the medical school. “We work with 
the faculty to provide opportunities 
for students to acquire the skills and 
discipline they are going to need to 
get there.” 
“Another facet of the collaboration 
has been the opportunity for every 
student to take advantage of at least 
one of a series of internships offered at 
the hospital and medical school. Stu¬ 
dents spend two days a week working 
in a clinical or laboratory setting while 
gaining academic credit for their 
work. These internships give our stu¬ 
dents the chance to apply and expand 
upon skills learned in the classrooms 
at a first-rate medical center,” says 
school principal Charles Williams. 
“The kids love it.” 
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synthase deficiency, in which blood 
ammonia levels can become lethal 
without proper management. “I 
would hate to see her have to take a 
position based on her medical cover¬ 
age, as opposed to what she wanted 
to do,” he said. 
A new tool to combat 
cocaine addiction 
Yale researchers have found that a com¬ 
bination of medication and counseling 
can be effective in treating cocaine ad¬ 
diction, a significant finding given the 
lack to date of any generally effective 
medication to treat cocaine depen¬ 
dence. The research also suggests a 
promising strategy involving treatment 
of those who abuse a combination of 
drugs, such as alcohol and cocaine. 
The study, led by Kathleen M. 
Carroll, Ph.D., associate professor of 
psychiatry, and researchers at the Sub¬ 
stance Abuse Treatment Unit at the 
Department of Psychiatry, compared 
different treatments for alcohol and 
cocaine abusing patients. Some pa¬ 
tients received a combination of disul- 
firam and one of three types of coun¬ 
seling while others received counseling 
but no medication. Because most 
cocaine-dependent people also abuse 
alcohol, the application of disulfiram, 
also known as antabuse, could have 
broad implications in the treatment 
of cocaine abuse. The researchers’ 
findings were published this year in 
Addiction. The National Institute on 
Drug Abuse sponsored the study. 
The best outcomes in the 12-week 
study of 122 people who abused both 
cocaine and alcohol occurred among 
those who received both disulfiram 
and psychotherapies which encouraged 
them to get involved in self-help 
groups or taught them skills for coping 
with situations in which they were 
likely to use illicit drugs. 
Alcohol dependence is often a prob¬ 
lem among cocaine users, according to 
the authors. A 1990 study found that 
85 percent of those considered cocaine- 
dependent also met standards for alco¬ 
hol abuse. Also, once use of both sub¬ 
stances becomes a pattern, it is hard to 
Brain surgery, without opening the skull 
Neurosurgeons 
Juan Bartolomei 
and Alain 
deLotbiniere 
prepare the 
gamma knife to 
specify the pre¬ 
cise location in 
the brain where 
radiation will be 
concentrated. 
By varying 
which of the 
helmet's 201 
openings are 
plugged, sur¬ 
geons exercise 
fine control over 
the target 
beams. 
For decades neurosurgeons have treated diseases of the brain by beaming 
radiation inside the skull, sidestepping the need to cut through scalp and 
bone. The arrival ol a 30-ton gamma knife at Yale in July enables this 
intricate form of brain surgery with a previously unmatched precision. 
The Swedish-made gamma knife beams up to 201 gamma rays around a single 
point in the brain, letting the radiation accumulate on that point without 
disturbing surrounding tissue. Individually, the rays do no harm, but when they 
converge on their target the concentration of radiation can destroy lesions, 
tumors and blood vessel malformations. Based at the Temple Medical Center, 
the $2.9 million instrument :s the first of its kind in Connecticut and one of 
only 35 in the whole country. 
Treatment with the gamma knile requires placing the patient in a fixed frame 
that keeps the head absolutely steady during the procedure. Once ready, the 
patient lies inside the gamma knife for between 15 minutes and two hours. 
The radiation treatment is accurate to within .3 millimeters. After the treatment 
the radiation can take days or weeks to achieve the desired effect. 
Because it is more accurate and easier to use, the gamma knife has largely 
replaced its precursor, the linear accelerator which beams X-rays into the brain. 
The linear accelerator was accurate to within plus or minus 1 millimeter and 
could take hours to do what the gamma knife does in minutes. 
“With the gamma knife,” said Alain deLotbiniere, M.D., associate clinical 
professor of neurosurgery and director of radiosurgery at Yale-New Haven 
Hospital and of the Gamma Knife Surgery Center, “we can destroy abnormal 
tissue very precisely without damaging adjacent normal brain tissue and without 
subjecting patients to the trauma of surgery. The gamma knife enables us to 
destroy tumors in areas of the brain that are inaccessible to the surgeon’s scalpel 
or so close to vital structures, such as the optic nerve, that surgery could irrepara¬ 
bly harm normal brain tissue.” 
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abstain from one without renouncing 
both. Researchers have begun new 
studies to determine the best combi¬ 
nation of antabuse and counseling to 
reduce cocaine use and craving. 
A new strategy for stroke 
and Alzheimer's? 
Researchers at the School of Medicine 
have found that blocking an enzyme 
known to be involved in cell death 
could help treat Alzheimer’s disease, 
Parkinson’s disease, strokes and other 
age-related neurological diseases. 
Dissecting the body Exploring the depths of the hu¬ 
man body is one of the hall¬ 
marks of the first year of medi¬ 
cal school. Through new computer 
software that offers three-dimensional 
views of human anatomy, Yale stu¬ 
dents can now dissect the body with 
the click of a mouse. 
The new computer teaching tool 
provides a complement to standard 
anatomy training in the cadaver lab. 
Based on data from the National 
Library of Medicine’s Visible Human 
Project, the software called the Divis¬ 
ible Human allows students to view 
three different images of the same 
body part simultaneously on a com¬ 
puter monitor. “This is the first time 
that the Visible Human data has been 
available in a form where students can 
actually manipulate and learn some¬ 
thing from it,” said William B. 
Stewart, Ph.D., associate professor of 
surgery and section chief for anatomy 
and experimental surgery. “What one 
can do is pick a plane and dissect into 
it. From the anatomist’s point of view 
one of the most critical skills you can 
teach students is how to reason and 
problem solve in three dimensions.” 
“The difference in technology be¬ 
tween moving from plane to plane 
and true animation is extraordinary,” 
The findings, published in the Aug. 
7 issue of Cell, were the result of obser¬ 
vations of mice bred with defective 
copies of the Caspase-9 gene. The 
Caspase family of genes plays a role in 
programmed cell death, called 
apoptosis, a necessary element of nor¬ 
mal biological processes. “The balance 
between cell production and cell death 
is important for normal brain devel¬ 
opment,” said Pasko Rakic, M.D., 
SC.D., the Dorys McConnell Duberg 
Professor of Neurobiology. “Too 
much or too little cell death can cause 
severe malformations leading to disor¬ 
ders such as mental retardation and 
said John A. Paton, Ph.D., director of 
academic computing at the school, 
describing the software developed by 
Shane Dunne, Ph.D., a computer 
scientist from Kingston, Ontario. 
“It means people can explore much 
more effectively than they could 
before.” Adds Dr. Stewart “This is 
the way that in the future they will 
be viewing radiology.” Dr. Stewart is 
the first anatomy instructor in the 
country to use the software and also 
has developed laboratory exercises to 
use with it. 
The new software allows access to 
childhood epilepsy. This study shows 
that Caspase-9 is essential for cell 
death and therefore gives new insight 
into how the brain develops in normal 
and pathological conditions.” 
In experiments with mice lacking 
Caspase-9, the investigators found 
that the absence of the gene blocked 
neuronal apoptosis. Abnormal activa¬ 
tion of cell death is implicated in 
many human diseases and specific 
caspases have been linked to a handful 
of diseases. The research suggests that 
a therapy could be designed to stop 
Caspase-9 from triggering apoptosis, 
thereby blocking cell death linked to 
cross-sectional slice images of the ana¬ 
tomy, at any orientation and in any 
combination. Although each slice im¬ 
age is two-dimensional, the program 
presents multiple slices in a three-di¬ 
mensional format which clearly illus¬ 
trates relative position and orienta¬ 
tion. Other commercial and academic 
software using the visible human al¬ 
low access only in two dimensions, in 
standard orientations and much more 
slowly. And while most programs tend 
to be difficult to learn, Dr. Dunne 
says his software is “as quick and easy 
to use as a video game.” 
with the click of a mouse 
Anatomy professor William Stewart instructs students Ron Samet and Fred Cobey in the 
use of Divisible Human software. 
YALE MEDICINE 9 
The delegation toured the ancient city of Persepolis near the desert city of Shiraz. 
Personal warmth, 
hostile slogans 
for medical 
delegation to Iran 
On their arrival at a hotel in the 
Iranian desert city of Shiraz, 
members of a medical delega¬ 
tion from the West, including three 
Yale physicians, were greeted by a ban¬ 
ner declaring, in English, “Down with 
USA.” Inside the hotel, however, a 
friendlier reception awaited. “You’re 
from the United States?” the clerk 
asked the physicians. “It’s nice to have 
you here.” 
The physicians were members of a 
delegation sent by the International 
Society of Nephrology in March. 
It was the first exchange involving 
nephrologists since the society spon¬ 
sored an exploratory trip three years 
ago. Other scientific exchanges are 
planned over the next two years. 
“There had been a lot ol concern 
in Iran about scientific isolation,” said 
Asghar Rastegar, M.D., associate chair 
for academic affairs in the department 
of medicine, who three years ago 
made the exploratory trip on behalf of 
the society. “The society then decided 
to support scientific exchanges with 
Iran.” The March trip was at the 
invitation of the Iranian Society of 
Nephrology and was timed to coin¬ 
cide with their annual scientific 
conference in Tehran. 
The delegation included Dr. 
Rastegar, Fredric O. Finkelstein, 
M.D., clinical professor of medicine; 
Michael Kashgarian, M.D., ’58, pro¬ 
fessor of pathology and biology; Saeed 
Fatenejad, M.D., assistant professor of 
medicine; Bernd Sterzel, M.D., chair 
of nephrology at the University of 
Erlangen in Germany. Also on the trip 
were Dr. Finkelstein’s wife, Susan H. 
Finkelstein, M.S.W., an assistant 
clinical professor of social work and 
psychiatry, and Dr. Sterzel’s daughter, 
Fdannah. During their two weeks in 
Iran, the physicians traveled about the 
Members of the delegation in the lobby of 
their hotel in Shiraz, where an unfriendly 
banner belied the warmth of the staff. 
country, met with fellow nephrologists 
and gave lectures at nephrology and 
pathology conferences in Tehran 
and Shiraz. 
Although a U.S.-imposed eco¬ 
nomic embargo never barred scientific 
exchanges, American academics have 
been reluctant to travel to Iran over 
fears about conditions there and a 
perceived hostility towards Americans. 
The embargo has also denied the 
country the economic wherewithal to 
import modern medical equipment. 
“Medicine in Iran has always 
been very sophisticated,” said Dr. 
Finkelstein. “ There is an artistic tradi¬ 
tion and education is really revered in 
Iran. The problem is the rigidity of 
the Islamic government and the limits 
placed on Iranian access to knowledge 
from the outside world.” 
Dr. Finkelstein and Dr. Rastegar 
first met in Iran in 1978, when Dr. 
Finkelstein was visiting on a three- 
month exchange. Five years later, Dr. 
Rastegar left when religious funda¬ 
mentalists dismissed him from a uni¬ 
versity post. Over the past nine years, 
however, he has made regular visits to 
Iran to maintain contact with Iranian 
physicians and to see his family. 
“Iranian scientists look to the 
United States and many of them have 
trained here,” he said. 
Dr. Kashgarian offered a mixed 
assessment of Iranian medicine. “The 
quality of care is probably equivalent 
to care anywhere in the West,” he 
said. “Some of the facilities are not 
quite up to date. Their access to the 
latest drugs is more restricted.” 
The physicians said the Islamic 
regime’s dictates have changed the 
teaching of medicine. The student 
body is of mixed caliber, Dr. 
Kashgarian said, because it is divided 
into students who compete for admis¬ 
sion and those who are admitted, 
under lower standards, because of 
links to religious or revolutionary 
organizations. Also, because the 
Islamic government rapidly expanded 
the number of medical schools from 
seven to 34 and the number of 
graduates from 800 to 5,000 each 
year, the quality of education has 
fallen, Dr. Rastegar said. 
The role of women in medicine has 
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also changed because of religious dic¬ 
tates. Only women should examine 
women, according to religious leaders. 
As a result, more than half the medical 
students are female. They are expected 
to enter certain specialties such as ob¬ 
stetrics and gynecology, but Dr. Raste- 
gar noted that women also study neu¬ 
rosurgery. “It has opened certain doors 
and closed certain doors,” he said. 
Medicine is not the only area 
where women’s status has changed. 
Ms. Finkelstein contrasted the oppres¬ 
sion she felt as a woman with the 
vibrant, intelligent Iranian women 
she met there. On the plane to Iran, 
she said, women wore fashionable 
Western clothing—until they entered 
Iranian air space. “Out came the 
scarves and the coats,” she said, refer¬ 
ring to the clothing women, including 
foreign visitors, must wear in Iran. 
Even in a Tehran hotel she was ex¬ 
pected to cover all but her face every 
time she ventured outside her room. 
Some Iranian women, she said, turn 
their clothing into a political state¬ 
ment by including brighter colors 
than religious law permits or wearing 
scarves looser than allowed. “Things 
are loosening up a little bit,” she said. 
“There really is a kind of cohesive so¬ 
ciety, wonderful family life, wonderful 
food, a rich culture that people really 
enjoy and appreciate. There is a lot 
there that is truly very positive.” 
According to Dr. Rastegar, to 
understand the attitudes of Iranians 
one must place the events of the past 
20 years in the context of the revolu¬ 
tionary changes that have occurred. 
Although he is quick to acknowledge 
that Iran is not a democracy, he finds 
that debate about the nature of politics 
and society is more open than it was 
under the repressive regime of the Shah 
Mohamad Reza Pahlavi. Television 
images of mobs storming the U.S. 
Embassy, however, have created a 
“scar” that taints American perceptions 
of Iran and defines relations. “For the 
American people to deal with that scar 
they had to demonize the people be¬ 
hind it,” says Dr. Rastegar. “This can 
only be broken if there is face to face 
contact between individuals. This trip 
was a step in that direction.” 
certain neurological diseases. 
“When mitochondria, the energy 
factories of cells, are damaged, 
Caspase-9 is activated, leading to cell 
death,” said Richard A. Flavell, M.D., 
professor of immunobiology and biol¬ 
ogy, and one of the researchers. “In 
cells lacking Caspase-9 this damage 
did not give rise to cell death.” 
Yale ethicist defends 
safeguards in human 
investigations 
Is the pace of medical advances mov¬ 
ing beyond existing safeguards regard¬ 
ing the use of human subjects in ex¬ 
perimentation? A series of recent 
federal reports to the U.S. Congress 
asserted just that. Responding to the 
reports, Yale faculty member Robert J. 
Levine, M.D., told Congress in June 
that the present methods and guide¬ 
lines employed by medical schools to 
assure the safe and ethical use of hu¬ 
mans in investigations are “working 
very well.” 
According to four reports recently 
issued by the inspector general’s office 
of the Department of Health and Hu¬ 
man Services, the system designed to 
protect human subjects in clinical tri¬ 
als has failed to keep pace with ad¬ 
vances in medicine such as gene 
therapy. “Our total effort reveals a 
brittle system and even a few cracks,” 
George Grab, deputy inspector gen¬ 
eral for evaluations and inspections, 
testified in June on his office’s year¬ 
long inquiry before the House Gov¬ 
ernment Reform and Oversight Sub¬ 
committee on Human Resources. 
Not so, said Dr. Levine, a professor 
of medicine and lecturer in pharma¬ 
cology, who testified in rebuttal on be¬ 
half of the Association of American 
Medical Colleges. Dr. Levine, who 
chairs the Human Investigation Com¬ 
mittee at the School of Medicine, said, 
the reports “created the impression 
that the IRB [Institutional Review 
Board] system is a disaster just looking 
for a place to happen. 
“It would be easy to infer there is a 
systemic threat to patients,” Dr. 
Levine testified. “Yet, quite to the con¬ 
trary, the report acknowledges the 
study yielded no evidence of harm or 
abuse to patients.” 
For the past two decades, medical 
schools have been required to follow 
federal regulations for in-house insti¬ 
tutional review boards. Any federally 
funded research involving human sub¬ 
jects must pass through several layers 
of review by the school’s board. 
While Dr. Levine disagreed with 
many of the reports’ findings, he did 
agree with some recommendations for 
improving the existing system. He 
concurred that IRBs, in which partici¬ 
pation is voluntary, face tremendous 
workloads and would benefit from 
greater resources. Requiring IRB re¬ 
view after funding has been approved 
would reduce the workload, he said, 
and ensure that research involving 
humans has been reviewed. He also 
agreed that training for investigators 
and IRB members is essential. 
Although he described IRBs as 
overworked and short of resources, 
he said, “By any standards of realistic 
performance the IRB system works 
very well.” 
Children thrive when 
fathers stay at home 
Fathers can play the traditional child- 
rearing role of mothers with no detri¬ 
ment to the children, according to a 
12-year Yale study. The study, led by 
Kyle D. Pruett, M.D., who presented 
his findings last December at the 
American Psychoanalytic Society’s an¬ 
nual meeting in New York City, found 
that stay-at-home fathers raise “vital 
and vigorous” children while enhanc¬ 
ing their own capacities for intimacy 
and self-regard. The study followed 18 
Hispanic, white and African-Ameri¬ 
can children from two-parent house¬ 
holds of various income levels. 
According to Dr. Pruett, clinical 
professor in the Child Study Center 
and psychiatry, the fathers initially 
feared they would become intellectu¬ 
ally bored and overweight, lose physi¬ 
cal prowess and become more isolated 
socially. They confronted problems 
such as a baby’s persistent crying by 
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wondering whar their wives would do. 
Then, according to the report, within 
io days to a few months later the fa¬ 
thers developed their own care-giving 
styles. The children thrived and, on 
average, exceeded norms on standard 
development tests, especially those 
measuring problem-solving skills. 
Researchers, who conducted biennial 
evaluations over 12 years, reported 
no signs of intellectual or emotional 
trouble among the children. “They 
felt a zest for life, were both assertive 
and comfortably dependent, showed 
a vigorous drive for mastery and ex¬ 
pressed the usual childhood worries 
for boys and girls,” the report said. 
The fathers’ involvement stimulated 
the emotional attachment that is vital 
to development of personality in the 
early years, according to the report. 
I he findings have been published 
in a variety of journals and lay publi¬ 
cations, including The Psychoanalytic 
Study of the Child. 
HIV drug resistance 
an increasing threat 
Despite the clinical gains a new 
generation of AIDS medications 
have yielded, drug-resistant strains 
of HIV and the frequency of their 
transmission increasingly threaten 
public health efforts to thwart the 
spread of AIDS, according to an 
analysis co-authored by the director 
ol the Yale AIDS Program. 
“Prevention of both development 
ol HIV drug resistance as well as 
transmission of drug-resistant variants 
is a central issue of public health im¬ 
portance,” wrote Gerald H. Friedland, 
M.D., professor of medicine and epi¬ 
demiology and director ol the Yale 
AIDS Program, and Mark A.Wainberg, 
Ph.D., of the McGill University AIDS 
Center in Montreal. In their report, 
published in the June 24 issue of 
The Journal of the American Medical 
Association, the two sounded a warn¬ 
ing about antiretroviral therapy. 
Researchers have identified 
viruses resistant to the antiviral agents 
longest in use, according to the 
report. Current methods for detecting 
HIV resistance may be inadequate 
and resistance may be more wide¬ 
spread than previously thought. 
They also found that failure to adhere 
to just one of three medications in 
a regimen can lead to a resistance to 
all three. 
The authors call for increased 
emphasis on adherence to medications 
and population-based studies of the 
prevalence, mechanisms and transmis¬ 
sion rates of drug-resistant strains 
ol HIV. “In the meantime,” they 
wrote, “prevention of both occurrence 
and transmission ol drug-resistant 
HIV is important in the public health 
arena. These subjects must be ad¬ 
dressed if antiviral therapy is to play 
its optimal role in blunting and alter¬ 
ing the course of the HIV pandemic.” 
Seeing the whole person instead of the disease Tracing the rise of medical tech¬ 
nology from ancient examples of 
trepanation to the advent of the 
X-ray, John H. Lienhard, Ph.D., host 
of a popular National Public Radio 
science program, urged physicians to 
look at the whole human rather than 
individual ailments. The keynote 
speaker at the 50th annual meeting 
of Associates of the Cushing/Whitney 
Medical Library at Yale University 
on May 6, Dr. Lienhard spoke on the 
dangers of reducing the person to an 
illness during treatment. He is the 
M.D. Anderson Professor of Mechani¬ 
cal Engineering and History at the 
University of Houston. 
“Medicine has to find its way back 
to the tough problem of curing the 
whole body instead of just pieces of 
it, ’ Dr. Lienhard said during his talk, 
The Lesion Within: What Happened to 
Medicine When 19th Century Ingenuity 
Seized Upon an 18th Century Percep- 
' v'V His radio program, Engines of 
Before giving his talk in the Historical 
Library, John H. Lienhard, left, chats with 
former deputy dean Arthur Ebbert Jr., 
professor emeritus of medicine. 
Our Ingenuity, describes the way art, 
technology and ideas have shaped 
mankind. 
According to Dr. Lienhard, 18th 
century physicians discovered how 
“specific disorders caused suffering 
and death” and in the 19th century 
physicians invented stethoscopes and 
X-rays to peer inside the body without 
violating it. But, he argued, technol¬ 
ogy shifted emphasis from the patient 
to the disease. “Handling a bedpan is 
no less essential to the healing process 
than transplanting a human heart,” 
he said. 
The following morning Dr. 
Lienhard returned to the relationship 
between technology and medicine at 
Grand Rounds in the Fitkin Amphi¬ 
theater. He praised computers and 
their use in medicine, but cautioned 
that they affect human thought by 
creating on a two-dimensional screen 
what “the mind’s eye” once had to 
imagine. Medieval architects, he said, 
designed Gothic cathedrals, not with 
advanced mathematics or detailed 
drawings, but from a vision in their 
minds. “See to it that your children in 
public schools aren’t allowed to avoid 
thought by pushing buttons,” he said. 
“Believe me, the eye of the mind is 
under attack.” 
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A medieval 
oculist 
Bartisch’s manual of eye surgery shows 
how far medicine has progressed. 
Top right The medieval volume Augendienst by royal oculist Georg 
Bartisch of Saxony described many ophthalmological procedures, 
including a method of removing a cataract. A needle should be drawn 
across the pupil and uvea, he wrote, and then the cataract pushed 
out of the way as shown on the right hand side of the drawing. 
Above Bartisch went on to recommend that the patient be seated 
lower than the surgeon, braced by an assistant. Prior to the 
surgery, the patient should be purged and abstain from drink and 
“conjugal deeds.” 
From glass spheres that magnify letters to laser- 
driven radial keratotomy that corrects myopia, 
physicians through the centuries have sought 
devices and procedures to protect, restore and improve 
sight. Not all their ideas worked—ophthalmologists 
enjoyed a dubious reputation as “eye-destroyers” during 
the Renaissance—but one of their number, Georg 
Bartisch, wrote and illustrated what would be hailed 
as the first modern work on eye surgery. 
Published in 1583, Augendienst includes 91 woodcuts 
based on drawings by Bartisch that illustrate ailments 
and their treatments in often gruesome detail. The 
woodcuts show not only ophthalmological procedures 
prevalent in the Renaissance, but the latest fashions in 
waistcoats, caps, jewelry, coiffures and other finery. The 
author served as oculist, the medieval term for ophthal¬ 
mologist, to the court of Lord Augustus I of Saxony and 
was the first eye surgeon to practice extirpation of the 
bulbus in cancer of the eye. 
A copy of the book, from its original printing in 
1583, is part of the legacy of neurosurgeon Harvey 
Cushing, M.D., who bequeathed it to the library with 
his collection of historical medical volumes. Also in the 
library’s collection are assorted ophthalmological tools 
from the past, including wood and leather cases contain¬ 
ing antique scalpels for removing cataracts and refraction 
lenses for measuring vision. 
—-John Curtis 
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DISCOVERY 
Found in tram 
Studying the genetics of fruit flies, nematodes 
and other model organisms may greatly speed 
the search for cures for human disease. 
By Neeraja Sankaran 
8 
o. 
z 
i 
The collaboration of Allen Bale, left, and Tian Xu has led to a new 
understanding of basal cell carcinoma, the most common form of 
skin cancer. 
When cancer researcher Alien Bale, M.D., and 
his team discovered a gene associated with the 
development of basal cell carcinoma in 1996, 
he decided that if he really wanted this new knowledge 
to help his patients, the thing to do was learn more 
about fruit flies. So the associate professor of genetics 
and medicine and director of the DNA Diagnostics 
Laboratory went to work studying the genetics of 
Drosophila melanogaster in the laboratory of his genetics 
department colleague Tian Xu, Ph.D, 
Until less than a decade ago, Dr. Bale’s move from 
humans to Drosophila would have seemed startling. 
“Those connections just weren’t made,” he says. “People 
were working on fruit flies and people were working on 
humans, but they weren’t working on both/’ Today, 
moving between species has emerged as an increasingly 
necessary part of scientific research and an ever more 
common path at Yale. The result in Dr. Bale’s case was 
that he was able to open up entirely new ways of looking 
at the most common form of skin cancer in humans. 
Although Dr. Bale’s laboratory had found a link 
between the occurrence of basal cell carcinoma and the 
gene—which they named NBCCS (for nevoid basal cell 
carcinoma syndrome)—they had no idea how this 
association gave rise to the cancer. Moreover, its function 
in a normal human ceil was a complete mystery. With¬ 
out this information, it -was virtually impossible to assess 
how the cancer might be triggered through the workings 
of NBCCS. Pinpointing the function of a single gene in 
humans would be a monumental and expensive task. So 
Dr. Bale turned to Dr. Xu and Drosophila melanogaster, 
the tiny fruit fly. 
Neeraja Sankaran is a first-year graduate student in the 
History of Medicine program. 
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By comparing the genetic se¬ 
quence of NBCCS against other 
previously identified genes of the 
fruit fly, Dr. Bale eventually was 
able to find that it was structur¬ 
ally similar to a gene called 
Patched. Patched was known to 
produce a protein that controls 
the development of distinct ante¬ 
rior and posterior segments of 
the fly. Using this information, 
Dr. Bale had the key he needed 
to direct his own investigations 
into the human version of the 
Cell biologist Peter 
Novick works in 
yeast, left, to draw 
lessons about human 
function. “The funda¬ 
mental machinery 
that makes a cell a 
cell,” he says, “is es¬ 
sentially the same in 
all living organisms.” 
Below Michael Stern's discoveries in the 
species of worm known as C. elegans have 
had important implications for understand¬ 
ing how cancers grow. The top image 
shows a normal worm; the smaller one 
below has mutation in the gene that 
controls the migration of muscle cells. 
gene. “Once we could show the human gene was similar 
to Patched," he says, “we knew what other genes it would 
be likely to function with.” The NBCCS gene is now 
widely recognized as the key gene that causes basal cell 
carcinoma. Moreover, researchers have found that muta¬ 
tions in these other genes are also responsible for other 
cancers. Dr. Bale’s laboratory is now looking at the ways 
existing medicines for basal cell carcinoma affect the 
Patched gene in hopes of coming up with more effective 
treatments and, one day, a cure. 
Dr. Bale’s approach—to switch hunting grounds 
from the human genome to that of the fruit fly—is an 
example of an ever-increasing trend within the medical 
community to use simple model systems to learn about 
the function and behavior of our own genes. Transla¬ 
tional research, as this growing body of work has come 
to be known, is based on the notion that the genetic 
similarities among species—from single-cell organisms 
to humans-are far greater than the differences. 
By understanding the genetics of the simpler organism, 
investigators believe they can identify and understand 
the functioning of the shared genes in humans. Translat¬ 
ing the complex activities of human genes into the 
activities of similar genes in simpler species makes it far 
easier to interpret the biology of humans and especially 
human diseases. 
“Simple cells have much to teach us,” says Carolyn 
Slayman, Ph.D., a geneticist who is deputy dean for 
academic and scientific affairs at the medical school. 
“It is becoming increasingly clear that the basic pathways 
of cell growth and development arose very early in 
evolution and have remained virtually unchanged since.” 
The increasing availability of genome sequence informa¬ 
tion coming in from all over the world has provided a 
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major impetus for the recent explosion in translational 
research. Scientists now believe that some 80 percent 
of all human genes appear to have a functional counter¬ 
part in the fruit fly. The nematode Caenorhabditis 
elegans, whose genome size is comparable to Drosophila, 
and even the single-cell yeast Saccharomyces cerevisiae are 
some other widely used model organisms for which most 
genes have human equivalents. 
The resemblance goes beyond mere structural simi¬ 
larities of genes to entire networks and pathways inside 
the cells of different organisms. Like jigsaw puzzles that 
become more difficult and time-consuming as the 
number of pieces increases, complex organisms contain 
more genes than simpler organisms do. But the links be¬ 
tween these pieces appear to be the same. So by learning 
how the pieces fit together in simpler puzzles, scientists 
are putting together a map to guide them through the 
labyrinth of human genetics as well. “The fundamental 
machinery that makes a cell a cell is essentially the same 
in all living organisms,” says cell biologist Peter Novick, 
Ph.D. “If one can understand the basic working of a 
simpler system such as the yeast, then the rest is just a 
matter of specialization.” 
A SIMPLER APPROACH 
The high degree of evolutionary conservation among 
all species allows scientists to substitute a gene in one 
organism with its counterpart from another. Moreover, 
experimentation on humans in most of these cases is 
simply not feasible, making animal models a necessary 
substitute. Using animal models can vastly speed up re¬ 
searchers’ capacities to analyze new genes and mutations 
associated with a huge range of human diseases. The 
savings can be tremendous. Where the estimated time 
and cost for the completion of a genetic experiment on 
a mammalian system might typically run one year at a 
cost of $10,000 and take about five to io technicians, 
the same test on C. elegans or Drosophila systems can 
take a single person a matter of weeks to complete at a 
fraction of the cost. 
“As recently as io years ago we only had indications 
that the mechanisms used by these different organisms 
were related, but this is now an established fact,” says 
Michael Stern, Ph.D., associate professor of genetics in 
the Boyer Center for Molecular Medicine and a pioneer 
in demonstrating the importance of those relations. 
During his postdoctoral research at the Massachusetts 
Institute of Technology, he studied the migration of 
post-embryonic precursor muscle cells to their eventual 
locations in the adult nematode. After he arrived at Yale, 
he learned that SEM-5, a gene product of one of the 
crucial members of this pathway, looked much like a 
protein known to be important in human cell-to-cell 
communication. Probing into the sequence and struc- 
From worms and yeast, clues about human disease 
Model System Gene 
Yeast SEC 4 
Human Homologue 
Rab 
Function 
Molecular switch to control 
membrane traffic 
Potential disease target 
Blindness 
Saccharomyces 
cerevisiae GDI GDI Localization cycle necessary 
for polarization 
Mental retardation 
Nematode 
Caenorhabditis 
elegans 
Fruitfly 
Drosophila 
melanogaster 
sem-5 GRB2 
Drk GRB2 
Hif-1 
Lats 
Myosin V 
Patched 
Human Hit analog 
Human Lats 
Myosin V 
NBCCS 
Cell-to-cell communication 
Cell-to-cell communication 
Activation of p53 oncogene 
Tumor suppression 
Cytoskeletal rearrangement 
Distinguishes anterior and 
posterior segments in the 
developing fly 
Cancer 
Cancer 
Hypoxia 
Cancer 
Gricelli’s disease 
Basal cel! carcinoma syndrome 
cure of the gene, Dr. Stern found that the gene bore a 
remarkable resemblance to a human gene called C1RB2 
(Growth factor Receptor Binding protein) and also to a 
fly gene named Drk. 
The finding was useful in learning about the conser¬ 
vation of these pathways among different species, and it 
also had important implications for understanding how 
cancers grow. Further investigation showed that these 
genes helped activate the human ./for gene, which is 
found to be mutated in some 30 percent of human can¬ 
cers. What was perhaps most surprising of all was that 
either the human gene or the fly gene could functionally 
replace the worm gene. “This underscored the remark¬ 
able conservation of entire pathways that are important 
for cellular communication,” says Dr. Stern. “The know¬ 
ledge that we gain about how these pathways work in 
both systems can now be used to derive a comprehensive 
understanding of the pathway in humans. This will help 
us put together the pieces of a jumbled genetic puzzle 
that we didn’t know would fit together so elegantly.” 
By moving genes from one model organism to an¬ 
other as Dr. Stern is doing, investigators can get an ever 
more precise understanding of the fundamentals of cell 
life and, from there, cell dysfunction and human disease. 
This multi-lane, two-way street between humans 
and simple models has become a familiar path for other 
researchers around Yale. Much of the credit goes to Dr. 
Xu, who is an associate professor of genetics in Yale’s 
Boyer Center and an assistant investigator in the 
Howard Hughes Medical Institute. In his own work, he 
employs fruit flies and mice to understand the molecular 
mechanisms of human diseases. With a new genetic 
approach that he developed during his postdoctoral 
research at the University of California Berkeley, Dr. 
Xu developed fruit fly models that develop tumors and 
neurodegenerative disease. He then demonstrated that 
mice and humans also contain homologues of the fly 
genes that he identified, and that mice lacking these 
genes also develop these diseases. These models, Dr. Xu 
says, are useful not only to study the function of known 
proteins, but also to discover important regulators not 
yet revealed by other methods. 
OXYGEN AND THE BRAIN 
Cancer is not the only domain in which translational 
research holds promise. Gabriel Haddad, M.D., chief of 
respiratory medicine in the Department of Pediatrics, 
frequently sees children experiencing breathing difficul¬ 
ties and associated problems due to respiratory ailments. 
Also a professor of cellular and molecular physiology, he 
has long been exploring how and why the different types 
of cells in the body respond differently to a lack of oxy¬ 
gen. “Nerve cells in particular are sensitive to oxygen 
deprivation,” he says. “The brain for example will suffer 
irreversible damage if the oxygen or blood supply is cut 
off for even five to 10 minutes. In contrast, the cells of a 
newly born animal and cancer cells show considerable 
tolerance to the lack of oxygen.” 
In the hope of developing ways to prevent or 
minimize the damage to brain cells under conditions of 
hypoxia (low oxygen), such as happens during a stroke, 
Dr. Haddad began to investigate the molecular pathways 
- tl. 
Gabriel Haddad, left, turned to the Xu lab to learn about Drosophila 
genetics in an effort to better explain how nerve cells respond to 
oxygen deprivation. The research relates directly to stroke and 
respiratory disease. Above: Drosophila chromosomes taken from 
the salivary glands. 
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triggered by these conditions. “We were able to carry out 
some tests in tissue cultures but in order to understand 
the true progression of events we needed living systems,” 
he recalls. He began his studies on a species of turtle able 
to withstand oxygen deprivation for several months. 
His aim was to understand how its cells could withstand 
such a long period without oxygen. While these animals 
were useful for figuring out some of the physiological 
aspects of tissue hypoxia, they were not easily amenable 
to advanced molecular approaches. Consequently, he 
considered alternative models. Six years ago, he began 
looking into the Drosophila system. “It not only had 
the advantage of being an ideal genetic system,” he 
says, “but also was extremely tolerant to hypoxia— 
demonstrating the ability to recover even after hours 
of oxygen deprivation.” 
A clinician by training, Dr. Haddad needed to 
broaden his knowledge. Like Dr. Bale, he turned to Dr. 
Xu’s lab to learn the practicalities of working with the 
fruit fly before launching a full scale investigation in 
his own laboratory. He is now investigating the hypoxia 
response on the fruit fly model via a number of 
approaches. He explains: “One of the methods is to 
try and identify genes that help the flies recover from 
oxygen depletion. To this end, we have selected for 
mutants that are highly sensitive to oxygen deprivation 
and we are zooming in at the moment on a few muta¬ 
tions that produce this effect.” His laboratory is also 
trying to identify similar genes in the mammalian and 
human genome. “Given the fact that flies and mammals 
have very similar genes for so many different functions 
such as ion channels and embryonic development, it is 
quite likely that they will also share genes in pathways 
that are relevant to oxygen deprivation.” Eventually, Dr. 
Haddad envisions the development of biochemical 
therapies for stroke and other conditions that could 
induce anoxia tolerance in human cells to minimize 
damage in sensitive areas of the body. 
Basic researchers also find they can benefit from 
switching between model systems. Lynn Cooley, Ph.D., 
associate professor of genetics, studies the building of 
the cytoskeleton during development in fruit flies. Her 
findings may have fundamental implications in under¬ 
standing the behavior of cancer cells in humans, because 
they undergo significant rearrangements in their struc¬ 
ture during the growth and metastasis of a tumor. “To 
understand the underlying biology,” she says, “one really 
has no choice but to turn to a model system.” 
Even the most basic, one-cell organism shares fun¬ 
damental genetic properties with humans. The complete 
yeast genome sequence is now available. Furthermore 
most of the expressed genes of mammalian cells have 
Lynn Cooley’s study of the 
development of the fruit fly 
cytoskeleton has fundamental 
implications for cancer 
metastasis. 
been identified. “Once we are able to see what a gene 
does in the yeast,” says cell biologist Dr. Novick, “we 
can apply principles of reverse genetics to look for the 
function of the homologues.” 
Dr. Novick’s own research explores the mechanisms 
by which the yeast cell secretes different proteins from 
specific locations on the cell membrane. “This property 
of cellular polarization has very obvious relevance in cells 
like neurons and epithelial cells,” he says. “For instance, 
if an epithelial cell in the lining of the digestive tract were 
to secrete the enzymes in the wrong direction, you would 
destroy your own tissues rather than digest the food.” 
To date, his investigations in yeast have turned up 
more than a dozen genes with human homologues for 
polarization alone. Six of these genes are produced as 
one big complex, which have been found to be involved 
in the polarization of cells in the lining of the kidney. 
Mutations in other proteins that interact with these 
gene products have been implicated in diseases such as 
retinal degeneration leading to blindness and one form 
of mental retardation. 
What of the future? By all indications the different 
model systems continue to yield useful results with 
increasing relevance to many human diseases. Says Dr. 
Slayman: “These days a researcher who finds a new 
human gene will immediately look for homologues 
in fruit flies, yeasts or nematodes where functional 
experiments are much easier. Conversely, a scientist who 
finds a new yeast or nematode gene will rush to find a 
human homologue which may offer a clue to a known 
human disease.” Its all there, it seems, if only the right 
translations can be found. DEI 
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OPHTHALMOLOGY 
A vision for vision 
With new emphasis on retinal disease, research and the community, 
Yales ophthalmology departmentfinds its focus. 
N NOVEMBER 1996, when Bruce Shields arrived 
as the new chair of the Department of Ophthalmology 
and Visual Science, he had his work cut out for him. 
While Yale remained a world leader in vision research 
and the treatment of glaucoma, the department had sig¬ 
nificant problems to solve. With the advent of managed 
health care, reimbursement rates for clinical services 
were dropping, with no end in sight. At the same time, 
insurers began moving to redirect all but the most com¬ 
plex eye-care cases back to primary care physicians. Fac¬ 
ulty had to increase their patient load to compensate for 
the reimbursement deficit, and the more difficult 
caseload had begun to cut sharply into teaching time. 
“Ophthalmology,” says Dr. Shields, “was hit as hard as 
any specialty.” 
Meanwhile, the future of funding for all biomedical 
research was under fierce debate in Washington. As aca¬ 
demic medicine faced its most serious challenges in de¬ 
cades, the ophthalmology department was without per¬ 
manent leadership. Two acting chairs forged ahead as 
Yale searched for a successor to glaucoma pioneer 
Marvin Sears, who had stepped down as chair in 1993. 
Two years after Dr. Shields’ arrival, the department 
still faces challenges but a plan is in place. Faculty have 
worked together to define a concise mission for the de¬ 
partment, which has launched new programs and re¬ 
cruited promising young faculty to its ranks. One of Dr. 
Shields’ first decisions was to strengthen Yale’s expertise 
in retina care and research, with the goal of creating a 
world-class program as the department has done with 
glaucoma since the 1960s. 
Other new programs are in the works. Cooperation 
among community ophthalmologists, Yale-New Haven 
Hospital and the School of Medicine led to the estab¬ 
lishment this summer of the Yale-New Haven Eye Laser 
Center, which specializes in refractive surgery to correct 
nearsightedness and astigmatism. The department has 
transformed its residents clinic—a concept that has be¬ 
come outmoded in modern academic medicine—into a 
comprehensive eye service that has solved part of the pri¬ 
mary care-referral problem while eliminating a two- 
tiered system that had channeled indigent patients to the 
care of physicians-in-training. Another initiative has 
been the establishment of a low-vision center to offer 
practical help to patients whose poor vision cannot be 
improved. Meanwhile, Dr. Shields is cultivating alumni 
of the residency program to increase their involvement 
in departmental activities, enhancing continuing medi¬ 
cal education, and devoting time to fund-raising. 
An authority in glaucoma like his predecessor, Dr. 
Shields speaks enthusiastically about maintaining excel¬ 
lence in glaucoma research and specialized care. His own 
research has been devoted to the development of new la¬ 
ser treatments for advanced forms of the disease. Focus¬ 
ing on retina, too, makes sense not only financially, he 
says, but also in terms of public service. “When we 
talked with ophthalmologists in the community, one of 
their messages was that Yale should strive to offer ser¬ 
vices that aren’t readily available elsewhere,” he says. 
“Glaucoma and disorders of the retina are two major 
disciplines in ophthalmology that account for most of 
the blinding disorders in this country. They also repre¬ 
sent areas of significant technological advances and the 
promise of better care.” stories begin on page 22 
2 O FALL 1998 
in this report Saving the retina 22 Facts about vision 
loss 23 Lessons from jellyfish 25Q&A: Bruce Shields 28 
Timeline 28 Glaucoma breakthroughs 30 Reshaping the 
eye with lasers 33 AIDS and the preservation of sight 34 
Workarounds for low vision 34 
YALE MEDICINE 
B
A
C
K
G
R
O
U
N
D
: 
Y
A
LE
 
O
PH
T
H
A
L
M
O
L
O
G
Y
_
R
O
B
E
R
T
J
J
_
S
A
K
 
The retina 
From the smallest infants to the oldest patients, 
new approaches to retinal disease are 
repairing disorders of this delicate layer 
of sight-giving tissue. 
By Julie Miller 
Born more than three months prematurely in April 
1997, twins Rosalie and Alexander Comfort 
weighed a pound and a half each, suffered from 
respiratory distress and faced the serious possibility of 
losing all or most ol their sight. Along with their early 
delivery at only 24 weeks came exposure to a rare condi¬ 
tion known as retinopathy of prematurity, in which 
normal formation of blood vessels in the retina is 
interrupted. “The worst case,” says their father, Tim 
Comfort, a chief petty officer in the Navy, “was that 
they would be able to see only shapes. The best was that 
with surgery, they would have very good, useable vision.” 
Until recently, little could be done to prevent retin¬ 
opathy of prematurity, or ROP. Although 80 percent of 
cases typically resolve themselves without intervention, 
more than 500 infants a year are blinded by this disorder, 
in which the retina can be torn from its base by the pres¬ 
sure of rampaging capillaries. But with better screening 
in place, physicians are able to identify most infants at 
risk for the syndrome and prepare for a critical 72-hour 
window in which preventive treatment can be given. 
In the Comfort family’s case, that moment came in 
late July 1997, when their ophthalmologist in New 
London saw the first signs of impending retinal detach¬ 
ment and referred them to Yale. Two days later, associate 
professor Kathleen Stoessel, M.D., performed a proce¬ 
dure called cryopexy on the tiny infants, then only 
eight weeks old and still a month shy of their due date. 
One of several tools in the ophthalmologist’s arsenal, 
cryopexy freezes the rear portion of the retina, causing 
the threatening vessels to shrivel harmlessly away. The 
twins left Yale for Lawrence and Memorial Hospital in 
Julie Miller is a writer in North Stonington, Conn. 
New London, and returned home to rural Uncasville, 
Conn., soon after with their sight intact. 
The retina, a critical link in the complex chain that 
turns light into sight, is the thin layer of tissue that 
generates nerve impulses from the stimulus of light and 
dark. When all is in good working order, words on a 
page or the view from our window reach the brain with 
perfect clarity. When retinal problems arise, the cause 
most often is the abnormal growth of the minute blood 
vessels within the retina. While not all cases are revers¬ 
ible, many once-discouraging cases respond to advanced 
techniques being applied at Yale, including cryopexy and 
laser surgery. Moreover, new diagnostic tools such as 
digital angiography are enabling ophthalmologists to 
diagnose retinal disorders earlier and more precisely than 
ever before—and to intervene before sight is lost. 
More than any other group of vision disorders, reti¬ 
nal disease affects patients along an extremely wide span 
of ages. Retinopathy of prematurity affects tens of thou¬ 
sands of infants born in the United States every year, al¬ 
though it spares most of them the loss of sight. Diabetic 
retinopathy, which is more widespread, is the leading 
cause of serious visual impairment among Americans be¬ 
tween the ages of 20 and 64. And age-related macular 
degeneration is the chief cause of moderate to profound 
visual loss among adults over age 60 in the United States. 
► 24 
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Facts about vision loss 
Retinal disorders, which are among the leading causes of blindness in 
the United States, span the generations from infancy to the later years 
of life. Twins Rosalie and Alexander Comfort, top right, were born with 
retinopathy of prematurity while Theresa Kalman, above, developed the 
disease in midlife as a complication of diabetes. Eighty-six-year-old 
Hazel Swift, top left, was treated by Kathleen Stoessel for macular 
degeneration. 
Right The retina lines the inside of the eyeball with photoreceptive 
cells, known as rods and cones, that convert light into nerve im¬ 
pulses. The macula distinguishes fine detail at the center of the 
field of vision. 
► 
► 
► 
► 
► 
► 
► 
► 
► 
Almost all blindness in the United States is the 
result of common eye diseases. Less than 3 
percent is the result of injuries. 
100 million Americans are visually 
disabled without corrective lenses (70 
million are myopic). 14 million have 
severe visual conditions not 
correctable by glasses. 
80 million people in the United 
States alone are afflicted 
with potentially blinding eye 
disorders and the majority 
are visually disabled 
without glasses. 
12 million are handicapped 
by motor sensory diseases 
such as amblyopia and 
strabismus. 
11 million experience corneal 
disorders including 
herpes and dry eye. 
5.5 million have cataracts 
that obstruct vision. 
2.8 million are colorblind. 
2.3 million endure visual loss from 
inflammatory diseases such as uveitis. 
1.1 million are legally blind. 
All statistics refer to United States 
Source: Research to Prevent Blindness 
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IN MIDLIFE, AN ASSAULT FROM DIABETES 
The Comfort children’s bout with retinopathy demon¬ 
strates the fragility of the retina early in life, when 
immature vessels are most at risk for disturbance. In 
midlife, retinal disease occurs most often among people 
with diabetes. Excessively high blood-sugar levels can 
damage small blood vessels in the eye, particularly in the 
retina, says Dante Pieramici, M.D., assistant professor of 
ophthalmology. Some of the blood vessels close com¬ 
pletely, while others leak fluid or blood into the retina. 
The retina becomes wet and swollen and fails to work 
properly. New vessels grow abnormally in the places 
where others have closed, causing further bleeding, scar¬ 
ring and retinal detachment that can result in blindness. 
In some ways, this process is a mystery. “We don’t 
know the actual connection between diabetes and dis¬ 
ease of the small blood vessels. What we have learned is 
that keeping tight control over blood sugar levels signifi¬ 
cantly reduces the chances of diabetes complications in 
the eye, and if you have complications already, it reduces 
the chances ol their becoming worse,” Dr. Pieramici says. 
Theresa Kalman was not prepared lor the damage 
diabetes did to her eyesight. The 53-year-old woman, who 
also has cardiovascular and kidney problems, awoke one 
morning unable to see. Her only warning had come the 
day before, when vision in one eye was cloudy. For the 
next several months, family members helped her negoti¬ 
ate a suddenly unfamiliar house and tend to the daily 
necessities of living. A series of visits to local doctors pro¬ 
duced no clear explanation for the sudden loss of sight. 
Dr. Pieramici’s diagnosis was severe diabetic retin¬ 
opathy in both eyes. He surgically removed a portion of 
the vitreous gel, along with the abnormal blood vessels 
and scar tissue. Once cleared of debris, the retina could 
be reattached. The surgeon also removed a cataract and 
placed an artificial lens in one eye. While the chances for 
partial success were good, he says, “We weren’t sure how 
much vision she would get back. We had to see how 
much damage there was to the retina.” 
Mrs. Kalman’s recovery was the happy kind. Several 
days after surgery, she could see well enough to read, 
watch television and care for herself again. For the first 
time in five months she saw her 16-month-old 
grandson’s face. “It was amazing,” she says. “I cried.” 
Faser and surgical treatments have reduced the 
incidence of legal blindness in patients with severe dia¬ 
betic retinopathy from 50 percent to less than 5 percent, 
Dr. Pieramici notes, adding that Yale helped develop 
many ol the advanced laser techniques during the past 
20 years as a center for clinical trials. In addition, trials 
are being designed for surgical techniques to treat 
patients with chronic swelling of the retina that fails 
to respond to laser treatment. 
As remarkable as these interventions are compared 
to what was available to patients only a few years ago, 
the laser is still an invasive tool and can damage the 
retina. As molecular biology provides more tools for 
drug development, ophthalmologists are hopeful that 
new medications will provide less damaging ways of 
treating abnormal blood vessel growth. 
A PUZZLE OF THE AGING PROCESS 
One day four years ago, Hazel Swift noticed a blurring of 
vision in her left eye. When an exam revealed swelling in 
the macula near the center of the retina, Mrs. Swift, now 
86, went to see Dr. Stoessel. An angiogram confirmed 
the presence of an abnormal blood vessel in the macula, 
the area responsible for central vision and the sharp, 
fine-detail sight that is crucial to reading and driving. 
Age-related macular degeneration is the most com¬ 
mon cause of vision loss among people over 65. In Mrs. 
Swift’s case, the presence of the abnormal blood vessel 
indicated the more destructive “wet” form of the disease 
in her left eye. “Dry” macular degeneration was diag¬ 
nosed in the right. In the wet form, errant vessels from 
the wall of the eye make their way through the pigment 
layer and can slip under the retina. The vessels leak fluid 
or blood around the macula and damage sight. The hall¬ 
mark of the more common dry macular degeneration Is 
the atrophy of pigment cells, which appears as yellow 
spots in the retina. 
During the delicate laser surgery that followed, Dr. 
Stoessel cauterized the abnormal vessel in Mrs. Swift’s 
left eye in an attempt to prevent further damage. But 
over the past several years, additional laser treatments 
► 27 
Retinopathy and 
macular degeneration 
A normal eye, far left, is compared to those 
damaged by diabetic retinopathy, middle, 
and macular degeneration, left. Errant blood 
vessels in the patient with diabetes leak fluid 
or blood into the retina, threatening sight. 
In macular degeneration, injury to the macula 
appears as a sea of small yellow spots. 
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Lessons from the lab 
From the eyes of newts to the green glow of the jellyfish, 
clues to the mystery of sight. 
F'ifty years ago, a Yale scientist named Leon 
Stone made a remarkable discovery about 
the vision of newts. If the eye is dislodged 
and then reattached, the retina not surprisingly 
is destroyed. But in the newt, unlike humans, 
the cells of the retina grow back and sensitivity 
to light returns. Dr. Stone’s newts could regen¬ 
erate retinal cells even when the eyes were com¬ 
pletely removed and then put back. 
Why should newts regain their sight while 
humans and other mammals lose it forever to 
injury or disease? What other clues 
from simpler organisms might there 
be to lead us to new treatments for 
vision loss? And on a much more ba¬ 
sic level, how is it that we are able to 
convert the patterns of a million pho¬ 
tons into images in our mind’s eye? 
These questions drive the work of 
the Visual Neuroscience Program at 
Yale, where basic scientists pursue 
knowledge that may some day provide 
new and better treatments for retinal 
disorders. In addition to the explosion in molecular biol¬ 
ogy and genetics that promises to shed light on all hu¬ 
man disease, basic research in ophthalmology benefits 
from an extremely rich base of knowledge generated over 
the past 150 years. 
“More is known about the vision pathway than any 
other part of the nervous system,” says Colin Barnstable, 
D.Phil., professor of neuroscience and director of re¬ 
search at the Yale Eye Center. “Because vision is so im¬ 
portant to us as humans, it has led to a fascination of 
how sight works. Scientists have been at it for centuries.” 
Basic research at Yale is relevant to many of the 
degenerative diseases that rob sight. In their efforts to 
learn more about retinal disorders, researchers at Yale are 
focusing much of their attention on the photoreceptor 
cells, known as rods and cones, that process light energy. 
Macular degeneration involves the loss of cone photore¬ 
ceptors in the central part of the visual field, and retini¬ 
tis pigmentosa is caused by loss of rod photoreceptors 
that are used for night vision. Many forms of retinitis 
Colin Barnstable, director of research at the Yale Eye Center, is apply¬ 
ing molecular tools to a discovery made 50 years ago by Yale anato¬ 
mist Leon Stone, left. Stone’s research in newts suggested a means 
of restoring retinal cells. 
pigmentosa are caused by mutations in rod photorecep¬ 
tor genes associated with the conversion of light energy 
into electrical nerve signals. 
“We’re asking how a change in the protein leads to 
the death of the cell. Once we understand the sequence 
of events, we can design therapies to stop the death of 
the photoreceptor,” says Dr. Barnstable. Much of his 
research centers on transcription factors, proteins that 
regulate the expression of other genes in photoreceptors. 
Scientists around the world have isolated transcription 
factors in which mutations may be causing photorecep¬ 
tors to degenerate. Dr. Barnstable and M.D./Ph.D. stu¬ 
dent Julian Martinez recently isolated a transcription 
factor named Erx that regulates the expression of 
rhodopsin, the light sensing molecule in rods. It is pos¬ 
sible that mutations in Erx itself may cause some forms 
of retinitis pigmentosa. On a broader level understand¬ 
ing how genes like Erx work may lead to identification 
of new targets for drug or gene therapy. 
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A time-lapse series of images, left, 
shows the movement of a protein 
known as Sec 3 during the life of a 
yeast. By tagging the proteins with 
a fluorescent reporter produced in 
jellyfish, Thomas Hughes, below, 
and colleagues are able to discern 
the function of certain genes 
relevant to vision more quickly 
than ever before. 
A FLUORESCENT MARKER 
Five years ago, scientists at Columbia University found 
they could use an unusual substance produced by jelly¬ 
fish to follow the activities of gene products within cells. 
This green fluorescent protein, or GFP as it is known to 
researchers today, showed enormous potential as a re¬ 
porter—a detectable molecule that allows scientists to 
take a snapshot of a cell and determine the movement 
and function of proteins within it. 
What was new about GFP was that for the first 
time one could study function without killing the cell, 
as previous reporter techniques based on antibodies had 
required. Instead of a snapshot, scientists now had a 
movie to study for clues to the inner working of genes 
and the proteins they expressed. 
Yale scientist Thomas Hughes, Ph.D., was among 
the first to recognize the potential of the GFP reporter 
and to develop techniques for its use, in particular for 
the study of mammalian genes. “The [NIH-sponsored] 
Human Genome Project promises to reveal the sequence 
of every human gene by the year 2005,” says Dr. 
Hughes, associate professor of ophthalmology and visual 
Thomas Hughes 
science, and of neurobiology. “Having all the sequences 
is comparable to having all the books in a library. The 
problem is, we don’t have a card catalog. We don’t know 
what the genes do yet, just that they’re there.” 
Dr. Hughes and his team have tacked GFP onto the 
proteins expressed by genes in cells from organisms as 
varied as yeast and human and watched them light up 
as they travel to the nucleus, the cell surface, or the 
cytoskeleton, for example. “By fusing GFP to these 
proteins,” he says, “we can learn where these genes are 
in the cell and how they are used—in a matter of two 
days instead of the months it used to take.” 
POTENTIAL FOR TRANSPLANTATION 
While a better understanding of transcription factors 
and gene products may someday help prevent degenera¬ 
tive diseases that destroy sight, another strategy is 
needed to help the large group of patients who have 
already lost the photoreceptor cells that make vision 
possible. One avenue being explored is the transplanta¬ 
tion of cells to rebuild the damaged retina. For this to 
work, a source of photoreceptors needs to be identified. 
Dr. Barnstable had long known of the work of Leon 
Stone with newts and wondered how the retina could 
regenerate. What genes might humans hold in common? 
Would it be possible, he wondered, to transform the 
pigmented cells that lie behind the retina and turn them 
into functioning photoreceptors? 
Working in mice, the early results of research in this 
area have been encouraging. “So far,” Dr. Barnstable 
says, “we have been able to take these cells and turn 
them into retinal cells using a cocktail of growth factors. 
We also have a mouse strain in which a single mutation 
causes this to happen spontaneously.” 
Understanding how to control this process might 
allow some degree of vision restoration for patients who 
have lost their sight. And while transforming pigment 
cells into functioning photoreceptors that can detect 
light might sound fantastic, it’s not that far-fetched. “The 
trillions of cells that make up the human body,” says Dr. 
Barnstable, “were initially derived from a single cell.” 
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have been required to treat abnormal vessels that devel¬ 
oped from the underlying macular degeneration. Al¬ 
though her left-eye vision is blurred, management of her 
right eye has been more successful. Despite its progres¬ 
sion from dry to wet form of the disease, the right eye 
has responded well to laser treatment. Two years ago, a 
buildup of blood and fluid in the macula of her right eye 
was treated promptly with laser, and her blurred vision 
has improved and been stable for more than a year. 
Mrs. Swift, who lives alone, has a life filled with 
friends, church activities and three grandchildren. With 
the help of glasses, her eyes still work. She lives indepen¬ 
dently, drives a car, cooks, reads and enjoys watching 
birds at the feeder in her back yard. Her sight is gener¬ 
ally good, she feels, despite the loss of central vision on 
the left side. “When I put my glasses on,” she says, “I’m 
not really aware of it.” 
More than 90 percent of patients with macular de¬ 
generation have the dry form, for which there is no ef¬ 
fective treatment, according to the National Eye Insti¬ 
tute. Laser treatment, the only proven therapy for the wet 
form, is most effective if the condition is diagnosed early. 
The incidence of macular degeneration increases 
dramatically with age. Whereas fewer than 10 percent of 
people have significant macular changes at age 65, nearly 
50 percent have some degree of change at age 80, says 
clinical faculty member David Parke, M.D. “The impor¬ 
tance of these figures takes on even greater meaning as 
we tend to live longer.” 
Many people in their 70s and 80s develop signifi¬ 
cant macular disease, while others show little evidence 
of it. “If we knew which variables were involved in pre¬ 
venting macular degeneration in some patients, there is 
the potential that they could be used as a treatment to 
prevent the growth of abnormal vessels,” says Dr. 
Stoessel. “We have to examine the growth factors that 
allow blood vessels to develop normally and the factors 
that prevent too much blood vessel growth. We need to 
understand these better in order to learn what goes 
wrong when children are born prematurely with stunt¬ 
ing of the retinal blood vessels. The growth factors in 
retinopathy of prematurity may turn out to be similar 
to the growth factors in macular degeneration.” 
LOOKING TO THE FUTURE 
The chief of the department’s retinal service is looking at 
precisely that question in the laboratory. Like his coun¬ 
terparts in other disciplines including cancer biology and 
cardiovascular research, Ray Gariano, M.D., Ph.D., is 
interested in the process of angiogenesis—the formation 
and differentiation of blood vessels—as a potential area 
for intervention. His approach as an ophthalmologist 
has been to study in utero the development of retinal 
blood vessels to learn what growth factors regulate nor¬ 
mal blood vessel growth. “What’s exciting,” he says, “is 
that one molecule has been implicated in both normal 
angiogenesis and the abnormal blood-vessel growth that 
occurs in retinal disease. We’re getting closer to a much 
better understanding of the process.” 
More than a year has passed since Rosalie and 
Alexander Comfort’s eyes were treated with cryopexy. 
The retinal vessels have regressed, and the children, now 
17 months old in late September, are doing well. Alex 
had surgery at the end of August on his eye muscles. 
He is doing well but is frustrated at having to wear eye¬ 
glasses for nearsightedness, which is common among 
children with retinopathy. “Now the biggest challenge is 
keeping his glasses on. He has the habit of flinging them 
off,” says his mother, Diana Comfort. They keep two 
pairs around the house because they never know where 
his glasses will end up. 
Rosalie doesn’t wear glasses and didn’t need the sur¬ 
gery. Like her brother, her development seems to have 
been delayed slightly by weaker eyesight, but both chil¬ 
dren seem to be catching up. The Comforts, who also 
have a 4-year-old daughter, are happy with the twins’ 
progress. And while they had hoped Alex wouldn’t need 
glasses, they feel good about his future. “He’ll be able to 
see. Without some kind of vision, he would be very lim¬ 
ited,” says his father, who looks forward to introducing 
his son one day to the outdoor pursuits he enjoys. “I like 
to hunt and fish, and I want to take him along.” QE] 
A year after his initial treatment for retinopathy, Alexander Com¬ 
fort sees well with the aid of corrective lenses. “Now the biggest 
challenge is keeping his glasses on,” his mother says fondly. “He 
has the habit of flinging them off.” 
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Q&A:BRUCE SHIELDS 
Over a few short decades, 
dazzling advances in the 
study of vision 
The advances in medical technology that have 
taken place over the past century would have 
dazzled the physician of the early 1900s, says 
M. Bruce Shields, M.D., chair of the Department of 
Ophthalmology and Visual Science. Comparing his 
early days as a physician with the era in which his grand- 
lather, a physician in Oklahoma, began his practice, 
Dr. Shields says: “My grandlather made house calls on 
horseback. I began practicing medicine in the U.S. 
Navy on a nuclear submarine.” 
Dr. Shields, who is 57 and a trim 6 feet 2 inches tall, 
was born and raised in Oklahoma. He is one of five 
physicians in his family. In addition to his grandfather, 
his brother is a physician in rehabilitative medicine, and 
two uncles were ophthalmologists. 
You came to Yale in November 1996. What has changed in 
the department since then? Because retinal diseases such 
as diabetic retinopathy and macular degeneration are 
among the leading causes ol blindness in this country, 
our plan has been to broaden our emphasis significantly 
in this area ol ophthalmology. We’ve added to our 
clinical laculty and strengthened the clinical service with 
support Irom our group ol researchers. Retinal diseases 
and glaucoma encompass the majority ol blinding disor- 
“The linkage of computers with lasers has been truly remarkable,” 
says department chair Bruce Shields, “allowing us to perform 
diagnostic procedures that were impossible before." 
ders in this country. Over the past year, I surveyed 
ophthalmologists around the state to learn how we can 
provide better services in the community. A frequent 
response was that we need to provide clinical services 
that are not readily available in the community. That's 
one of the things were trying to do. 
What lies ahead? Well, first, to continue the aspects 
of the department that have been historically strong. 
Yale has been known for its excellence in research, so 
A history of ophthalmology at Yale 
1876 
Yale School of 
Medicine intro¬ 
duces ophthalmol¬ 
ogy as a separate 
subject in the 
;||||§&^m. Arthur 
" BrooRyh lectures 
the medical 
students. 
1884 
The New Haven 
Dispensary orga¬ 
nizes a separate 
eye clinic under 
William Carmalt. 
who also practices 
general surgery. 
1895 
Henry W. Ring 
becomes chief of 
the Section of 
Ophthalmology. 
1914 
Arthur Ailing is 
made section 
chief. 
1935 
Eugene Blake 
assumes leader¬ 
ship of the section. 
Dr. Blake has a 
special interest in 
glaucoma and will 
organize major 
glaucoma screen¬ 
ing programs in 
Connecticut. 
1948 
Yale anatomy 
professor Leon 
Stone publishes 
studies in newts 
demonstrating 
that retinal cells 
are capable of 
regenerating. 
1951 
Rocko Fasanella 
becomes chief of 
the ophthalmology 
section and estab¬ 
lishes the first 
residency training 
program. Gregory 
Flynn is the first 
trainee. 
1961 
Marvin Sears joins 
as the first full-time 
chief of ophthal¬ 
mology. still a 
section in the 
Department of 
Surgery. 
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one of our goals for the future is to expand that area. 
Secondly, I’m devoting a large amount of time to 
making our education programs for residents, fellows 
and medical students among the best in the country. 
We also plan to continue increasing our clinical services 
to the community. Were growing in stature as the 
tertiary center in Connecticut for eye problems, and 
we’re trying to structure that in a way that will be 
financially sound for the institution. 
What are some of the current trends in ophthalmology? 
What strikes me is the progress in technology, specifi¬ 
cally laser technology. So much of the surgery we do 
today is with a laser beam rather than a scalpel. Eye 
surgeons were the first to apply this technology to medi¬ 
cine, first in the treatment of retinal disorders and then 
in the management of glaucoma. Later applications have 
included surgery of the eyelids and refractive surgery, in 
which we reshape the front of the eye to eliminate the 
need for glasses or contact lenses. 
The application of computer technology represents 
another major advance for functions such as measuring a 
patient’s field of vision. The linkage of lasers with com¬ 
puters has been truly remarkable, allowing us to perform 
diagnostic procedures that were impossible before. One 
example is image analysis ol the optic nerve for diagnos¬ 
ing glaucoma, in which a laser beam scans the nerve 
tissue, while a computer analyzes the data and creates 
three-dimensional images of the tissue. Computers are 
also used to guide therapeutic laser beams for delicate 
reshaping of the cornea in refractive surgery. 
The development of optical systems has allowed us 
to diagnose eye conditions more precisely than before 
and to perform delicate operations by providing infor¬ 
mation that cannot be obtained with the naked eye. 
There also have been remarkable advances in phar¬ 
macology, especially in glaucoma treatment. There are 
now six categories of eye drops for treating glaucoma, 
most of which have been developed since the pioneering 
work with timolol in the 1970s in which Dr. Sears 
played a major role. Other advances in ocular pharma¬ 
cology include new medications to treat infection and 
inflammatory disorders of the eye. 
What interests you most about your work? My life’s work 
has centered on my chosen subspecialty, glaucoma, 
which represents a large group of disorders. After my 
residency in ophthalmology at Duke, I completed a 
fellowship in glaucoma at Massachusetts Eye and Ear 
Infirmary in Boston. Then I returned to Duke, where 
I was a member of the faculty for 22 years and director 
of Duke’s glaucoma service. In recent years, I have been 
developing laser treatments for the most advanced types 
of glaucoma. If there’s one thing I’ve enjoyed most about 
my profession, it’s teaching. 
How did you come to be a physician? I was born in 
Okmulgee, a small town just outside Tulsa, Okla. 
My family moved to Enid when I was 4, and I grew 
up there. The wide, open spaces and wheat fields of 
Oklahoma were a good place for a boy to grow up. 
I met my wife, Sharon, while I was attending 
Oklahoma University School of Medicine, and she was 
a student at the university’s nursing school. We married 
after graduation in 1966 and have two children. Sarah, 
25, is a student at Elon College in North Carolina, and 
John, 24, attends Tulane University in New Orleans. 
We live in Hamden. 
As for entering medicine, I thought about many 
things, including law and business, but felt that being a 
physician was the most challenging thing I could do 
with my life. 
1971 1978 1979 1986 1993 1995 1996 
Dr. Sears creates Timolol, based Establishment of Opening of the Joseph Caprioli Caleb Gonzalez Bruce Shields 
the Department of on Dr. Sears’ the Connecticut Yale Eye Center. appointed acting appointed acting joins as chair 
Ophthalmology and research, is Lions Glaucoma chair. chair. and the Marvin 
Visual Sciences approved by the Research Center Sears Professor of 
and serves as the FDA for glaucoma for advanced Ophthalmology. 
first chair. treatment. glaucoma 
research. 
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Explaining glaucoma 
New studies in gene expression, 
neural signaling add to a solid core 
of basic research. 
LENS 
\ FLUID EXITS HERE 
FLUID FORMS HERE 
Glaucoma can result from a buildup of pressure within 
the eye when fluid between the iris and cornea is un¬ 
able to drain freely, ultimately damaging the optic nerve. 
When Marvin Sears, M.D., came to Yale in 1961 
to head the eye service, ophthalmology occu¬ 
pied 130 square feet in the Department of 
Surgery and had one full-time faculty member: a young 
recruit from Hopkins named Marvin Sears. 
Under his leadership during the next three decades, 
ophthalmology developed into a full-fledged department 
with top-flight research and clinical care, culminating in 
the opening of the Yale Eye Center in 1986. Under Dr. 
Sears, Yale turned out specialists in eye care and visual 
science who went on to lead their own departments 
around the United States, Europe and Japan. 
Much of that excellence revolved around glaucoma, 
a disease that affects 3 million Americans and has 
blinded more than 120,000 people in the United States 
alone. Dr. Sears started the glaucoma service at Yale and 
has devoted his research to explaining how glaucoma in¬ 
creases pressure within the eye with such devastating re¬ 
sults. His work in adrenergic pharmacology made Yale 
an international center for glaucoma treatment and led 
to the development, and FDA approval in 1978, of 
timolol, the first useful topical medication for glaucoma 
since 1908. He also developed two innovative 
surgical procedures for clot removal and tumor removal 
from the eye, used worldwide. 
Although Yale is now branching out into other areas 
of ophthalmology—retinal treatment and research in 
particular—new department chair Bruce Shields is a 
dyed-in-the-wool glaucoma specialist, and pupil of 
Sears. “When I was studying to become an ophthal¬ 
mologist, his writings and teachings were already part of 
the foundation of our understanding,” says Dr. Shields, 
who headed the glaucoma service at Duke before com¬ 
ing to Yale in 1996. Dr. Shields was named the first Sears 
Professor of Ophthalmology and Visual Science in 1997. 
Glaucoma damages vision in most cases by increas¬ 
ing pressure inside the eye through the buildup of fluid 
known as the aqueous humor. In the most common 
form, open-angle glaucoma, fluid between the iris and 
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Glaucoma research pioneer Marvin Sears at the bench in the 1970s, when his work in 
pharmacology made possible the development of timolol. 
cornea is unable to drain freely and 
ultimately exerts pressure on the optic 
nerve at the rear of the eye. If this 
pressure is not relieved over time, pe¬ 
ripheral vision begins to fade and can 
progress to blindness. 
Dr. Shields says that despite new 
areas of focus, “we are very committed 
to maintaining excellence in glaucoma 
and continuing to build there.” Physi¬ 
cians and scientists in the department 
are exploring several promising lines 
of research. For example, Yale re¬ 
searchers have found that mutations 
in a gene called myocilin (also known 
as TIGR) affect the drainage of aque¬ 
ous humor from the eye in many pa¬ 
tients with glaucoma. Yale scientists 
also have found expression of the gene 
in the ciliary body, which produces 
the aqueous humor. 
The myocilin gene encodes a pro¬ 
tein critical to structures in the eye 
that regulate pressure. Its discovery 
may be useful in identifying people at 
risk for glaucoma before they begin to 
lose their sight. Because symptoms of 
glaucoma often do not appear until 
the disease has progressed, early diag¬ 
nosis is important. “In the future there may be great 
value in detecting whether or not a person carries 
these gene mutations,” says Miguel Coca-Prados, Ph.D., 
professor of ophthalmology and visual science, in 
whose laboratory the myocilin gene research is 
being conducted. 
Pressure within the eye follows a circadian rhythm, 
rising during the day and falling at night. Research sci¬ 
entist Douglas Gregory, Ph.D., and colleagues have 
found that catecholamines, substances that function as 
neurotransmitters, are important in controlling aqueous 
humor flow in both humans and rabbits. This informa¬ 
tion is being used to study the interaction between cat¬ 
echolamines and the cells that produce aqueous humor. 
Glaucoma results specifically from the loss of nerve 
cells in the retina known as ganglion cells. And while 
glaucoma is most often characterized by increased pres¬ 
sure within the eye, a significant number of patients 
with this disease have normal intraocular pressure, says 
Colin Barnstable, D.Phik, professor of neuroscience and 
director of research in the department. If one could dis¬ 
cover what causes these ganglion cells to die, he suggests, 
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Clockwise from top left: Linking lasers with computers has enabled 
much earlier diagnosis of glaucoma through analysis of the optic 
nerve head. Other technological advances allow ophthalmologists 
to measure a patient's field of vision and the response of the rod 
and cone cells to flickering light. 
it might be possible to help patients with normal 
pressure glaucoma. 
Dr. Barnstable, who has been studying the 
formation of retinal ganglion cells for many years, is 
testing the theory that a high concentration of 
the neurotransmitter glutamate may be the cause of 
ganglion cell death. Because glutamate in high concen¬ 
trations is thought to be the cause of brain damage in 
strokes, cell death in glaucoma could be similar to 
other brain injuries and diseases. 
This hypothesis is being tested by isolating ganglion 
cells, growing them in culture and studying the effects 
of glutamate on the cells. A system has been designed 
to study the effects of drugs that may block the damage 
caused by glutamate. Dr. Barnstable is also examining 
whether increasing any of the factors important in 
the growth of retinal ganglion cells allows the cells 
to withstand high concentrations of glutamate. 
According to Dr. Barnstable, growth factors can be 
supplied that allow the cells to survive for extended 
periods in culture. 
Yale is one of n centers participating in the 
Advanced Glaucoma Intervention Study, a clinical trial 
to determine the optimum surgical intervention when 
medical therapy is no longer adequate. Eydie Miller, 
M.D., associate professor of ophthalmology, is the 
principal investigator at the Yale site. Although argon 
laser surgery decreases resistance to aqueous outflow, the 
results last only about five years, 
and repeating the procedure is less 
effective, says Marc Weitzman, 
M.D., assistant professor of oph¬ 
thalmology. “The AGIS study 
should give us answers to ques¬ 
tions about when to use argon la¬ 
ser surgery in advanced glaucoma 
and what types of patients are the 
best candidates for it.” 
Among the newest instru¬ 
ments in glaucoma treatment are 
the semiconductor diode lasers, which have recently 
been obtained at Yale and are being evaluated in the 
hope of finding better therapies to prevent blindness in 
patients with advanced forms of glaucoma. Over the 
past io years, Dr. Shields has studied the effectiveness of 
laser surgical techniques to reduce the pressure in eyes by 
destroying portions of the ciliary body. “This has been a 
major advance,” says Dr. Weitzman, “because there is 
much less pain and inflammation, and there are fewer 
complications than with similar, earlier procedures.” 
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Miguel Coca-Prados has found that mutations in the myocilin gene 
affect the drainage of fluid in glaucoma. 
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For the myopic among us, 
a new center for laser surgery 
Imagine a clear, gel-filled orb that captures light and 
projects it on a screen. Through it unfold a million 
small dramas as well as the important scenes that 
make up life. 
That light-refracting 
structure is the eye, and, 
when it is misshapen, sight 
is distorted or impaired. 
For centuries, artificial 
lenses—in monocles, eye¬ 
glasses and other devices— 
have corrected poor vision. 
Now, thanks to the refine¬ 
ment of laser techniques 
during the past decade, 
people with nearsighted¬ 
ness and certain other 
disorders have another 
option. 
Laser vision correction 
permanently reshapes the 
front of the cornea, alter¬ 
ing the focus of light on 
the retina. The procedure 
is used to correct myopia, 
or nearsightedness, and 
astigmatism. Myopia oc¬ 
curs when the cornea is ei¬ 
ther highly curved or the eyeball is abnormally long. 
People who are nearsighted see near objects clearly, but 
distant objects are blurry. In astigmatism, the cornea is 
curved more in one direction than another. Light rays 
that enter the eye are unequally bent, creating a dis¬ 
torted image. 
The Yale-New Haven Eye Laser Center opened in 
July of this year at Temple Medical Center in downtown 
New Haven, as a cooperative effort of the School of 
Medicine and Yale-New Haven Hospital. David 
Silverstone, M.D., assistant chief of ophthalmology at 
YNHH, played a principal role in the concept and suc¬ 
cess of the project. The center offers two surgical proce¬ 
dures to reshape the cornea: PRK (photorefractive kera¬ 
tectomy) and LASIK (laser in situ keratomileusis). PRK 
helps patients with mild to moderate myopia as well as 
those with astigmatism. In this procedure, the excimer 
laser, which produces a beam of ultraviolet light in 
pulses that last a few billionths of a second, removes mi¬ 
croscopic portions of cor¬ 
neal tissue to reshape the 
front corneal surface. 
LASIK, a more ad¬ 
vanced procedure for treat¬ 
ing myopia and astigma¬ 
tism, is particularly 
effective for patients with 
higher degrees of nearsight¬ 
edness and has been shown 
in recent research to be ef¬ 
fective treatment for all 
forms of refractive error, 
says Shachar Tauber, M.D., 
director of refractive sur¬ 
gery at the new laser center. 
In LASIK surgery, a flap is 
made in the cornea with an 
instrument called a 
g keratome. 
t The laser beam is ap- 
o plied to the cornea under 
the flap, treating the cor¬ 
neal tissue as it does in 
PRK. The flap is then re¬ 
placed in its natural position, where it protects the newly 
treated cornea. Both procedures are performed on an 
outpatient basis and take just minutes to complete, 
according to Dr. Tauber. Many patients recover their 
vision quickly and experience little postoperative 
discomfort from the procedures. 
Laser vision correction can greatly improve the 
life of the firefighter who wears contact lenses and the 
police officer who worries he may lose his glasses in a 
scuffle and won’t be able to protect his partner or him¬ 
self. It also makes a great difference in the lives of people 
who are excluded from jobs in industries that do not 
hire employees who wear contact lenses or glasses. 
“That’s where the laser has become a true workhorse,” 
says Dr. Tauber. “It really has revolutionized the field of 
refractive surgery.” 
Improving the odds, and 
for AIDS patients In surveys, iear oi vision loss has ranked consistently 
as the leading quality-of-life concern among people 
living with AIDS—and with good reason. Among 
the opportunistic infections that often accompany the 
disease is a blinding disorder known as cytomegalovirus 
retinitis. One in lour patients with AIDS develops CMV 
retinitis, which attacks and destroys the retina and leads 
to irreversible loss of sight il left untreated. 
A decade ago, the only treatment for this form of 
viral retinitis was daily intravenous therapy, an expensive 
and unpleasant ordeal that carried with it the serious 
side-effects of kidney toxicity and reduced immune 
function—less than ideal for patients with HIV. 
That picture has brightened somewhat since the 
introduction of new medications and surgical interven¬ 
tions during the past several years. Yale is among a 
handful of centers evaluating a new delivery system for 
the antiviral agent ganciclovir, one of a half-dozen drugs 
now available to treat CMV retinitis. Concentrated into 
tiny pellets in slow-release form, ganciclovir is implanted 
into the vitreous cavity of the eye, where it bathes the 
retina for as long as eight months before the implant 
quality of life, 
An ultrasound 
image shows 
detachment of 
the retina, arrow, 
a blinding condi¬ 
tion that can 
result from 
CMV retinitis 
in patients 
with AIDS. 
procedure must be repeated. 
Although the implant is effective in the majority of 
patients, says Ray Gariano, M.D., Ph.D., chief of the 
retinal service at Yale, it can cause retinal detachment or 
bleeding in the eye. Some patients develop resistance to 
the drug while others, with no systemic agent working 
against CMV, are left vulnerable elsewhere in the body, 
especially in the colon and lungs. 
Even without the implant, retinal detachment 
occurs frequently among patients with CMV. Ophthal- 
‘We teach patients to see all over again’ If you’re curious what it’s like to 
read a book one word at a time, 
pay a visit to the Lions Low 
Vision Center at Yale. 
I was and I did. With one end of 
a high-powered magnifier pressed 
against my eye, I placed the other 
end against a copy of A Tale of 
Two Cities then slowly moved the 
page sideways. 
It. Was. The. Best. Of. Times. 
It. Was. The. Worst. Of. Times. 
Finding my visual sphere reduced 
to a circle of glass, I became impa¬ 
tient and soon gave up. I wondered 
how long it would take to read several 
hundred pages by grasping a word, 
instead of a sentence, at a time. 
Others, out of necessity, are 
more patient. In fact, with time and 
support most people with visual 
impairment can regain a high degree 
of function, says David Parke, M.D., 
associate clinical professor of oph¬ 
thalmology and a consultant in the 
low-vision clinic. “Many people with 
near-blindness live alone and are 
independent. You’d be surprised at 
how innovative people can be when 
they’re motivated.” 
The center’s staff trains people 
with impaired vision to use their re¬ 
maining visual abilities to the fullest 
with magnification, glare control, pro¬ 
per lighting and special reading tech¬ 
niques. Telescopic devices, fitted to a 
pair of glasses, expand the field of vi¬ 
sion, enabling a person whose periph¬ 
eral vision has been lost to walk 
through a doorway without hitting the 
doorjamb or to shop for groceries 
without jostling people in the aisles. 
Monocular telescopes, small 
enough to carry in a pocket or purse, 
help people with limited vision to spot 
a bus, read the writing on signs in a 
supermarket or watch television. 
Low-power magnifying glasses, used 
by people with moderately low vision, 
encompass a column of newsprint. 
Closed-circuit television units magnify 
print, pictures and maps up to 60 
times their original size and can be 
equipped with voice output. The Lions 
Clubs subsidize the cost ofvisual aids 
for people living on small incomes. 
Time is needed for the brain to 
process the limited information it 
receives from impaired eyes. It per¬ 
ceives the world in an entirely new 
way. The compensatory skills the pa¬ 
tient must acquire are improved only 
by diligent, systematic practice, ac- 
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Three thieves of sight mologists are now able to correct 
the condition by surgically remov¬ 
ing a portion of the vitreous humor 
at the back of the eye and replacing 
it with clear, silicone oil. The oil 
pushes the retina back against the 
inside wall of the eye and holds it in 
place. In 80 percent of the surgeries, 
the retina remains in place, and the 
patient’s vision is improved. 
“Despite the fact that we have 
these options, none is perfect,” Dr. 
Gariano says. “We’re always looking 
for less toxic, more effective anti- 
CMV medications than have been 
studied in the past.” 
One encouraging note is that 
with the partial success of a new 
generation of AIDS medications, 
better immune function has begun 
to offset the incidence of viral re¬ 
tinitis. Nowhere is this more appar¬ 
ent than among the youngest AIDS 
patients. Of 70 children with con¬ 
genital HIV followed at Yale during 
the past three years, none has shown 
signs of viral retinitis. 
Retinal disease, macular degeneration and glaucoma are among the 
leading causes of blindness in the United States. Some statistics: 
RETINAL DISEASE 
► 14 million diabetics are prime targets for 
blinding disorders. 
► 1.8 million have severe visual impair¬ 
ment from retinal disease. 
► 700,000 diabetics are presently at risk 
of blindness. 
► 100,000 have retinitis pigmentosa, a 
family of progressive inherited diseases 
that cause deterioration of the retina 
and blindness. 
► 65,000 diabetics each year develop 
proliferative retinopathy, the most 
sight-threatening stage. 
► 30,000 working-age Americans with 
diabetic retinopathy could preserve their 
vision by having timely laser therapy. 
► 25,000 cases of retinal detachment are 
treated each year (7,000 suffer irrepa¬ 
rable damage) 
► 8,000 new cases of blindness are 
caused annually by complications of 
diabetes. 
cording to Dr. Parke. “Learning to re¬ 
align their eyes correctly to avoid blind 
spots and to use subtle visual clues 
represents a new talent. We teach 
patients to see all over again.” 
In addition to evaluation at the 
Yale center, occupational therapists 
visit patients’ homes and suggest 
improvements, like better lighting, to 
meet their needs. Mobility experts 
teach patients to move about with 
limited vision, and social workers refer 
them to other supportive agencies. 
“Patients need to know that 
there will not be a return to the quality 
of vision they once enjoyed," Dr. 
Parke says, “but they must be 
encouraged to believe that their 
visual performance can be measur¬ 
ably improved.” 
—Julie Miller 
MACULAR DEGENERATION 
► 21 million Americans (a third of those 
over age 50) are at risk of developing 
macular degeneration. 
► 10 million suffer visual loss due to 
macular degeneration. 
► 200,000 people develop neovascular 
macular degeneration each year. 
► 104,000 are legally blind from the 
disease. 
Compared to normal sight (1), 
glaucoma (2) causes the loss 
of peripheral vision as shown 
in these simulations. Diabetic 
retinopathy (3) causes vision 
to blur, while macular degen¬ 
eration (4) attacks the center 
of one’s field of view. 
GLAUCOMA 
► 10 million people have above-normal intraocular pressure that may lead to 
glaucoma. 
► 2.6 million glaucoma-related office visits are made to doctors each year. 
► 2 million are visually impaired by glaucoma; 1 million more have the disease 
but don’t know it. 
► 120,000 are presently blind from glaucoma. 
► 5,500 become blind each year from the disease. 
Source: Research to Prevent Blindness 
3 5 YALE MEDICINE 
INTERVIEW 
FALL 
Dennis Spencer 
Since the first scalpel was applied to the 
brain in the late 19th century, neurosurgery 
has evolved in ways that are truly 
remarkable. The chair of Yales newly 
established department talks about Harvey 
Cushings legacy, the lessons ofiepilepsy 
and the view from a Harley. 
Dennis Spencer, M.D., is a tall man with 
glasses and a thick beard. He laughs easily and 
looks comfortable in casual clothes, which often 
include a black leather vest and cowboy boots. The walls 
and shelves of his cramped office are lined with photo¬ 
graphs and memorabilia reflecting his professional inter¬ 
est in the history of neurosurgery and a passion for 
Harley-Davidson motorcycles. His easy-going manner 
belies his prominence as one of the foremost neurosur¬ 
geons in the country and his position as the Harvey and 
Kate Cushing Professor and chair of the newly estab¬ 
lished Department of Neurosurgery. He has been at Yale 
since 1971, where he has pioneered surgical procedures 
that have now become standard in operations for treat¬ 
ing severe epileptic and other seizure disorders. Shortly 
before the interview with Contributing Editor Marc 
Wortman began in the department’s conference room, he 
had completed surgery on a io-year-old boy with epilepsy 
and was awaiting the report from the recovery room. 
Could you describe a bit of what you did in surgery today? 
We operated on a young boy who has seizures that be¬ 
gan in the areas of his brain controlling his left foot and 
leg and had then spread to the rest of his brain. Initially, 
we identified on an fMRI scan—functional magnetic 
resonance imaging—the relative positions of his motor 
and sensory cortex and then, using a grid of electrodes 
implanted beneath the skull, determined where the sei¬ 
zures were beginning. After we recorded a number of 
seizures in the epilepsy unit, we then stimulated between 
electrode contact points on the grid to more precisely lo¬ 
calize movement and sensation—to determine precisely 
which square inch or so of brain tissue controls them. 
Then we mapped these regions relative to the area where 
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the seizures begin and where there are cortical develop¬ 
mental abnormalities. Those small sections of the cortex 
are what we removed during surgery today. 
We performed an additional procedure called mul¬ 
tiple subpial transection, in which we separate superficial 
layers ol the brain, interrupting the connection so that 
the seizures can't spread. Seizures spread across the sur¬ 
face ol the brain, or from cortical cell to cortical cell. By 
cutting these connections with a fine knife underneath 
the brain’s surface, you interrupt the short connecting 
fibers and you destroy their ability to communicate. 
This interrupts the initial spread of the seizure. 
In operating on the brain in this way, what sort of risks do 
you run of causing other problems? Regarding multiple 
subpial transections, the risks are primarily when operat¬ 
ing in the language association cortex. Transections may 
cause some difficulties in naming things, but the extent 
ol the loss varies from patient to patient. The younger 
patients are most likely to regain lull function. For 
example, we have a few-month-old baby in our service 
right now who has a developmental abnormality ol the 
entire brain. She has seizures that cause her to live in a 
dazed state. But they involve just one hemisphere, so we 
will actually remove the back half of the brain. 11 a baby 
has a stroke at birth or has developed a bad hemisphere 
before birth—or in fact any time up until the age of 
i year—all functions can transfer from one hemisphere 
to the other except for fine finger movement and toe 
movement. Up until the age of i, you can transfer 
language, sensation and cognitive functions completely. 
How did surgeons begin to think about cutting open the 
living brain to treat disorders? Much of what we under¬ 
stand about the human brain today has actually come 
from epilepsy surgery over the years. Other than now, 
I think the time to be alive in the history of medicine 
would have been the end of the 19th century. Until then, 
the brain was thought to be a rather homogeneous 
organ. How do you know how to parcel out a portion 
of the brain into a specific function or put those parcels 
together as more complicated functions? Nobody really 
did. They thought that the brain behaved in a holistic 
fashion because of animal experiments in which investi¬ 
gators would cut out pieces of the brain and the animal 
would still function fine. Then the development of elec¬ 
trical stimulation led scientists to stimulate the surface 
of an animal’s brain. 1 his caused movement on the op¬ 
posite side of the body, and they found that there was an 
area of the brain that they could stimulate and elicit the 
same movement and reproduce the results. For the first 
time, they began to think about localization of function. 
A famous English neurologist, Hughlings Jackson, 
thought that the effect of electrical stimulation was very 
much like focal seizures that he had seen in his patients. 
He thought that it probably represented the same kind 
of phenomenon that happened when somebody had a 
motor seizure of the hand, for instance. He speculated 
that the seizure probably represented a local area of the 
brain on the opposite side that was diseased and excit¬ 
able. This is very logical today, but it was a revolutionary 
concept a hundred years ago. Sir Victor Horsley was the 
leading neurosurgeon in England at the time. Working 
with Jackson in the late 1880s, he operated on a patient 
who had a focal seizure. They had no way of knowing 
whether somebody had a specific disease of the nervous 
system and no way of knowing where that disease was 
located or how to get there. Horsley exposed the sus¬ 
pected motor area of the brain, found the tumor and 
removed it, and the patient’s seizures went away. That 
was really the beginning, not only of thinking about 
surgery for epilepsy and a radical treatment for tumors, 
but it was also the beginning of learning about the brain 
and localization of function. 
How did neurosurgery arrive at Yale? Not long after 
Horsley did his first operation, Harvey Cushing was an 
undergraduate at Yale. He became fascinated by brain 
physiology and, after graduation in 1891, went to Johns 
Hopkins to study medicine. Following up on Horsley’s 
work, he began to explore neurosurgery in the United 
States. During his general surgery training at Hopkins, 
he started the first laboratory for the investigation of 
neuroscientific issues there. After he finished his 
training, he went to the Peter Bent Brigham Hospital 
in Boston, where he spent most of his active career. 
He removed many brain tumors during his career with a 
morbidity and mortality rate that rivals modern practice 
statistics. He’s known in the United States as our father 
of modern neurosurgery. 
Neurosurgery continued at Yale while Cushing was 
at Brigham. Sam Harvey was the first chairman of the 
Department of Surgery here in 1924. He had been trained 
by Cushing as a neurosurgeon, but like all of the early 
neurosurgeons, he was a general surgeon too. He was the 
first neurosurgeon to head a general surgery department, 
however, and so the first surgery department at Yale 
trained individuals in both disciplines. One of his first 
students, Bill German, also had spent a year training with 
Cushing in neurosurgery. Harvey appointed him the first 
chief of what would become the Section of Neurosurgery. 
Didn’t Cushing eventually come back to Yale? Yes, when 
he retired from the Brigham in 1934, he came to Yale 
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as a professor of neurology and neurosurgery. He brought 
everything with him, all of his records and his collection 
of brains and tumors in bottles. Cushing photographed 
every patient whom he ever saw. There are 15,000 
five-by-seven photographs stored here at Yale. They’re 
really incredible pieces that document neurological 
disease and the early days of neurosurgery. Right now, 
we are procuring resources to again preserve all of the 
brains and to archive the photographs and to get them 
safely put away in a museum-like surrounding. The 
collection is housed in the John Fulton House, a mansion 
just outside New Haven that is provided by the Axion 
Foundation to the medical school library. Cushing was 
a bibliophile as well. He and Fulton, who was a famous 
physiologist at Yale at that time and a good friend of his, 
put their book collections together and began what is 
now the medical library’s world-renowned historical 
library. They also started the first journal in the field 
here at Yale, The Journal of Neurosurgery, which is still 
our principal academic journal. 
Bill Collins came to Yale in 1967 as the second chief 
of neurosurgery and put true academic credibility into 
the program. He began the process of subspecialization 
within neurosurgery, started a basic laboratory in the 
study of pain, and obtained the first spinal cord injury 
grant, which is still ongoing in the department. I came 
as a resident in 1971 and became a faculty member in 
1977. Ten years later, I became chief of the section. 
Dennis Spencer, center, in the operating room during epilepsy surgery. Advances in imaging, combined with increased knowledge of the brain, 
allow surgeons to operate on areas of the brain linked to specific anatomical and metabolic functions. 
Researching the whole brain 
The father of neurosurgery in 
America, Harvey Cushing, 
was a Yale undergraduate who 
returned to New Haven to join the 
medical school faculty late in his 
career. He brought with him a vast 
collection ol papers, case records, 
photographs, medical illustrations— 
even tumor specimens and bottled 
brains accumulated during his years 
at the Peter Bent Brigham Hospital in 
Boston. Cushing brought not only 
a wealth of knowledge but also an 
appreciation for inquiry and research 
in neurosurgery. The recently estab¬ 
lished Department of Neurosurgery 
at Yale, which had been a section 
within the Department of Surgery, is 
regarded as one of the worlds premier 
research centers. 
Under the leadership of Charles 
Greer, Ph.D., vice chairman for 
research, the department’s numerous 
research programs have followed a 
general principle of studying how the 
brain and spinal cord respond in both 
restorative and pathologic ways to 
trauma and disease. Dr. Greer himself 
is a leader in spinal cord research. 
Along with colleagues Anthony van 
den Pol, Ph.D., and Carole LaMotte, 
Ph.D., and others from around the 
medical school, he has been looking 
at pathways and projections of the 
central nervous system and how spe¬ 
cific connections can be functionally 
altered. The work holds promise for 
developing new ways to help spinal 
cord injury patients regain function. 
Beyond his regular administrative 
and teaching duties and surgical 
schedule, Dr. Spencer directs the 
departments epilepsy research pro¬ 
gram, working with investigators 
Anne Williamson, Ph.D., and Nihal 
de Lanerolle, Ph.D. The program is 
unique in the world for its studies of 
the human tissue surgically removed 
to treat epilepsy. Dr. Spencer says, 
“Anatomical and electrophysiological 
study of this tissue is beginning to un¬ 
ravel the mechanisms of how seizures 
are maintained in humans.” 
Many of the departments re¬ 
search areas have an emerging com¬ 
mon theme in molecular genetics, 
including gene therapy. “This field,” 
says Dr. Spencer, “will be of critical 
importance to the understanding of 
basic disease mechanisms, which must 
precede rational therapy.” The depart¬ 
ment recently added a new faculty 
member, Murat Gunel, M.D., an 
alumnus of the departments resi¬ 
dency program who is internationally 
recognized for his genetic analysis of 
cerebrovascular malformations. 
One of the most technologically 
complex fields, neurosurgery is 
constantly dealing with and evaluat¬ 
ing new equipment. Part of the 
departments research efforts include 
studying and applying new technol¬ 
ogy in the operating room. Clinical 
vice-chairman, Joseph Piepmeier, 
M.D., directs the state-of-the-art 
neuro-oncology program. Issam 
Awad, M.D., heads the neurovascular 
program, dedicated to the epidemiol¬ 
ogy of hemorrhagic stroke and basic 
research on angiogenesis. 
Gene and cell replacement 
therapy is one of the most challenging 
fields in medicine. The departments 
cellular transplant program, sup¬ 
ported by the basic research of D. 
Eugene Redmond Jr., Ph.D., who 
is also a professor of psychiatry, com¬ 
pleted the first organized approach to 
cell transplants for Parkinsons disease. 
Recently, the department launched a 
clinical trial to replace the gene miss¬ 
ing in the fatal childhood disease of 
Canavan, with Charles Duncan, 
M.D., chief of pediatric neurosurgery, 
providing neurosurgical support. 
The section of neurosurgery separated completely 
from the Department of Surgery last year and became 
a free-standing department. Why did that happen? 
Departmental status has historically emerged from a 
specific discipline’s academic maturity. The ways of 
treating and researching nervous system disease has 
wandered far from general surgery principles and 
stands more as an interdisciplinary field, sharing a 
knowledge base primarily with the basic neurosciences, 
neurology, psychology and psychiatry. Our section had 
received national and international recognition in 
clinical and basic neuroscience, NIH funding, for 
example, growing 10-fold over a io-year period. Our 
vision, therefore, required more freedom to form the 
interdisciplinary programs essential to caring for 
patients with diseases of the nervous system. Thus, with 
solid support by the Department of Surgery and the 
academic and clinical deans, we became a department 
in January of 1997. 
Subspecialization seems to be an even more important 
professional pathway in neurosurgery than other special¬ 
ties. Why is that? It’s clear that patients gain the most 
and do the best with individuals who do the same tech- 
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nologically difficult things every day. Subspecialization is 
a natural evolution in neurosurgery, which seems so sub¬ 
specialized in itself, yet is enhanced when concentrating 
on subdivisions of the very complicated nervous system. 
Your subspecialty is epilepsy. How has that developed as 
a field? The study and treatment of epilepsy have much 
of their origins here at Yale, in the late 1960s and 70s. 
One of the first epilepsy monitoring units in the world 
was established by Richard Mattson at the VA hospital 
in West Haven, where cameras were placed to study the 
behavior of patients, coupled with electrodes that had 
been locally constructed and then implanted in the 
brain. We could then watch a spontaneous seizure and 
correlate that with the electrical source. We began to 
identify that in certain of these patients we could find 
scars, tumors, vascular lesions and other abnormal areas 
that were sources of seizures. 
Magnetic resonance imaging, or MRI, came along 
in the mid-1980s. Early on, we adapted the computer 
to our imaging systems. Two Yale undergraduate 
students worked with Greg McCarthy and me to 
design the first computerized imaging work station 
anywhere in neurosurgery. We wished to replace our 
old system, which was based on plain X-rays coupled 
with injecting air into the brain’s fluid cavities and 
Harvey Cushing photographed every patient who came to him, collecting a life's 
work of images that not only tell the story of modern neurosurgery but reveal 
Cushing's skill as a visual interpreter. His illustrations, left, sketched from sur¬ 
gery, were elegant as well as finely detailed. 
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A neurosurgical operating room at Yale-New Haven Hospital is represented in this exhibit 
at The Computer Museum in Boston, recreating the occasion in 1972 when a DEC PDP-8 
computer was used to guide a procedure. For the first time, a programmable lab computer 
was small enough to put on a cart and wheel into surgery. 
dye localization of cerebral arteries. Combining 
stereotaxy with the MRI using the computer, we could 
then create a virtual image of where our electrodes were 
to go along specific trajectories within the brain. MRI 
also allowed such detailed anatomical views of the brain 
that more subtle brain developmental abnormalities 
could be viewed as easily as the more discrete lesions, 
such as tumors and vascular anomalies. 
We’ve made enormous advances since then. 
Now, we can see epileptogenic developmental and 
atrophic areas of brain. Many patients no longer even 
have electrodes implanted at all. They can have an 
image correlated with scalp recordings and then go 
directly to surgery. It all goes back to what we talked 
about originally, localizing function of the brain. Now 
we have better localization techniques, but electrical 
stimulation has remained the best technique for identi¬ 
fying brain function. It’s not very long ago, 1978, that 
we were injecting air into people’s heads to identify 
structures and to help place homemade electrodes. 
Boston has a computer museum in which our original 
operating room from the 1970s has been set up to 
illustrate the first utilization of computers to localize 
function in brain surgery. 
What attracted you to work on epilepsy? Epilepsy surgery 
is my passion. I spend all my clinical and research time 
with these patients. Epilepsy affects one percent of the 
population. It’s a chronic problem, primarily in young 
people. It destroys their lives. They can’t work, they can’t 
drive. Often, it destroys their socializa¬ 
tion, so they don’t establish normal rela¬ 
tionships and often don’t get married, 
maintaining dependency on their fami¬ 
lies. It’s estimated that there are 250,000 
to 300,000 patients in the United States 
who could be helped with the surgical 
treatment of epilepsy. This is a group of 
patients in whom you can identify the 
source of the seizures and, by removing 
it, can cure their epilepsy. You may cure 
epilepsy overnight. It is the only 
chronic disease that can be cured in 
the operating room. 
Imaging is an increasingly important 
part of neurosurgery. What are its 
advantages? Imaging is absolutely criti¬ 
cal for growth in neurosurgery right 
now. We re still in an experimental stage. 
Jim Duncan, senior physicist in the 
Department of Diagnostic Radiology, 
and I have formed the Laboratory of Image-Guided 
Neurosurgery. It brings together the investigators from 
spectroscopy, functional MR, neuropsychology, linguis¬ 
tics and physicists to provide graphic analysis. Through 
interdisciplinary methods, we can enhance learning 
about brain functions and real-time imaging during brain 
surgery. Were still at the beginning of what we envision 
as a long-term collaboration. We are combining the MR 
image with measurements of the brain in the operating 
room so that we can more precisely predict dynamic 
changes during brain surgery. We can do a variety of 
anatomical, metabolic and functional localizations that 
were never possible before. We need to superimpose all 
of those images and data when we go to the operating 
room so that we know what to resect and how to operate 
without harming critical brain structures. The purpose is 
to make neurosurgery safer and less invasive. You can 
minimize cranial openings if you know your position 
precisely before you have to open the skull. That greatly 
decreases morbidity and costs. 
What’s on the horizon for neurosurgery? We think that 
regional brain perfusion of drugs or genes or stimulation 
is going to be the next step for delivering treatment to 
patients. One of the problems with drug treatments 
for nervous system diseases is that drugs are relatively 
non-specific in many instances. Drug treatment of a 
convulsive state slows the entire brain. Not only does 
it help suppress the seizure focus, it suppresses many nor¬ 
mal activities. Now that we’re able to localize diseases 
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within regions of the brain, our next step is to develop 
a probe system that will allow us to sense and measure 
biochemical changes, and then to provide focused, 
measured delivery of therapies. It may be delivery of 
genes or drugs or electrical stimulation for instance, but 
through an implantable source that is varied and that 
doesn’t require being connected to the outside. We’re 
working on such a device that can regionally deliver 
these drugs without affecting the rest of the brain. 
Then the next step might be to deliver a gene that will 
help regulate that cell so that it would behave itself 
Your wife, Susan Spencer, is a neurologist. It is interesting 
that you two work together so closely. Yes. We both be¬ 
gan our work at about the same time. For 20 years we’ve 
been publishing papers together. She is the medical co¬ 
director of the epilepsy program and now the director of 
the monitoring unit that we have in the hospital. In fact, 
beginning July 1999, she’s the next president of the 
American Epilepsy Society. She sees most ol the epilepsy 
patients when they come in and establishes who needs 
new drugs and who may be a candidate for surgery. 
We have a two-hour conference in the Department of 
Neurosurgery every Monday afternoon, to which we 
bring patient histories and their relatively complicated 
evaluations involving PET and SPECT scans and 
readings from depth electrodes and such. We have about 
25 people who come representing psychiatry, neuropsy¬ 
chology, neurology, etc. 
You’ve got what sounds like an incredibly demanding life, 
between the stress of surgery and the demands of re¬ 
search and running a major medical department. How do 
you manage? On the back of a Harley, a hog. Dr. Greer, 
Charles Greer, the department’s vice chairman for 
research, and I spend occasional Sunday mornings 
terrorizing the Connecticut countryside. 
You drive a motorcycle? That’s not the typical image of a 
brain surgeon. No. I recently gave a talk to the Hospital’s 
Board ofTrustees, where Joe Zaccagnino [President and 
Chief Executive Officer ofYale-New Haven Hospital] 
introduced me to this roomful of prominent officials, as 
the Harvey and Kate Cushing Professor of Neurosurgery, 
chairman of the department and so on. Then he added 
that I was the only person who showed up at our hospital 
retreat in full leathers on a Harley. It was really not the 
introduction that I expected. My love before Harleys is 
actually my children, the mystery and wonder of raising 
them—and water lilies. I have two ponds, and in the 
summertime what I like to do is gardening—gardening 
and riding hogs. 
As a brain surgeon, you deal with the core of what 
makes us humans and individuals. That must be a heady 
experience. Neurosurgeons have a tendency to be prima 
donnas because of what they do, but the residents we 
train and the patients we treat do more to humanize us 
than anything else. The patients whom we take care of, 
in my case, the epilepsy patients, make us focus on 
giving back health. We all become more human in the 
process. We have the smartest and most talented resident 
staff of any neurosurgical department in the country. 
Every time you make a clinical decision or touch a 
patient, the headiness disappears and is replaced by the 
responsibility of mentoring the next generation and 
helping another person in grave need. You cannot be 
selfish and do that job well. QE1 
The brain surgeon in a resting state, on the back of a hog. 
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FACULTY NEWS 
High honors for psychiatric research 
Mental health awards recognize cutting-edge work. 
Nine School ol Medicine re¬ 
searchers have been awarded 
grants from the National Alli¬ 
ance for Research on Schizophrenia 
and Depression (NARSAD). Two of 
the researchers are among 16 scientists 
around the world to receive the 1998 
Distinguished Investigators Award, 
NARSAD’s highest honor. Seven of 
the Yale researchers are among 130 
scientists worldwide to receive the 
1998 Young Investigators Award Irom 
NARSAD. The non-profit organiza¬ 
tion, based in Great Neck, N.Y., funds 
research into the causes and potential 
treatments of mental illness. 
George R. Heninger, M.D., pro¬ 
fessor of psychiatry, and Robert H. 
Roth Jr., Ph.D., professor of psychia¬ 
try and pharmacology, were awarded 
the 1998 Distinguished Investigators 
Award, which supports their work 
with $100,000 for one year. Dr. 
Heninger's research aims to identify 
the immune abnormalities in some 
patients with schizophrenia. Dr. Roth 
is studying the psychiatric symptoms 
associated with marijuana abuse. 
Additionally, NARSAD announced 
in May that Gerald A. Conway and 
his wife Martine, trustees for The 
Fairfax Foundation, have pledged to 
support NARSAD and Yale with a 
cumulative gift totaling $30,000. 
The funds are to be applied toward 
the support of a 1999 Young Investiga¬ 
tor conducting research at the School 
of Medicine. 
Recipients of the 1998 Young 
Investigators Award will receive 
$30,000 for two years to help support 
their research. The winners and their 
research projects are: 
John P. Alsobrook, Ph.D., associ¬ 
ate research scientist in the Child 
Study Center, will analyze genes that 
may be associated with obsessive- 
compulsive disorder. 
Noboru Hiroi, Ph.D., associate 
research scientist in psychiatry, will 
Pathology chair becomes department’s 
first Yesner Professor 
Jon S. Morrow, M.D., professor and 
chair of pathology, and professor of 
molecular, cellular and developmental 
biology, has been named the 
Raymond Yesner Professor of Pathol¬ 
ogy. Dr. Morrow has led pioneering 
studies to define the structure and 
function of the membrane-associated 
cytoskeleton. His work led to an 
understanding of the origin of several 
inherited blood diseases of children. 
In addition, his studies on the regula¬ 
tion of cell-cell adhesion receptors 
Li«tve revealed molecular mechanisms 
S fundamental to an 
understanding of 
I fetal growth and 
4 a . I development, as 
I well as cancer 
causation and 
JBH metastasis control. 
■ j| JmM Other research he 
Jon Morrow has conducted has 
implications for 
understanding brain disorders and for 
treating neonatal brain injury, epi¬ 
lepsy, Alzheimer’s disease and AIDS 
dementia and other disorders. 
study ways of reducing the side 
effects of drugs used to improve 
the voluntary motor skills of 
schizophrenic patients. 
Sheena Josselyn, Ph.D., 
postdoctoral associate in psychiatry, 
will investigate the neural basis of 
inhibition of fear and/or anxiety. 
Karen Y. Mechanic, M.D., 
postgraduate year IV resident in psy¬ 
chiatry, will examine the relationship 
between cocaine dependence and 
depression. 
Marc N. Potenza, M.D. ’94, 
Ph.D. ’93, postgraduate year IV 
resident in psychiatry, will study the 
link between the response to stress 
and the onset of mental illness. 
Alexander A. Stevens, Ph.D., 
postdoctoral associate in diagnostic 
radiology, will map areas of the 
brain responsible for language to 
gain a better understanding of how 
schizophrenia affects language 
processing. 
Active in the field of medical 
informatics, Dr. Morrow has been an 
advocate of the early translation of 
basic science advances to clinical 
medicine. He headed the team that 
designed the pathology department’s 
computerized patient information 
system, and established the medical 
school’s Critical Technologies 
Program, which facilitates physicians’ 
access to basic science advances and 
assists basic scientists in the extension 
of their studies to problems of 
human relevance. 
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Nancy Angoff named associate dean for student affairs 
Nancy R. Angoff, M.RH. ’81, 
M.D. ’90, H.S. ’90-93, an 
assistant clinical professor of 
medicine who began her career in 
medicine after raising a family and 
working as a teacher and guidance 
counselor, has been named associate 
dean for student affairs. 
Dr. Angoff specializes in treatment 
of patients with HIV and will con¬ 
tinue to see patients at the Nathan 
Smith Clinic. She joined the faculty in 
1993 after completing her residency 
here. She obtained a degree in public 
health from Yale in 1981 and her medi¬ 
cal degree, also from Yale, in 1990. She 
has served as course director of inte¬ 
grative clinical medicine, chaired a 
working group on death and dying, 
co-chaired a working group on end- 
of-life care and co-taught a course in 
medical ethics at the divinity school. 
She has been an attending physician at 
Yale-New Haven Hospital and the 
Nathan Smith Clinic. 
In 1990 she received the Miriam 
Kathleen Dasey Award, presented to 
the student who, by strength of char¬ 
acter, personal integrity and academic 
achievement, gives promise of fulfill¬ 
ing the ideal of the compassionate 
physician. Highly regarded for her 
clinical knowledge and compassionate 
treatment of patients, she has three 
times received the Meyer Etkind Prize, 
awarded by house staff to the physi¬ 
cian who embodies those qualities. 
“Like many Yale students her back¬ 
ground is not traditional,” said Dean 
David A. Kessler, M.D., as he an¬ 
nounced Dr. Angoff’s appointment at 
a luncheon for second-year students in 
September. “She was a working 
mother when she went to medical 
school and did her residency. She 
knows Yale from the inside out, from 
a number of different vantage 
points—as a student, as a resident, as 
a practitioner, as a teacher.” 
In her remarks after Dr. Kessler’s 
announcement, Dr. Angoff de¬ 
scribed her path to medicine. “I 
grew up,” she said, “at a time and in 
Nancy Angoff 
a family when 
women didn’t 
become doctors. 
They married 
doctors but they 
didn’t become 
doctors. I was 
told that I 
should become a 
teacher, that I would have some¬ 
thing to fall back on when my kids 
were in school.” 
She graduated from Case Western 
Reserve University in 1968 and re¬ 
ceived a master’s degree in education 
from the University of Cincinnati in 
1971. Although she started out in 
education, her interest in medicine 
led her into public health in 1981. A 
few years later a lunchtime conversa¬ 
tion with a colleague provided the 
spark for her career in medicine. 
When her colleague asked what she 
truly wanted to do, Dr. Angoff said 
she wanted to study medicine, then 
ticked off a list of obstacles. “I was too 
old. It cost too much money. I had 
kids. I had never taken a science 
course in my life,” Dr. Angoff recalled 
telling her colleague, who answered, 
“You haven’t told me one reason why 
you can’t.” Her husband, Ronald 
Angoff, M.D., a pediatrician on Yale’s 
clinical faculty, also encouraged her 
medical studies. 
Dr. Angoff’s appointment con¬ 
cludes an internal search that began 
earlier this year when the duties of 
Robert H. Gifford, M.D., H.S. ’67, 
then associate dean for medical educa¬ 
tion and student affairs, were divided 
into two jobs. Dr. Gifford became the 
school’s first deputy dean for educa¬ 
tion on July 1. As associate dean for 
student affairs, Dr. Angoff handles 
student needs and concerns. Her du¬ 
ties include counseling, writing rec¬ 
ommendation letters for students, or¬ 
ganizing events such as Match Day 
and Commencement, working with 
student organizations and handling 
disciplinary problems. 
“From the moment I set foot here I 
have been devoted to this place. It’s an 
incredible institution. It’s home for 
me,” she told students, who greeted 
her appointment with a standing ova¬ 
tion. “If I can help any of you to love 
medicine as much as I do, I will have 
fulfilled my duty.” 
Judah Folkman speaks at Grand Rounds 
Speaking to a standing-room-only audience in Fitkin Amphitheater in June, angiogenesis 
pioneer Judah Folkman, M.D., second from right, described the application of his discover¬ 
ies about blood vessel formation to the treatment of certain cancers. Dr. Folkman delivered 
the Massimo Calabresi Lecture in the Yale Cancer Center as well as a talk titled New 
Directions in Angiogenesis Research during Grand Rounds in the Section of Cardiovascular 
Medicine. A cancer researcher at Children’s Hospital in Boston who teaches anatomy and 
cell biology at Harvard Medical School, Dr. Folkman was the Farr lecturer at Yale in 1997 
and gained worldwide attention earlier this year when news of his successful anti-cancer 
experiments 
in mice were 
reported. Among 
those attending 
the lecture were 
Dean David A. 
Kessler, left, a 
former student 
of Dr. Folkman 
at Harvard, and 
Paul and Guido 
Calabresi, in 
whose father’s 
memory the lec¬ 
ture series was 
established. 
</) 
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Richard J. Antaya, 
M.D., an authority in 
skin disorders affecting 
children, joined the 
faculty of the depart¬ 
ments of Dermatology 
and Pediatrics in Sep¬ 
tember. Dr. Antaya received his B.S. 
degree in chemistry from Rensselaer 
Polytechnic Institute in 1985, and re¬ 
ceived his M.D. degree at Tufts Uni¬ 
versity in 1989. He completed his resi¬ 
dency training in pediatrics at Tripler 
Army Medical Center in Honolulu in 
1992, and spent the following three 
years practicing general pediatrics in 
the Army at Fort Polk, La. There he 
served as chief of the pediatrics service 
and chief of the department of medi¬ 
cine. Dr. Antaya completed a second 
residency in dermatology at Duke 
University, where he worked closely 
under the direction of the internation¬ 
ally recognized pediatric dermatologist 
Neil S. Prose. 
Michael B. Bracken, Ph.D., M.P.H. 
’70, professor and head of chronic dis¬ 
ease epidemiology and professor of 
neurology, obstetrics and gynecology, 
gave the keynote speech at the 37th 
Yale Cancer Center Director Vincent T. DeVita 
Jr., H.S. '66, professor of medicine, epidemi¬ 
ology and public health, received an award 
from David S. Rosenthal, M.D., president of 
the American Cancer Society, during the 
13th Annual Excaliber Round Table, held in 
New Haven and Greenwich in August. The 
jade glass work was in honor of Dr. DeVita's 
efforts on behalf of the round table and the 
cancer society. During the three-day sympo¬ 
sium, researchers discussed various topics 
including dendritic cells, peptidomimetic 
therapy and thyroid cancer. 
annual meeting of the International 
Medical Society of Paraplegia in June 
in Brazil. The theme of the talk was 
current and future prospects for the 
pharmacologic treatment of acute spi¬ 
nal cord injury. 
Erol Fikrig, M.D., associate professor 
of internal medicine, was a recipient 
of a $750,000, five-year grant from 
the Burroughs Wellcome Fund. The 
Clinical Scientist Awards were given 
for the first time this year and went to 
10 U.S. and Canadian researchers to 
foster the transfer of knowledge be¬ 
tween basic research and the treat¬ 
ment of patients. 
Heidi L. Gaspary, 
M.D., Gilbert 
Glaser Fellow in 
Epilepsy and chief 
resident in neurol¬ 
ogy at Yale-New 
Haven Hospital, 
has been named 
the 10th annual winner of the Hugh 
Dwyer Award. The award, presented 
by Dr. Dwyer’s widow, Dorothea 
Peck, M.D. ’43, is given each year 
to a senior resident who consistently 
demonstrates characteristics exempli¬ 
fied by Dr. Dwyer: dedication, 
sound judgment, sharp diagnostic 
skills, compassion, the pursuit of 
continuing education and achieve¬ 
ment in practicing the art and 
science of medicine. 
An international, multicenter study 
headed by Roberto J. Groszmann, 
M.D., F.R.C.P., professor of medicine 
at Yale and chief of the digestive dis¬ 
ease section at the VA Connecticut 
Healthcare System, will be funded by 
a $2.5 million grant from the National 
Institute of Diabetes and Digestive 
and Kidney Diseases. The five-year 
grant will support continuation of a 
study of the prevention of esophageal 
varices by beta-adrenergic blockers. 
Co-investigator for the project is 
Guadalupe Garcia-Tsao, M.D., assis¬ 
tant professor of medicine (digestive 
diseases). Robert Makuch, Ph.D., as¬ 
sociate professor of public health (bio¬ 
statistics) and a Cancer Center mem- 
Richard Antaya 
Heidi Gaspary 
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ber, is in charge of statistical analysis 
for the study. 
Joseph F. Hoffman, Ph.D., Eugene 
Higgins Professor of Physiology and a 
member of the faculty since 1965, was 
honored for his work studying mem¬ 
brane transport and cellular physiol¬ 
ogy in April with the Yale Science and 
Engineering Association Award for the 
Advancement of Basic and Applied 
Science. 
Peter J. Hotez, M.D., associate 
professor of epidemiology and 
pediatrics (infectious diseases), was 
named visiting professor at the Peking 
Union Medical College in Beijing in 
February. In 1996 he was also named 
visiting professor at the Institute of 
Parasitic Diseases, Chinese Academy 
of Preventive Medicine. Dr. Hotez, 
an expert on hookworm infection, 
is working to develop a vaccine 
against the parasite, which is prevalent 
in China. 
Dean David A. Kessler, M.D., has 
accepted an invitation from the 
Mayday Fund to serve as honorary 
chair of its newly formed National 
Advisory Committee. Mayday, a 
New York-based philanthropy, is 
dedicated to reducing the profound 
human problems associated with pain 
and its consequences. In his role as 
honorary chair, Dr. Kessler will 
advocate increased attention to the 
undertreatment of pain in the United 
States by working with medical pro¬ 
fessionals and public policy leaders 
whose intervention could help 
alleviate unnecessary pain for millions 
of Americans. 
Associate Clinical Professor of Medi¬ 
cine Siegfried J. Kra, M.D., F.A.C.P., 
was a guest lecturer at the Trumbull 
College Fellows Luncheon in April. 
His talk entitled III and Deranged 
Leaders That Changed Our World, is 
also the subject of his 13th book which 
is in preparation. He also toured the 
country in late 1997, discussing his 
book What Every Woman Must Know 
about Heart Disease, published in 1996 
and now available in paperback. 
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Marc I. Lorber, M.D., 
B professor of surgery and 
* chief of the section of 
organ transplantation 
and immunology in the 
Marc Lorber Department of Surgery, 
was elected in June to 
serve a two-year term on the board of 
directors of the United Network for 
Organ Sharing (UNOS). A private, 
nonprofit organization, UNOS unifies 
transplantation activities nationwide 
by establishing policies to govern or¬ 
gan procurement, distribution and 
transplantation. Dr. Lorber also serves 
as treasurer of the American Society of 
Transplant Surgeons. 
Frederick Nafitolin, M.D., D.Phil., 
professor and chairman of obstetrics 
and gynecology, and director of the 
Center for Research in Reproductive 
Biology, was admitted to Britain’s 
Royal College of Obstetricians & 
Gynaecologists in September. Dr. 
Naftolin was also elected president of 
the North American Menopause Soci¬ 
ety in September. 
Eric J. Nestler, Ph.D. ’82, M.D. ’83, 
HS ’83-87, the Elizabeth Mears and 
House Jameson Professor of Psychia¬ 
try, Pharmacology and Neurobiology, 
was one of three recipients of the 1997 
Robert J. and Claire Pasarow Founda¬ 
tion Medical Research Award. Recipi¬ 
ents received a $35,000 prize from the 
Beverly Hills-based foundation and 
delivered a lecture at a ceremony and 
scientific symposium held at the Uni¬ 
versity of Southern California’s health 
sciences campus in June. Dr. Nestler 
was recognized for his research into 
neuropsychiatric disorders. In a talk 
entitled Towards a Molecular Psychia¬ 
try, Dr. Nestler spoke about his cur¬ 
rent research into the connection be¬ 
tween neurobiology and behavior. 
Two Yale researchers, Robert 
Rosenheck, M.D., clinical professor 
of psychiatry and Rani A. HofF, M.P.H 
’91, Ph.D., postdoctoral fellow in the 
Child Study Center, received the 1997 
Excellence in Women’s Health Re¬ 
search Award from the National Cen¬ 
ter of Excellence in Women’s Health 
(NCEWH), for a series of studies on 
how women veterans use Veterans 
Administration mental health services, 
Carolyn Mazure, M.D., director of 
research for the women’s health pro¬ 
gram and the NCEWH at Yale, pre¬ 
sented the awards. 
Sally Shaywitz 
The Society for the Ad¬ 
vancement of Women’s 
Health Research gave 
Professor of Pediatrics 
Sally Shaywitz, M.D., 
the 1998 Clinical Ser¬ 
vice Award for her work 
in the science of reading and for her 
advancements in the scientific under¬ 
standing of gender differences in brain 
organization and function. Dr. 
Shaywitz is co-director of the National 
Institute of Child Health and Devel- 
opment-Yale Center for the Study of 
Learning and Attention and founder 
and director of the Yale Learning Dis¬ 
orders Unit. The award was presented 
at a ceremony in Washington in June. 
Stephen G. Waxman, M.D., Ph.D., 
professor of neurology and pharma¬ 
cology and chair of the Department 
of Neurology, was elected a member 
of the Connecticut Academy of 
Science and Engineering (CASE) on 
the basis of his internationally recog¬ 
nized research. He is an authority in 
the molecular architecture of nerve 
fibers and the glial cells that surround 
them, and the mechanisms by which 
nerve fibers in the brain and spinal 
cord adapt to injury. CASE is a 
private, nonprofit public-service 
institution chartered by the 
Connecticut General Assembly in 
1976 and patterned after the National 
Academy of Sciences. Dr. Waxman 
also serves as director of the PVA/ 
EPVA Neuroscience Research Center 
in the VA Connecticut Healthcare 
System in West Haven. 
Barry L. Zaret, M.D., the Robert W. 
Berliner Professor of Medicine, profes¬ 
sor of radiology and chief of cardio¬ 
vascular medicine, received the 1998 
Solomon A. Berson Medical Alumni 
Achievement Award in Clinical Sci¬ 
ence from his alma mater, New York 
University School of Medicine. The 
award ceremony was part of the 
school’s April alumni day celebration. 
In February, Dr. Zaret was a guest lec¬ 
turer at the 25th anniversary of the 
Egyptian Society of Cardiology in 
Cairo. He spoke on Clinical Relevance 
of Myocardial Perfision Imaging and 
Mental Stress and Myocardial Ischemia. 
Dr. Zaret was also a guest speaker at 
the XVII Congress of Nuclear Cardi¬ 
ology which was held in June in 
Rosario, Argentina. 
Daniel Zelterman, Ph.D. ’83, profes¬ 
sor of medicine (EPH), was elected a 
Fellow of the American Statistical As¬ 
sociation in August. This honor recog¬ 
nizes his development of models of 
human longevity and his continuing 
service to the statistical profession. 
Fewer than one third of one percent 
of all members of the American Statis¬ 
tical Association can be elected fellows 
in any year. 
Gordon Shepherd, M.D., D.Phil., pro¬ 
fessor of neuroscience in the section of 
neurobiology, has been elected editor-in- 
chief of the Journal of Neuroscience, pub¬ 
lished by the Society of Neuroscience. 
He will begin his five-year term as editor 
on Jan. 1. The journal is published every 
two weeks in both printed and electronic 
versions, comprising some 10,000 pages 
annually. On the Yale faculty since 1967, 
he has previously served as editor-in- 
chief of The Journal of Neurophysiology. 
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‘Do some good 
in the world,’ 
dean exhorts 
Class of 1998 
As the 106 members of the Class 
of 1998 received their medical 
degrees in May, Dean David A. 
Kessler, M.D., urged them to think 
back to the altruism that guided and 
propelled them as they made the deci¬ 
sion to become doctors. “You wanted 
to do some good in the world,” he 
said, “and you were able to say those 
words flat out, without any embarrass¬ 
ment or hesitation.” 
The 1998 Commencement was 
Dr. Kessler’s first at Yale and the first 
in recent memory to be conducted 
in pouring rain, which drove gradu¬ 
ates and their families under a tent 
on Harkness Lawn. After ceremonies 
on the main campus, graduates 
followed bagpiper Glenn Pryor as he 
led the class along College Street to 
the medical school Commencement 
under the tent. 
“This is a teacher’s dream,” said 
Dr. Kessler, “a last chance to exhort, 
challenge and inspire.” His own ex¬ 
hortation was that students remain 
true to the idealism that comes with 
being a healer. “You are a healer when 
you understand that the amount of 
health you can actually promote is 
relatively small when weighed on the 
scale of human mortality,” he said. 
“You are a healer when you throw 
away that scale and fight for every 
inch of health, against the odds, as if 
immortality were embedded in your 
fingertips. And you are a healer if you 
know when it’s time to quit.” 
In closing, Dr. Kessler offered the 
graduates warm wishes for the future. 
“I wish you mornings of great prom¬ 
ise,” he said, “evenings of pleasant 
weariness and nights filled with the 
1) Three generations take to the podium 
at Commencement. Katherine Auerswald, 
holding her daughter, Cecilia, receives her 
diploma accompanied by her father Benjamin 
Bunney, psychiatry chair. 2) Jennifer Eras 
smiles under the tent. 3) Banner-bearer 
Merle Carter leads the procession with 
bagpiper Glenn Pryor. 4) Deans David 
Kessler and Robert Gifford speak before 
the ceremony. 5) Sydney Butts and Merle 
Carter applaud during the ceremony. 
sleep that comes to those who have 
done their best. ... The most fortu¬ 
nate among you will be able to say, 
'I occupied some space on Earth and 
I did some good. I was a healer.’ ” 
Before the presentation of diplo¬ 
mas, students and faculty received 
awards for work of distinction in 
research, education and clinical care. 
FACULTY AWARDS 
► Bohmfalk Prizes: Stuart D. Flynn, 
M.D., associate professor of pathol¬ 
ogy, and Richard J. Gusberg, M.D., 
professor of surgery 
► NBI Humanism in Medicine Faculty 
Award: Jack Van Hoff, M.D., associ¬ 
ate professor of pediatrics 
► Dean’s Medical Education Farr Prize: 
Ervin E. Jones, M.D., associate pro¬ 
fessor of obstetrics and gynecology 
► The Leah M. Lowenstein Award: 
Ronnie A. Rosenthal, M.D., associ¬ 
ate professor of surgery 
► The Francis Gilman Blake Award: 
Richard Belitsky, M.D., assistant 
clinical professor of psychiatry 
► The Betsy Winters House Staff 
Award: Anju Nohria, M.D., instruc¬ 
tor in medicine 
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► Parker Prize: Hahnah J. Kasowski 
► The Miriam Kathleen Dasey Award: 
Michelle A. Barton 
► The Norma Bailey Berniker Prize: 
Matthew H.T. Bui 
► The Dean’s Prize for Community 
Service: Heather J. Lynch 
► NBI Healthcare Foundation 
Humanism in Medicine Student 
Award: Lynda S. Kauls 
► The Campbell Prize: 
Russel C. Huang 
► The Perkins Prize: Russel C. Huang 
► Merck Book Awards: Lynda S. Kauls 
and Ellen A. Komisaruk 
► Lange Book Award: James F. Borin 
► M.D./Ph.D. Award: Matthew H.T 
Bui and Charles C. Hong 
► Connecticut Society of American 
Board of Obstetricians and 
Gynecologists Prize: 
Ellen A. Komisaruk 
► New England Pediatric Society Prize: 
Daniel T. Coghlin 
► The Society for Academic Emer¬ 
gency Medicine Award: 
Kevin P. Daly 
► Connecticut Society of American 
Board Surgeons Prize: 
Hahnah J. Kasowski 
► Peter A.T. Grannum Award: Sydney 
C. Butts, Merle A. Carter and 
Olivia I. Okereke 
► Lauren Weinstein Award: 
Joanne M. Quinones 
► The Winternitz Prize in Pathology: 
John Tilton 
► Endocrine Society Medical Student 
Achievement Award: 
Christi M. Cavaliere 
► William U. Gardner Thesis Prize: 
Alan Cheng 
► Louis G. Welt Prize: 
Jeffrey T. Reynolds 
► American Cancer Society Prize: 
John P. Forman 
► Peter F. Curran Prize: Nirit Weiss 
► M.D./Ph.D. Thesis Prize: 
Nicole Ullrich 
► Association for Academic Surgery 
Research Award: David J. Chang 
► The Dr. Louis H. Nahum Prize: 
Helen M. Chun 
► The Harold H. Lamport Biomedical 
Research Prize: Robert M. Kalus 
► The Ferris Prize: 
Kent Kwasind Huston 
► The International Health Prize: 
Kent Kang Hu 
► The Nicholas J. Giarman Prize: 
James D. O’Holleran 
► Transfusion Medicine/Laboratory 
Medicine Award: Tobias T.P. Lee 
► Vernon W. Lippard Prize: 
Samir S. Shah 
► The John P. Peters Prize: 
Katherine B. Auerswald 
► The Keese Prize: 
Naomi S. Donnelley 
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with ease across the globe, which is 
fast becoming “one massive, human 
petri dish." Public health workers will 
also find themselves dealing with 
people whose native languages are 
spoken by only a few thousand people 
in remote pockets of the Third World. 
“How do you say 'push’ to a woman 
in labor who just came to San Diego 
from a small village in Guatemala?” 
she asked. “Spanish won’t do. No mat¬ 
ter how many languages you speak, it 
isn’t enough.” 
Graduates cheered and applauded 
when she criticized the federal 
government’s refusal to fund needle 
exchange programs. Students taped 
syringes to their mortarboards in a 
gesture of support for the programs. 
As they advance in their careers, 
she said, graduates will absorb foreign 
languages and cultures, learn how gov¬ 
ernment works, teach people about 
public health and learn to survive 
“monsoons” like the one that blew in 
during Commencement. Graduates, 
friends and families gathered under a 
tent on the lawn for the ceremony. 
Echoing Ms. Garrett’s thoughts, 
Dean Michael H. Merson, M.D., 
said, “This is a time when challenges 
to our profession have never been so 
many and the needs so great.” 
In her class address, student 
Health is a 
global affair, EPH 
graduates are told 
at Commencement 
People entering the field of pub¬ 
lic health face issues that are 
becoming more complex by the 
day, journalist Laurie Garrett told 
graduating students at the EPH Com¬ 
mencement Day in May. “Your work 
will by necessity be global. It will 
probably have to be executed with 
fewer resources than you have today.” 
Ms. Garrett, a medical writer for 
Newsday and author of The Coming 
Plague: Newly Emerging Diseases in a 
World Out of Balance, won the 1996 
Pulitzer Prize for explanatory journal¬ 
ism for her coverage of the Ebola virus 
outbreak in Africa. She began her 
Commencement remarks by citing the 
optimism that reigned in public 
health 20 years ago. There was hope, 
she said, that many diseases would be 
eradicated, changing the role of public 
health workers. “For the last 20 years 
at least one aspect of that scenario has 
Above Commencement speaker Laurie 
Garrett chats with professors Lowell Levin 
and Elizabeth Claus after the ceremony. 
Right Speaker Laurie Garrett. 
Below Susie Tanefo receives her diploma from 
Dean Michael H. Merson, M.D. 
become true,” she said. “It is the loss 
of the traditional role of public health 
Government no longer wishes to pay 
for it.” 
And in that time, she said, health 
problems have become more compli¬ 
cated as the population ages, HIV 
continues to spread and illness travels 
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speaker Andrea Kim stressed what she 
considered to be the unique quality of 
the class. “There is a feeling of 
camraderie and respect among all of 
us,” she said as she urged her class¬ 
mates to abandon “comfort zones” 
and try get to know others. “Some¬ 
times we completely miss the oppor¬ 
tunity to get to know someone be¬ 
cause of the walls we build around us. 
Public health is a field where relating 
to people is essential.” 
Some graduates are continuing 
their education and plan to obtain 
M.D. or Ph.D. degrees. Others have 
obtained jobs in health care manage¬ 
ment consulting firms, managed 
care firms or organizations such as 
the Inter-American Development 
Bank and Centers for Disease 
Control. 
In addition to 107 M.P.H. 
graduates, two students received 
doctor of public health degrees 
and 10 students received Ph.D.s. 
The graduates honored Elizabeth 
Claus, Ph.D., M.D., with the 
award for excellence in teaching. 
Students taped 
syringes to their 
mortarboards 
to show their 
support for needle 
exchange pro¬ 
grams, which the 
Clinton administra¬ 
tion had recently 
declined to fund. 
Physician associates celebrate 
Thirty-two graduates of the Physician Associate Program celebrate in late August in Harkness 
Auditorium. U.S. Rep. Nancy Johnson, a Republican who represents Connecticut's 6th district, 
urged the new practioners to use their knowledge to transform themselves and their communi¬ 
ties. She also urged them to treat the whole patient, not a person with symptoms. "Restoring a 
holistic approach is extremely important,” she said. “We are struggling with it as a society even 
to the point where Congress is legislating—always a dangerous sign.” 
Stock 
Options 
Awash in 
appreciation? 
Let us keep you from 
drowning in capital 
gains taxes. 
If the recent bull market 
has been good to you, you 
will be liable for substantial 
capital gains taxes when 
you sell your stocks. A gift 
to Yale of appreciated stock 
owned more than one year 
will avoid capital gains 
taxes, offer you a significant 
charitable tax deduction, 
and could provide income 
benefits as well. 
w 
Yale University 
Office of Planned Giving 
B5§= 
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Smiles of relief after the boards 
Strawberries and champagne greeted members of the Class of 2000 in June as they emerged from 
their board examinations in Harkness Auditorium. The refreshments, and a barbecue that followed 
on Harkness lawn, were gifts from the Class of 2001. 
In doctor’s black bag, decades 
of family history In choosing a medical career, 
many budding physicians receive 
friendly bits of advice and the occa¬ 
sional keepsake from established phy¬ 
sicians hoping to encourage them in 
their pursuits. When Alison Days 
received just such encouragement as 
a second-year medical student in the 
form of a battered old medical bag last 
year, she also got a piece of her own 
family’s past. How she came to receive 
the bag involved a remarkable series 
of coincidences. 
When Ms. Days’ grandfather John 
Langdon, M.D., a Providence pedia¬ 
trician, died more than 40 years ago, 
his wife gave his black medical bag 
bearing the initials JL to Providence 
ophthalmologist Frank Dimmit, M.D. 
In 1954, Dr. Dimmitt passed the bag 
on to a young family friend who then 
was beginning medical school at Yale. 
The student, Gerard N. Burrow, even¬ 
tually would become dean of the 
School of Medicine from 1992 
to 1997. 
When Dr. Burrow’s daughter, 
Sarah, entered medical school, he 
handed the bag down to her. She later 
returned it to the Dimmitt family in 
Providence, entrusting the bag to her 
father’s childhood friend, Sterling 
Dimmitt, the son of Frank Dimmit. 
Mr. Dimmit, not a doctor him¬ 
self, recalled that the granddaughter 
of the original JL was herself an 
aspiring pediatrician. He decided 
that Alison Days should have the 
bag. So, the historic, much traveled 
medical bag returned to its original 
family and Ms. Days now guards the 
family treasure. 
Alison Days with former Dean Gerard Burrow 
and her parents, Ann R. Langdon and Drew S. 
Days III. 
STUDENT N 
A team of three Yale Physician Associ¬ 
ate students took first prize in the 
medical challenge bowl playoffs held 
in March at the annual American 
Academy ol Physician Assistants 
(AAPA) Northeast Regional Meeting 
on the campus of the University of 
Medicine and Dentistry ol New Jer¬ 
sey. The meeting was sponsored by the 
New Jersey State Society ol Physician 
Assistants and the Northeast Consor¬ 
tium of PA Programs. Teams from 14 
regional PA programs competed. The 
Yale program was represented by first- 
year students Tony Barrett, Broheen 
Elias and Debra Strigun and by a 
second-year team composed ol Aviva 
Asnis, Grace Barresi and Joe Castro, 
who were last year’s champions. The 
Barrett-Elias-Strigun team took first 
place against a team from Rutgers 
University and moved onto the annual 
Student Academy of the AAPA/Searle 
National Medical Challenge Bowl in 
Salt Lake City, where they reached the 
semi-finals May 24. 
The Yale champions, from left: Strigun, 
Barrett and Elias 
Shannon Turley was presented the 
1998 Richard K. Gershon Pre- and 
Postdoctoral Fellowship Award. 
This award in the amount of $16,750, 
will support her research project 
Functional Pathways of Antigen 
Processing in Dendritic Cells. She is 
a graduate student in the laboratory 
of Ira Mellman, Ph.D., in the 
Department of Cell Biology. 
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Holding on to idealism 
A Yale medical student surveys her classmates 
and finds that cynicism is actually on the wane. 
By Rachel Engers 
“If you anticipate that you can save 
every patient, you’re bound to be 
disappointed. ” 
— A medical school professor For decades, medical educators 
have wrestled with a phenom¬ 
enon that goes to the core of 
training young physicians. Most, if 
not all, enter medical school filled 
with youthful idealism and the desire 
to help others. Many leave four years 
later more cynical about medicine and 
their ability to make a difference. 
One might think, in this cost- 
conscious era in health care, that 
cynicism would be on the rise. But 
the current generation of medical 
students has baffled the conventional 
wisdom. Comparing attitudes in the 
1990s to opinions recorded in 1955 
and 1957 surveys at Yale, Lisa Sanders, 
M.D. ’97, found cynicism to be in 
fact declining. 
Mental illness, suicide and chemi¬ 
cal dependency occur in higher fre¬ 
quency among physicians than in the 
general population. Studies at Yale 
and elsewhere have shown that the 
medical school experience promotes 
cynicism among at least a portion of 
the student body. Leonard D. Eron, 
Ph.D., now a professor of psychology 
and a research scientist at the Institute 
for Social Research at the University 
of Michigan in Ann Arbor, studied the 
topic in depth while on the Yale psy¬ 
chology faculty during the late 1950s. 
His survey analysis showed not only 
that medical students became increas¬ 
ingly cynical over the course of their 
education, but also that the phenom¬ 
enon was peculiar to the discipline. 
Nursing and law students tested at the 
same time by Dr. Eron did not exhibit 
increased cynicism. 
How did he explain it? “Students 
just defended against the anxiety of 
seeing all these sick people,’’ Dr. Eron 
said during a telephone interview 
from his home, in Michigan. “But it 
was not a successful defense, because 
they became more anxious, more 
cynical and less humanitarian.” 
When Dr. Sanders entered medical 
school in 1993, she had some concern 
that the experience would harden her. 
“One of the things everyone going to 
medical school hears about is what it 
does to you—that it is this intensely 
molding experience,” she recalled. 
Her faculty advisor, Alvan R. 
Feinstein, M.D., encouraged her to 
make the subject her thesis topic. She 
presented her work at Student Re¬ 
search Day in 1997. 
From the start, Dr. Sanders as¬ 
sumed her classmates would be much 
more cynical than the students tested 
in Dr. Eron’s study, because she be¬ 
lieved cynicism to be more prevalent 
in American culture today than it was 
in the 1950s. She expected that beliefs 
such as When you come right down to 
it, medicine is a business, and it’s up to 
the doctor to sell his skills for as much as 
the market will bear might be more 
common sentiments now than 40 
years ago. 
Her results showed little difference 
in the average level of cynicism be¬ 
tween students in 1957 and 1995. But 
statistically, her survey indicated that 
most tended to become either slightly 
more cynical or much less cynical in 
1995. Dr. Eron’s 1957 study, on the 
other hand, showed the opposite 
trend: Most students then became ei¬ 
ther much more cynical or slightly less 
cynical. Dr. Sanders’ reaction? “I was 
astonished.” 
Dr. Eron wasn’t. “I would expect 
them to be less cynical,” he said, “be¬ 
cause medicine has made so much 
progress in the last 40 years.” 
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Nobelist returns to New Haven for Student Research Day 
Above Matthew Bui explains his re¬ 
search The Regulation of Nuclear Trans¬ 
port of Influenza vRNPs to Eric Hughes. 
Left For her paper, Motherhood and 
Medicine: A Study of Women from Yale 
School of Medicine 1922-1999, Ruth 
Potee, M.D., '99, researched women 
who balanced the demands of careers 
in medicine with their roles as mothers. 
Below Sydney Butts explains her re¬ 
search The Correlation Between the 
Glutomate Receptor GluR2 and 
Calbindin D-28K in the Developing 
Gerbil Cochlear Nucleus to Alfred 
Gilman, who received the 1994 Nobel 
Prize for his research into G proteins. 
Growing up in New Haven as 
the son of a Yale pharmacolo¬ 
gist, Allred G. Gilman, M.D., 
Ph.D., recalls feeling at home in the 
laboratory from an early age. “My fa¬ 
ther was spectacularly good at show¬ 
ing me the joy of science,” said Dr. 
Gilman, who also pursued a career in 
pharmacology and in 1994 won the 
Nobel Prize for his research into G 
proteins. He discussed research into 
the proteins, his own and that of other 
scientists, during the nth Annual Lee 
E. Farr, M.D., Lecture on Student 
Research Day, in May. 
“G proteins mediate everything 
from sex in yeast to cognition in 
humans,” said Dr. Gilman, the 
Raymond and Ellen Willie Distin¬ 
guished Chair in Molecular Neuro¬ 
pharmacology, Regental Professor and 
Chairman, Department of Pharmacol¬ 
ogy at University of Texas Southwest¬ 
ern Medical Center in Dallas. The 
proteins have been likened to a 
switchboard operator who receives 
messages and makes sure they reach 
the proper recipient. Failure in that 
task can cause disease. Researchers 
have linked malfunctioning G pro¬ 
teins to alcoholism, diabetes, cancer¬ 
ous tumors and cholera. Dr. Gilman 
and Martin Rodbell, Ph.D., a scientist 
emeritus at the National Institute of 
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Environmental Health Sciences in 
North Carolina, shared the Nobel 
Prize for identifying G proteins and 
their role in the signaling process. 
John N. Forrest Jr., M.D., director 
of the Office of Student Research, said 
the day “celebrates 159 years of a tradi¬ 
tion unique in American medicine.” 
Yale requires medical students to write 
a thesis on a research project in order 
to graduate. “The value of the thesis,” 
Dr. Forrest said, “is not the concept of 
trying for a scientific career, but to 
teach that all physicians are scientists.” 
“This is the day that a lot of us 
look forward to,” said Dean David 
A. Kessler, M.D., “because it really 
defines us as a school.” 
“Being in a laboratory situation 
and working with a leading scientist 
in the field of interest is really a 
critical part of my medical educa¬ 
tion,” said Jeffrey Reynolds, one of 
Five students who won awards for 
their theses. “I feel that, having 
done this project, I have access intel¬ 
lectually to most of the things I can 
read in the literature. Without it, I 
wouldn’t really be able to look criti¬ 
cally at the literature.” 
“It changes your perspective 
when you’re in a clinical situation to 
have that research perspective,” said 
Nicole Ullrich, another award¬ 
winning student. 
This year students prepared 63 
posters showing the results of their 
studies. Five students made oral pre¬ 
sentations of their award-winning 
theses. They were: Dr. Reynolds, 
Phenotypic Expression of Glucorticoid- 
Remediable Aldosteronism in a Large 
Kindred (Internal Medicine); Alan 
Cheng, JAK3 and the Pathogenesis of 
Severe Combined Immunodeficiency: 
Insights into Structure and Function 
(Immunobiology); John Forman, 
Recombinant Vesicular Stomatitis Vi¬ 
ruses Expressing HIV-i Gag and Env 
Genes Generate HIV-Like Particles 
and Elicit Anti-HIV Immune Re¬ 
sponses in Mice (Pathology); Nirit 
Weiss, Carotid Body Chemoreceptors: 
Mechanisms of Neurotransmitter Re¬ 
lease (Pediatrics); and Dr. Ullrich, 
Properties and Function of Chloride 
Channels in Human Glial Tumors 
(Neurobiology). 
« 53 
In addition, the advent of managed 
health care and falling physician in¬ 
comes may serve as a screening 
mechanism, scaring off those who 
would enter medicine for less than al¬ 
truistic reasons. “Knowing that the 
field has some problems and still 
wanting to make a difference—is 
there a better definition of idealism 
than that?” Dr. Sanders says of her 
classmates. 
Still, her research showed that the 
majority of graduating medical stu¬ 
dents continue to believe that they 
have become more cynical in the 
course of their education. Of the 72 
students (or 77 percent of the class) 
participating in her study, 49 reported 
increased cynicism. 
Now a resident in internal medi¬ 
cine at Yale-New Haven Hospital, Dr. 
Sanders hopes next year to further 
study the connection between cyni¬ 
cism and blame-laying. In the survey, 
she found that the class of 1995 
showed a disturbing tendency to 
blame the patient for the illness. “Stu¬ 
dents,” she wrote, “seem to have both 
unrealistic expectations of patients 
and excessive faith, not currently sup¬ 
ported by scientific evidence, in the 
efficacy ol lifestyle changes.” 
Dr. Sanders’ research also showed 
that students became less discouraged 
and more humanitarian with in¬ 
creased teaching from attending phy¬ 
sicians. She hersell became less cynical 
during her studies at Yale and at¬ 
tributes this in part to what the study 
of medicine taught her about evaluat¬ 
ing problems and to simply growing 
up. “Adulthood is a decynicizing pro¬ 
cess,” Dr. Sanders says. “The essence 
of cynicism is a suspicion of ‘them’— 
them as being different from you. The 
process of adulthood teaches us how 
similar we really are.” 
Rachel Engers is a free-lance writer. 
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NEW BOOKS 
Atlas on the Surgical Anatomy of Laryn¬ 
geal Cancer by John A. Kirchner, 
M.D., professor emeritus of surgery 
(otolaryngology), Singular Publishing 
Group Inc. (San Diego/London) 1998. 
The Beach by Lena Lencek and 
Gideon Bosker, M.D., assistant clini¬ 
cal professor of surgery (emergency 
medicine). Viking (N.Y.) 1998. 
The Bends: Compressed Air in the His¬ 
tory of Science, Diving, and Engineering 
by John L. Phillips, M.D. ’92, Yale 
University Press 1998. 
Between the Raindrops by David V. 
Pecora, M.D. ’41, HS ’49, Vantage 
Press, Inc. (N.Y.) 1998. 
Clinical Electrocardiography: A 
Simplified Approach by Ary L. 
Goldberger, M.D. ’74, HS ’77, 
Mosby (St. Louis) 1998. 
Guilty by Reason of Insanity: A 
Psychiatrist Explores the Minds of Killers 
by Dorothy O. Lewis, M.D. ’63, HS 
’65, Fawcett (N.Y.) 1998. 
The Power of Hope: A Doctor's Perspec- 
tive by Howard Spiro, M.D., professor 
oi medicine, 
Yale University 
Press 1998. 
The Surgeons 
Surgeon: 
Theodor Bilroth 
(1829-1894) vol¬ 
ume IVby Karel 
B. Abolson, 
M.D. ’52, Kabel 
Publishers (Rockville, 
Md.) 1998. 
GUILTY 
by REASON 
of INSANITY 
The Program for Humanities in Medicine 
1998-1999 LECTURE SERIES 
Lectures, free and open to the public, begin at 5 p.m. in the Beaumont Room, 333 Cedar Street. Refreshments at 
4:30 p.m. For information call Howard Spiro or Clara Gyorgyey at (203) 785-5494. 
DECEMBER 10 
The Human Encounters 
in Medicine 
The McGovern Lecture 
John Stone, M.D. 
Professor of Cardiology 
Emory University School of Medicine 
DECEMBER 17 
Covert Communication in Clinics, 
Classrooms, Corporations 
& Courtrooms 
The Bayer Lecture 
Robert Rosenthal, Ph.D. 
Edgar Pierce Professor of Psychology 
Harvard Medical School 
JANUARY 7 
Conflict In Classical Arabic Medicine 
Dimitri Gutas, Ph.D. 
Professor of Arabic Languages & Literature 
Yale University 
JANUARY 21 
From Quarantine to Condoms: 
HIV Control in Cuba* 
Helena Hansen, MS 
M.D./Ph.D. Candidate 
Yale University School of Medicine 
JANUARY 28 
My Brother, Madness & Survival: 
Memoir 
Jay Neugeboren, Ph.D. 
Professor of English/Writer in Residence 
University of Massachusetts 
FEBRUARY 4 
Hygeia Revisited: Lessons to Comfort 
Michael Berman, M.D. 
Clinical Professor of Obstetrics & Gynecology 
Yale University School of Medicine 
FEBRUARY 11 
Young Cushing: The Right Stuff 
Robert M. Crowell, M.D. 
Professor of Neurosurgery 
University of Massachusetts Medical School 
FEBRUARY 25 
Match Day: Stories of Adoption 
& Reunion 
Morris A. Wessel, M.D. 
Clinical Professor Emeritus of Pediatrics 
Yale University School of Medicine 
Diana K.R. Jowdy, MA 
Ph.D. Candidate 
American Culture 
University of Michigan 
MARCH 4 
Cultural Competence? Immigrant 
Patients American Doctors 
The Robert Penn Warren Lecture 
Anne Fadiman, BA 
Editor of The American Scholar 
MARCH 18 
Eye of Doctors: Enhancing Observational 
Skills With Fine Arts 
Irwin M. Braverman, M.D. 
Professor of Dermatology 
Yale University School of Medicine 
APRIL 1 
Meeting the Challenge of 
Alternative Medicine 
Joseph J. Jacobs M.D., MBA 
Former Director 
Office of Alternative Medicine at NIH 
APRIL 15 
When a Patient Wants to Die 
Charles F. McKhann, M.D. 
Professor of Surgery 
Yale University School of Medicine 
APRIL 29 
Forty Years of Medical Education at Yale 
Howard Levitin, M.D. 
Professor of Internal Medicine 
Yale University School of Medicine 
MAY 6 
Carlo Levi, MD & the Italian Anti-Fascist 
Movement 
Harvey Mandell, M.D. 
Retired Internist 
David Ward, Ph.D. 
Associate Professor of Italian 
Wellesley College 
MAY 13 
A Surprise 
Jacques Pepin, MA 
Master Chef, Columnist, Author, Teacher 
PBS-TV Host 
Note: Lectures marked by an asterisk (*) are co¬ 
sponsored by the Office of Multiclutural Affairs. 
ALUMNI NEWS 
’40s 
Hunter H. Comly, M.D. ’43, retired 
from practice in 1992 following the 
death of his wife, Mary Ellen, and 
moved to San Diego. He reports 
doing some locum tenens work and six 
days per month of child psychiatry. 
He travels regularly to see theater and 
opera in Oregon and Utah and 
returned to New Haven in June for 
his 55th reunion. He writes: “Hope to 
see more classmates for the 60th!” 
Connecticut College awarded Morris 
A. Wessel, M.D. ’43, an honorary 
doctor of science degree for his long, 
multifaceted career as a pediatrician. 
Retired from practice since 1992, Dr. 
Wessel remains a clinical professor of 
pediatrics at Yale. 
Richard W. Breck, M.D. 45 wrote 
with news of his classmates. James 
R. Mason, M.D. ’45, of Ormond 
Beach, Fla., was evacuated for several 
days during the wildfires of early 
summer that came within 100 yards 
of his home. A tornado also came 
close to his home this year. Elliot R. 
Reiner, M.D. ’45, and his wife, 
Catherine, traveled on a Smithsonian- 
sponsored tour to Scotland and 
England in June 1997. Alice Shepard 
Carey, M.D. ’45, retired from medical 
practice in Japan and now lives in 
Oakland, Calif. She returned three 
times to Japan during the past year, 
and traveled to Turkey as well. Six 
1945 classmates attended the John P. 
Peters, M.D., Symposium, June 5 and 
6, during their reunion. (See related 
article in Reunion section.) Richard 
Peters, M.D., ’45 son of the Yale 
professor, came from California and 
provided reflections on his father’s life 
as an early advocate of socialized 
medicine who was attacked by 
conservatives during the late 1940s 
and early ’50s. Others attending 
included Roger Hollan, M.D. ’45 
from Texas, Charles McLean, M.D. 
’45 from Cape Cod. William Jenney, 
M.D. ’45, and his wife Marge came 
from Massachusetts as well, while 
Dick Breck, M.D., ’45 came from 
Connecticut. 
’50s 
Asa Barnes Jr., M.D. ’59, HS ’65, 
reports hearing from missionary and 
medical colleagues in Nairobi, about 
the bombing of the U.S. Embassy 
there. Dr. Barnes, who retired in 1995 
after 18 years as clinical professor of 
pathology at the University of 
Californ2ia at Irvine, has made three 
trips to Kenya on behalf of the World 
Medical Mission. While there he 
serves as pathologist for the Kijabe 
Medical Center, which analyzes 
specimens for 42 hospitals in coun¬ 
tries along Africa’s eastern coast. “The 
hospitals, including Kijabe, were 
packed with patients and bodies,’’ 
says Dr. Barnes, who heard about the 
bombing Irom his colleagues in Africa 
by e-mail. He has also traveled to 
Vietnam, where he arranges exchange 
trips for American physicians and 
donations of used medical equipment 
such as cardiopulmonary bypass 
machines and pediatric respirators. 
When not traveling, Dr. Barnes and 
his wife, Jean, live on their ranch on 
the East Fork of the Gila River in 
New Mexico. 
’60s 
Charles A. Dinarello, M.D. ’69, 
professor of medicine at the Univer¬ 
sity of Colorado School of Medicine 
in Denver, was elected to the Na¬ 
tional Academy of Sciences in April. 
Dr. Dinarello is a world expert in 
cytokines, clinically important 
molecules that regulate the immune 
and inflammatory responses. He was 
one of the first scientists to work on 
the molecular biology and cloning of 
cytokines. The Institute for Scientific 
Information listed him as the world’s 
third most cited life scientist. He has 
trained over 25 young investigators, 
many of whom are recognized experts 
in their fields. Dr. Dinarello was the 
winner of the Borden Undergraduate 
Research Award in Medicine in 1969 
for his medical school thesis. 
Chief of surgery at 
the Robert Wood 
Johnson University 
Hospital in New 
Brunswick, N.J., 
Ralph S. Greco, 
M.D. '68, HS ’73, 
keeps his hands 
and eyes nimble by 
producing abstract 
and representa¬ 
tional art in stone 
and wood. His 
work was exhibited o O 
in the spring at the g 
Quietude Gallery | 
in East Brunswick. 
He has shown at several other 
galleries and in the Johnson & 
Johnson Worldwide Corporate 
Headquarters. 
’70s 
Richard D. Bey, M.D. ’79, was 
named outstanding teacher 
for 1998 by the residents in 
family medicine at Wake Forest 
University Medical School, 
Winston-Salem, N.C. 
Robert B. Diasio, M.D. ’71, chair 
of the department of pharmacology 
and toxicology and director of the 
division of clinical pharmacology at 
the University of Alabama (UAB) 
School of Medicine, was one of 55 
physician-scientists elected recently 
to the Association of American 
Physicians. Dr. Diasio was also 
recently named associate director 
for basic science research in the UAB 
Comprehensive Cancer Center. 
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Edward C. Halperin, M.D. 79, 
has been named the L.R. Prosnitz 
Professor of Radiation Oncology at 
the Duke University Medical Center, 
where he chairs the department of 
radiation oncology and is professor of 
pediatrics. The third edition of 
Pediatric Radiation Oncology, which 
he co-authored with three colleagues, 
will be published this year. The first 
Russian language edition will be 
published in 1999. 
Jesse B. Jupiter, M.D. ’72, director 
of the Orthopaedic Hand Surgery 
Service at the Massachusetts General 
Hospital, has been named professor 
of orthopaedic surgery at Harvard 
Medical School. 
Professor of Psychiatry Charles 
“Chip” E Reynolds III, M.D. ’73, 
was appointed senior associate dean 
at the University of Pittsburgh School 
of Medicine overseeing faculty affairs 
and monitoring the development of 
the curriculum. He is also director of 
the Sleep and Chronobiology Center 
and of the NIMH-General CRC on 
Late-Life Mood Disorders. 
’80s 
Kathleen M. Craig, M.PH. ’85, of 
Bronxville, N.Y., recently became 
director of consulting services for 
NewSolutions Inc., an information 
services company serving the health 
care industry in New Jersey, New 
York and Pennsylvania. She is the 
past president of the New York 
Society for Health Planning, an 
organization of health professionals 
in the greater New York area. 
Burlington psychiatrist and Univer¬ 
sity of Vermont College of Medicine 
clinical associate professor David 
Fassler, M.D. ’82, received the 1998 
Annual Exemplary Psychiatrist Award 
from the National Alliance for the 
Mentally Ill (NAMI). The award was 
presented at the American Psychiatric 
' ssociation’s annual meeting in 
loronto in June. Dr. Fassler is clinical 
director of Otter Creek Associates, an 
outpatient group practice, and the co¬ 
author of seven books for children 
and parents. 
Eric P. Winer, M.D. ’83, HS ’87, 
B.A. 78, was named director of the 
Breast Oncology Center at Dana- 
Farber Cancer Institute/Brigham and 
Women’s Hospital in Boston. For the 
previous six years. Dr. Winer served 
as co-director of the Multidisciplinary 
Breast Program at Duke University 
Medical Center in North Carolina. 
’90s 
Michael C. Brown, M.D. 93, 
married Melissa A. Brown in March 
in New York City. Dr. Brown is a 
gastroenterology fellow at the 
University of Washington Medical 
Center. His wife is a television 
news producer. 
Imtiaz A. Chaudhry, M.D., Ph.D., 
HS ’94-98, has been accepted as a 
fellow in oculoplastic-surgery in the 
Department of Ophthalmology at 
Baylor College of Medicine in 
Houston. 
Andreas Eicher, M.P.H. ’96, M.F. 
’96, director of Disha, which means 
“direction” in Hindi, a community 
health and development program, 
works out of the Nav Jivan Hospital 
in Bihar in eastern India. He was 
visited recently by classmates Bindo 
Mahanti, M.P.H. ’96, and Rachel 
Salks, M.P.H. ’96. 
It was a May wedding for David L.S. 
Morales, M.D. ’95, and Mary 
Elizabeth Collins in Saddle River, 
N.J. Dr. Morales is a resident in 
general surgery at Columbia-Presby- 
terian Medical Center in New York. 
His wife is a pediatric case manager in 
AIDS health services at the Jersey 
City Medical Center. 
Before recently moving to New York 
City, DonfengTan, M.D., HS ’94- 
98, and Hong Zou, M.P.H., had a 
baby daughter, Christina. Their first 
daughter, Connie, was also born in 
New Haven. Dr. Tan, newly board 
certified in pathology, is now an 
oncological pathology fellow at 
Memorial Sloan-Kettering 
Cancer Center. 
First it was marriage and then 
graduation for Amy E. Taylor, M.D. 
’98, B.A. ’93, and Jaimie D. Nathan, 
M.D. ’98, B.S. ’93, who married in 
Buffalo in early May before their 
graduation from the medical school 
at month’s end. Dr. Taylor began 
a residency in pediatrics at the 
University of North Carolina 
Hospital and Dr. Nathan began a 
general surgical residency at the 
Duke University Hospital. 
Marc A. Weinstein, M.D. ’93, and 
Kristine M. Medina married in 
March in West Orange, N.J. Dr. 
Weinstein is a resident in orthopedic 
surgery at Yale-New Haven Hospital. 
His wife is a senior account director 
at Pharmadesign, a pharmaceutical 
marketing firm. 
Associate professor of surgery and 
public health sciences at the 
University of Toronto, James G. 
Wright, M.P.H. ’91, has been 
awarded the 1998 Annual Gold Medal 
for Research in Surgery of the Royal 
College of Physicians and Surgeons 
of Canada. He was also recipient of 
the 1998 J. Edouard Samson Award 
of the Canadian Orthopaedic 
Foundation/Canadian Orthopaedic 
Association (their highest research 
award), and a five-year Scientist 
Award of the Medical Research 
Council of Canada. 
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OBITUARIES 
FRANK R. ALLEN 
Frank R. Allen, M.D. ’51, of 
Wolfeboro, N.H., died in Huggins 
Hospital on July 17. He was 76. 
Dr. Allen graduated from Yale 
School of Medicine after serving as a 
pilot in the Naval Air Corps during 
World War II. He practiced family 
medicine in Wolfeboro for 38 years 
and was chief of medicine at Huggins 
Hospital. In 1984, he was voted 
Wolfeboro’s Citizen of the Year. 
Retiring from family practice in 
1986, Dr. Allen moved to Tucson, 
Ariz., where he practiced emergency 
medicine at the Davis-Morrison 
Air Force Base Hospital until 1991. 
He returned to Wolfeboro in 1992 to 
lull retirement. 
ALBERT S. ATWOOD 
Albert S. Atwood, M.D. ’45, of 
Stonington, Conn., died Aug. 8. He 
was 77 years old. He was active in 
medical school alumni affairs until his 
death, serving on the executive com¬ 
mittee of the Association of Yale 
Alumni in Medicine and as secretary 
for his class. 
Raised in West Hartford, Conn., 
Dr. Atwood attended the University 
of Connecticut, where he played foot¬ 
ball and held the rank of captain in 
the ROTC. In 1945, he graduated 
from the School of Medicine and 
went on to serve in the United States 
Medical Corps in Japan. He did his 
orthopaedic surgery residency at 
Grace-New Haven Hospital and prac¬ 
ticed orthopaedics at Charlotte 
Hungerford Hospital in Litchfield 
County, Conn., for 25 years. 
In 1977, he was named the first 
chair of the Department of Rehabili¬ 
tation at Lawrence and Memorial 
Hospitals in New London. After retir¬ 
ing from practice in 1987, he worked 
as a surveyor for the national organi¬ 
zation, the Joint Commission for the 
Accreditation of Hospitals. 
MELVIN J. COHEN 
Professor emeritus of biology Melvin 
J. Cohen, Ph.D., died Feb. 22 in 
Berkeley, Calif. A member ol the 
National Academy of Sciences, he was 
69 and had been affiliated as a neuro¬ 
biologist with Yale for 29 years. 
Dr. Cohen joined the Yale faculty 
in 1969. His research focused on ele¬ 
ments influencing the shape of nerve 
cells and the pattern of synaptic con¬ 
nections between them, especially in 
injured neurons. His work has dem¬ 
onstrated that axonal die-back follow¬ 
ing spinal injury is caused primarily 
by excess amounts of calcium ions, 
which can be blocked by direct elec¬ 
tric current. 
EDWARD F. EDINGER 
Considered one of the leading Jungian 
analysts in America, Edward F. 
Edinger, M.D. ’46, HS 51, died of 
cancer on July 17 at his home in Los 
Angeles. He was 75. 
Dr. Edinger published numerous 
books on the interplay between sym¬ 
bols and psychology, drawing on the 
concepts of Carl Jung. Dr. Edinger 
was a supervising psychiatrist at 
Rockland State Hospital in 
Orangeburg, N.Y., and later was a 
founding member of the C.G. Jung 
Foundation in Manhattan and the 
C.G. Jung Institute of New York. He 
was president of the institute from 
1968 until 1979, when he moved to 
Los Angeles. There, he continued his 
practice and his writings until shortly 
before his death. 
ARAM GLORIG 
Aram Glorig, M.D., HS ’46-47, a 
leading expert on the effects of work¬ 
place noise and a former Yale faculty 
member, died June 22 at the South 
Coast Medical Center in San 
Clemente, Calif. He was 92. 
Dr. Glorig helped develop smaller 
and more effective hearing aids and 
set standards for noise levels on the 
job. He was the founder, in 1973, of 
the American Auditory Society, an as¬ 
sociation of professionals working to 
improve understanding and treatment 
of hearing and ear disorders. Follow¬ 
ing service in the Army during World 
War II, Dr. Glorig was an assistant 
professor at Yale, leaving in 1948 to set 
up a hearing disorders center at Walter 
Reed Army Hospital. 
HARRIET P. LEACH 
Harriet P. Leach, M.D. ’35, died at the 
Shaughnessy-Kaplan Rehabilitation 
Hospital in Salem, Mass., on May 25. 
She was 93. 
Dr. Leach was a general 
practitioner in private practice in 
Chelmsford and Billerica, Mass., for 
nearly 50 years before retiring a decade 
ago. When she opened her practice in 
1940, she found herself covering for 
numerous physicians in her area who 
had gone on to service during World 
War II. According to the nephew with 
whom she lived at the time of her 
death, she ran her practice out of her 
own house and charged very modest 
fees. Dr. Leach was associated with 
Lowell General Hospital, St. Joseph’s 
Hospital and St. John’s Hospital, all in 
Lowell, Mass. An active member of 
the Appalachian Mountain Club, she 
climbed 40 of the 48 4,000-foot 
mountains in New Hampshire. She 
also never lost her interest in zoology, 
which was her undergraduate major at 
Smith College. 
ROBERT A. MACKEY 
Robert A. Mackey, M.D. ’71, died 
April 19 in York, Maine, where he had 
lived for 22 years. He was 52. 
After completing his residency at 
LJniversity Hospitals in Cleveland, he 
served as a major in the U.S. Air 
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Force, as a pediatrician. Dr. Mackey 
then set up a pediatric practice and 
was on the medical staff at York Hos- 
pital. An avid sports enthusiast, he 
was nicknamed the “Voice of York” 
for his work as the sports announcer 
for York High School. 
JOHN G. MARTIN 
John Garthwaite Martin, M.D. ’33, 
B.S. ’29, of Scotland, Conn., died 
at Windham Hospital on May 3. 
He was 90. 
After completing medical school at 
Yale and interning at Hartford Hospi¬ 
tal, he began a family practice in West 
Hartford, Conn., in 1933, which he 
continued, except for service as a 
medical officer in the Army Air Corps 
from 1942 to 1946. Dr. Martin retired 
in 1983 and pursued his varied inter¬ 
ests in gardening, bird watching, pho¬ 
tography and his grandchildren. 
CLIFFORD B. REIFLER 
Clifford B. Reifler, M.D. ’57, died at 
Strong Memorial Hospital in Roches¬ 
ter, N.Y., on May 12. He was 66. 
Dr. Reifler served as director of the 
University Health Service at the Uni¬ 
versity of Rochester from 1970 until 
his retirement in 1994 and held several 
positions at Strong Memorial Hospital 
including that of medical director 
from 1983 to 1985. He was considered 
a leader in helping to establish a pub¬ 
lic health model for college health ser¬ 
vices, directing resources toward pre¬ 
vention and improving the living and 
working environments of students. 
Dr. Reifler served as president of the 
American College Health Association 
for 1977-78. He was senior editor of 
the Journal of American College Health 
from 1983 to 1996. 
W. ADAMS STANDISH 
Welles Adams Standish, M.D. ’25, 
B.A. ’22, died on May 29 in West 
Hartford, Conn. He was 98. 
After completing a surgical resi¬ 
dency at Barnes Hospital in St. Louis, 
following his studies at Yale, Dr. 
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Standish joined the surgical staff at 
Hartford Hospital, where he spent his 
entire career, except during World 
War II when he served in the Navy. 
He started the surgical residency 
program at the hospital and served as 
director of surgery. He was former 
president of the New England 
Surgical Society. 
KENNETH C. STEELE 
Kenneth C. Steele, M.D. ’45, HS ’46, 
M. S. ’42, died July 11 at St. Luke's 
Memorial Hospital Center in New 
Hartford, N.Y. He was 79 years old. 
Following his graduation from 
Yale, he served as a Captain in the 
U.S. Army Medical Corps. In 1956, he 
established a surgical practice in Utica, 
N. Y. After retiring from practice, he 
served as medical director of Mohawk 
Valley General Hospital. 
ROBERT L. STEIN 
Robert L. Stein, M.D. ’54, died of 
cancer at his home in Pleasant Hill, 
Calif., on May 10, 1997. He was 68. 
While at Yale, he was the only 
medical student in the Yale March¬ 
ing Band, playing the clarinet. Dr. 
Stein did a straight surgical intern¬ 
ship at the University of North 
Carolina in Chapel Hill. He spent 12 
years in the Army as a general prac¬ 
titioner. After resigning his commis¬ 
sion with the rank of lieutenant- 
colonel in 1967, he spent a year as a 
National Institutes of Health fellow 
in neuroradiology at the University 
of California, San Francisco. Follow¬ 
ing two years as a radiologist at the 
VA hospital in San Francisco, he be¬ 
gan private practice in radiology, 
which he continued for 16 years un¬ 
til his retirement in 1994. 
BERNARD ZUGER 
Bernard Zuger, M.D., HS ’32-33, died 
of a stroke on April 19 at the age of 92. 
Dr. Zuger was born in Russia and 
emigrated to New York City at age 
8. He received his bachelor’s degree 
from Columbia College and a medi¬ 
cal degree from the College of Phy¬ 
sicians and Surgeons of Columbia 
University. Dr. Zuger did his resi¬ 
dency training in pediatrics at Yale- 
New Haven Hospital and the 
Brooklyn Jewish Hospital, and in 
psychiatry at Bellevue Flospital. 
In addition to maintaining a pri¬ 
vate practice in child and adult psy¬ 
chiatry in New York City, he was staff 
psychiatrist at Roosevelt and Bellevue 
hospitals and for 30 years at the 
Greenwich Hospital in Connecticut. 
Dr. Zuger was a pioneer in the study of 
male homosexuality, arguing for 30 
years that the condition is present from 
birth, the result of innate biochemical 
or genetic factors. Much of his work 
on gender identity has since been vali¬ 
dated by more sophisticated studies. 
IN MEMORIAM 
The School of Medicine has received 
notification of the death of the 
following persons: 
Stanley M.K. Chung, M.D. ’60 
April 21, 1998 
Aram Glorig, M.D., HS ’46-47 
June 22, 1998 
Sumner Goldenthal, M.D. ’51 
April 24, 1998 
William P. Koughan Jr., M.P.H. ’71 
April 6, 1998 
Robert A. Mackey, M.D. ’71 
April 19, 1998 
John G. Martin, M.D. ’33 
May 3, 1998 
Rhoda M. Mickey, M.D. ’31 
February 3, 1998 
Clifford B. Reifler, M.D. ’57 
May 12, 1998 
John Keith Rose, M.D. ’54 
July 11, 1998 
W. Adams Standish, M.D. ’25 
May 29, 1998 
Charles F. Stroebel, M.D. ’72 
April 10, 1998 
Douglas R. Wilkie, M.D. ’43 
May 21, 1998 
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Back on Cedar Street, 600 celebrate 
John Peters, the Yale System and reunions 
By John Curtis 
More than 400 medical alumni and friends and 
close to 200 public health alumni gathered in 
New Haven June 5 and 6 for a reunion week¬ 
end that featured a New England clambake, the roasting 
of retiring public health professor Lowell Levin, D.Ed., 
and a symposium on John P. Peters, M.D., a legendary 
Yale professor accused of disloyalty in the McCarthy era. 
Alumni began trickling into the school Lriday, June 
5, for a series of lectures sponsored by the Yale Surgical 
Society in the Hope Building. Alumni also toured the 
historical library and Yale-New Haven Hospital. AYAM 
President Nicholas M. Passarelli, M.D. ’59, opened the 
weekend with welcoming remarks in the Hope Building. 
Robert H. Gifford, M.D., deputy dean for education, 
made a presentation on The Yale System, Its Evolution, 
Its Strengths and Problems. 
At a symposium Saturday morning, speakers de¬ 
scribed the life and achievements of Dr. Peters, known 
for his pioneering work in metabolism and his fight to 
clear his name during the McCarthy era, when his loy¬ 
alty was questioned by a review board. 
Before a buffet luncheon in Harkness Hall, alumni 
attended presentations on research at Yale by three pro¬ 
fessors who discussed new lines of inquiry in hyperten¬ 
sion, women’s health and molecular psychiatry. 
John Peters’ legacy 62 
Class reunion reports 64 
The Yale System revisited 66 
A global perspective at EPH 68 
Surgical society bestows honors 69 
A glimpse into the lab 71 
Distinguished alumnus 71 
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REUNION 1999: JUNE 4 AND 5 Toby Appel leads alumni on a tour of the Historical Library. 
Symposium honors a hero of metabolism 
research who fell victim to McCarthy 
At a symposium on John P. Peters, M.D., speakers 
paid tribute to one of the nation’s leading experts 
in metabolism who stood up to McCarthyism in 
the 1950s. 
A nephrologist who taught at Yale from 1922 until 
his death in 1955, Dr. Peters came to national attention 
in the 1930s as secretary of the Committee of 430 Physi¬ 
cians, a group that advocated reforms that have become 
standard features of modern medicine. They believed 
that the health of the public should be a concern of gov¬ 
ernment and that government should be involved in 
providing medical care. During the McCarthy era, Dr. 
Peters’ views and his signature on open letters espousing 
liberal causes surfaced as evidence of his alleged disloy¬ 
alty to the United States. Although loyalty boards twice 
dismissed the case against him, a third board found his 
loyalty questionable and he was removed as a member of 
a study section of the Division of Research Grants and 
Fellowships of the National Institutes of Health. 
Dr. Peters was distinguished by his persistent efforts 
to apply scientific advances to the treatment of patients. 
“At the same time this was incorporated in a context of 
moral dignity so that the application of science to the 
patient was associated with kindness, with a great deal of 
concern and followup,” said Donald W. Seldin, M.D. 
’43, Professor Emeritus of Internal Medicine at the Uni¬ 
versity of Texas Southwest Medical Center, in his talk, 
Reflections of a Student of Peters. “The plain fact of the 
More than a dozen members of Peters’ family, including his son 
and two granddaughters, came to New Haven for the symposium 
in his honor. 
Franklin H. Epstein, M.D. ’47, discussed John P. Peters, whose image is 
in the background, and his contributions to the study of renal disease. 
matter is that he was a courageous man and a morally 
dignified man. He did for the profession what the pro¬ 
fession needs, self-criticism, self-policing. Now, hope¬ 
fully, Dr. Peters’ vision of medicine available to all the 
people and at high quality will be reinstituted.” 
The discussion ranged from his medical contribu¬ 
tions to his legal and moral battles. Catherine G. 
Roraback, LL.B. ’48, a Yale-educated attorney who rep¬ 
resented dissenters in the 1950s, noted that Dr. Peters be¬ 
came a target of loyalty boards not because he broke a 
law, but because he exercised his right of free speech and 
association. George D. Lundberg, M.D., editor-in-chief 
of the fournal of the American Medical Association, traced 
the longstanding acrimony between the Committee of 
430 Physicians and the AMA, which vehemently op¬ 
posed the reforms the committee proposed. Many of 
those reforms, he said, are now integral pieces of medical 
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practice in this country, such as federal support of medi¬ 
cine and programs such as Medicaid and Medicare. 
Richard M. Peters, M.D. ’45, one of Dr. Peters’ 
sons, described how the loyalty hearings absorbed his 
father’s final years and, his family believes, shortened his 
life. Close to a dozen family members traveled to New 
Haven including Dr. Peters’ granddaughter, Barbara 
Ann Peters, M.D. ’79. 
Franklin H. Epstein, M.D. ’47, professor of medi¬ 
cine at Harvard Medical School and Beth Israel Hospi¬ 
tal, cited Dr. Peters’ contributions to the study of renal 
disease, noting that Dr. Peters was interested in the 
chemical derangements of disease. “It was the measure¬ 
ment of the chemical constituents of body fluids that 
provided the first of three solid foundation blocks, the 
cornerstones of Peters’ approach,” Dr. Epstein said. 
“He understood and appreciated the importance of 
accurate, impeccable measurement.” 
Dr. Peters’ most enduring technical achievement 
was the introduction into the clinic of the flame pho¬ 
tometer, which made possible within minutes accurate 
measurements of sodium and potassium in serum or 
urine samples. He used those measurements, an exact¬ 
ing analysis of diet, urine and feces, to treat his patients. 
Colleagues and students marveled at his ability to take 
the raw data and synthesize it into a logical framework. 
“His associates might experiment on animals, but he 
preferred to concentrate on examining disordered physi¬ 
ology at the bedside with accurate chemical techniques 
and the power of logical inference,” said Dr. Epstein. 
According to Phillip Gorden, M.D., HS ’61-66, 
the director of the National Institute of Diabetes and 
Digestive and Kidney Diseases, Dr. Peters’ studies of 
body water, electrolytes, and acid-base balance were 
extremely important in the management of patients 
with diabetes mellitus. 
Dr. Peters was secretary of the Committee of 430 Physicians, a 
group dedicated to reforming their profession. They believed govern¬ 
ment should care for the poor and finance medical facilities, research 
and education. The committee felt that responsibility for health care 
fell on local, state and federal governments and volunteer agencies. 
With the advent of Medicare, Medicaid, Veterans Administration 
hospitals and the Food and Drug Administration, many of their goals 
have been realized. 
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CLASS REUNION REPORTS 
1938 
Charles J. Petrillo 
The Class of 1938 held its 60th reunion 
on June 5 and 6. Of the 48 students 
who matriculated in September 1934, 39 
graduated in 1938. According to my 
records, eight are still living, and two 
were able to attend the reunion, Ben 
Lyons and Charlie Petrillo. At our 
55th reunion, 15 were known to be alive. 
In the intervening five-year period, our 
class was reduced almost by half. 
As usual the alumni office had arranged 
an excellent program of lectures, semi¬ 
nars, receptions, luncheons and tours. 
Congratulations and thanks to its staff. 
No reunion activities had been planned 
for our class. The grand finale on Satur¬ 
day night was the dinner at the Gradu¬ 
ate Club hosted by the School of Medi¬ 
cine and the AYAM. Present were Ben 
and his wile Blanche, and Charlie with 
his daughter Terri Connolly. 
Ben and I have attempted to contact 
those classmates who were not present. 
Ed Roberge, who has overcome several 
major medical problems, is presently 
doing well and keeps busy with garden¬ 
ing and numerous other garden and 
house chores. He regrets that he, and 
his wife, Genevieve, were not able to 
join us. 
Lester Wallman reported that he is 
in good health, is on the admissions 
committee of the University of Ver¬ 
mont Medical School, gives an occa¬ 
sional anatomy lecture, and keeps an 
interest in medical history. He has a son 
who is a radiologist in California, two 
daughters and four grandchildren. 
Ben is quite busy with many interests. 
He is one of six medical school del¬ 
egates to the Association of Yale 
Alumni and in that capacity is in con¬ 
stant contact with the University and 
with the medical school. Ben also re¬ 
ports that he keeps his interest in the 
arts. He sings with a group of 25 retired 
people who give recitals at AARP and 
other senior gatherings. He has been a 
great help in tracking down our class¬ 
mates. Many thanks Ben. 
Charlie Petrillo, who married Mary 
Sullivan in 1995, likes to boast that be¬ 
tween his and her families, he is now 
the proud grandfather of 23, and by the 
time this report appears in print, it 
could be 24. He is well and keeps busy 
with golf, gardening, bowling and 
entertaining grandchildren. 
Jim Radcliff and his wife both have 
had open heart surgery and are unable 
to travel any distance. Jack 
McGillicuddy is in poor health and 
also unable to travel. 
1 hope to be able to give a more cheer¬ 
ful report next year. 
1943 
March 
Dorothea Peck Dwyer and 
Lycurgus M. Davey 
Ten members ol the Class of 1943 
March showed up and seven members 
brought their wives along. Transporta¬ 
tion and escort services were provided 
in a timely and helpful fashion. In place 
of a class dinner for Friday night, we 
joined the other reunion classes for a 
superb clambake in the courtyard of the 
Harkness dormitory. Dean Kessler 
made every effort to meet and greet our 
returning alumni. On Saturday night 
we were included at the Friends of the 
50th Dinner at the Graduate Club. 
Highlighting our activities was the 
Friday afternoon seminar entitled 
Our Second Life. Morris Wessel started 
the conversation with a recital of his ef¬ 
forts both at the hospital and in the 
community to orient our medical stu¬ 
dents and house staff toward some of 
the more humanistic aspects of medical 
practice. Bill Davey then read, some¬ 
what to Morris’ embarrassment, the 
citation conferring an honorary degree 
of doctor of science to Morris front 
Connecticut College in May. Morris 
was also honored by the American 
Academy of Pediatrics with the C. 
Anderson Aldrich Award in Child 
Development. Bill Davey called atten¬ 
tion to his own second career as a 
farmer, details of which were contained 
in a publication of the Farm Credit 
Bank of Texas, Growing Grapefruit, 
Doctor-Turned-Farmer Pursues Child¬ 
hood Dream. Dee Peck spoke briefly 
about her limitations resulting from 
two lengthy hospitalizations in the past 
few months. She had been teaching 
Yale medical students basic principles 
of X-ray interpretation. Lennie Kemler 
said that he decided to give up his 
practice and has taken a position as 
medical director at Aetna Life Insur¬ 
ance. Sophie Trent has turned more 
seriously to her first love and obtained 
a master’s degree in art from Central 
Connecticut State University. She is 
docent at the American Museum of 
Modern Art in New Britain, Conn. 
Jerry Fountain has turned to art as a 
form of expression and paints almost 
every day. He, too, is a museum docent 
but also has returned to his college 
major of languages. 
Mark Sanford finally found the time 
to do creative woodworking, and Hilly 
Spitz is devoting his time to watching 
and helping his grandchildren in their 
athletic endeavors. Hank Markley, for 
the past few years, has been director of 
the home care department of Green¬ 
wich Hospital, an activity he started in 
1956 on a part-time basis. Stu Joslin, 
after a successful career as a pediatri¬ 
cian, went back to school and has been 
a pediatric psychiatrist for the past 20 
years. Rocko Fasanella has taken up 
the ideal golf game—no score and no 
rules. He has maintained interest in 
macular degeneration and blepharo¬ 
spasm. He reminded us of our 
teacher, Dr. Leon Stone, and his experi¬ 
ments of transplanting the eye of the 
salamander. He spoke of his concern 
about the long-term potential complica¬ 
tions of refractive eye surgery. We were 
sorry to miss John Brobeck who had to 
cancel his trip at the last minute. 
Hank Riedel felt that he wasn’t up 
to making the transcontinental trip. 
Bob Wyatt has just moved to a new 
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condominium in Delray Beach, Fla. 
Nick Stahl has moved ro Charlestown, 
R.I., where he is having some difficulty 
adjusting to medication to improve 
his eyesight, but is enjoying local staples 
such as lobster, fish and clams. Bob 
Turner, Jess Goerner, Doug Lindsey 
and Phil Loge wrote to say they were 
sorry not to be able to attend. Edward 
Rabe wrote to say that despite fractures 
of the hip and pelvis he was well enough 
to take a river trip in 
Central Europe with his wife, Emily. 
After the Saturday seminar for John P. 
Peters, M.D., we assembled in front of 
the Sterling Hall of Medicine for our 
class photograph and then were off to 
the traditional Saturday luncheon on 
the Elarkness lawn. 
1943 
December 
Robert F Bradley and 
Thomas L. Bucky 
Five members of the Class of 1943 
December attended the reception— 
Hunter H. Comly and Rita Iannaci; 
Robert F. Bradley and his son, David; 
Donald W. Seldin and Ellen Taylor; 
Jane B. Cadbury; Thomas L. Bucky 
and his wife, Doris. They report that 
the Friday evening clambake was lots of 
fun and the food was great. 
Jeffrey (Larchmont, N.Y.); Anne 
Godley St. Goar and husband, Dr. 
Walter St. Goar (Brookline, Mass.); 
Paul Goldstein and wife, Betty 
(Branford, Conn.); Paul Koehler and 
wife, Margaret (Newbury, N.H.); Bob 
Lempke and wife, Mary (Indianapolis, 
Ind.); Arden Miller and wife, Helen 
(Chapel Hill, N.C.); John Morrison 
and wife, Gerry (Orange, Conn.); 
Dave Morton and wife, Kayo (Pueblo, 
Colo.); Dick Peterson (Stratford, 
Conn.); Jane Rivers (Columbus, Ga.); 
Bud Rowland and wife, Esther (New 
York, N.Y.); Ben Rush Jr. and wife 
Norah (Summit, N.J.); Jerry Shapiro 
and wife, Meredith (Boston); Bill 
Sibley (Tucson, Ariz.); and Howie 
Simon (Rye, N.Y.). Classmates were 
particularly grateful and appreciative 
that two members of the class, Julie 
Frieden and John Morrison, had 
made very special efforts to attend 
our 50th reunion. 
Friday evening, our class dinner was 
held at the New Haven Lawn Club. 
For entertainment, each classmate, 
randomly selected, made an extempora¬ 
neous, two-minute talk on some 
humorous, sad or memorable event 
that had happened in their life follow¬ 
ing graduation from medical school, 
or during their four years ol formal 
training at Yale. Most of those 
presentations were truly outstanding 
and entertaining. 
Our Saturday morning was devoted to 
the symposium on John P. Peters, M.D. 
The reunion was climaxed by our final 
dinner at the Graduate Club, hosted by 
the Alumni Association and called the 
Friends oi the 50th. A souvenir reunion 
booklet containing autobiographical 
sketches of 25 classmates, most with 
current, color photographs, was pro¬ 
vided to each classmate. Dick Hannah 
and Sylvia Preston Griffiths, who 
could not attend, wrote interesting let¬ 
ters for this booklet. 
In conclusion, the 50th reunion was in¬ 
formative and entertaining. Anne 
Godley St. Goar, class agent for many 
years and to whom we owe our sincere 
gratitude, will be succeeded by Ben 
Rush Jr. It was a memorable get-to¬ 
gether, but we truly missed our 15 de¬ 
ceased classmates: Russ Barrnett, Lee 
Brown, Art Coleman, Brad Colwell, 
Bob Downie, Vic Drill, Boy Frame, 
A1 Green, Ray Johnson, Bob Lawson, 
Jim Leslie, Bob Maurer, Bernie Naab, 
Gerry Nowlis and Gabe Saviano. 
1953 
Harold D. Bomstein Jr. 
Our 45th reunion was almost identical 
in turnout to our 40th, and would 
have exceeded it except for a few last- 
minute cancellations due to illness. 
1948 
Paul B. Koehler 
Beautiful, refreshingly cool weather on 
June 5 and 6 graced our 50th reunion. 
Those in attendance were: George 
Batten and wife, Barbara (Carmichael, 
Calif); Edith Beck (Greenwich, 
Conn.); “Jock” Bishop (Minneapolis, 
Minn.); Al Bridge and wife, Charline 
(Moreno Valley, Calif); Dick Buker, 
and wife, Jean, and daughter, Candace 
Chang (Chester, Mont., and Boston); 
Elizabeth Fuller Eisner and husband, 
Bob (Ester, Ark. and Assonet, Mass.); 
Al Fisk and wife, Ruth (Sonoma, 
Calif.); Tom Frei and wife, Dori 
(Boston); Julie Frieden and son, 
gK«j 
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Yale System thriving, says new deputy dean 
Although it is alternately misunderstood, revered, 
tolerated and adored, the Yale System is alive and 
well, Robert H. Gifford, M.D., deputy dean for 
education, told alumni gathered in the Hope Building 
during reunion weekend. Dr. Gifford noted that “the 
wheel has simply come round again” and cited F.R 
Underhill, who chaired the school's curriculum commit¬ 
tee in 1922. “The student,” Dr. Underhill complained at 
the time," has become the defenseless recipient of an 
overwhelming mass of facts.” 
Reaffirming the goals of Milton C. Winternitz, 
M.D., who served as dean of the medical school from 
What did the Yale 
System mean to you? 
We’re preparing an article 
for Yale Medicine on The 
Yale System Through the 
Decades and invite letters, 
thoughts and memories 
from alumni. In particular, 
we would like to explore 
which essential threads of 
Yale’s approach to medical 
education have remained 
unchanged over the years, 
as well as the evolution of 
the tradition from genera¬ 
tion to generation. 
Letters should be brief, no 
more than 250 words, and 
touch on one major facet of 
the Yale System specific to 
the era in which the author 
experienced it as a stu¬ 
dent, faculty member or in 
some other capacity. 
Please send letters to Edi¬ 
tor, Yale Medicine, P.0. Box 
7612, New Haven, CT 
06519-0612 [or via e-mail 
to ymm@yale.edu] and 
include a daytime phone 
number. A representative 
selection of essays will be 
published in a future issue. 
1920 to 1935, Dr. Gifford said, 
“Memorization of a 'mass of 
facts’ was far less important 
than a well-rounded education 
in fundamental principles, 
training in methods of investi¬ 
gation and acquisition of the 
scientific habit of mind.” Bur¬ 
dening the students with a 
heavy curriculum discourages 
independence and initiative and 
leaves little time for electives, 
independent thought or reading 
in the library, Dr. Gifford said. 
Underlying the Yale System 
is the presumption that gradu¬ 
ate students are mature indi¬ 
viduals with a strong motiva¬ 
tion to learn. As a result, 
attendance is not taken at lec¬ 
tures, small group teaching is 
emphasized and there are no 
grades or class rankings. Al¬ 
though examinations remain 
anonymous, a qualifying exam 
must be passed in every course 
and all students must write a 
thesis based on original research 
in order to graduate. According 
to Dr. Gifford, the school still 
adheres to these principles, but 
the number of lectures has 
gradually increased. And honor 
Robert Gifford 
societies such as Alpha Omega Alpha, which recognizes 
only the top students in each class, have somewhat un¬ 
dermined the Yale System’s traditional opposition to 
class rankings, he said. 
The freedom accorded to students brings with it a 
responsibility that is at times ignored, Dr. Gifford said. 
He took students to task for what he described as a 
“cavalier” attitude towards small group seminars which 
depend on student to student interaction. Attendance, 
he said, tends to drop, particularly around the time of 
the second year show in February and national board 
examinations in the spring. 
While most of the faculty support the system, he 
said, a minority “look at it with some derision as a way 
for students to slip by without academic rigor, to be self- 
indulgent, spoiled, entitled to do anything they want.” 
Dr. Gifford also took on the issue of payment of fac¬ 
ulty who assume major teaching burdens. Most faculty, 
those who give lectures or moderate seminars, receive no 
remuneration, and that is appropriate. “But asking 
someone to be a course coordinator, to organize a new 
course, to chair a curriculum committee, to organize and 
run a new course is a very different matter,” Dr. Gifford 
said, “and, in my judgment, should be accompanied by 
partial salary support.” He proposed enlarging an educa¬ 
tional fund so that those who shoulder unusual time 
commitments to teaching can receive a portion of their 
salary for their efforts. 
Noting the curriculum requires attendance at too 
many lectures, Dr. Gifford called for more case-based 
conferences as an alternative. 
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Friday afternoon, we met for a spirited 
gabfest without a formal seminar. 
Friday’s dinner, in what has become a 
tradition, was held at our home. There 
were 32 people in attendance: 
Manhattan’s Claude Bloch; Maureen 
and Hal Bornstein, the hosts; Jeanne 
and Remi Cadoret, who always arrive 
from Iowa; Joan and AI Chetrick, now 
residing in Branford, Conn.; 
Phildelphian Rex Conn; Lou Del 
Guercio ot Larchmont, N.Y.; Fielen 
and Don Etzwiler from Minnesota; de¬ 
pendable Betty and Tom Gentsch from 
the mountains of North Carolina; 
Robin and Bob Hamlisch from Ithaca 
with their delightful son, Eliot; Barbara 
and Dave Holman, our travel champs 
from San Francisco; Carol and Fred 
Lane of New York City; Hyla and Bob 
Melnick, regulars also from 
Larchmont; New Jerseyites Betty Th¬ 
ompson and Harvey Peck; Joann and 
Wick Potter, who tooled down from 
Wellesley, Mass.; Barbara and Irv 
Rosenberg of Maine; Manhattanite 
Ora Smith; and Mary Lou and Fred 
Young from Lancaster, Pa. Maureen’s 
dinner was superb, Hyla contributed 
delicious cookies, and conversation 
never ceased. 
Our Saturday dinner was at the elegant 
Quinnipiack Club with cocktails and 
picture-taking in the library, followed 
by an excellent meal in the Board of 
Governors Room. Though the Del 
Guercios and the Lanes had to leave, 
we added Andrea and Seth Abramson 
from New York City and Howie Smith 
joined the rest of us. After dinner each 
attendee shared autobiographical com¬ 
ments with the assemblage. We had 
communications from Claude Ander¬ 
son, Bill Chaffee, Jack Doppman, 
Doe Dunn, Jack Durell, Irv Goldberg, 
Al Keroack, Dick Knowles (who had 
planned to come), Bob Nolan, Rhoda 
and Ed Powsner (who also had hoped 
to attend), Paul Quie, Jose Ramirez 
Rivera, (normally a regular). Matt 
Tandysh, and Bill Vandervort. We 
look forward to an even larger gather¬ 
ing for our 50th in 2003. 
1958 
Michael Kashgarian 
The 40th reunion of the Class of 1958 
was an outstanding event. Some 26 
members of our class attended, nearly 
50 percent of those remaining from our 
class, which started out as 80 in the 
year we entered and was 72 in the year 
we graduated. 
The reunion was a special one in many 
ways. The principal Saturday morning 
event was a symposium honoring John 
Punnett Peters. Our class was the last to 
have had contact with him as a teacher 
and it was fitting that the symposium 
was organized and moderated by Jerry 
Burrow and Mike Kashgariau. Jerry 
retired from the deanship last year and 
was the recipient of this year’s Distin¬ 
guished Alumni Service Award. After 
the morning formalities, the bridge 
Mafia of Hartmann, Kislak, Muggia 
and Schlaepfer retired to their ongoing 
series of bridge contests. Most of the 
rest of us boarded a bus loaded with box 
lunches and beverages and headed off to 
Mystic Marinelife Aquarium where 
aquarium trustee Burrow and staff 
took us behind the scenes of the opera¬ 
tion and provided us with some close 
contact with bottlenose dolphins and 
beluga whales. The ability of these sea 
mammals to entertain us was such that 
we all felt they should be made honor¬ 
ary members of our class. Upon return 
to New Haven, we reassembled at the 
New Haven Lawn Club for our class 
dinner which was attended by George 
Aghajanian, Don Amren, John Arnot, 
Gerard Burrow, John Creatura, 
Robert Donohue, Lawrence Dubin, 
Donald Duncan, Raymond Gaito, 
Ernest Hartmann, Michael 
Kashgarian, Jay Kislak, Marcia Kraft, 
Myron Lotz, Jack Love, William 
McClanahan, Andrew McGowan, 
Frank McKegney, Thomas Mauro, 
Richard Miller, Albert Muggia, Rob¬ 
ert Neuwirth, Carol Phillips, William 
Schlaepfer, John Wood and Pauline 
Wood. Also present in spirit but not in 
person were Bill Radcliffe, Paul 
Rudnick and Ray Turner, all of whom 
had written with good excuses for their 
absence. 
The dinner ended with unveiling of the 
architectural plans of the Class of 1958 
fitness center, which is part of the on¬ 
going renovations of Harkness Dormi¬ 
tory, of which our class was among the 
first inhabitants. 
1963 
Jon Michael Fessel 
The 35th reunion began where the 30th 
ended, with a discussion of the Yale 
System. Deputy Dean Robert Gifford, 
delivered an amusing and thoroughly 
reassuring discussion of the current 
health of the system. The Dean’s recep- 
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At EPH reunion, a global perspective 
Public health has become a global affair, John Ashton, 
M.D., told alumni of Epidemiology and Public 
Health who gathered for their annual reunion on 
June 5. Today’s pressing issues—HIV and AIDS, drugs, food 
technology, genetic engineering—know no boundaries, said 
Dr. Ashton, the keynote speaker for the reunion. Although 
he is regional director of public health in Liverpool, En¬ 
gland, Dr. Ashton said he felt like a “virtual alumnus” of 
Yale, because of his work over the past decade with Lowell 
Levin, M.P.H., ’60, D.Ed., who retired this year. 
Dr. Ashton made his reference to Dr. Levin during his 
talk, Health Threats to Urban Life; Is It Too Late to Save Our 
Children? “We need a public health response which is a glo¬ 
bal public health response,” Dr. Ashton said, contrasting 
the present with the past. “The cities of 150 years ago could 
quite happily think of themselves as self-contained. We are 
now at the point where the majority of the world’s people 
will be living in large cities and towns. Most babies are be¬ 
ing born into large towns and cities for the first time.” In¬ 
creased speed of travel and the increased urbanization of the 
planet often divorce health issues front their local origins 
and deny public health workers local solutions, he said. 
Public Health Dean Michael Merson, M.D., addresses alumni 
at a luncheon. 
Lowell Levin receives a toast from colleagues 
and alumni to honor him at his retirement. 
He noted a danger in the concentration in cities of large 
numbers of young men with no stake in their communities. 
“The events in Jakarta over the last two weeks are the tip of 
an iceberg which we have yet to see,” he said, referring to ri¬ 
ots in Indonesia in May. “Is it too late to save the cities? In 
many ways that is the wrong question. The fate of our cities 
is indivisible from the fate of the planet.” 
Many of those at the reunion had come to bid farewell to 
Dr. Levin, who started teaching public health at Yale in 1963 
and plans to continue teaching part-time in his retirement. 
“It’s unfortunate that it takes Lowell threatening to leave 
that brings us all together,” Dean Michael H. Merson, M.D., 
joked before turning reflective. “We would never want 
Lowell to leave us. He will be a major part of our school for 
many years, even though he claims to be retiring.” 
Friends and colleagues took turns telling tales about 
Dr. Levin at a Lriday evening roast under a tent on the lawn 
in front of the EPH building. Dr. Merson described Dr. 
Levin’s unorthodox approach to founding the school’s inter¬ 
national division. “There is no record of this division ever 
being created,” the dean joked, noting that he can find no 
memos, no paperwork, nothing to trace the division’s his¬ 
tory. Mr. Levin simply created it, he said. “Lowell just took 
advantage of people being out of town and on sabbatical.” 
About 200 people came to the roast and reunion. 
“Maybe this time you’ve come to see if he’s really going to 
do what he keeps threatening to do—say bye-bye to Yale,” 
Joel Kavet, M.P.H. ’67, master of ceremonies, told the 
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Samuel Korper, M.P.H. '69, was honored as this 
year's distinguished alumnus. 
crowd. “We risk the prospect of turning Lowell Levin loose 
on an unsuspecting world.” 
Friday morning, alumni attended a series of seminars on 
a variety of public health issues, including HIV/AIDS, ur¬ 
ban health, alcohol and asthma. In the afternoon, alumni 
panels described their experiences and discussed the rel¬ 
evance of programs to public health practice. 
For many alumni, the reunion was more than a coming 
together of former classmates—many had crossed paths in 
their professional lives. “It’s striking,” said David A. Kessler, 
M.D., dean of the medical school, at a Friday afternoon 
luncheon for EPH alumni. “There are so many ol you that 
I know and have grown up with.” 
Dr. Kessler singled out one alumnus who served as his 
mentor in Washington in the 1980s: Samuel P. Korper, 
MPFi ’69, Ph.D. ’76, was honored as this year’s distin¬ 
guished alumnus. “I decided, on a volunteer basis,” Dr. 
Kessler recalled, “to spend some time on the Hill. I walked 
in in 1981 and I knew nothing. I had no idea ol how that 
town worked.” Working as an unpaid aide to the Senate’s 
labor and human resources committee, Dr. Kessler was as¬ 
signed to reauthorize three programs. “I had no idea what 
to do. It was at that time I was fortunate enough to meet 
Sam.” Dr. Kessler, of course, went on to become commis¬ 
sioner of the Food and Drug Administration. “I could not 
have been in a position to contribute and function in that 
town had I not been trained by Sam Korper. He has shown 
throughout his career such tremendous dedication to im¬ 
proving the health of our country.” 
Dr. Korper started his career as a Peace Corps volunteer 
in Nyasaland in central Africa. By the time he and Dr. 
Kessler met, Dr. Korper had been in Washington for about 
three years. Dr. Korper worked at the Department of 
Health and Human Services and the National Institutes of 
Health, where he was director of the division of legislative 
analysis. He now serves as senior advisor to the Substance 
Abuse and Mental Health Services Administration. 
In his talk to alumni. Dr. Korper offered a mixed view 
of the state of public health in this country. Too lew gradu¬ 
ates are seeking long-term careers in the public health, he 
lamented. On the other hand, he added, “the opportunities 
in public health, in both the public and private sectors, 
from the molecular to the global, are truly breathtaking.” 
The ethos of public health, he noted, includes public 
service, usefulness and altruism. It is, he said, “a profession 
that has an incredible array of critically important 
responsibilities.” 
Karl Smith, M.P.H. '65, chats with 
Max Pepper, M.P.H. '59, during the 
reunion of public health alumni. 
Surgical society meets during reunion 
The Yale Surgical Society held its third annua! spring alumni re¬ 
union in conjunction with the medical school reunions. The June 
4 and 5 gathering included the second C. Elton Cahow Memorial 
Lecture given by Arnold Diethelm as part of the Grand Rounds 
schedule. All except emergency activities of the Department of 
Surgery were suspended on Friday, June 5, to permit attendings, 
house officers and medical students to participate in the day’s 
events. These included papers honoring William Glenn, M.D., 
Charles Ohse Professor Emeritus of Surgery, and John Kirschner, 
M.D., past chairs of cardiothoracic and ear, nose and throat sur¬ 
gery respectively, and general papers and reports encompassing 
the entire department. 
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tion, which followed, gave us an oppor¬ 
tunity to renew acquaintances with 
old faculty friends including Howard 
Levitin and Arthur Ebbert. After a 
Saturday of varied activities, we con¬ 
vened in the Captain's Room at Mory’s 
for a collegial dinner and conversation. 
Attending the dinner were Arthur and 
Carol Ackerman, David and Cheryl 
Cross, Michael and Kathy Fessel, 
David and Carol Fulmer, Alex and 
Chris Gaudio, Craig Llewellyn, 
Jay and Farida Pomerantz, and 
Helen Walsh. 
1968 
Donald O. Lyman 
Eight classmates gathered in New Ha¬ 
ven for the 30th reunion of the Class of 
1968. These included Grace and Larry 
Boxer, Alan Finesilver, Richard and 
Paula Getnick, Peter and Linda Jokl, 
J. Allen and Emily McCutchan, 
Charles and Bonnie Post, Joseph and 
Rosemary Renda and Bruce and Lynn 
Wenger. Sounds like things are pretty 
much status quo for most of us. Peter 
Jokl is now vice-chair of orthopaedic 
surgery at Yale, Chuck Post is a pilot 
flying here and there around the coun¬ 
try, while Bruce Wenger and his wife 
still do body-heat related research for 
the Army in Massachusetts. Frank 
Lucente is now vice president of the 
American Academy of Otolaryngol¬ 
ogy—Head and Neck Surgery and 
vice dean for graduate medical educa¬ 
tion at SUNY Brooklyn in addition to 
his ongoing ENT responsibilities. 
Meanwhile on the West Coast, Gordon 
and Joanne Sasaki and Donald and 
Betsey Lyman joined the wedding 
celebration for Harmon and Edie 
Michelson’s daughter Abby in Napa, 
Calif. We mourn the death of Kevin 
Hennessey of colon cancer. 
1973 
Thomas F. Sweeney 
A small but enthusiastic group from the 
Class of 1973 gathered to celebrate our 
25th reunion. The weekend began with 
a seafood feast held under a huge tent 
70 
implanted in the Harkness lawn. The 
food was great, and renewing acquain¬ 
tances was even better. Mary and Victor 
Pappoe were proud to announce that 
they have a daughter presently at the 
medical school. Rick Boland, and Kip 
and Maureen Doran all showed up 
looking younger than they did in 1973. 
They also showed us pictures of lots of 
beautiful daughters. Chris Kull Walsh 
dragged poor Shawn to yet another re¬ 
union. 
Also up to their elbows in lobsters were 
Lee Goldman, Barbara and Marvin 
Chassin, Lynne Liptay, Jane Ferguson, 
and Sue and Harold Mancusi-Ungaro. 
It was great to have this time to chat 
after not seeing many for 25 years. Later 
we sipped champagne at the top of 
New Haven’s new Omni Hotel. Harold 
suggested the bubbly and his taste has 
gotten more expensive since he became 
a plastic surgeon. 
On Saturday people went off on various 
tours and seminars, all except for Lee 
Goldman who claimed he shot in the 
low 80s at the Yale Golf Course. Oh, 
and also Joe Simeone, who promised to 
come to the Saturday dinner if he could 
come to my two boys’ baseball games 
that afternoon. He, along with my wife 
Anne and 1 cheered them both on suc¬ 
cessfully. Joe’s Anne was left home pre¬ 
paring for their son’s high school gradu¬ 
ation on Sunday. 
Karen and Rob Sirota, Sandy and 
George Lister, Rita and Jim Sullivan, 
Carole Stashwick, Laura, Eli and Jerry 
Nagler, Rich and Dotty Young, joined 
all of the above at the Graduate Club 
for our class reunion dinner. Dean 
Kessler stopped by and said hello. Many 
photos and lots of stories were ex¬ 
changed. We partied to the wee hours 
and then the first 25 years were com¬ 
plete. Make your reservations early for 
the 30th. 
1978 
Seth M. Powsner 
Managed care and missing classmates 
were roundly criticized during a select 
seminar Friday and Saturday, June 5 and 
6. Duke Cameron, John Wagner and 
Seth Powsner presented themselves 
Friday evening outside Harkness Hall. 
There was much catching up and 
cholesterol. Saturday, John and Duke 
had to head home, but Eric Einstein, 
Linda Hall, Marcia Wade, and Steve 
Schick joined us for a dinner session at 
the Graduate Club on Elm Street across 
from New Haven's Green. For those of 
you who did not demonstrate a suitable 
mastery of the material, a make-up 
session is scheduled for June 2003. 
1983 
Judy Melin 
One ... singular sensation, Yale Medi¬ 
cal Class of 1983 ... Fifteen years later, 
and it still feels like just yesterday we 
were together for the first time in the 
Beaumont Room for our introduction 
to med school, to the Yale System and 
to each other. And then fast forward 
through the first anatomy lab, our first 
encounter with a patient, our unsur¬ 
passed second year show, boards part I, 
clerkships, subinternships, boards part 
II, our theses, our fourth year show and 
then goodbye for five, then 10, and 
now ... 15 years! 
Attending our 15th YSM reunion were 
Elena Citkowitz, M.D. (head of the 
cardiac rehabilitation and lipid pro¬ 
grams and teaching attending at the 
Hospital of Saint Raphael, New Ha¬ 
ven); Rob Homer, M.D. (pathology 
faculty, Yale); Don Johns, M.D., (neu- 
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Yale scientists offer glimpse of cutting edge research 
U \ K I e are in the midst of one of the great 
1/ revolutions in the history of medicine,” 
w V Richard P. Lilton, M.D., Ph.D., told 
medical school alumni during the reunion weekend, 
referring to progress in charting the human genome. 
Dr. Lifton, professor of medicine, genetics and 
molecular biophysics and biochemistry, was one of 
three faculty researchers who highlighted their work to 
alumni. Joining him were Carolyn Mazure, Ph.D., 
professor of psychiatry and director of the Donaghue 
Women’s Health Investigator Program at Yale; and 
Eric J. Nestler, M.D., Ph.D., director of the molecular 
psychiatry program. Dr. Nestler studies genetic and 
biomedical links to addiction. 
Dr. Lifton searches for genetic causes of diseases 
such as hypertension. Underlying the medical revolution 
he described are tools that include genetic maps of hu¬ 
man chromosomes and the development of complete 
physical maps of the genome. 
“With these tools we can begin to unravel the source 
of those diseases,” Dr. Lifton said. “Ultimately it gives us 
some insight to develop new strategies to treat those dis¬ 
orders.” He cited a family in which high blood pressure 
was identified in 23 members and was subsequently 
linked to a single gene, one of 10 genes he and members 
of his team have isolated that regulate blood pressure. 
After more than five years of exciting progress in this 
work, his lab is poised to apply the knowledge to more 
common forms of the disease affecting at least 50 million 
people in this country alone. “We can offer them spe¬ 
cific treatment tailored to the genetic abnormality,” Dr. 
Lifton said. “This has really accelerated the pace of bio¬ 
medical research. We can apply those tools coming out 
of the Human Genome Project to the investigation of 
disorders such as hypertension.” 
Women, noted Dr. Mazure, live about six years 
longer than men on average but spend more time in the 
hospital. “We do need to know more about how to keep 
women healthy,” she said. “We need more data for un¬ 
derstanding and treating the disorders which women 
present.” 
Although federal regulations require the inclusion of 
women in federally-funded research projects, that was 
not always the case. “The assumption frequently was 
made that treatment and procedures which were devel¬ 
oped for men also worked for women,” said Dr. Mazure. 
“We now have a growing body of significant data to 
cause us to revisit those assumptions.” 
Dr. Nestler’s laboratory, in a study of gene expres¬ 
sion using transgenic mice, has found that turning on 
certain genes recreates biochemical and behavioral 
changes characteristic of addiction. Dr. Nestler is trying 
to understand lasting effects of addiction on the brain. 
Scientists believe these changes are regulated by gene ex¬ 
pression in neurons in areas of the brain known as the 
mesolimbic dopamine system. 
“We can examine an animal,” said Dr. Nestler, 
“study molecular changes in specific brain regions, dem¬ 
onstrate that those changes are important for the behav¬ 
ior of addiction in our animal models, and then use that 
information to come up with ways to perturb that sys¬ 
tem in people.” This information is critical to the under¬ 
standing of relapse and recurring addictive behavior, and 
may very likely provide the basis for new treatments for 
addiction in the next five to 10 years. 
Former dean recognized 
for alumni service 
achievements as a bio¬ 
medical investigator and 
authority on thyroid dis¬ 
ease. Dr. Burrow now 
serves on the faculty and 
as a special advisor to Yale 
President Richard C. Levin. 
Dr. Kashgarian also noted 
that Dr. Burrow had a vari¬ 
ety of interests outside of 
medicine, including, to the 
delight of the audience, 
the attainment of a black 
belt in judo. “You have 
demonstrated you are not a 
one-dimensional man,” Dr. 
Kashgarian said. 
Gerard N. Burrow, M.D. ’58, 
the School of Medicine’s 
14th dean, received this 
year’s Distinguished Alumni 
Service Award at reunion. 
“I am proud to acknowl¬ 
edge your many contribu¬ 
tions to the medical 
school,” said classmate 
Michael Kashgarian, M.D. 
’58, in presenting the 
award. “You have worked to 
preserve the Yale System 
of medical education in 
this chaotic period of 
change in the delivery of 
health care.” The AYAM 
cited Dr. Burrow’s service 
as dean from 1992 to 1997, 
his dedication as a mentor 
to students and his 
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rology faculty, Beth Israel Deaconess/ 
Harvard); Lois Morton, M.D. (psy¬ 
chiatry, Greenwich, Conn.) with hus¬ 
band Tony Alieva and son Christopher; 
David Norton, M.D. (pediatric prac¬ 
tice and teaching, Baystate Medical 
Center, Massachusetts) with Claire 
Norton; Dan Oren, M.D. (psychiatry 
(acuity, Yale); Alan Reznik, M.D. (or¬ 
thopedics/sports medicine, Greater 
New Haven, and recent MBA, Univer¬ 
sity of New Haven) with Liz Reznik; 
Michael Tom, M.D. (ear, nose and 
throat, Westchester County, N.Y.) with 
Linda Tom. And participating via re¬ 
mote (portable telephone, courtesy of 
Mory’s) due to a spring flu was Judy 
Melin, M.D. (internal medicine, Lahey 
Clinic, and clinical faculty. Harvard 
Medical School). 
Other classmates heard from, or at least 
about, recently (with hopefully recent 
location info) include Peter Blier, 
M.D., (pediatrics, Western Massachu¬ 
setts); April Chang-Miller, M.D. 
(rheumatology, Mayo Clinic, Roches¬ 
ter); Michael Choti, M.D., (Johns 
Hopkins); Tammy Harris, M.D., (fam¬ 
ily practice, Southboro, Mass.); David 
Helfgott, M.D., (internal medicine, in¬ 
fectious diseases, New York City); 
Elizabeth Nolan, M.D., (software de- 
veloper/ER game, writer); Harlan 
Pinto, M.D., (medical oncology fac¬ 
ulty, Stanford); Susan Seward, M.D. 
(internal medicine, MGH, and faculty, 
Harvard Medical School); Daniel 
Sosin, M.D., (Centers for Disease 
Control, Atlanta); Nancy Terrell, 
M.D., (internal medicine clinical fac¬ 
ulty, Columbia Presbyterian, New York 
City). You, too, may see your name in 
print if you write to Judith.A.Melin@ 
Lahey.org. or Judy Melin, M.D., Medi¬ 
cal Director, Managed Care, Lahey 
Clinic, Burlington, MA 01805. 
We owe a special thanks to David 
Helfgott, M.D., co-reunion coordina¬ 
tor, William Jenkins, managing director 
of Office of Alumni Affairs, who 
oversees the entire event; Sharon 
McManus, who arranged all the details 
to make our reunion a success; and 
Claire Bessinger of Yale Medicine. 
Hope to see us all together at our 
20th reunion in 2003! 
1988 
Michael Rigsby 
Nearly 20 members of the Class of 1988 
gathered in New Haven for our 10th 
reunion. For many of us, it was the 
first time we had seen each other 
since graduation, so there was a lot of 
catching up to do. Our class family is 
definitely growing. Kathleen Carney- 
Godley and Lisa Murphy both had 
children with them. (The dean offered 
Lisa’s io-year-old son a spot in the 
class of 2015.) Many others had stories 
and pictures of their youngsters. Find¬ 
ing ways to balance the demands of 
family and career seemed to be high 
on the minds of many like Joi Barrett, 
who shares a primary care practice 
with another medical mom in the 
Sacramento area. 
Re-exploring old haunts in and around 
New Haven occupied much of the 
weekend for some out-of-towners. 
Peter Merkel and Laura Dember, both 
faculty members at Boston University, 
spent much of Saturday morning reac¬ 
quainting themselves with Hope no, 
where they attended the John Peters 
symposium. In case you didn’t know, 
Laura and Peter are married and re¬ 
cently bought a home in Newton. 
Nicole Davis and Alex Vukasin are an¬ 
other married couple from within our 
class ranks. Nicole and Alex live and 
practice (gynecology and urology, re¬ 
spectively) in Princeton, N.J., and occa¬ 
sionally manage to operate together. 
Now there’s a creative way of solving 
the problem of two-career families! 
Many of our classmates have remained 
in the Northeast. Lance Markbreiter 
practices orthopedic surgery near the 
Jersey shore; Rhonda Karol has a solo 
dermatology practice on Long Island 
and Robert Kim has only gone as far as 
Fairfield County, Conn. Martha 
Brochin, Leslie Jacobsen, Michael 
DiGiovanni and I all remain in the 
New Haven area. Martha has a pediat¬ 
ric practice and two children of her 
own while the rest of us are all on the 
full time faculty at Yale. 
We also heard some recent bulletins 
from class members who could not at¬ 
tend the reunion. Sue Valley wrote to 
say that she couldn't attend because of a 
family wedding, but that she still has 
her costume from the second year show 
and will wear it to our 15th. Steven 
Dobscha couldn’t attend because he’s 
busy moving himself and his family 
back to the West Coast (Oregon) after 
several years in Massachusetts. Joi 
Barrett brought pictures from a visit 
with Peggy Liao and Terry Yee at their 
home in Hawaii. Looks idyllic! 
Also sighted at the clambake (which I 
could not attend) were Steve Slovic 
and his family. My apologies and best 
wishes to Steve and any others in town 
for the weekend whom I was not able 
to speak with for this report. Hope to 
see you all again at the next reunion. 
Thanks to all who attended for helping 
to make this a memorable weekend. 
1993 
Michael Kaiser and Lisa Kotler 
Five years after graduation, members of 
the Class of 1993 are seeking fellow¬ 
ships, completing their residencies or 
making the transition to attending phy¬ 
sicians, obligations that kept many 
away from the reunion. Five members 
of the class met in New Haven for an 
off-campus reunion. Michael Kaiser is 
training in neurosurgery at Columbia- 
Presbyterian Medical Center in New 
York; Dave Tendler is at Beth Israel 
Hospital in Boston; Stephen Solomon 
is at Johns Hopkins; Myles Greenberg 
is an emergency room attending at Beth 
Israel; and Ed Weaver is a resident at 
Yale-New Haven Hospital. Lisa Kotler, 
a child psychiatry research fellow in eat¬ 
ing disorders at Columbia-Presbyterian 
Medical Center in New York City, at¬ 
tended the reunion with her husband, 
Howard Shafer, who is an attorney. 
Also attending were Stephen 
Marshalko, a resident in internal medi¬ 
cine at Yale-New Haven Hospital, and 
his wife, Lisa Amerino-Marshalko, 
M.P.H. ’91. 
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Continuing Medical 
Education at Yale 
Ongoing 
1998 
Jan. 22-23 
Friday-Saturday 
Jan. 22-24 
Friday-Sunday 
Feb. 26-27 
Friday-Saturday 
March 6 
Saturday 
March 12-13 
Friday-Saturday 
Pain Management Programs 
Course Director: Lloyd Saberski, M.D. 
Individually tailored tutorials for physicians in the clinical management of pain. 
Center for Pain Management, 40 Temple St., New Haven 
Workshop on Positron Coincidence Imaging 
Course Directors: Chin Ng, Ph.D. and Holly Dey, M.D. 
New Haven Hotel, New Haven 
Anesthesia Conference 
Course Directors: Ed Delgado, M.D. and Raymond Sinatra, M.D. 
Technological and Pharmaceutical information regarding patient care. 
Stratton Mountain, Vt. 
Workshop on Positron Coincidence Imaging 
Course Directors: Chin Ng, Ph.D. and Holly Dey, M.D. 
New Haven Hotel 
New Diagnostic Therapeutic and Assessment 
Approaches to Epilepsy in Children and Adults 
Course Director: Susan Spencer, M.D. 
Foxwoods, Ledyard, Conn. 
B 
Autism 
Course Director: Fred Volkmar, 
Omni Hotel, New Haven 
I.D. 
For information, contact the Office of Postgraduate and Continuing Education, Yale University School of 
Medicine, 333 Cedar Street, P.O. Box 208052, New Haven, CT 06520-8052; Tel: (203) 785-4578 
Yale Medicine 
P.O. Box 7612 
New Haven, CT 06519-0612 
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Flag the 
programs 
you want; 
travel and 
learn with 
Yale Faculty 
Use the reply form 
in the Passport, 
listing over 40 
AYA Educational 
Programs. 
Get it by calling 
1-800-456-9253 
Ancient Coast of Turkey 
May 6-19, 1999 
London Theater Seminar 
May 13-20, 1999 
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